PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Rusconi, E; Gonzaga, M; Adriani, M; Braun, C; Haggard, P				Rusconi, Elena; Gonzaga, Mirandola; Adriani, Michela; Braun, Christoph; Haggard, Patrick			Know Thyself: Behavioral Evidence for a Structural Representation of the Human Body	PLOS ONE			English	Article							PARIETAL CORTEX; PARTS; AGNOSIA; MEMORY; SIZE	Background: Representing one's own body is often viewed as a basic form of self-awareness. However, little is known about structural representations of the body in the brain. Methods and Findings: We developed an inter-manual version of the classical "in-between'' finger gnosis task: participants judged whether the number of untouched fingers between two touched fingers was the same on both hands, or different. We thereby dissociated structural knowledge about fingers, specifying their order and relative position within a hand, from tactile sensory codes. Judgments following stimulation on homologous fingers were consistently more accurate than trials with no or partial homology. Further experiments showed that structural representations are more enduring than purely sensory codes, are used even when number of fingers is irrelevant to the task, and moreover involve an allocentric representation of finger order, independent of hand posture. Conclusions: Our results suggest the existence of an allocentric representation of body structure at higher stages of the somatosensory processing pathway, in addition to primary sensory representation.			Rusconi, E (corresponding author), UCL, Inst Cognit Neurosci, London, England.	p.haggard@ucl.ac.uk	Braun, Christoph/E-4561-2010; Braun, Christoph/J-4160-2014; Haggard, Patrick/A-5081-2010	Braun, Christoph/0000-0002-7836-4010; Braun, Christoph/0000-0002-7836-4010; Haggard, Patrick/0000-0001-7798-793X				Azanon E, 2008, CURR BIOL, V18, P1044, DOI 10.1016/j.cub.2008.06.045; BENEDETTI F, 1985, J EXP PSYCHOL HUMAN, V11, P517, DOI 10.1037/0096-1523.11.4.517; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Buxbaum LJ, 2001, COGNITIVE NEUROPSYCH, V18, P289, DOI 10.1080/02643290126172; Corradi-Dell'Acqua C, 2008, CEREB CORTEX, V18, P2879, DOI 10.1093/cercor/bhn046; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Fitzgerald PJ, 2006, J NEUROSCI, V26, P6485, DOI 10.1523/JNEUROSCI.5061-05.2006; Gainotti G, 1972, Cortex, V8, P364; GALLACE A, 2008, EXP BRAIN R IN PRESS; Gallace A, 2008, BRAIN RES, V1190, P132, DOI 10.1016/j.brainres.2007.11.014; Gallace A, 2008, PERCEPTION, V37, P782, DOI 10.1068/p5767; Gerstmann J, 1940, ARCH NEURO PSYCHIATR, V44, P398, DOI 10.1001/archneurpsyc.1940.02280080158009; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Guariglia C, 2002, NEUROPSYCHOLOGIA, V40, P1744, DOI 10.1016/S0028-3932(02)00013-1; Harris JA, 2002, J NEUROSCI, V22, P8720; Harris JA, 2001, J NEUROSCI, V21, P8262, DOI 10.1523/JNEUROSCI.21-20-08262.2001; IRIKI A, 2008, PHILOS T R SOC B, V27, P2229; KINSBOURNE M, 1962, BRAIN, V85, P47, DOI 10.1093/brain/85.1.47; Mayer E, 1999, BRAIN, V122, P1107, DOI 10.1093/brain/122.6.1107; OGDEN JA, 1985, BRAIN, V108, P1009, DOI 10.1093/brain/108.4.1009; Poeck K, 1971, Cortex, V7, P254; Rusconi E, 2005, NEUROPSYCHOLOGIA, V43, P1609, DOI 10.1016/j.neuropsychologia.2005.01.009; Rushworth MFS, 1997, EXP BRAIN RES, V117, P311, DOI 10.1007/s002210050225; SEMENZA C, 1985, NEUROPSYCHOLOGIA, V23, P161, DOI 10.1016/0028-3932(85)90101-0; SIRIGU A, 1991, BRAIN, V114, P629, DOI 10.1093/brain/114.1.629; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Taylor-Clarke M, 2004, NAT NEUROSCI, V7, P219, DOI 10.1038/nn1199; Tucha O, 1997, J NEUROL NEUROSUR PS, V63, P399, DOI 10.1136/jnnp.63.3.399	28	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5418	10.1371/journal.pone.0005418	http://dx.doi.org/10.1371/journal.pone.0005418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	440GG	19412538	Green Published, gold, Green Submitted			2022-12-27	WOS:000265688200006
J	Trumbower, RD; Krutky, MA; Yang, BS; Perreault, EJ				Trumbower, Randy D.; Krutky, Matthew A.; Yang, Bing-Shiang; Perreault, Eric J.			Use of Self-Selected Postures to Regulate Multi-Joint Stiffness During Unconstrained Tasks	PLOS ONE			English	Article							HUMAN ANKLE STIFFNESS; SYSTEM-IDENTIFICATION; REFLEX CONTRIBUTIONS; ARM STIFFNESS; SHORT-LATENCY; STABILITY; DYNAMICS; ADAPTATION; VARIABILITY; MODULATION	Backgound: The human motor system is highly redundant, having more kinematic degrees of freedom than necessary to complete a given task. Understanding how kinematic redundancies are utilized in different tasks remains a fundamental question in motor control. One possibility is that they can be used to tune the mechanical properties of a limb to the specific requirements of a task. For example, many tasks such as tool usage compromise arm stability along specific directions. These tasks only can be completed if the nervous system adapts the mechanical properties of the arm such that the arm, coupled to the tool, remains stable. The purpose of this study was to determine if posture selection is a critical component of endpoint stiffness regulation during unconstrained tasks. Methodology/Principal Findings: Three-dimensional (3D) estimates of endpoint stiffness were used to quantify limb mechanics. Most previous studies examining endpoint stiffness adaptation were completed in 2D using constrained postures to maintain a non-redundant mapping between joint angles and hand location. Our hypothesis was that during unconstrained conditions, subjects would select arm postures that matched endpoint stiffness to the functional requirements of the task. The hypothesis was tested during endpoint tracking tasks in which subjects interacted with unstable haptic environments, simulated using a 3D robotic manipulator. We found that arm posture had a significant effect on endpoint tracking accuracy and that subjects selected postures that improved tracking performance. For environments in which arm posture had a large effect on tracking accuracy, the self-selected postures oriented the direction of maximal endpoint stiffness towards the direction of the unstable haptic environment. Conclusions/Significance: These results demonstrate how changes in arm posture can have a dramatic effect on task performance and suggest that postural selection is a fundamental mechanism by which kinematic redundancies can be exploited to regulate arm stiffness in unconstrained tasks.			Trumbower, RD (corresponding author), Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA.	e-perreault@northwestern.edu	Trumbower, Randy/C-1334-2016; Perreault, Eric/B-7632-2009; Trumbower, Randy/O-1321-2019	Trumbower, Randy/0000-0002-2282-9974	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007418] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K25HD044720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053813] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD007418, K25 HD044720] Funding Source: Medline; NINDS NIH HHS [NS053813, R01 NS053813] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLUM JHJ, 1982, EXP BRAIN RES, V48, P153; Bendat J.S., 2000, RANDOM DATA ANAL MEA; Biess A, 2007, J NEUROSCI, V27, P13045, DOI 10.1523/JNEUROSCI.4334-06.2007; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Cohen RG, 2009, EXP BRAIN RES, V193, P69, DOI 10.1007/s00221-008-1596-1; Darainy M, 2004, J NEUROPHYSIOL, V92, P3344, DOI 10.1152/jn.00596.2004; de Vlugt E, 2002, BIOL CYBERN, V87, P10, DOI 10.1007/s00422-002-0311-8; DIETZ V, 1994, ELECTROEN CLIN NEURO, V93, P49, DOI 10.1016/0168-5597(94)90091-4; DOEMGES F, 1992, J PHYSIOL-LONDON, V447, P575, DOI 10.1113/jphysiol.1992.sp019019; FLASH T, 1990, EXP BRAIN RES, V82, P315; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin DW, 2004, J NEUROPHYSIOL, V92, P3097, DOI 10.1152/jn.00364.2004; Franklin DW, 2003, EXP BRAIN RES, V152, P211, DOI 10.1007/s00221-003-1540-3; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; Gomi H, 1998, J NEUROSCI, V18, P8965; Gribble PL, 2003, J NEUROPHYSIOL, V89, P2396, DOI 10.1152/jn.01020.2002; HOGAN N, 1985, BIOL CYBERN, V52, P315, DOI 10.1007/BF00355754; Kearney RE, 1997, IEEE T BIO-MED ENG, V44, P493, DOI 10.1109/10.581944; KEARNEY RE, 1990, CLIN BIOMECH, V5, P205, DOI 10.1016/0268-0033(90)90004-P; Kimura T, 2006, J NEUROSCI, V26, P9272, DOI 10.1523/JNEUROSCI.3886-05.2006; Lenarcic J, 1999, LAB ROBOTICS AUTOMAT, V11, P272, DOI 10.1002/(SICI)1098-2728(1999)11:5<272::AID-LRA5>3.0.CO;2-L; Linde Van der RQ, 2002, HAPTICMASTER NEW HIG, P1; Ljung L., 1999, SYSTEM IDENTIFICATIO; MILNER TE, 1993, EXP BRAIN RES, V94, P522; Milner TE, 2002, EXP BRAIN RES, V143, P406, DOI 10.1007/s00221-002-1001-4; Mirbagheri MM, 2000, EXP BRAIN RES, V135, P423, DOI 10.1007/s002210000534; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; Perreault EJ, 2000, IEEE ENG MED BIOL, V19, P53, DOI 10.1109/51.887246; Perreault EJ, 1999, BIOL CYBERN, V80, P327, DOI 10.1007/s004220050529; Perreault EJ, 2004, EXP BRAIN RES, V157, P507, DOI 10.1007/s00221-004-1864-7; Perreault EJ, 2001, EXP BRAIN RES, V141, P312, DOI 10.1007/s002210100880; Perreault EJ, 2008, J NEUROPHYSIOL, V99, P2101, DOI 10.1152/jn.01094.2007; Politis DN, 1998, IEEE SIGNAL PROC MAG, V15, P39, DOI 10.1109/79.647042; PRESS W, 1992, NUMERICAN RECIPES C; R Core Team, 2018, R LANG ENV STAT COMP; Rancourt D, 2001, J MOTOR BEHAV, V33, P351, DOI 10.1080/00222890109601919; Rancourt D, 2001, J MOTOR BEHAV, V33, P193, DOI 10.1080/00222890109603150; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schouten AC, 2001, BIOL CYBERN, V84, P143, DOI 10.1007/s004220000202; Sciavicco L., 2000, MODELLING CONTROL RO, Vsecond; SINKJAER T, 1988, J NEUROPHYSIOL, V60, P1110, DOI 10.1152/jn.1988.60.3.1110; SOECHTING JF, 1995, J NEUROSCI, V15, P6271; TSUJI T, 1995, BIOL CYBERN, V72, P475, DOI 10.1007/BF00199890; Winter D, 2005, BIOMECHANICS MOTOR C	44	58	59	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5411	10.1371/journal.pone.0005411	http://dx.doi.org/10.1371/journal.pone.0005411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412540	Green Published, gold, Green Submitted			2022-12-27	WOS:000265688200004
J	Bohm, M; Hutchings, MR; White, PCL				Boehm, Monika; Hutchings, Michael R.; White, Piran C. L.			Contact Networks in a Wildlife-Livestock Host Community: Identifying High-Risk Individuals in the Transmission of Bovine TB among Badgers and Cattle	PLOS ONE			English	Article							TUBERCULOSIS MYCOBACTERIUM-BOVIS; MELES-MELES; DISEASE; MOVEMENTS; INFECTION; PROXIMITY; DYNAMICS; PATTERNS; DENSITY; MAMMALS	Background: The management of many pathogens, which are of concern to humans and their livestock, is complicated by the pathogens' ability to cross-infect multiple host species, including wildlife. This has major implications for the management of such diseases, since the dynamics of infection are dependent on the rates of both intra- and inter-specific transmission. However, the difficulty of studying transmission networks in free-living populations means that the relative opportunities for intra- versus inter-specific disease transmission have not previously been demonstrated empirically within any wildlife-livestock disease system. Methodology/Principal Findings: Using recently-developed proximity data loggers, we quantify both intra- and interspecific contacts in a wildlife-livestock disease system, using bovine tuberculosis (bTB) in badgers and cattle in the UK as our example. We assess the connectedness of individuals within the networks in order to identify whether there are certain 'high-risk' individuals or groups of individuals for disease transmission within and between species. Our results show that contact patterns in both badger and cattle populations vary widely, both between individuals and over time. We recorded only infrequent interactions between badger social groups, although all badgers fitted with data loggers were involved in these inter-group contacts. Contacts between badgers and cattle occurred more frequently than contacts between different badger groups. Moreover, these inter-specific contacts involved those individual cows, which were highly connected within the cattle herd. Conclusions/Significance: This work represents the first continuous time record of wildlife-host contacts for any free-living wildlife-livestock disease system. The results highlight the existence of specific individuals with relatively high contact rates in both livestock and wildlife populations, which have the potential to act as hubs in the spread of disease through complex contact networks. Targeting testing or preventive measures at high-contact groups and individuals within livestock populations would enhance the effectiveness and efficiency of disease management strategies.			White, PCL (corresponding author), Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England.	PCLW1@york.ac.uk	Böhm, Monika/E-1153-2018; White, Piran C.L./F-5091-2010; White, Piran Crawfurd Limond/AAH-6851-2021; Hutchings, Mike/P-6836-2019	Böhm, Monika/0000-0003-0585-0832; White, Piran Crawfurd Limond/0000-0002-7496-5775; Hutchings, Mike/0000-0003-3338-471X				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Ball F, 1997, ANN APPL PROBAB, V7, P46; BENHAM PFJ, 1989, BRIT VET J, V145, P226, DOI 10.1016/0007-1935(89)90075-4; Bohm M, 2008, J ANIM ECOL, V77, P735, DOI 10.1111/j.1365-2656.2008.01377.x; Bowers RG, 1997, J THEOR BIOL, V187, P95, DOI 10.1006/jtbi.1997.0418; Brennan ML, 2008, PREV VET MED, V84, P242, DOI 10.1016/j.prevetmed.2007.12.009; Buesching CD, 2003, BEHAVIOUR, V140, P965, DOI 10.1163/156853903322589597; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; COWAN DP, 1987, J ANIM ECOL, V56, P779, DOI 10.2307/4948; Davidson RS, 2008, J THEOR BIOL, V253, P424, DOI 10.1016/j.jtbi.2008.03.021; Day TD, 2000, APPL ANIM BEHAV SCI, V70, P157, DOI 10.1016/S0168-1591(00)00144-1; *DEFR, 2007, OPT VACC CATTL BOV T; *DEFR, 2005, GOV STRAT FRAM SUST; *DEFR BOV TB HUSB, 2007, ADV HUSB BEST PRACT; Delahay RJ, 2000, J ANIM ECOL, V69, P428, DOI 10.1046/j.1365-2656.2000.00406.x; DONCASTER CP, 1990, J THEOR BIOL, V143, P431, DOI 10.1016/S0022-5193(05)80020-7; Fenton A, 2005, EMERG INFECT DIS, V11, P1815, DOI 10.3201/eid1112.050306; Gallagher J, 2000, RES VET SCI, V69, P203, DOI 10.1053/rvsc.2000.0422; Gannon BW, 2007, RES VET SCI, V82, P169, DOI 10.1016/j.rvsc.2006.07.011; Garnett BT, 2003, APPL ANIM BEHAV SCI, V80, P1, DOI 10.1016/S0168-1591(02)00204-6; Garnett BT, 2002, P ROY SOC B-BIOL SCI, V269, P1487, DOI 10.1098/rspb.2002.2072; Gavier-Widen D, 2001, VET REC, V148, P299, DOI 10.1136/vr.148.10.299; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Goodman E.L., 2007, THESIS U YORK YORK; Gopal R, 2006, VET REC, V159, P265, DOI 10.1136/vr.159.9.265; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; HARRIS S, 1992, J ZOOL, V228, P679, DOI 10.1111/j.1469-7998.1992.tb04467.x; Holt RD, 2003, ECOL LETT, V6, P837, DOI 10.1046/j.1461-0248.2003.00501.x; *ISG, 2007, BOV TB SCI EV; Ji WH, 2005, J APPL ECOL, V42, P595, DOI 10.1111/j.1365-2664.2005.01026.x; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Keeling M, 2005, THEOR POPUL BIOL, V67, P1, DOI 10.1016/j.tpb.2004.08.002; Kiss IZ, 2008, J R SOC INTERFACE, V5, P791, DOI 10.1098/rsif.2007.1272; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; MUIRHEAD RH, 1974, VET REC, V95, P552, DOI 10.1136/vr.95.24.552; Nolan A., 1994, VET MICROBIOL, V43, P256; PALPHRAMAND KL, 2005, THESIS U YORK YORK; Prange S, 2006, WILDLIFE SOC B, V34, P1333, DOI 10.2193/0091-7648(2006)34[1333:NRFTDO]2.0.CO;2; Roper TJ, 2001, BEHAVIOUR, V138, P173, DOI 10.1163/15685390151074366; Sauter CM, 1995, NEW ZEAL VET J, V43, P301, DOI 10.1080/00480169./1995.35910; *SIRTR LTD, 2006, SIRTR PROX LOGG INF; Swain DL, 2007, APPL ANIM BEHAV SCI, V102, P1, DOI 10.1016/j.applanim.2006.03.008; Totton SC, 2002, J WILDLIFE DIS, V38, P313, DOI 10.7589/0090-3558-38.2.313; Turner J, 2008, J THEOR BIOL, V254, P45, DOI 10.1016/j.jtbi.2008.05.007; Tuyttens FAM, 2001, J APPL ECOL, V38, P1114, DOI 10.1046/j.1365-2664.2001.00665.x; Vonhof MJ, 2004, ANIM BEHAV, V68, P507, DOI 10.1016/j.anbehav.2003.08.025; WHITE PCL, 1993, P ROY SOC B-BIOL SCI, V253, P277, DOI 10.1098/rspb.1993.0114; WHITE PCL, 1994, J ANIM ECOL, V63, P315, DOI 10.2307/5550; White PCL, 2008, TRENDS MICROBIOL, V16, P420, DOI 10.1016/j.tim.2008.06.005; WILESMITH JW, 1982, J HYG-CAMBRIDGE, V89, P195, DOI 10.1017/S002217240007073X; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Woolhouse MEJ, 2005, BIOL LETTERS, V1, P350, DOI 10.1098/rsbl.2005.0331; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	53	154	154	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5016	10.1371/journal.pone.0005016	http://dx.doi.org/10.1371/journal.pone.0005016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401755	Green Published, gold			2022-12-27	WOS:000265601100001
J	Tanaka, S; Tani, T; Ribot, J; O'Hashi, K; Imamura, K				Tanaka, Shigeru; Tani, Toshiki; Ribot, Jerome; O'Hashi, Kazunori; Imamura, Kazuyuki			A Postnatal Critical Period for Orientation Plasticity in the Cat Visual Cortex	PLOS ONE			English	Article								Orientation selectivity of primary visual cortical neurons is an important requisite for shape perception. Although numerous studies have been previously devoted to a question of how orientation selectivity is established and elaborated in early life, how the susceptibility of orientation plasticity to visual experience changes in time remains unclear. In the present study, we showed a postnatal sensitive period profile for the modifiability of orientation selectivity in the visual cortex of kittens reared with head-mounted goggles for stable single-orientation exposure. When goggle rearing (GR) started at P16-P30, 2 weeks of GR induced a marked over-representation of the exposed orientation, and 2 more weeks of GR consolidated the altered orientation maps. GR that started later than P50, in turn, induced the under-representation of the exposed orientation. Orientation plasticity in the most sensitive period was markedly suppressed by cortical infusion of NMDAR antagonist. The present study reveals that the plasticity and consolidation of orientation selectivity in an early life are dynamically regulated in an experience-dependent manner.			Tanaka, S (corresponding author), RIKEN, Brain Sci Inst, Lab Visual Neurocomp, Wako, Saitama, Japan.	shigeru@riken.jp		Ribot, Jerome/0000-0003-1227-4773				BEAR MF, 1990, J NEUROSCI, V10, P909; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; BONHOEFFER T, 1995, EUR J NEUROSCI, V7, P1973, DOI 10.1111/j.1460-9568.1995.tb00720.x; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Buller AL, 1997, EUR J PHARMACOL, V320, P87, DOI 10.1016/S0014-2999(96)00880-1; CARLSON M, 1986, DEV BRAIN RES, V25, P71, DOI 10.1016/0165-3806(86)90153-7; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; CREUTZFELDT OD, 1975, SCIENCE, V188, P1025, DOI 10.1126/science.1145187; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Godde B, 2002, P NATL ACAD SCI USA, V99, P6352, DOI 10.1073/pnas.082407499; Gordon JA, 1996, J NEUROSCI, V16, P3274; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HIRSCH HVB, 1970, SCIENCE, V168, P869, DOI 10.1126/science.168.3933.869; Huang Y, 2008, J NEUROSCI, V28, P7074, DOI 10.1523/JNEUROSCI.0899-08.2008; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Imamura K, 1999, P ROY SOC B-BIOL SCI, V266, P1507, DOI 10.1098/rspb.1999.0808; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Kasamatsu T, 1997, BRAIN RES PROTOC, V1, P57, DOI 10.1016/S1385-299X(96)00008-6; KASAMATSU T, 1976, SCIENCE, V194, P206, DOI 10.1126/science.959850; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; Liu CH, 2008, NEURON, V58, P340, DOI 10.1016/j.neuron.2008.02.020; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; Mower GD, 2003, MOL BRAIN RES, V119, P19, DOI 10.1016/j.molbrainres.2003.08.007; O'Hasi K, 2007, NEUROSCI RES, V58, P86, DOI 10.1016/j.neures.2007.01.005; Ohki K, 2000, CEREB CORTEX, V10, P593, DOI 10.1093/cercor/10.6.593; OLSON CR, 1980, EXP BRAIN RES, V39, P17; RATZLAFF EH, 1991, J NEUROSCI METH, V36, P127, DOI 10.1016/0165-0270(91)90038-2; RAUSCHECKER JP, 1991, PHYSIOL REV, V71, P587, DOI 10.1152/physrev.1991.71.2.587; RAUSCHECKER JP, 1981, J PHYSIOL-LONDON, V310, P215, DOI 10.1113/jphysiol.1981.sp013545; Ribot J, 2006, J NEUROSCI METH, V153, P8, DOI 10.1016/j.jneumeth.2005.09.016; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; STRYKER MP, 1978, J NEUROPHYSIOL, V41, P896, DOI 10.1152/jn.1978.41.4.896; Tanaka S, 2006, NEUROIMAGE, V30, P462, DOI 10.1016/j.neuroimage.2005.09.056; Tanaka S, 2004, NEURAL NETWORKS, V17, P1363, DOI 10.1016/j.neunet.2004.06.014; Tanaka S, 2007, J NEUROSCI METH, V160, P206, DOI 10.1016/j.jneumeth.2006.09.004; Tran DH, 2007, NEUROPHARMACOLOGY, V53, P252, DOI 10.1016/j.neuropharm.2007.05.005; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yokoo T, 2001, NEUROIMAGE, V14, P1309, DOI 10.1006/nimg.2001.0950	46	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5380	10.1371/journal.pone.0005380	http://dx.doi.org/10.1371/journal.pone.0005380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401781	Green Published, gold, Green Submitted			2022-12-27	WOS:000265601100017
J	Brady, A; Maxwell, K; Daniels, N; Cowen, LJ				Brady, Arthur; Maxwell, Kyle; Daniels, Noah; Cowen, Lenore J.			Fault Tolerance in Protein Interaction Networks: Stable Bipartite Subgraphs and Redundant Pathways	PLOS ONE			English	Article							GENETIC INTERACTIONS; SGS1; ROBUSTNESS; MAINTENANCE; STABILITY; REVEALS; ABSENCE; BLOOMS	As increasing amounts of high-throughput data for the yeast interactome become available, more system-wide properties are uncovered. One interesting question concerns the fault tolerance of protein interaction networks: whether there exist alternative pathways that can perform some required function if a gene essential to the main mechanism is defective, absent or suppressed. A signature pattern for redundant pathways is the BPM (between-pathway model) motif, introduced by Kelley and Ideker. Past methods proposed to search the yeast interactome for BPM motifs have had several important limitations. First, they have been driven heuristically by local greedy searches, which can lead to the inclusion of extra genes that may not belong in the motif; second, they have been validated solely by functional coherence of the putative pathways using GO enrichment, making it difficult to evaluate putative BPMs in the absence of already known biological annotation. We introduce stable bipartite subgraphs, and show they form a clean and efficient way of generating meaningful BPMs which naturally discard extra genes included by local greedy methods. We show by GO enrichment measures that our BPM set outperforms previous work, covering more known complexes and functional pathways. Perhaps most importantly, since our BPMs are initially generated by examining the genetic-interaction network only, the location of edges in the protein-protein physical interaction network can then be used to statistically validate each candidate BPM, even with sparse GO annotation (or none at all). We uncover some interesting biological examples of previously unknown putative redundant pathways in such areas as vesicle-mediated transport and DNA repair.			Brady, A (corresponding author), Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA.	abrady@umiacs.umd.edu; cowen@cs.tufts.edu		Daniels, Noah/0000-0002-9538-825X; Brady, Arthur/0000-0002-8809-2477	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080330] Funding Source: NIH RePORTER; NIGMS NIH HHS [1R01 GM080330-01A1, R01 GM080330] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Berger KH, 1998, MOL CELL BIOL, V18, P4043, DOI 10.1128/MCB.18.7.4043; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Blank LM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r49; BRADY AR, 2008, DETECTING HIGH LEVEL; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Dimmer KS, 2005, J CELL BIOL, V168, P103, DOI 10.1083/jcb.200410030; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Garey M.R., 1979, COMPUTERS INTRACTABI; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Hurst LD, 2008, EVOLUTIONARY GENOMICS AND PROTEOMICS, P141; Karp R. M., 1972, P COMPL COMP COMP, P85; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Lovasz L., 1966, STUDIA SCI MATH HUNG, V1, P237; Ma XT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001922; Mullen JR, 2001, GENETICS, V157, P103; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Ulitsky I, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100144; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bies.20170; Wagner M, 2006, GENETICS, V174, P555, DOI 10.1534/genetics.104.036905; Watt PM, 1996, GENETICS, V144, P935; Zeng XM, 2007, MOL BIOL CELL, V18, P617, DOI 10.1091/mbc.E06-09-0801	30	29	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5364	10.1371/journal.pone.0005364	http://dx.doi.org/10.1371/journal.pone.0005364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399174	Green Submitted, Green Published, gold			2022-12-27	WOS:000265514900018
J	Du, HD; Daphne, LV; Ginder, V; Jebb, SA; Forouhi, NG; Wareham, NJ; Halkjaer, J; Tjonneland, A; Overvad, K; Jakobsen, MU; Buijsse, B; Steffen, A; Palli, D; Masala, G; Saris, WHM; Sorensen, TIA; Feskens, EJM				Du, Huaidong; Daphne, L. van der A.; Ginder, Vanessa; Jebb, Susan A.; Forouhi, Nita G.; Wareham, Nicholas J.; Halkjaer, Jytte; Tjonneland, Anne; Overvad, Kim; Jakobsen, Marianne Uhre; Buijsse, Brian; Steffen, Annika; Palli, Domenico; Masala, Giovanna; Saris, Wim H. M.; Sorensen, Thorkild I. A.; Feskens, Edith J. M.			Dietary Energy Density in Relation to Subsequent Changes of Weight and Waist Circumference in European Men and Women	PLOS ONE			English	Article								Background: Experimental studies show that a reduction in dietary energy density (ED) is associated with reduced energy intake and body weight. However, few observational studies have investigated the role of ED on long-term weight and waist circumference change. Methods and Principal Findings: This population-based prospective cohort study included 89,432 participants from five European countries with mean age 53 years (range: 20-78 years) at baseline and were followed for an average of 6.5 years (range: 1.9-12.5 years). Participants were free of cancer, cardiovascular diseases and diabetes at baseline. ED was calculated as the energy intake (kcal) from foods divided by the weight (g) of foods. Multiple linear regression analyses were performed to investigate the associations of ED with annual weight and waist circumference change. Mean ED was 1.7 kcal/g and differed across study centers. After adjusting for baseline anthropometrics, demographic and lifestyle factors, follow-up duration and energy from beverages, ED was not associated with weight change, but significantly associated with waist circumference change overall. For 1 kcal/g ED, the annual weight change was -42 g/year [95% confidence interval (CI): -112, 28] and annual waist circumference change was 0.09 cm/year [95% CI: 0.01, 0.18]. In participants with baseline BMI<25 kg/m(2), 1 kcal/g ED was associated with a waist circumference change of 0.17 cm/year [95% CI: 0.09, 0.25]. Conclusion: Our results suggest that lower ED diets do not prevent weight gain but have a weak yet potentially beneficial effect on the prevention of abdominal obesity as measured by waist circumference.			Du, HD (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.	huaidong.du@rivm.nl	Masala, Giovanna/AAC-5474-2022; Feskens, Edith JM/A-3757-2012; Feskens, Edith/ABI-1446-2020; Jakobsen, Marianne Uhre/I-8550-2018; Steffen, Annika/H-7709-2018; Buijsse, Brian/E-5079-2011; Steffen, Annika/E-8540-2016	Masala, Giovanna/0000-0002-5758-9069; Feskens, Edith/0000-0001-5819-2488; Jakobsen, Marianne Uhre/0000-0001-6518-4136; Steffen, Annika/0000-0003-4072-9245; Steffen, Annika/0000-0003-4072-9245; Du, Huaidong/0000-0002-9814-0049; Tjonneland, Anne/0000-0003-4385-2097; tumino, rosario/0000-0003-2666-414X; Forouhi, Nita/0000-0002-5041-248X; Jebb, Susan/0000-0001-9190-2920; Overvad, Kim/0000-0001-6429-7921; PALLI, Domenico/0000-0002-5558-2437	MRC [MC_U105960389] Funding Source: UKRI; Medical Research Council [MC_U105960389] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bes-Rastrollo M, 2008, AM J CLIN NUTR, V88, P769, DOI 10.1093/ajcn/88.3.769; Brustad M, 2003, EUR J CLIN NUTR, V57, P107, DOI 10.1038/sj.ejcn.1601498; Cox DN, 2000, INT J OBESITY, V24, P49, DOI 10.1038/sj.ijo.0801084; Day N, 1999, BRIT J CANCER, V80, P95; Ello-Martin JA, 2007, AM J CLIN NUTR, V85, P1465, DOI 10.1093/ajcn/85.6.1465; Ferrari P, 2008, INT J EPIDEMIOL, V37, P368, DOI 10.1093/ije/dym242; Goris AHC, 2000, AM J CLIN NUTR, V71, P130; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1147, DOI 10.1079/PHN2002396; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P39, DOI 10.1001/jama.295.1.39; Iqbal SI, 2006, OBESITY, V14, P106, DOI 10.1038/oby.2006.13; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Johnson L, 2008, INT J OBESITY, V32, P586, DOI 10.1038/sj.ijo.0803746; Kant AK, 2005, INT J OBESITY, V29, P950, DOI 10.1038/sj.ijo.0802980; Kien CL, 2004, AM J CLIN NUTR, V80, P876, DOI 10.1093/ajcn/80.4.876; Ledikwe JH, 2007, AM J CLIN NUTR, V85, P1212, DOI 10.1093/ajcn/85.5.1212; Ledikwe JH, 2006, AM J CLIN NUTR, V83, P1362, DOI 10.1093/ajcn/83.6.1362; Ledikwe JH, 2005, J NUTR, V135, P273, DOI 10.1093/jn/135.2.273; Ludwig DS, 2007, LANCET, V369, P890, DOI 10.1016/S0140-6736(07)60427-9; Ma YS, 2005, AM J EPIDEMIOL, V161, P359, DOI 10.1093/aje/kwi051; Macdiarmid J, 1998, NUTR RES REV, V11, P231, DOI 10.1079/NRR19980017; Mattisson I, 2005, BRIT J NUTR, V94, P832, DOI 10.1079/BJN20051573; McCaffrey TA, 2008, AM J CLIN NUTR, V87, P1230, DOI 10.1093/ajcn/87.5.1230; McCrory MA, 2006, PHYSIOL BEHAV, V87, P451, DOI 10.1016/j.physbeh.2004.10.025; Mendoza JA, 2007, DIABETES CARE, V30, P974, DOI 10.2337/dc06-2188; Molag ML, 2007, AM J EPIDEMIOL, V166, P1468, DOI 10.1093/aje/kwm236; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Murakami K, 2007, NUTRITION, V23, P798, DOI 10.1016/j.nut.2007.08.014; Prentice AM, 1996, INT J OBESITY, V20, pS18; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rinaldi S, 2006, INT J CANCER, V118, P2832, DOI 10.1002/ijc.21730; Rolls BJ, 2005, OBES RES, V13, P1052, DOI 10.1038/oby.2005.123; Saris WHM, 2005, OBES REV, V6, P175, DOI 10.1111/j.1467-789x.2005.00200.x; Savage JS, 2008, AM J CLIN NUTR, V88, P677, DOI 10.1093/ajcn/88.3.677; Slimani N, 2007, EUR J CLIN NUTR, V61, P1037, DOI 10.1038/sj.ejcn.1602679; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; Slimani N, 1999, COMPUT METH PROG BIO, V58, P251, DOI 10.1016/S0169-2607(98)00088-1; Stookey JD, 2001, EUR J CLIN NUTR, V55, P349, DOI 10.1038/sj.ejcn.1601163; *USDA, 2005, NUTR YOUR HLTH DIET; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; Westerterp-Plantenga MS, 2001, BRIT J NUTR, V85, P351, DOI 10.1079/BJN2000272; WHO/FAO, 2003, DIET NUTR; WILLETT WC, 1994, AM J CLIN NUTR, V59, p171S, DOI 10.1093/ajcn/59.1.171S	42	54	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2009	4	4							e5339	10.1371/journal.pone.0005339	http://dx.doi.org/10.1371/journal.pone.0005339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VI	19396357	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514600004
J	Gokce, O; Runne, H; Kuhn, A; Luthi-Carter, R				Gokce, Ozgun; Runne, Heike; Kuhn, Alexandre; Luthi-Carter, Ruth			Short-Term Striatal Gene Expression Responses to Brain-Derived Neurotrophic Factor Are Dependent on MEK and ERK Activation	PLOS ONE			English	Article								Background: Brain-derived neurotrophic factor (BDNF) is believed to be an important regulator of striatal neuron survival, differentiation, and plasticity. Moreover, reduction of BDNF delivery to the striatum has been implicated in the pathophysiology of Huntington's disease. Nevertheless, many essential aspects of BDNF responses in striatal neurons remain to be elucidated. Methodology/Principal Findings: In this study, we assessed the relative contributions of multipartite intracellular signaling pathways to the short-term induction of striatal gene expression by BDNF. To identify genes regulated by BDNF in these GABAergic cells, we first used DNA microarrays to quantify their transcriptomic responses following 3 h of BDNF exposure. The signal transduction pathways underlying gene induction were subsequently dissected using pharmacological agents and quantitative real-time PCR. Gene expression responses to BDNF were abolished by inhibitors of TrkB (K252a) and calcium (chelator BAPTA-AM and transient receptor potential cation channel [TRPC] antagonist SKF-96365). Interestingly, inhibitors of mitogen-activated protein kinase kinases 1 and 2 (MEK1/2) and extracellular signal-regulated kinase ERK also blocked the BDNF-mediated induction of all tested BDNF-responsive genes. In contrast, inhibitors of nitric oxide synthase (NOS), phosphotidylinositol-3-kinase (PI3K), and CAMK exhibited less prevalent, gene-specific effects on BDNF-induced RNA expression. At the nuclear level, the activation of both Elk-1 and CREB showed MEK dependence. Importantly, MEK-dependent activation of transcription was shown to be required for BDNF-induced striatal neurite outgrowth, providing evidence for its contribution to striatal neuron plasticity. Conclusions: These results show that the MEK/ERK pathway is a major mediator of neuronal plasticity and other important BDNF-dependent striatal functions that are fulfilled through the positive regulation of gene expression.			Gokce, O (corresponding author), Ecole Polytech Fed Lausanne, Lab Funct Neurogen, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	ruth.luthi-carter@epfl.ch		gokce, ozgun/0000-0001-6319-404X; Kuhn, Alexandre/0000-0003-3839-5282				Alder J, 2003, J NEUROSCI, V23, P10800; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanquet PR, 1997, J BIOL CHEM, V272, P24133, DOI 10.1074/jbc.272.39.24133; Bogush A, 2007, J BIOL CHEM, V282, P7352, DOI 10.1074/jbc.M606508200; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Donai H, 2003, NEUROSCI RES, V47, P399, DOI 10.1016/j.neures.2003.08.004; Drees F, 2008, CURR OPIN NEUROBIOL, V18, P53, DOI 10.1016/j.conb.2008.05.007; Egea J, 2000, MOL CELL BIOL, V20, P1931, DOI 10.1128/MCB.20.6.1931-1946.2000; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Gao X, 2009, EXP NEUROL, V215, P178, DOI 10.1016/j.expneurol.2008.10.009; Gartner AG, 2002, P NATL ACAD SCI USA, V99, P6386, DOI 10.1073/pnas.092129699; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gavalda N, 2004, MOL CELL NEUROSCI, V25, P460, DOI 10.1016/j.mcn.2003.11.012; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Hashimoto T, 2005, J NEUROSCI, V25, P372, DOI 10.1523/JNEUROSCI.4035-04.2005; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Hottinger AF, 2000, J NEUROSCI, V20, P5587, DOI 10.1523/JNEUROSCI.20-15-05587.2000; Ivkovic S, 1999, J NEUROSCI, V19, P5409; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Kajiya M, 2008, J BIOL CHEM, V283, P16259, DOI 10.1074/jbc.M800668200; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Kim B, 1997, J BIOL CHEM, V272, P21268, DOI 10.1074/jbc.272.34.21268; Levkovitz Y, 2002, J NEUROSCI, V22, P3845, DOI 10.1523/JNEUROSCI.22-10-03845.2002; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Lynch G, 2007, J NEUROSCI, V27, P4424, DOI 10.1523/JNEUROSCI.5113-06.2007; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; Nakao N, 1995, DEV BRAIN RES, V90, P92, DOI 10.1016/0165-3806(96)83489-4; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; Pandey SC, 2008, J NEUROSCI, V28, P2589, DOI 10.1523/JNEUROSCI.4752-07.2008; PARENT A, 1983, NEUROSCIENCE, V10, P1137, DOI 10.1016/0306-4522(83)90104-5; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Ring RH, 2006, J NEUROBIOL, V66, P361, DOI 10.1002/neu.20223; Runne H, 2008, J NEUROSCI, V28, P9723, DOI 10.1523/JNEUROSCI.3044-08.2008; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spencer TK, 2008, MOL CELL NEUROSCI, V38, P110, DOI 10.1016/j.mcn.2008.02.005; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; Strand AD, 2007, J NEUROSCI, V27, P11758, DOI 10.1523/JNEUROSCI.2461-07.2007; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; VENTIMIGLIA R, 1995, EUR J NEUROSCI, V7, P213, DOI 10.1111/j.1460-9568.1995.tb01057.x; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017; Zheng F, 2009, J NEUROSCI RES, V87, P380, DOI 10.1002/jnr.21863; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003; Zucker B, 2005, HUM MOL GENET, V14, P179, DOI 10.1093/hmg/ddi014	59	46	47	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5292	10.1371/journal.pone.0005292	http://dx.doi.org/10.1371/journal.pone.0005292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390590	Green Published, gold, Green Submitted			2022-12-27	WOS:000265514200011
J	Saccone, SF; Bierut, LJ; Chesler, EJ; Kalivas, PW; Lerman, C; Saccone, NL; Uhl, GR; Li, CY; Philip, VM; Edenberg, HJ; Sherry, ST; Feolo, M; Moyzis, RK; Rutter, JL				Saccone, Scott F.; Bierut, Laura J.; Chesler, Elissa J.; Kalivas, Peter W.; Lerman, Caryn; Saccone, Nancy L.; Uhl, George R.; Li, Chuan-Yun; Philip, Vivek M.; Edenberg, Howard J.; Sherry, Stephen T.; Feolo, Michael; Moyzis, Robert K.; Rutter, Joni L.			Supplementing High-Density SNP Microarrays for Additional Coverage of Disease-Related Genes: Addiction as a Paradigm	PLOS ONE			English	Article								Commercial SNP microarrays now provide comprehensive and affordable coverage of the human genome. However, some diseases have biologically relevant genomic regions that may require additional coverage. Addiction, for example, is thought to be influenced by complex interactions among many relevant genes and pathways. We have assembled a list of 486 biologically relevant genes nominated by a panel of experts on addiction. We then added 424 genes that showed evidence of association with addiction phenotypes through mouse QTL mappings and gene co-expression analysis. We demonstrate that there are a substantial number of SNPs in these genes that are not well represented by commercial SNP platforms. We address this problem by introducing a publicly available SNP database for addiction. The database is annotated using numeric prioritization scores indicating the extent of biological relevance. The scores incorporate a number of factors such as SNP/gene functional properties (including synonymy and promoter regions), data from mouse systems genetics and measures of human/mouse evolutionary conservation. We then used HapMap genotyping data to determine if a SNP is tagged by a commercial microarray through linkage disequilibrium. This combination of biological prioritization scores and LD tagging annotation will enable addiction researchers to supplement commercial SNP microarrays to ensure comprehensive coverage of biologically relevant regions.			Saccone, SF (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	ssaccone@wustl.edu	Chesler, Elissa/K-4641-2019; Bierut, Laura Jean/W-6806-2019; Lerman, Caryn/AHC-5180-2022	Chesler, Elissa/0000-0002-5642-5062; Bierut, Laura Jean/0000-0002-9952-4810; Li, Chuan-Yun/0000-0002-8008-8430; Edenberg, Howard/0000-0003-0344-9690; Rutter, Joni/0000-0002-6502-2361; Sherry, Stephen/0000-0002-7982-076X; Philip, Vivek/0000-0001-5126-707X	NATIONAL CANCER INSTITUTE [P01CA089392, P50CA084718] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013513, U01AA013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020677, K02DA021237, ZIADA000401, R01DA019963, U01DA020830, Z01DA000537, K01DA015129, ZIADA000537, Z01DA000401] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER; NCI NIH HHS [CA084718, P01 CA089392, P50 CA084718, CA089392] Funding Source: Medline; NHGRI NIH HHS [HG004422, U01 HG004422] Funding Source: Medline; NIAAA NIH HHS [U01 AA013513, AA13499, U01 AA013499, AA13513] Funding Source: Medline; NIDA NIH HHS [DA020830, DA019963, K02 DA021237, DA021237, U01 DA020830, R01 DA019963, K01 DA015129, R01 DA020677, DA020677, DA015129, DA07079] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; CRADDOCK N, 2008, MOL PSYCHIAT; Fredette BJ, 1996, DEVELOPMENT, V122, P3163; HAWKS J, 2007, P NATL ACAD SCI US; HODGKINSON CA, 2008, ALCOHOL ALCOHOL; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Ivanov DB, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1174, DOI 10.1023/A:1012445316415; Kipmen-Korgun D, 2005, J CARDIOVASC PHARM, V45, P418, DOI 10.1097/01.fjc.0000157458.91433.86; Li CY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040002; LI M, 2008, EUR J HUM GENET; Loots G, 2007, BIOINFORMATICS, V23, P122, DOI 10.1093/bioinformatics/btl546; Nielsen DA, 2008, MOL PSYCHIATR, V13, P417, DOI 10.1038/sj.mp.4002147; Philippova M, 2005, FASEB J, V19, P588, DOI 10.1096/fj.04-2430fje; Saccone SF, 2008, BIOINFORMATICS, V24, P1805, DOI 10.1093/bioinformatics/btn315; *SAS I, 2004, SAS REL 9 1 3; Takeuchi T, 2000, J NEUROCHEM, V74, P1489, DOI 10.1046/j.1471-4159.2000.0741489.x; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; WALL L, 1987, PEARL VERSION 5 8 5; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102	21	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5225	10.1371/journal.pone.0005225	http://dx.doi.org/10.1371/journal.pone.0005225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381300	Green Submitted, gold, Green Published			2022-12-27	WOS:000265513800006
J	Estep, PW; Warner, JB; Bulyk, ML				Estep, Preston Wayne, III; Warner, Jason B.; Bulyk, Martha L.			Short-Term Calorie Restriction in Male Mice Feminizes Gene Expression and Alters Key Regulators of Conserved Aging Regulatory Pathways	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; DIETARY RESTRICTION; MAMMALIAN TARGET; BODY-WEIGHT; DWARF MICE; GROWTH; RAPAMYCIN; STRESS; LONGEVITY; TOR	Background: Calorie restriction (CR) is the only intervention known to extend lifespan in a wide range of organisms, including mammals. However, the mechanisms by which it regulates mammalian aging remain largely unknown, and the involvement of the TOR and sirtuin pathways (which regulate aging in simpler organisms) remain controversial. Additionally, females of most mammals appear to live longer than males within species; and, although it remains unclear whether this holds true for mice, the relationship between sex-biased and CR-induced gene expression remains largely unexplored. Methodology/Principal Findings: We generated microarray gene expression data from livers of male mice fed high calorie or CR diets, and we find that CR significantly changes the expression of over 3,000 genes, many between 10- and 50-fold. We compare our data to the GenAge database of known aging-related genes and to prior microarray expression data of genes expressed differently between male and female mice. CR generally feminizes gene expression and many of the most significantly changed individual genes are involved in aging, hormone signaling, and p53-associated regulation of the cell cycle and apoptosis. Among the genes showing the largest and most statistically significant CR-induced expression differences are Ddit4, a key regulator of the TOR pathway, and Nnmt, a regulator of lifespan linked to the sirtuin pathway. Using western analysis we confirmed post-translational inhibition of the TOR pathway. Conclusions: Our data show that CR induces widespread gene expression changes and acts through highly evolutionarily conserved pathways, from microorganisms to mammals, and that its life-extension effects might arise partly from a shift toward a gene expression profile more typical of females.			Estep, PW (corresponding author), Longenity Inc, Lincoln, MA USA.	pestep@post.harvard.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR051287] Funding Source: NIH RePORTER; NIAMS NIH HHS [F32 AR051287] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; BURGER JM, 2004, SCI AGING KNOWLEDGE, pPE30, DOI DOI 10.1126/SAGEKE.2004.28.PE30; Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; de Magalhaes JP, 2005, NUCLEIC ACIDS RES, V33, pD537, DOI 10.1093/nar/gki017; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fu CX, 2006, MECH AGEING DEV, V127, P905, DOI 10.1016/j.mad.2006.09.006; Fu CX, 2004, J NUTR, V134, P2965, DOI 10.1093/jn/134.11.2965; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; HOAG WG, 1963, ANN NY ACAD SCI, V108, P805, DOI 10.1111/j.1749-6632.1963.tb13421.x; *I LAB AN RES I, 1996, GUID CAR US LAB AN; INGRAM DK, 1982, MECH AGEING DEV, V20, P253, DOI 10.1016/0047-6374(82)90092-6; Jiang WQ, 2008, CANCER RES, V68, P5492, DOI 10.1158/0008-5472.CAN-07-6721; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2007, AGING CELL, V6, P731, DOI 10.1111/j.1474-9726.2007.00341.x; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kawauchi K, 2005, J IMMUNOL, V174, P5261, DOI 10.4049/jimmunol.174.9.5261; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kennedy BK, 2007, CELL MOL LIFE SCI, V64, P1323, DOI 10.1007/s00018-007-6470-y; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Lane MA, 2001, ANN NY ACAD SCI, V928, P287; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Linford NJ, 2007, AGING CELL, V6, P673, DOI 10.1111/j.1474-9726.2007.00319.x; Liss B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf088; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Miller RA, 2002, AGING CELL, V1, P22, DOI 10.1046/j.1474-9728.2002.00006.x; Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142; *NCBI, 2007, ENTR GEN; Novoradovskaya N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-20; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; ORENTREICH N, 1993, J NUTR, V123, P269; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V247, P203, DOI 10.1098/rspb.1992.0030; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Ramsey JJ, 2000, EXP GERONTOL, V35, P1131, DOI 10.1016/S0531-5565(00)00166-2; Redman LM, 2009, MOL CELL ENDOCRINOL, V299, P129, DOI 10.1016/j.mce.2008.10.014; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SEGALL PE, 1976, MECH AGEING DEV, V5, P109, DOI 10.1016/0047-6374(76)90012-9; Selman C, 2006, PHYSIOL GENOMICS, V27, P187, DOI 10.1152/physiolgenomics.00084.2006; Sharp ZD, 2005, J GERONTOL A-BIOL, V60, P293, DOI 10.1093/gerona/60.3.293; Shimokawa I, 2003, FASEB J, V17, P1108, DOI 10.1096/fj.02-0819fje; Sjogren K, 2002, Minerva Endocrinol, V27, P299; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Strand AD, 2002, HUM MOL GENET, V11, P2207, DOI 10.1093/hmg/11.19.2207; Suckow M. A., 2000, LAB MOUSE; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-353; Tsuchiya M, 2006, AGING CELL, V5, P505, DOI 10.1111/j.1474-9726.2006.00240.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Walford RL, 2002, J GERONTOL A-BIOL, V57, pB211, DOI 10.1093/gerona/57.6.B211; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; YUAN R, 2008, AGING STUDY LIFESPAN	73	62	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5242	10.1371/journal.pone.0005242	http://dx.doi.org/10.1371/journal.pone.0005242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370158	Green Published, gold			2022-12-27	WOS:000265510600006
J	Hahn, CG; Banerjee, A; MacDonald, ML; Cho, DS; Kamins, J; Nie, ZP; Borgmann-Winter, KE; Grosser, T; Pizarro, A; Ciccimaro, E; Arnold, SE; Wang, HY; Blair, IA				Hahn, Chang-Gyu; Banerjee, Anamika; MacDonald, Matthew L.; Cho, Dan-Sung; Kamins, Joshua; Nie, Zhiping; Borgmann-Winter, Karin E.; Grosser, Tilo; Pizarro, Angel; Ciccimaro, Eugene; Arnold, Steven E.; Wang, Hoau-Yan; Blair, Ian A.			The Post-Synaptic Density of Human Postmortem Brain Tissues: An Experimental Study Paradigm for Neuropsychiatric Illnesses	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; GENE-EXPRESSION; RAT FOREBRAIN; PROTEIN; SCHIZOPHRENIA; MASS; IDENTIFICATION; FRACTION; PHOSPHORYLATION; ORGANIZATION	Recent molecular genetics studies have suggested various trans-synaptic processes for pathophysiologic mechanisms of neuropsychiatric illnesses. Examination of pre- and post-synaptic scaffolds in the brains of patients would greatly aid further investigation, yet such an approach in human postmortem tissue has yet to be tested. We have examined three methods using density gradient based purification of synaptosomes followed by detergent extraction (Method 1) and the pH based differential extraction of synaptic membranes (Methods 2 and 3). All three methods separated fractions from human postmortem brains that were highly enriched in typical PSD proteins, almost to the exclusion of pre-synaptic proteins. We examined these fractions using electron microscopy (EM) and verified the integrity of the synaptic membrane and PSD fractions derived from human postmortem brain tissues. We analyzed protein composition of the PSD fractions using two dimensional liquid chromatography tandem mass spectrometry (2D LC-MS/MS) and observed known PSD proteins by mass spectrometry. Immunoprecipitation and immunoblot studies revealed that expected protein-protein interactions and certain posttranscriptional modulations were maintained in PSD fractions. Our results demonstrate that PSD fractions can be isolated from human postmortem brain tissues with a reasonable degree of integrity. This approach may foster novel postmortem brain research paradigms in which the stoichiometry and protein composition of specific microdomains are examined.			Hahn, CG (corresponding author), Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA.	hahnc@mail.med.upenn.edu	Blair, Ian A/B-3320-2010; MacDonald, Matthew/X-2356-2019; Arnold, Steven E/J-7546-2012; Grosser, Tilo/A-1057-2007	Grosser, Tilo/0000-0001-8569-8396	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES016004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075916] Funding Source: NIH RePORTER; NIEHS NIH HHS [U01 ES016004, P30 ES0135080] Funding Source: Medline; NIMH NIH HHS [R01-MH-075916, R01 MH075916] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BEHAN A, 2008, MOL PSYCHIAT; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chen XB, 2005, P NATL ACAD SCI USA, V102, P11551, DOI 10.1073/pnas.0505359102; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; COTMAN CW, 1974, J CELL BIOL, V63, P441, DOI 10.1083/jcb.63.2.441; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Crecelius A, 2008, PROTEOMICS, V8, P1276, DOI 10.1002/pmic.200700728; Dosemeci A, 2006, BIOCHEM BIOPH RES CO, V339, P687, DOI 10.1016/j.bbrc.2005.11.069; Dosemeci A, 2007, MOL CELL PROTEOMICS, V6, P1749, DOI 10.1074/mcp.M700040-MCP200; Eastwood SL, 2004, INT REV NEUROBIOL, V59, P47; Harrison PJ, 2008, J PSYCHOPHARMACOL, V22, P308, DOI 10.1177/0269881108089818; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Harrison PJ, 2001, HIPPOCAMPUS, V11, P508, DOI 10.1002/hipo.1067.abs; Hashimoto R, 2007, DRUG TODAY, V43, P645, DOI 10.1358/dot.2007.43.9.1088821; Heresco-Levy U, 1998, EUR NEUROPSYCHOPHARM, V8, P141, DOI 10.1016/S0924-977X(97)00050-3; Honer WG, 2004, INT REV NEUROBIOL, V59, P175; Hunsucker SW, 2008, J NEUROCHEM, V105, P725, DOI 10.1111/j.1471-4159.2007.05183.x; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jaffe H, 2004, BIOCHEM BIOPH RES CO, V321, P210, DOI 10.1016/j.bbrc.2004.06.122; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Leliveld SR, 2008, J NEUROSCI, V28, P3839, DOI 10.1523/JNEUROSCI.5389-07.2008; Lewis DA, 2002, NEUROPSYCHOPHARMACOL, V26, P143, DOI 10.1016/S0893-133X(01)00393-1; Lewis DA, 2006, ARCH NEUROL-CHICAGO, V63, P1372, DOI 10.1001/archneur.63.10.1372; Meador-Woodruff JH, 2003, ANN NY ACAD SCI, V1003, P75, DOI 10.1196/annals.1300.005; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Novikova SI, 2006, NEUROBIOL DIS, V23, P61, DOI 10.1016/j.nbd.2006.02.002; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Petersen JD, 2003, J NEUROSCI, V23, P11270; Phillips GR, 2005, J NEUROSCI RES, V81, P762, DOI 10.1002/jnr.20614; Phillips GR, 2003, J NEUROSCI, V23, P5096; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Price TS, 2007, MOL CELL PROTEOMICS, V6, P527, DOI 10.1074/mcp.T600049-MCP200; Seagar M, 1999, PHILOS T ROY SOC B, V354, P289, DOI 10.1098/rstb.1999.0380; Seagar M, 1998, J BIOENERG BIOMEMBR, V30, P347, DOI 10.1023/A:1021937605818; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Talbot K, 2006, HUM MOL GENET, V15, P3041, DOI 10.1093/hmg/ddl246; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Yoshimura Y, 2004, J NEUROCHEM, V88, P759, DOI 10.1046/j.1471-4159.2003.02136.x	47	59	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5251	10.1371/journal.pone.0005251	http://dx.doi.org/10.1371/journal.pone.0005251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370153	Green Published, gold			2022-12-27	WOS:000265510600009
J	Kiselev, AO; Skinner, MC; Lampe, MF				Kiselev, Andrey O.; Skinner, Megan C.; Lampe, Mary F.			Analysis of pmpD Expression and PmpD Post-Translational Processing during the Life Cycle of Chlamydia trachomatis Serovars A, D, and L2	PLOS ONE			English	Article								Background: The polymorphic membrane protein D (PmpD) in Chlamydia is structurally similar to autotransporter proteins described in other bacteria and may be involved in cellular and humoral protective immunity against Chlamydia. The mechanism of PmpD post-translational processing and the role of its protein products in the pathogenesis of chlamydial infection have not been very well elucidated to date. Methodology/Principal Findings: Here we examined the expression and post-translational processing of the protein product of the pmpD gene during the life cycle of C. trachomatis serovars A, D, and L2. Each of these three serovars targets different human organs and tissues and encodes a different pmpD gene nucleotide sequence. Our quantitative real-time reverse transcription polymerase chain reaction results demonstrate that the pmpD gene is up-regulated at 12-24 hours after infection regardless of the Chlamydia serovar. This up-regulation is coincidental with the period of exponential growth and replication of reticulate bodies (RB) of Chlamydia and indicates a probable similarity in function of pmpD in serovars A, D, and L2 of Chlamydia. Using mass spectrometry analysis, we identified the protein products of post-translational processing of PmpD of C. trachomatis serovar L2 and propose a double pathway model for PmpD processing, with one cleavage site between the passenger and autotransporter domains and the other site in the middle of the passenger domain. Notably, when Chlamydia infected culture cells were subjected to low (28 degrees C) temperature, PmpD post-translational processing and secretion was found to be uninhibited in the resulting persistent infection. In addition, confocal microscopy of cells infected with Chlamydia confirms our earlier hypothesis that PmpD is secreted outside Chlamydia and its secretion increases with growth of the chlamydial inclusion. Conclusion/Significance: The results of this current study involving multiple Chlamydia serovars support the general consensus that the pmpD gene is maximally expressed at mid infection and provide new information about PmpD as an autotransporter protein which is post-translationally processed and secreted outside Chlamydia during normal and low temperature induced persistent chlamydial infection.			Kiselev, AO (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	lampe@u.washington.edu						Alberts B., 1994, MOL BIOL CELL; BARBOUR AG, 1982, J BACTERIOL, V151, P420, DOI 10.1128/JB.151.1.420-428.1982; BEATTY WL, 1993, P NATL ACAD SCI USA, V90, P3998, DOI 10.1073/pnas.90.9.3998; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Dautin N, 2007, EMBO J, V26, P1942, DOI 10.1038/sj.emboj.7601638; Elwell C, 2005, CELL MICROBIOL, V7, P725, DOI 10.1111/j.1462-5822.2005.00508.x; Fadel S, 2008, J MED MICROBIOL, V57, P1058, DOI 10.1099/jmm.0.2008/001305-0; Goellner S, 2006, INFECT IMMUN, V74, P4801, DOI 10.1128/IAI.01487-05; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Gomes JP, 2006, J BACTERIOL, V188, P275, DOI 10.1128/JB.188.1.275-286.2006; Gomes JP, 2004, J BACTERIOL, V186, P4295, DOI 10.1128/JB.186.13.4295-4306.2004; Goodall JC, 2001, EUR J IMMUNOL, V31, P1513, DOI 10.1002/1521-4141(200105)31:5<1513::AID-IMMU1513>3.0.CO;2-U; Henderson IR, 2001, TRENDS MICROBIOL, V9, P573, DOI 10.1016/S0966-842X(01)02234-X; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hendrixson DR, 1997, MOL MICROBIOL, V26, P505, DOI 10.1046/j.1365-2958.1997.5921965.x; Hogan RJ, 2003, MICROB PATHOGENESIS, V34, P11, DOI 10.1016/S0882-4010(02)00187-0; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Kari L, 2008, J INFECT DIS, V197, P449, DOI 10.1086/525285; Kiselev AO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000568; Klos A, 2009, FEMS MICROBIOL LETT, V291, P120, DOI 10.1111/j.1574-6968.2008.01446.x; KUO D, 1994, BIOCHEMISTRY-US, V33, P8347, DOI 10.1021/bi00193a023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CK, 1978, ANTIMICROB AGENTS CH, V13, P441, DOI 10.1128/AAC.13.3.441; Maurer AP, 2007, PLOS PATHOG, V3, P752, DOI 10.1371/journal.ppat.0030083; Maniatis T., 1989, MOL CLONING LAB MANU; Mathews SA, 1999, FEBS LETT, V458, P354, DOI 10.1016/S0014-5793(99)01182-5; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Navarro-Garcia F, 2001, INFECT IMMUN, V69, P1053, DOI 10.1128/IAI.69.2.1053-1060.2001; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; Niessner A, 2003, J INFECT DIS, V188, P108, DOI 10.1086/375827; Nunes A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r153; Nunes A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000878; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; SHACHTER J, 1999, CHLAMYDIA INTRACELLU; Shaw AC, 2002, PROTEOMICS, V2, P164, DOI 10.1002/1615-9861(200202)2:2<164::AID-PROT164>3.0.CO;2-U; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stothard DR, 2003, INFECT IMMUN, V71, P1200, DOI 10.1128/IAI.71.3.1200-1208.2003; SUCHLAND RJ, 1991, J CLIN MICROBIOL, V29, P1333, DOI 10.1128/JCM.29.7.1333-1338.1991; Swanson KA, 2009, INFECT IMMUN, V77, P508, DOI 10.1128/IAI.01173-08; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Turner DPJ, 2002, INFECT IMMUN, V70, P4447, DOI 10.1128/IAI.70.8.4447-4461.2002; Vandahl BBS, 2005, CELL MICROBIOL, V7, P825, DOI 10.1111/j.1462-5822.2005.00514.x; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; Wilmouth RC, 1999, BIOCHEMISTRY-US, V38, P7989, DOI 10.1021/bi990098y	49	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2009	4	4							e5191	10.1371/journal.pone.0005191	http://dx.doi.org/10.1371/journal.pone.0005191			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TS	19367336	Green Submitted, Green Published, gold			2022-12-27	WOS:000265510400004
J	Gonthier, B; Koncina, E; Satkauskas, S; Perraut, M; Roussel, G; Aunis, D; Kapfhammer, JP; Bagnard, D				Gonthier, Bertrand; Koncina, Eric; Satkauskas, Saulius; Perraut, Martine; Roussel, Guy; Aunis, Dominique; Kapfhammer, Josef P.; Bagnard, Dominique			A PKC-Dependent Recruitment of MMP-2 Controls Semaphorin-3A Growth-Promoting Effect in Cortical Dendrites	PLOS ONE			English	Article								There is increasing evidence for a crucial role of proteases and metalloproteinases during axon growth and guidance. In this context, we recently described a functional link between the chemoattractive Sema3C and Matrix metalloproteinase 3 (MMP3). Here, we provide data demonstrating the involvement of MMP-2 to trigger the growth-promoting effect of Sema3A in cortical dendrites. The in situ analysis of MMP-2 expression and activity is consistent with a functional growth assay demonstrating in vitro that the pharmacological inhibition of MMP-2 reduces the growth of cortical dendrites in response to Sema3A. Hence, our results suggest that the selective recruitment and activation of MMP-2 in response to Sema3A requires a PKC alpha dependent mechanism. Altogether, we provide a second set of data supporting MMPs as effectors of the growth-promoting effects of semaphorins, and we identify the potential signalling pathway involved.			Gonthier, B (corresponding author), INSERM, U575, Strasbourg, France.	dominique.bagnard@inserm.fr	Satkauskas, Saulius/AAD-7045-2020; Bagnard, Dominique/I-6535-2013; Dominique, Aunis/W-1419-2019; Satkauskas, Saulius/Z-4144-2019	Satkauskas, Saulius/0000-0002-9001-7767; Bagnard, Dominique/0000-0002-5261-902X				Antonov A A, 1997, Aviakosm Ekolog Med, V31, P34; Bagnard D, 2001, J NEUROSCI, V21, P3332, DOI 10.1523/JNEUROSCI.21-10-03332.2001; Bagnard D, 2004, MOL CELL NEUROSCI, V25, P722, DOI 10.1016/j.mcn.2003.12.007; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; da Rocha AB, 2000, PATHOBIOLOGY, V68, P113, DOI 10.1159/000055911; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fujioka S, 2003, BIOCHEM BIOPH RES CO, V301, P304, DOI 10.1016/S0006-291X(02)03023-1; Galko MJ, 2000, SCIENCE, V289, P1365, DOI 10.1126/science.289.5483.1365; Good PF, 2004, J NEUROCHEM, V91, P716, DOI 10.1111/j.1471-4159.2004.02766.x; Gundlfinger A, 2003, J NEUROBIOL, V57, P95, DOI 10.1002/neu.10259; Hanbali M, 2004, J NEUROCHEM, V90, P1423, DOI 10.1111/j.1471-4159.2004.02601.x; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hehr CL, 2005, DEVELOPMENT, V132, P3371, DOI 10.1242/dev.01908; Husain S, 2005, INVEST OPHTH VIS SCI, V46, P1706, DOI 10.1167/iovs.04-0993; Kennedy TE, 2000, BIOCHEM CELL BIOL, V78, P569, DOI 10.1139/bcb-78-5-569; Kolodkin AL, 1998, PROG BRAIN RES, V117, P115; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Koncina E, 2007, ADV EXP MED BIOL, V621, P50, DOI 10.1007/978-0-387-76715-4_4; Li L, 2005, DIABETES, V54, P2227, DOI 10.2337/diabetes.54.7.2227; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McAllister AK, 2002, NEURON, V33, P2, DOI 10.1016/S0896-6273(01)00577-3; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Metzger F, 2003, CEREBELLUM, V2, P206, DOI 10.1080/14734220310016150; Metzger F, 2000, EUR J NEUROSCI, V12, P1993, DOI 10.1046/j.1460-9568.2000.00086.x; Mikule K, 2003, J BIOL CHEM, V278, P21168, DOI 10.1074/jbc.M211828200; Miyazaki N, 1999, NEUROSCI RES, V33, P269, DOI 10.1016/S0168-0102(99)00015-2; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Oh LYS, 1999, J NEUROSCI, V19, P8464; Papadimitriou E, 2001, ENDOTHELIUM-J ENDOTH, V8, P181; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; QATSHA KA, 1993, P NATL ACAD SCI USA, V90, P4674, DOI 10.1073/pnas.90.10.4674; RANASINGHE HS, 2008, NEUROSCIENCE; Reber M, 2007, ADV EXP MED BIOL, V621, P32, DOI 10.1007/978-0-387-76715-4_3; ROTH L, 2008, CELL MOL LIFE SCI; Sakai T, 1999, J BIOL CHEM, V274, P29666, DOI 10.1074/jbc.274.42.29666; Schimmelpfeng K, 2001, MECH DEVELOP, V106, P25, DOI 10.1016/S0925-4773(01)00402-6; Schrenk K, 2002, NEUROSCIENCE, V110, P675, DOI 10.1016/S0306-4522(01)00559-0; SCHWAMBORN JC, 2004, J BIOL CHEM; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tsai CH, 2003, ORAL SURG ORAL MED O, V95, P710, DOI 10.1067/moe.2003.121; Vaillant C, 2003, MOL CELL NEUROSCI, V24, P395, DOI 10.1016/S1044-7431(03)00196-9; Vaillant C, 1999, J NEUROSCI, V19, P4994; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Wolman MA, 2004, J NEUROSCI, V24, P8428, DOI 10.1523/JNEUROSCI.2349-04.2004; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807	57	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5099	10.1371/journal.pone.0005099	http://dx.doi.org/10.1371/journal.pone.0005099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352510	Green Published, gold, Green Submitted			2022-12-27	WOS:000265505700010
J	Vargesson, N; Laufer, E				Vargesson, Neil; Laufer, Ed			Negative Smad Expression and Regulation in the Developing Chick Limb	PLOS ONE			English	Article								The inhibitory or negative Smads, Smad6 and Smad7, block TGF beta superfamily signals of both the BMP and TGF beta classes by antagonizing the intracellular signal transduction machinery. We report the cloning of one Smad6 and two Smad7 (Smad7a and Smad7b) chick homologs and their expression and regulation in the developing limb. Smad6 and Smad7a are expressed in dynamic patterns reflecting the domains of BMP gene expression in the limb. Activation and inhibition of the BMP signaling pathway in limb mesenchyme indicates that negative Smad gene expression is regulated, at least in part, by BMP family signals.			Vargesson, N (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen, Scotland.	elaufer@columbia.edu		Laufer, Edward/0000-0002-4933-1017; Vargesson, Neil/0000-0001-8027-114X				Amthor H, 2002, DEV BIOL, V243, P115, DOI 10.1006/dbio.2001.0555; Benson DA, 1998, NUCLEIC ACIDS RES, V26, P1, DOI 10.1093/nar/26.1.1; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Capdevila J, 1998, DEV BIOL, V197, P205, DOI 10.1006/dbio.1997.8824; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; FRANCIS PH, 1994, DEVELOPMENT, V120, P209; Hamburger H, 1951, J MORPHOL, V88, P49; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Laufer E, 1997, NATURE, V388, P400, DOI 10.1038/41143; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; MACKEM S, 1991, DEVELOPMENT, V112, P791; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Merino R, 1999, DEVELOPMENT, V126, P5515; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Montero JA, 2008, DEV BIOL, V321, P343, DOI 10.1016/j.ydbio.2008.06.022; Mowbray C, 2001, MECH DEVELOP, V108, P179, DOI 10.1016/S0925-4773(01)00479-8; Nakayama T, 1998, DEVELOPMENT, V125, P857; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Park SH, 2005, J BIOCHEM MOL BIOL, V38, P9; Pizette S, 2001, DEVELOPMENT, V128, P4463; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Robert B, 2007, DEV GROWTH DIFFER, V49, P455, DOI 10.1111/j.1440-169x.2007.00946.x; Suzuki T, 2008, P NATL ACAD SCI USA, V105, P4185, DOI 10.1073/pnas.0707899105; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Vargesson N, 2001, DEV BIOL, V240, P499, DOI 10.1006/dbio.2001.0481; Verheyden JM, 2008, NATURE, V454, P638, DOI 10.1038/nature07085; Yamada M, 1999, DEV BIOL, V215, P48, DOI 10.1006/dbio.1999.9419; Yokouchi Y, 1996, DEVELOPMENT, V122, P3725; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157; Zuzarte-Luis V, 2004, DEV BIOL, V272, P39, DOI 10.1016/j.ydbio.2004.04.015	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5173	10.1371/journal.pone.0005173	http://dx.doi.org/10.1371/journal.pone.0005173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352514	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505700025
J	Virador, VM; Davidson, B; Czechowicz, J; Mai, A; Kassis, J; Kohn, EC				Virador, Victoria M.; Davidson, Ben; Czechowicz, Josephine; Mai, Alisha; Kassis, Jareer; Kohn, Elise C.			The Anti-Apoptotic Activity of BAG3 Is Restricted by Caspases and the Proteasome	PLOS ONE			English	Article								Background: Caspase-mediated cleavage and proteasomal degradation of ubiquitinated proteins are two independent mechanisms for the regulation of protein stability and cellular function. We previously reported BAG3 overexpression protected ubiquitinated clients, such as AKT, from proteasomal degradation and conferred cytoprotection against heat shock. We hypothesized that the BAG3 protein is regulated by proteolysis. Methodology/Principal Findings: Staurosporine (STS) was used as a tool to test for caspase involvement in BAG3 degradation. MDA435 and HeLa human cancer cell lines exposed to STS underwent apoptosis with a concomitant time and dose-dependent loss of BAG3, suggesting the survival role of BAG3 was subject to STS regulation. zVAD-fmk or caspase 3 and 9 inhibitors provided a strong but incomplete protection of both cells and BAG3 protein. Two putative caspase cleavage sites were tested: K (E) under barV (D) under bar (BAG3(E345A/D347A)) within the proline-rich center of BAG3 (PXXP) and the C-terminal L (E) under barA (D) under bar site (BAG3(E516A/D518A)). PXXP deletion mutant and BAG3(E345A/D347A), or BAG3(E516A/D518A) respectively slowed or stalled STS-mediated BAG3 loss. BAG3, ubiquitinated under basal growth conditions, underwent augmented ubiquitination upon STS treatment, while there was no increase in ubiquitination of the BAG3(E516A/D518A) caspase-resistant mutant. Caspase and proteasome inhibition resulted in partial and independent protection of BAG3 whereas inhibitors of both blocked BAG3 degradation. STS-induced apoptosis was increased when BAG3 was silenced, and retention of BAG3 was associated with cytoprotection. Conclusions/Significance: BAG3 is tightly controlled by selective degradation during STS exposure. Loss of BAG3 under STS injury required sequential caspase cleavage followed by polyubiquitination and proteasomal degradation. The need for dual regulation of BAG3 in apoptosis suggests a key role for BAG3 in cancer cell resistance to apoptosis.			Virador, VM (corresponding author), NCI, Mol Signaling Sect, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	vvirador@helix.nih.gov	Virador, Victoria M./A-8173-2009		Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01SC009163, ZIASC009163] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Annunziata CM, 2007, CLIN CANCER RES, V13, P6585, DOI 10.1158/1078-0432.CCR-07-0327; Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Beere H M, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.93.re1; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Bonelli P, 2004, LEUKEMIA, V18, P358, DOI 10.1038/sj.leu.2403219; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Coulson M, 2005, GENETICS, V171, P1799, DOI 10.1534/genetics.105.043265; Didelot C, 2006, HANDB EXP PHARM, V172, P171; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Doong H, 2000, ONCOGENE, V19, P4385, DOI 10.1038/sj.onc.1203797; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Eichholtz-Wirth H, 2003, CANCER LETT, V194, P81, DOI 10.1016/S0304-3835(03)00009-0; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Frisch SM, 1999, CURR BIOL, V9, P1047, DOI 10.1016/S0960-9822(99)80455-2; Gao BX, 2006, J BIOL CHEM, V281, P29711, DOI 10.1074/jbc.M604596200; Han Z, 2000, CELL DEATH DIFFER, V7, P521, DOI 10.1038/sj.cdd.4400681; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.2353/ajpath.2006.060250; Karran L, 2001, CRIT REV EUKAR GENE, V11, P269; Kassis JN, 2006, EXP CELL RES, V312, P2962, DOI 10.1016/j.yexcr.2006.05.023; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Lauber K, 2001, J BIOL CHEM, V276, P29772, DOI 10.1074/jbc.M101524200; Lee JH, 1999, ONCOGENE, V18, P6183, DOI 10.1038/sj.onc.1203043; Mollerup J, 2005, FEBS LETT, V579, P4187, DOI 10.1016/j.febslet.2005.06.045; Nicholson DW, 2003, SCIENCE, V299, P214, DOI 10.1126/science.1081274; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Pochampally R, 1998, ONCOGENE, V17, P2629, DOI 10.1038/sj.onc.1202206; Romano MF, 2003, CELL DEATH DIFFER, V10, P383, DOI 10.1038/sj.cdd.4401167; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200; YOUN DY, 2008, AM J PHYSL ENDOCRINO	37	40	43	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5136	10.1371/journal.pone.0005136	http://dx.doi.org/10.1371/journal.pone.0005136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352495	gold, Green Submitted, Green Published			2022-12-27	WOS:000265505700023
J	Sudhakar, C; Nagabhushana, A; Jain, N; Swarup, G				Sudhakar, Cherukuri; Nagabhushana, Ananthamurthy; Jain, Nishant; Swarup, Ghanshyam			NF-kappa B Mediates Tumor Necrosis Factor alpha-Induced Expression of Optineurin, a Negative Regulator of NF-kappa B	PLOS ONE			English	Article								Optineurin is a ubiquitously expressed multifunctional cytoplasmic protein encoded by OPTN gene. The expression of optineurin is induced by various cytokines. Here we have investigated the molecular mechanisms which regulate optineurin gene expression and the relationship between optineurin and nuclear factor kappa B (NF-kappa B). We cloned and characterized human optineurin promoter. Optineurin promoter was activated upon treatment of HeLa and A549 cells with tumor necrosis factor alpha (TNF alpha). Mutation of a putative NF-kappa B-binding site present in the core promoter resulted in loss of basal as well as TNF alpha-induced activity. Overexpression of p65 subunit of NF-kappa B activated this promoter through NF-kappa B site. Oligonucleotides corresponding to this putative NF-kappa B-binding site showed binding to NF-kappa B. TNF alpha-induced optineurin promoter activity was inhibited by expression of inhibitor of NF-kappa B (kappa B alpha) super-repressor. Blocking of NF-kappa B activation resulted in inhibition of TNF alpha-induced optineurin gene expression. Overexpressed optineurin partly inhibited TNF alpha-induced NF-kappa B activation in Hela cells. Downregulation of optineurin by shRNA resulted in an increase in TNF alpha-induced as well as basal NF-kappa B activity. These results show that optineurin promoter activity and gene expression are regulated by NF-kappa B pathway in response to TNF alpha. In addition these results suggest that there is a negative feedback loop in which TNF alpha-induced NF-kappa B activity mediates expression of optineurin, which itself functions as a negative regulator of NF-kappa B.	[Sudhakar, Cherukuri; Nagabhushana, Ananthamurthy; Jain, Nishant; Swarup, Ghanshyam] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sudhakar, C (corresponding author), Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India.	gshyam@ccmb.res.in		Swarup, Ghanshyam/0000-0002-8098-0509				Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Alward WLM, 2003, AM J OPHTHALMOL, V136, P904, DOI 10.1016/S0002-9394(03)00577-4; Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Anto RJ, 2003, J BIOL CHEM, V278, P25490, DOI 10.1074/jbc.M301790200; Aung T, 2005, INVEST OPHTH VIS SCI, V46, P2816, DOI 10.1167/iovs.04-1133; Boye K, 2008, INT J CANCER, V123, P1301, DOI 10.1002/ijc.23617; Chalasani ML, 2007, INVEST OPHTH VIS SCI, V48, P1607, DOI 10.1167/iovs.06-0834; CHATURVEDI MM, 1994, J BIOL CHEM, V269, P14575; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; Fiedler MA, 1998, AM J RESP CELL MOL, V19, P259, DOI 10.1165/ajrcmb.19.2.3149; Funayama T, 2004, INVEST OPHTH VIS SCI, V45, P4359, DOI 10.1167/iovs.03-1403; Fuse N, 2004, J GLAUCOMA, V13, P299, DOI 10.1097/00061198-200408000-00007; Gupta V, 2006, J CELL SCI, V119, P1703, DOI 10.1242/jcs.02885; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Jain N, 2005, J BIOL CHEM, V280, P36664, DOI 10.1074/jbc.M413261200; Jain N, 2007, FEBS J, V274, P4396, DOI 10.1111/j.1742-4658.2007.05969.x; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kroeber M, 2006, EXP EYE RES, V82, P1075, DOI 10.1016/j.exer.2005.11.004; Leung YF, 2003, INVEST OPHTH VIS SCI, V44, P3880, DOI 10.1167/iovs.02-0693; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Mrowka R, 2008, FEBS J, V275, P3178, DOI 10.1111/j.1742-4658.2008.06471.x; Mukhopadhyay A, 2005, MOL VIS, V11, P792; Paliwal P, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-45; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Rezaie T, 2005, INVEST OPHTH VIS SCI, V46, P2404, DOI 10.1167/iovs.04-1243; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Sarfarazi Mansoor, 2003, Ophthalmol Clin North Am, V16, P529; Schwamborn K, 2000, J BIOL CHEM, V275, P22780, DOI 10.1074/jbc.M001500200; Takahashi Y, 2007, NEUROPATH APPL NEURO, V33, P692, DOI 10.1111/j.1365-2990.2007.00862.x; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Weisschuh N, 2007, EXP EYE RES, V85, P450, DOI 10.1016/j.exer.2007.06.012; Willoughby CE, 2004, INVEST OPHTH VIS SCI, V45, P3122, DOI 10.1167/iovs.04-0107; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	40	89	93	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5114	10.1371/journal.pone.0005114	http://dx.doi.org/10.1371/journal.pone.0005114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340308	Green Published, gold, Green Submitted			2022-12-27	WOS:000265500700017
J	Almog, M; Korngreen, A				Almog, Mara; Korngreen, Alon			Characterization of Voltage-Gated Ca2+ Conductances in Layer 5 Neocortical Pyramidal Neurons from Rats	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; CALCIUM-CHANNEL CURRENTS; T-TYPE; N-TYPE; TRANSMITTER RELEASE; APICAL DENDRITES; PROPAGATION; ACTIVATION; CELLS; FACILITATION	Neuronal voltage-gated Ca2+ channels are involved in electrical signalling and in converting these signals into cytoplasmic calcium changes. One important function of voltage-gated Ca2+ channels is generating regenerative dendritic Ca2+ spikes. However, the Ca2+ dependent mechanisms used to create these spikes are only partially understood. To start investigating this mechanism, we set out to kinetically and pharmacologically identify the sub-types of somatic voltage-gated Ca2+ channels in pyramidal neurons from layer 5 of rat somatosensory cortex, using the nucleated configuration of the patch-clamp technique. The activation kinetics of the total Ba2+ current revealed conductance activation only at medium and high voltages suggesting that T-type calcium channels were not present in the patches. Steady-state inactivation protocols in combination with pharmacology revealed the expression of R-type channels. Furthermore, pharmacological experiments identified 5 voltage-gated Ca2+ channel sub-types -L-, N-, R- and P/Q-type. Finally, the activation of the Ca2+ conductances was examined using physiologically derived voltage-clamp protocols including a calcium spike protocol and a mock back-propagating action potential (mBPAP) protocol. These experiments enable us to suggest the possible contribution of the five Ca2+ channel sub-types to Ca2+ current flow during activation under physiological conditions.	[Almog, Mara; Korngreen, Alon] Bar Ilan Univ, Leslie & Susan Gonda Interdisciplinary Brain Res, Ramat Gan, Israel; [Almog, Mara; Korngreen, Alon] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Almog, M (corresponding author), Bar Ilan Univ, Leslie & Susan Gonda Interdisciplinary Brain Res, Ramat Gan, Israel.	korngra@mail.biu.ac.il		Korngreen, Alon/0000-0002-2036-6160; Almog, Mara/0000-0002-6600-4966	Israeli Science Foundation [212/07]	Israeli Science Foundation(Israel Science Foundation)	This work was supported by a grant from the Israeli Science Foundation (212/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; BARGAS J, 1994, J NEUROSCI, V14, P6667; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; BROWN AM, 1993, J NEUROPHYSIOL, V70, P1530, DOI 10.1152/jn.1993.70.4.1530; Carrasco MA, 2006, CELL CALCIUM, V40, P575, DOI 10.1016/j.ceca.2006.08.021; COX DH, 1992, J NEUROSCI, V12, P906; CREUTZFELDT OD, 1977, NATURWISSENSCHAFTEN, V64, P507, DOI 10.1007/BF00483547; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; Gasparini S, 1997, PFLUG ARCH EUR J PHY, V435, P99, DOI 10.1007/s004240050488; Gulledge AT, 2003, J NEUROSCI, V23, P11363; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; Johnson SL, 2008, J PHYSIOL-LONDON, V586, P1029, DOI 10.1113/jphysiol.2007.145219; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Larkum ME, 2003, J PHYSIOL-LONDON, V549, P471, DOI 10.1113/jphysiol.2002.037614; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; Li LY, 2007, J NEUROSCI, V27, P13420, DOI 10.1523/JNEUROSCI.1709-07.2007; LORENZON NM, 1995, J NEUROPHYSIOL, V73, P1443, DOI 10.1152/jn.1995.73.4.1443; LORENZON NM, 1995, J NEUROPHYSIOL, V73, P1430, DOI 10.1152/jn.1995.73.4.1430; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; Mermelstein PG, 1999, J NEUROSCI, V19, P7268, DOI 10.1523/JNEUROSCI.19-17-07268.1999; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; REUTER H, 1983, NATURE, V301, P569, DOI 10.1038/301569a0; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; Scamps F, 1998, NEUROSCIENCE, V87, P719, DOI 10.1016/S0306-4522(98)00165-1; Schaefer AT, 2007, J PHYSIOL-LONDON, V579, P737, DOI 10.1113/jphysiol.2006.122564; SCHILLER J, 1995, J PHYSIOL-LONDON, V487, P583, DOI 10.1113/jphysiol.1995.sp020902; Schnee ME, 2003, J PHYSIOL-LONDON, V549, P697, DOI 10.1113/jphysiol.2002.037481; Serrano JR, 1999, J GEN PHYSIOL, V114, P185, DOI 10.1085/jgp.114.2.185; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Suedof Thomas C., 2008, V184, P1; TAKAHASHI K, 1991, J PHARMACOL EXP THER, V256, P169; TAKAHASHI K, 1991, J NEUROPHYSIOL, V65, P148, DOI 10.1152/jn.1991.65.1.148; Tanabe M, 1998, J NEUROPHYSIOL, V80, P2268, DOI 10.1152/jn.1998.80.5.2268; Tarasenko AN, 1998, J PHYSIOL-LONDON, V509, P385, DOI 10.1111/j.1469-7793.1998.385bn.x; Taverna E, 2002, J CELL SCI, V115, P3909, DOI 10.1242/jcs.00072; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; Wang G, 1999, J NEUROSCI, V19, P9235; Wu LG, 1999, J NEUROSCI, V19, P726; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; YE JH, 1993, BRAIN RES, V606, P111, DOI 10.1016/0006-8993(93)91577-F; Zamponi GW, 1998, P NATL ACAD SCI USA, V95, P4035, DOI 10.1073/pnas.95.7.4035; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x	56	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e4841	10.1371/journal.pone.0004841	http://dx.doi.org/10.1371/journal.pone.0004841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337371	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500600001
J	Stephen, ID; Coetzee, V; Smith, ML; Perrett, DI				Stephen, Ian D.; Coetzee, Vinet; Smith, Miriam Law; Perrett, David I.			Skin Blood Perfusion and Oxygenation Colour Affect Perceived Human Health	PLOS ONE			English	Article							FACIAL ATTRACTIVENESS; SEXUAL SELECTION; FLOW; AGE; PERCEPTION; IMMUNOCOMPETENCE; AVERAGENESS; PERFORMANCE; SYMMETRY; EXERCISE	Skin blood perfusion and oxygenation depends upon cardiovascular, hormonal and circulatory health in humans and provides socio-sexual signals of underlying physiology, dominance and reproductive status in some primates. We allowed participants to manipulate colour calibrated facial photographs along empirically-measured oxygenated and deoxygenated blood colour axes both separately and simultaneously, to optimise healthy appearance. Participants increased skin blood colour, particularly oxygenated, above basal levels to optimise healthy appearance. We show, therefore, that skin blood perfusion and oxygenation influence perceived health in a way that may be important to mate choice.	[Stephen, Ian D.; Coetzee, Vinet; Smith, Miriam Law; Perrett, David I.] Univ St Andrews, Sch Psychol, Percept Lab, St Andrews KY16 9AJ, Fife, Scotland	University of St Andrews	Stephen, ID (corresponding author), Univ St Andrews, Sch Psychol, Percept Lab, St Andrews KY16 9AJ, Fife, Scotland.	is77@st-andrews.ac.uk; dp@st-andrews.ac.uk	Coetzee, Vinet/F-2155-2011; Stephen, Ian/ABA-6218-2021	Coetzee, Vinet/0000-0003-1716-0804; Perrett, David/0000-0002-6025-0939; Stephen, Ian/0000-0001-9714-8295	BBSRC; Unilever Research	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Unilever Research(Unilever)	This work was supported by the BBSRC and Unilever Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen T, 2001, P NATL ACAD SCI USA, V98, P13155, DOI 10.1073/pnas.211439298; Armstrong N, 2001, EUR J APPL PHYSIOL, V85, P546, DOI 10.1007/s004210100485; Barber N, 1995, ETHOL SOCIOBIOL, V16, P395, DOI 10.1016/0162-3095(95)00068-2; Barton RA, 2005, NATURE, V437, pE10, DOI 10.1038/nature04307; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Bourne GR, 2003, NATURWISSENSCHAFTEN, V90, P402, DOI 10.1007/s00114-003-0444-1; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; BUSSE W W, 1989, Drugs, V37, P1; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Charkoudian N, 2003, MAYO CLIN PROC, V78, P603, DOI 10.4065/78.5.603; Charkoudian N, 1999, J APPL PHYSIOL, V87, P1719, DOI 10.1152/jappl.1999.87.5.1719; Drummond PD, 2000, PERS INDIV DIFFER, V29, P1123, DOI 10.1016/S0191-8869(99)00259-7; Drummond PD, 2001, PSYCHOPHYSIOLOGY, V38, P190, DOI 10.1111/1469-8986.3820190; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; FEATHER JW, 1988, PHYS MED BIOL, V33, P711, DOI 10.1088/0031-9155/33/6/005; Fink B, 2001, J COMP PSYCHOL, V115, P92, DOI 10.1037//0735-7036.115.1.92; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Greenlees I, 2008, J SPORT SCI, V26, P569, DOI 10.1080/02640410701744446; HILL GE, 1990, ANIM BEHAV, V40, P563, DOI 10.1016/S0003-3472(05)80537-8; Hill RA, 2005, NATURE, V435, P293, DOI 10.1038/435293a; Hong GW, 2001, COLOR RES APPL, V26, P76, DOI 10.1002/1520-6378(200102)26:1<76::AID-COL8>3.0.CO;2-3; Johnson JM, 1998, MED SCI SPORT EXER, V30, P382, DOI 10.1097/00005768-199803000-00007; Jones BC, 2005, P ROY SOC B-BIOL SCI, V272, P347, DOI 10.1098/rspb.2004.2962; Jones BC, 2004, PERCEPTION, V33, P569, DOI 10.1068/p3463; Jones D., 2000, ADAPTATION HUMAN BEH, P133; Kilner R, 1997, P ROY SOC B-BIOL SCI, V264, P963, DOI 10.1098/rspb.1997.0133; LEARY MR, 1992, PSYCHOL BULL, V112, P446, DOI 10.1037/0033-2909.112.3.446; Little A.C., 2007, J EVOLUTIONARY PSYCH, V5, P161, DOI [10. 1556/JEP. 2007. 1008, DOI 10.1556/JEP.2007.1008, https://doi.org/10.1556/JEP.2007.1008]; LIU D, 1992, DIABETOLOGIA, V35, P287, DOI 10.1007/BF00400932; Maddox KB, 2002, PERS SOC PSYCHOL B, V28, P250, DOI 10.1177/0146167202282010; Massaro M, 2003, BEHAV ECOL SOCIOBIOL, V55, P169, DOI 10.1007/s00265-003-0683-3; Matts PJ, 2007, J AM ACAD DERMATOL, V57, P977, DOI 10.1016/j.jaad.2007.07.040; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; Muhe L, 1999, ARCH DIS CHILD, V81, P216, DOI 10.1136/adc.81.3.216; Muhe L, 2000, TROP MED INT HEALTH, V5, P805, DOI 10.1046/j.1365-3156.2000.00637.x; Negro JJ, 2006, COMP BIOCHEM PHYS A, V143, P78, DOI 10.1016/j.cbpa.2005.10.028; PANZA JA, 1990, NEW ENGL J MED, V323, P22, DOI 10.1056/NEJM199007053230105; Peters A, 2004, J EVOLUTION BIOL, V17, P1111, DOI 10.1111/j.1420-9101.2004.00743.x; Ponsonby AL, 1997, PEDIATRICS, V99, pE31, DOI 10.1542/peds.99.1.e3; Reybrouck T, 1999, CHEST, V115, P788, DOI 10.1378/chest.115.3.788; Rhodes G, 2007, PERCEPTION, V36, P1244, DOI 10.1068/p5712; Rhodes L, 1997, J REPROD FERTIL, V111, P51; RICHARDSON D, 1987, ARCH ENVIRON HEALTH, V42, P19, DOI 10.1080/00039896.1987.9935790; Roberts SC, 2005, EVOL HUM BEHAV, V26, P213, DOI 10.1016/j.evolhumbehav.2004.09.002; Russell R, 2003, PERCEPTION, V32, P1093, DOI 10.1068/p5101; Saks L, 2003, OECOLOGIA, V134, P301, DOI 10.1007/s00442-002-1125-z; Setchell JM, 2005, ETHOLOGY, V111, P25, DOI 10.1111/j.1439-0310.2004.01054.x; Setchell JM, 2006, P ROY SOC B-BIOL SCI, V273, P2395, DOI 10.1098/rspb.2006.3573; Sotchell JM, 2001, HORM BEHAV, V39, P177, DOI 10.1006/hbeh.2000.1628; SYMON D, 1995, CHIC SEX HIST SOC, P80; Symons D, 1979, EVOLUTION HUMAN SEXU; TANKERSLEY CG, 1991, J APPL PHYSIOL, V71, P236, DOI 10.1152/jappl.1991.71.1.236; THORNHILL R, 1993, HUM NATURE-INT BIOS, V4, P237, DOI 10.1007/BF02692201; Thornton MJ, 2002, EXP DERMATOL, V11, P487, DOI 10.1034/j.1600-0625.2002.110601.x; Waitt C, 2003, P ROY SOC B-BIOL SCI, V270, pS144, DOI 10.1098/rsbl.2003.0065; Waitt C, 2006, AM J PRIMATOL, V68, P738, DOI 10.1002/ajp.20264	56	139	140	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5083	10.1371/journal.pone.0005083	http://dx.doi.org/10.1371/journal.pone.0005083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PY	19337378	Green Submitted, Green Published, gold			2022-12-27	WOS:000265500600021
J	Petrie, KA; Lee, WH; Bullock, AN; Pointon, JJ; Smith, R; Russell, RGG; Brown, MA; Wordsworth, BP; Triffitt, JT				Petrie, Kirsten A.; Lee, Wen Hwa; Bullock, Alex N.; Pointon, Jenny J.; Smith, Roger; Russell, R. Graham G.; Brown, Matthew A.; Wordsworth, B. Paul; Triffitt, James T.			Novel Mutations in ACVR1 Result in Atypical Features in Two Fibrodysplasia Ossificans Progressiva Patients	PLOS ONE			English	Article							TGF-BETA RECEPTOR; CLINICAL-FEATURES; RECURRENT; GENE	Fibrodysplasia Ossificans Progressiva (FOP) is a rare, heritable condition typified by progression of extensive ossification within skeletal muscle, ligament and tendon together with defects in skeletal development. The condition is easily diagnosed by the presence of shortened great toes and there is severe advancement of disability with age. FOP has been shown to result from a point mutation (c.617G>A) in the ACVR1 gene in almost all patients reported. Very recently two other mutations have been described in three FOP patients. We present here evidence for two further unique mutations (c.605G>T and c.983G>A) in this gene in two FOP patients with some atypical digit abnormalities and other clinical features. The observation of disparate missense mutations mapped to the GS and kinase domains of the protein supports the disease model of mild kinase activation and provides a potential rationale for phenotypic variation.	[Petrie, Kirsten A.; Pointon, Jenny J.; Smith, Roger; Russell, R. Graham G.; Wordsworth, B. Paul; Triffitt, James T.] Univ Oxford, Nuffield Dept Orthopaed Surg, Botnar Res Ctr, Inst Musculoskeletal Sci, Oxford, England; [Lee, Wen Hwa; Bullock, Alex N.] Univ Oxford, ORCRB, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford, England; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metabol Med, Woolloongabba, Qld 4067, Australia	University of Oxford; University of Oxford; University of Queensland	Petrie, KA (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Surg, Botnar Res Ctr, Inst Musculoskeletal Sci, Oxford, England.	jim.triffitt@gmail.com	Lee, Wen Hwa/GZA-8183-2022; Lee, Wen Hwa/G-1250-2013; Brown, Matthew A/E-5749-2010	Lee, Wen Hwa/0000-0002-4098-5225; Lee, Wen Hwa/0000-0002-4098-5225; Brown, Matthew A/0000-0003-0538-8211; Russell, Robert Graham G/0000-0002-4136-1828	University of Oxford FOP Research Fund; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck & Co., Inc.; Novartis Research Foundation; Swedish Foundation for Strategic Research; Wellcome Trust;  [1097737]	University of Oxford FOP Research Fund; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Genomics Institute; GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck & Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); 	This work was funded in part by the University of Oxford FOP Research Fund. W.H.L and A.N.B are funded by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Bocciardi R, 2009, EUR J HUM GENET, V17, P311, DOI 10.1038/ejhg.2008.178; CONNOR JM, 1982, BRIT J RADIOL, V55, P492, DOI 10.1259/0007-1285-55-655-492; CONNOR JM, 1982, J BONE JOINT SURG BR, V64, P76, DOI 10.1302/0301-620X.64B1.7068725; FUKUDA T, 2008, J BIOL CHEM; Furuya H, 2008, AM J MED GENET A, V146A, P459, DOI 10.1002/ajmg.a.32151; Groppe JC, 2007, CLIN ORTHOP RELAT R, P87, DOI 10.1097/BLO.0b013e318126c049; Hebela N, 2005, CLIN REV BONE MINER, V3, P205, DOI 10.1385/BMM:3:3-4:205; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Lin GT, 2006, J HUM GENET, V51, P1083, DOI 10.1007/s10038-006-0069-2; Nakajima M, 2007, J HUM GENET, V52, P473, DOI 10.1007/s10038-007-0128-3; Shore EM, 2005, CLIN REV BONE MINER, V3, P201, DOI 10.1385/BMM:3:3-4:201; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Smith R, 1997, NEUROMUSCULAR DISORD, V7, P407, DOI 10.1016/S0960-8966(97)87158-1; SMITH R, 1976, J BONE JOINT SURG BR, V58, P48, DOI 10.1302/0301-620X.58B1.818090; WANG TW, 1994, SCIENCE, V265, P674, DOI 10.1126/science.7518616; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	19	60	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2009	4	3							e5005	10.1371/journal.pone.0005005	http://dx.doi.org/10.1371/journal.pone.0005005			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PP	19330033	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499700003
J	Wadia, JS; Schaller, M; Williamson, RA; Dowdy, SF				Wadia, Jehangir S.; Schaller, Monica; Williamson, R. Anthony; Dowdy, Steven F.			Pathologic Prion Protein Infects Cells by Lipid-Raft Dependent Macropinocytosis	PLOS ONE			English	Article							SUBCELLULAR TRAFFICKING; N-TERMINUS; PRP; MECHANISMS; PEPTIDES; MICE; NEURODEGENERATION; NEUROTOXICITY; TRANSDUCTION; CHOLESTEROL	Transmissible spongiform encephalopathies, including variant-Creutzfeldt-Jakob disease (vCJD) in humans and bovine spongiform encephalopathies in cattle, are fatal neurodegenerative disorders characterized by protein misfolding of the host cellular prion protein (PrPC) to the infectious scrapie form (PrPSc). However, the mechanism that exogenous PrPSc infects cells and where pathologic conversion of PrPC to the PrPSc form occurs remains uncertain. Here we report that similar to the mechanism of HIV-1 TAT-mediated peptide transduction, processed mature, full length PrP contains a conserved N-terminal cationic domain that stimulates cellular uptake by lipid raft-dependent, macropinocytosis. Inhibition of macropinocytosis by three independent means prevented cellular uptake of recombinant PrP; however, it did not affect recombinant PrP cell surface association. In addition, fusion of the cationic N-terminal PrP domain to a Cre recombinase reporter protein was sufficient to promote both cellular uptake and escape from the macropinosomes into the cytoplasm. Inhibition of macropinocytosis was sufficient to prevent conversion of PrPC to the pathologic PrPSc form in N2a cells exposed to strain RML PrPSc infected brain homogenates, suggesting that a critical determinant of PrPC conversion occurs following macropinocytotic internalization and not through mere membrane association. Taken together, these observations provide a cellular mechanism that exogenous pathological PrPSc infects cells by lipid raft dependent, macropinocytosis.	[Wadia, Jehangir S.; Dowdy, Steven F.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Wadia, Jehangir S.; Dowdy, Steven F.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Schaller, Monica; Williamson, R. Anthony] Scripps Res Inst, Dept Immunol, La Jolla, CA USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Scripps Research Institute	Wadia, JS (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	sdowdy@ucsd.edu	wadia, jay/AAQ-9944-2021	Schaller, Monica/0000-0002-5002-2238				Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Cai SR, 2006, EUR J PHARM SCI, V27, P311, DOI 10.1016/j.ejps.2005.10.011; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; Gilch S, 2007, FEBS J, V274, P5834, DOI 10.1111/j.1742-4658.2007.06105.x; Griffiths RE, 2007, BLOOD, V110, P4518, DOI 10.1182/blood-2007-04-085183; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Harris D A, 1999, Curr Issues Mol Biol, V1, P65; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kiachopoulos S, 2004, TRAFFIC, V5, P426, DOI 10.1111/j.1398-9219.2004.00185.x; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Lofgren I, 2008, FASEB J, V22; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Magzoub M, 2006, BIOCHEM BIOPH RES CO, V348, P379, DOI 10.1016/j.bbrc.2006.07.065; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Medina-Kauwe LK, 2007, ADV DRUG DELIVER REV, V59, P798, DOI 10.1016/j.addr.2007.06.009; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; Murriel Christopher L, 2006, Expert Opin Drug Deliv, V3, P739, DOI 10.1517/17425247.3.6.739; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Nunziante M, 2003, CHEMBIOCHEM, V4, P1268, DOI 10.1002/cbic.200300704; Nunziante M, 2003, J BIOL CHEM, V278, P3726, DOI 10.1074/jbc.M206313200; OLIVER JM, 1984, METHOD ENZYMOL, V108, P336; Pan T, 2002, BIOCHEM J, V368, P81, DOI 10.1042/BJ20020773; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Perez M, 1998, BIOCHEM J, V335, P369, DOI 10.1042/bj3350369; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Tatzelt J, 2007, FEBS J, V274, P606, DOI 10.1111/j.1742-4658.2007.05633.x; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Walmsley AR, 2003, J BIOL CHEM, V278, P37241, DOI 10.1074/jbc.M302036200; WATTS JC, 2006, PLOS PATHOG E, V26, P152; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Weissmann C, 2003, BRIT MED BULL, V66, P43, DOI 10.1093/bmb/66.1.43; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731	53	54	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3314	10.1371/journal.pone.0003314	http://dx.doi.org/10.1371/journal.pone.0003314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	19390657	gold, Green Submitted, Green Published			2022-12-27	WOS:000264797300005
J	Ounpraseuth, S; Rafferty, TM; McDonald-Phillips, RE; Gammill, WM; Siegel, ER; Wheeler, KL; Nilsson, EA; Cooney, CA				Ounpraseuth, Songthip; Rafferty, Tonya M.; McDonald-Phillips, Rachel E.; Gammill, Whitney M.; Siegel, Eric R.; Wheeler, Kristin L.; Nilsson, Erik A.; Cooney, Craig A.			A Method to Quantify Mouse Coat-Color Proportions	PLOS ONE			English	Article							AGOUTI GENE-EXPRESSION; GERM-LINE TRANSMISSION; EMBRYONIC STEM-CELLS; DNA METHYLATION; MUTATIONS; PHENOTYPE; AGREEMENT; GENOME; SITES; LOCUS	Coat-color proportions and patterns in mice are used as assays for many processes such as transgene expression, chimerism, and epigenetics. In many studies, coat-color readouts are estimated from subjective scoring of individual mice. Here we show a method by which mouse coat color is quantified as the proportion of coat shown in one or more digital images. We use the yellow-agouti mouse model of epigenetic variegation to demonstrate this method. We apply this method to live mice using a conventional digital camera for data collection. We use a raster graphics editing program to convert agouti regions of the coat to a standard, uniform, brown color and the yellow regions of the coat to a standard, uniform, yellow color. We use a second program to quantify the proportions of these standard colors. This method provides quantification that relates directly to the visual appearance of the live animal. It also provides an objective analysis with a traceable record, and it should allow for precise comparisons of mouse coats and mouse cohorts within and between studies.			Ounpraseuth, S (corresponding author), Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA.	CooneyCraigA@uams.edu		Cooney, Craig/0000-0003-4279-557X; Siegel, Eric/0000-0001-9824-6612	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020641] Funding Source: NIH RePORTER; NIA NIH HHS [P01AG20641, P01 AG020641] Funding Source: Medline; NIDDK NIH HHS [R01DK63945, R01 DK063945] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Badger TM, 2008, EXP BIOL MED, V233, P1242, DOI 10.3181/0802-RM-60; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Castilho A, 1999, J CELL SCI, V112, P4397; Cooney CA, 2002, J NUTR, V132, p2393S; COONEY CA, 2006, NUTRIGENOMICS CONCEP, P219; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Fayers P., 2007, QUALITY LIFE ASSESSM; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Grahn RA, 2005, ANIM GENET, V36, P67, DOI 10.1111/j.1365-2052.2005.01239.x; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Koji T, 2008, HISTOCHEM CELL BIOL, V130, P917, DOI 10.1007/s00418-008-0487-7; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8927, DOI 10.1073/pnas.86.22.8927; Komashko VM, 2008, GENOME RES, V18, P521, DOI 10.1101/gr.074609.107; Leakey TI, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn210; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Mynatt RL, 2001, AM J PHYSIOL-CELL PH, V280, pC954, DOI 10.1152/ajpcell.2001.280.4.C954; R Core Team, 2018, R LANG ENV STAT COMP; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Trut LN, 1999, AM SCI, V87, P160, DOI 10.1511/1999.20.813; VANBELLE G, 2002, STAT RULES THUMB, P65; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Ware CB, 2003, TRANSGENIC RES, V12, P743, DOI 10.1023/B:TRAG.0000005246.35812.c8; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Wolff GL, 1999, PHYSIOL GENOMICS, V1, P151, DOI 10.1152/physiolgenomics.1999.1.3.151; WOLFF GL, 1978, GENETICS, V88, P529; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Wu M, 1997, P NATL ACAD SCI USA, V94, P890, DOI 10.1073/pnas.94.3.890; Yan Pearlly S., 2009, V507, P89, DOI 10.1007/978-1-59745-522-0_8	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5414	10.1371/journal.pone.0005414	http://dx.doi.org/10.1371/journal.pone.0005414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404391	Green Published, Green Submitted, gold			2022-12-27	WOS:000265614900023
J	Wei, JX; Yang, J; Sun, JF; Jia, LT; Zhang, Y; Zhang, HZ; Li, X; Meng, YL; Yao, LB; Yang, AG				Wei, Jun-Xia; Yang, Jie; Sun, Ji-Feng; Jia, Lin-Tao; Zhang, Yong; Zhang, Hui-Zhong; Li, Xia; Meng, Yan-Ling; Yao, Li-Bo; Yang, An-Gang			Both Strands of siRNA Have Potential to Guide Posttranscriptional Gene Silencing in Mammalian Cells	PLOS ONE			English	Article							PASSENGER-STRAND; RNAI; EXPRESSION; SURVIVIN; CLEAVAGE; DICER; TRBP	Despite the widespread application of RNA interference (RNAi) as a research tool for diverse purposes, the key step of strand selection of siRNAs during the formation of RNA-induced silencing complex (RISC) remains poorly understood. Here, using siRNAs targeted to the complementary region of Survivin and the effector protease receptor 1 (EPR-1), we show that both strands of the siRNA duplex can find their target mRNA and are equally eligible for assembly into Argonaute 2 (Ago2) of RISC in HEK293 cells. Transfection of the synthetic siRNA duplexes with different thermodynamic profiles or short hairpin RNA (shRNA) vectors that generate double-stranded RNAs (dsRNAs), permitting processing specifically from either the 59 or 39 end of the incipient siRNA, results in the degradation of the respective target mRNAs of either strand of the siRNA duplex with comparable efficiencies. Thus, while most RNAi reactions may follow the thermodynamic asymmetry rule in strand selection, our study suggests an exceptional mode for certain siRNAs in which both strands of the duplex are competent in sponsoring RNAi, and implies additional factors that might dictate the RNAi targets.			Wei, JX (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Biochem & Mol Biol, Xian 710032, Peoples R China.	agyang@fmmu.edu.cn	meng, yan/GSE-2653-2022; Meng, Yan/HGC-0394-2022					ALTIERI DC, 1995, FASEB J, V9, P860, DOI 10.1096/fasebj.9.10.7615156; Altieri DC, 2001, TRENDS MOL MED, V7, P542, DOI 10.1016/S1471-4914(01)02243-2; Ambrosini G, 1998, J BIOL CHEM, V273, P11177, DOI 10.1074/jbc.273.18.11177; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Clark PR, 2008, NUCLEIC ACIDS RES, V36, P1081, DOI 10.1093/nar/gkm630; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hong J, 2008, BIOCHEM BIOPH RES CO, V368, P703, DOI 10.1016/j.bbrc.2008.01.116; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; JONATHAN BP, 2006, CURR BIOL, V16, P530; JULIANA ML, 2004, RNA, V10, P766; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Mahotka C, 1999, CANCER RES, V59, P6097; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; OZGUR AO, 2007, LEUKEMIA RES, V31, P1495; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shinozawa I, 2000, LEUKEMIA RES, V24, P965, DOI 10.1016/S0145-2126(00)00065-5; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; TETSUHISA Y, 2001, MED ELECT MICROSC, V34, P12; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	30	31	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5382	10.1371/journal.pone.0005382	http://dx.doi.org/10.1371/journal.pone.0005382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401777	Green Published, gold, Green Submitted			2022-12-27	WOS:000265601100019
J	Distel, MA; Rebollo-Mesa, I; Willemsen, G; Derom, CA; Trull, TJ; Martin, NG; Boomsma, DI				Distel, Marijn A.; Rebollo-Mesa, Irene; Willemsen, Gonneke; Derom, Catherine A.; Trull, Timothy J.; Martin, Nicholas G.; Boomsma, Dorret I.			Familial Resemblance of Borderline Personality Disorder Features: Genetic or Cultural Transmission?	PLOS ONE			English	Article							MENTAL-ILLNESS; SEXUAL ABUSE; RISK-FACTORS; TWINS; PSYCHOPATHOLOGY; COMORBIDITY; INHERITANCE; RELATIVES; MODEL; POWER	Borderline personality disorder is a severe personality disorder for which genetic research has been limited to family studies and classical twin studies. These studies indicate that genetic effects explain 35 to 45% of the variance in borderline personality disorder and borderline personality features. However, effects of non-additive (dominance) genetic factors, non-random mating and cultural transmission have generally not been explored. In the present study an extended twin-family design was applied to self-report data of twins (N = 5,017) and their siblings (N = 1,266), parents (N = 3,064) and spouses (N = 939) from 4,015 families, to estimate the effects of additive and non-additive genetic and environmental factors, cultural transmission and non-random mating on individual differences in borderline personality features. Results showed that resemblance among biological relatives could completely be attributed to genetic effects. Variation in borderline personality features was explained by additive genetic (21%; 95% CI 17-26%) and dominant genetic (24%; 95% CI 17-31%) factors. Environmental influences (55%; 95% CI 51-60%) explained the remaining variance. Significant resemblance between spouses was observed, which was best explained by phenotypic assortative mating, but it had only a small effect on the genetic variance (1% of the total variance). There was no effect of cultural transmission from parents to offspring.			Distel, MA (corresponding author), Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands.	ma.distel@psy.vu.nl	Trull, Timothy/E-9804-2019; Rebollo Mesa, Irene/D-2678-2009; Boomsma, Dorret I/AAX-4470-2020	Rebollo Mesa, Irene/0000-0002-0264-9538; Willemsen, Gonneke/0000-0003-3755-0236; Martin, Nicholas/0000-0003-4069-8020; Derom, Catherine/0000-0001-5574-796X	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018673, R37DA018673] Funding Source: NIH RePORTER; NIDA NIH HHS [R37 DA018673, R01 DA018673, DA018673] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bandelow B, 2005, PSYCHIAT RES, V134, P169, DOI 10.1016/j.psychres.2003.07.008; BOOMSMA DI, 1987, ACTA GENET MED GEMEL, V36, P29, DOI 10.1017/S0001566000004566; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; CLONINGER CR, 1979, AM J HUM GENET, V31, P176; CLONINGER CR, 1980, GENET RES, V36, P133, DOI 10.1017/S0016672300019765; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; De Moor MHM, 2009, PSYCHOL ASSESSMENT, V21, P125, DOI 10.1037/a0014502; DEROM C, 2005, MULTIPLE PREGNANCY E, P39; Derom CA, 2006, TWIN RES HUM GENET, V9, P733, DOI 10.1375/183242706779462723; Distel MA, 2008, PSYCHOL MED, V38, P1219, DOI 10.1017/S0033291707002024; Distel MA, 2007, TWIN RES HUM GENET, V10, P348, DOI 10.1375/twin.10.2.348; Distel MA, 2008, PSYCHIAT GENET, V18, P302, DOI 10.1097/YPG.0b013e3283118468; Eaves L, 1999, Twin Res, V2, P62, DOI 10.1375/twin.2.2.62; Eaves L J, 1998, Twin Res, V1, P131, DOI 10.1375/twin.1.3.131; EAVES LJ, 1978, HEREDITY, V41, P249, DOI 10.1038/hdy.1978.101; EAVES LJ, 1999, AM PSYCHOP, P269; Falconer D. S., 1996, INTRO QUANTITATIVE G; FULKER DW, 1982, HUMAN GENETICS A, P395; GARRISON RJ, 1968, EUGEN QUART, V15, P113, DOI 10.1080/19485565.1968.9987762; HEATH AC, 1985, BEHAV GENET, V15, P439, DOI 10.1007/BF01066238; HEATH AC, 1985, BEHAV GENET, V15, P15, DOI 10.1007/BF01071929; Jacobo MC, 2007, J PERS ASSESS, V88, P74, DOI 10.1207/s15327752jpa8801_10; Keller MC, 2005, TWIN RES HUM GENET, V8, P201, DOI 10.1375/twin.8.3.201; Keller MC, 2005, BEHAV GENET, V35, P707, DOI 10.1007/s10519-005-6041-7; Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P1438, DOI 10.1001/archpsyc.65.12.1438; Lake RIE, 2000, BEHAV GENET, V30, P223, DOI 10.1023/A:1001918408984; Lenzenweger MF, 2007, BIOL PSYCHIAT, V62, P553, DOI 10.1016/j.biopsych.2006.09.019; Machizawa-Summers S, 2007, INT J PSYCHOL, V42, P265, DOI 10.1080/00207590601109276; Maes HHM, 1998, PSYCHOL MED, V28, P1389, DOI 10.1017/S0033291798007326; MARTIN NG, 1978, HEREDITY, V40, P97, DOI 10.1038/hdy.1978.10; Mathews CA, 2001, COMPR PSYCHIAT, V42, P257, DOI 10.1053/comp.2001.24575; McCrae RR, 2001, J PERS, V69, P155, DOI 10.1111/1467-6494.00140; MERIKANGAS KR, 1982, ARCH GEN PSYCHIAT, V39, P1173; Morey L.C., 1991, PERSONALITY ASSESSME; Morey L.C., 2003, ESSENTIALS PAI ASSES, V29; MOREY LC, 1988, J ABNORM PSYCHOL, V97, P314, DOI 10.1037/0021-843X.97.3.314; NEALE MC, 1994, BEHAV GENET, V24, P119, DOI 10.1007/BF01067816; Neale MC, 2003, MX STAT MODELLING; NIGG JT, 1994, PSYCHOL BULL, V115, P346, DOI 10.1037/0033-2909.115.3.346; Penrose LS, 1944, PSYCHIAT QUART, V18, P161, DOI 10.1007/BF01561963; Posthuma D, 2000, BEHAV GENET, V30, P147, DOI 10.1023/A:1001959306025; Rebollo I, 2006, BEHAV GENET, V36, P216, DOI 10.1007/s10519-005-9025-8; Rettew DC, 2008, BEHAV GENET, V38, P223, DOI 10.1007/s10519-008-9192-5; Reynolds CA, 2006, BEHAV GENET, V36, P201, DOI 10.1007/s10519-005-9026-7; Skodol AE, 2002, BIOL PSYCHIAT, V51, P936, DOI 10.1016/S0006-3223(02)01324-0; Stein MB, 2007, J PERS ASSESS, V88, P81, DOI 10.1207/s15327752jpa8801_11; Torgersen S, 2008, PSYCHOL MED, V38, P1617, DOI 10.1017/S0033291708002924; Trull TJ, 2001, J PERS DISORD, V15, P19, DOI 10.1521/pedi.15.1.19.18647; TRULL TJ, 1995, PSYCHOL ASSESSMENT, V7, P33, DOI 10.1037/1040-3590.7.1.33; van Grootheest DS, 2008, PSYCHOL MED, V38, P1731, DOI 10.1017/S0033291708003024; WESTEN D, 1990, AM J ORTHOPSYCHIAT, V60, P55, DOI 10.1037/h0079175; White CN, 2003, HARVARD REV PSYCHIAT, V11, P8, DOI 10.1080/10673220303937; Willemsen G, 2005, TWIN RES HUM GENET, V8, P312, DOI 10.1375/twin.8.4.312; Zanarini MC, 2002, J NERV MENT DIS, V190, P381, DOI 10.1097/00005053-200206000-00006; Zanarini MC, 2004, J PERS DISORD, V18, P439, DOI 10.1521/pedi.18.5.439.51327	56	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5334	10.1371/journal.pone.0005334	http://dx.doi.org/10.1371/journal.pone.0005334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437VG	19390632	gold, Green Published			2022-12-27	WOS:000265514400019
J	Reuter, S; Schnockel, U; Schroter, R; Schober, O; Pavenstadt, H; Schafers, M; Gabriels, G; Schlatter, E				Reuter, Stefan; Schnoeckel, Uta; Schroeter, Rita; Schober, Otmar; Pavenstaedt, Hermann; Schaefers, Michael; Gabrieels, Gert; Schlatter, Eberhard			Non-Invasive Imaging of Acute Renal Allograft Rejection in Rats Using Small Animal F-18-FDG-PET	PLOS ONE			English	Article								Background: At present, renal grafts are the most common solid organ transplants world-wide. Given the importance of renal transplantation and the limitation of available donor kidneys, detailed analysis of factors that affect transplant survival are important. Despite the introduction of new and effective immunosuppressive drugs, acute cellular graft rejection (AR) is still a major risk for graft survival. Nowadays, AR can only be definitively by renal biopsy. However, biopsies carry a risk of renal transplant injury and loss. Most important, they can not be performed in patients taking anticoagulant drugs. Methodology/Principal Findings: We present a non-invasive, entirely image-based method to assess AR in an allogeneic rat renal transplantation model using small animal positron emission tomography (PET) and 18 F-fluorodeoxyglucose (FDG). 3 h after i.v. injection of 30 MBq FDG into adult uni-nephrectomized, allogeneically transplanted rats, tissue radioactivity of renal parenchyma was assessed in vivo by a small animal PET-scanner (post operative day (POD) 1,2,4, and 7) and post mortem dissection. The mean radioactivity (cps/mm(3) tissue) as well as the percent injected dose (%ID) was compared between graft and native reference kidney. Results were confirmed by histological and autoradiographic analysis. Healthy rats, rats with acute CSA nephrotoxicity, with acute tubular necrosis, and syngeneically transplanted rats served as controls. FDG-uptake was significantly elevated only in allogeneic grafts from POD 1 on when compared to the native kidney (%ID graft POD 1: 0.54 +/- 0.06; POD 2: 0.58 +/- 0.12; POD 4: 0.81 +/- 0.06; POD 7: 0.77 +/- 0.1; CTR: 0.22 +/- 0.01, n = 3-28). Renal FDG-uptake in vivo correlated with the results obtained by micro-autoradiography and the degree of inflammatory infiltrates observed in histology. Conclusions/Significance: We propose that graft FDG-PET imaging is a new option to non-invasively, specifically, early detect, and follow-up acute renal rejection. This method is potentially useful to improve post-transplant rejection monitoring.			Reuter, S (corresponding author), Univ Klinikum Munster, Med Klin & Poliklin D, Munster, Germany.	sreuter@uni-muenster.de						Blodgett TM, 2007, RADIOLOGY, V242, P360, DOI 10.1148/radiol.2422051113; Bos R, 2002, J CLIN ONCOL, V20, P379, DOI 10.1200/JCO.20.2.379; Broekema M, 2007, J AM SOC NEPHROL, V18, P165, DOI 10.1681/ASN.2005070730; Chapman JR, 2005, J AM SOC NEPHROL, V16, P3015, DOI 10.1681/ASN.2005050463; Dubovsky EV, 1999, SEMIN NUCL MED, V29, P175, DOI 10.1016/S0001-2998(99)80007-5; El-Mekresh M, 2001, BJU INT, V87, P295, DOI 10.1046/j.1464-410x.2001.00113.x; Fischer T, 2006, NEPHROL DIAL TRANSPL, V21, P2921, DOI 10.1093/ndt/gfl313; Gabriels G, 2003, TRANSPLANTATION, V75, P689, DOI 10.1097/01.TP.0000044111.12370.ED; Gallon L, 2006, CLIN J AM SOC NEPHRO, V1, P539, DOI 10.2215/CJN.01741105; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Heaf JG, 2000, EUR J NUCL MED, V27, P871, DOI 10.1007/s002590000281; Kaim AH, 2002, RADIOLOGY, V223, P446, DOI 10.1148/radiol.2232010914; Kim KJ, 2003, INVEST RADIOL, V38, P473, DOI 10.1097/00004424-200308000-00001; Kirkpantur A, 2008, TRANSPL P, V40, P104, DOI 10.1016/j.transproceed.2007.11.032; Massy ZA, 1996, KIDNEY INT, V49, P518, DOI 10.1038/ki.1996.74; MATAS AJ, 1994, TRANSPLANTATION, V57, P857, DOI 10.1097/00007890-199403270-00015; Meier-Kriesche HU, 2000, TRANSPLANTATION, V70, P1098, DOI 10.1097/00007890-200010150-00018; Meller J, 2007, J NUCL MED, V48, P35; Opelz G, 2008, TRANSPLANTATION, V85, P661, DOI 10.1097/TP.0b013e3181661695; Pellegrino D, 2005, J NUCL MED, V46, P1522; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Reuter S, 2008, PFLUG ARCH EUR J PHY, V456, P1075, DOI 10.1007/s00424-008-0484-7; Rush D, 2006, CLIN J AM SOC NEPHRO, V1, P138, DOI 10.2215/CJN.00390705; Sarwal M, 2003, NEW ENGL J MED, V349, P125, DOI 10.1056/NEJMoa035588; Schafers KP, 2005, J NUCL MED, V46, P996; Schnockel U, 2008, EUR J NUCL MED MOL I, V35, P2267, DOI 10.1007/s00259-008-0878-y; Schwarz A, 2008, AM J TRANSPLANT, V8, P826, DOI 10.1111/j.1600-6143.2008.02160.x; Sis B, 2006, J CLIN PATHOL, V59, P377, DOI 10.1136/jcp.2005.029181; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Velic A, 2005, AM J TRANSPLANT, V5, P1276, DOI 10.1111/j.1600-6143.2005.00890.x; Velic A, 2004, J AM SOC NEPHROL, V15, P967, DOI 10.1097/01.ASN.0000117287.74203.89; Xue JL, 2001, J AM SOC NEPHROL, V12, P2753, DOI 10.1681/ASN.V12122753	33	38	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5296	10.1371/journal.pone.0005296	http://dx.doi.org/10.1371/journal.pone.0005296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390685	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514400002
J	Ward, DR; Dear, FM; Ward, IA; Anderson, SI; Spergel, DJ; Smith, PA; Ebling, FJP				Ward, Daniel R.; Dear, Fiona M.; Ward, Ian A.; Anderson, Susan I.; Spergel, Daniel J.; Smith, Paul A.; Ebling, Francis J. P.			Innervation of Gonadotropin-Releasing Hormone Neurons by Peptidergic Neurons Conveying Circadian or Energy Balance Information in the Mouse	PLOS ONE			English	Article								Background: Secretion of gonadotropin-releasing hormone (GnRH) produced in neurons in the basal forebrain is the primary regulator of reproductive maturation and function in mammals. Peptidergic signals relating to circadian timing and energy balance are an important influence on the reproductive axis. The aim of this study was to investigate the innervation of GnRH neurons by peptidergic neurons. Methodology/Principal Findings: Immunohistochemistry and confocal microscopy were used to detect appositions of peptidergic fibers (NPY, beta-endorphin, MCH) associated with energy balance and metabolic status in transgenic mice expressing a green fluorescent protein reporter construct in GnRH neurons. The frequency of these appositions was compared to those of vasoactive intestinal peptide (VIP), a hypothalamic neuropeptide likely to convey circadian timing information to the GnRH secretory system. The majority of GnRH neurons (73-87%) were closely apposed by fibers expressing NPY, beta-endorphin, or MCH, and a significant proportion of GnRH neurons (28%) also had close contacts with VIP-ir fibers. Conclusions/Significance: It is concluded that GnRH neurons in the mouse receive a high frequency of direct modulatory inputs from multiple hypothalamic peptide systems known to be important in conveying circadian information and signalling energy balance.			Ward, DR (corresponding author), Univ Nottingham, Sch Med, Sch Biomed Sci, Nottingham, England.	fran.ebling@nottingham.ac.uk	Spergel, David N/A-4410-2011; Ebling, Francis/Q-6193-2019; Ebling, Francis/A-1900-2013; Oka, Yoshitaka/C-9670-2010	Spergel, David N/0000-0002-5151-0006; Ebling, Francis/0000-0002-7316-9582; Ebling, Francis/0000-0002-7316-9582; Oka, Yoshitaka/0000-0002-3482-3051; Smith, Paul/0000-0002-8710-6830; Spergel, Daniel/0000-0002-5753-4332	Biotechnology and Biological Sciences Research Council [BB/E020437/1] Funding Source: Medline; BBSRC [BB/E020437/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Bittman EL, 1996, AM J PHYSIOL-REG I, V271, pR64, DOI 10.1152/ajpregu.1996.271.1.R64; Campbell RE, 2001, NEUROENDOCRINOLOGY, V74, P106, DOI 10.1159/000054676; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chiocchio SR, 2001, BIOL REPROD, V64, P1466, DOI 10.1095/biolreprod64.5.1466; Christian CA, 2008, ENDOCRINOLOGY, V149, P3130, DOI 10.1210/en.2007-1098; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Crown A, 2007, NEUROENDOCRINOLOGY, V86, P175, DOI 10.1159/000109095; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; Dardente H, 2004, MOL BRAIN RES, V124, P143, DOI 10.1016/j.molbrainres.2004.01.010; DELAIGLESIA HO, 1995, NEUROREPORT, V6, P1715, DOI 10.1097/00001756-199509000-00004; Ebling FJP, 2005, REPRODUCTION, V129, P675, DOI 10.1530/rep.1.00367; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Gerhold LM, 2006, ENDOCRINOLOGY, V147, P2197, DOI 10.1210/en.2005-1262; Gonzalez MI, 1997, NEUROENDOCRINOLOGY, V66, P254, DOI 10.1159/000127246; Gore AC, 2004, ENDOCRINOLOGY, V145, P4016, DOI 10.1210/en.2004-0855; Hakansson ML, 1998, J NEUROSCI, V18, P559; HERBERT J, 1993, PROG NEUROBIOL, V41, P723, DOI 10.1016/0301-0082(93)90033-O; Herbison AE, 2001, MOL CELL ENDOCRINOL, V185, P185, DOI 10.1016/S0303-7207(01)00618-9; HORTON RJE, 1989, J ENDOCRINOL, V122, P509, DOI 10.1677/joe.0.1220509; Horvath TL, 1998, BRAIN RES, V795, P277, DOI 10.1016/S0006-8993(98)00208-X; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; KALRA SP, 1992, FRONT NEUROENDOCRIN, V13, P1; KALRA SP, 1984, OPIOID MODULATION EN, P171; Kamiji MM, 2007, ENDOCR REV, V28, P664, DOI 10.1210/er.2007-0003; Kiyoshi K, 1998, CELL TISSUE RES, V293, P39, DOI 10.1007/s004410051096; Kriegsfeld LJ, 2002, J NEUROENDOCRINOL, V14, P685, DOI 10.1046/j.1365-2826.2002.00818.x; Li C, 1999, ENDOCRINOLOGY, V140, P5382, DOI 10.1210/en.140.11.5382; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; Maywood ES, 1997, EUR J NEUROSCI, V9, P1739, DOI 10.1111/j.1460-9568.1997.tb01531.x; McBriar MD, 2007, CURR TOP MED CHEM, V7, P1440, DOI 10.2174/156802607782194752; MIKKELSEN JD, 1994, BRAIN RES, V656, P95, DOI 10.1016/0006-8993(94)91370-6; MILLER GM, 1994, NEUROENDOCRINOLOGY, V59, P277, DOI 10.1159/000126669; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; ODONOHUE TL, 1979, BRAIN RES, V176, P101, DOI 10.1016/0006-8993(79)90873-4; Ojeda SR, 2006, ENDOCRINOLOGY, V147, P1166, DOI 10.1210/en.2005-1136; Raposinho PD, 2000, NEUROENDOCRINOLOGY, V71, P2, DOI 10.1159/000054514; Raposinho PD, 1999, ENDOCRINOLOGY, V140, P4046, DOI 10.1210/en.140.9.4046; Sannella MI, 1997, ENDOCRINOLOGY, V138, P1667, DOI 10.1210/en.138.4.1667; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; Schuhler S, 2006, PEPTIDES, V27, P301, DOI 10.1016/j.peptides.2005.03.060; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Smith MJ, 2000, ENDOCRINOLOGY, V141, P4317, DOI 10.1210/en.141.11.4317; Spergel DJ, 1999, J NEUROSCI, V19, P2037; Suter KJ, 2000, ENDOCRINOLOGY, V141, P412, DOI 10.1210/en.141.1.412; Takenoya F, 2006, PEPTIDES, V27, P2885, DOI 10.1016/j.peptides.2006.05.012; TILLET Y, 1989, J CHEM NEUROANAT, V2, P319; Todman MG, 2005, NEUROSCIENCE, V132, P703, DOI 10.1016/j.neuroscience.2005.01.035; Tritos NA, 2001, BRAIN RES, V895, P160, DOI 10.1016/S0006-8993(01)02066-2; Tsukamura H, 2000, J NEUROENDOCRINOL, V12, P529, DOI 10.1046/j.1365-2826.2000.00482.x; Turi GF, 2003, ENDOCRINOLOGY, V144, P4967, DOI 10.1210/en.2003-0470; VanderBeek EM, 1997, J COMP NEUROL, V384, P569, DOI 10.1002/(SICI)1096-9861(19970811)384:4<569::AID-CNE6>3.0.CO;2-0; VANDERBEEK EM, 1993, J NEUROENDOCRINOL, V5, P137; Williamson-Hughes PS, 2005, BRAIN RES, V1041, P117, DOI 10.1016/j.brainres.2004.11.066; Yang Y, 2005, ACTA PHARMACOL SIN, V26, P976, DOI 10.1111/j.1745-7254.2005.00118.x; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; YOSHIDA M, 1988, ARCH HISTOL CYTOL, V51, P175, DOI 10.1679/aohc.51.175	59	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5322	10.1371/journal.pone.0005322	http://dx.doi.org/10.1371/journal.pone.0005322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390688	Green Published, gold, Green Submitted			2022-12-27	WOS:000265514400010
J	Zheng, LS; Wang, F; Li, YH; Zhang, X; Chen, LM; Liang, YJ; Dai, CL; Yan, YY; Tao, LY; Mi, YJ; Yang, AK; To, KKW; Fu, LW				Zheng, Li-sheng; Wang, Fang; Li, Yu-hong; Zhang, Xu; Chen, Li-ming; Liang, Yong-ju; Dai, Chun-ling; Yan, Yan-yan; Tao, Li-yang; Mi, Yan-jun; Yang, An-kui; To, Kenneth Kin Wah; Fu, Li-wu			Vandetanib (Zactima, ZD6474) Antagonizes ABCC1-and ABCG2-Mediated Multidrug Resistance by Inhibition of Their Transport Function	PLOS ONE			English	Article								Background: ABCC1 and ABCG2 are ubiquitous ATP-binding cassette transmembrane proteins that play an important role in multidrug resistance (MDR). In this study, we evaluated the possible interaction of vandetanib, an orally administered drug inhibiting multiple receptor tyrosine kinases, with ABCC1 and ABCG2 in vitro. Methodology and Principal Findings: MDR cancer cells overexpressing ABCC1 or ABCG2 and their sensitive parental cell lines were used. MTT assay showed that vandetanib had moderate and almost equal-potent anti-proliferative activity in both sensitive parental and MDR cancer cells. Concomitant treatment of MDR cells with vandetanib and specific inhibitors of ABCC1 or ABCG2 did not alter their sensitivity to the former drug. On the other hand, clinically attainable but non-toxic doses of vandetanib were found to significantly enhance the sensitivity of MDR cancer cells to ABCC1 or ABCG2 substrate antitumor drugs. Flow cytometric analysis showed that vandetanib treatment significantly increase the intracellular accumulation of doxorubicin and rhodamine 123, substrates of ABCC1 and ABCG2 respectively, in a dose-dependent manner (P < 0.05). However, no significant effect was shown in sensitive parental cell lines. Reverse transcription-PCR and Western blot analysis showed that vandetanib did not change the expression of ABCC1 and ABCG2 at both mRNA and protein levels. Furthermore, total and phosphorylated forms of AKT and ERK1/2 remained unchanged after vandetanib treatment in both sensitive and MDR cancer cells. Conclusions: Vandetanib is unlikely to be a substrate of ABCC1 or ABCG2. It overcomes ABCC1- and ABCG2-mediated drug resistance by inhibiting the transporter activity, independent of the blockade of AKT and ERK1/2 signal transduction pathways.			Zheng, LS (corresponding author), Sun Yat Sen Univ, Res Dept, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	Fulw@mail.sysu.edu.cn	To, Kenneth K W/M-4500-2013; wang, fang/GYD-4295-2022; Fu, Liwu/AAE-8835-2020	To, Kenneth K W/0000-0003-2755-0283; 				Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Bakos E, 2007, PFLUG ARCH EUR J PHY, V453, P621, DOI 10.1007/s00424-006-0160-8; Bianco C, 2006, CLIN CANCER RES, V12, P7099, DOI 10.1158/1078-0432.CCR-06-0833; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Brendel C, 2007, LEUKEMIA, V21, P1267, DOI 10.1038/sj.leu.2404638; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Cabebe Elwyn, 2007, Curr Treat Options Oncol, V8, P15, DOI 10.1007/s11864-007-0022-4; Carlomagno F, 2002, CANCER RES, V62, P7284; Checkley D, 2003, BRIT J CANCER, V89, P1889, DOI 10.1038/sj.bjc.6601386; Chen LM, 2004, ONCOL RES, V14, P355, DOI 10.3727/0965040041292378; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Dai CL, 2008, CANCER RES, V68, P7905, DOI 10.1158/0008-5472.CAN-08-0499; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Fetsch PA, 2006, CANCER LETT, V235, P84, DOI 10.1016/j.canlet.2005.04.024; Fu LW, 2004, CANCER CHEMOTH PHARM, V53, P349, DOI 10.1007/s00280-003-0742-5; Giannelli G, 2006, BIOCHEM PHARMACOL, V71, P479, DOI 10.1016/j.bcp.2005.11.005; Hegedus T, 2002, BBA-MOL BASIS DIS, V1587, P318, DOI 10.1016/S0925-4439(02)00095-9; Herbst RS, 2007, EXPERT OPIN INV DRUG, V16, P239, DOI 10.1517/13543784.16.2.239; Heymach JV, 2006, CLIN CANCER RES, V12, p4441S, DOI 10.1158/1078-0432.CCR-06-0286; Holden SN, 2005, ANN ONCOL, V16, P1391, DOI 10.1093/annonc/mdi247; Kitazaki T, 2005, LUNG CANCER, V49, P337, DOI 10.1016/j.lungcan.2005.03.035; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Levitzki A, 1999, PHARMACOL THERAPEUT, V82, P231, DOI 10.1016/S0163-7258(98)00066-7; Litman T, 2001, CELL MOL LIFE SCI, V58, P931, DOI 10.1007/PL00000912; Matsurnori Y, 2006, ONCOL RES, V16, P15, DOI 10.3727/000000006783981260; McCarty MF, 2004, MOL CANCER THER, V3, P1041; Mi Y, 2007, BRIT J CANCER, V97, P934, DOI 10.1038/sj.bjc.6603985; Miyake K, 1999, CANCER RES, V59, P8; Morelli MP, 2005, ANN ONCOL, V16, P61, DOI 10.1093/annonc/mdi910; Nakanishi T, 2006, BLOOD, V108, P678, DOI 10.1182/blood-2005-10-4020; Navolanic PM, 2003, INT J ONCOL, V22, P237; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rabindran SK, 2000, CANCER RES, V60, P47; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rich JN, 2005, CLIN CANCER RES, V11, P8145, DOI 10.1158/1078-0432.CCR-05-0319; Robey RW, 2003, BRIT J CANCER, V89, P1971, DOI 10.1038/sj.bjc.6601370; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Ryan AJ, 2005, BRIT J CANCER, V92, pS6, DOI 10.1038/sj.bjc.6602603; Sequist LV, 2007, ONCOLOGIST, V12, P325, DOI 10.1634/theoncologist.12-3-325; Shi Z, 2006, CANCER BIOL THER, V5, P39, DOI 10.4161/cbt.5.1.2236; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Shibuya M, 2006, ENDOTHELIUM-J ENDOTH, V13, P63, DOI 10.1080/10623320600697955; SUMIZAWA T, 1994, SOMAT CELL MOLEC GEN, V20, P423, DOI 10.1007/BF02257459; Tamura T, 2006, J THORAC ONCOL, V1, P1002, DOI 10.1097/01243894-200611000-00014; Troiani T, 2007, CLIN CANCER RES, V13, P6450, DOI 10.1158/1078-0432.CCR-07-1094; Volk EL, 2002, CANCER RES, V62, P5035; Wedge SR, 2002, CANCER RES, V62, P4645; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Yang CH, 2005, CANCER RES, V65, P6943, DOI 10.1158/0008-5472.CAN-05-0641; Yano S, 2005, CLIN CANCER RES, V11, P8789, DOI 10.1158/1078-0432.CCR-05-0674; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	55	78	82	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5172	10.1371/journal.pone.0005172	http://dx.doi.org/10.1371/journal.pone.0005172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390592	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514200001
J	Mahut, B; Trinquart, L; Bokov, P; Le Bourgeois, M; Waernessyckle, S; Peiffer, C; Delclaux, C				Mahut, Bruno; Trinquart, Ludovic; Bokov, Plamen; Le Bourgeois, Muriel; Waernessyckle, Serge; Peiffer, Claudine; Delclaux, Christophe			Relationships between Specific Airway Resistance and Forced Expiratory Flows in Asthmatic Children	PLOS ONE			English	Article								Background: The earliest changes associated with airflow obstruction in asthmatic children are a proportionally greater reduction in FEF50% than in FEV1 using spirometry, and an increase in specific airway resistance (sRaw) using body plethysmography. Consequently, we hypothesized that sRaw could be better linked to FEF50% than to FEV1. The first aim was to assess the relationships between forced expiratory flows and sRaw in a large group of asthmatic children in a transversal study. We then performed a longitudinal study in order to determine whether sRaw of preschool children could predict subsequent impairment of forced expiratory flows at school age. Methodology: Pulmonary function tests (sRaw and forced expiratory flows) of 2193 asthmatic children were selected for a transversal analysis, while 365 children were retrospectively selected for longitudinal assessment from preschool to school age. Principal Findings: The transversal data showed that sRaw is differently related to FEF50% (21/sRaw) and to FEV1 (near linearly). These results were further explained by a simple one-compartment lung model, which justified the shape of the observed relationships. As hypothesized, sRaw correlated more strongly to FEF50% than to FEV1 (r = 0.64 versus 0.39, respectively; p<0.001). In the longitudinal part of the study, sRaw at preschool age correlated with subsequent FEF50% (% predicted) (-0.31, 95% CI, -0.40 to -0.22), but weakly with subsequent FEV1 (% predicted) (-0.09, 95% CI, -0.20 to 0). Conclusion: Specific Raw is more strongly related to FEF50% than to FEV1 and could be used in preschool children to predict subsequent mild airflow limitation.			Mahut, B (corresponding author), Cabinet La Berma, Antony, France.	christophe.delclaux@egp.aphp.fr	Trinquart, Ludovic/H-4961-2019	Trinquart, Ludovic/0000-0002-3028-4900				AEBISCHER CC, 1995, MONALDI ARCH CHEST D, V50, P140; Arets HGM, 2001, EUR RESPIR J, V18, P655, DOI 10.1183/09031936.01.00204301; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Bisgaard H, 2005, CHEST, V128, P355, DOI 10.1378/chest.128.1.355; Bisgaard H, 1995, EUR RESPIR J, V8, P2067, DOI 10.1183/09031936.95.08122067; BRISCOE WA, 1958, J CLIN INVEST, V37, P1279, DOI 10.1172/JCI103715; DAB I, 1976, PEDIATR RES, V10, P996, DOI 10.1203/00006450-197612000-00009; Delacourt C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001180; DUBOIS AB, 1956, J CLIN INVEST, V35, P327, DOI 10.1172/JCI103282; GUYATT AR, 1968, J APPL PHYSIOL, V24, P310, DOI 10.1152/jappl.1968.24.3.310; Lemaire F, 2006, AM J RESP CRIT CARE, V174, P363, DOI 10.1164/rccm.2603003; Macklem PT, 1998, AM J RESP CRIT CARE, V157, pS181, DOI 10.1164/ajrccm.157.5.rsaa-2; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Milligan G, 2005, J MOL NEUROSCI, V26, P161, DOI 10.1385/JMN:26:2-3:161; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; TAGER IB, 1986, AM REV RESPIR DIS, V134, P502; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Zapletal A, 1977, Cesk Pediatr, V32, P513	18	21	21	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5270	10.1371/journal.pone.0005270	http://dx.doi.org/10.1371/journal.pone.0005270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381269	gold, Green Submitted, Green Published			2022-12-27	WOS:000265510800012
J	Guinovart, C; Aponte, JJ; Sacarlal, J; Aide, P; Leach, A; Bassat, Q; Macete, E; Dobano, C; Lievens, M; Loucq, C; Ballou, WR; Cohen, J; Alonso, PL				Guinovart, Caterina; Aponte, John J.; Sacarlal, Jahit; Aide, Pedro; Leach, Amanda; Bassat, Quique; Macete, Eusebio; Dobano, Carlota; Lievens, Marc; Loucq, Christian; Ballou, W. Ripley; Cohen, Joe; Alonso, Pedro L.			Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; FOLLOW-UP; EFFICACY; IMMUNITY; IMMUNOGENICITY; INFANTS; DISEASE; SAFETY	Background: The pre-erythrocytic malaria vaccine RTS,S/AS02A has shown to confer protection against clinical malaria for at least 21 months in a trial in Mozambican children. Efficacy varied between different endpoints, such as parasitaemia or clinical malaria; however the underlying mechanisms that determine efficacy and its duration remain unknown. We performed a new, exploratory analysis to explore differences in the duration of protection among participants to better understand the protection afforded by RTS,S. Methodology/Principal Findings: The study was a Phase IIb double-blind, randomized controlled trial in 2022 children aged 1 to 4 years. The trial was designed with two cohorts to estimate vaccine efficacy against two different endpoints: clinical malaria (cohort 1) and infection (cohort 2). Participants were randomly allocated to receive three doses of RTS,S/AS02A or control vaccines. We did a retrospective, unplanned sub-analysis of cohort 2 data using information collected for safety through the health facility-based passive case detection system. Vaccine efficacy against clinical malaria was estimated over the first six-month surveillance period (double-blind phase) and over the following 12 months (single-blind phase), and analysis was per-protocol. Adjusted vaccine efficacy against first clinical malaria episodes in cohort 2 was of 35.4% (95% CI 4.5-56.3; p = 0.029) over the double-blind phase and of 9.0% (-30.6-36.6; p = 0.609) during the single-blind phase. Conclusions/Significance: Contrary to observations in cohort 1, where efficacy against clinical malaria did not wane over time, in cohort 2 the efficacy decreases with time. We hypothesize that this reduced duration of protection is a result of the early diagnosis and treatment of infections in cohort 2 participants, preventing sufficient exposure to asexual-stage antigens. On the other hand, the long-term protection against clinical disease observed in cohort 1 may be a consequence of a prolonged exposure to low-dose blood-stage asexual parasitaemia.			Alonso, PL (corresponding author), Univ Barcelona, Hosp Clin IDIBAPS, Barcelona Ctr Int Hlth Res, Barcelona, Spain.	palonso@clinic.ub.es	Sacarlal, Jahit/R-3172-2016; Alonso, Pedro L/AAZ-3645-2020; Leach, Amanda/AAS-1120-2020; Guinovart, Caterina/ABH-2981-2020; Aide, Pedro/D-8771-2018; Bassat, Quique/P-2341-2016; Dobaño, Carlota/N-4119-2014	Sacarlal, Jahit/0000-0003-1059-217X; Alonso, Pedro L/0000-0003-3292-3443; Leach, Amanda/0000-0002-7114-9967; Bassat, Quique/0000-0003-0875-7596; Dobaño, Carlota/0000-0002-6751-4060				Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Alonso Pedro L, 2002, Methods Mol Med, V72, P607, DOI 10.1385/1-59259-271-6:607; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; Alonso PL, 2002, POPULATION HLTH DEV, P189; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Favila-Castillo L, 1999, EXP PARASITOL, V92, P73, DOI 10.1006/expr.1999.4399; Guinovart C, 2007, AM J TROP MED HYG, V77, P276, DOI 10.4269/ajtmh.2007.77.276; HESS KR, 1995, STAT MED, V14, P1707, DOI 10.1002/sim.4780141510; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; John CC, 2008, J INFECT DIS, V197, P519, DOI 10.1086/526787; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Moorthy Vasee, 2007, Vaccine, V25, P5115, DOI 10.1016/j.vaccine.2007.01.085; Owusu-Agyei S, 2001, AM J TROP MED HYG, V65, P197, DOI 10.4269/ajtmh.2001.65.197; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Saute F, 2003, T ROY SOC TROP MED H, V97, P661, DOI 10.1016/S0035-9203(03)80098-6; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Sutherland CJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-161; Therneau T.M., 2000, MODELING SURVIVAL DA; WIRTZ RA, 1987, EXP PARASITOL, V63, P166, DOI 10.1016/0014-4894(87)90158-5	25	65	70	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2009	4	4							e5165	10.1371/journal.pone.0005165	http://dx.doi.org/10.1371/journal.pone.0005165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TO	19365567	Green Published, Green Submitted, gold			2022-12-27	WOS:000265510000001
J	Deng, MQ; Gao, JT; Suraneni, P; Li, R				Deng, Manqi; Gao, Juntao; Suraneni, Praveen; Li, Rong			Kinetochore-Independent Chromosome Poleward Movement during Anaphase of Meiosis II in Mouse Eggs	PLOS ONE			English	Article								Kinetochores are considered to be the key structures that physically connect spindle microtubules to the chromosomes and play an important role in chromosome segregation during mitosis. Due to different mechanisms of spindle assembly between centrosome-containing mitotic cells and acentrosomal meiotic oocytes, it is unclear how a meiotic spindle generates the poleward forces to drive two rounds of meiotic chromosome segregation to achieve genome haploidization. We took advantage of the fact that DNA beads are able to induce bipolar spindle formation without kinetochores and studied the behavior of DNA beads in the induced spindle in mouse eggs during meiosis II. Interestingly, DNA beads underwent poleward movements that were similar in timing and speed to the meiotic chromosomes, although all the beads moved together to the same spindle pole. Disruption of dynein function abolished the poleward movements of DNA beads but not of the meiotic chromosomes, suggesting the existence of different dynein-dependent and dynein-independent force generation mechanisms for the chromosome poleward movement, and the latter may be dependent on the presence of kinetochores. Consistent with the observed DNA bead poleward movement, sperm haploid chromatin (which also induced bipolar spindle formation after injection to a metaphase egg without forming detectable kinetochore structures) also underwent similar poleward movement at anaphase as DNA beads. The results suggest that in the chromatin-induced meiotic spindles, kinetochore attachments to spindle microtubules are not absolutely required for chromatin poleward movements at anaphase.			Deng, MQ (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	MQD@stowers-institute.org; RLI@stowers-institute.org						Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Biggins S, 2003, CURR BIOL, V13, pR449, DOI 10.1016/S0960-9822(03)00369-5; Brunet S, 1998, CURR BIOL, V8, P1231, DOI 10.1016/S0960-9822(07)00516-7; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Clarke PR, 2005, SCIENCE, V309, P1334, DOI 10.1126/science.1117842; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2004, CURR BIOL, V14, pR921, DOI 10.1016/j.cub.2004.10.014; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Deng MQ, 2005, DEV BIOL, V278, P358, DOI 10.1016/j.ydbio.2004.11.013; Desai A, 1998, J CELL BIOL, V141, P703, DOI 10.1083/jcb.141.3.703; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HAYS TS, 1990, J CELL BIOL, V110, P391, DOI 10.1083/jcb.110.2.391; Heald R, 2000, TRENDS CELL BIOL, V10, P1, DOI 10.1016/S0962-8924(99)01691-8; Heald R, 1999, CURR OPIN STRUC BIOL, V9, P268, DOI 10.1016/S0959-440X(99)80037-2; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hogan B, 1994, MANIPULATING MOUSE E; Khodjakov A, 1996, J CELL BIOL, V132, P1093, DOI 10.1083/jcb.132.6.1093; Kline-Smith SL, 2005, CURR OPIN CELL BIOL, V17, P35, DOI 10.1016/j.ceb.2004.12.009; LaFountain JR, 2001, MOL BIOL CELL, V12, P4054, DOI 10.1091/mbc.12.12.4054; LeMaire-Adkins R, 2000, GENETICS, V156, P775; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Mazumdar M, 2005, TRENDS CELL BIOL, V15, P349, DOI 10.1016/j.tcb.2005.05.006; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; Mitchison TJ, 2005, PHILOS T R SOC B, V360, P623, DOI 10.1098/rstb.2004.1616; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; PFARR CM, 1990, NATURE, V345, P263, DOI 10.1038/345263a0; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; Shimoda SL, 2002, CELL, V109, P9, DOI 10.1016/S0092-8674(02)00712-2; SKIBBENS RV, 1995, J CELL SCI, V108, P2537; STEUER ER, 1990, NATURE, V345, P266, DOI 10.1038/345266a0; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; SZOLLOSI D, 1972, J CELL SCI, V11, P521; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Tanaka TU, 2002, CURR OPIN CELL BIOL, V14, P365, DOI 10.1016/S0955-0674(02)00328-9; Tomashov-Matar R, 2005, REPRODUCTION, V130, P467, DOI 10.1530/rep.1.00746; Vagnarelli P, 2008, FEBS LETT, V582, P1950, DOI 10.1016/j.febslet.2008.04.014; Van Hooser AA, 2001, CURR BIOL, V11, pR855, DOI 10.1016/S0960-9822(01)00515-2; Vernos I, 1996, CURR OPIN CELL BIOL, V8, P4, DOI 10.1016/S0955-0674(96)80041-X; Waters JC, 1996, MOL BIOL CELL, V7, P1547, DOI 10.1091/mbc.7.10.1547; Wittmann T, 1999, METHOD CELL BIOL, V61, P137; Yen TJ, 1996, CURR OPIN CELL BIOL, V8, P381, DOI 10.1016/S0955-0674(96)80014-7	48	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5249	10.1371/journal.pone.0005249	http://dx.doi.org/10.1371/journal.pone.0005249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365562	Green Published, gold, Green Submitted			2022-12-27	WOS:000265509900021
J	Poshusta, TL; Sikkink, LA; Leung, N; Clark, RJ; Dispenzieri, A; Ramirez-Alvarado, M				Poshusta, Tanya L.; Sikkink, Laura A.; Leung, Nelson; Clark, Raynell J.; Dispenzieri, Angela; Ramirez-Alvarado, Marina			Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis	PLOS ONE			English	Article							PRIMARY SYSTEMIC AMYLOIDOSIS; CLINICAL PRESENTATION; ORGAN INVOLVEMENT; CONSTANT-REGION; GENE USE; CELL; AGGREGATION; STABILITY; SURVIVAL; FEATURES	Background: The amyloidoses are protein misfolding diseases characterized by the deposition of amyloid that leads to cell death and tissue degeneration. In immunoglobulin light chain amyloidosis (AL), each patient has a unique monoclonal immunoglobulin light chain (LC) that forms amyloid deposits. Somatic mutations in AL LCs make these proteins less thermodynamically stable than their non-amyloidogenic counterparts, leading to misfolding and ultimately the formation of amyloid fibrils. We hypothesize that location rather than number of non-conservative mutations determines the amyloidogenicity of light chains. Methodology/Principal Findings: We performed sequence alignments on the variable domain of 50 kappa and 91 lambda AL light chains and calculated the number of non-conservative mutations over total number of patients for each secondary structure element in order to identify regions that accumulate non-conservative mutations. Among patients with AL, the levels of circulating immunoglobulin free light chain varies greatly, but even patients with very low levels can have very advanced amyloid deposition. Conclusions: Our results show that in specific secondary structure elements, there are significant differences in the number of non-conservative mutations between normal and AL sequences. AL sequences from patients with different levels of secreted light chain have distinct differences in the location of non-conservative mutations, suggesting that for patients with very low levels of light chains and advanced amyloid deposition, the location of non-conservative mutations rather than the amount of free light chain in circulation may determine the amyloidogenic propensity of light chains.			Poshusta, TL (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	Ramirezalvarado.marina@mayo.edu		Leung, Nelson/0000-0002-5651-1411; Ramirez-Alvarado, Marina/0000-0003-2325-6773; Dispenzieri, Angela/0000-0001-8780-9512	NCI NIH HHS [R01 CA111345, CA111345, P01 CA062242, CA062242] Funding Source: Medline; NIGMS NIH HHS [R01 GM071514, GM071514] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA111345, P01CA062242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071514] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RS, 2007, J CLIN IMMUNOL, V27, P69, DOI 10.1007/s10875-006-9056-9; Abraham RS, 2003, BLOOD, V101, P3801, DOI 10.1182/blood-2002-09-2707; Arendt BK, 2008, BLOOD, V112, P1931, DOI 10.1182/blood-2008-03-143040; Baden EM, 2008, J BIOL CHEM, V283, P30950, DOI 10.1074/jbc.M804822200; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Branden C., 1999, INTRO PROTEIN STRUCT; Buxbaum JN, 2003, TRENDS BIOCHEM SCI, V28, P585, DOI 10.1016/j.tibs.2003.09.009; Comenzo RL, 1999, BRIT J HAEMATOL, V106, P744, DOI 10.1046/j.1365-2141.1999.01591.x; Comenzo RL, 2001, BLOOD, V98, P714, DOI 10.1182/blood.V98.3.714; Comenzo RL, 1998, BLOOD, V91, P3662; Dispenzieri A, 2006, BLOOD, V107, P3378, DOI 10.1182/blood-2005-07-2922; Dispenzieri A, 2008, BLOOD, V111, P4908, DOI 10.1182/blood-2008-02-138602; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Kim YS, 2000, J BIOL CHEM, V275, P1570, DOI 10.1074/jbc.275.3.1570; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; O'Nuallain B, 2007, BIOCHEMISTRY-US, V46, P1240, DOI 10.1021/bi0616605; Olsen KE, 1998, BIOCHEM BIOPH RES CO, V251, P642, DOI 10.1006/bbrc.1998.9508; Prokaeva T, 2007, ARTHRITIS RHEUM-US, V56, P3858, DOI 10.1002/art.22959; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P4538, DOI 10.1021/bi00412a047; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Schiffer M, 1996, AM J PATHOL, V148, P1339; Sikkink LA, 2008, AMYLOID, V15, P29, DOI 10.1080/13506120701815324; Stevens FJ, 2000, AMYLOID, V7, P200, DOI 10.3109/13506120009146835; STEVENS FJ, 1999, ANTIBODIES, P175; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wally J, 1999, BBA-MOL BASIS DIS, V1454, P49, DOI 10.1016/S0925-4439(99)00019-8; WELSCHOF M, 1995, J IMMUNOL METHODS, V179, P203, DOI 10.1016/0022-1759(94)00286-6; Wetzel R, 1997, ADV PROTEIN CHEM, V50, P183, DOI 10.1016/S0065-3233(08)60322-8	28	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5169	10.1371/journal.pone.0005169	http://dx.doi.org/10.1371/journal.pone.0005169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365555	Green Published, Green Submitted, gold			2022-12-27	WOS:000265509900004
J	Vadivel, K; Namasivayam, G				Vadivel, Kanagasabai; Namasivayam, Gautham			An Estimate of the Numbers and Density of Low-Energy Structures (or Decoys) in the Conformational Landscape of Proteins	PLOS ONE			English	Article							ORTHOGONAL LATIN SQUARES; MULTIPLE-MINIMA PROBLEM; NEAR-NATIVE FOLDS; ATOM FORCE-FIELD; STRUCTURE PREDICTION; PATHWAYS; FUNNELS; DETERMINANTS; MINIMIZATION; POTENTIALS	Background: The conformational energy landscape of a protein, as calculated by known potential energy functions, has several minima, and one of these corresponds to its native structure. It is however difficult to comprehensively estimate the actual numbers of low energy structures (or decoys), the relationships between them, and how the numbers scale with the size of the protein. Methodology: We have developed an algorithm to rapidly and efficiently identify the low energy conformers of oligo peptides by using mutually orthogonal Latin squares to sample the potential energy hyper surface. Using this algorithm, and the ECEPP/3 potential function, we have made an exhaustive enumeration of the low-energy structures of peptides of different lengths, and have extrapolated these results to larger polypeptides. Conclusions and Significance: We show that the number of native-like structures for a polypeptide is, in general, an exponential function of its sequence length. The density of these structures in conformational space remains more or less constant and all the increase appears to come from an expansion in the volume of the space. These results are consistent with earlier reports that were based on other models and techniques.			Vadivel, K (corresponding author), Univ Madras, Ctr Adv Study Crystallog & Biophys, Madras 600005, Tamil Nadu, India.	n_gautham@hotmail.com		Vadivel, Kanagasabai/0000-0003-3777-9540				Almog O, 2003, J MOL BIOL, V332, P1071, DOI 10.1016/j.jmb.2003.07.011; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betancourt MR, 2001, J COMPUT CHEM, V22, P339, DOI 10.1002/1096-987X(200102)22:3<339::AID-JCC1006>3.0.CO;2-R; Bonneau R, 2001, ANNU REV BIOPH BIOM, V30, P173, DOI 10.1146/annurev.biophys.30.1.173; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dinner AR, 1999, J PHYS CHEM B, V103, P7976, DOI 10.1021/jp990851x; Felts AK, 2002, PROTEINS, V48, P404, DOI 10.1002/prot.10171; FINNEY DJ, 1955, EXPT DESIGN ITS STAT, P45; FLOUDAS CA, 1999, DIMACS SERIES DISCRE, P141; Gilis D, 2004, J BIOMOL STRUCT DYN, V21, P725, DOI 10.1080/07391102.2004.10506963; Goldbeck RA, 1999, P NATL ACAD SCI USA, V96, P2782, DOI 10.1073/pnas.96.6.2782; GRIFFIN JF, 1986, P NATL ACAD SCI USA, V83, P3272, DOI 10.1073/pnas.83.10.3272; Hardin C, 2002, J COMPUT CHEM, V23, P138, DOI 10.1002/jcc.1162; Heikinheimo P, 2001, P NATL ACAD SCI USA, V98, P3121, DOI 10.1073/pnas.061612498; Herges T, 2005, STRUCTURE, V13, P661, DOI 10.1016/j.str.2005.01.018; HOLM L, 1992, J MOL BIOL, V225, P93, DOI 10.1016/0022-2836(92)91028-N; Huang ES, 1996, J MOL BIOL, V257, P716, DOI 10.1006/jmbi.1996.0196; Kanagasabai V, 2007, PROTEINS, V67, P908, DOI 10.1002/prot.21333; Keasar C, 2003, J MOL BIOL, V329, P159, DOI 10.1016/S0022-2836(03)00323-1; KOEHL P, 1995, NAT STRUCT BIOL, V2, P163, DOI 10.1038/nsb0295-163; Lazaridis T, 1999, J MOL BIOL, V288, P477, DOI 10.1006/jmbi.1999.2685; Levy Y, 2001, J CHEM PHYS, V114, P993, DOI 10.1063/1.1329646; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Liu C.L, 1968, INTRO COMBINATORIAL, P359; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Mirny LA, 2000, P NATL ACAD SCI USA, V97, P9978, DOI 10.1073/pnas.160271197; NEMETHY G, 1992, J PHYS CHEM-US, V96, P6472, DOI 10.1021/j100194a068; OLSZEWSKI KA, 1992, J PHYS CHEM-US, V96, P4672, DOI 10.1021/j100190a096; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Park B, 1996, J MOL BIOL, V258, P367, DOI 10.1006/jmbi.1996.0256; Petrey D, 2000, PROTEIN SCI, V9, P2181, DOI 10.1110/ps.9.11.2181; Plotkin SS, 2000, P NATL ACAD SCI USA, V97, P6509, DOI 10.1073/pnas.97.12.6509; Plotkin SS, 2002, Q REV BIOPHYS, V35, P111, DOI 10.1017/S0033583502003761; Samudrala R, 2000, PROTEIN SCI, V9, P1399, DOI 10.1110/ps.9.7.1399; Samudrala R, 1998, PROTEIN ENG, V11, P991, DOI 10.1093/protein/11.11.991; Samudrala R, 1998, J MOL BIOL, V279, P287, DOI 10.1006/jmbi.1998.1689; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Samudrala R., 1999, PAC S BIOCOMPUT, V4, P505; Scheraga HA, 1999, J GLOBAL OPTIM, V15, P235, DOI 10.1023/A:1008328218931; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; SIPPL MJ, 1995, CURR OPIN STRUC BIOL, V5, P229, DOI 10.1016/0959-440X(95)80081-6; SOSNICK TR, 1994, NAT STRUCT BIOL, V1, P149, DOI 10.1038/nsb0394-149; Tsai J, 2003, PROTEINS, V53, P76, DOI 10.1002/prot.10454; Vengadesan K, 2004, BIOPOLYMERS, V74, P476, DOI 10.1002/bip.20021; Vengadesan K, 2004, J PHYS CHEM B, V108, P11196, DOI 10.1021/jp049581v; Vengadesan K, 2003, BIOPHYS J, V84, P2897, DOI 10.1016/S0006-3495(03)70017-4; WANG YH, 1995, P NATL ACAD SCI USA, V92, P709, DOI 10.1073/pnas.92.3.709; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEISSMAN JS, 1995, CHEM BIOL, V2, P255, DOI 10.1016/1074-5521(95)90044-6; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447	53	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5148	10.1371/journal.pone.0005148	http://dx.doi.org/10.1371/journal.pone.0005148			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357778	Green Submitted, gold, Green Published			2022-12-27	WOS:000265505900014
J	Gomes, CM; Boesch, C				Gomes, Cristina M.; Boesch, Christophe			Wild Chimpanzees Exchange Meat for Sex on a Long-Term Basis	PLOS ONE			English	Article							TAI-NATIONAL-PARK; REPRODUCTIVE SUCCESS; FEMALE CHIMPANZEES; HUNTING BEHAVIOR; COOPERATION; EVOLUTION; ECOLOGY; FOREST	Humans and chimpanzees are unusual among primates in that they frequently perform group hunts of mammalian prey and share meat with conspecifics. Especially interesting are cases in which males give meat to unrelated females. The meat-for-sex hypothesis aims at explaining these cases by proposing that males and females exchange meat for sex, which would result in males increasing their mating success and females increasing their caloric intake without suffering the energetic costs and potential risk of injury related to hunting. Although chimpanzees have been shown to share meat extensively with females, there has not been much direct evidence in this species to support the meat-for-sex hypothesis. Here we show that female wild chimpanzees copulate more frequently with those males who, over a period of 22 months, share meat with them. We excluded other alternative hypotheses to exchanging meat for sex, by statistically controlling for rank of the male, age, rank and gregariousness of the female, association patterns of each male-female dyad and meat begging frequency of each female. Although males were more likely to share meat with estrous than anestrous females given their proportional representation in hunting parties, the relationship between mating success and sharing meat remained significant after excluding from the analysis sharing episodes with estrous females. These results strongly suggest that wild chimpanzees exchange meat for sex, and do so on a long-term basis. Similar studies on humans will determine if the direct nutritional benefits that women receive from hunters in foraging societies could also be driving the relationship between reproductive success and good hunting skills.			Gomes, CM (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	gomes@eva.mpg.de						Baayen R. H., 2008, ANAL LINGUISTIC DATA; BATES D, 2007, LME4 PACKAGE LINEAR; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Boesch C, 2000, CHIMPANZEES TAI FORE; Boesch C, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P139, DOI 10.1007/3-540-28277-7_8; Bolker B., 2007, ECOLOGICAL MODELS DA; CHIVERS DJ, 1980, J MORPHOL, V166, P337, DOI 10.1002/jmor.1051660306; Deschner T, 2003, ANIM BEHAV, V66, P551, DOI 10.1006/anbe.2003.2210; Field A, 2013, DISCOVERING STAT USI; Gilby IC, 2008, ANIM BEHAV, V75, P351, DOI 10.1016/j.anbehav.2007.06.008; Gilby IC, 2006, ANIM BEHAV, V72, P169, DOI 10.1016/j.anbehav.2006.01.013; Gilby IC, 2006, ANIM BEHAV, V71, P953, DOI 10.1016/j.anbehav.2005.09.009; GOMES CM, 2009, P R SOC B, V276; Goodall J., 1986, CHIMPANZEES GOMBE PA; GRAND TI, 1977, AM J PHYS ANTHROPOL, V47, P211, DOI 10.1002/ajpa.1330470204; Gurven M, 2006, CURR ANTHROPOL, V47, P185, DOI 10.1086/499552; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; Gurven Michael, 2006, Soc Biol, V53, P81; Hasegawa T., 1983, J ETHOL, V1, P75, DOI DOI 10.1007/BF02347833; Hawkes K, 2001, EVOL HUM BEHAV, V22, P113, DOI 10.1016/S1090-5138(00)00066-0; JONES NGB, 1987, SOC SCI INFORM, V26, P31; KAPLAN H, 1985, CURR ANTHROPOL, V26, P131, DOI 10.1086/203235; Lee Richard, 1968, MAN HUNTER; Lehmann J, 2009, ANIM BEHAV, V77, P377, DOI 10.1016/j.anbehav.2008.09.038; LOVEJOY CO, 1981, SCIENCE, V211, P341, DOI 10.1126/science.211.4480.341; Manly BFJ, 1997, RANDOMIZATION BOOTST; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; Muller MN, 2007, P ROY SOC B-BIOL SCI, V274, P1009, DOI 10.1098/rspb.2006.0206; Nishida T., 1968, Primates, V9, P167, DOI 10.1007/BF01730971; OATES JF, 1990, ECOLOGY, V71, P328, DOI 10.2307/1940272; Quinn G.P., 2002, EXPT DESIGNS DATA AN; *R DEVELOPMENTCORE, 2004, R LANG ENV STAT COMP; Smith EA, 2000, EVOL HUM BEHAV, V21, P245, DOI 10.1016/S1090-5138(00)00031-3; Smith EA, 2004, HUM NATURE-INT BIOS, V15, P343, DOI 10.1007/s12110-004-1013-9; STANFORD CB, 1994, BEHAVIOUR, V131, P1, DOI 10.1163/156853994X00181; Stanford Craig B., 1999, HUNTING APES MEAT EA; Stumpf RM, 2006, BEHAV ECOL SOCIOBIOL, V60, P749, DOI 10.1007/s00265-006-0219-8; TELEKI G, 1973, PREDATORY BEHAV WILD; Watts DP, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P244, DOI 10.1017/CBO9780511606397.024; Wittig RM, 2003, INT J PRIMATOL, V24, P847, DOI 10.1023/A:1024632923180; WRANGHAM RW, 1975, THESIS CAMBRIDGE U T; ZAHAVI A, 1995, J AVIAN BIOL, V26, P1, DOI 10.2307/3677205	43	157	159	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5116	10.1371/journal.pone.0005116	http://dx.doi.org/10.1371/journal.pone.0005116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437RX	19352509	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505700016
J	Dross, N; Spriet, C; Zwerger, M; Muller, G; Waldeck, W; Langowski, J				Dross, Nicolas; Spriet, Corentin; Zwerger, Monika; Mueller, Gabriele; Waldeck, Waldemar; Langowski, Joerg			Mapping eGFP Oligomer Mobility in Living Cell Nuclei	PLOS ONE			English	Article								Movement of particles in cell nuclei can be affected by viscosity, directed flows, active transport, or the presence of obstacles such as the chromatin network. Here we investigate whether the mobility of small fluorescent proteins is affected by the chromatin density. Diffusion of inert fluorescent proteins was studied in living cell nuclei using fluorescence correlation spectroscopy (FCS) with a two-color confocal scanning detection system. We first present experiments exposing FCS-specific artifacts encountered in live cell studies as well as strategies to prevent them, in particular those arising from the choice of the fluorophore used for calibration of the focal volume, as well as temperature and acquisition conditions used for fluorescence fluctuation measurements. After defining the best acquisition conditions, we show for various human cell lines that the mobility of GFP varies significantly within the cell nucleus, but does not correlate with chromatin density. The intranuclear diffusional mobility strongly depends on protein size: in a series of GFP-oligomers, used as free inert fluorescent tracers, the diffusion coefficient decreased from the monomer to the tetramer much more than expected for molecules free in aqueous solution. Still, the entire intranuclear chromatin network is freely accessible for small proteins up to the size of eGFP-tetramers, regardless of the chromatin density or cell line. Even the densest chromatin regions do not exclude free eGFP-monomers or multimers.	[Dross, Nicolas; Mueller, Gabriele; Waldeck, Waldemar; Langowski, Joerg] German Canc Res Ctr, Div Biophys Macromol, Heidelberg, Germany; [Spriet, Corentin] IRI, Parc Haute Borne, Villeneuve Dascq, France; [Zwerger, Monika] German Canc Res Ctr, Div Funct Cell Biol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Universite de Lille - ISITE; Universite de Lille; Helmholtz Association; German Cancer Research Center (DKFZ)	Dross, N (corresponding author), German Canc Res Ctr, Div Biophys Macromol, Heidelberg, Germany.	jl@dkfz.de	Langowski, Jörg/A-1843-2011; Spriet, Corentin/ABE-4215-2021	Langowski, Jörg/0000-0001-8600-0666; Spriet, Corentin/0000-0002-5805-3426	DFG [La 500/13]; Region-Nord-Pas-de-Calais; ANR [05-MIIM-042]; CNRS MRCT; RT-MFM;  [GDR2588]	DFG(German Research Foundation (DFG)); Region-Nord-Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); ANR(French National Research Agency (ANR)); CNRS MRCT(Centre National de la Recherche Scientifique (CNRS)); RT-MFM; 	This work was supported by DFG grant La 500/13 to JL and by grants from the Region-Nord-Pas-de-Calais, ANR-05-MIIM-042, CNRS MRCT, GDR2588 and RT-MFM to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beetz C, 2004, BIOCHEM BIOPH RES CO, V318, P1079, DOI 10.1016/j.bbrc.2004.03.195; BERLAND KM, 1995, BIOPHYS J, V68, P694, DOI 10.1016/S0006-3495(95)80230-4; Brown CM, 2008, J MICROSC-OXFORD, V229, P78, DOI 10.1111/j.1365-2818.2007.01871.x; Bulseco Dylan A, 2003, Methods Cell Biol, V72, P465, DOI 10.1016/S0091-679X(03)72022-6; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Curl CL, 2005, CYTOM PART A, V65A, P88, DOI 10.1002/cyto.a.20134; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; DIGMAN MA, 2007, IMAGE ANAL MED MICRO, P207; DROSS N, 2008, Patent No. 2020080108950; Gao Y, 2007, APPL SPECTROSC, V61, P956, DOI 10.1366/000370207781745883; GENO G, 2005, BIOTECHNIQUES, V39, P818; Genove G, 2005, BIOTECHNIQUES, V39, P814, DOI 10.2144/000112056; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gorisch S, 2005, HISTOCHEM CELL BIOL, V123, P217, DOI 10.1007/s00418-005-0752-y; Gorisch SM, 2005, J CELL SCI, V118, P5825, DOI 10.1242/jcs.02689; Gorisch SM, 2004, P NATL ACAD SCI USA, V101, P13221, DOI 10.1073/pnas.0402958101; Gorisch SM, 2003, EXP CELL RES, V289, P282, DOI 10.1016/S0014-4827(03)00265-9; Grunwald D, 2008, BIOPHYS J, V94, P2847, DOI 10.1529/biophysj.107.115014; Guigas G, 2008, BIOPHYS J, V94, P90, DOI 10.1529/biophysj.107.117044; HAYES L, PHILO SEDNTERP; Hess ST, 2002, BIOPHYS J, V83, P2300, DOI 10.1016/S0006-3495(02)73990-8; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104; KOHLRAUSCH F, 1985, PRAKTISCHE PHYS; KOPPEL DE, 1976, BIOPHYS J, V16, P1315, DOI 10.1016/S0006-3495(76)85776-1; Mallengo G, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940570; Medina MA, 2002, BIOESSAYS, V24, P758, DOI 10.1002/bies.10118; Monier K, 2000, NAT CELL BIOL, V2, P661, DOI 10.1038/35023615; MULLER CB, 2009, SOFT MATTER; Pack C, 2006, BIOPHYS J, V91, P3921, DOI 10.1529/biophysj.106.079467; Perche PY, 2000, CURR BIOL, V10, P1531, DOI 10.1016/S0960-9822(00)00832-0; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Politz JCR, 2003, MOL BIOL CELL, V14, P4805, DOI 10.1091/mbc.E03-06-0395; Roth CM, 2007, ANAL CHEM, V79, P7340, DOI 10.1021/ac071039q; Sadoni N, 2001, CHROMOSOMA, V110, P39, DOI 10.1007/s004120000123; Schenk A, 2004, BIOPHYS J, V86, P384, DOI 10.1016/S0006-3495(04)74114-4; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; TEWES M, 1998, THESIS RUPRECHT KARL; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Verschure PJ, 2003, EMBO REP, V4, P861, DOI 10.1038/sj.embor.embor922; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Wachsmuth M, 2003, BIOPHYS J, V84, P3353, DOI 10.1016/S0006-3495(03)70059-9; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; WACHSMUTH M, 2001, FLUORESZENZFLUKTUATI; Wei XB, 2003, BIOPHYS J, V84, P1317, DOI 10.1016/S0006-3495(03)74947-9; Weidemann T, 2003, J MOL BIOL, V334, P229, DOI 10.1016/j.jmb.2003.08.063; Weidemann T, 2002, SINGLE MOL, V3, P49, DOI 10.1002/1438-5171(200204)3:1<49::AID-SIMO49>3.3.CO;2-K; REVERSIBLE ASS STRUC	55	111	113	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2009	4	4							e5041	10.1371/journal.pone.0005041	http://dx.doi.org/10.1371/journal.pone.0005041			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QB	19347038	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500900002
J	Fan, XC; Struhl, K				Fan, Xiaochun; Struhl, Kevin			Where Does Mediator Bind In Vivo?	PLOS ONE			English	Article								Background: The Mediator complex associates with RNA polymerase (Pol) II, and it is recruited to enhancer regions by activator proteins under appropriate environmental conditions. However, the issue of Mediator association in yeast cells is controversial. Under optimal growth conditions (YPD medium), we were unable to detect Mediator at essentially any S. cerevisiae promoter region, including those supporting very high levels of transcription. In contrast, whole genome microarray experiments in synthetic complete (SC) medium reported that Mediator associates with many genes at both promoter and coding regions. Principal Findings: As assayed by chromatin immunoprecipitation, we show that there are a small number of Mediator targets in SC medium that are not observed in YPD medium. However, most Mediator targets identified in the genome-wide analysis are false positives that arose for several interrelated reasons: the use of overly lenient cut-offs; artifactual differences in apparent IP efficiencies among different genomic regions in the untagged strain; low fold-enrichments making it difficult to distinguish true Mediator targets from false positives that occur in the absence of the tagged Mediator protein. Lastly, apparent Mediator association in highly active coding regions is due to a non-specific effect on accessibility due to the lack of nucleosomes, not to a specific association of Mediator. Conclusions: These results indicate that Mediator does not bind to numerous sites in the yeast genome, but rather selectively associates with a limited number of upstream promoter regions in an activator- and stress-specific manner.	[Fan, Xiaochun; Struhl, Kevin] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Fan, XC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	kevin@hms.harvard.edu			National Institutes of Health [GM 30186]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030186, R37GM030186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM 30186 from the National Institutes of Health to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; APARICIO O, 2004, CURRENT PROTOCOLS MO; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Fan XC, 2006, NAT STRUCT MOL BIOL, V13, P117, DOI 10.1038/nsmb1049; GIARDINA C, 1995, MOL CELL BIOL, V15, P2737; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kim YJ, 2005, TRENDS BIOCHEM SCI, V30, P245, DOI 10.1016/j.tibs.2005.03.010; KORNBERG RD, 2005, TRENDS BIOCHEM SCI, V30, P240; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kuras L, 2003, P NATL ACAD SCI USA, V100, P13887, DOI 10.1073/pnas.2036346100; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Proft M, 2005, EUKARYOT CELL, V4, P1343, DOI 10.1128/EC.4.8.1343-1352.2005; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Struhl K., 2007, EVALUATING TECHNIQUE, P29; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Wade JT, 2004, NATURE, V432, P1054, DOI 10.1038/nature03175; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	29	53	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5029	10.1371/journal.pone.0005029	http://dx.doi.org/10.1371/journal.pone.0005029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343176	gold, Green Submitted, Green Published			2022-12-27	WOS:000265500800003
J	Zhang, YF; Li, H; Wang, XM; Gao, X; Liu, XL				Zhang, Yafeng; Li, Hai; Wang, Xiaoming; Gao, Xiang; Liu, Xiaolong			Regulation of T Cell Development and Activation by Creatine Kinase B	PLOS ONE			English	Article							NEGATIVE SELECTION; CD4(+)CD8(+) THYMOCYTES; PROTEIN; EXPRESSION; DIFFERENTIATION; APOPTOSIS; ENZYME; SIGNAL; BCL-2; MUSCLES	Creatine kinase catalyzes the reversible transfer of the N-phosphoryl group from phosphocreatine to ADP to generate ATP and plays a key role in highly energy-demanding processes such as muscle contraction and flagellar motility; however, its role in signal transduction (which frequently involves ATP-consuming phosphorylation) and consequent cell-fate decisions remains largely unknown. Here we report that creatine kinase B was significantly up-regulated during the differentiation of double-positive thymocytes into single-positive thymocytes. Ectopic expression of creatine kinase B led to increased ATP level and enhanced phosphorylation of the TCR signaling proteins. Consequentially, transgenic expression of creatine kinase B promoted the expression of Nur77 and Bim proteins and the cell death of TCR signaled thymocyte. In addition, the activation, proliferation and cytokine secretion of T cells were also enhanced by the expression of creatine kinase B transgene. In contrast, treatment of T cells with specific creatine kinase inhibitor or creatine kinase B shRNA resulted in severely impaired T cell activation. Taken together, our results indicate that creatine kinase B plays an unexpected role in modulating TCR-mediated signaling and critically regulates thymocyte selection and T cell activation.	[Zhang, Yafeng; Li, Hai; Wang, Xiaoming; Liu, Xiaolong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China; [Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Nanjing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing University	Zhang, YF (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China.	liux@sibs.ac.cn	Li, Hai/AAI-9163-2021	Li, Hai/0000-0002-4762-9362	National Natural Science Foundation of China [30623003]; Ministry of Science and Technology [2006CB504303, 2007CB815802]; National High-Tech Research and Development Program of China [2007AA02Z167]; National Basic Research Program of China [2007CB914504]; Chinese Academy of Sciences [KSCX1-YW-R-43, 180KSCX2-YW-R-108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	National Natural Science Foundation of China (30623003), the Ministry of Science and Technology (2006CB504303, 2007CB815802), National High-Tech Research and Development Program of China (2007AA02Z167), National Basic Research Program of China (2007CB914504) and Chinese Academy of Sciences (KSCX1-YW-R-43, 180KSCX2-YW-R-108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Amsen D, 1999, P NATL ACAD SCI USA, V96, P622, DOI 10.1073/pnas.96.2.622; Balasubramani M, 2006, CANCER RES, V66, P763, DOI 10.1158/0008-5472.CAN-05-3771; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Burklen TS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/35936; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; Cheng AM, 1997, CURR OPIN IMMUNOL, V9, P528, DOI 10.1016/S0952-7915(97)80106-9; Debrincat MA, 2007, J BIOL CHEM, V282, P4728, DOI 10.1074/jbc.M609164200; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Huddleston HG, 2005, GYNECOL ONCOL, V96, P77, DOI 10.1016/j.ygyno.2004.08.047; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Ishikawa J, 2005, CLIN CHIM ACTA, V361, P135, DOI 10.1016/j.cccn.2005.05.028; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Kuiper JWP, 2008, PLOS BIOL, V6, P568, DOI 10.1371/journal.pbio.0060051; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Liu XL, 2003, J EXP MED, V197, P363, DOI 10.1084/jem.20021698; Mahajan VB, 2000, P NATL ACAD SCI USA, V97, P12062, DOI 10.1073/pnas.97.22.12062; Meffert G, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-9; Mulvaney PT, 1998, INT J CANCER, V78, P46, DOI 10.1002/(SICI)1097-0215(19980925)78:1<46::AID-IJC9>3.0.CO;2-X; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Ohashi PS, 2003, CURR OPIN IMMUNOL, V15, P668, DOI 10.1016/j.coi.2003.09.013; Owen MJ, 1996, CURR OPIN IMMUNOL, V8, P191, DOI 10.1016/S0952-7915(96)80057-4; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; Sprent J, 2002, IMMUNOL REV, V185, P126, DOI 10.1034/j.1600-065X.2002.18512.x; SPRENT J, 1995, CURR OPIN IMMUNOL, V7, P196, DOI 10.1016/0952-7915(95)80004-2; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Swainson L, 2005, P NATL ACAD SCI USA, V102, P12867, DOI 10.1073/pnas.0503603102; Tachikawa M, 2004, EUR J NEUROSCI, V20, P144, DOI 10.1111/j.1460-9568.2004.03478.x; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; Ventura-Clapier R, 1998, MOL CELL BIOCHEM, V184, P231, DOI 10.1023/A:1006840508139; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wallimann T, 1998, MAGN RESON MATER PHY, V6, P116; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765	50	53	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5000	10.1371/journal.pone.0005000	http://dx.doi.org/10.1371/journal.pone.0005000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337362	Green Submitted, gold, Green Published			2022-12-27	WOS:000265500600007
J	Lamers, SL; Salemi, M; Galligan, DC; de Oliveira, T; Fogel, GB; Granier, SC; Zhao, L; Brown, JN; Morris, A; Masliah, E; McGrath, MS				Lamers, Susanna L.; Salemi, Marco; Galligan, Derek C.; de Oliveira, Tulio; Fogel, Gary B.; Granier, Sara C.; Zhao, Li; Brown, Joseph N.; Morris, Alanna; Masliah, Eliezer; McGrath, Michael S.			Extensive HIV-1 Intra-Host Recombination Is Common in Tissues with Abnormal Histopathology	PLOS ONE			English	Article								There is evidence that immune-activated macrophages infected with the Human Immunodeficiency Virus (HIV) are associated with tissue damage and serve as a long-lived viral reservoir during therapy. In this study, we analyzed 780 HIV genetic sequences generated from 53 tissues displaying normal and abnormal histopathology. We found up to 50% of the sequences from abnormal lymphoid and macrophage rich non-lymphoid tissues were intra-host viral recombinants. The presence of extensive recombination, especially in non-lymphoid tissues, implies that HIV-1 infected macrophages may significantly contribute to the generation of elusive viral genotypes in vivo. Because recombination has been implicated in immune evasion, the acquisition of drug-resistance mutations, and alterations of viral co-receptor usage, any attempt towards the successful eradication of HIV-1 requires therapeutic approaches targeting tissue macrophages.	[Lamers, Susanna L.; Salemi, Marco; de Oliveira, Tulio; Granier, Sara C.] BioInfoExperts, Thibodaux, LA USA; [Salemi, Marco; Brown, Joseph N.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Galligan, Derek C.; Morris, Alanna; McGrath, Michael S.] Univ Calif San Francisco, Dept Lab Med, Positive Hlth Program, San Francisco, CA 94143 USA; [de Oliveira, Tulio] Univ Western Cape, S African Natl Bioinformat Inst, Cape Town, South Africa; [Fogel, Gary B.] Nat Select Inc, San Diego, CA USA; [Zhao, Li] Shandong Univ, Dept Toxicol, Jinan, Peoples R China; [McGrath, Michael S.] Pathol Inc, Burlingame, CA USA; [Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Pathol, San Diego, CA USA; [McGrath, Michael S.] AIDS & Canc Specimen Resource, San Francisco, CA USA	State University System of Florida; University of Florida; University of California System; University of California San Francisco; South African National Biodiversity Institute; University of the Western Cape; Shandong University; University of California System; University of California San Diego	Lamers, SL (corresponding author), BioInfoExperts, Thibodaux, LA USA.	mmcgrath@hemeonc.ucsf.edu			NIH [R01 MH073510-01]; SBIR [DMI-0349669]; West Coast AIDS and Cancer Specimen Resource Consortium [U01 CA066529-12]; Department of Pediatrics at the University of Florida, Gainesville [AI065265, HD32259]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032259, R55HD032259] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA066529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073510] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBIR; West Coast AIDS and Cancer Specimen Resource Consortium; Department of Pediatrics at the University of Florida, Gainesville; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project was primarily funded through NIH R01 MH073510-01. Additional support was provided to S.L. Lamers through SBIR grant DMI- 0349669. Additional support was provided to M.S. McGrath through the West Coast AIDS and Cancer Specimen Resource Consortium U01 CA066529-12. Additional support for M. Salemi was provided by grants AI065265 and HD32259 and the Department of Pediatrics at the University of Florida, Gainesville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Carvajal-Rodriguez A, 2007, INFECT GENET EVOL, V7, P476, DOI 10.1016/j.meegid.2007.02.001; Charpentier C, 2006, J VIROL, V80, P2472, DOI 10.1128/JVI.80.5.2472-2482.2006; Chen JB, 2005, J VIROL, V79, P9337, DOI 10.1128/JVI.79.14.9337-9340.2005; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; COFFIN JM, 1979, J GEN VIROL, V42, P1, DOI 10.1099/0022-1317-42-1-1; Cotter Bruno R, 2006, Curr HIV/AIDS Rep, V3, P126, DOI 10.1007/BF02696656; Forsman A, 2008, TRENDS MICROBIOL, V16, P555, DOI 10.1016/j.tim.2008.09.004; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Hansen AB, 2006, HIV MED, V7, P38, DOI 10.1111/j.1468-1293.2005.00334.x; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lamers S, 2004, BIOINFORMATICS, V20, P436, DOI 10.1093/bioinformatics/btg445; Lamers SL, 1996, AIDS RES HUM RETROV, V12, P1169, DOI 10.1089/aid.1996.12.1169; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mack KD, 2003, JAIDS-J ACQ IMM DEF, V33, P308, DOI 10.1097/00126334-200307010-00004; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Meyerhans A, 2003, SWISS MED WKLY, V133, P451; Mild M, 2007, J VIROL, V81, P3369, DOI 10.1128/JVI.01295-06; Morris A, 1999, J VIROL, V73, P8720, DOI 10.1128/JVI.73.10.8720-8731.1999; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Perez-Bercoff D, 2007, J VIROL, V81, P4540, DOI 10.1128/JVI.01620-06; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Rodrigo AG, 1999, P NATL ACAD SCI USA, V96, P2187, DOI 10.1073/pnas.96.5.2187; Rodrigo AG, 1997, AIDS RES HUM RETROV, V13, P737, DOI 10.1089/aid.1997.13.737; Salemi M, 2005, J VIROL, V79, P11343, DOI 10.1128/JVI.79.17.11343-11352.2005; SALEMI M, 2003, PHYLOGENETIC HDB PRA, P348; Salemi M, 2008, MOL PHYLOGENET EVOL, V49, P618, DOI 10.1016/j.ympev.2008.08.017; Salemi M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000950; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Samaras K, 2007, DIABETES CARE, V30, P113, DOI 10.2337/dc06-1075; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SERAFINI S, 2008, ANTIVIRAL RES; Shriner D, 2004, GENETICS, V167, P1573, DOI 10.1534/genetics.103.023382; SMITH JM, 1992, J MOL EVOL, V34, P126; Swingler S, 2008, CELL HOST MICROBE, V4, P63, DOI 10.1016/j.chom.2008.05.015; Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Yu H, 1998, J BIOL CHEM, V273, P28384, DOI 10.1074/jbc.273.43.28384; Zhang CY, 2008, INFECT GENET EVOL, V8, P693, DOI 10.1016/j.meegid.2008.04.001; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002	52	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5065	10.1371/journal.pone.0005065	http://dx.doi.org/10.1371/journal.pone.0005065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333384	Green Submitted, Green Published, gold			2022-12-27	WOS:000265499900017
J	Melchers, A; Stockl, L; Radszewski, J; Anders, M; Krenzlin, H; Kalischke, C; Scholz, R; Jordan, A; Nebrich, G; Klose, J; Sperling, K; Digweed, M; Demuth, I				Melchers, Anna; Stoeckl, Lars; Radszewski, Janina; Anders, Marco; Krenzlin, Harald; Kalischke, Candy; Scholz, Regina; Jordan, Andreas; Nebrich, Grit; Klose, Joachim; Sperling, Karl; Digweed, Martin; Demuth, Ilja			A Systematic Proteomic Study of Irradiated DNA Repair Deficient Nbn-Mice	PLOS ONE			English	Article								The Background: NBN gene codes for the protein nibrin, which is involved in the detection and repair of DNA double strand breaks (DSBs). The NBN gene is essential in mammals. Methodology/Principal Findings: We have used a conditional null mutant mouse model in a proteomics approach to identify proteins with modified expression levels after 4 Gy ionizing irradiation in the absence of nibrin in vivo. Altogether, amongst,8,000 resolved proteins, 209 were differentially expressed in homozygous null mutant mice in comparison to control animals. One group of proteins significantly altered in null mutant mice were those involved in oxidative stress and cellular redox homeostasis (p<0.0001). In substantiation of this finding, analysis of Nbn null mutant fibroblasts indicated an increased production of reactive oxygen species following induction of DSBs. Conclusions/Significance: In humans, biallelic hypomorphic mutations in NBN lead to Nijmegen breakage syndrome (NBS), an autosomal recessive genetic disease characterised by extreme radiosensitivity coupled with growth retardation, immunoinsufficiency and a very high risk of malignancy. This particularly high cancer risk in NBS may be attributable to the compound effect of a DSB repair defect and oxidative stress.			Melchers, A (corresponding author), Charite Univ Med Berlin, Inst Humangenet, Ctr Biomed Nanotechnol, Campus Virchow Klinikum, D-13353 Berlin, Germany.	ilja.demuth@charite.de	Krenzlin, Harald/AAM-5444-2020; Krenzlin, Harald/AAS-7602-2020; Demuth, Ilja/ABD-5352-2021	Demuth, Ilja/0000-0002-4340-2523				Adema AD, 2003, INT J RADIAT BIOL, V79, P655, DOI 10.1080/09553000310001596968; ANTONOV AV, 2008, NUCL ACIDS RES; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Barzilai A, 2007, ANTIOXID REDOX SIGN, V9, P211, DOI 10.1089/ars.2007.9.211; Bertram C, 2008, BIOL CHEM, V389, P211, DOI 10.1515/BC.2008.031; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; CARTER SG, 1982, BIOCHEMISTRY-US, V21, P5475, DOI 10.1021/bi00265a015; CEDERVALL B, 1995, RADIAT RES, V143, P8, DOI 10.2307/3578920; Cerosaletti K, 2006, MOL CELL BIOL, V26, P1691, DOI 10.1128/MCB.26.5.1691-1699.2006; Cloos J, 1996, CARCINOGENESIS, V17, P327, DOI 10.1093/carcin/17.2.327; Demuth I, 2007, ONCOGENE, V26, P7792, DOI 10.1038/sj.onc.1210876; Demuth I, 2004, HUM MOL GENET, V13, P2385, DOI 10.1093/hmg/ddh278; Demuth I, 2008, DNA REPAIR, V7, P1192, DOI 10.1016/j.dnarep.2008.03.020; Dikomey E, 1998, INT J RADIAT BIOL, V73, P269, DOI 10.1080/095530098142365; Dumon-Jones V, 2003, CANCER RES, V63, P7263; Frappart PO, 2005, NAT MED, V11, P538, DOI 10.1038/nm1228; Gallagher BM, 2007, FREE RADICAL BIO MED, V42, P1270, DOI 10.1016/j.freeradbiomed.2007.01.023; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; JANSSEN YMW, 1993, LAB INVEST, V69, P261; Kasten-Pisula U, 2005, INT J RADIAT BIOL, V81, P409, DOI 10.1080/09553000500140498; Kirsch M, 2001, FASEB J, V15, P1569, DOI 10.1096/fj.00-0823hyp; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Kraakman-van der Zwet M, 1999, MUTAT RES-DNA REPAIR, V434, P17, DOI 10.1016/S0921-8777(99)00009-9; Kracker S, 2005, P NATL ACAD SCI USA, V102, P1584, DOI 10.1073/pnas.0409191102; Kruger L, 2007, CARCINOGENESIS, V28, P107, DOI 10.1093/carcin/bgl126; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liu J, 2007, FEBS LETT, V581, P5043, DOI 10.1016/j.febslet.2007.09.042; Liu SX, 2001, P NATL ACAD SCI USA, V98, P1643, DOI 10.1073/pnas.031482998; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Mattow J, 2006, ELECTROPHORESIS, V27, P1683, DOI 10.1002/elps.200500703; Mukherjee SK, 1997, EUR J PHARMACOL, V330, P27, DOI 10.1016/S0014-2999(97)00171-4; Nebrich G, 2007, ELECTROPHORESIS, V28, P1607, DOI 10.1002/elps.200600656; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Park EC, 2006, PREP BIOCHEM BIOTECH, V36, P19, DOI 10.1080/10826060500388470; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Reichenbach J, 1999, CLIN EXP IMMUNOL, V117, P535; Sullivan KE, 1997, CLIN IMMUNOL IMMUNOP, V82, P43, DOI 10.1006/clin.1996.4275; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Vanlangenakker N, 2008, CURR MOL MED, V8, P207, DOI 10.2174/156652408784221306; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Yang YG, 2006, EMBO J, V25, P5527, DOI 10.1038/sj.emboj.7601411; YI M, 1990, CANCER LETT, V54, P43, DOI 10.1016/0304-3835(90)90089-G; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	48	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5423	10.1371/journal.pone.0005423	http://dx.doi.org/10.1371/journal.pone.0005423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412544	Green Published, gold, Green Submitted			2022-12-27	WOS:000265688200010
J	Esteban, V; Heringer-Walther, S; Sterner-Kock, A; de Bruin, R; van den Engel, S; Wang, Y; Mezzano, S; Egido, J; Schultheiss, HP; Ruiz-Ortega, M; Walther, T				Esteban, Vanesa; Heringer-Walther, Silvia; Sterner-Kock, Anja; de Bruin, Ron; van den Engel, Sandra; Wang, Yong; Mezzano, Sergio; Egido, Jesus; Schultheiss, Heinz-Peter; Ruiz-Ortega, Marta; Walther, Thomas			Angiotensin-(1-7) and the G Protein-Coupled Receptor Mas Are Key Players in Renal Inflammation	PLOS ONE			English	Article							HEMATOPOIETIC RECOVERY; MICE LACKING; KIDNEY; NEPHROPATHY; ACTIVATION; EXPRESSION; CHEMOKINES; BLOCKADE; FIBROSIS; SYSTEM	Angiotensin (Ang) II mediates pathophysiologial changes in the kidney. Ang-(1-7) by interacting with the G protein-coupled receptor Mas may also have important biological activities. In this study, renal deficiency for Mas diminished renal damage in models of renal insufficiency as unilateral ureteral obstruction and ischemia/reperfusion injury while the infusion of Ang-(1-7) to wild-type mice pronounced the pathological outcome by aggravating the inflammatory response. Mas deficiency inhibited NF-kappa B activation and thus the elevation of inflammation-stimulating cytokines, while Ang-(1-7) infusion had proinflammatory properties in experimental models of renal failure as well as under basal conditions. The Ang-(1-7)-mediated NF-kappa B activation was Mas dependent but did not involve Ang II receptors. Therefore, the blockade of the NF-kappa B-activating properties of the receptor Mas could be a new strategy in the therapy of failing kidney.			Esteban, V (corresponding author), Univ Autonoma Madrid, Fdn Jimenez Diaz, Cellular Biol Renal Dis Lab, Madrid, Spain.	thomas.walther@hyms.ac.uk	Esteban, Vanesa/J-8075-2012; Ruiz-Ortega, Marta/D-3584-2012; Ortega, Marta Ruiz/AAN-2136-2020; ruiz-ortega, marta/D-3584-2012	Esteban, Vanesa/0000-0002-7500-6277; Ruiz-Ortega, Marta/0000-0002-1495-6535; Ortega, Marta Ruiz/0000-0002-1495-6535; ruiz-ortega, marta/0000-0002-1403-2690				Alcazar JM, 2000, AM J KIDNEY DIS, V36, P883, DOI 10.1053/ajkd.2000.19077; Alenina N, 2002, J HISTOCHEM CYTOCHEM, V50, P691, DOI 10.1177/002215540205000510; AMBROZ C, 1991, BIOCHIM BIOPHYS ACTA, V1133, P107, DOI 10.1016/0167-4889(91)90248-V; Burgelova M, 2005, KIDNEY INT, V67, P1453, DOI 10.1111/j.1523-1755.2005.00222.x; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Ellefson DD, 2004, CANCER CHEMOTH PHARM, V53, P15, DOI 10.1007/s00280-003-0710-0; Esteban V, 2004, J AM SOC NEPHROL, V15, P1514, DOI 10.1097/01.ASN.0000130564.75008.F5; Ferrario CM, 2003, CURR HYPERTENS REP, V5, P129, DOI 10.1007/s11906-003-0069-y; Ferrario CM, 2002, J HYPERTENS, V20, P805, DOI 10.1097/00004872-200205000-00004; Ferreira AJ, 2006, REGUL PEPTIDES, V137, P128, DOI 10.1016/j.regpep.2006.06.005; Gembardt F, 2008, FASEB J, V22, P3068, DOI 10.1096/fj.08-108316; Inan MS, 2003, CONTRIB NEPHROL, V139, P90; Iwata M, 2005, AM J PHYSIOL-HEART C, V289, pH2356, DOI 10.1152/ajpheart.00317.2005; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Langeveld B, 2005, HYPERTENSION, V45, P138, DOI 10.1161/01.HYP.0000149382.83973.c2; Loot AE, 2002, CIRCULATION, V105, P1548, DOI 10.1161/01.CIR.0000013847.07035.B9; Ma J, 1998, KIDNEY INT, V53, P937, DOI 10.1111/j.1523-1755.1998.00893.x; MacKinnon M, 2006, AM J KIDNEY DIS, V48, P8, DOI 10.1053/j.ajkd.2006.04.077; MCLACHLAN N, 1994, ACTA CYTOL, V38, P531; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; Padi SSV, 2002, PHARMACOL RES, V45, P413, DOI 10.1006/phrs.2002.0959; Rodgers K, 2003, CANCER CHEMOTH PHARM, V51, P97, DOI 10.1007/s00280-002-0509-4; Rodriguez-Iturbe B, 2006, NEPHROL DIAL TRANSPL, V21, P260, DOI 10.1093/ndt/gfi319; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Ruiz-Ortega M, 2006, CURR OPIN NEPHROL HY, V15, P159, DOI 10.1097/01.mnh.0000203190.34643.d4; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Satoh M, 2001, J AM SOC NEPHROL, V12, P317, DOI 10.1681/ASN.V122317; Schoolwerth AC, 2005, ADV CHRONIC KIDNEY D, V12, P418, DOI 10.1053/j.ackd.2005.07.012; Segerer S, 2003, CURR OPIN NEPHROL HY, V12, P243, DOI 10.1097/00041552-200305000-00004; Segerer S, 2007, SEMIN NEPHROL, V27, P260, DOI 10.1016/j.semnephrol.2007.02.003; Segerer S, 2005, THESCIENTIFICWORLDJO, V5, P835, DOI 10.1100/tsw.2005.105; Tallant EA, 2005, AM J PHYSIOL-HEART C, V289, pH1560, DOI 10.1152/ajpheart.00941.2004; Taneda S, 2003, J AM SOC NEPHROL, V14, P968, DOI 10.1097/01.ASN.0000054498.83125.90; Thorp Micah L, 2006, Dis Manag, V9, P115, DOI 10.1089/dis.2006.9.115; Walther T, 1998, J BIOL CHEM, V273, P11867, DOI 10.1074/jbc.273.19.11867; Walther T, 2000, BRAZ J MED BIOL RES, V33, P1, DOI 10.1590/S0100-879X2000000100001; Walther T, 2007, CIRCULATION, V115, P333, DOI 10.1161/CIRCULATIONAHA.106.643296; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; WREFORD NG, 1995, MICROSC RES TECHNIQ, V32, P423, DOI 10.1002/jemt.1070320505	42	95	102	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5406	10.1371/journal.pone.0005406	http://dx.doi.org/10.1371/journal.pone.0005406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404405	gold, Green Published, Green Submitted			2022-12-27	WOS:000265614900017
J	Rossy, J; Schlicht, D; Engelhardt, B; Niggli, V				Rossy, Jeremie; Schlicht, Dominique; Engelhardt, Britta; Niggli, Verena			Flotillins Interact with PSGL-1 in Neutrophils and, upon Stimulation, Rapidly Organize into Membrane Domains Subsequently Accumulating in the Uropod	PLOS ONE			English	Article								Background: Neutrophils polarize and migrate in response to chemokines. Different types of membrane microdomains (rafts) have been postulated to be present in rear and front of polarized leukocytes and disruption of rafts by cholesterol sequestration prevents leukocyte polarization. Reggie/flotillin-1 and -2 are two highly homologous proteins that are ubiquitously enriched in detergent resistant membranes and are thought to shape membrane microdomains by forming homo- and hetero-oligomers. It was the goal of this study to investigate dynamic membrane microdomain reorganization during neutrophil activation. Methodology/Principal Findings: We show now, using immunofluorescence staining and co-immunoprecipitation, that endogenous flotillin-1 and -2 colocalize and associate in resting spherical and polarized primary neutrophils. Flotillins redistribute very early after chemoattractant stimulation, and form distinct caps in more than 90% of the neutrophils. At later time points flotillins accumulate in the uropod of polarized cells. Chemotactic peptide-induced redistribution and capping of flotillins requires integrity and dynamics of the actin cytoskeleton, but does not involve Rho-kinase dependent signaling related to formation of the uropod. Both flotillin isoforms are involved in the formation of this membrane domain, as uropod location of exogenously expressed flotillins is dramatically enhanced by co-overexpression of tagged flotillin-1 and -2 in differentiated HL-60 cells as compared to cells expressing only one tagged isoform. Flotillin-1 and -2 associate with P-selectin glycoprotein ligand 1 (PSGL-1) in resting and in stimulated neutrophils as shown by colocalization and co-immunoprecipitation. Neutrophils isolated from PSGL-1-deficient mice exhibit flotillin caps to the same extent as cells isolated from wild type animals, implying that PSGL-1 is not required for the formation of the flotillin caps. Finally we show that stimulus-dependent redistribution of other uropod-located proteins, CD43 and ezrin/radixin/moesin, occurs much slower than that of flotillins and PSGL-1. Conclusions/Significance: These results suggest that flotillin-rich actin-dependent membrane microdomains are importantly involved in neutrophil uropod formation and/or stabilization and organize uropod localization of PSGL-1.			Rossy, J (corresponding author), Univ Bern, Dept Pathol, CH-3000 Bern, Switzerland.	verena.niggli@pathology.unibe.ch	Engelhardt, Britta/K-7267-2014; Rossy, Jeremie/N-8554-2016	Engelhardt, Britta/0000-0003-3059-9846; Rossy, Jeremie/0000-0002-5128-5283				Abbal C, 2006, BLOOD, V108, P3352, DOI 10.1182/blood-2006-04-013912; Alonso-Lebrero JL, 2000, BLOOD, V95, P2413, DOI 10.1182/blood.V95.7.2413.007k17_2413_2419; Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; BOYUM A, 1968, SCAND J CLIN LAB S97, V21, P1; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; Cooper KM, 2008, MOL BIOL CELL, V19, P3180, DOI 10.1091/mbc.E08-02-0225; Engelhardt B, 2005, J IMMUNOL, V175, P1267, DOI 10.4049/jimmunol.175.2.1267; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Giri B, 2007, EUR J IMMUNOL, V37, P2104, DOI 10.1002/eji.200636680; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Hauert AB, 2002, INT J BIOCHEM CELL B, V34, P838, DOI 10.1016/S1357-2725(02)00010-9; Hoehne M, 2005, MOL CELL NEUROSCI, V30, P326, DOI 10.1016/j.mcn.2005.07.007; Jockusch BM, 2006, TRENDS CELL BIOL, V16, P391, DOI 10.1016/j.tcb.2006.06.006; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Langhorst MF, 2007, FEBS LETT, V581, P4697, DOI 10.1016/j.febslet.2007.08.074; Langhorst MF, 2006, FASEB J, V20, P711, DOI 10.1096/fj.05-4760fje; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; LORANT DE, 1995, J CLIN INVEST, V96, P171, DOI 10.1172/JCI118018; Ma YQ, 2004, BLOOD, V104, P2549, DOI 10.1182/blood-2004-03-1108; Manes S, 2003, TRENDS IMMUNOL, V24, P320, DOI 10.1016/S1471-4906(03)00137-6; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Niggli V, 2003, J CELL SCI, V116, P813, DOI 10.1242/jcs.00306; Niggli V, 1999, FEBS LETT, V445, P69, DOI 10.1016/S0014-5793(99)00098-8; Niggli V, 2004, EXP CELL RES, V296, P358, DOI 10.1016/j.yexcr.2004.02.015; Niggli V, 2003, INT J BIOCHEM CELL B, V35, P1619, DOI 10.1016/S1357-2725(03)00144-4; Nuzzi Paul A, 2007, Methods Mol Biol, V370, P23; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Pierini LM, 2003, J BIOL CHEM, V278, P10831, DOI 10.1074/jbc.M212386200; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Serrador JM, 2002, EUR J IMMUNOL, V32, P1560, DOI 10.1002/1521-4141(200206)32:6<1560::AID-IMMU1560>3.0.CO;2-U; Seveau S, 1997, J CELL SCI, V110, P1465; Seveau S, 2001, MOL BIOL CELL, V12, P3550, DOI 10.1091/mbc.12.11.3550; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; Yanagida M, 2007, PROTEOMICS, V7, P2398, DOI 10.1002/pmic.200700056; Yoshinaga-Ohara N, 2002, EXP CELL RES, V278, P112, DOI 10.1006/excr.2002.5571	45	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5403	10.1371/journal.pone.0005403	http://dx.doi.org/10.1371/journal.pone.0005403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404397	Green Published, gold			2022-12-27	WOS:000265614900014
J	Zhang, PP; Allahverdiyeva, Y; Eisenhut, M; Aro, EM				Zhang, Pengpeng; Allahverdiyeva, Yagut; Eisenhut, Marion; Aro, Eva-Mari			Flavodiiron Proteins in Oxygenic Photosynthetic Organisms: Photoprotection of Photosystem II by Flv2 and Flv4 in Synechocystis sp PCC 6803	PLOS ONE			English	Article							INORGANIC CARBON LIMITATION; GENE-EXPRESSION; ELECTRON-TRANSPORT; NITRIC-OXIDE; SP PCC-6803; LIGHT; PHOTOINHIBITION; FLAVOPROTEINS; INACTIVATION; RUBREDOXIN	Background: Flavodiiron proteins (FDPs) comprise a group of modular enzymes that function in oxygen and nitric oxide detoxification in Bacteria and Archaea. The FDPs in cyanobacteria have an extra domain as compared to major prokaryotic enzymes. The physiological role of cyanobacteria FDPs is mostly unknown. Of the four putative flavodiiron proteins (Flv1-4) in the cyanobacterium Synechocystis sp. PCC 6803, a physiological function in Mehler reaction has been suggested for Flv1 and Flv3. Principal Findings: We demonstrate a novel and crucial function for Flv2 and Flv4 in photoprotection of photosystem II (PSII) in Synechocystis. It is shown that the expression of Flv2 and Flv4 is high under air level of CO2 and negligible at elevated CO2. Moreover, the rate of accumulation of flv2 and flv4 transcripts upon shift of cells from high to low CO2 is strongly dependent on light intensity. Characterization of FDP inactivation mutants of Synechocystis revealed a specific decline in PSII centers and impaired translation of the D1 protein in Delta flv2 and Delta flv4 when grown at air level CO2 whereas at high CO2 the Flvs were dispensable. Delta flv2 and Delta flv4 were also more susceptible to high light induced inhibition of PSII than WT or Delta flv1 and Delta flv3. Significance: Analysis of published sequences revealed the presence of cyanobacteria-like FDPs also in some oxygenic photosynthetic eukaryotes like green algae, mosses and lycophytes. Our data provide evidence that Flv2 and Flv4 have an important role in photoprotection of water-splitting PSII against oxidative stress when the cells are acclimated to air level CO2. It is conceivable that the function of FDPs has changed during evolution from protection against oxygen in anaerobic microbes to protection against reactive oxygen species thus making the sustainable function of oxygen evolving PSII possible. Higher plants lack FDPs and distinctly different mechanisms have evolved for photoprotection of PSII.			Zhang, PP (corresponding author), Univ Turku, Dept Biol Plant Physiol & Mol Biol, Turku, Finland.	evaaro@utu.fi	Aro, Eva-Mari/Q-8664-2017; Allahverdiyeva, Yagut/I-5652-2013	Aro, Eva-Mari/0000-0002-2922-1435; Allahverdiyeva, Yagut/0000-0002-9262-1757				Allahverdiyeva Y, 2004, EUR J BIOCHEM, V271, P3523, DOI 10.1111/j.0014-2956.2004.04287.x; Andersson JO, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148/6/27; Andersson JO, 2003, CURR BIOL, V13, P94, DOI 10.1016/S0960-9822(03)00003-4; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Baroli I, 1998, PLANTA, V205, P288, DOI 10.1007/s004250050323; CHEN L, 1993, BIOCHEM BIOPH RES CO, V193, P100, DOI 10.1006/bbrc.1993.1595; Eisenhut M, 2007, PLANT PHYSIOL, V144, P1946, DOI 10.1104/pp.107.103341; Folea IM, 2008, FEBS LETT, V582, P249, DOI 10.1016/j.febslet.2007.12.012; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; Gomes CM, 1997, J BIOL CHEM, V272, P22502, DOI 10.1074/jbc.272.36.22502; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; Helman Y, 2003, CURR BIOL, V13, P230, DOI 10.1016/S0960-9822(03)00046-0; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Huang LX, 2002, J BACTERIOL, V184, P6845, DOI 10.1128/JB.184.24.6845-6858.2002; Kawasaki S, 2004, FEBS LETT, V571, P21, DOI 10.1016/j.febslet.2004.06.047; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li H, 2004, J BACTERIOL, V186, P3331, DOI 10.1128/JB.186.11.3331-3345.2004; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; McGinn PJ, 2003, PLANT PHYSIOL, V132, P218, DOI 10.1104/pp.102.019349; Mulo P, 1997, PLANT MOL BIOL, V33, P1059, DOI 10.1023/A:1005765305956; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; NOLLING J, 1995, EUR J BIOCHEM, V231, P628, DOI 10.1111/j.1432-1033.1995.0628d.x; Sarti P, 2004, CELL MOL LIFE SCI, V61, P618, DOI 10.1007/s00018-003-3413-8; Sicora CI, 2006, BBA-BIOENERGETICS, V1757, P47, DOI 10.1016/j.bbabio.2005.11.002; Singh M, 2008, INDIAN J BIOCHEM BIO, V45, P237; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vicente JB, 2002, BIOCHEM BIOPH RES CO, V294, P82, DOI 10.1016/S0006-291X(02)00434-5; Vicente JB, 2008, METHOD ENZYMOL, V437, P21, DOI 10.1016/S0076-6879(07)37002-X; Vicente JB, 2008, METHOD ENZYMOL, V437, P3, DOI 10.1016/S0076-6879(07)37001-8; Wang H, 2004, J BIOL CHEM, V279, P1468, DOI 10.1074/jbc.M309106200; Wasserfallen A, 1998, EUR J BIOCHEM, V254, P325, DOI 10.1046/j.1432-1327.1998.2540325.x; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Zhang PP, 2007, MOL MICROBIOL, V65, P728, DOI 10.1111/j.1365-2958.2007.05822.x; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526	35	123	124	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5331	10.1371/journal.pone.0005331	http://dx.doi.org/10.1371/journal.pone.0005331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390625	Green Published, gold, Green Submitted			2022-12-27	WOS:000265514400017
J	Zhang, TT; Song, KW; Hekmat-Nejad, M; Morris, DG; Wong, BR				Zhang, Tingting; Song, Kyung W.; Hekmat-Nejad, Mohammad; Morris, David G.; Wong, Brian R.			A Modeling-Derived Hypothesis on Chronicity in Respiratory Diseases: Desensitized Pathogen Recognition Secondary to Hyperactive IRAK/TRAF6 Signaling	PLOS ONE			English	Article								Several chronic respiratory diseases exhibit hyperactive immune responses in the lung: abundant inflammatory mediators; infiltrating neutrophils, macrophages, lymphocytes and other immune cells; and increased level of proteases. Such diseases include cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD) and severe/neutrophilic asthma. Paradoxically, patients with these diseases are also susceptible to detrimental bacterial infection and colonization. In this paper, we seek to explain how a positive feedback mechanism via IL-8 could lead to desensitization of epithelial cells to pathogen recognition thus perpetuating bacterial colonization and chronic disease states in the lung. Such insight was obtained from mathematical modeling of the IRAK/TRAF6 signaling module, and is consistent with existing clinical evidence. The potential implications for targeted treatment regimes for these persistent respiratory diseases are explored.			Zhang, TT (corresponding author), Roche Palo Alto LLC, Palo Alto, CA USA.	tingting.zhang@roche.com						Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Bartlett Jennifer A., 2008, V15, P147, DOI 10.1159/000136349; Carrabino S, 2006, J CYST FIBROS, V5, P113, DOI 10.1016/j.jcf.2005.12.003; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Hajjar AM, 2005, AM J RESP CELL MOL, V33, P470, DOI 10.1165/rcmb.2005-0199OC; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Liu G, 2007, J IMMUNOL, V179, P4125, DOI 10.4049/jimmunol.179.6.4125; Liu Y, 2005, J MOL EVOL, V61, P691, DOI 10.1007/s00239-005-0039-x; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Malerba M, 2006, THORAX, V61, P129, DOI 10.1136/thx.2005.043471; Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; ODA K, 2006, MOL SYST BIOL, V2, pNI137; Pavord ID, 2007, THORAX, V62, P193, DOI 10.1136/thx.2006.065805; RENDA T, 2007, EUR RESPIR J; Rocha-De-Souza CM, 2008, INFECT IMMUN, V76, P4489, DOI 10.1128/IAI.00270-08; Roth M, 2008, INT J TUBERC LUNG D, V12, P375; Sauro Herbert M., 2003, OMICS A Journal of Integrative Biology, V7, P355, DOI 10.1089/153623103322637670; Sebban H, 2006, BIOCHEM PHARMACOL, V72, P1153, DOI 10.1016/j.bcp.2006.08.006; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shannon J, 2008, CHEST, V133, P420, DOI 10.1378/chest.07-1881; SIBLEY CD, 2008, P NATL ACAD SCI; Simpson JL, 2007, THORAX, V62, P211, DOI 10.1136/thx.2006.061358; SONG KW, 2009, MOL IMMUNOL; Sun Y, 2006, INFECT IMMUN, V74, P5325, DOI 10.1128/IAI.00645-06; van de Sande WWJ, 2007, J IMMUNOL, V179, P3065, DOI 10.4049/jimmunol.179.5.3065; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Zhang Z, 2005, INFECT IMMUN, V73, P7151, DOI 10.1128/IAI.73.11.7151-7160.2005	34	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5332	10.1371/journal.pone.0005332	http://dx.doi.org/10.1371/journal.pone.0005332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390631	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514400018
J	Forgber, M; Trefzer, U; Sterry, W; Walden, P				Forgber, Michael; Trefzer, Uwe; Sterry, Wolfram; Walden, Peter			Proteome Serological Determination of Tumor-Associated Antigens in Melanoma	PLOS ONE			English	Article								Proteome serology may complement expression library-based approaches as strategy utilizing the patients' immune responses for the identification pathogenesis factors and potential targets for therapy and markers for diagnosis. Melanoma is a relatively immunogenic tumor and antigens recognized by melanoma-specific T cells have been extensively studied. The specificities of antibody responses to this malignancy have been analyzed to some extent by molecular genetic but not proteomics approaches. We screened sera of 94 melanoma patients for anti-melanoma reactivity and detected seropositivity in two-thirds of the patients with 2-6 antigens per case detected by 1D and an average of 2.3 per case by 2D Western blot analysis. For identification, antigen spots in Western blots were aligned with proteins in 2-DE and analyzed by mass spectrometry. 18 antigens were identified, 17 of which for the first time for melanoma. One of these antigens, galectin-3, has been related to various oncogenic processes including metastasis formation and invasiveness. Similarly, enolase has been found deregulated in different cancers. With at least 2 of 18 identified proteins implicated in oncogenic processes, the work confirms the potential of proteome-based antigen discovery to identify pathologically relevant proteins.			Forgber, M (corresponding author), Humboldt Univ, Charite Univ Med, Dept Dermatol Venerol & Allergy, Berlin, Germany.	peter.walden@charite.de						Bacarese-Hamilton T, 2002, BIOTECHNIQUES, P24; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Califice S, 2004, INT J ONCOL, V25, P983; Caron M, 2007, MOL CELL PROTEOMICS, V6, P1115, DOI 10.1074/mcp.R600016-MCP200; Chan C, 1999, ELECTROPHORESIS, V20, P3467, DOI 10.1002/(SICI)1522-2683(19991101)20:17<3467::AID-ELPS3467>3.3.CO;2-0; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; Chen YT, 1996, P NATL ACAD SCI USA, V93, P5915, DOI 10.1073/pnas.93.12.5915; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Craven RA, 2006, PROTEOMICS, V6, P2853, DOI 10.1002/pmic.200500549; Cui JW, 2005, MOL CELL PROTEOMICS, V4, P1718, DOI 10.1074/mcp.M400165-MCP200; De Monte L, 2008, J PROTEOME RES, V7, P504, DOI 10.1021/pr070360m; Demine R, 2004, RAPID COMMUN MASS SP, V18, P907, DOI 10.1002/rcm.1420; Ehlken H, 2004, INT J CANCER, V108, P307, DOI 10.1002/ijc.11537; Forgber M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000040; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Ghoshal A, 2009, GLYCOCONJUGATE J, V26, P675, DOI 10.1007/s10719-008-9223-8; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; Gunawardana CG, 2007, CANCER LETT, V249, P110, DOI 10.1016/j.canlet.2007.01.002; GUNNING AP, 2008, FASEB J; Gure AO, 2000, INT J CANCER, V85, P726, DOI 10.1002/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO;2-F; Hardouin J, 2007, ANN NY ACAD SCI, V1107, P223, DOI 10.1196/annals.1381.024; Hartmann TB, 2008, EXP DERMATOL, V17, P324, DOI 10.1111/j.1600-0625.2007.00637.x; Hartmann TB, 2005, INT J CANCER, V114, P88, DOI 10.1002/ijc.20762; Jager D, 2000, CANCER RES, V60, P3584; Jungblut PR, 2002, METHOD ENZYMOL, V358, P307; Kellner R, 2002, PROTEOMICS, V2, P1743, DOI 10.1002/1615-9861(200212)2:12<1743::AID-PROT1743>3.0.CO;2-U; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Krah Alexander, 2004, Methods Mol Med, V94, P19; Lee M, 2007, CANCER IMMUNOL IMMUN, V56, P783, DOI 10.1007/s00262-006-0239-2; Li C, 2006, PROTEOMICS, V6, P547, DOI 10.1002/pmic.200500256; Li C, 2005, PROTEOMICS, V5, P1125, DOI 10.1002/pmic.200401141; Lichtenfels R, 2003, BBA-PROTEINS PROTEOM, V1646, P21, DOI 10.1016/S1570-9639(02)00547-2; Looi KS, 2008, J PROTEOME RES, V7, P4004, DOI 10.1021/pr800273h; Mobley JA, 2004, J UROLOGY, V172, P331, DOI 10.1097/01.ju.0000132355.97888.50; Mourad-Zeidan AA, 2008, AM J PATHOL, V173, P1839, DOI 10.2353/ajpath.2008.080380; Nakahara S, 2005, APOPTOSIS, V10, P267, DOI 10.1007/s10495-005-0801-y; Neumann F, 2004, CANCER IMMUNOL IMMUN, V53, P589, DOI 10.1007/s00262-003-0492-6; Philip R, 2007, J PROTEOME RES, V6, P2509, DOI 10.1021/pr0606777; Pocza P, 2008, INT J CANCER, V122, P1972, DOI 10.1002/ijc.23296; Rattner JB, 1997, CLIN INVEST MED, V20, P308; Shimura T, 2005, CANCER RES, V65, P3535, DOI 10.1158/0008-5472.CAN-05-0104; Shoshan Stacy H., 2007, Cancer Biomarkers, V3, P141; Tomaino B, 2007, J PROTEOME RES, V6, P4025, DOI 10.1021/pr070281a; Tureci O, 1996, CANCER RES, V56, P4766; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P384, DOI 10.1074/mcp.R500009-MCP200; Unwin RD, 2003, PROTEOMICS, V3, P45, DOI 10.1002/pmic.200390008; Usener D, 2003, BRIT J DERMATOL, V149, P282, DOI 10.1046/j.1365-2133.2003.05410.x; Vereecken P, 2006, J INT MED RES, V34, P119, DOI 10.1177/147323000603400116; Yang F, 2007, J PROTEOME RES, V6, P751, DOI 10.1021/pr0602287; Zippelius A, 2007, CANCER IMMUNOL IMMUN, V56, P249, DOI 10.1007/s00262-006-0177-z; Zubieta MR, 2006, AM J PATHOL, V168, P1666, DOI 10.2353/ajpath.2006.050971	51	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5199	10.1371/journal.pone.0005199	http://dx.doi.org/10.1371/journal.pone.0005199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381273	Green Submitted, gold, Green Published			2022-12-27	WOS:000265510800005
J	Fabre, V; Condemi, S; Degioanni, A				Fabre, Virginie; Condemi, Silvana; Degioanni, Anna			Genetic Evidence of Geographical Groups among Neanderthals	PLOS ONE			English	Article							POPULATION SIZE; DNA; SEQUENCE; REMAINS; SIMCOAL	The Neanderthals are a well-distinguished Middle Pleistocene population which inhabited a vast geographical area extending from Europe to western Asia and the Middle East. Since the 1950s paleoanthropological studies have suggested variability in this group. Different sub-groups have been identified in western Europe, in southern Europe and in the Middle East. On the other hand, since 1997, research has been published in paleogenetics, carried out on 15 mtDNA sequences from 12 Neanderthals. In this paper we used a new methodology derived from different bioinformatic models based on data from genetics, demography and paleoanthropology. The adequacy of each model was measured by comparisons between simulated results (obtained by BayesianSSC software) and those estimated from nucleotide sequences (obtained by DNAsp4 software). The conclusions of this study are consistent with existing paleoanthropological research and show that Neanderthals can be divided into at least three groups: one in western Europe, a second in the Southern area and a third in western Asia. Moreover, it seems from our results that the size of the Neanderthal population was not constant and that some migration occurred among the demes.			Fabre, V (corresponding author), Univ Mediterranee, CNRS, UMR6578, EFS,Lab Anthropol Bioculturelle, Marseille, France.	anna.degioanni@univmed.fr	Condemi, Silvana/ABE-2701-2021	Condemi, Silvana/0000-0002-6516-0879				Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; BARYOSEF O, 1995, LIEGE E R A U L, V62, P247; BARYOSEF O, 1991, JJHEAMT ORIGINES HOM, P217; Beauval C, 2005, P NATL ACAD SCI USA, V102, P7085, DOI 10.1073/pnas.0502656102; Belle EMS, 2009, HEREDITY, V102, P218, DOI 10.1038/hdy.2008.103; Belle EMS, 2006, P NATL ACAD SCI USA, V103, P8012, DOI 10.1073/pnas.0509718103; BIRABEN JN, 1979, POPULATION, V34, P13, DOI 10.2307/1531855; Bocquet-Appel, 2008, PALEODEMOGRAPHIE 99; Bocquet-Appel JP, 2005, J ARCHAEOL SCI, V32, P1656, DOI 10.1016/j.jas.2005.05.006; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; CONDEMI S, 2001, 15 CTHS; Condemi S, 1992, HOMMES FOSSILES SACC; Condemi S., 2007, BAR INT SERIES, V1603, P28; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; CURRAT M, 2004, EFFETS EXPANSIONS PO; de Lumley M.A., 1973, ANTENEANDERTALIENS N; Dean D, 1998, J HUM EVOL, V34, P485, DOI 10.1006/jhev.1998.0214; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; Excoffier L, 2000, J HERED, V91, P506, DOI 10.1093/jhered/91.6.506; GAMBIER D, 1997, GACECMW CONCEPTUAL I, P117; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; HAMBUCKEN A, 1997, ANTHR PREHIST, V108, P109; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lalueza-Fox C, 2006, CURR BIOL, V16, pR629, DOI 10.1016/j.cub.2006.07.044; Mussi M., 2001, EARLIEST ITALY OVERV; Orlando L, 2006, CURR BIOL, V16, pR400, DOI 10.1016/j.cub.2006.05.019; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; RAY N, 2003, MODELISATION DEMOGRA; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Schmitz RW, 2002, P NATL ACAD SCI USA, V99, P13342, DOI 10.1073/pnas.192464099; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tattersall I., 2006, P9; TILLIER AM, 2006, DIOGENE, V214, P132; Trinkaus E, 2003, J HUM EVOL, V45, P245, DOI 10.1016/j.jhevol.2003.08.003; Trinkaus E, 2006, CURR ANTHROPOL, V47, P597, DOI 10.1086/504165; Vandermeersch B., 1981, HOMMES FOSSILES QAFZ; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Voisin J.-L., 2006, P299, DOI 10.1007/978-1-4020-5121-0_17; WAGNER GA, 1997, WGAUBKW EUROPAS BEIT, P186; WOOD J, 1987, AM NAT, P165; ZILHAO J, 2002, AURIGNACIAN BEHAV MO, P52	45	78	81	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2009	4	4							e5151	10.1371/journal.pone.0005151	http://dx.doi.org/10.1371/journal.pone.0005151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437TS	19367332	gold, Green Submitted, Green Published			2022-12-27	WOS:000265510400001
J	Gustafsson, L; Aits, S; Onnerfjord, P; Trulsson, M; Storm, P; Svanborg, C				Gustafsson, Lotta; Aits, Sonja; Onnerfjord, Patrik; Trulsson, Maria; Storm, Petter; Svanborg, Catharina			Changes in Proteasome Structure and Function Caused by HAMLET in Tumor Cells	PLOS ONE			English	Article								Background: Proteasomes control the level of endogenous unfolded proteins by degrading them in the proteolytic core. Insufficient degradation due to altered protein structure or proteasome inhibition may trigger cell death. This study examined the proteasome response to HAMLET, a partially unfolded protein-lipid complex, which is internalized by tumor cells and triggers cell death. Methodology/Principal Findings: HAMLET bound directly to isolated 20S proteasomes in vitro and in tumor cells significant co-localization of HAMLET and 20S proteasomes was detected by confocal microscopy. This interaction was confirmed by co-immunoprecipitation from extracts of HAMLET-treated tumor cells. HAMLET resisted in vitro degradation by proteasomal enzymes and degradation by intact 20S proteasomes was slow compared to fatty acid-free, partially unfolded alpha-lactalbumin. After a brief activation, HAMLET inhibited proteasome activity in vitro and in parallel a change in proteasome structure occurred, with modifications of catalytic (beta 1 and beta 5) and structural subunits (alpha 2, alpha 3, alpha 6 and beta 3). Proteasome inhibition was confirmed in extracts from HAMLET-treated cells and there were indications of proteasome fragmentation in HAMLET-treated cells. Conclusions/Significance: The results suggest that internalized HAMLET is targeted to 20S proteasomes, that the complex resists degradation, inhibits proteasome activity and perturbs proteasome structure. We speculate that perturbations of proteasome structure might contribute to the cytotoxic effects of unfolded protein complexes that invade host cells.			Gustafsson, L (corresponding author), Lund Univ, Dept Microbiol Immunol & Glycobiol, Inst Lab Med, Lund, Sweden.	Catharina_Svanborg@immunol.a-star.edu.sg	Onnerfjord, Patrik/R-3131-2019; Aits, Sonja/D-1496-2011	Onnerfjord, Patrik/0000-0002-2345-2937; Aits, Sonja/0000-0002-1321-0678; Storm, Petter/0000-0002-7655-3731; Gustafsson, Lotta/0000-0002-9826-9133				ACHARYA KR, 1991, J MOL BIOL, V221, P571; BREW K, 1968, P NATL ACAD SCI USA, V59, P491, DOI 10.1073/pnas.59.2.491; BRODBECK U, 1966, J BIOL CHEM, V241, P762; Chandra N, 1998, BIOCHEMISTRY-US, V37, P4767, DOI 10.1021/bi973000t; Ciechanover A, 2006, EXP BIOL MED, V231, P1197; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; EBNER KE, 1966, BIOCHEM BIOPH RES CO, V24, P232, DOI 10.1016/0006-291X(66)90725-X; EWBANK JJ, 1993, BIOCHEMISTRY-US, V32, P3677, DOI 10.1021/bi00065a022; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GOLDBERG AL, 1995, SCIENCE, V268, P522, DOI 10.1126/science.7725095; GREGORI L, 1995, J BIOL CHEM, V270, P19702, DOI 10.1074/jbc.270.34.19702; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; GUSTAFSSON L, 2005, THESIS LUND U LUND; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hedlund M, 1996, J EXP MED, V183, P1037, DOI 10.1084/jem.183.3.1037; Hill CP, 2002, CURR TOP MICROBIOL, V268, P73; Karpman D, 1998, INFECT IMMUN, V66, P636, DOI 10.1128/IAI.66.2.636-644.1998; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kuwajima K, 1996, FASEB J, V10, P102, DOI 10.1096/fasebj.10.1.8566530; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; RAO KR, 1989, BIOCHEM BIOPH RES CO, V163, P1390, DOI 10.1016/0006-291X(89)91133-9; SAFAR J, 1994, BIOCHEMISTRY-US, V33, P8375, DOI 10.1021/bi00193a027; Satoh J, 2006, J NEUROSCI METH, V152, P278, DOI 10.1016/j.jneumeth.2005.09.015; Smith LJ, 1999, PROTEINS, V36, P77, DOI 10.1002/(SICI)1097-0134(19990701)36:1<77::AID-PROT7>3.0.CO;2-X; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 2003, PROTEIN SCI, V12, P2794, DOI 10.1110/ps.0231003; Svensson M, 1999, J BIOL CHEM, V274, P6388, DOI 10.1074/jbc.274.10.6388; Watanabe N, 1996, PLANT CELL PHYSIOL, V37, P147, DOI 10.1093/oxfordjournals.pcp.a028925; WENZEL T, 1995, NAT STRUCT BIOL, V2, P199, DOI 10.1038/nsb0395-199; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Wu LC, 1996, BIOCHEMISTRY-US, V35, P859, DOI 10.1021/bi951408p	41	53	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2009	4	4							e5229	10.1371/journal.pone.0005229	http://dx.doi.org/10.1371/journal.pone.0005229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TO	19365565	Green Submitted, Green Published, gold			2022-12-27	WOS:000265510000005
J	Sauzullo, I; Mengoni, F; Lichtner, M; Massetti, AP; Rossi, R; Iannetta, M; Marocco, R; Del Borgo, C; Soscia, F; Vullo, V; Mastroianni, CM				Sauzullo, Ilaria; Mengoni, Fabio; Lichtner, Miriam; Massetti, Anna Paola; Rossi, Raffaella; Iannetta, Marco; Marocco, Raffaella; Del Borgo, Cosmo; Soscia, Fabrizio; Vullo, Vincenzo; Mastroianni, Claudio Maria			In Vivo and In Vitro Effects of Antituberculosis Treatment on Mycobacterial Interferon-gamma T Cell Response	PLOS ONE			English	Article							LATENT TUBERCULOSIS INFECTION; SKIN-TEST; ELISPOT TEST; ASSAYS; DIAGNOSIS; GOLD; ENUMERATION; ESAT-6; INDIVIDUALS; EFFICACY	Background: In recent years, the impact of antituberculous treatment on interferon (IFN)-gamma response to Mycobacterium tuberculosis antigens has been widely investigated, but the results have been controversial. The objective of the present study was: i) to evaluate longitudinal changes of IFN-gamma response to M. tuberculosis-specific antigens in TB patients during antituberculous treatment by using the QuantiFERON-TB Gold (QFT-G) assay; ii) to compare the differences in T-cell response after a short or prolonged period of stimulation with mycobacterial antigens; iii) to assess the CD4+ and CD8+ T cells with effector/memory and central/memory phenotype; iv) to investigate the direct in vitro effects of antituberculous drugs on the secretion of IFN-gamma. Principal Findings: 38 TB patients was evaluated at baseline and at month 2 and 4 of treatment and at month 6 (treatment completion). 27 (71%) patients had a QFT-G reversion (positive to negative) at the end of therapy, while 11 (29%) TB patients remained QFT-G positive at the end of therapy. Among the 11 patients with persistent positive QFT-G results, six had a complete response to the treatment, while the remaining 5 patients did not have a resolution of the disease. All 27 patients who became QFT-G negative had a complete clinical and microbiological recovery of the TB disease. In these patients the release of IFN-gamma is absent even after a prolonged 6-day incubation with both ESAT-6 and CFP-10 antigens and the percentage of effector/memory T-cells phenotype was markedly lower than subjects with persistent positive QFT-G results. The in vitro study showed that antituberculous drugs did not exert any inhibitory effect on IFN-gamma production within the range of therapeutically achievable concentrations. Conclusions: The present study suggests that the decrease in the M. tuberculosis-specific T cells responses following successful anti-TB therapy may have a clinical value as a supplemental tool for the monitoring of the efficacy of pharmacologic intervention for active TB. In addition, the antituberculous drugs do not have any direct down-regulatory effect on the specific IFN-gamma response.			Sauzullo, I (corresponding author), Sapienza Univ, Dept Infect & Trop Dis, Rome, Italy.	claudio.mastroianni@uniroma1.it	MASTROIANNI, Claudio Maria/O-9741-2019; Iannetta, Marco/M-4619-2019; Iannetta, Marco/B-5596-2017	MASTROIANNI, Claudio Maria/0000-0002-1286-467X; Iannetta, Marco/0000-0002-6938-8627; Iannetta, Marco/0000-0002-6938-8627; Sauzullo, Ilaria/0000-0002-0060-0749; Massetti, Anna Paola/0000-0003-0520-8743				Aiken AM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-66; Al-Attiyah R, 2003, FEMS IMMUNOL MED MIC, V38, P249, DOI 10.1016/S0928-8244(03)00166-4; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; CORBETT EL, 2006, INT J TUBERC LUNG D, V10, pS231; Dheda K, 2007, J INFECTION, V55, P169, DOI 10.1016/j.jinf.2007.02.005; Dominguez J, 2009, DIAGN MICR INFEC DIS, V63, P43, DOI 10.1016/j.diagmicrobio.2008.09.010; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Ferrand RA, 2005, INT J TUBERC LUNG D, V9, P1034; Hill PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000183; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3; Jones S, 2007, INT J TUBERC LUNG D, V11, P1190; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Katiyar SK, 2008, INT J TUBERC LUNG D, V12, P1146; Kobashi Y, 2007, INTERNAL MED, V46, P1543, DOI 10.2169/internalmedicine.46.0088; Kobashi Y, 2009, J INFECTION, V58, P197, DOI 10.1016/j.jinf.2008.08.009; Lalvani A, 2004, CLIN INFECT DIS, V38, P757, DOI 10.1086/381763; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Leyten EMS, 2006, J CLIN MICROBIOL, V44, P1197, DOI 10.1128/JCM.44.3.1197-1201.2006; Manuel O, 2007, AM J TRANSPLANT, V7, P2797, DOI 10.1111/j.1600-6143.2007.02011.x; Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sauzullo I, 2008, DIAGN MICR INFEC DIS, V62, P395, DOI 10.1016/j.diagmicrobio.2008.08.015; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Ulrichs T, 2000, INT J TUBERC LUNG D, V4, P1181; Vekemans J, 2001, INFECT IMMUN, V69, P6554, DOI 10.1128/IAI.69.10.6554-6557.2001; Wu-Hsieh BA, 2001, CLIN INFECT DIS, V33, P1336, DOI 10.1086/323044	40	41	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5187	10.1371/journal.pone.0005187	http://dx.doi.org/10.1371/journal.pone.0005187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365543	Green Submitted, Green Published, gold			2022-12-27	WOS:000265509900015
J	Zcharia, E; Jia, J; Zhang, X; Baraz, L; Lindahl, U; Peretz, T; Vlodavsky, I; Li, JP				Zcharia, Eyal; Jia, Juan; Zhang, Xiao; Baraz, Lea; Lindahl, Ulf; Peretz, Tamar; Vlodavsky, Israel; Li, Jin-Ping			Newly Generated Heparanase Knock-Out Mice Unravel Co-Regulation of Heparanase and Matrix Metalloproteinases	PLOS ONE			English	Article								Background: Heparanase, a mammalian endo-beta-D-glucuronidase, specifically degrades heparan sulfate proteoglycans ubiquitously associated with the cell surface and extracellular matrix. This single gene encoded enzyme is over-expressed in most human cancers, promoting tumor metastasis and angiogenesis. Principal Findings: We report that targeted disruption of the murine heparanase gene eliminated heparanase enzymatic activity, resulting in accumulation of long heparan sulfate chains. Unexpectedly, the heparanase knockout (Hpse-KO) mice were fertile, exhibited a normal life span and did not show prominent pathological alterations. The lack of major abnormalities is attributed to a marked elevation in the expression of matrix metalloproteinases, for example, MMP2 and MMP14 in the Hpse-KO liver and kidney. Co-regulation of heparanase and MMPs was also noted by a marked decrease in MMP (primarily MMP-2,-9 and 14) expression following transfection and over-expression of the heparanase gene in cultured human mammary carcinoma (MDA-MB-231) cells. Immunostaining (kidney tissue) and chromatin immunoprecipitation (ChIP) analysis (Hpse-KO mouse embryonic fibroblasts) suggest that the newly discovered co-regulation of heparanase and MMPs is mediated by stabilization and transcriptional activity of beta-catenin. Conclusions/Significance: The lack of heparanase expression and activity was accompanied by alterations in the expression level of MMP family members, primarily MMP-2 and MMP-14. It is conceivable that MMP-2 and MMP-14, which exert some of the effects elicited by heparanase (i.e., over branching of mammary glands, enhanced angiogenic response) can compensate for its absence, in spite of their different enzymatic substrate. Generation of viable Hpse-KO mice lacking significant abnormalities may provide a promising indication for the use of heparanase as a target for drug development.			Zcharia, E (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Oncol, Jerusalem, Israel.	vlodavsk@cc.huji.ac.il; jin-ping.li@imbim.uu.se			NCI NIH HHS [R01 CA106456, R01-CA106456] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; BARNER M, 1985, INT J CANCER, V35, P483, DOI 10.1002/ijc.2910350411; Basche M, 2006, CLIN CANCER RES, V12, P5471, DOI 10.1158/1078-0432.CCR-05-2423; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; Cohen I, 2007, CLIN CANCER RES, V13, P4069, DOI 10.1158/1078-0432.CCR-06-2546; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; DANIEL CW, 1995, DEV BIOL, V169, P511, DOI 10.1006/dbio.1995.1165; Davidson D, 2007, GYNECOL ONCOL, V104, P311, DOI 10.1016/j.ygyno.2006.08.045; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Doweck I, 2006, NEOPLASIA, V8, P1055, DOI 10.1593/neo.06577; Dredge Keith, 2004, Curr Opin Investig Drugs, V5, P668; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Elkin M, 2000, FASEB J, V14, P2477, DOI 10.1096/fj.00-0292com; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Freeman C, 1998, BIOCHEM J, V330, P1341, DOI 10.1042/bj3301341; Galvis MLE, 2007, NAT CHEM BIOL, V3, P773, DOI 10.1038/nchembio.2007.41; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Hulett MD, 2000, BIOCHEMISTRY-US, V39, P15659, DOI 10.1021/bi002080p; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; Kelly T, 2003, CANCER RES, V63, P8749; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kram V, 2006, J CELL PHYSIOL, V207, P784, DOI 10.1002/jcp.20625; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Lin XH, 1999, DEVELOPMENT, V126, P3715; Loo BM, 2001, J BIOL CHEM, V276, P16868, DOI 10.1074/jbc.M011226200; Mannello F, 2005, CURR CANCER DRUG TAR, V5, P285, DOI 10.2174/1568009054064615; McKenzie E, 2000, BIOCHEM BIOPH RES CO, V276, P1170, DOI 10.1006/bbrc.2000.3586; McParland BJ, 1998, BRIT J RADIOL, V71, P950, DOI 10.1259/bjr.71.849.10195010; Medhora M, 2003, AM J PHYSIOL-HEART C, V284, pH215, DOI 10.1152/ajpheart.01118.2001; Merry CLR, 2002, BBA-GEN SUBJECTS, V1573, P319, DOI 10.1016/S0304-4165(02)00399-9; Nadir Y, 2006, J THROMB HAEMOST, V4, P2443, DOI 10.1111/j.1538-7836.2006.02212.x; Naggi A, 2005, J BIOL CHEM, V280, P12103, DOI 10.1074/jbc.M414217200; Nobuhisa T, 2005, BIOCHEM BIOPH RES CO, V331, P175, DOI 10.1016/j.bbrc.2005.03.129; Ohkawa T, 2004, LAB INVEST, V84, P1289, DOI 10.1038/labinvest.3700159; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Shteper PJ, 2003, ONCOGENE, V22, P7737, DOI 10.1038/sj.onc.1207056; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; VANDENHOVEN MJ, 2007, KIDNEY INT; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; VLODAVSKY I, 1983, CANCER RES, V43, P2704; VLODAVSKY I, 1992, INVAS METAST, V12, P112; Vlodavsky I, 2001, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1004s01; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470; VLODAVSKY I, 1993, BASEMENT MEMBRANES C, P327; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Zcharia E, 2005, AM J PATHOL, V166, P999, DOI 10.1016/S0002-9440(10)62321-8; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811	66	139	145	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2009	4	4							e5181	10.1371/journal.pone.0005181	http://dx.doi.org/10.1371/journal.pone.0005181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437SB	19360105	Green Published, gold, Green Submitted			2022-12-27	WOS:000265506100004
J	Hsieh, PJ; Tse, PU				Hsieh, Po-Jang; Tse, Peter U.			Microsaccade Rate Varies with Subjective Visibility during Motion-Induced Blindness	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; PHYSIOLOGICAL CORRELATE; ATTENTIONAL MODULATION; NEURAL ACTIVITY; DISTINCT MODES; FILLING-IN; STRIATE; AREAS; REPRESENTATIONS; RESPONSES	Motion-induced blindness (MIB) occurs when a dot embedded in a motion field subjectively vanishes. Here we report the first psychophysical data concerning effects of microsaccade/eyeblink rate upon perceptual switches during MIB. We find that the rate of microsaccades/eyeblink rises before and after perceptual transitions from not seeing to seeing the dot, and decreases before perceptual transitions from seeing it to not seeing it. In addition, event-related fMRI data reveal that, when a dot subjectively reappears during MIB, the blood oxygen-level dependent (BOLD) signal increases in V1v and V2v and decreases in contralateral hMT+. These BOLD signal changes observed upon perceptual state changes in MIB could be driven by the change of perceptual states and/or a confounding factor, such as the microsaccade/eyeblink rate.			Hsieh, PJ (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Moore Hall, Hanover, NH 03755 USA.	pjh@mit.edu			NIMH NIH HHS [R03 MH0609660-01] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BREWER AA, 2004, SOC NEUR M; Castelo-Branco M, 2002, P NATL ACAD SCI USA, V99, P13914, DOI 10.1073/pnas.202049999; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; CLARKE FJJ, 1962, VISION RES, V2, P53, DOI 10.1016/0042-6989(62)90063-9; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Funk AP, 2003, PERCEPTION, V32, P1325, DOI 10.1068/p5088; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Gawne TJ, 2002, J NEUROPHYSIOL, V88, P2178, DOI 10.1152/jn.00151.200; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Graf EW, 2002, VISION RES, V42, P2731, DOI 10.1016/S0042-6989(02)00390-5; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Horwitz GD, 2003, J NEUROPHYSIOL, V90, P1333, DOI 10.1152/jn.00146.2003; Hsu LC, 2004, VISION RES, V44, P2857, DOI 10.1016/j.visres.2003.10.029; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KINGSTONE A, 1995, PERCEPT PSYCHOPHYS, V57, P796, DOI 10.3758/BF03206795; KOTULAK JC, 1986, PERCEPTION, V15, P7, DOI 10.1068/p150007; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Liu TS, 2004, NEUROIMAGE, V21, P1772, DOI 10.1016/j.neuroimage.2003.12.025; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Millodot M, 1967, PSYCHOL FR, V12, P190; Mitroff SR, 2004, PERCEPTION, V33, P1267, DOI 10.1068/p5341no; Mitroff SR, 2005, VISION RES, V45, P961, DOI 10.1016/j.visres.2004.09.044; Muckli L, 2005, PLOS BIOL, V3, P1501, DOI 10.1371/journal.pbio.0030265; Muckli L, 2002, J NEUROSCI, V22; Muller NG, 2003, J NEUROSCI, V23, P3561; Pollen DA, 2003, CEREB CORTEX, V13, P807, DOI 10.1093/cercor/13.8.807; RAMACHANDRAN VS, 1992, SCI AM, V266, P86, DOI 10.1038/scientificamerican0592-86; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Safran AB, 1998, SURV OPHTHALMOL, V42, P449, DOI 10.1016/S0039-6257(97)00134-3; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shulman GL, 2002, CEREB CORTEX, V12, P1124, DOI 10.1093/cercor/12.11.1124; Slotnick SD, 2003, HUM BRAIN MAPP, V18, P22, DOI 10.1002/hbm.10077; Slotnick SD, 2003, NEUROIMAGE, V19, P1602, DOI 10.1016/S1053-8119(03)00187-3; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Sylvester R, 2005, CURR BIOL, V15, P37, DOI 10.1016/j.cub.2004.12.061; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Troxler D, 1804, OPHTHALMOLOGISCHES B, P51; Tse PU, 2004, PSYCHOL SCI, V15, P708, DOI 10.1111/j.0956-7976.2004.00745.x; TSE PU, CORTICAL ACTIV UNPUB; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; WATANABE T, 1991, PERCEPT PSYCHOPHYS, V50, P459, DOI 10.3758/BF03205062; Zur D, 2003, VISION RES, V43, P971, DOI 10.1016/S0042-6989(03)00038-5	50	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5163	10.1371/journal.pone.0005163	http://dx.doi.org/10.1371/journal.pone.0005163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437RZ	19357789	Green Submitted, Green Published, gold			2022-12-27	WOS:000265505900019
J	Smit-Rigter, LA; Champagne, DL; van Hooft, JA				Smit-Rigter, Laura A.; Champagne, Danielle L.; van Hooft, Johannes A.			Lifelong Impact of Variations in Maternal Care on Dendritic Structure and Function of Cortical Layer 2/3 Pyramidal Neurons in Rat Offspring	PLOS ONE			English	Article							REELIN; HIPPOCAMPUS; MATURATION; PLASTICITY; RESPONSES; INTEGRIN; BEHAVIOR; CORTEX; MODEL; CA1	Maternal licking and grooming (LG) exerts profound influence on hippocampal development and function in the offspring. However, little information is available on the effects of variations in maternal care on other brain regions. Here we examined the effects of variation in the frequency of maternal LG on morphological and electrophysiological properties of layer 2/3 pyramidal neurons in the somatosensory cortex in adult offspring. Compared to low LG offspring, high LG offspring displayed decreased dendritic complexity, reduced spine density and decreased amplitude of spontaneous postsynaptic currents. These changes were accompanied by higher levels of reelin expression in offspring of high LG mothers. Taken together, these findings suggest that differential amount of naturally-occurring variations in maternal LG is associated with enduring changes in dendritic morphology and synaptic function in layer 2/3 pyramidal neurons of the somatosensory cortex.			Smit-Rigter, LA (corresponding author), Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	j.a.vanhooft@uva.nl						Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Bock J, 2005, CEREB CORTEX, V15, P802, DOI 10.1093/cercor/bhh181; Bredy TW, 2003, EUR J NEUROSCI, V18, P2903, DOI 10.1111/j.1460-9568.2003.02965.x; BROWNE MAO, 1995, AUST NZ J PSYCHIAT, V29, P437; Cameron NM, 2008, J NEUROENDOCRINOL, V20, P795, DOI 10.1111/j.1365-2826.2008.01725.x; CHAMEAU P, 2009, P NATL ACAD IN PRESS; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; CHAMPAGNE FA, 2008, NEUROSCI BIOBEHAV R, V18, P1; Dong E, 2005, P NATL ACAD SCI USA, V102, P12578, DOI 10.1073/pnas.0505394102; Dong E, 2003, P NATL ACAD SCI USA, V100, P5479, DOI 10.1073/pnas.1031602100; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Groc L, 2007, J NEUROSCI, V27, P10165, DOI 10.1523/JNEUROSCI.1772-07.2007; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Levenson JM, 2008, BBA-GENE REGUL MECH, V1779, P422, DOI 10.1016/j.bbagrm.2008.01.001; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Lom B, 1999, J NEUROSCI, V19, P9928; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; MCGOWAN PO, 2009, NAT NEUROSCI, P2; Meaney MJ, 2005, TRENDS NEUROSCI, V28, P456, DOI 10.1016/j.tins.2005.07.006; Nakajima K, 1997, P NATL ACAD SCI USA, V94, P8196, DOI 10.1073/pnas.94.15.8196; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Pinaud R, 2004, INT J NEUROSCI, V114, P321, DOI 10.1080/00207450490264142; Poeggel G, 2003, P NATL ACAD SCI USA, V100, P16137, DOI 10.1073/pnas.2434663100; Qiu SF, 2007, J NEUROPHYSIOL, V97, P2312, DOI 10.1152/jn.00869.2006; Qiu SF, 2006, J NEUROSCI, V26, P12943, DOI 10.1523/JNEUROSCI.2561-06.2006; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Segal M, 2002, PROG BRAIN RES, V138, P53, DOI 10.1016/S0079-6123(02)38070-1; Turner CA, 2003, DEV PSYCHOBIOL, V43, P20, DOI 10.1002/dev.10116; van Hooft JA, 2002, NEUROSCI LETT, V318, P163, DOI 10.1016/S0304-3940(01)02452-1; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Williams SR, 2007, NEURON, V56, P947, DOI 10.1016/j.neuron.2007.12.004	38	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5167	10.1371/journal.pone.0005167	http://dx.doi.org/10.1371/journal.pone.0005167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357777	gold, Green Published, Green Submitted			2022-12-27	WOS:000265505900020
J	Penteriani, V; Delgado, MD				Penteriani, Vincenzo; Delgado, Maria del Mar			The Dusk Chorus from an Owl Perspective: Eagle Owls Vocalize When Their White Throat Badge Contrasts Most	PLOS ONE			English	Article							AMBIENT LIGHT; DAWN CHORUS; VISUAL CUES; BEHAVIOR; COLOR; SIGNAL; SELECTION; DISPLAYS; BIRDS	Background: An impressive number of studies have investigated bird vocal displays, and many of them have tried to explain the widespread phenomenon of the so-called dawn and dusk chorus, the sunrise and sunset peaks in bird song output. As many as twelve non-exclusive hypotheses have been proposed to explain why twilight peaks in vocal display might be advantageous; but, even after more than two decades of study, the basis underlying the dusk and dawn chorus is still unclear. Moreover, to date, the majority of studies on this topic have focused on songbirds. Methodology/Principal Findings: We investigate here a novel hypothesis on why nocturnal birds with patches of white feathers call at twilight. We propose that white plumage patches and the timing of visual signaling have co-evolved to maximize the effectiveness of social communication such as the dusk chorus. This hypothesis centers on the recent discovery that eagle owls can adopt specific forms of visual signaling and is supported by the observation that adult eagle owls possess a white throat badge that is only visible during vocal displays. By monitoring the calling of eagle owls at dusk, a peak time for bird call output, we found that white throat badges contrasted most with the surrounding background during the owls' twilight chorusing. Conclusions/Significance: Crepuscular and nocturnal species appear to have evolved white patches that, shown in association with vocal displays, allow them to communicate in dark surroundings. The evolution of a white badge that operates jointly with call displays at dawn and dusk may be relevant to the eagle owls' social dynamics. Our explanation for the dusk chorus may possibly represent an overlooked but common pattern of signaling among crepuscular and nocturnal birds that combine patches of white feathers with twilight displays. Furthermore, our findings could be relevant to songbirds that breed in dark forest habitats and have contrasting white badges, as well as birds living in open habitats and showing contrasting bars.			Penteriani, V (corresponding author), Estac Biol Donana, Dept Conservat Biol, E-41013 Seville, Spain.	penteriani@ebd.csic.es		Delgado, Maria del Mar/0000-0002-3009-738X				Aragones J, 1999, WILSON BULL, V111, P340; Bradbury Jack W., 1998, pi; Brown TJ, 2003, IBIS, V145, P120, DOI 10.1046/j.1474-919X.2003.00130.x; Burt John M., 2005, P320, DOI 10.1017/CBO9780511610363.019; Catchpole CK, 1995, BIRD SONG BIOL THEME; Dabelsteen Torben, 2002, Acta Ethologica, V4, P65; Delgado MM, 2007, J ZOOL, V271, P3, DOI 10.1111/j.1469-7998.2006.00205.x; Delibes M., 1979, P WORLD LAGOMORPH C, P614, DOI DOI 10.1007/BF00275171; DONAZAR JA, 1987, BIOL CONSERVATION NO, P220; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; Endler JA, 1996, AM NAT, V148, P421, DOI 10.1086/285934; Gomez D, 2004, ECOL LETT, V7, P279, DOI 10.1111/j.1461-0248.2004.00584.x; HENWOOD K, 1979, AM NAT, V114, P260, DOI 10.1086/283473; HOGLUND J, 1990, ANIM BEHAV, V40, P23, DOI 10.1016/S0003-3472(05)80662-1; Hutchinson JMC, 2002, ANIM BEHAV, V64, P527, DOI 10.1006/anbe.2002.3091; Jiguet F, 2001, BEHAV PROCESS, V55, P107, DOI 10.1016/S0376-6357(01)00173-5; McCullagh P, 1989, GEN LINEAR MODELLING; McNaught MK, 2002, J EVOLUTION BIOL, V15, P505, DOI 10.1046/j.1420-9101.2002.00431.x; Penteriani V, 2003, IBIS, V145, pE127, DOI 10.1046/j.1474-919X.2003.00173.x; Penteriani V, 2002, ETHOL ECOL EVOL, V14, P275; Penteriani V, 2006, J AVIAN BIOL, V37, P110, DOI 10.1111/j.0908-8857.2006.03569.x; Penteriani V, 2005, IBIS, V147, P155, DOI 10.1111/j.1474-919x.2004.00381.x; Penteriani V, 2007, ETHOLOGY, V113, P934, DOI 10.1111/j.1439-0310.2007.01414.x; Penteriani V, 2007, BEHAV ECOL, V18, P143, DOI 10.1093/beheco/arl060; Penteriani V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003014; SASInstitute, 2001, SAS STAT SOFTW CHANG, P2001; Staicer Cynthia A., 1996, P426; Villafuerte R, 1994, THESIS U CORDOBA COR	28	25	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e4960	10.1371/journal.pone.0004960	http://dx.doi.org/10.1371/journal.pone.0004960			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352433	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505700001
J	Alvarez-Iglesias, V; Mosquera-Miguel, A; Cerezo, M; Quintans, B; Zarrabeitia, MT; Cusco, I; Lareu, MV; Garcia, O; Perez-Jurado, L; Carracedo, A; Salas, A				Alvarez-Iglesias, Vanesa; Mosquera-Miguel, Ana; Cerezo, Maria; Quintans, Beatriz; Teresa Zarrabeitia, Maria; Cusco, Ivon; Victoria Lareu, Maria; Garcia, Oscar; Perez-Jurado, Luis; Carracedo, Angel; Salas, Antonio			New Population and Phylogenetic Features of the Internal Variation within Mitochondrial DNA Macro-Haplogroup R0	PLOS ONE			English	Article							MTDNA VARIATION; NEAR-EASTERN; GENE FLOW; ANCESTRY; EVOLUTIONARY; MUTATIONS; ORIGIN; POLYMORPHISMS; DISSECTION; EXPANSION	Background: R0 embraces the most common mitochondrial DNA (mtDNA) lineage in West Eurasia, namely, haplogroup H (similar to 40%). R0 sub-lineages are badly defined in the control region and therefore, the analysis of diagnostic coding region polymorphisms is needed in order to gain resolution in population and medical studies. Methodology/Principal Findings: We sequenced the first hypervariable segment (HVS-I) of 518 individuals from different North Iberian regions. The mtDNAs belonging to R0 (similar to 57%) were further genotyped for a set of 71 coding region SNPs characterizing major and minor branches of R0. We found that the North Iberian Peninsula shows moderate levels of population stratification; for instance, haplogroup V reaches the highest frequency in Cantabria (north-central Iberia), but lower in Galicia (northwest Iberia) and Catalonia (northeast Iberia). When compared to other European and Middle East populations, haplogroups H1, H3 and H5a show frequency peaks in the Franco-Cantabrian region, declining from West towards the East and South Europe. In addition, we have characterized, by way of complete genome sequencing, a new autochthonous clade of haplogroup H in the Basque country, named H2a5. Its coalescence age, 15.668 thousand years ago (kya), dates to the period immediately after the Last Glacial Maximum (LGM). Conclusions/Significance: In contrast to other H lineages that experienced re-expansion outside the Franco-Cantabrian refuge after the LGM (e. g. H1 and H3), H2a5 most likely remained confined to this area till present days.	[Alvarez-Iglesias, Vanesa; Mosquera-Miguel, Ana; Cerezo, Maria; Victoria Lareu, Maria; Carracedo, Angel; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Inst Med Legal, Unidade Xenet, Galicia, Spain; [Alvarez-Iglesias, Vanesa; Mosquera-Miguel, Ana; Cerezo, Maria; Victoria Lareu, Maria; Carracedo, Angel; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Dept Anatom Patol Ciencias Forenses, Galicia, Spain; [Quintans, Beatriz; Carracedo, Angel] Univ Santiago de Compostela, Hosp Clin Univ, FPGMX, Galicia, Spain; [Quintans, Beatriz; Carracedo, Angel] Univ Santiago de Compostela, Hosp Clin Univ, CIBERER, Galicia, Spain; [Teresa Zarrabeitia, Maria] Univ Cantabria, Santander, Spain; [Cusco, Ivon; Perez-Jurado, Luis] Univ Pompeu Fabra, Unidad Genet, Barcelona, Spain; [Cusco, Ivon; Perez-Jurado, Luis] CIBERER, U735, Barcelona, Spain; [Garcia, Oscar] Lab Ertzaintza, Bilbao, Spain; [Perez-Jurado, Luis] Hosp Univ Vall Hebron, Programa Med Mol Genet, Barcelona, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Universidad de Cantabria; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari Vall d'Hebron	Alvarez-Iglesias, V (corresponding author), Univ Santiago de Compostela, Fac Med, Inst Med Legal, Unidade Xenet, Galicia, Spain.	antonio.salas@usc.es	Cusco, I/H-2096-2014; Miguel, Ana Mosquera/ABG-9735-2020; Pérez Jurado, Luis Alberto/M-7706-2015; Salas, Antonio/E-3977-2012; Cusco, Ivon/AAF-4662-2021; Salas, Antonio/U-2029-2019; Lareu, Maviky/E-4909-2013; Carracedo, Angel/D-4257-2012	Cusco, I/0000-0003-2104-9332; Miguel, Ana Mosquera/0000-0003-3939-8338; Salas, Antonio/0000-0002-2336-702X; Cusco, Ivon/0000-0003-2104-9332; Salas, Antonio/0000-0002-2336-702X; Lareu, Maviky/0000-0002-6165-9795; Carracedo, Angel/0000-0003-1085-8986; Cerezo Fernandez, Maria/0000-0003-3073-1130; Zarrabeitia, Maria T./0000-0002-2836-7766	Xunta de Galicia (Grupos Emerxentes) [2008/XA122]; Fundacion de Investigacion Medica Mutua Madrilena; Ministerio de Ciencia e Innovacion [SAF2008-02971]	Xunta de Galicia (Grupos Emerxentes)(Xunta de Galicia); Fundacion de Investigacion Medica Mutua Madrilena; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This research received support from Xunta de Galicia (Grupos Emerxentes; 2008/XA122), two grants from the Fundacion de Investigacion Medica Mutua Madrilena, and a grant from the Ministerio de Ciencia e Innovacion (SAF2008-02971) given to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-32; Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; Alvarez-Iglesias V, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-26; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt H.J., 2006, HUMAN MITOCHONDRIAL; Bandelt HJ, 2008, INT J CARDIOL, V126, P439, DOI 10.1016/j.ijcard.2007.02.049; Bandelt HJ, 2006, J HUM GENET, V51, P1073, DOI 10.1007/s10038-006-0066-5; Bandelt HJ, 2004, SCIENCE, V305, P1402; Bandelt HJ, 2004, INT J LEGAL MED, V118, P267, DOI 10.1007/s00414-004-0455-2; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Barbujani G, 2000, HUM BIOL, V72, P133; Behar DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002062; Brandstatter A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-191; Brandstatter A, 2006, ELECTROPHORESIS, V27, P2541, DOI 10.1002/elps.200500772; Cerny V, 2007, ANN HUM GENET, V71, P433, DOI 10.1111/j.1469-1809.2006.00339.x; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Egeland T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003988; FU YX, 1993, GENETICS, V133, P693; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Maca-Meyer N, 2003, ANN HUM GENET, V67, P329, DOI 10.1046/j.1469-1809.2003.00045.x; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mosquera-Miguel A, 2008, CANCER RES, V68, P623, DOI 10.1158/0008-5472.CAN-07-2385; Nei N, 1987, MOL EVOLUTIONARY GEN; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pereira L, 2004, INT CONGR SER, V1261, P416, DOI 10.1016/S0531-5131(03)01651-0; Pulkes T, 2003, NEUROLOGY, V61, P1144, DOI 10.1212/01.WNL.0000090465.27024.3D; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salas A, 2005, AM J HUM GENET, V77, P676, DOI 10.1086/491675; Salas A, 2005, AM J PHYS ANTHROPOL, V128, P855, DOI 10.1002/ajpa.20117; Salas A, 2005, FORENSIC SCI INT, V148, P191, DOI 10.1016/j.forsciint.2004.06.008; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Salas A, 2000, INT CONGR SER, P329; Salas A, 2017, EUR J HUM GENET, V25, pS33, DOI 10.1038/sj.ejhg.5200202; SANTOS M, 1994, HUM BIOL, V66, P963; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; TAJIMA F, 1993, MOL BIOL EVOL, V10, P677; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; VANOVEN M, 2008, HUM MUTAT IN PRESS	61	73	73	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5112	10.1371/journal.pone.0005112	http://dx.doi.org/10.1371/journal.pone.0005112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340307	Green Published, gold, Green Submitted			2022-12-27	WOS:000265500700016
J	Granziera, C; Schmahmann, JD; Hadjikhani, N; Meyer, H; Meuli, R; Wedeen, V; Krueger, G				Granziera, Cristina; Schmahmann, Jeremy Dan; Hadjikhani, Nouchine; Meyer, Heiko; Meuli, Reto; Wedeen, Van; Krueger, Gunnar			Diffusion Spectrum Imaging Shows the Structural Basis of Functional Cerebellar Circuits in the Human Cerebellum In Vivo	PLOS ONE			English	Article								Background: The cerebellum is a complex structure that can be affected by several congenital and acquired diseases leading to alteration of its function and neuronal circuits. Identifying the structural bases of cerebellar neuronal networks in humans in vivo may provide biomarkers for diagnosis and management of cerebellar diseases. Objectives: To define the anatomy of intrinsic and extrinsic cerebellar circuits using high-angular resolution diffusion spectrum imaging (DSI). Methods: We acquired high-resolution structural MRI and DSI of the cerebellum in four healthy female subjects at 3T. DSI tractography based on a streamline algorithm was performed to identify the circuits connecting the cerebellar cortex with the deep cerebellar nuclei, selected brainstem nuclei, and the thalamus. Results: Using in-vivo DSI in humans we were able to demonstrate the structure of the following cerebellar neuronal circuits: (1) connections of the inferior olivary nucleus with the cerebellar cortex, and with the deep cerebellar nuclei (2) connections between the cerebellar cortex and the deep cerebellar nuclei, (3) connections of the deep cerebellar nuclei conveyed in the superior (SCP), middle (MCP) and inferior (ICP) cerebellar peduncles, (4) complex intersections of fibers in the SCP, MCP and ICP, and (5) connections between the deep cerebellar nuclei and the red nucleus and the thalamus. Conclusion: For the first time, we show that DSI tractography in humans in vivo is capable of revealing the structural bases of complex cerebellar networks. DSI thus appears to be a promising imaging method for characterizing anatomical disruptions that occur in cerebellar diseases, and for monitoring response to therapeutic interventions.	[Granziera, Cristina] CHU Vaudois, Dept Neurol, Lausanne, Switzerland; [Schmahmann, Jeremy Dan] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA; [Hadjikhani, Nouchine; Wedeen, Van] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imag, Charlestown, MA USA; [Hadjikhani, Nouchine] Ecole Polytechn Fed, Brain Mind Inst, Lausanne, Switzerland; [Meyer, Heiko] Siemens AG, Erlangen, Germany; [Meuli, Reto] CHU Vaudois, Dept Radiol, Lausanne, Switzerland; [Krueger, Gunnar] Siemens Schweiz AG, Healthcare Sector IM&WS S, Renens, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Siemens AG; Siemens Germany; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Siemens AG	Granziera, C (corresponding author), CHU Vaudois, Dept Neurol, Lausanne, Switzerland.	Cristina.Granziera@chuv.ch	Hadjikhani, Nouchine/C-2018-2008; Schmahmann, Jeremy/ABF-1215-2021; Hoogkamer, Wouter/G-4498-2010	Hadjikhani, Nouchine/0000-0003-4075-3106; Schmahmann, Jeremy/0000-0003-0706-5125; Granziera, Cristina/0000-0002-4917-8761	Center for Biomedical Imaging (CIBM) of Geneva - Lausanne; University of Geneva; University of Lasuanne; Ecole Polytechnique Federale de Lausanne (EPFL); Leenaards foundation; Louis-Jeantet Foundation; Siemens AG (Erlangen) Foundation; NIH [5PO1NS 35611]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035611] Funding Source: NIH RePORTER	Center for Biomedical Imaging (CIBM) of Geneva - Lausanne; University of Geneva; University of Lasuanne; Ecole Polytechnique Federale de Lausanne (EPFL); Leenaards foundation; Louis-Jeantet Foundation; Siemens AG (Erlangen) Foundation(Siemens AG); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the Center for Biomedical Imaging (CIBM) of Geneva - Lausanne, the Universities of Geneva and Lasuanne as welll as the Ecole Polytechnique Federale de Lausanne (EPFL), the foundations Leenaards and Louis-Jeantet and Siemens AG (Erlangen). NH was also supported by NIH 5PO1NS 35611.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bolk L, 1906, CEREBELLUM SAUGETIER; Braitenberg V, 1997, BEHAV BRAIN SCI, V20, P229, DOI 10.1017/S0140525X9700143X; BRODAL P, 1981, J COMP NEUROL, V201, P375, DOI 10.1002/cne.902010306; Catani M, 2008, NEUROIMAGE, V41, P1184, DOI 10.1016/j.neuroimage.2008.03.041; CHAMBERS WW, 1955, J COMP NEUROL, V103, P105, DOI 10.1002/cne.901030107; CHAMBERS WW, 1955, ARCH NEURO PSYCHIATR, V74, P653, DOI 10.1001/archneurpsyc.1955.02330180071008; DeLano MC, 2002, NEUROIMAG CLIN N AM, V12, P21, DOI 10.1016/S1052-5149(03)00068-6; Dimitrova A, 2002, NEUROIMAGE, V17, P240, DOI 10.1006/nimg.2002.1124; Duvernoy H, 1995, HUMAN BRAINSTEM CERE; Habas C, 2007, NEURORADIOLOGY, V49, P849, DOI 10.1007/s00234-007-0267-4; Haines D.E., 2008, NEUROANATOMY ATLAS S; HAINES DE, 1989, J MOTOR BEHAV, V21, P518; Holmes G, 1939, BRAIN, V62, P1, DOI 10.1093/brain/62.1.1; Jansen J, 1940, J COMP NEUROL, V73, P267, DOI 10.1002/cne.900730204; Jansen J., 1942, NORSK AKAD AVH 1 MAT, V3, P1; Larsell O, 1972, COMP ANATOMY HISTOLO; MALACARNE M, 1776, NUOVA ESPOSIZIONE ST; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nandhini ATA, 2002, AMINO ACIDS, V22, P27; Okugawa G, 2006, PROG NEURO-PSYCHOPH, V30, P1408, DOI 10.1016/j.pnpbp.2006.05.014; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Salamon N, 2007, J NEURORADIOLOGY, V34, P115, DOI 10.1016/j.neurad.2007.03.002; Schmahmann J. D., 2007, SPINOCEREBELLAR DEGE, P1; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; SCHMAHMANN JD, 1991, ARCH NEUROL-CHICAGO, V48, P1178, DOI 10.1001/archneur.1991.00530230086029; SCHMAHMANN JD, 1997, INT REV NEUROBIOL, V41; SCHMAHMANN JD, 2000, MRI ADAS HUMAN CEREB; Schmahmann JD, 2007, CEREBELLUM, V6, P254, DOI 10.1080/14734220701490995; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; SNIDER RS, 1952, J NEUROPHYSIOL, V15, P27, DOI 10.1152/jn.1952.15.1.27; Tuch DS, 2005, PHILOS T R SOC B, V360, P869, DOI 10.1098/rstb.2005.1651; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Van Essen DC, 2002, ANN NY ACAD SCI, V978, P468; Voogd J, 2004, J NEUROCYTOL, V33, P5, DOI 10.1023/B:NEUR.0000029645.72074.2b; WANG R, 2007, BERL P INT SOC MAG R; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925	41	96	100	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5101	10.1371/journal.pone.0005101	http://dx.doi.org/10.1371/journal.pone.0005101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340289	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500700014
J	Klopstock, N; Katzenellenbogen, M; Pappo, O; Sklair-Levy, M; Olam, D; Mizrahi, L; Potikha, T; Galun, E; Goldenberg, D				Klopstock, Naama; Katzenellenbogen, Mark; Pappo, Orit; Sklair-Levy, Miriam; Olam, Devorah; Mizrahi, Lina; Potikha, Tamara; Galun, Eithan; Goldenberg, Daniel			HCV Tumor Promoting Effect Is Dependent on Host Genetic Background	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; AMYOTROPHIC-LATERAL-SCLEROSIS; HEPATOCELLULAR-CARCINOMA; TRANSGENIC MICE; LIVER CARCINOGENESIS; MOLECULAR-MECHANISMS; CORE PROTEIN; MOUSE MODEL; EXPRESSION; CANCER	Background: The hepatitis C virus (HCV) is one of the major risk factors for the development of hepatocellular carcinoma (HCC). Nevertheless, transgenic mice which express the whole HCV polyprotein (HCV-Tg) do not develop HCC. Whereas chronic HCV infection causes inflammation in patients, in HCV-Tg mice, the host immune reaction against viral proteins is lacking. We aimed to test the role of HCV proteins in HCC development on the background of chronic inflammation in vivo. Methodology/Principal Findings: We crossed HCV-Tg mice that do not develop HCC with the Mdr2-knockout (Mdr2-KO) mice which develop inflammation-associated HCC, to generate Mdr2-KO/HCV-Tg mice. We studied the effect of the HCV transgene on tumor incidence, hepatocyte mitosis and apoptosis, and investigated the potential contributing factors for the generated phenotype by gene expression and protein analyses. The Mdr2-KO/HCV-Tg females from the N2 generation of this breeding (having 75% of the FVB/N genome and 25% of the C57BL/6 genome) produced significantly larger tumors in comparison with Mdr2-KO mice. In parallel, the Mdr2-KO/HCV-Tg females had an enhanced inflammatory gene expression signature. However, in the N7 generation (having 99.2% of the FVB/N genome and 0.8% of the C57BL/6 genome) there was no difference in tumor development between Mdr2-KO/HCV-Tg and Mdr2-KO animals of both sexes. The HCV transgene was similarly expressed in the livers of Mdr2-KO/HCV-Tg females of both generations, as revealed by detection of the HCV transcript and the core protein. Conclusion: These findings suggest that the HCV transgene accelerated inflammation-associated hepatocarcinogenesis in a host genetic background-dependent manner.	[Klopstock, Naama; Olam, Devorah; Mizrahi, Lina; Potikha, Tamara; Galun, Eithan; Goldenberg, Daniel] Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Katzenellenbogen, Mark] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Bioinformat & Microarray Unit, IL-52100 Ramat Gan, Israel; [Pappo, Orit] Hadassah Hebrew Univ, Med Ctr, Dept Pathol, Jerusalem, Israel; [Sklair-Levy, Miriam] Sheba Med Ctr, Breast Imag Ctr, Tel Hashomer, Israel	Hebrew University of Jerusalem; Bar Ilan University; Hebrew University of Jerusalem; Hadassah University Medical Center; Chaim Sheba Medical Center	Klopstock, N (corresponding author), Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	goldenberg@hadassah.org.il	Galun, Eithan/AAD-9117-2022	Galun, Eithan/0000-0002-6243-6702	EC [LSHB-CT-2004-512034, LSHB-CT-2005-018961]; Barbara Fox Foundation; Harold Grinspoon Foundation; Horowitz Foundation; Wolfson Foundation; Sam and Ellie Fishman Chair in Gene Therapy; Kamea Scientific Foundation of the Israeli Government	EC(European CommissionEuropean Commission Joint Research Centre); Barbara Fox Foundation; Harold Grinspoon Foundation; Horowitz Foundation; Wolfson Foundation; Sam and Ellie Fishman Chair in Gene Therapy; Kamea Scientific Foundation of the Israeli Government	E.G. is supported by the EC grants LSHB-CT-2004-512034 (MOLEDA) and LSHB-CT-2005-018961 (INTHER), and by grants from the Barbara Fox, the Harold Grinspoon, the Horowitz and the Wolfson Foundations. E.G. holds the Sam and Ellie Fishman Chair in Gene Therapy. D.G. is supported by the Kamea Scientific Foundation of the Israeli Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2006, MICROVASC RES, V72, P136, DOI 10.1016/j.mvr.2006.05.010; Ahn SG, 2002, EXP MOL MED, V34, P243, DOI 10.1038/emm.2002.34; Alonzi T, 2004, J GEN VIROL, V85, P1509, DOI 10.1099/vir.0.19724-0; Amin J, 2006, J HEPATOL, V45, P197, DOI 10.1016/j.jhep.2006.02.014; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Berruyer C, 2004, MOL CELL BIOL, V24, P7214, DOI 10.1128/MCB.24.16.7214-7224.2004; Blindenbacher A, 2003, GASTROENTEROLOGY, V124, P1465, DOI 10.1016/S0016-5085(03)00290-7; Bursch W, 2004, TOXICOL LETT, V149, P25, DOI 10.1016/j.toxlet.2003.12.018; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Damdinsuren B, 2005, INT J ONCOL, V26, P319; Davie SA, 2007, TRANSGENIC RES, V16, P193, DOI 10.1007/s11248-006-9056-9; El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; FREUND R, 1992, VIROLOGY, V191, P724, DOI 10.1016/0042-6822(92)90248-N; Furutani T, 2006, GASTROENTEROLOGY, V130, P2087, DOI 10.1053/j.gastro.2006.02.060; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; HAGEN TM, 1994, P NATL ACAD SCI USA, V91, P12808, DOI 10.1073/pnas.91.26.12808; Huang H, 1999, AM J PATHOL, V155, P1795, DOI 10.1016/S0002-9440(10)65496-X; *JACKS LAB, MOUS GEN INF DAT; Kamegaya Y, 2005, HEPATOLOGY, V41, P660, DOI 10.1002/hep.20621; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; Katzenellenbogen M, 2007, MOL CANCER RES, V5, P1159, DOI 10.1158/1541-7786.MCR-07-0172; Katzenellenbogen M, 2007, MOL CANCER THER, V6, P1283, DOI 10.1158/1535-7163.MCT-06-0420; Kim J, 2005, CANCER RES, V65, P6189, DOI 10.1158/0008-5472.CAN-04-4439; Kurt-Jones EA, 2007, INFECT IMMUN, V75, P471, DOI 10.1128/IAI.02039-05; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Liang TJ, 2004, GASTROENTEROLOGY, V127, pS62, DOI 10.1053/j.gastro.2004.09.017; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; Liu L, 2004, CANCER RES, V64, P3491, DOI 10.1158/0008-5472.CAN-03-2106; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lu SN, 2006, INT J CANCER, V119, P1946, DOI 10.1002/ijc.22045; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Marden JJ, 2007, J CLIN INVEST, V117, P2913, DOI 10.1172/JCI31265; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076; MAUAD TH, 1994, AM J PATHOL, V145, P1237; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Naas T, 2005, J GEN VIROL, V86, P2185, DOI 10.1099/vir.0.80969-0; Nakamoto Y, 1998, J EXP MED, V188, P341, DOI 10.1084/jem.188.2.341; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Okamoto M, 2006, ANN SURG ONCOL, V13, P947, DOI 10.1245/ASO.2006.07.018; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Ren JW, 2006, J BIOL CHEM, V281, P11413, DOI 10.1074/jbc.M507218200; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Shackel NA, 2002, AM J PATHOL, V160, P641, DOI 10.1016/S0002-9440(10)64884-5; Smith MW, 2003, HEPATOLOGY, V38, P1458, DOI [10.1016/jhep.2003.09.024, 10.1053/jhep.2003.09024]; Starr A, 2006, INT J CANCER, V119, P269, DOI 10.1002/ijc.21818; Tang WL, 2007, AM J PATHOL, V171, P1831, DOI 10.2353/ajpath.2007.070413; Tsafrir D, 2005, BIOINFORMATICS, V21, P2301, DOI 10.1093/bioinformatics/bti329; Tsutsumi T, 2003, HEPATOLOGY, V38, P820, DOI 10.1053/jhep.2003.50399; Vietor I, 2007, DIFFERENTIATION, V75, P891, DOI 10.1111/j.1432-0436.2007.00205.x; Wakabayashi Y, 2007, NATURE, V445, P761, DOI 10.1038/nature05489; Wu DC, 2006, P NATL ACAD SCI USA, V103, P12132, DOI 10.1073/pnas.0603670103; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Yamashita T, 2001, BIOCHEM BIOPH RES CO, V282, P647, DOI 10.1006/bbrc.2001.4610; Yan XR, 2008, CANCER LETT, V262, P133, DOI 10.1016/j.canlet.2007.12.010; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Yu MC, 2004, GASTROENTEROLOGY, V127, pS72, DOI 10.1016/j.gastro.2004.09.018	59	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5025	10.1371/journal.pone.0005025	http://dx.doi.org/10.1371/journal.pone.0005025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340302	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500700008
J	Noh, T; Gabet, Y; Cogan, J; Shi, YF; Tank, A; Sasaki, T; Criswell, B; Dixon, A; Lee, C; Tam, J; Kohler, T; Segev, E; Kockeritz, L; Woodgett, J; Muller, R; Chai, Y; Smith, E; Bab, I; Frenkel, B				Noh, Tommy; Gabet, Yankel; Cogan, Jon; Shi, Yunfan; Tank, Archana; Sasaki, Tomoyo; Criswell, Braden; Dixon, Alexis; Lee, Christopher; Tam, Joseph; Kohler, Thomas; Segev, Eran; Kockeritz, Lisa; Woodgett, James; Mueller, Ralph; Chai, Yang; Smith, Elisheva; Bab, Itai; Frenkel, Baruch			Lef1 Haploinsufficient Mice Display a Low Turnover and Low Bone Mass Phenotype in a Gender- and Age-Specific Manner	PLOS ONE			English	Article								We investigated the role of Lef1, one of the four transcription factors that transmit Wnt signaling to the genome, in the regulation of bone mass. Microcomputed tomographic analysis of 13- and 17-week-old mice revealed significantly reduced trabecular bone mass in Lef1(+/-) females compared to littermate wild-type females. This was attributable to decreased osteoblast activity and bone formation as indicated by histomorphometric analysis of bone remodeling. In contrast to females, bone mass was unaffected by Lef1 haploinsufficiency in males. Similarly, females were substantially more responsive than males to haploinsufficiency in Gsk3 beta, a negative regulator of the Wnt pathway, displaying in this case a high bone mass phenotype. Lef1 haploinsufficiency also led to low bone mass in males lacking functional androgen receptor (AR) (tfm mutants). The protective skeletal effect of AR against Wnt-related low bone mass is not necessarily a result of direct interaction between the AR and Wnt signaling pathways, because Lef1(+/-) female mice had normal bone mass at the age of 34 weeks. Thus, our results indicate an age- and gender-dependent role for Lef1 in regulating bone formation and bone mass in vivo. The resistance to Lef1 haploinsufficiency in males with active AR and in old females could be due to the reduced bone turnover in these mice.			Noh, T (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA.	frenkel@usc.edu	Müller, Ralph/A-1198-2008; Woodgett, Jim/F-1087-2010; Gabet, Yankel/I-6244-2019	Müller, Ralph/0000-0002-5811-7725; Woodgett, Jim/0000-0003-3731-5797; Gabet, Yankel/0000-0002-7494-0631; Cogan, Jon/0000-0001-9327-8711	CIHR [74711] Funding Source: Medline; NCI NIH HHS [CA62528-01, C06 CA062528] Funding Source: Medline; NCRR NIH HHS [RR14514-01, C06 RR10600-01, C06 RR014514] Funding Source: Medline; NIAMS NIH HHS [R01 AR047052, AR047052] Funding Source: Medline; NATIONAL CANCER INSTITUTE [C06CA062528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014514, C06RR010600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047052] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akhter MP, 2004, BONE, V35, P162, DOI 10.1016/j.bone.2004.02.018; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Bab I. A., 2007, MICROTOMOGRAPHIC ATL; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bajayo A, 2005, P NATL ACAD SCI USA, V102, P12956, DOI 10.1073/pnas.0502562102; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; DeMambro VE, 2008, ENDOCRINOLOGY, V149, P2051, DOI 10.1210/en.2007-1068; Dubrow S. A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P166; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Galceran J, 2000, DEVELOPMENT, V127, P469; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Glass DA, 2006, CURR TOP DEV BIOL, V73, P43, DOI 10.1016/S0070-2153(05)73002-7; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Juttner KV, 2007, BONE, V41, P25, DOI 10.1016/j.bone.2007.03.012; Kahler RA, 2006, J CELL BIOCHEM, V97, P969, DOI 10.1002/jcb.20702; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Kang HY, 2004, J BONE MINER RES, V19, P1181, DOI 10.1359/JBMR.040306; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; LECLERC N, 2007, J CELL BIOCH; Leclerc N, 2008, J CELL BIOCHEM, V103, P1938, DOI 10.1002/jcb.21587; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Liu XH, 2007, ANN NY ACAD SCI, V1116, P423, DOI 10.1196/annals.1402.017; Liu XH, 2007, CANCER RES, V67, P5747, DOI 10.1158/0008-5472.CAN-07-0478; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MacDonald H, 2006, BONE, V39, P598, DOI 10.1016/j.bone.2006.02.057; Matsumoto C, 2006, BONE, V38, P220, DOI 10.1016/j.bone.2005.08.019; Migliaccio A, 2007, ONCOGENE, V26, P6619, DOI 10.1038/sj.onc.1210487; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Mishina Y, 2004, J BIOL CHEM, V279, P27560, DOI 10.1074/jbc.M404222200; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Nantermet PV, 2004, J BIOL CHEM, V279, P1310, DOI 10.1074/jbc.M310206200; Neu CM, 2001, BONE, V28, P227, DOI 10.1016/S8756-3282(00)00429-4; Ohnaka K, 2004, BIOCHEM BIOPH RES CO, V318, P259, DOI 10.1016/j.bbrc.2004.04.025; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Pantschenko AG, 2005, J BONE MINER RES, V20, P1414, DOI 10.1359/JBMR.050315; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PENNYPACKER B, 2008, BONE; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Smith E, 2005, J BIOL CHEM, V280, P2388, DOI 10.1074/jbc.M406294200; Smith E, 2002, J BIOL CHEM, V277, P18191, DOI 10.1074/jbc.M109708200; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Vandenput L, 2004, J BONE MINER RES, V19, P1462, DOI 10.1359/JBMR.040505; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Wang FS, 2005, ENDOCRINOLOGY, V146, P2415, DOI 10.1210/en.2004-1050; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wu YL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000586; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Yirmiya R, 2006, P NATL ACAD SCI USA, V103, P16876, DOI 10.1073/pnas.0604234103	71	49	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2009	4	5							e5438	10.1371/journal.pone.0005438	http://dx.doi.org/10.1371/journal.pone.0005438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440RC	19412553	Green Published, gold, Green Submitted			2022-12-27	WOS:000265716400005
J	Turriziani, P; Oliveri, M; Bonni, S; Koch, G; Smirni, D; Cipolotti, L				Turriziani, Patrizia; Oliveri, Massimiliano; Bonni, Sonia; Koch, Giacomo; Smirni, Daniela; Cipolotti, Lisa			Exploring the Relationship between Semantics and Space	PLOS ONE			English	Article							MENTAL NUMBER LINE; SPATIAL NEGLECT; PARIETAL RTMS; BISECTION; REPRESENTATION; PSEUDONEGLECT; ATTENTION; SEQUENCES; COGNITION; PICTURES	The asymmetric distribution of human spatial attention has been repeatedly documented in both patients and healthy controls. Biases in the distribution of attention and/or in the mental representation of space may also affect some aspects of language processing. We investigated whether biases in attention and/or mental representation of space affect semantic representations. In particular, we investigated whether semantic judgments could be modulated by the location in space where the semantic information was presented and the role of the left and right parietal cortices in this task. Healthy subjects were presented with three pictures arranged horizontally (one middle and two outer pictures) of items belonging to the same semantic category. Subjects were asked to indicate the spatial position in which the semantic distance between the outer and middle pictures was smaller. Subjects systematically overestimated the semantic distance of items presented in the right side of space. We explored the neural correlates underpinning this bias using rTMS over the left and right parietal cortex. rTMS of the left parietal cortex selectively reduced this rightward bias. Our findings suggest the existence of an attentional and/or mental representational bias in semantic judgments, similar to that observed for the processing of space and numbers. Spatial manipulation of semantic material results in the activation of specialised attentional resources located in the left hemisphere.			Turriziani, P (corresponding author), Univ Palermo, Dipartimento Psicol, Palermo, Italy.	p.turriziani@unipa.it	Oliveri, Massimiliano/HDO-5602-2022; Koch, Giacomo/G-3155-2012; Smirni, Daniela/R-3445-2019	Smirni, Daniela/0000-0002-4410-2047; cipolotti, lisa/0000-0001-5838-3647; Turriziani, Patrizia/0000-0003-4802-280X; KOch, Giacomo/0000-0001-6155-9439				BISIACH E, 1978, CORTEX, V14, P129, DOI 10.1016/S0010-9452(78)80016-1; Bjoertomt O, 2002, BRAIN, V125, P2012, DOI 10.1093/brain/awf211; BOWERS D, 1980, NEUROPSYCHOLOGIA, V18, P491, DOI 10.1016/0028-3932(80)90151-7; Buchanan L, 2001, PSYCHON B REV, V8, P531, DOI 10.3758/BF03196189; Cappelletti M, 2007, NEUROPSYCHOLOGIA, V45, P2989, DOI 10.1016/j.neuropsychologia.2007.05.014; CHATTERJEE A, 1995, NEUROPSYCHOLOGIA, V33, P643, DOI 10.1016/0028-3932(94)00134-B; Coslett HB, 1999, NEUROPSYCHOLOGIA, V37, P695, DOI 10.1016/S0028-3932(98)00116-X; Cristescu TC, 2006, NEUROIMAGE, V33, P1178, DOI 10.1016/j.neuroimage.2006.08.017; Danckert J, 2007, J COGNITIVE NEUROSCI, V19, P1706, DOI 10.1162/jocn.2007.19.10.1706; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dell'acqua R, 2000, BEHAV RES METH INS C, V32, P588, DOI 10.3758/BF03200832; Doricchi F, 2005, NAT NEUROSCI, V8, P1663, DOI 10.1038/nn1563; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Fierro B, 2000, NEUROREPORT, V11, P1519, DOI 10.1097/00001756-200005150-00030; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Fink GR, 2001, NEUROIMAGE, V14, pS59, DOI 10.1006/nimg.2001.0819; Fischer MH, 2001, TRENDS COGN SCI, V5, P460, DOI 10.1016/S1364-6613(00)01790-3; Fischer MH, 1996, COGNITIVE BRAIN RES, V4, P163, DOI 10.1016/S0926-6410(96)00029-8; Fischer MH, 2000, PERCEPTION, V29, P337; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Gobel SM, 2006, NEUROPSYCHOLOGIA, V44, P860, DOI 10.1016/j.neuropsychologia.2005.09.007; Gross C.G., 1995, NEUROSCIENTIST, V1, P43, DOI [10.1177/107385849500100107, DOI 10.1177/107385849500100107]; Halligan PW, 2003, TRENDS COGN SCI, V7, P125, DOI 10.1016/S1364-6613(03)00032-9; HEILMAN KM, 1993, CLIN NEUROPSYCHOLOGY, P268; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Kinsbourne M, 1970, Trans Am Neurol Assoc, V95, P143; Kinsbourne M., 1993, UNILATERAL NEGLECT C, DOI DOI 10.4324/9780203765258; Lee BH, 2004, NEUROPSYCHOLOGIA, V42, P1715, DOI 10.1016/j.neuropsychologia.2004.02.015; Lee SY, 2004, MOL CELLS, V17, P174; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Mohr C, 2007, NEUROPSYCHOLOGIA, V45, P295, DOI 10.1016/j.neuropsychologia.2006.07.003; Nicholls MER, 2007, BRAIN RES, V1152, P130, DOI 10.1016/j.brainres.2007.03.036; Oliveri M, 2004, NEUROLOGY, V63, P2139, DOI 10.1212/01.WNL.0000145975.58478.6D; Pexman PM, 2007, PSYCHOL SCI, V18, P401, DOI 10.1111/j.1467-9280.2007.01913.x; Priftis K, 2006, J COGNITIVE NEUROSCI, V18, P680, DOI 10.1162/jocn.2006.18.4.680; Rinaldi C, 2003, NEUROREPORT, V14, P1381, DOI 10.1097/00001756-200307180-00020; Rinaldi MC, 2006, NEUROPSYCHOLOGIA, V44, P556, DOI 10.1016/j.neuropsychologia.2005.07.007; Siakaluk PD, 2003, MEM COGNITION, V31, P100, DOI 10.3758/BF03196086; Siman-Tov T, 2007, J NEUROSCI, V27, P11271, DOI 10.1523/JNEUROSCI.0599-07.2007; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Vigliocco G, 2004, COGNITIVE PSYCHOL, V48, P422, DOI 10.1016/j.cogpsych.2003.09.001; Vuilleumier P, 2004, CORTEX, V40, P399, DOI 10.1016/S0010-9452(08)70134-5; Zannino GD, 2006, COGN NEUROPSYCHOL, V23, P515, DOI 10.1080/02643290542000067; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a; Zorzi M, 2006, NEUROPSYCHOLOGIA, V44, P1061, DOI 10.1016/j.neuropsychologia.2005.10.025	46	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2009	4	4							e5319	10.1371/journal.pone.0005319	http://dx.doi.org/10.1371/journal.pone.0005319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437VI	19396359	gold, Green Published			2022-12-27	WOS:000265514600003
J	Dotan-Cohen, D; Letovsky, S; Melkman, AA; Kasif, S				Dotan-Cohen, Dikla; Letovsky, Stan; Melkman, Avraham A.; Kasif, Simon			Biological Process Linkage Networks	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; SEMANTIC SIMILARITY MEASURES; SACCHAROMYCES-CEREVISIAE; FUNCTION PREDICTION; GENE ONTOLOGY; YEAST; EXPRESSION; DISCOVERY; DATABASE; MODULES	Background: The traditional approach to studying complex biological networks is based on the identification of interactions between internal components of signaling or metabolic pathways. By comparison, little is known about interactions between higher order biological systems, such as biological pathways and processes. We propose a methodology for gleaning patterns of interactions between biological processes by analyzing protein-protein interactions, transcriptional co-expression and genetic interactions. At the heart of the methodology are the concept of Linked Processes and the resultant network of biological processes, the Process Linkage Network (PLN). Results: We construct, catalogue, and analyze different types of PLNs derived from different data sources and different species. When applied to the Gene Ontology, many of the resulting links connect processes that are distant from each other in the hierarchy, even though the connection makes eminent sense biologically. Some others, however, carry an element of surprise and may reflect mechanisms that are unique to the organism under investigation. In this aspect our method complements the link structure between processes inherent in the Gene Ontology, which by its very nature is species-independent. As a practical application of the linkage of processes we demonstrate that it can be effectively used in protein function prediction, having the power to increase both the coverage and the accuracy of predictions, when carefully integrated into prediction methods. Conclusions: Our approach constitutes a promising new direction towards understanding the higher levels of organization of the cell as a system which should help current efforts to re-engineer ontologies and improve our ability to predict which proteins are involved in specific biological processes.			Dotan-Cohen, D (corresponding author), Ben Gurion Univ Negev, Dept Comp Sci, IL-84105 Beer Sheva, Israel.	dotna@cs.bgu.ac.il		Melkman, Avraham/0000-0002-6832-0102	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003367, R33HG002850] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER; NHGRI NIH HHS [1R33HG002850-01A1, R01 HG003367-01A1, R01 HG003367, R33 HG002850] Funding Source: Medline; NLM NIH HHS [U54 LM008748] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Battle A, 2005, J COMPUT BIOL, V12, P909, DOI 10.1089/cmb.2005.12.909; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guo X, 2006, BIOINFORMATICS, V22, P967, DOI 10.1093/bioinformatics/btl042; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huynen MA, 2003, CURR OPIN CELL BIOL, V15, P191, DOI 10.1016/S0955-0674(03)00009-7; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Larochelle M, 2006, MOL CELL BIOL, V26, P6690, DOI 10.1128/MCB.02450-05; Lin D, 1998, P INT C MACH LEARN; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; LU JL, 2007, TRENDS BIOCHEM SCI, V32, P320; Lubovac Z, 2006, PROTEINS, V64, P948, DOI 10.1002/prot.21071; Luo F, 2007, BIOINFORMATICS, V23, P207, DOI 10.1093/bioinformatics/btl562; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stavreva DA, 2006, MOL CELL BIOL, V26, P5131, DOI 10.1128/MCB.02227-05; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303	40	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5313	10.1371/journal.pone.0005313	http://dx.doi.org/10.1371/journal.pone.0005313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390589	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514200023
J	Bosgraaf, L; Van Haastert, PJM				Bosgraaf, Leonard; Van Haastert, Peter J. M.			The Ordered Extension of Pseudopodia by Amoeboid Cells in the Absence of External Cues	PLOS ONE			English	Article								Eukaryotic cells extend pseudopodia for movement. In the absence of external cues, cells move in random directions, but with a strong element of persistence that keeps them moving in the same direction Persistence allows cells to disperse over larger areas and is instrumental to enter new environments where spatial cues can lead the cell. Here we explore cell movement by analyzing the direction, size and timing of similar to 2000 pseudopodia that are extended by Dictyostelium cells. The results show that pseudpopod are extended perpendicular to the surface curvature at the place where they emerge. The location of new pseudopods is not random but highly ordered. Two types of pseudopodia may be formed: frequent splitting of an existing pseudopod, or the occasional extension of a de novo pseudopod at regions devoid of recent pseudopod activity. Split-pseudopodia are extended at similar to 60 degrees relative to the previous pseudopod, mostly as alternating Right/Left/Right steps leading to relatively straight zigzag runs. De novo pseudopodia are extended in nearly random directions thereby interrupting the zigzag runs. Persistence of cell movement is based on the ratio of split versus de novo pseudopodia. We identify PLA2 and cGMP signaling pathways that modulate this ratio of splitting and de novo pseudopodia, and thereby regulate the dispersal of cells. The observed ordered extension of pseudopodia in the absence of external cues provides a fundamental insight into the coordinated movement of cells, and might form the basis for movement that is directed by internal or external cues.			Bosgraaf, L (corresponding author), Univ Groningen, Dept Cell Biochem, Haren, Netherlands.	P.J.M.van.haastert@rug.nl						Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Blagg SL, 2003, CURR BIOL, V13, P1480, DOI 10.1016/S0960-9822(03)00580-3; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; BOSGRAAF L, 2009, QUIMP3 AUTOMATED PSE; BOSGRAAF L, 2009, CELL MOTIL IN PRESS; Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; CODLING EA, 2008, J R SOC INTERFACE, V15, P15; Dormann D, 2002, CELL MOTIL CYTOSKEL, V52, P221, DOI 10.1002/cm.10048; GAIL MH, 1970, BIOPHYS J, V10, P980, DOI 10.1016/S0006-3495(70)86347-0; HALL RL, 1977, J MATH BIOL, V4, P327, DOI 10.1007/BF00275081; Janetopoulos C, 2008, FEBS LETT, V582, P2075, DOI 10.1016/j.febslet.2008.04.035; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Loovers HM, 2006, MOL BIOL CELL, V17, P1503, DOI 10.1091/mbc.E05-09-0825; Maeda YT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003734; PATLAK CLIFFORD S., 1953, BULL MATH BIOPHYS, V15, P311, DOI 10.1007/BF02476407; Pegtel DM, 2007, CURR BIOL, V17, P1623, DOI 10.1016/j.cub.2007.08.035; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; POTEL MJ, 1979, J CELL SCI, V36, P281; SWANSON JA, 1982, CELL, V28, P225, DOI 10.1016/0092-8674(82)90340-3; Takagi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002648; Tang L, 2008, GENE DEV, V22, P2278, DOI 10.1101/gad.1694508; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Veltman DM, 2008, J CELL BIOL, V180, P747, DOI 10.1083/jcb.200709180; Veltman DM, 2006, MOL BIOL CELL, V17, P3921, DOI 10.1091/mbc.E06-05-0381; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102	32	131	132	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5253	10.1371/journal.pone.0005253	http://dx.doi.org/10.1371/journal.pone.0005253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384419	gold, Green Published, Green Submitted			2022-12-27	WOS:000265513900009
J	Younger, JW; Zautra, AJ; Cummins, ET				Younger, Jarred W.; Zautra, Alex J.; Cummins, Eric T.			Effects of Naltrexone on Pain Sensitivity and Mood in Fibromyalgia: No Evidence for Endogenous Opioid Pathophysiology	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; CEREBROSPINAL-FLUID LEVELS; BETA-ENDORPHIN; 6-BETA-NALTREXOL LEVELS; MUSCULOSKELETAL PAIN; IMPACT QUESTIONNAIRE; NEGATIVE AFFECT; MODULATION; MECHANISMS; HYDROMORPHONE	The pathophysiological mechanisms underlying fibromyalgia are still unknown, although some evidence points to endogenous opioid dysfunction. We examined how endogenous opioid antagonism affects pain and mood for women with and without fibromyalgia. Ten women with fibromyalgia and ten age-and gender-matched, healthy controls each attended two laboratory sessions. Each participant received naltrexone (50mg) at one session, and placebo at the other session, in a randomized and double-blind fashion. Participants were tested for changes in sensitivity to heat, cold, and mechanical pain. Additionally, we collected measures of mood and opioid withdrawal symptoms during the laboratory sessions and at home the night following each session. At baseline, the fibromyalgia group exhibited more somatic complaints, greater sensory sensitivity, more opioid withdrawal somatic symptoms, and lower mechanical and cold pain-tolerance than did the healthy control group. Neither group experienced changes in pain sensitivity due to naltrexone administration. Naltrexone did not differentially affect self-reported withdrawal symptoms, or mood, in the fibromyalgia and control groups. Consistent with prior research, there was no evidence found for abnormal endogenous opioid activity in women with fibromyalgia.			Younger, JW (corresponding author), Stanford Univ, Sch Med, Dept Anesthesia, Palo Alto, CA 94304 USA.	Jarred.Younger@stanford.edu			Arthritis Research UK Funding Source: Medline	Arthritis Research UK(Versus Arthritis)		Aaron LA, 2003, BEST PRACT RES CL RH, V17, P563, DOI 10.1016/S1521-6942(03)00033-0; Anderberg UM, 1998, Z RHEUMATOL, V57, P77; Baraniuk JN, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-48; Bell IR, 1998, J WOMENS HEALTH, V7, P1135, DOI 10.1089/jwh.1998.7.1135; BENGTSSON M, 1989, PAIN, V39, P171, DOI 10.1016/0304-3959(89)90004-3; BENHAM G, 2004, SENSORY SENSITIVITY; Bennett R, 2005, CLIN EXP RHEUMATOL, V23, pS154; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Cook DB, 2000, AM J PHYSIOL-REG I, V279, pR1565, DOI 10.1152/ajpregu.2000.279.5.R1565; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Derogatis L.R., 1994, USE PSYCHOL TESTING, P217; Ferrari A, 1998, DRUG ALCOHOL DEPEN, V52, P211, DOI 10.1016/S0376-8716(98)00098-2; Geenen R, 2001, Curr Opin Anaesthesiol, V14, P533, DOI 10.1097/00001503-200110000-00012; Geisser ME, 2008, PSYCHOSOMATICS, V49, P235, DOI 10.1176/appi.psy.49.3.235; Geisser ME, 2007, EUR J PAIN, V11, P202, DOI 10.1016/j.ejpain.2006.02.001; Giovengo SL, 1999, J RHEUMATOL, V26, P1564; GUIEU R, 1994, CLIN RHEUMATOL, V13, P605, DOI 10.1007/BF02243002; Hamaty D, 1989, J Rheumatol Suppl, V19, P164; HANDELSMAN L, 1987, AM J DRUG ALCOHOL AB, V13, P293, DOI 10.3109/00952998709001515; Harris RE, 2007, J NEUROSCI, V27, P10000, DOI 10.1523/JNEUROSCI.2849-07.2007; HUDSON JI, 1985, AM J PSYCHIAT, V142, P441; IGNELZI RJ, 1980, NEUROSURGERY, V6, P584, DOI 10.1227/00006123-198005000-00016; Julien N, 2005, PAIN, V114, P295, DOI 10.1016/j.pain.2004.12.032; KAPLAN KH, 1993, GEN HOSP PSYCHIAT, V15, P284, DOI 10.1016/0163-8343(93)90020-O; King AC, 1997, ALCOHOL CLIN EXP RES, V21, P906, DOI 10.1097/00000374-199708000-00020; Kosek E, 1996, PAIN, V68, P375, DOI 10.1016/S0304-3959(96)03188-0; KRUESI ME, 2004, J TRAUMA DISSOCIATIO, V5, P121; Laughlin TM, 2001, J PHARMACOL EXP THER, V299, P6; Lautenbacher S, 1997, CLIN J PAIN, V13, P189, DOI 10.1097/00002508-199709000-00003; LEE MC, 1988, J NUCL MED, V29, P1207; MALCOLM R, 1987, BIOL PSYCHIAT, V22, P710, DOI 10.1016/0006-3223(87)90202-2; MARTIN WR, 1973, ARCH GEN PSYCHIAT, V28, P784; McCaul ME, 2000, ALCOHOL CLIN EXP RES, V24, P1385, DOI 10.1097/00000374-200009000-00009; MEYER MC, 1984, J CLIN PSYCHIAT, V45, P15; Neumann Lily, 2003, Curr Pain Headache Rep, V7, P362, DOI 10.1007/s11916-003-0035-z; Panerai AE, 2002, CLIN J PAIN, V18, P270, DOI 10.1097/00002508-200207000-00008; Park DC, 2001, ARTHRITIS RHEUM, V44, P2125, DOI 10.1002/1529-0131(200109)44:9<2125::AID-ART365>3.0.CO;2-1; Petzke F, 2000, Curr Rheumatol Rep, V2, P116, DOI 10.1007/s11926-000-0051-5; PRESTON KL, 1993, J PHARMACOL EXP THER, V264, P813; Price DD, 2002, PAIN, V99, P49, DOI 10.1016/S0304-3959(02)00053-2; Riley JL, 1999, PAIN, V81, P225, DOI 10.1016/S0304-3959(98)00258-9; Robinson RL, 2003, J RHEUMATOL, V30, P1318; Rollman GB, 2001, CLIN J PAIN, V17, P20, DOI 10.1097/00002508-200103000-00004; SAX DS, 1994, J CLIN PHARMACOL, V34, P898, DOI 10.1002/j.1552-4604.1994.tb04002.x; Schuh KJ, 1999, PSYCHOPHARMACOLOGY, V145, P162, DOI 10.1007/s002130051045; Shaver JLF, 2006, J WOMENS HEALTH, V15, P1035, DOI 10.1089/jwh.2006.15.1035; Slotkoff AT, 1997, SCAND J RHEUMATOL, V26, P364, DOI 10.3109/03009749709065700; Vaeroy H, 1989, J Rheumatol Suppl, V19, P94; VAEROY H, 1988, J RHEUMATOL, V15, P1804; VAEROY H, 1991, PAIN, V46, P139, DOI 10.1016/0304-3959(91)90068-9; Walker EA, 1997, PSYCHOSOM MED, V59, P565, DOI 10.1097/00006842-199711000-00002; Walsh SL, 1996, J PHARMACOL EXP THER, V279, P524; WASSEM R, 2002, CLIN NURSE SPEC, V16, P29; Wassem Rebecca, 2002, Clin Nurse Spec, V16, P24, DOI 10.1097/00002800-200201000-00009; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WAYLONIS GW, 1992, AM J PHYS MED REHAB, V71, P343, DOI 10.1097/00002060-199212000-00006; White KP, 1999, J RHEUMATOL, V26, P1570; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Younger JW, 2006, PSYCHOSOM MED, V68, P734, DOI 10.1097/01.psy.0000234029.38245.c9; YUNUS MB, 1986, J RHEUMATOL, V13, P183; YUNUS MB, 1992, J RHEUMATOL, V19, P846	61	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5180	10.1371/journal.pone.0005180	http://dx.doi.org/10.1371/journal.pone.0005180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437TN	19365548	Green Published, Green Submitted, gold			2022-12-27	WOS:000265509900010
J	Nakagawa, Y; Nagasawa, M; Yamada, S; Hara, A; Mogami, H; Nikolaev, VO; Lohse, MJ; Shigemura, N; Ninomiya, Y; Kojima, I				Nakagawa, Yuko; Nagasawa, Masahiro; Yamada, Satoko; Hara, Akemi; Mogami, Hideo; Nikolaev, Viacheslav O.; Lohse, Martin J.; Shigemura, Noriatsu; Ninomiya, Yuzo; Kojima, Itaru			Sweet Taste Receptor Expressed in Pancreatic beta-Cells Activates the Calcium and Cyclic AMP Signaling Systems and Stimulates Insulin Secretion	PLOS ONE			English	Article							MAMMALIAN SWEET; SENSITIVITY; SUCRALOSE; BITTER	Background: Sweet taste receptor is expressed in the taste buds and enteroendocrine cells acting as a sugar sensor. We investigated the expression and function of the sweet taste receptor in MIN6 cells and mouse islets. Methodology/Principal Findings: The expression of the sweet taste receptor was determined by RT-PCR and immunohistochemistry. Changes in cytoplasmic Ca2+ ([Ca2+](c)) and cAMP ([cAMP](c)) were monitored in MIN6 cells using fura-2 and Epac1-camps. Activation of protein kinase C was monitored by measuring translocation of MARCKS-GFP. Insulin was measured by radioimmunoassay. mRNA for T1R2, T1R3, and gustducin was expressed in MIN6 cells. In these cells, artificial sweeteners such as sucralose, succharin, and acesulfame-K increased insulin secretion and augmented secretion induced by glucose. Sucralose increased biphasic increase in [Ca2+](c). The second sustained phase was blocked by removal of extracellular calcium and addition of nifedipine. An inhibitor of inositol(1, 4, 5)-trisphophate receptor, 2-aminoethoxydiphenyl borate, blocked both phases of [Ca2+](c) response. The effect of sucralose on [Ca2+](c) was inhibited by gurmarin, an inhibitor of the sweet taste receptor, but not affected by a G(q) inhibitor. Sucralose also induced sustained elevation of [cAMP](c), which was only partially inhibited by removal of extracellular calcium and nifedipine. Finally, mouse islets expressed T1R2 and T1R3, and artificial sweeteners stimulated insulin secretion. Conclusions: Sweet taste receptor is expressed in beta-cells, and activation of this receptor induces insulin secretion by Ca2+ and cAMP-dependent mechanisms.			Nakagawa, Y (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan.	ikojima@showa.gunma-u.ac.jp	Alshali, Rasha A/K-8051-2012; Lohse, Martin J/A-7160-2012; Nikolaev, Vyacheslav/AAT-7746-2020	Lohse, Martin J/0000-0002-0599-3510; Shigemura, Noriatsu/0000-0002-3061-6362				Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; FEIHAN F, 2006, J BIOL CHEM, V281, P21942; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Grotz VL, 2003, J AM DIET ASSOC, V103, P1607, DOI 10.1016/j.jada.2003.09.021; GRYHKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hara A, 2007, DEV DYNAM, V236, P3451, DOI 10.1002/dvdy.21359; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; LINDERMAN B, 2002, NATURE, V413, P219; Malaisse WJ, 1998, CELL SIGNAL, V10, P727, DOI 10.1016/S0898-6568(98)00017-5; Margolskee RF, 2002, J BIOL CHEM, V277, P1, DOI 10.1074/jbc.R100054200; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Mezitis NHE, 1996, DIABETES CARE, V19, P1004, DOI 10.2337/diacare.19.9.1004; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; MURAYAMA T, 1997, J BIOCH, V122, P498; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Shigemura N, 2008, BIOCHEM BIOPH RES CO, V367, P356, DOI 10.1016/j.bbrc.2007.12.146; Straub SG, 2003, DIABETES, V52, P356, DOI 10.2337/diabetes.52.2.356; Suzuki Y, 2006, J BIOL CHEM, V281, P28499, DOI 10.1074/jbc.M604291200; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; TEITELMAN G, 2001, REC PROG HOR RES, V47, P259; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; ZHANG H, 2004, J PHYSL, V61, P133; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	30	223	235	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5106	10.1371/journal.pone.0005106	http://dx.doi.org/10.1371/journal.pone.0005106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352508	Green Submitted, gold, Green Published			2022-12-27	WOS:000265505700012
J	Wu, FTH; Stefanini, MO; Gabhann, FM; Popel, AS				Wu, Florence T. H.; Stefanini, Marianne O.; Gabhann, Feilim Mac; Popel, Aleksander S.			A Compartment Model of VEGF Distribution in Humans in the Presence of Soluble VEGF Receptor-1 Acting as a Ligand Trap	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PERIPHERAL-ARTERIAL-DISEASE; HUMAN SKELETAL-MUSCLE; CAPILLARY BASEMENT-MEMBRANE; HEPARAN-SULFATE PROTEOGLYCAN; COLLAGEN-INDUCED ARTHRITIS; FLT-1 GENE-THERAPY; INHIBITS ANGIOGENESIS; ANTIANGIOGENIC GENE; SIGNAL-TRANSDUCTION	Vascular endothelial growth factor (VEGF), through its activation of cell surface receptor tyrosine kinases including VEGFR1 and VEGFR2, is a vital regulator of stimulatory and inhibitory processes that keep angiogenesis - new capillary growth from existing microvasculature - at a dynamic balance in normal physiology. Soluble VEGF receptor-1 (sVEGFR1) - a naturally-occurring truncated version of VEGFR1 lacking the transmembrane and intracellular signaling domains - has been postulated to exert inhibitory effects on angiogenic signaling via two mechanisms: direct sequestration of angiogenic ligands such as VEGF; or dominant-negative heterodimerization with surface VEGFRs. In pre-clinical studies, sVEGFR1 gene and protein therapy have demonstrated efficacy in inhibiting tumor angiogenesis; while in clinical studies, sVEGFR1 has shown utility as a diagnostic or prognostic marker in a widening array of angiogenesis - dependent diseases. Here we developed a novel computational multi-tissue model for recapitulating the dynamic systemic distributions of VEGF and sVEGFR1. Model features included: physiologically-based multi-scale compartmentalization of the human body; intercompartmental macromolecular biotransport processes (vascular permeability, lymphatic drainage); and molecularly-detailed binding interactions between the ligand isoforms VEGF(121) and VEGF(165), signaling receptors VEGFR1 and VEGFR2, non-signaling co-receptor neuropilin-1 (NRP1), as well as sVEGFR1. The model was parameterized to represent a healthy human subject, whereupon we investigated the effects of sVEGFR1 on the distribution and activation of VEGF ligands and receptors. We assessed the healthy baseline stability of circulating VEGF and sVEGFR1 levels in plasma, as well as their reliability in indicating tissue-level angiogenic signaling potential. Unexpectedly, simulated results showed that sVEGFR1 acting as a diffusible VEGF sink alone, i.e., without sVEGFR1-VEGFR heterodimerization - did not significantly lower interstitial VEGF, nor inhibit signaling potential in tissues. Additionally, the sensitivity of plasma VEGF and sVEGFR1 to physiological fluctuations in transport rates may partially account for the heterogeneity in clinical measurements of these circulating angiogenic markers, potentially hindering their diagnostic reliability for diseases.			Wu, FTH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	florence.wu@jhu.edu	Popel, Aleksander S/A-6724-2009; Mac Gabhann, Feilim/A-3436-2010	Mac Gabhann, Feilim/0000-0003-3481-7740; Popel, Aleksander/0000-0002-6706-9235; Wu, Florence/0000-0002-6439-4606	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079653, R33HL087351, T32HL007284] Funding Source: NIH RePORTER; NHLBI NIH HHS [R33 HL087351, T32 HL7284, R01 HL079653, T32 HL007284] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Afuwape AO, 2003, GENE THER, V10, P1950, DOI 10.1038/sj.gt.3302104; Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; Ambati BK, 2007, BRIT J OPHTHALMOL, V91, P505, DOI 10.1136/bjo.2006.107417; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; ANDERSEN P, 1977, J PHYSIOL-LONDON, V270, P677, DOI 10.1113/jphysiol.1977.sp011975; Anne A., 2007, ESSENTIAL CLIN ANATO, V3rd; Aref S, 2005, HEMATOLOGY, V10, P131, DOI 10.1080/10245330500065797; Arner P, 1999, P NUTR SOC, V58, P913, DOI 10.1017/S0029665199001214; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; AUKLAND K, 1981, PHYSIOL REV, V61, P556, DOI 10.1152/physrev.1981.61.3.556; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bailey AP, 2006, MED SCI MONITOR, V12, pCR45; Bando H, 2005, BRIT J CANCER, V92, P553, DOI 10.1038/sj.bjc.6602374; Barleon B, 1997, J BIOL CHEM, V272, P10382; BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047; Baum O, 2005, MICROCIRCULATION, V12, P527, DOI 10.1080/10739680591003413; Belgore FM, 2001, CLIN SCI, V100, P567, DOI 10.1042/CS20000234; BIKFALVI A, 1991, J CELL PHYSIOL, V149, P50, DOI 10.1002/jcp.1041490108; Blann AD, 2002, CLIN SCI, V102, P187, DOI 10.1042/CS20010178; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Chen RR, 2007, FASEB J, V21, P3896, DOI 10.1096/fj.06-7873com; Chung NA, 2003, HEART, V89, P1411, DOI 10.1136/heart.89.12.1411; Cisek PL, 1997, ANN VASC SURG, V11, P49, DOI 10.1007/s100169900009; Clark M, 2008, J APPL PHYSIOL, V104, P900, DOI 10.1152/japplphysiol.01318.2007; Collinson DJ, 2004, EUR J VASC ENDOVASC, V28, P9, DOI 10.1016/j.ejvs.2004.03.021; Croley AN, 2005, J APPL PHYSIOL, V99, P1872, DOI 10.1152/japplphysiol.00498.2005; Dawson D, 2002, AM J PHYSIOL-ENDOC M, V282, pE714, DOI 10.1152/ajpendo.00373.2001; Diab AE, 2008, INT J GYNECOL OBSTET, V102, P146, DOI 10.1016/j.ijgo.2008.02.016; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; Duval M, 2007, MOL BIOL CELL, V18, P4659, DOI 10.1091/mbc.E07-05-0467; Ebos JML, 2004, MOL CANCER RES, V2, P315; Elliott MA, 1997, MAGN RESON MATER PHY, V5, P93, DOI 10.1007/BF02592238; Eppler SM, 2002, CLIN PHARMACOL THER, V72, P20, DOI 10.1067/mcp.2002.126179; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; FEINGOLD KR, 1986, J CLIN INVEST, V78, P102, DOI 10.1172/JCI112537; Felmeden DC, 2003, J INTERN MED, V253, P81, DOI 10.1046/j.1365-2796.2003.01087.x; Feng D, 2000, J HISTOCHEM CYTOCHEM, V48, P545, DOI 10.1177/002215540004800412; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Filion RJ, 2004, ANN BIOMED ENG, V32, P645, DOI 10.1023/B:ABME.0000030231.88326.78; Findley CM, 2008, J AM COLL CARDIOL, V52, P387, DOI 10.1016/j.jacc.2008.02.045; Fuh G, 2000, J BIOL CHEM, V275, P26690; Gabhann FM, 2008, MICROCIRCULATION, V15, P715, DOI 10.1080/10739680802095964; GABHANN FM, 2006, PLOS COMPUT BIOL, V2, pE180, DOI DOI 10.1371/JOURNAL.PCBI.0020180; Gagnon ML, 2000, P NATL ACAD SCI USA, V97, P2573, DOI 10.1073/pnas.040337597; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Gao ZN, 2007, ORAL ONCOL, V43, P477, DOI 10.1016/j.oraloncology.2006.05.009; GARLICK DG, 1970, AM J PHYSIOL, V219, P1595, DOI 10.1152/ajplegacy.1970.219.6.1595; Gavin TP, 2007, ACTA PHYSIOL, V191, P139, DOI 10.1111/j.1748-1716.2007.01723.x; Gavin TP, 2007, J PHYSIOL-LONDON, V585, P231, DOI 10.1113/jphysiol.2007.143198; Gehlbach P, 2003, HUM GENE THER, V14, P129, DOI 10.1089/104303403321070829; Green H, 1999, ACTA PHYSIOL SCAND, V165, P177; Gustafsson T, 2005, J APPL PHYSIOL, V98, P2137, DOI 10.1152/japplphysiol.01402.2004; Guyton A.C., 2006, TXB MED PHYSL; Havas E, 1997, J PHYSIOL-LONDON, V504, P233, DOI 10.1111/j.1469-7793.1997.233bf.x; Havas E, 2000, EXP PHYSIOL, V85, P863; Hazarika S, 2007, CIRC RES, V101, P948, DOI 10.1161/CIRCRESAHA.107.160630; Hernandez N, 1999, ANAT REC, V256, P425; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hoffner L, 2003, J PHYSIOL-LONDON, V550, P217, DOI 10.1113/jphysiol.2002.037051; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Hornig C, 2000, LAB INVEST, V80, P443, DOI 10.1038/labinvest.3780050; Huang K, 2001, INT J BIOCHEM CELL B, V33, P315, DOI 10.1016/S1357-2725(01)00019-X; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; ITO T, 2008, BLOOD; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Jaroszewicz J, 2008, CYTOKINE, V44, P14, DOI 10.1016/j.cyto.2008.06.002; Jelkmann W, 2001, CLIN CHEM, V47, P617; Jenniskens GJ, 2006, J CELL PHYSIOL, V206, P283, DOI 10.1002/jcp.20450; Ji JW, 2007, AM J PHYSIOL-HEART C, V293, pH3740, DOI 10.1152/ajpheart.00009.2007; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Karumanchi SA, 2004, ENDOCRINOLOGY, V145, P4835, DOI 10.1210/en.2004-1028; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Kim NH, 2005, KIDNEY INT, V67, P167, DOI 10.1111/j.1523-1755.2005.00067.x; Kim WJ, 2006, J CONTROL RELEASE, V114, P381, DOI 10.1016/j.jconrel.2006.05.029; Kivela R, 2007, AM J PHYSIOL-HEART C, V293, pH2573, DOI 10.1152/ajpheart.00126.2007; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Kommareddy S, 2007, CANCER GENE THER, V14, P488, DOI 10.1038/sj.cgt.7701041; Kraus RM, 2004, J APPL PHYSIOL, V96, P1445, DOI 10.1152/japplphysiol.01031.2003; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Krilleke D, 2007, J BIOL CHEM, V282, P28045, DOI 10.1074/jbc.M700319200; Kumai Y, 2007, J CEREBR BLOOD F MET, V27, P1152, DOI 10.1038/sj.jcbfm.9600420; Ladomery MR, 2007, CANCER LETT, V249, P133, DOI 10.1016/j.canlet.2006.08.015; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lamszus K, 2003, CLIN CANCER RES, V9, P1399; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; LEVESQUE MJ, 1986, ARTERIOSCLEROSIS, V6, P220, DOI 10.1161/01.ATV.6.2.220; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Levitt David G, 2003, BMC Clin Pharmacol, V3, P3, DOI 10.1186/1472-6904-3-3; Li YJ, 2007, DIABETES, V56, P656, DOI 10.2337/db06-0999; Lip PL, 2002, BRIT J OPHTHALMOL, V86, P1299, DOI 10.1136/bjo.86.11.1299; LIU H, 2007, INT J INNOV COMPUT I, V1, P39, DOI [DOI 10.1109/ICHIS.2005.49, DOI 10.1504/IJICA.2007.013400]; Lorquet S, 2008, AM J REPROD IMMUNOL, V60, P85; Luttun A, 2003, J CLIN INVEST, V111, P600, DOI 10.1172/JCI200318015; Mac Gabhann F, 2004, AM J PHYSIOL-HEART C, V286, pH153, DOI 10.1152/ajpheart.00254.2003; Mac Gabhann F, 2007, AM J PHYSIOL-HEART C, V292, pH459, DOI 10.1152/ajpheart.00637.2006; Mac Gabhann F, 2007, ANN BIOMED ENG, V35, P982, DOI 10.1007/s10439-007-9303-0; Mac Gabhann F, 2007, J APPL PHYSIOL, V102, P722, DOI 10.1152/japplphysiol.00800.2006; Mac Gabhann F, 2006, PLOS COMPUT BIOL, V2, P1107, DOI 10.1371/journal.pcbi.0020127; Mac Gabhann F, 2007, BIOPHYS CHEM, V128, P125, DOI 10.1016/j.bpc.2007.03.010; MACGABHANN F, 2005, FASEB J, V19, pA1660; Maharaj ASR, 2007, MICROVASC RES, V74, P100, DOI 10.1016/j.mvr.2007.03.004; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; Mahasreshti PJ, 2001, CLIN CANCER RES, V7, P2057; Mahendra G, 2005, CANCER GENE THER, V12, P26, DOI 10.1038/sj.cgt.7700754; Makin AJ, 2003, CLIN SCI, V104, P397, DOI 10.1042/CS20020182; McDonald DM, 2005, CHEST, V128, p602S, DOI 10.1378/chest.128.6_suppl.602S-a; McGuigan MRM, 2001, MED SCI SPORT EXER, V33, P2016, DOI 10.1097/00005768-200112000-00007; Miotla J, 2000, LAB INVEST, V80, P1195, DOI 10.1038/labinvest.3780127; Mitsi M, 2006, BIOCHEMISTRY-US, V45, P10319, DOI 10.1021/bi060974p; MOSHER DF, 1984, ANNU REV MED, V35, P561, DOI 10.1146/annurev.me.35.020184.003021; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Mulay M., 2006, ASCO M, V24, P13061; MYOKEN Y, 1991, P NATL ACAD SCI USA, V88, P5819, DOI 10.1073/pnas.88.13.5819; Neagoe PE, 2005, J BIOL CHEM, V280, P9904, DOI 10.1074/jbc.M412017200; Ng YS, 2001, DEV DYNAM, V220, P112, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1093>3.0.CO;2-D; Nguyen QD, 2006, OPHTHALMOLOGY, V113, P1522, DOI 10.1016/j.ophtha.2006.05.055; Norgren L, 2007, INT ANGIOL, V26, P81; Ohira Y, 1999, J APPL PHYSIOL, V87, P1776, DOI 10.1152/jappl.1999.87.5.1776; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; OLSZEWSKI W, 1977, ACTA PHYSIOL SCAND, V99, P149, DOI 10.1111/j.1748-1716.1977.tb10365.x; OLSZEWSKI WL, 1977, LYMPHOLOGY, V10, P178; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; QUHONG, 1995, J HISTOCHEM CYTOCHEM, V43, P381, DOI 10.1177/43.4.7534783; Regensteiner JG, 2002, AM J MED, V112, P49, DOI 10.1016/S0002-9343(01)01034-8; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; ROHRBACH DH, 1983, J BIOL CHEM, V258, P1672; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; Rota R, 2004, J GENE MED, V6, P992, DOI 10.1002/jgm.586; Ryan NA, 2006, J APPL PHYSIOL, V100, P178, DOI 10.1152/japplphysiol.00827.2005; Sako A, 2004, CANCER RES, V64, P3624, DOI 10.1158/0008-5472.CAN-04-0304; Schmittmann G, 2000, J PHARM SCI, V89, P115, DOI 10.1002/(SICI)1520-6017(200001)89:1<115::AID-JPS12>3.0.CO;2-7; Shapiro NI, 2008, SHOCK, V29, P452, DOI 10.1097/SHK.0b013e31815072c1; Signorelli SS, 2005, VASC MED, V10, P1, DOI 10.1191/1358863x05vm582oa; SIPERSTEIN MD, 1968, J CLIN INVEST, V47, P1973, DOI 10.1172/JCI105886; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; Stefanini MO, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-77; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Takei T, 2006, BIOTECHNOL BIOENG, V95, P1, DOI 10.1002/bit.20903; Tayebjee MH, 2005, J INTERN MED, V257, P110, DOI 10.1111/j.1365-2796.2004.01431.x; TAYLOR RN, 1991, AM J OBSTET GYNECOL, V165, P895, DOI 10.1016/0002-9378(91)90435-T; TRUSKEY GA, 2004, TRANSPORT PHENOMENA, P389; Tsao PN, 2007, CRIT CARE MED, V35, P1955, DOI 10.1097/01.CCM.0000275273.56547.B8; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Verheu HMW, 2007, CLIN CANCER RES, V13, P5341, DOI 10.1158/1078-0432.CCR-07-0847; Vlodavsky EA, 1999, VIRCHOWS ARCH, V435, P58, DOI 10.1007/s004280050395; VRACKO R, 1970, CIRCULATION, V41, P271, DOI 10.1161/01.CIR.41.2.271; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang DF, 2002, AM J PHYSIOL-GASTR L, V282, pG1088, DOI 10.1152/ajpgi.00250.2001; Ward SR, 2005, J BIOMECH, V38, P2317, DOI 10.1016/j.jbiomech.2004.10.001; Widmer M, 2007, OBSTET GYNECOL, V109, P168, DOI 10.1097/01.AOG.0000249609.04831.7c; Wijelath ES, 2006, CIRC RES, V99, P853, DOI 10.1161/01.RES.0000246849.17887.66; Williamson JR, 1996, J APPL PHYSIOL, V80, P747, DOI 10.1152/jappl.1996.80.3.747; Woolcock J, 2008, AUST NZ J OBSTET GYN, V48, P64, DOI 10.1111/j.1479-828X.2007.00804.x; Xiao HY, 1999, HAEMOSTASIS, V29, P237; Xu XG, 2000, HEALTH PHYS, V78, P476, DOI 10.1097/00004032-200005000-00003; Ye CS, 2004, ENDOCRINOLOGY, V145, P817, DOI 10.1210/en.2003-1106; Yla-Herttuala S, 2007, J AM COLL CARDIOL, V49, P1015, DOI 10.1016/j.jacc.2006.09.053; Yuan F, 2001, ANN BIOMED ENG, V29, P1150, DOI 10.1114/1.1424915; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zhang ZL, 2005, MOL THER, V11, P553, DOI 10.1016/j.ymthe.2004.12.015	167	47	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5108	10.1371/journal.pone.0005108	http://dx.doi.org/10.1371/journal.pone.0005108			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352513	Green Submitted, gold, Green Published			2022-12-27	WOS:000265505700013
J	Alvarez, M; Ruiz, MF; Sanchez, L				Alvarez, Mercedes; Fernanda Ruiz, Maria; Sanchez, Lucas			Effect of the Gene doublesex of Anastrepha on the Somatic Sexual Development of Drosophila	PLOS ONE			English	Article							GENITAL DISC; FRUIT-FLY; HOX GENE; MELANOGASTER; EVOLUTION; EXPRESSION; PROTEIN; DIFFERENTIATION; DOMINANT; WINGLESS	Background: The gene doublesex (dsx) is at the bottom of the sex determination genetic cascade and is transcribed in both sexes, but gives rise to two different proteins, DsxF and DsxM, which impose female and male sexual development respectively via the sex-specific regulation of the so-called sexual cyto-differentiation genes. The present manuscript addressed the question about the functional conservation of the tephritid Anastrepha DsxF and DsxM proteins to direct the sexual development in Drosophila (Drosophilidae). Methodology: To express these proteins in Drosophila, the GAL4-UAS system was used. The effect of these proteins was monitored in the sexually dimorphic regions of the fly: the foreleg basitarsus, the 5th, 6th and 7th tergites, and the external terminalia. In addition, we analysed the effect of Anastrepha DsxF and DsxM proteins on the regulation of Drosophila yolk protein genes, which are expressed in the fat body of adult females under the control of dsx. Conclusions: The Anastrepha DsxF and DsxM proteins transformed doublesex intersexual Drosophila flies into females and males respectively, though this transformation was incomplete and the extent of their influence varied in the different sexually dimorphic regions of the adult fly. The Anastrepha DsxF and DsxM proteins also behaved as activators and repressors, respectively, of the Drosophila yolk protein genes, as do the DsxF and DsxM proteins of Drosophila itself. Finally, the Anastrepha DsxF and DsxM proteins were found to counteract the functions of Drosophila DsxM and DsxF respectively, reflecting the normal behaviour of the latter proteins towards one another. Collectively, these results indicate that the Anastrepha DsxF and DsxM proteins show conserved female and male sex-determination function respectively in Drosophila, though it appears that they cannot fully substitute the latter's own Dsx proteins. This incomplete function might be partly due to a reduced capacity of the Anastrepha Dsx proteins to completely control the Drosophila sexual cytodifferentiation genes, a consequence of the accumulation of divergence between these species resulting in the formation of different co-adapted complexes between the Dsx proteins and their target genes.	[Alvarez, Mercedes; Fernanda Ruiz, Maria; Sanchez, Lucas] CSIC, Ctr Invest Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Alvarez, M (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	lsanchez@cib.csic.es	Sánchez, Lucas/K-4238-2015; Ruiz, Maria Fernanda/F-3290-2016	Sánchez, Lucas/0000-0002-7725-8961; Ruiz, Maria Fernanda/0000-0002-1649-2105	D.G.I.C.Y.T. (Spanish Government). [BFU2005-03000]	D.G.I.C.Y.T. (Spanish Government).(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was financed by grant BFU2005-03000 awarded to L. Sanchez by the D.G.I.C.Y.T. (Spanish Government). The funding agency did not take part in this work but only provided the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WQ, 1996, MOL CELL BIOL, V16, P3106; BAKER BS, 1980, GENETICS, V94, P383; BOWNES M, 1994, BIOESSAYS, V16, P745, DOI 10.1002/bies.950161009; BOWNES M, 1990, EMBO J, V9, P3975, DOI 10.1002/j.1460-2075.1990.tb07618.x; BOWNES M, 1981, MOL GEN GENET, V182, P222, DOI 10.1007/BF00269661; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bull J.J., 1983, EVOLUTION SEX DETERM; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; CHASE BA, 1995, GENETICS, V139, P1649; Chen SL, 2008, INSECT BIOCHEM MOLEC, V38, P155, DOI 10.1016/j.ibmb.2007.10.003; Cho S, 1997, J BIOL CHEM, V272, P3185, DOI 10.1074/jbc.272.6.3185; Cho S, 2007, GENETICS, V177, P1733, DOI 10.1534/genetics.107.078980; Christiansen AE, 2002, TRENDS GENET, V18, P510, DOI 10.1016/S0168-9525(02)02769-5; DENELL RE, 1972, DROS INFORM SERV, V48, P45; EPPER F, 1981, DEV BIOL, V88, P104, DOI 10.1016/0012-1606(81)90222-0; Estrada B, 2001, DEVELOPMENT, V128, P331; Ruiz MF, 2007, DEV GENES EVOL, V217, P725, DOI 10.1007/s00427-007-0178-8; Garrett-Engele CM, 2002, DEVELOPMENT, V129, P4661; Gorfinkiel N, 1999, MECH DEVELOP, V86, P113, DOI 10.1016/S0925-4773(99)00122-7; Gowen J. W., 1942, DROSOPH INFORM SERV, V16, P63; Hediger M, 2004, DEV GENES EVOL, V214, P29, DOI 10.1007/s00427-003-0372-2; JURSNICH VA, 1993, DEV BIOL, V155, P235, DOI 10.1006/dbio.1993.1021; Keisman EL, 2001, DEVELOPMENT, V128, P1643; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Kuhn S, 2000, GENOME, V43, P1011, DOI 10.1139/gen-43-6-1011; Lagos D, 2005, GENE, V348, P111, DOI 10.1016/j.gene.2004.12.053; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Moreno E, 1999, NATURE, V400, P873, DOI 10.1038/23709; NOTHIGER R, 1987, GENET RES, V50, P113, DOI 10.1017/S001667230002351X; Ohbayashi F, 2001, COMP BIOCHEM PHYS B, V128, P145, DOI 10.1016/S1096-4959(00)00304-3; Ramos-Onsins S, 1998, MOL PHYLOGENET EVOL, V9, P33, DOI 10.1006/mpev.1997.0438; Ruiz MF, 2005, GENETICS, V171, P849, DOI 10.1534/genetics.105.044925; Saccone G, 2008, INT J DEV BIOL, V52, P1051, DOI 10.1387/ijdb.082657gs; Sanchez L, 2001, BIOESSAYS, V23, P698, DOI 10.1002/bies.1099; Sanchez L, 2001, DEVELOPMENT, V128, P1033; Sanchez L, 1997, GENETICS, V147, P231; SANCHEZ L, 2005, COMPREHENSIVE MOL IN, V1, P1; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Scali C, 2005, J EXP BIOL, V208, P3701, DOI 10.1242/jeb.01819; Shearman DCA, 1998, INSECT MOL BIOL, V7, P355, DOI 10.1046/j.1365-2583.1998.740355.x; Sievert V, 1997, GENOME, V40, P211, DOI 10.1139/g97-030; Suzuki MG, 2001, INSECT BIOCHEM MOLEC, V31, P1201, DOI 10.1016/S0965-1748(01)00067-4; Waterbury JA, 1999, GENETICS, V152, P1653; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052	45	13	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5141	10.1371/journal.pone.0005141	http://dx.doi.org/10.1371/journal.pone.0005141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340310	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500700023
J	Chen, J; Zheng, RJ; Melman, YF; McDonald, TV				Chen, Jerri; Zheng, Renjian; Melman, Yonathan F.; McDonald, Thomas V.			Functional Interactions between KCNE1 C-Terminus and the KCNQ1 Channel	PLOS ONE			English	Article								The KCNE1 gene product (minK protein) associates with the cardiac KvLQT1 potassium channel (encoded by KCNQ1) to create the cardiac slowly activating delayed rectifier, I-Ks. Mutations throughout both genes are linked to the hereditary cardiac arrhythmias in the Long QT Syndrome (LQTS). KCNE1 exerts its specific regulation of KCNQ1 activation via interactions between membrane-spanning segments of the two proteins. Less detailed attention has been focused on the role of the KCNE1 C-terminus in regulating channel behavior. We analyzed the effects of an LQT5 point mutation (D76N) and the truncation of the entire C-terminus (Delta 70) on channel regulation, assembly and interaction. Both mutations significantly shifted voltage dependence of activation in the depolarizing direction and decreased I-Ks current density. They also accelerated rates of channel deactivation but notably, did not affect activation kinetics. Truncation of the C-terminus reduced the apparent affinity of KCNE1 for KCNQ1, resulting in impaired channel formation and presentation of KCNQ1/KCNE1 complexes to the surface. Complete saturation of KCNQ1 channels with KCNE1-D70 could be achieved by relative over-expression of the KCNE subunit. Rate-dependent facilitation of K+ conductance, a key property of I-Ks that enables action potential shortening at higher heart rates, was defective for both KCNE1 C-terminal mutations, and may contribute to the clinical phenotype of arrhythmias triggered by heart rate elevations during exercise in LQTS mutations. These results support several roles for KCNE1 C-terminus interaction with KCNQ1: regulation of channel assembly, open-state destabilization, and kinetics of channel deactivation.	[Chen, Jerri; McDonald, Thomas V.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Zheng, Renjian; McDonald, Thomas V.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Melman, Yonathan F.] Brigham and Womens Hosp, Dept Med, Boston, MA USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chen, J (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	mcdonald@aecom.yu.edu			NIH/NHLBI [R01 HL075615]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093440, R01HL075615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH/NHLBI: grant R01 HL075615. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abitbol I, 1999, EMBO J, V18, P4137, DOI 10.1093/emboj/18.15.4137; Angelo K, 2002, BIOPHYS J, V83, P1997, DOI 10.1016/S0006-3495(02)73961-1; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BASS BG, 1975, AM J PHYSIOL, V228, P1717, DOI 10.1152/ajplegacy.1975.228.6.1717; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; BOYETT MR, 1978, J PHYSIOL-LONDON, V285, P359, DOI 10.1113/jphysiol.1978.sp012576; CARMELIET E, 1977, J PHYSIOL-PARIS, V73, P903; Chen H, 2007, BIOPHYS J, V93, P2332, DOI 10.1529/biophysj.107.109702; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Duggal P, 1998, CIRCULATION, V97, P142, DOI 10.1161/01.CIR.97.2.142; Gage SD, 2004, J GEN PHYSIOL, V124, P759, DOI 10.1085/jgp.200409114; GETTES LS, 1972, CIRC RES, V30, P55, DOI 10.1161/01.RES.30.1.55; GOLDSTEIN SAN, 1991, NEURON, V7, P403, DOI 10.1016/0896-6273(91)90292-8; Grunnet M, 2005, BIOCHEM BIOPH RES CO, V328, P1146, DOI 10.1016/j.bbrc.2005.01.071; HOFFMAN BF, 1959, AM J PHYSIOL, V196, P1297, DOI 10.1152/ajplegacy.1959.196.6.1297; Krumerman A, 2004, AM J PHYSIOL-CELL PH, V286, pC1453, DOI 10.1152/ajpcell.00275.2003; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Melman YF, 2002, J BIOL CHEM, V277, P25187, DOI 10.1074/jbc.M200564200; Melman YF, 2004, NEURON, V42, P927, DOI 10.1016/j.neuron.2004.06.001; Melman YF, 2001, J BIOL CHEM, V276, P6439, DOI 10.1074/jbc.M010713200; Panaghie G, 2006, J PHYSIOL-LONDON, V570, P455, DOI 10.1113/jphysiol.2005.100644; Pusch M, 1998, PFLUG ARCH EUR J PHY, V437, P172, DOI 10.1007/s004240050765; Ravn LS, 2008, HEART RHYTHM, V5, P427, DOI 10.1016/j.hrthm.2007.12.019; Rudy Y, 2006, Q REV BIOPHYS, V39, P57, DOI 10.1017/S0033583506004227; SAENEN JB, 2008, J MOL CELL CARDIOL; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Schwartz PJ, 2001, CIRCULATION, V103, P89; Seebohm G, 2008, CIRC RES, V103, P1451, DOI 10.1161/CIRCRESAHA.108.177360; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; TAKUMI T, 1991, J BIOL CHEM, V266, P22192; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; Terrenoire C, 2005, CIRC RES, V96, pE25, DOI 10.1161/01.RES.0000160555.58046.9a; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; Yang YQ, 2004, AM J HUM GENET, V75, P899, DOI 10.1086/425342; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140	41	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5143	10.1371/journal.pone.0005143	http://dx.doi.org/10.1371/journal.pone.0005143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340287	Green Published, gold, Green Submitted			2022-12-27	WOS:000265500700024
J	Pandey, M; Batzloff, MR; Good, MF				Pandey, Manisha; Batzloff, Michael R.; Good, Michael F.			Mechanism of Protection Induced by Group A Streptococcus Vaccine Candidate J8-DT: Contribution of B and T-Cells Towards Protection	PLOS ONE			English	Article								Vaccination with J8-DT, a leading GAS vaccine candidate, results in protective immunity in mice. Analysis of immunologic correlates of protection indicated a role of J8-specific antibodies that were induced post-immunization. In the present study, several independent experimental approaches were employed to investigate the protective immunological mechanisms involved in J8-DT-mediated immunity. These approaches included the passive transfer of mouse or rabbit immune serum/antibodies in addition to selective depletion of T-cell subsets prior to bacterial challenge. Passive transfer of J8-DT antiserum/antibodies from mice and rabbits conferred significant resistance against challenge to mice. To exclude the possibility of involvement of other host immune factors, the studies were repeated in SCID mice, which highlighted the need for an ongoing immune response for long-lived protection. Depletion of CD4(+) and CD8(+) T-cell subsets confirmed that an active de novo immune response, involving CD4(+) T-helper cells, is required for continued synthesis of antibodies resulting in protection against GAS infection. Taken together these results indicate an involvement of CD4(+) T-cells in J8-DT-mediated protection possibly via an ability to maintain antibody levels. These results have considerable relevance to the development of a broad spectrum passive immunotherapy for GAS disease.	[Pandey, Manisha; Batzloff, Michael R.; Good, Michael F.] Queensland Inst Med Res, PO Royal Brisbane Hosp, Australian Ctr Vaccine Dev, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Pandey, M (corresponding author), Queensland Inst Med Res, PO Royal Brisbane Hosp, Australian Ctr Vaccine Dev, Brisbane, Qld 4006, Australia.	Michael.Good@qimr.edu.au			National Institutes of Health (NIH), USA [5-U01-AI060579]; National Heart Foundation of Australia [G 06B 2523, Fellowship]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI060579] Funding Source: NIH RePORTER	National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart Foundation of Australia(National Heart Foundation of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by The National Institutes of Health (NIH), USA, (Grant reference #5-U01-AI060579) [http://www.nih.gov]; and The National Heart Foundation of Australia (Grant ID G 06B 2523) [http://www.heartfoundation.org.au]. Michael Batzloff is supported by a Fellowship from the National Heart Foundation of Australia) [http://www.heartfoundation.org.au]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzloff MR, 2003, J INFECT DIS, V187, P1598, DOI 10.1086/374800; Beedham RJ, 2001, VACCINE, V19, P4409, DOI 10.1016/S0264-410X(01)00197-9; BJORKHOLM B, 1986, SCAND J INFECT DIS, V18, P235, DOI 10.3109/00365548609032332; COLIGAN JE, CURRENT PROTOCOLS IM; Darenberg J, 2004, CLIN INFECT DIS, V38, P836, DOI 10.1086/381979; Gupta M, 2001, J VIROL, V75, P4649, DOI 10.1128/JVI.75.10.4649-4654.2001; Hayman WA, 1997, INT IMMUNOL, V9, P1723, DOI 10.1093/intimm/9.11.1723; Hemachudha T, 1999, CLIN INFECT DIS, V28, P143, DOI 10.1086/517179; Hirunpetcharat C, 1999, J IMMUNOL, V162, P7309; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Kar S, 2005, INFECT IMMUN, V73, P3823, DOI 10.1128/IAI.73.6.3823-3827.2005; Kennedy BJ, 2000, INFECT IMMUN, V68, P2756, DOI 10.1128/IAI.68.5.2756-2765.2000; Li JSY, 2003, INFECT IMMUN, V71, P4229, DOI 10.1128/IAI.71.8.4229-4237.2003; Liu MY, 2007, INFECT IMMUN, V75, P3651, DOI 10.1128/IAI.00038-07; Ohashi N, 1998, INFECT IMMUN, V66, P132, DOI 10.1128/IAI.66.1.132-139.1998; PANDEY M, 2006, INT C SERIES, V1289, P336; Plotkin SA, 2000, CLIN INFECT DIS, V30, P4, DOI 10.1086/313632; Relf WA, 1996, PEPTIDE RES, V9, P12; RHINEHARTJONES TR, 1994, INFECT IMMUN, V62, P3129, DOI 10.1128/IAI.62.8.3129-3137.1994; Siegert J, 2006, MICROBES INFECT, V8, P347, DOI 10.1016/j.micinf.2005.06.024; Smith DJ, 2001, INFECT IMMUN, V69, P3135, DOI 10.1128/IAI.69.5.3135-3142.2001; Sriskandan S, 2006, J ANTIMICROB CHEMOTH, V58, P117, DOI 10.1093/jac/dkl173; Winslow GM, 2000, INFECT IMMUN, V68, P2187, DOI 10.1128/IAI.68.4.2187-2195.2000	23	38	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5147	10.1371/journal.pone.0005147	http://dx.doi.org/10.1371/journal.pone.0005147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340309	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500700025
J	Ribeiro, PL; Helene, AF; Xavier, G; Navas, C; Ribeiro, FL				Ribeiro, Pedro Leite; Helene, Andre Frazao; Xavier, Gilberto; Navas, Carlos; Ribeiro, Fernando Leite			Ants Can Learn to Forage on One-Way Trails	PLOS ONE			English	Article							LASIUS-NIGER; FOOD RECRUITMENT; DECISION-MAKING; ATTA-CEPHALOTES; ARGENTINE ANT; CUTTING ANT; DESERT ANTS; ORIENTATION; FORMICIDAE; HYMENOPTERA	The trails formed by many ant species between nest and food source are two-way roads on which outgoing and returning workers meet and touch each other all along. The way to get back home, after grasping a food load, is to take the same route on which they have arrived from the nest. In many species such trails are chemically marked by pheromones providing orientation cues for the ants to find their way. Other species rely on their vision and use landmarks as cues. We have developed a method to stop foraging ants from shuttling on two-way trails. The only way to forage is to take two separate roads, as they cannot go back on their steps after arriving at the food or at the nest. The condition qualifies as a problem because all their orientation cues-chemical, visual or any other - are disrupted, as all of them cannot but lead the ants back to the route on which they arrived. We have found that workers of the leaf-cutting ant Atta sexdens rubropilosa can solve the problem. They could not only find the alternative way, but also used the unidirectional traffic system to forage effectively. We suggest that their ability is an evolutionary consequence of the need to deal with environmental irregularities that cannot be negotiated by means of excessively stereotyped behavior, and that it is but an example of a widespread phenomenon. We also suggest that our method can be adapted to other species, invertebrate and vertebrate, in the study of orientation, memory, perception, learning and communication.	[Ribeiro, Pedro Leite; Helene, Andre Frazao; Xavier, Gilberto; Navas, Carlos] Univ Sao Paulo, Inst Biosci, Dept Physiol, Sao Paulo, Brazil; [Ribeiro, Pedro Leite; Ribeiro, Fernando Leite] Univ Sao Paulo, Inst Psychol, Dept Expt Psychol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Ribeiro, PL (corresponding author), Univ Sao Paulo, Inst Biosci, Dept Physiol, Sao Paulo, Brazil.	pedrorib@ib.usp.br	Helene, Andre/R-9720-2016; Xavier, Gilberto F/B-9464-2013; Navas, Carlos/B-2138-2013	Xavier, Gilberto F/0000-0002-8567-7031; Navas, Carlos/0000-0002-9859-0568	Brazilian National Counsel of Technological and Scientific Development	Brazilian National Counsel of Technological and Scientific Development	Brazilian National Counsel of Technological and Scientific Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKERS R, 1992, INSECT SOC, V39, P59, DOI 10.1007/BF01240531; BECKERS R, 1992, J THEOR BIOL, V159, P397, DOI 10.1016/S0022-5193(05)80686-1; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; Bregy P, 2008, J EXP BIOL, V211, P1868, DOI 10.1242/jeb.018036; Burd M, 2003, INSECT SOC, V50, P3, DOI 10.1007/s000400300001; Burd M, 2002, AM NAT, V159, P283, DOI 10.1086/338541; CAMAZINE S, 2003, SELF ORGANIZATION BI; CARTHY JD, 1951, BEHAVIOUR, V3, P304, DOI 10.1163/156853951X00313; CARTHY JD, 1950, NATURE, V166, P154, DOI 10.1038/166154a0; Couzin ID, 2003, P ROY SOC B-BIOL SCI, V270, P139, DOI 10.1098/rspb.2002.2210; Dussutour A, 2005, J EXP BIOL, V208, P2903, DOI 10.1242/jeb.01711; Dussutour A, 2006, BEHAV ECOL SOCIOBIOL, V61, P17, DOI 10.1007/s00265-006-0233-x; Evison SEF, 2008, ANIM BEHAV, V75, P963, DOI 10.1016/j.anbehav.2007.07.013; GOSS S, 1989, NATURWISSENSCHAFTEN, V76, P579, DOI 10.1007/BF00462870; GOTWALD WH, 1982, SOCIAL INSECTS; HOLT SJ, 1955, J ANIM ECOL, V24, P1, DOI 10.2307/1877; Jackson DE, 2004, NATURE, V432, P907, DOI 10.1038/nature03105; Jackson DE, 2006, CURR BIOL, V16, pR570, DOI 10.1016/j.cub.2006.07.015; JANDER R, 1974, INSECT SOC, V21, P45, DOI 10.1007/BF02222979; LAMB AE, 1994, BEHAV PROCESS, V31, P111, DOI 10.1016/0376-6357(94)90040-X; Miura T, 1998, J INSECT BEHAV, V11, P179, DOI 10.1023/A:1021039722402; MOGLICH M, 1975, J COMP PHYSIOL, V101, P275; NONACS P, 1990, DEATH DISTANCE MORTA, P23; Ratnieks F, 2005, NATURE, V436, P465, DOI 10.1038/436465a; Robinson EJH, 2005, NATURE, V438, P442, DOI 10.1038/438442a; Robinson EJH, 2008, J THEOR BIOL, V255, P250, DOI 10.1016/j.jtbi.2008.08.015; Rosengren R., 1971, Acta Zoologica Fennica, V133, P1; Rosengren R., 1977, ACTA ZOOL FENN, V149, P1; Sommer S, 2008, P NATL ACAD SCI USA, V105, P317, DOI 10.1073/pnas.0710157104; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; SUNDSTROM L, 1993, INSECT SOC, V40, P147, DOI 10.1007/BF01240703; TAUTZ J, 1994, ZOOL-ANAL COMPLEX SY, V98, P1; Theraulaz G, 2001, B MATH BIOL, V63, P1079, DOI 10.1006/bulm.2001.0260; TRANIELLO JFA, 1977, BEHAV ECOL SOCIOBIOL, V2, P61, DOI 10.1007/BF00299289; Vandermeer J, 2008, NATURE, V451, P457, DOI 10.1038/nature06477; Vick K, 2004, SOCIOBIOLOGY, V44, P505; VILELA EF, 1987, ANIM BEHAV, V35, P1443, DOI 10.1016/S0003-3472(87)80017-9; Wehner R, 2003, J COMP PHYSIOL A, V189, P579, DOI 10.1007/s00359-003-0431-1; WILSON EO, 1971, INSECT SOC, P560; Zar J. H., 1996, BIOSTATISTICAL ANAL	40	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5024	10.1371/journal.pone.0005024	http://dx.doi.org/10.1371/journal.pone.0005024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337369	Green Submitted, Green Published, gold			2022-12-27	WOS:000265500600009
J	Vitiello, C; Faraso, S; Sorrentino, NC; Di Salvo, G; Nusco, E; Nigro, G; Cutillo, L; Calabro, R; Auricchio, A; Nigro, V				Vitiello, Carmen; Faraso, Stefania; Sorrentino, Nicolina Cristina; Di Salvo, Giovanni; Nusco, Edoardo; Nigro, Gerardo; Cutillo, Luisa; Calabro, Raffaele; Auricchio, Alberto; Nigro, Vincenzo			Disease Rescue and Increased Lifespan in a Model of Cardiomyopathy and Muscular Dystrophy by Combined AAV Treatments	PLOS ONE			English	Article								Background: The BIO14.6 hamster is an excellent animal model for inherited cardiomyopathy, because of its lethal and well-documented course, due to a spontaneous deletion of delta-sarcoglycan gene promoter and first exon. The muscle disease is progressive and average lifespan is 11 months, because heart slowly dilates towards heart failure. Methodology/Principal Findings: Based on the ability of adeno-associated viral (AAV) vectors to transduce heart together with skeletal muscle following systemic administration, we delivered human delta-sarcoglycan cDNA into male BIO14.6 hamsters by testing different ages of injection, routes of administration and AAV serotypes. Body-wide restoration of delta-SG expression was associated with functional reconstitution of the sarcoglycan complex and with significant lowering of centralized nuclei and fibrosis in skeletal muscle. Motor ability and cardiac functions were completely rescued. However, BIO14.6 hamsters having less than 70% of fibers recovering sarcoglycan developed cardiomyopathy, even if the total rescued protein was normal. When we used serotype 2/8 in combination with serotype 2/1, lifespan was extended up to 22 months with sustained heart function improvement. Conclusions/Significance: Our data support multiple systemic administrations of AAV as a general therapeutic strategy for clinical trials in cardiomyopathies and muscle disorders.	[Vitiello, Carmen; Faraso, Stefania; Sorrentino, Nicolina Cristina; Nusco, Edoardo; Cutillo, Luisa; Auricchio, Alberto; Nigro, Vincenzo] Telethon Inst Genet & Med, Naples, Italy; [Di Salvo, Giovanni; Nigro, Gerardo; Calabro, Raffaele] Seconda Univ Studi Napoli, Dip Sci Cardiotorac Resp, AO Monaldi, Naples, Italy; [Auricchio, Alberto] Univ Federico II, Dip Pediat, Naples, Italy; [Nigro, Vincenzo] Seconda Univ Studi Napoli, Dip Patol Gen, Lab Genet Med, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli; University of Naples Federico II; Universita della Campania Vanvitelli	Vitiello, C (corresponding author), Telethon Inst Genet & Med, Naples, Italy.	vincenzo.nigro@unina2.it	AURICCHIO, Alberto/AHE-7979-2022; Sorrentino, Nicolina/AAB-1472-2020; Di Salvo, Giovanni/O-7033-2015; Nigro, Vincenzo/AAB-2274-2022	AURICCHIO, Alberto/0000-0002-0832-2472; Di Salvo, Giovanni/0000-0002-0305-0113; Nigro, Vincenzo/0000-0002-3378-5006; Sorrentino, Nicolina Cristina/0000-0002-3426-5109; Cutillo, Luisa/0000-0002-2205-0338; Calabro, Raffaele/0000-0001-9546-8914	Telethon (TIGEM-TNP42TELC); Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR) [2006061957_003]	Telethon (TIGEM-TNP42TELC)(Fondazione Telethon); Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants from Telethon (TIGEM-TNP42TELC), Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR: PRIN 2006 Prot.2006061957_003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocca M, 2008, J CLIN INVEST, V118, P1955, DOI 10.1172/JCI34316; Blankinship MJ, 2004, MOL THER, V10, P671, DOI 10.1016/j.ymthe.2004.07.016; Bostick B, 2008, CIRC RES, V102, P121, DOI 10.1161/CIRCRESAHA.107.162982; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chao HJ, 2000, MOL THER, V2, P619, DOI 10.1006/mthe.2000.0219; Chao HJ, 2001, MOL THER, V4, P217, DOI 10.1006/mthe.2001.0449; Choi VW, 2005, CURR GENE THER, V5, P299, DOI 10.2174/1566523054064968; Cohen N, 2004, HEART, V90, P835, DOI 10.1136/hrt.2003.023390; Do T, 2002, CURR OPIN PEDIATR, V14, P50, DOI 10.1097/00008480-200202000-00009; Duan DS, 2001, J VIROL, V75, P7662, DOI 10.1128/JVI.75.16.7662-7671.2001; Gao GP, 2000, HUM GENE THER, V11, P2079, DOI 10.1089/104303400750001390; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Heydemann A, 2007, HUM MOL GENET, V16, P355, DOI 10.1093/hmg/ddl453; Holt KH, 1998, MOL CELL, V1, P841, DOI 10.1016/S1097-2765(00)80083-0; HOMBURGER F, 1962, ARCH INTERN MED, V110, P660, DOI 10.1001/archinte.1962.03620230106015; Homburger F, 1979, Ann N Y Acad Sci, V317, P1, DOI 10.1111/j.1749-6632.1979.tb56503.x; Ikeda Y, 2002, CIRCULATION, V105, P502, DOI 10.1161/hc0402.102953; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Jiang HY, 2006, MOL THER, V14, P452, DOI 10.1016/j.ymthe.2006.05.004; Kobuke K, 2008, HUM MOL GENET, V17, P1201, DOI 10.1093/hmg/ddn009; Li J, 2003, GENE THER, V10, P1807, DOI 10.1038/sj.gt.3302078; Li XY, 1999, NAT BIOTECHNOL, V17, P241, DOI 10.1038/6981; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; Muntoni F, 2003, CURR OPIN NEUROL, V16, P577, DOI 10.1097/00019052-200310000-00003; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; NIGRO G, 1990, INT J CARDIOL, V26, P271, DOI 10.1016/0167-5273(90)90082-G; Nigro V, 1997, HUM MOL GENET, V6, P601, DOI 10.1093/hmg/6.4.601; Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; Pacak CA, 2006, CIRC RES, V99, pE3, DOI 10.1161/01.RES.0000237661.18885.f6; Politano L, 1996, JAMA-J AM MED ASSOC, V275, P1335, DOI 10.1001/jama.275.17.1335; RAGOT T, 1993, NATURE, V361, P647, DOI 10.1038/361647a0; Scott JM, 2002, NEUROMUSCULAR DISORD, V12, pS23, DOI 10.1016/S0960-8966(02)00078-0; Simonds AK, 2006, CHEST, V130, P1879, DOI 10.1378/chest.130.6.1879; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Zhu T, 2005, CIRCULATION, V112, P2650, DOI 10.1161/CIRCULATIONAHA.105.565598	39	19	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5051	10.1371/journal.pone.0005051	http://dx.doi.org/10.1371/journal.pone.0005051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333401	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499900013
J	Robert, F; Carrier, M; Rawe, S; Chen, S; Lowe, S; Pelletier, J				Robert, Francis; Carrier, Marilyn; Rawe, Svea; Chen, Samuel; Lowe, Scott; Pelletier, Jerry			Altering Chemosensitivity by Modulating Translation Elongation	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; C-MYC; CLINICAL-PHARMACOLOGY; MYELOID-LEUKEMIA; MESSENGER-RNAS; HUMAN BREAST; DIDEMNIN-B; CANCER; APOPTOSIS; INHIBITION	Background: The process of translation occurs at a nexus point downstream of a number of signal pathways and developmental processes. Modeling activation of the PTEN/AKT/mTOR pathway in the Em-Myc mouse is a valuable tool to study tumor genotype/chemosensitivity relationships in vivo. In this model, blocking translation initiation with silvestrol, an inhibitor of the ribosome recruitment step has been showed to modulate the sensitivity of the tumors to the effect of standard chemotherapy. However, inhibitors of translation elongation have been tested as potential anti-cancer therapeutic agents in vitro, but have not been extensively tested in genetically well-defined mouse tumor models or for potential synergy with standard of care agents. Methodology/Principal Findings: Here, we chose four structurally different chemical inhibitors of translation elongation: homoharringtonine, bruceantin, didemnin B and cycloheximide, and tested their ability to alter the chemoresistance of E mu-myc lymphomas harbouring lesions in Pten, Tsc2, Bcl-2, or elF4E. We show that in some genetic settings, translation elongation inhibitors are able to synergize with doxorubicin by reinstating an apoptotic program in tumor cells. We attribute this effect to a reduction in levels of pro-oncogenic or pro-survival proteins having short half-lives, like Mcl-1, cyclin D1 or c-Myc. Using lymphomas cells grown ex vivo we reproduced the synergy observed in mice between chemotherapy and elongation inhibition and show that this is reversed by blocking protein degradation with a proteasome inhibitor. Conclusion/Significance: Our results indicate that depleting short-lived pro-survival factors by inhibiting their synthesis could achieve a therapeutic response in tumors harboring PTEN/AKT/mTOR pathway mutations.			Robert, F (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	jerry.pelletier@mcgill.ca			NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; Alarcon-Vargas D, 2002, ONCOGENE, V21, P4384, DOI 10.1038/sj.onc.1205543; Bai JX, 2006, J PHARMACOL EXP THER, V319, P1435, DOI 10.1124/jpet.106.110007; Beasley VR, 2005, BIOPHARM DRUG DISPOS, V26, P341, DOI 10.1002/bdd.466; BENVENUTO JA, 1992, INVEST NEW DRUG, V10, P113, DOI 10.1007/BF00873128; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Budihardjo II, 2000, MOL PHARMACOL, V57, P529, DOI 10.1124/mol.57.3.529; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cuendet M, 2004, J NAT PROD, V67, P269, DOI 10.1021/np030304+; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; DUNCAN R, 1987, J BIOL CHEM, V262, P380; FONG KLL, 1982, CANCER CHEMOTH PHARM, V9, P169, DOI 10.1007/BF00257747; Freemantle SJ, 2007, J CELL BIOCHEM, V102, P869, DOI 10.1002/jcb.21519; FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x; FURUSAWA E, 1981, CHEMOTHERAPY, V27, P277, DOI 10.1159/000237992; Furusawa S, 1996, RES COMMUN MOL PATH, V91, P245; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HEYS SD, 1991, CLIN SCI, V80, P587, DOI 10.1042/cs0800587; HOFS HP, 1994, ANTI-CANCER DRUG, V5, P35, DOI 10.1097/00001813-199402000-00006; HROMAS R, 1983, CANCER RES, V43, P1135; HUANG MT, 1975, MOL PHARMACOL, V11, P511; KANO Y, 1991, LEUKEMIA RES, V15, P1059, DOI 10.1016/0145-2126(91)90112-7; Larsson O, 2006, NUCLEIC ACIDS RES, V34, P4375, DOI 10.1093/nar/gkl558; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Le Tourneau C, 2007, CURR PHARM DESIGN, V13, P3427; LIAO LL, 1976, MOL PHARMACOL, V12, P167; LU K, 1988, CANCER CHEMOTH PHARM, V21, P139; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; MERINO R, 1994, EMBO J, V13, P683, DOI 10.1002/j.1460-2075.1994.tb06307.x; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Novac O, 2004, NUCLEIC ACIDS RES, V32, P902, DOI 10.1093/nar/gkh235; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; Pelletier J, 2007, THERAPEUTIC OPPORTUN; Podar K, 2008, ONCOGENE, V27, P721, DOI 10.1038/sj.onc.1210679; Quintas-Cardama A, 2007, CANCER-AM CANCER SOC, V109, P248, DOI 10.1002/cncr.22398; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Raught B, 2000, COLD SPRING HARBOR M, V39, P245; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Sah NK, 2003, J BIOL CHEM, V278, P20593, DOI 10.1074/jbc.M211010200; SAKAI T, 1989, CANCER RES, V49, P1193; SAVARAJ N, 1986, CANCER TREAT REP, V70, P1403; Schmitt CA, 2002, J MOL MED-JMM, V80, P137, DOI 10.1007/s00109-001-0293-3; Schubert KM, 2001, BIOCHEM J, V356, P473, DOI 10.1042/0264-6021:3560473; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smukste I, 2006, CANCER CELL, V9, P133, DOI 10.1016/j.ccr.2006.01.012; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Tang RP, 2006, MOL CANCER THER, V5, P723, DOI 10.1158/1535-7163.MCT-05-0164; THAKKAR NS, 1992, BIOCHEM PHARMACOL, V43, P1683, DOI 10.1016/0006-2952(92)90697-H; TUJEBAJEVA RM, 1992, BIOCHIM BIOPHYS ACTA, V1129, P177, DOI 10.1016/0167-4781(92)90484-H; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wendel HG, 2006, CANCER RES, V66, P7639, DOI 10.1158/0008-5472.CAN-06-0419; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; WILLINGHAM W, 1981, BIOCHIM BIOPHYS ACTA, V654, P169, DOI 10.1016/0005-2787(81)90168-4; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; ZYLICZ Z, 1987, J NATL CANCER I, V78, P701	64	73	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5428	10.1371/journal.pone.0005428	http://dx.doi.org/10.1371/journal.pone.0005428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412536	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000265688200014
J	Torosantucci, A; Chiani, P; Bromuro, C; De Bernardis, F; Palma, AS; Liu, Y; Mignogna, G; Maras, B; Colone, M; Stringaro, A; Zamboni, S; Feizi, T; Cassone, A				Torosantucci, Antonella; Chiani, Paola; Bromuro, Carla; De Bernardis, Flavia; Palma, Angelina S.; Liu, Yan; Mignogna, Giuseppina; Maras, Bruno; Colone, Marisa; Stringaro, Annarita; Zamboni, Silvia; Feizi, Ten; Cassone, Antonio			Protection by Anti-beta-Glucan Antibodies Is Associated with Restricted beta-1,3 Glucan Binding Specificity and Inhibition of Fungal Growth and Adherence	PLOS ONE			English	Article								Anti-beta-glucan antibodies elicited by a laminarin-conjugate vaccine confer cross-protection to mice challenged with major fungal pathogens such as Candida albicans, Aspergillus fumigatus and Cryptococcus neoformans. To gain insights into protective beta-glucan epitope(s) and protection mechanisms, we studied two anti-beta-glucan monoclonal antibodies (mAb) with identical complementarity-determining regions but different isotypes (mAb 2G8, IgG2b and mAb 1E12, IgM). C. albicans, the most relevant fungal pathogen for humans, was used as a model. Both mAbs bound to fungal cell surface and to the beta 1,3-beta 1,6 glucan of the fungal cell wall skeleton, as shown by immunofluorescence, electron-microscopy and ELISA. They were also equally unable to opsonize fungal cells in a J774 macrophage phagocytosis and killing assay. However, only the IgG2b conferred substantial protection against mucosal and systemic candidiasis in passive vaccination experiments in rodents. Competition ELISA and microarray analyses using sequence-defined glucan oligosaccharides showed that the protective IgG2b selectively bound to beta 1,3-linked (laminarin-like) glucose sequences whereas the nonprotective IgM bound to beta 1,6- and beta 1,4-linked glucose sequences in addition to beta 1,3-linked ones. Only the protective IgG2b recognized heterogeneous, polydisperse high molecular weight cell wall and secretory components of the fungus, two of which were identified as the GPI-anchored cell wall proteins Als3 and Hyr1. In addition, only the IgG2b inhibited in vitro two critical virulence attributes of the fungus, hyphal growth and adherence to human epithelial cells. Our study demonstrates that the isotype of anti-beta-glucan antibodies may affect details of the beta-glucan epitopes recognized, and this may be associated with a differing ability to inhibit virulence attributes of the fungus and confer protection in vivo. Our data also suggest that the anti-virulence properties of the IgG2b mAb may be linked to its capacity to recognize beta-glucan epitope(s) on some cell wall components that exert critical functions in fungal cell wall structure and adherence to host cells.			Torosantucci, A (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	antonio.cassone@iss.it	Maras, Bruno/A-2020-2010; Cassone, Antonio/J-4666-2019; BROMURO, CARLA/C-9591-2016; STRINGARO, ANNARITA/E-9092-2015; /AAQ-2983-2020; Liu, Yan/D-9117-2013; Palma, Angelina S/D-2052-2013; DE BERNARDIS, FLAVIA/C-9589-2016; COLONE, MARISA/E-9089-2015; Chiani, Paola/AAC-4436-2021; Mignogna, Giuseppina/A-2126-2010; TOROSANTUCCI, ANTONELLA/C-9594-2016	BROMURO, CARLA/0000-0002-5668-9009; STRINGARO, ANNARITA/0000-0002-0143-2978; Palma, Angelina S/0000-0001-5797-6555; DE BERNARDIS, FLAVIA/0000-0001-9440-8629; COLONE, MARISA/0000-0002-7522-7483; Chiani, Paola/0000-0001-9836-3579; TOROSANTUCCI, ANTONELLA/0000-0002-0074-4486; Mignogna, Giuseppina/0000-0001-9238-132X; Feizi, Ten/0000-0001-6495-0329	Engineering and Physical Sciences Research Council [GR/S79268/02] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Bailey DA, 1996, J BACTERIOL, V178, P5353, DOI 10.1128/jb.178.18.5353-5360.1996; Bodey GP, 2005, CLIN INFECT DIS, V40, pS239, DOI 10.1086/427328; Brena S, 2007, INFECT IMMUN, V75, P3680, DOI 10.1128/IAI.01840-06; Bromuro C, 2002, INFECT IMMUN, V70, P5462, DOI 10.1128/IAI.70.10.5462-5470.2002; Casadevall A, 2002, CURR OPIN MICROBIOL, V5, P386, DOI 10.1016/S1369-5274(02)00337-5; Cassone A, 1997, J LEUKOCYTE BIOL, V62, P60, DOI 10.1002/jlb.62.1.60; CASSONE A, 1988, J MED MICROBIOL, V27, P233, DOI 10.1099/00222615-27-4-233; Cassone A, 2005, CURR MOL MED, V5, P377, DOI 10.2174/1566524054022549; Cassone A, 2008, LANCET INFECT DIS, V8, P114, DOI 10.1016/S1473-3099(08)70016-1; Chaturvedi AK, 2005, CLIN DIAGN LAB IMMUN, V12, P1063, DOI 10.1128/CDLI.12.9.1063-1068.2005; COOPER LJN, 1993, J IMMUNOL, V150, P2231; Cutler JE, 2005, CURR MOL MED, V5, P383, DOI 10.2174/1566524054022576; Cutler JE, 2007, NAT REV MICROBIOL, V5, P13, DOI 10.1038/nrmicro1537; Datta K, 2008, CLIN VACCINE IMMUNOL, V15, P1176, DOI 10.1128/CVI.00130-08; De Bernardis F, 2002, INFECT IMMUN, V70, P2725, DOI 10.1128/IAI.70.5.2725-2729.2002; De Bernardis F, 2007, J INFECT DIS, V195, P149, DOI 10.1086/509891; De Groot PWJ, 2005, FUNGAL GENET BIOL, V42, P657, DOI 10.1016/j.fgb.2005.04.002; Deepe George S Jr, 2004, Expert Rev Vaccines, V3, P701, DOI 10.1586/14760584.3.6.701; DELACRUZ J, 1995, J BACTERIOL, V177, P1864, DOI 10.1128/jb.177.7.1864-1871.1995; Enoch DA, 2006, J MED MICROBIOL, V55, P809, DOI 10.1099/jmm.0.46548-0; Fernandez-Arenas E, 2007, MOL CELL PROTEOMICS, V6, P460, DOI 10.1074/mcp.M600210-MCP200; Fleuridor R, 2001, J IMMUNOL, V166, P1087, DOI 10.4049/jimmunol.166.2.1087; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Fu Y, 2008, EUKARYOT CELL, V7, P483, DOI 10.1128/EC.00445-07; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Garcia-Sanchez S, 2005, MOL BIOL CELL, V16, P2913, DOI 10.1091/mbc.E05-01-0071; Gomez MJ, 1996, INFECT IMMUN, V64, P2577, DOI 10.1128/IAI.64.7.2577-2584.1996; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Han Y, 1999, J INFECT DIS, V179, P1477, DOI 10.1086/314779; Han YM, 1998, INFECT IMMUN, V66, P5771, DOI 10.1128/IAI.66.12.5771-5776.1998; Heinsbroek SEM, 2005, TRENDS IMMUNOL, V26, P352, DOI 10.1016/j.it.2005.05.005; Herre J, 2004, CRIT REV IMMUNOL, V24, P193, DOI 10.1615/CritRevImmunol.v24.i3.30; Hoyer LL, 2001, GENETICS, V157, P1555; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Iorio E, 2008, CARBOHYD RES, V343, P1050, DOI 10.1016/j.carres.2008.02.020; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Kapteyn JC, 2000, MOL MICROBIOL, V35, P601, DOI 10.1046/j.1365-2958.2000.01729.x; KAPTEYN JC, 1995, J BACTERIOL, V177, P3788, DOI 10.1128/jb.177.13.3788-3792.1995; Kapteyn JC, 1999, BBA-GEN SUBJECTS, V1426, P373, DOI 10.1016/S0304-4165(98)00137-8; Kedzierska A, 2007, EUR J CLIN MICROBIOL, V26, P755, DOI 10.1007/s10096-007-0373-6; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; Larsen RA, 2005, ANTIMICROB AGENTS CH, V49, P952, DOI 10.1128/AAC.49.3.952-958.2005; Lavigne LM, 2006, J IMMUNOL, V177, P8667, DOI 10.4049/jimmunol.177.12.8667; Lee SA, 2003, YEAST, V20, P595, DOI 10.1002/yea.988; Liu Y, 2007, CHEM BIOL, V14, P847, DOI 10.1016/j.chembiol.2007.06.009; Magliani W, 2005, NEW MICROBIOL, V28, P299; Magliani W, 2005, CURR MOL MED, V5, P443, DOI 10.2174/1566524054022558; Martinez-Esparza M, 2006, J IMMUNOL METHODS, V314, P90, DOI 10.1016/j.jim.2006.06.004; Maschmeyer G, 2006, INT J ANTIMICROB AG, V27, pS3, DOI 10.1016/j.ijantimicag.2006.03.006; Matthews RC, 2004, VACCINE, V22, P865, DOI 10.1016/j.vaccine.2003.11.032; Matthews RC, 2003, ANTIMICROB AGENTS CH, V47, P2208, DOI 10.1128/AAC.47.7.2208-2216.2003; McCloskey N, 1996, IMMUNOLOGY, V88, P169, DOI 10.1111/j.1365-2567.1996.tb00001.x; McFadden DC, 2004, J IMMUNOL, V172, P3670, DOI 10.4049/jimmunol.172.6.3670; MUKHERJEE J, 1995, J EXP MED, V181, P405, DOI 10.1084/jem.181.1.405; MUKHERJEE J, 1992, INFECT IMMUN, V60, P4534, DOI 10.1128/IAI.60.11.4534-4541.1992; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Nett J, 2007, ANTIMICROB AGENTS CH, V51, P510, DOI 10.1128/AAC.01056-06; Nisini R, 2007, J LEUKOCYTE BIOL, V82, P1136, DOI 10.1189/jlb.0307160; Nobile CJ, 2008, CURR BIOL, V18, P1017, DOI 10.1016/j.cub.2008.06.034; Oh SH, 2005, MICROBIOL-SGM, V151, P673, DOI 10.1099/mic.0.27680-0; Pachl J, 2006, CLIN INFECT DIS, V42, P1404, DOI 10.1086/503428; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Pirofski LA, 2001, TRENDS MICROBIOL, V9, P445, DOI 10.1016/S0966-842X(01)02134-5; Rachini A, 2007, INFECT IMMUN, V75, P5085, DOI 10.1128/IAI.00278-07; Read SM, 1996, CARBOHYD RES, V281, P187, DOI 10.1016/0008-6215(95)00350-9; Richard ML, 2007, EUKARYOT CELL, V6, P119, DOI 10.1128/EC.00297-06; Richardson M, 2005, CANCER CHEMOTH PHARM, V56, P1, DOI 10.1007/s00280-004-0955-2; Rodrigues ML, 2007, CLIN VACCINE IMMUNOL, V14, P1372, DOI 10.1128/CVI.00202-07; Romagnoli G, 2004, J LEUKOCYTE BIOL, V75, P117, DOI 10.1189/jlb.0503226; Sevilla MJ, 2006, INFECT IMMUN, V74, P3042, DOI 10.1128/IAI.74.5.3042-3045.2006; Sheppard DC, 2004, J BIOL CHEM, V279, P30480, DOI 10.1074/jbc.M401929200; Shoham S, 2005, BRIT J HAEMATOL, V129, P569, DOI 10.1111/j.1365-2141.2005.05397.x; Spellberg BJ, 2006, J INFECT DIS, V194, P256, DOI 10.1086/504691; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Tarcha EJ, 2006, INFECT IMMUN, V74, P516, DOI 10.1128/IAI.74.1.516-527.2006; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; TOROSANTUCCI A, 1990, J GEN MICROBIOL, V136, P2155, DOI 10.1099/00221287-136-11-2155; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; Torosantucci A, 2000, J LEUKOCYTE BIOL, V68, P923; Torres M, 2005, J IMMUNOL, V174, P2132, DOI 10.4049/jimmunol.174.4.2132; Torres M, 2008, TRENDS IMMUNOL, V29, P91, DOI 10.1016/j.it.2007.11.004; Vilanova M, 2004, IMMUNOLOGY, V111, P334, DOI 10.1111/j.1365-2567.2004.01819.x; Warnock DW, 2006, MED MYCOL, V44, P697, DOI 10.1080/13693780601009493; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Xin H, 2008, P NATL ACAD SCI USA, V105, P13526, DOI 10.1073/pnas.0803195105; Yuan RR, 1998, INFECT IMMUN, V66, P1057, DOI 10.1128/IAI.66.3.1057-1062.1998; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0	92	158	168	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5392	10.1371/journal.pone.0005392	http://dx.doi.org/10.1371/journal.pone.0005392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399183	Green Submitted, gold, Green Published			2022-12-27	WOS:000265514900024
J	Corcoran, DL; Pandit, KV; Gordon, B; Bhattacharjee, A; Kaminski, N; Benos, PV				Corcoran, David L.; Pandit, Kusum V.; Gordon, Ben; Bhattacharjee, Arindam; Kaminski, Naftali; Benos, Panayiotis V.			Features of Mammalian microRNA Promoters Emerge from Polymerase II Chromatin Immunoprecipitation Data	PLOS ONE			English	Article								Background: MicroRNAs (miRNAs) are short, non-coding RNA regulators of protein coding genes. miRNAs play a very important role in diverse biological processes and various diseases. Many algorithms are able to predict miRNA genes and their targets, but their transcription regulation is still under investigation. It is generally believed that intragenic miRNAs (located in introns or exons of protein coding genes) are co-transcribed with their host genes and most intergenic miRNAs transcribed from their own RNA polymerase II (Pol II) promoter. However, the length of the primary transcripts and promoter organization is currently unknown. Methodology: We performed Pol II chromatin immunoprecipitation (ChIP)-chip using a custom array surrounding regions of known miRNA genes. To identify the true core transcription start sites of the miRNA genes we developed a new tool (CPPP). We showed that miRNA genes can be transcribed from promoters located several kilobases away and that their promoters share the same general features as those of protein coding genes. Finally, we found evidence that as many as 26% of the intragenic miRNAs may be transcribed from their own unique promoters. Conclusion: miRNA promoters have similar features to those of protein coding genes, but miRNA transcript organization is more complex.			Corcoran, DL (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA.	kaminx@upmc.edu; benos@pitt.edu	; Pandit, Kusum/E-7265-2018	Kaminski, Naftali/0000-0001-5917-4601; Benos, Panayiotis/0000-0003-3172-3132; Corcoran, David/0000-0001-7460-9247; Pandit, Kusum/0000-0001-7458-4705	NIAID NIH HHS [N01AI50018] Funding Source: Medline; NLM NIH HHS [R01 LM009657, 1R01LM009657] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [R01LM009657] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Abeel T, 2008, GENOME RES, V18, P310, DOI 10.1101/gr.6991408; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bird A, 1999, SCIENCE, V286, P2287, DOI 10.1126/science.286.5448.2287; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Bussemaker HJ, 2000, P NATL ACAD SCI USA, V97, P10096, DOI 10.1073/pnas.180265397; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chapelle O, 1999, IEEE T NEURAL NETWOR, V10, P1055, DOI 10.1109/72.788646; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Corcoran DL, 2005, GENOME RES, V15, P840, DOI 10.1101/gr.2952005; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Gangal R, 2005, NUCLEIC ACIDS RES, V33, P1332, DOI 10.1093/nar/gki271; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Mahony S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r84; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Megraw M, 2006, RNA, V12, P1612, DOI 10.1261/rna.130506; Ohler U, 2001, Bioinformatics, V17 Suppl 1, pS199; Ohler U, 2006, NUCLEIC ACIDS RES, V34, P5943, DOI 10.1093/nar/gkl608; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; PRESTRIDGE DS, 1993, HUM MOL GENET, V2, P1449, DOI 10.1093/hmg/2.9.1449; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Sandelin A, 2004, J MOL BIOL, V338, P207, DOI 10.1016/j.jmb.2004.02.048; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Schmid CD, 2006, NUCLEIC ACIDS RES, V34, pD82, DOI 10.1093/nar/gkj146; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Wang T, 2005, P NATL ACAD SCI USA, V102, P17400, DOI 10.1073/pnas.0505147102; WINGENDER E, 2004, IN SILICO BIOL, V4, P55; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Zhao XY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r17; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	53	215	229	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5279	10.1371/journal.pone.0005279	http://dx.doi.org/10.1371/journal.pone.0005279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390574	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000265514200009
J	Koziel, J; Maciag-Gudowska, A; Mikolajczyk, T; Bzowska, M; Sturdevant, DE; Whitney, AR; Shaw, LN; Deleo, FR; Potempa, J				Koziel, Joanna; Maciag-Gudowska, Agnieszka; Mikolajczyk, Tomasz; Bzowska, Malgorzata; Sturdevant, Daniel E.; Whitney, Adeline R.; Shaw, Lindsey N.; DeLeo, Frank R.; Potempa, Jan			Phagocytosis of Staphylococcus aureus by Macrophages Exerts Cytoprotective Effects Manifested by the Upregulation of Antiapoptotic Factors	PLOS ONE			English	Article							NF-KAPPA-B; PROGRAMMED CELL-DEATH; BCL-2 FAMILY-MEMBER; INTRACELLULAR REPLICATION; CHLAMYDIA-PNEUMONIAE; HEMATOPOIETIC-CELLS; HUMAN NEUTROPHILS; APOPTOSIS; SURVIVAL; EXPRESSION	It is becoming increasingly apparent that Staphylococcus aureus are able to survive engulfment by macrophages, and that the intracellular environment of these host cells, which is essential to innate host defenses against invading microorganisms, may in fact provide a refuge for staphylococcal survival and dissemination. Based on this, we postulated that S. aureus might induce cytoprotective mechanisms by changing gene expression profiles inside macrophages similar to obligate intracellular pathogens, such as Mycobacterium tuberculosis. To validate our hypothesis we first ascertained whether S. aureus infection could affect programmed cell death in human (hMDMs) and mouse (RAW 264.7) macrophages and, specifically, protect these cells against apoptosis. Our findings indicate that S. aureus-infected macrophages are more resistant to staurosporine-induced cell death than control cells, an effect partly mediated via the inhibition of cytochrome c release from mitochondria. Furthermore, transcriptome analysis of human monocyte-derived macrophages during S. aureus infection revealed a significant increase in the expression of antiapoptotic genes. This was confirmed by quantitative RT-PCR analysis of selected genes involved in mitochondria-dependent cell death, clearly showing overexpression of BCL2 and MCL1. Cumulatively, the results of our experiments argue that S. aureus is able to induce a cytoprotective effect in macrophages derived from different mammal species, which can prevent host cell elimination, and thus allow intracellular bacterial survival. Ultimately, it is our contention that this process may contribute to the systemic dissemination of S. aureus infection.			Koziel, J (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland.	kaniajoanna@gmail.com	Potempa, Jan/AAA-6850-2021; Mikolajczyk, Tomasz/AFQ-2278-2022; Bzowska, Małgorzata/A-6947-2019; Shaw, Lindsey/AAI-1741-2020	Mikolajczyk, Tomasz/0000-0002-7990-2896; Shaw, Lindsey/0000-0002-0629-8990; Potempa, Jan/0000-0002-3600-7461; DeLeo, Frank/0000-0003-3150-2516	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001079, ZIAAI001079, Z01AI000900, ZIAAI000900] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abu-Zant A, 2005, INFECT IMMUN, V73, P5339, DOI 10.1128/IAI.73.9.5339-5349.2005; Akarid K, 2004, J LEUKOCYTE BIOL, V76, P95, DOI 10.1189/jlb.1001877; AMEISEN JC, 1994, IMMUNOL REV, V142, P9, DOI 10.1111/j.1600-065X.1994.tb00882.x; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Baran J, 1996, INFECT IMMUN, V64, P4242, DOI 10.1128/IAI.64.10.4242-4248.1996; Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; Bender LM, 2005, CELL DEATH DIFFER, V12, P473, DOI 10.1038/sj.cdd.4401578; Bernal-Mizrachi L, 2006, P NATL ACAD SCI USA, V103, P9220, DOI 10.1073/pnas.0507809103; Binnicker MJ, 2004, INFECT IMMUN, V72, P6408, DOI 10.1128/IAI.72.11.6408-6417.2004; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Droin N, 1998, ONCOGENE, V16, P2885, DOI 10.1038/sj.onc.1201821; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Fischer SF, 2001, INFECT IMMUN, V69, P7121, DOI 10.1128/IAI.69.11.7121-7129.2001; Freeman SN, 2008, J BIOL CHEM, V283, P2353, DOI 10.1074/jbc.M705986200; Fujisawa A, 2007, BLOOD, V109, P2903, DOI 10.1182/blood-2006-07-033597; Goepel F, 2004, J LEUKOCYTE BIOL, V75, P836, DOI 10.1189/jlb.0703317; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hacker G, 2006, MED MICROBIOL IMMUN, V195, P11, DOI 10.1007/s00430-005-0239-4; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Hiroi M, 1998, ANTICANCER RES, V18, P3475; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Hu XL, 1998, BLOOD, V92, P2759, DOI 10.1182/blood.V92.8.2759.420k29_2759_2765; Hudson MC, 1995, MICROB PATHOGENESIS, V19, P409, DOI 10.1006/mpat.1995.0075; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Joshi SG, 2004, FEMS MICROBIOL LETT, V234, P333, DOI 10.1016/j.femsle.2004.03.046; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; KATOH O, 1995, CANCER RES, V55, P5687; Keita M, 2007, BIOCHEM BIOPH RES CO, V361, P481, DOI 10.1016/j.bbrc.2007.07.048; Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; Lee NK, 2002, J BIOCHEM MOL BIOL, V35, P61; Lee SY, 2007, INFECT IMMUN, V75, P1291, DOI 10.1128/IAI.01700-06; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Linares J, 2001, CLIN MICROBIOL INFEC, V7, P8, DOI 10.1046/j.1469-0691.2001.00054.x; Liu HT, 2001, J EXP MED, V194, P113, DOI 10.1084/jem.194.2.113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotz S, 2004, J LEUKOCYTE BIOL, V75, P467, DOI 10.1189/jlb.0803360; Lowy FD, 2000, TRENDS MICROBIOL, V8, P341, DOI 10.1016/S0966-842X(00)01803-5; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lundqvist-Gustafsson H, 2001, J LEUKOCYTE BIOL, V70, P642; MANGAN DF, 1991, J IMMUNOL, V146, P1541; Menzies BE, 1998, INFECT IMMUN, V66, P5994, DOI 10.1128/IAI.66.12.5994-5998.1998; Monack DM, 2001, MICROBES INFECT, V3, P1201, DOI 10.1016/S1286-4579(01)01480-0; Nakhjiri SF, 2001, FEMS MICROBIOL LETT, V200, P145, DOI 10.1111/j.1574-6968.2001.tb10706.x; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Okuda J, 2006, MICROB PATHOGENESIS, V41, P226, DOI 10.1016/j.micpath.2006.08.002; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Rebollo A, 2000, MOL CELL BIOL, V20, P3407, DOI 10.1128/MCB.20.10.3407-3416.2000; ROGERS DE, 1952, J EXP MED, V95, P209, DOI 10.1084/jem.95.2.209; Shikama Y, 2003, EUR J IMMUNOL, V33, P1998, DOI 10.1002/eji.200324013; Shirin H, 2000, INFECT IMMUN, V68, P5321, DOI 10.1128/IAI.68.9.5321-5328.2000; Sly LM, 2003, J IMMUNOL, V170, P430, DOI 10.4049/jimmunol.170.1.430; Smagur J, 2009, J INNATE IMMUN, V1, P98, DOI 10.1159/000181014; TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Wahl C, 2001, INFECT IMMUN, V69, P7039, DOI 10.1128/IAI.69.11.7039-7045.2001; Wajant H, 2003, ESSAYS BIOCHEM, V39, P53, DOI 10.1042/bse0390053; Weil M, 1996, J CELL BIOL, V133, P1053, DOI 10.1083/jcb.133.5.1053; Williams G T, 1994, Trends Microbiol, V2, P463, DOI 10.1016/0966-842X(94)90648-3; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang T, 1996, J CELL PHYSIOL, V166, P523, DOI 10.1002/(SICI)1097-4652(199603)166:3<523::AID-JCP7>3.0.CO;2-R; Ying SM, 2005, INFECT IMMUN, V73, P1399, DOI 10.1128/IAI.73.3.1399-1403.2005; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	72	116	121	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5210	10.1371/journal.pone.0005210	http://dx.doi.org/10.1371/journal.pone.0005210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381294	Green Submitted, Green Published, gold			2022-12-27	WOS:000265513800004
J	Barnabe, GF; Schwindt, TT; Calcagnotto, ME; Motta, FL; Martinez, GJ; Oliveira, AC; Keim, LMN; D'Almeida, V; Mendez-Otero, R; Mello, LE				Barnabe, Gabriela F.; Schwindt, Telma T.; Calcagnotto, Maria E.; Motta, Fabiana L.; Martinez, Gilberto Jr.; de Oliveira, Allan C.; Keim, Leda M. N.; D'Almeida, Vania; Mendez-Otero, Rosalia; Mello, Luiz E.			Chemically-Induced RAT Mesenchymal Stem Cells Adopt Molecular Properties of Neuronal-Like Cells but Do Not Have Basic Neuronal Functional Properties	PLOS ONE			English	Article								Induction of adult rat bone marrow mesenchymal stem cells (MSC) by means of chemical compounds (beta-mercaptoethanol, dimethyl sulfoxide and butylated hydroxyanizole) has been proposed to lead to neuronal transdifferentiation, and this protocol has been broadly used by several laboratories worldwide. Only a few hours of MSC chemical induction using this protocol is sufficient for the acquisition of neuronal-like morphology and neuronal protein expression. However, given that cell death is abundant, we hypothesize that, rather than true neuronal differentiation, this particular protocol leads to cellular toxic effects. We confirm that the induced cells with neuronal-like morphology positively stained for NF-200, S100, beta-tubulin III, NSE and MAP-2 proteins. However, the morphological and molecular changes after chemical induction are also associated with an increase in the apoptosis of over 50% of the plated cells after 24 h. Moreover, increased intracellular cysteine after treatment indicates an impairment of redox circuitry during chemical induction, and in vitro electrophysiological recordings (patch-clamp) of the chemically induced MSC did not indicate neuronal properties as these cells do not exhibit Na+ or K+ currents and do not fire action potentials. Our findings suggest that a disruption of redox circuitry plays an important role in this specific chemical induction protocol, which might result in cytoskeletal alterations and loss of functional ion-gated channels followed by cell death. Despite the neuronal-like morphology and neural protein expression, induced rat bone marrow MSC do not have basic functional neuronal properties, although it is still plausible that other methods of induction and/or sources of MSC can achieve a successful neuronal differentiation in vitro.			Barnabe, GF (corresponding author), Univ Fed Sao Paulo, Dept Fisiol, Sao Paulo, Brazil.	lemello@unifesp.br	D'Almeida, Vânia/B-5092-2011; calcagnotto, maria elisa/B-1645-2013; Mendez-Otero, Rosalia/AAL-7551-2020; Mello, Luiz E/B-4177-2009; CALCAGNOTTO, MARIA ELISA/AAU-7718-2020; D'Almeida, Vânia/AAV-3955-2020; D'Almeida, Vania/AAB-7115-2020; Barnabe, Gabriela/E-9033-2013; de Oliveira, Allan/B-1871-2013	D'Almeida, Vânia/0000-0003-0947-5312; calcagnotto, maria elisa/0000-0001-8196-0596; Mendez-Otero, Rosalia/0000-0002-1798-9930; Mello, Luiz E/0000-0002-6969-1108; CALCAGNOTTO, MARIA ELISA/0000-0001-8196-0596; D'Almeida, Vânia/0000-0003-0947-5312; Barnabe, Gabriela/0000-0001-8790-4480; Motta, Fabiana/0000-0003-2230-995X; Neumann Keim, Leda Maria/0000-0002-5483-8808				Abouelfetouh A, 2004, BRAIN RES, V1029, P114, DOI 10.1016/j.brainres.2004.07.092; ALEXANIAN AR, 2008, STEM CELLS DEV; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bae JS, 2007, STEM CELLS, V25, P1307, DOI 10.1634/stemcells.2006-0561; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bonilla S, 2005, NEUROSCIENCE, V133, P85, DOI 10.1016/j.neuroscience.2005.02.019; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Bossolasco P, 2005, EXP NEUROL, V193, P312, DOI 10.1016/j.expneurol.2004.12.013; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Corti S, 2002, EXP NEUROL, V177, P443, DOI 10.1006/exnr.2002.8004; Croft AP, 2006, STEM CELLS, V24, P1841, DOI 10.1634/stemcells.2005-0609; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Goodwin PA, 1998, J PHARMACOL TOXICOL, V39, P229, DOI 10.1016/S1056-8719(98)00029-X; Goolsby J, 2003, P NATL ACAD SCI USA, V100, P14926, DOI 10.1073/pnas.2434383100; Gurok U, 2004, J NEUROSCI, V24, P5982, DOI 10.1523/JNEUROSCI.0809-04.2004; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hool LC, 2007, ANTIOXID REDOX SIGN, V9, P409, DOI 10.1089/ars.2006.1446; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Jin KL, 2003, EXP NEUROL, V184, P78, DOI 10.1016/S0014-4886(03)00133-X; Jones DP, 2004, FASEB J, V18, P1246, DOI 10.1096/fj.03-0971fje; Kabos P, 2002, EXP NEUROL, V178, P288, DOI 10.1006/exnr.2002.8039; Kelly CM, 2005, BRAIN RES BULL, V68, P83, DOI 10.1016/j.brainresbull.2005.08.020; Kohyama J, 2001, DIFFERENTIATION, V68, P235, DOI 10.1046/j.1432-0436.2001.680411.x; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Krampera M, 2007, BONE, V40, P382, DOI 10.1016/j.bone.2006.09.006; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lang F, 2007, ARCH BIOCHEM BIOPHYS, V462, P189, DOI 10.1016/j.abb.2006.12.028; Laterza OF, 2006, CLIN CHEM, V52, P1713, DOI 10.1373/clinchem.2006.070912; Li GR, 2006, STEM CELLS, V24, P1519, DOI 10.1634/stemcells.2005-0307; Liu YP, 2002, CLIN EXP PHARMACOL P, V29, P305, DOI 10.1046/j.1440-1681.2002.03649.x; Lu P, 2005, EXP NEUROL, V193, P273, DOI 10.1016/j.expneurol.2005.01.031; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Martin D, 2003, J BIOL CHEM, V278, P53082, DOI 10.1074/jbc.M306861200; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; Munoz-Elias G, 2003, STEM CELLS, V21, P437, DOI 10.1634/stemcells.21-4-437; Munoz-Elias G, 2004, J NEUROSCI, V24, P4585, DOI 10.1523/JNEUROSCI.5060-03.2004; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Pfeiffer CM, 1999, CLIN CHEM, V45, P290; Ratajczak MZ, 2004, LEUKEMIA, V18, P29, DOI 10.1038/sj.leu.2403184; Rismanchi N, 2003, BRAIN RES, V991, P46, DOI 10.1016/j.brainres.2003.07.004; SAGARA JI, 2007, NEUROCHEM RES; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Scintu F, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-14; Suzuki H, 2004, BIOCHEM BIOPH RES CO, V322, P918, DOI 10.1016/j.bbrc.2004.07.201; Svendsen CN, 1999, BRAIN PATHOL, V9, P499, DOI 10.1111/j.1750-3639.1999.tb00538.x; Taschenberger H, 2005, J PHYSIOL-LONDON, V568, P513, DOI 10.1113/jphysiol.2005.093468; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; WATANABE M, 1990, DEV BRAIN RES, V53, P89, DOI 10.1016/0165-3806(90)90127-K; Wenisch S, 2006, BONE, V38, P911, DOI 10.1016/j.bone.2005.10.021; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zhao L, 2007, CELL BIOL INT, V31, P916, DOI 10.1016/j.cellbi.2007.02.006	58	61	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5222	10.1371/journal.pone.0005222	http://dx.doi.org/10.1371/journal.pone.0005222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370156	Green Submitted, Green Published, gold			2022-12-27	WOS:000265510600005
J	Alvarez, G; Ceballos, FC; Quinteiro, C				Alvarez, Gonzalo; Ceballos, Francisco C.; Quinteiro, Celsa			The Role of Inbreeding in the Extinction of a European Royal Dynasty	PLOS ONE			English	Article							RENAL TUBULAR-ACIDOSIS; MUTATIONS	The kings of the Spanish Habsburg dynasty (1516-1700) frequently married close relatives in such a way that uncle-niece, first cousins and other consanguineous unions were prevalent in that dynasty. In the historical literature, it has been suggested that inbreeding was a major cause responsible for the extinction of the dynasty when the king Charles II, physically and mentally disabled, died in 1700 and no children were born from his two marriages, but this hypothesis has not been examined from a genetic perspective. In this article, this hypothesis is checked by computing the inbreeding coefficient (F) of the Spanish Habsburg kings from an extended pedigree up to 16 generations in depth and involving more than 3,000 individuals. The inbreeding coefficient of the Spanish Habsburg kings increased strongly along generations from 0.025 for king Philip I, the founder of the dynasty, to 0.254 for Charles II and several members of the dynasty had inbreeding coefficients higher than 0.20. In addition to inbreeding due to unions between close relatives, ancestral inbreeding from multiple remote ancestors makes a substantial contribution to the inbreeding coefficient of most kings. A statistically significant inbreeding depression for survival to 10 years is detected in the progenies of the Spanish Habsburg kings. The results indicate that inbreeding at the level of first cousin (F = 0.0625) exerted an adverse effect on survival of 17.8% +/- 12.3. It is speculated that the simultaneous occurrence in Charles II (F = 0.254) of two different genetic disorders: combined pituitary hormone deficiency and distal renal tubular acidosis, determined by recessive alleles at two unlinked loci, could explain most of the complex clinical profile of this king, including his impotence/infertility which in last instance led to the extinction of the dynasty.			Alvarez, G (corresponding author), Univ Santiago de Compostela, Fac Biol, Dept Genet, La Coruna, Spain.	g.alvarez@usc.es	Ceballos, Francisco/ABG-3183-2020; Ceballos, Francisco C./C-6116-2011	Ceballos, Francisco C./0000-0001-7113-7387				Agarwal G, 2000, J CLIN ENDOCR METAB, V85, P4556, DOI 10.1210/jc.85.12.4556; ALVAREZ VA, 2002, HISTORIA UNIVERSAL E; BENNASSAR B, 2000, ESPAN AUSTRIAS 1516; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x; BITTLES AH, 1994, NAT GENET, V8, P117, DOI 10.1038/ng1094-117; BITTLES AH, 1991, SCIENCE, V252, P789, DOI 10.1126/science.2028254; BITTLES AH, 2008, CONSANGUINITY ENDOGA; BOYCE AJ, 1983, J HERED, V74, P400, DOI 10.1093/oxfordjournals.jhered.a109825; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; Cavalli-Sforza L. L., 2004, MG POP BIOL, V39; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Encyclopaedia Britannica Inc, 2007, NEW ENC BRIT; *FSPEED PRO, 2005, FAST INBR COMP SOFTW; Gargantilla P., 2005, ENFERMEDADES REYES E; *GEN PROJ, 2008, GEN INF EUR COUNTR; Hashmi M. A., 1997, JPMA (Journal of the Pakistan Medical Association), V47, P75; JUNCEDA E, 1991, GINECOLOGIA VIDA INT; KAMEN H, 1983, SPAIN 1469 1714 SOC; Kelberman Daniel, 2007, Eur J Endocrinol, V157 Suppl 1, pS3, DOI 10.1530/EJE-07-0156; LYNCH J, 1991, SPAIN 1516 1700 NATI; Lynch John, 1992, HISPANIC WORLD CRISI; MACCLUER JW, 1983, J HERED, V74, P394, DOI 10.1093/oxfordjournals.jhered.a109824; PHILLIPS JA, 2005, GENEREVIEWS GENE TES; Puri RK, 1978, MED GENETICS INDIA, V2, P129; Reynaud R, 2005, J CLIN ENDOCR METAB, V90, P4880, DOI 10.1210/jc.2005-0119; Stover EH, 2002, J MED GENET, V39, P796, DOI 10.1136/jmg.39.11.796; Vargas-Poussou R, 2006, J AM SOC NEPHROL, V17, P1437, DOI 10.1681/ASN.2005121305; Vogel F., 1997, HUMAN GENETICS; WILLIAMS GH, 2006, HARRISON PRINCIPIOS; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875	30	50	50	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2009	4	4							e5174	10.1371/journal.pone.0005174	http://dx.doi.org/10.1371/journal.pone.0005174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TS	19367331	Green Submitted, Green Published, gold			2022-12-27	WOS:000265510400003
J	Zhou, XJ; Tang, W; Greenwood, TA; Guo, SZ; He, L; Geyer, MA; Kelsoe, JR				Zhou, Xianjin; Tang, Wei; Greenwood, Tiffany A.; Guo, Shengzhen; He, Lin; Geyer, Mark A.; Kelsoe, John R.			Transcription Factor SP4 Is a Susceptibility Gene for Bipolar Disorder	PLOS ONE			English	Article							SENSORIMOTOR GATING DEFICITS; PREPULSE INHIBITION; GENOME SCAN; DOPAMINE RELEASE; SCHIZOPHRENIA; PEDIGREES; FAMILIES; STARTLE; AUTISM; LOCUS	The Sp4 transcription factor plays a critical role for both development and function of mouse hippocampus. Reduced expression of the mouse Sp4 gene results in a variety of behavioral abnormalities relevant to human psychiatric disorders. The human SP4 gene is therefore examined for its association with both bipolar disorder and schizophrenia in European Caucasian and Chinese populations respectively. Out of ten SNPs selected from human SP4 genomic locus, four displayed significant association with bipolar disorder in European Caucasian families (rs12668354, p = 0.022; rs12673091, p = 0.0005; rs3735440, p = 0.019; rs11974306, p = 0.018). To replicate the genetic association, the same set of SNPs was examined in a Chinese bipolar case control sample. Four SNPs displayed significant association (rs40245, p = 0.009; rs12673091, p = 0.002; rs1018954, p = 0.001; rs3735440, p = 0.029), and two of them (rs12673091, rs3735440) were shared with positive SNPs from European Caucasian families. Considering the genetic overlap between bipolar disorder and schizophrenia, we extended our studies in Chinese trios families for schizophrenia. The SNP7 (rs12673091, p = 0.012) also displayed a significant association. The SNP7 (rs12673091) was therefore significantly associated in all three samples, and shared the same susceptibility allele (A) across all three samples. On the other hand, we found a gene dosage effect for mouse Sp4 gene in the modulation of sensorimotor gating, a putative endophenotype for both schizophrenia and bipolar disorder. The deficient sensorimotor gating in Sp4 hypomorphic mice was partially reversed by the administration of dopamine D2 antagonist or mood stabilizers. Both human genetic and mouse pharmacogenetic studies support Sp4 gene as a susceptibility gene for bipolar disorder or schizophrenia. The studies on the role of Sp4 gene in hippocampal development may provide novel insights for the contribution of hippocampal abnormalities in these psychiatric disorders.			Zhou, XJ (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	helin@nhgg.org; jkelsoe@ucsd.edu	Tang, Wei/H-7103-2013; Greenwood, Tiffany/F-6356-2012	Tang, Wei/0000-0002-7089-4391; Greenwood, Tiffany/0000-0002-6080-6503	Intramural NIH HHS [Z01 MH002810] Funding Source: Medline; NIMH NIH HHS [MH47612, R01 MH59533, MH073991, R01 MH059534, R01 MH59553, R01 MH59535, U01 MH46274, R01 MH059548, R01 MH059553, R01 MH059556, R01 MH60068, U01 MH46280, R01 MH059533, MH68503, R01 MH068503, U01 MH46282, R01 MH059545, MH59567, R01 MH59567, R01 MH059535, R01 MH060068, R01 MH59545, R01 MH059567, R01 MH073991] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH047612, R01MH059567, U01MH046274, R01MH068503, R01MH059545, R01MH059553, Z01MH002810, R01MH059535, R01MH060068, R01MH073991, R01MH059533, R01MH059534, R01MH059556, U01MH046280, U01MH046282, R01MH059548] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bakker SC, 2003, AM J HUM GENET, V72, P1251, DOI 10.1086/375143; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ben-Shachar D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000817; Berrettini Wade, 2003, World Psychiatry, V2, P68; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Cannon TD, 2006, ANNU REV CLIN PSYCHO, V2, P267, DOI 10.1146/annurev.clinpsy.2.022305.095232; Crowe RR, 2001, AM J MED GENET, V105, P105, DOI 10.1002/1096-8628(20010108)105:1<105::AID-AJMG1072>3.0.CO;2-P; Curtis D, 2003, PSYCHIAT GENET, V13, P77, DOI 10.1097/01.ypg.0000056684.89558.d2; DeteraWadleigh SD, 1997, AM J MED GENET, V74, P254, DOI 10.1002/(SICI)1096-8628(19970531)74:3<254::AID-AJMG4>3.0.CO;2-Q; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Fallin MD, 2003, AM J HUM GENET, V73, P601, DOI 10.1086/378158; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Geyer MA, 2002, MOL PSYCHIATR, V7, P1039, DOI 10.1038/sj.mp.4001159; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; GIAKOUMAKI SG, 2007, BIOL PSYCHIAT; Gogos JA, 2001, AM J MED GENET, V105, P50, DOI 10.1002/1096-8628(20010108)105:1<50::AID-AJMG1058>3.3.CO;2-X; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; Heisler LE, 2005, NUCLEIC ACIDS RES, V33, P2952, DOI 10.1093/nar/gki582; Ingram JL, 2000, TERATOLOGY, V62, P393, DOI 10.1002/1096-9926(200012)62:6<393::AID-TERA6>3.3.CO;2-M; Kelsoe JR, 2001, P NATL ACAD SCI USA, V98, P585, DOI 10.1073/pnas.011358498; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kita JM, 2007, J NEUROCHEM, V102, P1115, DOI 10.1111/j.1471-4159.2007.04621.x; Knowles JA, 1998, AM J MED GENET, V81, P139, DOI 10.1002/(SICI)1096-8628(19980328)81:2<139::AID-AJMG4>3.0.CO;2-R; Le-Niculescu H, 2009, AM J MED GENET B, V150B, P155, DOI 10.1002/ajmg.b.30887; Lerer B, 2003, MOL PSYCHIATR, V8, P488, DOI 10.1038/sj.mp.4001322; Maier W, 2006, CURR OPIN PSYCHIATR, V19, P165, DOI 10.1097/01.yco.0000214342.52249.82; Meincke U, 2004, EUR ARCH PSY CLIN N, V254, P415, DOI 10.1007/S00406-004-0523-0; MESSIHA FS, 1986, ALCOHOL, V3, P131, DOI 10.1016/0741-8329(86)90022-4; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Nurnberger JI, 1997, AM J MED GENET, V74, P227, DOI 10.1002/(SICI)1096-8628(19970531)74:3<227::AID-AJMG1>3.0.CO;2-N; Perry W, 2001, BIOL PSYCHIAT, V50, P418, DOI 10.1016/S0006-3223(01)01184-2; Purcell S, 2005, AM J HUM GENET, V76, P249, DOI 10.1086/427886; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; STAMFORD JA, 1988, BRIT J PHARMACOL, V94, P924, DOI 10.1111/j.1476-5381.1988.tb11605.x; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Swerdlow NR, 2006, ARCH GEN PSYCHIAT, V63, P1325, DOI 10.1001/archpsyc.63.12.1325; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Wolpert CM, 2001, AM J MED GENET, V105, P222, DOI 10.1002/ajmg.1258; Zhou X, 2007, GENES BRAIN BEHAV, V6, P269, DOI 10.1111/j.1601-183X.2006.00256.x; Zhou X, 2005, MOL PSYCHIATR, V10, P393, DOI 10.1038/sj.mp.4001621	44	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5196	10.1371/journal.pone.0005196	http://dx.doi.org/10.1371/journal.pone.0005196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19401786	Green Submitted, gold, Green Published			2022-12-27	WOS:000265505900024
J	Amleh, A; Nair, SJ; Sun, J; Sutherland, A; Hasty, P; Li, R				Amleh, Asma; Nair, Sreejith J.; Sun, Jianlong; Sutherland, Ann; Hasty, Paul; Li, Rong			Mouse Cofactor of BRCA1 (Cobra1) Is Required for Early Embryogenesis	PLOS ONE			English	Article								Background: Negative elongation factor (NELF) is a four-subunit protein complex conserved from Drosophila to humans. In vitro biochemical and tissue culture-based studies have demonstrated an important role of NELF in controlling RNA polymerase II (Pol II) pausing in transcription. However, the physiological significance of NELF function is not clear due to the lack of any genetic systems for studying NELF. Principal Findings: Here we show that disruption of the mouse B subunit of NELF (NELF-B), also known as cofactor of BRCA1 (Cobra1), causes inner cell mass (ICM) deficiency and embryonic lethality at the time of implantation. Consistent with the phenotype of the Cobra1 knockout (KO) embryos, knockdown of Cobra1 in mouse embryonic stem cells (ESCs) reduces the efficiency of colony formation and increases spontaneous differentiation. Cobra1-depleted ESCs maintain normal levels of Oct4, Nanog, and Sox2, master regulators of pluripotency in ESCs. However, knockdown of Cobra1 leads to precocious expression of developmental regulators including lymphoid enhancer-binding factor 1 (Lef1). Chromatin immunoprecipitation (ChIP) indicates that Cobra1 binds to the Lef1 promoter and modulates the abundance of promoter-bound RNA polymerase. Conclusions: Cobra1 is essential for early embryogenesis. Our findings also indicate that Cobra1 helps maintain the undifferentiated state of mESCs by preventing unscheduled expression of developmental genes.	[Amleh, Asma; Nair, Sreejith J.; Sun, Jianlong; Hasty, Paul; Li, Rong] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78229 USA; [Sutherland, Ann] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22903 USA	University of Texas System; University of Texas Health San Antonio; University of Virginia	Amleh, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78229 USA.	lir3@uthscsa.edu		Hasty, Paul/0000-0003-3046-0131; Sutherland, Ann/0000-0003-1925-2825; Amleh, Asma/0000-0003-3613-3182; Nair, Sreejith Janardhanan/0000-0001-6295-1133	National Institutes of Health [DK064604]; Department of Defense Breast Cancer Research Program [predoctoral fellowships]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064604] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by a grant to R.L. from the National Institutes of Health (DK064604), and predoctoral fellowships to J.S. and S.J.N. from the Department of Defense Breast Cancer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Aiyar SE, 2007, INT J BIOL SCI, V3, P486; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; He SY, 2008, STEM CELLS, V26, P842, DOI 10.1634/stemcells.2007-0356; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Moynahan ME, 2002, ONCOGENE, V21, P8994, DOI 10.1038/sj.onc.1206177; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rotureau B, 2005, EXP PARASITOL, V111, P207, DOI 10.1016/j.exppara.2005.07.003; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Sun J, 2007, J STEROID BIOCHEM, V107, P131, DOI 10.1016/j.jsbmb.2007.05.031; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	39	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5034	10.1371/journal.pone.0005034	http://dx.doi.org/10.1371/journal.pone.0005034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340312	Green Submitted, gold, Green Published			2022-12-27	WOS:000265500700009
J	Anish, R; Hossain, MB; Jacobson, RH; Takada, S				Anish, Ramakrishnan; Hossain, Mohammad B.; Jacobson, Raymond H.; Takada, Shinako			Characterization of Transcription from TATA-Less Promoters: Identification of a New Core Promoter Element XCPE2 and Analysis of Factor Requirements	PLOS ONE			English	Article							RNA-POLYMERASE-II; PREINITIATION COMPLEX; GENE-EXPRESSION; DNA-SEQUENCES; GENOME-WIDE; BINDING; PROTEIN; TBP; RECOGNITION; RECRUITMENT	Background: More than 80% of mammalian protein-coding genes are driven by TATA-less promoters which often show multiple transcriptional start sites (TSSs). However, little is known about the core promoter DNA sequences or mechanisms of transcriptional initiation for this class of promoters. Methodology/Principal Findings: Here we identify a new core promoter element XCPE2 (X core promoter element 2) (consensus sequence: A/C/G-C-C/T-C-G/A-T-T-G/A-C-C/A(+1)-C/T) that can direct specific transcription from the second TSS of hepatitis B virus X gene mRNA. XCPE2 sequences can also be found in human promoter regions and typically appear to drive one of the start sites within multiple TSS-containing TATA-less promoters. To gain insight into mechanisms of transcriptional initiation from this class of promoters, we examined requirements of several general transcription factors by in vitro transcription experiments using immunodepleted nuclear extracts and purified factors. Our results show that XCPE2-driven transcription uses at least TFIIB, either TFIID or free TBP, RNA polymerase II (RNA pol II) and the MED26-containing mediator complex but not Gcn5. Therefore, XCPE2-driven transcription can be carried out by a mechanism which differs from previously described TAF-dependent mechanisms for initiator (Inr)- or downstream promoter element (DPE)containing promoters, the TBP- and SAGA (Spt-Ada-Gcn5-acetyltransferase)-dependent mechanism for yeast TATA-containing promoters, or the TFTC (TBP-free-TAF-containing complex)-dependent mechanism for certain Inr-containing TATA-less promoters. EMSA assays using XCPE2 promoter and purified factors further suggest that XCPE2 promoter recognition requires a set of factors different from those for TATA box, Inr, or DPE promoter recognition. Conclusions/Significance: We identified a new core promoter element XCPE2 that are found in multiple TSS-containing TATA-less promoters. Mechanisms of promoter recognition and transcriptional initiation for XCPE2-driven promoters appear different from previously shown mechanisms for classical promoters that show single "focused'' TSSs. Our studies provide insight into novel mechanisms of RNA Pol II transcription from multiple TSS-containing TATA-less promoters.	[Anish, Ramakrishnan; Hossain, Mohammad B.; Jacobson, Raymond H.; Takada, Shinako] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Dept Biochem & Mol Biol, Genes & Dev Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Anish, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Dept Biochem & Mol Biol, Genes & Dev Program, Houston, TX 77030 USA.	stakada@mdanderson.org		Thachangattuthodi, Anish/0000-0002-8029-5421	M.D. Anderson Cancer Center; American Gastroenterological Association (AGA)/Elsevier Research Initiative Award; NIH [AI057504, GM069769]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069769] Funding Source: NIH RePORTER	M.D. Anderson Cancer Center; American Gastroenterological Association (AGA)/Elsevier Research Initiative Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by an institutional research grant from M.D. Anderson Cancer Center, an American Gastroenterological Association (AGA)/Elsevier Research Initiative Award, and a grant (AI057504) from the NIH to S.T., and a grant (GM069769) from the NIH to R.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI E, 1988, NUCLEIC ACIDS RES, V16, P1627, DOI 10.1093/nar/16.4.1627; ASO T, 1994, J BIOL CHEM, V269, P26575; Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Butler JEF, 2001, GENE DEV, V15, P2515, DOI 10.1101/gad.924301; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cavusoglu N, 2003, PROTEOMICS, V3, P217, DOI 10.1002/pmic.200390030; Cheng JX, 2002, CURR BIOL, V12, P1828, DOI 10.1016/S0960-9822(02)01257-5; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Hasegawa J, 2003, J BIOCHEM, V133, P133, DOI 10.1093/jb/mvg013; HAYASHIDA T, 1994, GENE, V141, P267; Hilton TL, 2005, MOL CELL BIOL, V25, P4321, DOI 10.1128/MCB.25.10.4321-4332.2005; Hube F, 2005, MOL BIOTECHNOL, V31, P81, DOI 10.1385/MB:31:1:081; Izawa M, 2006, JPN J VET RES, V53, P159; KOBAYASHI M, 1984, GENE, V30, P227; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; Li XY, 2002, CURR BIOL, V12, P1240, DOI 10.1016/S0960-9822(02)00932-6; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; Oelgeschlager T, 1998, MOL CELL, V1, P925, DOI 10.1016/S1097-2765(00)80092-1; Ohler U., 2002, GENOME BIOL, V3, pRESEARCH0087, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; Ren DL, 2005, ARCH BIOCHEM BIOPHYS, V435, P347, DOI 10.1016/j.abb.2004.12.028; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; Takada S, 1996, VIROLOGY, V216, P80, DOI 10.1006/viro.1996.0036; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tokusumi Y, 2004, J VIROL, V78, P10856, DOI 10.1128/JVI.78.20.10856-10864.2004; Tokusumi Y, 2007, MOL CELL BIOL, V27, P1844, DOI 10.1128/MCB.01363-06; VERRIJZER CP, 1995, CELL, V81, P1115, DOI 10.1016/S0092-8674(05)80016-9; WANG BQ, 1994, PROTEIN EXPRES PURIF, V5, P476, DOI 10.1006/prep.1994.1067; WANG EH, 1994, SCIENCE, V263, P811, DOI 10.1126/science.8303298; Weis L, 1997, MOL CELL BIOL, V17, P2973, DOI 10.1128/MCB.17.6.2973; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005; Wu SY, 2003, MOL CELL BIOL, V23, P6229, DOI 10.1128/MCB.23.17.6229-6242.2003; Wu SY, 1998, EMBO J, V17, P4478, DOI 10.1093/emboj/17.15.4478	47	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5103	10.1371/journal.pone.0005103	http://dx.doi.org/10.1371/journal.pone.0005103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337366	Green Submitted, Green Published, gold			2022-12-27	WOS:000265500600023
J	Mennerat, A; Perret, P; Lambrechts, MM				Mennerat, Adele; Perret, Philippe; Lambrechts, Marcel M.			Local Individual Preferences for Nest Materials in a Passerine Bird	PLOS ONE			English	Article							BLUE TIT; AROMATIC PLANTS; COMMON RAVENS; GREEN PLANTS; CORVUS-CORAX; INFORMATION; NESTLINGS; POPULATION; HYPOTHESIS; OLFACTION	Background: Variation in the behavioural repertoire of animals is acquired by learning in a range of animal species. In nest-building birds, the assemblage of nest materials in an appropriate structure is often typical of a bird genus or species. Yet plasticity in the selection of nest materials may be beneficial because the nature and abundance of nest materials vary across habitats. Such plasticity can be learned, either individually or socially. In Corsican populations of blue tits Cyanistes caeruleus, females regularly add in their nests fragments of several species of aromatic plants during the whole breeding period. The selected plants represent a small fraction of the species present in the environment and have positive effects on nestlings. Methodology/Principal Findings: We investigated spatiotemporal variations of this behaviour to test whether the aromatic plant species composition in nests depends on 1) plant availability in territories, 2) female experience or 3) female identity. Our results indicate that territory plays a very marginal role in the aromatic plant species composition of nests. Female experience is not related to a change in nest plant composition. Actually, this composition clearly depends on female identity, i.e. results from individual preferences which, furthermore, are repeatable both within and across years. A puzzling fact is the strong difference in plant species composition of nests across distinct study plots. Conclusions/Significance: This study demonstrates that plant species composition of nests results from individual preferences that are homogeneous within study plots. We propose several hypotheses to interpret this pattern of spatial variation before discussing them in the light of preliminary results. As a conclusion, we cannot exclude the possibility of social transmission of individual preferences for aromatic plants. This is an exciting perspective for further work in birds, where nest construction behaviour has classically been considered as a stereotypic behaviour.	[Mennerat, Adele; Perret, Philippe; Lambrechts, Marcel M.] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Mennerat, Adele] Lab Evolut & Divers Biol, UMR 5174, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA)	Mennerat, A (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France.	adele.mennerat@bio.uib.no	Mennerat, Adele/K-4133-2019	Mennerat, Adele/0000-0003-0368-7197	ANR [ANR-05 NT05-3_42075]	ANR(French National Research Agency (ANR))	This study was partly funded by an ANR research grant to M.M. Lambrechts and P. Heeb (ANR-05 NT05-3_42075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Benskin CMWH, 2002, ANIM BEHAV, V64, P823, DOI 10.1006/anbe.2002.2005; BLONDEL J, 1985, J ANIM ECOL, V54, P531, DOI 10.2307/4497; CLARK L, 1988, OECOLOGIA, V77, P174, DOI 10.1007/BF00379183; CLARK L, 1985, OECOLOGIA, V67, P169, DOI 10.1007/BF00384280; Collias NE, 1997, CONDOR, V99, P253, DOI 10.2307/1369932; Fritz J, 1999, ANIM BEHAV, V57, P785, DOI 10.1006/anbe.1998.1035; Gajdon GK, 2004, LEARN BEHAV, V32, P62; GALEF BG, 1983, ANIM BEHAV, V31, P748, DOI 10.1016/S0003-3472(83)80232-2; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Giraldeau LA, 2008, ADV STUD BEHAV, V38, P59, DOI 10.1016/S0065-3454(08)00002-8; Gorley C.K., 2006, GETTING STARTED PRIM; Gwinner H, 2000, ANIM BEHAV, V59, P301, DOI 10.1006/anbe.1999.1306; Gwinner H, 1997, BEHAVIOUR, V134, P337, DOI 10.1163/156853997X00575; Gwinner H, 2008, ANIM BEHAV, V75, P971, DOI 10.1016/j.anbehav.2007.08.008; Hansell M.H., 2000, BIRD NESTS CONSTRUCT, DOI [10.1017/CBO9781139106788, DOI 10.1017/CBO9781139106788]; Healy S, 2008, CURR BIOL, V18, pR271, DOI 10.1016/j.cub.2008.01.020; Lafuma L, 2001, BEHAV PROCESS, V56, P113, DOI 10.1016/S0376-6357(01)00191-7; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Laland KN, 1998, BEHAV ECOL, V9, P493, DOI 10.1093/beheco/9.5.493; Laland KN, 1997, ANIM BEHAV, V53, P1161, DOI 10.1006/anbe.1996.0318; Lambrechts MM, 2000, ACTA OECOL, V21, P175, DOI 10.1016/S1146-609X(00)00122-3; Lambrechts MM, 1997, EVOL ECOL, V11, P599, DOI 10.1007/s10682-997-1515-0; Lambrechts MM, 2004, OECOLOGIA, V141, P555, DOI 10.1007/s00442-004-1681-5; Legendre P., 2012, NUMERICAL ECOLOGY; Liu WC, 2007, P NATL ACAD SCI USA, V104, P20398, DOI 10.1073/pnas.0710067104; Mennerat A, 2008, BEHAV PROCESS, V79, P189, DOI 10.1016/j.beproc.2008.07.003; Mennerat A, 2008, J AVIAN BIOL, V39, P127, DOI 10.1111/j.0908-8857.2008.04400.x; Mennerat A, 2009, ANIM BEHAV, V77, P569, DOI 10.1016/j.anbehav.2008.11.008; Nicol CJ, 2004, LEARN BEHAV, V32, P72; Petit C, 2002, ECOL LETT, V5, P585, DOI 10.1046/j.1461-0248.2002.00361.x; Rossi PG, 2007, J ESSENT OIL RES, V19, P176, DOI 10.1080/10412905.2007.9699254; Schwab C, 2008, ANIM BEHAV, V75, P501, DOI 10.1016/j.anbehav.2007.06.006; Wheelwright NT, 2008, ANIM BEHAV, V75, P1479, DOI 10.1016/j.anbehav.2007.08.030; WIMBERGER PH, 1984, AUK, V101, P615, DOI 10.1093/auk/101.3.615; Zohar O, 1995, MAMMALIA, V59, P481, DOI 10.1515/mamm.1995.59.4.481	36	45	48	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5104	10.1371/journal.pone.0005104	http://dx.doi.org/10.1371/journal.pone.0005104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337365	Green Published, gold, Green Submitted			2022-12-27	WOS:000265500600024
J	Guda, C; King, BR; Pal, LR; Guda, P				Guda, Chittibabu; King, Brian R.; Pal, Lipika R.; Guda, Purnima			A Top-Down Approach to Infer and Compare Domain-Domain Interactions across Eight Model Organisms	PLOS ONE			English	Article								Knowledge of specific domain-domain interactions (DDIs) is essential to understand the functional significance of protein interaction networks. Despite the availability of an enormous amount of data on protein-protein interactions (PPIs), very little is known about specific DDIs occurring in them. Here, we present a top-down approach to accurately infer functionally relevant DDIs from PPI data. We created a comprehensive, non-redundant dataset of 209,165 experimentally-derived PPIs by combining datasets from five major interaction databases. We introduced an integrated scoring system that uses a novel combination of a set of five orthogonal scoring features covering the probabilistic, evolutionary, evidence-based, spatial and functional properties of interacting domains, which can map the interacting propensity of two domains in many dimensions. This method outperforms similar existing methods both in the accuracy of prediction and in the coverage of domain interaction space. We predicted a set of 52,492 high-confidence DDIs to carry out cross-species comparison of DDI conservation in eight model species including human, mouse, Drosophila, C. elegans, yeast, Plasmodium, E. coli and Arabidopsis. Our results show that only 23% of these DDIs are conserved in at least two species and only 3.8% in at least 4 species, indicating a rather low conservation across species. Pair-wise analysis of DDI conservation revealed a 'sliding conservation' pattern between the evolutionarily neighboring species. Our methodology and the high-confidence DDI predictions generated in this study can help to better understand the functional significance of PPIs at the modular level, thus can significantly impact further experimental investigations in systems biology research.	[Guda, Chittibabu; King, Brian R.; Pal, Lipika R.; Guda, Purnima] SUNY Albany, GenNYsis Ctr Excellence Canc Genom, Rensselaer, NY USA; [Guda, Chittibabu; King, Brian R.; Pal, Lipika R.; Guda, Purnima] SUNY Albany, Dept Epidemiol & Biostat, Rensselaer, NY USA; [King, Brian R.] Mansfield Univ, Dept Comp Informat Sci, Mansfield, PA USA; [Pal, Lipika R.] Univ Maryland, Biotechnol Inst, Ctr Advanced Res Biotechnol, Rockville, MD USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Pennsylvania State System of Higher Education (PASSHE); Mansfield University - Pennsylvania	Guda, C (corresponding author), SUNY Albany, GenNYsis Ctr Excellence Canc Genom, Rensselaer, NY USA.	cguda@albany.edu	Ray, Lipika/N-1245-2019; King, Brian R/A-1581-2011; Ray, Lipika/D-1007-2011	Ray, Lipika/0000-0002-3390-110X; King, Brian R/0000-0002-8703-6596; Ray, Lipika/0000-0002-3390-110X	AREA (Academic Research Enhancement Award); NIGMS [1R15GM080681-01A1]; State University of New York at Albany; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM080681] Funding Source: NIH RePORTER	AREA (Academic Research Enhancement Award); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); State University of New York at Albany; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by the AREA (Academic Research Enhancement Award) grant to CG from NIGMS (award# 1R15GM080681-01A1), and partly supported by the startup funds to CG from the State University of New York at Albany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Deng MH, 2002, GENOME RES, V12, P1540, DOI 10.1101/gr.153002; Dueber JE, 2004, CURR OPIN STRUC BIOL, V14, P690, DOI 10.1016/j.sbi.2004.10.004; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Guda C, 2005, BIOINFORMATICS, V21, P3963, DOI 10.1093/bioinformatics/bti650; Guimaraes KS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-171; Guimaraes KS, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r104; Han Dongsoo, 2003, Genome Inform, V14, P250; Itzhaki Z, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r125; Jothi R, 2006, J MOL BIOL, V362, P861, DOI 10.1016/j.jmb.2006.07.072; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kim WK, 2005, PROTEINS, V61, P1075, DOI 10.1002/prot.20693; King BR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r68; Lee H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-269; Liu Y, 2005, BIOINFORMATICS, V21, P3279, DOI 10.1093/bioinformatics/bti492; Loregian A, 2002, REV MED VIROL, V12, P239, DOI 10.1002/rmv.356; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Ng SK, 2003, BIOINFORMATICS, V19, P923, DOI 10.1093/bioinformatics/btg118; Nye TMW, 2005, BIOINFORMATICS, V21, P993, DOI 10.1093/bioinformatics/bti086; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Prieto C, 2006, NUCLEIC ACIDS RES, V34, pW298, DOI 10.1093/nar/gkl128; Resch A, 2004, J PROTEOME RES, V3, P76, DOI 10.1021/pr034064v; Riley R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r89; Schuster-Bockler B, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-259; Shoemaker BA, 2006, PROTEIN SCI, V15, P352, DOI 10.1110/ps.051760806; Smadja F, 1996, COMPUT LINGUIST, V22, P1; Sprinzak E, 2001, J MOL BIOL, V311, P681, DOI 10.1006/jmbi.2001.4920; Stein A, 2005, NUCLEIC ACIDS RES, V33, pD413, DOI 10.1093/nar/gki037; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Vogel C, 2005, J MOL BIOL, V346, P355, DOI 10.1016/j.jmb.2004.11.050; Vucetic Slobodan, 2001, LECT NOTES COMPUTER, V2167, P527, DOI [10.1007/3-540-44795-4_45, DOI 10.1007/3-540-44795-4_45]; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Zutshi R, 1998, CURR OPIN CHEM BIOL, V2, P62, DOI 10.1016/S1367-5931(98)80036-7	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5096	10.1371/journal.pone.0005096	http://dx.doi.org/10.1371/journal.pone.0005096			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333396	gold, Green Submitted, Green Published			2022-12-27	WOS:000265499900026
J	Schmuckli-Maurer, J; Casanova, C; Schmied, S; Affentranger, S; Parvanova, I; Kang'a, S; Nene, V; Katzer, F; McKeever, D; Muller, J; Bishop, R; Pain, A; Dobbelaere, DAE				Schmuckli-Maurer, Jacqueline; Casanova, Carlo; Schmied, Stefanie; Affentranger, Sarah; Parvanova, Iana; Kang'a, Simon; Nene, Vishvanath; Katzer, Frank; McKeever, Declan; Mueller, Joachim; Bishop, Richard; Pain, Arnab; Dobbelaere, Dirk A. E.			Expression Analysis of the Theileria parva Subtelomere-Encoded Variable Secreted Protein Gene Family	PLOS ONE			English	Article								Background: The intracellular protozoan parasite Theileria parva transforms bovine lymphocytes inducing uncontrolled proliferation. Proteins released from the parasite are assumed to contribute to phenotypic changes of the host cell and parasite persistence. With 85 members, genes encoding subtelomeric variable secreted proteins (SVSPs) form the largest gene family in T. parva. The majority of SVSPs contain predicted signal peptides, suggesting secretion into the host cell cytoplasm. Methodology/Principal Findings: We analysed SVSP expression in T. parva-transformed cell lines established in vitro by infection of T or B lymphocytes with cloned T. parva parasites. Microarray and quantitative real-time PCR analysis revealed mRNA expression for a wide range of SVSP genes. The pattern of mRNA expression was largely defined by the parasite genotype and not by host background or cell type, and found to be relatively stable in vitro over a period of two months. Interestingly, immunofluorescence analysis carried out on cell lines established from a cloned parasite showed that expression of a single SVSP encoded by TP03_0882 is limited to only a small percentage of parasites. Epitope-tagged TP03_0882 expressed in mammalian cells was found to translocate into the nucleus, a process that could be attributed to two different nuclear localisation signals. Conclusions: Our analysis reveals a complex pattern of Theileria SVSP mRNA expression, which depends on the parasite genotype. Whereas in cell lines established from a cloned parasite transcripts can be found corresponding to a wide range of SVSP genes, only a minority of parasites appear to express a particular SVSP protein. The fact that a number of SVSPs contain functional nuclear localisation signals suggests that proteins released from the parasite could contribute to phenotypic changes of the host cell. This initial characterisation will facilitate future studies on the regulation of SVSP gene expression and the potential biological role of these enigmatic proteins.	[Schmuckli-Maurer, Jacqueline; Casanova, Carlo; Schmied, Stefanie; Affentranger, Sarah; Parvanova, Iana; Dobbelaere, Dirk A. E.] Univ Bern, Vetsuisse Fac, Bern, Switzerland; [Kang'a, Simon; Nene, Vishvanath] The Inst Genom Res TIGR, Rockville, MD USA; [Katzer, Frank; McKeever, Declan] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush Vet Ctr, Ctr Trop Vet Med, Edinburgh EH8 9YL, Midlothian, Scotland; [Mueller, Joachim] Univ Bern, Inst Parasitol, CH-3012 Bern, Switzerland; [Bishop, Richard] Int Livestock Res Inst, Nairobi, Kenya; [Pain, Arnab] Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England	University of Bern; J. Craig Venter Institute; University of Edinburgh; University of Bern; CGIAR; International Livestock Research Institute (ILRI); Wellcome Trust Sanger Institute	Schmuckli-Maurer, J (corresponding author), Univ Bern, Vetsuisse Fac, Bern, Switzerland.	dirk.dobbelaere@mopa.unibe.ch	Katzer, Frank/AAG-2042-2020; Pain, Arnab/L-5766-2015; Dobbelaere, Dirk/A-3885-2013	Katzer, Frank/0000-0001-5902-4136; Pain, Arnab/0000-0002-1755-2819; Dobbelaere, Dirk/0000-0003-0672-8468; Muller, Joachim/0000-0001-8189-9270; Nene, Vishvanath/0000-0001-7066-4169; Casanova, Carlo/0000-0002-7888-6329; Schmuckli-Maurer, Jacqueline/0000-0002-8721-1163	Wellcome Trust [GR075820MA, 064654, 077431] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Barry JD, 2003, INT J PARASITOL, V33, P29, DOI 10.1016/S0020-7519(02)00247-3; Baydoun H, 2007, GENE, V386, P191, DOI 10.1016/j.gene.2006.09.008; BAYLIS HA, 1993, MOL BIOCHEM PARASIT, V61, P171, DOI 10.1016/0166-6851(93)90063-4; Bevington JM, 2007, VIROLOGY, V357, P102, DOI 10.1016/j.virol.2006.07.050; Bishop R, 2005, NUCLEIC ACIDS RES, V33, P5503, DOI 10.1093/nar/gki818; Bishop R, 2000, MOL BIOCHEM PARASIT, V110, P359, DOI 10.1016/S0166-6851(00)00291-7; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Borst P, 2001, MOL BIOCHEM PARASIT, V114, P17, DOI 10.1016/S0166-6851(01)00243-2; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; BROWN CGD, 1973, NATURE, V245, P101, DOI 10.1038/245101a0; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Dobbelaere D, 1999, ANNU REV MICROBIOL, V53, P1, DOI 10.1146/annurev.micro.53.1.1; DOBBELAERE DAE, 1990, INFECT IMMUN, V58, P3847, DOI 10.1128/IAI.58.12.3847-3855.1990; Dobbelaere DAE, 2004, CURR OPIN IMMUNOL, V16, P524, DOI 10.1016/j.coi.2004.05.009; Dobbelaere DAE, 2003, CURR OPIN MICROBIOL, V6, P377, DOI 10.1016/S1369-5274(03)00085-7; Dudoit S, 2003, BIOTECHNIQUES, P45; Filler SG, 2006, CURR OPIN MICROBIOL, V9, P333, DOI 10.1016/j.mib.2006.06.005; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Graham Simon P, 2007, Immunome Res, V3, P2, DOI 10.1186/1745-7580-3-2; Graham SP, 2006, P NATL ACAD SCI USA, V103, P3286, DOI 10.1073/pnas.0511273103; HEUSSLER V, 2006, PARASITOLOGY S, V132, pS429; Heussler VT, 2008, PARASITE, V15, P211, DOI 10.1051/parasite/2008153211; Heussler VT, 2002, SCIENCE, V298, P1033, DOI 10.1126/science.1075462; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Katzer F, 2007, INFECT IMMUN, V75, P4909, DOI 10.1128/IAI.00710-07; Katzer F, 2006, INFECT IMMUN, V74, P5456, DOI 10.1128/IAI.00472-06; Mckeever DJ, 2006, PARASITE IMMUNOL, V28, P339, DOI 10.1111/j.1365-3024.2006.00824.x; MCKEEVER DJ, 1994, CURR OPIN IMMUNOL, V6, P564, DOI 10.1016/0952-7915(94)90142-2; Merrick CJ, 2006, MOL MICROBIOL, V62, P612, DOI 10.1111/j.1365-2958.2006.05397.x; Morrison WI, 2006, PARASITOLOGY, V133, pS169, DOI 10.1017/S0031182006001867; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Oura CAL, 2003, INT J PARASITOL, V33, P1641, DOI 10.1016/S0020-7519(03)00280-7; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Ravindran S, 2008, TRAFFIC, V9, P647, DOI 10.1111/j.1600-0854.2008.00723.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800; Shaw MK, 2002, WORLD CL PARASITES, V3, P1; Shiels B, 2006, INT J PARASITOL, V36, P9, DOI 10.1016/j.ijpara.2005.09.002; Shiels BR, 2004, EUKARYOT CELL, V3, P495, DOI 10.1128/EC.3.2.495-505.2004; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Swan DG, 1999, MOL BIOCHEM PARASIT, V101, P117, DOI 10.1016/S0166-6851(99)00064-X; Swan DG, 2003, CELL MICROBIOL, V5, P947, DOI 10.1046/j.1462-5822.2003.00340.x; Swan DG, 2001, J CELL SCI, V114, P2747; TOYE P, 1995, MOL BIOCHEM PARASIT, V73, P165, DOI 10.1016/0166-6851(95)00110-M; Volkman SK, 2002, SCIENCE, V298, P216, DOI 10.1126/science.1075642	50	35	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e4839	10.1371/journal.pone.0004839	http://dx.doi.org/10.1371/journal.pone.0004839			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PO	19325907	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499600001
J	Chen, Y; Qin, J; Cai, JY; Chen, ZW				Chen, Yong; Qin, Jie; Cai, Jiye; Chen, Zheng W.			Cold Induces Micro- and Nano-Scale Reorganization of Lipid Raft Markers at Mounds of T-Cell Membrane Fluctuations	PLOS ONE			English	Article								Whether and how cold causes changes in cell-membrane or lipid rafts remain poorly characterized. Using the NSOM/QD and confocal imaging systems, we found that cold caused microscale redistribution of lipid raft markers, GM1 for lipid and CD59 for protein, from the peripheral part of microdomains to the central part on Jurkat T cells, and that cold also induced the nanoscale size-enlargement (1/3- to 2/3-fold) of the nanoclusters of lipid raft markers and even the colocalization of GM1 and CD59 nanoclusters. These findings indicate cold-induced lateral rearrangement/coalescence of raft-related membrane heterogeneity. The cold-induced re-distribution of lipid raft markers under a nearly-natural condition provide clues for their alternations, and help to propose a model in which raft lipids associate themselves or interact with protein components to generate functional membrane heterogeneity in response to stimulus. The data also underscore the possible cold-induced artifacts in early-described cold-related experiments and the detergent-resistance-based analyses of lipid rafts at 4 degrees C, and provide a biophysical explanation for recently-reported cold-induced activation of signaling pathways in T cells. Importantly, our fluorescence-topographic NSOM imaging demonstrated that GM1/CD59 raft markers distributed and re-distributed at mounds but not depressions of T-cell membrane fluctuations. Such mound-top distribution of lipid raft markers or lipid rafts provides spatial advantage for lipid rafts or contact molecules interacting readily with neighboring cells or free molecules.			Chen, Y (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Ctr Primate Biomed Res, Chicago, IL 60612 USA.	zchen@uic.edu	Chen, Yong/A-8143-2008	Chen, Yong/0000-0003-1678-1537; Cai, Jiye/0000-0002-4791-3320	NCRR NIH HHS [R01 RR013601, R01 RR13601] Funding Source: Medline; NHLBI NIH HHS [R01 HL064560, R01 HL64560] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR013601] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064560] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Burgos P, 2003, LANGMUIR, V19, P8002, DOI 10.1021/la034551p; Chen Y, 2008, J LIPID RES, V49, P2268, DOI 10.1194/jlr.D800031-JLR200; Chen Y, 2008, BLOOD, V111, P4220, DOI 10.1182/blood-2007-07-101691; de Bakker BI, 2008, J CELL SCI, V121, P627, DOI 10.1242/jcs.019513; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Harder T, 2007, CURR OPIN IMMUNOL, V19, P470, DOI 10.1016/j.coi.2007.05.002; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Heerklotz H, 2003, J MOL BIOL, V329, P793, DOI 10.1016/S0022-2836(03)00504-7; Hwang J, 1998, BIOPHYS J, V74, P2184, DOI 10.1016/S0006-3495(98)77927-5; Koopman M, 2004, FEBS LETT, V573, P6, DOI 10.1016/j.febslet.2004.07.035; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Magee AI, 2005, J CELL SCI, V118, P3141, DOI 10.1242/jcs.02442; Mitchell JS, 2002, J IMMUNOL, V168, P2737, DOI 10.4049/jimmunol.168.6.2737; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nagy P, 1999, J CELL SCI, V112, P1733; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Tokumasu F, 2004, LANGMUIR, V20, P614, DOI 10.1021/la0355388; Viola A, 2001, TRENDS IMMUNOL, V22, P322, DOI 10.1016/S1471-4906(01)01938-X; WINOKUR R, 1995, BLOOD, V85, P1796, DOI 10.1182/blood.V85.7.1796.bloodjournal8571796; ZUCKER MB, 1954, BLOOD, V9, P602, DOI 10.1182/blood.V9.6.602.602	31	41	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5386	10.1371/journal.pone.0005386	http://dx.doi.org/10.1371/journal.pone.0005386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404395	Green Published, Green Submitted, gold			2022-12-27	WOS:000265614900005
J	Lavhale, MS; Kumar, S; Mishra, SH; Sitasawad, SL				Lavhale, Manish S.; Kumar, Santosh; Mishra, Shri Hari; Sitasawad, Sandhya L.			A Novel Triterpenoid Isolated from the Root Bark of Ailanthus excelsa Roxb (Tree of Heaven), AECHL-1 as a Potential Anti-Cancer Agent	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INHIBITOR; CANCER; PHOSPHORYLATION; DERIVATIVES; DESIGN	Background: We report here the isolation and characterization of a new compound Ailanthus excelsa chloroform extract-1 (AECHL-1) (C29H36O10; molecular weight 543.8) from the root bark of Ailanthus excelsa Roxb. The compound possesses anticancer activity against a variety of cancer cell lines of different origin. Principal Findings: AECHL-1 treatment for 12 to 48 hr inhibited cell proliferation and induced death in B16F10, MDA-MB-231, MCF-7, and PC3 cells with minimum growth inhibition in normal HEK 293. The antitumor effect of AECHL-1 was comparable with that of the conventional antitumor drugs paclitaxel and cisplatin. AECHL-1-induced growth inhibition was associated with S/G(2)-M arrests in MDA-MB-231, MCF-7, and PC3 cells and a G(1) arrest in B16F10 cells. We observed microtubule disruption in MCF-7 cells treated with AECHL-1 in vitro. Compared with control, subcutaneous injection of AECHL-1 to the sites of tumor of mouse melanoma B16F10 implanted in C57BL/6 mice and human breast cancer MCF-7 cells in athymic nude mice resulted in significant decrease in tumor volume. In B16F10 tumors, AECHL-1 at 50 mu g/mouse/day dose for 15 days resulted in increased expression of tumor suppressor proteins P53/p21, reduction in the expression of the oncogene c-Myc, and downregulation of cyclin D1 and cdk4. Additionally, AECHL-1 treatment resulted in the phosphorylation of p53 at serine 15 in B16F10 tumors, which seems to exhibit p53-dependent growth inhibitory responses. Conclusions: The present data demonstrate the activity of a triterpenoid AECHL-1 which possess a broad spectrum of activity against cancer cells. We propose here that AECHL-1 is a futuristic anti-cancer drug whose therapeutic potential needs to be widely explored for chemotherapy against cancer.			Lavhale, MS (corresponding author), Maharaja Sayajirao Univ Baroda, Dept Pharm, Fac Engn & Technol, Vadodara, Gujarat, India.	ssitaswad@nccs.res.in						Alderden RA, 2006, J CHEM EDUC, V83, P728, DOI 10.1021/ed083p728; American Cancer Society, 2002, CANC FACTS FIG; Baruah H, 2004, CURR TOP MED CHEM, V4, P1537, DOI 10.2174/1568026043387313; BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505; Brady H, 2002, CANCER RES, V62, P1439; Chung KT, 1998, CRIT REV FOOD SCI, V38, P421, DOI 10.1080/10408699891274273; CORDELL GA, 1978, LLOYDIA, V41, P166; CRAGG GM, 2004, ENCY LIFE SUPPORT SY; Dzubak P, 2006, NAT PROD REP, V23, P394, DOI 10.1039/b515312n; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Ginestier C, 2002, AM J PATHOL, V161, P1223, DOI 10.1016/S0002-9440(10)64399-4; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Honda T, 1998, BIOORG MED CHEM LETT, V8, P2711, DOI 10.1016/S0960-894X(98)00479-X; Honda T, 2002, BIOORG MED CHEM LETT, V12, P1027, DOI 10.1016/S0960-894X(02)00105-1; HONDA T, 1987, Patent No. 4665201; Hussain SP, 1998, CANCER RES, V58, P4023; KARN J, 1989, ONCOGENE, V4, P773; KIRTIKAR KR, INDIAN MED PLANTS, V1, P505; LASEK W, 1995, CANCER IMMUNOL IMMUN, V40, P315, DOI 10.1007/BF01519632; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; PALLAVICINI MG, 1987, TECHNIQUES CELL CYCL, P139; Philip PA, 2005, SEMIN ONCOL, V32, pS24, DOI 10.1053/j.seminoncol.2005.04.004; Ronconi L, 2005, INORG CHEM, V44, P1867, DOI 10.1021/ic048260v; Ruohola JK, 2001, CANCER RES, V61, P4229; Schneider L, 2008, ONCOGENE, V27, P116, DOI 10.1038/sj.onc.1210628; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; Stewart ZA, 2001, ONCOGENE, V20, P113, DOI 10.1038/sj.onc.1204060; Tang WC, 2003, PLANTA MED, V69, P97, DOI 10.1055/s-2003-37718; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yim D, 2005, CANCER RES, V65, P1035; Zhang LH, 2006, CANCER RES, V66, P951, DOI 10.1158/0008-5472.CAN-05-2083	32	33	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5365	10.1371/journal.pone.0005365	http://dx.doi.org/10.1371/journal.pone.0005365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399188	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514900019
J	Richardson, JS; Yao, MK; Tran, KN; Croyle, MA; Strong, JE; Feldmann, H; Kobinger, GP				Richardson, Jason S.; Yao, Michel K.; Tran, Kaylie N.; Croyle, Maria A.; Strong, James E.; Feldmann, Heinz; Kobinger, Gary P.			Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine	PLOS ONE			English	Article								Background: The Ebola virus is transmitted by direct contact with bodily fluids of infected individuals, eliciting death rates as high as 90% among infected humans. Currently, replication defective adenovirus-based Ebola vaccine is being studied in a phase I clinical trial. Another Ebola vaccine, based on an attenuated vesicular stomatitis virus has shown efficacy in post-exposure treatment of nonhuman primates to Ebola infection. In this report, we modified the common recombinant adenovirus serotype 5-based Ebola vaccine expressing the wild-type ZEBOV glycoprotein sequence from a CMV promoter (Ad-CMVZGP). The immune response elicited by this improved expression cassette vector (Ad-CAGoptZGP) and its ability to afford protection against lethal ZEBOV challenge in mice was compared to the standard Ad-CMVZGP vector. Methodology/Principal Findings: Ad-CMVZGP was previously shown to protect mice, guinea pigs and nonhuman primates from an otherwise lethal challenge of Zaire ebolavirus. The antigenic expression cassette of this vector was improved through codon optimization, inclusion of a consensus Kozak sequence and reconfiguration of a CAG promoter (Ad-CAGoptZGP). Expression of GP from Ad-CAGoptZGP was substantially higher than from Ad-CMVZGP. Ad-CAGoptZGP significantly improved T and B cell responses at doses 10 to 100-fold lower than that needed with Ad-CMVZGP. Additionally, Ad-CAGoptZGP afforded full protections in mice against lethal challenge at a dose 100 times lower than the dose required for Ad-CMVZGP. Finally, Ad-CAGoptZGP induced full protection to mice when given 30 minutes post-challenge. Conclusions/Significance: We describe an improved adenovirus-based Ebola vaccine capable of affording post-exposure protection against lethal challenge in mice. The molecular modifications of the new improved vaccine also translated in the induction of significantly enhanced immune responses and complete protection at a dose 100 times lower than with the previous generation adenovirus-based Ebola vaccine. Understanding and improving the molecular components of adenovirus-based vaccines can produce potent, optimized product, useful for vaccination and post-exposure therapy.			Richardson, JS (corresponding author), Publ Hlth Agcy Canada, Special Pathogens Program, Natl Microbiol Lab, Winnipeg, MB, Canada.	gary_kobinger@phac-aspc.gc.ca	Croyle, Maria/L-4586-2019	Croyle, Maria/0000-0003-0809-901X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Brunetti-Pierri N, 2004, HUM GENE THER, V15, P35, DOI 10.1089/10430340460732445; Daddario-DiCaprio KM, 2006, LANCET, V367, P1399, DOI 10.1016/S0140-6736(06)68546-2; Ebihara H, 2007, J INFECT DIS, V196, pS313, DOI 10.1086/520590; Feldmann H, 2003, NAT REV IMMUNOL, V3, P677, DOI 10.1038/nri1154; Fitzsimons HL, 2002, METHODS, V28, P227, DOI 10.1016/S1046-2023(02)00227-X; FURTH PA, 1991, NUCLEIC ACIDS RES, V19, P6205, DOI 10.1093/nar/19.22.6205; Hensley LE, 2005, CURR MOL MED, V5, P761, DOI 10.2174/156652405774962344; Hoenen T, 2006, J VIROL, V80, P7260, DOI 10.1128/JVI.00051-06; Kobinger GP, 2006, VIROLOGY, V346, P394, DOI 10.1016/j.virol.2005.10.042; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; McConnell MJ, 2004, HUM GENE THER, V15, P1022, DOI 10.1089/hum.2004.15.1022; Nazir SA, 2005, J INVEST MED, V53, P292, DOI 10.2310/6650.2005.53605; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Rao M, 1999, VACCINE, V17, P2991, DOI 10.1016/S0264-410X(99)00170-X; Reed DS, 2007, VACCINE, V25, P1923, DOI 10.1016/j.vaccine.2006.11.037; SANCHEZ A, 2007, MARBURG EBOLA VIRUSE, P1409; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Wilson JA, 2001, CELL MOL LIFE SCI, V58, P1826, DOI 10.1007/PL00000821	26	65	80	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5308	10.1371/journal.pone.0005308	http://dx.doi.org/10.1371/journal.pone.0005308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390586	Green Published, gold, Green Submitted			2022-12-27	WOS:000265514200019
J	Vergni, D; Castiglione, F; Briani, M; Middei, S; Alberdi, E; Reymann, KG; Natalini, R; Volonte, C; Matute, C; Cavaliere, F				Vergni, Davide; Castiglione, Filippo; Briani, Maya; Middei, Silvia; Alberdi, Elena; Reymann, Klaus G.; Natalini, Roberto; Volonte, Cinzia; Matute, Carlos; Cavaliere, Fabio			A Model of Ischemia-Induced Neuroblast Activation in the Adult Subventricular Zone	PLOS ONE			English	Article							NEURAL STEM-CELLS; GLUCOSE DEPRIVATION; PROGENITOR CELLS; SLICE CULTURES; PROLIFERATION; HIPPOCAMPUS; ATP; NEUROGENESIS; MIGRATION; MICROGLIA	We have developed a rat brain organotypic culture model, in which tissue slices contain cortex-subventricular zone-striatum regions, to model neuroblast activity in response to in vitro ischemia. Neuroblast activation has been described in terms of two main parameters, proliferation and migration from the subventricular zone into the injured cortex. We observed distinct phases of neuroblast activation as is known to occur after in vivo ischemia. Thus, immediately after oxygen/glucose deprivation (6-24 hours), neuroblasts reduce their proliferative and migratory activity, whereas, at longer time points after the insult (2 to 5 days), they start to proliferate and migrate into the damaged cortex. Antagonism of ionotropic receptors for extracellular ATP during and after the insult unmasks an early activation of neuroblasts in the subventricular zone, which responded with a rapid and intense migration of neuroblasts into the damaged cortex (within 24 hours). The process is further enhanced by elevating the production of the chemoattractant SDf-1 alpha and may also be boosted by blocking the activation of microglia. This organotypic model which we have developed is an excellent in vitro system to study neurogenesis after ischemia and other neurodegenerative diseases. Its application has revealed a SOS response to oxygen/glucose deprivation, which is inhibited by unfavorable conditions due to the ischemic environment. Finally, experimental quantifications have allowed us to elaborate a mathematical model to describe neuroblast activation and to develop a computer simulation which should have promising applications for the screening of drug candidates for novel therapies of ischemia-related pathologies.			Vergni, D (corresponding author), CNR, IAC, Rome, Italy.	fabio.cavaliere@ciberned.es	cavaliere, fabio/L-2111-2014; Castiglione, Filippo/B-1366-2010; Briani, Maya/GZN-0556-2022; Reymann, Klaus G/J-8507-2013; Alberdi, Elena/D-6383-2017; Matute, Carlos/N-5559-2014; Alberdi, Elena/AAH-1757-2019; Natalini, Roberto/P-6189-2018; Cavaliere, Fabio/L-7247-2019; Volonté, Cinzia/N-6474-2013	cavaliere, fabio/0000-0003-2003-522X; Castiglione, Filippo/0000-0002-1442-3552; Alberdi, Elena/0000-0002-8000-142X; Matute, Carlos/0000-0001-8672-711X; Alberdi, Elena/0000-0002-8000-142X; Natalini, Roberto/0000-0002-5453-6383; Cavaliere, Fabio/0000-0003-2003-522X; Volonté, Cinzia/0000-0001-7362-8307; Vergni, Davide/0000-0003-3227-5765; middei, silvia/0000-0002-0488-323X				Agasse F, 2004, EUR J NEUROSCI, V19, P1459, DOI 10.1111/j.1460-9568.2004.03259.x; Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; AlvarezBuylla A, 1997, SEMIN CELL DEV BIOL, V8, P207, DOI 10.1006/scdb.1996.0134; Baker SA, 2004, EUR J NEUROSCI, V20, P575, DOI 10.1111/j.1460-9568.2004.03486.x; Brana C, 2002, BRAIN RES PROTOC, V10, P109, DOI 10.1016/S1385-299X(02)00201-5; Cavaliere F, 2005, NEUROSCIENCE, V136, P615, DOI 10.1016/j.neuroscience.2005.04.038; Cavaliere F, 2001, NEUROCHEM INT, V38, P189, DOI 10.1016/S0197-0186(00)00088-7; Cavaliere F, 2007, J PHARMACOL EXP THER, V323, P70, DOI 10.1124/jpet.106.119024; Cavaliere F, 2006, EXP NEUROL, V201, P66, DOI 10.1016/j.expneurol.2006.03.020; Chechneva O, 2005, NEUROSCIENCE, V136, P343, DOI 10.1016/j.neuroscience.2005.07.058; Chechneva O, 2006, NEUROBIOL DIS, V23, P247, DOI 10.1016/j.nbd.2006.02.015; Coppi E, 2007, STEM CELLS, V25, P1840, DOI 10.1634/stemcells.2006-0669; CORRADIN SB, 1993, GLIA, V7, P255, DOI 10.1002/glia.440070309; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Ernst C, 2006, J NEUROSCI RES, V83, P349, DOI 10.1002/jnr.20724; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GIVAN AL, 1992, FLOW CYTOMETRY; Hammerle B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001169; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Keener J., 1998, INTERD APPL, V8; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kokaia Z, 2006, CEREB CORTEX, V16, pI162, DOI 10.1093/cercor/bhj174; Kristensen BW, 1999, BRAIN RES, V841, P143, DOI 10.1016/S0006-8993(99)01833-8; Lambrecht G, 2000, N-S ARCH PHARMACOL, V362, P340, DOI 10.1007/s002100000312; Langer D, 2007, NEUROSCIENCE, V150, P863, DOI 10.1016/j.neuroscience.2007.07.064; Laskowski A, 2007, NEUROSCI LETT, V415, P17, DOI 10.1016/j.neulet.2006.12.050; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Lim DA, 2007, NEUROSURG CLIN N AM, V18, P81, DOI 10.1016/j.nec.2006.10.002; Liu XX, 2008, P NATL ACAD SCI USA, V105, P11802, DOI 10.1073/pnas.0805180105; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; Maysami S, 2008, J CEREBR BLOOD F MET, V28, P1104, DOI 10.1038/jcbfm.2008.4; MILLER LDP, 1994, NEUROSCIENCE, V63, P471, DOI 10.1016/0306-4522(94)90544-4; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Nomura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001454; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Okano H, 2007, J NEUROCHEM, V102, P1459, DOI 10.1111/j.1471-4159.2007.04674.x; Pardal R, 2007, CELL, V131, P364, DOI 10.1016/j.cell.2007.07.043; Plenz D, 1996, NEUROSCI LETT, V209, P177, DOI 10.1016/0304-3940(96)12644-6; Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809; Sacco RL, 2007, LANCET, V369, P331, DOI 10.1016/S0140-6736(07)60155-X; Schmidt W, 2002, NEUROSCI LETT, V334, P153, DOI 10.1016/S0304-3940(02)01072-8; Slusarski DC, 2007, DEV BIOL, V307, P1, DOI 10.1016/j.ydbio.2007.04.043; Stafford MR, 2007, MOL CELL NEUROSCI, V35, P535, DOI 10.1016/j.mcn.2007.04.013; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; Takasawa K, 2002, J CEREBR BLOOD F MET, V22, P299, DOI 10.1097/00004647-200203000-00007; Taupin P, 2006, CURR OPIN MOL THER, V8, P225; Volonte C, 2003, CNS NEUROL DISORD-DR, V2, P403, DOI 10.2174/1568007033482643; Waldau B, 2008, CELL MOL LIFE SCI, V65, P2372, DOI 10.1007/s00018-008-8053-y; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	53	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5278	10.1371/journal.pone.0005278	http://dx.doi.org/10.1371/journal.pone.0005278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390597	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514200008
J	Dzirasa, K; Santos, LM; Ribeiro, S; Stapleton, J; Gainetdinov, RR; Caron, MG; Nicolelis, MAL				Dzirasa, Kafui; Santos, Lucas M.; Ribeiro, Sidarta; Stapleton, Jennifer; Gainetdinov, Raul R.; Caron, Marc G.; Nicolelis, Miguel A. L.			Persistent Hyperdopaminergia Decreases the Peak Frequency of Hippocampal Theta Oscillations during Quiet Waking and REM Sleep	PLOS ONE			English	Article								Long-term changes in dopaminergic signaling are thought to underlie the pathophysiology of a number of psychiatric disorders. Several conditions are associated with cognitive deficits such as disturbances in attention processes and learning and memory, suggesting that persistent changes in dopaminergic signaling may alter neural mechanisms underlying these processes. Dopamine transporter knockout (DAT-KO) mice exhibit a persistent five-fold increase in extracellular dopamine levels. Here, we demonstrate that DAT-KO mice display lower hippocampal theta oscillation frequencies during baseline periods of waking and rapid-eye movement sleep. These altered theta oscillations are not reversed via treatment with the antidopaminergic agent haloperidol. Thus, we propose that persistent hyperdopaminergia, together with secondary alterations in other neuromodulatory systems, results in lower frequency activity in neural systems responsible for various cognitive processes.			Dzirasa, K (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	nicoleli@neuro.duke.edu	Gainetdinov, Raul R/G-5875-2011; Dzirasa, Kafui/GQB-1424-2022; Ribeiro, Sidarta/C-5794-2016	Gainetdinov, Raul R/0000-0003-2951-6038; Ribeiro, Sidarta/0000-0001-9325-9545	NINDS NIH HHS [R33 NS049534] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R33NS049534] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRAGIN A, 1995, J NEUROSCI, V15, P47; Breitenstein C, 2006, NEUROPSYCHOPHARMACOL, V31, P2552, DOI 10.1038/sj.npp.1301167; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CARLSSON A, 1987, ANNU REV NEUROSCI, V10, P19; Dzirasa K, 2006, J NEUROSCI, V26, P10577, DOI 10.1523/JNEUROSCI.1767-06.2006; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Gainetdinov RR, 2001, P NATL ACAD SCI USA, V98, P11047, DOI 10.1073/pnas.191353298; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gordon JA, 2005, J NEUROSCI, V25, P6509, DOI 10.1523/JNEUROSCI.1211-05.2005; Horschitz S, 2005, MOL PSYCHIATR, V10, P1104, DOI 10.1038/sj.mp.4001730; Jones SR, 1998, J NEUROSCI, V18, P1979; JOUVET M, 1969, SCIENCE, V163, P32, DOI 10.1126/science.163.3862.32; Jucaite A, 2005, BIOL PSYCHIAT, V57, P229, DOI 10.1016/j.biopsych.2004.11.009; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kichigina V F, 2004, Zh Vyssh Nerv Deiat Im I P Pavlova, V54, P210; Kudina T A, 2004, Neurosci Behav Physiol, V34, P929, DOI 10.1023/B:NEAB.0000042576.39132.f5; Laruelle M, 1999, J PSYCHOPHARMACOL, V13, P358, DOI 10.1177/026988119901300405; Lu J, 2006, J NEUROSCI, V26, P193, DOI 10.1523/JNEUROSCI.2244-05.2006; Nakagawa T, 2000, Nihon Shinkei Seishin Yakurigaku Zasshi, V20, P71; Neumeister A, 2004, J NEUROSCI, V24, P589, DOI 10.1523/JNEUROSCI.4921-03.2004; Pogorelov VM, 2005, NEUROPSYCHOPHARMACOL, V30, P1818, DOI 10.1038/sj.npp.1300724; SANTOS LM, 2008, BEHAV BRAIN IN PRESS; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; SHIN J, 2005, P NATL ACAD SCI US, V102; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Staub DR, 2006, BRAIN RES, V1070, P77, DOI 10.1016/j.brainres.2005.10.096; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; TEITELBAUM H, 1975, Science (Washington D C), V188, P1114, DOI 10.1126/science.175440; TIMOIARIA C, 1970, PHYSIOL BEHAV, V5, P1057, DOI 10.1016/0031-9384(70)90162-9; VANDERWOLF CH, 1986, BRAIN RES, V374, P342, DOI 10.1016/0006-8993(86)90428-2; Vanderwolf CH, 1977, CIBA F SYMP, P199; Wespatat V, 2004, J NEUROSCI, V24, P9067, DOI 10.1523/JNEUROSCI.2221-04.2004; Wu NP, 2007, J NEUROPHYSIOL, V98, P423, DOI 10.1152/jn.00971.2006; Yamamoto J, 1997, PSYCHOPHARMACOLOGY, V131, P379, DOI 10.1007/s002130050306; ZETLER G, 1985, PHARMACOLOGY, V31, P318, DOI 10.1159/000138140	37	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5238	10.1371/journal.pone.0005238	http://dx.doi.org/10.1371/journal.pone.0005238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381303	Green Published, gold, Green Submitted			2022-12-27	WOS:000265513800011
J	He, Y; Wang, JH; Wang, L; Chen, ZJ; Yan, CG; Yang, H; Tang, HH; Zhu, CZ; Gong, QY; Zang, YF; Evans, AC				He, Yong; Wang, Jinhui; Wang, Liang; Chen, Zhang J.; Yan, Chaogan; Yang, Hong; Tang, Hehan; Zhu, Chaozhe; Gong, Qiyong; Zang, Yufeng; Evans, Alan C.			Uncovering Intrinsic Modular Organization of Spontaneous Brain Activity in Humans	PLOS ONE			English	Article							RESTING-STATE NETWORKS; FUNCTIONAL CONNECTIVITY; DEFAULT MODE; COMMUNITY STRUCTURE; COMPONENT ANALYSIS; CEREBRAL-CORTEX; LOW-FREQUENCY; FLUCTUATIONS; ARCHITECTURE; ATTENTION	The characterization of topological architecture of complex brain networks is one of the most challenging issues in neuroscience. Slow (< 0.1 Hz), spontaneous fluctuations of the blood oxygen level dependent (BOLD) signal in functional magnetic resonance imaging are thought to be potentially important for the reflection of spontaneous neuronal activity. Many studies have shown that these fluctuations are highly coherent within anatomically or functionally linked areas of the brain. However, the underlying topological mechanisms responsible for these coherent intrinsic or spontaneous fluctuations are still poorly understood. Here, we apply modern network analysis techniques to investigate how spontaneous neuronal activities in the human brain derived from the resting-state BOLD signals are topologically organized at both the temporal and spatial scales. We first show that the spontaneous brain functional networks have an intrinsically cohesive modular structure in which the connections between regions are much denser within modules than between them. These identified modules are found to be closely associated with several well known functionally interconnected subsystems such as the somatosensory/motor, auditory, attention, visual, subcortical, and the "default'' system. Specifically, we demonstrate that the module-specific topological features can not be captured by means of computing the corresponding global network parameters, suggesting a unique organization within each module. Finally, we identify several pivotal network connectors and paths (predominantly associated with the association and limbic/paralimbic cortex regions) that are vital for the global coordination of information flow over the whole network, and we find that their lesions (deletions) critically affect the stability and robustness of the brain functional system. Together, our results demonstrate the highly organized modular architecture and associated topological properties in the temporal and spatial brain functional networks of the human brain that underlie spontaneous neuronal dynamics, which provides important implications for our understanding of how intrinsically coherent spontaneous brain activity has evolved into an optimal neuronal architecture to support global computation and information integration in the absence of specific stimuli or behaviors.	[He, Yong; Wang, Jinhui; Wang, Liang; Yan, Chaogan; Zhu, Chaozhe; Zang, Yufeng] Beijing Normal Univ, State Key Lab Cognit Neurosci, Beijing 100875, Peoples R China; [Chen, Zhang J.; Evans, Alan C.] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Yang, Hong] Zhejiang Univ, Affiliated Hosp 1, Coll Med Sci, Dept Radiol, Hangzhou, Peoples R China; [Yang, Hong; Tang, Hehan; Gong, Qiyong] Sichuan Univ, West China Hosp, Huaxi MR Res Ctr, Dept Radiol, Chengdu, Peoples R China	Beijing Normal University; McGill University; Zhejiang University; Sichuan University	He, Y (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci, Beijing 100875, Peoples R China.	yong.he@bnu.edu.cn	Evans, Alan C/B-2373-2013; Gong, Qiyong/W-3052-2019; Yan, Chao-Gan/D-1713-2015; Wang, jinhui/AAF-8668-2019; He, Yong/C-2161-2009; He, Yong/Q-5756-2018; ZANG, Yu-Feng/J-1558-2012	Evans, Alan C/0000-0003-3841-6098; Gong, Qiyong/0000-0002-5912-4871; Yan, Chao-Gan/0000-0003-3413-5977; ZANG, Yu-Feng/0000-0003-1833-8010				Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BOCCALETTI S, 2006, COMPLEX NETWORKS STR, P175; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullinaria JA, 2007, COGNITIVE SCI, V31, P673, DOI 10.1080/15326900701399939; CHEN ZJ, 2008, CEREB CORTEX; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Cohen MX, 2008, EUR J NEUROSCI, V27, P1534, DOI 10.1111/j.1460-9568.2008.06117.x; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Ferrarini L., 2008, HUM BRAIN MAPP; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; GONG G, 2008, CEREB CORTEX; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hintze A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040023; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Kaiser M, 2004, BIOL CYBERN, V90, P311, DOI 10.1007/s00422-004-0479-1; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Kiviniemi V, 2003, NEUROIMAGE, V19, P253, DOI 10.1016/S1053-8119(03)00097-1; Kotter R, 2003, NEURAL NETWORKS, V16, P1261, DOI 10.1016/j.neunet.2003.06.002; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Popuri K, 2020, HUM BRAIN MAPP, V41, P4127, DOI 10.1002/hbm.25115; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Schwarz AJ, 2008, MAGN RESON IMAGING, V26, P914, DOI 10.1016/j.mri.2008.01.048; Spirin V, 2006, P NATL ACAD SCI USA, V103, P8774, DOI 10.1073/pnas.0510258103; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; WANG J, 2008, HUM BRAIN MAPP; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wink AM, 2006, NEUROBIOL AGING, V27, P1395, DOI 10.1016/j.neurobiolaging.2005.08.011; Wolf DM, 2003, CURR OPIN MICROBIOL, V6, P125, DOI 10.1016/S1369-5274(03)00033-X; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	84	472	495	3	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5226	10.1371/journal.pone.0005226	http://dx.doi.org/10.1371/journal.pone.0005226			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381298	Green Submitted, Green Published, gold			2022-12-27	WOS:000265513800007
J	Kucharz, K; Krogh, M; Ng, AN; Toresson, H				Kucharz, Krzysztof; Krogh, Morten; Ng, Ai Na; Toresson, Hakan			NMDA Receptor Stimulation Induces Reversible Fission of the Neuronal Endoplasmic Reticulum	PLOS ONE			English	Article								With few exceptions the endoplasmic reticulum (ER) is considered a continuous system of endomembranes within which proteins and ions can move. We have studied dynamic structural changes of the ER in hippocampal neurons in primary culture and organotypic slices. Fluorescence recovery after photobleaching (FRAP) was used to quantify and model ER structural dynamics. Ultrastructure was assessed by electron microscopy. In live cell imaging experiments we found that, under basal conditions, the ER of neuronal soma and dendrites was continuous. The smooth and uninterrupted appearance of the ER changed dramatically after glutamate stimulation. The ER fragmented into isolated vesicles in a rapid fission reaction that occurred prior to overt signs of neuronal damage. ER fission was found to be independent of ER calcium levels. Apart from glutamate, the calcium ionophore ionomycin was able to induce ER fission. The N-methyl, D-aspartate (NMDA) receptor antagonist MK-801 inhibited ER fission induced by glutamate as well as by ionomycin. Fission was not blocked by either ifenprodil or kinase inhibitors. Interestingly, sub-lethal NMDA receptor stimulation caused rapid ER fission followed by fusion. Hence, ER fission is not strictly associated with cellular damage or death. Our results thus demonstrate that neuronal ER structure is dynamically regulated with important consequences for protein mobility and ER luminal calcium tunneling.			Kucharz, K (corresponding author), Lund Univ, Dept Clin Sci Lund, Wallenberg Neurosci Ctr, Expt Brain Res Lab, Lund, Sweden.	hakan.toresson@med.lu.se		Kucharz, Krzysztof/0000-0002-6852-5300; Ng, Ai Na/0000-0002-6219-5523				Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Cheung ECC, 2007, APOPTOSIS, V12, P979, DOI 10.1007/s10495-007-0745-5; Choi YM, 2006, J NEUROSCI, V26, P12127, DOI 10.1523/JNEUROSCI.3158-06.2006; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; Fam NP, 1997, MOL CELL BIOL, V17, P1396, DOI 10.1128/MCB.17.3.1396; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Harmer AR, 2002, BIOCHEM J, V367, P137, DOI 10.1042/BJ20020305; Horton AC, 2003, J NEUROSCI, V23, P6188; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Jones VC, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-10; KOCH GLE, 1988, J CELL SCI, V91, P511; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; MARTONE ME, 1993, J NEUROSCI, V13, P4636; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mattson MP, 2000, J NEUROSCI, V20, P1358; Meldolesi J, 2001, PROG NEUROBIOL, V65, P309, DOI 10.1016/S0301-0082(01)00004-1; Ng AN, 2008, FASEB J, V22, P2832, DOI 10.1096/fj.07-103903; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; Paschen W, 2005, CELL CALCIUM, V38, P409, DOI 10.1016/j.ceca.2005.06.019; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; Petersen OH, 2007, CELL CALCIUM, V42, P373, DOI 10.1016/j.ceca.2007.05.012; PETITO CK, 1984, J CEREBR BLOOD F MET, V4, P194, DOI 10.1038/jcbfm.1984.28; PETITO CK, 1984, J NEUROPATH EXP NEUR, V43, P141, DOI 10.1097/00005072-198403000-00004; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Ribeiro CMP, 2000, CELL CALCIUM, V27, P175, DOI 10.1054/ceca.2000.0108; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Rytter A, 2003, J CEREBR BLOOD F MET, V23, P23, DOI 10.1097/01.WCB.0000034361.37277.1B; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Solovyova N, 2003, PFLUG ARCH EUR J PHY, V446, P447, DOI 10.1007/s00424-003-1094-z; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Subramanian K, 1997, CELL, V89, P963, DOI 10.1016/S0092-8674(00)80281-0; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Terasaki M, 1996, DEV BIOL, V179, P320, DOI 10.1006/dbio.1996.0263; TERASAKI M, 1991, J CELL BIOL, V114, P929, DOI 10.1083/jcb.114.5.929; TERASAKI M, 1994, P NATL ACAD SCI USA, V91, P7510, DOI 10.1073/pnas.91.16.7510; Toresson H, 2005, EUR J NEUROSCI, V22, P1793, DOI 10.1111/j.1460-9568.2005.04342.x; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Wang C, 2002, J CEREBR BLOOD F MET, V22, P206, DOI 10.1097/00004647-200202000-00008; Wei HF, 1996, J NEUROCHEM, V67, P2390; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	48	34	37	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5250	10.1371/journal.pone.0005250	http://dx.doi.org/10.1371/journal.pone.0005250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381304	Green Published, gold, Green Submitted			2022-12-27	WOS:000265513800015
J	Majumdar, I; Kinch, LN; Grishin, NV				Majumdar, Indraneel; Kinch, Lisa N.; Grishin, Nick V.			A Database of Domain Definitions for Proteins with Complex Interdomain Geometry	PLOS ONE			English	Article								Protein structural domains are necessary for understanding evolution and protein folding, and may vary widely from functional and sequence based domains. Although, various structural domain databases exist, defining domains for some proteins is non-trivial, and definitions of their domain boundaries are not available. Here, we present a novel database of manually defined structural domains for a representative set of proteins from the SCOP "multi-domain proteins'' class. (http://prodata.swmed.edu/multidom/). We consider our domains as mobile evolutionary units, which may rearrange during protein evolution. Additionally, they may be visualized as structurally compact and possibly independently folding units. We also found that representing domains as evolutionary and folding units do not always lead to a unique domain definition. However, unlike existing databases, we retain and refine these "alternate'' domain definitions after careful inspection of structural similarity, functional sites and automated domain definition methods. We provide domain definitions, including actual residue boundaries, for proteins that well known databases like SCOP and CATH do not attempt to split. Our alternate domain definitions are suitable for sequence and structure searches by automated methods. Additionally, the database can be used for training and testing domain delineation algorithms. Since our domains represent structurally compact evolutionary units, the database may be useful for studying domain properties and evolution.			Majumdar, I (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	indraneel@chop.swmed.edu; grishin@chop.swmed.edu		Kinch, Lisa/0000-0003-3041-2615	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067165] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM67165, R01 GM067165] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandrov N, 2003, BIOINFORMATICS, V19, P429, DOI 10.1093/bioinformatics/btg006; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Augustin MA, 2001, NAT STRUCT BIOL, V8, P57, DOI 10.1038/83060; BARON M, 1991, TRENDS BIOCHEM SCI, V16, P13, DOI 10.1016/0968-0004(91)90009-K; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Hegyi H, 1997, J PROTEIN CHEM, V16, P545, DOI 10.1023/A:1026382032119; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; JANIN J, 1985, METHOD ENZYMOL, V115, P420; Kamada K, 1996, NATURE, V383, P598, DOI 10.1038/383598a0; Kinch LN, 2003, PROTEINS, V53, P395, DOI 10.1002/prot.10557; LEVITT M, 1976, NATURE, V261, P552, DOI 10.1038/261552a0; Majumdar I, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-202; Murzin AG, 1998, CURR OPIN STRUC BIOL, V8, P380, DOI 10.1016/S0959-440X(98)80073-0; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; PHILLIPS DC, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1166-78; ROSE GD, 1979, J MOL BIOL, V134, P447, DOI 10.1016/0022-2836(79)90363-2; RUSSELL RB, 1994, PROTEIN ENG, V7, P1407, DOI 10.1093/protein/7.12.1407; SIDDIQUI AS, 1995, PROTEIN SCI, V4, P872; SWINDELLS MB, 1995, PROTEIN SCI, V4, P103; Veretnik S, 2004, J MOL BIOL, V339, P647, DOI 10.1016/j.jmb.2004.03.053; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; WETLAUFER DB, 1973, ANNU REV BIOCHEM, V42, P135, DOI 10.1146/annurev.bi.42.070173.001031; ZEHFUS MH, 1986, BIOCHEMISTRY-US, V25, P5759, DOI 10.1021/bi00367a062	28	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5084	10.1371/journal.pone.0005084	http://dx.doi.org/10.1371/journal.pone.0005084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352501	Green Submitted, Green Published, gold			2022-12-27	WOS:000265505700007
J	Irelan, JT; del Arroyo, AG; Gutierrez, A; Peters, G; Quon, KC; Miraglia, L; Chanda, SK				Irelan, Jeffrey T.; del Arroyo, Ana Gutierrez; Gutierrez, Abel; Peters, Gordon; Quon, Kim C.; Miraglia, Loren; Chanda, Sumit K.			A Functional Screen for Regulators of CKDN2A Reveals MEOX2 as a Transcriptional Activator of INK4a	PLOS ONE			English	Article								The CDKN2A locus encodes two important tumor suppressors, INK4a and ARF, which respond to oncogenic stresses by inducing cellular senescence. We conducted a genome-scale cDNA overexpression screen using a reporter containing INK4a regulatory sequences to identify novel transcriptional activators of this locus. This screen revealed 285 cDNAs that putatively regulate the transcriptional activation of INK4a. Of these, 56 are annotated as transcription factors, including two previously reported activators of the locus, ETS2 and JUNB. Fourteen genes were further validated for activity and specificity, including several homeodomain proteins. We found that the transcription of one of these, the homeodomain protein MEOX2 ( GAX) is enhanced in primary cells during the induction of senescence, and forced expression of this protein results in the induction of premature senescence. We further demonstrate that MEOX2-induced senescence is dependent upon INK4a activity, and chromatin immunoprecipitation studies indicate that MEOX2 directly binds the INK4a promoter. These results support a role for this homeodomain protein as a direct regulator of INK4a transcription and senescence in human cells.	[Irelan, Jeffrey T.; Gutierrez, Abel; Quon, Kim C.; Miraglia, Loren; Chanda, Sumit K.] Novo Res Fdn, Genom Inst, San Diego, CA USA; [del Arroyo, Ana Gutierrez; Peters, Gordon] CRUK London Res Inst, London, England	Cancer Research UK	Irelan, JT (corresponding author), Novo Res Fdn, Genom Inst, San Diego, CA USA.	jirelan@gmail.com; schanda@burnham.org			Genomics Institute of the Novartis Research Foundation	Genomics Institute of the Novartis Research Foundation	This work was supported by the Genomics Institute of the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen Y, 2007, J BIOL CHEM, V282, P507, DOI 10.1074/jbc.M606604200; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Cortese R, 2008, INT J BIOCHEM CELL B, V40, P1494, DOI 10.1016/j.biocel.2007.11.018; GORSKI DH, 1993, MOL CELL BIOL, V13, P3722, DOI 10.1128/MCB.13.6.3722; Mankoo BS, 2003, DEVELOPMENT, V130, P4655, DOI 10.1242/dev.00687; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Owens BM, 2002, STEM CELLS, V20, P364, DOI 10.1634/stemcells.20-5-364; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Park YB, 2002, CANCER GENET CYTOGEN, V133, P105, DOI 10.1016/S0165-4608(01)00575-1; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sherr CJ, 2001, CELL, V106, P531, DOI 10.1016/S0092-8674(01)00486-X; Smith RC, 1997, GENE DEV, V11, P1674, DOI 10.1101/gad.11.13.1674; Wang W, 2001, J BIOL CHEM, V276, P48655, DOI 10.1074/jbc.M108278200; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287	22	24	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5067	10.1371/journal.pone.0005067	http://dx.doi.org/10.1371/journal.pone.0005067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340300	gold, Green Published, Green Submitted			2022-12-27	WOS:000265500700011
J	Shen, HCJ; Adem, A; Ylaya, K; Wilson, A; He, M; Lorang, D; Hewitt, SM; Pechhold, K; Harlan, DM; Lubensky, IA; Schmidt, LS; Linehan, WM; Libutti, SK				Shen, H. -C. Jennifer; Adem, Asha; Ylaya, Kris; Wilson, Arianne; He, Mei; Lorang, Dominique; Hewitt, Stephen M.; Pechhold, Klaus; Harlan, David M.; Lubensky, Irina A.; Schmidt, Laura S.; Linehan, W. Marston; Libutti, Steven K.			Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations	PLOS ONE			English	Article								The von Hippel-Lindau (VHL) syndrome is a pleomorphic familial disease characterized by the development of highly vascularized tumors, such as hemangioblastomas of the central nervous system, pheochromocytomas, renal cell carcinomas, cysts and neuroendocrine tumors of the pancreas. Up to 75% of VHL patients are affected by VHL-associated pancreatic lesions; however, very few reports in the published literature have described the cellular origins and biological roles of VHL in the pancreas. Since homozygous loss of Vhl in mice resulted in embryonic lethality, this study aimed to characterize the functional significance of VHL in the pancreas by conditionally inactivating Vhl utilizing the Cre/LoxP system. Specifically, Vhl was inactivated in different pancreatic cell populations distinguished by their roles during embryonic organ development and their endocrine lineage commitment. With Cre recombinase expression directed by a glucagon promoter in a-cells or an insulin promoter in beta-cells, we showed that deletion of Vhl is dispensable for normal functions of the endocrine pancreas. In addition, deficiency of VHL protein (pVHL) in terminally differentiated alpha-cells or beta-cells is insufficient to induce pancreatic neuroendocrine tumorigenesis. Most significantly, we presented the first mouse model of VHL-associated pancreatic disease in mice lacking pVHL utilizing Pdx1-Cre transgenic mice to inactivate Vhl in pancreatic progenitor cells. The highly vascularized microcystic adenomas and hyperplastic islets that developed in Pdx1-Cre; Vhl f/f homozygous mice exhibited clinical features similar to VHL patients. Establishment of three different, cell-specific Vhl knockouts in the pancreas have allowed us to provide evidence suggesting that VHL is functionally important for postnatal ductal and exocrine pancreas, and that VHL-associated pancreatic lesions are likely to originate from progenitor cells, not mature endocrine cells. The novel model systems reported here will provide the basis for further functional and genetic studies to define molecular mechanisms involved in VHL-associated pancreatic diseases.	[Shen, H. -C. Jennifer; Adem, Asha; Wilson, Arianne; He, Mei; Lorang, Dominique; Libutti, Steven K.] NCI, Surg Branch, Tumor Angiogenesis Sect, Bethesda, MD 20892 USA; [Ylaya, Kris; Hewitt, Stephen M.] NCI, Lab Pathol, Tissue Array Res Program, Bethesda, MD USA; [Pechhold, Klaus; Harlan, David M.] NIDDKD, Diabetes Branch, Bethesda, MD USA; [Lubensky, Irina A.] NCI, Div Canc Treatment & Diagnosis, Rockville, MD USA; [Schmidt, Laura S.; Linehan, W. Marston] NCI, Urol Oncol Branch, Bethesda, MD USA; [Schmidt, Laura S.] NCI, Sci Applicat Int Corp SAIC Frederick Inc, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Shen, HCJ (corresponding author), NCI, Surg Branch, Tumor Angiogenesis Sect, Bldg 10, Bethesda, MD 20892 USA.	Steven_Libutti@nih.gov		Hewitt, Stephen/0000-0001-8283-1788	Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute (NCI), [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC011038, ZIABC011028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055113] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute (NCI),(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute (NCI), and with federal funds from the NIH-NCI, under contract HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT LC, 1988, AM J SURG PATHOL, V12, P251, DOI 10.1097/00000478-198804000-00001; Biju MP, 2004, MOL CELL BIOL, V24, P9038, DOI 10.1128/MCB.24.20.9038-9047.2004; BINKOVITZ LA, 1990, AM J ROENTGENOL, V155, P501, DOI 10.2214/ajr.155.3.1974734; Blansfield JA, 2007, SURGERY, V142, P814, DOI 10.1016/j.surg.2007.09.012; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Cohen HT, 1999, BIOCHEM BIOPH RES CO, V266, P43, DOI 10.1006/bbrc.1999.1767; Couch V, 2000, MAYO CLIN PROC, V75, P265; Esteban-Barragan MA, 2002, CANCER RES, V62, P2929; Flamme I, 1998, AM J PATHOL, V153, P25, DOI 10.1016/S0002-9440(10)65541-1; Friedrich CA, 2001, HUM MOL GENET, V10, P763, DOI 10.1093/hmg/10.7.763; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; Glavac D, 1996, HUM GENET, V98, P271, DOI 10.1007/s004390050206; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Herrera PL, 2002, ENDOCRINE, V19, P267, DOI 10.1385/ENDO:19:3:267; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hong SB, 2006, LAB INVEST, V86, P664, DOI 10.1038/labinvest.3700431; HOUGH DM, 1994, AM J ROENTGENOL, V162, P1091, DOI 10.2214/ajr.162.5.8165988; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; KESSLER PM, 1995, MOL MED, V1, P457, DOI 10.1007/BF03401583; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Libutti SK, 1998, SURGERY, V124, P1153, DOI 10.1067/msy.1998.91823; LINEHAN WM, 1995, JAMA-J AM MED ASSOC, V273, P564; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lubensky IA, 1998, AM J PATHOL, V153, P223, DOI 10.1016/S0002-9440(10)65563-0; Ma WB, 2003, CANCER RES, V63, P5320; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mohr VH, 2000, AM J PATHOL, V157, P1615, DOI 10.1016/S0002-9440(10)64799-2; MOROHOSHI T, 1983, HISTOPATHOLOGY, V7, P645, DOI 10.1111/j.1365-2559.1983.tb02277.x; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; NEUMANN HPH, 1991, GASTROENTEROLOGY, V101, P465, DOI 10.1016/0016-5085(91)90026-H; NYONGO A, 1985, AM J CLIN PATHOL, V84, P114, DOI 10.1093/ajcp/84.1.114; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Pal S, 1997, J BIOL CHEM, V272, P27509, DOI 10.1074/jbc.272.44.27509; Park DM, 2007, PLOS MED, V4, P333, DOI 10.1371/journal.pmed.0040060; Park SK, 2007, INT J ONCOL, V30, P341; Pfander D, 2004, DEVELOPMENT, V131, P2497, DOI 10.1242/dev.01138; Pioli PA, 2001, J BIOL CHEM, V276, P40346, DOI 10.1074/jbc.M105391200; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Richards FM, 1996, HUM MOL GENET, V5, P639, DOI 10.1093/hmg/5.5.639; Shen HCJ, 2008, ENDOCR-RELAT CANCER, V15, P267, DOI 10.1677/ERC-07-0191; SHORTEN SD, 1986, AM J SURG PATHOL, V10, P365, DOI 10.1097/00000478-198606000-00001; Tang N, 2006, MOL CELL BIOL, V26, P2519, DOI 10.1128/MCB.26.7.2519-2530.2006; Thurston G, 1996, AM J PHYSIOL-HEART C, V271, pH2547, DOI 10.1152/ajpheart.1996.271.6.H2547	50	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e4897	10.1371/journal.pone.0004897	http://dx.doi.org/10.1371/journal.pone.0004897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340311	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500700001
J	Tan, M; Xia, M; Chen, YT; Bu, WM; Hegde, RS; Meller, J; Li, XM; Jiang, X				Tan, Ming; Xia, Ming; Chen, Yutao; Bu, Weiming; Hegde, Rashmi S.; Meller, Jarek; Li, Xuemei; Jiang, Xi			Conservation of Carbohydrate Binding Interfaces - Evidence of Human HBGA Selection in Norovirus Evolution	PLOS ONE			English	Article							BLOOD GROUP ANTIGENS; NORWALK VIRUS-INFECTION; CAPSID PROTEIN FORMS; RECEPTOR-BINDING; STRUCTURAL BASIS; P-DOMAIN; PARTICLE; FAMILY; ABO; CLASSIFICATION	Background: Human noroviruses are the major viral pathogens of epidemic acute gastroenteritis. These genetically diverse viruses comprise two major genogroups (GI and GII) and approximately 30 genotypes. Noroviruses recognize human histo-blood group antigens (HBGAs) in a diverse, strain-specific manner. Recently the crystal structures of the HBGA-binding interfaces of the GI Norwalk virus and the GII VA387 have been determined, which allows us to examine the genetic and structural relationships of the HBGA-binding interfaces of noroviruses with variable HBGA-binding patterns. Our hypothesis is that, if HBGAs are the viral receptors necessary for norovirus infection and spread, their binding interfaces should be under a selection pressure in the evolution of noroviruses. Methods and Findings: Structural comparison of the HBGA-binding interfaces of the two noroviruses has revealed shared features but significant differences in the location, sequence composition, and HBGA-binding modes. On the other hand, the primary sequences of the HBGA-binding interfaces are highly conserved among strains within each genogroup. The roles of critical residues within the binding sites have been verified by site-directed mutagenesis followed by functional analysis of strains with variable HBGA-binding patterns. Conclusions and Significance: Our data indicate that the human HBGAs are an important factor in norovirus evolution. Each of the two major genogroups represents an evolutionary lineage characterized by distinct genetic traits. Functional convergence of strains with the same HBGA targets subsequently resulted in acquisition of analogous HBGA binding interfaces in the two genogroups that share an overall structural similarity, despite their distinct locations and amino acid compositions. On the other hand, divergent evolution may have contributed to the observed overall differences between and within the two lineages. Thus, both divergent and convergent evolution, as well as the polymorphic human HBGAs, likely contribute to the diversity of noroviruses. The finding of genogroup-specific conservation of HBGA binding interfaces will facilitate the development of rational strategies to control and prevent norovirus-associated gastroenteritis.	[Tan, Ming; Xia, Ming; Jiang, Xi] Cincinnati Childrens Hosp, Med Ctr, Div Infect Dis, Cincinnati, OH USA; [Tan, Ming; Hegde, Rashmi S.; Meller, Jarek; Jiang, Xi] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Bu, Weiming; Hegde, Rashmi S.] Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH USA; [Meller, Jarek] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45221 USA; [Chen, Yutao; Li, Xuemei] Chinese Acad Sci, Inst Biophys, Natl Lab Bio Macromol, Beijing 100864, Peoples R China	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Chinese Academy of Sciences; Institute of Biophysics, CAS	Tan, M (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Infect Dis, Cincinnati, OH USA.	jason.jiang@cchmc.org	Xia, Ming/AAY-7154-2021; Meller, Jaroslaw/A-1971-2011	Meller, Jaroslaw/0000-0002-1162-8253	National Institute of Health, the National Institute of Allergy and Infectious diseases [R01 AI37093, R01 AI55649]; National Institute of Child Health [PO1 HD13021]; Department of Defense [PR033018]; Translational Research Initiative of Cincinnati Children's Hospital Medical Center [SPR102032]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD013021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055649, R01AI037093] Funding Source: NIH RePORTER	National Institute of Health, the National Institute of Allergy and Infectious diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Department of Defense(United States Department of Defense); Translational Research Initiative of Cincinnati Children's Hospital Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research described in this article was supported by the National Institute of Health, the National Institute of Allergy and Infectious diseases (R01 AI37093 and R01 AI55649) and National Institute of Child Health (PO1 HD13021), and the Department of Defense (PR033018) to X.J. This work was also supported by a grant from the Translational Research Initiative of Cincinnati Children's Hospital Medical Center (SPR102032) to M.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briscoe AD, 2000, J MOL EVOL, V51, P110, DOI 10.1007/s002390010071; Bu WM, 2008, J VIROL, V82, P5340, DOI 10.1128/JVI.00135-08; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; da Silva AK, 2007, APPL ENVIRON MICROB, V73, P7891, DOI 10.1128/AEM.01428-07; Estes MK, 2006, CURR OPIN INFECT DIS, V19, P467, DOI 10.1097/01.qco.0000244053.69253.3d; FARKAS T, 2008, 27 ANN M AM SOC VIR; Farkas T, 2008, J VIROL, V82, P5408, DOI 10.1128/JVI.00070-08; Fukami-Kobayashi K, 2003, MOL BIOL EVOL, V20, P267, DOI 10.1093/molbev/msg038; GREEN KY, 2001, FIELDS VIROLOGY, P841; GREENBERG HB, 1981, J VIROL, V37, P994, DOI 10.1128/JVI.37.3.994-999.1981; HARDY ME, 1995, J VIROL, V69, P1693, DOI 10.1128/JVI.69.3.1693-1698.1995; Harrington PR, 2004, J VIROL, V78, P3035, DOI 10.1128/JVI.78.6.3035-3045.2004; Harrington PR, 2002, J VIROL, V76, P12335, DOI 10.1128/JVI.76.23.12335-12343.2002; HEDLUND K, 2007, 3 INT CAL C, P38; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; Hutson AM, 2005, J MED VIROL, V77, P116, DOI 10.1002/jmv.20423; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; Ming Tan, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000348; MOE C, 2007, 3 INT CAL C; Oliver SL, 2006, VIROLOGY, V350, P240, DOI 10.1016/j.virol.2006.02.027; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Ruvoen-Clouet N, 2000, J VIROL, V74, P11950, DOI 10.1128/JVI.74.24.11950-11954.2000; Scipioni A, 2008, VET J, V178, P32, DOI 10.1016/j.tvjl.2007.11.012; Shirato H, 2008, J VIROL, V82, P10756, DOI 10.1128/JVI.00802-08; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Stuart AD, 2007, J GEN VIROL, V88, P177, DOI 10.1099/vir.0.82158-0; Sumiyama K, 2000, GENE, V259, P75, DOI 10.1016/S0378-1119(00)00440-6; Tan M, 2005, J VIROL, V79, P14017, DOI 10.1128/JVI.79.22.14017-14030.2005; Tan M, 2005, TRENDS MICROBIOL, V13, P285, DOI 10.1016/j.tim.2005.04.004; Tan M, 2004, J VIROL, V78, P6233, DOI 10.1128/JVI.78.12.6233-6242.2004; Tan M, 2004, J MED VIROL, V74, P641, DOI 10.1002/jmv.20228; Tan M, 2003, J VIROL, V77, P12562, DOI 10.1128/JVI.77.23.12562-12571.2003; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Tan M, 2008, VIROLOGY, V379, P324, DOI 10.1016/j.virol.2008.06.041; Tan M, 2008, CURR OPIN INVEST DR, V9, P146; Tan M, 2006, J VIROL, V80, P7322, DOI 10.1128/JVI.00233-06; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	45	98	106	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5058	10.1371/journal.pone.0005058	http://dx.doi.org/10.1371/journal.pone.0005058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337380	Green Submitted, Green Published, gold			2022-12-27	WOS:000265500600017
J	Py, B; Basmaciogullari, S; Bouchet, J; Zarka, M; Moura, IC; Benhamou, M; Monteiro, RC; Hocini, H; Madrid, R; Benichou, S				Py, Benedicte; Basmaciogullari, Stephane; Bouchet, Jerome; Zarka, Marion; Moura, Ivan C.; Benhamou, Marc; Monteiro, Renato C.; Hocini, Hakim; Madrid, Ricardo; Benichou, Serge			The Phospholipid Scramblases 1 and 4 Are Cellular Receptors for the Secretory Leukocyte Protease Inhibitor and Interact with CD4 at the Plasma Membrane	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEINASE-INHIBITOR; EPITHELIAL-CELLS; DENDRITIC CELLS; HUMAN SALIVA; BINDS; EXPRESSION; INFECTION; IDENTIFICATION; TRANSMISSION	Secretory leukocyte protease inhibitor (SLPI) is secreted by epithelial cells in all the mucosal fluids such as saliva, cervical mucus, as well in the seminal liquid. At the physiological concentrations found in saliva, SLPI has a specific antiviral activity against HIV-1 that is related to the perturbation of the virus entry process at a stage posterior to the interaction of the viral surface glycoprotein with the CD4 receptor. Here, we confirm that recombinant SLPI is able to inhibit HIV-1 infection of primary T lymphocytes, and show that SLPI can also inhibit the transfer of HIV-1 virions from primary monocyte-derived dendritic cells to autologous T lymphocytes. At the molecular level, we show that SLPI is a ligand for the phospholipid scramblase 1 (PLSCR1) and PLSCR4, membrane proteins that are involved in the regulation of the movements of phospholipids between the inner and outer leaflets of the plasma membrane. Interestingly, we reveal that PLSCR1 and PLSCR4 also interact directly with the CD4 receptor at the cell surface of T lymphocytes. We find that the same region of the cytoplasmic domain of PLSCR1 is involved in the binding to CD4 and SLPI. Since SLPI was able to disrupt the association between PLSCR1 and CD4, our data suggest that SLPI inhibits HIV-1 infection by modulating the interaction of the CD4 receptor with PLSCRs. These interactions may constitute new targets for antiviral intervention.	[Py, Benedicte; Basmaciogullari, Stephane; Bouchet, Jerome; Zarka, Marion; Madrid, Ricardo; Benichou, Serge] Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France; [Py, Benedicte; Basmaciogullari, Stephane; Bouchet, Jerome; Zarka, Marion; Madrid, Ricardo; Benichou, Serge] INSERM, U567, Paris, France; [Moura, Ivan C.; Benhamou, Marc; Monteiro, Renato C.] INSERM, U699, Paris, France; [Moura, Ivan C.; Benhamou, Marc; Monteiro, Renato C.] Univ Paris 07 Denis Diderot, F-75221 Paris, France; [Hocini, Hakim] INSERM, U743, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Benichou, S (corresponding author), Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France.	serge.benichou@inserm.fr	Moura, Ivan C/A-9510-2013; bouchet, jerome/I-7716-2019; Py, Benedicte/M-6129-2014; Monteiro, Renato C/U-8633-2017; Cruz Moura, Ivan/A-9510-2013	Moura, Ivan C/0000-0002-2977-0354; bouchet, jerome/0000-0002-6611-4380; Monteiro, Renato C/0000-0001-5202-5646; Madrid Gonzalez, Ricardo/0000-0002-1350-9864; Cruz Moura, Ivan/0000-0002-8418-2803; py, benedicte/0000-0001-6716-7807; Benhamou, Marc/0000-0001-7763-3795; Benichou, Serge/0000-0003-3602-3530	INSERM; CNRS; Universite Paris-Descartes; French National Agency for AIDS Research (ANRS); Sidaction	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Descartes; French National Agency for AIDS Research (ANRS)(ANRSFrench National Research Agency (ANR)); Sidaction	This work was supported in part by INSERM, CNRS, Universite Paris-Descartes, the French National Agency for AIDS Research (ANRS), and Sidaction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baqui AAMA, 1999, CLIN DIAGN LAB IMMUN, V6, P808, DOI 10.1128/CDLI.6.6.808-811.1999; BENICHOU S, 1994, J BIOL CHEM, V269, P30073; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Bouchard D, 2006, LANCET ONCOL, V7, P167, DOI 10.1016/S1470-2045(06)70579-4; Bouhlal H, 2005, J IMMUNOL, V174, P7202, DOI 10.4049/jimmunol.174.11.7202; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; DEVAUX PF, 1992, ANNU REV BIOPH BIOM, V21, P417, DOI 10.1146/annurev.bb.21.060192.002221; Farquhar C, 2002, J INFECT DIS, V186, P1173, DOI 10.1086/343805; Hocini H, 2000, CLIN DIAGN LAB IMMUN, V7, P515, DOI 10.1128/CDLI.7.3.515-518.2000; Jana NK, 2005, J VIROL, V79, P6432, DOI 10.1128/JVI.79.10.6432-6440.2005; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Kazmi SH, 2006, CLIN VACCINE IMMUNOL, V13, P1111, DOI 10.1128/CDLI.00426-05; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; Li J, 2001, J BIOL CHEM, V276, P18579, DOI 10.1074/jbc.M100846200; Ma G, 2004, J EXP MED, V200, P1337, DOI 10.1084/jem.20041115; MCNEELY TB, 1995, J CLIN INVEST, V96, P456, DOI 10.1172/JCI118056; McNeely TB, 1997, BLOOD, V90, P1141, DOI 10.1182/blood.V90.3.1141.1141_1141_1149; Pastorelli C, 2001, J BIOL CHEM, V276, P20407, DOI 10.1074/jbc.M100790200; Peytavi R, 1999, J BIOL CHEM, V274, P1635, DOI 10.1074/jbc.274.3.1635; Pillay K, 2001, J INFECT DIS, V183, P653, DOI 10.1086/318535; Py B, 2007, APOPTOSIS, V12, P1879, DOI 10.1007/s10495-007-0106-4; RICE WG, 1990, SCIENCE, V249, P178, DOI 10.1126/science.2371565; Ryzhova EV, 2006, J VIROL, V80, P2694, DOI 10.1128/JVI.80.6.2694-2704.2006; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; Sallenave JM, 1997, J LEUKOCYTE BIOL, V61, P695, DOI 10.1002/jlb.61.6.695; Samsom JN, 2007, J IMMUNOL, V179, P6588, DOI 10.4049/jimmunol.179.10.6588; Selig L, 1999, J VIROL, V73, P592, DOI 10.1128/JVI.73.1.592-600.1999; Shine NR, 2002, BIOORG CHEM, V30, P249, DOI 10.1016/S0045-2068(02)00008-1; Shugars D C, 1997, Oral Dis, V3 Suppl 1, pS70; Skott P, 2002, ORAL DIS, V8, P160, DOI 10.1034/j.1601-0825.2002.01807.x; Sun J, 2001, J BIOL CHEM, V276, P28984, DOI 10.1074/jbc.M102505200; Taggart CC, 2005, J EXP MED, V202, P1659, DOI 10.1084/jem.20050768; THOMPSON RC, 1986, P NATL ACAD SCI USA, V83, P6692, DOI 10.1073/pnas.83.18.6692; Tseng CC, 2000, FEBS LETT, V475, P232, DOI 10.1016/S0014-5793(00)01700-2; Wahl S M, 1997, Oral Dis, V3 Suppl 1, pS64; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; Wilflingseder D, 2005, MOL IMMUNOL, V42, P229, DOI 10.1016/j.molimm.2004.06.019; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Zamoyska R, 1998, CURR OPIN IMMUNOL, V10, P82, DOI 10.1016/S0952-7915(98)80036-8; Zhao J, 1998, J BIOL CHEM, V273, P6603, DOI 10.1074/jbc.273.12.6603; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240	42	56	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5006	10.1371/journal.pone.0005006	http://dx.doi.org/10.1371/journal.pone.0005006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333378	Green Submitted, Green Published, gold			2022-12-27	WOS:000265499900010
J	Pozzi, S; Zambelli, F; Merico, D; Pavesi, G; Robert, A; Maltere, P; Gidrol, X; Mantovani, R; Vigano, MA				Pozzi, Silvia; Zambelli, Federico; Merico, Daniele; Pavesi, Giulio; Robert, Amelie; Maltere, Peggy; Gidrol, Xavier; Mantovani, Roberto; Vigano, M. Alessandra			Transcriptional Network of p63 in Human Keratinocytes	PLOS ONE			English	Article								p63 is a transcription factor required for the development and maintenance of ectodermal tissues in general, and skin keratinocytes in particular. The identification of its target genes is fundamental for understanding the complex network of gene regulation governing the development of epithelia. We report a list of almost 1000 targets derived from ChIP on chip analysis on two platforms; all genes analyzed changed in expression during differentiation of human keratinocytes. Functional annotation highlighted unexpected GO terms enrichments and confirmed that genes involved in transcriptional regulation are the most significant. A detailed analysis of these transcriptional regulators in condition of perturbed p63 levels confirmed the role of p63 in the regulatory network. Rather than a rigid master-slave hierarchical model, our data indicate that p63 connects different hubs involved in the multiple specific functions of the skin.	[Pozzi, Silvia; Zambelli, Federico; Merico, Daniele; Pavesi, Giulio; Mantovani, Roberto; Vigano, M. Alessandra] Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy; [Robert, Amelie; Maltere, Peggy; Gidrol, Xavier] CEA, Lab Explorat Fonctionnelle Genomes, Evry, France	University of Milan; CEA	Pozzi, S (corresponding author), Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy.	mantor@unimi.it; alessandra.vigano@guest.unimi.it	Pavesi, Giulio/AAB-3230-2022; Zambelli, Federico/B-8198-2017; Zambelli, Federico/GRR-2570-2022	Zambelli, Federico/0000-0003-3487-4331; Zambelli, Federico/0000-0003-3487-4331; vigano, maria alessandra/0000-0003-2009-0384; Merico, Daniele/0000-0002-3728-4401; Gidrol, Xavier/0000-0002-4233-3749	EPISTEM [LSHB-CT-2005-019067]	EPISTEM	This work was supported by the EPISTEM LSHB-CT-2005-019067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdam D, 2007, CR BIOL, V330, P479, DOI 10.1016/j.crvi.2007.03.007; Antonini D, 2006, MOL CELL BIOL, V26, P3308, DOI 10.1128/MCB.26.8.3308-3318.2006; Bakkers J, 2002, DEV CELL, V2, P617, DOI 10.1016/S1534-5807(02)00163-6; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Blais A, 2004, CURR OPIN GENET DEV, V14, P527, DOI 10.1016/j.gde.2004.07.003; Borrelli S, 2009, CELL DEATH DIFFER, V16, P253, DOI 10.1038/cdd.2008.147; Borrelli S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-85; Candi E, 2006, J CELL SCI, V119, P4617, DOI 10.1242/jcs.03265; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Della Gatta G, 2008, GENOME RES, V18, P939, DOI 10.1101/gr.073601.107; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Gu XL, 2008, CANCER LETT, V263, P26, DOI 10.1016/j.canlet.2007.12.011; Han GW, 2006, DEV CELL, V11, P301, DOI 10.1016/j.devcel.2006.06.014; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Kennedy RE, 2006, BIOINFORMATICS, V22, P1272, DOI 10.1093/bioinformatics/btl108; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; King KE, 2008, CANCER RES, V68, P5122, DOI 10.1158/0008-5472.CAN-07-6123; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 2003, J MED GENET, V40, P473, DOI 10.1136/jmg.40.7.473; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Koster MI, 2007, CELL CYCLE, V6, P269, DOI 10.4161/cc.6.3.3792; Koster MI, 2007, P NATL ACAD SCI USA, V104, P3255, DOI 10.1073/pnas.0611376104; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Man MQ, 2008, J INVEST DERMATOL, V128, P370, DOI 10.1038/sj.jid.5701026; Mathur D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r126; Mikkola ML, 2008, CYTOKINE GROWTH F R, V19, P219, DOI 10.1016/j.cytogfr.2008.04.008; Miller FD, 2007, CELL CYCLE, V6, P312, DOI 10.4161/cc.6.3.3795; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Ortt K, 2006, FEBS LETT, V580, P4544, DOI 10.1016/j.febslet.2006.07.004; Pavesi G, 2007, LECT NOTES ARTIF INT, V4578, P651; Perez CA, 2007, CELL CYCLE, V6, P246, DOI 10.4161/cc.6.3.3801; Reichrath J, 2007, HORM METAB RES, V39, P71, DOI 10.1055/s-2007-958715; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Sur I, 2008, INT REV IMMUNOL, V27, P205, DOI 10.1080/08830180802130319; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Testoni B, 2006, CELL CYCLE, V5, P2805, DOI 10.4161/cc.5.23.3525; Trink B, 2007, CELL CYCLE, V6, P240, DOI 10.4161/cc.6.3.3803; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vigano MA, 2007, CELL CYCLE, V6, P233, DOI 10.4161/cc.6.3.3802; Vigano MA, 2006, EMBO J, V25, P5105, DOI 10.1038/sj.emboj.7601375; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zouboulis CC, 2007, HORM METAB RES, V39, P85, DOI 10.1055/s-2007-961807	56	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e5008	10.1371/journal.pone.0005008	http://dx.doi.org/10.1371/journal.pone.0005008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19390658	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499200020
J	Pei, AN; Nossa, CW; Chokshi, P; Blaser, MJ; Yang, LY; Rosmarin, DM; Pei, ZH				Pei, Anna; Nossa, Carlos W.; Chokshi, Pooja; Blaser, Martin J.; Yang, Liying; Rosmarin, David M.; Pei, Zhiheng			Diversity of 23S rRNA Genes within Individual Prokaryotic Genomes	PLOS ONE			English	Article							SECONDARY-STRUCTURE; CONCERTED EVOLUTION; SEQUENCE; 16S; CONVERSION; BACTERIA; DATABASE; OPERONS; STRAIN; SPACER	Background: The concept of ribosomal constraints on rRNA genes is deduced primarily based on the comparison of consensus rRNA sequences between closely related species, but recent advances in whole-genome sequencing allow evaluation of this concept within organisms with multiple rRNA operons. Methodology/Principal Findings: Using the 23S rRNA gene as an example, we analyzed the diversity among individual rRNA genes within a genome. Of 184 prokaryotic species containing multiple 23S rRNA genes, diversity was observed in 113 (61.4%) genomes (mean 0.40%, range 0.01%- 4.04%). Significant (1.17%-4.04%) intragenomic variation was found in 8 species. In 5 of the 8 species, the diversity in the primary structure had only minimal effect on the secondary structure (stem versus loop transition). In the remaining 3 species, the diversity significantly altered local secondary structure, but the alteration appears minimized through complex rearrangement. Intervening sequences (IVS), ranging between 9 and 1471 nt in size, were found in 7 species. IVS in Deinococcus radiodurans and Nostoc sp. encode transposases. T. tengcongensis was the only species in which intragenomic diversity > 3% was observed among 4 paralogous 23S rRNA genes. Conclusions/Significance: These findings indicate tight ribosomal constraints on individual 23S rRNA genes within a genome. Although classification using primary 23S rRNA sequences could be erroneous, significant diversity among paralogous 23S rRNA genes was observed only once in the 184 species analyzed, indicating little overall impact on the mainstream of 23S rRNA gene-based prokaryotic taxonomy.			Pei, ZH (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10003 USA.	zhiheng.pei@nyumc.org		Yang, Liying/0000-0003-1442-4915; Pei, Zhiheng/0000-0001-8570-6747	NATIONAL CANCER INSTITUTE [R01CA097946, UH2CA140233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063477] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA097946, R01 CA97946, UH2 CA140233] Funding Source: Medline; NIAID NIH HHS [R01 AI063477] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Asai T, 1999, P NATL ACAD SCI USA, V96, P1971, DOI 10.1073/pnas.96.5.1971; Bao QY, 2002, GENOME RES, V12, P689, DOI 10.1101/gr.219302; BURGIN AB, 1990, CELL, V60, P405, DOI 10.1016/0092-8674(90)90592-3; CEDERGREN R, 1988, J MOL EVOL, V28, P98, DOI 10.1007/BF02143501; Coenye T, 2003, FEMS MICROBIOL LETT, V228, P45, DOI 10.1016/S0378-1097(03)00717-1; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; CURTISS WC, 1984, J MOL EVOL, V20, P351, DOI 10.1007/BF02104741; DeRijk P, 1997, NUCLEIC ACIDS RES, V25, P4679, DOI 10.1093/nar/25.22.4679; DERIJK P, 1995, J MOL EVOL, V41, P366, DOI 10.1007/BF01215184; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Evguenieva-Hackenberg E, 2005, MOL MICROBIOL, V57, P318, DOI 10.1111/j.1365-2958.2005.04662.x; Gurtler V, 1999, GENE, V238, P241, DOI 10.1016/S0378-1119(99)00224-3; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Harrington CS, 1999, INT J SYST BACTERIOL, V49, P1171, DOI 10.1099/00207713-49-3-1171; Higgs PG, 1998, GENETICA, V102-3, P91, DOI 10.1023/A:1017059530664; HORI H, 1986, BIOSYSTEMS, V19, P163, DOI 10.1016/0303-2647(86)90037-7; Hunt DE, 2006, APPL ENVIRON MICROB, V72, P2221, DOI 10.1128/AEM.72.3.2221-2225.2006; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Liao DQ, 2000, J MOL EVOL, V51, P305, DOI 10.1007/s002390010093; LUDWIG W, 1994, FEMS MICROBIOL REV, V15, P155, DOI 10.1111/j.1574-6976.1994.tb00132.x; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mattatall NR, 1996, J BACTERIOL, V178, P2272, DOI 10.1128/jb.178.8.2272-2278.1996; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Oberreuter H, 2002, MICROBIOL-SGM, V148, P1523, DOI 10.1099/00221287-148-5-1523; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Relman DA, 1999, SCIENCE, V284, P1308, DOI 10.1126/science.284.5418.1308; Santoyo G, 2005, FEMS MICROBIOL REV, V29, P169, DOI 10.1016/j.femsre.2004.10.004; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; STACKEBRANDT E, 1994, TAXONOMIC NOTE PLACE, P846; Stewart FJ, 2007, J MOL EVOL, V65, P44, DOI 10.1007/s00239-006-0235-3; STIEGLER P, 1981, EUR J BIOCHEM, V120, P487, DOI 10.1111/j.1432-1033.1981.tb05727.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vandamme P, 2000, J CLIN MICROBIOL, V38, P2261; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Wuyts J, 2001, NUCLEIC ACIDS RES, V29, P5017, DOI 10.1093/nar/29.24.5017; Yokoyama T, 2008, NUCLEIC ACIDS RES, V36, P3539, DOI 10.1093/nar/gkn224; ZWIEB C, 1981, NUCLEIC ACIDS RES, V9, P3621, DOI 10.1093/nar/9.15.3621	47	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5437	10.1371/journal.pone.0005437	http://dx.doi.org/10.1371/journal.pone.0005437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415112	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000265836700010
J	Kauer, M; Ban, J; Kofler, R; Walker, B; Davis, S; Meltzer, P; Kovar, H				Kauer, Maximilian; Ban, Jozef; Kofler, Reinhard; Walker, Bob; Davis, Sean; Meltzer, Paul; Kovar, Heinrich			A Molecular Function Map of Ewing's Sarcoma	PLOS ONE			English	Article								Background: EWS-FLI1 is a chimeric ETS transcription factor that is, due to a chromosomal rearrangement, specifically expressed in Ewing's sarcoma family tumors (ESFT) and is thought to initiate the development of the disease. Previous genomic profiling experiments have identified EWS-FLI1-regulated genes and genes that discriminate ESFT from other sarcomas, but so far a comprehensive analysis of EWS-FLI1-dependent molecular functions characterizing this aggressive cancer is lacking. Methodology/Principal Findings: In this study, a molecular function map of ESFT was constructed based on an integrative analysis of gene expression profiling experiments following EWS-FLI1 knockdown in a panel of five ESFT cell lines, and on gene expression data from the same platform of 59 primary ESFT. Out of 80 normal tissues tested, mesenchymal progenitor cells (MPC) were found to fit the hypothesis that EWS-FLI1 is the driving transcriptional force in ESFT best and were therefore used as the reference tissue for the construction of the molecular function map. The interrelations of molecular pathways were visualized by measuring the similarity among annotated gene functions by gene sharing. The molecular function map highlighted distinct clusters of activities for EWS-FLI1 regulated genes in ESFT and revealed a striking difference between EWS-FLI1 up-and down-regulated genes: EWS-FLI1 induced genes mainly belong to cell cycle regulation, proliferation, and response to DNA damage, while repressed genes were associated with differentiation and cell communication. Conclusions/Significance: This study revealed that EWS-FLI1 combines by distinct molecular mechanisms two important functions of cellular transformation in one protein, growth promotion and differentiation blockage. By taking MPC as a reference tissue, a significant EWS-FLI1 signature was discovered in ESFT that only partially overlapped with previously published EWS-FLI1-dependent gene expression patterns, identifying a series of novel targets for the chimeric protein in ESFT. Our results may guide target selection for future ESFT specific therapies.			Kauer, M (corresponding author), St Anna Childrens Hosp, Childrens Canc Res Inst, Kinderspitalgasse 6, A-1090 Vienna, Austria.	heinrich.kovar@ccri.at	Davis, Sean/AAD-1801-2021	Davis, Sean/0000-0002-8991-6458; Walker, Robert/0000-0001-8235-4686; Kovar, Heinrich/0000-0001-6873-9109	Austrian Science Fund FWF [P 18046] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010759] Funding Source: NIH RePORTER	Austrian Science Fund FWF(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abaan OD, 2005, ONCOGENE, V24, P2715, DOI 10.1038/sj.onc.1208247; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Ban J, 2008, CANCER RES, V68, P7100, DOI 10.1158/0008-5472.CAN-07-6145; Bernstein M, 2006, ONCOLOGIST, V11, P503, DOI 10.1634/theoncologist.11-5-503; Boquest AC, 2006, METH MOL B, V325, P35; Braunreiter CL, 2006, CELL CYCLE, V5, P2753, DOI 10.4161/cc.5.23.3505; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; Cheung IY, 2007, CLIN CANCER RES, V13, P6978, DOI 10.1158/1078-0432.CCR-07-1417; Cironi L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002634; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Deneen B, 2003, CANCER RES, V63, P4268; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dziegiel Piotr, 2004, Polish Journal of Pathology, V55, P3; Endo Y, 2008, MOL CELL BIOL, V28, P2368, DOI 10.1128/MCB.01780-07; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Hattinger CM, 2002, BRIT J CANCER, V86, P1763, DOI 10.1038/sj.bjc.6600332; Henderson SR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r76; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hu-Lieskovan S, 2005, CANCER RES, V65, P4633, DOI 10.1158/0008-5472.CAN-04-2857; Kikuchi R, 2007, ONCOGENE, V26, P1802, DOI 10.1038/sj.onc.1209973; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kovar H, 1997, ONCOGENE, V15, P2225, DOI 10.1038/sj.onc.1201397; Kovar H, 2005, SEMIN CANCER BIOL, V15, P189, DOI 10.1016/j.semcancer.2005.01.004; KOVAR H, 1993, ONCOGENE, V8, P2683; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; Miyagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004634; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nishimori H, 2002, ONCOGENE, V21, P8302, DOI 10.1038/sj.onc.1206025; Potikyan G, 2008, LAB INVEST, V88, P1291, DOI 10.1038/labinvest.2008.99; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Schaefer KL, 2008, EUR J CANCER, V44, P699, DOI 10.1016/j.ejca.2008.01.020; Siligan C, 2005, ONCOGENE, V24, P2512, DOI 10.1038/sj.onc.1208455; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Staege MS, 2004, CANCER RES, V64, P8213, DOI 10.1158/0008-5472.CAN-03-4059; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi A, 2003, CANCER RES, V63, P8338; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Uren Aykut, 2005, Future Oncol, V1, P521, DOI 10.2217/14796694.1.4.521; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yeny CT, 2005, CANCER RES, V65, P8698, DOI 10.1158/0008-5472.CAN-05-1704; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102; Zwerner JP, 2003, EXP CELL RES, V290, P414, DOI 10.1016/S0014-4827(03)00371-9; Zwerner JP, 2001, ONCOGENE, V20, P626, DOI 10.1038/sj.onc.1204133	53	118	127	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5415	10.1371/journal.pone.0005415	http://dx.doi.org/10.1371/journal.pone.0005415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404404	Green Submitted, Green Published, gold			2022-12-27	WOS:000265614900024
J	Koo, QY; Khan, AM; Jung, KO; Ramdas, S; Miotto, O; Tan, TW; Brusic, V; Salmon, J; August, JT				Koo, Qi Ying; Khan, Asif M.; Jung, Keun-Ok; Ramdas, Shweta; Miotto, Olivo; Tan, Tin Wee; Brusic, Vladimir; Salmon, Jerome; August, J. Thomas			Conservation and Variability of West Nile Virus Proteins	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MHC CLASS-I; COMPUTATIONAL SYSTEM; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; INFLUENZA-A; EPITOPE; BINDING; DENGUE; POLYMERASE	West Nile virus (WNV) has emerged globally as an increasingly important pathogen for humans and domestic animals. Studies of the evolutionary diversity of the virus over its known history will help to elucidate conserved sites, and characterize their correspondence to other pathogens and their relevance to the immune system. We describe a large-scale analysis of the entire WNV proteome, aimed at identifying and characterizing evolutionarily conserved amino acid sequences. This study, which used 2,746 WNV protein sequences collected from the NCBI GenPept database, focused on analysis of peptides of length 9 amino acids or more, which are immunologically relevant as potential T-cell epitopes. Entropy-based analysis of the diversity of WNV sequences, revealed the presence of numerous evolutionarily stable nonamer positions across the proteome (entropy value of <= 1). The representation (frequency) of nonamers variant to the predominant peptide at these stable positions was, generally, low (<= 10% of the WNV sequences analyzed). Eighty-eight fragments of length 9-29 amino acids, representing similar to 34% of the WNV polyprotein length, were identified to be identical and evolutionarily stable in all analyzed WNV sequences. Of the 88 completely conserved sequences, 67 are also present in other flaviviruses, and several have been associated with the functional and structural properties of viral proteins. Immunoinformatic analysis revealed that the majority (78/88) of conserved sequences are potentially immunogenic, while 44 contained experimentally confirmed human T-cell epitopes. This study identified a comprehensive catalogue of completely conserved WNV sequences, many of which are shared by other flaviviruses, and majority are potential epitopes. The complete conservation of these immunologically relevant sequences through the entire recorded WNV history suggests they will be valuable as components of peptide-specific vaccines or other therapeutic applications, for sequence-specific diagnosis of a wide-range of Flavivivirus infections, and for studies of homologous sequences among other flaviviruses.			Koo, QY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	taugust@jhmi.edu	Khan, M. Asif/ABE-7839-2021; Brusic, Vladimir/B-1478-2008; Tan, Tin Wee/B-8963-2009; Ramdas, Shweta/J-7712-2019; Khan, Mohammad Asif/F-4663-2010; Miotto, Olivo/AAE-7124-2019	Khan, M. Asif/0000-0001-9202-279X; Brusic, Vladimir/0000-0003-0523-5266; Tan, Tin Wee/0000-0002-4062-2854; Ramdas, Shweta/0000-0001-8888-4661; Khan, Mohammad Asif/0000-0001-9202-279X; Miotto, Olivo/0000-0001-8060-6771; Jung, Keunok/0000-0003-2967-8432	PHS HHS [HHSN266200400085C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bian HJ, 2004, METHODS, V34, P468, DOI 10.1016/j.ymeth.2004.06.002; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; Bondre VP, 2007, J GEN VIROL, V88, P875, DOI 10.1099/vir.0.82403-0; Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196; Bui HH, 2005, IMMUNOGENETICS, V57, P304, DOI 10.1007/s00251-005-0798-y; Cheng Y, 2004, J INFECT DIS, V189, P658, DOI 10.1086/381501; Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; De Groot AS, 2001, EMERG INFECT DIS, V7, P706; Domingo E, 1997, BIOL TRACE ELEM RES, V56, P23, DOI 10.1007/BF02778981; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; Freeman S., 2003, BIOL SCI; Gottesman ME, 2004, MICROBIOL MOL BIOL R, V68, P796, DOI 10.1128/MMBR.68.4.796-813.2004; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Horga MA, 2001, PEDIATR INFECT DIS J, V20, P801, DOI 10.1097/00006454-200108000-00016; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Feito MJ, 2008, VIRUS RES, V135, P166, DOI 10.1016/j.virusres.2008.03.008; Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06; Khan AM, 2006, CELL IMMUNOL, V244, P141, DOI 10.1016/j.cellimm.2007.02.005; Khan AM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000272; KURANE I, 1995, J GEN VIROL, V76, P2243, DOI 10.1099/0022-1317-76-9-2243; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lanteri MC, 2008, J INFECT DIS, V197, P1296, DOI 10.1086/586898; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; Mackenzie JM, 2007, J GEN VIROL, V88, P1163, DOI 10.1099/vir.0.82552-0; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Marfin AA, 2001, EMERG INFECT DIS, V7, P730; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; O'Donovan Claire, 2002, Brief Bioinform, V3, P275; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Petersen LR, 2001, EMERG INFECT DIS, V7, P611; Petersen LR, 2003, JAMA-J AM MED ASSOC, V290, P524, DOI 10.1001/jama.290.4.524; Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shrestha B, 2006, J VIROL, V80, P5338, DOI 10.1128/JVI.00274-06; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Wheeler DL, 2005, NUCLEIC ACIDS RES, V33, pD39, DOI 10.1093/nar/gki062; Zhang GL, 2005, NUCLEIC ACIDS RES, V33, pW172, DOI 10.1093/nar/gki452; Zhang GL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S19	52	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5352	10.1371/journal.pone.0005352	http://dx.doi.org/10.1371/journal.pone.0005352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401763	Green Submitted, Green Published, gold			2022-12-27	WOS:000265601100008
J	Leotard, G; Debout, G; Dalecky, A; Guillot, S; Gaume, L; Mckey, D; Kjellberg, F				Leotard, Guillaume; Debout, Gabriel; Dalecky, Ambroise; Guillot, Sylvain; Gaume, Laurence; Mckey, Doyle; Kjellberg, Finn			Range Expansion Drives Dispersal Evolution In An Equatorial Three-Species Symbiosis	PLOS ONE			English	Article							ANT PETALOMYRMEX-PHYLAX; GENETIC CONSEQUENCES; LEONARDOXA-AFRICANA; F-STATISTICS; PLANT-ANTS; CLIMATE; PHYLOGEOGRAPHY; COLONIZATION; OSCILLATIONS; POLYMORPHISM	Background: Recurrent climatic oscillations have produced dramatic changes in species distributions. This process has been proposed to be a major evolutionary force, shaping many life history traits of species, and to govern global patterns of biodiversity at different scales. During range expansions selection may favor the evolution of higher dispersal, and symbiotic interactions may be affected. It has been argued that a weakness of climate fluctuation-driven range dynamics at equatorial latitudes has facilitated the persistence there of more specialized species and interactions. However, how much the biology and ecology of species is changed by range dynamics has seldom been investigated, particularly in equatorial regions. Methodology/Principal Findings: We studied a three-species symbiosis endemic to coastal equatorial rainforests in Cameroon, where the impact of range dynamics is supposed to be limited, comprised of two species-specific obligate mutualists - an ant-plant and its protective ant - and a species-specific ant parasite of this mutualism. We combined analyses of within-species genetic diversity and of phenotypic variation in a transect at the southern range limit of this ant-plant system. All three species present congruent genetic signatures of recent gradual southward expansion, a result compatible with available regional paleoclimatic data. As predicted, this expansion has been accompanied by the evolution of more dispersive traits in the two ant species. In contrast, we detected no evidence of change in lifetime reproductive strategy in the tree, nor in its investment in food resources provided to its symbiotic ants. Conclusions/Significance: Despite the decreasing investment in protective workers and the increasing investment in dispersing females by both the mutualistic and the parasitic ant species, there was no evidence of destabilization of the symbiosis at the colonization front. To our knowledge, we provide here the first evidence at equatorial latitudes that biological traits associated with dispersal are affected by the range expansion dynamics of a set of interacting species.			Leotard, G (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France.	ambroise.dalecky@ird.fr	Kjellberg, Finn/S-3281-2019; Dalecky, Ambroise/AAF-9578-2021	Kjellberg, Finn/0000-0001-6708-9538; Dalecky, Ambroise/0000-0002-5075-4121				Austerlitz F, 2000, GENETICS, V154, P1309; BERGER A, 1988, REV GEOPHYS, V26, P624, DOI 10.1029/RG026i004p00624; Bernasconi G, 1998, BEHAV ECOL, V9, P478, DOI 10.1093/beheco/9.5.478; BORN C, 2007, THESIS U MONTPELLIER; Bowie RCK, 2006, MOL PHYLOGENET EVOL, V38, P171, DOI 10.1016/j.ympev.2005.06.001; Brochmann C, 2003, TAXON, V52, P417, DOI 10.2307/3647444; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Castric V, 2003, GENETICS, V163, P983; Cody ML, 1996, J ECOL, V84, P53, DOI 10.2307/2261699; Cruzan MB, 2000, TRENDS ECOL EVOL, V15, P491, DOI 10.1016/S0169-5347(00)01998-4; CWYNAR LC, 1987, AM NAT, V129, P463, DOI 10.1086/284651; Dalecky A, 2005, BIOL J LINN SOC, V86, P133, DOI 10.1111/j.1095-8312.2005.00524.x; Dalecky A, 2007, EVOLUTION, V61, P579, DOI 10.1111/j.1558-5646.2007.00044.x; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Debout G, 2005, INSECT SOC, V52, P205, DOI 10.1007/s00040-004-0795-4; DEBOUT G, 2003, THESIS U MONTPELLIER; DEBOUT GDG, 2009, OIKOS IN PRESS; Delegue MA, 2001, OECOLOGIA, V129, P106, DOI 10.1007/s004420100696; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Espadaler X, 2001, INSECT SOC, V48, P159, DOI 10.1007/PL00001760; Estoup A, 1998, NATO ADV SCI I A-LIF, V306, P55; Gaume L, 2005, EVOL ECOL RES, V7, P435; Gaume L, 1999, OIKOS, V84, P130, DOI 10.2307/3546873; Gaume L, 1997, OECOLOGIA, V112, P209, DOI 10.1007/s004420050302; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hampe A, 2000, ECOGRAPHY, V23, P603, DOI 10.1034/j.1600-0587.2000.230511.x; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt Godfrey M., 2004, Frontiers in Zoology, V1, P1, DOI 10.1186/1742-9994-1-4; Holldobler B., 1990, pi; Holmgren M, 2007, J BIOGEOGR, V34, P1100, DOI 10.1111/j.1365-2699.2006.01683.x; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; Jablonski D, 2008, EVOLUTION, V62, P715, DOI 10.1111/j.1558-5646.2008.00317.x; Jansson R, 2002, ANNU REV ECOL SYST, V33, P741, DOI 10.1146/annurev.ecolsys.33.010802.150520; Johnson RA, 2002, OECOLOGIA, V132, P60, DOI 10.1007/s00442-002-0960-2; Kebede M, 2007, MOL ECOL, V16, P1233, DOI 10.1111/j.1365-294X.2007.03232.x; Kimmel M, 1998, GENETICS, V148, P1921; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Leger EA, 2003, ECOL LETT, V6, P257, DOI 10.1046/j.1461-0248.2003.00423.x; Leotard G, 2008, J EVOLUTION BIOL, V21, P1133, DOI 10.1111/j.1420-9101.2008.01521.x; Maley J, 2002, IDS BULL-I DEV STUD, V33, P13, DOI 10.1111/j.1759-5436.2002.tb00003.x; Maley J, 1998, REV PALAEOBOT PALYNO, V99, P157, DOI 10.1016/S0034-6667(97)00047-X; MCKEY D, 1984, BIOTROPICA, V16, P81, DOI 10.2307/2387840; McKey Doyle B., 2000, Adansonia (Paris), V22, P71; MINTZER AC, 1987, INSECT SOC, V34, P108, DOI 10.1007/BF02223829; Nei M., 1987, MOL EVOLUTIONARY GEN; Ngomanda A, 2005, HOLOCENE, V15, P1021, DOI 10.1191/0959683605hl875ra; Nieberding CM, 2007, TRENDS ECOL EVOL, V22, P156, DOI 10.1016/j.tree.2006.11.012; Niemela Jari, 1999, Diversity and Distributions, V5, P121, DOI 10.1046/j.1472-4642.1999.00048.x; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Querouil S, 2003, MOL PHYLOGENET EVOL, V28, P24, DOI 10.1016/S1055-7903(03)00027-7; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reich DE, 1998, P NATL ACAD SCI USA, V95, P11026; Richardson DHS, 1999, MYCOL RES, V103, P641, DOI 10.1017/S0953756298008259; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Rousset F, 1997, GENETICS, V145, P1219; Roy K, 1996, TRENDS ECOL EVOL, V11, P458, DOI 10.1016/0169-5347(96)10054-9; Ruppell O, 1999, INSECT SOC, V46, P6, DOI 10.1007/s000400050106; Simmons AD, 2004, AM NAT, V164, P378, DOI 10.1086/423430; Smith TB, 2000, MOL ECOL, V9, P1505, DOI 10.1046/j.1365-294x.2000.01032.x; *SPSS I, 1998, SYSTAT 9 STAT; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Telfer PT, 2003, MOL ECOL, V12, P2019, DOI 10.1046/j.1365-294X.2003.01877.x; Travis JMJ, 2002, EVOL ECOL RES, V4, P1119; Tschinkel Walter R., 2002, Journal of Insect Science (Tucson), V2, P1; Vincens A, 1999, J BIOGEOGR, V26, P879, DOI 10.1046/j.1365-2699.1999.00333.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	74	45	45	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5377	10.1371/journal.pone.0005377	http://dx.doi.org/10.1371/journal.pone.0005377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401769	gold, Green Published, Green Submitted			2022-12-27	WOS:000265601100015
J	Jiang, HY; Orr, A; Guernsey, DL; Robitaille, J; Asselin, G; Samuels, ME; Dube, MP				Jiang, Haiyan; Orr, Andrew; Guernsey, Duane L.; Robitaille, Johane; Asselin, Geraldine; Samuels, Mark E.; Dube, Marie-Pierre			Application of Homozygosity Haplotype Analysis to Genetic Mapping with High-Density SNP Genotype Data	PLOS ONE			English	Article								Background: In families segregating a monogenic genetic disorder with a single disease gene introduction, patients share a mutation-carrying chromosomal interval with identity-by-descent (IBD). Such a shared chromosomal interval or haplotype, surrounding the actual pathogenic mutation, is typically detected and defined by multipoint linkage and phased haplotype analysis using microsatellite or SNP genotype data. High-density SNP genotype data presents a computational challenge for conventional genetic analyses. A novel non-parametric method termed Homozygosity Haplotype (HH) was recently proposed for the genome-wide search of the autosomal segments shared among patients using high density SNP genotype data. Methodology/Principal Findings: The applicability and the effectiveness of HH in identifying the potential linkage of disease causative gene with high-density SNP genotype data were studied with a series of monogenic disorders ascertained in eastern Canadian populations. The HH approach was validated using the genotypes of patients from a family affected with a rare autosomal dominant disease Schnyder crystalline corneal dystrophy. HH accurately detected the similar to 1 Mb genomic interval encompassing the causative gene UBIAD1 using the genotypes of only four affected subjects. The successful application of HH to identify the potential linkage for a family with pericentral retinal disorder indicates that HH can be applied to perform family-based association analysis by treating affected and unaffected family members as cases and controls respectively. A new strategy for the genome-wide screening of known causative genes or loci with HH was proposed, as shown the applications to a myoclonus dystonia and a renal failure cohort. Conclusions/Significance: Our study of the HH approach demonstrates that HH is very efficient and effective in identifying potential disease linked region. HH has the potential to be used as an efficient alternative approach to sequencing or microsatellite-based fine mapping for screening the known causative genes in genetic disease study.			Jiang, HY (corresponding author), Dalhousie Univ, Dept Pathol, Halifax, NS, Canada.	haiyan.jiang@dal.ca	Dubé, Marie-Pierre/B-9364-2008	Dubé, Marie-Pierre/0000-0001-8442-4393; Orr, Andrew/0000-0002-9388-9034				Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Ehm MG, 1996, AM J HUM GENET, V58, P225; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Geller F, 2002, HUM HERED, V54, P111, DOI 10.1159/000068836; Gordon D, 1999, HUM HERED, V49, P65, DOI 10.1159/000022846; Gusfield D, 2001, J COMPUT BIOL, V8, P305, DOI 10.1089/10665270152530863; Gusfield D., 2002, P 6 ANN INT C COMP B, P166; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; Hao K, 2004, GENOMICS, V84, P623, DOI 10.1016/j.ygeno.2004.05.003; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Kirk KM, 2002, EUR J HUM GENET, V10, P616, DOI 10.1038/sj.ejhg.5200855; Klein C, 2000, AM J HUM GENET, V67, P1314; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANCIA G, 2001, LECT NOTES COMPUTER, V2161, P182; Lin GH, 2008, BIOINFORMATICS, V24, P86, DOI 10.1093/bioinformatics/btm552; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; LONG JC, 1995, AM J HUM GENET, V56, P799; Lunetta KL, 2000, AM J HUM GENET, V66, P605, DOI 10.1086/302782; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; MCKUSICK VA, 2000, ONLINE MENDELIAN INH; Miyazawa H, 2007, AM J HUM GENET, V80, P1090, DOI 10.1086/518176; Mukhopadhyay N, 2005, BIOINFORMATICS, V21, P2556, DOI 10.1093/bioinformatics/bti364; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; R Development Core Team, 2005, R LANG ENV STAT COMP; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Theendakara V, 2004, HUM GENET, V114, P594, DOI 10.1007/s00439-004-1110-1; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; Yellore VS, 2007, MOL VIS, V13, P1777; Zimprich A, 2001, NAT GENET, V29, P66, DOI 10.1038/ng709; WHOLE GENOME DNA ANA	42	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5280	10.1371/journal.pone.0005280	http://dx.doi.org/10.1371/journal.pone.0005280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399176	Green Published, gold, Green Submitted			2022-12-27	WOS:000265514900001
J	Zhong, BJ; Yonezawa, T; Zhong, Y; Hasegawa, M				Zhong, Bojian; Yonezawa, Takahiro; Zhong, Yang; Hasegawa, Masami			Episodic Evolution and Adaptation of Chloroplast Genomes in Ancestral Grasses	PLOS ONE			English	Article							NUCLEOTIDE SUBSTITUTION RATES; MONOCOT-DICOT DIVERGENCE; ORIGIN; TIMES; DIVERSIFICATION; PHYLOGENETICS; PATTERNS; SEQUENCE; SUPPORT; HISTORY	Background: It has been suggested that the chloroplast genomes of the grass family, Poaceae, have undergone an elevated evolutionary rate compared to most other angiosperms, yet the details of this phenomenon have remained obscure. To know how the rate change occurred during evolution, estimation of the time-scale with reliable calibrations is needed. The recent finding of 65 Ma grass phytoliths in Cretaceous dinosaur coprolites places the diversification of the grasses to the Cretaceous period, and provides a reliable calibration in studying the tempo and mode of grass chloroplast evolution. Methodology/Principal Findings: By using chloroplast genome data from angiosperms and by taking account of new paleontological evidence, we now show that episodic rate acceleration both in terms of non-synonymous and synonymous substitutions occurred in the common ancestral branch of the core Poaceae (a group formed by rice, wheat, maize, and their allies) accompanied by adaptive evolution in several chloroplast proteins, while the rate reverted to the slow rate typical of most monocot species in the terminal branches. Conclusions/Significance: Our finding of episodic rate acceleration in the ancestral grasses accompanied by adaptive molecular evolution has a profound bearing on the evolution of grasses, which form a highly successful group of plants. The widely used model for estimating divergence times was based on the assumption of correlated rates between ancestral and descendant lineages. However, the assumption is proved to be inadequate in approximating the episodic rate acceleration in the ancestral grasses, and the assumption of independent rates is more appropriate. This finding has implications for studies of molecular evolutionary rates and time-scale of evolution in other groups of organisms.			Zhong, BJ (corresponding author), Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China.	hasegawa@fudan.edu.cn	Zhong, Bojian/AAH-1236-2020	Zhong, Bojian/0000-0002-6496-7646; Yonezawa, Takahiro/0000-0002-0012-1887				Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Aris-Brosou S, 2003, MOL BIOL EVOL, V20, P1947, DOI 10.1093/molbev/msg226; BOUSQUET J, 1992, P NATL ACAD SCI USA, V89, P7844, DOI 10.1073/pnas.89.16.7844; Bremer K, 2002, EVOLUTION, V56, P1374, DOI 10.1111/j.0014-3820.2002.tb01451.x; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Erixon P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001386; GAUT BS, 1992, J MOL EVOL, V35, P292, DOI 10.1007/BF00161167; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guisinger MM, 2008, P NATL ACAD SCI USA, V105, P18424, DOI 10.1073/pnas.0806759105; Hasegawa M, 2003, GENES GENET SYST, V78, P267, DOI 10.1266/ggs.78.267; Herendeen P.S., 1995, MONOCOTYLEDONS SYSTE, P1; Huelsenbeck JP, 2000, GENETICS, V154, P1879; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Kitazoe Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000384; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Linder HP, 2005, ANNU REV ECOL EVOL S, V36, P107, DOI 10.1146/annurev.ecolsys.36.102403.135635; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Martin W, 2005, TRENDS PLANT SCI, V10, P203, DOI 10.1016/j.tplants.2005.03.007; Matsuoka Y, 2002, MOL BIOL EVOL, V19, P2084, DOI 10.1093/oxfordjournals.molbev.a004033; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Muse SV, 1997, GENETICS, V146, P393; Nikaido M, 2001, P NATL ACAD SCI USA, V98, P7384, DOI 10.1073/pnas.121139198; Piperno DR, 2005, SCIENCE, V310, P1126, DOI 10.1126/science.1121020; Prasad V, 2005, SCIENCE, V310, P1177, DOI 10.1126/science.1118806; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Renner SS, 2008, SYST BIOL, V57, P795, DOI 10.1080/10635150802422282; Sanderson MJ, 2004, AM J BOT, V91, P1656, DOI 10.3732/ajb.91.10.1656; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; YANG Z, 2006, COMPUTAIONAL MOL EVO; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoder AD, 2004, MOL ECOL, V13, P757, DOI 10.1046/j.1365-294X.2004.02106.x	45	41	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5297	10.1371/journal.pone.0005297	http://dx.doi.org/10.1371/journal.pone.0005297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390686	Green Published, gold			2022-12-27	WOS:000265514400003
J	Dunshea, G				Dunshea, Glenn			DNA-Based Diet Analysis for Any Predator	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GUT CONTENTS; PREY DNA; PCR; SOFTWARE; IDENTIFICATION; SEQUENCES; PRIMERS; RESTRICTION; PSEUDOGENES	Background: Prey DNA from diet samples can be used as a dietary marker; yet current methods for prey detection require a priori diet knowledge and/or are designed ad hoc, limiting their scope. I present a general approach to detect diverse prey in the feces or gut contents of predators. Methodology/Principal Findings: In the example outlined, I take advantage of the restriction site for the endonuclease Pac I which is present in 16S mtDNA of most Odontoceti mammals, but absent from most other relevant non-mammalian chordates and invertebrates. Thus in DNA extracted from feces of these mammalian predators Pac I will cleave and exclude predator DNA from a small region targeted by novel universal primers, while most prey DNA remain intact allowing prey selective PCR. The method was optimized using scat samples from captive bottlenose dolphins (Tursiops truncatus) fed a diet of 6-10 prey species from three phlya. Up to five prey from two phyla were detected in a single scat and all but one minor prey item (2% of the overall diet) were detected across all samples. The same method was applied to scat samples from free-ranging bottlenose dolphins; up to seven prey taxa were detected in a single scat and 13 prey taxa from eight teleost families were identified in total. Conclusions/Significance: Data and further examples are provided to facilitate rapid transfer of this approach to any predator. This methodology should prove useful to zoologists using DNA-based diet techniques in a wide variety of study systems.			Dunshea, G (corresponding author), Univ Tasmania, Antarctic Wildlife Res Unit, Sch Zool, Hobart, Tas, Australia.	glenn.dunshea@aad.gov.au		Dunshea, Glenn/0000-0002-8683-0181				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barros NB, 1998, J MAMMAL, V79, P1045, DOI 10.2307/1383114; BARROS NB, 1990, FOOD HABITS BOTTLENO, P309; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Blankenship LE, 2005, MOL ECOL, V14, P891, DOI 10.1111/j.1365-294X.2005.02448.x; CASPER RM, 2007, J EXPT MARINE BIOL A, DOI DOI 10.1016/J.JEMBE.2007.1004.1002; Casper RM, 2007, MAR BIOL, V152, P815, DOI 10.1007/s00227-007-0732-y; Deagle BE, 2005, J HERED, V96, P417, DOI 10.1093/jhered/esi036; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; DEAGLE BE, 2006, CONSERV GENET, DOI DOI 10.1007/S10592-00609197-00609197; DEAGLE BE, 2009, MOL ECOLOGY IN PRESS; DEAGLE BE, 2006, FRONTIERS ZOOLOGY, V3; Deagle BE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000831; Dunshea G, 2008, B ENTOMOL RES, V98, P239, DOI 10.1017/S0007485308005993; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gonzalez JM, 2005, BIOINFORMATICS, V21, P333, DOI 10.1093/bioinformatics/bti008; Green SJ, 2005, APPL ENVIRON MICROB, V71, P4721, DOI 10.1128/AEM.71.8.4721-4727.2005; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harper GL, 2005, MOL ECOL, V14, P819, DOI [10.1111/j.1365-294X.2005.02442.x, 10.1111/j.1365-294x.2005.02442.x]; Huber JA, 2002, APPL ENVIRON MICROB, V68, P1585, DOI 10.1128/AEM.68.4.1585-1594.2002; Iverson SJ, 2004, ECOL MONOGR, V74, P211, DOI 10.1890/02-4105; Jarman SN, 2006, BIOINFORMATICS, V22, P2160, DOI 10.1093/bioinformatics/btl330; Jarman SN, 2006, MOL ECOL NOTES, V6, P268, DOI 10.1111/j.1471-8286.2005.01172.x; Jarman SN, 2004, BIOINFORMATICS, V20, P1644, DOI 10.1093/bioinformatics/bth121; Jarman SN, 2004, MOL ECOL, V13, P1313, DOI 10.1111/j.1365-294X.2004.02109.x; Jarman SN, 2002, MOL ECOL, V11, P2679, DOI 10.1046/j.1365-294X.2002.01641.x; Juen A, 2005, OECOLOGIA, V142, P344, DOI 10.1007/s00442-004-1736-7; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kvitrud MA, 2005, MAR BIOL, V147, P1459, DOI 10.1007/s00227-005-0047-9; Martin DL, 2006, MAR ECOL PROG SER, V319, P155, DOI 10.3354/meps319155; Parsons KM, 2005, J ZOOL, V266, P275, DOI 10.1017/S0952836905006904; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Steinke D, 2005, PHILOS T R SOC B, V360, P1975, DOI 10.1098/rstb.2005.1729; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; SUTHERLAND RM, 2000, THESIS U OXFORD OXFO; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Vences M, 2005, FRONTIERS ZOOLOGY, DOI [10. 1186/1742-9994-1182-1185, DOI 10.1186/1742-9994-1182-1185]; Venkatesh B, 2006, GENOMICS, V87, P307, DOI 10.1016/j.ygeno.2005.11.007; VESTHEIM H, 2008, FRONTIERS ZOOLOGY, V5, DOI DOI 10.1186/1742-9994-1185-1112; von Wintzingerode F, 2000, APPL ENVIRON MICROB, V66, P549, DOI 10.1128/AEM.66.2.549-557.2000; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Zaidi RH, 1999, MOL ECOL, V8, P2081, DOI 10.1046/j.1365-294x.1999.00823.x	46	47	49	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5252	10.1371/journal.pone.0005252	http://dx.doi.org/10.1371/journal.pone.0005252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390570	Green Published, Green Accepted, gold			2022-12-27	WOS:000265514200002
J	Spring, MD; Cummings, JF; Ockenhouse, CF; Dutta, S; Reidler, R; Angov, E; Bergmann-Leitner, E; Stewart, VA; Bittner, S; Juompan, L; Kortepeter, MG; Nielsen, R; Krzych, U; Tierney, E; Ware, LA; Dowler, M; Hermsen, CC; Sauerwein, RW; de Vlas, SJ; Ofori-Anyinam, O; Lanar, DE; Williams, JL; Kester, KE; Tucker, K; Shi, M; Malkin, E; Long, C; Diggs, CL; Soisson, L; Dubois, MC; Ballou, WR; Cohen, J; Heppner, DG				Spring, Michele D.; Cummings, James F.; Ockenhouse, Christian F.; Dutta, Sheetij; Reidler, Randall; Angov, Evelina; Bergmann-Leitner, Elke; Stewart, V. Ann; Bittner, Stacey; Juompan, Laure; Kortepeter, Mark G.; Nielsen, Robin; Krzych, Urszula; Tierney, Ev; Ware, Lisa A.; Dowler, Megan; Hermsen, Cornelus C.; Sauerwein, Robert W.; de Vlas, Sake J.; Ofori-Anyinam, Opokua; Lanar, David E.; Williams, Jack L.; Kester, Kent E.; Tucker, Kathryn; Shi, Meng; Malkin, Elissa; Long, Carole; Diggs, Carter L.; Soisson, Lorraine; Dubois, Marie-Claude; Ballou, W. Ripley; Cohen, Joe; Heppner, D. Gray, Jr.			Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A	PLOS ONE			English	Article							FALCIPARUM CIRCUMSPOROZOITE PROTEIN; NATURAL IMMUNE-RESPONSES; PLASMODIUM-FALCIPARUM; NAIVE ADULTS; PRECLINICAL EVALUATION; IMMUNOGENICITY TRIAL; SAFETY; MONKEYS; FORMULATIONS; IMMUNIZATION	Background: This Phase 1/2a study evaluated the safety, immunogenicity, and efficacy of an experimental malaria vaccine comprised of the recombinant Plasmodium falciparum protein apical membrane antigen-1 (AMA-1) representing the 3D7 allele formulated with either the AS01B or AS02A Adjuvant Systems. Methodology/Principal Findings: After a preliminary safety evaluation of low dose AMA-1/AS01B (10 mu g/0.5 mL) in 5 adults, 30 malaria-naive adults were randomly allocated to receive full dose (50 mu g/0.5 mL) of AMA-1/AS01B (n = 15) or AMA-1/AS02A (n = 15), followed by a malaria challenge. All vaccinations were administered intramuscularly on a 0-, 1-, 2-month schedule. All volunteers experienced transient injection site erythema, swelling and pain. Two weeks post-third vaccination, anti-AMA-1 Geometric Mean Antibody Concentrations (GMCs) with 95% Confidence Intervals (CIs) were high: low dose AMA-1/AS01B 196 mu g/mL (103-371 mu g/mL), full dose AMA-1/AS01B 279 mu g/mL (210-369 mu g/mL) and full dose AMA-1/AS02A 216 mu g/mL (169-276 mu g/mL) with no significant difference among the 3 groups. The three vaccine formulations elicited equivalent functional antibody responses, as measured by growth inhibition assay (GIA), against homologous but not against heterologous (FVO) parasites as well as demonstrable interferon-gamma (IFN-gamma) responses. To assess efficacy, volunteers were challenged with P. falciparum-infected mosquitoes, and all became parasitemic, with no significant difference in the prepatent period by either light microscopy or quantitative polymerase chain reaction (qPCR). However, a small but significant reduction of parasitemia in the AMA-1/AS02A group was seen with a statistical model employing qPCR measurements. Significance: All three vaccine formulations were found to be safe and highly immunogenic. These immune responses did not translate into significant vaccine efficacy in malaria-naive adults employing a primary sporozoite challenge model, but encouragingly, estimation of parasite growth rates from qPCR data may suggest a partial biological effect of the vaccine. Further evaluation of the immunogenicity and efficacy of the AMA-1/AS02A formulation is ongoing in a malaria-experienced pediatric population in Mali.			Spring, MD (corresponding author), Walter Reed Army Inst Res, US Mil Malaria Vaccine Program, Silver Spring, MD 20910 USA.	michele.spring@us.army.mil	Kester, Kent/AAF-8235-2020; Bergmann-Leitner, Elke/I-5431-2019; Kester, Kent/A-2114-2011; Bergmann-Leitner, Elke S./B-3548-2011; Hermsen, C.C./L-4368-2015; Nielsen, Robin/B-6811-2011; Spring, Michele/B-3564-2011; Sauerwein, Robert/C-8519-2013; Lanar, David E/B-3560-2011	Kester, Kent/0000-0002-5056-0802; Bergmann-Leitner, Elke/0000-0002-8571-8956; Kester, Kent/0000-0002-5056-0802; Bergmann-Leitner, Elke S./0000-0002-8571-8956; de Vlas, Sake J./0000-0002-1830-5668	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020, Z01AI001020] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Andrews L, 2005, AM J TROP MED HYG, V73, P191, DOI 10.4269/ajtmh.2005.73.191; Bergmann-Leitner ES, 2006, AM J TROP MED HYG, V75, P437, DOI 10.4269/ajtmh.2006.75.437; CHULAY JD, 1986, AM J TROP MED HYG, V35, P66, DOI 10.4269/ajtmh.1986.35.66; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Duffy PE, 2005, CURR TOP MICROBIOL, V295, P169; Dunachie SJ, 2006, INFECT IMMUN, V74, P5933, DOI 10.1128/IAI.00590-06; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Genton B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001018; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042; Hermsen CC, 2004, AM J TROP MED HYG, V71, P196, DOI 10.4269/ajtmh.2004.71.2.0700196; Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Howell SA, 2001, J BIOL CHEM, V276, P31311, DOI 10.1074/jbc.M103076200; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; KRZYCH U, 1995, J IMMUNOL, V155, P4072; Lal AA, 1996, INFECT IMMUN, V64, P1054, DOI 10.1128/IAI.64.3.1054-1059.1996; Lawrence G, 2000, VACCINE, V18, P1925, DOI 10.1016/S0264-410X(99)00444-2; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Meth MJ, 2006, MT SINAI J MED, V73, P769; Mettens P, 2008, VACCINE, V26, P1072, DOI 10.1016/j.vaccine.2007.12.018; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Moorthy VS, 2004, LANCET, V363, P150, DOI 10.1016/S0140-6736(03)15267-1; Ockenhouse CF, 2006, VACCINE, V24, P3009, DOI 10.1016/j.vaccine.2005.11.028; Pichyangkul S, 2004, VACCINE, V22, P3831, DOI 10.1016/j.vaccine.2004.07.023; Polhemus ME, 2007, VACCINE, V25, P4203, DOI 10.1016/j.vaccine.2007.03.012; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Roestenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003960; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Stewart VA, 2006, VACCINE, V24, P6483, DOI 10.1016/j.vaccine.2006.06.033; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Takala SL, 2007, PLOS MED, V4, P523, DOI 10.1371/journal.pmed.0040093; Thera MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001465; Udhayakumar V, 2001, AM J TROP MED HYG, V65, P100, DOI 10.4269/ajtmh.2001.65.100; *WHO UNICEF, 2005, WHOHTMMAL20051102, P271; Yoon IK, 2005, AM J TROP MED HYG, V72, P714, DOI 10.4269/ajtmh.2005.72.714	45	155	158	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5254	10.1371/journal.pone.0005254	http://dx.doi.org/10.1371/journal.pone.0005254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390585	Green Submitted, gold, Green Published			2022-12-27	WOS:000265514200003
J	Luo, MJ; Cui, XF; Fredman, D; Brookes, AJ; Azaro, MA; Greenawalt, DM; Hu, GH; Wang, HY; Tereshchenko, IV; Lin, Y; Shentu, Y; Gao, RC; Shen, L; Li, HH				Luo, Minjie; Cui, Xiangfeng; Fredman, David; Brookes, Anthony J.; Azaro, Marco A.; Greenawalt, Danielle M.; Hu, Guohong; Wang, Hui-Yun; Tereshchenko, Irina V.; Lin, Yong; Shentu, Yue; Gao, Richeng; Shen, Li; Li, Honghua			Genetic Structures of Copy Number Variants Revealed by Genotyping Single Sperm	PLOS ONE			English	Article							SEGMENTAL DUPLICATIONS; NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; GENOME; SEQUENCE; REGIONS; HAPLOTYPE; DELETIONS; SNPS	Background: Copy number variants (CNVs) occupy a significant portion of the human genome and may have important roles in meiotic recombination, human genome evolution and gene expression. Many genetic diseases may be underlain by CNVs. However, because of the presence of their multiple copies, variability in copy numbers and the diploidy of the human genome, detailed genetic structure of CNVs cannot be readily studied by available techniques. Methodology/Principal Findings: Single sperm samples were used as the primary subjects for the study so that CNV haplotypes in the sperm donors could be studied individually. Forty-eight CNVs characterized in a previous study were analyzed using a microarray-based high-throughput genotyping method after multiplex amplification. Seventeen single nucleotide polymorphisms (SNPs) were also included as controls. Two single-base variants, either allelic or paralogous, could be discriminated for all markers. Microarray data were used to resolve SNP alleles and CNV haplotypes, to quantitatively assess the numbers and compositions of the paralogous segments in each CNV haplotype. Conclusions/Significance: This is the first study of the genetic structure of CNVs on a large scale. Resulting information may help understand evolution of the human genome, gain insight into many genetic processes, and discriminate between CNVs and SNPs. The highly sensitive high-throughput experimental system with haploid sperm samples as subjects may be used to facilitate detailed large-scale CNV analysis.			Luo, MJ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Canc Inst New Jersey, Piscataway, NJ 08854 USA.	holi@umdnj.edu	Shen, Lishuang/B-3040-2013; Fredman, David J/H-3566-2013	Fredman, David J/0000-0003-3507-0554; Hu, Guohong/0000-0002-2980-5166	NCI NIH HHS [R33 CA096309, R01CA77363, R33 CA 96309] Funding Source: Medline; NHGRI NIH HHS [R01 HG002094, R01 HG02094] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R33CA096309, R01CA077363] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002094] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; Estivill X, 2002, HUM MOL GENET, V11, P1987, DOI 10.1093/hmg/11.17.1987; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Greenawalt DM, 2006, GENOME RES, V16, P208, DOI 10.1101/gr.4641706; Gut IG, 2004, NAT GENET, V36, P789, DOI 10.1038/ng0804-789; Hasin Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000249; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hu GH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl601; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jiang RH, 2003, PHARMACOGENOMICS, V4, P779; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Pastinen T, 1997, GENOME RES, V7, P606, DOI 10.1101/gr.7.6.606; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wang HY, 2005, GENOME RES, V15, P276, DOI 10.1101/gr.2885205; Warburton PE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-533; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5236	10.1371/journal.pone.0005236	http://dx.doi.org/10.1371/journal.pone.0005236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384415	Green Published, gold			2022-12-27	WOS:000265513900007
J	Suied, C; Viaud-Delmon, I				Suied, Clara; Viaud-Delmon, Isabelle			Auditory-Visual Object Recognition Time Suggests Specific Processing for Animal Sounds	PLOS ONE			English	Article							NATURAL SOUNDS; DIVIDED ATTENTION; HUMAN BRAIN; CORTEX; DEFICITS; REPRESENTATION; INTEGRATION; KNOWLEDGE; RESPONSES; PATHWAYS	Background: Recognizing an object requires binding together several cues, which may be distributed across different sensory modalities, and ignoring competing information originating from other objects. In addition, knowledge of the semantic category of an object is fundamental to determine how we should react to it. Here we investigate the role of semantic categories in the processing of auditory-visual objects. Methodology/Findings: We used an auditory-visual object-recognition task (go/no-go paradigm). We compared recognition times for two categories: a biologically relevant one (animals) and a non-biologically relevant one (means of transport). Participants were asked to react as fast as possible to target objects, presented in the visual and/or the auditory modality, and to withhold their response for distractor objects. A first main finding was that, when participants were presented with unimodal or bimodal congruent stimuli (an image and a sound from the same object), similar reaction times were observed for all object categories. Thus, there was no advantage in the speed of recognition for biologically relevant compared to non-biologically relevant objects. A second finding was that, in the presence of a biologically relevant auditory distractor, the processing of a target object was slowed down, whether or not it was itself biologically relevant. It seems impossible to effectively ignore an animal sound, even when it is irrelevant to the task. Conclusions/Significance: These results suggest a specific and mandatory processing of animal sounds, possibly due to phylogenetic memory and consistent with the idea that hearing is particularly efficient as an alerting sense. They also highlight the importance of taking into account the auditory modality when investigating the way object concepts of biologically relevant categories are stored and retrieved.			Suied, C (corresponding author), IRCAM CNRS, UMR 9912, Paris, France.	clarasuied@gmail.com		Viaud-Delmon, Isabelle/0000-0002-8664-3941				Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Caramazza A, 2003, TRENDS COGN SCI, V7, P354, DOI 10.1016/S1364-6613(03)00159-1; Chi TS, 1999, J ACOUST SOC AM, V106, P2719, DOI 10.1121/1.428100; Chocholle R, 1940, ANN PSYCHOL, V41-42, P65; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; Clarke S, 1996, NEUROPSYCHOLOGIA, V34, P587, DOI 10.1016/0028-3932(95)00142-5; Doehrmann O, 2008, BRAIN RES, V1242, P136, DOI 10.1016/j.brainres.2008.03.071; Humphreys GW, 2001, BEHAV BRAIN SCI, V24, P453, DOI 10.1017/S0140525X01004150; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Laurienti PJ, 2004, EXP BRAIN RES, V158, P405, DOI 10.1007/s00221-004-1913-2; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Lewis JW, 2004, CEREB CORTEX, V14, P1008, DOI 10.1093/cercor/bhh061; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; MILLER J, 1986, PERCEPT PSYCHOPHYS, V40, P331, DOI 10.3758/BF03203025; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Molholm S, 2004, CEREB CORTEX, V14, P452, DOI 10.1093/cercor/bhh007; Murray MM, 2006, J NEUROSCI, V26, P1293, DOI 10.1523/JNEUROSCI.4511-05.2006; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Rousselet GA, 2003, J VISION, V3, P440, DOI 10.1167/3.6.5; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Suied C, 2008, J EXP PSYCHOL-APPL, V14, P201, DOI 10.1037/1076-898X.14.3.201; Suied C, 2009, EXP BRAIN RES, V194, P91, DOI 10.1007/s00221-008-1672-6; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Ulrich R, 2007, BEHAV RES METHODS, V39, P291, DOI 10.3758/BF03193160; VanRullen R, 2001, PERCEPTION, V30, P655, DOI 10.1068/p3029; von Kriegstein K, 2006, PLOS BIOL, V4, P1809, DOI 10.1371/journal.pbio.0040326; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WARRINGTON EK, 1983, BRAIN, V106, P859, DOI 10.1093/brain/106.4.859; YUVALGREENBERG S, 2009, EXP BRAIN R IN PRESS	33	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5256	10.1371/journal.pone.0005256	http://dx.doi.org/10.1371/journal.pone.0005256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437VB	19384414	Green Published, gold, Green Submitted			2022-12-27	WOS:000265513900010
J	Cohen, AA; Kalisky, T; Mayo, A; Geva-Zatorsky, N; Danon, T; Issaeva, I; Kopito, RB; Perzov, N; Milo, R; Sigal, A; Alon, U				Cohen, Ariel Aharon; Kalisky, Tomer; Mayo, Avi; Geva-Zatorsky, Naama; Danon, Tamar; Issaeva, Irina; Kopito, Ronen Benjamine; Perzov, Natalie; Milo, Ron; Sigal, Alex; Alon, Uri			Protein Dynamics in Individual Human Cells: Experiment and Theory	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; RNA-POLYMERASE-II; TRANSCRIPTION; NOISE; CYCLE; PRC1; FLUCTUATIONS; DEPENDENCE; PROTEOMICS; STABILITY	A current challenge in biology is to understand the dynamics of protein circuits in living human cells. Can one define and test equations for the dynamics and variability of a protein over time? Here, we address this experimentally and theoretically, by means of accurate time-resolved measurements of endogenously tagged proteins in individual human cells. As a model system, we choose three stable proteins displaying cell-cycle-dependant dynamics. We find that protein accumulation with time per cell is quadratic for proteins with long mRNA life times and approximately linear for a protein with short mRNA lifetime. Both behaviors correspond to a classical model of transcription and translation. A stochastic model, in which genes slowly switch between ON and OFF states, captures measured cell-cell variability. The data suggests, in accordance with the model, that switching to the gene ON state is exponentially distributed and that the cell-cell distribution of protein levels can be approximated by a Gamma distribution throughout the cell cycle. These results suggest that relatively simple models may describe protein dynamics in individual human cells.			Cohen, AA (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	uri.alon@weizmann.ac.il	Milo, Hilla/C-8767-2016; MAYO, AVI E/K-1736-2012; Sigal, Alex/GWC-7488-2022; mayo, avi/N-3756-2019; Geva-Zatorsky, Naama/AAP-9176-2021	Sigal, Alex/0000-0001-8571-2004; mayo, avi/0000-0002-4479-3423; Geva-Zatorsky, Naama/0000-0002-7303-854X; Milo, Ron/0000-0003-1641-2299				Alon U, 2007, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Beucher S., 1992, SCANNING MICROSCOPY, P28; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; Jarvik JW, 1996, BIOTECHNIQUES, V20, P896; Jarvik JW, 2002, BIOTECHNIQUES, V33, P852, DOI 10.2144/02334rr02; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; KO MSH, 1990, EMBO J, V9, P2835, DOI 10.1002/j.1460-2075.1990.tb07472.x; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kopito RB, 2007, P NATL ACAD SCI USA, V104, P12743, DOI 10.1073/pnas.0702690104; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; MONOD J, 1952, BIOCHIM BIOPHYS ACTA, V9, P648, DOI 10.1016/0006-3002(52)90227-8; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2000, PHYS REV LETT, V84, P5447, DOI 10.1103/PhysRevLett.84.5447; PRICE VE, 1962, J BIOL CHEM, V237, P3468; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2003, J MOL BIOL, V329, P645, DOI 10.1016/S0022-2836(03)00506-0; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; ROSENFELD NY, 2005, GENE REGULATION SING, V307, P1962; ROSS IL, 1994, IMMUNOL CELL BIOL, V72, P177, DOI 10.1038/icb.1994.26; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103	48	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e4901	10.1371/journal.pone.0004901	http://dx.doi.org/10.1371/journal.pone.0004901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381343	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000265510800001
J	Orengo, JM; Leliwa-Sytek, A; Evans, JE; Evans, B; van de Hoef, D; Nyako, M; Day, K; Rodriguez, A				Orengo, Jamie Marie; Leliwa-Sytek, Aleksandra; Evans, James E.; Evans, Barbara; van de Hoef, Diana; Nyako, Marian; Day, Karen; Rodriguez, Ana			Uric Acid Is a Mediator of the Plasmodium falciparum-Induced Inflammatory Response	PLOS ONE			English	Article								Background: Malaria triggers a high inflammatory response in the host that mediates most of the associated pathologies and contributes to death. The identification of pro-inflammatory molecules derived from Plasmodium is essential to understand the mechanisms of pathogenesis and to develop targeted interventions. Uric acid derived from hypoxanthine accumulated in infected erythrocytes has been recently proposed as a mediator of inflammation in rodent malaria. Methods and Findings: We found that human erythrocytes infected with Plasmodium falciparum gradually accumulate hypoxanthine in their late stages of development. To analyze the role of hypoxanthine-derived uric acid induced by P. falciparum on the inflammatory cytokine response from human blood mononuclear cells, cultures were treated with allopurinol, to inhibit uric acid formation from hypoxanthine, or with uricase, to degrade uric acid. Both treatments significantly reduce the secretion of TNF, IL-6, IL-1 beta and IL-10 from human cells. Conclusions and Significance: Uric acid is a major contributor of the inflammatory response triggered by P. falciparum in human peripheral blood mononuclear cells. Since the inflammatory reaction induced by P. falciparum is considered a major cause of malaria pathogenesis, identifying the mechanisms used by the parasite to induce the host inflammatory response is essential to develop urgently needed therapies against this disease.			Orengo, JM (corresponding author), Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	ana.rodriguez@nyu.edu	Day, Karen/F-3697-2015	Day, Karen/0000-0002-6115-6135; Rodriguez, Ana/0000-0002-0060-3405; Orengo, Jamie/0000-0002-2695-6508	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007180] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007180, 5 T32 AI 07180] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2000, T R SOC TROP MED S1, V94, pS1; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Cronstein BN, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1908; DAS BS, 1993, AM J TROP MED HYG, V49, P720, DOI 10.4269/ajtmh.1993.49.720; El-Nashar Thanaa M., 2002, Journal of the Egyptian Society of Parasitology, V32, P525; FEIGELSON P, 1957, J BIOL CHEM, V226, P993; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Gillman BM, 2004, INFECT IMMUN, V72, P6359, DOI 10.1128/IAI.72.11.6359-6366.2004; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Kanellis J, 2005, SEMIN NEPHROL, V25, P39, DOI 10.1016/j.semnephrol.2004.09.007; Karunaweera ND, 2003, TRENDS PARASITOL, V19, P188, DOI 10.1016/S1471-4922(03)00036-9; KIPPEN I, 1974, ANN RHEUM DIS, V33, P313, DOI 10.1136/ard.33.4.313; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; Mackintosh CL, 2004, TRENDS PARASITOL, V20, P597, DOI 10.1016/j.pt.2004.09.006; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Orengo JM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000013; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Pascual E, 2004, CURR OPIN RHEUMATOL, V16, P282, DOI 10.1097/00002281-200405000-00020; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283; Sarma PSA, 1998, AM J TROP MED HYG, V58, P454, DOI 10.4269/ajtmh.1998.58.454; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; VANDERPOLL T, 1994, J EXP MED, V180, P1985, DOI 10.1084/jem.180.5.1985; Vorbach C, 2003, TRENDS IMMUNOL, V24, P512, DOI 10.1016/S1471-4906(03)00237-0; Walther M, 2006, J IMMUNOL, V177, P5736, DOI 10.4049/jimmunol.177.8.5736	30	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5194	10.1371/journal.pone.0005194	http://dx.doi.org/10.1371/journal.pone.0005194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381275	Green Published, gold			2022-12-27	WOS:000265510800004
J	Yang, XJ; Karuturi, RKM; Sun, F; Aau, MY; Yu, K; Shao, RG; Miller, LD; Tan, PBO; Yu, Q				Yang, Xiaojing; Karuturi, R. K. Murthy; Sun, Feng; Aau, Meiyee; Yu, Kun; Shao, Rongguang; Miller, Lance D.; Tan, Patrick Boon Ooi; Yu, Qiang			CDKN1C (p57(KIP2)) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; PROMOTER DNA METHYLATION; GROUP PROTEIN EZH2; PROSTATE-CANCER; HISTONE H3; LYSINE-27 METHYLATION; CHROMATIN PATTERN; COLORECTAL-CANCER; GENE-EXPRESSION; HUMAN GENOME	CDKN1C (encoding tumor suppressor p57(KIP2)) is a cyclin-dependent kinase (CDK) inhibitor whose family members are often transcriptionally downregulated in human cancer via promoter DNA methylation. In this study, we show that CDKN1C is repressed in breast cancer cells mainly through histone modifications. In particular, we show that CDKN1C is targeted by histone methyltransferase EZH2-mediated histone H3 lysine 27 trimethylation (H3K27me3), and can be strongly activated by inhibition of EZH2 in synergy with histone deacetylase inhibitor. Consistent with the overexpression of EZH2 in a variety of human cancers including breast cancer, CDKN1C in these cancers is downregulated, and breast tumors expressing low levels of CDKN1C are associated with a poor prognosis. We further show that assessing both EZH2 and CDKN1C expression levels as a measurement of EZH2 pathway activity provides a more predictive power of disease outcome than that achieved with EZH2 or CDKN1C alone. Taken together, our study reveals a novel epigenetic mechanism governing CDKN1C repression in breast cancer. Importantly, as a newly identified EZH2 target with prognostic value, it has implications in patient stratification for cancer therapeutic targeting EZH2-mediated gene repression.	[Yang, Xiaojing; Karuturi, R. K. Murthy; Sun, Feng; Aau, Meiyee; Miller, Lance D.; Tan, Patrick Boon Ooi; Yu, Qiang] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Yang, Xiaojing; Shao, Rongguang] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing, Peoples R China; [Sun, Feng] Natl Univ Singapore, Dept Pharm, Singapore, Singapore; [Yu, Kun; Tan, Patrick Boon Ooi] Duke NUS, Grad Med Sch, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; National University of Singapore; National University of Singapore	Yang, XJ (corresponding author), ASTAR, Genome Inst Singapore, Singapore, Singapore.	yuq@gis.a-star.edu.sg	Yang, Xiaojing/G-9201-2012	Miller, Lance/0000-0003-3799-2528; Yu, Qiang/0000-0003-2132-8278	Agency for Science, Technology & Research (A* Star) of Singapore	Agency for Science, Technology & Research (A* Star) of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by Agency for Science, Technology & Research (A* Star) of Singapore.(http://www.a-star.edu.sg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Egger G, 2007, CANCER RES, V67, P346, DOI 10.1158/0008-5472.CAN-06-2845; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Hall P, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-16; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Li YH, 2002, BLOOD, V100, P2572, DOI 10.1182/blood-2001-11-0026; Marks PA, 2004, ADV CANCER RES, V91, P137, DOI 10.1016/S0065-230X(04)91004-4; McGarvey KM, 2008, CANCER RES, V68, P5753, DOI 10.1158/0008-5472.CAN-08-0700; McGarvey KM, 2007, CANCER RES, V67, P5097, DOI 10.1158/0008-5472.CAN-06-2029; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Nguyen CT, 2002, CANCER RES, V62, P6456; Ohm JE, 2007, CELL CYCLE, V6, P1040, DOI 10.4161/cc.6.9.4210; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pateras IS, 2006, INT J CANCER, V119, P2546, DOI 10.1002/ijc.22214; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Soejima H, 2004, ONCOGENE, V23, P4380, DOI 10.1038/sj.onc.1207576; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	43	138	150	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5011	10.1371/journal.pone.0005011	http://dx.doi.org/10.1371/journal.pone.0005011			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340297	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500700006
J	Geissbuhler, Y; Kannady, K; Chaki, PP; Emidi, B; Govella, NJ; Mayagaya, V; Kiama, M; Mtasiwa, D; Mshinda, H; Lindsay, SW; Tanner, M; Fillinger, U; de Castro, MC; Killeen, GF				Geissbuehler, Yvonne; Kannady, Khadija; Chaki, Prosper Pius; Emidi, Basiliana; Govella, Nicodem James; Mayagaya, Valeliana; Kiama, Michael; Mtasiwa, Deo; Mshinda, Hassan; Lindsay, Steven William; Tanner, Marcel; Fillinger, Ulrike; de Castro, Marcia Caldas; Killeen, Gerry Francis			Microbial Larvicide Application by a Large-Scale, Community-Based Program Reduces Malaria Infection Prevalence in Urban Dar Es Salaam, Tanzania	PLOS ONE			English	Article							BACILLUS-SPHAERICUS; ANOPHELES-GAMBIAE; CULEX-QUINQUEFASCIATUS; ENVIRONMENTAL-MANAGEMENT; MOSQUITO-CONTROL; BREEDING SITES; TRANSMISSION; POPULATIONS; EFFICACY; URBANIZATION	Background: Malaria control in Africa is most tractable in urban settlements yet most research has focused on rural settings. Elimination of malaria transmission from urban areas may require larval control strategies that complement adult mosquito control using insecticide-treated nets or houses, particularly where vectors feed outdoors. Methods and Findings: Microbial larvicide (Bacillus thuringiensis var. israelensis (Bti)) was applied weekly through programmatic, non-randomized community-based, but vertically managed, delivery systems in urban Dar es Salaam, Tanzania. Continuous, randomized cluster sampling of malaria infection prevalence and non-random programmatic surveillance of entomological inoculation rate (EIR) respectively constituted the primary and secondary outcomes surveyed within a population of approximately 612,000 residents in 15 fully urban wards covering 55 km(2). Bti application for one year in 3 of those wards (17 km 2 with 128,000 residents) reduced crude annual transmission estimates (Relative EIR [95% Confidence Interval] = 0.683 [0.491-0.952], P = 0.024) but program effectiveness peaked between July and September (Relative EIR [CI] = 0.354 [0.193 to 0.650], P = 0.001) when 45% (9/20) of directly observed transmission events occurred. Larviciding reduced malaria infection risk among children <= 5 years of age (OR [CI] = 0.284 [0.101 to 0.801], P = 0.017) and provided protection at least as good as personal use of an insecticide treated net (OR [CI] = 0.764 [0.614-0.951], P = 0.016). Conclusions: In this context, larviciding reduced malaria prevalence and complemented existing protection provided by insecticide-treated nets. Larviciding may represent a useful option for integrated vector management in Africa, particularly in its rapidly growing urban centres.	[Geissbuehler, Yvonne; Tanner, Marcel] Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland; [Geissbuehler, Yvonne; Kannady, Khadija; Chaki, Prosper Pius; Emidi, Basiliana; Govella, Nicodem James; Kiama, Michael] Minist of Region Adm Local Gov, Dar es Salaam City Council, Dar Es Salaam, Tanzania; [Geissbuehler, Yvonne; Chaki, Prosper Pius; Govella, Nicodem James; Mayagaya, Valeliana; Mshinda, Hassan; Killeen, Gerry Francis] Ifakara Hlth Inst, Coordinat Office, Dar Es Salaam, Tanzania; [Chaki, Prosper Pius; Govella, Nicodem James; Lindsay, Steven William; Fillinger, Ulrike; Killeen, Gerry Francis] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Emidi, Basiliana; Mayagaya, Valeliana] Univ Dar Es Salaam, Dept Zool & Marine Biol, Dar Es Salaam, Tanzania; [Mtasiwa, Deo] Minist Hlth & Social Welfare, Dar Es Salaam, Tanzania; [de Castro, Marcia Caldas] Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA USA; [Killeen, Gerry Francis] Univ Liverpool Liverpool Sch Trop Med, Vector Grp, Liverpool, Merseyside, England	University of Basel; Swiss Tropical & Public Health Institute; Ifakara Health Institute; Durham University; University of Dar es Salaam; Harvard University; Harvard T.H. Chan School of Public Health; Liverpool School of Tropical Medicine	Geissbuhler, Y (corresponding author), Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland.	gkilleen@ihi.or.tz	Emidi, Basiliana/AAL-2962-2021	Emidi, Basiliana/0000-0001-6856-541X; Lindsay, Steve/0000-0002-3461-9050; Fillinger, Ulrike/0000-0002-4037-431X	Bill & Melinda Gates Foundation [23750]; Valent Biosciences Corporation; US Centers for Disease Control and Prevention; US Agency for International Development; Wellcome Trust [076806]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Valent Biosciences Corporation; US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US Agency for International Development(United States Agency for International Development (USAID)); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported financially by the Bill & Melinda Gates Foundation (Award number 23750), Valent Biosciences Corporation, US Centers for Disease Control and Prevention and US Agency for International Development (Environmental Health Program, Dar es Salaam Mission and the President's Malaria Initiative, all administered through Research Triangle International) and a Wellcome Trust Research Career Development Fellowship (Award number 076806) to GFK. These funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, OPERATIONS COSTS COS; [Anonymous], 1968, ANOPHELINAE AFR S SA; BANG YH, 1977, E AFR MED J, V54, P403; BANG YH, 1975, E AFR MED J, V52, P578; Barbazan P, 1998, J AM MOSQUITO CONTR, V14, P33; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; BURKOT TR, 1984, AM J TROP MED HYG, V33, P783, DOI 10.4269/ajtmh.1984.33.783; CHAVASSE DC, 1995, MED VET ENTOMOL, V9, P147, DOI 10.1111/j.1365-2915.1995.tb00171.x; Chavasse DC, 1996, T ROY SOC TROP MED H, V90, P493, DOI 10.1016/S0035-9203(96)90291-6; CHAVASSE DC, 1995, MED VET ENTOMOL, V9, P141, DOI 10.1111/j.1365-2915.1995.tb00170.x; Clyde David F, 1967, MALARIA TANZANIA; De Castro MC, 2004, AM J TROP MED HYG, V71, P103, DOI 10.4269/ajtmh.2004.71.103; Dongus S, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-37; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; FILLINGER U, 2008, B WHO IN PRESS; Fillinger U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-20; Fillinger Ulrike, 2006, Trop Med Int Health, V11, P1629, DOI 10.1111/j.1365-3156.2006.01733.x; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Gillies M, 1987, ANOPHELINAE AFRICA S; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; KARCH S, 1992, J AM MOSQUITO CONTR, V8, P376; Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Kilama WL, 1994, P 11 ANN JOINT SCI C; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Killeen GF, 2006, AM J TROP MED HYG, V74, P517, DOI 10.4269/ajtmh.2006.74.517; Killeen GF, 2003, LANCET INFECT DIS, V3, P663, DOI 10.1016/S1473-3099(03)00776-X; Killeen GF, 2002, LANCET INFECT DIS, V2, P618, DOI 10.1016/S1473-3099(02)00397-3; Kiszewski A, 2007, B WORLD HEALTH ORGAN, V85, P623, DOI 10.2471/BLT.06.039529; KUMAR A, 1994, J AM MOSQUITO CONTR, V10, P534; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Macpherson CNL, 1991, HLTH DIS TANZANIA, P117; Majambere S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-76; MTASIWA D, 2003, DAR SALAAM CITY REGI; Mukabana WR, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-9; National Bureau of Statistics, 2003, 2002 POP HOUS CENS G; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184; Shililu JI, 2003, J AM MOSQUITO CONTR, V19, P251; Shililu J, 2007, AM J TROP MED HYG, V76, P103, DOI 10.4269/ajtmh.2007.76.103; SHOUSHA A. T., 1948, BULL WORLD HEALTH ORGAN, V1, P309; Skovmand O, 1997, J VECTOR ECOL, V22, P43; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Soper FL, 1943, ANOPHELES GAMBIAE BR; STEPHENS C, 1995, B WORLD HEALTH ORGAN, V73, P97; United Nations, 2004, WORLD URB PROSP 2003; Utzinger J, 2002, TROP MED INT HEALTH, V7, P657, DOI 10.1046/j.1365-3156.2002.00916.x; Utzinger J, 2001, TROP MED INT HEALTH, V6, P677, DOI 10.1046/j.1365-3156.2001.00769.x; Wang SJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-29; Watson, 2001, BATTLE BANNOCKBURN; WORRALL E, 2007, INTEGRATED VECTOR MA; 2002, NATL MALARIA MEDIUM	58	148	151	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5107	10.1371/journal.pone.0005107	http://dx.doi.org/10.1371/journal.pone.0005107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333402	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000265499900028
J	Durer, ZAO; Cohlberg, JA; Dinh, P; Padua, S; Ehrenclou, K; Downes, S; Tan, JK; Nakano, Y; Bowman, CJ; Hoskins, JL; Kwon, CH; Mason, AZ; Rodriguez, JA; Doucette, PA; Shaw, BF; Valentine, JS				Durer, Zeynep A. Oztug; Cohlberg, Jeffrey A.; Dinh, Phong; Padua, Shelby; Ehrenclou, Krista; Downes, Sean; Tan, James K.; Nakano, Yoko; Bowman, Christopher J.; Hoskins, Jessica L.; Kwon, Chuhee; Mason, Andrew Z.; Rodriguez, Jorge A.; Doucette, Peter A.; Shaw, Bryan F.; Valentine, Joan Selverstone			Loss of Metal Ions, Disulfide Reduction and Mutations Related to Familial ALS Promote Formation of Amyloid-Like Aggregates from Superoxide Dismutase	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU,ZN-SUPEROXIDE DISMUTASE; ALPHA-SYNUCLEIN; FIBRIL FORMATION; TRANSGENIC MICE; MUTANT SOD1; BETA-SHEET; POSTTRANSLATIONAL MODIFICATIONS; SOLUBLE OLIGOMERS; RECOMBINANT HUMAN	Mutations in the gene encoding Cu-Zn superoxide dismutase (SOD1) are one of the causes of familial amyotrophic lateral sclerosis (FALS). Fibrillar inclusions containing SOD1 and SOD1 inclusions that bind the amyloid-specific dye thioflavin S have been found in neurons of transgenic mice expressing mutant SOD1. Therefore, the formation of amyloid fibrils from human SOD1 was investigated. When agitated at acidic pH in the presence of low concentrations of guanidine or acetonitrile, metalated SOD1 formed fibrillar material which bound both thioflavin T and Congo red and had circular dichroism and infrared spectra characteristic of amyloid. While metalated SOD1 did not form amyloid-like aggregates at neutral pH, either removing metals from SOD1 with its intramolecular disulfide bond intact or reducing the intramolecular disulfide bond of metalated SOD1 was sufficient to promote formation of these aggregates. SOD1 formed amyloid-like aggregates both with and without intermolecular disulfide bonds, depending on the incubation conditions, and a mutant SOD1 lacking free sulfhydryl groups (AS-SOD1) formed amyloid-like aggregates at neutral pH under reducing conditions. ALS mutations enhanced the ability of disulfide-reduced SOD1 to form amyloid-like aggregates, and apo-AS-SOD1 formed amyloid-like aggregates at pH 7 only when an ALS mutation was also present. These results indicate that some mutations related to ALS promote formation of amyloid-like aggregates by facilitating the loss of metals and/or by making the intramolecular disulfide bond more susceptible to reduction, thus allowing the conversion of SOD1 to a form that aggregates to form resembling amyloid. Furthermore, the occurrence of amyloid-like aggregates per se does not depend on forming intermolecular disulfide bonds, and multiple forms of such aggregates can be produced from SOD1.	[Durer, Zeynep A. Oztug; Cohlberg, Jeffrey A.; Dinh, Phong; Padua, Shelby; Ehrenclou, Krista; Downes, Sean; Tan, James K.; Nakano, Yoko; Bowman, Christopher J.] Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA; [Hoskins, Jessica L.; Kwon, Chuhee] Calif State Univ Long Beach, Dept Phys & Astron, Long Beach, CA 90840 USA; [Mason, Andrew Z.] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA; [Rodriguez, Jorge A.; Doucette, Peter A.; Shaw, Bryan F.; Valentine, Joan Selverstone] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	California State University System; California State University Long Beach; California State University System; California State University Long Beach; California State University System; California State University Long Beach; University of California System; University of California Los Angeles	Durer, ZAO (corresponding author), Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA.	cohlberg@csulb.edu	Valentine, Joan S/B-6665-2008; Shaw, Bryan/A-7001-2008; durer, zeynep/G-5626-2019	Valentine, Joan S/0000-0002-7174-925X; Durer, Zeynep/0000-0001-9912-510X	Research Corporation [CC5571]; ALS Association [3Q1Y]; NIH [GM28222]; California State University, Long Beach; NSF [OCE-9977564]; Beckman Scholars Program; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028222] Funding Source: NIH RePORTER	Research Corporation(Research Corporation for Science Advancement); ALS Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California State University, Long Beach; NSF(National Science Foundation (NSF)); Beckman Scholars Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Research Corporation grant CC5571 and ALS Association grant 3Q1Y to JAC, NIH grant GM28222 and a grant from the ALS Association to JSV, and California State University, Long Beach. The ICP-MS was purchased with support from NSF grant OCE-9977564. PD and CJB were supported by the Beckman Scholars Program and JKT by a grant to CSULB from the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahtoniemi T, 2008, NEUROBIOL DIS, V32, P479, DOI 10.1016/j.nbd.2008.08.010; Aisenbrey C, 2008, EUR BIOPHYS J BIOPHY, V37, P247, DOI 10.1007/s00249-007-0237-0; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Banci L, 1998, BIOCHEMISTRY-US, V37, P11780, DOI 10.1021/bi9803473; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Bartnikas TB, 2003, J BIOL CHEM, V278, P33602, DOI 10.1074/jbc.M305435200; Bieler S, 2005, J BIOL CHEM, V280, P26880, DOI 10.1074/jbc.M502031200; Boissinot M, 1997, EMBO J, V16, P2171, DOI 10.1093/emboj/16.9.2171; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Choi J, 2005, J BIOL CHEM, V280, P11648, DOI 10.1074/jbc.M414327200; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Crow JP, 1997, J NEUROCHEM, V69, P1936; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Dennison SM, 2002, BIOCHEMISTRY-US, V41, P14925, DOI 10.1021/bi0203233; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; DIVRY PAUL, 1927, JOUR NEUROL ET PSYCHIATR, V27, P643; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; El-Agnaf OMA, 1998, EUR J BIOCHEM, V258, P157, DOI 10.1046/j.1432-1327.1998.2580157.x; FABIAN H, 1994, EUR J BIOCHEM, V221, P959, DOI 10.1111/j.1432-1033.1994.tb18811.x; FEE JA, 1975, BIOCHIM BIOPHYS ACTA, V412, P26, DOI 10.1016/0005-2795(75)90336-0; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Giacomelli CE, 2003, BIOMACROMOLECULES, V4, P1719, DOI 10.1021/bm034151g; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; Gross M, 1999, PROTEIN SCI, V8, P1350, DOI 10.1110/ps.8.6.1350; HALLEWELL RA, 1991, BIOCHEM BIOPH RES CO, V181, P474, DOI 10.1016/S0006-291X(05)81443-3; HARTZ JW, 1972, J BIOL CHEM, V247, P7043; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Heller J, 1996, PROTEIN SCI, V5, P1655, DOI 10.1002/pro.5560050819; Hong DP, 2002, J BIOL CHEM, V277, P21554, DOI 10.1074/jbc.M200188200; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Hough MA, 2003, STRUCTURE, V11, P937, DOI 10.1016/S0969-2126(03)00155-2; Huang THJ, 2000, J MOL BIOL, V297, P73, DOI 10.1006/jmbi.2000.3559; JARVIS JA, 1994, INT J PEPT PROT RES, V44, P388; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1293, DOI 10.1177/37.8.2666512; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; Koide T, 1998, NEUROSCI LETT, V257, P29, DOI 10.1016/S0304-3940(98)00800-3; LEPOCK JR, 1990, J BIOL CHEM, V265, P21612; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Lyons TJ, 2000, J BIOL INORG CHEM, V5, P189, DOI 10.1007/s007750050363; McDuff FO, 2004, BIOCHEM CELL BIOL, V82, P305, DOI 10.1139/o03-072; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; OZTUG ZA, 2005, THESIS CALIFORNIA ST; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Petrovic N, 1996, J BIOL CHEM, V271, P28335, DOI 10.1074/jbc.271.45.28335; Petrovic N, 1996, J BIOL CHEM, V271, P28331, DOI 10.1074/jbc.271.45.28331; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2006, BBA-MOL BASIS DIS, V1762, P1025, DOI 10.1016/j.bbadis.2006.05.004; Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; Rumfeldt JAO, 2006, J MOL BIOL, V355, P106, DOI 10.1016/j.jmb.2005.10.042; Sasaki S, 2005, ACTA NEUROPATHOL, V109, P247, DOI 10.1007/s00401-004-0939-7; Schladitz C, 1999, BIOPHYS J, V77, P3305, DOI 10.1016/S0006-3495(99)77161-4; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; Stieber A, 2000, J NEUROL SCI, V177, P114, DOI 10.1016/S0022-510X(00)00351-8; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Tcherkasskaya O, 2003, J BIOMOL STRUCT DYN, V21, P353, DOI 10.1080/07391102.2003.10506931; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vassall KA, 2006, BIOCHEMISTRY-US, V45, P7366, DOI 10.1021/bi0600953; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Yamagishi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001030; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104; ZHANG H, 1995, J MOL BIOL, V250, P514, DOI 10.1006/jmbi.1995.0395	91	100	100	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e5004	10.1371/journal.pone.0005004	http://dx.doi.org/10.1371/journal.pone.0005004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PO	19325915	Green Submitted, Green Published, gold			2022-12-27	WOS:000265499600004
J	Song, SQ; Huang, QL; Guo, JM; Li-Ling, J; Chen, XP; Ma, F				Song, Shiqin; Huang, Qianli; Guo, Jiaming; Li-Ling, Jesse; Chen, Xueping; Ma, Fei			Comparative Component Analysis of Exons with Different Splicing Frequencies	PLOS ONE			English	Article							SELECTION PRESSURE; INTRONIC SEQUENCES; MESSENGER-RNA; GC CONTENT; EVENTS; CONSERVATION; EVOLUTION; ELEMENTS; MOUSE; IDENTIFICATION	Transcriptional isoforms are not just random combinations of exons. What has caused exons to be differentially spliced and whether exons with different splicing frequencies are subjected to divergent regulation by potential elements or splicing signals? Beyond the conventional classification for alternatively spliced exons (ASEs) and constitutively spliced exons (CSEs), we have classified exons from alternatively spliced human genes and their mouse orthologs (12,314 and 5,464, respectively) into four types based on their splicing frequencies. Analysis has indicated that different groups of exons presented divergent compositional and regulatory properties. Interestingly, with the decrease of splicing frequency, exons tend to have greater lengths, higher GC content, and contain more splicing elements and repetitive elements, which seem to imply that the splicing frequency is influenced by such factors. Comparison of non-alternatively spliced (NAS) mouse genes with alternatively spliced human orthologs also suggested that exons with lower splicing frequencies may be newly evolved ones which gained functions with splicing frequencies altered through the evolution. Our findings have revealed for the first time that certain factors may have critical influence on the splicing frequency, suggesting that exons with lower splicing frequencies may originate from old repetitive sequences, with splicing sites altered by mutation, gaining novel functions and become more frequently spliced.			Song, SQ (corresponding author), Univ Sci & Technol China, Dept Chem, Hefei 230026, Peoples R China.	ustcchxp@sina.com; feima1968@gmail.com						Alekseyenko AV, 2007, RNA, V13, P661, DOI 10.1261/rna.325107; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Baek D, 2005, P NATL ACAD SCI USA, V102, P12813, DOI 10.1073/pnas.0506139102; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Boue S, 2003, BIOESSAYS, V25, P1031, DOI 10.1002/bies.10371; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Clark F, 2002, HUM MOL GENET, V11, P451, DOI 10.1093/hmg/11.4.451; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Garg K, 2007, GENOME RES, V17, P1015, DOI 10.1101/gr.6347907; Gotea V, 2006, TRENDS GENET, V22, P260, DOI 10.1016/j.tig.2006.03.006; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P5491, DOI 10.1093/nar/gkl706; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; Itoh H, 2004, RNA, V10, P1005, DOI 10.1261/rna.5221604; Kan Z, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P42; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kondrashov FA, 2001, HUM MOL GENET, V10, P2661, DOI 10.1093/hmg/10.23.2661; Ladd AN, 2002, GENOME BIOL, V3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Letunic I, 2002, HUM MOL GENET, V11, P1561, DOI 10.1093/hmg/11.13.1561; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Lev-Maor G, 2007, PLOS GENET, V3, P2221, DOI 10.1371/journal.pgen.0030203; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; MAKALOWSKI W, 1994, TRENDS GENET, V10, P188, DOI 10.1016/0168-9525(94)90254-2; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Nurtdinov RN, 2003, HUM MOL GENET, V12, P1313, DOI 10.1093/hmg/ddg137; Oliver JL, 1996, J MOL EVOL, V43, P216, DOI 10.1007/PL00006080; Pozzoli U, 2005, CELL MOL LIFE SCI, V62, P1579, DOI 10.1007/s00018-005-5030-6; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Sorek R, 2004, GENOME RES, V14, P1617, DOI 10.1101/gr.2572604; Sorek R, 2004, MOL CELL, V14, P221, DOI 10.1016/S1097-2765(04)00181-9; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Stamm S, 2000, DNA CELL BIOL, V19, P739, DOI 10.1089/104454900750058107; Su ZX, 2006, GENOME RES, V16, P182, DOI 10.1101/gr.4197006; Sugnet CW, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P66; Thanaraj T A, 2003, Prog Mol Subcell Biol, V31, P1; Thanaraj TA, 2003, NUCLEIC ACIDS RES, V31, P2544, DOI 10.1093/nar/gkg355; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang JH, 2005, NUCLEIC ACIDS RES, V33, P5053, DOI 10.1093/nar/gki810; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Xia XH, 2003, J MOL EVOL, V56, P362, DOI 10.1007/s00239-002-2406-1; Xing Y, 2005, P NATL ACAD SCI USA, V102, P13526, DOI 10.1073/pnas.0501213102; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhang XHF, 2005, MOL CELL BIOL, V25, P7323, DOI 10.1128/MCB.25.16.7323-7332.2005; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zhang XHF, 2006, P NATL ACAD SCI USA, V103, P13427, DOI 10.1073/pnas.0603042103; Zheng CL, 2005, RNA, V11, P1777, DOI 10.1261/rna.2660805	60	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5387	10.1371/journal.pone.0005387	http://dx.doi.org/10.1371/journal.pone.0005387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404386	gold, Green Published, Green Submitted			2022-12-27	WOS:000265614900006
J	Schumann, S; Terao, M; Garattini, E; Saggu, M; Lendzian, F; Hildebrandt, P; Leimkuhler, S				Schumann, Silvia; Terao, Mineko; Garattini, Enrico; Saggu, Miguel; Lendzian, Friedhelm; Hildebrandt, Peter; Leimkuehler, Silke			Site Directed Mutagenesis of Amino Acid Residues at the Active Site of Mouse Aldehyde Oxidase AOX1	PLOS ONE			English	Article								Mouse aldehyde oxidase (mAOX1) forms a homodimer and belongs to the xanthine oxidase family of molybdoenzymes which are characterized by an essential equatorial sulfur ligand coordinated to the molybdenum atom. In general, mammalian AOs are characterized by broad substrate specificity and an yet obscure physiological function. To define the physiological substrates and the enzymatic characteristics of mAOX1, we established a system for the heterologous expression of the enzyme in Eschericia coli. The recombinant protein showed spectral features and a range of substrate specificity similar to the native protein purified from mouse liver. The EPR data of recombinant mAOX1 were similar to those of AO from rabbit liver, but differed from the homologous xanthine oxidoreductase enzymes. Site-directed mutagenesis of amino acids Val806, Met884 and Glu1265 at the active site resulted in a drastic decrease in the oxidation of aldehydes with no increase in the oxidation of purine substrates. The double mutant V806E/M884R and the single mutant E1265Q were catalytically inactive enzymes regardless of the aldehyde or purine substrates tested. Our results show that only Glu1265 is essential for the catalytic activity by initiating the base-catalyzed mechanism of substrate oxidation. In addition, it is concluded that the substrate specificity of molybdo-flavoenzymes is more complex and not only defined by the three characterized amino acids in the active site.			Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	sleim@uni-potsdam.de	Hildebrandt, Peter/J-5658-2014; Saggu, Miguel/B-1224-2009; terao, mineko/AAU-8089-2020; Garattini, Enrico/AAI-1998-2019; Terao, Mineko/AAA-6415-2020	Hildebrandt, Peter/0000-0003-1030-5900; Terao, Mineko/0000-0002-9976-9869; Leimkuhler, Silke/0000-0003-3238-2122; Garattini, Enrico/0000-0001-8983-886X				Adachi M, 2007, J BIOCHEM MOL BIOL, V40, P1021; Anantharaman V, 2002, FEMS MICROBIOL LETT, V207, P55, DOI 10.1016/S0378-1097(01)00515-8; BARBER MJ, 1982, BIOCHEMISTRY-US, V21, P3561, DOI 10.1021/bi00258a006; Garattini E, 2008, CELL MOL LIFE SCI, V65, P1019, DOI 10.1007/s00018-007-7398-y; Garattini E, 2003, BIOCHEM J, V372, P15, DOI 10.1042/BJ20030121; Godber BLJ, 2005, BIOCHEM J, V388, P501, DOI 10.1042/BJ20041984; HILLE R, 1987, J BIOL CHEM, V262, P10914; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Huang DY, 1999, ARCH BIOCHEM BIOPHYS, V364, P264, DOI 10.1006/abbi.1999.1129; Ichida K, 2001, BIOCHEM BIOPH RES CO, V282, P1194, DOI 10.1006/bbrc.2001.4719; Koiwai H, 2000, J BIOCHEM-TOKYO, V127, P659, DOI 10.1093/oxfordjournals.jbchem.a022654; KRENITSKY TA, 1972, ARCH BIOCHEM BIOPHYS, V150, P585, DOI 10.1016/0003-9861(72)90078-1; Kundu TK, 2007, ARCH BIOCHEM BIOPHYS, V460, P113, DOI 10.1016/j.abb.2006.12.032; Kurosaki M, 2004, J BIOL CHEM, V279, P50482, DOI 10.1074/jbc.M408734200; Kurosaki M, 1999, BIOCHEM J, V341, P71, DOI 10.1042/0264-6021:3410071; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leimkuhler S, 1998, MOL MICROBIOL, V27, P853, DOI 10.1046/j.1365-2958.1998.00733.x; Leimkuhler S, 2004, J BIOL CHEM, V279, P40437, DOI 10.1074/jbc.M405778200; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Neumann M, 2007, J BIOL CHEM, V282, P28493, DOI 10.1074/jbc.M704020200; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; Parschat K, 2001, BBA-PROTEIN STRUCT M, V1544, P151, DOI 10.1016/S0167-4838(00)00214-4; Pauff JM, 2007, J BIOL CHEM, V282, P12785, DOI 10.1074/jbc.M700364200; REITER S, 1990, CLIN CHIM ACTA, V187, P221, DOI 10.1016/0009-8981(90)90107-4; RYAN MG, 1995, J BIOL CHEM, V270, P19209, DOI 10.1074/jbc.270.33.19209; Schumann S, 2008, J BIOL CHEM, V283, P16602, DOI 10.1074/jbc.M709894200; STESMANS A, 1989, J MAGN RESON, V178, P42; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; Terao M, 2001, J BIOL CHEM, V276, P46347, DOI 10.1074/jbc.M105744200; Truglio JJ, 2002, STRUCTURE, V10, P115, DOI 10.1016/S0969-2126(01)00697-9; Vila R, 2004, J BIOL CHEM, V279, P8668, DOI 10.1074/jbc.M308137200; WAHL RC, 1982, J BIOL CHEM, V257, P1354; Wollers S, 2008, J BIOL CHEM, V283, P9642, DOI 10.1074/jbc.M708549200; Yamaguchi Y, 2007, J BIOCHEM, V141, P513, DOI 10.1093/jb/mvm053	36	41	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5348	10.1371/journal.pone.0005348	http://dx.doi.org/10.1371/journal.pone.0005348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401776	Green Published, Green Submitted, gold			2022-12-27	WOS:000265601100007
J	Lankinen, M; Schwab, U; Erkkila, A; Seppanen-Laakso, T; Hannila, ML; Mussalo, H; Lehto, S; Uusitupa, M; Gylling, H; Oresic, M				Lankinen, Maria; Schwab, Ursula; Erkkila, Arja; Seppanen-Laakso, Tuulikki; Hannila, Marja-Leena; Mussalo, Hanna; Lehto, Seppo; Uusitupa, Matti; Gylling, Helena; Oresic, Matej			Fatty Fish Intake Decreases Lipids Related to Inflammation and Insulin Signaling-A Lipidomics Approach	PLOS ONE			English	Article							ACIDS; RESISTANCE; SUPPLEMENTATION; SENSITIVITY; OVERWEIGHT; GLUCOSE; DIET; PLASMALOGENS; CONSUMPTION; CERAMIDES	Background: The evidence of the multiple beneficial health effects of fish consumption is strong, but physiological mechanisms behind these effects are not completely known. Little information is available on the effects of consumption of different type of fish. The aim of this study was to investigate how fatty fish or lean fish in a diet affect serum lipidomic profiles in subjects with coronary heart disease. Methodology and Principal Findings: A pilot study was designed which included altogether 33 subjects with myocardial infarction or unstable ischemic attack in an 8-week parallel controlled intervention. The subjects were randomized to either fatty fish (n = 11), lean fish (n = 12) or control (n = 10) groups. Subjects in the fish groups had 4 fish meals per week and subjects in the control group consumed lean beef, pork and chicken. A fish meal was allowed once a week maximum. Lipidomics analyses were performed using ultra performance liquid chromatography coupled to electrospray ionization mass spectrometry and gas chromatography. Multiple bioactive lipid species, including ceramides, lysophosphatidylcholines and diacylglycerols, decreased significantly in the fatty fish group, whereas in the lean fish group cholesterol esters and specific long-chain triacylglycerols increased significantly (False Discovery Rate q-value <0.05). Conclusions/Significance: The 8-week consumption of fatty fish decreased lipids which are potential mediators of lipid-induced insulin resistance and inflammation, and may be related to the protective effects of fatty fish on the progression of atherosclerotic vascular diseases or insulin resistance.			Lankinen, M (corresponding author), VTT Tech Res Ctr Finland, Espoo, Finland.	matej.oresic@vtt.fi	Uusitupa, Matti Ilmari Julius/AAX-4929-2020; Oresic, Matej/AAV-3978-2020; Mussalo, Hanna/GLR-2552-2022; Oresic, Matej/K-7673-2016	Oresic, Matej/0000-0002-2856-9165; Lehto, Seppo/0000-0003-0414-5285; /0000-0002-9158-283X; Lyytinen, Arja/0000-0002-9111-2838				Aiyar N, 2007, MOL CELL BIOCHEM, V295, P113, DOI 10.1007/s11010-006-9280-x; BLANK ML, 1994, BBA-LIPID LIPID MET, V1214, P295, DOI 10.1016/0005-2760(94)90076-0; BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; Breslow JL, 2006, AM J CLIN NUTR, V83, p1477S, DOI 10.1093/ajcn/83.6.1477S; Browning LM, 2007, DIABETES OBES METAB, V9, P70, DOI 10.1111/j.1463-1326.2006.00576.x; Engelmann B, 2004, BIOCHEM SOC T, V32, P147, DOI 10.1042/BST0320147; Erkkila AT, 2008, EUR J NUTR, V47, P319, DOI 10.1007/s00394-008-0728-5; FESKENS EJM, 1991, DIABETES CARE, V14, P935, DOI 10.2337/diacare.14.11.935; Gaposchkin DP, 1999, J LIPID RES, V40, P495; Giacco R, 2007, NUTR METAB CARDIOVAS, V17, P572, DOI 10.1016/j.numecd.2006.06.006; He K, 2004, CIRCULATION, V109, P2705, DOI 10.1161/01.CIR.0000132503.19410.6B; Holland WL, 2007, NUTR REV, V65, pS39, DOI 10.1301/nr.2007.jun.S39-S46; Huang YH, 1999, CLIN EXP IMMUNOL, V116, P326; Jolly CA, 1997, J NUTR, V127, P37, DOI 10.1093/jn/127.1.37; Laaksonen R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000097; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lombardo YB, 2007, LIPIDS, V42, P427, DOI 10.1007/s11745-007-3039-3; Madsen T, 2001, AM J CARDIOL, V88, P1139, DOI 10.1016/S0002-9149(01)02049-5; Mori TA, 1999, AM J CLIN NUTR, V70, P817; Mozaffarian D, 2003, CIRCULATION, V107, P1372, DOI 10.1161/01.CIR.0000055315.79177.16; Nettleton JA, 2005, J AM DIET ASSOC, V105, P428, DOI 10.1016/j.jada.2004.11.029; Philibert A, 2006, AM J CLIN NUTR, V84, P1299, DOI 10.1093/ajcn/84.6.1299; R Development Core Team, 2007, R LANG ENV STAT COMP; Ramel A, 2008, DIABETOLOGIA, V51, P1261, DOI 10.1007/s00125-008-1035-7; Rasic-Milutinovic Z, 2007, RENAL FAILURE, V29, P321, DOI 10.1080/08860220601184092; Schwab U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002630; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Taouis M, 2002, AM J PHYSIOL-ENDOC M, V282, pE664, DOI 10.1152/ajpendo.00320.2001; TIMMERS S, 2008, PHYSL BEHAV IN PRESS; Turpin SM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1341, DOI 10.1152/ajpendo.00095.2006; Wang CC, 2006, AM J CLIN NUTR, V84, P5, DOI 10.1093/ajcn/84.1.5; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335	34	93	96	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5258	10.1371/journal.pone.0005258	http://dx.doi.org/10.1371/journal.pone.0005258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390588	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514200004
J	Raman, B; Pan, C; Hurst, GB; Rodriguez, M; McKeown, CK; Lankford, PK; Samatova, NF; Mielenz, JR				Raman, Babu; Pan, Chongle; Hurst, Gregory B.; Rodriguez, Miguel, Jr.; McKeown, Catherine K.; Lankford, Patricia K.; Samatova, Nagiza F.; Mielenz, Jonathan R.			Impact of Pretreated Switchgrass and Biomass Carbohydrates on Clostridium thermocellum ATCC 27405 Cellulosome Composition: A Quantitative Proteomic Analysis	PLOS ONE			English	Article								Background: Economic feasibility and sustainability of lignocellulosic ethanol production requires the development of robust microorganisms that can efficiently degrade and convert plant biomass to ethanol. The anaerobic thermophilic bacterium Clostridium thermocellum is a candidate microorganism as it is capable of hydrolyzing cellulose and fermenting the hydrolysis products to ethanol and other metabolites. C. thermocellum achieves efficient cellulose hydrolysis using multiprotein extracellular enzymatic complexes, termed cellulosomes. Methodology/Principal Findings: In this study, we used quantitative proteomics (multidimensional LC-MS/MS and N-15-metabolic labeling) to measure relative changes in levels of cellulosomal subunit proteins (per CipA scaffoldin basis) when C. thermocellum ATCC 27405 was grown on a variety of carbon sources [dilute-acid pretreated switchgrass, cellobiose, amorphous cellulose, crystalline cellulose (Avicel) and combinations of crystalline cellulose with pectin or xylan or both]. Cellulosome samples isolated from cultures grown on these carbon sources were compared to N-15 labeled cellulosome samples isolated from crystalline cellulose-grown cultures. In total from all samples, proteomic analysis identified 59 dockerin-and 8 cohesin-module containing components, including 16 previously undetected cellulosomal subunits. Many cellulosomal components showed differential protein abundance in the presence of non-cellulose substrates in the growth medium. Cellulosome samples from amorphous cellulose, cellobiose and pretreated switchgrass-grown cultures displayed the most distinct differences in composition as compared to cellulosome samples from crystalline cellulose-grown cultures. While Glycoside Hydrolase Family 9 enzymes showed increased levels in the presence of crystalline cellulose, and pretreated switchgrass, in particular, GH5 enzymes showed increased levels in response to the presence of cellulose in general, amorphous or crystalline. Conclusions/Significance: Overall, the quantitative results suggest a coordinated substrate-specific regulation of cellulosomal subunit composition in C. thermocellum to better suit the organism's needs for growth under different conditions. To date, this study provides the most comprehensive comparison of cellulosomal compositional changes in C. thermocellum in response to different carbon sources. Such studies are vital to engineering a strain that is best suited to grow on specific substrates of interest and provide the building blocks for constructing designer cellulosomes with tailored enzyme composition for industrial ethanol production.			Raman, B (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	mielenzjr@ornl.gov	Pan, Chongle/C-6960-2008	Pan, Chongle/0000-0003-2860-0334; Hurst, Gregory/0000-0002-7650-8009				Arai T, 2001, APPL MICROBIOL BIOT, V57, P660, DOI 10.1007/s00253-001-0832-4; Barr BK, 1996, BIOCHEMISTRY-US, V35, P586, DOI 10.1021/bi9520388; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; BAYER EA, 1985, J BACTERIOL, V163, P552, DOI 10.1128/JB.163.2.552-559.1985; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; BAYER EA, 1986, J BACTERIOL, V167, P828, DOI 10.1128/jb.167.3.828-836.1986; Bayer EA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P578, DOI 10.1007/0-387-30742-7_19; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Dror TW, 2005, J BACTERIOL, V187, P2261, DOI 10.1128/JB.187.7.2261-2266.2005; Dror TW, 2003, J BACTERIOL, V185, P5109, DOI 10.1128/JB.185.17.5109-5116.2003; Dror TW, 2003, J BACTERIOL, V185, P3042, DOI 10.1128/JB.185.10.3042-3048.2003; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fuchs KP, 2003, MICROBIOL-SGM, V149, P1021, DOI 10.1099/mic.0.26153-0; GERWIG GJ, 1989, J BIOL CHEM, V264, P1027; Gold ND, 2007, J BACTERIOL, V189, P6787, DOI 10.1128/JB.00882-07; Halstead JR, 1999, MICROBIOL-SGM, V145, P3101, DOI 10.1099/00221287-145-11-3101; Hayashi H, 1997, J BACTERIOL, V179, P4246, DOI 10.1128/jb.179.13.4246-4253.1997; Hayashi H, 1999, APPL MICROBIOL BIOT, V51, P348, DOI 10.1007/s002530051401; JOLIFF G, 1986, NUCLEIC ACIDS RES, V14, P8605, DOI 10.1093/nar/14.21.8605; Kataeva I, 1999, J BACTERIOL, V181, P5288, DOI 10.1128/JB.181.17.5288-5295.1999; KRUUS K, 1995, J BACTERIOL, V177, P1641, DOI 10.1128/jb.177.6.1641-1644.1995; KRUUS K, 1995, P NATL ACAD SCI USA, V92, P9254, DOI 10.1073/pnas.92.20.9254; Kurokawa J, 2002, APPL MICROBIOL BIOT, V59, P455, DOI 10.1007/s00253-002-1048-y; Kurokawa J, 2001, BIOSCI BIOTECH BIOCH, V65, P548, DOI 10.1271/bbb.65.548; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; LEMAIRE M, 1993, J BACTERIOL, V175, P3353, DOI 10.1128/jb.175.11.3353-3360.1993; LEMAIRE M, 1995, J BACTERIOL, V177, P2451, DOI 10.1128/jb.177.9.2451-2459.1995; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MISHRA S, 1991, J BACTERIOL, V173, P80, DOI 10.1128/jb.173.1.80-85.1991; MORAG E, 1990, J BACTERIOL, V172, P6098, DOI 10.1128/jb.172.10.6098-6105.1990; Newcomb M, 2007, P NATL ACAD SCI USA, V104, P3747, DOI 10.1073/pnas.0700087104; Pan CL, 2006, ANAL CHEM, V78, P7121, DOI 10.1021/ac060654b; Pan CL, 2006, ANAL CHEM, V78, P7110, DOI 10.1021/ac0606554; SALAMITOU S, 1994, J BACTERIOL, V176, P2822, DOI 10.1128/JB.176.10.2822-2827.1994; SALAMITOU S, 1994, J BACTERIOL, V176, P2828, DOI 10.1128/JB.176.10.2828-2834.1994; Schell DJ, 2003, APPL BIOCHEM BIOTECH, V105, P69, DOI 10.1385/ABAB:105:1-3:69; Schwarz WH, 2001, APPL MICROBIOL BIOT, V56, P634, DOI 10.1007/s002530100710; Stevenson DM, 2005, APPL ENVIRON MICROB, V71, P4672, DOI 10.1128/AEM.71.8.4672-4678.2005; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; WANG WK, 1993, J BACTERIOL, V175, P1293, DOI 10.1128/JB.175.5.1293-1302.1993; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c; Zhang YHP, 2005, J BACTERIOL, V187, P99, DOI 10.1128/JB.187.1.99-106.2005; Zverlov VV, 2008, ANN NY ACAD SCI, V1125, P298, DOI 10.1196/annals.1419.008; Zverlov VV, 2005, PROTEOMICS, V5, P3646, DOI 10.1002/pmic.200401199; Zverlov VV, 2005, MICROBIOL-SGM, V151, P3395, DOI 10.1099/mic.0.28206-0; Zverlov VV, 2005, FEMS MICROBIOL LETT, V249, P353, DOI 10.1016/j.femsle.2005.06.037; Zverlov VV, 2003, MICROBIOL-SGM, V149, P515, DOI 10.1099/mic.0.25959-0; Zverlov VV, 2002, APPL ENVIRON MICROB, V68, P3176, DOI 10.1128/AEM.68.6.3176-3179.2002; Zverlov VV, 2002, MICROBIOL-SGM, V148, P247, DOI 10.1099/00221287-148-1-247; Zverlov VV, 1999, APPL MICROBIOL BIOT, V51, P852, DOI 10.1007/s002530051473; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	58	195	201	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5271	10.1371/journal.pone.0005271	http://dx.doi.org/10.1371/journal.pone.0005271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384422	Green Published, gold			2022-12-27	WOS:000265513900014
J	Wu, ZH; Hansmann, B; Meyer-Hoffert, U; Glaser, R; Schroder, JM				Wu, Zhihong; Hansmann, Britta; Meyer-Hoffert, Ulf; Glaeser, Regine; Schroeder, Jens-Michael			Molecular Identification and Expression Analysis of Filaggrin-2, a Member of the S100 Fused-Type Protein Family	PLOS ONE			English	Article							EPIDERMAL DIFFERENTIATION COMPLEX; CALCIUM-BINDING PROTEINS; PROLINE-RICH PROTEINS; CORNIFIED ENVELOPE; STRUCTURAL PROTEINS; GENE FAMILY; PEPTIDYLARGININE DEIMINASE; HUMAN PROFILAGGRIN; SKIN-BARRIER; TRICHOHYALIN	Genes of the S100 fused-type protein (SFTP) family are clustered within the epidermal differentiation complex and encode essential components that maintain epithelial homeostasis and barrier functions. Recent genetic studies have shown that mutations within the gene encoding the SFTP filaggrin cause ichthyosis vulgaris and are major predisposing factors for atopic dermatitis. As a vital component of healthy skin, filaggrin is also a precursor of natural moisturizing factors. Here we present the discovery of a member of this family, designated as filaggrin-2 (FLG2) that is expressed in human skin. The FLG2 gene encodes a histidine-and glutamine-rich protein of approximately 248 kDa, which shares common structural features with other SFTP members, in particular filaggrin. We found that FLG2 transcripts are present in skin, thymus, tonsils, stomach, testis and placenta. In cultured primary keratinocytes, FLG2 mRNA expression displayed almost the same kinetics as that of filaggrin following Ca2+ stimulation, suggesting an important role in molecular regulation of epidermal terminal differentiation. We provide evidences that like filaggrin, FLG2 is initially expressed by upper granular cells, proteolytically processed and deposited in the stratum granulosum and stratum corneum (SC) layers of normal epidermis. Thus, FLG2 and filaggrin may have overlapping and perhaps synergistic roles in the formation of the epidermal barrier, protecting the skin from environmental insults and the escape of moisture by offering precursors of natural moisturizing factors.			Wu, ZH (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany.	jschroeder@dermatology.uni-kiel.de	Wu, Zhihong/AAK-3433-2020; Wu, Zhihong/G-3569-2011; Meyer-Hoffert, Ulf/F-4623-2012; Gläser, Regine/B-3168-2010	Meyer-Hoffert, Ulf/0000-0003-2305-1428; 				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BANKSSCHLEGEL S, 1981, J CELL BIOL, V90, P732, DOI 10.1083/jcb.90.3.732; BRIAND JP, 1985, J IMMUNOL METHODS, V78, P59, DOI 10.1016/0022-1759(85)90329-1; Cabral A, 2001, J BIOL CHEM, V276, P19231, DOI 10.1074/jbc.M100336200; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Contzler R, 2005, J INVEST DERMATOL, V124, P990, DOI 10.1111/j.0022-202X.2005.23694.x; Dale B. A., 1994, KERATINOCYTE HDB, P323; DALE BA, 1985, J CELL BIOL, V101, P1257, DOI 10.1083/jcb.101.4.1257; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; GAN SQ, 1990, BIOCHEMISTRY-US, V29, P9432, DOI 10.1021/bi00492a018; Gross Liza, 2008, PLoS Biol, V6, pe133, DOI 10.1371/journal.pbio.0060133; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; HOHL D, 1991, J BIOL CHEM, V266, P6626; Huber M, 2005, J INVEST DERMATOL, V124, P998, DOI 10.1111/j.0022-202X.2005.23675.x; IshidaYamamoto A, 1997, BRIT J DERMATOL, V137, P9, DOI 10.1046/j.1365-2133.1997.17611855.x; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Kahlem P, 1996, P NATL ACAD SCI USA, V93, P14580, DOI 10.1073/pnas.93.25.14580; Kalinin A, 2001, J CELL SCI, V114, P3069; Kanno T, 2000, J INVEST DERMATOL, V115, P813, DOI 10.1046/j.1523-1747.2000.00131.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Krieg P, 1997, GENOMICS, V43, P339, DOI 10.1006/geno.1997.4818; Lee JH, 1996, J BIOL CHEM, V271, P4561; LEE SC, 1993, J INVEST DERMATOL, V100, P65, DOI 10.1111/1523-1747.ep12354504; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Makino T, 2001, J BIOL CHEM, V276, P47445, DOI 10.1074/jbc.M107512200; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Marenholz I, 1996, GENOMICS, V37, P295, DOI 10.1006/geno.1996.0563; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; McGrath JA, 2008, TRENDS MOL MED, V14, P20, DOI 10.1016/j.molmed.2007.10.006; MCKINLEYGRANT LJ, 1989, P NATL ACAD SCI USA, V86, P4848, DOI 10.1073/pnas.86.13.4848; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pearton DJ, 2002, J INVEST DERMATOL, V119, P661, DOI 10.1046/j.1523-1747.2002.01831.x; Pendegrass CJ, 2006, J ANAT, V209, P59, DOI 10.1111/j.1469-7580.2006.00595.x; PILLAI S, 1990, J CELL PHYSIOL, V143, P294, DOI 10.1002/jcp.1041430213; Presland RB, 1997, J INVEST DERMATOL, V108, P170, DOI 10.1111/1523-1747.ep12333356; PRESLAND RB, 1992, J BIOL CHEM, V267, P23772; Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383, DOI 10.1177/10454411000110040101; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandilands A, 2007, J INVEST DERMATOL, V127, P1282, DOI 10.1038/sj.jid.5700876; Sastry M, 1998, STRUCTURE, V6, P223, DOI 10.1016/S0969-2126(98)00023-9; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Segre JA, 2006, J INVEST DERMATOL, V126, P1202, DOI 10.1038/sj.jid.5700367; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Smith FJD, 1996, NAT GENET, V13, P450, DOI 10.1038/ng0896-450; Steinert PM, 1998, J STRUCT BIOL, V122, P76, DOI 10.1006/jsbi.1998.3957; STEINERT PM, 1981, P NATL ACAD SCI-BIOL, V78, P4097, DOI 10.1073/pnas.78.7.4097; Steinert PM, 2003, J BIOL CHEM, V278, P41409, DOI 10.1074/jbc.M302037200; Steinert PM, 1998, J BIOL CHEM, V273, P11758, DOI 10.1074/jbc.273.19.11758; TAKAHASHI M, 1994, FEBS LETT, V340, P173, DOI 10.1016/0014-5793(94)80131-2; Takaishi M, 2005, J BIOL CHEM, V280, P4696, DOI 10.1074/jbc.M409026200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarcsa E, 1997, J BIOL CHEM, V272, P27893, DOI 10.1074/jbc.272.44.27893; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; VARADARAJ K, 1994, GENE, V140, P1, DOI 10.1016/0378-1119(94)90723-4; Wan H, 2003, J CELL SCI, V116, P4239, DOI 10.1242/jcs.00701; WATANABE S, 1991, Journal of Dermatology (Tokyo), V18, P143; Wiedow O, 1998, BIOCHEM BIOPH RES CO, V248, P904, DOI 10.1006/bbrc.1998.9069; WU Z, 2009, J INVEST DE IN PRESS; Xu ZX, 2000, GENOMICS, V69, P322, DOI 10.1006/geno.2000.6344; Zhao XP, 1997, GENOMICS, V45, P250, DOI 10.1006/geno.1997.4952; Zhao Y, 2007, J INVEST DERMATOL, V127, P1878, DOI 10.1038/sj.jid.5700817	69	83	87	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5227	10.1371/journal.pone.0005227	http://dx.doi.org/10.1371/journal.pone.0005227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384417	Green Submitted, gold, Green Published			2022-12-27	WOS:000265513900005
J	Vepachedu, R; Karim, Z; Patel, O; Goplen, N; Alam, R				Vepachedu, Ramarao; Karim, Zunayet; Patel, Ojas; Goplen, Nicholas; Alam, Rafeul			Unc119 Protects from Shigella Infection by Inhibiting the Abl Family Kinases	PLOS ONE			English	Article							ACTIN-BINDING DOMAINS; TYROSINE KINASE; F-ACTIN; EPITHELIAL-CELLS; FLEXNERI; INVASION; ENTRY; PHOSPHORYLATION; CORTACTIN; INNATE	Background: Bacteria engage cell surface receptors and intracellular signaling molecules to enter the cell. Unc119 is an adaptor protein, which interacts with receptors and tyrosine kinases. Its role in bacterial invasion of cells is unknown. Methodology/Principal Findings: We used biochemical, molecular and cell biology approaches to identify the binding partners of Unc119, and to study the effect of Unc119 on Abl family kinases and Shigella infection. We employed loss-of-function and gain-in-function approaches to study the effect of Unc119 in a mouse model of pulmonary shigellosis. Unc119 interacts with Abl family kinases and inhibits their kinase activity. As a consequence, it inhibits Crk phosphorylation, which is essential for Shigella infection. Unc119 co-localizes with Crk and Shigella in infected cells. Shigella infectivity increases in Unc119-deficient epithelial and macrophage cells. In a mouse model of shigellosis cell-permeable TAT-Unc119 inhibits Shigella infection. Conversely, Unc119 knockdown in vivo results in enhanced bacterial invasion and increased lethality. Unc119 is an inducible protein. Its expression is upregulated by probacteria and bacterial products such as lipopolysacharide and sodium butyrate. The latter inhibits Shigella infection in mouse lungs but is ineffective in Unc119 deficiency. Conclusions: Unc119 inhibits signaling pathways that are used by Shigella to enter the cell. As a consequence it provides partial but significant protection from Shigella infections. Unc119 induction in vivo boosts host defense against infections.			Vepachedu, R (corresponding author), Natl Jewish Hlth, Denver, CO USA.	alamr@njc.org			NHLBI NIH HHS [HL 36577, P01 HL036577] Funding Source: Medline; NIAID NIH HHS [AI68088, HHSN272200700048C, R01 AI059719, R01 AI068088] Funding Source: Medline; PHS HHS [N01 HHSN 272200700048C] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059719, R01AI068088] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bougneres L, 2004, J CELL BIOL, V166, P225, DOI 10.1083/jcb.200402073; Bourdet-Sicard R, 1999, EMBO J, V18, P5853, DOI 10.1093/emboj/18.21.5853; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; Cen O, 2003, J BIOL CHEM, V278, P8837, DOI 10.1074/jbc.M208261200; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; DEHIO C, 1995, EMBO J, V14, P2471, DOI 10.1002/j.1460-2075.1995.tb07244.x; Dumenil G, 1998, J CELL BIOL, V143, P1003, DOI 10.1083/jcb.143.4.1003; Dumenil G, 2000, J CELL SCI, V113, P71; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; Elwell CA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000021; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; Handa Y, 2007, NAT CELL BIOL, V9, P121, DOI 10.1038/ncb1526; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Ingersoll MA, 2006, INFECT IMMUN, V74, P2317, DOI 10.1128/IAI.74.4.2317-2327.2006; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; NORIEGA FR, 1994, INFECT IMMUN, V62, P5168, DOI 10.1128/IAI.62.11.5168-5172.1994; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; PHALIPON A, 1995, J EXP MED, V182, P769, DOI 10.1084/jem.182.3.769; Phalipon A, 2007, IMMUNOL CELL BIOL, V85, P119, DOI 10.1038/sj.icb7100025; Phillips C, 2000, CANCER PRACT, V8, P165, DOI 10.1046/j.1523-5394.2000.84009.x; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Skoudy A, 2000, CELL MICROBIOL, V2, P19, DOI 10.1046/j.1462-5822.2000.00028.x; TENHOEVE J, 1994, BLOOD, V84, P1731; Van Nhieu GT, 1999, CURR OPIN MICROBIOL, V2, P51; VANDEVERG LL, 1995, INFECT IMMUN, V63, P1947, DOI 10.1128/IAI.63.5.1947-1954.1995; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; VANNHIEU GT, 2000, CELL MICROBIOL, V2, P187, DOI DOI 10.1046/J.1462-5822.2000.00046.X; Vepachedu R, 2007, J IMMUNOL, V179, P682, DOI 10.4049/jimmunol.179.1.682; Wang YX, 2001, P NATL ACAD SCI USA, V98, P14865, DOI 10.1073/pnas.251249298; Watarai M, 1996, J EXP MED, V183, P991, DOI 10.1084/jem.183.3.991; Way SS, 1998, INFECT IMMUN, V66, P1342, DOI 10.1128/IAI.66.4.1342-1348.1998; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Yoshida S, 2003, TRENDS MICROBIOL, V11, P139, DOI 10.1016/S0966-842X(03)00023-4; Zhu JY, 1996, MOL CELL BIOL, V16, P7054	50	12	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5211	10.1371/journal.pone.0005211	http://dx.doi.org/10.1371/journal.pone.0005211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381274	gold, Green Published, Green Submitted			2022-12-27	WOS:000265510800006
J	Villaescusa, JC; Buratti, C; Penkov, D; Mathiasen, L; Planaguma, J; Ferretti, E; Blasi, F				Villaescusa, J. Carlos; Buratti, Claudia; Penkov, Dmitry; Mathiasen, Lisa; Planaguma, Jesus; Ferretti, Elisabetta; Blasi, Francesco			Cytoplasmic Prep1 Interacts with 4EHP Inhibiting Hoxb4 Translation	PLOS ONE			English	Article							HOMEOBOX-CONTAINING GENES; MESSENGER-RNA; MEIOTIC MATURATION; OOCYTE MATURATION; MOUSE OOCYTES; PROTEIN; EXPRESSION; DROSOPHILA; PBX; POLYADENYLATION	Background: Homeobox genes are essential for embryonic patterning and cell fate determination. They are regulated mostly at the transcriptional level. In particular, Prep1 regulates Hox transcription in association with Pbx proteins. Despite its nuclear role as a transcription factor, Prep1 is located in the cytosol of mouse oocytes from primary to antral follicles. The homeodomain factor Bicoid (Bcd) has been shown to interact with 4EHP (eukaryotic translation initiation factor 4E homolog protein) to repress translation of Caudal mRNA and to drive Drosophila embryo development. Interestingly, Prep1 contains a putative binding motif for 4EHP, which may reflect a novel unknown function. Methodology/Principal Findings: In this paper we show by confocal microscopy and deconvolution analysis that Prep1 and 4EHP co-localize in the cytosol of growing mouse oocytes, demonstrating their interaction by co-immunoprecipitation and pull-down experiments. A functional 4EHP-binding motif present in Prep1 has been also identified by mutagenesis analysis. Moreover, Prep1 inhibits (>95%) the in vitro translation of a luciferase reporter mRNA fused to the Hoxb4 3'UTR, in the presence of 4EHP. RNA electrophoretic mobility shift assay was used to demonstrate that Prep1 binds the Hoxb4 3'UTR. Furthermore, conventional histology and immunohistochemistry has shown a dramatic oocyte growth failure in hypomorphic mouse Prep1(i/i) females, accompanied by an increased production of Hoxb4. Finally, Hoxb4 overexpression in mouse zygotes showed a slow in vitro development effect. Conclusions: Prep1 has a novel cytoplasmic, 4EHP-dependent, function in the regulation of translation. Mechanistically, the Prep1-4EHP interaction might bridge the 3'UTR of Hoxb4 mRNA to the 59 cap structure. This is the first demonstration that a mammalian homeodomain transcription factor regulates translation, and that this function can be possibly essential for the development of female germ cells and involved in mammalian zygote development.			Villaescusa, JC (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Stockholm, Sweden.	blasi.Francesco@hsr.it	Ferretti, Elisabetta/ABD-7257-2021	Villaescusa, J. Carlos/0000-0001-9456-9828; Blasi, Francesco/0000-0001-9406-1784	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; Telethon [GGP06028] Funding Source: Medline	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon)		Angenstein F, 2005, J BIOL CHEM, V280, P6496, DOI 10.1074/jbc.M412742200; BACHVAROVA R, 1989, DEVELOPMENT, V106, P561; BACHVAROVA R, 1985, DEV BIOL, V108, P325, DOI 10.1016/0012-1606(85)90036-3; BACHVAROVA R, 1981, DEV BIOL, V86, P384, DOI 10.1016/0012-1606(81)90196-2; Berthelsen J, 1999, GENE DEV, V13, P946, DOI 10.1101/gad.13.8.946; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; Brun ACM, 2004, BLOOD, V103, P4126, DOI 10.1182/blood-2003-10-3557; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Chawengsaksophak K, 1996, GENOMICS, V34, P270, DOI 10.1006/geno.1996.0286; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Deflorian G, 2004, DEVELOPMENT, V131, P613, DOI 10.1242/dev.00948; Diaz VM, 2007, MOL CELL BIOL, V27, P7981, DOI 10.1128/MCB.01290-07; DIROSA P, 2007, DEV BIOL; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Ferretti E, 2000, DEVELOPMENT, V127, P155; Ferretti E, 2005, MOL CELL BIOL, V25, P8541, DOI 10.1128/MCB.25.19.8541-8552.2005; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; GEBAUER F, 1994, EMBO J, V13, P5712, DOI 10.1002/j.1460-2075.1994.tb06909.x; HUARTE J, 1987, GENE DEV, V1, P1201, DOI 10.1101/gad.1.10.1201; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Kuliev A, 1996, J ASSIST REPROD GEN, V13, P177, DOI 10.1007/BF02072541; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; MURTHA MT, 1991, P NATL ACAD SCI USA, V88, P10711, DOI 10.1073/pnas.88.23.10711; Niessing D, 2002, GENE DEV, V16, P2576, DOI 10.1101/gad.240002; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Oh B, 2000, DEVELOPMENT, V127, P3795; Penkov D, 2005, MOL CELL BIOL, V25, P10768, DOI 10.1128/MCB.25.24.10768-10781.2005; Ponsuksili S, 2001, MOL REPROD DEV, V60, P297, DOI 10.1002/mrd.1091; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; SCHULTZ RM, 1983, DEV BIOL, V97, P264, DOI 10.1016/0012-1606(83)90085-4; SCHULTZ RM, 1983, DEV BIOL, V95, P294, DOI 10.1016/0012-1606(83)90030-1; Sedarat F, 2004, J APPL PHYSIOL, V97, P1098, DOI 10.1152/japplphysiol.00089.2004; Semotok JL, 2007, DIFFERENTIATION, V75, P482, DOI 10.1111/j.1432-0436.2007.00178.x; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; Small S, 1991, CURR OPIN GENET DEV, V1, P255, DOI 10.1016/S0959-437X(05)80079-6; Stauber M, 1999, P NATL ACAD SCI USA, V96, P3786, DOI 10.1073/pnas.96.7.3786; Tee AR, 2004, FEBS LETT, V564, P58, DOI 10.1016/S0014-5793(04)00313-8; Thomson AM, 1999, BIOTECHNIQUES, V27, P1032, DOI 10.2144/99275rr03; Topisirovic I, 2005, HISTOL HISTOPATHOL, V20, P1275, DOI 10.14670/HH-20.1275; Villaescusa JC, 2004, GENE, V330, P1, DOI 10.1016/j.gene.2004.01.024; Waskiewicz AJ, 2002, DEV CELL, V3, P723, DOI 10.1016/S1534-5807(02)00319-2; Zuberek J, 2007, RNA, V13, P691, DOI 10.1261/rna.453107	43	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5213	10.1371/journal.pone.0005213	http://dx.doi.org/10.1371/journal.pone.0005213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365557	Green Published, Green Submitted, gold			2022-12-27	WOS:000265509900018
J	Calvo-Pinilla, E; Rodriguez-Calvo, T; Anguita, J; Sevilla, N; Ortego, J				Calvo-Pinilla, Eva; Rodriguez-Calvo, Teresa; Anguita, Juan; Sevilla, Noemi; Ortego, Javier			Establishment of a Bluetongue Virus Infection Model in Mice that Are Deficient in the Alpha/Beta Interferon Receptor	PLOS ONE			English	Article								Bluetongue (BT) is a noncontagious, insect-transmitted disease of ruminants caused by the bluetongue virus (BTV). A laboratory animal model would greatly facilitate the studies of pathogenesis, immune response and vaccination against BTV. Herein, we show that adult mice deficient in type I IFN receptor (IFNAR((-/-))) are highly susceptible to BTV-4 and BTV-8 infection when the virus is administered intravenously. Disease was characterized by ocular discharges and apathy, starting at 48 hours post-infection and quickly leading to animal death within 60 hours of inoculation. Infectious virus was recovered from the spleen, lung, thymus, and lymph nodes indicating a systemic infection. In addition, a lymphoid depletion in spleen, and severe pneumonia were observed in the infected mice. Furthermore, IFNAR((-/-)) adult mice immunized with a BTV-4 inactivated vaccine showed the induction of neutralizing antibodies against BTV-4 and complete protection against challenge with a lethal dose of this virus. The data indicate that this mouse model may facilitate the study of BTV pathogenesis, and the development of new effective vaccines for BTV.			Calvo-Pinilla, E (corresponding author), CISA INIA, Ctr Invest Sanidad Anim, Madrid, Spain.	ortego@inia.es	Rodriguez-Calvo, Teresa/A-6831-2010; Ortego, Javier/M-6810-2019; Rodriguez-Calvo, Teresa/AAH-2365-2019; ortego, javier/K-6020-2014; Sevilla, Noemi/K-8648-2014; Anguita, Juan/D-5432-2011; CALVO-PINILLA, EVA/L-5348-2014	Ortego, Javier/0000-0002-4275-7277; ortego, javier/0000-0002-4275-7277; Sevilla, Noemi/0000-0003-0118-0376; Anguita, Juan/0000-0003-2061-7182; CALVO-PINILLA, EVA/0000-0002-4667-4081				BARRATTBOYES SM, 1994, VET MICROBIOL, V40, P361, DOI 10.1016/0378-1135(94)90123-6; Barros SC, 2007, VET MICROBIOL, V124, P25, DOI 10.1016/j.vetmic.2007.04.014; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Breard E, 2007, VIRUS RES, V125, P191, DOI 10.1016/j.virusres.2007.01.002; Brewer AW, 1998, ARCH VIROL, V143, P145, DOI 10.1007/s007050050274; CARR MA, 1995, ARCH VIROL, V140, P915, DOI 10.1007/BF01314967; DeMaula CD, 2000, VIRUS RES, V67, P59, DOI 10.1016/S0168-1702(00)00130-1; FIETTE L, 1995, J EXP MED, V181, P2069, DOI 10.1084/jem.181.6.2069; FOSTER NM, 1991, AM J VET RES, V52, P192; Franchi P, 2008, J VIROL METHODS, V153, P263, DOI 10.1016/j.jviromet.2008.07.007; FULTON RW, 1982, CAN J COMP MED, V46, P100; Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005; Jameson P, 1981, Methods Enzymol, V78, P254; JAMESON P, 1978, INFECT IMMUN, V20, P321, DOI 10.1128/IAI.20.1.321-323.1978; Jones LD, 1997, CLIN DIAGN LAB IMMUN, V4, P297, DOI 10.1128/CDLI.4.3.297-301.1997; LETCHWORTH GJ, 1983, INFECT IMMUN, V39, P208, DOI 10.1128/IAI.39.1.208-212.1983; MACLACHLAN NJ, 1985, AM J VET RES, V46, P1238; MACLACHLAN NJ, 1990, VET PATHOL, V27, P223, DOI 10.1177/030098589002700402; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mellor PS, 2002, VET J, V164, P20, DOI 10.1053/tvjl.2002.0713; Mertens PPC, 2004, VIRUS RES, V101, P29, DOI 10.1016/j.virusres.2003.12.004; Mrkic B, 1998, J VIROL, V72, P7420, DOI 10.1128/JVI.72.9.7420-7427.1998; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; NARAYAN O, 1972, AM J PATHOL, V68, P1; Ohka S, 2007, J VIROL, V81, P7902, DOI 10.1128/JVI.02675-06; Ohno S, 2007, J VIROL, V81, P1650, DOI 10.1128/JVI.02134-06; PARADELL HMM, 2008, BLUET MIN BRESC; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; SEN GC, 1993, ADV VIRUS RES, V42, P57, DOI 10.1016/S0065-3527(08)60083-4; Staeheli P, 1990, Adv Virus Res, V38, P147, DOI 10.1016/S0065-3527(08)60862-3; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; VERWOERD DW, 1970, J VIROL, V5, P1; VERWOERD DW, 1972, J VIROL, V10, P783, DOI 10.1128/JVI.10.4.783-794.1972; Waibler Z, 2007, J VIROL, V81, P12102, DOI 10.1128/JVI.01190-07	38	70	70	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5171	10.1371/journal.pone.0005171	http://dx.doi.org/10.1371/journal.pone.0005171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357779	Green Published, gold, Green Submitted			2022-12-27	WOS:000265505900022
J	Adeney, JM; Christensen, NL; Pimm, SL				Adeney, J. Marion; Christensen, Norman L., Jr.; Pimm, Stuart L.			Reserves Protect against Deforestation Fires in the Amazon	PLOS ONE			English	Article							LAND-USE; CONSERVATION; CLIMATE; HIGHWAY; FEEDBACKS; PATTERNS; DROUGHT; IMPACT; POLICY; FUTURE	Background: Reserves are the principal means to conserve forests and biodiversity, but the question of whether reserves work is still debated. In the Amazon, fires are closely linked to deforestation, and thus can be used as a proxy for reserve effectiveness in protecting forest cover. We ask whether reserves in the Brazilian Amazon provide effective protection against deforestation and consequently fires, whether that protection is because of their location or their legal status, and whether some reserve types are more effective than others. Methodology/Principal Findings: Previous work has shown that most Amazonian fires occur close to roads and are more frequent in El Nino years. We quantified these relationships for reserves and unprotected areas by examining satellite-detected hot pixels regressed against road distance across the entire Brazilian Amazon and for a decade with 2 El Nino-related droughts. Deforestation fires, as measured by hot pixels, declined exponentially with increasing distance from roads in all areas. Fewer deforestation fires occurred within protected areas than outside and the difference between protected and unprotected areas was greatest near roads. Thus, reserves were especially effective at preventing these fires where they are known to be most likely to burn; but they did not provide absolute protection. Even within reserves, at a given distance from roads, there were more deforestation fires in regions with high human impact than in those with low impact. The effect of El Nino on deforestation fires was greatest outside of reserves and near roads. Indigenous reserves, limited-use reserves, and fully protected reserves all had fewer fires than outside areas and did not appear to differ in their effectiveness. Conclusions/Significance: Taking time, regional factors, and climate into account, our results show that reserves are an effective tool for curbing destructive burning in the Amazon.			Adeney, JM (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	stuartpimm@aol.com	pimm, stuart/ABF-1082-2020					Alencar A, 2006, EARTH INTERACT, V10; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Arima EY, 2007, J REGIONAL SCI, V47, P541, DOI 10.1111/j.1467-9787.2007.00519.x; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Bell GD, 1999, B AM METEOROL SOC, V80, pS1, DOI 10.1175/1520-0477-80.5s.S1; BOWMAN MS, 2008, ECOLOGICAL EC; Campos MT, 2006, CONSERV BIOL, V20, P1553, DOI 10.1111/j.1523-1739.2006.00546.x; Carvalho GO, 2002, ENVIRONMENT, V44, P34, DOI 10.1080/00139150209605606; Chomitz KM, 2003, AM J AGR ECON, V85, P1016, DOI 10.1111/1467-8276.00504; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Curtis S, 2007, J HYDROMETEOROL, V8, P678, DOI 10.1175/JHM601.1; de Mendonca MJC, 2004, ECOL ECON, V49, P89, DOI 10.1016/j.ecolecon.2003.11.011; *ESA ESRIN, 2004, ION ATSR WORLD FIR A; Fearnside PM, 2007, ENVIRON MANAGE, V39, P601, DOI 10.1007/s00267-006-0149-2; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Fearnside PM, 2003, WORLD DEV, V31, P757, DOI 10.1016/S0305-750X(03)00011-1; Ferreira LV, 2005, ESTUD AV-SAO PAULO, V19, P157, DOI DOI 10.1590/S0103-40142005000100010; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; GOODLAND RJ, 1975, AMAZON JUNGLE GREEN; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; MESQUITA RCG, 2007, BIODIVERSIDADE MEDIO, P239; *MIN MEIO AMB, 2000, SNUC SIST NAC UN CON; Moran EF, 2006, CLIMATIC CHANGE, V77, P343, DOI 10.1007/s10584-005-9035-9; Mota BW, 2006, ATMOS CHEM PHYS, V6, P1409, DOI 10.5194/acp-6-1409-2006; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad D, 2004, GLOBAL CHANGE BIOL, V10, P704, DOI 10.1111/j.1529-8817.2003.00772.x; Nepstad D, 2001, FOREST ECOL MANAG, V154, P395, DOI 10.1016/S0378-1127(01)00511-4; Nepstad DC, 2006, CONSERV BIOL, V20, P1595, DOI 10.1111/j.1523-1739.2006.00510.x; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Peres CA, 2001, CONSERV BIOL, V15, P793, DOI 10.1046/j.1523-1739.2001.015003793.x; Pfaff A, 2007, J REGIONAL SCI, V47, P109, DOI 10.1111/j.1467-9787.2007.00502.x; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; Pimm SL, 2001, WORLD ACCORDING PIMM; RIBEIRO B, 2005, SERIE ESTADO AMAZONI, V6; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Roman-Cuesta RM, 2006, CONSERV BIOL, V20, P1074, DOI 10.1111/j.1523-1739.2006.00478.x; Ruiz-Perez M, 2005, AMBIO, V34, P218, DOI 10.1639/0044-7447(2005)034[0218:CADIAE]2.0.CO;2; SCHROEDER W, 2007, LBAECO LC 23 CHARACT; Schroeder W, 2005, EARTH INTERACT, V9; Schwartzman S, 2005, CONSERV BIOL, V19, P721, DOI 10.1111/j.1523-1739.2005.00695.x; SERRA MA, 2004, I PESQUISA EC APLICA, V27, P193; Setzer A.W., 1996, BIOMASS BURNING GLOB, P25; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; Soares B, 2004, GLOBAL CHANGE BIOL, V10, P745, DOI 10.1111/j.1529-8817.2003.00769.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; Souza C., 2006, DINAMICA DESMATAMENT; Stolle F, 2004, INT J REMOTE SENS, V25, P471, DOI 10.1080/01431160310001618022; TEIXEIRA G, 2008, PRESIDENTE LULA CARL; Vale MM, 2007, BIRD CONSERV INT, V17, P245, DOI 10.1017/S0959270907000743; Vanclay JK, 2001, SCIENCE, V293, P1007, DOI 10.1126/science.293.5532.1007a; WOLTER K, 2007, MULTIVARIATE ENSO IN; [No title captured], DOI DOI 10.1029/2006E0260001	61	102	104	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5014	10.1371/journal.pone.0005014	http://dx.doi.org/10.1371/journal.pone.0005014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437RX	19352423	gold, Green Published, Green Submitted			2022-12-27	WOS:000265505700002
J	Miller, TL; McNabb, SJN; Hilsenrath, P; Pasipanodya, J; Weis, SE				Miller, Thaddeus L.; McNabb, Scott J. N.; Hilsenrath, Peter; Pasipanodya, Jotam; Weis, Stephen E.			Personal and Societal Health Quality Lost to Tuberculosis	PLOS ONE			English	Article							NEW-YORK-CITY; PULMONARY IMPAIRMENT; COST-EFFECTIVENESS; UNITED-STATES; FOLLOW-UP; MORTALITY; SURVIVORS; LESSONS; LIFE	Background: In developed countries, tuberculosis is considered a disease with little loss of Quality-Adjusted Life Years (QALYs). Tuberculosis treatment is predominantly ambulatory and death from tuberculosis is rare. Research has shown that there are chronic pulmonary sequelae in a majority of patients who have completed treatment for pulmonary tuberculosis (PTB). This and other health effects of tuberculosis have not been considered in QALY calculations. Consequently both the burden of tuberculosis on the individual and the value of tuberculosis prevention to society are underestimated. We estimated QALYs lost to pulmonary TB patients from all known sources, and estimated health loss to prevalent TB disease. Methodology/Principal Findings: We calculated values for health during illness and treatment, pulmonary impairment after tuberculosis (PIAT), death rates, years-of-life-lost to death, and normal population health. We then compared the lifetime expected QALYs for a cohort of tuberculosis patients with that expected for comparison populations with latent tuberculosis infection and without tuberculosis infection. Persons with culture-confirmed tuberculosis accrued fewer lifetime QALYs than those without tuberculosis. Acute tuberculosis morbidity cost 0.046 QALYs (4% of total) per individual. Chronic morbidity accounted for an average of 0.96 QALYs (78% of total). Mortality accounted for 0.22 QALYs lost (18% of total). The net benefit to society of averting one case of PTB was about 1.4 QALYs. Conclusions/Significance: Tuberculosis, a preventable disease, results in QALYs lost owing to illness, impairment, and death. The majority of QALYs lost from tuberculosis resulted from impairment after microbiologic cure. Successful TB prevention efforts yield more health quality than previously thought and should be given high priority by health policy makers. (Refer to Abstracto S1 for Spanish language abstract)			Miller, TL (corresponding author), Univ N Texas, Hlth Sci Ctr, Sch Publ Hlth, Ft Worth, TX USA.	sweis@hsc.unt.edu		Hilsenrath, Peter/0000-0002-0866-8043				*AM THOR SOC, 1999, AM J RESP CRIT CARE, V161, P5221; Angus DC, 2002, AM J RESP CRIT CARE, V165, P540; [Anonymous], 2003, MMWR RECOMM REP; [Anonymous], GLOB TUB CONTR SURV; BASS JB, 1994, AM J RESP CRIT CARE, V149, P1359, DOI 10.1164/ajrccm.149.5.8173779; *CDC DIV TUB EL NA, VIR HEP STD TB PREV; *CDCP, 2005, REP TUB US 2004; *CDCP, US LIF TABL 2002; COCCHIARELLA L, 2000, GUIDES EVALUATION PE; Coker R, 1998, BRIT MED J, V317, P616, DOI 10.1136/bmj.317.7159.616; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; Cooper AB, 1999, CRIT CARE MED, V27, P2616, DOI 10.1097/00003246-199912000-00002; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Garcia-Garcia MD, 2002, EMERG INFECT DIS, V8, P1327; GRAHAM JD, 2003, VALUING HLTH OMB PER; GROSS CR, 2001, ETIOLOGY TREATMENT A, P50; GROSS CR, 2001, ETIOLOGY TREATMENT A, P52; Hansel NN, 2004, CHEST, V126, P1079, DOI 10.1378/chest.126.4.1079; *HARV CTR RISK AN, COST UT AN PUBL 1976; Jamison D.T., 1993, DIS CONTROL PRIORITI; KEELER EB, 1983, MANAGE SCI, V29, P300, DOI 10.1287/mnsc.29.3.300; LANDESMAN SH, 1993, AM J PUBLIC HEALTH, V83, P766, DOI 10.2105/AJPH.83.5.766; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; MAUCHAND R, 1999, INT J EPIDEMIOL, V28, P563; MCHUGH LG, 1994, AM J RESP CRIT CARE, V150, P90, DOI 10.1164/ajrccm.150.1.8025779; Miller TL, 2006, ANN EPIDEMIOL, V16, P777, DOI 10.1016/j.annepidem.2006.04.007; Miller TL, 2006, ANN EPIDEMIOL, V16, P305, DOI 10.1016/j.annepidem.2005.07.053; MILLER WF, 1981, CLIN CHEST MED, V2, P327; Niskanen M, 1999, CRIT CARE MED, V27, P1132, DOI 10.1097/00003246-199906000-00035; Pasipanodya JG, 2007, CHEST, V132, P1591, DOI 10.1378/chest.07-0755; Pasipanodya JG, 2007, CHEST, V131, P1817, DOI 10.1378/chest.06-2949; REICHMAN LB, 1991, AM REV RESPIR DIS, V144, P741, DOI 10.1164/ajrccm/144.4.741; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Schwartzman K, 2005, NEW ENGL J MED, V353, P1008, DOI 10.1056/NEJMsa043194; Sterling TR, 2006, INT J TUBERC LUNG D, V10, P542; Taylor Z, 2000, INT J TUBERC LUNG D, V4, pS127; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; Tocque K, 2005, INT J TUBERC LUNG D, V9, P797; van Praag B.M.S., 2008, HAPPINESS QUANTIFIED; VECINO M, 2009, STABILITY PULM UNPUB; Weis SE, 2005, INT J TUBERC LUNG D, V9, P467; *WHO, HLTH STAT VAL SUSC P	43	47	47	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5080	10.1371/journal.pone.0005080	http://dx.doi.org/10.1371/journal.pone.0005080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437RX	19352424	Green Published, gold, Green Submitted			2022-12-27	WOS:000265505700006
J	Yang, XR; Zhou, XB; Huang, WT; Wu, LY; Monzon, FA; Chang, CC; Wong, STC				Yang, Xiaorong; Zhou, Xiaobo; Huang, Wan-Ting; Wu, Lingyun; Monzon, Federico A.; Chang, Chung-Che; Wong, Stephen T. C.			Pattern-Selection Based Power Analysis and Discrimination of Low- and High-Grade Myelodysplastic Syndromes Study Using SNP Arrays	PLOS ONE			English	Article							COPY NUMBER; PROGNOSTIC-SIGNIFICANCE; CANCER	Copy Number Aberration (CNA) in myelodysplastic syndromes (MDS) study using single nucleotide polymorphism (SNP) arrays have been received increasingly attentions in the recent years. In the current study, a new Constraint Moving Average (CMA) algorithm is adopted to determine the regions of CNA regions first. In addition to large regions of CNA, using the proposed CMA algorithm, small regions of CNA can also be detected. Real-time Polymerase Chain Reaction (qPCR) results prove that the CMA algorithm presents an insightful discovery of both large and subtle regions. Based on the results of CMA, two independent applications are studied. The first one is power analysis for sample estimation. An accurate estimation of sample size needed for the desired purpose of an experiment will be important for effort-efficiency and cost-effectiveness. The power analysis is performed to determine the minimum sample size required for ensuring at least 100 lambda% (0<lambda <= 1) detected regions statistically different from normal references. As expected, power increase with increasing sample size for a fixed significance level. The second application is the distinguishment of high-grade MDS patients from low-grade ones. We propose to calculate the General Variant Level (GVL) score to integrate the general information of each patient at genotype level, and use it as the unified measurement for the classification. Traditional MDS classifications usually refer to cell morphology and The International Prognostic Scoring System (IPSS), which belongs to the classification at the phenotype level. The proposed GVL score integrates the information of CNA region, the number of abnormal chromosomes and the total number of the altered SNPs at the genotype level. Statistical tests indicate that the high and low grade MDS patients can be well separated by GVL score, which appears to correlate better with clinical outcome than the traditional classification approaches using morphology and IPSS sore at the phenotype level.			Yang, XR (corresponding author), Cornell Univ, Weill Med Coll, Methodist Hosp Res Inst, Ctr Biotechnol & Informat, Houston, TX USA.	xzhou@tmhs.org	Wu, Ling-Yun/C-4222-2008	Wu, Ling-Yun/0000-0001-9487-0215	NATIONAL LIBRARY OF MEDICINE [R01LM010185] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Delforge Michel, 2003, Hematol J, V4, P303, DOI 10.1038/sj.thj.6200315; Fridlyand J, 2004, J MULTIVARIATE ANAL, V90, P132, DOI 10.1016/j.jmva.2004.02.008; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gondek LP, 2007, EXP HEMATOL, V35, P1728, DOI 10.1016/j.exphem.2007.08.009; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Gumus G, 2002, CANCER GENET CYTOGEN, V133, P168, DOI 10.1016/S0165-4608(01)00569-6; HAASE D, 1995, ANN HEMATOL, V70, P171, DOI 10.1007/BF01700373; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Hofmann WK, 2004, HEMATOL J, V5, P1, DOI 10.1038/sj.thj.6200335; Huang T, 2005, BIOINFORMATICS, V21, P3811, DOI 10.1093/bioinformatics/bti646; HUANG WT, 2009, LEUKEMIA RE IN PRESS; Johnson R., 2007, APPL MULTIVARIATE ST; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Mohamedali A, 2007, BLOOD, V110, P3365, DOI 10.1182/blood-2007-03-079673; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; OLSHEN AB, 2004, BIOINFORMATICS, V5, P577; Sole F, 2005, HAEMATOLOGICA, V90, P1168; Thomas JG, 2001, GENOME RES, V11, P1227, DOI 10.1101/gr.165101; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	23	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5054	10.1371/journal.pone.0005054	http://dx.doi.org/10.1371/journal.pone.0005054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352488	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505700005
J	Laakkonen, JP; Makela, AR; Kakkonen, E; Turkki, P; Kukkonen, S; Peranen, J; Yla-Herttuala, S; Airenne, KJ; Oker-Blom, C; Vihinen-Ranta, M; Marjomaki, V				Laakkonen, Johanna P.; Makela, Anna R.; Kakkonen, Elina; Turkki, Paula; Kukkonen, Sari; Peranen, Johan; Yla-Herttuala, Seppo; Airenne, Kari J.; Oker-Blom, Christian; Vihinen-Ranta, Maija; Marjomaki, Varpu			Clathrin-Independent Entry of Baculovirus Triggers Uptake of E. coli in Non-Phagocytic Human Cells	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; EFFICIENT GENE-TRANSFER; RECOMBINANT BACULOVIRUS; MAMMALIAN-CELLS; MACROPINOCYTOSIS; EXPRESSION; MACROPINOSOMES; TRANSDUCTION; ENDOCYTOSIS; MECHANISMS	The prototype baculovirus, Autographa californica multiple nucleopolyhedrovirus, an insect pathogen, holds great potential as a gene therapy vector. To develop transductional targeting and gene delivery by baculovirus, we focused on characterizing the nature and regulation of its uptake in human cancer cells. Baculovirus entered the cells along fluid-phase markers from the raft areas into smooth-surfaced vesicles devoid of clathrin. Notably, regulators associated with macropinocytosis, namely EIPA, Pak1, Rab34, and Rac1, had no significant effect on viral transduction, and the virus did not induce fluid-phase uptake. The internalization and nuclear uptake was, however, affected by mutants of RhoA, and of Arf6, a regulator of clathrin-independent entry. Furthermore, the entry of baculovirus induced ruffle formation and triggered the uptake of fluorescent E. coli bioparticles. To conclude, baculovirus enters human cells via a clathrin-independent pathway, which is able to trigger bacterial uptake. This study increases our understanding of virus entry strategies and gives new insight into baculovirus-mediated gene delivery in human cells.			Laakkonen, JP (corresponding author), Univ Jyvaskyla, Nanosci Ctr, Dept Biol & Environm Sci, Jyvaskyla, Finland.	vmarjoma@cc.jyu.fi		Turkki, Paula/0000-0002-5969-4807; Vihinen-Ranta, Maija/0000-0003-0959-1153; Laakkonen, Johanna/0000-0002-8556-9727; Marjomaki, Varpu/0000-0002-4592-5926; Siljamaki, Elina/0000-0003-1709-8633; Yla-Herttuala, Seppo/0000-0001-7593-2708				Airenne KJ, 2000, GENE THER, V7, P1499, DOI 10.1038/sj.gt.3301269; Amstutz B, 2008, EMBO J, V27, P956, DOI 10.1038/emboj.2008.38; BALANA ME, 2005, J CELL SCI; Bishop NE, 2003, INT REV CYTOL, V232, P1, DOI 10.1016/S0074-7696(03)32001-7; BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; BRAUNAGEL SC, 1994, VIROLOGY, V202, P315, DOI 10.1006/viro.1994.1348; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Day PM, 2003, VIROLOGY, V307, P1, DOI 10.1016/S0042-6822(02)00143-5; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Duisit G, 1999, J GENE MED, V1, P93; Ghigo E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000087; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; Haeseleer F, 2001, INVEST OPHTH VIS SCI, V42, P3294; HOFMANN C, 1995, P NATL ACAD SCI USA, V92, P10099, DOI 10.1073/pnas.92.22.10099; Hu YC, 2006, ADV VIRUS RES, V68, P287, DOI 10.1016/S0065-3527(06)68008-1; Jones AT, 2007, J CELL MOL MED, V11, P670, DOI 10.1111/j.1582-4934.2007.00062.x; Kalia M, 2006, MOL BIOL CELL, V17, P3689, DOI 10.1091/mbc.E05-10-0980; KANKAANPAA P, 2006, BIOIMAGEXD WORLD WID; Kansau I, 2004, INFECT IMMUN, V72, P3733, DOI 10.1128/IAI.72.7.3733-3742.2004; KARJALAINEN M, 2008, MOL BIOL CELL; KIRKHAM M, 2005, BIOCH BIOPHYS ACTA; Kitajima M, 2008, CLIN VACCINE IMMUNOL, V15, P376, DOI 10.1128/CVI.00285-07; Kukkonen SP, 2003, MOL THER, V8, P853, DOI 10.1016/j.ymthe.2003.07.009; Laakkonen JP, 2008, CELL MICROBIOL, V10, P667, DOI 10.1111/j.1462-5822.2007.01074.x; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08; Lehtolainen P, 2002, GENE THER, V9, P1693, DOI 10.1038/sj.gt.3301854; Liberali P, 2008, EMBO J, V27, P970, DOI 10.1038/emboj.2008.59; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Long G, 2006, J VIROL, V80, P8830, DOI 10.1128/JVI.00880-06; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mahonen AJ, 2007, J BIOTECHNOL, V131, P1, DOI 10.1016/j.jbiotec.2007.05.022; Makela AR, 2008, J BIOTECHNOL, V134, P20, DOI 10.1016/j.jbiotec.2007.12.010; Makela AR, 2008, COMB CHEM HIGH T SCR, V11, P86, DOI 10.2174/138620708783744525; Makela AR, 2006, J VIROL, V80, P6603, DOI 10.1128/JVI.00528-06; Matilainen H, 2005, J VIROL, V79, P15452, DOI 10.1128/JVI.79.24.15452-15459.2005; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Niedergang F, 2005, CURR TOP MICROBIOL, V291, P43; Nishibe Y, 2008, GENE THER, V15, P990, DOI 10.1038/gt.2008.29; Nunes-Correia I, 2004, CELL MOL BIOL LETT, V9, P47; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Sansonetti PJ, 2001, AM J PHYSIOL-GASTR L, V280, pG319, DOI 10.1152/ajpgi.2001.280.3.G319; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Slack J, 2007, ADV VIRUS RES, V69, P99, DOI 10.1016/S0065-3527(06)69003-9; Summers MD, 2006, ADV VIRUS RES, V68, P3, DOI 10.1016/S0065-3527(06)68001-9; SUMMERS MD, 1976, J VIROL, V17, P962, DOI 10.1128/JVI.17.3.962-972.1976; Sun P, 2003, J BIOL CHEM, V278, P4063, DOI 10.1074/jbc.M208699200; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Tani H, 2001, VIROLOGY, V279, P343, DOI 10.1006/viro.2000.0699; THEILMANN DA, 2005, FAMILY BACULOVIRIDAE; van Loo ND, 2001, J VIROL, V75, P961, DOI 10.1128/JVI.75.2.961-970.2001; Van Nhieu GT, 1999, CURR OPIN MICROBIOL, V2, P51; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; VOLKMAN LE, 1983, APPL ENVIRON MICROB, V45, P1085, DOI 10.1128/AEM.45.3.1085-1093.1983; Wang CY, 2006, CANCER RES, V66, P5798, DOI 10.1158/0008-5472.CAN-05-4514	64	38	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5093	10.1371/journal.pone.0005093	http://dx.doi.org/10.1371/journal.pone.0005093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352496	Green Submitted, Green Published, gold			2022-12-27	WOS:000265505300014
J	Avnit-Sagi, T; Kantorovich, L; Kredo-Russo, S; Hornstein, E; Walker, MD				Avnit-Sagi, Tali; Kantorovich, Lia; Kredo-Russo, Sharon; Hornstein, Eran; Walker, Michael D.			The Promoter of the pri-miR-375 Gene Directs Expression Selectively to the Endocrine Pancreas	PLOS ONE			English	Article								microRNAs ( miRNAs) are known to play an essential role in controlling a broad range of biological processes including animal development. Accordingly, many miRNAs are expressed preferentially in one or a small number of cell types. Yet the mechanisms responsible for this selectivity are not well understood. The aim of this study was to elucidate the molecular basis of cell-specific expression of the pri-miR-375 gene, which is selectively expressed in pancreatic islets, and has been implicated both in the development of islets, and the function of mature pancreatic beta cells. An evolutionarily conserved 768 bp region of DNA upstream of the pri-miR-375 gene was linked to GFP and luciferase reporter genes, and expression monitored in transgenic mice and transfected cultured cells. Deletion and targeted mutagenesis analysis was used to evaluate the functional significance of sequence blocks within the upstream fragment. 5'-RACE analysis was used for mapping the pri-miR-375 gene transcription start site. The conserved 768 bp region was able to direct preferential expression of a GFP reporter gene to pancreatic islets in transgenic mice. Deletion analysis using a luciferase reporter gene in transfected cultured cell lines confirmed the cell specificity of the putative promoter region, and identified several key cis-elements essential for optimal activity, including E-boxes and a TATA sequence. Consistent with this, 5'-RACE analysis identified a transcription start site within this DNA region, 24 bp downstream of the TATA sequence. These studies define the promoter of the pri-miR-375 gene, and show that islet-specific expression of the pri-miR-375 gene is controlled at the transcriptional level. Detailed analysis of the transcriptional mechanisms controlling expression of miRNA genes will be essential to permit a comprehensive understanding of the complex role of miRNAs such as miR-375 in developmental processes.	[Avnit-Sagi, Tali; Kantorovich, Lia; Walker, Michael D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kredo-Russo, Sharon; Hornstein, Eran] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Avnit-Sagi, T (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	m.walker@weizmann.ac.il	HORNSTEIN, ERAN/K-1340-2012	HORNSTEIN, ERAN/0000-0002-5534-1924	Juvenile Diabetes Research Foundation, New York; D-CURE Diabetes Care in Israel	Juvenile Diabetes Research Foundation, New York(Juvenile Diabetes Research Foundation); D-CURE Diabetes Care in Israel	Supported by research grants from the Juvenile Diabetes Research Foundation, New York (to MDW and EH), from D-CURE Diabetes Care in Israel (to MDW) and from Mrs. Judith Bennatar (to MDW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; BOSHART M, 1992, GENE, V110, P129, DOI 10.1016/0378-1119(92)90456-Y; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chakrabarti SK, 2003, TRENDS ENDOCRIN MET, V14, P78, DOI 10.1016/S1043-2760(02)00039-5; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gleason CE, 2007, P NATL ACAD SCI USA, V104, P8681, DOI 10.1073/pnas.0702844104; Glick E, 2000, J BIOL CHEM, V275, P2199, DOI 10.1074/jbc.275.3.2199; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Huang HP, 2002, MOL ENDOCRINOL, V16, P541, DOI 10.1210/me.16.3.541; Joglekar MV, 2007, TRENDS ENDOCRIN MET, V18, P393, DOI 10.1016/j.tem.2007.10.001; Joglekar MV, 2007, DEV BIOL, V311, P603, DOI 10.1016/j.ydbio.2007.09.008; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Keller DM, 2007, J BIOL CHEM, V282, P32084, DOI 10.1074/jbc.M700899200; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; SANTERRE RF, 1981, P NATL ACAD SCI-BIOL, V78, P4339, DOI 10.1073/pnas.78.7.4339; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; WALKER MD, 1983, NATURE, V306, P557, DOI 10.1038/306557a0; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200	42	98	100	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5033	10.1371/journal.pone.0005033	http://dx.doi.org/10.1371/journal.pone.0005033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343226	gold, Green Submitted, Green Published			2022-12-27	WOS:000265500800004
J	Chen, CH; Lai, JM; Chou, TY; Chen, CY; Su, LJ; Lee, YC; Cheng, TS; Hong, YR; Chou, CK; Whang-Peng, J; Wu, YC; Huang, CYF				Chen, Chang-Han; Lai, Jin-Mei; Chou, Teh-Ying; Chen, Cheng-Yu; Su, Li-Jen; Lee, Yuan-Chii; Cheng, Tai-Shan; Hong, Yi-Ren; Chou, Chen-Kung; Whang-Peng, Jacqueline; Wu, Yu-Chung; Huang, Chi-Ying F.			VEGFA Upregulates FLJ10540 and Modulates Migration and Invasion of Lung Cancer via PI3K/AKT Pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; MESENCHYMAL TRANSITION; AKT ACTIVATION; CELL INVASION; EXPRESSION; PROTEIN; TUMOR; ADENOCARCINOMA	Background: Lung adenocarcinoma is the leading cause of cancer-related deaths among both men and women in the world. Despite recent advances in diagnosis and treatment, the mortality rates with an overall 5-year survival of only 15%. This high mortality is probably attributable to early metastasis. Although several well-known markers correlated with poor/metastasis prognosis in lung adenocarcinoma patients by immunohistochemistry was reported, the molecular mechanisms of lung adenocarcinoma development are still not clear. To explore novel molecular markers and their signaling pathways will be crucial for aiding in treatment of lung adenocarcinoma patients. Methodology/Principal Findings: To identify novel lung adenocarcinoma-associated/metastasis genes and to clarify the underlying molecular mechanisms of these targets in lung cancer progression, we created a bioinformatics scheme consisting of integrating three gene expression profile datasets, including pairwise lung adenocarcinoma, secondary metastatic tumors vs. benign tumors, and a series of invasive cell lines. Among the novel targets identified, FLJ10540 was overexpressed in lung cancer tissues and is associated with cell migration and invasion. Furthermore, we employed two co-expression strategies to identify in which pathway FLJ10540 was involved. Lung adenocarcinoma array profiles and tissue microarray IHC staining data showed that FLJ10540 and VEGF-A, as well as FLJ10540 and phospho-AKT exhibit positive correlations, respectively. Stimulation of lung cancer cells with VEGF-A results in an increase in FLJ10540 protein expression and enhances complex formation with PI3K. Treatment with VEGFR2 and PI3K inhibitors affects cell migration and invasion by activating the PI3K/AKT pathway. Moreover, knockdown of FLJ10540 destabilizes formation of the P110-alpha/P85-alpha-(PI3K) complex, further supporting the participation of FLJ10540 in the VEGF-A/PI3K/AKT pathway. Conclusions/Significance: This finding set the stage for further testing of FLJ10540 as a new therapeutic target for treating lung cancer and may contribute to the development of new therapeutic strategies that are able to block the PI3K/AKT pathway in lung cancer cells.	[Chen, Chang-Han] Chang Gung Univ, Coll Med, Chang Gung Mem Hospital, Kaohsiung Med Ctr,Dept Otolaryngol, Kaohsiung, Taiwan; [Lai, Jin-Mei] Fu Jen Catholic Univ, Dept Life Sci, Taipei, Hsien, Taiwan; [Chou, Teh-Ying; Chen, Cheng-Yu; Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Su, Li-Jen; Wu, Yu-Chung] Taipei Vet Gen Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan; [Lee, Yuan-Chii] Taipei Med Univ, Grad Inst Med Informat, Taipei, Taiwan; [Cheng, Tai-Shan; Hong, Yi-Ren] Kaohsiung Med Univ, Grad Inst Biochem, Kaohsiung, Taiwan; [Chou, Chen-Kung] Chang Gung Univ, Dept Life Sci, Tao Yuan, Taiwan; [Whang-Peng, Jacqueline] Wan Fang Hosp, Div Canc Ctr, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Fu Jen Catholic University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Medical University; Kaohsiung Medical University; Chang Gung University; Taipei Municipal WanFang Hospital	Chen, CH (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hospital, Kaohsiung Med Ctr,Dept Otolaryngol, Kaohsiung, Taiwan.	jqwpeng@tmu.edu.tw; wuyc@vghtpe.gov.tw; cyhuang5@ym.edu.tw	Huang, Chi-Ying/AAG-7672-2022; Huang, Chi-Ying/AFL-7729-2022	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937; Su, Li-Jen/0000-0002-8342-9800; Hong, Yi-Ren/0000-0001-5470-6090	NRPGM; National Yang Ming University [Program for Promoting Academic Excellence of Universities]; Taichung Veteran General Hospital [TCVGH-957326D]; NSC [96-3112-B-075-001, 95-3112-B-075-002, NSC97-3112-B-010-025-CC1, NSC97-2627-B-030-001, NSC97-2627-B-010-011, 94-2752-B-010-002-PAE]; Chang Gung Hosp [CMRPD140211]	NRPGM; National Yang Ming University; Taichung Veteran General Hospital; NSC(Ministry of Science and Technology, Taiwan); Chang Gung Hosp	This study was supported in part by grants from the Chang Gung Hospital (CMRPD140211) and NSC (94-2752-B-010-002-PAE) to Chen-Kung Chou, NSC (Program for Interdisciplinary Research Project: NSC97-2627-B-010-011 to Chi-Ying Huang, NSC97-2627-B-030-001 to J.-M. Lai), and NSC97-3112-B-010-025-CC1, Taichung Veteran General Hospital (TCVGH-957326D), and the Program for Promoting Academic Excellence of Universities (National Yang Ming University) to Chi- Ying Huang, and NSC (95-3112-B-075-002 and 96-3112-B-075-001) to Yu-Chung Wu. The Gene Expression Analysis Core Facility is supported by the National Research Program for Genomic Medicine (NRPGM), National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Alitalo K, 2002, CANCER CELL, V1, P219, DOI 10.1016/S1535-6108(02)00051-X; Bouwknecht J. Adriaan, 2002, Behavioural Brain Research, V136, P489, DOI 10.1016/S0166-4328(02)00200-0; Brognard J, 2001, CANCER RES, V61, P3986; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen CH, 2007, ONCOGENE, V26, P4272, DOI 10.1038/sj.onc.1210207; Chen JJW, 2001, CANCER RES, V61, P5223; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Dance M, 2006, J BIOL CHEM, V281, P23285, DOI 10.1074/jbc.M600987200; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fontanini G, 2002, BRIT J CANCER, V86, P558, DOI 10.1038/sj.bjc.6600130; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fu SL, 2005, BIOCHEM BIOPH RES CO, V338, P830, DOI 10.1016/j.bbrc.2005.10.045; *GA KBAP, 2008, SURG MAN NONSM CELL, P765; Gupta AK, 2004, LUNG, V182, P151, DOI 10.1007/S00408/004/0310-8; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim SA, 2006, CANCER LETT, V235, P53, DOI 10.1016/j.canlet.2005.04.003; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Lantuejoul S, 2003, J PATHOL, V200, P336, DOI 10.1002/path.1367; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li X, 2006, ONCOGENE, V25, P609, DOI 10.1038/sj.onc.1209077; Lin XB, 2001, LANGENBECK ARCH SURG, V386, P293, DOI 10.1007/s004230100203; Marinov M, 2007, CRIT REV ONCOL HEMAT, V63, P172, DOI 10.1016/j.critrevonc.2007.04.002; Martinez-Garay I, 2006, GENOMICS, V87, P243, DOI 10.1016/j.ygeno.2005.11.006; Massion PP, 2004, AM J RESP CRIT CARE, V170, P1088, DOI 10.1164/rccm.200404-487OC; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Ohta Y, 1997, BRIT J CANCER, V76, P1041, DOI 10.1038/bjc.1997.505; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ramesh R, 2004, MOL THER, V9, P510, DOI 10.1016/j.ymthe.2004.01.019; Sakai M, 2006, ONCOGENE, V25, P480, DOI 10.1038/sj.onc.1209051; Shibusa T, 1998, CLIN CANCER RES, V4, P1483; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Shijubo N, 1999, AM J RESP CRIT CARE, V160, P1269, DOI 10.1164/ajrccm.160.4.9807094; Su ZD, 2007, CURR OPIN INVEST DR, V8, P140; Tanaka F, 2001, CLIN CANCER RES, V7, P3410; Tanno S, 2001, CANCER RES, V61, P589; Thakker GD, 1999, J BIOL CHEM, V274, P10002, DOI 10.1074/jbc.274.15.10002; Tsao AS, 2003, CANCER EPIDEM BIOMAR, V12, P660; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Volm M, 1997, INT J CANCER, V74, P64, DOI 10.1002/(SICI)1097-0215(19970220)74:1<64::AID-IJC11>3.0.CO;2-I; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	54	103	108	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5052	10.1371/journal.pone.0005052	http://dx.doi.org/10.1371/journal.pone.0005052			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337377	gold, Green Published, Green Submitted			2022-12-27	WOS:000265500600015
J	Freitas, JM; Andrade, LO; Pires, SF; Lima, R; Chiari, E; Santos, RR; Soares, M; Machado, CR; Franco, GR; Pena, SDJ; Macedo, AM				Freitas, Jorge M.; Andrade, Luciana O.; Pires, Simone F.; Lima, Ricardo; Chiari, Egler; Santos, Ricardo R.; Soares, Milena; Machado, Carlos R.; Franco, Gloria R.; Pena, Sergio D. J.; Macedo, Andrea M.			The MHC Gene Region of Murine Hosts Influences the Differential Tissue Tropism of Infecting Trypanosoma cruzi Strains	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II DRB1; CHAGAS-DISEASE; DENDRITIC CELLS; H2 COMPLEX; MICE; POLYMORPHISM; HLA; CARDIOMYOPATHY; SUSCEPTIBILITY	We have previously demonstrated that both parasite genetic variability and host genetic background were important in determining the differential tissue distribution of the Col1.7G2 and JG T. cruzi monoclonal strains after artificial infections in mice. We observed that the JG strain was most prevalent in hearts of mouse lineages with the MHC haplotype H-2(d) (BALB/c and DBA2), while Col1.7G2 was predominant in hearts from C57BL/6 mice, which have the H-2(b) haplotype. To assess whether the MHC gene region indeed influenced tissue tropism of T. cruzi, we used the same two parasite strains to infect C57BL/6 (H-2(b)) and C57BLKS/J (H-2(d)) mice; the latter strain results from the introgression of DBA2 MHC region into the C57BL/6 background. We also performed ex vivo infections of cardiac explants from four congenic mice lineages with the H-2(b) and H-2(d) haplotypes arranged in two different genetic backgrounds: C57BLKS/J (H-2(d)) versus C57BL/6 (H-2(b)) and BALB/c (H-2(d)) versus BALB/B10-H2(b) (H-2(b)). In agreement with our former observations, Col1.7G2 was predominant in hearts from C57BL/6 mice (H-2(b)), but we observed a clear predominance of the JG strain in hearts from C57BLKS/J animals (H-2(d)). In the ex vivo experiments Col1.7G2 also prevailed in explants from H-2(b) animals while no predominance of any of the strains was observed in H-2(d) mice explants, regardless of the genetic background. These observations clearly demonstrate that the MHC region influences the differential tissue distribution pattern of infecting T. cruzi strains, which by its turn may be in a human infection the determinant for the clinical forms of the Chagas disease.	[Freitas, Jorge M.; Pires, Simone F.; Machado, Carlos R.; Franco, Gloria R.; Pena, Sergio D. J.; Macedo, Andrea M.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Andrade, Luciana O.] Univ Fed Minas Gerais, Dept Morfol, Belo Horizonte, MG, Brazil; [Chiari, Egler] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil; [Lima, Ricardo; Santos, Ricardo R.; Soares, Milena] Ctr Pesquisas Goncalo Moniz CPqGM, Salvador, BA, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Freitas, JM (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	landrade@icb.ufmg.br	Macedo, Andréa M/C-1506-2013; MACHADO, CARLOS/AAW-1492-2020; Machado, Carlos Renato/H-1043-2015; Soares, Milena B. P./O-3771-2018; Andrade, Luciana Oliveira/F-8912-2012; Franco, Glória/I-3654-2013	Machado, Carlos Renato/0000-0002-8724-3165; Andrade, Luciana Oliveira/0000-0002-0536-8790; Franco, Glória/0000-0001-5245-2365; Soares, Milena/0000-0001-7549-2992; Santana de Lima, Ricardo/0000-0002-1279-3445	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); WHO Special Program for Research and Training in Tropical Diseases	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); WHO Special Program for Research and Training in Tropical Diseases	This work has received funding from the following agnecies: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and WHO Special Program for Research and Training in Tropical Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguillon JC, 2000, INT J PARASITOL, V30, P981, DOI 10.1016/S0020-7519(00)00078-3; Amadou C, 1999, IMMUNOL REV, V167, P211, DOI 10.1111/j.1600-065X.1999.tb01394.x; Andrade LO, 1999, MOL BIOCHEM PARASIT, V100, P163, DOI 10.1016/S0166-6851(99)90035-X; Andrade LO, 2002, EXP PARASITOL, V100, P269, DOI 10.1016/S0014-4894(02)00024-3; Borras SG, 2006, ANN CLIN BIOCHEM, V43, P214, DOI 10.1258/000456306776865205; Colorado IA, 2000, HUM IMMUNOL, V61, P320, DOI 10.1016/S0198-8859(99)00177-9; Cruz-Robles D, 2004, HUM IMMUNOL, V65, P60, DOI 10.1016/j.humimm.2003.10.008; Fae KC, 2000, MICROBES INFECT, V2, P745, DOI 10.1016/S1286-4579(00)00501-3; FEDERICI EE, 1964, AM J TROP MED HYG, V13, P272, DOI 10.4269/ajtmh.1964.13.272; Freitas JM, 2005, INT J PARASITOL, V35, P411, DOI 10.1016/j.ijpara.2004.10.023; Fux B, 2003, INFECT IMMUN, V71, P6392, DOI 10.1128/IAI.71.11.6392-6401.2003; Graefe SEB, 2003, GENES IMMUN, V4, P321, DOI 10.1038/sj.gene.6363972; Macedo AM, 2004, MEM I OSWALDO CRUZ, V99, P1, DOI 10.1590/S0074-02762004000100001; Macedo AM, 1998, PARASITOL TODAY, V14, P119, DOI 10.1016/S0169-4758(97)01179-4; Oliveira RP, 1998, P NATL ACAD SCI USA, V95, P3776, DOI 10.1073/pnas.95.7.3776; SANTOS FR, 1993, HUM GENET, V90, P655; Soto CDA, 2003, INFECT IMMUN, V71, P1194, DOI 10.1128/IAI.71.3.1194-1199.2003; Terabe M, 2004, PARASITOL INT, V53, P217, DOI 10.1016/j.parint.2003.12.002; TRISCHMANN TM, 1982, INFECT IMMUN, V35, P546, DOI 10.1128/IAI.35.2.546-551.1982; Vago AR, 1996, LANCET, V348, P891, DOI 10.1016/S0140-6736(05)64761-7; Van Overtvelt L, 2002, INT IMMUNOL, V14, P1135, DOI 10.1093/intimm/dxf077; WRIGHTSMAN RA, 1984, INFECT IMMUN, V44, P351, DOI 10.1128/IAI.44.2.351-354.1984	22	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5113	10.1371/journal.pone.0005113	http://dx.doi.org/10.1371/journal.pone.0005113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337367	gold, Green Submitted, Green Published			2022-12-27	WOS:000265500600026
J	McPartland, JM				McPartland, John M.			Obesity, the Endocannabinoid System, and Bias Arising from Pharmaceutical Sponsorship	PLOS ONE			English	Article							CARDIOMETABOLIC RISK-FACTORS; CONFLICTS-OF-INTEREST; CANNABINOID RECEPTORS; METABOLIC SYNDROME; WEIGHT-LOSS; RIMONABANT; OVERWEIGHT; INDUSTRY; DISEASE; ATHEROSCLEROSIS	Background: Previous research has shown that academic physicians conflicted by funding from the pharmaceutical industry have corrupted evidence based medicine and helped enlarge the market for drugs. Physicians made pharmaceutical-friendly statements, engaged in disease mongering, and signed biased review articles ghost-authored by corporate employees. This paper tested the hypothesis that bias affects review articles regarding rimonabant, an anti-obesity drug that blocks the central cannabinoid receptor. Methods/Principal Findings: A MEDLINE search was performed for rimonabant review articles, limited to articles authored by USA physicians who served as consultants for the company that manufactures rimonabant. Extracted articles were examined for industry-friendly bias, identified by three methods: analysis with a validated instrument for monitoring bias in continuing medical education (CME); analysis for bias defined as statements that ran contrary to external evidence; and a tally of misrepresentations about the endocannabinoid system. Eight review articles were identified, but only three disclosed authors' financial conflicts of interest, despite easily accessible information to the contrary. The Takhar CME bias instrument demonstrated statistically significant bias in all the review articles. Biased statements that were nearly identical reappeared in the articles, including disease mongering, exaggerating rimonabant's efficacy and safety, lack of criticisms regarding rimonabant clinical trials, and speculations about surrogate markers stated as facts. Distinctive and identical misrepresentations regarding the endocannabinoid system also reappeared in articles by different authors. Conclusions: The findings are characteristic of bias that arises from financial conflicts of interest, and suggestive of ghostwriting by a common author. Resolutions for this scenario are proposed.	[McPartland, John M.] Michigan State Univ, Dept Osteopath Manipulat Med, E Lansing, MI 48824 USA	Michigan State University	McPartland, JM (corresponding author), Michigan State Univ, Dept Osteopath Manipulat Med, E Lansing, MI 48824 USA.	mcpruitt@verizon.net						Addy C, 2008, CELL METAB, V7, P68, DOI 10.1016/j.cmet.2007.11.012; Angeli M, 1996, NEW ENGL J MED, V335, P1055, DOI 10.1056/NEJM199610033351410; [Anonymous], 2006, Prescrire Int, V15, P123; Aronne LJ, 2007, AM J MED, V120, pS26, DOI 10.1016/j.amjmed.2007.01.005; Banzi R, 2008, INTERN EMERG MED, V3, P53, DOI 10.1007/s11739-008-0139-x; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Birmingham K, 1999, NAT MED, V5, P717, DOI 10.1038/10421; Bosman A, 2007, AM J TROP MED HYG, V77, P193, DOI 10.4269/ajtmh.2007.77.193; Cannon Christopher P, 2005, Clin Cornerstone, V7, P17, DOI 10.1016/S1098-3597(05)80064-X; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Cleland SJ, 2006, LANCET, V368, P1632, DOI 10.1016/S0140-6736(06)69572-X; Curioni C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006162.pub2; Davis SN, 2006, J MANAGE CARE PHARM, V12, pS4, DOI 10.18553/jmcp.2006.12.s1-A.S4; Dora JM, 2008, JAMA-J AM MED ASSOC, V300, P280, DOI 10.1001/jama.2008.24; *EMA, 2007, SUMM PROD CHAR ACOMP; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Errami M, 2008, NATURE, V451, P397, DOI 10.1038/451397a; *FDA, 2007, 21888 FDA; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Fugh-Berman A, 2005, J GEN INTERN MED, V20, P546, DOI 10.1111/j.1525-1497.2005.05857.x; Gadde KM, 2006, JAMA-J AM MED ASSOC, V296, P649, DOI 10.1001/jama.296.6.649; Gagnon MA, 2008, PLOS MED, V5, P29, DOI 10.1371/journal.pmed.0050001; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gotzsche PC, 2007, PLOS MED, V4, P47, DOI 10.1371/journal.pmed.0040019; Healy D, 2003, BRIT J PSYCHIAT, V183, P22, DOI 10.1192/bjp.183.1.22; HENRY RR, 2006, J AM ACAD PHYS S NOV, P8; Hollander P, 2007, AM J MED, V120, pS18, DOI 10.1016/j.amjmed.2006.11.014; Jensen MD, 2006, OBESITY, V14, p143S, DOI 10.1038/oby.2006.294; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Lambert ML, 2007, LANCET, V369, P553, DOI 10.1016/S0140-6736(07)60262-1; Ledford H, 2008, NATURE, V452, P510, DOI 10.1038/452510a; Lillo JL, 2007, J AM OSTEOPATH ASSOC, V107, pS12; Lurie P, 2006, JAMA-J AM MED ASSOC, V295, P1921, DOI 10.1001/jama.295.16.1921; LYNN AB, 1994, J PHARMACOL EXP THER, V268, P1612; MACPHERSON K, 1997, NEWARK STAR LED 0217; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; McPartland JM, 2007, BRIT J PHARMACOL, V152, P583, DOI 10.1038/sj.bjp.0707399; McPartland JM, 2008, J AM OSTEOPATH ASSOC, V108, P586, DOI 10.7556/jaoa.2008.108.10.586; McPartland JM, 2008, J AM OSTEOPATH ASSOC, V108, P190; Moffatt B, 2007, PERSPECT BIOL MED, V50, P18, DOI 10.1353/pbm.2007.0009; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Moynihan R, 2006, BRIT MED J, V332, P745, DOI 10.1136/bmj.332.7544.745-a; Moynihan R, 2006, PLOS MED, V3, P425, DOI 10.1371/journal.pmed.0030191; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; *NAASO, 2004, UND TREAT PN; *NAASO, 2008, UND TREAT OB; National Institutes of Health, 1998, OBES RES S2, V6, p51S, DOI DOI 10.1002/J.1550-8528.1998.TB00690.X; Nieri P, 2003, N-S ARCH PHARMACOL, V368, P352, DOI 10.1007/s00210-003-0831-3; *NIH, 2007, NAT I HLTH CLIN TRIA; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Padwal R, 2006, NEW ENGL J MED, V354, P974; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; PLUTZKY J, 2006, DOC NEWS S       SEP, P1; Prentice A M, 2001, Obes Rev, V2, P141, DOI 10.1046/j.1467-789x.2001.00031.x; Roberfroid D, 2007, LANCET, V369, P553, DOI 10.1016/S0140-6736(07)60261-X; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Rumsfeld JS, 2008, JAMA-J AM MED ASSOC, V299, P1601, DOI 10.1001/jama.299.13.1601; Ryberg E, 2005, FEBS LETT, V579, P259, DOI 10.1016/j.febslet.2004.11.085; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Saguy AC, 2008, SOCIOL FORUM, V23, P53, DOI 10.1111/j.1600-0838.2004.00399.x-i1; *SAN AV, 2006, PACK INS ACOMPLIA 20; Simons-Morton DG, 2006, JAMA-J AM MED ASSOC, V295, P826, DOI 10.1001/jama.295.7.826; Smith R, 2005, PLOS MED, V2, P364, DOI 10.1371/journal.pmed.0020138.g001; *STAT VERM, 2008, PHARM MARK DISCL; Steinbrook R, 2005, NEW ENGL J MED, V353, P116, DOI 10.1056/NEJMp058108; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Strawbridge WJ, 2000, AM J PUBLIC HEALTH, V90, P340, DOI 10.2105/AJPH.90.3.340; Takhar J, 2007, J CONTIN EDUC HEALTH, V27, P118, DOI 10.1002/chp.110; Taylor R, 2005, NATURE, V437, P1070, DOI 10.1038/4371070a; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Tierney WM, 2005, J GEN INTERN MED, V20, P550, DOI 10.1111/j.1525-1497.2005.41008.x; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Van Gaal L, 2008, DIABETES CARE, V31, pS229, DOI 10.2337/dc08-s258; Watson KE, 2007, REV CARDIOVASC MED, V8, pS37; WAXMAN HA, 2004, COMMITTEE OVERSIGHT; Yanovski SZ, 2005, NEW ENGL J MED, V353, P2187, DOI 10.1056/NEJMe058243; 2006, JAMA, V295, P1252	88	9	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5092	10.1371/journal.pone.0005092	http://dx.doi.org/10.1371/journal.pone.0005092			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333392	Green Submitted, gold, Green Published			2022-12-27	WOS:000265499900025
J	Schmidt, J; Kirsch, S; Rappold, GA; Schempp, W				Schmidt, Julia; Kirsch, Stefan; Rappold, Gudrun A.; Schempp, Werner			Complex Evolution of a Y-Chromosomal Double Homeobox 4 (DUX4)-Related Gene Family in Hominoids	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; PRIMATE SEGMENTAL DUPLICATIONS; DNA-SEQUENCES; HUMAN GENOME; GREAT-APE; LONG ARM; REPEAT; RECOMBINATION; ORIGIN; REGION	The human Y chromosome carries four human Y-chromosomal euchromatin/heterochromatin transition regions, all of which are characterized by the presence of interchromosomal segmental duplications. The Yq11.1/Yq11.21 transition region harbours a peculiar segment composed of an imperfectly organized tandem-repeat structure encoding four members of the double homeobox ( DUX) gene family. By comparative fluorescence in situ hybridization ( FISH) analysis we have documented the primary appearance of Y-chromosomal DUX genes (DUXY) on the gibbon Y chromosome. The major amplification and dispersal of DUXY paralogs occurred after the gibbon and hominid lineages had diverged. Orthologous DUXY loci of human and chimpanzee show a highly similar structural organization. Sequence alignment survey, phylogenetic reconstruction and recombination detection analyses of human and chimpanzee DUXY genes revealed the existence of all copies in a common ancestor. Comparative analysis of the circumjacent beta-satellites indicated that DUXY genes and beta-satellites evolved in concert. However, evolutionary forces acting on DUXY genes may have induced amino acid sequence differences in the orthologous chimpanzee and human DUXY open reading frames (ORFs). The acquisition of complete ORFs in human copies might relate to evolutionary advantageous functions indicating neo-functionalization. We propose an evolutionary scenario in which an ancestral tandem array DUX gene cassette transposed to the hominoid Y chromosome followed by lineage-specific chromosomal rearrangements paved the way for a species-specific evolution of the Y-chromosomal members of a large highly diverged homeobox gene family.			Schmidt, J (corresponding author), Univ Freiburg, Inst Human Genet, Freiburg, Germany.	werner.schempp@uniklinik-freiburg.de						AGRESTI A, 1989, J MOL BIOL, V205, P625, DOI 10.1016/0022-2836(89)90308-2; ASHLEY E, 2004, HEATMAP BUILDER 1 0; AVARELLO R, 1992, HUM GENET, V89, P247; Bailey JA, 2003, COLD SPRING HARB SYM, V68, P115, DOI 10.1101/sqb.2003.68.115; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; BAILEY TL, 2006, NUCLEIC ACIDS RES, V34, pW39; Beckers MC, 2001, GENE, V264, P51, DOI 10.1016/S0378-1119(00)00602-8; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bullaughey K, 2008, GENOME RES, V18, P544, DOI 10.1101/gr.071548.107; Calendini F., 2005, PAUPUP FREE GRAPHICA; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; Clark LN, 1996, CHROMOSOMA, V105, P180, DOI 10.1007/BF02509499; COOPER KF, 1992, J MOL BIOL, V228, P421, DOI 10.1016/0022-2836(92)90831-4; Deidda G, 1996, J MED GENET, V33, P361, DOI 10.1136/jmg.33.5.361; Ding H, 1998, HUM MOL GENET, V7, P1681, DOI 10.1093/hmg/7.11.1681; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Eichler EE, 1998, GENOME RES, V8, P791, DOI 10.1101/gr.8.8.791; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Force A, 1999, GENETICS, V151, P1531; Gerrard DT, 2005, MOL BIOL EVOL, V22, P1423, DOI 10.1093/molbev/msi128; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Goidts V, 2005, GENOME RES, V15, P1232, DOI 10.1101/gr.3732505; GRUMMT I, 1979, NUCLEIC ACIDS RES, V6, P1351, DOI 10.1093/nar/6.4.1351; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Horvath JE, 2005, GENOME RES, V15, P914, DOI 10.1101/gr.3916405; Horvath JE, 2003, MOL BIOL EVOL, V20, P1463, DOI 10.1093/molbev/msg158; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; HUGHES JF, 2004, ALRY MAJOR PT MAJOR; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Kehrer-Sawatzki H, 2005, GENOMICS, V85, P542, DOI 10.1016/j.ygeno.2005.01.012; Kirsch S, 2005, GENOME RES, V15, P195, DOI 10.1101/gr.3302705; Kirsch S, 2008, GENOME RES, V18, P1030, DOI 10.1101/gr.076711.108; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; LAURSEN HB, 1992, EMBO J, V11, P2367, DOI 10.1002/j.1460-2075.1992.tb05300.x; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Lernmers RJLF, 2001, ANN NEUROL, V50, P816, DOI 10.1002/ana.10057; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; McConkey EH, 2004, CYTOGENET GENOME RES, V105, P157, DOI 10.1159/000078022; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MILATOVICH A, 1993, AM J HUM GENET, V53, P1146; Montefalcone G, 1999, GENOME RES, V9, P1184, DOI 10.1101/gr.9.12.1184; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nguyen DQ, 2008, GENOME RES, V18, P1711, DOI 10.1101/gr.077289.108; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; Roberto R, 2007, GENOME RES, V17, P249, DOI 10.1101/gr.6052507; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rudd MK, 2006, GENOME RES, V16, P88, DOI 10.1101/gr.3810906; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; SCHEMPP W, 1995, CHROMOSOME RES, V3, P227, DOI 10.1007/BF00713047; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Shiels C, 1997, GENOMICS, V44, P35, DOI 10.1006/geno.1997.4817; SINGH L, 1984, NUCLEIC ACIDS RES, V12, P5627, DOI 10.1093/nar/12.14.5627; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; SMITH JM, 1992, J MOL EVOL, V34, P126; SWOFFORD D.L., 2000, PHYLOGENETIC ANAL US; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tawil R, 1998, ANN NEUROL, V43, P279, DOI 10.1002/ana.410430303; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TYLERSMITH C, 1987, J MOL BIOL, V195, P457, DOI 10.1016/0022-2836(87)90175-6; VOGT P, 1990, HUM GENET, V84, P301; WEBER B, 1986, CYTOGENET CELL GENET, V43, P72, DOI 10.1159/000132300; Weiller GF, 1998, MOL BIOL EVOL, V15, P326, DOI 10.1093/oxfordjournals.molbev.a025929; Wienberg J, 1994, CHROMOSOME RES, V2, P405, DOI 10.1007/BF01552800; WILLARD HF, 1990, TRENDS GENET, V6, P410, DOI 10.1016/0168-9525(90)90302-M; Winokur ST, 1994, CHROMOSOME RES, V2, P225, DOI 10.1007/BF01553323; Winokur ST, 1996, HUM MOL GENET, V5, P1567, DOI 10.1093/hmg/5.10.1567; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861	82	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5288	10.1371/journal.pone.0005288	http://dx.doi.org/10.1371/journal.pone.0005288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404400	Green Submitted, Green Published, gold			2022-12-27	WOS:000265614900002
J	Diederich, K; Schabitz, WR; Kuhnert, K; Hellstrom, N; Sachser, N; Schneider, A; Kuhn, HG; Knecht, S				Diederich, Kai; Schaebitz, Wolf-Ruediger; Kuhnert, Katharina; Hellstrom, Nina; Sachser, Norbert; Schneider, Armin; Kuhn, Hans-Georg; Knecht, Stefan			Synergetic Effects of Granulocyte-Colony Stimulating Factor and Cognitive Training on Spatial Learning and Survival of Newborn Hippocampal Neurons	PLOS ONE			English	Article								Granulocyte-Colony Stimulating Factor (G-CSF) is an endogenous hematopoietic growth factor known for its role in the proliferation and differentiation of cells of the myeloic lineage. Only recently its significance in the CNS has been uncovered. G-CSF attenuates apoptosis and controls proliferation and differentiation of neural stem cells. G-CSF activates upstream kinases of the cAMP response element binding protein (CREB), which is thought to facilitate the survival of neuronal precursors and to recruit new neurons into the dentate gyrus. CREB is also essential for spatial long-term memory formation. To assess the role and the potential of this factor on learning and memory-formation we systemically administered G-CSF in rats engaged in spatial learning in an eight-arm radial maze. G-CSF significantly improved spatial learning and increased in combination with cognitive training the survival of newborn neurons in the hippocampus as measured by bromodeoxyuridine and doublecortin immunohistochemistry. Additionally, G-CSF improved re-acquisition of spatial information after 26 days. These findings support the hypothesis that G-CSF can enhance learning and memory formation. Due to its easy applicability and its history as a well-tolerated hematological drug, the use of G-CSF opens up new neurological treatment opportunities in conditions where learning and memory-formation deficits occur.			Diederich, K (corresponding author), Univ Munster, Dept Neurol, D-4400 Munster, Germany.	kai.diederich@uni-muenster.de	Kuhn, Hans-Georg/L-8127-2014	Kuhn, Hans-Georg/0000-0003-4247-5613; Hellstrom Erkenstam, Nina/0000-0002-4336-5419; Diederich, Kai/0000-0002-6550-9460; Schneider, Armin/0000-0003-0296-0059; Knecht, Stefan/0000-0003-1056-9228				Ambrogini P, 2004, NEUROSCI LETT, V359, P13, DOI 10.1016/j.neulet.2003.12.123; Cao XQ, 2006, J NEUROCHEM, V99, P861, DOI 10.1111/j.1471-4159.2006.04125.x; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Drapeau E, 2007, J NEUROSCI, V27, P6037, DOI 10.1523/JNEUROSCI.1031-07.2007; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Epp JR, 2007, NEUROSCIENCE, V149, P273, DOI 10.1016/j.neuroscience.2007.07.046; Florian C, 2006, LEARN MEMORY, V13, P465, DOI 10.1101/lm.249306; Gibson CL, 2005, J CEREBR BLOOD F MET, V25, P431, DOI 10.1038/sj.jcbfm.9600033; Gilman CP, 2003, J NEUROCHEM, V87, P1137, DOI 10.1046/j.1471-4159.2003.02073.x; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Greenough WT, 1999, NAT NEUROSCI, V2, P203, DOI 10.1038/6300; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Komine-Kobayashi M, 2006, J CEREBR BLOOD F MET, V26, P402, DOI 10.1038/sj.jcbfm.9600195; Leuner B, 2004, J NEUROSCI, V24, P7477, DOI 10.1523/JNEUROSCI.0204-04.2004; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; Meuer K, 2006, J NEUROCHEM, V97, P675, DOI 10.1111/j.1471-4159.2006.03727.x; Minnerup J, 2008, STROKE, V39, P1855, DOI 10.1161/STROKEAHA.107.506816; Mizuno K, 2005, J PHARMACOL SCI, V98, P191, DOI 10.1254/jphs.CRJ05005X; Mizuno M, 2002, BEHAV BRAIN RES, V133, P135, DOI 10.1016/S0166-4328(01)00470-3; Nottebohm F, 2002, BRAIN RES BULL, V57, P737, DOI 10.1016/S0361-9230(02)00750-5; Peters M, 2003, J NEUROSCI, V23, P9752; Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schabitz WR, 2007, TRENDS PHARMACOL SCI, V28, P157, DOI 10.1016/j.tips.2007.02.007; Schneider A, 2005, CELL CYCLE, V4, P1753, DOI 10.4161/cc.4.12.2213; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Solaroglu I, 2007, FRONT BIOSCI-LANDMRK, V12, P712, DOI 10.2741/2095; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Sweatt JD, 2004, PSYCHOPHARMACOLOGY, V174, P99, DOI 10.1007/s00213-004-1795-9; Tsai KJ, 2007, J EXP MED, V204, P1273, DOI 10.1084/jem.20062481; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; WILLIAMS RW, 1988, J COMP NEUROL, V278, P344, DOI 10.1002/cne.902780305; Zhu DY, 2004, P NATL ACAD SCI USA, V101, P9453, DOI 10.1073/pnas.0401063101	42	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5303	10.1371/journal.pone.0005303	http://dx.doi.org/10.1371/journal.pone.0005303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390691	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514400004
J	Young, RP; Hopkins, RJ; Hay, BA; Epton, MJ; Mills, GD; Black, PN; Gardner, HD; Sullivan, R; Gamble, GD				Young, Robert P.; Hopkins, Raewyn J.; Hay, Bryan A.; Epton, Michael J.; Mills, Graham D.; Black, Peter N.; Gardner, Heather D.; Sullivan, Richard; Gamble, Gregory D.			Lung Cancer Susceptibility Model Based on Age, Family History and Genetic Variants	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; RISK; POLYMORPHISMS; ASSOCIATION; INFLAMMATION; EMPHYSEMA; INTEGRIN; PATHWAY; DEATH; COPD	Background: Epidemiological and pedigree studies suggest that lung cancer results from the combined effects of age, smoking, impaired lung function and genetic factors. In a case control association study of healthy smokers and lung cancer cases, we identified genetic markers associated with either susceptibility or protection to lung cancer. Methodology/Principal Findings: We screened 157 candidate single nucleotide polymorphisms (SNP) in a discovery cohort of 439 subjects (200 controls and 239 lung cancer cases) and identified 30 SNPs associated with either the healthy smokers (protective) or lung cancer (susceptibility) phenotype. After genotyping this 30 SNP panel in a validation cohort of 491 subjects (248 controls and 207 lung cancers) and, using the same protective and susceptibility genotypes from our discovery cohort, a 20 SNP panel was selected based on replication of SNP associations in the validation cohort. Following multivariate logistic regression analyses, including the selected SNPs from runs 1 and 2, we found age and family history of lung cancer to be significantly and independently associated with lung cancer. Numeric scores were assigned to both the SNP and demographic data, and combined to form a simple algorithm of risk. Conclusions/Significance: Significant differences in the distribution of the lung cancer susceptibility score was found between normal controls and lung cancer cases, which remained after accounting for differences in lung function. Validation in other case-control and prospective cohorts are underway to further define the potential clinical utility of this model.			Young, RP (corresponding author), Auckland Hosp, Dept Med, Auckland, New Zealand.	roberty@adhb.govt.nz	Wang, Weili/D-1546-2011	Gamble, Greg/0000-0003-0412-3203; Epton, Michael/0000-0003-4644-366X; Hopkins, Raewyn/0000-0003-2168-6235				ALBERG AJ, 2003, CHEST S1, V123, P21; AMOS CI, 2008, NAT GENETICS    0402, P1; ANTHONISEN NR, 1989, AM REV RESPIR DIS, V140, pS95, DOI 10.1164/ajrccm/140.3_Pt_2.S95; Brody Jerome S, 2006, Proc Am Thorac Soc, V3, P535, DOI 10.1513/pats.200603-089MS; Campa D, 2004, CARCINOGENESIS, V25, P229, DOI 10.1093/carcin/bgh008; Campa D, 2007, LUNG CANCER, V56, P17, DOI 10.1016/j.lungcan.2006.11.007; Chong IW, 2006, ONCOL REP, V16, P981; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-1; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Engels EA, 2007, CANCER RES, V67, P6520, DOI 10.1158/0008-5472.CAN-07-0370; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gwilt CR, 2007, PHARMACOL THERAPEUT, V115, P208, DOI 10.1016/j.pharmthera.2007.05.007; Hoshino T, 2007, AM J RESP CRIT CARE, V176, P49, DOI 10.1164/rccm.200603-316OC; Hu Z, 2004, LUNG CANCER, V46, P1, DOI 10.1016/j.lungcan.2004.03.016; Ishii T, 2000, EUR J CLIN INVEST, V30, P543; Jain M, 2007, CANCER DETECT PREV, V31, P225, DOI 10.1016/j.cdp.2007.04.005; Jakubowska A, 2007, J MED GENET, V44, P408, DOI 10.1136/jmg.2006.047498; Lee KI, 1997, COMMUN STAT-SIMUL C, V26, P559, DOI 10.1080/03610919708813397; Lerman C, 1997, HEALTH PSYCHOL, V16, P87, DOI 10.1037/0278-6133.16.1.87; Li GJ, 2004, CANCER RES, V64, P6863, DOI 10.1158/0008-5472.CAN-04-1804; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lokke A, 2006, THORAX, V61, P935, DOI 10.1136/thx.2006.062802; MATTSON ME, 1987, AM J PUBLIC HEALTH, V77, P425, DOI 10.2105/AJPH.77.4.425; McBride CM, 2002, CANCER EPIDEM BIOMAR, V11, P521; Moskvina V, 2005, ANN HUM GENET, V69, P566, DOI 10.1111/j.1529-8817.2005.00175.x; Neugut AI, 2006, JAMA-J AM MED ASSOC, V296, P218, DOI 10.1001/jama.296.2.218; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; RUDD MF, 2007, GENOME RES       AUG, P693; Sata M, 2007, RESPIROLOGY, V12, P34, DOI 10.1111/j.1440-1843.2006.00959.x; Schwartz AG, 2007, CARCINOGENESIS, V28, P507, DOI 10.1093/carcin/bgl253; Shields PG, 2000, J CLIN ONCOL, V18, P2309, DOI 10.1200/JCO.2000.18.11.2309; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Strange C, 2004, GENET MED, V6, P204, DOI 10.1097/01.GIM.0000132669.09819.79; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Wikman H, 2001, PHARMACOGENETICS, V11, P157, DOI 10.1097/00008571-200103000-00006; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; Wu XF, 2000, CANCER EPIDEM BIOMAR, V9, P1021; Wu XF, 1998, CANCER EPIDEM BIOMAR, V7, P13; Xu HY, 2005, HUM GENET, V116, P121, DOI 10.1007/s00439-004-1212-9; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452; Young RP, 2008, EUR RESPIR J, V32, P1158, DOI 10.1183/09031936.00093908; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707; YOUNG RP, 2006, THORAX, V30, P1; Zhang X, 2005, J MED GENET, V42, P479, DOI 10.1136/jmg.2004.030106; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zhou W, 2005, CANCER EPIDEM BIOMAR, V14, P491, DOI 10.1158/1055-9965.EPI-04-0612; Zhu CQ, 2007, P NATL ACAD SCI USA, V104, P11754, DOI 10.1073/pnas.0703040104	48	38	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5302	10.1371/journal.pone.0005302	http://dx.doi.org/10.1371/journal.pone.0005302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390575	Green Submitted, Green Published, gold			2022-12-27	WOS:000265514200015
J	Natan, D; Nagler, A; Arav, A				Natan, Dity; Nagler, Arnon; Arav, Amir			Freeze-Drying of Mononuclear Cells Derived from Umbilical Cord Blood Followed by Colony Formation	PLOS ONE			English	Article							GREEN TEA; EPIGALLOCATECHIN GALLATE; DESICCATION TOLERANCE; LARGE-VOLUME; SUCCESSFUL PREGNANCIES; CHILLING SENSITIVITY; SALT CONCENTRATION; PHASE-TRANSITIONS; STEM-CELLS; CRYOPRESERVATION	Background: We recently showed that freeze-dried cells stored for 3 years at room temperature can direct embryonic development following cloning. However, viability, as evaluated by membrane integrity of the cells after freeze-drying, was very low; and it was mainly the DNA integrity that was preserved. In the present study, we improved the cells' viability and functionality after freeze-drying. Methodology/Principal Findings: We optimized the conditions of directional freezing, i.e. interface velocity and cell concentration, and we added the antioxidant EGCG to the freezing solution. The study was performed on mononuclear cells (MNCs) derived from human umbilical cord blood. After freeze-drying, we tested the viability, number of CD34(+)-presenting cells and ability of the rehydrated hematopoietic stem cells to differentiate into different blood cells in culture. The viability of the MNCs after freeze-drying and rehydration with pure water was 88%-91%. The total number of CD34(+)-presenting cells and the number of colonies did not change significantly when evaluated before freezing, after freeze-thawing, and after freeze-drying (5.4x10 (4)+/- 4.7, 3.49x10(4)+/- 6 and 6.31x10(4 +/-)12.27 cells, respectively, and 31 +/- 25.15, 47 +/- 45.8 and 23.44 +/- 13.3 colonies, respectively). Conclusions: This is the first report of nucleated cells which have been dried and then rehydrated with double-distilled water remaining viable, and of hematopoietic stem cells retaining their ability to differentiate into different blood cells.			Natan, D (corresponding author), Core Dynam Ltd, Ness Ziona, Israel.	dity@coredynamics.com						Abdelwahed W, 2006, INT J PHARM, V324, P74, DOI 10.1016/j.ijpharm.2006.06.047; Allison SD, 1998, ARCH BIOCHEM BIOPHYS, V358, P171, DOI 10.1006/abbi.1998.0832; Arav A, 1996, CRYOBIOLOGY, V33, P589, DOI 10.1006/cryo.1996.0062; Arav A., 1992, Embryonic development and manipulation in animal production: trends in research and applications., P255; Arav A, 2005, HUM REPROD, V20, P3554, DOI 10.1093/humrep/dei278; Arav A, 2002, REPROD NUTR DEV, V42, P583, DOI 10.1051/rnd:2002044; Arav A, 2002, MOL CELL ENDOCRINOL, V187, P77, DOI 10.1016/S0303-7207(01)00700-6; Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; Bielanski A, 2003, CRYOBIOLOGY, V46, P146, DOI 10.1016/S0011-2240(03)00020-8; Choi CW, 2001, INT J HEMATOL, V73, P245, DOI 10.1007/BF02981945; Crowe JH, 2005, INTEGR COMP BIOL, V45, P810, DOI 10.1093/icb/45.5.810; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; Crowe JH, 1997, CRYOBIOLOGY, V35, P20, DOI 10.1006/cryo.1997.2020; CROWE JH, 1994, CRYOBIOLOGY, V31, P355, DOI 10.1006/cryo.1994.1043; CROWE LM, 1991, BIOCHIM BIOPHYS ACTA, V1064, P267, DOI 10.1016/0005-2736(91)90311-U; Crowe LM, 1996, BIOPHYS J, V71, P2087, DOI 10.1016/S0006-3495(96)79407-9; CROWE LM, 1985, ARCH BIOCHEM BIOPHYS, V242, P240, DOI 10.1016/0003-9861(85)90498-9; CROWE LM, 1988, BIOCHIM BIOPHYS ACTA, V946, P193, DOI 10.1016/0005-2736(88)90392-6; De Loecker W, 1998, CRYOBIOLOGY, V37, P103, DOI 10.1006/cryo.1998.2106; DROBNIS EZ, 1993, J EXP ZOOL, V265, P432, DOI 10.1002/jez.1402650413; FAHY GM, 1987, CRYOBIOLOGY, V24, P196, DOI 10.1016/0011-2240(87)90023-X; Fujiki H, 1999, P SOC EXP BIOL MED, V220, P225, DOI 10.1046/j.1525-1373.1999.d01-38.x; Gacitua H, 2005, THERIOGENOLOGY, V63, P931, DOI 10.1016/j.theriogenology.2004.05.012; Gavish Z, 2008, REJUV RES, V11, P765, DOI 10.1089/rej.2008.0706; Halle P, 2001, TRANSFUSION, V41, P667, DOI 10.1046/j.1537-2995.2001.41050667.x; Hamza A, 2006, J PHYS CHEM B, V110, P2910, DOI 10.1021/jp0550762; Han DW, 2008, BIOORGAN MED CHEM, V16, P9652, DOI 10.1016/j.bmc.2008.10.009; Hassan HT, 1996, STEM CELLS, V14, P419, DOI 10.1002/stem.140419; Hosu BG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002787; HUBEL A, 1992, CRYOBIOLOGY, V29, P183, DOI 10.1016/0011-2240(92)90019-X; JENNINGS TA, 2002, LYOPHILIZATION; Kawai K, 2004, J ALLERGY CLIN IMMUN, V113, P1211, DOI 10.1016/j.jaci.2004.02.044; Kumazawa S, 2004, BIOSCI BIOTECH BIOCH, V68, P1743, DOI 10.1271/bbb.68.1743; Kusadasi N, 2000, LEUKEMIA, V14, P1944, DOI 10.1038/sj.leu.2401917; Laroche V, 2005, TRANSFUSION, V45, P1909, DOI 10.1111/j.1537-2995.2005.00638.x; Leidy C, 2004, CELL BIOCHEM BIOPHYS, V40, P123, DOI 10.1385/CBB:40:2:123; Loi P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002978; Ma LP, 2000, CHINESE SCI BULL, V45, P2052, DOI 10.1007/BF03183525; Ma XC, 2005, CRYOBIOLOGY, V51, P15, DOI 10.1016/j.cryobiol.2005.04.007; MAZUR P, 1981, BIOPHYS J, V36, P653, DOI 10.1016/S0006-3495(81)84757-1; MAZUR P, 1985, CRYOBIOLOGY, V22, P509, DOI 10.1016/0011-2240(85)90029-X; MAZUR P, 1963, J GEN PHYSIOL, V47, P347, DOI 10.1085/jgp.47.2.347; MCGANN LE, 1988, CRYOBIOLOGY, V25, P178, DOI 10.1016/0011-2240(88)90024-7; Morris GJ, 2005, CRYOBIOLOGY, V50, P231, DOI 10.1016/j.cryobiol.2005.01.005; Mounier Nicolas, 2005, Bull Cancer, V92, pE31; O'Brien JK, 2006, REPROD FERT DEVELOP, V18, P319, DOI 10.1071/RD05108; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Potts M, 2005, INTEGR COMP BIOL, V45, P800, DOI 10.1093/icb/45.5.800; Rindler V, 1999, CRYOBIOLOGY, V38, P2, DOI 10.1006/cryo.1998.2143; Rindler V, 1999, CRYOBIOLOGY, V39, P228, DOI 10.1006/cryo.1999.2204; Rogers I, 2001, CYTOTHERAPY, V3, P269, DOI 10.1080/146532401317070907; Roth Z, 2008, THERIOGENOLOGY, V70, P887, DOI 10.1016/j.theriogenology.2008.05.053; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Saragusty J, 2006, THERIOGENOLOGY, V66, P775, DOI 10.1016/j.theriogenology.2006.01.055; Searles JA, 2001, J PHARM SCI, V90, P872, DOI 10.1002/jps.1040; Si W, 2006, THERIOGENOLOGY, V65, P788, DOI 10.1016/j.theriogenology.2005.06.010; Sun WQ, 1996, BIOPHYS J, V70, P1769, DOI 10.1016/S0006-3495(96)79740-0; Thephinlap C, 2007, MED CHEM, V3, P289, DOI 10.2174/157340607780620608; Tipoe George L., 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P135; Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3; WEISS L, 1959, BIOPHYSIC BIOCH CYTO, V7, P673; Wolkers WF, 2002, COMP BIOCHEM PHYS A, V131, P535, DOI 10.1016/S1095-6433(01)00505-0; WU D, 2007, FASEB J, V21; Yamakov V, 2002, NAT MATER, V1, P45, DOI 10.1038/nmat700; Yanagawa Y, 2003, CURR MICROBIOL, V47, P244, DOI 10.1007/s00284-002-3956-6; Zeron Y, 2002, CRYOBIOLOGY, V45, P143, DOI 10.1016/S0011-2240(02)00123-2; Zeron Y, 2002, MOL REPROD DEV, V61, P271, DOI 10.1002/mrd.1156	67	50	51	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5240	10.1371/journal.pone.0005240	http://dx.doi.org/10.1371/journal.pone.0005240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381290	Green Submitted, Green Published, gold			2022-12-27	WOS:000265513800012
J	Hanson, S; Thorson, A; Rosling, H; Ortendahl, C; Hanson, C; Killewo, J; Ekstrom, AM				Hanson, Stefan; Thorson, Anna; Rosling, Hans; Ortendahl, Claes; Hanson, Claudia; Killewo, Japhet; Ekstrom, Anna Mia			Estimating the Capacity for ART Provision in Tanzania with the Use of Data on Staff Productivity and Patient Losses	PLOS ONE			English	Article								Background: International targets for access to antiretroviral therapy (ART) have over-estimated the capacity of health systems in low-income countries in Sub-Saharan Africa. The WHO target for number on treatment by end 2005 for Tanzania was 10 times higher than actually achieved. The target of the national Care and Treatment Plan (CTP) was also not reached. We aimed at estimating the capacity for ART provision and created five scenarios for ART production given existing resource limitations. Methods: A situation analysis including scrutiny of staff factors, such as available data on staff and patient factors including access to ART and patient losses, made us conclude that the lack of clinical staff is the main limiting factor for ART scale-up, assuming that sufficient drugs and supplies are provided by donors. We created a simple formula to estimate the number of patients on ART based on availability and productivity of clinical staff, time needed to initiate vs maintain a patient on ART and patient losses using five different scenarios with varying levels of these parameters. Findings: Our scenario assuming medium productivity (40% higher than that observed in 2002) and medium loss of patients (20% in addition to 15% first-year mortality) coincides with the actual reported number of patients initiated on ART up to 2008, but is considerably below the national CTP target of 90% coverage for 2009, corresponding to 420,000 on ART and 710,000 life-years saved (LY's). Our analysis suggests that a coverage of 40% or 175,000 on treatment and 350,000 LY's saved is more achievable. Conclusion: A comparison of our scenario estimations and actual output 2006-2008 indicates that a simple user-friendly dynamic model can estimate the capacity for ART scale-up in resource-poor settings based on identification of a limiting staff factor and information on availability of this staff and patient losses. Thus, it is possible to set more achievable targets.			Hanson, S (corresponding author), Karolinska Inst, Div Int Hlth IHCAR, Stockholm, Sweden.	Stefan.Hanson@ki.se	Visan, Delia/GXW-3349-2022	Thorson, Anna/0000-0002-8703-6561				[Anonymous], 2001, MACR HLTH INV HLTH E; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Binswanger HP, 2000, SCIENCE, V288, P2173, DOI 10.1126/science.288.5474.2173; BISSON G, 2007, C RETR OPP INF LOS A; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; FERRADINI L, 2004, 15 INT C AIDS BANGK; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; *GLOB FUND FIGHT A, 2002, FRAM DOC GLOB FUND F; High Level Forum, 2005, PAR DECL AID EFF OWN; Jaffar S, 2004, B WORLD HEALTH ORGAN, V82, P462; Kabugo C, 2005, JAIDS-J ACQ IMM DEF, V38, P578, DOI 10.1097/01.qai.0000134742.26338.2f; KILLEWO J, 2004, NAT HIV AIDS CAR TRE; Kurowski C, 2004, HUMAN RESOURCES HLTH; Lowrance DW, 2008, JAIDS-J ACQ IMM DEF, V49, P287, DOI 10.1097/QAI.0b013e3181893ef0; Marston M, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000299412.82893.62; *MIN HLTH, 2003, BURD DIS PROF COAST; *MIN HLTH, 2003, POL IMPL TANZ MORT B, V2; *MIN HLTH, 2001, CENS HUM RE IN PRESS; *MIN HLTH NAT AIDS, 2006, SURV HIV SYPH INF AN; *MOHSW CAP PROJ NA, 2006, LAB MARK STUD TANZ H; *OECD DAC, 2007, EXT EV TANZ HLTH SEC; Piot P, 2006, LANCET, V368, P526, DOI 10.1016/S0140-6736(06)69161-7; *POP DIV DEP EC SO, 2006 REV WORLD URB P; Ramiah I, 2005, HEALTH AFFAIR, V24, P545, DOI 10.1377/hlthaff.24.2.545; Rosen S, 2005, LANCET, V365, P354, DOI 10.1016/S0140-6736(05)70202-6; Spacek LA, 2006, INT J STD AIDS, V17, P116, DOI 10.1258/095646206775455766; *TANZ COMM AIDS SA, 2005, HIV AIDS IND SURV; Tassie JM, 2003, AIDS, V17, P1995, DOI 10.1097/00002030-200309050-00023; *UN GEN ASS, 2000, UNS MILL DEV GOALS; *UN REP TANZ, HIV AIDS CAR TREATM; *UNAIDS, 2006, UNAIDS WHO AIDS EP U; *UNAIDS, 2005, SPECTR MOD VERS 2005; *UNAIDS, 2007, AIDS EP UPD; *UNAIDS, 2005, EP PROJ PACK EPP VER; Van Damme W, 2006, AIDS, V20, P653, DOI 10.1097/01.aids.0000216364.44409.b1; van Oosterhout JJ, 2005, TROP MED INT HEALTH, V10, P464, DOI 10.1111/j.1365-3156.2005.01409.x; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WHO, 2006, 3 5 IN PROGR GLOB AC; *WHO UNAIDS UNICEF, 2008, UN ACC SCAL UP HIV A; *WHO UNFPA UNICEF, 2006, STAT KEN UG TRIAL FI; *WJ CLINT FDN, HIV AIDS IN; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea	42	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5294	10.1371/journal.pone.0005294	http://dx.doi.org/10.1371/journal.pone.0005294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381270	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000265510800015
J	Gnocchi, VF; White, RB; Ono, Y; Ellis, JA; Zammit, PS				Gnocchi, Viola F.; White, Robert B.; Ono, Yusuke; Ellis, Juliet A.; Zammit, Peter S.			Further Characterisation of the Molecular Signature of Quiescent and Activated Mouse Muscle Satellite Cells	PLOS ONE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; MYOGENIC STEM-CELLS; SKELETAL-MUSCLE; SELF-RENEWAL; M-CADHERIN; EXPRESSION; MUTATIONS; MARKER; PROGRESSION; CONTRIBUTE	Satellite cells are the resident stem cells of adult skeletal muscle. To date though, there is a paucity of native markers that can be used to easily identify quiescent satellite cells, with Pax7 probably being the best that is currently available. Here we have further characterized a number of recently described satellite cell markers, and also describe novel ones. Caveolin-1, integrin alpha 7 and the calcitonin receptor proved reliable markers for quiescent satellite cells, being expressed by all satellite cells identified with Pax7. These three markers remained expressed as satellite cells were activated and underwent proliferation. The nuclear envelope proteins lamin A/C and emerin, mutations in which underlie Emery-Dreifuss muscular dystrophy, were also expressed in both quiescent and proliferating satellite cells. Conversely, Jagged-1, a Notch ligand, was not expressed in quiescent satellite cells but was induced upon activation. These findings further contribute to defining the molecular signature of muscle satellite cells.			Gnocchi, VF (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, Guys Campus, London WC2R 2LS, England.	peter.zammit@kcl.ac.uk	Zammit, peter/GXV-7746-2022; White, Robert/H-6080-2014	Ono, Yusuke/0000-0002-4802-7507; White, Robert/0000-0002-2854-0936; zammit, peter/0000-0001-9562-3072	MRC [G0700307] Funding Source: UKRI; Medical Research Council [G0700307] Funding Source: Medline; Wellcome Trust [085137/Z/08/Z] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; BISCHOFF R, 2004, SATELLITE STEM CELLS; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; Ellis JA, 2006, CELL MOL LIFE SCI, V63, P2702, DOI 10.1007/s00018-006-6247-8; Ellis JA, 1998, J CELL SCI, V111, P781; FIDZIANSKA A, 1995, FOLIA NEUROPATHOL, V33, P125; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Garry DJ, 1997, DEV BIOL, V188, P280, DOI 10.1006/dbio.1997.8657; Gnocchi VF, 2008, BIOCHEM SOC T, V36, P1344, DOI 10.1042/BST0361344; Hayashi YK, 1998, NAT GENET, V19, P94, DOI 10.1038/ng0598-94; ILLA I, 1992, ANN NEUROL, V31, P46, DOI 10.1002/ana.410310109; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lee HJ, 2004, MOL CELL BIOL, V24, P8428, DOI 10.1128/MCB.24.19.8428-8436.2004; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Nagata Y, 2006, J HISTOCHEM CYTOCHEM, V54, P375, DOI 10.1369/jhc.5A6675.2006; Nawrotzki R, 2003, HUM MOL GENET, V12, P483, DOI 10.1093/hmg/ddg047; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; PARK YE, 2008, NEUROMUSCUL DISORD; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; ROSENBLATT JD, 1992, J APPL PHYSIOL, V73, P2538, DOI 10.1152/jappl.1992.73.6.2538; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sajko S, 2004, J HISTOCHEM CYTOCHEM, V52, P179, DOI 10.1177/002215540405200205; Schmidt K, 2003, J BIOL CHEM, V278, P29769, DOI 10.1074/jbc.M301539200; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sinha-Hikim I, 2004, J CLIN ENDOCR METAB, V89, P5245, DOI 10.1210/jc.2004-0084; Volonte D, 2004, FASEB J, V18, P237, DOI 10.1096/fj.04-2215fje; WHALEN RG, 1990, DEV BIOL, V141, P24, DOI 10.1016/0012-1606(90)90099-5; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	45	105	110	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5205	10.1371/journal.pone.0005205	http://dx.doi.org/10.1371/journal.pone.0005205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370151	Green Published, Green Submitted, gold			2022-12-27	WOS:000265510600002
J	Schweitzer, JK; Pietrini, SD; D'Souza-Schorey, C				Schweitzer, Jill Kuglin; Pietrini, Sean D.; D'Souza-Schorey, Crislyn			ARF6-Mediated Endosome Recycling Reverses Lipid Accumulation Defects in Niemann-Pick Type C Disease	PLOS ONE			English	Article								In human Niemann-Pick Type C (NPC) disease, endosomal trafficking defects lead to an accumulation of free cholesterol and other lipids in late endosome/lysosome (LE/LY) compartments, a subsequent block in cholesterol esterification and significantly reduced cholesterol efflux out of the cell. Here we report that nucleotide cycling or cellular knockdown of the small GTP-binding protein, ARF6, markedly impacts cholesterol homeostasis. Unregulated ARF6 activation attenuates the NPC phenotype at least in part by decreasing cholesterol accumulation and restoring normal sphingolipid trafficking. These effects depend on ARF6-stimulated cholesterol efflux out of the endosomal recycling compartment, a major cell repository for free cholesterol. We also show that fibroblasts derived from different NPC patients displayed varying levels of ARF6 that is GTP-bound, which correlate with their response to sustained ARF6 activation. These studies support emerging evidence that early endocytic defects impact NPC disease and suggest that such heterogeneity in NPC disease could result in diverse responses to therapeutic interventions aimed at modulating the trafficking of lipids.			Schweitzer, JK (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	D'Souza-Schorey.1@nd.edu						Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Choi HY, 2003, J BIOL CHEM, V278, P32569, DOI 10.1074/jbc.M304553200; Choudhury A, 2004, MOL BIOL CELL, V15, P4500, DOI 10.1091/mbc.E04-05-0432; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Cruz JC, 2000, J BIOL CHEM, V275, P41309, DOI 10.1074/jbc.M008272200; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Holtta-Vuori M, 2002, MOL BIOL CELL, V13, P3107, DOI 10.1091/mbc.E02-01-0025; Ikonen E, 2004, SEMIN CELL DEV BIOL, V15, P445, DOI 10.1016/j.semcdb.2004.03.001; Kaptzan T, 2009, AM J PATHOL, V174, P14, DOI 10.2353/ajpath.2009.080660; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Linder MD, 2007, MOL BIOL CELL, V18, P47, DOI 10.1091/mbc.E06-07-0575; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Narita K, 2005, FASEB J, V19, P1558, DOI 10.1096/fj.04-2714fje; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Pagano RE, 2003, PHILOS T R SOC B, V358, P885, DOI 10.1098/rstb.2003.1275; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Pipalia NH, 2007, TRAFFIC, V8, P130, DOI 10.1111/j.1600-0854.2006.00513.x; Schweitzer JK, 2005, EXP CELL RES, V311, P74, DOI 10.1016/j.yexcr.2005.07.033; Schweitzer JK, 2002, J BIOL CHEM, V277, P27210, DOI 10.1074/jbc.M201569200; Sugii S, 2003, J LIPID RES, V44, P1033, DOI 10.1194/jlr.D200036-JLR200; Walter M, 2003, J LIPID RES, V44, P243, DOI 10.1194/jlr.M200230-JLR200; Wang MD, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700326200; Wastney ME, 2003, ADV EXP MED BIOL, V537, P63	29	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2009	4	4							e5193	10.1371/journal.pone.0005193	http://dx.doi.org/10.1371/journal.pone.0005193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TO	19365558	Green Published, Green Submitted, gold			2022-12-27	WOS:000265510000002
J	Le, TT; Cheng, JX				Le, Thuc T.; Cheng, Ji-Xin			Single-Cell Profiling Reveals the Origin of Phenotypic Variability in Adipogenesis	PLOS ONE			English	Article							RAMAN SCATTERING MICROSCOPY; ADIPOCYTE DIFFERENTIATION; LIPID DROPLETS; GLUCOSE; GENE; METABOLISM; PATHWAYS; PROTEIN; PREF-1	Phenotypic heterogeneity in a clonal cell population is a well-observed but poorly understood phenomenon. Here, a single-cell approach is employed to investigate non-mutative causes of phenotypic heterogeneity during the differentiation of 3T3-L1 cells into fat cells. Using coherent anti-Stokes Raman scattering microscopy and flow cytometry, adipogenic gene expression, insulin signaling, and glucose import are visualized simultaneously with lipid droplet accumulation in single cells. Expression of adipogenic genes PPAR gamma, C/EBP alpha, aP2, LP2 suggests a commitment to fat cell differentiation in all cells. However, the lack of lipid droplet in many differentiating cells suggests adipogenic gene expression is insufficient for lipid droplet formation. Instead, cell-to-cell variability in lipid droplet formation is dependent on the cascade responses of an insulin signaling pathway which includes insulin sensitivity, kinase activity, glucose import, expression of an insulin degradation enzyme, and insulin degradation rate. Increased and prolonged insulin stimulation promotes lipid droplet accumulation in all differentiating cells. Single-cell profiling reveals the kinetics of an insulin signaling cascade as the origin of phenotypic variability in drug-inducible adipogenesis.			Le, TT (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	jcheng@purdue.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL089074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB004966] Funding Source: NIH RePORTER; NHLBI NIH HHS [F32 HL089074, F32HL089074] Funding Source: Medline; NIBIB NIH HHS [R21 EB004966] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Chen SB, 2007, P NATL ACAD SCI USA, V104, P10482, DOI 10.1073/pnas.0704360104; Cheng JX, 2004, J PHYS CHEM B, V108, P827, DOI 10.1021/jp035693v; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Duckworth WC, 1997, BBA-MOL CELL RES, V1358, P163, DOI 10.1016/S0167-4889(97)00066-9; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kepler TB, 1998, P NATL ACAD SCI USA, V95, P11514, DOI 10.1073/pnas.95.20.11514; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Le TT, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2795437; Le TT, 2007, MOL IMAGING, V6, P205, DOI 10.2310/7290.2007.00018; Le TT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-42; Le TT, 2005, P NATL ACAD SCI USA, V102, P9160, DOI 10.1073/pnas.0503311102; Lee YH, 2004, J LIPID RES, V45, P1162, DOI 10.1194/jlr.D300028-JLR200; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; Mattick JS, 2007, J EXP BIOL, V210, P1526, DOI 10.1242/jeb.005017; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; MURPHY RF, 1982, CYTOMETRY, V2, P402; Nan XL, 2006, BIOPHYS J, V91, P728, DOI 10.1529/biophysj.105.074534; Nan XL, 2003, J LIPID RES, V44, P2202, DOI 10.1194/jlr.D300022-JLR200; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Potma EO, 2005, CHEMPHYSCHEM, V6, P77, DOI 10.1002/cphc.200400390; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shigematsu S, 2001, J BIOL CHEM, V276, P15292, DOI 10.1074/jbc.M009684200; Smas CM, 1998, J BIOL CHEM, V273, P31751, DOI 10.1074/jbc.273.48.31751; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Temple KA, 2007, FEBS LETT, V581, P469, DOI 10.1016/j.febslet.2007.01.007; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wang HW, 2008, OPT EXPRESS, V16, P5782, DOI 10.1364/OE.16.005782; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Yamada K, 2000, J BIOL CHEM, V275, P22278, DOI 10.1074/jbc.M908048199; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Zhang HB, 2003, J BIOL CHEM, V278, P20906, DOI 10.1074/jbc.M300022200; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004	52	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5189	10.1371/journal.pone.0005189	http://dx.doi.org/10.1371/journal.pone.0005189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357775	Green Published, gold, Green Submitted			2022-12-27	WOS:000265505900023
J	Michelfelder, S; Kohlschutter, J; Skorupa, A; Pfennings, S; Muller, O; Kleinschmidt, JA; Trepel, M				Michelfelder, Stefan; Kohlschuetter, Johannes; Skorupa, Alexandra; Pfennings, Sabrina; Mueller, Oliver; Kleinschmidt, Juergen A.; Trepel, Martin			Successful Expansion but Not Complete Restriction of Tropism of Adeno-Associated Virus by In Vivo Biopanning of Random Virus Display Peptide Libraries	PLOS ONE			English	Article							TARGETED GENE DELIVERY; PHAGE DISPLAY; TUMOR-CELLS; MOUSE MODEL; VECTORS; VASCULATURE; TITRATION; SELECTION; MUTANTS; THERAPY	Targeting viral vectors to certain tissues in vivo has been a major challenge in gene therapy. Cell type-directed vector capsids can be selected from random peptide libraries displayed on viral capsids in vitro but so far this system could not easily be translated to in vivo applications. Using a novel, PCR-based amplification protocol for peptide libraries displayed on adeno-associated virus (AAV), we selected vectors for optimized transduction of primary tumor cells in vitro. However, these vectors were not suitable for transduction of the same target cells under in vivo conditions. We therefore performed selections of AAV peptide libraries in vivo in living animals after intravenous administration using tumor and lung tissue as prototype targets. Analysis of peptide sequences of AAV clones after several rounds of selection yielded distinct sequence motifs for both tissues. The selected clones indeed conferred gene expression in the target tissue while gene expression was undetectable in animals injected with control vectors. However, all of the vectors selected for tumor transduction also transduced heart tissue and the vectors selected for lung transduction also transduced a number of other tissues, particularly and invariably the heart. This suggests that modification of the heparin binding motif by target-binding peptide insertion is necessary but not sufficient to achieve tissue-specific transgene expression. While the approach presented here does not yield vectors whose expression is confined to one target tissue, it is a useful tool for in vivo tissue transduction when expression in tissues other than the primary target is uncritical.			Michelfelder, S (corresponding author), Univ Freiburg, Med Ctr, Dept Hematol & Oncol, Freiburg, Germany.	m.trepel@uke.de	Müller, Oliver J./H-4739-2016; Müller, Oliver/AAA-4399-2021	Müller, Oliver/0000-0001-8223-2638; Michelfelder, Stefan/0000-0001-8678-1546				Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Arap W, 2002, P NATL ACAD SCI USA, V99, P1527, DOI 10.1073/pnas.241655998; Bessis N, 2004, GENE THER, V11, pS10, DOI 10.1038/sj.gt.3302364; Black ME, 2001, CANCER RES, V61, P3022; Burg MA, 1999, CANCER RES, V59, P2869; Carter BJ, 2005, HUM GENE THER, V16, P541, DOI 10.1089/hum.2005.16.541; Coura RD, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-99; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Epperly MW, 1999, INT J RADIAT ONCOL, V43, P169, DOI 10.1016/S0360-3016(98)00355-1; Essler M, 2002, P NATL ACAD SCI USA, V99, P2252, DOI 10.1073/pnas.251687998; Girod A, 1999, NAT MED, V5, P1438, DOI 10.1038/71021; Grifman M, 2001, MOL THER, V3, P964, DOI 10.1006/mthe.2001.0345; Grimm D, 1999, GENE THER, V6, P1322, DOI 10.1038/sj.gt.3300946; GRIMM D, 2008, J VIROL; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Halbert CL, 2007, HUM GENE THER, V18, P344, DOI 10.1089/hum.2006.182; Hauswirth WW, 2000, METHOD ENZYMOL, V316, P743; Hermens WTJMC, 1999, HUM GENE THER, V10, P1885, DOI 10.1089/10430349950017563; Joyce JA, 2003, CANCER CELL, V4, P393, DOI 10.1016/S1535-6108(03)00271-X; Kern A, 2003, J VIROL, V77, P11072, DOI 10.1128/JVI.77.20.11072-11081.2003; Koivunen E, 1999, NAT BIOTECHNOL, V17, P768, DOI 10.1038/11703; Kokoris MS, 2002, PROTEIN SCI, V11, P2267, DOI 10.1110/ps.2460102; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kolonin MG, 2002, P NATL ACAD SCI USA, V99, P13055, DOI 10.1073/pnas.162468499; Kolonin MG, 2006, FASEB J, V20, P979, DOI 10.1096/fj.05-5186fje; Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720; Lai LJ, 2007, J BIOMED SCI, V14, P313, DOI 10.1007/s11373-007-9153-7; Lee SM, 2007, MOL CANCER RES, V5, P11, DOI 10.1158/1541-7786.MCR-06-0069; Li W, 2008, MOL THER, V16, P1252, DOI 10.1038/mt.2008.100; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Michelfelder S, 2007, EXP HEMATOL, V35, P1766, DOI 10.1016/j.exphem.2007.07.018; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Nicklin Stuart A., 2002, Current Gene Therapy, V2, P273, DOI 10.2174/1566523023347797; Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Perabo L, 2003, MOL THER, V8, P151, DOI 10.1016/S1525-0016(03)00123-0; Perabo L, 2006, J VIROL, V80, P7265, DOI 10.1128/JVI.00076-06; Porkka K, 2002, P NATL ACAD SCI USA, V99, P7444, DOI 10.1073/pnas.062189599; Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008; Rohr UP, 2002, J VIROL METHODS, V106, P81, DOI 10.1016/S0166-0934(02)00138-6; Rohr UP, 2005, J VIROL METHODS, V127, P40, DOI 10.1016/j.jviromet.2005.03.006; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SELLNER L, 2008, EXP HEMATOL; Shi WF, 2003, MOL THER, V7, P515, DOI 10.1016/S1525-0016(03)00042-X; Shi XQ, 2006, HUM GENE THER, V17, P353, DOI 10.1089/hum.2006.17.353; SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4; Trepel M, 2001, CANCER RES, V61, P8110; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Wang YG, 2008, J GENE MED, V10, P518, DOI 10.1002/jgm.1177; Waterkamp DA, 2006, J GENE MED, V8, P1307, DOI 10.1002/jgm.967; White K, 2008, GENE THER, V15, P443, DOI 10.1038/sj.gt.3303077; White SJ, 2004, CIRCULATION, V109, P513, DOI 10.1161/01.CIR.0000109697.68832.5D; Wickham TJ, 2003, NAT MED, V9, P135, DOI 10.1038/nm0103-135; Work LM, 2006, MOL THER, V13, P683, DOI 10.1016/j.ymthe.2005.11.013; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Yao X, 2007, BIOCHEM BIOPH RES CO, V362, P419, DOI 10.1016/j.bbrc.2007.08.001; Zhang LL, 2006, CANCER RES, V66, P5696, DOI 10.1158/0008-5472.CAN-05-3876; ZINCARELLI C, 2008, MOL THER	63	59	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5122	10.1371/journal.pone.0005122	http://dx.doi.org/10.1371/journal.pone.0005122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357785	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505900005
J	Berg, S; Firdessa, R; Habtamu, M; Gadisa, E; Mengistu, A; Yamuah, L; Ameni, G; Vordermeier, M; Robertson, BD; Smith, NH; Engers, H; Young, D; Hewinson, RG; Aseffa, A; Gordon, SV				Berg, Stefan; Firdessa, Rebuma; Habtamu, Meseret; Gadisa, Endalamaw; Mengistu, Araya; Yamuah, Lawrence; Ameni, Gobena; Vordermeier, Martin; Robertson, Brian D.; Smith, Noel H.; Engers, Howard; Young, Douglas; Hewinson, R. Glyn; Aseffa, Abraham; Gordon, Stephen V.			The Burden of Mycobacterial Disease in Ethiopian Cattle: Implications for Public Health	PLOS ONE			English	Article								Background: Bovine tuberculosis (bTB), caused by Mycobacterium bovis, is a debilitating disease of cattle. Ethiopia has one of the largest cattle populations in the world, with an economy highly dependent on its livestock. Furthermore, Ethiopia has one of the highest incidence rates of human extrapulmonary TB in the world, a clinical presentation that is often associated with transmission of M. bovis from cattle to humans. Methodology/Principal Findings: Here we present a comprehensive investigation of the prevalence of bTB in Ethiopia based on cases identified at slaughterhouses. Out of approximately 32,800 inspected cattle, similar to 4.7% showed suspect tuberculous lesions. Culture of suspect lesions yielded acid-fast bacilli in similar to 11% of cases, with M. bovis accounting for 58 of 171 acid-fast cultures, while 53 isolates were non-tuberculous mycobacteria. Strikingly, M. tuberculosis was isolated from eight cattle, an unusual finding that suggests human to animal transmission. Conclusions/Significance: Our analysis has revealed that bTB is widely spread throughout Ethiopia, albeit at a low prevalence, and provides underpinning evidence for public health policy formulation.			Berg, S (corresponding author), Vet Labs Agcy, TB Res Grp, Addlestone, Surrey, England.	stephen.gordon@ucd.ie	Hewinson, Glyn/F-7077-2010; Hewinson, Glyn/AAA-2364-2019; Aseffa, Abraham/J-3248-2016; Smith, Noel H/C-6708-2011; Berg, Stefan/AAU-6463-2020; Vordermeier, H Martin/C-6936-2011; Berg, Stefan O/D-3847-2011; Firdessa, Rebuma/P-6238-2019; Hewinson, Glyn/J-1902-2014; Ameni, Gobena/AAR-4201-2020	Aseffa, Abraham/0000-0002-8028-1150; Berg, Stefan/0000-0002-3470-7579; Firdessa, Rebuma/0000-0003-2523-165X; Ameni, Gobena/0000-0003-3987-0671; Robertson, Brian D./0000-0001-5785-5307; Hewinson, Glyn/0000-0002-5517-4281; Gordon, Stephen/0000-0002-4833-5542	MRC [MC_U117581288] Funding Source: UKRI; Medical Research Council [MC_U117581288] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Allix C, 2006, J CLIN MICROBIOL, V44, P1951, DOI 10.1128/JCM.01775-05; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ameni G, 2007, VET REC, V161, P782; Ameni G., 2003, Bulletin of Animal Health and Production in Africa, V51, P125; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Aranaz A, 1996, J CLIN MICROBIOL, V34, P2734, DOI 10.1128/JCM.34.11.2734-2740.1996; Asseged B, 2004, TROP ANIM HEALTH PRO, V36, P537, DOI 10.1023/B:TROP.0000040934.32330.44; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Diguimbaye-Djaibe C, 2006, SCHWEIZ ARCH TIERH, V148, P251, DOI 10.1024/0036-7281.148.5.251; Esparcia O, 2008, J CLIN MICROBIOL, V46, P1885, DOI 10.1128/JCM.01441-07; GALLAGHER J, 1977, J HYG-CAMBRIDGE, V79, P155, DOI 10.1017/S0022172400052943; Halderman MN, 2004, POLITICAL EC PROPOOR; Han XY, 2002, AM J CLIN PATHOL, V118, P796, DOI 10.1309/HN44-XQYM-JMAQ-2EDL; Harmsen D, 2002, NUCLEIC ACIDS RES, V30, P416, DOI 10.1093/nar/30.1.416; Hogardt M, 2008, JPN J INFECT DIS, V61, P77; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kazwala RR, 2006, VET MICROBIOL, V112, P201, DOI 10.1016/j.vetmic.2005.11.026; Kidane D, 2002, J CLIN MICROBIOL, V40, P4230, DOI 10.1128/JCM.40.11.4230-4234.2002; KIRSCHNER P, 1993, J CLIN MICROBIOL, V31, P2882, DOI 10.1128/JCM.31.11.2882-2889.1993; Liebana E, 2008, VET J, V176, P354, DOI 10.1016/j.tvjl.2007.07.001; Lyashchenko KP, 2006, CLIN VACCINE IMMUNOL, V13, P722, DOI 10.1128/CVI.00133-06; Mayo J, 1998, EMERG INFECT DIS, V4, P124, DOI 10.3201/eid0401.980119; McCorry TP, 2004, VET MICROBIOL, V99, P281, DOI 10.1016/j.vetmic.2003.12.006; Michel AL, 2007, BMC VET RES, V3, P23, DOI DOI 10.1186/1746-6148-3-23; Muller B, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-26; Ocepek M, 2005, J CLIN MICROBIOL, V43, P3555, DOI 10.1128/JCM.43.7.3555-3557.2005; Oloya J, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-95; Prasad HK, 2005, TUBERCULOSIS, V85, P421, DOI 10.1016/j.tube.2005.08.005; Reischl U, 2006, INT J SYST EVOL MICR, V56, P2575, DOI 10.1099/ijs.0.64527-0; Roberts GD, 1991, MANUAL CLIN MICROBIO, P304; SHITAYE JE, 2007, VET MED, P317; Smith NH, 2006, NAT REV MICROBIOL, V4, P670, DOI 10.1038/nrmicro1472; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; Vordermeier HM, 2007, CLIN VACCINE IMMUNOL, V14, P1203, DOI 10.1128/CVI.00116-07; Wilton S, 1992, PCR Methods Appl, V1, P269; World Health Organisation, 2008, GLOB TUB CONTR SURV, P1	38	95	100	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5068	10.1371/journal.pone.0005068	http://dx.doi.org/10.1371/journal.pone.0005068			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352493	Green Published, gold, Green Submitted			2022-12-27	WOS:000265505300009
J	Barco, R; Garcia, CB; Eid, JE				Barco, Roy; Garcia, Christina B.; Eid, Josiane E.			The Synovial Sarcoma-Associated SYT-SSX2 Oncogene Antagonizes the Polycomb Complex Protein Bmi1	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; METHYLTRANSFERASE ACTIVITY; DEVELOPMENTAL REGULATORS; TUMOR-SUPPRESSOR; ONCOPROTEIN SYT; BREAST-CANCER; SSX; MICROARRAY; IDENTIFICATION	This study demonstrates deregulation of polycomb activity by the synovial sarcoma-associated SYT-SSX2 oncogene, also known as SS18-SSX2. Synovial sarcoma is a soft tissue cancer associated with a recurrent t(X: 18) translocation event that generates one of two fusion proteins, SYT-SSX1 or SYT-SSX2. The role of the translocation products in this disease is poorly understood. We present evidence that the SYT-SSX2 fusion protein interacts with the polycomb repressive complex and modulates its gene silencing activity. SYT-SSX2 causes destabilization of the polycomb subunit Bmi1, resulting in impairment of polycomb-associated histone H2A ubiquitination and reactivation of polycomb target genes. Silencing by polycomb complexes plays a vital role in numerous physiological processes. In recent years, numerous reports have implicated gain of polycomb silencing function in several cancers. This study provides evidence that, in the appropriate context, expression of the SYT-SSX2 oncogene leads to loss of polycomb function. It challenges the notion that cancer is solely associated with an increase in polycomb function and suggests that any imbalance in polycomb activity could drive the cell toward oncogenesis. These findings provide a mechanism by which the SYT-SSX2 chimera may contribute to synovial sarcoma pathogenesis.	[Barco, Roy; Garcia, Christina B.; Eid, Josiane E.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37235 USA	Vanderbilt University	Barco, R (corresponding author), Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37235 USA.	josiane.eid@vanderbilt.edu		Garcia, Christina/0000-0001-7892-0120	Public Health Service award [T32 GM07347]; National Institute of General Medical Studies; Vanderbilt Ingram Cancer Center [P30 CA068485];  [RO1CA106481]; NATIONAL CANCER INSTITUTE [T32CA009592, R01CA106481, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	Public Health Service award(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of General Medical Studies(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Vanderbilt Ingram Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant RO1CA106481, by the Public Health Service award T32 GM07347 from the National Institute of General Medical Studies for the Vanderbilt Medical-Scientist Training Program, and by the Vanderbilt Ingram Cancer Center Core Grant P30 CA068485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich C, 2005, ANN NY ACAD SCI, V1044, P109, DOI 10.1196/annals.1349.014; Barco R, 2007, MOL BIOL CELL, V18, P4003, DOI 10.1091/mbc.E07-05-0496; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; de Bruijn DRH, 2006, CANCER RES, V66, P9474, DOI 10.1158/0008-5472.CAN-05-3726; Eid JE, 2000, CELL, V102, P839, DOI 10.1016/S0092-8674(00)00072-6; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Kirmizis A, 2003, MOL CANCER THER, V2, P113; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee YF, 2003, BRIT J CANCER, V88, P510, DOI 10.1038/sj.bjc.6600766; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Nagayama S, 2002, CANCER RES, V62, P5859; Nielsen TO, 2003, AM J PATHOL, V163, P1449, DOI 10.1016/S0002-9440(10)63502-X; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Perani M, 2003, ONCOGENE, V22, P8156, DOI 10.1038/sj.onc.1207031; Pretto D, 2006, ONCOGENE, V25, P3661, DOI 10.1038/sj.onc.1209413; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sanchez-Beato M, 2006, MODERN PATHOL, V19, P684, DOI 10.1038/modpathol.3800577; Satijn DPE, 1997, MOL CELL BIOL, V17, P4105, DOI 10.1128/MCB.17.7.4105; Soulez M, 1999, ONCOGENE, V18, P2739, DOI 10.1038/sj.onc.1202613; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Subramaniam MM, 2006, VIRCHOWS ARCH, V449, P435, DOI 10.1007/s00428-006-0271-9; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vider BZ, 2000, BIOCHEM BIOPH RES CO, V272, P513, DOI 10.1006/bbrc.2000.2804; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wu FT, 2007, FRONT BIOSCI-LANDMRK, V12, P4370, DOI 10.2741/2394; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	40	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5060	10.1371/journal.pone.0005060	http://dx.doi.org/10.1371/journal.pone.0005060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337376	Green Submitted, Green Published, gold			2022-12-27	WOS:000265500600018
J	Brouwer, GJ; Tong, F; Hagoort, P; van Ee, R				Brouwer, Gijs Joost; Tong, Frank; Hagoort, Peter; van Ee, Raymond			Perceptual Incongruence Influences Bistability and Cortical Activation	PLOS ONE			English	Article								We employed a parametric psychophysical design in combination with functional imaging to examine the influence of metric changes in perceptual incongruence on perceptual alternation rates and cortical responses. Subjects viewed a bistable stimulus defined by incongruent depth cues; bistability resulted from incongruence between binocular disparity and monocular perspective cues that specify different slants (slant rivalry). Psychophysical results revealed that perceptual alternation rates were positively correlated with the degree of perceived incongruence. Functional imaging revealed systematic increases in activity that paralleled the psychophysical results within anterior intraparietal sulcus, prior to the onset of perceptual alternations. We suggest that this cortical activity predicts the frequency of subsequent alternations, implying a putative causal role for these areas in initiating bistable perception. In contrast, areas implicated in form and depth processing (LOC and V3A) were sensitive to the degree of slant, but failed to show increases in activity when these cues were in conflict.	[Brouwer, Gijs Joost; van Ee, Raymond] Univ Utrecht, Helmholtz Inst, Dept Phys, NL-3508 TC Utrecht, Netherlands; [Tong, Frank] Vanderbilt Univ, Dept Psychol, Nashville, TN USA; [Hagoort, Peter] FC Donders Ctr Cognit Neuroimaging, Nijmegen, Netherlands	Utrecht University; Vanderbilt University	Brouwer, GJ (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	gbrouwer@cns.nyu.edu	Hagoort, Peter/B-7417-2012; van Ee, Raymond/C-4881-2013	van Ee, Raymond/0000-0002-1134-8665	Utrecht University	Utrecht University	GB and RvE were supported by a High Potential grant from Utrecht University to RvE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2001, NAT NEUROSCI, V4, P1063, DOI 10.1038/nn729; Backus BT, 2001, J NEUROPHYSIOL, V86, P2054, DOI 10.1152/jn.2001.86.4.2054; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brouwer GJ, 2007, J NEUROSCI, V27, P1015, DOI 10.1523/JNEUROSCI.4593-06.2007; Brouwer GJ, 2005, J NEUROSCI, V25, P10403, DOI 10.1523/JNEUROSCI.2408-05.2005; Chandrasekaran C, 2007, J NEUROPHYSIOL, V97, P1553, DOI 10.1152/jn.01074.2006; Cusack R, 2005, J COGNITIVE NEUROSCI, V17, P641, DOI 10.1162/0898929053467541; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Georgieva S, 2009, J NEUROSCI, V29, P727, DOI 10.1523/JNEUROSCI.4753-08.2009; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Hinkle DA, 2002, NAT NEUROSCI, V5, P665, DOI 10.1038/nn875; Hol K, 2003, J VISION, V3, P486, DOI 10.1167/3.7.3; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Janssen P, 2001, J NEUROSCI, V21, P9419, DOI 10.1523/JNEUROSCI.21-23-09419.2001; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; Kamphuisen A, 2008, J VISION, V8, DOI 10.1167/8.5.4; Kleinschmidt A, 1998, P ROY SOC B-BIOL SCI, V265, P2427, DOI 10.1098/rspb.1998.0594; Knapen T, 2006, VISION RES, V46, P3381, DOI 10.1016/j.visres.2006.03.027; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2003, CEREB CORTEX, V13, P911, DOI 10.1093/cercor/13.9.911; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; LUI Y, 2004, J NEUROSCI, V24, P3795; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Muckli L, 2002, J NEUROSCI, V22; Neri P, 2004, J NEUROPHYSIOL, V92, P1880, DOI 10.1152/jn.01042.2003; Nguyenkim JD, 2003, J NEUROSCI, V23, P7117, DOI 10.1523/JNEUROSCI.23-18-07117.2003; Pettigrew JD, 1998, P ROY SOC B-BIOL SCI, V265, P2141, DOI 10.1098/rspb.1998.0551; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Raemaekers M, 2009, BRAIN RES, V1252, P161, DOI 10.1016/j.brainres.2008.11.078; Shikata E, 1996, NEUROREPORT, V7, P2389, DOI 10.1097/00001756-199610020-00022; Shikata E, 2003, EUR J NEUROSCI, V17, P1105, DOI 10.1046/j.1460-9568.2003.02540.x; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; Slotnick SD, 2003, HUM BRAIN MAPP, V18, P22, DOI 10.1002/hbm.10077; Slotnick SD, 2005, COGNITIVE BRAIN RES, V24, P97, DOI 10.1016/j.cogbrainres.2004.12.008; Sterzer P, 2007, P NATL ACAD SCI USA, V104, P323, DOI 10.1073/pnas.0609006104; Suzuki S, 2000, PSYCHOL SCI, V11, P202, DOI 10.1111/1467-9280.00242; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Talairach J., 1988, COPLANAR STEREOTAXIC; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tononi G, 2000, BRAIN RES REV, V31, P391, DOI 10.1016/S0165-0173(99)00056-9; Tononi G, 1998, P NATL ACAD SCI USA, V95, P3198, DOI 10.1073/pnas.95.6.3198; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Tsutsui KI, 2001, J NEUROPHYSIOL, V86, P2856, DOI 10.1152/jn.2001.86.6.2856; van Dam LCJ, 2005, VISION RES, V45, P2417, DOI 10.1016/j.visres.2005.03.013; van Ee R, 2005, VISION RES, V45, P29, DOI 10.1016/j.visres.2004.07.039; van Ee R, 2003, J OPT SOC AM A, V20, P1398, DOI 10.1364/JOSAA.20.001398; van Ee R, 2002, PERCEPTION, V31, P51, DOI 10.1068/p3303; van Ee R, 2001, NATURE, V410, P690, DOI 10.1038/35070569; van Ee R, 2002, J VISION, V2, P597, DOI 10.1167/2.9.2; Wandell BA, 1999, ANNU REV NEUROSCI, V22, P145, DOI 10.1146/annurev.neuro.22.1.145; Welchman AE, 2005, NAT NEUROSCI, V8, P820, DOI 10.1038/nn1461	63	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5056	10.1371/journal.pone.0005056	http://dx.doi.org/10.1371/journal.pone.0005056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333385	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499900014
J	Di Pasquale, E; Chahinian, H; Sanchez, P; Fantini, J				Di Pasquale, Eric; Chahinian, Henri; Sanchez, Patrick; Fantini, Jacques			The Insertion and Transport of Anandamide in Synthetic Lipid Membranes Are Both Cholesterol-Dependent	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; CANNABINOID RECEPTORS; RAFTS; ACID; SPHINGOSINE; HYDROLYSIS; MONOLAYERS; CELLS	Background: Anandamide is a lipid neurotransmitter which belongs to a class of molecules termed the endocannabinoids involved in multiple physiological functions. Anandamide is readily taken up into cells, but there is considerable controversy as to the nature of this transport process (passive diffusion through the lipid bilayer vs. involvement of putative proteic transporters). This issue is of major importance since anandamide transport through the plasma membrane is crucial for its biological activity and intracellular degradation. The aim of the present study was to evaluate the involvement of cholesterol in membrane uptake and transport of anandamide. Methodology/Principal Findings: Molecular modeling simulations suggested that anandamide can adopt a shape that is remarkably complementary to cholesterol. Physicochemical studies showed that in the nanomolar concentration range, anandamide strongly interacted with cholesterol monolayers at the air-water interface. The specificity of this interaction was assessed by: i) the lack of activity of structurally related unsaturated fatty acids (oleic acid and arachidonic acid at 50 nM) on cholesterol monolayers, and ii) the weak insertion of anandamide into phosphatidylcholine or sphingomyelin monolayers. In agreement with these data, the presence of cholesterol in reconstituted planar lipid bilayers triggered the stable insertion of anandamide detected as an increase in bilayer capacitance. Kinetics transport studies showed that pure phosphatidylcholine bilayers were weakly permeable to anandamide. The incorporation of cholesterol in phosphatidylcholine bilayers dose-dependently stimulated the translocation of anandamide. Conclusions/Significance: Our results demonstrate that cholesterol stimulates both the insertion of anandamide into synthetic lipid monolayers and bilayers, and its transport across bilayer membranes. In this respect, we suggest that besides putative anandamide protein-transporters, cholesterol could be an important component of the anandamide transport machinery. Finally, this study provides a mechanistic explanation for the key regulatory activity played by membrane cholesterol in the responsiveness of cells to anandamide.	[Di Pasquale, Eric; Chahinian, Henri; Sanchez, Patrick; Fantini, Jacques] Univ Aix Marseille 2, Ctr Rech Neurobiol & Neurophysiol Marseille,CNRS, Fac Sci St Jerome, Univ Aix Marseille 3,UMR 6231,INRA,USC 2027, F-13284 Marseille 07, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Aix-Marseille Universite	Di Pasquale, E (corresponding author), Univ Aix Marseille 2, Ctr Rech Neurobiol & Neurophysiol Marseille,CNRS, Fac Sci St Jerome, Univ Aix Marseille 3,UMR 6231,INRA,USC 2027, F-13284 Marseille 07, France.	jacques.fantini@univ-cezanne.fr		Fantini, Jacques/0000-0001-8653-5521	University Paul Cezanne; Centre National de la Recherche Scientifique (CNRS); Institut National du Cancer (INCA)	University Paul Cezanne; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France)	This work has been supported by academic funds from University Paul Cezanne, the Centre National de la Recherche Scientifique (CNRS) and a grant (FAN-BCL) from the Institut National du Cancer (INCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam G., 1968, STRUCTURAL CHEM MOL, P198; Ambrosi S, 2005, J LIPID RES, V46, P1953, DOI 10.1194/jlr.M500121-JLR200; Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Bari M, 2006, J IMMUNOL, V177, P4971, DOI 10.4049/jimmunol.177.8.4971; Biswas KK, 2003, HEPATOLOGY, V38, P1167, DOI 10.1053/jhep.2003.50459; Bojesen IN, 2003, J LIPID RES, V44, P1790, DOI 10.1194/jlr.M300170-JLR200; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Fegley D, 2004, P NATL ACAD SCI USA, V101, P8756, DOI 10.1073/pnas.0400997101; Fowler CJ, 2004, EUR J PHARMACOL, V492, P1, DOI 10.1016/j.ejphar.2004.03.048; Garmy N, 2005, ARCH BIOCHEM BIOPHYS, V440, P91, DOI 10.1016/j.abb.2005.06.001; Garmy N, 2005, J LIPID RES, V46, P36, DOI 10.1194/jlr.M400199-JLR200; Glaser ST, 2003, P NATL ACAD SCI USA, V100, P4269, DOI 10.1073/pnas.0730816100; Glaser ST, 2005, LIFE SCI, V77, P1584, DOI 10.1016/j.lfs.2005.05.007; HARRIS JS, 1995, BIOCHEMISTRY-US, V34, P3851, DOI 10.1021/bi00011a043; Jarho P, 1996, LIFE SCI, V58, pPL181; MAKRIYANNIS A, 1995, CANNABINOID RECEPTOR, P87; McFarland MJ, 2004, J BIOL CHEM, V279, P41991, DOI 10.1074/jbc.M407250200; Mechoulam R, 2005, P NATL ACAD SCI USA, V102, P17541, DOI 10.1073/pnas.0508644102; NAKANISHI K, 1989, CHEM PHARM BULL, V37, P211; Ohvo H, 1996, BIOCHEMISTRY-US, V35, P8018, DOI 10.1021/bi9528816; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Risselada HJ, 2008, P NATL ACAD SCI USA, V105, P17367, DOI 10.1073/pnas.0807527105; ROSE IA, 1980, P NATL ACAD SCI-BIOL, V77, P2439, DOI 10.1073/pnas.77.5.2439; Sarker KP, 2003, CELL MOL LIFE SCI, V60, P1200, DOI 10.1007/s00018-003-3055-2; Siegmund SV, 2005, HEPATOLOGY, V41, P1085, DOI 10.1002/hep.20667; Song ZH, 1996, MOL PHARMACOL, V49, P891; Tian X., 2000, J BIOL CHEM, V280, P29788; Tien H.T., 1974, BILAYER LIPID MEMBRA; van Zadelhoff G, 1998, BIOCHEM BIOPH RES CO, V248, P33, DOI 10.1006/bbrc.1998.8910; Vargas J, 2000, BIOPHYS J, V79, P934, DOI 10.1016/S0006-3495(00)76348-X	34	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2009	4	3							e4989	10.1371/journal.pone.0004989	http://dx.doi.org/10.1371/journal.pone.0004989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PP	19330032	gold, Green Published, Green Submitted			2022-12-27	WOS:000265499700002
J	Singh, S; Soe, S; Weisman, S; Barnwell, JW; Perignon, JL; Druilhe, P				Singh, Subhash; Soe, Soe; Weisman, Simon; Barnwell, John W.; Perignon, Jean Louis; Druilhe, Pierre			A Conserved Multi-Gene Family Induces Cross-Reactive Antibodies Effective in Defense against Plasmodium falciparum	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-3; MALARIA VACCINE; GAMMA-GLOBULIN; COOPERATION; IMMUNITY; DISRUPTION; PROTECTION; MONOCYTES; INVASION; ELICITS	Background: Two related merozoite surface proteins, MSP3 and MSP6, have previously been identified as targets of antibody-dependent cellular inhibition (ADCI), a protective mechanism against Plasmodium falciparum malaria. Both MSP3 and MSP6 share a common characteristic small N-terminal signature amino-acid stretch (NLRNA/G), a feature similar to MSP3-like orthologs identified in other human and primate malaria parasites. Methods/Results: This signature amino-acid sequence led to the identification of eight ORFs contiguously located on P. falciparum chromosome 10. Our subsequent investigations on their expression, localization, sequence conservation, epitope sharing, immunogenicity and the functional role of antibodies in defense are reported here. Six members of P. falciparum MSP3-multigene family share similar sequence organization within their C-terminal regions, are simultaneously expressed as merozoite surface proteins and are highly conserved among parasite isolates. Each of these proteins is a target of naturally occurring antibodies effective at parasite killing in ADCI assays. Moreover, both naturally occurring antibodies and those generated by immunization display cross-reactivity with other members of the family and exhibit varied binding avidities. Conclusions/Significance: The unusual characteristics of the MSP3 multi-gene family lead us to hypothesize that the simultaneous expression of targets eliciting cross-reactive antibody responses capable of controlling parasite densities could represent an immune process selected through evolution to maintain homeostasis between P. falciparum and human hosts; a process that allows the continuous transmission of the parasite without killing the host. Our observations also have practical consequences for vaccine development by suggesting MSP3 vaccine efficacy might be improved when combined with the various C-terminus regions of the MSP3 family members to generate a wider range of antibodies acting and to increase vaccine immunogenicity in varied human genetic backgrounds.			Singh, S (corresponding author), Gennova Biopharmaceut Ltd, Div Res & Dev, Pune, Maharashtra, India.	subhash.singh@gennova.co.in; druilhe@pasteur.fr						Audran R, 2005, INFECT IMMUN, V73, P8017, DOI 10.1128/IAI.73.12.8017-8026.2005; Black CG, 2003, MOL BIOCHEM PARASIT, V127, P59, DOI 10.1016/S0166-6851(02)00308-0; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chattopadhyay R, 2003, INFECT IMMUN, V71, P597, DOI 10.1128/IAI.71.2.597-604.2003; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Cowman AF, 2002, SCIENCE, V298, P126, DOI 10.1126/science.1078169; DAVID PH, 1985, J IMMUNOL, V134, P4146; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Druilhe Pierre, 2002, Methods Mol Med, V72, P457, DOI 10.1385/1-59259-271-6:457; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; EDOZIEN JC, 1962, LANCET, V2, P951; Galinski MR, 2001, MOL BIOCHEM PARASIT, V115, P41, DOI 10.1016/S0166-6851(01)00267-5; Hisaeda H, 2002, J INFECT DIS, V185, P657, DOI 10.1086/339187; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Kaneko O, 2000, MOL BIOCHEM PARASIT, V110, P135, DOI 10.1016/S0166-6851(00)00263-2; KHUSMITH S, 1983, INFECT IMMUN, V41, P219, DOI 10.1128/IAI.41.1.219-223.1983; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lusingu JP, 2008, AM J TROP MED HYG, V79, P7; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; McGREGOR I. A., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P170, DOI 10.1016/0035-9203(63)90058-0; MCGREGOR IA, 1988, PRINCIPLES PRACTICE, P559; Mills KE, 2002, MOL MICROBIOL, V43, P1401, DOI 10.1046/j.1365-2958.2002.02834.x; OEUVRAY C, 1994, BLOOD, V84, P1594; Osier FHA, 2007, PARASITE IMMUNOL, V29, P387, DOI 10.1111/j.1365-3024.2007.00951.x; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Pearce JA, 2005, MOL BIOCHEM PARASIT, V139, P141, DOI 10.1016/j.molbiopara.2004.09.012; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Rayner JC, 2002, PARASITOLOGY, V125, P393, DOI 10.1017/S0031182002002317; Rayner JC, 2004, INFECT GENET EVOL, V4, P309, DOI 10.1016/j.meegid.2004.03.003; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; SERGENT ED, 1935, IMMUNITE PREMUNITION, P279; Singh S, 2005, INFECT IMMUN, V73, P1235, DOI 10.1128/IAI.73.2.1235-1238.2005; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; Stepniewska K, 2008, AM J TROP MED HYG, V79, P253; Trucco C, 2001, MOL BIOCHEM PARASIT, V112, P91, DOI 10.1016/S0166-6851(00)00350-9; Wang L, 1999, INFECT IMMUN, V67, P2193, DOI 10.1128/IAI.67.5.2193-2200.1999; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606	43	52	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5410	10.1371/journal.pone.0005410	http://dx.doi.org/10.1371/journal.pone.0005410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404387	Green Published, Green Submitted, gold			2022-12-27	WOS:000265614900021
J	Cencic, R; Carrier, M; Galicia-Vazquez, G; Bordeleau, ME; Sukarieh, R; Bourdeau, A; Brem, B; Teodoro, JG; Greger, H; Tremblay, ML; Porco, JA; Pelletier, J				Cencic, Regina; Carrier, Marilyn; Galicia-Vazquez, Gabriela; Bordeleau, Marie-Eve; Sukarieh, Rami; Bourdeau, Annie; Brem, Brigitte; Teodoro, Jose G.; Greger, Harald; Tremblay, Michel L.; Porco, John A., Jr.; Pelletier, Jerry			Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol	PLOS ONE			English	Article								Background: Flavaglines are a family of natural products from the genus Aglaia that exhibit anti-cancer activity in vitro and in vivo and inhibit translation initiation. They have been shown to modulate the activity of eIF4A, the DEAD-box RNA helicase subunit of the eukaryotic initiation factor (eIF) 4F complex, a complex that stimulates ribosome recruitment during translation initiation. One flavagline, silvestrol, is capable of modulating chemosensitivity in a mechanism-based mouse model. Methodology/Principal Findings: Among a number of flavagline family members tested herein, we find that silvestrol is the more potent translation inhibitor among these. We find that silvestrol impairs the ribosome recruitment step of translation initiation by affecting the composition of the eukaryotic initiation factor (eIF) 4F complex. We show that silvestrol exhibits significant anticancer activity in human breast and prostate cancer xenograft models, and that this is associated with increased apoptosis, decreased proliferation, and inhibition of angiogenesis. We demonstrate that targeting translation by silvestrol results in preferential inhibition of weakly initiating mRNAs. Conclusions/Significance: Our results indicate that silvestrol is a potent anti-cancer compound in vivo that exerts its activity by affecting survival pathways as well as angiogenesis. We propose that silvestrol mediates its effects by preferentially inhibiting translation of malignancy-related mRNAs. Silvestrol appears to be well tolerated in animals.			Pelletier, J (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	jerry.pelletier@mcgill.ca	Teodoro, Joe/AFT-2440-2022	Teodoro, Joe/0000-0002-3713-6839; GALICIA VAZQUEZ, GABRIELA/0000-0001-6706-7742; Sukarieh, Rami/0000-0002-4890-3079	NIGMS NIH HHS [R01 GM073855] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073855] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anthony TG, 2001, J NUTR, V131, P1171, DOI 10.1093/jn/131.4.1171; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Bordeleau ME, 2006, CHEM BIOL, V13, P1287, DOI 10.1016/j.chembiol.2006.10.005; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; EDERY I, 1983, J BIOL CHEM, V258, P1398; Gerard B, 2007, ANGEW CHEM INT EDIT, V46, P7831, DOI 10.1002/anie.200702707; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; Graff JR, 2003, CLIN EXP METASTAS, V20, P265, DOI 10.1023/A:1022943419011; GREENBERG JR, 1981, P NATL ACAD SCI-BIOL, V78, P2923, DOI 10.1073/pnas.78.5.2923; GRIFO JA, 1982, J BIOL CHEM, V257, P5246; Hwang BY, 2004, J ORG CHEM, V69, P3350, DOI 10.1021/jo040120f; Jiang LC, 1997, CHEM BIOL, V4, P35, DOI 10.1016/S1074-5521(97)90235-0; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim Soyoung, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P319, DOI 10.2174/187152006777698123; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lee SK, 1998, CHEM-BIOL INTERACT, V115, P215, DOI 10.1016/S0009-2797(98)00073-8; Lin CJ, 2008, CANCER RES, V68, P5326, DOI 10.1158/0008-5472.CAN-07-5876; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; Maeshima Y, 2002, SCIENCE, V295, P140, DOI 10.1126/science.1065298; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Merrick WC, 1997, METHODS, V11, P333, DOI 10.1006/meth.1996.0431; MEURERGRIMES BM, 2004, THERAPEUTIC COMPOUND; Mi QW, 2006, ANTICANCER RES, V26, P947; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Morley SJ, 1997, J BIOL CHEM, V272, P17887, DOI 10.1074/jbc.272.28.17887; Mungamuri SK, 2006, CANCER RES, V66, P4715, DOI 10.1158/0008-5472.CAN-05-3830; Novac O, 2004, NUCLEIC ACIDS RES, V32, P902, DOI 10.1093/nar/gkh235; Ohse T, 1996, J NAT PROD, V59, P650, DOI 10.1021/np960346g; PARKIN NT, 1988, EMBO J, V7, P2831, DOI 10.1002/j.1460-2075.1988.tb03139.x; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Polunovsky VA, 1996, MOL CELL BIOL, V16, P6573; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; RAUGHT B, 2000, REGULATION RIBOSOME, P245; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; SONENBERG N, 1981, NUCLEIC ACIDS RES, V9, P1643, DOI 10.1093/nar/9.7.1643; Svitkin YV, 2001, RNA, V7, P1743; Tee AR, 2000, ONCOGENE, V19, P3021, DOI 10.1038/sj.onc.1203622; Wendel HG, 2006, CANCER RES, V66, P7639, DOI 10.1158/0008-5472.CAN-06-0419; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369	53	219	229	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5223	10.1371/journal.pone.0005223	http://dx.doi.org/10.1371/journal.pone.0005223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401772	Green Published, gold			2022-12-27	WOS:000265601100002
J	Tsahar, E; Izhaki, I; Lev-Yadun, S; Bar-Oz, G				Tsahar, Ella; Izhaki, Ido; Lev-Yadun, Simcha; Bar-Oz, Guy			Distribution and Extinction of Ungulates during the Holocene of the Southern Levant	PLOS ONE			English	Article							BODY-SIZE; CAVE	Background: The southern Levant (Israel, Palestinian Authority and Jordan) has been continuously and extensively populated by succeeding phases of human cultures for the past 15,000 years. The long human impact on the ancient landscape has had great ecological consequences, and has caused continuous and accelerating damage to the natural environment. The rich zooarchaeological data gathered at the area provide a unique opportunity to reconstruct spatial and temporal changes in wild species distribution, and correlate them with human demographic changes. Methodology: Zoo-archaeological data (382 animal bone assemblages from 190 archaeological sites) from various time periods, habitats and landscapes were compared. The bone assemblages were sorted into 12 major cultural periods. Distribution maps showing the presence of each ungulate species were established for each period. Conclusions: The first major ungulate extinction occurred during the local Iron Age (1,200-586 BCE), a period characterized by significant human population growth. During that time the last of the largest wild ungulates, the hartebeest (Alcelaphus buselaphus), aurochs (Bos primigenius) and the hippopotamus (Hippopotamus amphibius) became extinct, followed by a shrinking distribution of forest-dwelling cervids. A second major wave of extinction occurred only in the 19th and 20th centuries CE. Furthermore, a negative relationship was found between the average body mass of ungulate species that became extinct during the Holocene and their extinction date. It is thus very likely that the intensified human activity through habitat destruction and uncontrolled hunting were responsible for the two major waves of ungulate extinction in the southern Levant during the late Holocene.			Tsahar, E (corresponding author), Univ Haifa, Zinman Inst Archaeol, Lab Archaeozool, IL-31999 Haifa, Israel.	ella@ellarnon.com	Izhaki, Ido/D-5586-2011; Izhaki, Ido/I-9712-2019; BarOz, Guy/ABF-6518-2020	Izhaki, Ido/0000-0002-4525-4683; Izhaki, Ido/0000-0002-4525-4683; BarOz, Guy/0000-0002-1009-5619				Amr ZS., 2000, JORDAN COUNTRY STUDY; Bar-Yosef O, 2004, INT J OSTEOARCHAEOL, V14, P333, DOI 10.1002/oa.765; BarMatthews M, 1997, QUATERNARY RES, V47, P155, DOI 10.1006/qres.1997.1883; BARUCH U, 1990, MANS ROLE IN THE SHAPING OF THE EASTERN MEDITERRANEAN LANDSCAPE, P283; Baruch U., 1986, PALEORIENT, V12, P37, DOI DOI 10.3406/PALE0.1986.4407; Beck MW, 1996, PALEOBIOLOGY, V22, P91, DOI 10.1017/S0094837300016043; Blackburn TM, 1999, ADV ECOL RES, V28, P181, DOI 10.1016/S0065-2504(08)60033-1; Bodmer RE, 1997, CONSERV BIOL, V11, P460, DOI 10.1046/j.1523-1739.1997.96022.x; BREWER DJ, 2007, EGYPT EGYPTIANS; Brook BW, 2005, POPUL ECOL, V47, P137, DOI 10.1007/s10144-005-0213-4; Brook BW, 2002, P NATL ACAD SCI USA, V99, P14624, DOI 10.1073/pnas.232126899; BROSHI M, 1992, BASOR, V287, P47; Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; DOLEV A., 2004, VERTEBRATES ISRAEL R; DRIESCH AVD, 1995, HESBAN, V13, P67; Finkelstein I., 1994, NOMADISM MONARCHY AR; Frumkin A, 1999, HOLOCENE, V9, P677, DOI 10.1191/095968399669422210; Horowitz A., 1979, QUATERNARY ISRAEL; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; KARSCHON R, 1982, LA YAAARAN, V32, P54; LEVY TE, 1998, ARCHAEOLOGY SOC HOLY, pR10; LEVYADUN S, 1997, HIGHLANDS MANY CULTU, V1, P85; Liphschitz N, 1986, J ISRAEL PREHISTORIC, V19, P80; Martin P.S., 1984, P354; Mazar A., 1990, ARCHAEOLOGY LAND BIB, V1st; Mendelssohn H., 1999, FAUNA PALESTINA MAMM; Neumann F, 2007, VEG HIST ARCHAEOBOT, V16, P329, DOI 10.1007/s00334-006-0046-x; Nowak R.M., 1999, WALKERS MAMMALS WORL, P680; NOWAK RM, 1999, WALKERS MAMMALS WORL, V2, P1068; Quemsiyeh MB, 1996, MAMMALIA, V60, P417; Redman C.L., 1999, HUMAN IMPACT ANCIENT; Uerpmann HP, 1987, ANCIENT DISTRIBUTION; VANDENBRINK FH, 1968, FIELD GUIDE MAMMALS; Weinstein-Evron, 2005, J ISRAEL PREHISTORIC, V35, P285; Yom-Tov Y., 1988, MONOGRAPHIAE BIOL, V62, P515; ZOHARY M, 1973, GEOBOTANICAL FDN MID, P738; Zohary M., 1962, PLANT LIFE PALESTINE	39	45	45	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5316	10.1371/journal.pone.0005316	http://dx.doi.org/10.1371/journal.pone.0005316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401760	gold, Green Published			2022-12-27	WOS:000265601100004
J	Janzi, M; Sjoberg, R; Wan, JH; Fischler, B; von Dobeln, U; Isaac, L; Nilsson, P; Hammarstrom, L				Janzi, Magdalena; Sjoberg, Ronald; Wan, Jinghong; Fischler, Bjorn; von Dobeln, Ulrika; Isaac, Lourdes; Nilsson, Peter; Hammarstrom, Lennart			Screening for C3 Deficiency in Newborns Using Microarrays	PLOS ONE			English	Article								Background: Dried blood spot samples (DBSS) from newborns are widely used in neonatal screening for selected metabolic diseases and diagnostic possibilities for additional disorders are continuously being evaluated. Primary immunodeficiency disorders comprise a group of more than one hundred diseases, several of which are fatal early in life. Yet, a majority of the patients are not diagnosed due to lack of high-throughput screening methods. Methodology/Principal Findings: We have previously developed a system using reverse phase protein microarrays for analysis of IgA levels in serum samples. In this study, we extended the applicability of the method to include determination of complement component C3 levels in eluates from DBSS collected at birth. Normal levels of C3 were readily detected in 269 DBSS from healthy newborns, while no C3 was detected in sera and DBSS from C3 deficient patients. Conclusions/Significance: The findings suggest that patients with deficiencies of specific serum proteins can be identified by analysis of DBSS using reverse phase protein microarrays.			Janzi, M (corresponding author), KUS Huddinge, Karolinska Inst, Div Clin Immunol, Stockholm, Sweden.	nipe@kth.se; lennart.hammarstrom@ki.se	Nilsson, Peter/E-4547-2010; Isaac, Lourdes/I-7186-2012	Nilsson, Peter/0000-0002-4657-8532; Isaac, Lourdes/0000-0002-7746-8942; Venkatasubramanian, Siddharth/0000-0002-5860-0768				[Anonymous], 1999, CLIN EXP IMMUNOL, V118, P1; BOTTO M, 1990, J CLIN INVEST, V86, P1158, DOI 10.1172/JCI114821; BOTTO M, 1992, P NATL ACAD SCI USA, V89, P4957, DOI 10.1073/pnas.89.11.4957; Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; Fujioka H, 2005, AM J MED GENET A, V138A, P399, DOI 10.1002/ajmg.a.30964; Ghannam A, 2008, J IMMUNOL, V181, P5158, DOI 10.4049/jimmunol.181.7.5158; HUANG JL, 1994, CLIN IMMUNOL IMMUNOP, V73, P267, DOI 10.1006/clin.1994.1197; Ingvarsson J, 2007, J PROTEOME RES, V6, P3527, DOI 10.1021/pr070204f; Janzi M, 2005, MOL CELL PROTEOMICS, V4, P1942, DOI 10.1074/mcp.M500213-MCP200; *JEFFR MOD FDN, 2009, JEFFR MOD FDN BREAK; Kida M, 2008, BLOOD CELL MOL DIS, V40, P410, DOI 10.1016/j.bcmd.2007.11.002; Lannergard A, 2001, SCAND J MED SCI SPOR, V11, P274, DOI 10.1034/j.1600-0838.2001.110504.x; Matsuyama W, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<79::AID-HUMU22>3.3.CO;2-X; Mcdade TW, 2007, DEMOGRAPHY, V44, P899, DOI 10.1353/dem.2007.0038; Reis ED, 2002, J CLIN IMMUNOL, V22, P321, DOI 10.1023/A:1020665614139; Reis ES, 2006, SCAND J IMMUNOL, V63, P155, DOI 10.1111/j.1365-3083.2006.01729.x; Reis ES, 2004, IMMUNOGENETICS, V55, P667, DOI 10.1007/s00251-003-0624-3; SINGER L, 1994, J BIOL CHEM, V269, P28494; SINGER L, 1994, PATHOBIOLOGY, V62, P14, DOI 10.1159/000163873; Sjoholm AG, 2006, MOL IMMUNOL, V43, P78, DOI 10.1016/j.molimm.2005.06.025; Skogstrand K, 2005, CLIN CHEM, V51, P1854, DOI 10.1373/clinchem.2005.052241; Tsukamoto H, 2005, BIOCHEM BIOPH RES CO, V330, P298, DOI 10.1016/j.bbrc.2005.02.159; Ulbrich AG, 2001, SCAND J IMMUNOL, V53, P622, DOI 10.1046/j.1365-3083.2001.00934.x	23	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5321	10.1371/journal.pone.0005321	http://dx.doi.org/10.1371/journal.pone.0005321			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390687	Green Published, gold			2022-12-27	WOS:000265514400009
J	Matukumalli, LK; Lawley, CT; Schnabel, RD; Taylor, JF; Allan, MF; Heaton, MP; O'Connell, J; Moore, SS; Smith, TPL; Sonstegard, TS; Van Tassell, CP				Matukumalli, Lakshmi K.; Lawley, Cynthia T.; Schnabel, Robert D.; Taylor, Jeremy F.; Allan, Mark F.; Heaton, Michael P.; O'Connell, Jeff; Moore, Stephen S.; Smith, Timothy P. L.; Sonstegard, Tad S.; Van Tassell, Curtis P.			Development and Characterization of a High Density SNP Genotyping Assay for Cattle	PLOS ONE			English	Article								The success of genome-wide association (GWA) studies for the detection of sequence variation affecting complex traits in human has spurred interest in the use of large-scale high-density single nucleotide polymorphism (SNP) genotyping for the identification of quantitative trait loci (QTL) and for marker-assisted selection in model and agricultural species. A cost-effective and efficient approach for the development of a custom genotyping assay interrogating 54,001 SNP loci to support GWA applications in cattle is described. A novel algorithm for achieving a compressed inter-marker interval distribution proved remarkably successful, with median interval of 37 kb and maximum predicted gap of,350 kb. The assay was tested on a panel of 576 animals from 21 cattle breeds and six outgroup species and revealed that from 39,765 to 46,492 SNP are polymorphic within individual breeds (average minor allele frequency (MAF) ranging from 0.24 to 0.27). The assay also identified 79 putative copy number variants in cattle. Utility for GWA was demonstrated by localizing known variation for coat color and the presence/absence of horns to their correct genomic locations. The combination of SNP selection and the novel spacing algorithm allows an efficient approach for the development of high-density genotyping platforms in species having full or even moderate quality draft sequence. Aspects of the approach can be exploited in species which lack an available genome sequence. The BovineSNP50 assay described here is commercially available from Illumina and provides a robust platform for mapping disease genes and QTL in cattle.			Matukumalli, LK (corresponding author), George Mason Univ, Dept Bioinformat & Computat Biol, Manassas, VA USA.	curtvt@ars.usda.gov	Moore, Stephen S/F-5285-2013; Van Tassell, Curtis P./O-4247-2019	Van Tassell, Curtis P./0000-0002-8416-2087; Moore, Stephen/0000-0002-9758-166X; Schnabel, Robert/0000-0001-5018-7641; Heaton, Michael/0000-0003-1386-1208				Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Banos G, 2001, J DAIRY SCI, V84, P2523, DOI 10.3168/jds.S0022-0302(01)74703-0; Brenneman RA, 1996, J HERED, V87, P156, DOI 10.1093/oxfordjournals.jhered.a022975; CHRISTENSEN LG, 2008, INFLUENCE INCORRECT, P200; GELDERMANN H, 1986, J ANIM SCI, V63, P1759, DOI 10.2527/jas1986.6361759x; Harmegnies N, 2006, ANIM GENET, V37, P225, DOI 10.1111/j.1365-2052.2006.01438.x; Hassanin A, 2004, MOL PHYLOGENET EVOL, V33, P896, DOI 10.1016/j.ympev.2004.08.009; Heaton MP, 2005, JAVMA-J AM VET MED A, V226, P1311, DOI 10.2460/javma.2005.226.1311; Heaton MP, 2002, MAMM GENOME, V13, P272, DOI 10.1007/s00335-001-2146-3; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Israel C, 2000, J DAIRY SCI, V83, P181, DOI 10.3168/jds.S0022-0302(00)74869-7; Klein RJ, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-58; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Massey DCO, 2007, AUTOPHAGY, V3, P649, DOI 10.4161/auto.5075; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; Meuwissen THE, 2001, GENETICS, V157, P1819; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ron M, 1996, J DAIRY SCI, V79, P676, DOI 10.3168/jds.S0022-0302(96)76413-5; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Warren W, 2000, MAMM GENOME, V11, P662, DOI 10.1007/s003350010126; Werth LA, 1996, J ANIM SCI, V74, P262; Wilk JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S8; SCIENCE IN PRESS	25	665	691	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5350	10.1371/journal.pone.0005350	http://dx.doi.org/10.1371/journal.pone.0005350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390634	Green Published, gold			2022-12-27	WOS:000265514400020
J	Zhu, TF; Szostak, JW				Zhu, Ting F.; Szostak, Jack W.			Preparation of Large Monodisperse Vesicles	PLOS ONE			English	Article								Preparation of monodisperse vesicles is important both for research purposes and for practical applications. While the extrusion of vesicles through small pores (similar to 100 nm in diameter) results in relatively uniform populations of vesicles, extrusion to larger sizes results in very heterogeneous populations of vesicles. Here we report a simple method for preparing large monodisperse multilamellar vesicles through a combination of extrusion and large-pore dialysis. For example, extrusion of polydisperse vesicles through 5-mu m-diameter pores eliminates vesicles larger than 5 mu m in diameter. Dialysis of extruded vesicles against 3-mu m-pore-size polycarbonate membranes eliminates vesicles smaller than 3 mu m in diameter, leaving behind a population of monodisperse vesicles with a mean diameter of 4 mu m. The simplicity of this method makes it an effective tool for laboratory vesicle preparation with potential applications in preparing large monodisperse liposomes for drug delivery.	[Zhu, Ting F.; Szostak, Jack W.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Zhu, Ting F.; Szostak, Jack W.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Zhu, Ting F.] Harvard Univ, Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT)	Zhu, TF (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu			NASA Exobiology Program [EXB02-0031-0018]; Howard Hughes Medical Institute	NASA Exobiology Program(National Aeronautics & Space Administration (NASA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported in part by grant EXB02-0031-0018 from the NASA Exobiology Program. JWS is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Chen IA, 2004, BIOPHYS J, V87, P988, DOI 10.1529/biophysj.104.039875; Chen IA, 2004, SCIENCE, V305, P1474, DOI 10.1126/science.1100757; Chen IA, 2004, P NATL ACAD SCI USA, V101, P7965, DOI 10.1073/pnas.0308045101; Dhand Rajiv, 2004, Respir Care, V49, P666; Edwards DA, 1998, J APPL PHYSIOL, V85, P379, DOI 10.1152/jappl.1998.85.2.379; ENOCH HG, 1979, P NATL ACAD SCI USA, V76, P145, DOI 10.1073/pnas.76.1.145; Grabielle-Madelmont C, 2003, J BIOCHEM BIOPH METH, V56, P189, DOI 10.1016/S0165-022X(03)00059-9; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; HARGREAVES WR, 1978, BIOCHEMISTRY-US, V17, P3759, DOI 10.1021/bi00611a014; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Knight V, 1999, CANCER CHEMOTH PHARM, V44, P177, DOI 10.1007/s002800050965; Korgel BA, 1998, BIOPHYS J, V74, P3264, DOI 10.1016/S0006-3495(98)78033-6; LIU DX, 1992, BIOCHIM BIOPHYS ACTA, V1104, P95, DOI 10.1016/0005-2736(92)90136-A; Lorenceau E, 2005, LANGMUIR, V21, P9183, DOI 10.1021/la050797d; Nagayasu A, 1999, ADV DRUG DELIVER REV, V40, P75, DOI 10.1016/S0169-409X(99)00041-1; NAGAYASU A, 1995, BIOL PHARM BULL, V18, P1020; OLSON F, 1979, BIOCHIM BIOPHYS ACTA, V557, P9, DOI 10.1016/0005-2736(79)90085-3; Patty PJ, 2003, BIOPHYS J, V85, P996, DOI 10.1016/S0006-3495(03)74538-X; Sugiura S, 2008, LANGMUIR, V24, P4581, DOI 10.1021/la703509r; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Utada AS, 2005, SCIENCE, V308, P537, DOI 10.1126/science.1109164; Verschraegen CF, 2004, CLIN CANCER RES, V10, P2319, DOI 10.1158/1078-0432.CCR-0929-3	23	61	61	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2009	4	4							e5009	10.1371/journal.pone.0005009	http://dx.doi.org/10.1371/journal.pone.0005009			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RS	19347043	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505200001
J	Liu, Y; Sanoff, HK; Cho, H; Burd, CE; Torrice, C; Mohlke, KL; Ibrahim, JG; Thomas, NE; Sharpless, NE				Liu, Yan; Sanoff, Hanna K.; Cho, Hyunsoon; Burd, Christin E.; Torrice, Chad; Mohlke, Karen L.; Ibrahim, Joseph G.; Thomas, Nancy E.; Sharpless, Norman E.			INK4/ARF Transcript Expression Is Associated with Chromosome 9p21 Variants Linked to Atherosclerosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; SMOOTH-MUSCLE-CELLS; GENETIC-VARIATION; P16(INK4A); LOCUS; SENESCENCE; SUSCEPTIBILITY; PROLIFERATION; REPLICATION	Background: Genome-wide association studies (GWAS) have linked common single nucleotide polymorphisms (SNPs) on chromosome 9p21 near the INK4/ARF (CDKN2A/B) tumor suppressor locus with risk of atherosclerotic diseases and type 2 diabetes mellitus. To explore the mechanism of this association, we investigated whether expression of proximate transcripts (p16(INK4a), p15(INK4b), ARF, ANRIL and MTAP) correlate with genotype of representative 9p21 SNPs. Methodology/Principal Findings: We analyzed expression of 9p21 transcripts in purified peripheral blood T-cells (PBTL) from 170 healthy donors. Samples were genotyped for six selected disease-related SNPs spanning the INK4/ARF locus. Correlations among these variables were determined by univariate and multivariate analysis. Significantly reduced expression of all INK4/ARF transcripts (p15(INK4b), p16(INK4a), ARF and ANRIL) was found in PBTL of individuals harboring a common SNP (rs10757278) associated with increased risk of coronary artery disease, stroke and aortic aneurysm. Expression of MTAP was not influenced by rs10757278 genotype. No association of any these transcripts was noted with five other tested 9p21 SNPs. Conclusions/Significance: Genotypes of rs10757278 linked to increased risk of atherosclerotic diseases are also associated with decreased expression in PBTL of the INK4/ARF locus, which encodes three related anti-proliferative transcripts of known importance in tumor suppression and aging.	[Liu, Yan; Burd, Christin E.; Torrice, Chad; Mohlke, Karen L.; Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Genet, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Liu, Yan; Sanoff, Hanna K.; Burd, Christin E.; Torrice, Chad; Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Cho, Hyunsoon; Ibrahim, Joseph G.] Univ N Carolina, Sch Med, Dept Biostat, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Thomas, Nancy E.] Univ N Carolina, Sch Med, Dept Dermatol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Liu, Y (corresponding author), Univ N Carolina, Sch Med, Dept Genet, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.	nes@med.unc.edu	Core, Mammalian Genotyping/AFU-1631-2022	Sharpless, Norman/0000-0001-7078-9455	NIH [RR023248, AG024379, DK072193, CA009156-34]; Ellison Medical Foundation; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [T32CA009156, R01CA112243] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024379] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the NIH (RR023248, AG024379, DK072193), the Ellison Medical Foundation and the Burroughs Wellcome Fund. Y.L. is supported by NIH training grant CA009156-34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Anderson JL, 2008, AM HEART J, V156, P1155, DOI 10.1016/j.ahj.2008.07.006; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Boehm Manfred, 2003, Prog Cell Cycle Res, V5, P19; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Gizard F, 2005, J CLIN INVEST, V115, P3228, DOI 10.1172/JCI22756; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P1391, DOI 10.1161/01.ATV.0000133605.89421.79; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kumar R, 2001, INT J CANCER, V95, P388, DOI 10.1002/1097-0215(20011120)95:6<388::AID-IJC1069>3.0.CO;2-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matarin M, 2008, STROKE, V39, P1586, DOI 10.1161/STROKEAHA.107.502963; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; McKeller RN, 2002, P NATL ACAD SCI USA, V99, P3848, DOI 10.1073/pnas.052484199; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Melzer D, 2007, MECH AGEING DEV, V128, P370, DOI 10.1016/j.mad.2007.03.005; MUENDLEIN A, 2008, ATHEROSCLER IN PRESS; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shields JM, 2007, CANCER RES, V67, P1502, DOI 10.1158/0008-5472.CAN-06-3311; Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808; Wutz A, 2007, TRENDS GENET, V23, P457, DOI 10.1016/j.tig.2007.07.004; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	41	185	194	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5027	10.1371/journal.pone.0005027	http://dx.doi.org/10.1371/journal.pone.0005027			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343170	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500800002
J	Maidhof, C; Rieger, M; Prinz, W; Koelsch, S				Maidhof, Clemens; Rieger, Martina; Prinz, Wolfgang; Koelsch, Stefan			Nobody Is Perfect: ERP Effects Prior to Performance Errors in Musicians Indicate Fast Monitoring Processes	PLOS ONE			English	Article							AUDITORY-FEEDBACK; BRAIN POTENTIALS; FUNCTIONAL-SIGNIFICANCE; MISMATCH NEGATIVITY; CINGULATE CORTEX; MOVEMENT; COMPONENTS; NOVELTY; ATTENTION; DYNAMICS	Background One central question in the context of motor control and action monitoring is at what point in time errors can be detected. Previous electrophysiological studies investigating this issue focused on brain potentials elicited after erroneous responses, mainly in simple speeded response tasks. In the present study, we investigated brain potentials before the commission of errors in a natural and complex situation. Methodology/Principal Findings: Expert pianists bimanually played scales and patterns while the electroencephalogram (EEG) was recorded. Event-related potentials (ERPs) were computed for correct and incorrect performances. Results revealed differences already 100 ms prior to the onset of a note (i.e., prior to auditory feedback). We further observed that erroneous keystrokes were delayed in time and pressed more slowly. Conclusions: Our data reveal neural mechanisms in musicians that are able to detect errors prior to the execution of erroneous movements. The underlying mechanism probably relies on predictive control processes that compare the predicted outcome of an action with the action goal.	[Maidhof, Clemens; Rieger, Martina; Prinz, Wolfgang; Koelsch, Stefan] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Koelsch, Stefan] Univ Sussex, Dept Psychol, Brighton BN1 9RH, E Sussex, England	Max Planck Society; University of Sussex	Maidhof, C (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	maidhof@cbs.mpg.de	Koelsch, Stefan/AAV-1556-2020	Rieger, Martina/0000-0002-2421-296X; Maidhof, Clemens/0000-0002-9562-9551	German Research Foundation (Deutsche Forschungsgemeinschaft) [KO 2266/4-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This study was supported in part by a grant from the German Research Foundation (Deutsche Forschungsgemeinschaft) awarded to S.K. (KO 2266/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Colebatch JG, 2007, MOVEMENT DISORD, V22, P601, DOI 10.1002/mds.21323; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Crapse TB, 2008, CURR OPIN NEUROBIOL, V18, P552, DOI 10.1016/j.conb.2008.09.017; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; EVARTS EV, 1974, J NEUROPHYSIOL, V37, P373, DOI 10.1152/jn.1974.37.2.373; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, P192; Finney SA, 2003, MEM COGNITION, V31, P51, DOI 10.3758/BF03196082; Finney SA, 2001, BEHAV RES METH INS C, V33, P167, DOI 10.3758/BF03195362; Finney SA, 1997, MUSIC PERCEPT, V15, P153; Finney SA, 2001, BEHAV RES METH INS C, V33, P65, DOI 10.3758/BF03195348; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 1995, EEG CL N SU, P261; Hajcak G, 2005, BIOL PSYCHOL, V70, P67, DOI 10.1016/j.biopsycho.2004.12.001; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; Hatsopoulos NG, 2007, J NEUROSCI, V27, P5105, DOI 10.1523/JNEUROSCI.3570-06.2007; Holdefer RN, 2002, EXP BRAIN RES, V146, P233, DOI 10.1007/s00221-002-1166-x; Kaiser J, 1997, INT J PSYCHOPHYSIOL, V27, P215, DOI 10.1016/S0167-8760(97)00055-X; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; MARTENIUK RG, 1984, Q J EXP PSYCHOL-A, V36, P335, DOI 10.1080/14640748408402163; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Moller J, 2007, CEREB CORTEX, V17, P1173, DOI 10.1093/cercor/bhl028; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Padilla ML, 2006, J COGNITIVE NEUROSCI, V18, P1477, DOI 10.1162/jocn.2006.18.9.1477; Palmer C, 2005, CURR DIR PSYCHOL SCI, V14, P247, DOI 10.1111/j.0963-7214.2005.00374.x; PALMER C, 1993, J EXP PSYCHOL LEARN, V19, P457, DOI 10.1037/0278-7393.19.2.457; Palmer C, 2003, PSYCHOL REV, V110, P683, DOI 10.1037/0033-295X.110.4.683; Pfordresher P. Q., 2006, ADV COGN PSYCHOL, V2, P183, DOI [10.2478/v10053-008-0054-8, DOI 10.2478/V10053-008-0054-8]; Pfordresher PQ, 2005, J EXP PSYCHOL HUMAN, V31, P1331, DOI 10.1037/0096-1523.31.6.1331; Pfordresher PQ, 2003, J EXP PSYCHOL HUMAN, V29, P949, DOI 10.1037/0096-1523.29.5.949; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; PORTER R, 1975, BRAIN RES, V98, P21, DOI 10.1016/0006-8993(75)90507-7; Poulet JFA, 2007, TRENDS NEUROSCI, V30, P14, DOI 10.1016/j.tins.2006.11.005; RABBITT P, 1978, ERGONOMICS, V21, P945, DOI 10.1080/00140137808931800; Ridderinkhof KR, 2003, NEUROSCI LETT, V348, P1, DOI 10.1016/S0304-3940(03)00566-4; SHIBASAKI H, 1980, ELECTROEN CLIN NEURO, V49, P213, DOI 10.1016/0013-4694(80)90216-3; Spijkers W, 1997, ACTA PSYCHOL, V96, P207, DOI 10.1016/S0001-6918(97)00017-6; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; van Boxtel GJM, 2005, J PSYCHOPHYSIOL, V19, P1, DOI 10.1027/0269-8803.19.1.1; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; van Veen V, 2006, CLIN EEG NEUROSCI, V37, P330, DOI 10.1177/155005940603700411; Verleger R, 2008, CLIN NEUROPHYSIOL, V119, P968, DOI 10.1016/j.clinph.2007.11.175; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	58	58	59	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5032	10.1371/journal.pone.0005032	http://dx.doi.org/10.1371/journal.pone.0005032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PY	19337379	Green Submitted, Green Published, gold			2022-12-27	WOS:000265500600010
J	Baral, S; Trapence, G; Motimedi, F; Umar, E; Iipinge, S; Dausab, F; Beyrer, C				Baral, Stefan; Trapence, Gift; Motimedi, Felistus; Umar, Eric; Iipinge, Scholastika; Dausab, Friedel; Beyrer, Chris			HIV Prevalence, Risks for HIV Infection, and Human Rights among Men Who Have Sex with Men (MSM) in Malawi, Namibia, and Botswana	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; PREVENTION; BEHAVIOR; EPIDEMIOLOGY; MOMBASA	Background: In the generalized epidemics of HIV in southern Sub-Saharan Africa, men who have sex with men have been largely excluded from HIV surveillance and research. Epidemiologic data for MSM in southern Africa are among the sparsest globally, and HIV risk among these men has yet to be characterized in the majority of countries. Methodology: A cross-sectional anonymous probe of 537 men recruited with non-probability sampling among men who reported ever having had sex with another man in Malawi, Namibia, and Botswana using a structured survey instrument and HIV screening with the OraQuick (c) rapid test kit. Principal Findings: The HIV prevalence among those between the ages of 18 and 23 was 8.3% (20/241); 20.0% (42/210) among those 24-29; and 35.7% (30/84) among those older than 30 for an overall prevalence of 17.4% (95% CI 14.4-20.8). In multivariate logistic regressions, being older than 25 (aOR 4.0, 95% CI 2.0-8.0), and not always wearing condoms during sex (aOR 2.6, 95% CI 1.3-4.9) were significantly associated with being HIV-positive. Sexual concurrency was common with 16.6% having ongoing concurrent stable relationships with a man and a woman and 53.7% had both male and female sexual partners in proceeding 6 months. Unprotected anal intercourse was common and the use of petroleum-based lubricants was also common when using condoms. Human rights abuses, including blackmail and denial of housing and health care was prevalent with 42.1% (222/527) reporting at least one abuse. Conclusions: MSM are a high-risk group for HIV infection and human rights abuses in Malawi, Namibia, and Botswana. Concurrency of sexual partnerships with partners of both genders may play important roles in HIV spread in these populations. Further epidemiologic and evaluative research is needed to assess the contribution of MSM to southern Africa's HIV epidemics and how best to mitigate this. These countries should initiate and adequately fund evidence-based and targeted HIV prevention programs for MSM.	[Baral, Stefan; Beyrer, Chris] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Ctr Publ Hlth & Human Rights, Baltimore, MD USA; [Trapence, Gift] Ctr Dev People, Blantyre, Malawi; [Motimedi, Felistus] Botswana Network Ethics Law & HIV AIDS, Gaborone, Botswana; [Umar, Eric] Univ Malawi, Coll Med, Dept Community Hlth, Blantyre, Malawi; [Iipinge, Scholastika] Univ Namibia, Windhoek, Namibia; [Dausab, Friedel] Rainbow Project, Windhoek, Namibia; [Baral, Stefan] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Malawi; University of Namibia; University of Toronto	Baral, S (corresponding author), Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Ctr Publ Hlth & Human Rights, Baltimore, MD USA.	sbaral@jhsph.edu	Baral, Stefan/D-2930-2013; Baral, Stefan/AAG-4818-2020	Baral, Stefan/0000-0002-5482-2419	Sexual Health and Rights Project (SHARP) of the Open Society Institute; Open Society Initiative for Southern Africa (OSISA)	Sexual Health and Rights Project (SHARP) of the Open Society Institute; Open Society Initiative for Southern Africa (OSISA)	This study was supported by the Sexual Health and Rights Project (SHARP) of the Open Society Institute and the Open Society Initiative for Southern Africa (OSISA). The decision to publish was made by the community partners and not the funders. Publication costs were offset by a grant from The Himmelfarb Family Foundation to the Center for Public Health and Human Rights.	[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Beckerleg Susan, 2005, Harm Reduct J, V2, P12, DOI 10.1186/1477-7517-2-12; Brody S, 2003, INT J STD AIDS, V14, P431, DOI 10.1258/095646203322025704; Caceres CF, 2008, SEX TRANSM INFECT, V84, pI49, DOI 10.1136/sti.2008.030569; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Delaney KP, 2006, AIDS, V20, P1655, DOI 10.1097/01.aids.0000238412.75324.82; Geibel S, 2008, SEX TRANSM DIS, V35, P746, DOI 10.1097/OLQ.0b013e318170589d; GRIJSEN ML, 2008, SEX TRANSM INFECT; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; IGLHRC, 2007, MAP HIV AIDS PROGR F; Johnson WD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001230.pub2; Johnson WD, 2005, AIDS EDUC PREV, V17, P568, DOI 10.1521/aeap.2005.17.6.568; Lane T, 2008, AIDS BEHAV, V12, pS78, DOI 10.1007/s10461-008-9389-x; MAH TL, 2008, AIDS BEHAV; Ntata P R T, 2008, Tanzan J Health Res, V10, P124; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Sharma A, 2008, SEX TRANSM DIS, V35, P352, DOI 10.1097/OLQ.0b013e31815e6320; Siegel K, 2008, ARCH SEX BEHAV, V37, P720, DOI 10.1007/s10508-008-9357-6; SIFAKIS F, 2008, RAPID ASSESSMENT HIV; Spitzberg B H, 1999, Violence Vict, V14, P241; StataCorp L, 2007, STAT DAT AN STAT SOF; *UNAIDS, 2008, 2008 REP GLOB AIDS E; Wade AS, 2005, AIDS, V19, P2133, DOI 10.1097/01.aids.0000194128.97640.07	28	257	264	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2009	4	3							e4997	10.1371/journal.pone.0004997	http://dx.doi.org/10.1371/journal.pone.0004997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PM	19325707	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499400005
J	Wang, ZH; Fan, ZC; Williamson, SM; Qin, HM				Wang, Zhaohui; Fan, Zhen-Chuan; Williamson, Shana M.; Qin, Hongmin			Intraflagellar Transport (IFT) Protein IFT25 Is a Phosphoprotein Component of IFT Complex B and Physically Interacts with IFT27 in Chlamydomonas	PLOS ONE			English	Article								Background: Intraflagellar transport (IFT) is the bidirectional movement of IFT particles between the cell body and the distal tip of a flagellum. Organized into complexes A and B, IFT particles are composed of at least 18 proteins. The function of IFT proteins in flagellar assembly has been extensively investigated. However, much less is known about the molecular mechanism of how IFT is regulated. Methodology/Principal Findings: We herein report the identification of a novel IFT particle protein, IFT25, in Chlamydomonas. Dephosphorylation assay revealed that IFT25 is a phosphoprotein. Biochemical analysis of temperature sensitive IFT mutants indicated that IFT25 is an IFT complex B subunit. In vitro binding assay confirmed that IFT25 binds to IFT27, a Rab-like small GTPase component of the IFT complex B. Immunofluorescence staining showed that IFT25 has a punctuate flagellar distribution as expected for an IFT protein, but displays a unique distribution pattern at the flagellar base. IFT25 co-localizes with IFT27 at the distal-most portion of basal bodies, probably the transition zones, and concentrates in the basal body region by partially overlapping with other IFT complex B subunits, such as IFT46. Sucrose density gradient centrifugation analysis demonstrated that, in flagella, the majority of IFT27 and IFT25 including both phosphorylated and non-phosphorylated forms are cosedimented with other complex B subunits in the 16S fractions. In contrast, in cell body, only a fraction of IFT25 and IFT27 is integrated into the preassembled complex B, and IFT25 detected in complex B is preferentially phosphorylated. Conclusion/Significance: IFT25 is a phosphoprotein component of IFT particle complex B. IFT25 directly interacts with IFT27, and these two proteins likely form a subcomplex in vivo. We postulate that the association and disassociation between the subcomplex of IFT25 and IFT27 and complex B might be involved in the regulation of IFT.			Wang, ZH (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	hqin@bio.mail.tamu.edu		Fan, Zhen-Chuan/0000-0003-1712-3413				Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Dutcher SK, 2002, MOL BIOL CELL, V13, P3859, DOI 10.1091/mbc.E02-04-0205; FOLLIT J, 2009, CELL MOTIL CYTOSKELE; Hou YQ, 2004, MOL BIOL CELL, V15, P4382, DOI 10.1091/mbc.E04-05-0377; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Huang K, 2007, J CELL BIOL, V179, P501, DOI 10.1083/jcb.200704069; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; JOHNSON KA, 1992, J CELL BIOL, V119, P1605, DOI 10.1083/jcb.119.6.1605; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; Miller MS, 2005, MOL BIOL CELL, V16, P3810, DOI 10.1091/mbc.E05-05-0404; Mueller J, 2005, MOL BIOL CELL, V16, P1341, DOI 10.1091/mbc.E04-10-0931; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pan JM, 2005, DEV CELL, V9, P431, DOI 10.1016/j.devcel.2005.07.010; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Pedersen LB, 2005, CURR BIOL, V15, P262, DOI 10.1016/j.cub.2005.01.037; Perrone CA, 2003, MOL BIOL CELL, V14, P2041, DOI 10.1091/mbc.e02-10-0682; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Qin HM, 2005, CURR BIOL, V15, P1695, DOI 10.1016/j.cub.2005.08.047; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Quarmby LM, 2004, INT REV CYTOL, V233, P47, DOI 10.1016/S0074-7696(04)33002-0; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Rompolas P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/jcs.012773; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Tam LW, 2007, J CELL BIOL, V176, P819, DOI 10.1083/jcb.200610022; Tsao CC, 2008, MOL BIOL CELL, V19, P1450, DOI 10.1091/mbc.E07-05-0403; Tsao CC, 2008, J CELL SCI, V121, P428, DOI 10.1242/jcs.015826; WALTHER Z, 1994, J CELL BIOL, V126, P175, DOI 10.1083/jcb.126.1.175; Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044; WITMAN GB, 1975, ANN NY ACAD SCI, V253, P178, DOI 10.1111/j.1749-6632.1975.tb19199.x	44	75	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5384	10.1371/journal.pone.0005384	http://dx.doi.org/10.1371/journal.pone.0005384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412537	Green Published, Green Submitted, gold			2022-12-27	WOS:000265688200003
J	Wang, AL; Lukas, TJ; Yuan, M; Du, N; Handa, JT; Neufeld, AH				Wang, Ai Ling; Lukas, Thomas J.; Yuan, Ming; Du, Nga; Handa, James T.; Neufeld, Arthur H.			Changes in Retinal Pigment Epithelium Related to Cigarette Smoke: Possible Relevance to Smoking as a Risk Factor for Age-Related Macular Degeneration	PLOS ONE			English	Article								Age-related Macular Degeneration (AMD) is a major cause of central vision loss in the elderly and smoking is a primary risk factor associated with the prevalence and incidence of AMD. To better understand the cellular and molecular bases for the association between smoking and AMD, we determined the effects of Benzo(a) Pyrene (B(a) P), a toxic element in cigarette smoke, on cultured retinal pigment epithelia (RPE) and we examined the RPE/choroid from mice exposed to chronic cigarette smoke. We measured: mitochondrial DNA (mtDNA) damage, phagocytic activity, lysosomal enzymes, exosome markers and selected complement pathway components. In the presence of a non-cytotoxic dose of B(a) P, there was extensive mtDNA damage but no nuclear DNA damage. RPE phagocytic activity was not altered but there were increased lysosomal activity, exocytotic activity and complement pathway components. Retinas from mice exposed to cigarette smoke contained markers for mtDNA damage, exosomes and complement pathway components surrounding Bruch's membrane. Markers for these processes are found in drusen from AMD patients. Thus, smoking may cause damage to mtDNA and increased degradative processes in the RPE. These altered cell biological processes in the RPE may contribute to the formation of drusen in individuals who are cigarette smokers and underlie susceptibility to genetic mutations associated with AMD.			Wang, AL (corresponding author), Northwestern Univ, Sch Med, Dept Ophthalmol, Forsythe Lab Invest Aging Retina, Chicago, IL 60611 USA.	a-wang@northwestern.edu			NATIONAL EYE INSTITUTE [R01EY014005, R01EY019904] Funding Source: NIH RePORTER; NEI NIH HHS [EY14005, R01 EY014005, R01 EY019904, R01 EY014005-06A2] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BACKER JM, 1980, SCIENCE, V209, P297, DOI 10.1126/science.6770466; BOULTON M, 1994, BRIT J OPHTHALMOL, V78, P125, DOI 10.1136/bjo.78.2.125; Canter JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002091; Chang YG, 2007, J CELL SCI, V120, P3053, DOI 10.1242/jcs.006361; CHEN H, 2009, INVEST OPHTHALMOL VI; Chen HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002339; Cingle KA, 1996, CURR EYE RES, V15, P433, DOI 10.3109/02713689608995834; CONNEY AH, 1982, CANCER RES, V42, P4875; DING X, 2008, PROG RETIN EYE RES; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Evans JR, 2005, BRIT J OPHTHALMOL, V89, P550, DOI 10.1136/bjo.2004.049726; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Fujihara M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003119; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Kimura K, 2000, AM J OPHTHALMOL, V130, P769, DOI 10.1016/S0002-9394(00)00552-3; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P115, DOI 10.1001/archopht.126.1.115; Milton RC, 2005, OPHTHALMOLOGY, V112, P533, DOI 10.1016/j.ophtha.2004.10.047; Mitchell P, 2002, ARCH OPHTHALMOL-CHIC, V120, P1357, DOI 10.1001/archopht.120.10.1357; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Patton WP, 2002, EXP EYE RES, V74, P513, DOI 10.1006/exer.2001.1160; Rakoczy PE, 1999, EXP EYE RES, V69, P367, DOI 10.1006/exer.1999.0700; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Verdugo ME, 1997, EXP EYE RES, V65, P231, DOI 10.1006/exer.1997.0325; Wang A.L., 2008, NEUROBIOL AGING; Wang AL, 2008, MOL VIS, V14, P644; WANG AL, 2008, PLOS ONE; Yamada Y, 2008, J NEUROCHEM, V105, P1187, DOI 10.1111/j.1471-4159.2008.05211.x	36	58	61	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5304	10.1371/journal.pone.0005304	http://dx.doi.org/10.1371/journal.pone.0005304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390692	gold, Green Submitted, Green Published			2022-12-27	WOS:000265514400005
J	Bartels, ED; Nielsen, JM; Hellgren, LI; Ploug, T; Nielsen, LB				Bartels, Emil D.; Nielsen, Jan M.; Hellgren, Lars I.; Ploug, Thorkil; Nielsen, Lars B.			Cardiac Expression of Microsomal Triglyceride Transfer Protein Is Increased in Obesity and Serves to Attenuate Cardiac Triglyceride Accumulation	PLOS ONE			English	Article								Obesity causes lipid accumulation in the heart and may lead to lipotoxic heart disease. Traditionally, the size of the cardiac triglyceride pool is thought to reflect the balance between uptake and beta-oxidation of fatty acids. However, triglycerides can also be exported from cardiomyocytes via secretion of apolipoproteinB-containing (apoB) lipoproteins. Lipoprotein formation depends on expression of microsomal triglyceride transfer protein (MTP); the mouse expresses two isoforms of MTP, A and B. Since many aspects of the link between obesity-induced cardiac disease and cardiac lipid metabolism remain unknown, we investigated how cardiac lipoprotein synthesis affects cardiac expression of triglyceride metabolism-controlling genes, insulin sensitivity, and function in obese mice. Heart-specific ablation of MTP-A in mice using Cre-loxP technology impaired upregulation of MTP expression in response to increased fatty acid availability during fasting and fat feeding. This resulted in cardiac triglyceride accumulation but unaffected cardiac insulin-stimulated glucose uptake. Longterm fat-feeding of male C57Bl/6 mice increased cardiac triglycerides, induced cardiac expression of triglyceride metabolism-controlling genes and attenuated heart function. Abolishing cardiac triglyceride accumulation in fat-fed mice by overexpression of an apoB transgene in the heart prevented the induction of triglyceride metabolism-controlling genes and improved heart function. The results suggest that in obesity, the physiological increase of cardiac MTP expression serves to attenuate cardiac triglyceride accumulation albeit without major effects on cardiac insulin sensitivity. Nevertheless, the data suggest that genetically increased lipoprotein secretion prevents development of obesity-induced lipotoxic heart disease.			Bartels, ED (corresponding author), Univ Copenhagen, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark.	larsbo@rh.dk	Bartels, Emil/AAY-3268-2020; Hellgren, Lars/B-5137-2010	Hellgren, Lars/0000-0001-9215-4880; Ploug, Thorkil/0000-0002-5375-6595				Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25; Bamba V, 2007, GASTROENTEROLOGY, V132, P2181, DOI 10.1053/j.gastro.2007.03.056; Bang CA, 2007, AM J PHYSIOL-RENAL, V293, pF1325, DOI 10.1152/ajprenal.00039.2007; Bartels ED, 2009, EUR J CLIN INVEST, V39, P190, DOI 10.1111/j.1365-2362.2009.02086.x; Bartels ED, 2002, DIABETES, V51, P1233, DOI 10.2337/diabetes.51.4.1233; Bjorkegren J, 2001, J BIOL CHEM, V276, P38511, DOI 10.1074/jbc.M106839200; Boren J, 1998, J CLIN INVEST, V101, P1197, DOI 10.1172/JCI1785; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Chess DJ, 2008, CARDIOVASC RES, V79, P269, DOI 10.1093/cvr/cvn074; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; Dougan SK, 2007, J EXP MED, V204, P533, DOI 10.1084/jem.20062006; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Georgakopoulos D, 1998, AM J PHYSIOL-HEART C, V274, pH1416, DOI 10.1152/ajpheart.1998.274.4.H1416; GORDON DA, 1994, P NATL ACAD SCI USA, V91, P7628, DOI 10.1073/pnas.91.16.7628; Hammer S, 2008, J CLIN ENDOCR METAB, V93, P497, DOI 10.1210/jc.2007-2015; Hollander MC, 2001, INT J CANCER, V96, P22, DOI 10.1002/1097-0215(20010220)96:1<22::AID-IJC3>3.0.CO;2-K; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Koutsari C, 2006, J LIPID RES, V47, P1643, DOI 10.1194/jlr.R600011-JLR200; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592; Ledmyr H, 2004, CIRCULATION, V109, P2279, DOI 10.1161/01.CIR.0000130070.96758.7b; Lee Y, 2004, P NATL ACAD SCI USA, V101, P13624, DOI 10.1073/pnas.0405499101; Lindegaard MLS, 2008, METABOLISM, V57, P766, DOI 10.1016/j.metabol.2008.01.016; Lopaschuk GD, 2007, CIRC RES, V101, P335, DOI 10.1161/CIRCRESAHA.107.150417; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Mohler PJ, 2007, J BIOL CHEM, V282, P26981, DOI 10.1074/jbc.M700500200; Nielsen JM, 2007, AM J PHYSIOL-HEART C, V293, pH534, DOI 10.1152/ajpheart.01268.2006; Nielsen LB, 2002, J BIOL CHEM, V277, P27014, DOI 10.1074/jbc.M203458200; Nielsen LB, 1998, CIRCULATION, V98, P13, DOI 10.1161/01.CIR.98.1.13; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Pedersen TX, 2009, ATHEROSCLEROSIS, V202, P372, DOI 10.1016/j.atherosclerosis.2008.04.041; PETERSEN S, 1991, FEBS LETT, V286, P1, DOI 10.1016/0014-5793(91)80927-U; Peterson LR, 2004, CIRCULATION, V109, P2191, DOI 10.1161/01.CIR.0000127959.28627.F8; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Raabe M, 1998, P NATL ACAD SCI USA, V95, P8686, DOI 10.1073/pnas.95.15.8686; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Somoza B, 2007, ENDOCRINOLOGY, V148, P924, DOI 10.1210/en.2006-0914; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Stanley William C, 2002, Heart Fail Rev, V7, P115, DOI 10.1023/A:1015320423577; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; WISNESKI JA, 1987, J CLIN INVEST, V79, P359, DOI 10.1172/JCI112820; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Ye G, 2003, DIABETES, V52, P777, DOI 10.2337/diabetes.52.3.777; Yokoyama M, 2004, J BIOL CHEM, V279, P4204, DOI 10.1074/jbc.M311995200; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	61	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5300	10.1371/journal.pone.0005300	http://dx.doi.org/10.1371/journal.pone.0005300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390571	Green Submitted, Green Published, gold			2022-12-27	WOS:000265514200013
J	Diaz-Pulido, G; McCook, LJ; Dove, S; Berkelmans, R; Roff, G; Kline, DI; Weeks, S; Evans, RD; Williamson, DH; Hoegh-Guldberg, O				Diaz-Pulido, Guillermo; McCook, Laurence J.; Dove, Sophie; Berkelmans, Ray; Roff, George; Kline, David I.; Weeks, Scarla; Evans, Richard D.; Williamson, David H.; Hoegh-Guldberg, Ove			Doom and Boom on a Resilient Reef: Climate Change, Algal Overgrowth and Coral Recovery	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PHASE-SHIFTS; COMMUNITY STRUCTURE; HARD CORAL; BROWN ALGA; HERBIVORY; COMPETITION; NUTRIENTS; DYNAMICS; RECRUITMENT	Background: Coral reefs around the world are experiencing large-scale degradation, largely due to global climate change, overfishing, diseases and eutrophication. Climate change models suggest increasing frequency and severity of warming-induced coral bleaching events, with consequent increases in coral mortality and algal overgrowth. Critically, the recovery of damaged reefs will depend on the reversibility of seaweed blooms, generally considered to depend on grazing of the seaweed, and replenishment of corals by larvae that successfully recruit to damaged reefs. These processes usually take years to decades to bring a reef back to coral dominance. Methodology/Principal Findings: In 2006, mass bleaching of corals on inshore reefs of the Great Barrier Reef caused high coral mortality. Here we show that this coral mortality was followed by an unprecedented bloom of a single species of unpalatable seaweed (Lobophora variegata), colonizing dead coral skeletons, but that corals on these reefs recovered dramatically, in less than a year. Unexpectedly, this rapid reversal did not involve reestablishment of corals by recruitment of coral larvae, as often assumed, but depended on several ecological mechanisms previously underestimated. Conclusions/Significance: These mechanisms of ecological recovery included rapid regeneration rates of remnant coral tissue, very high competitive ability of the corals allowing them to out-compete the seaweed, a natural seasonal decline in the particular species of dominant seaweed, and an effective marine protected area system. Our study provides a key example of the doom and boom of a highly resilient reef, and new insights into the variability and mechanisms of reef resilience under rapid climate change.			Diaz-Pulido, G (corresponding author), Univ Queensland, Ctr Marine Studies, Brisbane, Qld, Australia.	g.diazpulido@uq.edu.au	Hoegh-Guldberg, Ove/ABA-5420-2020; Evans, Richard D./O-3559-2019; Roff, George/C-8766-2015; Roff, George/ABB-4406-2021; Hoegh-Guldberg, Ove/H-6169-2011; Diaz-Pulido, Guillermo/B-3648-2013; Evans, Richard D/K-5779-2013; Weeks, Scarla J/E-8632-2013; Dove, Sophie/I-7873-2013	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Evans, Richard D./0000-0003-4364-4810; Roff, George/0000-0002-2823-0575; Roff, George/0000-0002-2823-0575; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Weeks, Scarla J/0000-0002-0579-7069; Dove, Sophie/0000-0003-1823-8634; Kline, David/0000-0001-5128-9439; Diaz-Pulido, Guillermo/0000-0002-0901-3727; Williamson, David/0000-0001-8447-039X				Anthony KRN, 2006, MAR ECOL PROG SER, V319, P111, DOI 10.3354/meps319111; Banks SA, 1995, MAR FRESHWATER RES, V46, P1137, DOI 10.1071/MF9951137; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Brown Barbara E., 1994, P279; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; CARPENTER RC, 1990, MAR BIOL, V104, P67, DOI 10.1007/BF01313159; COLGAN MW, 1987, ECOLOGY, V68, P1592, DOI 10.2307/1939851; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Crabbe MJC, 2005, CORAL REEFS, V24, P437, DOI 10.1007/s00338-005-0004-6; Davey M, 2008, CORAL REEFS, V27, P227, DOI 10.1007/s00338-007-0316-9; Diaz-Pulido G, 2003, ECOLOGY, V84, P2026, DOI 10.1890/01-3127; Diaz-Pulido G, 2002, MAR ECOL PROG SER, V232, P115, DOI 10.3354/meps232115; Diaz-Pulido G., 2007, CLIMATE CHANGE GREAT, P153; DIAZPULIDO G, 1997, P 8 INT COR REEF S P, V1, P827; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Endean R., 1973, Atoll Res Bull, VNo. 168, P1; FISHELSON L, 1973, MAR BIOL, V19, P183, DOI 10.1007/BF02097137; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Golbuu Y, 2007, CORAL REEFS, V26, P319, DOI 10.1007/s00338-007-0200-7; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; HATCHER BG, 1984, CORAL REEFS, V3, P199, DOI 10.1007/BF00288255; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1987, J EXP MAR BIOL ECOL, V113, P39, DOI 10.1016/0022-0981(87)90081-5; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1989, ECOLOGY, V70, P275, DOI 10.2307/1938434; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hunter Cynthia L., 1994, P339; Idjadi JA, 2006, CORAL REEFS, V25, P209, DOI 10.1007/s00338-006-0088-7; Jokiel P., 1978, CORAL REEFS RES METH, P529; JOKIEL PL, 1993, CORAL REEFS, V12, P177, DOI 10.1007/BF00334477; Jompa J, 2002, J EXP MAR BIOL ECOL, V271, P25, DOI 10.1016/S0022-0981(02)00040-0; Jompa J, 2002, LIMNOL OCEANOGR, V47, P527, DOI 10.4319/lo.2002.47.2.0527; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Krupp D.A., 1992, P 7 INT COR REEF S, VVol. 1, P527; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; LOYA Y, 1976, NATURE, V261, P490, DOI 10.1038/261490a0; McClanahan TR, 1999, CORAL REEFS, V18, P61, DOI 10.1007/s003380050155; McCook L.J., 2007, CLIMATE CHANGE GREAT, P75; McCook LJ, 1996, MAR ECOL PROG SER, V139, P179, DOI 10.3354/meps139179; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; PEARSON RG, 1981, MAR ECOL PROG SER, V4, P105, DOI 10.3354/meps004105; Riegl B, 2001, CORAL REEFS, V20, P67; RUSS G, 1984, MAR ECOL PROG SER, V20, P23, DOI 10.3354/meps020023; Russ GR, 2008, CURR BIOL, V18, pR514, DOI 10.1016/j.cub.2008.04.016; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Smith JE, 2001, CORAL REEFS, V19, P332, DOI 10.1007/s003380000124; Steneck R.S., 1988, P 6 INT COR REEF S A, P37; Steneck Robert S., 1994, P220; vanWoesik R, 1997, CORAL REEFS, V16, P103, DOI 10.1007/s003380050064; VanWoesik R, 1995, MAR ECOL PROG SER, V128, P261, DOI 10.3354/meps128261; Weeks SJ, 2008, LIMNOL OCEANOGR, V53, P1369, DOI 10.4319/lo.2008.53.4.1369	62	227	234	4	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5239	10.1371/journal.pone.0005239	http://dx.doi.org/10.1371/journal.pone.0005239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384423	Green Accepted, gold, Green Published			2022-12-27	WOS:000265513900008
J	Kilman, VL; Zhang, LY; Meissner, RA; Burg, E; Allada, R				Kilman, Valerie L.; Zhang, Luoying; Meissner, Rose-Anne; Burg, Elyssa; Allada, Ravi			Perturbing Dynamin Reveals Potent Effects on the Drosophila Circadian Clock	PLOS ONE			English	Article							TEMPERATURE-SENSITIVE MUTANT; PROTEIN-COUPLED RECEPTOR; PACEMAKER NEURONS; GENE-PRODUCT; TRANSCRIPTIONAL REPRESSOR; REVERSIBLE BLOCKAGE; INTRACELLULAR CA2+; NERVOUS-SYSTEM; BETA-ARRESTINS; TIMELESS GENES	Background: Transcriptional feedback loops are central to circadian clock function. However, the role of neural activity and membrane events in molecular rhythms in the fruit fly Drosophila is unclear. To address this question, we expressed a temperature-sensitive, dominant negative allele of the fly homolog of dynamin called shibire(ts1) (shi(ts1)), an active component in membrane vesicle scission. Principal Findings: Broad expression in clock cells resulted in unexpectedly long, robust periods (. 28 hours) comparable to perturbation of core clock components, suggesting an unappreciated role of membrane dynamics in setting period. Expression in the pacemaker lateral ventral neurons (LNv) was necessary and sufficient for this effect. Manipulation of other endocytic components exacerbated shi(ts1)'s behavioral effects, suggesting its mechanism is specific to endocytic regulation. PKA overexpression rescued period effects suggesting shi(ts1) may downregulate PKA pathways. Levels of the clock component PERIOD were reduced in the shi(ts1)-expressing pacemaker small LNv of flies held at a fully restrictive temperature (29 degrees C). Less restrictive conditions (25 degrees C) delayed cycling proportional to observed behavioral changes. Levels of the neuropeptide PIGMENT-DISPERSING FACTOR (PDF), the only known LNv neurotransmitter, were also reduced, but PERIOD cycling was still delayed in flies lacking PDF, implicating a PDF-independent process. Further, shi(ts1) expression in the eye also results in reduced PER protein and per and vri transcript levels, suggesting that shibire-dependent signaling extends to peripheral clocks. The level of nuclear CLK, transcriptional activator of many core clock genes, is also reduced in shi(ts1) flies, and Clk overexpression suppresses the period-altering effects of shi(ts1). Conclusions: We propose that membrane protein turnover through endocytic regulation of PKA pathways modulates the core clock by altering CLK levels and/or activity. These results suggest an important role for membrane scission in setting circadian period.			Kilman, VL (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	r-allada@northwestern.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067870, K01MH070456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052903] Funding Source: NIH RePORTER; NIMH NIH HHS [K01 MH070456, R01MH067870, R01 MH067870, K01MH070456] Funding Source: Medline; NINDS NIH HHS [R01 NS052903, R01NS052903] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Benito J, 2007, J NEUROSCI, V27, P2539, DOI 10.1523/JNEUROSCI.4870-06.2007; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BRODSKY FM, 1987, NATURE, V326, P203, DOI 10.1038/326203a0; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Chang HC, 2002, J CELL BIOL, V159, P477, DOI 10.1083/jcb.200205086; CHUNG BY, 2009, CURR BIOL IN PRESS; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; DARGENT B, 1995, J NEUROCHEM, V65, P407; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; EWER J, 1992, J NEUROSCI, V12, P3321; Fache MP, 2004, J CELL BIOL, V166, P571, DOI 10.1083/jcb.200312155; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Hamasaka Y, 2006, J COMP NEUROL, V494, P314, DOI 10.1002/cne.20807; HAMASAKA Y, 2005, J NEUROBIOL; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Hastings MH, 2008, CURR BIOL, V18, pR805, DOI 10.1016/j.cub.2008.07.021; Helfrich-Forster C, 2005, GENES BRAIN BEHAV, V4, P65, DOI 10.1111/j.1601-183X.2004.00092.X; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; HELFRICHFORSTER C, 1993, J COMP NEUROL, V337, P177, DOI 10.1002/cne.903370202; Hodge JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002274; Houl JH, 2006, J BIOL RHYTHM, V21, P93, DOI 10.1177/0748730405283697; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 1997, J NEUROSCI, V17, P6745; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Kim EY, 2006, P NATL ACAD SCI USA, V103, P6178, DOI 10.1073/pnas.0511215103; Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6; KIM YT, 1987, J NEUROSCI, V7, P3245; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Kula E, 2006, J BIOL RHYTHM, V21, P104, DOI 10.1177/0748730405285715; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; Lim C, 2007, CURR BIOL, V17, P1082, DOI 10.1016/j.cub.2007.05.039; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luttrell LM, 2002, J CELL SCI, V115, P455; Majercak J, 1997, MOL CELL BIOL, V17, P5915, DOI 10.1128/MCB.17.10.5915; MASUR SK, 1990, J NEUROGENET, V6, P191, DOI 10.3109/01677069009107110; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; O'Neill JS, 2008, J BIOL RHYTHM, V23, P483, DOI 10.1177/0748730408326682; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Shafer OT, 2006, J COMP NEUROL, V498, P180, DOI 10.1002/cne.21021; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; Staples RR, 1999, J NEUROGENET, V13, P119, DOI 10.3109/01677069909083470; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Suri V, 1999, EMBO J, V18, P675, DOI 10.1093/emboj/18.3.675; Tong YH, 2001, J GEN PHYSIOL, V117, P103, DOI 10.1085/jgp.117.2.103; Tsai LTY, 2004, PLOS BIOL, V2, P2122, DOI 10.1371/journal.pbio.0020408; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Weber F, 2006, J NEUROCHEM, V98, P248, DOI 10.1111/j.1471-4159.2006.03865.x; Wegener C, 2004, J NEUROPHYSIOL, V91, P912, DOI 10.1152/jn.00678.2003; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wu Y, 2008, J BIOL RHYTHM, V23, P117, DOI 10.1177/0748730407312984; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8	80	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5235	10.1371/journal.pone.0005235	http://dx.doi.org/10.1371/journal.pone.0005235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384421	gold, Green Published, Green Submitted			2022-12-27	WOS:000265513900006
J	Chatterjee, S; Szustakowski, JD; Nanguneri, NR; Mickanin, C; Labow, MA; Nohturfft, A; Dev, KK; Sivasankaran, R				Chatterjee, Sandipan; Szustakowski, Joseph D.; Nanguneri, Nirmala R.; Mickanin, Craig; Labow, Mark A.; Nohturfft, Axel; Dev, Kumlesh K.; Sivasankaran, Rajeev			Identification of Novel Genes and Pathways Regulating SREBP Transcriptional Activity	PLOS ONE			English	Article								Background: Lipid metabolism in mammals is orchestrated by a family of transcription factors called sterol regulatory element-binding proteins (SREBPs) that control the expression of genes required for the uptake and synthesis of cholesterol, fatty acids, and triglycerides. SREBPs are thus essential for insulin-induced lipogenesis and for cellular membrane homeostasis and biogenesis. Although multiple players have been identified that control the expression and activation of SREBPs, gaps remain in our understanding of how SREBPs are coordinated with other physiological pathways. Methodology: To identify novel regulators of SREBPs, we performed a genome-wide cDNA over-expression screen to identify proteins that might modulate the transcription of a luciferase gene driven from an SREBP-specific promoter. The results were verified through secondary biological assays and expression data were analyzed by a novel application of the Gene Set Enrichment Analysis (GSEA) method. Conclusions/Significance: We screened 10,000 different cDNAs and identified a number of genes and pathways that have previously not been implicated in SREBP control and cellular cholesterol homeostasis. These findings further our understanding of lipid biology and should lead to new insights into lipid associated disorders.			Chatterjee, S (corresponding author), 3V Biosci, Schlieren, Switzerland.	devk@tcd.ie; rajeev.sivasankaran@novartis.com	Szustakowski, Joseph/HGB-2712-2022	Dev, Kumlesh/0000-0003-4274-9119; Nohturfft, Axel/0000-0001-9484-3209; Szustakowski, Joseph/0000-0001-7900-3973; Nirmala, Nanguneri/0000-0003-0267-9793				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Cao S, 2005, J BIOL CHEM, V280, P1901, DOI 10.1074/jbc.M407941200; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; CONOVER WJ, 1981, TECHNOMETRICS, V23, P351, DOI 10.2307/1268225; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; Cruciani V, 2002, BIOL CELL, V94, P433, DOI 10.1016/S0248-4900(02)00014-X; de Preux AS, 2007, MOL CELL NEUROSCI, V35, P525, DOI 10.1016/j.mcn.2007.04.010; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Felder TK, 2005, BBA-GENE STRUCT EXPR, V1731, P41, DOI 10.1016/j.bbaexp.2005.08.004; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Harada N, 2008, BIOCHEM BIOPH RES CO, V368, P820, DOI 10.1016/j.bbrc.2008.02.004; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Hermey G, 2001, NEUROSCI LETT, V313, P83, DOI 10.1016/S0304-3940(01)02252-2; Hermey G, 2003, J BIOL CHEM, V278, P7390, DOI 10.1074/jbc.M210851200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; INOUE A, 1999, J METASTABLE NANOCRY, V1, P1; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Janowski BA, 2002, P NATL ACAD SCI USA, V99, P12675, DOI 10.1073/pnas.202471599; Kemp DM, 2007, BIOINFORMATICS, V23, P1356, DOI 10.1093/bioinformatics/btm116; Kotzka J, 2000, J LIPID RES, V41, P99; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mukhopadhyay A, 2007, EMBO REP, V8, P931, DOI 10.1038/sj.embor.7401055; Najima Y, 2005, J BIOL CHEM, V280, P27523, DOI 10.1074/jbc.M414549200; Natesampillai S, 2006, J BIOL CHEM, V281, P3040, DOI 10.1074/jbc.M509417200; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; Nohturfft A, 1996, P NATL ACAD SCI USA, V93, P13709, DOI 10.1073/pnas.93.24.13709; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Pai JT, 1998, J BIOL CHEM, V273, P26138, DOI 10.1074/jbc.273.40.26138; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; Pucadyil TJ, 2006, PROG LIPID RES, V45, P295, DOI 10.1016/j.plipres.2006.02.002; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; SATO R, 1994, J BIOL CHEM, V269, P17267; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Siegal, 1956, NONPARAMETRIC STAT B; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Szustakowski JD, 2006, GENOMICS, V87, P129, DOI 10.1016/j.ygeno.2005.08.009; Thewke DP, 1998, J BIOL CHEM, V273, P21402, DOI 10.1074/jbc.273.33.21402; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Verges M, 2007, FRONT BIOSCI-LANDMRK, V12, P3825, DOI 10.2741/2355; Vihanto MM, 2006, J CELL SCI, V119, P2299, DOI 10.1242/jcs.02946; Wang H, 2002, MOL CELL BIOL, V22, P8478, DOI 10.1128/MCB.22.24.8478-8490.2002; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Wang XH, 2006, CHINESE EDUC SOC, V39, P75, DOI 10.2753/CED1061-1932390506; Weber B, 1996, HUM MOL GENET, V5, P771, DOI 10.1093/hmg/5.6.771; Worgall TS, 1998, J BIOL CHEM, V273, P25537, DOI 10.1074/jbc.273.40.25537; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao HG, 1996, P NATL ACAD SCI USA, V93, P6101, DOI 10.1073/pnas.93.12.6101	84	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5197	10.1371/journal.pone.0005197	http://dx.doi.org/10.1371/journal.pone.0005197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381295	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000265513800001
J	Mouri, K; Nacher, JC; Akutsu, T				Mouri, Kazunari; Nacher, Jose C.; Akutsu, Tatsuya			A Mathematical Model for the Detection Mechanism of DNA Double-Strand Breaks Depending on Autophosphorylation of ATM	PLOS ONE			English	Article							P53-MDM2 FEEDBACK LOOP; HYDROGEN-PEROXIDE; POSITIVE-FEEDBACK; DAMAGE; MULTISTABILITY; BIFURCATION; ACTIVATION; SIMULATION; GENERATION; SWITCH	Background: After IR stress, DNA double-strand breaks (DSBs) occur and repair proteins (RPs) bind to them, generating DSB-RP complexes (DSBCs), which results in repaired DSBs (RDSBs). In recent experimental studies, it is suggested that the ATM proteins detect these DNA lesions depending on the autophosphorylation of ATM which exists as a dimer before phosphorylation. Interestingly, the ATM proteins can work as a sensor for a small number of DSBs (approximately 18 DSBs in a cell after exposure to IR). Thus the ATM proteins amplify the small input signals based on the phosphorylation of the ATM dimer proteins. The true DSB-detection mechanism depending on ATM autophosphorylation has yet to be clarified. Methodology/Principal Findings: We propose a mathematical model for the detection mechanism of DSBs by ATM. Our model includes both a DSB-repair mechanism and an ATM-phosphorylation mechanism. We model the former mechanism as a stochastic process, and obtain theoretical mean values of DSBs and DSBCs. In the latter mechanism, it is known that ATM autophosphorylates itself, and we find that the autophosphorylation induces bifurcation of the phosphorylated ATM (ATM*). The bifurcation diagram depends on the total concentration of ATM, which makes three types of steady state diagrams of ATM*: monostable, reversible bistable, and irreversible bistable. Bistability exists depending on the Hill coefficient in the equation of ATM autophosphorylation, and it emerges as the total concentration of ATM increases. Combining these two mechanisms, we find that ATM* exhibits switch-like behaviour in the presence of bistability, and the detection time after DNA damage decreases when the total concentration of ATM increases. Conclusions/Significance: This work provides a mathematical model that explains the DSB-detection mechanism depending on ATM autophosphorylation. These results indicate that positive auto-regulation works both as a sensor and amplifier of small input signals.			Mouri, K (corresponding author), Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Kyoto 606, Japan.	kmouri@kuicr.kyoto-u.ac.jp		Akutsu, Tatsuya/0000-0001-9763-797X				Alon U., 2006, INTRO SYSTEMS BIOL D; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Arkin A, 1998, GENETICS, V149, P1633; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Cantoni O, 1997, GEN PHARMACOL-VASC S, V29, P513, DOI 10.1016/S0306-3623(96)00363-1; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kiehl TR, 2004, BIOINFORMATICS, V20, P316, DOI 10.1093/bioinformatics/btg409; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; MELLO AC, 1984, BIOCHIM BIOPHYS ACTA, V781, P56, DOI 10.1016/0167-4781(84)90123-4; Nair VD, 2004, J BIOL CHEM, V279, P27494, DOI 10.1074/jbc.M312135200; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Samuni AM, 2001, BBA-GEN SUBJECTS, V1525, P70, DOI 10.1016/S0304-4165(00)00172-0; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Wilkinson DJ, 2006, MATH COMPUTATIONAL B, V2nd; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; You ZS, 2007, NAT CELL BIOL, V9, P311, DOI 10.1038/ncb1651	32	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5131	10.1371/journal.pone.0005131	http://dx.doi.org/10.1371/journal.pone.0005131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365581	Green Published, gold, Green Submitted			2022-12-27	WOS:000265509900002
J	Al-Aghbari, N; Al-Sonboli, N; Yassin, MA; Coulter, JBS; Atef, Z; Al-Eryani, A; Cuevas, LE				Al-Aghbari, Nasher; Al-Sonboli, Najla; Yassin, Mohammed A.; Coulter, John B. S.; Atef, Zayed; Al-Eryani, Ali; Cuevas, Luis E.			Multiple Sampling in One Day to Optimize Smear Microscopy in Children with Tuberculosis in Yemen	PLOS ONE			English	Article								Background and Aim: The diagnosis of pulmonary Tuberculosis (TB) in children is difficult and often requires hospitalization. We explored whether the yield of specimens collected for smear microscopy from different anatomical sites in one visit is comparable to the yield of specimens collected from a single anatomical site over several days. Methodology and Principal Findings: Children with signs/symptoms of pulmonary TB attending a reference hospital in Sana'a Yemen underwent one nasopharyngeal aspirate (NPA) the first day of consultation and three gastric aspirates (GA) plus three expectorated/induced sputa over 3 consecutive days. Specimens were examined using smear microscopy (Ziehl-Neelsen) and cultured in solid media (Ogawa). Two hundred and thirteen children (aged 2 months-15 years) were enrolled. One hundred and ninety seven (93%) underwent nasopharyngeal aspirates, 196 (92%) GA, 122 (57%) expectorated sputum and 88 induced sputum. A total 1309 specimens were collected requiring 237 hospitalization days. In total, 29 (13.6%) children were confirmed by culture and 18 (8.5%) by smear microscopy. The NPA identified 10 of the 18 smear-positives; three consecutive GA identified 10 and induced/expectorated sputa identified 13 (6 by induced, 8 by expectorated sputum and one positive by both). In comparison, 22 (3.7%) of 602 specimens obtained the first day were smear-positive and identified 14 (6.6%) smear-positive children. Conclusion/Significance: The examination of multiple tests the first day of consultation identified a similar proportion of smear-positive children than specimens collected over several days; would require half the number of tests and significantly less hospitalization. Optimized smear microscopy approaches for children should be explored further.			Al-Aghbari, N (corresponding author), Natl TB Inst, Sanaa, Yemen.	mayassin@liv.ac.uk	Yassin, Mohammed A/A-6489-2008; Cuevas, Luis E/I-3697-2015	Cuevas, Luis E/0000-0002-6581-0587; Yassin, Mohammed Ahmed/0000-0002-9766-2072				Andresen D, 2007, PAEDIATR RESPIR REV, V8, P221, DOI 10.1016/j.prrv.2007.07.002; Bell DJ, 2009, INT J TUBERC LUNG D, V13, P99; CROFTON J, 1998, CLIN TUBERCULOSIS; Franchi LM, 1998, LANCET, V352, P1681, DOI 10.1016/S0140-6736(05)61454-7; Graham SM, 2007, ANN TROP PAEDIATR, V27, P243, DOI 10.1179/146532807X245625; Maher D, 2006, INT J TUBERC LUNG D, V10, P1091; Owens S, 2007, ARCH DIS CHILD, V92, P693, DOI 10.1136/adc.2006.108308; Saglam L, 2005, J INT MED RES, V33, P260, DOI 10.1177/147323000503300215; STRUMPF IJ, 1979, AM REV RESPIR DIS, V119, P599; Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2; Zar HJ, 2000, ARCH DIS CHILD, V82, P305, DOI 10.1136/adc.82.4.305; Zar HJ, 2003, PEDIATR PULM, V36, P58, DOI 10.1002/ppul.10302	12	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5140	10.1371/journal.pone.0005140	http://dx.doi.org/10.1371/journal.pone.0005140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357770	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000265505900010
J	Tang, YW; Sriram, S; Li, HJ; Yao, SY; Meng, SF; Mitchell, WM; Stratton, CW				Tang, Yi-Wei; Sriram, Subramaniam; Li, Haijing; Yao, Song-yi; Meng, Shufang; Mitchell, William M.; Stratton, Charles W.			Qualitative and Quantitative Detection of Chlamydophila pneumoniae DNA in Cerebrospinal Fluid from Multiple Sclerosis Patients and Controls	PLOS ONE			English	Article								A standardized molecular test for the detection of Chlamydophila pneumoniae DNA in cerebrospinal fluid (CSF) would assist the further assessment of the association of C. pneumoniae with multiple sclerosis (MS). We developed and validated a qualitative colorimetric microtiter plate-based PCR assay (PCR-EIA) and a real-time quantitative PCR assay (TaqMan) for detection of C. pneumoniae DNA in CSF specimens from MS patients and controls. Compared to a touchdown nested-PCR assay, the sensitivity, specificity, and concordance of the PCR-EIA assay were 88.5%, 93.2%, and 90.5%, respectively, on a total of 137 CSF specimens. PCR-EIA presented a significantly higher sensitivity in MS patients (p = 0.008) and a higher specificity in other neurological diseases (p = 0.018). Test reproducibility of the PCR-EIA assay was statistically related to the volumes of extract DNA included in the test (p = 0.033); a high volume, which was equivalent to 100 mu l of CSF per reaction, yielded a concordance of 96.8% between two medical technologists running the test at different times. The TaqMan quantitative PCR assay detected 26 of 63 (41.3%) of positive CSF specimens that tested positive by both PCR-EIA and nested-PCR qualitative assays. None of the CSF specimens that were negative by the two qualitative PCR methods were detected by the TaqMan quantitative PCR. The PCR-EIA assay detected a minimum of 25 copies/ml C. pneumoniae DNA in plasmid-spiked CSF, which was at least 10 times more sensitive than TaqMan. These data indicated that the PCR-EIA assay possessed a sensitivity that was equal to the nested-PCR procedures for the detection of C. pneumoniae DNA in CSF. The TaqMan system may not be sensitive enough for diagnostic purposes due to the low C. pneumoniae copies existing in the majority of CSF specimens from MS patients.			Tang, YW (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA.	yiwei.tang@vanderbilt.edu						Apfalter P, 2001, J CLIN MICROBIOL, V39, P519, DOI 10.1128/JCM.39.2.519-524.2001; BLACK CM, 1994, EUR J CLIN MICROBIOL, V13, P752, DOI 10.1007/BF02276060; Boman J, 1999, J CLIN MICROBIOL, V37, P3791, DOI 10.1128/JCM.37.12.3791-3799.1999; Boman J, 2002, CLIN MICROBIOL REV, V15, P1, DOI 10.1128/CMR.15.1.1-20.2002; Boman J, 1997, J INFECT DIS, V175, P1523, DOI 10.1086/516492; Boman J, 2000, NEUROLOGY, V54, P265, DOI 10.1212/WNL.54.1.265; Contini C, 2004, MULT SCLER J, V10, P360, DOI 10.1191/1352458504ms1049oa; Contini C, 2008, NEUROSCI RES, V62, P58, DOI 10.1016/j.neures.2008.05.003; Derfuss T, 2001, BRAIN, V124, P1325, DOI 10.1093/brain/124.7.1325; Dong-Si T, 2004, J NEUROL, V251, P542, DOI 10.1007/s00415-004-0360-0; Dowell SF, 2001, CLIN INFECT DIS, V33, P492, DOI 10.1086/322632; Fainardi E, 2008, CURR NEUROVASC RES, V5, P60, DOI 10.2174/156720208783565609; Flamand L, 2008, J CLIN MICROBIOL, V46, P2700, DOI 10.1128/JCM.00370-08; Fredricks DN, 1999, CLIN INFECT DIS, V29, P475, DOI 10.1086/598618; Fukano H, 2004, MICROBIOL IMMUNOL, V48, P441, DOI 10.1111/j.1348-0421.2004.tb03534.x; Furrows SJ, 2004, J NEUROL NEUROSUR PS, V75, P152; Gieffers J, 2001, ANN NEUROL, V49, P585, DOI 10.1002/ana.1020.abs; GRAYSTON JT, 1990, J INFECT DIS, V161, P618, DOI 10.1093/infdis/161.4.618; Grimaldi LME, 2003, MULT SCLER, V9, P467, DOI 10.1191/1352458503ms944oa; Hammerschlag MR, 2000, J CLIN MICROBIOL, V38, P4274, DOI 10.1128/JCM.38.11.4274-4276.2000; Hao Q, 2002, MULT SCLER J, V8, P436, DOI 10.1191/1352458502ms840oa; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Ikejima H, 2001, CLIN DIAGN LAB IMMUN, V8, P499, DOI 10.1128/CDLI.8.3.499-502.2001; Inman-Bamber J, 2002, MOL CELL PROBE, V16, P57, DOI 10.1006/mcpr.2001.0399; Kaufman M, 2002, MULT SCLER, V8, P289, DOI 10.1191/1352458502ms815oa; Khan MA, 1996, J INFECTION, V33, P173, DOI 10.1016/S0163-4453(96)92177-5; Kong GY, 2002, GLIA, V37, P191, DOI 10.1002/glia.10030; Kuoppa Y, 2002, J CLIN MICROBIOL, V40, P2273, DOI 10.1128/JCM.40.6.2273-2274.2002; Layh-Schmitt G, 2000, ANN NEUROL, V47, P652, DOI 10.1002/1531-8249(200005)47:5<652::AID-ANA15>3.0.CO;2-5; Mahony JB, 2000, J CLIN MICROBIOL, V38, P2622, DOI 10.1128/JCM.38.7.2622-2627.2000; MELGOSA MP, 1991, INFECT IMMUN, V59, P2195, DOI 10.1128/IAI.59.6.2195-2199.1991; Morre SA, 2000, ANN NEUROL, V48, P399, DOI 10.1002/1531-8249(200009)48:3<399::AID-ANA19>3.3.CO;2-V; NG SY, 1985, MOL CELL BIOL, V5, P2720, DOI 10.1128/MCB.5.10.2720; Numazaki K, 2001, NEUROLOGY, V57, P746, DOI 10.1212/WNL.57.4.746; Pucci E, 2000, ANN NEUROL, V48, P399, DOI 10.1002/1531-8249(200009)48:3<399::AID-ANA20>3.3.CO;2-K; Saiz A, 2001, J NEUROL, V248, P617, DOI 10.1007/s004150170141; Smalling TW, 2002, J CLIN MICROBIOL, V40, P2317, DOI 10.1128/JCM.40.7.2317-2322.2002; Smieja M, 2001, J CLIN MICROBIOL, V39, P1796, DOI 10.1128/JCM.39.5.1796-1801.2001; Sotgiu S, 2001, MULT SCLER, V7, P371, DOI 10.1177/135245850100700605; Sriram S, 2005, J INFECT DIS, V192, P1219, DOI 10.1086/431518; Sriram S, 2002, CLIN DIAGN LAB IMMUN, V9, P1332, DOI 10.1128/CDLI.9.6.1332-1337.2002; Sriram S, 1998, NEUROLOGY, V50, P571, DOI 10.1212/WNL.50.2.571; Sriram S, 1999, ANN NEUROL, V46, P6, DOI 10.1002/1531-8249(199907)46:1<6::AID-ANA4>3.3.CO;2-D; Stratton CW, 2006, TRENDS MICROBIOL, V14, P474, DOI 10.1016/j.tim.2006.09.002; Tang YW, 1999, J CLIN MICROBIOL, V37, P2127, DOI 10.1128/JCM.37.7.2127-2136.1999; Tang YW, 1998, J CLIN MICROBIOL, V36, P2714, DOI 10.1128/JCM.36.9.2714-2717.1998; Tondella MLC, 2002, J CLIN MICROBIOL, V40, P575, DOI 10.1128/JCM.40.2.575-583.2002; WATSON MW, 1991, J CLIN MICROBIOL, V29, P1188, DOI 10.1128/JCM.29.6.1188-1193.1991; Yamamoto Y, 2002, CLIN DIAGN LAB IMMUN, V9, P508, DOI 10.1128/CDLI.9.3.508-514.2002; Yan Y, 2005, J MICROBIOL METH, V61, P127, DOI 10.1016/j.mimet.2004.11.003	51	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5200	10.1371/journal.pone.0005200	http://dx.doi.org/10.1371/journal.pone.0005200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357786	gold, Green Submitted, Green Published			2022-12-27	WOS:000265505900025
J	Henry, S; Richard-Yris, MA; Tordjman, S; Hausberger, M				Henry, Severine; Richard-Yris, Marie-Annick; Tordjman, Sylvie; Hausberger, Martine			Neonatal Handling Affects Durably Bonding and Social Development	PLOS ONE			English	Article							SKIN-TO-SKIN; INFANT-MOTHER ATTACHMENT; NEWBORN-INFANTS; MATERNAL SENSITIVITY; REARING CONDITIONS; EQUUS-CABALLUS; RHESUS-MONKEY; ANIMAL-MODELS; WARD ROUTINES; BEHAVIOR	The neonatal period in humans and in most mammals is characterized by intense mother-young interactions favoring pair bonding and the adaptation of neonates to their new environment. However, in many post-delivery procedures, human babies commonly experience combined maternal separation and intense handling for about one hour post-birth. Currently, the effects of such disturbances on later attachment and on the development of newborns are still debated: clearly, further investigations are required. As animals present good models for controlled experimentation, we chose domestic horses to investigate this issue. Horses, like humans, are characterized by single births, long lactating periods and selective mother-infant bonds. Routine postnatal procedures for foals, as for human babies, also involve intense handling and maternal separation. In the present study, we monitored the behavior of foals from early stages of development to "adolescence'', in a normal ecological context (social groups with adults and peers). Experimental foals, separated from their mothers and handled for only 1 hour post-birth, were compared to control foals, left undisturbed after birth. Our results revealed short- and long-term effects of this unique neonatal experience on attachment and subsequent social competences. Thus, experimental foals presented patterns of insecure attachment to their mothers (strong dependence on their mothers, little play) and impaired social competences (social withdrawal, aggressiveness) at all ages. We discuss these results in terms of mother-young interactions, timing of interactions and relationships between bonding and subsequent social competences. Our results indicate that this ungulate species could become an interesting animal model. To our knowledge, this is the first clear demonstration that intervention just after birth affects bonding and subsequent social competences (at least until "adolescence''). It opens new research directions for studies on both humans and other animals.			Henry, S (corresponding author), Univ Rennes 1, CNRS, UMR Ethos Ethol Anim & Humaine 6552, Rennes, France.	severine.henry@univ-rennes1.fr						ACOLET D, 1989, ACTA PAEDIATR SCAND, V78, P189, DOI 10.1111/j.1651-2227.1989.tb11055.x; Ainsworth M., 1978, PATTERNS ATTACHMENT; ALI Z, 1981, DEV MED CHILD NEUROL, V23, P337; Als H., 1995, ZERO 3, V16, P1; Anand KJS, 2000, BIOL NEONATE, V77, P69, DOI 10.1159/000014197; Arnold JL, 2002, DEV PSYCHOBIOL, V41, P205, DOI 10.1002/dev.10069; Bertin A, 2007, DEV PSYCHOBIOL, V49, P362, DOI 10.1002/dev.20223; BLASS EM, 1995, BEHAV NEUROSCI, V109, P342, DOI 10.1037/0735-7044.109.2.342; BLASS EM, 1980, SCIENCE, V210, P15, DOI 10.1126/science.6997992; Blass EM, 1999, PAIN, V83, P611, DOI 10.1016/S0304-3959(99)00166-9; Bowlby J, 1969, ATTACHMENT LOSS SEPA; BRAKE SC, 1982, DEV PSYCHOBIOL, V15, P529, DOI 10.1002/dev.420150605; Buranasin B, 1991, Asia Pac J Public Health, V5, P217; Bystrova K, 2003, ACTA PAEDIATR, V92, P320; Caldji C, 2000, NEUROPSYCHOPHARMACOL, V22, P219, DOI 10.1016/S0893-133X(99)00110-4; CARSON K, 1983, APPL ANIM ETHOL, V10, P165, DOI 10.1016/0304-3762(83)90138-4; CHAMPOUX M, 1989, AM J PRIMATOL, V19, P111, DOI 10.1002/ajp.1350190204; CHRISTENSSON K, 1995, ACTA PAEDIATR, V84, P468, DOI 10.1111/j.1651-2227.1995.tb13676.x; CHRISTENSSON K, 1992, ACTA PAEDIATR, V81, P488, DOI 10.1111/j.1651-2227.1992.tb12280.x; Crowell-Davis SL, 2005, Domestic Horse: The Origins, Development and Management of Its Behaviour, P126; CROWELLDAVIS SL, 1986, ANIM BEHAV, V34, P1007, DOI 10.1016/S0003-3472(86)80159-2; DECHATEAU P, 1977, ACTA PAEDIATR SCAND, V66, P145, DOI 10.1111/j.1651-2227.1977.tb07826.x; EGELAND B, 1984, CHILD DEV, V55, P753, DOI 10.1111/j.1467-8624.1984.tb03813.x; EGELAND B, 1987, PSYCHOL MALTREATMENT, P110; Fairbanks LA., 1996, ADV STUDY BEHAV VOL, V25, P579, DOI [10.1016/S0065-3454(08)60343-5, DOI 10.1016/S0065-3454(08)60343-5]; Feldman R, 2007, J CHILD PSYCHOL PSYC, V48, P329, DOI 10.1111/j.1469-7610.2006.01701.x; Ferber SG, 2004, PEDIATRICS, V113, P858, DOI 10.1542/peds.113.4.858; Fleming AS, 1999, NEUROSCI BIOBEHAV R, V23, P673, DOI 10.1016/S0149-7634(99)00011-1; FLEMING AS, 2002, HDB PARENTING BIOL E, P00061; GOLDBERG S, 1986, CHILD DEV, V57, P37, DOI 10.2307/1130635; Gottlieb G, 2004, SOC DEV, V13, P311, DOI 10.1111/j.1467-9507.2004.000269.x; Goursaud AP, 1999, PHYSIOL BEHAV, V67, P49, DOI 10.1016/S0031-9384(99)00037-2; Gray L, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e14; HALES DJ, 1977, DEV MED CHILD NEUROL, V19, P454; HARLOW HF, 1965, P NATL ACAD SCI USA, V54, P90, DOI 10.1073/pnas.54.1.90; Hausberger M, 2007, J COMP PSYCHOL, V121, P109, DOI 10.1037/0735-7036.121.1.109; Henry S, 2006, DEV PSYCHOBIOL, V48, P712, DOI 10.1002/dev.20189; HINDE RA, 1971, ANIM BEHAV, V19, P165, DOI 10.1016/S0003-3472(71)80152-5; HINDE RA, 1966, NATURE, V210, P1021, DOI 10.1038/2101021a0; HOFER MA, 1987, CHILD DEV, V58, P633, DOI 10.2307/1130203; HWANG CP, 1981, EARLY HUM DEV, V5, P279, DOI 10.1016/0378-3782(81)90035-9; Jaffe J, 2001, MONOGR SOC RES CHILD, V66, P1, DOI 10.1111/1540-5834.00137; Jansson UM, 1995, J TROP PEDIATRICS, V41, P360, DOI 10.1093/tropej/41.6.360; Klaus M, 1998, Pediatrics, V102, P1244; Klaus M, 2001, BIRTH-ISS PERINAT C, V28, P274, DOI 10.1046/j.1523-536X.2001.00274.x; KLAUS MH, 1970, PEDIATRICS, V46, P187; KLAUS MH, 1972, NEW ENGL J MED, V286, P460, DOI 10.1056/NEJM197203022860904; Koepke JE, 1997, INFANT BEHAV DEV, V20, P93, DOI 10.1016/S0163-6383(97)90064-3; LAMB ME, 1977, CHILD DEV, V48, P167, DOI 10.1111/j.1467-8624.1977.tb04257.x; LEVY F, 1983, PHYSIOL BEHAV, V31, P687, DOI 10.1016/S0031-9384(83)80004-3; Liu D, 2000, J NEUROENDOCRINOL, V12, P5; LONG JG, 1980, PEDIATRICS, V65, P203, DOI 10.1542/peds.65.2.203; Lvoff NM, 2000, ARCH PEDIAT ADOL MED, V154, P474, DOI 10.1001/archpedi.154.5.474; Lyons DM, 1998, DEV PSYCHOBIOL, V32, P285, DOI 10.1002/(SICI)1098-2302(199805)32:4<285::AID-DEV3>3.3.CO;2-N; Matthiesen AS, 2001, BIRTH-ISS PERINAT C, V28, P13, DOI 10.1046/j.1523-536x.2001.00013.x; McElwain NL, 2006, J FAM PSYCHOL, V20, P247, DOI 10.1037/0893-3200.20.2.247; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; Michelsson K, 1996, ACTA PAEDIATR, V85, P471, DOI 10.1111/j.1651-2227.1996.tb14064.x; MILLER RM, 1991, IMPRINT TRAINING NEW; Mooncey S, 1997, INFANT BEHAV DEV, V20, P553, DOI 10.1016/S0163-6383(97)90045-X; Moons CPH, 2005, APPL ANIM BEHAV SCI, V91, P321, DOI 10.1016/j.applanim.2004.10.007; Morelius E, 2006, EARLY HUM DEV, V82, P669, DOI 10.1016/j.earlhumdev.2005.12.013; Nievar MA, 2008, SOC DEV, V17, P102, DOI 10.1111/j.1467-9507.2007.00417.x; NOIROT E, 1983, BEHAV PROCESS, V8, P65, DOI 10.1016/0376-6357(83)90044-X; Nowak R, 1997, PHYSIOL BEHAV, V62, P681, DOI 10.1016/S0031-9384(97)00079-6; Nyqvist KH, 1997, MIDWIFERY, V13, P24, DOI 10.1016/S0266-6138(97)90029-2; OSWALT GL, 1975, DEV PSYCHOBIOL, V8, P129, DOI 10.1002/dev.420080205; PASTOR DL, 1981, DEV PSYCHOL, V17, P326, DOI 10.1037/0012-1649.17.3.326; PEDERSON DR, 1990, CHILD DEV, V61, P1974, DOI 10.1111/j.1467-8624.1990.tb03579.x; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Poindron P, 1993, Oxf Rev Reprod Biol, V15, P311; POINDRON P, 1993, REPROD MAMMALS MAN, P553; Polan HJ, 1999, DEV PSYCHOBIOL, V34, P269, DOI 10.1002/(SICI)1098-2302(199905)34:2<269::AID-DEV3>3.0.CO;2-L; Pryce Christopher R., 1996, Advances in the Study of Behavior, V25, P423; Pryce CR, 2005, NEUROSCI BIOBEHAV R, V29, P649, DOI 10.1016/j.neubiorev.2005.03.011; Pryce CR, 2001, BEHAV NEUROSCI, V115, P71, DOI 10.1037//0735-7044.115.1.71; RIGHARD L, 1990, LANCET, V336, P1105, DOI 10.1016/0140-6736(90)92579-7; Rosenblatt J. S., 1979, Advances in the Study of Behavior, V10, P225, DOI 10.1016/S0065-3454(08)60096-0; ROSENBLUM LA, 1984, CHILD DEV, V55, P305, DOI 10.1111/j.1467-8624.1984.tb00293.x; SCHAAL B, 1995, BEHAVIOUR, V132, P351, DOI 10.1163/156853995X00603; Schaal B, 1998, BIOL NEONATE, V74, P266, DOI 10.1159/000014033; SCHAPIRO S, 1970, PHYSIOL BEHAV, V5, P815, DOI 10.1016/0031-9384(70)90285-4; SELIGMAN ME, 1968, J ABNORM PSYCHOL, V73, P256, DOI 10.1037/h0025831; Sevi A, 2003, APPL ANIM BEHAV SCI, V83, P41, DOI 10.1016/S0168-1591(03)00088-1; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Simpson BS, 2002, APPL ANIM BEHAV SCI, V78, P303, DOI 10.1016/S0168-1591(02)00107-7; SMOTHERMAN WP, 1990, PHYSIOL BEHAV, V47, P863, DOI 10.1016/0031-9384(90)90010-2; Sroufe LA, 2005, ATTACH HUM DEV, V7, P349, DOI 10.1080/14616730500365928; SROUFE LA, 1983, CHILD DEV, V54, P1615, DOI 10.2307/1129825; Stern J.M., 1996, ADV STUD BEHAV, V25, P243; VARENDI H, 1994, LANCET, V344, P989, DOI 10.1016/S0140-6736(94)91645-4; Veissier I, 1998, APPL ANIM BEHAV SCI, V57, P233, DOI 10.1016/S0168-1591(98)00099-9; Waring G.H., 2003, HORSE BEHAV BEHAV TR; WATERS E, 1979, CHILD DEV, V50, P821, DOI 10.2307/1128949; WIDSTROM AM, 1993, ACTA PAEDIATR, V82, P281, DOI 10.1111/j.1651-2227.1993.tb12660.x; Winberg J, 2005, DEV PSYCHOBIOL, V47, P217, DOI 10.1002/dev.20094; WOLFF A, 1994, ETHOLOGY, V96, P1, DOI 10.1111/j.1439-0310.1994.tb00876.x; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	109	35	36	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5216	10.1371/journal.pone.0005216	http://dx.doi.org/10.1371/journal.pone.0005216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437RX	19352503	gold, Green Published, Green Submitted			2022-12-27	WOS:000265505700027
J	Abel, J; Eskeland, R; Raffa, GD; Kremmer, E; Imhof, A				Abel, Jochen; Eskeland, Ragnhild; Raffa, Grazia D.; Kremmer, Elisabeth; Imhof, Axel			Drosophila HP1c Is Regulated by an Auto-Regulatory Feedback Loop through Its Binding Partner Woc	PLOS ONE			English	Article								HP1 is a major component of chromatin and regulates gene expression through its binding to methylated histone H3. Most eukaryotes express at least three isoforms of HP1 with similar domain architecture. However, despite the common specificity for methylated histone H3, the three HP1 isoforms bind to different regions of the genome. Most of the studies so far focused on the HP1a isoform and its role in transcriptional regulation. As HP1a requires additional factors to bind methylated chromatin in vitro, we wondered whether another isoform might also require additional targeting factors. Indeed, we found that HP1c interacts with the DNA binding factors Woc and Row and requires Woc to become targeted to chromatin in vivo. Moreover, we show that the interaction between HP1c and Woc constitutes a transcriptional feedback loop that operates to balance the concentration of HP1c within the cell. This regulation may prevent HP1c from binding to methylated heterochromatin.			Abel, J (corresponding author), Univ Munich, Munich Ctr Integrated Prot Sci, Munich, Germany.	lmhof@lmu.de	Imhof, Axel/AAU-5313-2021; Eskeland, Ragnhild/K-7018-2014; Eskeland, Ragnhild/GSN-9383-2022; Eskeland, Ragnhild/AFM-2892-2022	Imhof, Axel/0000-0003-2993-8249; Eskeland, Ragnhild/0000-0003-2789-3171; Eskeland, Ragnhild/0000-0003-2789-3171; raffa, grazia daniela/0000-0002-5072-5240				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bonaldi T, 2008, MOL CELL, V31, P762, DOI 10.1016/j.molcel.2008.07.018; Clegg NJ, 1998, GENOME, V41, P495, DOI 10.1139/gen-41-4-495; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; De Lucia F, 2005, NUCLEIC ACIDS RES, V33, P2852, DOI 10.1093/nar/gki584; du Chene I, 2007, EMBO J, V26, P424, DOI 10.1038/sj.emboj.7601517; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Font-Burgada J, 2008, GENE DEV, V22, P3007, DOI 10.1101/gad.481408; Gocke CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003255; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kato M, 2007, CELL STRUCT FUNCT, V32, P57, DOI 10.1247/csf.06032; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; Kulkarni S, 1999, GENOMICS, V55, P118, DOI 10.1006/geno.1998.5634; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Lu BY, 2000, GENETICS, V155, P699; Mateescu B, 2008, EMBO REP, V9, P267, DOI 10.1038/embor.2008.1; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; MURAWSKA M, MOL CELL BIOL; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Raffa GD, 2005, MOL CELL, V20, P821, DOI 10.1016/j.molcel.2005.12.003; Reiter A, 1998, BLOOD, V92, P1735, DOI 10.1182/blood.V92.5.1735.417k11_1735_1742; SADAIE M, 2008, MOL CELL BIOL; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Smedley D, 1999, GENOMICS, V60, P244, DOI 10.1006/geno.1999.5918; Smothers JF, 2001, MOL CELL BIOL, V21, P2555, DOI 10.1128/MCB.21.7.2555-2569.2001; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Vermaak D, 2005, PLOS GENET, V1, P96, DOI 10.1371/journal.pgen.0010009; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Warren JT, 2001, MOL CELL ENDOCRINOL, V181, P1, DOI 10.1016/S0303-7207(01)00404-X; Wismar J, 2000, DEV BIOL, V226, P1, DOI 10.1006/dbio.2000.9811; Yahi H, 2008, J BIOL CHEM, V283, P23692, DOI 10.1074/jbc.M802647200	39	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5089	10.1371/journal.pone.0005089	http://dx.doi.org/10.1371/journal.pone.0005089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352434	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505300012
J	Wernimont, A; Edwards, A				Wernimont, Amy; Edwards, Aled			In Situ Proteolysis to Generate Crystals for Structure Determination: An Update	PLOS ONE			English	Article								For every 100 purified proteins that enter crystallization trials, an average of 30 form crystals, and among these only 13-15 crystallize in a form that enables structure determination. In 2007, Dong et al reported that the addition of trace amounts of protease to crystallization trials-in situ proteolysis-significantly increased the number of proteins in a given set that produce diffraction quality crystals. 69 proteins that had previously resisted structure determination were subjected to crystallization with in situ proteolysis and ten crystallized in a form that led to structure determination (14.5% success rate). Here we apply in situ proteolysis to over 270 new soluble proteins that had failed in the past to produce crystals suitable for structure determination. These proteins had produced no crystals, crystals that diffracted poorly, or produced twinned and/or unmanageable diffraction data. The new set includes yeast and prokaryotic proteins, enzymes essential to protozoan parasites, and human proteins such as GTPases, chromatin remodeling proteins, and tyrosine kinases. 34 proteins yielded deposited crystal structures of 2.8 A resolution or better, for an overall 12.6% success rate, and at least ten more yielded well-diffracting crystals presently in refinement. The success rate among proteins that had previously crystallized was double that of those that had never before yielded crystals. The overall success rate is similar to that observed in the smaller study, and appears to be higher than any other method reported to rescue stalled protein crystallography projects.			Wernimont, A (corresponding author), Univ Toronto, Midwest Ctr Struct Genom & Struct Genom Consortiu, Toronto, ON, Canada.	awernimont@gmail.com	Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130; Edwards, Aled/0000-0002-4782-6016	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BOCHKAREV A, 1995, CELL, V83, P39, DOI 10.1016/0092-8674(95)90232-5; COHEN SL, 1995, PROTEIN SCI, V4, P1088, DOI 10.1002/pro.5560040607; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dale GE, 2003, J STRUCT BIOL, V142, P88, DOI 10.1016/S1047-8477(03)00041-8; Derewenda ZS, 2004, METHODS, V34, P354, DOI 10.1016/j.ymeth.2004.03.024; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Gao Xia, 2005, Journal of Structural and Functional Genomics, V6, P129, DOI 10.1007/s10969-005-1918-5; Grabowski M, 2007, CURR OPIN STRUC BIOL, V17, P347, DOI 10.1016/j.sbi.2007.06.003; Graslund S, 2008, PROTEIN EXPRES PURIF, V58, P210, DOI 10.1016/j.pep.2007.11.008; Kim YC, 2008, NAT METHODS, V5, P853, DOI 10.1038/nmeth1008-853; Leulliot N, 2005, ACTA CRYSTALLOGR D, V61, P664, DOI 10.1107/S0907444905000028; Malawski GA, 2006, PROTEIN SCI, V15, P2718, DOI 10.1110/ps.062491906; O'Toole N, 2004, PROTEINS, V56, P201, DOI 10.1002/prot.20060; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005	18	68	72	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5094	10.1371/journal.pone.0005094	http://dx.doi.org/10.1371/journal.pone.0005094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352432	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505300015
J	Zhang, G; Ignatova, Z				Zhang, Gong; Ignatova, Zoya			Generic Algorithm to Predict the Speed of Translational Elongation: Implications for Protein Biogenesis	PLOS ONE			English	Article							TRANSFER-RNA GENES; CODON USAGE; ESCHERICHIA-COLI; COMPLETE GENOME; RARE CODONS; EXPRESSION; SELECTION; RATES; PREFERENCES; FREQUENCIES	Synonymous codon usage and variations in the level of isoaccepting tRNAs exert a powerful selective force on translation fidelity. We have developed an algorithm to evaluate the relative rate of translation which allows large-scale comparisons of the non-uniform translation rate on the protein biogenesis. Using the complete genomes of Escherichia coli and Bacillus subtilis we show that stretches of codons pairing to minor tRNAs form putative sites to locally attenuate translation; thereby the tendency is to cluster in near proximity whereas long contiguous stretches of slow-translating triplets are avoided. The presence of slow-translating segments positively correlates with the protein length irrespective of the protein abundance. The slow-translating clusters are predominantly located down-stream of the domain boundaries presumably to fine-tune translational accuracy with the folding fidelity of multidomain proteins. Translation attenuation patterns at highly structurally and functionally conserved domains are preserved across the species suggesting a concerted selective pressure on the codon selection and species-specific tRNA abundance in these regions.	[Zhang, Gong; Ignatova, Zoya] Univ Potsdam, Dept Biochem, Inst Biochem & Biol, Potsdam, Germany	University of Potsdam	Zhang, G (corresponding author), Univ Potsdam, Dept Biochem, Inst Biochem & Biol, Potsdam, Germany.	ignatova@uni-potsdam.de	Zhang, Gong/Q-7419-2017	Zhang, Gong/0000-0003-0418-3433; Ignatova, Zoya/0000-0002-9478-8825	SysMO; KAAD [fellowship]	SysMO; KAAD	This work was supported by SysMO (Kosmobac project) to ZI and KAAD-fellowship to GZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI H, 1994, GENETICS, V136, P927; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Apic Gordana, 2003, Journal of Structural and Functional Genomics, V4, P67, DOI 10.1023/A:1026113408773; Barak Z, 1996, J MOL BIOL, V256, P676, DOI 10.1006/jmbi.1996.0117; BONEKAMP F, 1989, J BACTERIOL, V171, P5812, DOI 10.1128/jb.171.11.5812-5816.1989; Buchan JR, 2006, NUCLEIC ACIDS RES, V34, P1015, DOI 10.1093/nar/gkj488; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; CHEN GFT, 1990, NUCLEIC ACIDS RES, V18, P1465, DOI 10.1093/nar/18.6.1465; Clarke TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003412; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Fedorov AN, 1997, J BIOL CHEM, V272, P32715, DOI 10.1074/jbc.272.52.32715; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; Gerstein M, 1998, FOLD DES, V3, P497, DOI 10.1016/S1359-0278(98)00066-2; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hubbard SJ, 1996, J MOL BIOL, V261, P289, DOI 10.1006/jmbi.1996.0460; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IRWIN B, 1995, J BIOL CHEM, V270, P22801, DOI 10.1074/jbc.270.39.22801; JANSSEN GMC, 1988, J BIOL CHEM, V263, P1773; Kanaya S, 2001, J MOL EVOL, V53, P290, DOI 10.1007/s002390010219; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; KRASHENINNIKOV I A, 1989, Biokhimiya, V54, P187; Kruger MK, 1998, J MOL BIOL, V284, P621, DOI 10.1006/jmbi.1998.2196; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102; Makhoul CH, 2002, J BIOMOL STRUCT DYN, V20, P413, DOI 10.1080/07391102.2002.10506859; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Phoenix DA, 1997, FEMS MICROBIOL LETT, V155, P63, DOI 10.1016/S0378-1097(97)00367-4; PURVIS IJ, 1987, J MOL BIOL, V193, P413, DOI 10.1016/0022-2836(87)90230-0; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Rodnina MV, 2001, TRENDS BIOCHEM SCI, V26, P124, DOI 10.1016/S0968-0004(00)01737-0; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Sorensen MA, 1998, METH MOL B, V77, P129; Teichmann SA, 1998, P NATL ACAD SCI USA, V95, P14658, DOI 10.1073/pnas.95.25.14658; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; TU CL, 1992, P NATL ACAD SCI USA, V89, P8636, DOI 10.1073/pnas.89.18.8636; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; WALL D, 1994, J BIOL CHEM, V269, P5446; Withey JH, 2003, ANNU REV MICROBIOL, V57, P101, DOI 10.1146/annurev.micro.57.030502.090945; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	52	64	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5036	10.1371/journal.pone.0005036	http://dx.doi.org/10.1371/journal.pone.0005036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343177	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500800005
J	Cobb, JE; White, SJ; Harrap, SB; Ellis, JA				Cobb, Joanna E.; White, Stefan J.; Harrap, Stephen B.; Ellis, Justine A.			Androgen Receptor Copy Number Variation and Androgenetic Alopecia: A Case-Control Study	PLOS ONE			English	Article								Background: The functional polymorphism that explains the established association of the androgen receptor (AR) with androgenetic alopecia (AGA) remains unidentified, but Copy Number Variation (CNV) might be relevant. CNV involves changes in copy number of large segments of DNA, leading to the altered dosage of gene regulators or genes themselves. Two recent reports indicate regions of CNV in and around AR, and these have not been studied in relation to AGA. The aim of this preliminary case-control study was to determine if AR CNV is associated with AGA, with the hypothesis that CNV is the functional AR variant contributing to this condition. Methodology/Principal Findings: Multiplex Ligation-dependent Probe Amplification was used to screen for CNV in five AR exons and a conserved, non-coding region upstream of AR in 85 men carefully selected as cases and controls for maximal phenotypic contrast. There was no evidence of CNV in AR in any of the cases or controls, and thus no evidence of significant association between AGA and AR CNV. Conclusions/Significance: The results suggest this form of genomic variation at the AR locus is unlikely to predispose to AGA.	[Cobb, Joanna E.; Harrap, Stephen B.; Ellis, Justine A.] Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia; [White, Stefan J.; Ellis, Justine A.] Murdoch Childrens Res Inst, Parkville, Vic, Australia	University of Melbourne; Murdoch Children's Research Institute	Cobb, JE (corresponding author), Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia.	justine.ellis@mcri.edu.au	Ellis, Justine A/G-5006-2011	Harrap, Stephen/0000-0003-2907-6714; Ellis, Justine/0000-0003-4103-4445; Cobb, Joanna/0000-0002-2760-3114	NHMRC [Fellowship]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	JE: NHMRC Australia Capacity Building Grant in Population Health. SW: NHMRC Fellowship (Australia). www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Ellis JA, 2001, J INVEST DERMATOL, V116, P452, DOI 10.1046/j.1523-1747.2001.01261.x; Ellis JA, 2007, HUM GENET, V121, P451, DOI 10.1007/s00439-006-0317-8; Harrap SB, 2000, AM J EPIDEMIOL, V152, P704, DOI 10.1093/aje/152.8.704; Hayes VM, 2005, CANCER EPIDEM BIOMAR, V14, P993, DOI 10.1158/1055-9965.EPI-04-0778; Hillmer AM, 2005, AM J HUM GENET, V77, P140, DOI 10.1086/431425; Lalic T, 2005, EUR J HUM GENET, V13, P1231, DOI 10.1038/sj.ejhg.5201465; Levy-Nissenbaum E, 2005, EUR J DERMATOL, V15, P339; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Taylor R, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-60; White SJ, 2004, HUM MUTAT, V24, P86, DOI 10.1002/humu.20054	15	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5081	10.1371/journal.pone.0005081	http://dx.doi.org/10.1371/journal.pone.0005081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340294	Green Published, gold			2022-12-27	WOS:000265500700012
J	Debellis, L; Diana, A; Arcidiacono, D; Fiorotto, R; Portincasa, P; Altomare, DF; Spirli, C; de Bernard, M				Debellis, Lucantonio; Diana, Anna; Arcidiacono, Diletta; Fiorotto, Romina; Portincasa, Piero; Altomare, Donato Francesco; Spirli, Carlo; de Bernard, Marina			The Vibrio cholerae Cytolysin Promotes Chloride Secretion from Intact Human Intestinal Mucosa	PLOS ONE			English	Article								Background: The pathogenicity of the Vibrio cholerae strains belonging to serogroup O1 and O139 is due to the production of virulence factors such as cholera toxin (CT) and the toxin-coregulated pilus (TCP). The remaining serogroups, which mostly lack CT and TCP, are more frequently isolated from aquatic environmental sources than from clinical samples; nevertheless, these strains have been reported to cause human disease, such as sporadic outbreaks of watery diarrhoea and inflammatory enterocolitis. This evidence suggested the possibility that other virulence factor(s) than cholera toxin might be crucial in the pathogenesis of Vibrio cholerae-induced diarrhoea, but their nature remains unknown. VCC, the hemolysin produced by virtually all Vibrio cholerae strains, has been proposed as a possible candidate, though a clear-cut demonstration attesting VCC as crucial in the pathogenesis of Vibrio cholerae-induced diarrhoea is still lacking. Methodology/Principal Findings: Electrophysiological parameters and paracellular permeability of stripped human healthy colon tissues, obtained at subtotal colectomy, mounted in Ussing chamber were studied in the presence or absence of VCC purified from culture supernatants of V. cholerae O1 El Tor strain. Short circuit current (I-SC) and transepithelial resistance (R-T) were measured by a computerized voltage clamp system. The exposure of sigmoid colon specimens to 1 nM VCC resulted in an increase of I-SC by 20.7%, with respect to the basal values, while R-T was reduced by 12.3%. Moreover, increase in I-SC was abolished by bilateral Cl- reduction. Conclusion/Significance: Our results demonstrate that VCC, by forming anion channels on the apical membrane of enterocytes, triggers an outward transcellular flux of chloride. Such an ion movement, associated with the outward movement of Na+ and water, might be responsible for the diarrhoea caused by the non-toxigenic strains of Vibrio cholerae.	[Debellis, Lucantonio; Diana, Anna] Univ Bari, Dept Gen & Environm Physiol, Bari, Italy; [Arcidiacono, Diletta; de Bernard, Marina] Venetian Inst Mol Med, Padua, Italy; [Fiorotto, Romina; Spirli, Carlo] Yale Univ, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA; [Portincasa, Piero] Univ Med Sch, Dept Internal & Publ Med, Bari, Italy; [Altomare, Donato Francesco] Univ Bari, Policlin, Dept Emergency, Organ Transplant Gen Surg & Liver Transplant Units, I-70121 Bari, Italy; [de Bernard, Marina] Univ Padua, Dept Biol, I-35100 Padua, Italy	Universita degli Studi di Bari Aldo Moro; Veneto Institute Molecular Medicine; Yale University; Universita degli Studi di Bari Aldo Moro; University of Padua	Debellis, L (corresponding author), Univ Bari, Dept Gen & Environm Physiol, Bari, Italy.	marina.debernard@unipd.it	Arcidiacono, Diletta/AAZ-8127-2021; Fiorotto, Romina/K-4088-2012; Arcidiacono, Diletta/B-2557-2017	Arcidiacono, Diletta/0000-0002-4417-6513; Arcidiacono, Diletta/0000-0002-4417-6513; Altomare, Donato Francesco/0000-0001-8980-2752; Debellis, Lucantonio/0000-0002-7571-0969; de Bernard, Marina/0000-0002-0091-4502; portincasa, piero/0000-0001-5359-1471	Italian Ministry of University and Research [2006064313]; Progetti di Ricerca di Ateneo [CPDA074121/07]; Fondazione Guido Berlucchi; University of Bari [2007]; ALF/AASLD liver scholar award	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Progetti di Ricerca di Ateneo; Fondazione Guido Berlucchi; University of Bari; ALF/AASLD liver scholar award	This work was supported by the following grants: Italian Ministry of University and Research, Prin projects (grant 2006064313), Progetti di Ricerca di Ateneo (grant CPDA074121/07) and Fondazione Guido Berlucchi to M.d.B.; University of Bari grant 2007 to L.D. C.S. is a recipient of an ALF/AASLD liver scholar award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Saka HA, 2008, MICROB PATHOGENESIS, V44, P118, DOI 10.1016/j.micpath.2007.08.013; ALM RA, 1988, MOL MICROBIOL, V2, P481; Alrefai WA, 2001, DIGEST DIS SCI, V46, P2209, DOI 10.1023/A:1011971117097; [Anonymous], 2001, Wkly Epidemiol Rec, V76, P117; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Bhakdi S, 1996, ARCH MICROBIOL, V165, P73, DOI 10.1007/s002030050300; BIWERSI J, 1991, BIOCHEMISTRY-US, V30, P7879, DOI 10.1021/bi00246a001; BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; Coelho A, 2000, INFECT IMMUN, V68, P1700, DOI 10.1128/IAI.68.3.1700-1705.2000; COELHO A, 1995, J CLIN MICROBIOL, V33, P114, DOI 10.1128/JCM.33.1.114-118.1995; Debellis L, 2001, AM J PHYSIOL-GASTR L, V281, pG1440, DOI 10.1152/ajpgi.2001.281.6.G1440; Eichstaedt S, 2009, CELL CALCIUM, V45, P165, DOI 10.1016/j.ceca.2008.09.001; Faruque SM, 2004, P NATL ACAD SCI USA, V101, P2123, DOI 10.1073/pnas.0308485100; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Figueroa-Arredondo P, 2001, INFECT IMMUN, V69, P1613, DOI 10.1128/IAI.69.3.1613-1624.2001; FINCH MJ, 1987, AM J TROP MED HYG, V36, P393, DOI 10.4269/ajtmh.1987.36.393; Flemstrom G, 1999, AM J PHYSIOL-GASTR L, V277, pG375, DOI 10.1152/ajpgi.1999.277.2.G375; Gitter AH, 2000, PFLUG ARCH EUR J PHY, V439, P477, DOI 10.1007/s004240050966; Greger R, 1997, NEWS PHYSIOL SCI, V12, P62; HALL RH, 1990, INFECT IMMUN, V58, P3375, DOI 10.1128/IAI.58.10.3375-3379.1990; HICHINOSE Y, 1987, INFECT IMMUN, V55, P1090; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Krasilnikov OV, 2007, BIOCHIMIE, V89, P271, DOI 10.1016/j.biochi.2006.12.003; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Laohachai KN, 2003, TOXICON, V42, P687, DOI 10.1016/j.toxicon.2003.08.010; Mall M, 1999, AM J PHYSIOL-GASTR L, V277, pG709, DOI 10.1152/ajpgi.1999.277.3.G709; Mayol JM, 2006, WORLD J GASTROENTERO, V12, P5523, DOI 10.3748/wjg.v12.i34.5523; Moschetta A, 2003, BIOL CELL, V95, P115, DOI 10.1016/S0248-4900(03)00011-X; Moschioni M, 2002, CELL MICROBIOL, V4, P397, DOI 10.1046/j.1462-5822.2002.00199.x; Nagamune K, 1997, J BIOL CHEM, V272, P1338, DOI 10.1074/jbc.272.2.1338; Ninin E, 2000, EUR J CLIN MICROBIOL, V19, P489, DOI 10.1007/s100960000296; Pantano S, 2006, TOXICON, V47, P35, DOI 10.1016/j.toxicon.2005.09.007; Peixoto EBMI, 2005, CELL STRUCT FUNCT, V29, P165, DOI 10.1247/csf.29.165; Prasad M, 1997, SURGERY, V121, P430, DOI 10.1016/S0039-6060(97)90314-7; Saha D. R., 2006, Indian Journal of Experimental Biology, V44, P221; Saha PK, 1996, J CLIN MICROBIOL, V34, P1114, DOI 10.1128/JCM.34.5.1114-1117.1996; Saka HA, 2007, AUTOPHAGY, V3, P363, DOI 10.4161/auto.4159; SANDLE GI, 1986, GUT, V27, P999, DOI 10.1136/gut.27.9.999; SANYAL SC, 1984, AUST J EXP BIOL MED, V62, P515, DOI 10.1038/icb.1984.48; Singh DV, 2001, APPL ENVIRON MICROB, V67, P910, DOI 10.1128/AEM.67.2.910-921.2001; Spirli C, 2001, GASTROENTEROLOGY, V121, P156, DOI 10.1053/gast.2001.25516; Strugala V, 2003, P NUTR SOC, V62, P237, DOI 10.1079/PNS2002205; Yamada Shozo, 1990, Endocr Pathol, V1, P58, DOI 10.1007/BF02915156; Zitzer A, 1999, J BIOL CHEM, V274, P1375, DOI 10.1074/jbc.274.3.1375; Zitzer A, 1997, EUR J BIOCHEM, V247, P209, DOI 10.1111/j.1432-1033.1997.00209.x; ZITZER AO, 1993, ZBL BAKT-INT J MED M, V279, P494, DOI 10.1016/S0934-8840(11)80421-4	46	24	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5074	10.1371/journal.pone.0005074	http://dx.doi.org/10.1371/journal.pone.0005074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333391	gold, Green Published, Green Submitted			2022-12-27	WOS:000265499900020
J	Ralser, M; Zeidler, U; Lehrach, H				Ralser, Markus; Zeidler, Ute; Lehrach, Hans			Interfering with Glycolysis Causes Sir2-Dependent Hyper-Recombination of Saccharomyces cerevisiae Plasmids	PLOS ONE			English	Article								Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a key metabolic regulator implicated in a variety of cellular processes. It functions as a glycolytic enzyme, a protein kinase, and a metabolic switch under oxidative stress. Its enzymatic inactivation causes a major shift in the primary carbohydrate flux. Furthermore, the protein is implicated in regulating transcription, ER-to-Golgi transport, and apoptosis. We found that Saccharomyces cerevisiae cells null for all GAPDH paralogues (Tdh1, Tdh2, and Tdh3) survived the counter-selection of a GAPDH-encoding plasmid when the NAD+ metabolizing deacetylase Sir2 was overexpressed. This phenotype required a fully functional copy of SIR2 and resulted from hyper-recombination between S. cerevisiae plasmids. In the wild-type background, GAPDH overexpression increased the plasmid recombination rate in a growth-condition dependent manner. We conclude that GAPDH influences yeast episome stability via Sir2 and propose a model for the interplay of Sir2, GAPDH, and the glycolytic flux.			Ralser, M (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	ralser@molgen.mpg.de		Ralser, Markus/0000-0001-9535-7413				Abdullah MFF, 2001, P NATL ACAD SCI USA, V98, P14524, DOI 10.1073/pnas.201529598; BOLES E, 1993, EUR J BIOCHEM, V217, P469, DOI 10.1111/j.1432-1033.1993.tb18266.x; Brachmann CB, 1998, YEAST, V14, P115; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Chiani F, 2006, NUCLEIC ACIDS RES, V34, P5426, DOI 10.1093/nar/gkl678; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Colussi C, 2000, FASEB J, V14, P2266, DOI 10.1096/fj.00-0074com; Cubizolles F, 2006, MOL CELL, V21, P825, DOI 10.1016/j.molcel.2006.02.006; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; Dastoor Z, 2001, J CELL SCI, V114, P1643; Duclos-Vallee JC, 1998, J GEN VIROL, V79, P1665, DOI 10.1099/0022-1317-79-7-1665; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grant Chris M, 2008, J Biol, V7, P1, DOI 10.1186/jbiol63; Grunweller A, 2002, GENETICS, V162, P59; Hadany L, 2003, GENETICS, V165, P2167; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Holtgrefe S, 2008, PHYSIOL PLANTARUM, V133, P211, DOI 10.1111/j.1399-3054.2008.01066.x; Ishii T, 1999, BIOCHEM PHARMACOL, V58, P133, DOI 10.1016/S0006-2952(99)00060-X; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2007, AGEING RES REV, V6, P128, DOI 10.1016/j.arr.2007.04.001; Laschet JJ, 2004, J NEUROSCI, V24, P7614, DOI 10.1523/JNEUROSCI.0868-04.2004; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Masri FA, 2005, AM J RESP CRIT CARE, V172, P597, DOI 10.1164/rccm.200411-1523OC; Matecic M, 2002, GENETICS, V162, P973; MCALISTER L, 1985, J BIOL CHEM, V260, P5019; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NEWMAN SF, 2007, J NEUROSCI RES; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Ralser M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000030; RAVICHANDRAN V, 1994, J BIOL CHEM, V269, P25010; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Shenton D, 2003, BIOCHEM J, V374, P513, DOI 10.1042/BJ20030414; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tisdale EJ, 2007, TRAFFIC, V8, P733, DOI 10.1111/j.1600-0854.2007.00569.x; Verho R, 2003, APPL ENVIRON MICROB, V69, P5892, DOI 10.1128/AEM.69.10.5892-5897.2003; Verho R, 2002, BIOCHEMISTRY-US, V41, P13833, DOI 10.1021/bi0265325; Voss P, 2007, BIOL CHEM, V388, P583, DOI 10.1515/BC.2007.068; Warburg O, 1939, BIOCHEM Z, V303, P40; Wentzel P, 2003, DIABETES, V52, P1222, DOI 10.2337/diabetes.52.5.1222; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	48	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5376	10.1371/journal.pone.0005376	http://dx.doi.org/10.1371/journal.pone.0005376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390637	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514400023
J	Yao, J; Bajjalieh, SM				Yao, Jia; Bajjalieh, Sandra M.			SVOP Is a Nucleotide Binding Protein	PLOS ONE			English	Article							SYNAPTIC VESICLE PROTEIN; SUGAR-TRANSPORT REGULATION; MEMBRANE-PROTEINS; LEVETIRACETAM; SV2; BRAIN; IDENTIFICATION; DETERMINANTS	Background: Synaptic Vesicle Protein 2 (SV2) and SV2-related protein (SVOP) are transporter-like proteins that localize to neurotransmitter-containing vesicles. Both proteins share structural similarity with the major facilitator (MF) family of small molecule transporters. We recently reported that SV2 binds nucleotides, a feature that has also been reported for another MF family member, the human glucose transporter 1 (Glut1). In the case of Glut1, nucleotide binding affects transport activity. In this study, we determined if SVOP also binds nucleotides and assessed its nucleotide binding properties. Methodology/Principal Findings: We performed in vitro photoaffinity labeling experiments with the photoreactive ATP analogue, 8-azido-ATP[gamma] biotin and purified recombinant SVOP-FLAG fusion protein. We found that SVOP is a nucleotide-binding protein, although both its substrate specificity and binding site differ from that of SV2. Within the nucleotides tested, ATP, GTP and NAD show same level of inhibition on SVOP-FLAG labeling. Dose dependent studies indicated that SVOP demonstrates the highest affinity for NAD, in contrast to SV2, which binds both NAD and ATP with equal affinity. Mapping of the binding site revealed a single region spanning transmembrane domains 9-12, which contrasts to the two binding sites in the large cytoplasmic domains in SV2A. Conclusions/Significance: SVOP is the third MF family member to be found to bind nucleotides. Given that the binding sites are unique in SVOP, SV2 and Glut1, this feature appears to have arisen separately.			Yao, J (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	bajjalie@u.washington.edu	Yao, Jia/D-3484-2009; Yao, Jia/E-8711-2011	Yao, Jia/0000-0003-3235-5351	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059842] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH059842, R01MH059842] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ardid D, 2003, EUR J PHARMACOL, V473, P27, DOI 10.1016/S0014-2999(03)01933-2; BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; BAJJALIEH SM, 1993, P NATL ACAD SCI USA, V90, P2150, DOI 10.1073/pnas.90.6.2150; Bornstein P, 1977, Methods Enzymol, V47, P132; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Carreno M, 2007, DRUG TODAY, V43, P769, DOI 10.1358/dot.2007.43.11.1136902; CARRUTHERS A, 1989, BIOCHEMISTRY-US, V28, P8337, DOI 10.1021/bi00447a011; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Enggaard TP, 2006, EUR J PAIN, V10, P193, DOI 10.1016/j.ejpain.2005.03.011; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; FLOOR E, 1989, J NEUROCHEM, V52, P1433, DOI 10.1111/j.1471-4159.1989.tb09190.x; Gillard M, 2006, EUR J PHARMACOL, V536, P102, DOI 10.1016/j.ejphar.2006.02.022; Henderson PJF, 1993, CURR OPIN CELL BIOL, V5, P708, DOI 10.1016/0955-0674(93)90144-F; Jacobsson JA, 2007, GENOMICS, V90, P595, DOI 10.1016/j.ygeno.2007.03.017; Janz R, 1999, NEUROSCIENCE, V94, P1279, DOI 10.1016/S0306-4522(99)00370-X; Janz R, 1998, J NEUROSCI, V18, P9269; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; Levine KB, 1998, BIOCHEMISTRY-US, V37, P12221, DOI 10.1021/bi980585y; Logan MA, 2005, DEV DYNAM, V234, P802, DOI 10.1002/dvdy.20618; LOWE AW, 1988, J CELL BIOL, V106, P51, DOI 10.1083/jcb.106.1.51; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Matagne A, 2008, BRIT J PHARMACOL, V154, P1662, DOI 10.1038/bjp.2008.198; Meco G, 2006, CLIN NEUROPHARMACOL, V29, P265, DOI 10.1097/01.WNF.0000228807.49044.7D; Schivell AE, 2005, MOL CELL NEUROSCI, V29, P56, DOI 10.1016/j.mcn.2004.12.011; Schivell AE, 1996, J BIOL CHEM, V271, P27770, DOI 10.1074/jbc.271.44.27770; Woods SW, 2008, J CLIN PSYCHIAT, V69, P546, DOI 10.4088/JCP.v69n0405; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000; Yao J, 2008, J BIOL CHEM, V283, P20628, DOI 10.1074/jbc.M800738200	32	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5315	10.1371/journal.pone.0005315	http://dx.doi.org/10.1371/journal.pone.0005315			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390693	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514400007
J	Kleene, SJ				Kleene, Steven J.			Limits of Calcium Clearance by Plasma Membrane Calcium ATPase in Olfactory Cilia	PLOS ONE			English	Article							ULTRASTRUCTURAL-LOCALIZATION; SODIUM/CALCIUM EXCHANGER; RECEPTOR NEURONS; CA2+ EXTRUSION; FROG; RAT; CHANNELS; CELLS; AMPLIFICATION; CONDUCTANCE	Background: In any fine sensory organelle, a small influx of Ca2+ can quickly elevate cytoplasmic Ca2+. Mechanisms must exist to clear the ciliary Ca2+ before it reaches toxic levels. One such organelle has been well studied: the vertebrate olfactory cilium. Recent studies have suggested that clearance from the olfactory cilium is mediated in part by plasma membrane Ca2+-ATPase (PMCA). Principal Findings: In the present study, electrophysiological assays were devised to monitor cytoplasmic free Ca2+ in single frog olfactory cilia. Ca2+ was allowed to enter isolated cilia, either through the detached end or through membrane channels. Intraciliary Ca2+ was monitored via the activity of ciliary Ca2+-gated Cl- channels, which are sensitive to free Ca2+ from about 2 to 10 mu M. No significant effect of MgATP on intraciliary free Ca2+ could be found. Carboxyeosin, which has been used to inhibit PMCA, was found to substantially increase a ciliary transduction current activated by cyclic AMP. This increase was ATP-independent. Conclusions: Alternative explanations are suggested for two previous experiments taken to support a role for PMCA in ciliary Ca2+ clearance. It is concluded that PMCA in the cilium plays a very limited role in clearing the micromolar levels of intraciliary Ca2+ produced during the odor response.			Kleene, SJ (corresponding author), Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA.	steve@syrano.acb.uc.edu						Antolin S, 2007, J PHYSIOL-LONDON, V581, P495, DOI 10.1113/jphysiol.2007.131094; Badamdorj D, 2008, MATH METHOD APPL SCI, V31, P1860, DOI 10.1002/mma.1007; BERS DM, 1982, AM J PHYSIOL, V242, pC404, DOI 10.1152/ajpcell.1982.242.5.C404; Brini M, 2000, CELL MOL LIFE SCI, V57, P354, DOI 10.1007/PL00000698; Castillo K, 2007, EUR J NEUROSCI, V26, P2524, DOI 10.1111/j.1460-9568.2007.05863.x; CHA YN, 1971, J GEN PHYSIOL, V57, P202, DOI 10.1085/jgp.57.2.202; Delgado R, 2004, EUR J NEUROSCI, V20, P2975, DOI 10.1111/j.1460-9568.2004.03778.x; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; FARBMAN AI, 1992, CELL BIOL OLFACTION; GRAF E, 1982, BIOCHEMISTRY-US, V21, P4511, DOI 10.1021/bi00261a049; JUNG A, 1994, NEUROREPORT, V5, P1741, DOI 10.1097/00001756-199409080-00013; KERN RC, 1991, BRAIN RES, V546, P8, DOI 10.1016/0006-8993(91)91153-R; KLEENE SJ, 1991, J MEMBRANE BIOL, V120, P75, DOI 10.1007/BF01868593; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Klimmeck D, 2008, NEUROSCIENCE, V151, P901, DOI 10.1016/j.neuroscience.2007.11.023; Kreitzer MA, 2007, J GEN PHYSIOL, V130, P169, DOI 10.1085/jgp.200709737; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; Kwon HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004260; Leinders-Zufall T, 1998, J NEUROSCI, V18, P5630; Lindemann B, 2001, BIOPHYS J, V80, P1712, DOI 10.1016/S0006-3495(01)76142-5; LO YH, 1994, BBA-BIOMEMBRANES, V1192, P153, DOI 10.1016/0005-2736(94)90113-9; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Mackiewicz U, 2009, CARDIOVASC RES, V81, P546, DOI 10.1093/cvr/cvn285; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; Menco BPM, 1997, CHEM SENSES, V22, P295, DOI 10.1093/chemse/22.3.295; MENCO BPM, 1980, CELL TISSUE RES, V207, P183; Menco BPM, 1998, CHEM SENSES, V23, P137, DOI 10.1093/chemse/23.2.137; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Noe J, 1997, NEUROCHEM INT, V30, P523, DOI 10.1016/S0197-0186(96)00090-3; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; REESE TS, 1965, J CELL BIOL, V25, P209, DOI 10.1083/jcb.25.2.209; REGA AF, 1973, BIOCHEM J, V136, P185, DOI 10.1042/bj1360185; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Shmigol A, 1998, PFLUG ARCH EUR J PHY, V437, P158, DOI 10.1007/s004240050761; SZEWCZYK M, 2007, PFLUGERS ARCH, V456, P255; Takeuchi H, 2008, J NEUROSCI, V28, P766, DOI 10.1523/JNEUROSCI.3531-07.2008; Tian J, 2008, PHYSIOLOGY, V23, P205, DOI 10.1152/physiol.00008.2008; Wanaverbecq N, 2003, J PHYSIOL-LONDON, V550, P83, DOI 10.1113/jphysiol.2002.035782; Weeraratne SD, 2006, CHEM SENSES, V31, P725, DOI 10.1093/chemse/bjl014	43	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5266	10.1371/journal.pone.0005266	http://dx.doi.org/10.1371/journal.pone.0005266			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390572	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514200005
J	Breneman, KD; Brownell, WE; Rabbitt, RD				Breneman, Kathryn D.; Brownell, William E.; Rabbitt, Richard D.			Hair Cell Bundles: Flexoelectric Motors of the Inner Ear	PLOS ONE			English	Article								Microvilli (stereocilia) projecting from the apex of hair cells in the inner ear are actively motile structures that feed energy into the vibration of the inner ear and enhance sensitivity to sound. The biophysical mechanism underlying the hair bundle motor is unknown. In this study, we examined a membrane flexoelectric origin for active movements in stereocilia and conclude that it is likely to be an important contributor to mechanical power output by hair bundles. We formulated a realistic biophysical model of stereocilia incorporating stereocilia dimensions, the known flexoelectric coefficient of lipid membranes, mechanical compliance, and fluid drag. Electrical power enters the stereocilia through displacement sensitive ion channels and, due to the small diameter of stereocilia, is converted to useful mechanical power output by flexoelectricity. This motor augments molecular motors associated with the mechanosensitive apparatus itself that have been described previously. The model reveals stereocilia to be highly efficient and fast flexoelectric motors that capture the energy in the extracellular electro-chemical potential of the inner ear to generate mechanical power output. The power analysis provides an explanation for the correlation between stereocilia height and the tonotopic organization of hearing organs. Further, results suggest that flexoelectricity may be essential to the exquisite sensitivity and frequency selectivity of non-mammalian hearing organs at high auditory frequencies, and may contribute to the "cochlear amplifier'' in mammals.			Breneman, KD (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.	r.rabbitt@utah.edu		Rabbitt, Richard/0000-0002-2959-7248	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002775, R01DC000354, F32DC000384, R01DC006685, R01DC004928] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002775, R01 DC004928, R01 DC000354-23, R01 DC002775-12, R01 DC00384, R01 DC000354, R01 DC04928, R01 DC006685, R01 DC06685, F32 DC000384, R01 DC002775-13, R01 DC000354-22] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abnet CC, 2000, HEARING RES, V144, P29, DOI 10.1016/S0378-5955(00)00041-1; ANVARI B, 2007, C P IEEE ENG MED BIO, V1, P5384; Benser ME, 1996, J NEUROSCI, V16, P5629; BRENEMAN KD, 2008, BIOPHYS J; BRENEMAN KD, 2008, SCIENCE UNPUB; Cotton J, 2004, HEARING RES, V197, P105, DOI 10.1016/j.heares.2004.06.005; Cotton JR, 2000, J BIOMECH ENG-T ASME, V122, P44, DOI 10.1115/1.429626; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Eguiluz VM, 2000, PHYS REV LETT, V84, P5232, DOI 10.1103/PhysRevLett.84.5232; FLOCK A, 1976, J PHYSIOL-LONDON, V257, P45, DOI 10.1113/jphysiol.1976.sp011355; FRISHKOPF LS, 1983, HEARING RES, V12, P393, DOI 10.1016/0378-5955(83)90008-4; FUCHS PA, 1992, J NEUROSCI, V12, P800; FUNG YC, 1979, 1 COURSE CONTINUUM M; GARFINKLE TJ, 1983, OTOLARYNG HEAD NECK, V91, P421, DOI 10.1177/019459988309100415; GEISLER CD, 1974, J ACOUST SOC AM, V56, P1910, DOI 10.1121/1.1903533; Glassinger E, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041926; GUINAN JJ, 1997, J ACOUST SOC AM, V100, P1980; HACKNEY CM, 1993, HEARING RES, V69, P163, DOI 10.1016/0378-5955(93)90104-9; Halter JA, 1997, NEUROREPORT, V8, P2517, DOI 10.1097/00001756-199707280-00020; Happel, 2012, LOW REYNOLDS NUMBER; HARASZTOSI C, 2009, LOCATING MET CHANNEL; HOCHMUTH RM, 1982, BIOPHYS J, V39, P71, DOI 10.1016/S0006-3495(82)84492-5; HOCHMUTH RM, 1982, BIOPHYS J, V39, P83, DOI 10.1016/S0006-3495(82)84493-7; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; HOLTON T, 1983, SCIENCE, V222, P508, DOI 10.1126/science.6623089; Hudspeth A, 2005, CR BIOL, V328, P155, DOI 10.1016/j.crvi.2004.12.003; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; HUDSPETH AJ, 1985, SCIENCE, V230, P745, DOI 10.1126/science.2414845; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; HUXLEY AF, 1974, J PHYSIOL-LONDON, V243, P1; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; LIBERMAN MC, 1980, HEARING RES, V3, P189, DOI 10.1016/0378-5955(80)90046-5; Lin HW, 2005, CURR OPIN CELL BIOL, V17, P55, DOI 10.1016/j.ceb.2004.12.005; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Meirovitch L., 1967, ANAL METHODS VIBRATI; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; MULROY MJ, 1987, HEARING RES, V25, P11, DOI 10.1016/0378-5955(87)90075-X; Murugasu E, 1996, J NEUROSCI, V16, P325; Nam JH, 2006, BIOPHYS J, V90, P2786, DOI 10.1529/biophysj.105.066027; Nam JH, 2007, BIOPHYS J, V92, P1918, DOI 10.1529/biophysj.106.085076; Petrov AG, 2002, BBA-BIOMEMBRANES, V1561, P1, DOI 10.1016/S0304-4157(01)00007-7; PETROV AG, 1994, EUR BIOPHYS J BIOPHY, V23, P1, DOI 10.1007/BF00192201; PETROV AG, 1975, FLEXOELECTRIC MODEL, P111; RABBITT RD, 2008, POWER EFFICIEN UNPUB; Raphael RM, 2000, BIOPHYS J, V78, P2844, DOI 10.1016/S0006-3495(00)76827-5; Rattay F, 1998, J ACOUST SOC AM, V103, P1558, DOI 10.1121/1.421291; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Stepanyan R, 2006, J PHYSIOL-LONDON, V576, P801, DOI 10.1113/jphysiol.2006.118547; TENKATE JH, 1970, J EXP BIOL, V53, P495; Tiersten H.F., 1969, LINEAR PIEZOELECTRIC, DOI [10.1007/978-1-4899-6453-3, DOI 10.1007/978-1-4899-6453-3]; TILNEY LG, 1983, J CELL BIOL, V96, P822, DOI 10.1083/jcb.96.3.822; Vater M, 1996, HEARING RES, V94, P63, DOI 10.1016/0378-5955(96)00005-6; Verpy E, 2008, NATURE, V456, P255, DOI 10.1038/nature07380; Weiss T., 1996, CELLULAR BIOPHYSICS, VII; WEISS TF, 1976, BRAIN RES, V115, P71, DOI 10.1016/0006-8993(76)90823-4; WRIGHT A, 1984, HEARING RES, V13, P89, DOI 10.1016/0378-5955(84)90099-6; Zetes DE, 1997, J ACOUST SOC AM, V101, P3593, DOI 10.1121/1.418320	57	57	59	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5201	10.1371/journal.pone.0005201	http://dx.doi.org/10.1371/journal.pone.0005201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384413	Green Published, Green Submitted, gold			2022-12-27	WOS:000265513900002
J	Gentili, RJ; Papaxanthis, C; Ebadzadeh, M; Eskiizmirliler, S; Ouanezar, S; Darlot, C				Gentili, Rodolphe J.; Papaxanthis, Charalambos; Ebadzadeh, Mehdi; Eskiizmirliler, Selim; Ouanezar, Sofiane; Darlot, Christian			Integration of Gravitational Torques in Cerebellar Pathways Allows for the Dynamic Inverse Computation of Vertical Pointing Movements of a Robot Arm	PLOS ONE			English	Article							BASAL GANGLIA; MOTOR CONTROL; REACHING MOVEMENTS; NEURONAL-ACTIVITY; INTERNAL-MODELS; SENSORIMOTOR; CORTEX; PREDICTION; DIRECTION; MUSCLES	Background: Several authors suggested that gravitational forces are centrally represented in the brain for planning, control and sensorimotor predictions of movements. Furthermore, some studies proposed that the cerebellum computes the inverse dynamics (internal inverse model) whereas others suggested that it computes sensorimotor predictions (internal forward model). Methodology/Principal Findings: This study proposes a model of cerebellar pathways deduced from both biological and physical constraints. The model learns the dynamic inverse computation of the effect of gravitational torques from its sensorimotor predictions without calculating an explicit inverse computation. By using supervised learning, this model learns to control an anthropomorphic robot arm actuated by two antagonists McKibben artificial muscles. This was achieved by using internal parallel feedback loops containing neural networks which anticipate the sensorimotor consequences of the neural commands. The artificial neural networks architecture was similar to the large-scale connectivity of the cerebellar cortex. Movements in the sagittal plane were performed during three sessions combining different initial positions, amplitudes and directions of movements to vary the effects of the gravitational torques applied to the robotic arm. The results show that this model acquired an internal representation of the gravitational effects during vertical arm pointing movements. Conclusions/Significance: This is consistent with the proposal that the cerebellar cortex contains an internal representation of gravitational torques which is encoded through a learning process. Furthermore, this model suggests that the cerebellum performs the inverse dynamics computation based on sensorimotor predictions. This highlights the importance of sensorimotor predictions of gravitational torques acting on upper limb movements performed in the gravitational field.			Gentili, RJ (corresponding author), Univ Paris 05, CNRS, UMR 7060, Paris, France.	charalambos.papaxanthis@u-bourgogne.fr	Ebadzadeh, Mohammad Mehdi/F-7542-2013; Ebadzadeh, Mohammad Mehdi/AAA-1476-2020	Ebadzadeh, Mohammad Mehdi/0000-0001-6466-5229				Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Blakemore SJ, 2001, NEUROREPORT, V12, P1879, DOI 10.1097/00001756-200107030-00023; BULLOCK D, 1993, J COGNITIVE NEUROSCI, V5, P408, DOI 10.1162/jocn.1993.5.4.408; Cheron G, 1997, ELECTROMYOGR MOTOR C, V105, P58, DOI 10.1016/S0924-980X(96)96544-3; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; Darlot C, 1996, BIOL CYBERN, V75, P173, DOI 10.1007/s004220050285; DATTA A, 1998, ADAPTIVE INTERNAL MO, P50; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Ebadzadeh M, 2005, NEUROSCIENCE, V133, P29, DOI 10.1016/j.neuroscience.2004.09.048; Ebadzadeh M, 2003, NEUROSCIENCE, V122, P941, DOI 10.1016/S0306-4522(03)00569-4; Eccles JC, 1967, CEREBELLUM NEURONAL; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Eskiizmirliler S, 2002, BIOL CYBERN, V86, P379, DOI 10.1007/s00422-001-0302-1; Flanagan JR, 2001, J NEUROSCI, V21, P1361; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; Gentili R, 2007, NEUROSCIENCE, V145, P20, DOI 10.1016/j.neuroscience.2006.11.035; Gentili R, 2006, NEUROSCIENCE, V137, P761, DOI 10.1016/j.neuroscience.2005.10.013; Gentili R, 2004, BEHAV BRAIN RES, V155, P231, DOI 10.1016/j.bbr.2004.04.027; Glickstein M, 2000, TRENDS NEUROSCI, V23, P613, DOI 10.1016/S0166-2236(00)01681-7; Grosse-Wentrup M, 2007, BIOL CYBERN, V96, P377, DOI 10.1007/s00422-007-0142-8; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Holscher C, 2003, BEHAV BRAIN RES, V142, P181, DOI 10.1016/S0166-4328(02)00422-9; Imamizu H, 2004, J NEUROSCI, V24, P1173, DOI 10.1523/JNEUROSCI.4011-03.2004; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; Ito M, 1984, CEREBELLUM NEURAL CO; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Jordan M., 1999, COGNITIVE NEUROSCIEN, P601; Jordan M. I., 1986, PROC C COGNITIVE SCI, P531; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; KAWATO M, 1992, TRENDS NEUROSCI, V15, P445, DOI 10.1016/0166-2236(92)90008-V; Kawato M, 2007, CURR OPIN NEUROBIOL, V17, P205, DOI 10.1016/j.conb.2007.03.004; Manzoni D, 2007, CEREBELLUM, V6, P24, DOI 10.1080/14734220601132135; Manzoni D, 2005, CEREBELLUM, V4, P178, DOI 10.1080/14734220500193493; Maschke M, 2004, J NEUROPHYSIOL, V91, P230, DOI 10.1152/jn.00557.2003; McIntyre J, 2000, NEURAL COMPUT, V12, P2823, DOI 10.1162/089976600300014746; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Middleton FA, 1998, TRENDS COGN SCI, V2, P348, DOI 10.1016/S1364-6613(98)01220-0; Mitsuo K, 2003, PROG BRAIN RES, V142, P171; Okatan M, 2009, HIPPOCAMPUS, V19, P487, DOI 10.1002/hipo.20535; Papaxanthis C, 2002, EXP BRAIN RES, V143, P447, DOI 10.1007/s00221-002-1012-1; Papaxanthis C, 1998, NEUROSCI LETT, V253, P103, DOI 10.1016/S0304-3940(98)00604-1; Pigeon P, 2003, J NEUROPHYSIOL, V89, P276, DOI 10.1152/jn.00159.2001; Pozzo T, 1998, BRAIN RES REV, V28, P92, DOI 10.1016/S0165-0173(98)00030-7; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rost K, 2005, CLIN NEUROPHYSIOL, V116, P1405, DOI 10.1016/j.clinph.2005.02.015; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schweighofer N, 1998, EUR J NEUROSCI, V10, P86, DOI 10.1046/j.1460-9568.1998.00006.x; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595, DOI 10.1152/jn.1989.62.2.595; Spoelstra J, 2000, BIOL CYBERN, V82, P321, DOI 10.1007/s004220050586; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tani J, 1999, NEURAL NETWORKS, V12, P1131, DOI 10.1016/S0893-6080(99)00060-X; Tani J, 2003, IEEE T SYST MAN CY A, V33, P481, DOI 10.1109/TSMCA.2003.809171; TANI J, 2007, FRONT NEUROROBOTICS, V1, P1; Tondu B, 2000, IEEE CONTR SYST MAG, V20, P15, DOI 10.1109/37.833638; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Yamashita Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000220; Zago M, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S04	65	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5176	10.1371/journal.pone.0005176	http://dx.doi.org/10.1371/journal.pone.0005176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437VB	19384420	gold, Green Published			2022-12-27	WOS:000265513900001
J	Nam, J; Aguda, BD; Rath, B; Agarwal, S				Nam, Jin; Aguda, Baltazar D.; Rath, Bjoern; Agarwal, Sudha			Biomechanical Thresholds Regulate Inflammation through the NF-kappa B Pathway: Experiments and Modeling	PLOS ONE			English	Article								Background: During normal physical activities cartilage experiences dynamic compressive forces that are essential to maintain cartilage integrity. However, at non-physiologic levels these signals can induce inflammation and initiate cartilage destruction. Here, by examining the pro-inflammatory signaling networks, we developed a mathematical model to show the magnitude-dependent regulation of chondrocytic responses by compressive forces. Methodology/Principal Findings: Chondrocytic cells grown in 3-D scaffolds were subjected to various magnitudes of dynamic compressive strain (DCS), and the regulation of pro-inflammatory gene expression via activation of nuclear factor-kappa B (NF-kappa B) signaling cascade examined. Experimental evidences provide the existence of a threshold in the magnitude of DCS that regulates the mRNA expression of nitric oxide synthase (NOS2), an inducible pro-inflammatory enzyme. Interestingly, below this threshold, DCS inhibits the interleukin-1 beta (IL-1 beta)-induced pro-inflammatory gene expression, with the degree of suppression depending on the magnitude of DCS. This suppression of NOS2 by DCS correlates with the attenuation of the NF-kappa B signaling pathway as measured by IL-1 beta-induced phosphorylation of the inhibitor of kappa B (I kappa B)-alpha, degradation of I alpha B-alpha and I kappa B-beta, and subsequent nuclear translocation of NF-kappa B p65. A mathematical model developed to understand the complex dynamics of the system predicts two thresholds in the magnitudes of DCS, one for the inhibition of IL-1 beta-induced expression of NOS2 by DCS at low magnitudes, and second for the DCS-induced expression of NOS2 at higher magnitudes. Conclusions/Significance: Experimental and computational results indicate that biomechanical signals suppress and induce inflammation at critical thresholds through activation/suppression of the NF-kappa B signaling pathway. These thresholds arise due to the bistable behavior of the networks originating from the positive feedback loop between NF-kappa B and its target genes. These findings lay initial groundwork for the identification of the thresholds in physical activities that can differentiate its favorable actions from its unfavorable consequences on joints.			Agarwal, S (corresponding author), Ohio State Univ, Coll Dent, Biomech & Tissue Engn Lab, Columbus, OH 43210 USA.	agarwal.61@osu.edu	Rath, Björn/AAF-3938-2022; Rath, Björn/AFI-8239-2022	Nam, Jin/0000-0001-5117-8958	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT000646] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048781] Funding Source: NIH RePORTER; NCCIH NIH HHS [R01 AT000646, AT000646] Funding Source: Medline; NCRR NIH HHS [UL1 RR025755] Funding Source: Medline; NIAMS NIH HHS [R01 AR048781, AR048781] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Agarwal S, 2004, ARTHRITIS RHEUM-US, V50, P3541, DOI 10.1002/art.20601; Buckwalter JA, 2003, J ORTHOP SPORT PHYS, V33, P578, DOI 10.2519/jospt.2003.33.10.578; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Delarue FL, 2001, ONCOGENE, V20, P6531, DOI 10.1038/sj.onc.1204801; Dossumbekova A, 2007, ARTHRITIS RHEUM, V56, P3284, DOI 10.1002/art.22933; Ferretti M, 2005, J ORTHOP RES, V23, P1165, DOI 10.1016/j.orthres.2005.01.025; Fransen M, 2002, J RHEUMATOL, V29, P1737; Gabay O, 2008, OSTEOARTHR CARTILAGE, V16, P373, DOI 10.1016/j.joca.2007.06.016; Goldmann WH, 2002, CELL BIOL INT, V26, P313, DOI 10.1006/cbir.2002.0857; Hernandez-Molina G, 2008, ARTHRIT RHEUM-ARTHR, V59, P1221, DOI 10.1002/art.24010; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; KUNZ D, 1994, P NATL ACAD SCI USA, V91, P5387, DOI 10.1073/pnas.91.12.5387; Madhavan S, 2007, J IMMUNOL, V179, P6246, DOI 10.4049/jimmunol.179.9.6246; Nam J, 2009, TISSUE ENG PT A, V15, P513, DOI 10.1089/ten.tea.2007.0353; Rath B, 2008, J BIOMECH, V41, P1095, DOI 10.1016/j.jbiomech.2007.11.024; Simkin PA, 1999, J RHEUMATOL, V26, P1987; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319	18	83	84	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5262	10.1371/journal.pone.0005262	http://dx.doi.org/10.1371/journal.pone.0005262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370157	Green Published, Green Submitted, gold			2022-12-27	WOS:000265510600011
J	Santana, MS; de Lacerda, MVG; Barbosa, MDV; Alecrim, WD; Alecrim, MDC				Santana, Marli Stela; Guimaraes de Lacerda, Marcus Vinicius; Vale Barbosa, Maria das Gracas; Alecrim, Wilson Duarte; Costa Alecrim, Maria das Gracas			Glucose-6-Phosphate Dehydrogenase Deficiency in an Endemic Area for Malaria in Manaus: A Cross-Sectional Survey in the Brazilian Amazon	PLOS ONE			English	Article							G6PD DEFICIENCY; MOLECULAR CHARACTERIZATION; MUTATIONS	Background: There is a paucity of information regarding glucose-6-phosphate dehydrogenase (G6PD) deficiency in endemic areas for malaria in Latin America. Methodology/Principal Findings: This study determined the prevalence of the G6PD deficiency in 200 male non-consanguineous individuals residing in the Ismail Aziz Community, on the outskirts of Manaus (Brazilian Amazon). Six individuals (3%) were deficient using the qualitative Brewer's test. Gel electrophoresis showed that five of these patients were G6PD A(-). The deficiency was not associated with the ethnic origin (P = 0.571). In a multivariate logistic regression analysis, G6PD deficiency protected against three or more episodes of malaria (P = 0.049), independently of the age, and was associated with a history of jaundice (P = 0.020) and need of blood transfusion (P = 0.045) during previous treatment for malarial infection, independently of the age and the previous malarial exposure. Conclusions/Significance: The frequency of G6PD deficiency was similar to other studies performed in Brazil and the finding of a predominant G6PD A 2 variant will help the clinical management of patients with drug-induced haemolysis. The history of jaundice and blood transfusion during previous malarial infection may trigger the screening of patients for G6PD deficiency. The apparent protection against multiple malarial infections in an area primarily endemic for Plasmodium vivax needs further investigation.			Santana, MS (corresponding author), Univ State Amazonas, Manaus, Amazonas, Brazil.	marli.maciel@uol.com.br; marcuslacerda@uol.com.br	Santana, Marli/ABB-1259-2021; Barbosa Guerra, Maria das Graças/AGZ-7397-2022	Santana, Marli/0000-0001-8170-5181; 				Al-Riyami A, 2003, J TROP PEDIATRICS, V49, P1; Alecrim M das G, 1999, Rev Soc Bras Med Trop, V32, P67, DOI 10.1590/S0037-86821999000100013; Badens C, 2000, Hematol J, V1, P264, DOI 10.1038/sj.thj.6200042; Beutler E, 2002, BLOOD CELL MOL DIS, V28, P93, DOI 10.1006/bcmd.2002.0490; Beutler E, 2007, AM J TROP MED HYG, V77, P779, DOI 10.4269/ajtmh.2007.77.779; *BRAZ MIN HLTH, 2006, EP B MAL SIVEP; BREWER GJ, 1962, JAMA-J AM MED ASSOC, V180, P386, DOI 10.1001/jama.1962.03050180032008; Castro S, 2006, J MED SCREEN, V13, P85, DOI 10.1258/096914106777589641; Compri M B, 2000, Cad Saude Publica, V16, P335, DOI 10.1590/S0102-311X2000000200004; De Araujo C, 2006, HAEMATOL-HEMATOL J, V91, P262; de Lacerda MVG, 2007, REV SOC BRAS MED TRO, V40, P489, DOI 10.1590/S0037-86822007000400026; FORBES J, 1991, CLIN CHIM ACTA, V199, P279, DOI 10.1016/0009-8981(91)90121-R; *FUNASA, 2001, MAL THER GUID; GONCALVES MJF, 2004, BRAZIL REV SALUD PUB, V6, P156; GREENE LS, 1993, ANN HUM BIOL, V20, P497, DOI 10.1080/03014469300002892; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Hamel AR, 2002, BLOOD CELL MOL DIS, V28, P399, DOI 10.1006/bcmd.2002.0524; Iwai K, 2001, HUM GENET, V108, P445, DOI 10.1007/s004390100527; Louicharoen C, 2005, J HUM GENET, V50, P448, DOI 10.1007/s10038-005-0276-2; LUZZATTO L, 1995, BRIT J HAEMATOL, V91, P511, DOI 10.1111/j.1365-2141.1995.tb05331.x; ROTH EF, 1983, P NATL ACAD SCI-BIOL, V80, P298, DOI 10.1073/pnas.80.1.298; Saad STO, 1997, HUM HERED, V47, P17, DOI 10.1159/000154383; Santana MS, 2007, REV SOC BRAS MED TRO, V40, P533, DOI 10.1590/S0037-86822007000500008; Silva Mônica C.M., 2004, Rev. Soc. Bras. Med. Trop., V37, P215, DOI 10.1590/S0037-86822004000300004; Sukumar S, 2004, BLOOD CELL MOL DIS, V33, P141, DOI 10.1016/j.bcmd.2004.06.003; Usanga EA, 2000, HUM HERED, V50, P158, DOI 10.1159/000022906; WEIMER TA, 1993, HUM BIOL, V65, P41; WHO, 2008, WHO REP; *WHO, 1975, J MED SCREEN, V13, P85; YOSHIDA A, 1971, B WORLD HEALTH ORGAN, V45, P243	30	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5259	10.1371/journal.pone.0005259	http://dx.doi.org/10.1371/journal.pone.0005259			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370159	gold, Green Submitted, Green Published			2022-12-27	WOS:000265510600010
J	Shachaf, CM; Elchuri, SV; Koh, AL; Zhu, J; Nguyen, LN; Mitchell, DJ; Zhang, JW; Swartz, KB; Sun, L; Chan, S; Sinclair, R; Nolan, GP				Shachaf, Catherine M.; Elchuri, Sailaja V.; Koh, Ai Leen; Zhu, Jing; Nguyen, Lienchi N.; Mitchell, Dennis J.; Zhang, Jingwu; Swartz, Kenneth B.; Sun, Lei; Chan, Selena; Sinclair, Robert; Nolan, Garry P.			A Novel Method for Detection of Phosphorylation in Single Cells by Surface Enhanced Raman Scattering (SERS) using Composite Organic-Inorganic Nanoparticles (COINs)	PLOS ONE			English	Article								Background: Detection of single cell epitopes has been a mainstay of immunophenotyping for over three decades, primarily using fluorescence techniques for quantitation. Fluorescence has broad overlapping spectra, limiting multiplexing abilities. Methodology/Principal Findings: To expand upon current detection systems, we developed a novel method for multi-color immuno-detection in single cells using "Composite Organic-Inorganic Nanoparticles'' (COINs) Raman nanoparticles. COINs are Surface-Enhanced Raman Scattering (SERS) nanoparticles, with unique Raman spectra. To measure Raman spectra in single cells, we constructed an automated, compact, low noise and sensitive Raman microscopy device (Integrated Raman BioAnalyzer). Using this technology, we detected proteins expressed on the surface in single cells that distinguish T-cells among human blood cells. Finally, we measured intracellular phosphorylation of Stat1 (Y701) and Stat6 (Y641), with results comparable to flow cytometry. Conclusions/Significance: Thus, we have demonstrated the practicality of applying COIN nanoparticles for measuring intracellular phosphorylation, offering new possibilities to expand on the current fluorescent technology used for immunoassays in single cells.			Shachaf, CM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Sinclair, Rodney/AAI-8355-2020; Nolan, Garry/AAE-7903-2019	Sinclair, Rodney/0000-0001-6751-1428; Nolan, Garry/0000-0002-8862-9043	NCI NIH HHS [U54 RFA-CA-05-024] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chattopadhyay PK, 2006, NAT MED, V12, P972, DOI 10.1038/nm1371; Doering WE, 2003, ANAL CHEM, V75, P6171, DOI 10.1021/ac034672u; FLEISCHMANN M, 1974, CHEM PHYS LETT, V26, P163, DOI 10.1016/0009-2614(74)85388-1; Goddard G, 2006, CYTOM PART A, V69A, P842, DOI 10.1002/cyto.a.20320; Grubisha DS, 2003, ANAL CHEM, V75, P5936, DOI 10.1021/ac034356f; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2007, BLOOD, V109, P2589, DOI 10.1182/blood-2006-02-004234; Irish JM, 2006, BLOOD, V108, P3135, DOI 10.1182/blood-2006-02-003921; Irish JM, 2006, J IMMUNOL, V177, P1581, DOI 10.4049/jimmunol.177.3.1581; Kneipp J, 2005, ANAL CHEM, V77, P2381, DOI 10.1021/ac050109v; Kneipp K, 1999, CHEM REV, V99, P2957, DOI 10.1021/cr980133r; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lee AW, 2008, J VIROL, V82, P3702, DOI 10.1128/JVI.01582-07; Mulvaney SP, 2003, LANGMUIR, V19, P4784, DOI 10.1021/la026706j; Ni J, 1999, ANAL CHEM, V71, P4903, DOI 10.1021/ac990616a; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Shachaf CM, 2007, BLOOD, V110, P2674, DOI 10.1182/blood-2006-09-048033; Su X, 2005, NANO LETT, V5, P49, DOI 10.1021/nl0484088; Sun L, 2007, NANO LETT, V7, P351, DOI 10.1021/nl062453t; Van Meter MEM, 2007, BLOOD, V109, P3945, DOI 10.1182/blood-2006-09-047530; VO-DINH T, 1994, ANAL CHEM, V66, P3379, DOI 10.1021/ac00092a014; Watson DA, 2008, CYTOM PART A, V73A, P119, DOI 10.1002/cyto.a.20520	25	33	35	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2009	4	4							e5206	10.1371/journal.pone.0005206	http://dx.doi.org/10.1371/journal.pone.0005206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TS	19367337	gold, Green Published, Green Submitted			2022-12-27	WOS:000265510400006
J	Noyes, HA; Alimohammadian, MH; Agaba, M; Brass, A; Fuchs, H; Gailus-Durner, V; Hulme, H; Iraqi, F; Kemp, S; Rathkolb, B; Wolf, E; de Angelis, MH; Roshandel, D; Naessens, J				Noyes, Harry A.; Alimohammadian, Mohammad H.; Agaba, Morris; Brass, Andy; Fuchs, Helmut; Gailus-Durner, Valerie; Hulme, Helen; Iraqi, Fuad; Kemp, Stephen; Rathkolb, Birgit; Wolf, Eckard; de Angelis, Martin Hrabe; Roshandel, Delnaz; Naessens, Jan			Mechanisms Controlling Anaemia in Trypanosoma congolense Infected Mice	PLOS ONE			English	Article								Background: Trypanosoma congolense are extracellular protozoan parasites of the blood stream of artiodactyls and are one of the main constraints on cattle production in Africa. In cattle, anaemia is the key feature of disease and persists after parasitaemia has declined to low or undetectable levels, but treatment to clear the parasites usually resolves the anaemia. Methodology/Principal Findings: The progress of anaemia after Trypanosoma congolense infection was followed in three mouse strains. Anaemia developed rapidly in all three strains until the peak of the first wave of parasitaemia. This was followed by a second phase, characterized by slower progress to severe anaemia in C57BL/6, by slow recovery in surviving A/J and a rapid recovery in BALB/c. There was no association between parasitaemia and severity of anaemia. Furthermore, functional T lymphocytes are not required for the induction of anaemia, since suppression of T cell activity with Cyclosporin A had neither an effect on the course of infection nor on anaemia. Expression of genes involved in erythropoiesis and iron metabolism was followed in spleen, liver and kidney tissues in the three strains of mice using microarrays. There was no evidence for a response to erythropoietin, consistent with anaemia of chronic disease, which is erythropoietin insensitive. However, the expression of transcription factors and genes involved in erythropoiesis and haemolysis did correlate with the expression of the inflammatory cytokines I/6 and Ifng. Conclusions/Significance: The innate immune response appears to be the major contributor to the inflammation associated with anaemia since suppression of T cells with CsA had no observable effect. Several transcription factors regulating haematopoiesis, Tal1, Gata1, Zfpm1 and Klf1 were expressed at consistently lower levels in C57BL/6 mice suggesting that these mice have a lower haematopoietic capacity and therefore less ability to recover from haemolysis induced anaemia after infection.			Noyes, HA (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.	j.naessens@cgiar.org	Noyes, Harry A/B-1151-2010; Rathkolb, Birgit/F-7041-2013; Zeef, Leo/D-6922-2011; Fuchs, Helmut/M-7347-2014; de Angelis, Martin Hrabe/F-5531-2012; Gailus-Durner, Valerie/M-7337-2014	Noyes, Harry A/0000-0002-0656-200X; Fuchs, Helmut/0000-0002-5143-2677; de Angelis, Martin Hrabe/0000-0002-7898-2353; Roshandel, Delnaz/0000-0002-4902-8587; Wolf, Eckhard/0000-0002-0430-9510; Brass, Andrew/0000-0002-0389-7058; Alimohammadian, Mohammad Hossein/0000-0003-3077-6638	Wellcome Trust [GR066764MA] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anosa VO, 1997, COMP HAEMATOL INT, V7, P14, DOI 10.1007/BF01320994; ASSOKU RKG, 1989, VET PARASITOL, V31, P199, DOI 10.1016/0304-4017(89)90070-8; Beaumont C, 2004, M S-MED SCI, V20, P68, DOI 10.1051/medsci/200420168; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; CHENG TC, 1976, P NATL ACAD SCI USA, V73, P1811, DOI 10.1073/pnas.73.6.1811; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; ESIEVO KAN, 1990, J COMP PATHOL, V102, P357, DOI 10.1016/S0021-9975(08)80157-0; FACER CA, 1982, J COMP PATHOL, V92, P393, DOI 10.1016/0021-9975(82)90025-1; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Goh SH, 2007, PHYSIOL GENOMICS, V30, P172, DOI 10.1152/physiolgenomics.00247.2006; GREENBLATT HC, 1984, INFECT IMMUN, V43, P337, DOI 10.1128/IAI.43.1.337-340.1984; Gregory RC, 2000, CYTOKINE, V12, P845, DOI 10.1006/cyto.2000.0686; HAAN G, 1997, INTRINSIC EXTRINSIC, P529; KAZAZIAN HH, 1974, ANN NY ACAD SCI, V241, P170, DOI 10.1111/j.1749-6632.1974.tb21876.x; Kemp SJ, 1996, VET IMMUNOL IMMUNOP, V54, P239, DOI 10.1016/S0165-2427(96)05692-9; Kemp SJ, 1997, NAT GENET, V16, P194, DOI 10.1038/ng0697-194; Kierstein S, 2006, GENES IMMUN, V7, P667, DOI 10.1038/sj.gene.6364345; KOBAYASHI A, 1976, TROPENMED PARASITOL, V27, P411; Kristjanson PM, 1999, AGR SYST, V59, P79, DOI 10.1016/S0308-521X(98)00086-9; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liang Y, 2007, NAT GENET, V39, P178, DOI 10.1038/ng1938; MABBOTT N, 1995, INFECT IMMUN, V63, P1563, DOI 10.1128/IAI.63.4.1563-1566.1995; Magez S, 2004, J INFECT DIS, V189, P527, DOI 10.1086/381151; Magez S, 1998, J IMMUNOL, V160, P1949; Mertens B, 1999, J INTERF CYTOK RES, V19, P59, DOI 10.1089/107999099314423; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; MORRISON WI, 1979, EXP PARASITOL, V48, P364, DOI 10.1016/0014-4894(79)90121-8; MORRISON WI, 1978, CLIN EXP IMMUNOL, V32, P25; MURRAY M, 1988, ACTA TROP, V45, P389; MURRAY M, 1982, ADV PARASIT, V21, P1, DOI 10.1016/S0065-308X(08)60274-2; Naessens J, 2006, INT J PARASITOL, V36, P521, DOI 10.1016/j.ijpara.2006.02.012; Naessens J, 2005, CLIN EXP IMMUNOL, V139, P405, DOI 10.1111/j.1365-2249.2004.02717.x; Naessens J, 2003, VET PARASITOL, V111, P125, DOI 10.1016/S0304-4017(02)00360-6; Naessens J, 2002, VET IMMUNOL IMMUNOP, V87, P187, DOI 10.1016/S0165-2427(02)00070-3; Nakamura Y, 2003, PARASITOL RES, V90, P171, DOI 10.1007/s00436-003-0844-3; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Ngure RM, 2008, VET PARASITOL, V151, P14, DOI 10.1016/j.vetpar.2007.10.007; Nok AJ, 2003, J BIOCHEM, V134, P173; Nok AJ, 2003, J BIOCHEM, V133, P725, DOI 10.1093/jb/mvg093; RIFKIN MR, 1990, P NATL ACAD SCI USA, V87, P801, DOI 10.1073/pnas.87.2.801; Sato T, 1999, BLOOD, V94, P2548, DOI 10.1182/blood.V94.8.2548.420k38_2548_2554; Schaer CA, 2007, J LEUKOCYTE BIOL, V82, P106, DOI 10.1189/jlb.0706453; Shamseddine A, 1998, EUR J GYNAECOL ONCOL, V19, P591; Shi MQ, 2005, INFECT IMMUN, V73, P8393, DOI 10.1128/IAI.73.12.8393-8396.2005; Shi MQ, 2004, J LEUKOCYTE BIOL, V76, P399, DOI 10.1189/jlb.1003500; Shih LY, 1999, J AM SOC NEPHROL, V10, P315; SILEGHEM M, 1995, EUR J IMMUNOL, V25, P1965, DOI 10.1002/eji.1830250725; Sileghem M, 2001, VET IMMUNOL IMMUNOP, V78, P325, DOI 10.1016/S0165-2427(01)00241-0; Stijemans B, 2007, VET PARASITOL, V148, P3, DOI 10.1016/j.vetpar.2007.05.005; Stijlemans B, 2008, IMMUNOBIOLOGY, V213, P823, DOI 10.1016/j.imbio.2008.07.023; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taniguchi S, 1997, BLOOD, V90, P2244, DOI 10.1182/blood.V90.6.2244.2244_2244_2252; TRAIL JCM, 1992, VET PARASITOL, V42, P213, DOI 10.1016/0304-4017(92)90063-F; VANASSENDAELFT O, 1970, SPECTROPHOTOMETRY HA; Vanhollebeke B, 2007, P NATL ACAD SCI USA, V104, P4118, DOI 10.1073/pnas.0609902104; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Weiss G, 2002, BLOOD REV, V16, P87, DOI 10.1054/blre.2002.0193; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Zumkeller W, 2002, LEUKEMIA LYMPHOMA, V43, P487, DOI 10.1080/10428190290011958	60	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5170	10.1371/journal.pone.0005170	http://dx.doi.org/10.1371/journal.pone.0005170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365556	Green Published, Green Submitted, gold			2022-12-27	WOS:000265509900005
J	Zinser, ER; Lindell, D; Johnson, ZI; Futschik, ME; Steglich, C; Coleman, ML; Wright, MA; Rector, T; Steen, R; McNulty, N; Thompson, LR; Chisholm, SW				Zinser, Erik R.; Lindell, Debbie; Johnson, Zackary I.; Futschik, Matthias E.; Steglich, Claudia; Coleman, Maureen L.; Wright, Matthew A.; Rector, Trent; Steen, Robert; McNulty, Nathan; Thompson, Luke R.; Chisholm, Sallie W.			Choreography of the Transcriptome, Photophysiology, and Cell Cycle of a Minimal Photoautotroph, Prochlorococcus	PLOS ONE			English	Article							LIGHT-INDUCIBLE POLYPEPTIDES; CYANOBACTERIUM SYNECHOCOCCUS-ELONGATUS; CIRCADIAN GENE-EXPRESSION; SYNECHOCYSTIS SP PCC-6803; GROUP-2 SIGMA-FACTORS; NORTH PACIFIC-OCEAN; SP STRAIN PCC-6803; PROBE LEVEL DATA; EQUATORIAL PACIFIC; PHOTOSYSTEM-II	The marine cyanobacterium Prochlorococcus MED4 has the smallest genome and cell size of all known photosynthetic organisms. Like all phototrophs at temperate latitudes, it experiences predictable daily variation in available light energy which leads to temporal regulation and partitioning of key cellular processes. To better understand the tempo and choreography of this minimal phototroph, we studied the entire transcriptome of the cell over a simulated daily light-dark cycle, and placed it in the context of diagnostic physiological and cell cycle parameters. All cells in the culture progressed through their cell cycles in synchrony, thus ensuring that our measurements reflected the behavior of individual cells. Ninety percent of the annotated genes were expressed, and 80% had cyclic expression over the diel cycle. For most genes, expression peaked near sunrise or sunset, although more subtle phasing of gene expression was also evident. Periodicities of the transcripts of genes involved in physiological processes such as in cell cycle progression, photosynthesis, and phosphorus metabolism tracked the timing of these activities relative to the light-dark cycle. Furthermore, the transitions between photosynthesis during the day and catabolic consumption of energy reserves at night-metabolic processes that share some of the same enzymes - appear to be tightly choreographed at the level of RNA expression. In-depth investigation of these patterns identified potential regulatory proteins involved in balancing these opposing pathways. Finally, while this analysis has not helped resolve how a cell with so little regulatory capacity, and a 'deficient' circadian mechanism, aligns its cell cycle and metabolism so tightly to a light- dark cycle, it does provide us with a valuable framework upon which to build when the Prochlorococcus proteome and metabolome become available.			Zinser, ER (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chisholm@mit.edu	Futschik, Matthias/AAK-8837-2020; Johnson, Zackary I/E-4601-2011; Thompson, Luke R./Z-3344-2019	Futschik, Matthias/0000-0002-6245-8071; Johnson, Zackary I/0000-0003-0793-8512; Thompson, Luke R./0000-0002-3911-1280; Chisholm, Sallie/0000-0003-1480-2445; Coleman, Maureen/0000-0001-5065-0106; Lindell, Debbie/0000-0003-0612-4517				ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Badger MR, 2006, J EXP BOT, V57, P249, DOI 10.1093/jxb/eri286; Barber RT, 1996, DEEP-SEA RES PT II, V43, P933, DOI 10.1016/0967-0645(96)00035-5; Baroli I, 1998, PLANTA, V205, P288, DOI 10.1007/s004250050323; Battchikova N, 2007, PHYSIOL PLANTARUM, V131, P22, DOI 10.1111/j.1399-3054.2007.00929.x; Behrenfeld MJ, 1998, PHOTOSYNTH RES, V58, P259, DOI 10.1023/A:1006138630573; Behrenfeld MJ, 2004, J PHYCOL, V40, P4, DOI 10.1046/j.1529-8817.2004.03083.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Bhaya D, 2002, FEMS MICROBIOL LETT, V215, P209, DOI 10.1111/j.1574-6968.2002.tb11393.x; Binder BJ, 1996, DEEP-SEA RES PT II, V43, P907, DOI 10.1016/0967-0645(96)00023-9; Bruyant F, 2005, LIMNOL OCEANOGR, V50, P850, DOI 10.4319/lo.2005.50.3.0850; Bukhov N, 2004, PHOTOSYNTH RES, V82, P17, DOI 10.1023/B:PRES.0000040442.59311.72; Burbage CD, 2007, J PHYCOL, V43, P266, DOI 10.1111/j.1529-8817.2007.00315.x; BUSTOS SA, 1990, J BACTERIOL, V172, P1998, DOI 10.1128/jb.172.4.1998-2004.1990; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; CARPENTER EJ, 1988, MAR ECOL PROG SER, V43, P105, DOI 10.3354/meps043105; Cavender-Bares KK, 1999, LIMNOL OCEANOGR, V44, P237, DOI 10.4319/lo.1999.44.2.0237; Chen YB, 1998, J BACTERIOL, V180, P3598, DOI 10.1128/JB.180.14.3598-3605.1998; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Claustre H, 2002, LIMNOL OCEANOGR, V47, P1637, DOI 10.4319/lo.2002.47.6.1637; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Espinosa J, 2006, MOL MICROBIOL, V61, P457, DOI 10.1111/j.1365-2958.2006.05231.x; Figge RM, 2000, MOL MICROBIOL, V36, P44, DOI 10.1046/j.1365-2958.2000.01806.x; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Futschik ME, 2008, BIOINFORMATICS, V24, P1063, DOI 10.1093/bioinformatics/btn072; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Garczarek L, 2001, ENVIRON MICROBIOL, V3, P168, DOI 10.1046/j.1462-2920.2001.00173.x; Garczarek L, 2001, PLANT MOL BIOL, V46, P683, DOI 10.1023/A:1011681726654; Goldberg RN, 2004, BIOINFORMATICS, V20, P2874, DOI 10.1093/bioinformatics/bth314; Golden SS, 2003, NAT REV MICROBIOL, V1, P191, DOI 10.1038/nrmicro774; Golden SS, 2003, CURR OPIN MICROBIOL, V6, P535, DOI 10.1016/j.mib.2003.10.012; Hagen KD, 2001, J BIOL CHEM, V276, P11477, DOI 10.1074/jbc.M010472200; Havaux M, 2003, BBA-BIOENERGETICS, V1557, P21, DOI 10.1016/S0005-2728(02)00391-2; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Holtzendorff J, 2001, J BACTERIOL, V183, P915, DOI 10.1128/JB.183.3.915-920.2001; Holtzendorff J, 2008, J BIOL RHYTHM, V23, P187, DOI 10.1177/0748730408316040; Howitt CA, 1999, J BACTERIOL, V181, P3994, DOI 10.1128/JB.181.13.3994-4003.1999; Imamura S, 2003, FEBS LETT, V554, P357, DOI 10.1016/S0014-5793(03)01188-8; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ivleva NB, 2006, P NATL ACAD SCI USA, V103, P17468, DOI 10.1073/pnas.0606639103; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Jacquet S, 2001, J PHYCOL, V37, P357, DOI 10.1046/j.1529-8817.2001.037003357.x; Johnson Z, 1999, DEEP-SEA RES PT II, V46, P1719, DOI 10.1016/S0967-0645(99)00041-7; Johnson Z, 2003, PHOTOSYNTH RES, V75, P85, DOI 10.1023/A:1022440305765; Johnson ZI, 2007, LIMNOL OCEANOGR-METH, V5, P417, DOI 10.4319/lom.2007.5.417; Johnson ZI, 2004, MAR ECOL PROG SER, V283, P73, DOI 10.3354/meps283073; Katayama M, 1999, J BACTERIOL, V181, P3516, DOI 10.1128/JB.181.11.3516-3524.1999; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kornberg A., 1992, DNA REPLICATION; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Labiosa RG, 2006, J PHYCOL, V42, P622, DOI 10.1111/j.1529-8817.2006.00217.x; LEWIS MR, 1983, MAR ECOL PROG SER, V13, P99, DOI 10.3354/meps013099; Li H, 2000, J BACTERIOL, V182, P4268, DOI 10.1128/JB.182.15.4268-4277.2000; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Lindell D, 2007, NATURE, V449, P83, DOI 10.1038/nature06130; Liu HB, 1997, AQUAT MICROB ECOL, V12, P39, DOI 10.3354/ame012039; LIU Y, 1995, J BACTERIOL, V177, P2080, DOI 10.1128/jb.177.8.2080-2086.1995; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Mary I, 2008, ENVIRON MICROBIOL, V10, P2124, DOI 10.1111/j.1462-2920.2008.01633.x; MONGER BC, 1993, APPL ENVIRON MICROB, V59, P905, DOI 10.1128/AEM.59.3.905-911.1993; Moore LR, 2007, LIMNOL OCEANOGR-METH, V5, P353, DOI 10.4319/lom.2007.5.353; Moore LR, 2005, AQUAT MICROB ECOL, V39, P257, DOI 10.3354/ame039257; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Muro-Pastor MI, 2005, PHOTOSYNTH RES, V83, P135, DOI 10.1007/s11120-004-2082-7; Nair U, 2002, J BACTERIOL, V184, P3530, DOI 10.1128/JB.184.13.3530-3538.2002; Nakamura Y, 1998, NUCLEIC ACIDS RES, V26, P63, DOI 10.1093/nar/26.1.63; OLSON RJ, 1985, DEEP-SEA RES, V32, P1273, DOI 10.1016/0198-0149(85)90009-3; Osmond CB, 1994, PHOTOINHIBITION PHOT, P1; Partensky F, 1996, DEEP-SEA RES PT I, V43, P1191, DOI 10.1016/0967-0637(96)00056-8; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Pichard SL, 1996, MAR ECOL PROG SER, V139, P257, DOI 10.3354/meps139257; Promnares K, 2006, J BIOL CHEM, V281, P32705, DOI 10.1074/jbc.M606360200; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sakshaug E, 1997, J PLANKTON RES, V19, P1637, DOI 10.1093/plankt/19.11.1637; Salem K, 2004, J BACTERIOL, V186, P1729, DOI 10.1128/JB.186.6.1729-1736.2004; SCHAEFER MR, 1989, J BIOL CHEM, V264, P7412; Shalapyonok A, 1998, APPL ENVIRON MICROB, V64, P1066; Smith RM, 2006, P NATL ACAD SCI USA, V103, P8564, DOI 10.1073/pnas.0508696103; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; Steglich C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000173; Steglich C, 2006, J BACTERIOL, V188, P7796, DOI 10.1128/JB.01097-06; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; Summerfield TC, 2007, J BACTERIOL, V189, P7829, DOI 10.1128/JB.01036-07; SWEENEY BM, 1989, J PHYCOL, V25, P183, DOI 10.1111/j.0022-3646.1989.00183.x; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; TALLING JF, 1966, J ECOL, V54, P99, DOI 10.2307/2257661; Tamoi M, 2005, PLANT J, V42, P504, DOI 10.1111/j.1365-313X.2005.02391.x; Toepel J, 2008, J BACTERIOL, V190, P3904, DOI 10.1128/JB.00206-08; Tolonen AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100087; Tsinoremas NF, 1996, EMBO J, V15, P2488, DOI 10.1002/j.1460-2075.1996.tb00606.x; Van Mooy BAS, 2006, P NATL ACAD SCI USA, V103, P8607, DOI 10.1073/pnas.0600540103; VAULOT D, 1995, SCIENCE, V268, P1480, DOI 10.1126/science.268.5216.1480; VAULOT D, 1989, CYTOMETRY, V10, P629, DOI 10.1002/cyto.990100519; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Wang Q, 2008, PLANT PHYSIOL, V147, P1239, DOI 10.1104/pp.108.121087; WEBB WL, 1974, OECOLOGIA, V17, P281, DOI 10.1007/BF00345747; Wedel N, 1997, P NATL ACAD SCI USA, V94, P10479, DOI 10.1073/pnas.94.19.10479; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; Woelfle MA, 2006, J BIOL RHYTHM, V21, P419, DOI 10.1177/0748730406294418; Xu H, 2004, J BIOL CHEM, V279, P27971, DOI 10.1074/jbc.M403307200; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yoshimura T, 2007, FEBS LETT, V581, P1495, DOI 10.1016/j.febslet.2007.03.010	115	142	142	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5135	10.1371/journal.pone.0005135	http://dx.doi.org/10.1371/journal.pone.0005135			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352512	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505700022
J	Di Filippo, M; Bernardi, G				Di Filippo, Miriam; Bernardi, Giorgio			The Early Apoptotic DNA Fragmentation Targets a Small Number of Specific Open Chromatin Regions	PLOS ONE			English	Article								We report here that early apoptotic DNA fragmentation, as obtained by using an entirely new approach, is the result of an attack at a small number of specific open chromatin regions of interphase nuclei. This was demonstrated as follows: (i) chicken liver was excised and kept in sterile tubes for 1 to 3 hours at 37 degrees C; (ii) this induced apoptosis (possibly because of oxygen deprivation), as shown by the electrophoretic nucleosomal ladder produced by DNA preparations; (iii) low molecular-weight DNA fragments (similar to 200 bp) were cloned, sequenced, and shown to derive predominantly from genes and surrounding 100 kb regions; (iv) a few hundred cuts were produced, very often involving the same chromosomal sites; (v) at comparable DNA degradation levels, micrococcal nuclease (MNase) also showed a general preference for genes and surrounding regions, but MNase cuts were located at sites that were quite distinct from, and less specific than, those cut by apoptosis. In conclusion, the approach presented here, which is the mildest and least intrusive approach, identifies a preferred accessibility landscape in interphase chromatin.	[Di Filippo, Miriam; Bernardi, Giorgio] Stn Zool Anton Dohrn, Lab Mol Evolut, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Di Filippo, M (corresponding author), Stn Zool Anton Dohrn, Lab Mol Evolut, Naples, Italy.	bernardi@szn.it	Bernardi, Giorgio/G-1639-2011		Stazione Zoologica Anton Dohrn	Stazione Zoologica Anton Dohrn	The financing of the experiments was covered by Stazione Zoologica Anton Dohrn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi G., 2005, STRUCTURAL EVOLUTION; Bernardi G, 2007, P NATL ACAD SCI USA, V104, P8385, DOI 10.1073/pnas.0701652104; COCKELL M, 1983, J MOL BIOL, V170, P423, DOI 10.1016/S0022-2836(83)80156-9; COMPTON MM, 1992, CANCER METAST REV, V11, P105, DOI 10.1007/BF00048058; Costantini M, 2007, GENE, V400, P9, DOI 10.1016/j.gene.2007.05.025; Coullin P, 2005, CHROMOSOME RES, V13, P665, DOI 10.1007/s10577-005-1004-7; Counis MF, 2006, BIOCHIMIE, V88, P1851, DOI 10.1016/j.biochi.2006.07.008; Counis MF, 2000, BIOCHEM CELL BIOL, V78, P405, DOI 10.1139/bcb-78-4-405; Di Filippo M, 2008, GENE, V419, P62, DOI 10.1016/j.gene.2008.02.012; DINGWALL C, 1981, NUCLEIC ACIDS RES, V9, P2659, DOI 10.1093/nar/9.12.2659; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FILIPSKI J, 1990, EMBO J, V9, P1319, DOI 10.1002/j.1460-2075.1990.tb08241.x; FLICK JT, 1986, J MOL BIOL, V190, P619, DOI 10.1016/0022-2836(86)90247-0; FOX KR, 1992, NUCLEIC ACIDS RES, V20, P1235, DOI 10.1093/nar/20.6.1235; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; HEWISH DR, 1973, BIOCHEM BIOPH RES CO, V52, P504, DOI 10.1016/0006-291X(73)90740-7; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; Hughes FM, 1998, CELL DEATH DIFFER, V5, P1017; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KORNBERG RD, 1989, METHOD ENZYMOL, V170, P3; Kornberg RD, 2007, NAT STRUCT MOL BIOL, V14, P986, DOI 10.1038/nsmb1107-986; OLOFSSON B, 1983, BIOCHIM BIOPHYS ACTA, V740, P339, DOI 10.1016/0167-4781(83)90143-4; Saccone S, 2002, GENE, V300, P169, DOI 10.1016/S0378-1119(02)01038-7; Scovassi AI, 2003, EUR J HISTOCHEM, V47, P185; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Varriale A, 2006, GENE, V385, P111, DOI 10.1016/j.gene.2006.05.031; Walker PR, 1997, BIOCHEM CELL BIOL, V75, P287, DOI 10.1139/bcb-75-4-287; Widlak P, 2006, BIOCHEM CELL BIOL, V84, P405, DOI 10.1139/O06-063; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	29	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2009	4	4							e5010	10.1371/journal.pone.0005010	http://dx.doi.org/10.1371/journal.pone.0005010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RS	19347039	Green Submitted, Green Published, gold			2022-12-27	WOS:000265505200002
J	Nemolato, S; Messana, I; Cabras, T; Manconi, B; Inzitari, R; Fanali, C; Vento, G; Tirone, C; Romagnoli, C; Riva, A; Fanni, D; Di Felice, E; Faa, G; Castagnola, M				Nemolato, Sonia; Messana, Irene; Cabras, Tiziana; Manconi, Barbara; Inzitari, Rosanna; Fanali, Chiara; Vento, Giovanni; Tirone, Chiara; Romagnoli, Costantino; Riva, Alessandro; Fanni, Daniela; Di Felice, Eliana; Faa, Gavino; Castagnola, Massimo			Thymosin beta(4) and beta(10) Levels in Pre-Term Newborn Oral Cavity and Foetal Salivary Glands Evidence a Switch of Secretion during Foetal Development	PLOS ONE			English	Article							PARALLEL RELATION; BETA-4; EXPRESSION; MIGRATION; HPLC	Background: Thymosin beta(4), its sulfoxide, and thymosin beta(10) were detected in whole saliva of human pre-term newborns by reversed-phase high performance chromatography coupled to electrospray ion-trap mass spectrometry. Methodology/Principal Findings: Despite high inter-individual variability, concentration of beta-thymosins increases with an inversely proportional trend to postmenstrual age (PMA: gestational age plus chronological age after birth) reaching a value more than twenty times higher than in adult whole saliva at 190 days (27 weeks) of PMA (thymosin beta(4) concentration: more than 2.0 mu mol/L versus 0.1 mu mol/L). On the other hand, the ratio between thymosin beta(4) and thymosin beta(10) exhibits a constant value of about 4 along all the range of PMA (190-550 days of PMA) examined. In order to investigate thymosin beta(4) origin and to better establish the trend of its production as a function of gestational age (GA), immunohistochemical analysis of major and minor salivary glands of different pre-term fetuses were carried out, starting from 84 days (12 weeks) of gestational age. Reactive granules were seen in all glands with a maximum of expression around 140-150 days of GA, even though with high inter-and intra-individual variability. In infants and adults reactive granules in acinar cells were not observed, but just a diffuse cytoplasmatic staining in ductal cells. Significance: This study outlines for the first time that salivary glands during foetal life express and secrete peptides such as b-thymosins probably involved in the development of the oral cavity and its annexes. The secretion increases from about 12 weeks till to about 21 weeks of GA, subsequently it decreases, almost disappearing in the period of expected date of delivery, when the gland switches towards the secretion of adult specific salivary peptides. The switch observed may be an example of further secretion switches involving other exocrine and endocrine glands during foetal development.	[Nemolato, Sonia; Riva, Alessandro; Fanni, Daniela; Di Felice, Eliana; Faa, Gavino] Univ Cagliari, Dipartimento Citomorfol, Cagliari, Italy; [Messana, Irene; Cabras, Tiziana; Manconi, Barbara] Univ Cagliari, Dipartimento Sci Appl Biosist, Cagliari, Italy; [Inzitari, Rosanna; Fanali, Chiara; Castagnola, Massimo] Univ Cattolica, Ist Biochim Biochim Clin, Rome, Italy; [Inzitari, Rosanna; Fanali, Chiara; Castagnola, Massimo] Ist Sci Int ISI Paolo VI, Ist Chim Riconoscimento Mol, CNR, Rome, Italy; [Vento, Giovanni; Tirone, Chiara; Romagnoli, Costantino] Univ Cattolica, Ist Clin Pediat, Div Neonatol, Rome, Italy	University of Cagliari; University of Cagliari; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Nemolato, S (corresponding author), Univ Cagliari, Dipartimento Citomorfol, Cagliari, Italy.	massimo.castagnola@icrm.cnr.it	Tirone, Chiara/K-5579-2018; Castagnola, Massimo/AAM-6355-2021; Castagnola, Massimo/AAB-2825-2019; Cabras, Tiziana/AAF-6231-2020; Fanni, Daniela/ABD-9643-2020; Messana, Irene/L-2478-2019; Fanni, Daniela/N-5669-2016	Castagnola, Massimo/0000-0002-0959-7259; Fanni, Daniela/0000-0003-2797-8343; Messana, Irene/0000-0002-1436-6105; Fanni, Daniela/0000-0003-2797-8343; Vento, Giovanni/0000-0003-3121-9569; Faa, Gavino/0000-0002-6129-0975	Universita di Cagliari; Universita Cattolica in Rome; MIUR; Italian National Research Council (CNR); Regione Sardegna; Fondazione Banco di Sardegna; International Scientific Institute Paolo VI (ISI); Telethon [GGP06170]	Universita di Cagliari; Universita Cattolica in Rome; MIUR(Ministry of Education, Universities and Research (MIUR)); Italian National Research Council (CNR)(Consiglio Nazionale delle Ricerche (CNR)); Regione Sardegna(Regione Sardegna); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna); International Scientific Institute Paolo VI (ISI); Telethon(Fondazione Telethon)	We acknowledge the financial support of Universita di Cagliari, Universita Cattolica in Rome, MIUR, Italian National Research Council (CNR), Regione Sardegna and Fondazione Banco di Sardegna, International Scientific Institute Paolo VI (ISI), and Telethon Grant N. GGP06170 thanks to their programs of scientific research promotion and diffusion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badamchian M, 2007, ANN NY ACAD SCI, V1112, P458, DOI 10.1196/annals.1415.046; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; GRANT DS, 1995, J CELL SCI, V108, P3685; Hannappel E, 2007, ANN NY ACAD SCI, V1112, P21, DOI 10.1196/annals.1415.018; Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X; Huff T, 1997, ANAL CHIM ACTA, V352, P249, DOI 10.1016/S0003-2670(97)00132-3; Inzitari R, 2007, J PROTEOME RES, V6, P1371, DOI 10.1021/pr060520e; Inzitari R, 2009, J SEP SCI, V32, P57, DOI 10.1002/jssc.200800496; Lourenco SV, 2007, HISTOCHEM CELL BIOL, V128, P361, DOI 10.1007/s00418-007-0322-6; Lourenco SV, 2008, VIRCHOWS ARCH, V452, P427, DOI 10.1007/s00428-007-0552-y; LOW TLK, 1981, P NATL ACAD SCI-BIOL, V78, P1162, DOI 10.1073/pnas.78.2.1162; Malinda KM, 1997, FASEB J, V11, P474, DOI 10.1096/fasebj.11.6.9194528; Philp D, 2003, FASEB J, V17, P385, DOI 10.1096/fj.03-0244fje; Reti R, 2008, EUR J ORAL SCI, V116, P424, DOI 10.1111/j.1600-0722.2008.00569.x; Smart Nicola, 2007, Angiogenesis, V10, P229, DOI 10.1007/s10456-007-9077-x; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Sosne G, 2001, EXP EYE RES, V72, P605, DOI 10.1006/exer.2000.0985; WELLER FE, 1987, J IMMUNOASSAY, V8, P203, DOI 10.1080/15321818708057022; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	19	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5109	10.1371/journal.pone.0005109	http://dx.doi.org/10.1371/journal.pone.0005109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337364	gold, Green Published, Green Submitted			2022-12-27	WOS:000265500600025
J	Corney, D; Haynes, JD; Rees, G; Lotto, RB				Corney, David; Haynes, John-Dylan; Rees, Geraint; Lotto, R. Beau			The Brightness of Colour	PLOS ONE			English	Article							SPECTRALLY OPPONENT INPUTS; HUMAN LUMINANCE PATHWAY; CONE INPUTS; VISUAL-CORTEX; WAVELENGTH; SENSITIVITIES; STATISTICS; LIGHTNESS; SLOW; PHOTORECEPTOR	Background: The perception of brightness depends on spatial context: the same stimulus can appear light or dark depending on what surrounds it. A less well-known but equally important contextual phenomenon is that the colour of a stimulus can also alter its brightness. Specifically, stimuli that are more saturated (i.e. purer in colour) appear brighter than stimuli that are less saturated at the same luminance. Similarly, stimuli that are red or blue appear brighter than equiluminant yellow and green stimuli. This non-linear relationship between stimulus intensity and brightness, called the Helmholtz-Kohlrausch (HK) effect, was first described in the nineteenth century but has never been explained. Here, we take advantage of the relative simplicity of this 'illusion' to explain it and contextual effects more generally, by using a simple Bayesian ideal observer model of the human visual ecology. We also use fMRI brain scans to identify the neural correlates of brightness without changing the spatial context of the stimulus, which has complicated the interpretation of related fMRI studies. Results: Rather than modelling human vision directly, we use a Bayesian ideal observer to model human visual ecology. We show that the HK effect is a result of encoding the non-linear statistical relationship between retinal images and natural scenes that would have been experienced by the human visual system in the past. We further show that the complexity of this relationship is due to the response functions of the cone photoreceptors, which themselves are thought to represent an efficient solution to encoding the statistics of images. Finally, we show that the locus of the response to the relationship between images and scenes lies in the primary visual cortex (V1), if not earlier in the visual system, since the brightness of colours (as opposed to their luminance) accords with activity in V1 as measured with fMRI. Conclusions: The data suggest that perceptions of brightness represent a robust visual response to the likely sources of stimuli, as determined, in this instance, by the known statistical relationship between scenes and their retinal responses. While the responses of the early visual system (receptors in this case) may represent specifically the statistics of images, post receptor responses are more likely represent the statistical relationship between images and scenes. A corollary of this suggestion is that the visual cortex is adapted to relate the retinal image to behaviour given the statistics of its past interactions with the sources of retinal images: the visual cortex is adapted to the signals it receives from the eyes, and not directly to the world beyond.	[Corney, David; Lotto, R. Beau] UCL, Inst Ophthalmol, London, England; [Haynes, John-Dylan] Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany; [Rees, Geraint] UCL, Inst Cognit Neurosci, London, England; [Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimag, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Corney, D (corresponding author), UCL, Inst Ophthalmol, London, England.	lotto@ucl.ac.uk	Haynes, John-Dylan/Q-1148-2016; Rees, Geraint/C-1493-2008; Corney, David/P-6941-2019; Corney, David/C-1601-2008	Haynes, John-Dylan/0000-0003-1786-6954; Rees, Geraint/0000-0002-9623-7007; Corney, David/0000-0002-0651-9028	European Union [27731]	European Union(European Commission)	Work partially supported by European Union grant 27731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TJ, 2004, CURR BIOL, V14, P418, DOI 10.1016/j.cub.2004.02.030; Ayama M, 1998, COLOR RES APPL, V23, P274, DOI 10.1002/(SICI)1520-6378(199810)23:5<274::AID-COL4>3.0.CO;2-T; Boots B, 2007, NETWORK-COMP NEURAL, V18, P11, DOI 10.1080/09548980601113254; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Boyaci H, 2007, CURR BIOL, V17, P989, DOI 10.1016/j.cub.2007.05.005; Brainard DH, 2008, J VISION, V8, DOI 10.1167/8.5.15; Brainard DH, 1997, J OPT SOC AM A, V14, P1393, DOI 10.1364/JOSAA.14.001393; Conway BR, 2001, J NEUROSCI, V21, P2768, DOI 10.1523/JNEUROSCI.21-08-02768.2001; Cornelissen FW, 2006, J NEUROSCI, V26, P3634, DOI 10.1523/JNEUROSCI.4382-05.2006; Corney D, 2007, PLOS COMPUT BIOL, V3, P1790, DOI 10.1371/journal.pcbi.0030180; FAIRCHILD MD, 1998, COLOR APPEARANCE MOD; Foster DH, 2006, J OPT SOC AM A, V23, P2359, DOI 10.1364/JOSAA.23.002359; Foster DH, 2004, VISUAL NEUROSCI, V21, P331, DOI 10.1017/S0952523804213335; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Geisler W.S., 2003, VISUAL NEUROSCIENCES, P825; Gurney K, 2007, PHILOS T R SOC B, V362, P339, DOI 10.1098/rstb.2006.1962; Haynes JD, 2004, P NATL ACAD SCI USA, V101, P4286, DOI 10.1073/pnas.0307948101; Howe CQ, 2005, P NATL ACAD SCI USA, V102, P1228, DOI 10.1073/pnas.0409311102; Hung CP, 2001, VISION RES, V41, P1389, DOI 10.1016/S0042-6989(01)00075-X; Johnson EN, 2004, J NEUROPHYSIOL, V91, P2501, DOI 10.1152/jn.01043.2003; Kaiser P.K, 1996, HUMAN COLOR VISION; Knill DC, 1996, PERCEPTION BAYESIAN; LENNIE P, 1993, J OPT SOC AM A, V10, P1283, DOI 10.1364/JOSAA.10.001283; LENNIE P, 1990, J NEUROSCI, V10, P649; Lewis A, 2006, J VISION, V6, P285, DOI 10.1167/6.3.8; Long F, 2003, P NATL ACAD SCI USA, V100, P15190, DOI 10.1073/pnas.2036361100; Lotto RB, 2005, P NATL ACAD SCI USA, V102, P3852, DOI 10.1073/pnas.0500681102; Lotto RB, 2005, P NATL ACAD SCI USA, V102, P16870, DOI 10.1073/pnas.0503773102; MacEvoy SP, 2001, P NATL ACAD SCI USA, V98, P8827, DOI 10.1073/pnas.161280398; MALONEY LT, 1986, J OPT SOC AM A, V3, P1673, DOI 10.1364/JOSAA.3.001673; Mullen KT, 2007, EUR J NEUROSCI, V25, P491, DOI 10.1111/j.1460-9568.2007.05302.x; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; Nayatani Y, 1998, COLOR RES APPL, V23, P374, DOI 10.1002/(SICI)1520-6378(199812)23:6<374::AID-COL5>3.0.CO;2-W; Oxtoby EK, 2005, PERCEPTION, V34, P961, DOI 10.1068/p5186; Pridmore RW, 2007, COLOR RES APPL, V32, P208, DOI 10.1002/col.20312; Purves D., 2003, WHY WE SEE WHAT WE D; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Roe AW, 2005, P NATL ACAD SCI USA, V102, P3869, DOI 10.1073/pnas.0500097102; Schlessinger E, 2005, GECCO 2005: Genetic and Evolutionary Computation Conference, Vols 1 and 2, P115; Sharpe LT, 2005, J VISION, V5, P948, DOI 10.1167/5.11.3; Stockman A, 2005, J VISION, V5, P702, DOI 10.1167/5.9.5; Stockman A, 2005, J PHYSIOL-LONDON, V566, P77, DOI 10.1113/jphysiol.2005.084095; Stockman A, 2005, J PHYSIOL-LONDON, V566, P61, DOI 10.1113/jphysiol.2005.084046; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Thomson EE, 2005, NEURAL COMPUT, V17, P741, DOI 10.1162/0899766053429435; von der Twer T, 2001, NETWORK-COMP NEURAL, V12, P395, DOI 10.1088/0954-898X/12/3/309; von Helmholtz H., 1867, TREATISE PHYSL OPTIC; Wachtler T, 2001, J OPT SOC AM A, V18, P65, DOI 10.1364/JOSAA.18.000065; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; Webster MA, 1997, VISION RES, V37, P3283, DOI 10.1016/S0042-6989(97)00125-9; WYSZECKI G, 1967, J OPT SOC AM, V57, P254, DOI 10.1364/JOSA.57.000254	53	28	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5091	10.1371/journal.pone.0005091	http://dx.doi.org/10.1371/journal.pone.0005091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333398	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499900024
J	Long, MA; Rossi, FMV				Long, Michael A.; Rossi, Fabio M. V.			Silencing Inhibits Cre-Mediated Recombination of the Z/AP and Z/EG Reporters in Adult Cells	PLOS ONE			English	Article								Background: The Cre-loxP system has been used to enable tissue specific activation, inactivation and mutation of many genes in vivo and has thereby greatly facilitated the genetic dissection of several cellular and developmental processes. In such studies, Cre-reporter strains, which carry a Cre-activated marker gene, are frequently utilized to validate the expression profile of Cre transgenes, to act as a surrogate marker for excision of a second allele, and to irreversibly label cells for lineage tracing experiments. Principal Findings: We have studied three commonly used Cre-reporter strains, Z/AP, Z/EG and R26R-EYFP and have demonstrated that although each reporter can be reliably activated by Cre during early development, exposure to Cre in adult hematopoietic cells results in a much lower frequency of marker-positive cells in the Z/AP or Z/EG strains than in the R26R-EYFP strain. In marker negative cells derived from the Z/AP and Z/EG strains, the transgenic promoter is methylated and Cre-mediated recombination of the locus is inhibited. Conclusions: These results show that the efficiency of Cre-mediated recombination is not only dependent on the genomic context of a given loxP-flanked sequence, but also on stochastic epigenetic mechanisms underlying transgene variegation. Furthermore, our data highlights the potential shortcomings of utilizing the Z/AP and Z/EG reporters as surrogate markers of excision or in lineage tracing experiments.			Rossi, FMV (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	fabio@brc.ubc.ca	Rossi, Fabio MV/B-5587-2013	Rossi, Fabio MV/0000-0002-0368-2620				Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; AUSTIN S, 1981, CELL, V25, P729, DOI 10.1016/0092-8674(81)90180-X; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cohen-Tannoudji M, 2000, TRANSGENIC RES, V9, P233, DOI 10.1023/A:1008916910392; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Harris RG, 2004, SCIENCE, V305, P90, DOI 10.1126/science.1098925; IWAMA A, 1993, BIOCHEM BIOPH RES CO, V195, P301, DOI 10.1006/bbrc.1993.2045; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Jullien N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001355; Kidder BL, 2008, CLONING STEM CELLS, V10, P231, DOI 10.1089/clo.2007.0039; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Rotolo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004099; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STERNBERG N, 1986, J MOL BIOL, V187, P197, DOI 10.1016/0022-2836(86)90228-7; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Yano M, 1997, BLOOD, V89, P4317, DOI 10.1182/blood.V89.12.4317; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhang XM, 2005, INVEST OPHTH VIS SCI, V46, P3515, DOI 10.1167/iovs.04-1201; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	29	50	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5435	10.1371/journal.pone.0005435	http://dx.doi.org/10.1371/journal.pone.0005435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415111	Green Published, gold, Green Submitted			2022-12-27	WOS:000265836700008
J	Sakamoto, KQ; Sato, K; Ishizuka, M; Watanuki, Y; Takahashi, A; Daunt, F; Wanless, S				Sakamoto, Kentaro Q.; Sato, Katsufumi; Ishizuka, Mayumi; Watanuki, Yutaka; Takahashi, Akinori; Daunt, Francis; Wanless, Sarah			Can Ethograms Be Automatically Generated Using Body Acceleration Data from Free-Ranging Birds?	PLOS ONE			English	Article							SHAGS PHALACROCORAX-ARISTOTELIS; BREEDING SUCCESS; DIVING BEHAVIOR; TIME BUDGET; CAMERAS; QUANTIFY; INSIGHTS; SEABIRD; STROKE; DEPTH	An ethogram is a catalogue of discrete behaviors typically employed by a species. Traditionally animal behavior has been recorded by observing study individuals directly. However, this approach is difficult, often impossible, in the case of behaviors which occur in remote areas and/or at great depth or altitude. The recent development of increasingly sophisticated, animal-borne data loggers, has started to overcome this problem. Accelerometers are particularly useful in this respect because they can record the dynamic motion of a body in e. g. flight, walking, or swimming. However, classifying behavior using body acceleration characteristics typically requires prior knowledge of the behavior of free-ranging animals. Here, we demonstrate an automated procedure to categorize behavior from body acceleration, together with the release of a user-friendly computer application, "Ethographer''. We evaluated its performance using longitudinal acceleration data collected from a foot-propelled diving seabird, the European shag, Phalacrocorax aristotelis. The time series data were converted into a spectrum by continuous wavelet transformation. Then, each second of the spectrum was categorized into one of 20 behavior groups by unsupervised cluster analysis, using k-means methods. The typical behaviors extracted were characterized by the periodicities of body acceleration. Each categorized behavior was assumed to correspond to when the bird was on land, in flight, on the sea surface, diving and so on. The behaviors classified by the procedures accorded well with those independently defined from depth profiles. Because our approach is performed by unsupervised computation of the data, it has the potential to detect previously unknown types of behavior and unknown sequences of some behaviors.	[Sakamoto, Kentaro Q.; Ishizuka, Mayumi] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Sato, Katsufumi] Univ Tokyo, Ocean Res Inst, Int Coastal Res Ctr, Otsuchi, Iwate, Japan; [Watanuki, Yutaka] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan; [Takahashi, Akinori] Natl Inst Polar Res, Tokyo, Tokyo, Japan; [Daunt, Francis; Wanless, Sarah] Bush Estate, Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland	Hokkaido University; University of Tokyo; Hokkaido University; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; UK Centre for Ecology & Hydrology (UKCEH)	Sakamoto, KQ (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan.	sakamoto@vetmed.hokudai.ac.jp	Wanless, Sarah/K-2338-2012; Ishizuka, Mayumi/F-9548-2012; Sakamoto, Kentaro/N-7424-2019; Daunt, Francis/K-6688-2012; Sakamoto, Kentaro/A-4843-2012	Wanless, Sarah/0000-0002-2788-4606; Sakamoto, Kentaro/0000-0002-8499-799X; Daunt, Francis/0000-0003-4638-3388; Sakamoto, Kentaro/0000-0002-8499-799X	Natural Environment Research Council [CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Boyd Ian L., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P1; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Daunt F, 2007, FUNCT ECOL, V21, P561, DOI 10.1111/j.1365-2435.2007.01260.x; Gentry R.L., 1986, P28; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Hooker SK, 2007, DEEP-SEA RES PT II, V54, P177, DOI 10.1016/j.dsr2.2007.01.001; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jenouvrier S, 2005, P ROY SOC B-BIOL SCI, V272, P887, DOI 10.1098/rspb.2004.2978; Karlsson S, 2000, IEEE T BIO-MED ENG, V47, P228, DOI 10.1109/10.821766; Lagarde F, 2008, ANIM BEHAV, V75, P319, DOI 10.1016/j.anbehav.2007.01.010; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; PERCIVAL DP, 1995, BIOMETRIKA, V82, P619, DOI 10.2307/2337538; Ropert-Coudert Y, 2004, ANIM BEHAV, V67, P985, DOI 10.1016/j.anbehav.2003.09.010; Rutz C, 2007, SCIENCE, V318, P765, DOI 10.1126/science.1146788; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sato K, 2008, J EXP BIOL, V211, P58, DOI 10.1242/jeb.009811; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tremblay Y, 2003, J EXP BIOL, V206, P1929, DOI 10.1242/jeb.00363; WANLESS S, 1993, IBIS, V135, P19, DOI 10.1111/j.1474-919X.1993.tb02805.x; WANLESS S, 1991, IBIS, V133, P37, DOI 10.1111/j.1474-919X.1991.tb04807.x; Wanless S., 1992, P591; WANLESS S, 1993, J ZOOL, V231, P11, DOI 10.1111/j.1469-7998.1993.tb05349.x; Watanabe S, 2005, APPL ANIM BEHAV SCI, V94, P117, DOI 10.1016/j.applanim.2005.01.010; Watanuki Y, 2005, J EXP BIOL, V208, P2207, DOI 10.1242/jeb.01639; Watanuki Y, 2008, MAR ECOL PROG SER, V356, P283, DOI 10.3354/meps07266; Watanuki Yutaka, 2007, British Birds, V100, P466; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2008, ENDANGER SPECIES RES, V10, P29, DOI [10.3354/esr00091, DOI 10.3354/ESR00091]; Yoda K, 2001, J EXP BIOL, V204, P685; Young SS., 2001, COMPUTERIZED DATA AC, DOI 10.1017/CBO9780511609558	34	239	247	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5379	10.1371/journal.pone.0005379	http://dx.doi.org/10.1371/journal.pone.0005379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404389	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000265614900004
J	Serrano, MA; Flammini, A; Menczer, F				Angeles Serrano, M.; Flammini, Alessandro; Menczer, Filippo			Modeling Statistical Properties of Written Text	PLOS ONE			English	Article							LANGUAGES	Written text is one of the fundamental manifestations of human language, and the study of its universal regularities can give clues about how our brains process information and how we, as a society, organize and share it. Among these regularities, only Zipf's law has been explored in depth. Other basic properties, such as the existence of bursts of rare words in specific documents, have only been studied independently of each other and mainly by descriptive models. As a consequence, there is a lack of understanding of linguistic processes as complex emergent phenomena. Beyond Zipf's law for word frequencies, here we focus on burstiness, Heaps' law describing the sublinear growth of vocabulary size with the length of a document, and the topicality of document collections, which encode correlations within and across documents absent in random null models. We introduce and validate a generative model that explains the simultaneous emergence of all these patterns from simple rules. As a result, we find a connection between the bursty nature of rare words and the topical organization of texts and identify dynamic word ranking and memory across documents as key mechanisms explaining the non trivial organization of written text. Our research can have broad implications and practical applications in computer science, cognitive science and linguistics.			Serrano, MA (corresponding author), Univ Barcelona, Dept Quim Fis, E-08028 Barcelona, Spain.	marian.serrano@ub.edu	Serrano, M. Ángeles/AAS-8246-2020; Serrano, M. Angeles/A-4198-2013	Serrano, M. Angeles/0000-0001-8779-5931; Menczer, Filippo/0000-0003-4384-2876				Adelman JS, 2006, PSYCHOL SCI, V17, P814, DOI 10.1111/j.1467-9280.2006.01787.x; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Allan J., 1998, Proceedings of the 21st Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P37, DOI 10.1145/290941.290954; Alvarez-Lacalle E, 2006, P NATL ACAD SCI USA, V103, P7956, DOI 10.1073/pnas.0510673103; Ananiadou S., 2005, TEXT MINING BIOL BIO; Atkinson QD, 2008, SCIENCE, V319, P588, DOI 10.1126/science.1149683; Baayen R. Harald, 2001, WORD FREQUENCY DISTR; Baeza-Yates RA, 1999, MODERN INFORM RETRIE; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Cattuto C, 2007, P NATL ACAD SCI USA, V104, P1461, DOI 10.1073/pnas.0610487104; Chakrabarti S., 2003, MINING WEB DISCOVERI; Chomsky N., 2006, LANGUAGE MIND; Church K. W., 1995, NAT LANG ENG, V1, P163, DOI [DOI 10.1017/S1351324900000139, 10.1017/S1351324900000139]; CLAUSET A, 2009, SIAM REV IN PRESS; DOLBY JL, 1971, J DOC, V27, P136, DOI 10.1108/eb026514; ELKAN C, 2006, P 23 INT C MACH LEAR; Feldman R., 2006, TEXT MINING HDB ADV; Fortunato S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.218701; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; GRIFFITHS TL, 2005, ADV NEURAL INFORM PR, V17, P537; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Heaps Harold Stanley, 1978, INFORM RETRIEVAL COM; Hofmann T, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P50, DOI 10.1145/312624.312649; Hsinchun C, 2006, INTEGR SER INFORM SY, V10, P1, DOI 10.1007/0-387-30332-4; Jansche M, 2003, 41ST ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P288; JOSHI AK, 1991, SCIENCE, V253, P1242, DOI 10.1126/science.253.5025.1242; Katz S., 1996, Natural Language Engineering, V2, P15, DOI 10.1017/S1351324996001246; Kleinberg J, 2002, P 8 ACM SIGKDD INT C, P91; KLEINBERG J, 2004, NATURE WEB FOCUS ACC; Li W, 2006, P 23 INT C MACH LEAR, P577, DOI DOI 10.1145/1143844.1143917; MADSEN RE, 2005, P 22 INT C MACH LEAR, P545; Manning C.D., 1999, FDN STAT NATURAL LAN; Maslov VP, 2006, MATH NOTES+, V80, P679, DOI 10.1007/s11006-006-0189-1; Menczer F, 2004, P NATL ACAD SCI USA, V101, P5261, DOI 10.1073/pnas.0307554100; Menczer F, 2002, P NATL ACAD SCI USA, V99, P14014, DOI 10.1073/pnas.212348399; Murray WS, 2004, PSYCHOL REV, V111, P721, DOI 10.1037/0033-295X.111.3.721; Newman D, 2006, LECT NOTES COMPUT SC, V3975, P93; Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771; PENNEBAKER JW, 2008, CONTENT ANAL READER; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; Saichev A, 2008, LECT NOTES EC MATH S; Salton G, 1983, INTRO MODERN INFORM; Sarkar A., 2005, P 9 C COMP NAT LANG, P48; SIMON HA, 1955, BIOMETRIKA, V42, P425; Yang Y., 1998, P 21 ANN INT ACM SIG, P28, DOI [DOI 10.1145/290941.290953, 10.1145/290941.290953]; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	50	69	70	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5372	10.1371/journal.pone.0005372	http://dx.doi.org/10.1371/journal.pone.0005372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	439BG	19401762	Green Submitted, Green Published, gold			2022-12-27	WOS:000265601100014
J	Cuesta, AM; Sanchez-Martin, D; Sanz, L; Bonet, J; Compte, M; Kremer, L; Blanco, FJ; Oliva, B; Alvarez-Vallina, L				Cuesta, Angel M.; Sanchez-Martin, David; Sanz, Laura; Bonet, Jaume; Compte, Marta; Kremer, Leonor; Blanco, Francisco J.; Oliva, Baldomero; Alvarez-Vallina, Luis			In Vivo Tumor Targeting and Imaging with Engineered Trivalent Antibody Fragments Containing Collagen-Derived Sequences	PLOS ONE			English	Article							SINGLE-CHAIN FV; BINDING-AFFINITY; GENE-THERAPY; PROTEIN; DOMAIN; GENERATION; INHIBITION; SELECTION; DIVALENT; DIABODY	There is an urgent need to develop new and effective agents for cancer targeting. In this work, a multivalent antibody is characterized in vivo in living animals. The antibody, termed "trimerbody", comprises a single-chain antibody (scFv) fragment connected to the N-terminal trimerization subdomain of collagen XVIII NC1 by a flexible linker. As indicated by computer graphic modeling, the trimerbody has a tripod-shaped structure with three highly flexible scFv heads radially outward oriented. Trimerbodies are trimeric in solution and exhibited multivalent binding, which provides them with at least a 100-fold increase in functional affinity than the monovalent scFv. Our results also demonstrate the feasibility of producing functional bispecific trimerbodies, which concurrently bind two different ligands. A trimerbody specific for the carcinoembryonic antigen (CEA), a classic tumor-associated antigen, showed efficient tumor targeting after systemic administration in mice bearing CEA-positive tumors. Importantly, a trimerbody that recognizes an angiogenesis-associated laminin epitope, showed excellent tumor localization in several cancer types, including fibrosarcomas and carcinomas. These results illustrate the potential of this new antibody format for imaging and therapeutic applications, and suggest that some laminin epitopes might be universal targets for cancer targeting.	[Cuesta, Angel M.; Sanchez-Martin, David; Sanz, Laura; Compte, Marta; Alvarez-Vallina, Luis] Hosp Univ Puerta de Hierro, Mol Immunol Unit, Madrid, Spain; [Bonet, Jaume; Oliva, Baldomero] Parc Recerca Biomed Barcelona, Biomed Informat Res Unit, Struct Bioinformat Lab, Barcelona, Spain; [Kremer, Leonor] CSIC, Ctr Nacl Biotecnol, Prot Tools Unit, Madrid, Spain; [Blanco, Francisco J.] Parque Tecnol Bizkaia, Struct Biol Unit, CIC bioGUNE, Bizkaia, Spain	Hospital Puerta de Hierro-Majadahonda; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIC bioGUNE	Cuesta, AM (corresponding author), Hosp Univ Puerta de Hierro, Mol Immunol Unit, Madrid, Spain.	lalvarezv.hpth@salud.madrid.org	Sánchez-Martín, David/C-9927-2013; Bonet, Jaume/C-5551-2011; Blanco, Francisco J/D-4401-2009; Cuesta, Angel/F-1668-2011; AM, Cuesta/AAA-9356-2020; Sanz, Laura/F-8542-2010; Alvarez-Vallina, Luis/ABD-2431-2020; Kremer, Leonor/L-5445-2015; cancer, biogune/H-7276-2012; Gasull, Martina/J-4076-2019; Álvarez-Vallina, Luis/A-2032-2010; Oliva, Baldomero/A-2690-2009; Alvarez-Vallina, Luis/A-2033-2010	Sánchez-Martín, David/0000-0002-2712-4762; Bonet, Jaume/0000-0001-5210-4387; Blanco, Francisco J/0000-0003-2545-4319; Cuesta, Angel/0000-0002-6596-9600; AM, Cuesta/0000-0002-6596-9600; Sanz, Laura/0000-0002-3119-3218; Alvarez-Vallina, Luis/0000-0003-3053-6757; Kremer, Leonor/0000-0002-2235-2010; Oliva, Baldomero/0000-0003-0702-0250; Compte Grau, Marta/0000-0002-7138-9266				Adams GP, 1998, BRIT J CANCER, V77, P1405, DOI 10.1038/bjc.1998.233; ADAMS GP, 1995, CANCER IMMUNOL IMMUN, V40, P299, DOI 10.1007/BF01519629; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beresford GW, 1999, INT J CANCER, V81, P911, DOI 10.1002/(SICI)1097-0215(19990611)81:6<911::AID-IJC12>3.0.CO;2-O; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Birchler M, 1999, J IMMUNOL METHODS, V231, P239, DOI 10.1016/S0022-1759(99)00160-X; Blanco B, 2003, J IMMUNOL, V171, P1070, DOI 10.4049/jimmunol.171.2.1070; CHESTER KA, 1994, LANCET, V343, P455, DOI 10.1016/S0140-6736(94)92695-6; Chester KA, 2000, CANCER CHEMOTH PHARM, V46, pS8, DOI 10.1007/PL00014055; Compte M, 2007, CANCER GENE THER, V14, P380, DOI 10.1038/sj.cgt.7701021; Ebbinghaus C, 2005, INT J CANCER, V116, P304, DOI 10.1002/ijc.20952; Fan CY, 2008, FASEB J, V22, P3795, DOI 10.1096/fj.08-111484; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; HOLLIGER P, 1993, P NATL ACAD SCI USA, V90, P6444, DOI 10.1073/pnas.90.14.6444; Hu SZ, 1996, CANCER RES, V56, P3055; Huang BC, 2006, J IMMUNOL METHODS, V313, P149, DOI 10.1016/j.jim.2006.04.006; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Lawrence LJ, 1998, FEBS LETT, V425, P479, DOI 10.1016/S0014-5793(98)00292-0; PACK P, 1995, J MOL BIOL, V246, P28, DOI 10.1006/jmbi.1994.0062; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Pluckthun A, 1997, IMMUNOTECHNOLOGY, V3, P83, DOI 10.1016/S1380-2933(97)00067-5; Lobo VJSA, 2006, INT J CANCER, V119, P455, DOI 10.1002/ijc.21851; Sanz L, 2004, TRENDS IMMUNOL, V25, P85, DOI 10.1016/j.it.2003.12.001; Sanz L, 2003, TRENDS MOL MED, V9, P256, DOI 10.1016/S1471-4914(03)00070-4; Sanz L, 2003, EMBO J, V22, P1508, DOI 10.1093/emboj/cdg150; Sanz L, 2002, GENE THER, V9, P1049, DOI 10.1038/sj.gt.3301725; Sanz L, 2001, CANCER IMMUNOL IMMUN, V50, P557, DOI 10.1007/s00262-001-0235-5; Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Viti F, 1999, CANCER RES, V59, P347; WHITLOW M, 1993, PROTEIN ENG, V6, P989, DOI 10.1093/protein/6.8.989; Williams LE, 2001, CANCER BIOTHER RADIO, V16, P25, DOI 10.1089/108497801750095989; Willuda J, 2001, J BIOL CHEM, V276, P14385, DOI 10.1074/jbc.M011669200; Wong JYC, 2004, CLIN CANCER RES, V10, P5014, DOI 10.1158/1078-0432.CCR-03-0576; Wu AM, 1996, IMMUNOTECHNOLOGY, V2, P21, DOI 10.1016/1380-2933(95)00027-5; Yazaki Paul J, 2003, Methods Mol Biol, V207, P351; YOKOTA T, 1993, CANCER RES, V53, P3776; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	42	48	59	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5381	10.1371/journal.pone.0005381	http://dx.doi.org/10.1371/journal.pone.0005381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401768	Green Published, gold			2022-12-27	WOS:000265601100018
J	Beltrand, J; Nicolescu, R; Kaguelidou, F; Verkauskiene, R; Sibony, O; Chevenne, D; Claris, O; Levy-Marchal, C				Beltrand, Jacques; Nicolescu, Ramona; Kaguelidou, Florentia; Verkauskiene, Rasa; Sibony, Oliver; Chevenne, Didier; Claris, Olivier; Levy-Marchal, Claire			Catch-Up Growth Following Fetal Growth Restriction Promotes Rapid Restoration of Fat Mass but Without Metabolic Consequences at One Year of Age	PLOS ONE			English	Article								Background: Fetal growth restriction (FGR) followed by rapid weight gain during early life has been suggested to be the initial sequence promoting central adiposity and insulin resistance. However, the link between fetal and early postnatal growth and the associated anthropometric and metabolic changes have been poorly studied. Methodology/Principal Findings: Over the first year of post-natal life, changes in body mass index, skinfold thickness and hormonal concentrations were prospectively monitored in 94 infants in whom the fetal growth velocity had previously been measured using a repeated standardized procedure of ultrasound fetal measurements. 45 infants, thinner at birth, had experienced previous FGR (FGR+) regardless of birth weight. Growth pattern in the first four months of life was characterized by greater change in BMI z-score in FGR+ (+1.26+/21.2 vs +0.58+/21.17 SD in FGR-) resulting in the restoration of BMI and of fat mass to values similar to FGR-, independently of caloric intakes. Growth velocity after 4 months was similar and BMI z-score and fat mass remained similar at 12 months of age. At both time-points, fetal growth velocity was an independent predictor of fat mass in FGR+. At one year, fasting insulin levels were not different but leptin was significantly higher in the FGR+ (4.43+/-1.41 vs 2.63+/-1 ng/ml in FGR-). Conclusion: Early catch-up growth is related to the fetal growth pattern itself, irrespective of birth weight, and is associated with higher insulin sensitivity and lower leptin levels after birth. Catch-up growth promotes the restoration of body size and fat stores without detrimental consequences at one year of age on body composition or metabolic profile. The higher leptin concentration at one year may reflect a positive energy balance in children who previously faced fetal growth restriction.			Beltrand, J (corresponding author), INSERM, U690, Paris, France.	claire.levy-marchal@inserm.fr	beltrand, jacques/AAV-6455-2021	beltrand, jacques/0000-0002-3759-3490				Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Bazaes RA, 2003, PEDIATRICS, V111, P804, DOI 10.1542/peds.111.4.804; Beltrand J, 2008, J CLIN ENDOCR METAB, V93, P4027, DOI 10.1210/jc.2008-0562; Beltrand J, 2008, PEDIATR RES, V64, P86, DOI 10.1203/PDR.0b013e318174e6d8; Botton J, 2008, AM J CLIN NUTR, V87, P1760, DOI 10.1093/ajcn/87.6.1760; Bouret SG, 2007, J NEUROENDOCRINOL, V19, P575, DOI 10.1111/j.1365-2826.2007.01563.x; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Brennan AM, 2006, NAT CLIN PRACT ENDOC, V2, P318, DOI 10.1038/ncpendmet0196; BROOK CGD, 1971, ARCH DIS CHILD, V46, P182, DOI 10.1136/adc.46.246.182; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Chomtho S, 2008, AM J CLIN NUTR, V87, P1776, DOI 10.1093/ajcn/87.6.1776; COLLE E, 1976, PEDIATRICS, V57, P363; Ekelund U, 2006, AM J CLIN NUTR, V83, P324; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Ezzahir N, 2005, PEDIATR RES, V58, P243, DOI 10.1203/01.PDR.0000169980.35179.89; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P925, DOI 10.1210/jc.2007-1618; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778; Ikenasio-Thorpe BA, 2007, J ENDOCRINOL, V193, P31, DOI 10.1677/joe.1.07017; Jaquet D, 2005, DIABETOLOGIA, V48, P849, DOI 10.1007/s00125-005-1724-4; Jaquet D, 1999, J CLIN ENDOCR METAB, V84, P1949, DOI 10.1210/jc.84.6.1949; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Larsen T, 1997, EARLY HUM DEV, V47, P157, DOI 10.1016/S0378-3782(96)01780-X; Law CM, 2002, CIRCULATION, V105, P1088, DOI 10.1161/hc0902.104677; Leroy B, 1971, Rev Fr Gynecol Obstet, V66, P391; Leunissen RWJ, 2008, J CLIN ENDOCR METAB, V93, P445, DOI 10.1210/jc.2007-1543; Mantzoros CS, 2009, PEDIATRICS, V123, P682, DOI 10.1542/peds.2008-0343; Martinez-Aguayo A, 2007, CLIN ENDOCRINOL, V67, P526, DOI 10.1111/j.1365-2265.2007.02919.x; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Rodriguez G, 2005, ARCH DIS CHILD-FETAL, V90, P273, DOI 10.1136/adc.2004.060723; RollandCachera MF, 1997, AM J CLIN NUTR, V65, P1709, DOI 10.1093/ajcn/65.6.1709; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Schubring C, 1999, CLIN ENDOCRINOL, V51, P199, DOI 10.1046/j.1365-2265.1999.00761.x; SEMPE M, 1977, ARCH FR PEDIATR, V34, P687; Singhal A, 2004, CIRCULATION, V109, P1108, DOI 10.1161/01.CIR.0000118500.23649.DF; Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4; Singhal A, 2007, CIRCULATION, V115, P213, DOI 10.1161/CIRCULATIONAHA.106.617811; Siri WE., 1956, ADV BIOL MED PHYS, V4, P239, DOI DOI 10.1016/B978-1-4832-3110-5.50011-X; Soto N, 2003, J CLIN ENDOCR METAB, V88, P3645, DOI 10.1210/jc.2002-030031; Stettler N, 2003, AM J CLIN NUTR, V77, P1374, DOI 10.1093/ajcn/77.6.1374; Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194; Veening MA, 2002, J CLIN ENDOCR METAB, V87, P4657, DOI 10.1210/jc.2001-011940; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Yliharsila H, 2008, AM J CLIN NUTR, V87, P1769, DOI 10.1093/ajcn/87.6.1769	50	53	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5343	10.1371/journal.pone.0005343	http://dx.doi.org/10.1371/journal.pone.0005343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19381307	Green Submitted, Green Published, gold			2022-12-27	WOS:000265514900008
J	Gerard, E; Moreira, D; Philippot, P; Van Kranendonk, MJ; Lopez-Garcia, P				Gerard, Emmanuelle; Moreira, David; Philippot, Pascal; Van Kranendonk, Martin J.; Lopez-Garcia, Purificacion			Modern Subsurface Bacteria in Pristine 2.7 Ga-Old Fossil Stromatolite Drillcore Samples from the Fortescue Group, Western Australia	PLOS ONE			English	Article							ANCIENT DNA; SP-NOV.; DIVERSITY; COMMUNITY; BIOMASS; ICE	Background: Several abiotic processes leading to the formation of life-like signatures or later contamination with actual biogenic traces can blur the interpretation of the earliest fossil record. In recent years, a large body of evidence showing the occurrence of diverse and active microbial communities in the terrestrial subsurface has accumulated. Considering the time elapsed since Archaean sedimentation, the contribution of subsurface microbial communities postdating the rock formation to the fossil biomarker pool and other biogenic remains in Archaean rocks may be far from negligible. Methodology/Principal Findings: In order to evaluate the degree of potential contamination of Archean rocks by modern microorganisms, we looked for the presence of living indigenous bacteria in fresh diamond drillcores through 2,724 Myr-old stromatolites (Tumbiana Formation, Fortescue Group, Western Australia) using molecular methods based on the amplification of small subunit ribosomal RNA genes (SSU rDNAs). We analyzed drillcore samples from 4.3 m and 66.2 m depth, showing signs of meteoritic alteration, and also from deeper "fresh'' samples showing no apparent evidence for late stage alteration (68 m, 78.8 m, and 99.3 m). We also analyzed control samples from drilling and sawing fluids and a series of laboratory controls to establish a list of potential contaminants introduced during sample manipulation and PCR experiments. We identified in this way the presence of indigenous bacteria belonging to Firmicutes, Actinobacteria, and Alpha-, Beta-, and Gammaproteobacteria in aseptically-sawed inner parts of drillcores down to at least 78.8 m depth. Conclusions/Significance: The presence of modern bacterial communities in subsurface fossil stromatolite layers opens the possibility that a continuous microbial colonization had existed in the past and contributed to the accumulation of biogenic traces over geological timescales. This finding casts shadow on bulk analyses of early life remains and makes claims for morphological, chemical, isotopic, and biomarker traces syngenetic with the rock unreliable in the absence of detailed contextual analyses at microscale.			Gerard, E (corresponding author), Univ Paris 07, IPGP IMPMC, Paris, France.	puri.lopez@u-psud.fr	Moreira, David/F-7445-2012; Philippot, Pascal/AAD-4313-2020; Van Kranendonk, Martin J/J-8755-2012; GERARD, Emmanuelle/A-3828-2013; Lopez-Garcia, Purificacion/B-6775-2012	Moreira, David/0000-0002-2064-5354; Van Kranendonk, Martin J/0000-0002-0611-2703; GERARD, Emmanuelle/0000-0002-4910-747X; Lopez-Garcia, Purificacion/0000-0002-0927-0651				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barton HA, 2006, J MICROBIOL METH, V66, P21, DOI 10.1016/j.mimet.2005.10.005; Baxter NJ, 2002, APPL ENVIRON MICROB, V68, P289, DOI 10.1128/AEM.68.1.289-296.2002; Brasier M, 2006, PHILOS T R SOC B, V361, P887, DOI 10.1098/rstb.2006.1835; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; Brocks JJ, 2005, TREATISE ON GEOCHEMISTRY, VOL 8: BIOGEOCHEMISTRY, P63; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; CANO RJ, 1995, SCIENCE, V268, P1060, DOI 10.1126/science.7538699; Cox TL, 1997, INT J SYST BACTERIOL, V47, P377, DOI 10.1099/00207713-47-2-377; DORN RI, 1981, SCIENCE, V213, P1245, DOI 10.1126/science.213.4513.1245; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ercole C, 1997, FUEL PROCESS TECHNOL, V52, P191, DOI 10.1016/S0378-3820(97)00028-3; Fish SA, 2002, NATURE, V417, P432, DOI 10.1038/417432a; FREDRICKSON JK, 1995, APPL ENVIRON MICROB, V61, P1917, DOI 10.1128/AEM.61.5.1917-1922.1995; Hayes J. M., 1994, EARLY LIFE EARTH, P220; Hebsgaard MB, 2005, TRENDS MICROBIOL, V13, P212, DOI 10.1016/j.tim.2005.03.010; Inagaki F, 2005, ASTROBIOLOGY, V5, P141, DOI 10.1089/ast.2005.5.141; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kanso S, 2003, INT J SYST EVOL MICR, V53, P401, DOI 10.1099/ijs.0.02348-0; Kanso S, 2002, INT J SYST EVOL MICR, V52, P869, DOI 10.1099/00207713-52-3-869; Kimura H, 2005, EXTREMOPHILES, V9, P407, DOI 10.1007/s00792-005-0454-3; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Lavire C, 2006, ENVIRON MICROBIOL, V8, P2106, DOI 10.1111/j.1462-2920.2006.01087.x; Lepot K, 2008, NAT GEOSCI, V1, P118, DOI 10.1038/ngeo107; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Miyake D, 2007, ARCH MICROBIOL, V188, P199, DOI 10.1007/s00203-007-0244-7; Moissl C, 2007, FEMS MICROBIOL ECOL, V61, P509, DOI 10.1111/j.1574-6941.2007.00360.x; Newman DK, 2002, SCIENCE, V296, P1071, DOI 10.1126/science.1010716; North NN, 2004, APPL ENVIRON MICROB, V70, P4911, DOI 10.1128/aem.70.8.4911-4920.2004; Onstott TC, 2003, ENVIRON MICROBIOL, V5, P1168, DOI 10.1046/j.1462-2920.2003.00512.x; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Pedersen K, 2000, FEMS MICROBIOL LETT, V185, P9, DOI 10.1016/S0378-1097(00)00061-6; Pedersen K, 2008, ISME J, V2, P760, DOI 10.1038/ismej.2008.43; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Rogers SO, 2004, APPL ENVIRON MICROB, V70, P2540, DOI 10.1128/AEM.70.4.2540-2544.2004; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shi T, 2001, J IND MICROBIOL BIOT, V26, P283, DOI 10.1038/sj.jim.7000130; Damste JSS, 2006, ASTROBIOLOGY, V6, P299, DOI 10.1089/ast.2006.6.299; Stapleton RD, 2000, MICROB ECOL, V39, P211; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Teske AP, 2005, TRENDS MICROBIOL, V13, P402, DOI 10.1016/j.tim.2005.07.004; van Zuilen MA, 2002, NATURE, V418, P627, DOI 10.1038/nature00934; VANKRANENDONK MJ, 2006, 200614 W AUSTR GEOL; Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060; Zhang GX, 2005, APPL ENVIRON MICROB, V71, P3213, DOI 10.1128/AEM.71.6.3213-3227.2005	48	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2009	4	4							e5298	10.1371/journal.pone.0005298	http://dx.doi.org/10.1371/journal.pone.0005298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VI	19396360	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514600002
J	Peltier, CA; Omes, C; Ndimubanzi, PC; Ndayisaba, GF; Stulac, S; Arendt, V; Courteille, O; Muganga, N; Kayumba, K; Van den Ende, J				Peltier, Cecile Alexandra; Omes, Christine; Ndimubanzi, Patrick Cyaga; Ndayisaba, Gilles Francois; Stulac, Sara; Arendt, Vic; Courteille, Olivier; Muganga, Narcisse; Kayumba, Kizito; Van den Ende, Jef			Validation of 2006 WHO Prediction Scores for True HIV Infection in Children Less than 18 Months with a Positive Serological HIV Test	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; ANTIRETROVIRAL THERAPY; SEVERE MALNUTRITION; MORTALITY; TUBERCULOSIS; DIAGNOSIS; MANIFESTATIONS; TRANSMISSION; INFANTS; KAMPALA	Introduction: All infants born to HIV-positive mothers have maternal HIV antibodies, sometimes persistent for 18 months. When Polymerase Chain Reaction (PCR) is not available, August 2006 World Health Organization (WHO) recommendations suggest that clinical criteria may be used for starting antiretroviral treatment (ART) in HIV seropositive children,18 months. Predictors are at least two out of sepsis, severe pneumonia and thrush, or any stage 4 defining clinical finding according to the WHO staging system. Methods and Results: From January 2005 to October 2006, we conducted a prospective study on 236 hospitalized children,18 months old with a positive HIV serological test at the national reference hospital in Kigali. The following data were collected: PCR, clinical signs and CD4 cell count. Current proposed clinical criteria were present in 148 of 236 children (62.7%) and in 95 of 124 infected children, resulting in 76.6% sensitivity and 52.7% specificity. For 87 children (59.0%), clinical diagnosis was made based on severe unexplained malnutrition (stage 4 clinical WHO classification), of whom only 44 (50.5%) were PCR positive. Low CD4 count had a sensitivity of 55.6% and a specificity of 78.5%. Conclusion: As PCR is not yet widely available, clinical diagnosis is often necessary, but these criteria have poor specificity and therefore have limited use for HIV diagnosis. Unexplained malnutrition is not clearly enough defined in WHO recommendations. Extra pulmonary tuberculosis (TB), almost impossible to prove in young children, may often be the cause of malnutrition, especially in HIV-affected families more often exposed to TB. Food supplementation and TB treatment should be initiated before starting ART in children who are staged based only on severe malnutrition.			Peltier, CA (corresponding author), Esther Project Luxembourg Lux Dev, Kigali, Rwanda.	alexandrapeltier@hotmail.com						Andreu J, 2004, EUR J RADIOL, V51, P139, DOI 10.1016/j.ejrad.2004.03.009; Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160; Bachou H, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-27; Badri M, 2003, AIDS, V17, P541, DOI 10.1097/00002030-200303070-00009; CHANTRY CJ, 1995, PEDIATR INFECT DIS J, V14, P382, DOI 10.1097/00006454-199505000-00009; Desire N, 2001, J CLIN MICROBIOL, V39, P1303, DOI 10.1128/JCM.39.4.1303-1310.2001; Dunn DT, 2005, LANCET, V366, P1868, DOI 10.1016/S0140-6736(05)67757-4; Fischer A, 2004, J CLIN MICROBIOL, V42, P16, DOI 10.1128/JCM.42.1.16-20.2004; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; Hesseling AC, 2005, ARCH DIS CHILD, V90, P1171, DOI 10.1136/adc.2004.070466; Ikeogu MO, 1997, ARCH DIS CHILD, V76, P124, DOI 10.1136/adc.76.2.124; Kruk A, 2008, PEDIATRICS, V121, pE1646, DOI 10.1542/peds.2007-3138; Lewinsohn DA, 2004, INT J TUBERC LUNG D, V8, P658; Maher D, 2006, INT J TUBERC LUNG D, V10, P1331; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Paillaud E, 2004, BRIT J NUTR, V92, P861, DOI 10.1079/BJN20041264; PELTIER CA, 2006, IAS C TOR CAN AUG 13; PRAZUCK T, 1993, AIDS, V7, P103, DOI 10.1097/00002030-199301000-00016; Rouet F, 2003, PEDIATRICS, V112, pE289, DOI 10.1542/peds.112.4.e289; SATYANARAYANA K, 1980, AM J CLIN NUTR, V33, P2334, DOI 10.1093/ajcn/33.11.2334; Sherman GG, 2004, PEDIATR INFECT DIS J, V23, P173, DOI 10.1097/01.inf.0000109332.83246.1a; Sherman GG, 2005, PEDIATR INFECT DIS J, V24, P993, DOI 10.1097/01.inf.0000187036.73539.8d; Singh M, 2005, ARCH DIS CHILD, V90, P624, DOI 10.1136/adc.2003.044255; *SOC CAN PED, 2004, PAEDIAT CHILD HEALTH, V9, P181; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO, 2007, INT J TUBERC LUNG D, V11, P12; *WHO, 2008, WHO TECHN REF GROUP; *WHO, 2006, NEW INT CHILD GROWTH; *WHO, 2007, EP; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, 2005, INT WHO CLIN STAG HI; Zar HJ, 2007, BRIT MED J, V334, P136, DOI 10.1136/bmj.39000.486400.55	32	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5312	10.1371/journal.pone.0005312	http://dx.doi.org/10.1371/journal.pone.0005312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390690	Green Submitted, gold, Green Published			2022-12-27	WOS:000265514400006
J	Camoletto, PG; Vara, H; Morando, L; Connell, E; Marletto, FP; Giustetto, M; Sassoe-Pognetto, M; Van Veldhoven, PP; Ledesma, MD				Camoletto, Paola G.; Vara, Hugo; Morando, Laura; Connell, Emma; Marletto, Fabio P.; Giustetto, Maurizio; Sassoe-Pognetto, Marco; Van Veldhoven, Paul P.; Ledesma, Maria Dolores			Synaptic Vesicle Docking: Sphingosine Regulates Syntaxin1 Interaction with Munc18	PLOS ONE			English	Article							SPHINGOMYELINASE-DEFICIENT MICE; CONFORMATIONAL SWITCH; SNARE COMPLEX; ACID; EXOCYTOSIS; METABOLISM; SUBSTRATE; MODEL	Consensus exists that lipids must play key functions in synaptic activity but precise mechanistic information is limited. Acid sphingomyelinase knockout mice (ASMko) are a suitable model to address the role of sphingolipids in synaptic regulation as they recapitulate a mental retardation syndrome, Niemann Pick disease type A (NPA), and their neurons have altered levels of sphingomyelin (SM) and its derivatives. Electrophysiological recordings showed that ASMko hippocampi have increased paired-pulse facilitation and post-tetanic potentiation. Consistently, electron microscopy revealed reduced number of docked vesicles. Biochemical analysis of ASMko synaptic membranes unveiled higher amounts of SM and sphingosine (Se) and enhanced interaction of the docking molecules Munc18 and syntaxin1. In vitro reconstitution assays demonstrated that Se changes syntaxin1 conformation enhancing its interaction with Munc18. Moreover, Se reduces vesicle docking in primary neurons and increases paired-pulse facilitation when added to wt hippocampal slices. These data provide with a novel mechanism for synaptic vesicle control by sphingolipids and could explain cognitive deficits of NPA patients.	[Camoletto, Paola G.; Ledesma, Maria Dolores] VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Camoletto, Paola G.; Ledesma, Maria Dolores] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium; [Camoletto, Paola G.; Ledesma, Maria Dolores] CSIC UAM, Dept Mol Neurobiol, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Vara, Hugo; Morando, Laura; Marletto, Fabio P.; Giustetto, Maurizio; Sassoe-Pognetto, Marco] Dept Anat Pharmacol & Forens Med, Turin, Italy; [Vara, Hugo; Morando, Laura; Marletto, Fabio P.; Giustetto, Maurizio; Sassoe-Pognetto, Marco] Natl Inst Neurosci Italy, Turin, Italy; [Connell, Emma] Med Res Council Lab Mol Biol, Cambridge, England; [Van Veldhoven, Paul P.] Katholieke Univ Leuven, LIPIT, Dept Mol Cell Biol, Leuven, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); KU Leuven	Ledesma, MD (corresponding author), VIB, Dept Mol & Dev Genet, Louvain, Belgium.	dledesma@cbm.uam.es	Vara Rivera, Hugo/L-4480-2018; giustetto, maurizio/D-6606-2011; Ledesma, Maria Dolores/I-5619-2015; Sassoe-Pognetto, Marco/AAE-3536-2022; , Van Veldhoven Paul/U-6359-2019	Vara Rivera, Hugo/0000-0002-7287-815X; giustetto, maurizio/0000-0003-1323-4060; Ledesma, Maria Dolores/0000-0002-5679-6891; , Van Veldhoven Paul/0000-0002-4478-2564; Sassoe-Pognetto, Marco/0000-0001-8906-0613	Medical Research Council [MC_U105178791] Funding Source: Medline; Telethon [GGP05236] Funding Source: Medline; MRC [MC_U105178791] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Telethon(Fondazione Telethon); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Banker G., 1991, CULTURING NERVE CELL; BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366; Connell E, 2007, EMBO REP, V8, P414, DOI 10.1038/sj.embor.7400935; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Galvan C, 2008, MOL BIOL CELL, V19, P509, DOI 10.1091/mbc.E07-05-0439; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Gijsbers S, 2002, BBA-MOL CELL BIOL L, V1580, P1, DOI 10.1016/S1388-1981(01)00166-4; Graham ME, 2008, BIOCHEM J, V409, P407, DOI 10.1042/BJ20071094; Hering H, 2003, J NEUROSCI, V23, P3262; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Kuemmel TA, 1997, J NEUROPATH EXP NEUR, V56, P171, DOI 10.1097/00005072-199702000-00008; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; NAGY A, 1984, J NEUROCHEM, V43, P1114, DOI 10.1111/j.1471-4159.1984.tb12851.x; OTTERBACH B, 1995, CELL, V81, P1053, DOI 10.1016/S0092-8674(05)80010-8; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Rickman C, 2005, CHEM BIOL, V12, P545, DOI 10.1016/j.chembiol.2005.03.004; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Sarna J, 2001, EUR J NEUROSCI, V13, P1873, DOI 10.1046/j.0953-816x.2001.01564.x; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; Stoffel W, 1999, CHEM PHYS LIPIDS, V102, P107, DOI 10.1016/S0009-3084(99)00079-1; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Toonen RFG, 2006, P NATL ACAD SCI USA, V103, P18332, DOI 10.1073/pnas.0608507103; Van Overloop H, 2006, J LIPID RES, V47, P268, DOI 10.1194/jlr.M500321-JLR200; Van Veldhoven PP, 1998, ANAL BIOCHEM, V258, P152, DOI 10.1006/abio.1998.2584; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Xu-Friedman MA, 2004, PHYSIOL REV, V84, P69, DOI 10.1152/physrev.00016.2003	32	45	46	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5310	10.1371/journal.pone.0005310	http://dx.doi.org/10.1371/journal.pone.0005310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390577	gold, Green Published, Green Submitted			2022-12-27	WOS:000265514200021
J	Denisova, G; Denisov, D; Evelegh, C; Weissgram, M; Beck, J; Foley, SR; Bramson, JL				Denisova, Galina; Denisov, Dimitri; Evelegh, Carole; Weissgram, Michaela; Beck, Jochen; Foley, Stephen Ronan; Bramson, Jonathan Lorne			Characterizing Complex Polysera Produced by Antigen-Specific Immunization through the Use of Affinity-Selected Mimotopes	PLOS ONE			English	Article								Background: Antigen-based (as opposed to whole organism) vaccines are actively being pursued for numerous indications. Even though different formulations may produce similar levels of total antigen-specific antibody, the composition of the antibody response can be quite distinct resulting in different levels of therapeutic activity. Methodology/Principal Findings: Using plasmid-based immunization against the proto-oncogene HER-2 as a model, we have demonstrated that affinity-selected epitope mimetics (mimotopes) can provide a defined signature of a polyclonal antibody response. Further, using novel computer algorithms that we have developed, these mimotopes can be used to predict epitope targets. Conclusions/Significance: By combining our novel strategy with existing methods of epitope prediction based on physical properties of an individual protein, we believe that this method offers a robust method for characterizing the breadth of epitope-specificity within a specific polyserum. This strategy is useful as a tool for monitoring immunity following vaccination and can also be used to define relevant epitopes for the creation of novel vaccines.			Denisova, G (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	bramsonj@mcmaster.ca		Bramson, Jonathan/0000-0003-2874-6886				Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Batori V, 2006, J MOL RECOGNIT, V19, P21, DOI 10.1002/jmr.752; Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; Bonnycastle LLC, 1996, J MOL BIOL, V258, P747, DOI 10.1006/jmbi.1996.0284; Bramson JL, 2003, VACCINE, V21, P1363, DOI 10.1016/S0264-410X(02)00694-1; Chen Y, 2001, GENE THER, V8, P316, DOI 10.1038/sj.gt.3301396; Dayball K, 2003, J IMMUNOL, V171, P3379, DOI 10.4049/jimmunol.171.7.3379; Denisov DA, 2009, MOL IMMUNOL, V46, P429, DOI 10.1016/j.molimm.2008.10.013; DENISOVA G, 1995, FASEB J, V9, P127, DOI 10.1096/fasebj.9.1.7529735; Denisova G, 1996, AIDS RES HUM RETROV, V12, P901, DOI 10.1089/aid.1996.12.901; Denisova G, 2003, MOL IMMUNOL, V40, P231, DOI 10.1016/s0161-5890(03)00147-0; Denisova GF, 2008, MOL IMMUNOL, V46, P125, DOI 10.1016/j.molimm.2008.07.020; Denisova GF, 2000, MOL IMMUNOL, V37, P53, DOI 10.1016/S0161-5890(00)00022-5; Enshell-Seijffers D, 2003, J MOL BIOL, V334, P87, DOI 10.1016/j.jmb.2003.09.002; ENSHELLSEIJFFER.D, 2002, CURR PROTOC IMMUNOL, pCH9; FELICI F, 1993, GENE, V128, P21, DOI 10.1016/0378-1119(93)90148-V; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; GERSHONI JM, 1993, FASEB J, V7, P1185, DOI 10.1096/fasebj.7.12.7690724; Gershoni JM, 1997, IMMUNOL TODAY, V18, P108, DOI 10.1016/S0167-5699(97)01024-4; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; IKEDA Y, 1987, BIOCHEM BIOPH RES CO, V144, P191, DOI 10.1016/S0006-291X(87)80494-1; Kianizad K, 2007, CANCER RES, V67, P6459, DOI 10.1158/0008-5472.CAN-06-4336; Lane C, 2004, CANCER RES, V64, P1509, DOI 10.1158/0008-5472.CAN-03-3227; LUZZAGO A, 1993, GENE, V128, P51, DOI 10.1016/0378-1119(93)90152-S; NOVOTNY J, 1986, J MOL BIOL, V189, P715, DOI 10.1016/0022-2836(86)90502-4; Paley EL, 2007, MOL IMMUNOL, V44, P541, DOI 10.1016/j.molimm.2006.02.006; Pupa SM, 2005, CANCER RES, V65, P1071; Quaglino E, 2004, CANCER RES, V64, P2858, DOI 10.1158/0008-5472.CAN-03-2962; Rovero S, 2000, J IMMUNOL, V165, P5133, DOI 10.4049/jimmunol.165.9.5133; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Shak S, 1999, SEMIN ONCOL, V26, P71; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SMITH GP, PHAGE DISPLAY VECTOR; Stern B, 1997, FASEB J, V11, P147, DOI 10.1096/fasebj.11.2.9039957; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; THORNTON JM, 1986, EMBO J, V5, P409, DOI 10.1002/j.1460-2075.1986.tb04226.x; Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054; WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0; Yip YL, 2001, J IMMUNOL, V166, P5271, DOI 10.4049/jimmunol.166.8.5271; ZACHER AN, 1980, GENE, V9, P127, DOI 10.1016/0378-1119(80)90171-7	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5309	10.1371/journal.pone.0005309	http://dx.doi.org/10.1371/journal.pone.0005309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390580	Green Published, gold, Green Submitted			2022-12-27	WOS:000265514200020
J	Yih, WK; Teates, KS; Abrams, A; Kleinman, K; Kulldorff, M; Pinner, R; Harmon, R; Wang, S; Platt, R				Yih, W. Katherine; Teates, Kathryn S.; Abrams, Allyson; Kleinman, Ken; Kulldorff, Martin; Pinner, Robert; Harmon, Robert; Wang, Stanley; Platt, Richard			Telephone Triage Service Data for Detection of Influenza-Like Illness	PLOS ONE			English	Article							SYNDROMIC SURVEILLANCE; PANDEMIC INFLUENZA; ONTARIO	Background: Surveillance for influenza and influenza-like illness (ILI) is important for guiding public health prevention programs to mitigate the morbidity and mortality caused by influenza, including pandemic influenza. Nontraditional sources of data for influenza and ILI surveillance are of interest to public health authorities if their validity can be established. Methods/Principal Findings: National telephone triage call data were collected through automated means for purposes of syndromic surveillance. For the 17 states with at least 500,000 inhabitants eligible to use the telephone triage services, call volume for respiratory syndrome was compared to CDC weekly number of influenza isolates and percentage of visits to sentinel providers for ILI. The degree to which the call data were correlated with either CDC viral isolates or sentinel provider percentage ILI data was highly variable among states. Conclusions: Telephone triage data in the U. S. are patchy in coverage and therefore not a reliable source of ILI surveillance data on a national scale. However, in states displaying a higher correlation between the call data and the CDC data, call data may be useful as an adjunct to state-level surveillance data, for example at times when sentinel surveillance is not in operation or in areas where sentinel provider coverage is considered insufficient. Sufficient population coverage, a specific ILI syndrome definition, and the use of a threshold of percentage of calls that are for ILI would likely improve the utility of such data for ILI surveillance purposes.			Yih, WK (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA.	katherine_yih@hphc.org	Kulldorff, Martin/H-4282-2011	CLAYPOOL, KATHRYN/0000-0003-0557-8330; Kulldorff, Martin/0000-0002-5284-2993; Kleinman, Ken/0000-0002-5600-5834	PHS HHS [UR8/CCU115079] Funding Source: Medline; PHPPO CDC HHS [R01 PH000032, R501 PH000032] Funding Source: Medline; PUBLIC HEALTH PRACTICE PROGRAM OFFICE [R01PH000032] Funding Source: NIH RePORTER	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); PHPPO CDC HHS; PUBLIC HEALTH PRACTICE PROGRAM OFFICE(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)		Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P631; Clothier HJ, 2006, COMMUN DIS INTELL, V30, P345; Cooper DL, 2007, J INFECTION, V55, P240, DOI 10.1016/j.jinf.2007.04.353; Cooper D L, 2002, Commun Dis Public Health, V5, P127; Dailey L, 2007, J AM MED INFORM ASSN, V14, P626, DOI 10.1197/jamia.M2328; Doroshenko Alexander, 2005, MMWR Suppl, V54, P117; Espino Jeremy U, 2003, AMIA Annu Symp Proc, P215; Harcourt S E, 2001, Commun Dis Public Health, V4, P178; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Henry Jade Vu, 2004, MMWR Suppl, V53, P112; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Lazarus R, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-9; Lewis MD, 2002, AM J PREV MED, V23, P180, DOI 10.1016/S0749-3797(02)00490-7; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Miller B, 2004, EMERG INFECT DIS, V10, P1806, DOI 10.3201/eid1010.030789; Moore K, 2004, EUR J EMERG MED, V11, P3, DOI 10.1097/00063110-200402000-00002; Paget J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-141; Platt R, 2003, J URBAN HEALTH, V80, pI25; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Ritzwoller Debra P, 2005, MMWR Suppl, V54, P151; Smith G E, 2006, Euro Surveill, V11, P220; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; van Dijk A, 2008, CAN J EMERG MED, V10, P18; Yih W Katherine, 2004, MMWR Suppl, V53, P43; Zheng W, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-250	26	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5260	10.1371/journal.pone.0005260	http://dx.doi.org/10.1371/journal.pone.0005260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381342	Green Submitted, Green Published, gold			2022-12-27	WOS:000265510800011
J	Hanauer, DA; Rhodes, DR; Chinnaiyan, AM				Hanauer, David A.; Rhodes, Daniel R.; Chinnaiyan, Arul M.			Exploring Clinical Associations Using '-Omics' Based Enrichment Analyses	PLOS ONE			English	Article								Background: The vast amounts of clinical data collected in electronic health records (EHR) is analogous to the data explosion from the "-omics'' revolution. In the EHR clinicians often maintain patient-specific problem summary lists which are used to provide a concise overview of significant medical diagnoses. We hypothesized that by tapping into the collective wisdom generated by hundreds of physicians entering problems into the EHR we could detect significant associations among diagnoses that are not described in the literature. Methodology/Principal Findings: We employed an analytic approach original developed for detecting associations between sets of gene expression data, called Molecular Concept Map (MCM), to find significant associations among the 1.5 million clinical problem summary list entries in 327,000 patients from our institution's EHR. An odds ratio (OR) and p-value was calculated for each association. A subset of the 750,000 associations found were explored using the MCM tool. Expected associations were confirmed and recently reported but poorly known associations were uncovered. Novel associations which may warrant further exploration were also found. Examples of expected associations included non-insulin dependent diabetes mellitus and various diagnoses such as retinopathy, hypertension, and coronary artery disease. A recently reported association included irritable bowel and vulvodynia (OR 2.9, p = 5.6x10(-4)). Associations that are currently unknown or very poorly known included those between granuloma annulare and osteoarthritis (OR 4.3, p = 1.1x10(-4)) and pyloric stenosis and ventricular septal defect (OR 12.1, p = 2.0x10(-3)). Conclusions/Significance: Computer programs developed for analyses of "-omic'' data can be successfully applied to the area of clinical medicine. The results of the analysis may be useful for hypothesis generation as well as supporting clinical care by reminding clinicians of likely problems associated with a patient's existing problems.			Hanauer, DA (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	hanauer@umich.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Arnold LD, 2006, OBSTET GYNECOL, V107, P617, DOI 10.1097/01.AOG.0000199951.26822.27; ARNOLD LD, 2007, AM J OBSTET GYNECOL, V128, pE121; Barnes Kathleen C, 2007, Proc Am Thorac Soc, V4, P58, DOI 10.1513/pats.200607-146JG; Cao H, 2007, J BIOMED INFORM, V40, P343, DOI 10.1016/j.jbi.2006.11.003; Cao Hui, 2005, AMIA Annu Symp Proc, P106; Croarkin E, 1999, PHYS THER, V79, P196, DOI 10.1093/ptj/79.2.196; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hamrock DJ, 2006, INT IMMUNOPHARMACOL, V6, P535, DOI 10.1016/j.intimp.2005.11.015; Jonas WB, 1996, INFLAMM RES, V45, P330, DOI 10.1007/BF02252945; Loscalzo ML, 2008, PEDIATR REV, V29, P219, DOI 10.1542/pir.29-7-219; MA A, 1983, ARCH DERMATOL, V119, P836, DOI 10.1001/archderm.119.10.836; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mullins IM, 2006, COMPUT BIOL MED, V36, P1351, DOI 10.1016/j.compbiomed.2005.08.003; Prather JC, 1997, J AM MED INFORM ASSN, P101; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Rhodes ET, 2007, DIABETES CARE, V30, P141, DOI 10.2337/dc06-1142; Robles David T, 2007, Dermatol Online J, V13, P9; Serdaroglu G, 2002, J CHILD NEUROL, V17, P41, DOI 10.1177/088307380201700110; Smith MT, 2004, SLEEP MED REV, V8, P119, DOI 10.1016/S1087-0792(03)00044-3; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wallace K, 2004, JNCI-J NATL CANCER I, V96, P921, DOI 10.1093/jnci/djh165; Williams Carl, 2007, AMIA Annu Symp Proc, P1155; Wilson JF, 2008, ANN INTERN MED, V148; Yang Jianji, 2006, AMIA Annu Symp Proc, P829	24	39	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5203	10.1371/journal.pone.0005203	http://dx.doi.org/10.1371/journal.pone.0005203			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365550	gold, Green Submitted, Green Published			2022-12-27	WOS:000265509900016
J	Lim, S; Ahn, SY; Song, IC; Chung, MH; Jang, HC; Park, KS; Lee, KU; Pak, YK; Lee, HK				Lim, Soo; Ahn, Sun Young; Song, In Chan; Chung, Myung Hee; Jang, Hak Chul; Park, Kyong Soo; Lee, Ki-Up; Pak, Youngmi Kim; Lee, Hong Kyu			Chronic Exposure to the Herbicide, Atrazine, Causes Mitochondrial Dysfunction and Insulin Resistance	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; FAST-FOOD RESTAURANTS; DNA-DAMAGE; SERUM CONCENTRATIONS; NATIONAL-HEALTH; RISK-ASSESSMENT; US ADULTS; OBESITY; FAT; LYMPHOCYTES	There is an apparent overlap between areas in the USA where the herbicide, atrazine (ATZ), is heavily used and obesity-prevalence maps of people with a BMI over 30. Given that herbicides act on photosystem II of the thylakoid membrane of chloroplasts, which have a functional structure similar to mitochondria, we investigated whether chronic exposure to low concentrations of ATZ might cause obesity or insulin resistance by damaging mitochondrial function. Sprague-Dawley rats (n = 48) were treated for 5 months with low concentrations (30 or 300 mu g kg(-1) day(-1)) of ATZ provided in drinking water. One group of animals was fed a regular diet for the entire period, and another group of animals was fed a high-fat diet (40% fat) for 2 months after 3 months of regular diet. Various parameters of insulin resistance were measured. Morphology and functional activities of mitochondria were evaluated in tissues of ATZ-exposed animals and in isolated mitochondria. Chronic administration of ATZ decreased basal metabolic rate, and increased body weight, intra-abdominal fat and insulin resistance without changing food intake or physical activity level. A high-fat diet further exacerbated insulin resistance and obesity. Mitochondria in skeletal muscle and liver of ATZ-treated rats were swollen with disrupted cristae. ATZ blocked the activities of oxidative phosphorylation complexes I and III, resulting in decreased oxygen consumption. It also suppressed the insulin-mediated phosphorylation of Akt. These results suggest that long-term exposure to the herbicide ATZ might contribute to the development of insulin resistance and obesity, particularly where a high-fat diet is prevalent.			Lim, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	ykpak@khu.ac.kr; hkleemd@snu.ac.kr	Pak, Youngmi Kim/AAI-1091-2020; Jang, Hak Chul/D-9637-2012; Park, Kyong Soo/C-2265-2008; Lim, Soo/AAU-8107-2020	Pak, Youngmi Kim/0000-0001-7424-3484; Jang, Hak Chul/0000-0002-4188-6536; Park, Kyong Soo/0000-0003-3597-342X; Lim, Soo/0000-0002-4137-1671; Song, In-Chan/0000-0002-5357-5751				ATTARDI G, 1996, MITOCHONDRIAL BIOG B; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Cantemir C, 1997, TOXICOL LETT, V93, P87, DOI 10.1016/S0378-4274(97)00050-7; Cheney MA, 1997, COMP BIOCHEM PHYS C, V118, P159, DOI 10.1016/S0742-8413(97)00102-3; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Clements C, 1997, ENVIRON MOL MUTAGEN, V29, P277, DOI 10.1002/(SICI)1098-2280(1997)29:3&lt;277::AID-EM8&gt;3.0.CO;2-9; De Roos AJ, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.9.e11; Della Croce C, 1996, J Environ Pathol Toxicol Oncol, V15, P21; *EPA, 2006, TRIAZ CUM RISK ASS A; Fisher MT, 2005, TOXICOL LETT, V157, P99, DOI 10.1016/j.toxlet.2005.01.008; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fukamachi K, 2004, CANCER SCI, V95, P404, DOI 10.1111/j.1349-7006.2004.tb03223.x; Gammon DW, 2005, PEST MANAG SCI, V61, P331, DOI 10.1002/ps.1000; Hayes T, 2002, NATURE, V419, P895, DOI 10.1038/419895a; Hessel PA, 2004, J OCCUP ENVIRON MED, V46, P379, DOI 10.1097/01.jom.0000121128.73921.a1; Jahren AH, 2008, P NATL ACAD SCI USA, V105, P17855, DOI 10.1073/pnas.0809870105; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jin CJ, 2007, J NUTR, V137, P339, DOI 10.1093/jn/137.2.339; Kandori H, 2005, CANCER SCI, V96, P221, DOI 10.1111/j.1349-7006.2005.00041.x; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kolpin DW, 1997, J ENVIRON QUAL, V26, P1007, DOI 10.2134/jeq1997.00472425002600040012x; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190; Lee DH, 2006, J EPIDEMIOL COMMUN H, V60, P1006, DOI 10.1136/jech.2006.053389; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lim S, 2009, OBESITY, V17, P188, DOI 10.1038/oby.2008.486; Lind PM, 2004, TOXICOL LETT, V150, P293, DOI 10.1016/j.toxlet.2004.02.008; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Machann J, 2004, DIABETES OBES METAB, V6, P239, DOI 10.1111/j.1462-8902.2004.00339.x; Maddock J, 2004, AM J HEALTH PROMOT, V19, P137, DOI 10.4278/0890-1171-19.2.137; MAY JB, 1987, CORN CHEM TECHNOLOGY; MCELROY JA, 2006, J EXPO SCI ENV EPIDE; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Nelson BA, 2002, AM J PHYSIOL-ENDOC M, V282, pE497, DOI 10.1152/ajpendo.00438.2001; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE31, DOI 10.1152/ajpendo.00500.2006; OULMI Y, 1995, ECOTOX ENVIRON SAFE, V32, P39, DOI 10.1006/eesa.1995.1083; Park KS, 2001, AM J PHYSIOL-ENDOC M, V280, pE1007, DOI 10.1152/ajpendo.2001.280.6.E1007; Park SY, 2005, J BIOL CHEM, V280, P9855, DOI 10.1074/jbc.M409399200; PCHELINTSEVA O, 1995, ARCH BIOCHEM BIOPHYS, V323, P54, DOI 10.1006/abbi.1995.0009; Pelletier C, 2003, Obes Rev, V4, P17, DOI 10.1046/j.1467-789X.2003.00085.x; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; PINO A, 1988, MUTAT RES, V209, P145, DOI 10.1016/0165-7992(88)90032-2; Poulton J, 1998, DIABETOLOGIA, V41, P54, DOI 10.1007/s001250050866; RIBAS G, 1995, MUTAT RES-GENET TOX, V344, P41, DOI 10.1016/0165-1218(95)90037-3; ROBERT J, 2002, 1291 USGS; Saldana TM, 2007, DIABETES CARE, V30, P529, DOI 10.2337/dc06-1832; Satia JA, 2004, PUBLIC HEALTH NUTR, V7, P1089, DOI 10.1079/PHN2004662; SCHOTTLER SP, 1994, ENVIRON SCI TECHNOL, V28, P2228, DOI 10.1021/es00061a036; Shertzer HG, 2006, TOXICOL APPL PHARM, V217, P363, DOI 10.1016/j.taap.2006.09.014; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Solomon KR, 1996, ENVIRON TOXICOL CHEM, V15, P31, DOI [10.1002/etc.5620150105, 10.1897/1551-5028(1996)015&lt;0031:ERAOAI&gt;2.3.CO;2]; Takahashi N, 2007, CELL METAB, V6, P506, DOI 10.1016/j.cmet.2007.10.011; Yoon YS, 2003, J BIOL CHEM, V278, P51577, DOI 10.1074/jbc.M308489200; Young HA, 2005, J OCCUP ENVIRON MED, V47, P1148, DOI 10.1097/01.jom.0000177044.43959.e8; Zeljezic D, 2006, TOXICOL IN VITRO, V20, P923, DOI 10.1016/j.tiv.2006.01.017	55	136	139	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5186	10.1371/journal.pone.0005186	http://dx.doi.org/10.1371/journal.pone.0005186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365547	Green Submitted, gold, Green Published			2022-12-27	WOS:000265509900014
J	Ararat, E; Brozovich, FV				Ararat, Erhan; Brozovich, Frank V.			Losartan Decreases p42/44 MAPK Signaling and Preserves LZ+MYPT1 Expression	PLOS ONE			English	Article								Heart failure is associated with impairment in nitric oxide (NO) mediated vasodilatation, which has been demonstrated to result from a reduction in the relative expression of the leucine zipper positive (LZ+) isoform of the myosin targeting subunit (MYPT1) of myosin light chain phosphatase. Further, captopril preserves normal LZ+ MYPT1 expression, the sensitivity to cGMP-mediated vasodilatation and modulates the expression of genes in the p42/44 MAPK and p38 MAPK signaling cascades. This study tests whether angiotensin receptor blockade (ARB) with losartan decreases p42/44 MAPK or p38 MAPK signaling and preserves LZ+ MYPT1 expression in a rat infarct model of heart failure. In aortic smooth muscle, p42/44 MAPK activation increases and LZ+ MYPT1 expression falls after LAD ligation. Losartan treatment decreases the activation of p42/44 MAPK to the uninfarcted control level and preserves normal LZ+ MYPT1 expression. The expression and activation of p38 MAPK, however, is low and does not change following LAD ligation or with losartan therapy. These data suggest that either reducing or blocking the effects of circulating angiotensin II, both decreases the activation of the p42/44 MAPK signaling cascade and preserves LZ+ MYPT1 expression. Thus, the ability of ACE-inhibitors and ARBs to modulate the vascular phenotype, to preserve normal flow mediated vasodilatation may explain the beneficial effects of these drugs compared to other forms of afterload reduction in the treatment of heart failure.			Ararat, E (corresponding author), Mayo Clin & Mayo Fdn, Mayo Med Sch, Div Cardiovasc Dis, Rochester, MN 55905 USA.	brozovich.frank@mayo.edu			NHLBI NIH HHS [R01 HL069894, HL69894] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069894] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abassi ZA, 1997, CIRCULATION, V96, P3655; Alioua A, 1998, J BIOL CHEM, V273, P32950, DOI 10.1074/jbc.273.49.32950; Chen FC, 2008, J VASC RES, V45, P445, DOI 10.1159/000126735; Chen FC, 2006, J MOL CELL CARDIOL, V41, P488, DOI 10.1016/j.yjmcc.2006.05.018; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Dirksen WP, 2000, AM J PHYSIOL-CELL PH, V278, pC589, DOI 10.1152/ajpcell.2000.278.3.C589; El-Toukhy A, 2006, FEBS LETT, V580, P5779, DOI 10.1016/j.febslet.2006.09.035; Fukao M, 1999, J BIOL CHEM, V274, P10927, DOI 10.1074/jbc.274.16.10927; Furchgott RF, 1999, BIOSCIENCE REP, V19, P235, DOI 10.1023/A:1020537506008; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Given AM, 2007, AM J PHYSIOL-CELL PH, V292, pC432, DOI 10.1152/ajpcell.00175.2006; GONG MC, 1992, J BIOL CHEM, V267, P14662; Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064; HARTSHORNE DJ, 1987, BIOCH CONTRACTILE PR, P432; Hoit BD, 1999, J CARD FAIL, V5, P324, DOI 10.1016/S1071-9164(99)91337-4; Huang QQ, 2004, J BIOL CHEM, V279, P597, DOI 10.1074/jbc.M308496200; Karim SM, 2004, CIRC RES, V95, P612, DOI 10.1161/01.RES.0000142736.39359.58; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Khromov AS, 2006, P NATL ACAD SCI USA, V103, P2440, DOI 10.1073/pnas.0508566103; Liang QR, 2006, J CARD FAIL, V12, P479, DOI 10.1016/j.cardfail.2006.04.006; Liu YH, 1997, J CLIN INVEST, V99, P1926, DOI 10.1172/JCI119360; Lu Y, 2008, AM J PHYSIOL-CELL PH, V294, pC564, DOI 10.1152/ajpcell.00285.2007; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Niiro N, 2001, J BIOL CHEM, V276, P29567, DOI 10.1074/jbc.M102753200; Ogut O, 2000, AM J PHYSIOL-CELL PH, V279, pC1722, DOI 10.1152/ajpcell.2000.279.6.C1722; Payne MC, 2006, J MOL CELL CARDIOL, V40, P274, DOI 10.1016/j.yjmcc.2005.07.009; Payne MC, 2004, AM J PHYSIOL-HEART C, V286, pH1801, DOI 10.1152/ajpheart.00696.2003; Pfeffer J M, 1987, Circulation, V75, pI149; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pourdjabbar A, 2005, AM J PHYSIOL-HEART C, V288, pH1997, DOI 10.1152/ajpheart.00671.2004; Pourdjabbar A, 2005, CAN J PHYSIOL PHARM, V83, P989, DOI 10.1139/Y05-072; Rembold CM, 2000, J PHYSIOL-LONDON, V524, P865, DOI 10.1111/j.1469-7793.2000.00865.x; Richer C, 1999, CARDIOVASC RES, V41, P100, DOI 10.1016/S0008-6363(98)00227-2; SCHMIDT HHHW, 1993, BIOCHIM BIOPHYS ACTA, V1178, P153, DOI 10.1016/0167-4889(93)90006-B; See F, 2004, J AM COLL CARDIOL, V44, P1679, DOI 10.1016/j.jacc.2004.07.038; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; Shukla S, 2008, CIRC RES, V103, P485, DOI 10.1161/CIRCRESAHA.108.178384; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Somlyo AV, 2007, CIRC RES, V101, P645, DOI 10.1161/CIRCRESAHA.107.161893; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Walker LA, 2001, J BIOL CHEM, V276, P24519, DOI 10.1074/jbc.M103560200; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Wu XQ, 1998, J BIOL CHEM, V273, P11362, DOI 10.1074/jbc.273.18.11362; Zhang HY, 2007, CIRC RES, V100, P730, DOI 10.1161/01.RES.0000260189.38975.35	48	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5144	10.1371/journal.pone.0005144	http://dx.doi.org/10.1371/journal.pone.0005144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357768	gold, Green Published, Green Submitted			2022-12-27	WOS:000265505900012
J	Mohamed, F; Gawarammana, I; Robertson, TA; Roberts, MS; Palangasinghe, C; Zawahir, S; Jayamanne, S; Kandasamy, J; Eddleston, M; Buckley, NA; Dawson, AH; Roberts, DM				Mohamed, Fahim; Gawarammana, Indika; Robertson, Thomas A.; Roberts, Michael S.; Palangasinghe, Chathura; Zawahir, Shukry; Jayamanne, Shaluka; Kandasamy, Jaganathan; Eddleston, Michael; Buckley, Nick A.; Dawson, Andrew H.; Roberts, Darren M.			Acute Human Self-Poisoning with Imidacloprid Compound: A Neonicotinoid Insecticide	PLOS ONE			English	Article								Background: Deliberate self-poisoning with older pesticides such as organophosphorus compounds are commonly fatal and a serious public health problem in the developing world. The clinical consequences of self-poisoning with newer pesticides are not well described. Such information may help to improve clinical management and inform pesticide regulators of their relative toxicity. This study reports the clinical outcomes and toxicokinetics of the neonicotinoid insecticide imidacloprid following acute self-poisoning in humans. Methodology/Principal Findings: Demographic and clinical data were prospectively recorded in patients with imidacloprid exposure in three hospitals in Sri Lanka. Blood samples were collected when possible for quantification of imidacloprid concentration. There were 68 patients (61 self-ingestions and 7 dermal exposures) with exposure to imidacloprid. Of the self-poisoning patients, the median time to presentation was 4 hours (IQR 2.3-6.0) and median amount ingested was 15 mL (IQR 10-50 mL). Most patients only developed mild symptoms such as nausea, vomiting, headache and diarrhoea. One patient developed respiratory failure needing mechanical ventilation while another was admitted to intensive care due to prolonged sedation. There were no deaths. Median admission imidacloprid concentration was 10.58 ng/L; IQR: 3.84-15.58 ng/L, Range: 0.02-51.25 ng/L. Changes in the concentration of imidacloprid in serial blood samples were consistent with prolonged absorption and/or saturable elimination. Conclusions: Imidacloprid generally demonstrates low human lethality even in large ingestions. Respiratory failure and reduced level of consciousness were the most serious complications, but these were uncommon. Substitution of imidacloprid for organophosphorus compounds in areas where the incidence of self-poisoning is high may help reduce deaths from self-poisoning.			Mohamed, F (corresponding author), Univ Peradeniya, Dept Clin Med, S Asian Clin Toxicol Res Collaborat, Peradeniya, Sri Lanka.	fahim@sactrc.org	Buckley, Nicholas A/D-4030-2012; Roberts, Darren/A-8986-2013; Roberts, Michael/F-7502-2010; Roberts, Michael/F-4289-2010; Robertson, Tom A/D-2325-2009; Roberts, Michael S/C-5247-2014; Dawson, Andrew/D-5085-2012; Dawson, Andrew H/U-8041-2019	Buckley, Nicholas A/0000-0002-6326-4711; Roberts, Darren/0000-0001-9101-7577; Roberts, Michael/0000-0002-5837-246X; Robertson, Tom A/0000-0003-1946-8984; Roberts, Michael S/0000-0003-3894-5301; Dawson, Andrew/0000-0002-8047-397X; Dawson, Andrew H/0000-0002-8047-397X; Zawahir, Mohamed Shukry/0000-0002-2101-5952; Mohamed, Fahim/0000-0003-2849-7269	Wellcome Trust [071669] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Agarwal R, 2007, AM J EMERG MED, V25, P844, DOI 10.1016/j.ajem.2006.11.044; *BAYER, 2005, ACT SUBST PROD FORM; *BAYER, 2002, IM EXP OV; Calumpang SMF, 1996, B ENVIRON CONTAM TOX, V57, P697, DOI 10.1007/s001289900246; Cox C., 2001, Journal of Pesticide Reform, V21, P15; David D, 2007, CLIN TOXICOL, V45, P485, DOI 10.1080/15563650701338229; Eddleston M, 2005, LANCET, V366, P1452, DOI 10.1016/S0140-6736(05)67598-8; Eddleston M, 2004, BMJ-BRIT MED J, V328, P42, DOI 10.1136/bmj.328.7430.42; FAUL J, 1996, NTN 33893 OCCU UNPUB; Gunnell D, 2007, INT J EPIDEMIOL, V36, P1235, DOI 10.1093/ije/dym164; Huang NC, 2006, AM J EMERG MED, V24, P883, DOI 10.1016/j.ajem.2006.03.008; JEYARATNAM J, 1990, World Health Statistics Quarterly, V43, P139; *JMPR, 2001, 167 JMPR FAO; Kahlich R, 2006, RAPID COMMUN MASS SP, V20, P275, DOI 10.1002/rcm.2257; Manuweera G, 2008, ENVIRON HEALTH PERSP, V116, P492, DOI 10.1289/ehp.11029; Meister R.T., 1995, FARM CHEM HDB 95; Proenca P, 2005, FORENSIC SCI INT, V153, P75, DOI 10.1016/j.forsciint.2005.04.015; Rao CS, 2005, TROP MED INT HEALTH, V10, P581, DOI 10.1111/j.1365-3156.2005.01412.x; Roberts DM, 2007, CLIN PHARMACOKINET, V46, P897, DOI 10.2165/00003088-200746110-00001; Roberts DM, 2003, B WORLD HEALTH ORGAN, V81, P789; Schulz-Jander DA, 2002, TOXICOL LETT, V132, P65, DOI 10.1016/S0378-4274(02)00068-1; Shadnia S., 2008, AM J EMERG MED, V26; Sheets LP, 2002, HDB NEUROTOXICOLOGY, VI, P79; STEEFENS W, 2000, COMMUNICATION   1026; Tamura Mitsuyo, 2002, Chudoku Kenkyu, V15, P309; Thyssen J., 1999, NICOTINOID INSECTICI, P213, DOI 10.1007/978-4-431-67933-2_9; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; WHO, 2020, WHO REC CLASS PEST H, V2019; Wu IW, 2001, J TOXICOL-CLIN TOXIC, V39, P617, DOI 10.1081/CLT-100108494	30	74	80	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5127	10.1371/journal.pone.0005127	http://dx.doi.org/10.1371/journal.pone.0005127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352499	Green Published, gold, Green Submitted			2022-12-27	WOS:000265505700020
J	Schmidt, JV; Schmidt, CL; Ozer, F; Ernst, RE; Feldheim, KA; Ashley, MV; Levine, M				Schmidt, Jennifer V.; Schmidt, Claudia L.; Ozer, Fusun; Ernst, Robin E.; Feldheim, Kevin A.; Ashley, Mary V.; Levine, Marie			Low Genetic Differentiation across Three Major Ocean Populations of the Whale Shark, Rhincodon typus	PLOS ONE			English	Article								Background: Whale sharks are a declining species for which little biological data is available. While these animals are protected in many parts of their range, they are fished legally and illegally in some countries. Baseline biological and ecological data are needed to allow the formulation of an effective conservation plan for whale sharks. It is not known, for example, whether the whale shark is represented by a single worldwide panmictic population or by numerous, reproductively isolated populations. Genetic analysis of population structure is one essential component of the baseline data required for whale shark conservation. Methodology/Principal Findings: We have identified 8 polymorphic microsatellites in the whale shark and used these markers to assess genetic variation and population structure in a panel of whale sharks covering a broad geographic region. This is the first record of microsatellite loci in the whale shark, which displayed an average of 9 alleles per locus and mean H-o = 0.66 and H-e = 0.69. All but one of the eight loci meet the expectations of Hardy-Weinberg equilibrium. Analysis of these loci in whale sharks representing three major portions of their range, the Pacific (P), Caribbean (C), and Indian (I) Oceans, determined that there is little population differentiation between animals sampled in different geographic regions, indicating historical gene flow between populations. F-ST values for inter-ocean comparisons were low (PxC = 0.0387, CxI = 0.0296 and PxI = -0.0022), and only CxI approached statistical significance (p = 0.0495). Conclusions/Significance: We have shown only low levels of genetic differentiation between geographically distinct whale shark populations. Existing satellite tracking data have revealed both regional and long-range migration of whale sharks throughout their range, which supports the finding of gene flow between populations. Whale sharks traverse geographic and political boundaries during their life history and interbreed with animals from distant populations; conservation efforts must therefore target international protection for this species.	[Schmidt, Jennifer V.; Schmidt, Claudia L.; Ozer, Fusun; Ashley, Mary V.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Schmidt, Jennifer V.; Ernst, Robin E.; Levine, Marie] Shark Res Inst, Princeton, NJ USA; [Feldheim, Kevin A.] Field Museum, Pritzker Lab Mol Systemat & Evolut, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Field Museum of Natural History (Chicago)	Schmidt, JV (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	jvs@uic.edu	Ozer, Fusun/ABH-2640-2021	Ozer, Fusun/0000-0003-0443-5805	University of Illinois at Chicago; The Shark Research Institute	University of Illinois at Chicago; The Shark Research Institute	This work was supported by start-up funds from the University of Illinois at Chicago (to JVS) and by The Shark Research Institute. Fragment data were collected in the Field Museum's Pritzker Laboratory for Molecular Systematics and Evolution operated with support from the Pritzker Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Bradshaw CJA, 2008, BIOL CONSERV, V141, P1894, DOI 10.1016/j.biocon.2008.05.007; Bradshaw CJA, 2007, J ANIM ECOL, V76, P480, DOI 10.1111/j.1365-2656.2006.01201.x; Bremer JRA, 1996, J EXP MAR BIOL ECOL, V197, P295, DOI 10.1016/0022-0981(95)00164-6; Broughton RE, 1997, MOL MAR BIOL BIOTECH, V6, P308; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; Castro ALF, 2007, MOL ECOL, V16, P5183, DOI 10.1111/j.1365-294X.2007.03597.x; Chapman DD, 2004, MOL ECOL, V13, P1965, DOI 10.1111/j.1365-294X.2004.02178.x; Chevolot M, 2007, J HERED, V98, P712, DOI 10.1093/jhered/esm077; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; Compagno LJV, 2001, SHARKS WORLD ANNOTAT; Coombs JA, 2008, MOL ECOL RESOUR, V8, P578, DOI 10.1111/j.1471-8286.2007.02036.x; Daly-Engel TS, 2006, ENVIRON BIOL FISH, V76, P419, DOI 10.1007/s10641-006-9008-5; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dudgeon CL, 2006, MOL ECOL NOTES, V6, P1086, DOI 10.1111/j.1471-8286.2006.01442.x; Eckert SA, 2002, J ZOOL, V257, P111, DOI 10.1017/S0952836902000705; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ely B, 2002, MAR BIOTECHNOL, V4, P583, DOI 10.1007/s10126-002-0040-y; Feldheim KA, 2001, MOL ECOL, V10, P295, DOI 10.1046/j.1365-294x.2001.01182.x; Feldheim KA, 2002, J FISH BIOL, V61, P1309, DOI 10.1006/jfbi.2002.2139; Feldheim KA, 2001, COPEIA, P781, DOI 10.1643/0045-8511(2001)001[0781:MPOALS]2.0.CO;2; Feldheim KA, 2007, MOL ECOL NOTES, V7, P1366, DOI 10.1111/j.1471-8286.2007.01888.x; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Gifford A, 2007, FISH RES, V84, P17, DOI 10.1016/j.fishres.2006.11.011; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Graham RT, 2007, FISH RES, V84, P71, DOI 10.1016/j.fishres.2006.11.026; Haberl M, 1999, MOL ECOL, V8, P1347, DOI 10.1046/j.1365-294X.1999.00692.x; Hamilton MB, 1999, BIOTECHNIQUES, V27, P500, DOI 10.2144/99273st03; Heist EJ, 1999, AM FISH S S, V23, P161; Heist EJ, 2003, MOL ECOL NOTES, V3, P59, DOI 10.1046/j.1471-8286.2003.00348.x; HEIST EJ, 1999, MICROSATELLITE DNA V, P182; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Hoffman JI, 2006, MOL ECOL, V15, P3841, DOI 10.1111/j.1365-294X.2006.03053.x; Holmberg J, 2008, ECOL APPL, V18, P222, DOI 10.1890/07-0315.1; Hsu HH, 2007, FISH RES, V84, P25, DOI 10.1016/j.fishres.2006.11.030; Jarman SN, 2004, J FISH BIOL, V65, P586, DOI 10.1111/j.0022-1112.2004.00466.x; Joung SJ, 1996, ENVIRON BIOL FISH, V46, P219, DOI 10.1007/BF00004997; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kanda N, 2007, CONSERV GENET, V8, P853, DOI 10.1007/s10592-006-9232-8; Keeney DB, 2003, MOL ECOL NOTES, V3, P501, DOI 10.1046/j.1471-8286.2003.00492.x; Keeney DB, 2005, MOL ECOL, V14, P1911, DOI 10.1111/j.1365-294X.2005.02549.x; Langella O, 1999, POPULATIONS 1 2 30; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Martin AP, 2002, MOL PHYLOGENET EVOL, V23, P205, DOI 10.1016/S1055-7903(02)00001-5; McCauley L, 2004, MOL ECOL NOTES, V4, P494, DOI 10.1111/j.1471-8286.2004.00724.x; Meekan MG, 2006, MAR ECOL PROG SER, V319, P275, DOI 10.3354/meps319275; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nelson JD, 2007, FISH RES, V84, P47, DOI 10.1016/j.fishres.2006.11.013; Norman BM, 2007, FISH RES, V84, P81, DOI 10.1016/j.fishres.2006.11.015; Ovenden JR, 2006, MOL ECOL NOTES, V6, P415, DOI 10.1111/j.1471-8286.2005.01254.x; Palsboll PJ, 1999, BIOL J LINN SOC, V68, P3, DOI 10.1111/j.1095-8312.1999.tb01155.x; Pardini AT, 2000, MOL ECOL, V9, P1176, DOI 10.1046/j.1365-294x.2000.00954-4.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Portnoy DS, 2006, MOL ECOL NOTES, V6, P431, DOI 10.1111/j.1471-8286.2006.01261.x; Portnoy DS, 2007, MOL ECOL, V16, P187, DOI 10.1111/j.1365-294X.2006.03138.x; Primmer CR, 1996, NAT GENET, V13, P391, DOI 10.1038/ng0896-391; Pritchard JK, 2000, GENETICS, V155, P945; Quattro JM, 2006, MAR BIOL, V148, P1143, DOI 10.1007/s00227-005-0151-x; Ramirez-Macias D, 2007, FISH RES, V84, P87, DOI 10.1016/j.fishres.2006.11.038; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2007, ENVIRON BIOL FISH, V80, P465, DOI 10.1007/s10641-006-9148-7; Schrey AW, 2002, CONSERV GENET, V3, P459, DOI 10.1023/A:1020583609967; Schug MD, 1997, NAT GENET, V15, P99, DOI 10.1038/ng0197-99; Stevens JD, 2007, FISH RES, V84, P4, DOI 10.1016/j.fishres.2006.11.008; Stewart BS, 2005, ENVIRON BIOL FISH, V74, P184, DOI 10.1007/s10641-005-2229-1; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Wilmer JW, 1999, MOL ECOL, V8, P1417, DOI 10.1046/j.1365-294x.1999.00705.x; Wilson SG, 2006, MAR BIOL, V148, P1157, DOI 10.1007/s00227-005-0153-8; Wilson SG, 2001, ENVIRON BIOL FISH, V61, P1, DOI 10.1023/A:1011069914753; Wintner SP, 2000, ENVIRON BIOL FISH, V59, P441, DOI 10.1023/A:1026564707027	77	78	81	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e4988	10.1371/journal.pone.0004988	http://dx.doi.org/10.1371/journal.pone.0004988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352489	Green Published, gold			2022-12-27	WOS:000265505300001
J	Spaeth, EL; Dembinski, JL; Sasser, AK; Watson, K; Klopp, A; Hall, B; Andreeff, M; Marini, F				Spaeth, Erika L.; Dembinski, Jennifer L.; Sasser, A. Kate; Watson, Keri; Klopp, Ann; Hall, Brett; Andreeff, Michael; Marini, Frank			Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression	PLOS ONE			English	Article								Background: Tumor associated fibroblasts (TAF), are essential for tumor progression providing both a functional and structural supportive environment. TAF, known as activated fibroblasts, have an established biological impact on tumorigenesis as matrix synthesizing or matrix degrading cells, contractile cells, and even blood vessel associated cells. The production of growth factors, cytokines, chemokines, matrix-degrading enzymes, and immunomodulatory mechanisms by these cells augment tumor progression by providing a suitable environment. There are several suggested origins of the TAF including tissue-resident, circulating, and epithelial-to-mesenchymal-transitioned cells. Methodology/Principal Findings: We provide evidence that TAF are derived from mesenchymal stem cells (MSC) that acquire a TAF phenotype following exposure to or systemic recruitment into adenocarcinoma xenograft models including breast, pancreatic, and ovarian. We define the MSC derived TAF in a xenograft ovarian carcinoma model by the immunohistochemical presence of 1) fibroblast specific protein and fibroblast activated protein; 2) markers phenotypically associated with aggressiveness, including tenascin-c, thrombospondin-1, and stromelysin-1; 3) production of protumorigenic growth factors including hepatocyte growth factor, epidermal growth factor, and interleukin-6; and 4) factors indicative of vascularization, including alpha-smooth muscle actin, desmin, and vascular endothelial growth factor. We demonstrate that under long-term tumor conditioning in vitro, MSC express TAF-like proteins. Additionally, human MSC but not murine MSC stimulated tumor growth primarily through the paracrine production of secreted IL6. Conclusions/Significance: Our results suggest the dependence of in vitro Skov-3 tumor cell proliferation is due to the presence of tumor-stimulated MSC secreted IL6. The subsequent TAF phenotype arises from the MSC which ultimately promotes tumor growth through the contribution of microvascularization, stromal networks, and the production of tumor-stimulating paracrine factors.	[Spaeth, Erika L.; Dembinski, Jennifer L.; Watson, Keri; Klopp, Ann; Andreeff, Michael; Marini, Frank] Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Sasser, A. Kate; Hall, Brett] Ohio State Univ, Ctr Childhood Canc, Columbus Childrens Res Inst, Dept Pediat, Columbus, OH USA	University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Spaeth, EL (corresponding author), Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA.	fmarini@mdanderson.org		Spaeth, Erika/0000-0002-5397-3493; Dembinski, Jennifer/0000-0001-9259-9572	National Cancer Institute [CA-109451, Ca-116199, CA-55164, CA-16672, CA-49639]; Paul and Mary Haas Chair in Genetics; Susan G. Komen Breast Cancer Foundation [BCTR0504372]; Army Department of Defense [BC083397]; NATIONAL CANCER INSTITUTE [P01CA049639, R01CA109451, P30CA016672, P50CA116199, P01CA055164, RC1CA146381] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Paul and Mary Haas Chair in Genetics; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Army Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Cancer Institute (CA-109451 and Ca-116199 for FCM and CA-55164, CA-16672, and CA-49639 for MA) and by the Paul and Mary Haas Chair in Genetics (MA). JLD and FCM are also supported in part by grants from the Susan G. Komen Breast Cancer Foundation (BCTR0504372). ELS is also supported by the Army Department of Defense (BC083397). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abounader R, 2005, NEURO-ONCOLOGY, V7, P436, DOI 10.1215/S1152851705000050; Annabi B, 2004, J CELL BIOCHEM, V91, P1146, DOI 10.1002/jcb.10763; Bae S, 2008, BRIT J HAEMATOL, V142, P827, DOI 10.1111/j.1365-2141.2008.07241.x; Ball SG, 2004, INT J BIOCHEM CELL B, V36, P714, DOI 10.1016/j.biocel.2003.10.015; BEXELL D, 2008, MOL THER; Corso S, 2008, ONCOGENE, V27, P684, DOI 10.1038/sj.onc.1210697; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dong JY, 2004, EMBO J, V23, P2800, DOI 10.1038/sj.emboj.7600289; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Emura M, 2000, IN VITRO CELL DEV-AN, V36, P77; Haddow A, 1972, Adv Cancer Res, V16, P181; Hall B., 2007, V180, P263; Hall B, 2007, INT J HEMATOL, V86, P8, DOI 10.1532/IJH97.06230; Harrison P, 2000, BIOCHEM BIOPH RES CO, V271, P203, DOI 10.1006/bbrc.2000.2612; Hung SC, 2005, CLIN CANCER RES, V11, P7749, DOI 10.1158/1078-0432.CCR-05-0876; Ilan N, 2003, CURR OPIN CELL BIOL, V15, P515, DOI 10.1016/S0955-0674(03)00100-5; Javazon EH, 2004, EXP HEMATOL, V32, P414, DOI 10.1016/j.exphem.2004.02.004; Jeon ES, 2008, STEM CELLS, V26, P789, DOI 10.1634/stemcells.2007-0742; Jiang Han fang, 2008, Beijing Da Xue Xue Bao Yi Xue Ban, V40, P453; Jodele S, 2005, CANCER RES, V65, P3200, DOI 10.1158/0008-5472.CAN-04-3770; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kanehira M, 2007, CANCER GENE THER, V14, P894, DOI 10.1038/sj.cgt.7701079; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561; Klopp AH, 2007, CANCER RES, V67, P11687, DOI 10.1158/0008-5472.CAN-07-1406; Koyama H, 2008, AM J PATHOL, V172, P179, DOI 10.2353/ajpath.2008.070360; Kunz-Schughart LA, 2002, HISTOL HISTOPATHOL, V17, P599, DOI 10.14670/HH-17.599; Labelle M, 2008, CANCER RES, V68, P1388, DOI 10.1158/0008-5472.CAN-07-2706; LAZARIDES E, 1981, COLD SPRING HARB SYM, V46, P351; Littlepage LE, 2005, CANCER CELL, V7, P499, DOI 10.1016/j.ccr.2005.05.019; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Matsumoto Y, 2008, BIOCHEM BIOPH RES CO, V366, P110, DOI 10.1016/j.bbrc.2007.11.089; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Ogawa M, 2006, BLOOD, V108, P2893, DOI 10.1182/blood-2006-04-016600; Ohlsson LB, 2003, EXP MOL PATHOL, V75, P248, DOI 10.1016/j.yexmp.2003.06.001; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Ruiter D, 2002, LANCET ONCOL, V3, P35, DOI 10.1016/S1470-2045(01)00620-9; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Sasser AK, 2007, CANCER LETT, V254, P255, DOI 10.1016/j.canlet.2007.03.012; Silzle T, 2004, INT J CANCER, V108, P173, DOI 10.1002/ijc.11542; Sonabend AM, 2008, STEM CELLS; SPAETH E, 2008, GENE THER; Spix JK, 2007, EXP CELL RES, V313, P3319, DOI 10.1016/j.yexcr.2007.06.006; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Studeny M, 2002, CANCER RES, V62, P3603; Studeny M, 2001, BLOOD, V98, p696A; Tsujino T, 2007, CLIN CANCER RES, V13, P2082, DOI 10.1158/1078-0432.CCR-06-2191; Udagawa T, 2006, FASEB J, V20, P95, DOI 10.1096/fj.04-3669com; Untergasser G, 2005, MECH AGEING DEV, V126, P59, DOI 10.1016/j.mad.2004.09.023; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; XIN H, 2007, STEM CELLS; Yang F, 2008, ONCOGENE, V27, P450, DOI 10.1038/sj.onc.1210663; Yazhou C, 2004, TUMOR BIOL, V25, P290, DOI 10.1159/000081394	57	616	639	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e4992	10.1371/journal.pone.0004992	http://dx.doi.org/10.1371/journal.pone.0004992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352430	Green Published, gold, Green Submitted			2022-12-27	WOS:000265505300002
J	Boon, K; Bailey, NW; Yang, J; Steel, MP; Groshong, S; Kervitsky, D; Brown, KK; Schwarz, MI; Schwartz, DA				Boon, Kathy; Bailey, Nathaniel W.; Yang, Jun; Steel, Mark P.; Groshong, Steve; Kervitsky, Dolly; Brown, Kevin K.; Schwarz, Marvin I.; Schwartz, David A.			Molecular Phenotypes Distinguish Patients with Relatively Stable from Progressive Idiopathic Pulmonary Fibrosis (IPF)	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; EPITHELIAL EXPRESSION; NATURAL-HISTORY; SERIAL ANALYSIS; POTENTIAL ROLE; PATHOGENESIS; SURVIVAL; ADENOCARCINOMA; ADRENOMEDULLIN; MICROARRAY	Background: Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic interstitial lung disease that is unresponsive to current therapy and often leads to death. However, the rate of disease progression differs among patients. We hypothesized that comparing the gene expression profiles between patients with stable disease and those in which the disease progressed rapidly will lead to biomarker discovery and contribute to the understanding of disease pathogenesis. Methodology and Principal Findings: To begin to address this hypothesis, we applied Serial Analysis of Gene Expression (SAGE) to generate lung expression profiles from diagnostic surgical lung biopsies in 6 individuals with relatively stable (or slowly progressive) IPF and 6 individuals with progressive IPF (based on changes in DLCO and FVC over 12 months). Our results indicate that this comprehensive lung IPF SAGE transcriptome is distinct from normal lung tissue and other chronic lung diseases. To identify candidate markers of disease progression, we compared the IPF SAGE profiles in stable and progressive disease, and identified a set of 102 transcripts that were at least 5-fold up regulated and a set of 89 transcripts that were at least 5-fold down regulated in the progressive group (P-value <= 0.05). The over expressed genes included surfactant protein A1, two members of the MAPK-EGR-1-HSP70 pathway that regulate cigarette-smoke induced inflammation, and Plunc (palate, lung and nasal epithelium associated), a gene not previously implicated in IPF. Interestingly, 26 of the up regulated genes are also increased in lung adenocarcinomas and have low or no expression in normal lung tissue. More importantly, we defined a SAGE molecular expression signature of 134 transcripts that sufficiently distinguished relatively stable from progressive IPF. Conclusions: These findings indicate that molecular signatures from lung parenchyma at the time of diagnosis could prove helpful in predicting the likelihood of disease progression or possibly understanding the biological activity of IPF.	NHLBI, Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA; Duke Univ, Med Ctr, Durham, NC 27706 USA; Natl Jewish Hlth, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Boon, K (corresponding author), NHLBI, Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA.	Kathy.Boon@gmail.com	Brown, Kevin/ABF-2544-2020		National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the intramural research programs at the National Heart, Lung, and Blood Institute, and the National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	American Thoracic Society/European Respiratory Society. International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), 2001, AM J RESP CRIT CARE, V165, P277, DOI DOI 10.1164/AJRCCM.165.2.ATS01; Baran CP, 2007, AM J RESP CRIT CARE, V176, P78, DOI 10.1164/rccm.200609-1279OC; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bingle CD, 2002, HUM MOL GENET, V11, P937, DOI 10.1093/hmg/11.8.937; Bingle L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-79; Boon K, 2002, P NATL ACAD SCI USA, V99, P11287, DOI 10.1073/pnas.152324199; Capelli A, 2005, EUR RESPIR J, V25, P701, DOI 10.1183/09031936.05.00082604; Chen JJ, 2002, P NATL ACAD SCI USA, V99, P12257, DOI 10.1073/pnas.192436499; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Di YP, 2003, J BIOL CHEM, V278, P1165, DOI 10.1074/jbc.M210523200; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fattman CL, 2008, AM J PHYSIOL-LUNG C, V294, pL572, DOI 10.1152/ajplung.00291.2007; Gharaee-Kermani M, 2003, CYTOKINE, V24, P266, DOI 10.1016/j.cyto.2003.08.003; Gharaee-Kermani M, 2007, PHARM RES-DORDR, V24, P819, DOI 10.1007/s11095-006-9216-x; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Gouyer V, 2005, CANCER-AM CANCER SOC, V103, P1676, DOI 10.1002/cncr.20965; Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; IYONAGA K, 1994, HUM PATHOL, V25, P455, DOI 10.1016/0046-8177(94)90117-1; Kadota J, 2005, RESP MED, V99, P111, DOI 10.1016/j.rmed.2004.04.018; Kaminski N, 2003, AM J RESP CELL MOL, V29, pS32; Kaminski Naftali, 2006, Proc Am Thorac Soc, V3, P339, DOI 10.1513/pats.200601-011TK; Kang HR, 2007, J EXP MED, V204, P1083, DOI 10.1084/jem.20061273; Kim Dong Soon, 2006, Proc Am Thorac Soc, V3, P285, DOI 10.1513/pats.200601-005TK; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; Lee KS, 2008, EUR RESPIR J, V31, P523, DOI 10.1183/09031936.00125007; Li CJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1297, DOI 10.1152/ajplung.00194.2006; Maher TM, 2007, EUR RESPIR J, V30, P835, DOI 10.1183/09031936.00069307; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Meek PM, 1999, AM J RESP CRIT CARE, V159, P321; Nevins JR, 2007, NAT REV GENET, V8, P601, DOI 10.1038/nrg2137; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Pardo Annie, 2006, Proc Am Thorac Soc, V3, P383, DOI 10.1513/pats.200601-012TK; Pio R, 2002, MICROSC RES TECHNIQ, V57, P23, DOI 10.1002/jemt.10047; Robertson N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r6; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SCHWARTZ DA, 1994, AM J RESP CRIT CARE, V149, P444, DOI 10.1164/ajrccm.149.2.8306043; Selman M, 2000, AM J PHYSIOL-LUNG C, V279, pL562, DOI 10.1152/ajplung.2000.279.3.L562; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Sentani K, 2008, MODERN PATHOL, V21, P464, DOI 10.1038/modpathol.3801050; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; St Croix B, 2000, SCIENCE, V289, P1197; Steele MP, 2005, AM J RESP CRIT CARE, V172, P1146, DOI 10.1164/rccm.200408-1104OC; Strieter RM, 2005, CHEST, V128, p526S, DOI 10.1378/chest.128.5_suppl_1.526S; Swiderski RE, 1998, AM J PATHOL, V152, P821; Thannickal Victor J, 2006, Proc Am Thorac Soc, V3, P350, DOI 10.1513/pats.200601-001TK; van 't Veer LJ, 2003, BREAST CANCER RES, V5, P57, DOI 10.1186/bcr562; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Vizza CD, 2005, REGUL PEPTIDES, V124, P187, DOI 10.1016/j.regpep.2004.07.021; Walters DM, 2008, ANTIOXID REDOX SIGN, V10, P321, DOI 10.1089/ars.2007.1901; Wang HY, 2007, IEEE ACM T COMPUT BI, V4, P163, DOI 10.1109/TCBB.2007.070204; Williams RE, 2005, MOL BIOSYST, V1, P166, DOI 10.1039/b500852b; Wittke A, 2004, J IMMUNOL, V173, P3432, DOI 10.4049/jimmunol.173.5.3432; Yang IV, 2007, AM J RESP CRIT CARE, V175, P45, DOI 10.1164/rccm.200601-062OC	55	138	143	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2009	4	4							e5134	10.1371/journal.pone.0005134	http://dx.doi.org/10.1371/journal.pone.0005134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RS	19347046	Green Published, gold			2022-12-27	WOS:000265505200007
J	Chamberlain, J; Francis, S; Brookes, Z; Shaw, G; Graham, D; Alp, NJ; Dower, S; Crossman, DC				Chamberlain, Janet; Francis, Sheila; Brookes, Zoe; Shaw, Gary; Graham, Delyth; Alp, Nicholas J.; Dower, Steven; Crossman, David C.			Interleukin-1 Regulates Multiple Atherogenic Mechanisms in Response to Fat Feeding	PLOS ONE			English	Article								Background: Atherosclerosis is an inflammatory process that develops in individuals with known risk factors that include hypertension and hyperlipidaemia, influenced by diet. However, the interplay between diet, inflammatory mechanisms and vascular risk factors requires further research. We hypothesised that interleukin-1 (IL-1) signaling in the vessel wall would raise arterial blood pressure and promote atheroma. Methodology/Principal Findings: Apoe(-/-) and Apoe(-/-)/IL-1R1(-/-) mice were fed high fat diets for 8 weeks, and their blood pressure and atherosclerosis development measured. Apoe(-/-)/IL-R1(-/-) mice had a reduced blood pressure and significantly less atheroma than Apoe(-/-) mice. Selective loss of IL-1 signaling in the vessel wall by bone marrow transplantation also reduced plaque burden (p<0.05). This was associated with an IL-1 mediated loss of endothelium-dependent relaxation and an increase in vessel wall Nox 4. Inhibition of IL-1 restored endothelium-dependent vasodilatation and reduced levels of arterial oxidative stress. Conclusions/Significance: The IL-1 cytokine system links atherogenic environmental stimuli with arterial inflammation, oxidative stress, increased blood pressure and atherosclerosis. This is the first demonstration that inhibition of a single cytokine can block the rise in blood pressure in response to an environmental stimulus. IL-1 inhibition may have profound beneficial effects on atherogenesis in man.	[Chamberlain, Janet; Francis, Sheila; Brookes, Zoe; Shaw, Gary; Crossman, David C.] Univ Sheffield, Cardiovasc Res Unit, Sch Med & Biomed Sci, Sheffield, S Yorkshire, England; [Graham, Delyth] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8QQ, Lanark, Scotland; [Alp, Nicholas J.] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX1 2JD, England; [Dower, Steven] Univ Sheffield, Sch Med & Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Glasgow; University of Oxford; University of Sheffield	Chamberlain, J (corresponding author), Univ Sheffield, Cardiovasc Res Unit, Sch Med & Biomed Sci, Sheffield, S Yorkshire, England.	j.chamberlain@sheffield.ac.uk		Brookes, Zoe/0000-0002-8096-6256; dower, steve/0000-0002-4675-4225	British Heart Foundation [RG 2001/008]; MRC [G0502131] Funding Source: UKRI; Medical Research Council [G0502131] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by British Heart Foundation Programme Grant RG 2001/008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; Alp NJ, 2003, J CLIN INVEST, V112, P725, DOI 10.1172/JCI200317786; Andrew PS, 2003, AM J PHYSIOL-REG I, V284, pR1567, DOI 10.1152/ajpregu.00417.2002; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BEVILACQUA MP, 1984, J EXP MED, V160, P618, DOI 10.1084/jem.160.2.618; Brookes ZLS, 2003, AM J PHYSIOL-REG I, V284, pR1604, DOI 10.1152/ajpregu.00411.2002; Chamberlain J, 2006, AM J PATHOL, V168, P1396, DOI 10.2353/ajpath.2006.051054; Chen JQ, 2001, CIRCULATION, V104, P2391, DOI 10.1161/hc4501.099729; Chi HH, 2004, CIRCULATION, V110, P1678, DOI 10.1161/01.CIR.0000142085.39015.31; COLOTTA F, 1994, IMMUNOL TODAY, V15, P562, DOI 10.1016/0167-5699(94)90217-8; Devlin CM, 2002, P NATL ACAD SCI USA, V99, P6280, DOI 10.1073/pnas.092324399; Dewberry R, 2000, ARTERIOSCL THROM VAS, V20, P2394, DOI 10.1161/01.ATV.20.11.2394; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Elhage R, 1998, CIRCULATION, V97, P242, DOI 10.1161/01.CIR.97.3.242; Ellmark SHM, 2005, CARDIOVASC RES, V65, P495, DOI 10.1016/j.cardiores.2004.10.026; Galea J, 1996, ARTERIOSCL THROM VAS, V16, P1000, DOI 10.1161/01.ATV.16.8.1000; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Guzik TJ, 2006, ARTERIOSCL THROM VAS, V26, P333, DOI 10.1161/01.ATV.0000196651.64776.51; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Ikonomidis I, 2008, CIRCULATION, V117, P2662, DOI 10.1161/CIRCULATIONAHA.107.731877; Isoda K, 2004, ARTERIOSCL THROM VAS, V24, P1068, DOI 10.1161/01.ATV.0000127025.48140.a3; Kamari Y, 2007, ATHEROSCLEROSIS, V195, P31, DOI 10.1016/j.atherosclerosis.2006.11.026; Kaur J, 2004, MED PRIN PRACT, V13, P26, DOI 10.1159/000074047; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Laursen JB, 2001, CIRCULATION, V103, P1282; LIBBY P, 1986, J CLIN INVEST, V78, P1432, DOI 10.1172/JCI112732; Massaro M, 2006, P NATL ACAD SCI USA, V103, P15184, DOI 10.1073/pnas.0510086103; MORRIS MC, 1993, CIRCULATION, V88, P523, DOI 10.1161/01.CIR.88.2.523; Morton AC, 2005, CARDIOVASC RES, V68, P493, DOI 10.1016/j.cardiores.2005.06.026; Ray KK, 2002, CLIN SCI, V103, P303, DOI 10.1042/cs1030303; SYMONS JA, 1995, P NATL ACAD SCI USA, V92, P1714, DOI 10.1073/pnas.92.5.1714; Takeuchi Hiroyuki, 2007, J Oleo Sci, V56, P347; Tamaru M, 1998, ARTERIOSCL THROM VAS, V18, P1292, DOI 10.1161/01.ATV.18.8.1292; Vergnes L, 2003, J BIOL CHEM, V278, P42774, DOI 10.1074/jbc.M306022200; Wilde DW, 2000, HYPERTENSION, V35, P832, DOI 10.1161/01.HYP.35.3.832; Yang Hagen, 2007, Conn Med, V71, P533	40	97	100	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2009	4	4							e5073	10.1371/journal.pone.0005073	http://dx.doi.org/10.1371/journal.pone.0005073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RS	19347044	Green Published, Green Accepted, gold			2022-12-27	WOS:000265505200005
J	Lucas, J; Bilzer, A; Moll, L; Zundorf, I; Dingermann, T; Eichinger, L; Siol, O; Winckler, T				Lucas, Joerg; Bilzer, Annika; Moll, Lorna; Zuendorf, Ilse; Dingermann, Theodor; Eichinger, Ludwig; Siol, Oliver; Winckler, Thomas			The Carboxy-Terminal Domain of Dictyostelium C-Module-Binding Factor Is an Independent Gene Regulatory Entity	PLOS ONE			English	Article							NUCLEAR-PROTEIN; EXPRESSION; VECTORS; DATABASE; CLONING; GENOME; GROWTH; MODEL	The C-module-binding factor (CbfA) is a multidomain protein that belongs to the family of jumonji-type (JmjC) transcription regulators. In the social amoeba Dictyostelium discoideum, CbfA regulates gene expression during the unicellular growth phase and multicellular development. CbfA and a related D. discoideum CbfA-like protein, CbfB, share a paralogous domain arrangement that includes the JmjC domain, presumably a chromatin-remodeling activity, and two zinc finger-like (ZF) motifs. On the other hand, the CbfA and CbfB proteins have completely different carboxy-terminal domains, suggesting that the plasticity of such domains may have contributed to the adaptation of the CbfA-like transcription factors to the rapid genome evolution in the dictyostelid clade. To support this hypothesis we performed DNA microarray and real-time RT-PCR measurements and found that CbfA regulates at least 160 genes during the vegetative growth of D. discoideum cells. Functional annotation of these genes revealed that CbfA predominantly controls the expression of gene products involved in housekeeping functions, such as carbohydrate, purine nucleoside/nucleotide, and amino acid metabolism. The CbfA protein displays two different mechanisms of gene regulation. The expression of one set of CbfA-dependent genes requires at least the JmjC/ZF domain of the CbfA protein and thus may depend on chromatin modulation. Regulation of the larger group of genes, however, does not depend on the entire CbfA protein and requires only the carboxy-terminal domain of CbfA (CbfA-CTD). An AT-hook motif located in CbfA-CTD, which is known to mediate DNA binding to A+T-rich sequences in vitro, contributed to CbfA-CTD-dependent gene regulatory functions in vivo.	[Lucas, Joerg; Bilzer, Annika; Siol, Oliver; Winckler, Thomas] Univ Jena, Inst Pharm, Sch Biol & Pharm, Dept Pharmaceut Biol, Jena, Germany; [Moll, Lorna; Eichinger, Ludwig] Univ Cologne, Med Fac, Inst Biochem I, D-5000 Cologne, Germany; [Zuendorf, Ilse; Dingermann, Theodor] Goethe Univ Frankfurt, Inst Pharmaceut Biol, D-6000 Frankfurt, Germany	Friedrich Schiller University of Jena; University of Cologne; Goethe University Frankfurt	Lucas, J (corresponding author), Univ Jena, Inst Pharm, Sch Biol & Pharm, Dept Pharmaceut Biol, Jena, Germany.	t.winckler@uni-jena.de	Eichinger, Ludwig/AAJ-8895-2021; Dingermann, Theodor/M-6970-2014	Eichinger, Ludwig/0000-0003-1594-6117; Dingermann, Theodor/0000-0002-2788-1085; Moll, Lorna/0000-0003-1194-7323	Deutsche Forschungsgemeinschaft DFG [SFB 604]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft DFG (SFB 604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chisholm RL, 2006, NUCLEIC ACIDS RES, V34, pD423, DOI 10.1093/nar/gkj090; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Farbrother P, 2006, CELL MICROBIOL, V8, P438, DOI 10.1111/j.1462-5822.2005.00633.x; Geier A, 1996, EUR J BIOCHEM, V241, P70, DOI 10.1111/j.1432-1033.1996.0070t.x; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hentschel U, 2001, ANAL BIOCHEM, V296, P83, DOI 10.1006/abio.2001.5207; Horn J, 1999, EUR J BIOCHEM, V265, P441, DOI 10.1046/j.1432-1327.1999.00768.x; JOHNSON KR, 1988, J BIOL CHEM, V263, P18338; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; MANFIOLETTI G, 1991, NUCLEIC ACIDS RES, V19, P6793, DOI 10.1093/nar/19.24.6793; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; Meima ME, 2007, PROTEIN EXPRES PURIF, V53, P283, DOI 10.1016/j.pep.2007.01.001; Na JB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-123; Otsuka H, 1998, GENE DEV, V12, P1738, DOI 10.1101/gad.12.11.1738; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PITT GS, 1993, GENE DEV, V7, P2172, DOI 10.1101/gad.7.11.2172; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Sillo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-291; Siol O, 2006, EUKARYOT CELL, V5, P658, DOI 10.1128/EC.5.4.658-664.2006; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Thomason PA, 2006, PLASMID, V56, P145, DOI 10.1016/j.plasmid.2006.04.001; Wemmer DE, 1999, BIOPOLYMERS, V52, P197, DOI 10.1002/1097-0282(1999)52:4<197::AID-BIP1004>3.0.CO;2-U; Winckler T, 2004, EUKARYOT CELL, V3, P1349, DOI 10.1128/EC.3.5.1349-1358.2004; Winckler T, 2001, J MOL BIOL, V305, P703, DOI 10.1006/jmbi.2000.4341; Xu Qikai, 2005, Appl Bioinformatics, V4, P281, DOI 10.2165/00822942-200504040-00008	30	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5012	10.1371/journal.pone.0005012	http://dx.doi.org/10.1371/journal.pone.0005012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343174	Green Submitted, Green Published, gold			2022-12-27	WOS:000265500800001
J	Bollyky, PL; Bice, JB; Sweet, IR; Falk, BA; Gebe, JA; Clark, AE; Gersuk, VH; Aderem, A; Hawn, TR; Nepom, GT				Bollyky, Paul L.; Bice, Jeffrey B.; Sweet, Ian R.; Falk, Ben A.; Gebe, John A.; Clark, April E.; Gersuk, Vivian H.; Aderem, Alan; Hawn, Thomas R.; Nepom, Gerald T.			The Toll-Like Receptor Signaling Molecule Myd88 Contributes to Pancreatic Beta-Cell Homeostasis in Response to Injury	PLOS ONE			English	Article							HUMAN GINGIVAL FIBROBLASTS; GLUCAGON-LIKE PEPTIDE-1; GENE-EXPRESSION; INNATE IMMUNITY; ISLET TRANSPLANTATION; MYD88-DEFICIENT MICE; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; GUT FLORA; LIPOPOLYSACCHARIDE	Commensal flora and pathogenic microbes influence the incidence of diabetes in animal models yet little is known about the mechanistic basis of these interactions. We hypothesized that Myd88, an adaptor molecule in the Toll-like-receptor (TLR) pathway, regulates pancreatic beta-cell function and homeostasis. We first examined beta-cells histologically and found that Myd88(-/-) mice have smaller islets in comparison to C57Bl/6 controls. Myd88(-/-) mice were nonetheless normoglycemic both at rest and after an intra-peritoneal glucose tolerance test (IPGTT). In contrast, after low-dose streptozotocin (STZ) challenge, Myd88(-/-) mice had an abnormal IPGTT relative to WT controls. Furthermore, Myd88(-/-) mice suffer enhanced beta-cell apoptosis and have enhanced hepatic damage with delayed recovery upon low-dose STZ treatment. Finally, we treated WT mice with broad-spectrum oral antibiotics to deplete their commensal flora. In WT mice, low dose oral lipopolysaccharide, but not lipotichoic acid or antibiotics alone, strongly promoted enhanced glycemic control. These data suggest that Myd88 signaling and certain TLR ligands mediate a homeostatic effect on b-cells primarily in the setting of injury.	Benaroya Res Inst, Seattle, WA USA; Inst Syst Biol, Seattle, WA USA; Univ Washington, Sch Med, Seattle, WA 98195 USA	Benaroya Research Institute; Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle	Bollyky, PL (corresponding author), Benaroya Res Inst, Seattle, WA USA.	pbollyky@benaroyaresearch.org		Nepom, Gerald/0000-0002-8063-1464	NIH [DK46635, HL18645, DK53004, DK080178-01]; JDRF (The Center for Translational Research at BRI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080178, R01DK046635] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF (The Center for Translational Research at BRI)(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH (DK46635, HL18645, and DK53004) and the JDRF (The Center for Translational Research at BRI). PLB is supported by NIH K-08 grant DK080178-01 and an NIH LRP grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Alyanakian MA, 2006, DIABETES, V55, P179, DOI 10.2337/diabetes.55.1.179; Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844; Balasa B, 2000, CLIN IMMUNOL, V95, P93, DOI 10.1006/clim.2000.4855; Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; CORNELL RP, 1985, DIABETES, V34, P1253, DOI 10.2337/diabetes.34.12.1253; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Drucker DJ, 2003, ENDOCRINOLOGY, V144, P5145, DOI 10.1210/en.2003-1147; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Heald KA, 1996, TRANSPLANT P, V28, P824; JACOB AI, 1977, GASTROENTEROLOGY, V72, P1268; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; LEY R, 2006, NATURE, V444, P1023; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Lombardo E, 2007, J IMMUNOL, V178, P3731, DOI 10.4049/jimmunol.178.6.3731; Macedo L, 2007, AM J PATHOL, V171, P1774, DOI 10.2353/ajpath.2007.061048; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; MONTANA E, 1993, J CLIN INVEST, V91, P780, DOI 10.1172/JCI116297; OBrien BA, 1996, J PATHOL, V178, P176; Oguri S, 2002, CLIN DIAGN LAB IMMUN, V9, P1307, DOI 10.1128/CDLI.9.6.1307-1312.2002; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Putnins EE, 2002, INFECT IMMUN, V70, P6541, DOI 10.1128/IAI.70.12.6541-6548.2002; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; RICORDI C, 1990, ACTA DIABETOL LAT, V27, P185, DOI 10.1007/BF02581331; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Sai P, 1996, DIABETES METAB, V22, P341; Saini KS, 1996, BIOCHEM MOL BIOL INT, V39, P1229; Saitoh N, 2004, MICROBIOL IMMUNOL, V48, P629, DOI 10.1111/j.1348-0421.2004.tb03471.x; Salaun B, 2007, EUR J IMMUNOL, V37, P3311, DOI 10.1002/eji.200737744; Sanaie AR, 2002, J PERIODONTAL RES, V37, P66, DOI 10.1034/j.1600-0765.2002.t01-1-90770.x; Sawa H, 2007, SURG TODAY, V37, P867, DOI 10.1007/s00595-007-3520-x; Seki E, 2005, HEPATOLOGY, V41, P443, DOI 10.1002/hep.20603; SERREZE DV, 1989, J AUTOIMMUN, V2, P759, DOI 10.1016/0896-8411(89)90003-6; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SOBEL DO, 1994, DIABETES, V43, P518, DOI 10.2337/diabetes.43.4.518; Sugiyama A, 1996, INFECT IMMUN, V64, P1426, DOI 10.1128/IAI.64.4.1426-1431.1996; TAKAHASHI K, 1993, CLIN IMMUNOL IMMUNOP, V69, P318, DOI 10.1006/clin.1993.1187; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; van der Werf N, 2007, DIABETES-METAB RES, V23, P169, DOI 10.1002/dmrr.695; van Tol EAF, 1999, AM J PHYSIOL-GASTR L, V277, pG245, DOI 10.1152/ajpgi.1999.277.1.G245; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; Wen L, 2004, J IMMUNOL, V172, P3173, DOI 10.4049/jimmunol.172.5.3173; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wideman RD, 2006, P NATL ACAD SCI USA, V103, P13468, DOI 10.1073/pnas.0600655103; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270	59	34	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5063	10.1371/journal.pone.0005063	http://dx.doi.org/10.1371/journal.pone.0005063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19357791	Green Submitted, Green Published, gold			2022-12-27	WOS:000265500600019
J	Branney, PA; Faas, L; Steane, SE; Pownall, ME; Isaacs, HV				Branney, Peter A.; Faas, Laura; Steane, Sarah E.; Pownall, Mary Elizabeth; Isaacs, Harry V.			Characterisation of the Fibroblast Growth Factor Dependent Transcriptome in Early Development	PLOS ONE			English	Article							MAP KINASE PHOSPHATASE; EARLY XENOPUS-EMBRYOS; MESODERM INDUCTION; SPEMANN ORGANIZER; NEURAL INDUCTION; GENE-EXPRESSION; SELF-RENEWAL; FGF; GASTRULATION; CELLS	Background: FGF signaling has multiple roles in regulating processes in animal development, including the specification and patterning of the mesoderm. In addition, FGF signaling supports self renewal of human embryonic stem cells and is required for differentiation of murine embryonic stem cells into a number of lineages. Methodology/Principal Findings: Given the importance of FGF signaling in regulating development and stem cell behaviour, we aimed to identify the transcriptional targets of FGF signalling during early development in the vertebrate model Xenopus laevis. We analysed the effects on gene expression in embryos in which FGF signaling was inhibited by dominant negative FGF receptors. 67 genes positively regulated by FGF signaling and 16 genes negatively regulated by FGF signaling were identified. FGF target genes are expressed in distinct waves during the late blastula to early gastrula phase. Many of these genes are expressed in the early mesoderm and dorsal ectoderm. A widespread requirement for FGF in regulating genes expressed in the Spemann organizer is revealed. The FGF targets MKP1 and DUSP5 are shown to be negative regulators of FGF signaling in early Xenopus tissues. FoxD3 and Lin28, which are involved in regulating pluripotency in ES cells are shown to be down regulated when FGF signaling is blocked. Conclusions: We have undertaken a detailed analysis of FGF target genes which has generated a robust, well validated data set. We have found a widespread role for FGF signaling in regulating the expression of genes mediating the function of the Spemann organizer. In addition, we have found that the FGF targets MKP1 and DUSP5 are likely to contribute to the complex feedback loops involved in modulating responses to FGF signaling. We also find a link between FGF signaling and the expression of known regulators of pluripotency.	[Branney, Peter A.; Faas, Laura; Steane, Sarah E.; Pownall, Mary Elizabeth; Isaacs, Harry V.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of York - UK	Branney, PA (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	hvi1@york.ac.uk		Pownall, Mary Elizabeth/0000-0003-2329-5844; steane, sarah/0000-0001-8594-3486	BBSRC [BB/D010039/1]; Biotechnology and Biological Sciences Research Council [BB/D010039/1, BB/C505408/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work funded by BBSRC grant BB/D010039/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAYA E, 1993, DEVELOPMENT, V118, P477; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Bottcher RT, 2004, NAT CELL BIOL, V6, P38, DOI 10.1038/ncb1082; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; BURKS PJ, 2008, BIOL CELL; Christen B, 1999, DEVELOPMENT, V126, P119; Christensen MM, 1997, CLIN ORAL IMPLAN RES, V8, P455, DOI 10.1034/j.1600-0501.1997.080603.x; CHRISTIAN JL, 1992, EMBO J, V11, P33, DOI 10.1002/j.1460-2075.1992.tb05024.x; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; CORNELL RA, 1994, DEVELOPMENT, V120, P453; CORNELL RA, 1995, DEVELOPMENT, V121, P2429; Delaune E, 2005, DEVELOPMENT, V132, P299, DOI 10.1242/dev.01582; Fisher ME, 2002, DEVELOPMENT, V129, P1307; Fletcher RB, 2006, DEVELOPMENT, V133, P1703, DOI 10.1242/dev.02342; Fletcher RB, 2008, DEV DYNAM, V237, P1243, DOI 10.1002/dvdy.21517; Frazzetto G, 2002, MECH DEVELOP, V113, P3, DOI 10.1016/S0925-4773(01)00664-5; Gomez AR, 2005, DEV DYNAM, V232, P695, DOI 10.1002/dvdy.20227; GRIFFIN K, 1995, DEVELOPMENT, V121, P2983; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hongo I, 1999, DEV BIOL, V216, P561, DOI 10.1006/dbio.1999.9515; Isaacs HV, 1998, EMBO J, V17, P3413, DOI 10.1093/emboj/17.12.3413; Isaacs HV, 1997, CELL MOL LIFE SCI, V53, P350, DOI 10.1007/PL00000611; ISAACS HV, 1994, EMBO J, V13, P4469, DOI 10.1002/j.1460-2075.1994.tb06769.x; ISAACS HV, 1992, DEVELOPMENT, V114, P711; Keenan ID, 2006, DEV BIOL, V299, P478, DOI 10.1016/j.ydbio.2006.08.040; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; Klingbeil P, 2001, INT J DEV BIOL, V45, P379; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; LABONNE C, 1994, DEVELOPMENT, V120, P463; LABONNE C, 1995, DEVELOPMENT, V121, P1475; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Levine B, 2007, DEV BIOL, V305, P217, DOI 10.1016/j.ydbio.2007.02.013; LEWIS T, 1995, J CELL SCI, V108, P2885; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Lombardo A, 1998, INT J DEV BIOL, V42, P1101; Mason C, 1996, MECH DEVELOP, V55, P133, DOI 10.1016/0925-4773(96)00495-9; Mathieu J, 2004, DEVELOPMENT, V131, P629, DOI 10.1242/dev.00964; Mitchell TS, 2001, DEV BIOL, V237, P295, DOI 10.1006/dbio.2001.0385; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Nutt SL, 2001, GENE DEV, V15, P1152, DOI 10.1101/gad.191301; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Pownall ME, 1996, DEVELOPMENT, V122, P3881; Ribisi S, 2000, DEV BIOL, V227, P183, DOI 10.1006/dbio.2000.9889; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; SCHULTEMERKER S, 1995, CURR BIOL, V5, P62, DOI 10.1016/S0960-9822(95)00017-0; Sheng GJ, 2003, CELL, V115, P603, DOI 10.1016/S0092-8674(03)00927-9; Shinga J, 2001, MECH DEVELOP, V109, P225, DOI 10.1016/S0925-4773(01)00528-7; Sivak JM, 2005, DEV CELL, V8, P689, DOI 10.1016/j.devcel.2005.02.011; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Steiner AB, 2006, DEVELOPMENT, V133, P4827, DOI 10.1242/dev.02663; Takeuchi M, 2003, CURR BIOL, V13, P674, DOI 10.1016/S0960-9822(03)00245-8; UMBHAUER M, 1995, NATURE, V376, P58, DOI 10.1038/376058a0; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Winning RS, 1996, DEV BIOL, V179, P309, DOI 10.1006/dbio.1996.0262; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; ZARAISKY AG, 1995, DEVELOPMENT, V121, P3839	64	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4951	10.1371/journal.pone.0004951	http://dx.doi.org/10.1371/journal.pone.0004951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333377	Green Submitted, Green Published, gold			2022-12-27	WOS:000265499900006
J	Cooper, HM; Huang, JY; Verdin, E; Spelbrink, JN				Cooper, Helen M.; Huang, Jing-Yi; Verdin, Eric; Spelbrink, Johannes N.			A New Splice Variant of the Mouse SIRT3 Gene Encodes the Mitochondrial Precursor Protein	PLOS ONE			English	Article							DEACETYLASE	Background: Mammals have seven NAD-dependent protein deacetylases. These proteins, called sirtuins, are homologous to yeast Sir2, and are emerging as important regulators of lifespan and intermediary metabolism. Three mammalian sirtuins, SIRT3-5 are mitochondrial. Sirtuins are highly conserved between species, yet mouse SIRT3 was reported to be markedly shorter than its human counterpart and to lack the N-terminal mitochondrial targeting signal present in the human protein. Results: We have isolated a novel mouse SIRT3 splice variant. This cDNA contains two translation initiation codons upstream of the originally reported start site. We show, using immunofluorescence and protein expression analysis that these longer variants are expressed and efficiently targeted to mitochondria, and that the processed forms of these longer variants are identical in size to the endogenous mouse SIRT3. We also show that the previously described form of SIRT3 is not mitochondrial. Conclusions: Our observations point to a high level of conservation of SIRT3 as a mitochondrial protein in mice and human and indicate that several previous studies, which addressed mouse Sirt3 function, need to be re-evaluated.	[Cooper, Helen M.; Spelbrink, Johannes N.] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Cooper, Helen M.; Spelbrink, Johannes N.] Tampere Univ Hosp, Tampere, Finland; [Huang, Jing-Yi; Verdin, Eric] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA	Tampere University; Tampere University; Tampere University Hospital; University of California System; University of California San Francisco; The J David Gladstone Institutes	Cooper, HM (corresponding author), Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland.	hans.spelbrink@uta.fi	Spelbrink, Johannes N/L-4661-2015; Verdin, Eric/AAB-7999-2019	Spelbrink, Johannes N/0000-0002-9756-2602; Verdin, Eric/0000-0003-3703-3183	Academy of Finland [110689, 103213]; Sigrid Juselius Foundation; Tampere University Hospital Medical Research Fund [9J119, 9H102]; Larry L. Hillblom Foundation [postdoctoral fellowship]; J. David Gladstone Institutes	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere University Hospital Medical Research Fund; Larry L. Hillblom Foundation; J. David Gladstone Institutes(University of California System)	This work was supported by the Academy of Finland [110689, 103213 and CoE funding to JNS]; Sigrid Juselius Foundation [to J.N.S.]; and the Tampere University Hospital Medical Research Fund [9J119 to J.N.S., 9H102 to H.M.C.]. J-Y.H is supported by a postdoctoral fellowship from the Larry L. Hillblom Foundation and E.V. is supported by the J. David Gladstone Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lecluyse E, 1999, DRUG METAB DISPOS, V27, P909; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Malka Florence, 2007, V372, P3, DOI 10.1007/978-1-59745-365-3_1; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Nakamura Y, 2008, BIOCHEM BIOPH RES CO, V366, P174, DOI 10.1016/j.bbrc.2007.11.122; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; Yang YH, 2000, GENOMICS, V69, P355, DOI 10.1006/geno.2000.6360	17	56	59	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4986	10.1371/journal.pone.0004986	http://dx.doi.org/10.1371/journal.pone.0004986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333382	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499900009
J	Reddy, A; Suri, S; Sargent, IL; Redman, CWG; Muttukrishna, S				Reddy, Aparna; Suri, Sangeeta; Sargent, Ian L.; Redman, Christopher W. G.; Muttukrishna, Shanthi			Maternal Circulating Levels of Activin A, Inhibin A, sFlt-1 and Endoglin at Parturition in Normal Pregnancy and Pre-Eclampsia	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-1; BLOOD MONONUCLEAR-CELLS; ELEVATED LIVER-ENZYMES; OXIDATIVE STRESS; TYROSINE KINASE-1; SOLUBLE ENDOGLIN; ANGIOGENIC FACTORS; SERUM-LEVELS; UTERINE; LABOR	Background: Maternal circulating levels of anti-angiogenic factors such as soluble fms-like tyrosine kinase-1 (sFlt-1), endoglin (sEng) and placental proteins like activin A and inhibin A are increased before the onset of pre-eclampsia. There is evidence for oxidative stress in pre eclampsia. Recently it was shown that placental oxygen concentration is related to sFlt-1 and inhibin A. In addition it is reported that oxidative stress markers are increased in placental tissue delivered after labour. Therefore, the objective of this study is to investigate if these proteins are altered in maternal circulation of labouring pre-eclampsia and normal pregnancies. Methodology: To assess the effects of labour, samples were taken from 10 normal pregnant (NP) and 10 pre-eclamptic (PE) women pre-labour, full dilation, placental delivery and 24 h. To assess the effects of placental delivery, plasma samples were taken from 10NP and 10PE women undergoing elective Caesarean section, pre-delivery, placental delivery and 10 min, 60 min and 24 h post delivery. SFlt-1 and sEng and activin A and inhibin A were measured using commercial and in house ELISA's respectively. Results: The levels of sFlt- 1 and sEng were significantly higher in PE compared to NP women in both groups. In labour, sFlt-1 levels increased significantly at full dilatation in PE women, before declining by 24 hr. However there was no significant rise in sEng levels in labour. Activin A and inhibin A levels declined rapidly with placental delivery in NP and PE pregnancies. There was a significant rise in activin A levels during labour in PE compared to pre labour, but inhibin levels did not increase. Conclusion: Labour in pre-eclamptic women increases the levels of sFlt-1 and activin A. This pilot data suggests that increase in the maternal levels of these factors in labour could predict and/or contribute to the maternal syndrome postpartum.	Univ Coll London Hosp, Elizabeth Gareth Anderson Hosp, Fetal Med Unit, London, England; [Suri, Sangeeta; Muttukrishna, Shanthi] Elizabeth Gareth Anderson UCL Inst Womens Hlth, London, England; [Sargent, Ian L.; Redman, Christopher W. G.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX1 2JD, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of Oxford	Reddy, A (corresponding author), Univ Coll London Hosp, Elizabeth Gareth Anderson Hosp, Fetal Med Unit, London, England.	s.muttukrishna@ucl.ac.uk			Silver Star Society, Oxford	Silver Star Society, Oxford	Supported by Silver Star Society, Oxford. The funding body did not have any input into the study.	BRAR HS, 1988, AM J OBSTET GYNECOL, V158, P952, DOI 10.1016/0002-9378(88)90100-7; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Buhimschi CS, 2006, OBSTET GYNECOL, V107, P1103, DOI 10.1097/01.AOG.0000207698.74104.4f; Bujold E, 2005, J MATERN-FETAL NEO M, V18, P9, DOI 10.1080/14767050500202493; Cindrova-Davies T, 2007, AM J PATHOL, V171, P1168, DOI 10.2353/ajpath.2007.070528; Donner MW., 1980, PLACENTAL VASCULATUR; DOUGLAS KA, 1994, BMJ-BRIT MED J, V309, P1395, DOI 10.1136/bmj.309.6966.1395; Fainaru O, 2002, BJOG-INT J OBSTET GY, V109, P938, DOI 10.1111/j.1471-0528.2002.01494.x; FLEISCHER A, 1987, AM J OBSTET GYNECOL, V157, P40, DOI 10.1016/S0002-9378(87)80342-3; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Gu Y, 2008, J CLIN ENDOCR METAB, V93, P260, DOI 10.1210/jc.2007-1550; Hirshfeld-Cytron J, 2006, OBSTET GYNECOL SURV, V61, P471, DOI 10.1097/01.ogx.0000219564.65999.0d; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Karumanchi SA, 2004, ENDOCRINOLOGY, V145, P4835, DOI 10.1210/en.2004-1028; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Leszczynska-Gorzelak B, 2002, GYNECOL OBSTET INVES, V54, P159, DOI 10.1159/000067884; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li H, 2005, PLACENTA, V26, P210, DOI 10.1016/j.placenta.2004.05.004; Madazli R, 2000, BRIT J OBSTET GYNAEC, V107, P514, DOI 10.1111/j.1471-0528.2000.tb13271.x; Makris A, 2007, KIDNEY INT, V71, P977, DOI 10.1038/sj.ki.5002175; Mandang S, 2007, J ENDOCRINOL, V192, P485, DOI 10.1677/JOE-06-0061; Manuelpillai U, 2003, PLACENTA, V24, P77, DOI 10.1053/plac.2002.0870; Many A, 1997, PLACENTA, V18, P725, DOI 10.1016/S0143-4004(97)90015-1; Matthys LA, 2004, AM J OBSTET GYNECOL, V190, P1464, DOI 10.1016/j.ajog.2004.02.037; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; Mohan A, 2001, EUR J ENDOCRINOL, V145, P505, DOI 10.1530/eje.0.1450505; Muttukrishna S, 1996, J CLIN ENDOCR METAB, V81, P3328, DOI 10.1210/jc.81.9.3328; Muttukrishna S, 2000, HUM REPROD, V15, P1640, DOI 10.1093/humrep/15.7.1640; MUTTUKRISHNA S, 1995, CLIN ENDOCRINOL, V42, P391, DOI 10.1111/j.1365-2265.1995.tb02648.x; Muttukrishna S, 1997, LANCET, V349, P1285, DOI 10.1016/S0140-6736(96)09264-1; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; PETRAGLIA F, 1994, OBSTET GYNECOL, V84, P278; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; PIJNENBORG R, 1994, REPRODUCTIVE MED REV, V3, P53; Powers RW, 2005, AM J OBSTET GYNECOL, V193, P185, DOI 10.1016/j.ajog.2004.11.038; Rajakumar A, 2005, PLACENTA, V26, P563, DOI 10.1016/j.placenta.2004.09.001; Reddy A, 2008, PLACENTA, V29, P942, DOI 10.1016/j.placenta.2008.08.018; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CWG, 2000, PLACENTA, V21, P597, DOI 10.1053/plac.2000.0560; Roberts JM, 1999, LANCET, V354, P788, DOI 10.1016/S0140-6736(99)80002-6; Schneider-Kolsky M, 2000, BRIT J OBSTET GYNAEC, V107, P995, DOI 10.1111/j.1471-0528.2000.tb10402.x; Sela S, 2008, CIRC RES, V102, P1566, DOI 10.1161/CIRCRESAHA.108.171504; SIBAI BM, 1993, AM J OBSTET GYNECOL, V169, P1000, DOI 10.1016/0002-9378(93)90043-I; Silver HM, 2002, J SOC GYNECOL INVEST, V9, P308, DOI 10.1016/S1071-5576(02)00165-X; Siristatidis Charalambos, 2005, Archives of Gynecology and Obstetrics, V272, P191, DOI 10.1007/s00404-004-0722-y; Stepan H, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.052; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Tannetta DS, 2003, J CLIN ENDOCR METAB, V88, P5995, DOI 10.1210/jc.2002-021924; Unal ER, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.05.022; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wikstom AK, 2007, OBSTET GYNECOL, V109, P1368, DOI 10.1097/01.AOG.0000264552.85436.a1; Yaacobi N, 1999, ARCH GYNECOL OBSTET, V263, P23, DOI 10.1007/s004040050255; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	56	73	77	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4453	10.1371/journal.pone.0004453	http://dx.doi.org/10.1371/journal.pone.0004453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19412349	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484100012
J	Cagigi, A; Du, LK; Dang, LVP; Grutzmeier, S; Atlas, A; Chiodi, F; Pan-Hammarstrom, Q; Nilsson, A				Cagigi, Alberto; Du, Likun; Dang, Linh Vu Phuong; Grutzmeier, Sven; Atlas, Ann; Chiodi, Francesca; Pan-Hammarstrom, Qiang; Nilsson, Anna			CD27(-) B-Cells Produce Class Switched and Somatically Hyper-Mutated Antibodies during Chronic HIV-1 Infection	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; SOLUBLE CD27; MEMORY; RECOMBINATION; EXPRESSION; HYPERGAMMAGLOBULINEMIA; IMMUNODEFICIENCY; DIFFERENTIATION	Class switch recombination and somatic hypermutation occur in mature B-cells in response to antigen stimulation. These processes are crucial for the generation of functional antibodies. During HIV-1 infection, loss of memory B-cells, together with an altered differentiation of naive B-cells result in production of low quality antibodies, which may be due to impaired immunoglobulin affinity maturation. In the current study, we evaluated the effect of HIV-1 infection on class switch recombination and somatic hypermutation by studying the expression of activation-induced cytidine deaminase (AID) in peripheral B-cells from a cohort of chronically HIV-1 infected patients as compared to a group of healthy controls. In parallel, we also characterized the phenotype of B-cells and their ability to produce immunoglobulins in vitro. Cells from HIV-1 infected patients showed higher baseline levels of AID expression and increased IgA production measured ex-vivo and upon CD40 and TLR9 stimulation in vitro. Moreover, the percentage of CD27(-) IgA(+) and CD27(-) IgG(+) B-cells in blood was significantly increased in HIV-1 infected patients as compared to controls. Interestingly, our results showed a significantly increased number of somatic hypermutations in the VH genes in CD27(-) cells from patients. Taken together, these results show that during HIV-1 infection, CD27(-) B-cells can also produce class switched and somatically hypermutated antibodies. Our data add important information for the understanding of the mechanisms underlying the loss of specific antibody production observed during HIV-1 infection.			Cagigi, A (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	Alberto.Cagigi@ki.se	hammarstrom, qiang pan/ABA-4589-2021; Cagigi, Alberto/K-4824-2016	Cagigi, Alberto/0000-0002-3567-9514; Du, Likun/0000-0002-8448-2187; Nilsson, Anna/0000-0001-5885-7101; Chiodi, Francesca/0000-0002-1385-8343; pan-hammarstrom, qiang/0000-0003-1990-8804				Agematsu K, 2000, HISTOL HISTOPATHOL, V15, P573, DOI 10.14670/HH-15.573; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cagigi A, 2008, BLOOD, V112, P4401, DOI 10.1182/blood-2008-02-140426; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; De Milito A, 2004, CURR HIV RES, V2, P11, DOI 10.2174/1570162043485068; De Milito A, 2002, CLIN EXP IMMUNOL, V127, P486, DOI 10.1046/j.1365-2249.2002.01786.x; De Milito A, 2001, AIDS, V15, P957, DOI 10.1097/00002030-200105250-00003; Epeldegui M, 2007, AIDS, V21, P2265, DOI 10.1097/QAD.0b013e3282ef9f59; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fecteau JF, 2006, J IMMUNOL, V177, P3728, DOI 10.4049/jimmunol.177.6.3728; Fondere JM, 2004, JAIDS-J ACQ IMM DEF, V35, P114, DOI 10.1097/00126334-200402010-00002; Frasca D, 2007, EXP GERONTOL, V42, P192, DOI 10.1016/j.exger.2006.09.003; He B, 2004, J IMMUNOL, V173, P4479, DOI 10.4049/jimmunol.173.7.4479; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Hsu HC, 2007, J IMMUNOL, V178, P5357, DOI 10.4049/jimmunol.178.8.5357; Huggins J, 2007, BLOOD, V109, P1611, DOI 10.1182/blood-2006-03-008441; ISLAM KB, 1991, INT IMMUNOL, V3, P1099, DOI 10.1093/intimm/3.11.1099; Kato K, 2007, EXP HEMATOL, V35, P434, DOI 10.1016/j.exphem.2006.10.018; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; Laurence Jeffrey, 2005, AIDS Read, V15, P330; Malisan F, 1996, J EXP MED, V183, P937, DOI 10.1084/jem.183.3.937; Manzardo C, 2005, J NEUROVIROL, V11, P72, DOI 10.1080/13550280500513846; Meyer-Bahlburg A, 2008, AUTOIMMUN REV, V7, P313, DOI 10.1016/j.autrev.2007.11.027; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; MOIR S, 2008, J INFECT DIS; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nannini Esteban C, 2002, Curr Gastroenterol Rep, V4, P392, DOI 10.1007/s11894-002-0009-z; Onlamoon N, 2005, ANN NY ACAD SCI, V1050, P397, DOI 10.1196/annals.1313.091; Pan-Hammarstrom Q, 2007, ADV IMMUNOL, V93, P1, DOI 10.1016/S0065-2776(06)93001-6; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Redgrave BE, 2005, HIV MED, V6, P307, DOI 10.1111/j.1468-1293.2005.00312.x; Revy P, 2005, ADV IMMUNOL, V87, P237, DOI 10.1016/S0065-2776(05)87007-5; Sgadari C, 2003, LANCET ONCOL, V4, P537, DOI 10.1016/S1470-2045(03)01192-6; Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Titanji K, 2005, AIDS, V19, P1947, DOI 10.1097/01.aids.0000191231.54170.89; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624; Wen SC, 2004, J IMMUNOL, V172, P2595, DOI 10.4049/jimmunol.172.4.2595; Xu W, 2008, J IMMUNOL, V181, P276, DOI 10.4049/jimmunol.181.1.276; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zinkernagel RM, 2000, PHILOS T R SOC B, V355, P369, DOI 10.1098/rstb.2000.0576	47	43	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5427	10.1371/journal.pone.0005427	http://dx.doi.org/10.1371/journal.pone.0005427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412542	Green Published, Green Submitted, gold			2022-12-27	WOS:000265688200013
J	Vigne, P; Tauc, M; Frelin, C				Vigne, Paul; Tauc, Michel; Frelin, Christian			Strong Dietary Restrictions Protect Drosophila against Anoxia/Reoxygenation Injuries	PLOS ONE			English	Article							LIFE-SPAN; STRESS RESISTANCE; INSULIN-RECEPTOR; HYPOXIA TOLERANCE; HOMOLOG; OVEREXPRESSION; STARVATION; MUTANT; MODEL; GENE	Background: Reoxygenation of ischemic tissues is a major factor that determines the severity of cardiovascular diseases. This paper describes the consequences of anoxia/reoxygenation (A/R) stresses on Drosophila, a useful, anoxia tolerant, model organism. Methodology/Principal Findings: Newly emerged adult male flies were exposed to anoxic conditions (<1% O-2) for 1 to 6 hours, reoxygenated and their survival was monitored. Results: A/R stresses induced a transient increase in mortality which peaked at the time of reoxygenation. Then flies recovered low mortality rates similar to those of control flies. A/R induced mortality was strongly dependent on dietary conditions during the 48 h that preceded anoxia. Well fed flies were anoxia sensitive. Strong dietary restrictions and starvation conditions protected flies against A/R injuries. The tolerance to anoxia was associated to large decreases in glycogen, protein, and ATP contents. During anoxia, anoxia tolerant flies produced more lactate, less phosphate and they maintained more stable ATP levels than anoxia sensitive flies. Moderate dietary restrictions, which increased the longevity of normoxic flies, did not promote resistance to A/R stresses. Diet dependent A/R injuries were still observed in sima loss of function mutants and they were insensitive to dietary rapamycin or resveratrol. AICAR (5-aminoimidazole-4-carboxamide-1-beta-D-ribosefuranoside), an activator AMP kinase decreased A/R injuries. Mutants in the insulin signalling pathway were more anoxia tolerant in a fed state. Conclusion/Significance: Long A/R stresses induce a transient increase in mortality in Drosophila. This mortality is highly dependent on dietary conditions prior to the stress. Strong dietary restrictions and starvation conditions protect flies against A/R injuries, probably by inducing a major remodelling of energy metabolism. The results also indicate that mechanistically different responses develop in response to dietary restrictions of different strengths. AMP kinase and the insulin signalling pathway are possible mediators of diet dependent anoxic tolerance in Drosophila.			Vigne, P (corresponding author), Univ Nice Sophia Antipolis, CNRS, IBDC, UMR 6543, Nice, France.	cfrelin@unice.fr	Tauc, Michel/F-1530-2013	Tauc, Michel/0000-0002-8383-9818				[Anonymous], 2005, FUNCTIONAL METABOLIS; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Arquier N, 2006, BIOCHEM J, V393, P471, DOI 10.1042/BJ20050675; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; Bickler PE, 2007, ANNU REV PHYSIOL, V69, P145, DOI 10.1146/annurev.physiol.69.031905.162529; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Centanin L, 2005, EMBO REP, V6, P1070, DOI 10.1038/sj.embor.7400528; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Chen ZY, 1998, J MOL CELL CARDIOL, V30, P2281, DOI 10.1006/jmcc.1998.0789; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Djawdan M, 1997, ECOLOGY, V78, P828, DOI 10.1890/0012-9658(1997)078[0828:DSFSRL]2.0.CO;2; Feala JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100139; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Good TP, 2001, J INSECT PHYSIOL, V47, P1467, DOI 10.1016/S0022-1910(01)00138-X; Haddad GG, 2006, EXP PHYSIOL, V91, P277, DOI 10.1113/expphysiol.2005.030767; Haddad GG, 2000, J APPL PHYSIOL, V88, P1481, DOI 10.1152/jappl.2000.88.4.1481; Harbison ST, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r36; Harbison ST, 2004, GENETICS, V166, P1807, DOI 10.1534/genetics.166.4.1807; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Knoppien P, 2000, J INSECT BEHAV, V13, P27, DOI 10.1023/A:1007759424777; Krishnan SN, 1997, J INSECT PHYSIOL, V43, P203, DOI 10.1016/S0022-1910(96)00084-4; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; LAZDUNSKI M, 1985, J MOL CELL CARDIOL, V17, P1029, DOI 10.1016/S0022-2828(85)80119-X; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Lighton JRB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001267; Magwere T, 2006, MECH AGEING DEV, V127, P356, DOI 10.1016/j.mad.2005.12.009; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Murakami K, 1997, STROKE, V28, P1797, DOI 10.1161/01.STR.28.9.1797; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Pletcher SD, 2005, AGEING RES REV, V4, P451, DOI 10.1016/j.arr.2005.06.007; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tu MP, 2002, AGING CELL, V1, P75, DOI 10.1046/j.1474-9728.2002.00010.x; Vigne P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000056; Vigne P, 2007, MECH AGEING DEV, V128, P401, DOI 10.1016/j.mad.2007.05.008; Vigne Paul, 2008, BMC Physiology, V8, P22, DOI 10.1186/1472-6793-8-22; Wang PH, 1998, P NATL ACAD SCI USA, V95, P4556, DOI 10.1073/pnas.95.8.4556; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yoshida T, 2000, CIRC RES, V86, P264, DOI 10.1161/01.RES.86.3.264; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	50	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5422	10.1371/journal.pone.0005422	http://dx.doi.org/10.1371/journal.pone.0005422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412543	Green Published, Green Submitted, gold			2022-12-27	WOS:000265688200009
J	Naddafi, R; Eklov, P; Pettersson, K				Naddafi, Rahmat; Eklov, Peter; Pettersson, Kurt			Stoichiometric Constraints Do Not Limit Successful Invaders: Zebra Mussels in Swedish Lakes	PLOS ONE			English	Article							DREISSENA-POLYMORPHA; FOOD QUALITY; ECOLOGICAL STOICHIOMETRY; SESTON STOICHIOMETRY; GROWTH; POPULATION; INVASION; ZOOPLANKTON; ENERGY; NITROGEN	Background: Elemental imbalances of carbon (C): nitrogen (N): phosphorus (P) ratios in food resources can constrain the growth of grazers owning to tight coupling between growth rate, RNA allocation and biomass P content in animals. Testing for stoichiometric constraints among invasive species is a novel challenge in invasion ecology to unravel how a successful invader tackles ecological barriers in novel ecosystems. Methodology/Principal Findings: We examined the C:P and N:P ratios and the condition factor of a successful invader in lakes, the zebra mussel (Dreissena polymorpha), collected from two Swedish lakes. Concurrently, we analyzed the elemental composition of the food (seston) and tissue of the mussels in which nutrient composition of food and mussels varied over time. Zebra mussel condition factor was weakly related to the their own tissue N:P and C:P ratios, although the relation with the later ratio was not significant. Smaller mussels had relatively lower tissue N:P ratio and higher condition factor. There was no difference in C:P and N:P ratios between seston and mussels' tissues. Our results indicated that the variation in nutrient stoichiometry of zebra mussels can be explained by food quality and quantity. Conclusions/Significance: Our study suggests that fitness of invasive zebra mussels is not constrained by nutrient stoichiometry which is likely to be important for their proliferation in novel ecosystems. The lack of imbalance in C:P and N:P ratios between seston and mussels along with high tissue C:P ratio of the mussel allow them to tolerate potential P limitation and maintain high growth rate. Moreover, zebra mussels are able to change their tissue C:P and N:P ratios in response to the variation in elemental composition of their food. This can also help them to bypass potential nutrient stoichiometric constraints. Our finding is an important step towards understanding the mechanisms contributing to the success of exotic species from stoichiometric principles.			Naddafi, R (corresponding author), Uppsala Univ, Dept Ecol & Evolut Erken Lab, Evolutionary Biol Ctr, Norrtalje, Sweden.	rahmat.naddafi@ebc.uu.se						Acharya K, 2006, ARCH HYDROBIOL, V165, P433, DOI 10.1127/0003-9136/2006/0165-0433; Andersen T, 2004, ECOL LETT, V7, P884, DOI 10.1111/j.1461-0248.2004.00646.x; Arnott DL, 1996, CAN J FISH AQUAT SCI, V53, P646, DOI 10.1139/cjfas-53-3-646; Baker SM, 1998, J SHELLFISH RES, V17, P1207; Cote IM, 2002, SCIENCE, V298, P1181; Cotner JB, 1995, J GREAT LAKES RES, V21, P517, DOI 10.1016/S0380-1330(95)71063-2; Cox GW, 2004, ALIEN SPECIES EVOLUT; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Frost PC, 2002, ECOL LETT, V5, P232, DOI 10.1046/j.1461-0248.2002.00307.x; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd; Hessen DO, 2005, J PLANKTON RES, V27, P449, DOI 10.1093/plankt/fbi018; Hessen DO, 2002, ECOLOGY, V83, P1886, DOI 10.2307/3071772; HICKMAN RW, 1980, MAR BIOL, V60, P27, DOI 10.1007/BF00395603; Hillebrand H, 2001, LIMNOL OCEANOGR, V46, P1881, DOI 10.4319/lo.2001.46.8.1881; Holway DA, 1998, SCIENCE, V282, P949, DOI 10.1126/science.282.5390.949; Jantz B, 1998, OECOLOGIA, V114, P213, DOI 10.1007/s004420050439; Josefsson M, 2001, AMBIO, V30, P514, DOI 10.1639/0044-7447(2001)030[0514:TECOAS]2.0.CO;2; Kahlert M, 2002, FRESHWATER BIOL, V47, P1191, DOI 10.1046/j.1365-2427.2002.00844.x; Karatayev AY, 1997, J SHELLFISH RES, V16, P187; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lennon JT, 2003, OIKOS, V103, P191, DOI 10.1034/j.1600-0706.2003.12260.x; Liess A, 2005, J N AM BENTHOL SOC, V24, P256, DOI 10.1899/04-015.1; MACISAAC HJ, 1991, CAN J FISH AQUAT SCI, V48, P2051, DOI 10.1139/f91-244; MacIsaac HJ, 1996, AM ZOOL, V36, P287; Malmaeus JM, 2006, ECOL MODEL, V190, P1, DOI 10.1016/j.ecolmodel.2005.03.017; Miller TE, 2005, AM NAT, V165, P439, DOI 10.1086/428681; Mitra A, 2007, AM NAT, V169, P632, DOI 10.1086/513187; Moe SJ, 2005, OIKOS, V109, P29, DOI 10.1111/j.0030-1299.2005.14056.x; Naddafi R, 2008, LIMNOL OCEANOGR, V53, P1973, DOI 10.4319/lo.2008.53.5.1973; Naddafi R, 2007, OIKOS, V116, P1289, DOI 10.1111/j.2007.0030-1299.15695.x; Naddafi R, 2007, FRESHWATER BIOL, V52, P823, DOI 10.1111/j.1365-2427.2007.01732.x; NALEPA TF, 1991, HYDROBIOLOGIA, V219, P239, DOI 10.1007/BF00024758; NIX ER, 1995, MAR BIOL, V122, P605, DOI 10.1007/BF00350682; Peacor SD, 2006, PLOS BIOL, V4, P2112, DOI 10.1371/journal.pbio.0040372; Ptacnik R, 2005, OIKOS, V109, P52, DOI 10.1111/j.0030-1299.2005.14051.x; QIN P, 2007, LIMNOL OCEANOGR, V42, P1436; Roditi HA, 2000, NATURE, V407, P78, DOI 10.1038/35024069; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; SEIMANN E, 2007, J ECOL, V95, P689; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; SMAAL AC, 1990, HYDROBIOLOGIA, V195, P179, DOI 10.1007/BF00026822; Smolders R, 2004, ENVIRON POLLUT, V129, P99, DOI 10.1016/j.envpol.2003.09.027; Soto M, 2000, SCI TOTAL ENVIRON, V247, P175, DOI 10.1016/S0048-9697(99)00489-1; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sterner RW, 2008, LIMNOL OCEANOGR, V53, P1169, DOI 10.4319/lo.2008.53.3.1169; Sterner RW, 1997, AM NAT, V150, P663, DOI 10.1086/286088; STERNER RW, 1994, ANNU REV ECOL SYST, V25, P1, DOI 10.1146/annurev.es.25.110194.000245; Stoeckmann A, 2003, CAN J FISH AQUAT SCI, V60, P126, DOI 10.1139/F03-005; Stoeckmann A. M., 1994, American Zoologist, V34, p47A; Stoeckmann AM, 1997, CAN J FISH AQUAT SCI, V54, P2743, DOI 10.1139/cjfas-54-12-2743; THEBAULT H, 2005, RADIOPROTECTION, V140, pS47; Tilman D., 1982, Monographs in Population Biology, pi; Urabe J, 1997, LIMNOL OCEANOGR, V42, P1436, DOI 10.4319/lo.1997.42.6.1436; Vanderploeg HA, 2002, CAN J FISH AQUAT SCI, V59, P1209, DOI 10.1139/F02-087; Villar-Argaiz M, 2002, ECOLOGY, V83, P1899, DOI 10.2307/3071773; Voets J, 2006, AQUAT TOXICOL, V79, P213, DOI 10.1016/j.aquatox.2006.06.001; Vrede T, 2004, ECOLOGY, V85, P1217, DOI 10.1890/02-0249; Wacker A, 2003, OECOLOGIA, V135, P332, DOI 10.1007/s00442-003-1208-5; WALZ N, 1978, Archiv fuer Hydrobiologie Supplement, V55, P83; White T. C. R., 1993, INADEQUATE ENV NITRO; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Wu RSS, 1998, AQUACULTURE, V163, P47, DOI 10.1016/S0044-8486(98)00218-X	65	30	33	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5345	10.1371/journal.pone.0005345	http://dx.doi.org/10.1371/journal.pone.0005345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401773	Green Published, Green Submitted, gold			2022-12-27	WOS:000265601100006
J	Flowers, M; Thompson, PA				Flowers, Margaret; Thompson, Patricia A.			t10c12 Conjugated Linoleic Acid Suppresses HER2 Protein and Enhances Apoptosis in SKBr3 Breast Cancer Cells: Possible Role of COX2	PLOS ONE			English	Article								Background: HER2-targeted therapy with the monoclonal antibody trastuzumab (Herceptin (R)) has improved disease-free survival for women diagnosed with HER2-positive breast cancers; however, treatment resistance and disease progression are not uncommon. Current data suggest that resistance to treatment in HER2 cancers may be a consequence of NF-kappa B overexpression and increased COX2-derived prostaglandin E2 (PGE(2)). Conjugated linoleic acid (CLA) has been shown to have anti-tumor properties and to inhibit NF-kappa B activity and COX2. Methods: In this study, HER2-overexpressing SKBr3 breast cancer cells were treated with t10c12 CLA. Protein expression of the HER2 receptor, nuclear NF-kappa B p65, and total and phosphorylated I kappa B were examined by western blot and immunofluorescence. PGE2 levels were determined by ELISA. Proliferation was measured by metabolism of 3-(4, 5-Dimethylthiazol- 2-yl)-2, 5-diphenyltetrazolium bromide (MTT), and apoptosis was measured by FITC-conjugated Annexin V staining and flow cytometry. Results/Conclusions: We observed a significant decrease in HER2 protein expression on western blot following treatment with 40 and 80 mu M t10c12 CLA (p < 0.01 and 0.001, respectively) and loss of HER2 protein in cells using immunoflourescence that was most pronounced at 80 mM. Protein levels of nuclear NF-kappa B p65 were also significantly reduced at the 80 mM dose. This was accompanied by a significant decrease in PGE2 levels (p = 0.05). Pretreatment with t10c12 CLA significantly enhanced TNF alpha-induced apoptosis and the anti-proliferative action of trastuzumab (p = 0.05 and 0.001, respectively). These data add to previous reports of an anti-tumor effect of t10c12 CLA and suggest an effect on the HER2 oncogene that may be through CLA mediated downregulation of COX2-derived PGE(2).			Flowers, M (corresponding author), Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA.	mflowers@email.arizona.edu						Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ahmed KM, 2006, ANTICANCER RES, V26, P4235; Basu A, 2001, BIOCHEM BIOPH RES CO, V280, P883, DOI 10.1006/bbrc.2000.4209; Benoit V, 2004, ONCOGENE, V23, P1631, DOI 10.1038/sj.onc.1207295; Biswas DK, 2006, J CELL PHYSIOL, V209, P645, DOI 10.1002/jcp.20785; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Biswas DK, 2001, P NATL ACAD SCI USA, V98, P10386, DOI 10.1073/pnas.151257998; Biswas DK, 2003, CANCER RES, V63, P290; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Chapkin RS, 2008, BRIT J NUTR, V100, P1152, DOI 10.1017/S0007114508992576; Cheng WL, 2004, J AGR FOOD CHEM, V52, P71, DOI 10.1021/jf0348626; Cho HJ, 2005, WORLD J GASTROENTERO, V11, P5142; Cho HJ, 2003, AM J PHYSIOL-GASTR L, V284, pG996, DOI 10.1152/ajpgi.00347.2002; Citri A, 2004, CELL CYCLE, V3, P51; DANG CT, 2004, PHASE 2 STUDY CELECO, P4062; Degner SC, 2006, J NUTR, V136, P421, DOI 10.1093/jn/136.2.421; ESPARISOGANDO A, 2008, ANN ONCOL; Furstenberger G, 2006, INT J CANCER, V119, P2247, DOI 10.1002/ijc.22153; Griffin JD, 2001, BLOOD, V98, P2291, DOI 10.1182/blood.V98.8.2291a; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hardy DB, 2008, MOL ENDOCRINOL, V22, P1812, DOI 10.1210/me.2007-0443; Howe LR, 2002, CANCER RES, V62, P5405; HOWE LR, 2005, HER2 NEUINDUCED MAMM, P10113; Hwang DM, 2007, CARCINOGENESIS, V28, P363, DOI 10.1093/carcin/bgl151; Ip MM, 2007, CARCINOGENESIS, V28, P1269, DOI 10.1093/carcin/bgm018; Ip MM, 1999, EXP CELL RES, V250, P22, DOI 10.1006/excr.1999.4499; Iwakiri Y, 2002, PROSTAG LEUKOTR ESS, V67, P435, DOI 10.1054/plef.2002.0454; Kao J, 2006, GENE CHROMOSOME CANC, V45, P761, DOI 10.1002/gcc.20339; Kelley NS, 2007, J NUTR, V137, P2599, DOI 10.1093/jn/137.12.2599; Kemp MQ, 2003, J NUTR, V133, P3670; Kim BY, 2002, ONCOGENE, V21, P4490, DOI 10.1038/sj.onc.1205547; Kim DW, 2000, ONCOGENE, V19, P5498, DOI 10.1038/sj.onc.1203945; Kim JM, 2008, LAB INVEST, V88, P541, DOI 10.1038/labinvest.2008.16; Kordes U, 2000, LEUKEMIA, V14, P399, DOI 10.1038/sj.leu.2401705; Lee S, 2002, CANCER RES, V62, P5703; Li GM, 2005, J LIPID RES, V46, P2134, DOI 10.1194/jlr.M500064-JLR200; Lim DY, 2005, J CELL PHYSIOL, V205, P107, DOI 10.1002/jcp.20380; Ma DWL, 2002, NUTR CANCER, V44, P202, DOI 10.1207/S15327914NC4402_13; Majumder B, 2002, FASEB J, V16, P1447, DOI 10.1096/fj.01-0720fje; Mann M, 2001, GASTROENTEROLOGY, V120, P1713, DOI 10.1053/gast.2001.24844; Masso-Welch PA, 2002, CANCER RES, V62, P4383; Menendez JA, 2005, ANN ONCOL, V16, P359, DOI 10.1093/annonc/mdi090; MENG X, 2008, T10 C12 CONJUGATED L, P1013; Miller A, 2001, LIPIDS, V36, P1161, DOI 10.1007/s11745-001-0827-0; Moulder S, 2008, CLIN PHARMACOL THER, V83, P26, DOI 10.1038/sj.clpt.6100449; Myers RB, 1996, INT J CANCER, V69, P398, DOI 10.1002/(SICI)1097-0215(19961021)69:5<398::AID-IJC8>3.0.CO;2-0; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Ohtsu H, 2005, NUTR RES, V25, P655, DOI 10.1016/j.nutres.2005.05.008; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Palayoor ST, 1999, ONCOGENE, V18, P7389, DOI 10.1038/sj.onc.1203160; Pianetti S, 2001, ONCOGENE, V20, P1287, DOI 10.1038/sj.onc.1204257; Ross JS, 1998, STEM CELLS, V16, P413, DOI 10.1002/stem.160413; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Song HJ, 2006, PROSTATE, V66, P839, DOI 10.1002/pros.20351; Sroka IC, 2007, NEOPLASIA, V9, P406, DOI 10.1593/neo.07193; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; Subbaramaiah K, 2002, CANCER RES, V62, P2522; Valabrega G, 2007, ANN ONCOL, V18, P977, DOI 10.1093/annonc/mdl475; VAN AD, 1996, SCIENCE, V274, P787; Van Laere SJ, 2007, BRIT J CANCER, V97, P659, DOI 10.1038/sj.bjc.6603906; Wahle KWJ, 2004, PROG LIPID RES, V43, P553, DOI 10.1016/j.plipres.2004.08.002; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zhou BP, 2000, J BIOL CHEM, V275, P8027, DOI 10.1074/jbc.275.11.8027; Zhou F, 2007, IET RADAR SONAR NAV, V1, P59, DOI 10.1049/iet-rsn:20060040	68	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5342	10.1371/journal.pone.0005342	http://dx.doi.org/10.1371/journal.pone.0005342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399184	Green Published, gold, Green Submitted			2022-12-27	WOS:000265514900007
J	Mullauer, FB; Kessler, JH; Medema, JP				Mullauer, Franziska B.; Kessler, Jan H.; Medema, Jan Paul			Betulin Is a Potent Anti-Tumor Agent that Is Enhanced by Cholesterol	PLOS ONE			English	Article								Betulinic Acid (BetA) and its derivatives have been extensively studied in the past for their anti-tumor effects, but relatively little is known about its precursor Betulin ( BE). We found that BE induces apoptosis utilizing a similar mechanism as BetA and is prevented by cyclosporin A (CsA). BE induces cell death more rapidly as compared to BetA, but to achieve similar amounts of cell death a considerably higher concentration of BE is needed. Interestingly, we observed that cholesterol sensitized cells to BE-induced apoptosis, while there was no effect of cholesterol when combined with BetA. Despite the significantly enhanced cytotoxicity, the mode of cell death was not changed as CsA completely abrogated cell death. These results indicate that BE has potent anti-tumor activity especially in combination with cholesterol.			Mullauer, FB (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, LEXOR, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	J.P.Medema@amc.nl	Kessler, Jan/C-5559-2009	Medema, Jan Paul/0000-0003-3045-2924				Abe K, 1999, NEUROSCI RES, V35, P165, DOI 10.1016/S0168-0102(99)00048-6; Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; Ahmad S, 2006, INT J TOXICOL, V25, P17, DOI 10.1080/10915810500488361; Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006; Bi Y, 2007, BIOORG MED CHEM LETT, V17, P1475, DOI 10.1016/j.bmcl.2006.09.096; Cichewicz RH, 2004, MED RES REV, V24, P90, DOI 10.1002/med.10053; Colell A, 2003, J BIOL CHEM, V278, P33928, DOI 10.1074/jbc.M210943200; de Souza MT, 2007, Z NATURFORSCH C, V62, P550; Fulda S, 1997, CANCER RES, V57, P4956; Fulda S, 1998, CANCER RES, V58, P4453; Fulda S, 1998, J BIOL CHEM, V273, P33942, DOI 10.1074/jbc.273.51.33942; Fulda S, 2000, MED PEDIATR ONCOL, V35, P616, DOI 10.1002/1096-911X(20001201)35:6<616::AID-MPO27>3.0.CO;2-N; Gao HY, 2003, CHEM PHARM BULL, V51, P1318, DOI 10.1248/cpb.51.1318; Gauthier C, 2009, J NAT PROD, V72, P72, DOI 10.1021/np800579x; Gniadecki R, 2004, BIOCHEM BIOPH RES CO, V320, P165, DOI 10.1016/j.bbrc.2004.05.145; Grimm S, 2007, APOPTOSIS, V12, P841, DOI 10.1007/s10495-007-0747-3; Hata K, 2003, TOXICOL LETT, V143, P1, DOI 10.1016/S0378-4274(03)00092-4; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Jager S, 2008, MOLECULES, V13, P3224, DOI 10.3390/molecules13123224; Jeong HJ, 1999, BIOORG MED CHEM LETT, V9, P1201, DOI 10.1016/S0960-894X(99)00165-1; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kessler JH, 2007, CANCER LETT, V251, P132, DOI 10.1016/j.canlet.2006.11.003; Kim DSHL, 1998, BIOORG MED CHEM LETT, V8, P1707, DOI 10.1016/S0960-894X(98)00295-9; Kvasnica M, 2005, BIOORGAN MED CHEM, V13, P3447, DOI 10.1016/j.bmc.2005.03.006; Malorni W, 2007, APOPTOSIS, V12, P941, DOI 10.1007/s10495-007-0757-1; Mollinedo F, 2006, DRUG RESIST UPDATE, V9, P51, DOI 10.1016/j.drup.2006.04.002; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Muceniece R, 2008, PHARMACOL BIOCHEM BE, V90, P712, DOI 10.1016/j.pbb.2008.05.015; Mukherjee Rama, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P271, DOI 10.2174/187152006776930846; Mullauer FB, 2009, APOPTOSIS, V14, P191, DOI 10.1007/s10495-008-0290-x; Pyo JS, 2009, PLANTA MED, V75, P127, DOI 10.1055/s-0028-1088366; Rajendran P, 2008, INVEST NEW DRUG, V26, P25, DOI 10.1007/s10637-007-9081-4; Sarek J, 2005, BIOORG MED CHEM LETT, V15, P4196, DOI 10.1016/j.bmcl.2005.06.087; SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4; Tan YM, 2003, CLIN CANCER RES, V9, P2866; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wick W, 1999, J PHARMACOL EXP THER, V289, P1306; Yamashita K, 2002, CLIN CHIM ACTA, V325, P91, DOI 10.1016/S0009-8981(02)00252-8	39	55	55	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e1	10.1371/journal.pone.0005361	http://dx.doi.org/10.1371/journal.pone.0005361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399186	Green Published, gold, Green Submitted			2022-12-27	WOS:000265514900017
J	Diezmann, S; Dietrich, FS				Diezmann, Stephanie; Dietrich, Fred S.			Saccharomyces cerevisiae: Population Divergence and Resistance to Oxidative Stress in Clinical, Domesticated and Wild Isolates	PLOS ONE			English	Article								Background: Saccharomyces cerevisiae has been associated with human life for millennia in the brewery and bakery. Recently it has been recognized as an emerging opportunistic pathogen. To study the evolutionary history of S. cerevisiae, the origin of clinical isolates and the importance of a virulence-associated trait, population genetics and phenotypic assays have been applied to an ecologically diverse set of 103 strains isolated from clinics, breweries, vineyards, fruits, soil, commercial supplements and insect guts. Methodology/Principal Findings: DNA sequence data from five nuclear DNA loci were analyzed for population structure and haplotype distribution. Additionally, all strains were tested for survival of oxidative stress, a trait associated with microbial pathogenicity. DNA sequence analyses identified three genetic subgroups within the recombining S. cerevisiae strains that are associated with ecology, geography and virulence. Shared alleles suggest that the clinical isolates contain genetic contribution from the fruit isolates. Clinical and fruit isolates exhibit high levels of recombination, unlike the genetically homogenous soil isolates in which no recombination was detected. However, clinical and soil isolates were more resistant to oxidative stress than any other population, suggesting a correlation between survival in oxidative stress and yeast pathogenicity. Conclusions/Significance: Population genetic analyses of S. cerevisiae delineated three distinct groups, comprising primarily the (i) human-associated brewery and vineyard strains, (ii) clinical and fruit isolates (iii) and wild soil isolates from eastern U.S. The interactions between S. cerevisiae and humans potentiate yeast evolution and the development of genetically, ecologically and geographically divergent groups.			Diezmann, S (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA.	sd21@duke.edu		Diezmann, Stephanie/0000-0002-9528-1495				Aa E, 2006, FEMS YEAST RES, V6, P702, DOI 10.1111/j.1567-1364.2006.00059.x; ABSHIRE KZ, 1993, J BACTERIOL, V175, P3734, DOI 10.1128/JB.175.12.3734-3743.1993; Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aref H, 1934, J BACTERIOL, V27, P443, DOI 10.1128/JB.27.5.443-452.1934; AUCOTT JN, 1990, REV INFECT DIS, V12, P406; Bassetti S, 1998, AM J MED, V105, P71, DOI 10.1016/S0002-9343(98)00133-8; Bougnoux ME, 2003, J CLIN MICROBIOL, V41, P5265, DOI 10.1128/JCM.41.11.5265-5266.2003; Bulmer GS, 1999, MYCOPATHOLOGIA, V146, P117, DOI 10.1023/A:1007025212469; BURKE D, 2000, TECHNIQUES PROTOCOLS, V18, P205; CAPRIOTTI A, 1967, ARCH MIKROBIOL, V57, P406, DOI 10.1007/BF00416939; CAPRIOTTI A, 1954, ANTON LEEUW INT J G, V21, P145; Cavalieri D, 2003, J MOL EVOL, V57, pS226, DOI 10.1007/s00239-003-0031-2; Cesaro S, 2000, SUPPORT CARE CANCER, V8, P504, DOI 10.1007/s005200000123; CHERTOW GM, 1991, CHEST, V99, P1518, DOI 10.1378/chest.99.6.1518; CHIA JKS, 1995, CLIN INFECT DIS, V20, P1581, DOI 10.1093/clinids/20.6.1581; CIMOLAI N, 1987, DIAGN MICR INFEC DIS, V8, P113, DOI 10.1016/0732-8893(87)90158-1; CLEMONS KV, 1994, J INFECT DIS, V169, P859, DOI 10.1093/infdis/169.4.859; Clemons KV, 1996, J MED VET MYCOL, V34, P259; Diezmann S, 2004, J CLIN MICROBIOL, V42, P5624, DOI 10.1128/JCM.42.12.5624-5635.2004; Enache-Angoulvant A, 2005, CLIN INFECT DIS, V41, P1559, DOI 10.1086/497832; Esseiva P, 2005, TALANTA, V67, P360, DOI 10.1016/j.talanta.2005.03.041; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GARZA S, 1994, INT J FOOD MICROBIOL, V23, P209, DOI 10.1016/0168-1605(94)90053-1; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; HAZEN KC, 1995, CLIN MICROBIOL REV, V8, P462, DOI 10.1128/CMR.8.4.462; IYER GY, 1961, NATURE, V192, P535, DOI 10.1038/192535a0; Konecny P, 1999, INT J STD AIDS, V10, P821, DOI 10.1258/0956462991913475; Kvitek DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000223; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Maddison W, 1997, MACCLADE ANAL PHYLOG; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; McCullough MJ, 1998, J CLIN MICROBIOL, V36, P557, DOI 10.1128/JCM.36.2.557-562.1998; McCullough MJ, 1998, J CLIN MICROBIOL, V36, P2613, DOI 10.1128/JCM.36.9.2613-2617.1998; MCCUSKER JH, 1994, INFECT IMMUN, V62, P5447, DOI 10.1128/IAI.62.12.5447-5455.1994; MCCUSKER JH, 1994, GENETICS, V136, P1261; McCusker JH, 2006, MOLECULAR PRINCIPLES OF FUNGAL PATHOGENESIS, P245; McFarland LV, 1996, CLIN INFECT DIS, V22, P200, DOI 10.1093/clinids/22.1.200; McGovern PE, 2004, P NATL ACAD SCI USA, V101, P17593, DOI 10.1073/pnas.0407921102; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; MORTIMER RK, 1986, GENETICS, V113, P35; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; NAUMOV G, 1992, ANTON LEEUW INT J G, V61, P237, DOI 10.1007/BF00584230; Naumov GI, 1998, CAN J MICROBIOL, V44, P1045, DOI 10.1139/cjm-44-11-1045; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perlstein EO, 2006, CHEM BIOL, V13, P319, DOI 10.1016/j.chembiol.2006.01.010; Rea RB, 2004, INFECT IMMUN, V72, P717, DOI 10.1128/IAI.72.2.717-727.2004; Replansky T, 2008, TRENDS ECOL EVOL, V23, P494, DOI 10.1016/j.tree.2008.05.005; Riboulet E, 2007, J MOL MICROB BIOTECH, V13, P140, DOI 10.1159/000103605; ROUSE AL, 2007, EVOLUTION YEAST TRAN; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SBARRA AJ, 1959, J BIOL CHEM, V234, P1355; Skovgaard N, 2007, INT J FOOD MICROBIOL, V120, P217, DOI 10.1016/j.ijfoodmicro.2007.07.046; Smith D, 2002, J CLIN MICROBIOL, V40, P2691, DOI 10.1128/JCM.40.7.2691-2692.2002; Sniegowski Paul D., 2002, FEMS Yeast Research, V1, P299, DOI 10.1016/S1567-1356(01)00043-5; SOBEL JD, 1993, CLIN INFECT DIS, V16, P93, DOI 10.1093/clinids/16.1.93; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suh SO, 2005, MYCOL RES, V109, P261, DOI 10.1017/S0953756205002388; TAWFIK OW, 1989, J CLIN MICROBIOL, V27, P1689, DOI 10.1128/JCM.27.7.1689-1691.1989; TEMPLETON AR, 1992, GENETICS, V132, P619; TORASKAR MV, 1989, ACTA HORTIC, V231, P697; VAUGHANMARTINI A, 1995, J IND MICROBIOL, V14, P514, DOI 10.1007/BF01573967; Weger SD, 2002, MED MYCOL, V40, P161, DOI 10.1080/mmy.40.2.161.168; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Williams JS, 2007, CLIN EXP DERMATOL, V32, P395, DOI 10.1111/j.1365-2230.2007.02375.x; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922	72	71	72	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5317	10.1371/journal.pone.0005317	http://dx.doi.org/10.1371/journal.pone.0005317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390633	Green Submitted, Green Published, gold			2022-12-27	WOS:000265514400008
J	Cabrol, C; Huzarska, MA; Dinolfo, C; Rodriguez, MC; Reinstatler, L; Ni, J; Yeh, LA; Cuny, GD; Stein, RL; Selkoe, DJ; Leissring, MA				Cabrol, Christelle; Huzarska, Malwina A.; Dinolfo, Christopher; Rodriguez, Maria C.; Reinstatler, Lael; Ni, Jake; Yeh, Li-An; Cuny, Gregory D.; Stein, Ross L.; Selkoe, Dennis J.; Leissring, Malcolm A.			Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound Screening	PLOS ONE			English	Article								Background: Hypocatabolism of the amyloid beta-protein (A beta) by insulin-degrading enzyme (IDE) is implicated in the pathogenesis of Alzheimer disease (AD), making pharmacological activation of IDE an attractive therapeutic strategy. However, it has not been established whether the proteolytic activity of IDE can be enhanced by drug-like compounds. Methodology/Principal Findings: Based on the finding that ATP and other nucleotide polyphosphates modulate IDE activity at physiological concentrations, we conducted parallel high-throughput screening campaigns in the absence or presence of ATP and identified two compounds -designated Ia1 and Ia2 -that significantly stimulate IDE proteolytic activity. Both compounds were found to interfere with the crosslinking of a photoaffinity ATP analogue to IDE, suggesting that they interact with a bona fide ATP-binding domain within IDE. Unexpectedly, we observed highly synergistic activation effects when the activity of Ia1 or Ia2 was tested in the presence of ATP, a finding that has implications for the mechanisms underlying ATP-mediated activation of IDE. Notably, Ia1 and Ia2 activated the degradation of A beta by similar to 700% and similar to 400%, respectively, albeit only when A beta was presented in a mixture also containing shorter substrates. Conclusions/Significance: This study describes the first examples of synthetic small-molecule activators of IDE, showing that pharmacological activation of this important protease with drug-like compounds is achievable. These novel activators help to establish the putative ATP-binding domain as a key modulator of IDE proteolytic activity and offer new insights into the modulatory action of ATP. Several larger lessons abstracted from this screen will help inform the design of future screening campaigns and facilitate the eventual development of IDE activators with therapeutic utility.			Cabrol, C (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	Leissring@mayo.edu	LEISSRING, MALCOLM/AAW-5361-2021	LEISSRING, MALCOLM/0000-0001-7185-4255; Cuny, Gregory/0000-0002-3188-4748; Rodriguez Benavente, Maria/0000-0001-8484-251X	NATIONAL INSTITUTE ON AGING [R21AG030718, R01AG012749] Funding Source: NIH RePORTER; NIA NIH HHS [R21 AG030718, AG030718, R01 AG012749, AG012749] Funding Source: Medline; NIDA NIH HHS [R03 DA024888] Funding Source: Medline; PHS HHS [A024888] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Camberos MC, 2001, EXP BIOL MED, V226, P334, DOI 10.1177/153537020122600411; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hamel FG, 2003, ENDOCRINOLOGY, V144, P2404, DOI 10.1210/en.2002-0007; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Jacobsen JS, 2008, P NATL ACAD SCI USA, V105, P8754, DOI 10.1073/pnas.0710823105; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Leissring MA, 2007, ADV GENETICS MOL CEL, P157; Leissring MA, 2008, J BIOL CHEM, V283, P29645, DOI 10.1074/jbc.R800022200; Leissring MA, 2006, NATURE, V443, P761, DOI 10.1038/nature05210; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Neant-Fery M, 2008, P NATL ACAD SCI USA, V105, P9582, DOI 10.1073/pnas.0801261105; Prince JA, 2003, HUM MUTAT, V22, P363, DOI 10.1002/humu.10282; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Roth R.A., 2004, HDB PROTEOLYTIC ENZY, V2nd ed., P871; ROYCHAUDHURI R, 2008, J BIOL CHEM; Saric T, 2003, MOL CELL ENDOCRINOL, V204, P11, DOI 10.1016/S0303-7207(03)00154-0; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2005, J MOL NEUROSCI, V25, P201, DOI 10.1385/JMN:25:3:201; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2001, J BIOL CHEM, V276, P1152, DOI 10.1074/jbc.M008702200; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Walker LC, 2005, BIOCHEM PHARMACOL, V69, P1001, DOI 10.1016/j.bcp.2004.12.015; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4	35	56	58	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5274	10.1371/journal.pone.0005274	http://dx.doi.org/10.1371/journal.pone.0005274			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384407	Green Published, Green Submitted, gold			2022-12-27	WOS:000265513900015
J	Gartner, T; Steinfath, M; Andorf, S; Lisec, J; Meyer, RC; Altmann, T; Willmitzer, L; Selbig, J				Gaertner, Tanja; Steinfath, Matthias; Andorf, Sandra; Lisec, Jan; Meyer, Rhonda C.; Altmann, Thomas; Willmitzer, Lothar; Selbig, Joachim			Improved Heterosis Prediction by Combining Information on DNA- and Metabolic Markers	PLOS ONE			English	Article								Background: Hybrids represent a cornerstone in the success story of breeding programs. The fundamental principle underlying this success is the phenomenon of hybrid vigour, or heterosis. It describes an advantage of the offspring as compared to the two parental lines with respect to parameters such as growth and resistance against abiotic or biotic stress. Dominance, overdominance or epistasis based models are commonly used explanations. Conclusion/Significance: The heterosis level is clearly a function of the combination of the parents used for offspring production. This results in a major challenge for plant breeders, as usually several thousand combinations of parents have to be tested for identifying the best combinations. Thus, any approach to reliably predict heterosis levels based on properties of the parental lines would be highly beneficial for plant breeding. Methodology/Principal Findings: Recently, genetic data have been used to predict heterosis. Here we show that a combination of parental genetic and metabolic markers, identified via feature selection and minimum-description-length based regression methods, significantly improves the prediction of biomass heterosis in resulting offspring. These findings will help furthering our understanding of the molecular basis of heterosis, revealing, for instance, the presence of nonlinear genotype-phenotype relationships. In addition, we describe a possible approach for accelerated selection in plant breeding.			Gartner, T (corresponding author), Univ Potsdam, Dept Bioinformat, Inst Biochem & Biol, Potsdam, Germany.	selbig@mpimp-golm.mpg.de	Meyer, Rhonda/X-7393-2019; Willmitzer, Lothar/F-7377-2011	Andorf, Sandra/0000-0002-3093-2568; Lisec, Jan/0000-0003-1220-2286; Meyer, Rhonda C./0000-0002-6210-4900; Altmann, Thomas/0000-0002-3759-360X				Barone A, 2004, AM J POTATO RES, V81, P111, DOI 10.1007/BF02853608; CHARLESWORTH B, 1992, AM NAT, V140, P126, DOI 10.1086/285406; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Crow J. F., 1952, Heterosis., P282; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Dubcovsky J, 2004, CROP SCI, V44, P1895, DOI 10.2135/cropsci2004.1895; Duvick DN, 2001, NAT REV GENET, V2, P69, DOI 10.1038/35047587; Eriksson L., 2001, MULTI MEGAVARIATE DA; Gehringer A, 2007, BREEDING SCI, V57, P315, DOI 10.1270/jsbbs.57.315; Hageman R. H., 1988, Corn and corn improvement. Third edition., P431; KACSER H, 1981, GENETICS, V97, P639; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Kusterer B, 2007, GENETICS, V175, P2009, DOI 10.1534/genetics.106.069005; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lisec J, 2008, PLANT J, V53, P960, DOI 10.1111/j.1365-313X.2007.03383.x; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; MANGELSDORF AJ, 1952, HETEROSIS, P321; Melchinger AE, 2007, GENETICS, V177, P1815, DOI 10.1534/genetics.107.077537; Melchinger AE, 2007, GENETICS, V177, P1827, DOI [10.1534/genetics.107.080564, 10.1534/genetics.107.084871]; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Miedaner T, 2002, PLANT BREEDING, V121, P475, DOI 10.1046/j.1439-0523.2002.00765.x; Ofori A, 2008, BIOENERG RES, V1, P98, DOI 10.1007/s12155-008-9001-2; Panella L, 2007, EUPHYTICA, V154, P383, DOI 10.1007/s10681-006-9209-1; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; R Development Core Team, 2007, R LANG ENV STAT COMP; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Schrader L., 1985, EXPLOITATION PHYSL G, P79; Schrag TA, 2006, THEOR APPL GENET, V113, P1037, DOI 10.1007/s00122-006-0363-6; Schrag TA, 2007, THEOR APPL GENET, V114, P1345, DOI 10.1007/s00122-007-0521-5; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHULL GH, 1948, GENETICS, V33, P439; THORBURN WM, 1915, MIND, V24, P287, DOI DOI 10.1093/MIND/XXIV.2.287; Torjek O, 2003, PLANT J, V36, P122, DOI 10.1046/j.1365-313X.2003.01861.x; Torjek O, 2006, THEOR APPL GENET, V113, P1551, DOI 10.1007/s00122-006-0402-3; VIRMANI SS, 1994, MONOGRAPHS THEORETIC, V22, P142; Vuylsteke M, 2000, HEREDITY, V85, P208, DOI 10.1046/j.1365-2540.2000.00747.x; Waaijenborg S, 2008, STAT APPL GENET MOL, V7; Wold H., 1975, PERSPECTIVES PROBABI, P520; Yang J, 2005, THEOR APPL GENET, V110, P1268, DOI 10.1007/s00122-005-1963-2; Young ND, 1999, MOL BREEDING, V5, P505	41	39	42	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5220	10.1371/journal.pone.0005220	http://dx.doi.org/10.1371/journal.pone.0005220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370148	Green Published, gold, Green Submitted			2022-12-27	WOS:000265510600004
J	Eriksson, MK; Franks, PW; Eliasson, M				Eriksson, Margareta K.; Franks, Paul W.; Eliasson, Mats			A 3-Year Randomized Trial of Lifestyle Intervention for Cardiovascular Risk Reduction in the Primary Care Setting: The Swedish Bjorknas Study	PLOS ONE			English	Article							DIABETES PREVENTION PROGRAM; PRIMARY-HEALTH-CARE; PHYSICAL-ACTIVITY; GLYCEMIC CONTROL; FOLLOW-UP; EXERCISE; OVERWEIGHT; WOMEN; PRESCRIPTION; METAANALYSIS	Background: Successfully transferring the findings of expensive and tightly controlled programmes of intensive lifestyle modification to the primary care setting is necessary if such knowledge is to be of clinical utility. The objective of this study was to test whether intensive lifestyle modification, shown previously in tightly-controlled clinical trials to be efficacious for diabetes risk-reduction among high-risk individuals, can reduce cardiovascular risk factor levels in the primary care setting. Methodology/Principal Findings: The Swedish Bjorknas study was a randomized controlled trial conducted from 2003 to 2006 with follow-up on cardiovascular risk factors at 3, 12, 24 and 36 months. A total of 151 middle-aged men and women at moderate-to high-risk of cardiovascular disease from northern Sweden were randomly assigned to either an intensive lifestyle intervention (n = 75) or control (n = 76) group. The intervention was based broadly on the protocol of the Diabetes Prevention Program. The three-month intervention period was administered in the primary care setting and consisted of supervised exercise sessions and diet counselling, followed by regular group meetings during three years. The control group was given general advice about diet and exercise and received standard clinical care. Outcomes were changes in anthropometrics, aerobic fitness, self-reported physical activity, blood pressure, and metabolic traits. At 36 months post-randomisation, intensive lifestyle modification reduced waist circumference (-2.2 cm: p = 0.001), waist-hip ratio (-0.02: p < 0.0001), systolic blood pressure (-4.9 mmHg: p = 0.036), and diastolic blood pressure (-1.6 mmHg: p = 0.005), and improved aerobic fitness (5%; p = 0.038). Changes in lipid or glucose values did not differ statistically between groups. At 36 months, self-reported time spent exercising and total physical activity had increased more in the intervention group than in the control group (p < 0.001). Conclusion/Significance: A program of intensive lifestyle modification undertaken in the primary health care setting can favourably influence cardiovascular risk-factor profiles in high-risk individuals.			Eriksson, MK (corresponding author), Bjorknas Primary Hlth Care Ctr, Boden, Sweden.	margareta.Eriksson@nll.se	Franks, Paul/AAA-3300-2020	Eriksson, Margareta K/0000-0001-8963-2247; Franks, Paul/0000-0002-0520-7604				Ackermann RT, 2008, AM J PREV MED, V35, P357, DOI 10.1016/j.amepre.2008.06.035; Albright A, 2000, MED SCI SPORT EXER, V32, P1345; ASTRAND I, 1960, ACTA PHYSIOL SCAND S, V169, P1; Bassuk SS, 2005, J APPL PHYSIOL, V99, P1193, DOI 10.1152/japplphysiol.00160.2005; Becker W., 2004, Scandinavian Journal of Nutrition, V48, P178, DOI 10.1080/1102680410003794; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218; Christian JG, 2008, ARCH INTERN MED, V168, P141, DOI 10.1001/archinternmed.2007.13; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Di Loreto C, 2005, DIABETES CARE, V28, P1295, DOI 10.2337/diacare.28.6.1295; Edelstein SL, 2005, DIABETES CARE, V28, P138, DOI 10.2337/diacare.28.1.138; Eriksson KM, 2006, SCAND J PUBLIC HEALT, V34, P453, DOI 10.1080/14034940500489826; Foster C., 2005, COCHRANE DB SYST REV, V1, P1, DOI 10.1002/14651858.cd003180.pub2; Franks PW., 2007, CAN J DIABETES, V31, P242; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Hellenius ML, 2005, SCAND J PRIM HEALTH, V23, P75, DOI 10.1080/02813430510018365; Herman WH, 2003, DIABETES CARE, V26, P3182, DOI 10.2337/diacare.26.11.3182; Holme I, 2007, J INTERN MED, V262, P235, DOI 10.1111/j.1365-2796.2007.01806.x; Johnson JL, 2007, AM J CARDIOL, V100, P1759, DOI 10.1016/j.amjcard.2007.07.027; Kallings LV, 2008, SCAND J MED SCI SPOR, V18, P154, DOI 10.1111/j.1600-0838.2007.00678.x; Ketola E, 2001, BRIT J GEN PRACT, V51, P291; Kirk A, 2004, DIABETOLOGIA, V47, P821, DOI 10.1007/s00125-004-1396-5; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Laaksonen DE, 2005, DIABETES, V54, P158, DOI 10.2337/diabetes.54.1.158; Lawton BA, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2509; Lindgren P, 2007, INT J TECHNOL ASSESS, V23, P177, DOI 10.1017/S0266462307070286; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Montori V, 2007, BMJ-BRIT MED J, V334, P882, DOI 10.1136/bmj.39169.447488.94; Mozaffarian D, 2008, CIRCULATION, V117, P3031, DOI 10.1161/CIRCULATIONAHA.107.738732; Muto T, 2001, PREV MED, V33, P571, DOI 10.1006/pmed.2001.0923; Nilsson PM, 2001, SCAND J WORK ENV HEA, V27, P57, DOI 10.5271/sjweh.587; Noonan V, 2000, PHYS THER, V80, P782, DOI 10.1093/ptj/80.8.782; Norris SL, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004096.pub2, 10.1002/14651858.CD004095.pub2, 10.1002/14651858.CD005270]; Orozco LJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003054.pub3; Payne WR, 2008, DIABETES CARE, V31, P2244, DOI 10.2337/dc08-0152; PONTILLO AE, 2003, JAMA-J AM MED ASSOC, V14, P1799; PROSHASKA JO, 1994, ADV EXERCISE ADHEREN, P161; Ruge Toralph, 2007, Diabetes Care, V30, pe61, DOI 10.2337/dc06-2466; Seidel MC, 2008, DIABETES CARE, V31, P684, DOI 10.2337/dc07-1869; Shaw K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003817.pub3; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Slentz CA, 2005, J APPL PHYSIOL, V99, P1613, DOI 10.1152/japplphysiol.00124.2005; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Yamaoka K, 2005, DIABETES CARE, V28, P2780, DOI 10.2337/diacare.28.11.2780; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	46	86	87	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2009	4	4							e5195	10.1371/journal.pone.0005195	http://dx.doi.org/10.1371/journal.pone.0005195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TO	19365563	Green Published, Green Submitted, gold			2022-12-27	WOS:000265510000003
J	Kok, K; Nock, GE; Verrall, EAG; Mitchell, MP; Hommes, DW; Peppelenbosch, MP; Vanhaesebroeck, B				Kok, Klaartje; Nock, Gemma E.; Verrall, Elizabeth A. G.; Mitchell, Michael P.; Hommes, Daan W.; Peppelenbosch, Maikel P.; Vanhaesebroeck, Bart			Regulation of p110 delta PI 3-Kinase Gene Expression	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTION FACTOR; BREAST-CANCER; MICE LACKING; SKELETAL-MUSCLE; ADIPOSE-TISSUE; B-CELL; EMBRYONIC LETHALITY; CATALYTIC SUBUNIT	Background: Despite an intense interest in the biological functions of the phosphoinositide 3-kinase (PI3K) signalling enzymes, little is known about the regulation of PI3K gene expression. This also applies to the leukocyte-enriched p110 delta catalytic subunit of PI3K, an enzyme that has attracted widespread interest because of its role in immunity and allergy. Principal Findings: We show that p110 delta expression is mainly regulated at the transcriptional level. In fibroblasts, lymphocytes and myeloid cells, p110 delta gene transcription appears to be constitutive and not subject to acute stimulation. 5'RACE experiments revealed that p110 delta mRNA transcripts contain distinct upstream untranslated exons (named exon -1, -2a, -2b, -2c and -2d), which are located up to 81 kb upstream of the translational start codon in exon 1. The levels of all the different p110 delta transcripts are higher in leukocytes compared to non-leukocytes, with the p110 delta transcript containing exon -2a most abundantly expressed. We have identified a highly conserved transcription factor (TF) binding cluster in the p110 delta gene which has enhanced promoter activity in leukocytes compared to non-leukocytes. In human, this TF cluster is located immediately upstream of exon -2a whilst in mouse, it is located within exon -2a. Conclusion: This study identifies a conserved PIK3CD promoter region that may account for the predominant leukocyte expression of delta.			Kok, K (corresponding author), Queen Mary Univ London, Inst Canc, Ctr Cell Signalling, Charterhouse Sq, London, England.	bart.vanh@qmul.ac.uk		Peppelenbosch, Maikel/0000-0001-9112-6028	MRC [G0800914, G0700755] Funding Source: UKRI; Medical Research Council [G0700755, G0800914] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abell K, 2005, NAT CELL BIOL, V7, P392, DOI 10.1038/ncb1242; Alloatti G, 2005, FEBS LETT, V579, P133, DOI 10.1016/j.febslet.2004.11.059; Andreelli F, 1999, DIABETOLOGIA, V42, P358, DOI 10.1007/s001250051163; Astanehe A, 2008, J CELL SCI, V121, P664, DOI 10.1242/jcs.013029; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Baier R, 1999, CELL GROWTH DIFFER, V10, P447; Barbier M, 2001, NATURE, V413, P796, DOI 10.1038/35101660; Barbour LA, 2004, ENDOCRINOLOGY, V145, P1144, DOI 10.1210/en.2003-1297; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Billottet C, 2009, CANCER RES, V69, P1027, DOI 10.1158/0008-5472.CAN-08-2608; Birney E., 2007, NATURE, V447, P799, DOI [10.1038/nature05874, DOI 10.1038/NATURE05874]; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Brickner AG, 1995, GENE, V167, P261, DOI 10.1016/0378-1119(95)00673-7; Buggy Y, 2006, EUR J CANCER, V42, P485, DOI 10.1016/j.ejca.2005.10.018; Buratowski S, 2008, SCIENCE, V322, P1804, DOI 10.1126/science.1168805; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chantry D, 1997, J BIOL CHEM, V272, P19236, DOI 10.1074/jbc.272.31.19236; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Clayton E, 2001, BIOCHEM BIOPH RES CO, V280, P1328, DOI 10.1006/bbrc.2001.4281; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; De Boer ML, 1999, INT J BIOCHEM CELL B, V31, P1221, DOI 10.1016/S1357-2725(99)00069-2; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Eickholt BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000869; Furlan A, 2008, J CELL PHYSIOL, V215, P782, DOI 10.1002/jcp.21360; Gebeshuber CA, 2007, CELLS TISSUES ORGANS, V185, P51, DOI 10.1159/000101303; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Geiman TM, 2002, J CELL BIOCHEM, V87, P117, DOI 10.1002/jcb.10286; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; GUO C, 2008, GENES CHROMOSOMES CA; Hart A, 2000, IMMUNITY, V13, P167, DOI 10.1016/S1074-7613(00)00017-0; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hirsch E, 2000, GENE, V256, P69, DOI 10.1016/S0378-1119(00)00328-0; HU P, 1993, MOL CELL BIOL, V13, P7677, DOI 10.1128/MCB.13.12.7677; HUI RC, 2008, MOL CELL BIOL; Ito Y, 1996, MOL BRAIN RES, V37, P329; Iwama A, 1998, NUCLEIC ACIDS RES, V26, P3034, DOI 10.1093/nar/26.12.3034; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Jin ZX, 2002, J IMMUNOL, V169, P3783, DOI 10.4049/jimmunol.169.7.3783; Kallin A, 2007, J LIPID RES, V48, P1628, DOI 10.1194/jlr.M700136-JLR200; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; KOK K, 2008, TRENDS BIOC IN PRESS; Krugmann S, 1999, J BIOL CHEM, V274, P17152, DOI 10.1074/jbc.274.24.17152; Laville M, 1996, J CLIN INVEST, V98, P43, DOI 10.1172/JCI118775; Lefai E, 2001, BIOCHEM J, V360, P117, DOI 10.1042/0264-6021:3600117; LEIDEN JM, 1994, CURR OPIN IMMUNOL, V6, P231, DOI 10.1016/0952-7915(94)90096-5; Li LX, 2006, ENDOCRINOLOGY, V147, P3318, DOI 10.1210/en.2006-0155; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; MacDonald PE, 2004, ENDOCRINOLOGY, V145, P4078, DOI 10.1210/en.2004-0028; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Northcott CA, 2005, CLIN EXP PHARMACOL P, V32, P851, DOI 10.1111/j.1440-1681.2010.04276.x; Northcott CA, 2004, HYPERTENSION, V43, P885, DOI 10.1161/01.HYP.0000118518.20331.e8; Northcott CA, 2002, CIRC RES, V91, P360, DOI 10.1161/01.RES.0000030861.13850.F1; Ogilvy S, 1998, BLOOD, V91, P419, DOI 10.1182/blood.V91.2.419.419_419_430; Okamotoa T, 2004, MOL BRAIN RES, V131, P119, DOI 10.1016/j.molbrainres.2004.08.015; Okkenhaug K, 2002, SCIENCE, V297, P1031; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Pankow S, 2006, J CELL SCI, V119, P4033, DOI 10.1242/jcs.03175; PARK SY, 2008, NAT STRUCT MOL BIOL; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Puri KD, 2005, BLOOD, V106, P150, DOI 10.1182/blood-2005-01-0023; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; Ravindranath A, 2008, CURR MOL MED, V8, P38; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; Sawyer C, 2003, CANCER RES, V63, P1667; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shestakova E, 2001, J VIROL, V75, P3444, DOI 10.1128/JVI.75.7.3444-3452.2001; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Span PN, 2002, ONCOGENE, V21, P8506, DOI 10.1038/sj.onc.1206040; Spender LC, 2006, J GEN VIROL, V87, P2859, DOI 10.1099/vir.0.82128-0; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Teschendorff AE, 2007, PLOS COMPUT BIOL, V3, P1539, DOI 10.1371/journal.pcbi.0030161; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Vecchione C, 2005, J EXP MED, V201, P1217, DOI 10.1084/jem.20040995; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; Yang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001758; Zhang H, 2005, J BIOL CHEM, V280, P43188, DOI 10.1074/jbc.M506598200	94	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5145	10.1371/journal.pone.0005145	http://dx.doi.org/10.1371/journal.pone.0005145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357769	Green Submitted, Green Published, gold			2022-12-27	WOS:000265505900013
J	Beider, K; Abraham, M; Begin, M; Wald, H; Weiss, ID; Wald, O; Pikarsky, E; Abramovitch, R; Zeira, E; Galun, E; Nagler, A; Peled, A				Beider, Katia; Abraham, Michal; Begin, Michal; Wald, Hanna; Weiss, Ido D.; Wald, Ori; Pikarsky, Eli; Abramovitch, Rinat; Zeira, Evelyne; Galun, Eithan; Nagler, Arnon; Peled, Amnon			Interaction between CXCR4 and CCL20 Pathways Regulates Tumor Growth	PLOS ONE			English	Article								The chemokine receptor CXCR4 and its ligand CXCL12 is overexpressed in the majority of tumors and is critically involved in the development and metastasis of these tumors. CXCR4 is expressed in malignant tumor cells whereas its ligand SDF-1 (CXCL12) is expressed mainly by cancer associated fibroblasts (CAF). Similarly to CXCR4, the chemokine CCL20 is overexpressed in variety of tumors; however its role and regulation in tumors is not fully clear. Here, we show that the chemokine receptor CXCR4 stimulates the production of the chemokine CCL20 and that CCL20 stimulates the proliferation and adhesion to collagen of various tumor cells. Furthermore, overexpression of CCL20 in tumor cells promotes growth and adhesion in vitro and increased tumor growth and invasiveness in vivo. Moreover, neutralizing antibodies to CCL20 inhibit the in vivo growth of tumors that either overexpress CXCR4 or CCL20 or naturally express CCL20. These results reveal a role for CCL20 in CXCR4-dependent and -independent tumor growth and suggest a therapeutic potential for CCL20 and CCR6 antagonists in the treatment of CXCR4- and CCL20-dependent malignancies.	[Beider, Katia; Abraham, Michal; Begin, Michal; Wald, Hanna; Weiss, Ido D.; Wald, Ori; Abramovitch, Rinat; Zeira, Evelyne; Galun, Eithan; Peled, Amnon] Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Pikarsky, Eli] Hadassah Hebrew Univ Hosp, Dept Pathol, Jerusalem, Israel; [Abramovitch, Rinat] Hadassah Hebrew Univ Hosp, HBRC, MRI Lab, Jerusalem, Israel; [Nagler, Arnon] Chaim Sheba Med Ctr, Bone Marrow Transplant Dept, Tel Hashomer, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Chaim Sheba Medical Center	Beider, K (corresponding author), Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	arnon.nagler@sheba.health.gov.il; peled@hadassah.org.il	pikarsky, eli/GXV-7099-2022; Galun, Eithan/AAD-9117-2022	Galun, Eithan/0000-0002-6243-6702; pikarsky, eli/0000-0003-4186-7105	Prostate Cancer Fund (PCF), USA; Israeli Science Foundation (ISF)	Prostate Cancer Fund (PCF), USA; Israeli Science Foundation (ISF)(Israel Science Foundation)	This work was supported by the Prostate Cancer Fund (PCF), USA, and the Israeli Science Foundation (ISF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelder RE, 2002, CANCER RES, V62, P7203; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill F, 2003, SEMIN IMMUNOL, V15, P49, DOI 10.1016/S1044-5323(02)00127-6; Barash H, 2007, RADIOLOGY, V243, P727, DOI 10.1148/radiol.2433060433; Barbero S, 2003, CANCER RES, V63, P1969; Bell D, 1999, J EXP MED, V190, P1417, DOI 10.1084/jem.190.10.1417; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bonnotte B, 2004, J IMMUNOL, V173, P4929, DOI 10.4049/jimmunol.173.8.4929; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Charbonnier AS, 1999, J EXP MED, V190, P1755, DOI 10.1084/jem.190.12.1755; Dagan-Berger M, 2006, BLOOD, V107, P3821, DOI 10.1182/blood-2004-01-0214; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fushimi T, 2000, J CLIN INVEST, V105, P1383, DOI 10.1172/JCI7548; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; Ghadjar P, 2008, J CANCER RES CLIN, V134, P1181, DOI 10.1007/s00432-008-0403-5; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Hieshima K, 1997, J BIOL CHEM, V272, P5846, DOI 10.1074/jbc.272.9.5846; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Kleeff J, 1999, INT J CANCER, V81, P650, DOI 10.1002/(SICI)1097-0215(19990517)81:4<650::AID-IJC23>3.0.CO;2-#; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Liang ZX, 2004, CANCER RES, V64, P4302, DOI 10.1158/0008-5472.CAN-03-3958; Liang ZX, 2005, CANCER RES, V65, P967; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; Peng SB, 2005, MOL CANCER RES, V3, P227; Rubie C, 2006, SCAND J IMMUNOL, V63, P468, DOI 10.1111/j.1365-3083.2006.001766.x; Rubie C, 2006, TUMOR BIOL, V27, P166, DOI 10.1159/000092777; Soriano SF, 2003, EUR J IMMUNOL, V33, P1328, DOI 10.1002/eji.200323897; Spiegel A, 2004, BLOOD, V103, P2900, DOI 10.1182/blood-2003-06-1891; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Sugita S, 2002, J IMMUNOL, V168, P5621, DOI 10.4049/jimmunol.168.11.5621; Sun YX, 2005, J BONE MINER RES, V20, P318, DOI 10.1359/JBMR.041109; Taichman RS, 2002, CANCER RES, V62, P1832; Tanaka Y, 1999, EUR J IMMUNOL, V29, P633, DOI 10.1002/(SICI)1521-4141(199902)29:02<633::AID-IMMU633>3.0.CO;2-I; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	40	59	62	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5125	10.1371/journal.pone.0005125	http://dx.doi.org/10.1371/journal.pone.0005125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340288	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500700020
J	Landgrebe, M; Frick, U; Hauser, S; Hajak, G; Langguth, B				Landgrebe, Michael; Frick, Ulrich; Hauser, Simone; Hajak, Goeran; Langguth, Berthold			Association of Tinnitus and Electromagnetic Hypersensitivity: Hints for a Shared Pathophysiology?	PLOS ONE			English	Article							AUDITORY-CORTEX; FIELD EXPOSURE; ANTICIPATION; EXCITABILITY; SYMPTOMS	Background: Tinnitus is a frequent condition with high morbidity and impairment in quality of life. The pathophysiology is still incompletely understood. Electromagnetic fields are discussed to be involved in the multi-factorial pathogenesis of tinnitus, but data proofing this relationship are very limited. Potential health hazards of electromagnetic fields (EMF) have been under discussion for long. Especially, individuals claiming themselves to be electromagnetic hypersensitive suffer from a variety of unspecific symptoms, which they attribute to EMF-exposure. The aim of the study was to elucidate the relationship between EMF-exposure, electromagnetic hypersensitivity and tinnitus using a case-control design. Methodology: Tinnitus occurrence and tinnitus severity were assessed by questionnaires in 89 electromagnetic hypersensitive patients and 107 controls matched for age-, gender, living surroundings and workplace. Using a logistic regression approach, potential risk factors for the development of tinnitus were evaluated. Findings: Tinnitus was significantly more frequent in the electromagnetic hypersensitive group (50.72% vs. 17.5%) whereas tinnitus duration and severity did not differ between groups. Electromagnetic hypersensitivity and tinnitus were independent risk factors for sleep disturbances. However, measures of individual EMF-exposure like e. g. cell phone use did not show any association with tinnitus. Conclusions: Our data indicate that tinnitus is associated with subjective electromagnetic hypersensitivity. An individual vulnerability probably due to an over activated cortical distress network seems to be responsible for, both, electromagnetic hypersensitivity and tinnitus. Hence, therapeutic efforts should focus on treatment strategies (e. g. cognitive behavioral therapy) aiming at normalizing this dysfunctional distress network.	[Landgrebe, Michael; Frick, Ulrich; Hauser, Simone; Hajak, Goeran; Langguth, Berthold] Univ Regensburg, Dept Psychiat Psychosomat & Psychotherapy, Regensburg, Germany; [Frick, Ulrich] Carinthia Univ Appl Sci, Feldkirchen, Austria	University of Regensburg	Landgrebe, M (corresponding author), Univ Regensburg, Dept Psychiat Psychosomat & Psychotherapy, Regensburg, Germany.	michael.landgrebe@medbo.de	Langguth, Berthold/AAP-2638-2021		German Federal Ministry for the Environment; Nature Conservation; Nuclear Safety [StSch 4357]; Tinnitus Research Initiative	German Federal Ministry for the Environment; Nature Conservation; Nuclear Safety; Tinnitus Research Initiative	This study has been supported by a grant from the German Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety (UFOPLAN project StSch 4357) and the Tinnitus Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold W, 1996, ORL J OTO-RHINO-LARY, V58, P195, DOI 10.1159/000276835; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; Davidson HC, 2007, INT J AUDIOL, V46, P113, DOI 10.1080/14992020600690472; Dobie RA, 1999, LARYNGOSCOPE, V109, P1202, DOI 10.1097/00005537-199908000-00004; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eulitz C, 1998, NEUROREPORT, V9, P3229, DOI 10.1097/00001756-199810050-00018; Frick U, 2005, BIOELECTROMAGNETICS, V26, P287, DOI 10.1002/bem.20085; Frick U, 2006, UMWELTMEDIZIN FORSCH, V11, P11; Giraud AL, 1999, NEUROREPORT, V10, P1, DOI 10.1097/00001756-199901180-00001; Hardell L, 2003, NEUROEPIDEMIOLOGY, V22, P124, DOI 10.1159/000068745; Hillert L, 1999, J PSYCHOSOM RES, V47, P429, DOI 10.1016/S0022-3999(99)00048-3; Hillert L, 1998, PSYCHOTHER PSYCHOSOM, V67, P302, DOI 10.1159/000012295; Hillert L, 2007, HUM BRAIN MAPP, V28, P172, DOI 10.1002/hbm.20266; Hoffman H., 2004, TINNITUS THEORY MANA, P16; Kleinjung T, 2007, PSYCHIAT PRAX, V34, pS140, DOI 10.1055/s-2006-940218; Krause CM, 2007, BIOELECTROMAGNETICS, V28, P296, DOI 10.1002/bem.20300; Landgrebe M, 2008, PSYCHOL MED, V38, P1781, DOI 10.1017/S0033291708003097; Landgrebe M, 2008, NEUROIMAGE, V41, P1336, DOI 10.1016/j.neuroimage.2008.04.171; Landgrebe M, 2007, J PSYCHOSOM RES, V62, P283, DOI 10.1016/j.jpsychores.2006.11.007; Langguth B, 2007, PROG BRAIN RES, V166, P221, DOI 10.1016/S0079-6123(07)66020-8; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Lyskov E, 2001, BIOELECTROMAGNETICS, V22, P457, DOI 10.1002/bem.73; Lyskov E, 2001, INT J PSYCHOPHYSIOL, V42, P233, DOI 10.1016/S0167-8760(01)00141-6; Maby E, 2004, MED BIOL ENG COMPUT, V42, P562, DOI 10.1007/BF02351000; Maier R, 2004, ACTA NEUROL SCAND, V110, P46, DOI 10.1111/j.1600-0404.2004.00260.x; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Moller AR, 2003, OTOLARYNG CLIN N AM, V36, P249, DOI 10.1016/S0030-6665(02)00170-6; Mortazavi SMJ, 2007, BIOELECTROMAGNETICS, V28, P326, DOI 10.1002/bem.20305; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Nelson C.B., 2001, SCORING WORLD HLTH O; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Nittby H, 2008, BIOELECTROMAGNETICS, V29, P219, DOI 10.1002/bem.20386; Papageorgioua CC, 2006, NEUROSCI LETT, V397, P99, DOI 10.1016/j.neulet.2005.12.001; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Roosli M, 2004, INT J HYG ENVIR HEAL, V207, P141, DOI 10.1078/1438-4639-00269; Rubin GJ, 2005, PSYCHOSOM MED, V67, P224, DOI 10.1097/01.psy.0000155664.13300.64; Rubin GJ, 2006, PSYCHOTHER PSYCHOSOM, V75, P12, DOI 10.1159/000089222; Sandstrom M, 2003, INT J PSYCHOPHYSIOL, V49, P227, DOI 10.1016/S0167-8760(03)00145-4; SCHLEE W, 2008, SEMINARS HE IN PRESS; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wassermann EM, 2001, BIOL PSYCHIAT, V50, P377, DOI 10.1016/S0006-3223(01)01210-0; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007	45	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e5026	10.1371/journal.pone.0005026	http://dx.doi.org/10.1371/journal.pone.0005026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PO	19325894	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499600008
J	Bartelt, RR; Cruz-Orcutt, N; Collins, M; Houtman, JCD				Bartelt, Rebekah R.; Cruz-Orcutt, Noemi; Collins, Michaela; Houtman, Jon C. D.			Comparison of T Cell Receptor-Induced Proximal Signaling and Downstream Functions in Immortalized and Primary T Cells	PLOS ONE			English	Article								Background: Human T cells play an important role in pathogen clearance, but their aberrant activation is also linked to numerous diseases. T cells are activated by the concurrent induction of the T cell receptor (TCR) and one or more costimulatory receptors. The characterization of signaling pathways induced by TCR and/or costimulatory receptor activation is critical, since these pathways are excellent targets for novel therapies for human disease. Although studies using human T cell lines have provided substantial insight into these signaling pathways, no comprehensive, direct comparison of these cell lines to activated peripheral blood T cells (APBTs) has been performed to validate their usefulness as a model of primary T cells. Methodology/Principal Findings: We used quantitative biochemical techniques to compare the activation of two widely used human T cell lines, Jurkat E6.1 and HuT78 T cells, to APBTs. We found that HuT78 cells were similar to APBTs in proximal TCR-mediated signaling events. In contrast, Jurkat E6.1 cells had significantly increased site-specific phosphorylation of Pyk2, PLC gamma 1, Vav1, and Erk1/Erk2 and substantially more Ca(2+) flux compared to HuT78 cells and APBTs. In part, these effects appear to be due to an overexpression of Itk in Jurkat E6.1 cells compared to HuT78 cells and APBTs. Both cell lines differ from APBTs in the expression and function of costimulatory receptors and in the range of cytokines and chemokines released upon TCR and costimulatory receptor activation. Conclusions/Significance: Both Jurkat E6.1 and HuT78 T cells had distinct similarities and differences compared to APBTs. Both cell lines have advantages and disadvantages, which must be taken into account when choosing them as a model T cell line.			Bartelt, RR (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	jon-houtman@uiowa.edu		Houtman, Jon/0000-0002-5307-9854				Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Arimura Y, 2008, MOL IMMUNOL, V45, P3074, DOI 10.1016/j.molimm.2008.03.019; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bisset LR, 2005, CURR OPIN PULM MED, V11, P35, DOI 10.1097/01.mcp.0000144502.50149.e0; Bogin Y, 2007, P NATL ACAD SCI USA, V104, P6638, DOI 10.1073/pnas.0609771104; Bunn PA, 1996, J CELL BIOCHEM, P12; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Couriel D, 2004, CANCER-AM CANCER SOC, V101, P1936, DOI 10.1002/cncr.20613; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Di Bartolo V, 1999, J BIOL CHEM, V274, P6285, DOI 10.1074/jbc.274.10.6285; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; FINGER LR, 1988, P NATL ACAD SCI USA, V85, P9158, DOI 10.1073/pnas.85.23.9158; Freeburn RW, 2002, J IMMUNOL, V169, P5441, DOI 10.4049/jimmunol.169.10.5441; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Houtman JCD, 2005, FEBS J, V272, P5426, DOI 10.1111/j.1742-4658.2005.04972.x; Houtman JCD, 2005, J IMMUNOL, V175, P2449, DOI 10.4049/jimmunol.175.4.2449; Howard Laurence M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P205, DOI 10.2174/1568010053586228; Inman BA, 2007, CURR CANCER DRUG TAR, V7, P15, DOI 10.2174/156800907780006878; Irvin BJ, 2000, MOL CELL BIOL, V20, P9149, DOI 10.1128/MCB.20.24.9149-9161.2000; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Monaco Claudia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P35, DOI 10.2174/1568010043483881; Nel AE, 2002, J ALLERGY CLIN IMMUN, V109, P758, DOI 10.1067/mai.2002.124259; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Ostergaard HL, 2005, IMMUNOL RES, V31, P267, DOI 10.1385/IR:31:3:267; QI Q, 2007, SCI STKE, pPE39; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; SEMINARIO MC, 2004, EUR J IMMUN IN PRESS, V34; Serrano CJ, 2005, J IMMUNOL, V174, P6233, DOI 10.4049/jimmunol.174.10.6233; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Uddin S, 2004, BIOCHEM BIOPH RES CO, V320, P932, DOI 10.1016/j.bbrc.2004.06.038; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Wu JN, 2004, SEMIN IMMUNOL, V16, P379, DOI 10.1016/j.smim.2004.08.018; Zeremski M, 2007, J VIRAL HEPATITIS, V14, P675, DOI 10.1111/j.1365-2893.2006.00838.x; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	40	56	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2009	4	5							e5430	10.1371/journal.pone.0005430	http://dx.doi.org/10.1371/journal.pone.0005430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440RC	19412549	Green Published, Green Submitted, gold			2022-12-27	WOS:000265716400003
J	Velazquez-Perez, L; Diaz, R; Perez-Gonzalez, R; Canales, N; Rodriguez-Labrada, R; Medrano, J; Sanchez, G; Almaguer-Mederos, L; Torres, C; Fernandez-Ruiz, J				Velazquez-Perez, Luis; Diaz, Rosalinda; Perez-Gonzalez, Ruth; Canales, Nalia; Rodriguez-Labrada, Roberto; Medrano, Jacquelin; Sanchez, Gilberto; Almaguer-Mederos, Luis; Torres, Cira; Fernandez-Ruiz, Juan			Motor Decline in Clinically Presymptomatic Spinocerebellar Ataxia Type 2 Gene Carriers	PLOS ONE			English	Article								Background: Motor deficits are a critical component of the clinical characteristics of patients with spinocerebellar ataxia type 2. However, there is no current information on the preclinical manifestation of those motor deficits in presymptomatic gene carriers. To further understand and characterize the onset of the clinical manifestation in this disease, we tested presymptomatic spinocerebellar ataxia type 2 gene carriers, and volunteers, in a task that evaluates their motor performance and their motor learning capabilities. Methods and Findings: 28 presymptomatic spinocerebellar ataxia type 2 gene carriers and an equal number of control volunteers matched for age and gender participated in the study. Both groups were tested in a prism adaptation task known to be sensible to both motor performance and visuomotor learning deficits. Our results clearly show that although motor learning capabilities are intact, motor performance deficits are present even years before the clinical manifestation of the disease start. Conclusions: The results show a clear deficit in motor performance that can be detected years before the clinical onset of the disease. This motor performance deficit appears before any motor learning or clinical manifestations of the disease. These observations identify the performance coefficient as an objective and quantitative physiological biomarker that could be useful to assess the efficiency of different therapeutic agents.			Velazquez-Perez, L (corresponding author), Ctr Invest & Rehabil Ataxias Hereditarias, Holguin, Cuba.	jfr@servidor.unam.mx	Mederos, Luis Almaguer/G-8625-2016; Velázquez-Pérez, Luis/AAM-4460-2020; RodrÃguez-Labrada, Roberto/AAM-1692-2020; Fernandez-Ruiz, Juan/B-6154-2012	Mederos, Luis Almaguer/0000-0003-0887-2359; Fernandez-Ruiz, Juan/0000-0002-4038-0904; Rodriguez-Labrada, Roberto/0000-0003-3193-7683				Blekher TM, 2004, VISION RES, V44, P2729, DOI 10.1016/j.visres.2004.06.006; Christova P, 2008, ARCH NEUROL-CHICAGO, V65, P530, DOI 10.1001/archneur.65.4.530; deBoo GM, 1997, ARCH NEUROL-CHICAGO, V54, P1353, DOI 10.1001/archneur.1997.00550230030012; Denny-Brown D., 1982, HDB NEUROLOGICAL EXA; Durr A, 1995, BRAIN, V118, P1573, DOI 10.1093/brain/118.6.1573; Farrow M, 2006, COGN BEHAV NEUROL, V19, P208, DOI 10.1097/01.wnn.0000213914.64772.b6; Feigin A, 2006, ANN NEUROL, V59, P53, DOI 10.1002/ana.20684; Fernandez-Ruiz J, 1999, LEARN MEMORY, V6, P47; Fernandez-Ruiz J, 2003, NEUROREPORT, V14, P1339, DOI 10.1097/01.wnr.0000077551.91466.d3; Fernandez-Ruiz J, 2007, NEUROPSYCHOLOGIA, V45, P2692, DOI 10.1016/j.neuropsychologia.2007.04.006; Fox NC, 1998, BRAIN, V121, P1631, DOI 10.1093/brain/121.9.1631; Geschwind DH, 1997, AM J HUM GENET, V60, P842; Globas C, 2008, MOVEMENT DISORD, V23, P2232, DOI 10.1002/mds.22288; Inagaki A, 2005, EUR J NEUROL, V12, P725, DOI 10.1111/j.1468-1331.2005.01011.x; Larsson M, 2006, J CLIN EXP NEUROPSYC, V28, P1373, DOI 10.1080/13803390500473746; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; OROZCO G, 1989, J NEUROL SCI, V93, P37, DOI 10.1016/0022-510X(89)90159-7; Pang JT, 2002, BRAIN, V125, P656, DOI 10.1093/brain/awf060; Perez LV, 2007, J NEUROL SCI, V263, P158, DOI 10.1016/j.jns.2007.07.013; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Rosa AL, 2006, MOVEMENT DISORD, V21, P66, DOI 10.1002/mds.20636; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; Siemers E, 1996, ARCH NEUROL-CHICAGO, V53, P487, DOI 10.1001/archneur.1996.00550060029011; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; Velazquez-Perez L, 2004, ANN NEUROL, V56, P444, DOI 10.1002/ana.20220; Velazquez-Perez L, 2006, J NEUROL, V253, P1165, DOI 10.1007/s00415-006-0183-2; Verny C, 2007, EUR J NEUROL, V14, P1344, DOI 10.1111/j.1468-1331.2007.01975.x; Wahlin TBR, 2007, NEUROPSYCHOLOGY, V21, P31, DOI 10.1037/0894-4105.21.1.31; Wolf RC, 2007, BRAIN, V130, P2845, DOI 10.1093/brain/awm210	30	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5398	10.1371/journal.pone.0005398	http://dx.doi.org/10.1371/journal.pone.0005398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401771	gold, Green Published, Green Submitted			2022-12-27	WOS:000265601100025
J	Kalb, SR; Lou, JL; Garcia-Rodriguez, C; Geren, IN; Smith, TJ; Moura, H; Marks, JD; Smith, LA; Pirkle, JL; Barr, JR				Kalb, Suzanne R.; Lou, Jianlong; Garcia-Rodriguez, Consuelo; Geren, Isin N.; Smith, Theresa J.; Moura, Hercules; Marks, James D.; Smith, Leonard A.; Pirkle, James L.; Barr, John R.			Extraction and Inhibition of Enzymatic Activity of Botulinum Neurotoxins/A1, /A2, and /A3 by a Panel of Monoclonal Anti-BoNT/A Antibodies	PLOS ONE			English	Article								Botulinum neurotoxins (BoNTs) are extremely potent toxins that are capable of causing death or respiratory failure leading to long-term intensive care. Treatment includes serotype-specific antitoxins, which must be administered early in the course of the intoxication. Rapidly determining human exposure to BoNT is an important public health goal. In previous work, our laboratory focused on developing Endopep-MS, a mass spectrometry-based endopeptidase method for detecting and differentiating BoNT/A-G serotypes in buffer and BoNT/A, /B, /E, and /F in clinical samples. We have previously reported the effectiveness of antibody-capture to purify and concentrate BoNTs from complex matrices, such as clinical samples. Because some antibodies inhibit or neutralize the activity of BoNT, the choice of antibody with which to extract the toxin is critical. In this work, we evaluated a panel of 16 anti-BoNT/A monoclonal antibodies (mAbs) for their ability to inhibit the in vitro activity of BoNT/A1, /A2, and /A3 complex as well as the recombinant LC of A1. We also evaluated the same antibody panel for the ability to extract BoNT/A1, /A2, and /A3. Among the mAbs, there were significant differences in extraction efficiency, ability to extract BoNT/A subtypes, and inhibitory effect on BoNT catalytic activity. The mAbs binding the C-terminal portion of the BoNT/A heavy chain had optimal properties for use in the Endopep-MS assay.			Kalb, SR (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30333 USA.	jbarr@cdc.gov	Geren, Isin/AAG-7281-2019	Geren, Isin/0000-0001-7777-1450; Kalb, Suzanne/0000-0002-8067-136X				Amersdorfer P, 1997, INFECT IMMUN, V65, P3743, DOI 10.1128/IAI.65.9.3743-3752.1997; Amersdorfer P, 2002, VACCINE, V20, P1640, DOI 10.1016/S0264-410X(01)00482-0; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Barr JR, 2005, EMERG INFECT DIS, V11, P1578, DOI 10.3201/eid1110.041279; Boyer AE, 2005, ANAL CHEM, V77, P3916, DOI 10.1021/ac050485f; Centers for Disease Control and Prevention, 1998, HDB EPID CLIN LAB WO; DIBELLO IC, 1994, EUR J BIOCHEM, V219, P161; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; Gaunt PS, 2007, J VET DIAGN INVEST, V19, P349, DOI 10.1177/104063870701900402; GEREN IN, J MOL BIOL UNPUB; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Jensen MJ, 2003, TOXICON, V41, P691, DOI 10.1016/S0041-0101(03)00042-4; Kalb SR, 2006, ANAL BIOCHEM, V351, P84, DOI 10.1016/j.ab.2006.01.027; Kalb SR, 2005, ANAL CHEM, V77, P6140, DOI 10.1021/ac0511748; Kalb SR, 2008, INT J MASS SPECTROM, V278, P101, DOI 10.1016/j.ijms.2008.04.004; KAUTTER DA, 1977, J ASSOC OFF ANA CHEM, V60, P541; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Mah DCW, 2003, HYBRIDOMA HYBRIDOM, V22, P277, DOI 10.1089/153685903322538791; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Pless DD, 2001, INFECT IMMUN, V69, P570, DOI 10.1128/IAI.69.1.570-574.2001; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SHONE C, 1985, APPL ENVIRON MICROB, V50, P63, DOI 10.1128/AEM.50.1.63-67.1985; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005	28	53	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5355	10.1371/journal.pone.0005355	http://dx.doi.org/10.1371/journal.pone.0005355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399171	Green Published, gold			2022-12-27	WOS:000265514900015
J	Radhakrishnan, S; Cabrera, R; Bruns, KM; Van Keulen, VP; Hansen, MJ; Felts, SJ; Pease, LR				Radhakrishnan, Suresh; Cabrera, Rosalyn; Bruns, Kristina M.; Van Keulen, Virginia P.; Hansen, Michael J.; Felts, Sara J.; Pease, Larry R.			Indirect Recruitment of a CD40 Signaling Pathway in Dendritic Cells by B7-DC Cross-Linking Antibody Modulates T Cell Functions	PLOS ONE			English	Article								The human IgM B7-DC XAb protects mice from tumors in both therapeutic and prophylactic settings. Its mechanism of action is mediated by its binding to B7-DC/PD-L2 molecules on the surface of dendritic cells (DCs) to induce a multimolecular cap and subsequent activation of signaling cascades that determine a unique combination of DC phenotypes. One such phenotype, the B7-DC XAb-induced antigen accumulation in mTLR-matured DCs, has been linked to signaling through TREM-2, but the signals required for other DC phenotypes critical for the therapeutic effects in animal models remain unclear. Here, FRET and co-immunoprecipitation studies show that CD40 is recruited to the multi-molecular complex by B7-DC XAb. Signals emanating from CD40 are important, as CD40(-/-) DCs treated with B7-DC XAb (DC XAb) activated DAP12, but failed to activate NFkB, and were not protected from cell death upon cytokine withdrawal or treatment with Vitamin D-3. CD40(-/-) DC XAb also failed to secrete IL-6 and were unable to support the conversion of T regulatory cells into IL-17+ effector T cells in vitro. Importantly, the expression of CD40 was required for the overall ability of B7-DC XAb to induce anti-tumor CTL, to provide protection from a number of tumor types, and for DC XAb to be effective anti-tumor vaccines in vivo. These results indicate that B7-DC XAb modulation of DC phenotypes is through its ability to indirectly recruit common signaling molecules and elements of their endogenous signaling pathways through targeted binding to a cell-specific surface determinant.			Radhakrishnan, S (corresponding author), Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA.	pease.larry@mayo.edu			NATIONAL CANCER INSTITUTE [R01CA104996, R56CA104996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077296] Funding Source: NIH RePORTER; NCI NIH HHS [R56 CA104996, R01 CA104996, CA104996-05] Funding Source: Medline; NHLBI NIH HHS [R01 HL077296, HL077296-3] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baccam M, 2003, J IMMUNOL, V170, P3099, DOI 10.4049/jimmunol.170.6.3099; Benson RJ, 2006, EUR J IMMUNOL, V36, P2535, DOI 10.1002/eji.200535483; Bishop GA, 2007, ADV EXP MED BIOL, V597, P131; Block MS, 2001, J IMMUNOL, V167, P821, DOI 10.4049/jimmunol.167.2.821; Blocki FA, 2006, FASEB J, V20, P2408, DOI 10.1096/fj.06-6171fje; Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Deambrosis I, 2005, INT J IMMUNOPATH PH, V18, P327, DOI 10.1177/039463200501800215; Heckman KL, 2007, EUR J IMMUNOL, V37, P1827, DOI 10.1002/eji.200637002; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kaisho T, 2008, TRENDS IMMUNOL, V29, P329, DOI 10.1016/j.it.2008.03.005; Kikuchi T, 2000, BLOOD, V96, P91, DOI 10.1182/blood.V96.1.91.013k19_91_99; Mann J, 2002, J BIOL CHEM, V277, P17125, DOI 10.1074/jbc.M109250200; Mazouz Naima, 2002, Cancer Immun, V2, P2; Nguyen LT, 2002, J EXP MED, V196, P1393, DOI 10.1084/jem.20021466; O'Sullivan BJ, 2002, J IMMUNOL, V168, P5491, DOI 10.4049/jimmunol.168.11.5491; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Pavelko KD, 2008, CANCER RES, V68, P2471, DOI 10.1158/0008-5472.CAN-07-5937; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Radhakrishnan S, 2005, J ALLERGY CLIN IMMUN, V116, P668, DOI 10.1016/j.jaci.2005.04.038; Radhakrishnan S, 2005, P NATL ACAD SCI USA, V102, P11438, DOI 10.1073/pnas.0501420102; Radhakrishnan S, 2004, J IMMUNOL, V173, P1360, DOI 10.4049/jimmunol.173.2.1360; Radhakrishnan S, 2004, CANCER RES, V64, P4965, DOI 10.1158/0008-5472.CAN-03-3025; Radhakrishnan S, 2003, J IMMUNOL, V170, P1830, DOI 10.4049/jimmunol.170.4.1830; Radhakrishnan S, 2008, J IMMUNOL, V181, P3137, DOI 10.4049/jimmunol.181.5.3137; Radhakrishnan S, 2007, J IMMUNOL, V178, P1426, DOI 10.4049/jimmunol.178.3.1426; Radhakrishnan S, 2008, J IMMUNOL, V181, P7863, DOI 10.4049/jimmunol.181.11.7863; Song W, 1997, J EXP MED, V186, P1247, DOI 10.1084/jem.186.8.1247; Van Keulen VP, 2006, CLIN EXP IMMUNOL, V143, P314, DOI 10.1111/j.1365-2249.2005.02992.x; Vonderheide RH, 2007, J CLIN ONCOL, V25, P876, DOI 10.1200/JCO.2006.08.3311; Yu QG, 2003, J IMMUNOL, V170, P1797, DOI 10.4049/jimmunol.170.4.1797; Zhu Jiye, 2002, Zhonghua Wai Ke Za Zhi, V40, P1	35	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5373	10.1371/journal.pone.0005373	http://dx.doi.org/10.1371/journal.pone.0005373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399172	Green Submitted, Green Published, gold			2022-12-27	WOS:000265514900022
J	Romanowska, M; Evans, A; Kellock, D; Bray, SE; McLean, K; Donandt, S; Foerster, J				Romanowska, Malgorzata; Evans, Alan; Kellock, David; Bray, Susan E.; McLean, Kathleen; Donandt, Susanne; Foerster, John			Wnt5a Exhibits Layer-Specific Expression in Adult Skin, Is Upregulated in Psoriasis, and Synergizes with Type 1 Interferon	PLOS ONE			English	Article								Background: Wnt5a is a member of the wingless-type patterning regulators important in pre-natal development. The expression and distribution of Wnt5a and its receptors frizzled (fzd) 3 and fzd 5 in adult human skin have not been comprehensively studied to date. Methodology/Principal Findings: We here show that Wnt5a, fzd3, fzd5, as well as fzd6 are restricted to specific layers in normal epidermis, analogous to their zonal distribution in hair follicles, suggesting a role in adult skin differentiation. In line, Wnt5a and fzd5 are both overexpressed and re-distributed in the epidermis of psoriasis which involves disturbed keratinocyte differentiation. Functionally, Wnt5a lowers the concentration of IFN required to induce target genes, and increases the magnitude of IFN target gene induction, suggesting a molecular mechanism underlying IFN hypersensitivity in psoriasis. Finally, we identify nedd8 and the amyloid precursor APP, previously shown to be upregulated in psoriasis, as targets of synergistic IFN alpha/Wnt5a induction. Conclusions/Significance: The present data (i) suggest that Wnt5a regulates epidermal differentiation even in adult skin and (ii) identify synergistic induction of type 1 IFN target genes as a novel mode of Wnt5a action. Targeting Wnt5a in the skin may reduce IFN hypersensitivity and be of therapeutical value.			Romanowska, M (corresponding author), Univ Dundee, Div Expt Med, Dundee, Scotland.	j.foerster@dundee.ac.uk			Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Al Yacoub N, 2007, J GENE MED, V9, P579, DOI 10.1002/jgm.1052; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Cheng CW, 2008, BIOCHEM BIOPH RES CO, V365, P285, DOI 10.1016/j.bbrc.2007.10.166; Downs AMR, 2000, CLIN EXP DERMATOL, V25, P351, DOI 10.1046/j.1365-2230.2000.00655-4.x; Eriksen KW, 2005, J INVEST DERMATOL, V125, P936, DOI 10.1111/j.0022-202X.2005.23864.x; Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157; Hampton PJ, 2007, BRIT J DERMATOL, V157, P1168, DOI 10.1111/j.1365-2133.2007.08195.x; Herzog V, 2004, EUR J CELL BIOL, V83, P613, DOI 10.1078/0171-9335-00401; Hida S, 2000, IMMUNITY, V13, P643, DOI 10.1016/S1074-7613(00)00064-9; Hung BS, 2001, J INVEST DERMATOL, V116, P940, DOI 10.1046/j.1523-1747.2001.01336.x; Ito M, 2004, J DERMATOL SCI, V36, P157, DOI 10.1016/j.jdermsci.2004.08.012; Katoh M, 2007, INT J MOL MED, V19, P273; KAWASAKI A, 2007, CELL SIGNAL; Kowalzick L, 1997, J AM ACAD DERMATOL, V36, P501, DOI 10.1016/S0190-9622(97)80248-4; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Murphy LLS, 2002, J IMMUNOL, V169, P3717, DOI 10.4049/jimmunol.169.7.3717; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Reddy ST, 2004, J INVEST DERMATOL, V123, P275, DOI 10.1111/j.0022-202X.2004.23215.x; Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; Safholm A, 2008, CLIN CANCER RES, V14, P6556, DOI 10.1158/1078-0432.CCR-08-0711; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sen M, 2001, ARTHRITIS RHEUM, V44, P772, DOI 10.1002/1529-0131(200104)44:4<772::AID-ANR133>3.3.CO;2-C; Siemes C, 2004, J INVEST DERMATOL, V123, P556, DOI 10.1111/j.0022-202X.2004.23320.x; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Wang S, 2004, FOREST POLICY ECON, V6, P205, DOI 10.1016/j.forpol.2004.03.004; Wolf R, 1999, ADV EXP MED BIOL, V455, P221; YU JM, 2007, CANC LETT	38	49	53	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5354	10.1371/journal.pone.0005354	http://dx.doi.org/10.1371/journal.pone.0005354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399181	gold, Green Submitted, Green Published			2022-12-27	WOS:000265514900014
J	MacKenzie, S; Ribas, L; Pilarczyk, M; Capdevila, DM; Kadri, S; Huntingford, FA				MacKenzie, Simon; Ribas, Laia; Pilarczyk, Maciej; Capdevila, Davinia Morera; Kadri, Sunil; Huntingford, Felicity A.			Screening for Coping Style Increases the Power of Gene Expression Studies	PLOS ONE			English	Article							BEHAVIORAL SYNDROMES; FISH; TEMPERAMENT; STRESS	Background: Individuals of many vertebrate species show different stress coping styles and these have a striking influence on how gene expression shifts in response to a variety of challenges. Principal Findings: This is clearly illustrated by a study in which common carp displaying behavioural predictors of different coping styles (characterised by a proactive, adrenaline-based or a reactive, cortisol-based response) were subjected to inflammatory challenge and specific gene transcripts measured in individual brains. Proactive and reactive fish differed in baseline gene expression and also showed diametrically opposite responses to the challenge for 80% of the genes investigated. Significance: Incorporating coping style as an explanatory variable can account for some the unexplained variation that is common in gene expression studies, can uncover important effects that would otherwise have passed unnoticed and greatly enhances the interpretive value of gene expression data.			MacKenzie, S (corresponding author), Univ Autonoma Barcelona, Unitat Fisiol Anim, Dept Biol Cellular Fisiol & Immunol, Fac Biociencies, E-08193 Barcelona, Spain.	Simon.MacKenzie@uab.es	MacKenzie, Simon/Q-2362-2019; Ribas, Laia/E-1466-2013	MacKenzie, Simon/0000-0003-1845-6826; Ribas, Laia/0000-0001-5538-6236				Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Cossins AR, 2005, NAT REV GENET, V6, P324, DOI 10.1038/nrg1590; Crawford DL, 2007, J EXP BIOL, V210, P1613, DOI 10.1242/jeb.005454; Cubitt K.F., 2008, PHYSL BEHAV; Garcia-Castillo J, 2002, IMMUNOGENETICS, V54, P200, DOI 10.1007/s00251-002-0451-y; Goetz FW, 2008, FISH FISH, V9, P378, DOI 10.1111/j.1467-2979.2008.00301.x; HESSING MJC, 1993, APPL ANIM BEHAV SCI, V37, P285, DOI 10.1016/0168-1591(93)90118-9; Iliev DB, 2005, FEBS LETT, V579, P6519, DOI 10.1016/j.febslet.2005.10.061; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Larsen PF, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-12; Larsen PF, 2007, MOL ECOL, V16, P4674, DOI 10.1111/j.1365-294X.2007.03530.x; MacKenzie S, 2004, IMMUNOGENETICS, V56, P611, DOI 10.1007/s00251-004-0698-6; Malmkvist J, 2002, ANIM BEHAV, V64, P487, DOI 10.1006/anbe.2002.3058; Martin JGA, 2008, ANIM BEHAV, V75, P309, DOI 10.1016/j.anbehav.2007.05.026; Oleksiak MF, 2005, NAT GENET, V37, P67, DOI 10.1038/ng1483; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Overli O, 2006, PHYSIOL BEHAV, V87, P506, DOI 10.1016/j.physbeh.2005.11.012; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Reale D, 2003, ANIM BEHAV, V65, P463, DOI 10.1006/anbe.2003.2100; Saeij JPJ, 2003, DEV COMP IMMUNOL, V27, P29, DOI 10.1016/S0145-305X(02)00064-2; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; van Hierden YM, 2002, APPL ANIM BEHAV SCI, V77, P183, DOI 10.1016/S0168-1591(02)00046-1; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13	29	56	57	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5314	10.1371/journal.pone.0005314	http://dx.doi.org/10.1371/journal.pone.0005314			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390591	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000265514200024
J	Xiridou, M; Borkent-Raven, B; Hulshof, J; Wallinga, J				Xiridou, Maria; Borkent-Raven, Barbara; Hulshof, Joost; Wallinga, Jacco			How Hepatitis D Virus Can Hinder the Control of Hepatitis B Virus	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; MATHEMATICAL-MODEL; INFECTION; TUBERCULOSIS; IMPACT; HIV; COINFECTION; COEXISTENCE; PERSISTENCE; PREVALENCE	Background: Hepatitis D (or hepatitis delta) virus is a defective virus that relies on hepatitis B virus (HBV) for transmission; infection with hepatitis D can occur only as coinfection with HBV or superinfection of an existing HBV infection. Because of the bond between the two viruses, control measures for HBV may have also affected the spread of hepatitis D, as evidenced by the decline of hepatitis D in recent years. Since the presence of hepatitis D is associated with suppressed HBV replication and possibly infectivity, it is reasonable to speculate that hepatitis D may facilitate the control of HBV. Methodology and Principal Findings: We introduced a mathematical model for the transmission of HBV and hepatitis D, where individuals with dual HBV and hepatitis D infection transmit both viruses. We calculated the reproduction numbers of single HBV infections and dual HBV and hepatitis D infections and examined the endemic prevalences of the two viruses. The results show that hepatitis D virus modulates not only the severity of the HBV epidemic, but also the impact of interventions for HBV. Surprisingly we find that the presence of hepatitis D virus may hamper the eradication of HBV. Interventions that aim to reduce the basic reproduction number of HBV below one may not be sufficient to eradicate the virus, as control of HBV depends also on the reproduction numbers of dual infections. Conclusions and Significance: For populations where hepatitis D is endemic, plans for control programs ignoring the presence of hepatitis D may underestimate the HBV epidemic and produce overoptimistic results. The current HBV surveillance should be augmented with monitoring of hepatitis D, in order to improve accuracy of the monitoring and the efficacy of control measures.			Xiridou, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	maria.xiridou@rivm.nl	Wallinga, Jacco/C-4382-2018	Wallinga, Jacco/0000-0003-1725-5627				Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Boots M, 2007, SCIENCE, V315, P1284, DOI 10.1126/science.1137126; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Currie CSM, 2003, AIDS, V17, P2501, DOI 10.1097/00002030-200311210-00013; Davidovich U, 2000, AIDS, V14, P701, DOI 10.1097/00002030-200004140-00009; EDMUNDS WJ, 1993, P ROY SOC B-BIOL SCI, V253, P197, DOI 10.1098/rspb.1993.0102; Edmunds WJ, 1996, STAT MED, V15, P2215, DOI 10.1002/(SICI)1097-0258(19961030)15:20&lt;2215::AID-SIM369&gt;3.0.CO;2-2; Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790; GAETA G, 2002, HEPATOLOGY, V32, P824; HADLER SC, 1984, ANN INTERN MED, V100, P339, DOI 10.7326/0003-4819-100-3-339; Inoue J, 2005, J MED VIROL, V76, P333, DOI 10.1002/jmv.20363; Jardi R, 2001, HEPATOLOGY, V34, P404, DOI 10.1053/jhep.2001.26511; Kao JH, 2002, J CLIN MICROBIOL, V40, P4068, DOI 10.1128/JCM.40.11.4068-4071.2002; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; Kirupaharan N, 2004, B MATH BIOL, V66, P841, DOI 10.1016/j.bulm.2003.11.007; Lloyd-Smith JO, 2008, PARASITOLOGY, V135, P795, DOI 10.1017/S0031182008000292; Martcheva M, 2007, MATH BIOSCI, V207, P58, DOI 10.1016/j.mbs.2006.09.010; Mast E., 2004, VACCINES, P299; MAY RM, 1995, P ROY SOC B-BIOL SCI, V261, P209, DOI 10.1098/rspb.1995.0138; MAY RM, 1994, J THEOR BIOL, V170, P95, DOI 10.1006/jtbi.1994.1171; MYERS MW, 1980, J VIROL, V35, P65, DOI 10.1128/JVI.35.1.65-75.1980; Nasell I, 2002, MATH BIOSCI, V179, P1, DOI 10.1016/S0025-5564(02)00098-6; Niro GA, 2005, J VIRAL HEPATITIS, V12, P2, DOI 10.1111/j.1365-2893.2005.00601.x; POLISH LB, 1993, CLIN MICROBIOL REV, V6, P211, DOI 10.1128/CMR.6.3.211-229.1993; Restif O, 2006, P ROY SOC B-BIOL SCI, V273, P409, DOI 10.1098/rspb.2005.3335; SUREAU C, 1993, J VIROL, V67, P366, DOI 10.1128/JVI.67.1.366-372.1993; van Houdt R, 2007, VACCINE, V25, P2698, DOI 10.1016/j.vaccine.2006.06.058; Webb SD, 2007, J THEOR BIOL, V249, P140, DOI 10.1016/j.jtbi.2007.06.013; *WHO, 2001, HEP DELT; WHO, 2002, HEP B; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; Williams JR, 1996, EPIDEMIOL INFECT, V116, P71, DOI 10.1017/S0950268800058970; Xridou M, 2009, EPIDEMIOL INFECT, V137, P504, DOI 10.1017/S0950268808000976; Zhao SJ, 2000, INT J EPIDEMIOL, V29, P744, DOI 10.1093/ije/29.4.744	34	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5247	10.1371/journal.pone.0005247	http://dx.doi.org/10.1371/journal.pone.0005247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381302	gold, Green Published, Green Submitted			2022-12-27	WOS:000265513800014
J	Alejo, A; Saraiva, M; Ruiz-Arguello, MB; Viejo-Borbolla, A; de Marco, MF; Salguero, FJ; Alcami, A				Alejo, Ali; Saraiva, Margarida; Begona Ruiz-Arguello, Maria; Viejo-Borbolla, Abel; Fernandez de Marco, Mar; Javier Salguero, Francisco; Alcami, Antonio			A Method for the Generation of Ectromelia Virus (ECTV) Recombinants: In Vivo Analysis of ECTV vCD30 Deletion Mutants	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTOR; BACTERIAL ARTIFICIAL CHROMOSOME; INTERFERON-BINDING PROTEIN; VACCINIA VIRUS; POXVIRUS PROTEIN; COWPOX VIRUSES; CD30 LIGAND; GENE; RESISTANCE; TNF	Background: Ectromelia virus (ECTV) is the causative agent of mousepox, a lethal disease of mice with similarities to human smallpox. Mousepox progression involves replication at the initial site of infection, usually the skin, followed by a rapid spread to the secondary replicative organs, spleen and liver, and finally a dissemination to the skin, where the typical rash associated with this and other orthopoxviral induced diseases appears. Case fatality rate is genetically determined and reaches up to 100% in susceptible mice strains. Like other poxviruses, ECTV encodes a number of proteins with immunomodulatory potential, whose role in mousepox progression remains largely undescribed. Amongst these is a secreted homologue of the cellular tumour necrosis factor receptor superfamily member CD30 which has been proposed to modulate a Th1 immune response in vivo. Methodology/Principal Findings: To evaluate the contribution of viral CD30 (vCD30) to virus pathogenesis in the infected host, we have adapted a novel transient dominant method for the selection of recombinant ECTVs. Using this method, we have generated an ECTV vCD30 deletion mutant, its corresponding revertant control virus as well as a virus encoding the extracellular domain of murine CD30. These viruses contain no exogenous marker DNA sequences in their genomes, as opposed to other ECTVs reported up to date. Conclusions/Significance: We show that the vCD30 is expressed as a secreted disulfide linked trimer and that the absence of vCD30 does not impair mousepox induced fatality in vivo. Replacement of vCD30 by a secreted version of mouse CD30 caused limited attenuation of ECTV. The recombinant viruses generated may be of use in the study of the role of the cellular CD30-CD30L interaction in the development of the immune response. The method developed might be useful for the construction of ECTV mutants for the study of additional genes.	[Alejo, Ali; Begona Ruiz-Arguello, Maria; Javier Salguero, Francisco] Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim, Madrid, Spain; [Saraiva, Margarida; Alcami, Antonio] Univ Cambridge, Dept Med, Addenbrookes Hosp, Cambridge, England; [Viejo-Borbolla, Abel; Fernandez de Marco, Mar; Alcami, Antonio] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Viejo-Borbolla, Abel; Fernandez de Marco, Mar; Alcami, Antonio] Univ Autonoma Madrid, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Alejo, A (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim, Madrid, Spain.	aalcami@cbm.uam.es	Alcami, Antonio/F-8512-2015; Viejo-Borbolla, Abel/AAO-1585-2020; Salguero, Francisco J/A-7336-2010; Saraiva, Margarida/E-8781-2011; Alejo, Ali/AAF-1477-2020	Alcami, Antonio/0000-0002-3333-6016; Viejo-Borbolla, Abel/0000-0001-6395-4010; Saraiva, Margarida/0000-0002-8180-1293; Alejo, Ali/0000-0002-1613-6063; Salguero, Francisco Javier/0000-0002-5315-3882	Medical Research Council [G9800943] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9800943] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Afonso CL, 2005, J VIROL, V79, P966, DOI 10.1128/JVI.79.2.966-977.2005; Alcami A, 1999, J GEN VIROL, V80, P949, DOI 10.1099/0022-1317-80-4-949; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Alcami A, 1996, TRENDS MICROBIOL, V4, P321, DOI 10.1016/0966-842X(96)10051-2; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Bartlett NW, 2004, J GEN VIROL, V85, P1401, DOI 10.1099/vir.0.79980-0; Born TL, 2000, J IMMUNOL, V164, P3246, DOI 10.4049/jimmunol.164.6.3246; Brunetti CR, 2003, P NATL ACAD SCI USA, V100, P4831, DOI 10.1073/pnas.0737244100; Cerutti A, 2000, J IMMUNOL, V165, P786, DOI 10.4049/jimmunol.165.2.786; Chan FKM, 2007, CYTOKINE, V37, P101, DOI 10.1016/j.cyto.2007.03.005; Chaudhri G, 2004, P NATL ACAD SCI USA, V101, P9057, DOI 10.1073/pnas.0402949101; Chaudhri G, 2006, J VIROL, V80, P6339, DOI 10.1128/JVI.00116-06; CHEN W, 1993, VIROLOGY, V196, P682, DOI 10.1006/viro.1993.1525; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Cunnion KM, 1999, MOL GENET METAB, V67, P278, DOI 10.1006/mgme.1999.2878; DAVISON AJ, 1989, J MOL BIOL, V210, P771, DOI 10.1016/0022-2836(89)90108-3; DELANO ML, 1995, J VIROL, V69, P5875, DOI 10.1128/JVI.69.9.5875-5877.1995; Demmin GL, 2001, J VIROL, V75, P10856, DOI 10.1128/JVI.75.22.10856-10869.2001; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Domi A, 2002, P NATL ACAD SCI USA, V99, P12415, DOI 10.1073/pnas.192420599; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; FALKNER FG, 1990, J VIROL, V64, P3108, DOI 10.1128/JVI.64.6.3108-3111.1990; Fang M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040030; Fenner Frank, 1997, P535; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Fleming SB, 1997, J VIROL, V71, P4857, DOI 10.1128/JVI.71.6.4857-4861.1997; Gileva IP, 2006, BBA-PROTEINS PROTEOM, V1764, P1710, DOI 10.1016/j.bbapap.2006.09.006; HU FQ, 1994, VIROLOGY, V204, P343, DOI 10.1006/viro.1994.1539; Huang JN, 2004, J BIOL CHEM, V279, P54110, DOI 10.1074/jbc.M410583200; Johnston JB, 2004, CELL MICROBIOL, V6, P695, DOI 10.1111/j.1462-5822.2004.00423.x; Kennedy MK, 2006, IMMUNOLOGY, V118, P143, DOI 10.1111/j.1365-2567.2006.02354.x; KOCHNEVA GV, 1994, VIRUS RES, V34, P49, DOI 10.1016/0168-1702(94)90118-X; Loparev VN, 1998, P NATL ACAD SCI USA, V95, P3786, DOI 10.1073/pnas.95.7.3786; MACKETT M, 1985, CONSTRUCTION CHARACT, P191; Moss B, 2007, FIELDS VIROLOGY; Nishimura H, 2005, J IMMUNOL, V175, P4627, DOI 10.4049/jimmunol.175.7.4627; Nuara AA, 2008, P NATL ACAD SCI USA, V105, P1861, DOI 10.1073/pnas.0705753105; Panchanathan V, 2006, J VIROL, V80, P6333, DOI 10.1128/JVI.00115-06; Panus JF, 2002, P NATL ACAD SCI USA, V99, P8348, DOI 10.1073/pnas.122238599; Rahman MM, 2006, J BIOL CHEM, V281, P22517, DOI 10.1074/jbc.M604645200; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Ruiz-Arguello MB, 2005, SYMP SOC GEN MICROBI, V64, P269; Sakala IG, 2007, J VIROL, V81, P3346, DOI 10.1128/JVI.01927-06; Sanchez-Puig JM, 2000, GENE, V257, P57, DOI 10.1016/S0378-1119(00)00398-X; Saraiva M, 2002, J EXP MED, V196, P829, DOI 10.1084/jem.20020319; Saraiva M, 2001, J VIROL, V75, P226, DOI 10.1128/JVI.75.1.226-233.2001; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; SENKEVICH TG, 1994, VIROLOGY, V198, P118, DOI 10.1006/viro.1994.1014; SENKEVICH TG, 1995, J VIROL, V69, P4103, DOI 10.1128/JVI.69.7.4103-4111.1995; SPRIGGS MK, 1992, CELL, V71, P145, DOI 10.1016/0092-8674(92)90273-F; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Tang C, 2008, J IMMUNOL, V181, P6316, DOI 10.4049/jimmunol.181.9.6316; Tulman ER, 2006, J VIROL, V80, P9244, DOI 10.1128/JVI.00945-06; Vanderplasschen A, 1997, J GEN VIROL, V78, P2041, DOI 10.1099/0022-1317-78-8-2041; Wassenaar TA, 2008, PROTEINS, V70, P333, DOI 10.1002/prot.21541; Xu RH, 2008, J EXP MED, V205, P981, DOI 10.1084/jem.20071854	59	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5175	10.1371/journal.pone.0005175	http://dx.doi.org/10.1371/journal.pone.0005175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365546	Green Published, Green Submitted, gold			2022-12-27	WOS:000265509900006
J	Steiling, K; Kadar, AY; Bergerat, A; Flanigon, J; Sridhar, S; Shah, V; Ahmad, QR; Brody, JS; Lenburg, ME; Steffen, M; Spira, A				Steiling, Katrina; Kadar, Aran Y.; Bergerat, Agnes; Flanigon, James; Sridhar, Sriram; Shah, Vishal; Ahmad, Q. Rushdy; Brody, Jerome S.; Lenburg, Marc E.; Steffen, Martin; Spira, Avrum			Comparison of Proteomic and Transcriptomic Profiles in the Bronchial Airway Epithelium of Current and Never Smokers	PLOS ONE			English	Article								Background: Although prior studies have demonstrated a smoking-induced field of molecular injury throughout the lung and airway, the impact of smoking on the airway epithelial proteome and its relationship to smoking-related changes in the airway transcriptome are unclear. Methodology/Principal Findings: Airway epithelial cells were obtained from never (n = 5) and current (n = 5) smokers by brushing the mainstem bronchus. Proteins were separated by one dimensional polyacrylamide gel electrophoresis (1D-PAGE). After in-gel digestion, tryptic peptides were processed via liquid chromatography/tandem mass spectrometry (LC-MS/MS) and proteins identified. RNA from the same samples was hybridized to HG-U133A microarrays. Protein detection was compared to RNA expression in the current study and a previously published airway dataset. The functional properties of many of the 197 proteins detected in a majority of never smokers were similar to those observed in the never smoker airway transcriptome. LC-MS/MS identified 23 proteins that differed between never and current smokers. Western blotting confirmed the smoking-related changes of PLUNC, P4HB1, and uteroglobin protein levels. Many of the proteins differentially detected between never and current smokers were also altered at the level of gene expression in this cohort and the prior airway transcriptome study. There was a strong association between protein detection and expression of its corresponding transcript within the same sample, with 86% of the proteins detected by LC-MS/MS having a detectable corresponding probeset by microarray in the same sample. Forty-one proteins identified by LC-MS/MS lacked detectable expression of a corresponding transcript and were detected in <= 5% of airway samples from a previously published dataset. Conclusions/Significance: 1D-PAGE coupled with LC-MS/MS effectively profiled the airway epithelium proteome and identified proteins expressed at different levels as a result of cigarette smoke exposure. While there was a strong correlation between protein and transcript detection within the same sample, we also identified proteins whose corresponding transcripts were not detected by microarray. This noninvasive approach to proteomic profiling of airway epithelium may provide additional insights into the field of injury induced by tobacco exposure.			Steiling, K (corresponding author), Boston Univ, Med Ctr, Ctr Pulm, Boston, MA 02215 USA.	steiling@bu.edu	Lenburg, Marc/B-8027-2008	Lenburg, Marc/0000-0002-5760-4708; Brody, Jerome/0000-0002-2824-802X; Steiling, Katrina/0000-0001-9663-2093; Steffen, Martin/0000-0002-7853-7364; Spira, Avrum/0000-0003-1467-0489	NCI NIH HHS [R01CA124640, R01 CA124640] Funding Source: Medline; NIEHS NIH HHS [U01ES016035, U01 ES016035] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA124640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES016035] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adachi J, 2007, MOL CELL PROTEOMICS, V6, P1257, DOI 10.1074/mcp.M600476-MCP200; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Beane J, 2008, CANCER PREV RES, V1, P56, DOI 10.1158/1940-6207.CAPR-08-0011; Beane J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r201; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P300; Chelius D, 2002, J PROTEOME RES, V1, P317, DOI 10.1021/pr025517j; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Chen GA, 2002, CLIN CANCER RES, V8, P2298; Chen YR, 2006, J PROTEOME RES, V5, P2727, DOI 10.1021/pr060212g; Crawford EL, 2000, CANCER RES, V60, P1609; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duan XB, 2008, J PROTEOME RES, V7, P4955, DOI 10.1021/pr800295j; Franklin WA, 1997, J CLIN INVEST, V100, P2133, DOI 10.1172/JCI119748; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghafouri B, 2002, PROTEOMICS, V2, P112, DOI 10.1002/1615-9861(200201)2:1<112::AID-PROT112>3.0.CO;2-N; Gianazza E, 2004, AM J MED, V117, P51, DOI 10.1016/j.amjmed.2004.01.022; Greenbaum D, 2002, BIOINFORMATICS, V18, P585, DOI 10.1093/bioinformatics/18.4.585; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Guo MZ, 2004, CLIN CANCER RES, V10, P5131, DOI 10.1158/1078-0432.CCR-03-0763; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Habermann JK, 2007, GENE CHROMOSOME CANC, V46, P10, DOI 10.1002/gcc.20382; Hackett NR, 2003, AM J RESP CELL MOL, V29, P331, DOI 10.1165/rcmb.2002-0321OC; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; Kelsen SG, 2008, AM J RESP CELL MOL, V38, P541, DOI 10.1165/rcmb.2007-0221OC; Lee EJ, 2009, CHEST, V135, P344, DOI 10.1378/chest.08-1583; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lorenz P, 2003, PROTEOMICS, V3, P991, DOI 10.1002/pmic.200300412; Mullins DN, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-141; National Center for Health Statistics, 2005, HLTH US 2005 CHARTB; Nissom PM, 2006, MOL BIOTECHNOL, V34, P125, DOI 10.1385/MB:34:2:125; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Pilette C, 2001, AM J RESP CRIT CARE, V163, P185, DOI 10.1164/ajrccm.163.1.9912137; Powell CA, 2003, LUNG CANCER-J IASLC, V39, P23, DOI 10.1016/S0169-5002(02)00384-7; Powell CA, 1999, CLIN CANCER RES, V5, P2025; Rahman SMJ, 2005, AM J RESP CRIT CARE, V172, P1556, DOI 10.1164/rccm.200502-274OC; Robin M, 2002, EUR RESPIR J, V20, P1152, DOI 10.1183/09031936.02.02042001; Ruse CI, 2004, PROTEOMICS, V4, P1505, DOI 10.1002/pmic.200300682; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shijubo N, 1997, EUR RESPIR J, V10, P1108, DOI 10.1183/09031936.97.10051108; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Siu FM, 2008, PROTEOMICS, V8, P3105, DOI 10.1002/pmic.200700829; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Unwin RD, 2006, CELL CYCLE, V5, P1587, DOI 10.4161/cc.5.15.3101; White SL, 2004, BRIT J CANCER, V90, P173, DOI 10.1038/sj.bjc.6601458; Willey JC, 1997, CHEST, V111, pS83, DOI 10.1378/chest.111.6_Supplement.83S; Wistuba II, 1997, JNCI-J NATL CANCER I, V89, P1366, DOI 10.1093/jnci/89.18.1366; Xia D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r116; Xie LF, 2009, BIOGERONTOLOGY, V10, P125, DOI 10.1007/s10522-008-9157-3; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Yi ZP, 2008, J PROTEOME RES, V7, P3230, DOI 10.1021/pr800064s; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; Zhang SP, 2008, TOXICOL LETT, V178, P191, DOI 10.1016/j.toxlet.2008.03.014	61	55	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5043	10.1371/journal.pone.0005043	http://dx.doi.org/10.1371/journal.pone.0005043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357784	Green Submitted, Green Published, gold			2022-12-27	WOS:000265505900002
J	Walkiewicz, MA; Stern, M				Walkiewicz, Magdalena A.; Stern, Michael			Increased Insulin/Insulin Growth Factor Signaling Advances the Onset of Metamorphosis in Drosophila	PLOS ONE			English	Article								Mechanisms by which attainment of specific body sizes trigger developmental transitions to adulthood (e. g. puberty or metamorphosis) are incompletely understood. In Drosophila, metamorphosis is triggered by ecdysone synthesis from the prothoracic gland (PG), whereas growth rate is increased by insulin/insulin growth factor signalling (IIS). Transgene-induced activation of PI3K, the major effector of IIS, within the PG advances the onset of metamorphosis via precocious ecdysone synthesis, raising the possibility that IIS triggers metamorphosis via PI3K activation in the PG. Here we show that blocking the protein kinase A (PKA) pathway in the insulin producing cells (IPCs) increases IIS. This increased IIS increases larval growth rate and also advances the onset of metamorphosis, which is accompanied by precocious ecdysone synthesis and increased transcription of at least one ecdysone biosynthetic gene. Our observations suggest that IIS is regulated by PKA pathway activity in the IPCs. In addition, taken together with previous findings, our observations are consistent with the possibility that, in Drosophila, attainment of a specific body size triggers metamorphosis via the IIS-mediated activation of PI3K and hence ecdysone synthesis in the PG.			Walkiewicz, MA (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	walkiewi@rice.edu			Division Of Integrative Organismal Systems [0820660] Funding Source: National Science Foundation	Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Arquier N, 2008, CELL METAB, V7, P333, DOI 10.1016/j.cmet.2008.02.003; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Eggers A, 1998, J BIOL CHEM, V273, P18499, DOI 10.1074/jbc.273.29.18499; Eresh S, 1997, EMBO J, V16, P2014, DOI 10.1093/emboj/16.8.2014; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Hussain MA, 2000, DIABETES, V49, P1681, DOI 10.2337/diabetes.49.10.1681; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kaplan DD, 2008, GENE DEV, V22, P1877, DOI 10.1101/gad.1670508; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Noda M, 2004, MOL NEUROBIOL, V29, P31, DOI 10.1385/MN:29:1:31; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; RIDDIFORD LM, 1993, RECEPTOR, V3, P203; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Rybczynski R, 2001, MOL CELL ENDOCRINOL, V184, P1, DOI 10.1016/S0303-7207(01)00664-5; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Simon D, 2002, HORM RES, V57, P53, DOI 10.1159/000058102; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567	29	80	82	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5072	10.1371/journal.pone.0005072	http://dx.doi.org/10.1371/journal.pone.0005072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352497	Green Submitted, Green Published, gold			2022-12-27	WOS:000265505300010
J	Schouls, LM; Spalburg, EC; van Luit, M; Huijsdens, XW; Pluister, GN; van Santen-Verheuvel, MG; van der Heide, HGJ; Grundmann, H; Heck, MEOC; de Neeling, AJ				Schouls, Leo M.; Spalburg, Emile C.; van Luit, Martijn; Huijsdens, Xander W.; Pluister, Gerlinde N.; van Santen-Verheuvel, Marga G.; van der Heide, Han G. J.; Grundmann, Hajo; Heck, Max E. O. C.; de Neeling, Albert J.			Multiple-Locus Variable Number Tandem Repeat Analysis of Staphylococcus Aureus: Comparison with Pulsed-Field Gel Electrophoresis and spa-Typing	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; METHICILLIN-RESISTANT; NOSOCOMIAL INFECTIONS; GENETIC DIVERSITY; STRAINS; POLYMORPHISM; PCR; EPIDEMIC; NETHERLANDS; PREVALENCE	Background: Molecular typing of methicillin-resistant Staphylococcus aureus (MRSA) is required to study the routes and rates of transmission of this pathogen. Currently available typing techniques are either resource-intensive or have limited discriminatory ability. Multiple-locus variable number tandem repeat analysis (MLVA) may provide an alternative high throughput molecular typing tool with high epidemiological resolution. Methodology/Principal Findings: A new MLVA scheme for S. aureus was validated using 1681 S. aureus isolates collected from Dutch patients and 100 isolates from pigs. MLVA using 8 tandem repeat loci was performed in 2 multiplex PCRs and the fluorescently labeled PCR products were accurately sized on an automated DNA sequencer. The assessed number of repeats was used to create MLVA profiles consisting of strings of 8 integers that were used for categorical clustering. MLVA yielded 511 types that clustered into 11 distinct MLVA complexes which appeared to coincide with MLST clonal complexes. MLVA was at least as discriminatory as PFGE and twice as discriminatory as spa-sequence typing. There was considerable congruence between MLVA, spa-sequence typing and PFGE, at the MLVA complex level with group separation values of 95.1% and 89.2%. MLVA could not discriminate between pig-related MRSA strains isolated from humans and pigs, corroborating the high degree of relationship. MLVA was also superior in the grouping of MRSA isolates previously assigned to temporal-spatial clusters with indistinguishable SpaTypes, demonstrating its enhanced epidemiological usefulness. Conclusions: The MLVA described in this study is a high throughput, relatively low cost genotyping method for S. aureus that yields discrete and unambiguous data that can be used to assign biological meaningful genotypes and complexes and can be used for interlaboratory comparisons in network accessible databases. Results suggest that MLVA offsets the disadvantages of other high discriminatory typing approaches and represents a promising tool for hospital, national and international molecular epidemiology.	[Schouls, Leo M.; Spalburg, Emile C.; van Luit, Martijn; Huijsdens, Xander W.; Pluister, Gerlinde N.; van Santen-Verheuvel, Marga G.; van der Heide, Han G. J.; Grundmann, Hajo; Heck, Max E. O. C.; de Neeling, Albert J.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Perinatal Screening, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Schouls, LM (corresponding author), Natl Inst Publ Hlth & Environm, Lab Infect Dis & Perinatal Screening, NL-3720 BA Bilthoven, Netherlands.	LM.Schouls@rivm.nl		de Neeling, Albert Johannes/0000-0001-8578-1990	Dutch Government (Ministry of Health, Welfare and Sport)	Dutch Government (Ministry of Health, Welfare and Sport)	Funding for this study was provided by the Dutch Government (Ministry of Health, Welfare and Sport). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Collery MM, 2008, J MED MICROBIOL, V57, P348, DOI 10.1099/jmm.0.47734-0; Cookson BD, 2007, J CLIN MICROBIOL, V45, P1830, DOI 10.1128/JCM.02402-06; Damiani G, 1996, EUR J EPIDEMIOL, V12, P163, DOI 10.1007/BF00145502; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; de Neeling AJ, 1998, J ANTIMICROB CHEMOTH, V41, P93, DOI 10.1093/jac/41.1.93; Della Coletta H, 2001, APPL ENVIRON MICROB, V67, P4091, DOI 10.1128/AEM.67.9.4091-4095.2001; Deplano A, 1997, J CLIN MICROBIOL, V35, P2580, DOI 10.1128/JCM.35.10.2580-2587.1997; EMORI TG, 1993, CLIN MICROBIOL REV, V6, P428, DOI 10.1128/CMR.6.4.428-442.1993; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Farlow J, 2002, J CLIN MICROBIOL, V40, P4612, DOI 10.1128/JCM.40.12.4612-4618.2002; Farlow J, 2001, J CLIN MICROBIOL, V39, P3186, DOI 10.1128/JCM.39.9.3186-3192.2001; Francois P, 2005, J CLIN MICROBIOL, V43, P3346, DOI 10.1128/JCM.43.7.3346-3355.2005; FRENAY HME, 1994, J CLIN MICROBIOL, V32, P846; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gilbert FB, 2006, VET MICROBIOL, V117, P297, DOI 10.1016/j.vetmic.2006.04.029; Grady R, 1999, J CLIN MICROBIOL, V37, P3198, DOI 10.1128/JCM.37.10.3198-3203.1999; GURTLER V, 1995, MICROBIOL-SGM, V141, P1255, DOI 10.1099/13500872-141-5-1255; HADORN K, 1990, EUR J CLIN MICROBIOL, V9, P649, DOI 10.1007/BF01964265; Hardy KJ, 2006, J CLIN MICROBIOL, V44, P271, DOI 10.1128/JCM.44.1.271-273.2006; Hardy KJ, 2004, MICROBIOL-SGM, V150, P4045, DOI 10.1099/mic.0.27413-0; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; ICHIYAMA S, 1991, J CLIN MICROBIOL, V29, P2690, DOI 10.1128/JCM.29.12.2690-2695.1991; Ikawaty R, 2008, J CLIN MICROBIOL, V46, P3147, DOI 10.1128/JCM.00861-08; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Keim P, 1999, J APPL MICROBIOL, V87, P215, DOI 10.1046/j.1365-2672.1999.00873.x; Klevytska AM, 2001, J CLIN MICROBIOL, V39, P3179, DOI 10.1128/JCM.39.9.3179-3185.2001; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Liu YC, 2003, J CLIN MICROBIOL, V41, P4388, DOI 10.1128/JCM.41.9.4388-4394.2003; Malachowa N, 2005, J CLIN MICROBIOL, V43, P3095, DOI 10.1128/JCM.43.7.3095-3100.2005; Melles DC, 2007, J MICROBIOL METH, V69, P371, DOI 10.1016/j.mimet.2007.01.013; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; PANLILIO AL, 1992, INFECT CONT HOSP EP, V13, P582; Pourcel C, 2003, J CLIN MICROBIOL, V41, P1819, DOI 10.1128/JCM.41.5.1819-1826.2003; Sabat A, 2003, J CLIN MICROBIOL, V41, P1801, DOI 10.1128/JCM.41.4.1801-1804.2003; Schouls LM, 2006, J CLIN MICROBIOL, V44, P1509, DOI 10.1128/JCM.44.4.1509-1518.2006; Schouls LM, 2005, J CLIN MICROBIOL, V43, P2741, DOI 10.1128/JCM.43.6.2741-2749.2005; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Speller DCE, 1997, LANCET, V350, P323, DOI 10.1016/S0140-6736(97)12148-1; Steinberg JP, 1996, CLIN INFECT DIS, V23, P255, DOI 10.1093/clinids/23.2.255; Stephens AJ, 2007, ANTIMICROB AGENTS CH, V51, P2954, DOI 10.1128/AAC.01323-06; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; Tenover FC, 2007, J CLIN MICROBIOL, V45, P2215, DOI 10.1128/JCM.02451-06; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; Top J, 2004, J CLIN MICROBIOL, V42, P4503, DOI 10.1128/JCM.42.10.4503-4511.2004; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Trijp MJCA, 2007, INFECT CONT HOSP EP, V28, P970, DOI 10.1086/519210; vanBelkum A, 1997, INFECT IMMUN, V65, P5017, DOI 10.1128/IAI.65.12.5017-5027.1997; VANBELKUM A, 1994, EUR J CLIN MICROBIOL, V13, P420; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026; WILLIAMS REO, 1953, LANCET, V264, P510; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924	58	120	130	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5082	10.1371/journal.pone.0005082	http://dx.doi.org/10.1371/journal.pone.0005082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343175	Green Submitted, Green Published, gold			2022-12-27	WOS:000265500800009
J	Wagner, KM; Rueegg, M; Niemann, A; Suter, U				Wagner, Konstanze M.; Rueegg, Marcel; Niemann, Axel; Suter, Ueli			Targeting and Function of the Mitochondrial Fission Factor GDAP1 Are Dependent on Its Tail-Anchor	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; DIFFERENTIATION-ASSOCIATED PROTEIN-1; OUTER-MEMBRANE PROTEINS; GLUTATHIONE TRANSFERASE; PEROXISOMAL FISSION	Proteins controlling mitochondrial dynamics are often targeted to and anchored into the mitochondrial outer membrane (MOM) by their carboxyl-terminal tail-anchor domain (TA). However, it is not known whether the TA modulates protein function. GDAP1 is a mitochondrial fission factor with two neighboring hydrophobic domains each flanked by basic amino acids (aa). Here we define GDAP1 as TA MOM protein. GDAP1 carries a single transmembrane domain (TMD) that is, together with the adjacent basic aa, critical for MOM targeting. The flanking N-terminal region containing the other hydrophobic domain is located in the cytoplasm. TMD sequence, length, and high hydrophobicity do not influence GDAP1 fission function if MOM targeting is maintained. The basic aa bordering the TMD in the cytoplasm, however, are required for both targeting of GDAP1 as part of the TA and GDAP1-mediated fission. Thus, this GDAP1 region contains critical overlapping motifs defining intracellular targeting by the TA concomitant with functional aspects.	[Wagner, Konstanze M.; Rueegg, Marcel; Niemann, Axel; Suter, Ueli] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Wagner, KM (corresponding author), ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland.	axel.niemann@cell.biol.ethz.ch; usuter@cell.biol.ethz.ch	Niemann, Axel/J-5245-2013; Suter, Ueli/A-1624-2010; Niemann, Axel/A-6245-2012	Niemann, Axel/0000-0002-2930-0950; 	Swiss National Science Foundation; ETH Zurich; NCCR Neural Plasticity and Repair	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich); NCCR Neural Plasticity and Repair(Swiss National Science Foundation (SNSF))	This study is supported by the Swiss National Science Foundation, the ETH Zurich, and the NCCR Neural Plasticity and Repair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; Borgese N, 2001, MOL BIOL CELL, V12, P2482, DOI 10.1091/mbc.12.8.2482; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; BORGESE N, 2007, CURR OPIN CELL BIOL; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; De Brito OM, 2008, ANTIOXID REDOX SIGN, V10, P621, DOI 10.1089/ars.2007.1934; Egan B, 1999, FEBS LETT, V451, P243, DOI 10.1016/S0014-5793(99)00581-5; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Habib SJ, 2003, FEBS LETT, V555, P511, DOI 10.1016/S0014-5793(03)01325-5; Henderson MPA, 2007, METHODS, V41, P427, DOI 10.1016/j.ymeth.2006.07.004; Isenmann S, 1998, MOL BIOL CELL, V9, P1649, DOI 10.1091/mbc.9.7.1649; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kuroda R, 1998, J BIOL CHEM, V273, P31097, DOI 10.1074/jbc.273.47.31097; Marco A, 2004, MOL BIOL EVOL, V21, P176, DOI 10.1093/molbev/msh013; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Pedrola L, 2005, HUM MOL GENET, V14, P1087, DOI 10.1093/hmg/ddi121; Rojo M, 2002, J CELL SCI, V115, P1663; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Shield AJ, 2006, BIOCHEM BIOPH RES CO, V347, P859, DOI 10.1016/j.bbrc.2006.06.189; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Wattenberg BW, 2007, BIOSCIENCE REP, V27, P385, DOI 10.1007/s10540-007-9061-0	28	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5160	10.1371/journal.pone.0005160	http://dx.doi.org/10.1371/journal.pone.0005160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340293	Green Submitted, gold, Green Published			2022-12-27	WOS:000265500700029
J	Chi, MN; Chalmel, F; Agius, E; Vanzo, N; Khabar, KSA; Jegou, B; Morello, D				Chi, Mai Nguyen; Chalmel, Frederic; Agius, Eric; Vanzo, Nathalie; Khabar, Khalid S. A.; Jegou, Bernard; Morello, Dominique			Temporally Regulated Traffic of HuR and Its Associated ARE-Containing mRNAs from the Chromatoid Body to Polysomes during Mouse Spermatogenesis	PLOS ONE			English	Article							CELL NUCLEAR FACTOR; CHROMOSOME SYNAPSIS; TRANSLATIONAL REGULATION; BINDING PROTEIN; GENE-EXPRESSION; MICE DEFICIENT; P-BODIES; IDENTIFICATION; PHOSPHORYLATION; DIFFERENTIATION	Background: In mammals, a temporal disconnection between mRNA transcription and protein synthesis occurs during late steps of germ cell differentiation, in contrast to most somatic tissues where transcription and translation are closely linked. Indeed, during late stages of spermatogenesis, protein synthesis relies on the appropriate storage of translationally inactive mRNAs in transcriptionally silent spermatids. The factors and cellular compartments regulating mRNA storage and the timing of their translation are still poorly understood. The chromatoid body (CB), that shares components with the P. bodies found in somatic cells, has recently been proposed to be a site of mRNA processing. Here, we describe a new component of the CB, the RNA binding protein HuR, known in somatic cells to control the stability/translation of AU-rich containing mRNAs (ARE-mRNAs). Methodology/Principal Findings: Using a combination of cell imagery and sucrose gradient fractionation, we show that HuR localization is highly dynamic during spermatid differentiation. First, in early round spermatids, HuR colocalizes with the Mouse Vasa Homolog, MVH, a marker of the CB. As spermatids differentiate, HuR exits the CB and concomitantly associates with polysomes. Using computational analyses, we identified two testis ARE-containing mRNAs, Brd2 and GCNF that are bound by HuR and MVH. We show that these target ARE-mRNAs follow HuR trafficking, accumulating successively in the CB, where they are translationally silent, and in polysomes during spermatid differentiation. Conclusions/Significance: Our results reveal a temporal regulation of HuR trafficking together with its target mRNAs from the CB to polysomes as spermatids differentiate. They strongly suggest that through the transport of ARE-mRNAs from the CB to polysomes, HuR controls the appropriate timing of ARE-mRNA translation. HuR might represent a major post-transcriptional regulator, by promoting mRNA storage and then translation, during male germ cell differentiation.	[Chi, Mai Nguyen; Agius, Eric; Vanzo, Nathalie; Morello, Dominique] Univ Toulouse 3, CNRS, UMR5547, CBD,IFR 109, F-31062 Toulouse, France; [Chalmel, Frederic; Jegou, Bernard] Inserm, U625, Rennes, France; [Chalmel, Frederic; Jegou, Bernard] Univ Rennes 1, GERHM, IFR 140, Campus Beaulieu, F-35014 Rennes, France; [Khabar, Khalid S. A.] King Faisal Specialist Hosp & Res Ctr, Program Biomol Res, Riyadh, Saudi Arabia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; King Faisal Specialist Hospital & Research Center	Chi, MN (corresponding author), Univ Toulouse 3, CNRS, UMR5547, CBD,IFR 109, F-31062 Toulouse, France.	morello@cict.fr	Chalmel, Frédéric/AAM-1079-2021; Jégou, Bernard/I-4742-2015; Chalmel, Frédéric/L-5360-2018; agius, Eric/AHC-9705-2022; Khabar, Khalid/AAG-3487-2019; Khabar, Khalid/A-4772-2011; Chalmel, Frederic/M-1297-2016	Chalmel, Frédéric/0000-0002-0535-3628; Chalmel, Frédéric/0000-0002-0535-3628; Khabar, Khalid/0000-0003-1003-9788; Khabar, Khalid/0000-0003-1003-9788; Agius, Eric/0000-0003-2123-9283; JEGOU, Bernard/0000-0003-0623-3609; Nguyen-Chi, Mai/0000-0003-2672-2426	ARC [3823]; ARECA network Pole proteomique et Cancer; INSERM; MRT; FRM; Universite Paul Sabatier; Universite Franco-Italienne (Leonardo da Vinci)	ARC(Australian Research Council); ARECA network Pole proteomique et Cancer; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); MRT; FRM(Fondation pour la Recherche Medicale); Universite Paul Sabatier; Universite Franco-Italienne (Leonardo da Vinci)	This work was supported by the ARC contract n 3823, ARECA network Pole proteomique et Cancer, INSERM and MRT. Mai Nguyen Chi is supported by FRM, Universite Paul Sabatier (ATUPS grant) and Universite Franco-Italienne (Leonardo da Vinci). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Cataldo L, 1999, MOL HUM REPROD, V5, P206, DOI 10.1093/molehr/5.3.206; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Chung ACK, 2001, MOL CELL BIOL, V21, P663, DOI 10.1128/MCB.21.2.663-677.2001; Cooney AJ, 1998, BIOCHEM BIOPH RES CO, V245, P94, DOI 10.1006/bbrc.1998.8391; Davies B, 2004, MOL CELL BIOL, V24, P8642, DOI 10.1128/MCB.24.19.8642-8648.2004; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; DOLLER A, 2008, CELL SIGNAL; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Ganguly A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1241, DOI 10.1152/ajpendo.00344.2006; Gouble A, 2002, CANCER RES, V62, P1489; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Iguchi N, 2006, P NATL ACAD SCI USA, V103, P7712, DOI 10.1073/pnas.0510999103; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Kimura T, 2003, MOL CELL BIOL, V23, P1304, DOI 10.1128/MCB.23.4.1304-1315.2003; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Kotaja N, 2006, J CELL SCI, V119, P2819, DOI 10.1242/jcs.03022; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Levadoux-Martin M, 2003, EMBO REP, V4, P394, DOI 10.1038/sj.embor.embor803; Li HW, 2002, J BIOL CHEM, V277, P44623, DOI 10.1074/jbc.M206187200; Li ZH, 2003, DEV GROWTH DIFFER, V45, P449; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Matsumoto K, 1999, HETEROCYCL COMMUN, V5, P19; MEISTRICH ML, 1978, FED PROC, V37, P2522; MONESI V, 1964, Arch Ital Anat Embriol, V69, P89; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Parvinen M, 2005, INT J ANDROL, V28, P189, DOI 10.1111/j.1365-2605.2005.00542.x; PARVINEN M, 1972, ANAT REC, V174, P435, DOI 10.1002/ar.1091740404; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Salmon NA, 2006, GENESIS, V44, P515, DOI 10.1002/dvg.20241; Schmidt EE, 1999, MOL CELL BIOL, V19, P3904; Shang EY, 2004, GENE EXPR PATTERNS, V4, P513, DOI 10.1016/j.modgep.2004.03.002; Soller M, 2004, CURR BIOL, V14, pR53, DOI 10.1016/j.cub.2003.12.041; Steger K, 1999, ANAT EMBRYOL, V199, P471, DOI 10.1007/s004290050245; Styhler S, 1998, DEVELOPMENT, V125, P1569; Tanaka SS, 2000, GENE DEV, V14, P841; Wang GH, 2003, GENESIS, V36, P48, DOI 10.1002/gene.10200; Yang GY, 2003, BIOL REPROD, V68, P1620, DOI 10.1095/biolreprod.102.012013; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Zechel C, 2005, MOL REPROD DEV, V72, P550, DOI 10.1002/mrd.20377; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	63	33	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4900	10.1371/journal.pone.0004900	http://dx.doi.org/10.1371/journal.pone.0004900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333380	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499900003
J	Dutta, D; Ensminger, AW; Zucker, JP; Chess, A				Dutta, Devkanya; Ensminger, Alexander W.; Zucker, Jacob P.; Chess, Andrew			Asynchronous Replication and Autosome-Pair Non-Equivalence in Human Embryonic Stem Cells	PLOS ONE			English	Article								A number of mammalian genes exhibit the unusual properties of random monoallelic expression and random asynchronous replication. Such exceptional genes include genes subject to X inactivation and autosomal genes including odorant receptors, immunoglobulins, interleukins, pheromone receptors, and p120 catenin. In differentiated cells, random asynchronous replication of interspersed autosomal genes is coordinated at the whole chromosome level, indicative of chromosome-pair non-equivalence. Here we have investigated the replication pattern of the random asynchronously replicating genes in undifferentiated human embryonic stem cells, using fluorescence in situ hybridization based assay. We show that allele-specific replication of X-linked genes and random monoallelic autosomal genes occur in human embryonic stem cells. The direction of replication is coordinated at the whole chromosome level and can cross the centromere, indicating the existence of autosome-pair non-equivalence in human embryonic stem cells. These results suggest that epigenetic mechanism(s) that randomly distinguish between two parental alleles are emerging in the cells of the inner cell mass, the source of human embryonic stem cells.	[Dutta, Devkanya; Ensminger, Alexander W.; Zucker, Jacob P.; Chess, Andrew] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Dutta, D (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02115 USA.	chess@chgr.mgh.harvard.edu		Ensminger, Alexander/0000-0003-0824-3704	National Institute of Health	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by funding obtained from National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Bergstrom R, 2007, CELL CYCLE, V6, P450, DOI 10.4161/cc.6.4.3854; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Ensminger AW, 2004, HUM MOL GENET, V13, P651, DOI 10.1093/hmg/ddh062; Gimelbrant AA, 2005, J BIOL CHEM, V280, P1354, DOI 10.1074/jbc.M411283200; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Goldmit M, 2004, IMMUNOL REV, V200, P197, DOI 10.1111/j.0105-2896.2004.00158.x; Gribnau J, 2003, GENE DEV, V17, P759, DOI 10.1101/gad.1059603; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; HARNDEN DG, 1961, LANCET, V2, P488; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Koestenbauer S, 2006, AM J REPROD IMMUNOL, V55, P169, DOI 10.1111/j.1600-0897.2005.00354.x; LYON MF, 1986, NATURE, V320, P313, DOI 10.1038/320313b0; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rhoades KL, 2000, CURR BIOL, V10, P789, DOI 10.1016/S0960-9822(00)00565-0; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Simon I, 1999, NATURE, V401, P929, DOI 10.1038/44866; Singh N, 2003, NAT GENET, V33, P339, DOI 10.1038/ng1102; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984	35	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e4970	10.1371/journal.pone.0004970	http://dx.doi.org/10.1371/journal.pone.0004970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PO	19325893	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499600003
J	Harrist, AV; Ryzhova, EV; Harvey, T; Gonzalez-Scarano, F				Harrist, Alexia V.; Ryzhova, Elena V.; Harvey, Thomas; Gonzalez-Scarano, Francisco			Anx2 Interacts with HIV-1 Gag at Phosphatidylinositol (4,5) Bisphosphate-Containing Lipid Rafts and Increases Viral Production in 293T Cells	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MONOCYTE-DERIVED MACROPHAGES; DETERGENT-RESISTANT MEMBRANES; FUSION INHIBITOR T-20; PLASMA-MEMBRANE; ANNEXIN-II; FLUORESCENCE COMPLEMENTATION; INTRACELLULAR TRAFFICKING; REGULATED EXOCYTOSIS; INFECTIOUS HIV-1	The neuronal damage characteristic of HIV-1-mediated CNS diseases is inflicted by HIV-1 infected brain macrophages. Several steps of viral replication, including assembly and budding, differ between macrophages and T cells; it is likely that cell-specific host factors mediate these differences. We previously defined Annexin 2 (Anx2) as an HIV Gag binding partner in human monocyte-derived macrophages (MDMs) that promotes proper viral assembly. Anx2, a calcium-dependent membrane-binding protein that can aggregate phospholipid-containing lipid rafts, is expressed to high levels in macrophages, but not in T lymphocytes or the 293T cell line. Here, we use bimolecular fluorescence complementation in the 293T cell model to demonstrate that Anx2 and HIV-1 Gag interact at the phosphatidylinositol (4,5) bisphosphate-containing lipid raft membrane domains at which Gag mediates viral assembly. Furthermore, we demonstrate that Anx2 expression in 293T cells increases Gag processing and HIV-1 production. These data provide new evidence that Anx2, by interacting with Gag at the membranes that support viral assembly, functions in the late stages of HIV-1 replication.	[Harrist, Alexia V.; Ryzhova, Elena V.; Harvey, Thomas; Gonzalez-Scarano, Francisco] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Harrist, Alexia V.; Ryzhova, Elena V.; Harvey, Thomas; Gonzalez-Scarano, Francisco] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Harrist, AV (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	scarano@upenn.edu			National Institute of Neurological Disorders and Stroke, National Institutes of Health [F30 NS055523]; Penn Center for AIDS Research (CFAR) [P30 AI 045008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS027405, P01NS027405, F30NS055523] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Penn Center for AIDS Research (CFAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by PHS Grant NS-27405; A.V.H. is supported by Ruth L. Kirschstein National Research Service Award F30 NS055523 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health. This publication was made possible through core services and support from the Penn Center for AIDS Research (CFAR) (P30 AI 045008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Albright AV, 2004, VIROLOGY, V325, P328, DOI 10.1016/j.virol.2004.04.028; Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; An SF, 1999, J NEUROPATH EXP NEUR, V58, P1156, DOI 10.1097/00005072-199911000-00005; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Ayala-Sanmartin J, 2001, BBA-BIOMEMBRANES, V1510, P18, DOI 10.1016/S0005-2736(00)00262-5; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Bhattacharya J, 2006, J VIROL, V80, P5292, DOI 10.1128/JVI.01469-05; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Boyko V, 2006, MOL CELL, V23, P281, DOI 10.1016/j.molcel.2006.05.028; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Brownstein C, 2004, BLOOD, V103, P317, DOI 10.1182/blood-2003-04-1304; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Campbell S, 2001, P NATL ACAD SCI USA, V98, P10875, DOI 10.1073/pnas.191224698; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; Chatel-Chaix L, 2004, MOL CELL BIOL, V24, P2637, DOI 10.1128/MCB.24.7.2637-2648.2004; Chatel-Chaix L, 2007, J VIROL, V81, P6216, DOI 10.1128/JVI.00284-07; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Derry MEC, 2007, J GEN VIROL, V88, P19, DOI 10.1099/vir.0.82294-0; DRUST DS, 1988, NATURE, V331, P88, DOI 10.1038/331088a0; EIDELS L, 1983, MICROBIOL REV, V47, P596, DOI 10.1128/MMBR.47.4.596-620.1983; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; Filipenko NR, 2001, J BIOL CHEM, V276, P5310, DOI 10.1074/jbc.M009710200; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Finzi A, 2006, J VIROL, V80, P9789, DOI 10.1128/JVI.01055-06; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; Freed EO, 2006, P NATL ACAD SCI USA, V103, P11101, DOI 10.1073/pnas.0604715103; GERKE V, 1984, EMBO J, V3, P227, DOI 10.1002/j.1460-2075.1984.tb01789.x; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Grigorov B, 2006, J MOL BIOL, V359, P848, DOI 10.1016/j.jmb.2006.04.017; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Hayes MJ, 2004, J BIOL CHEM, V279, P14157, DOI 10.1074/jbc.M313025200; Ilangumaran S, 1996, ANAL BIOCHEM, V235, P49, DOI 10.1006/abio.1996.0090; Jin J, 2007, J VIROL, V81, P11226, DOI 10.1128/JVI.00431-07; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Khorchid A, 2002, J VIROL, V76, P4131, DOI 10.1128/JVI.76.8.4131-4137.2002; Kisseleva MV, 2002, J BIOL CHEM, V277, P6266, DOI 10.1074/jbc.M105969200; Lambert O, 1997, J MOL BIOL, V272, P42, DOI 10.1006/jmbi.1997.1183; Leung K, 2008, CELL HOST MICROBE, V3, P285, DOI 10.1016/j.chom.2008.04.004; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; LI YX, 1992, J VIROL, V66, P6587, DOI 10.1128/JVI.66.11.6587-6600.1992; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900; Lindwasser OW, 2001, J VIROL, V75, P7913, DOI 10.1128/JVI.75.17.7913-7924.2001; Liu L, 1999, CELL SIGNAL, V11, P317, DOI 10.1016/S0898-6568(98)00047-3; Loomis RJ, 2006, TRAFFIC, V7, P1643, DOI 10.1111/j.1600-0854.2006.00503.x; Ma G, 2004, J EXP MED, V200, P1337, DOI 10.1084/jem.20041115; MAYORGA LS, 1994, J BIOL CHEM, V269, P30927; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Mouland AJ, 2000, J VIROL, V74, P5441, DOI 10.1128/JVI.74.12.5441-5451.2000; NAKATA T, 1990, J CELL BIOL, V110, P13, DOI 10.1083/jcb.110.1.13; Nermut MV, 2003, VIROLOGY, V305, P219, DOI 10.1006/viro.2002.1692; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; Nydegger S, 2006, J CELL BIOL, V173, P795, DOI 10.1083/jcb.200508165; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Ono A, 2005, J VIROL, V79, P14131, DOI 10.1128/JVI.79.22.14131-14140.2005; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Ono A, 2007, VIROLOGY, V360, P27, DOI 10.1016/j.virol.2006.10.011; ORENSTEIN JM, 1988, J VIROL, V62, P2578, DOI 10.1128/JVI.62.8.2578-2586.1988; Paillart JC, 1999, J VIROL, V73, P2604, DOI 10.1128/JVI.73.4.2604-2612.1999; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Raynor CM, 1999, BIOCHEMISTRY-US, V38, P5089, DOI 10.1021/bi982095b; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Rudner L, 2005, J VIROL, V79, P4055, DOI 10.1128/JVI.79.7.4055-4065.2005; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; Ryzhova EV, 2006, J VIROL, V80, P2694, DOI 10.1128/JVI.80.6.2694-2704.2006; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Salaun C, 2004, TRAFFIC, V5, P255, DOI 10.1111/j.1600-0854.2004.0162.x; Sato K, 2008, J VIROL, V82, P1021, DOI 10.1128/JVI.01044-07; SENDA T, 1994, CELL TISSUE RES, V277, P51; Spearman P, 1997, J VIROL, V71, P6582, DOI 10.1128/JVI.71.9.6582-6592.1997; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Swisher JFA, 2007, J LEUKOCYTE BIOL, V82, P1174, DOI 10.1189/jlb.0307154; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Verani A, 2005, MOL IMMUNOL, V42, P195, DOI 10.1016/j.molimm.2004.06.020; Wahl SM, 2006, J LEUKOCYTE BIOL, V80, P973, DOI 10.1189/jlb.0306130; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822; Wodrich H, 2000, NUCLEIC ACIDS RES, V28, P901, DOI 10.1093/nar/28.4.901; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387	107	28	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e5020	10.1371/journal.pone.0005020	http://dx.doi.org/10.1371/journal.pone.0005020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PO	19325895	gold, Green Published, Green Submitted			2022-12-27	WOS:000265499600006
J	Thye, T; Browne, EN; Chinbuah, MA; Gyapong, J; Osei, I; Owusu-Dabo, E; Brattig, NW; Niemann, S; Rusch-Gerdes, S; Horstmann, RD; Meyer, CG				Thye, Thorsten; Browne, Edmund N.; Chinbuah, Margaret A.; Gyapong, John; Osei, Ivy; Owusu-Dabo, Ellis; Brattig, Norbert W.; Niemann, Stefan; Ruesch-Gerdes, Sabine; Horstmann, Rolf D.; Meyer, Christian G.			IL 10 Haplotype Associated with Tuberculin Skin Test Response but Not with Pulmonary TB	PLOS ONE			English	Article							INTERLEUKIN-10 PROMOTER POLYMORPHISM; SINGLE-NUCLEOTIDE POLYMORPHISMS; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; CYTOKINE PRODUCTION; SUSCEPTIBILITY; GENE; FERTILITY; INFECTION; ANERGY	Evidence from genetic association and twin studies indicates that susceptibility to tuberculosis (TB) is under genetic control. One gene implicated in susceptibility to TB is that encoding interleukin-10 (IL10). In a group of 2010 Ghanaian patients with pulmonary TB and 2346 healthy controls exposed to Mycobacterium tuberculosis, among them 129 individuals lacking a tuberculin skin test (PPD) response, we genotyped four IL10 promoter variants at positions 22849, 21082, 2819, and 2592 and reconstructed the haplotypes. The IL10 low-producer haplotype 22849A/21082A/2819C/2592C, compared to the high-producer haplotype -2849G/-1082G/-819C/-592C, occurred less frequent among PPD-negative controls than among cases (OR 2.15, CI 1.3-3.6) and PPD-positive controls (OR 2.09, CI 1.2-3.5). Lower IL-10 plasma levels in homozygous -2849A/-1082A/-819C/-592C carriers, compared to homozygous -2849G/-1082G/-819C/-592C carriers, were confirmed by a IL-10 ELISA (p=0.016). Although we did not observe differences between the TB patients and all controls, our results provide evidence that a group of individuals exposed to M. tuberculosis transmission is genetically distinct from healthy PPD positives and TB cases. In these PPD-negative individuals, higher IL-10 production appears to reflect IL-10-dependent suppression of adaptive immune responses and sustained long-term specific anergy.			Thye, T (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany.	thye@bni-hamburg.de	Niemann, Stefan/C-9327-2011	Niemann, Stefan/0000-0002-6604-0684; Gyapong, John/0000-0002-8415-1468				ATES O, 2007, J CLIN IMMUNOL; BARNES PF, 1993, INFECT IMMUN, V61, P197, DOI 10.1128/IAI.61.1.197-203.1993; Bellamy R, 2005, CLIN CHEST MED, V26, P233, DOI 10.1016/j.ccm.2005.02.006; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; CROWLE AJ, 1990, INFECT IMMUN, V58, P632, DOI 10.1128/IAI.58.3.632-638.1990; de Groot CJM, 2004, GENES IMMUN, V5, P313, DOI 10.1038/sj.gene.6364092; de Jong BA, 2002, HUM IMMUNOL, V63, P281, DOI 10.1016/S0198-8859(02)00369-5; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; Delgado JC, 2002, P NATL ACAD SCI USA, V99, P7576, DOI 10.1073/pnas.062056099; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DUBOS R, 1952, WHITE PLAGUE TUBERCU, P1; El Baghdadi J, 2006, J EXP MED, V203, P1679, DOI 10.1084/jem.20060269; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; Gibson AW, 2001, J IMMUNOL, V166, P3915, DOI 10.4049/jimmunol.166.6.3915; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Herb F, 2008, HUM MOL GENET, V17, P1052, DOI 10.1093/hmg/ddm378; HOUK VN, 1968, ARCH ENVIRON HEALTH, V16, P26, DOI 10.1080/00039896.1968.10665011; Hudson LL, 2005, GENES IMMUN, V6, P274, DOI 10.1038/sj.gene.6364180; Jamieson SE, 2004, GENES IMMUN, V5, P46, DOI 10.1038/sj.gene.6364029; KALLMANN F. J., 1943, American Review of Tuberculosis and Pulmonary Diseases, V47, P549; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lard LR, 2003, ARTHRITIS RHEUM-US, V48, P1841, DOI 10.1002/art.11160; Lopez-Maderuelo D, 2003, AM J RESP CRIT CARE, V167, P970, DOI 10.1164/rccm.200205-438BC; Meyer CG, 2008, TUBERCULOSIS, V88, P482, DOI 10.1016/j.tube.2008.05.004; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; Moraes MO, 2004, GENES IMMUN, V5, P592, DOI 10.1038/sj.gene.6364122; Netsawang Janjuree, 2004, Journal of the Medical Association of Thailand, V87, pS117; Owusu-Dabo E, 2006, EMERG INFECT DIS, V12, P1170, DOI 10.3201/eid1207.051028; Shaw TC, 2000, CYTOKINE, V12, P483, DOI 10.1006/cyto.1999.0586; Shin HD, 2005, EXP MOL MED, V37, P128, DOI 10.1038/emm.2005.17; Simonds B., 1963, TUBERCULOSIS TWINS; Sousa AO, 1997, P NATL ACAD SCI USA, V94, P13227, DOI 10.1073/pnas.94.24.13227; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Suarez A, 2003, TRANSPLANTATION, V75, P711, DOI 10.1097/01.TP.0000055216.19866.9A; Takiff HE, 2007, TUBERCULOSIS 2007 BA, P207; Thye T, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037960; Timmann C, 2004, GENES IMMUN, V5, P256, DOI 10.1038/sj.gene.6364094; Tso HW, 2005, GENES IMMUN, V6, P358, DOI 10.1038/sj.gene.6364189; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; van Dunne FM, 2006, GENES IMMUN, V7, P688, DOI 10.1038/sj.gene.6364347; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vankayalapati R, 2003, CLIN INFECT DIS, V36, P24, DOI 10.1086/344903; Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110; Westendorp RGJ, 2001, NAT MED, V7, P873, DOI 10.1038/90868	47	48	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5420	10.1371/journal.pone.0005420	http://dx.doi.org/10.1371/journal.pone.0005420			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412539	Green Submitted, gold, Green Published			2022-12-27	WOS:000265688200007
J	Exner, V; Aichinger, E; Shu, H; Wildhaber, T; Alfarano, P; Caflisch, A; Gruissem, W; Kohler, C; Hennig, L				Exner, Vivien; Aichinger, Ernst; Shu, Huan; Wildhaber, Thomas; Alfarano, Pietro; Caflisch, Amedeo; Gruissem, Wilhelm; Koehler, Claudia; Hennig, Lars			The Chromodomain of LIKE HETEROCHROMATIN PROTEIN 1 Is Essential for H3K27me3 Binding and Function during Arabidopsis Development	PLOS ONE			English	Article							HISTONE H3; FLOWERING TIME; GENE-EXPRESSION; LHP1 PROTEIN; PLANT; HP1; METHYLATION; HOMOLOG; ARCHITECTURE; THALIANA	Polycomb group (PcG) proteins are essential to maintain gene expression patterns during development. Transcriptional repression by PcG proteins involves trimethylation of H3K27 (H3K27me3) by Polycomb Repressive Complex 2 (PRC2) in animals and plants. PRC1 binds to H3K27me3 and is required for transcriptional repression in animals, but in plants PRC1-like activities have remained elusive. One candidate protein that could be involved in PRC1-like functions in plants is LIKE HETEROCHROMATIN PROTEIN 1 (LHP1), because LHP1 associates with genes marked by H3K27me3 in vivo and has a chromodomain that binds H3K27me3 in vitro. Here, we show that disruption of the chromodomain of Arabidopsis thaliana LHP1 abolishes H3K27me3 recognition, releases gene silencing and causes similar phenotypic alterations as transcriptional lhp1 null mutants. Therefore, binding to H3K27me3 is essential for LHP1 protein function.			Exner, V (corresponding author), Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland.	lhennig@ethz.ch	Gruissem, Wilhelm/H-1752-2013; Caflisch, Amedeo/I-3459-2012; Köhler, Claudia/G-9668-2011; Hennig, Lars/G-2081-2011	Köhler, Claudia/0000-0002-2619-4857; Gruissem, Wilhelm/0000-0002-1872-2998; Hennig, Lars/0000-0002-6645-1862				Aubert D, 2001, PLANT CELL, V13, P1865, DOI 10.1105/tpc.13.8.1865; Bouveret R, 2006, DEVELOPMENT, V133, P1693, DOI 10.1242/dev.02340; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Calonje M, 2008, PLANT CELL, V20, P277, DOI 10.1105/tpc.106.049957; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dialynas GK, 2006, J BIOL CHEM, V281, P14350, DOI 10.1074/jbc.M600558200; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Germann S, 2006, PLANT J, V48, P153, DOI 10.1111/j.1365-313X.2006.02859.x; HAUGHN GW, 1991, PLANT PHYSIOL, V97, P217, DOI 10.1104/pp.97.1.217; Hennig L, 2003, DEVELOPMENT, V130, P2555, DOI 10.1242/dev.00470; Hennig L, 2005, TRENDS CELL BIOL, V15, P295, DOI 10.1016/j.tcb.2005.04.004; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Katz A, 2004, PLANT J, V37, P707, DOI 10.1111/j.1365-313X.2003.01996.x; Kim JH, 2004, PLANT MOL BIOL, V54, P671, DOI 10.1023/B:PLAN.0000040897.49151.98; Kohler C, 2008, TRENDS CELL BIOL, V18, P236, DOI 10.1016/j.tcb.2008.02.005; Kotake T, 2003, PLANT CELL PHYSIOL, V44, P555, DOI 10.1093/pcp/pcg091; Larsson AS, 1998, GENETICS, V149, P597; Libault M, 2005, PLANTA, V222, P910, DOI 10.1007/s00425-005-0129-4; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Mimida N, 2007, MOL GENET GENOMICS, V278, P295, DOI 10.1007/s00438-007-0250-0; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; MOMANY FA, 1992, J COMPUT CHEM, V13, P888, DOI 10.1002/jcc.540130714; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Nakahigashi K, 2005, PLANT CELL PHYSIOL, V46, P1747, DOI 10.1093/pcp/pci195; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Sanchez-Pulido L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-308; Schonrock N, 2006, GENE DEV, V20, P1667, DOI 10.1101/gad.377206; Schonrock N, 2006, J BIOL CHEM, V281, P9560, DOI 10.1074/jbc.M513426200; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Telfer A, 1997, DEVELOPMENT, V124, P645; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Xu L, 2008, CURR BIOL, V18, P1966, DOI 10.1016/j.cub.2008.11.019; Zemach A, 2006, PLANT CELL, V18, P133, DOI 10.1105/tpc.105.036855; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283	43	103	110	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5335	10.1371/journal.pone.0005335	http://dx.doi.org/10.1371/journal.pone.0005335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399177	Green Published, gold, Green Submitted			2022-12-27	WOS:000265514900003
J	Pouget, P; Wattiez, N; Rivaud-Pechoux, S; Gaymard, B				Pouget, Pierre; Wattiez, Nicolas; Rivaud-Pechoux, Sophie; Gaymard, Bertrand			A Fragile Balance: Perturbation of GABA Mediated Circuit in Prefrontal Cortex Generates High Intraindividual Performance Variability	PLOS ONE			English	Article							NEURONAL-ACTIVITY; EYE-MOVEMENTS; MONKEYS; INVOLVEMENT; INHIBITION; DEFICIT	High intraindividual performance variability is one of the most robust findings to emerge in cognitive-experimental research of attention deficit hyperactivity disorder (ADHD). Evidences from studies incorporating structural or functional human brain mapping methods indicate that this increased intraindividual variability is not simply a sequel of general brain dysfunction, but is likely related to the functioning of neural circuits that engage the prefrontal cortex, particularly the dorsolateral areas (dlPFC). In order to examine further the anatomical and pharmacological substrate responsible for this high intraindividual variability disorder, we injected GABA(A) antagonist (bicuculline) or GABA(A) agonist (muscimol) in the dlPFC of monkeys performing a reflexive oculomotor task. Here we show that, whereas GABA(A) agonist injection induced no or minimal impairments, injection of GABA(A) antagonist dramatically increased the intraindividual variability of saccade response time and of saccade spatial accuracy (amplitude and direction). Overall, this study demonstrates that the balance between excitatory/inhibitory activities in the dlPFC is fragile but crucial, since local micro-injection of GABA(A) antagonist can induce marked behavioural effects. It also reveals that higher cognitive areas such as the dlPFC are markedly capable to influence the productions and metrics of reflexive movements. Altogether, this study provides promising perspectives for the development of new therapeutic strategies for the treatment of diseases in which high intravariability disorders are a prominent feature.			Pouget, P (corresponding author), Hop La Pitie Salpetriere, INSERM, U975, Paris, France.	pierre.pouget@upmc.fr	Pouget, Pierre/N-8031-2019	Pouget, Pierre/0000-0002-4721-7376				Bellgrove MA, 2004, NEUROPSYCHOLOGIA, V42, P1910, DOI 10.1016/j.neuropsychologia.2004.05.007; BOCH RA, 1989, J NEUROPHYSIOL, V61, P1064, DOI 10.1152/jn.1989.61.5.1064; Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Condy C, 2007, CEREB CORTEX, V17, P221, DOI 10.1093/cercor/bhj140; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Di Martino A, 2008, BIOL PSYCHIAT, V64, P607, DOI 10.1016/j.biopsych.2008.03.008; FUNAHASHI S, 1991, J NEUROPHYSIOL, V65, P1464, DOI 10.1152/jn.1991.65.6.1464; Iba M, 2003, J NEUROPHYSIOL, V89, P587, DOI 10.1152/jn.00148.2002; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; SAWAGUCHI T, 1988, BEHAV BRAIN RES, V31, P193, DOI 10.1016/0166-4328(88)90023-X; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Sawaguchi T, 2001, NEUROSCI RES, V39, P123, DOI 10.1016/S0168-0102(00)00204-2; SCHILLER PH, 2003, PROG BRAIN RES, V149, P157; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	20	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5208	10.1371/journal.pone.0005208	http://dx.doi.org/10.1371/journal.pone.0005208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381296	Green Published, Green Submitted, gold			2022-12-27	WOS:000265513800003
J	Sakamoto, K; Onimaru, K; Munakata, K; Suda, N; Tamura, M; Ochi, H; Tanaka, M				Sakamoto, Koji; Onimaru, Koh; Munakata, Keijiro; Suda, Natsuno; Tamura, Mika; Ochi, Haruki; Tanaka, Mikiko			Heterochronic Shift in Hox-Mediated Activation of Sonic hedgehog Leads to Morphological Changes during Fin Development	PLOS ONE			English	Article								We explored the molecular mechanisms of morphological transformations of vertebrate paired fin/limb evolution by comparative gene expression profiling and functional analyses. In this study, we focused on the temporal differences of the onset of Sonic hedgehog (Shh) expression in paired appendages among different vertebrates. In limb buds of chick and mouse, Shh expression is activated as soon as there is a morphological bud, concomitant with Hoxd10 expression. In dogfish (Scyliorhinus canicula), however, we found that Shh was transcribed late in fin development, concomitant with Hoxd13 expression. We utilized zebrafish as a model to determine whether quantitative changes in hox expression alter the timing of shh expression in pectoral fins of zebrafish embryos. We found that the temporal shift of Shh activity altered the size of endoskeletal elements in paired fins of zebrafish and dogfish. Thus, a threshold level of hox expression determines the onset of shh expression, and the subsequent heterochronic shift of Shh activity can affect the size of the fin endoskeleton. This process may have facilitated major morphological changes in paired appendages during vertebrate limb evolution.			Sakamoto, K (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Nagatsuta Cho, Yokohama, Kanagawa, Japan.	mitanaka@bio.titech.ac.jp	Onimaru, Koh/K-5289-2014; Tanaka, Mikiko/B-9329-2015; Ochi, Haruki/AAR-7235-2020; Onimaru, Koh/AAB-4923-2019; Tanaka, Mikiko/X-1904-2019	Onimaru, Koh/0000-0002-2428-9510; Tanaka, Mikiko/0000-0001-8092-8594; Ochi, Haruki/0000-0002-0088-581X; Tanaka, Mikiko/0000-0001-8092-8594				Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; Capellini TD, 2006, DEVELOPMENT, V133, P2263, DOI 10.1242/dev.02395; Charite J, 2000, DEVELOPMENT, V127, P2461; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen YT, 2004, DEVELOPMENT, V131, P2339, DOI 10.1242/dev.01115; COATES M, 1993, NATURE, V364, P195, DOI 10.1038/364195b0; Covassin L, 2006, DEV BIOL, V299, P551, DOI 10.1016/j.ydbio.2006.08.020; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Freitas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000754; Gibert Y, 2006, DEVELOPMENT, V133, P2649, DOI 10.1242/dev.02438; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Horigome N, 1999, DEV BIOL, V207, P287, DOI 10.1006/dbio.1998.9175; Huang D, 1998, DEVELOPMENT, V125, P3235; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Maruoka Y, 1998, MECH DEVELOP, V74, P175, DOI 10.1016/S0925-4773(98)00061-6; Neumann CJ, 1999, DEVELOPMENT, V126, P4817; Niederreither K, 2002, DEVELOPMENT, V129, P3563; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; NISWANDER L, 1992, DEVELOPMENT, V114, P755; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; Scherz PJ, 2007, DEV BIOL, V308, P343, DOI 10.1016/j.ydbio.2007.05.030; Serpente P, 2005, DEVELOPMENT, V132, P503, DOI 10.1242/dev.01593; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Summerbell D., 1991, DEV PATTERNING VERTE; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Tanaka M, 2002, NATURE, V416, P527, DOI 10.1038/416527a; Tarchini B, 2006, NATURE, V443, P985, DOI 10.1038/nature05247; Thisse B, 2004, METHOD CELL BIOL, V77, P505; THOROGOOD P, 1993, NATURE, V364, P196, DOI 10.1038/364196a0; TICKLE C, 1981, NATURE, V289, P295, DOI 10.1038/289295a0; TICKLE C, 1975, NATURE, V254, P199, DOI 10.1038/254199a0; Towers M, 2008, NATURE, V452, P882, DOI 10.1038/nature06718; Waskiewicz AJ, 2002, DEV CELL, V3, P723, DOI 10.1016/S1534-5807(02)00319-2; Welscher PT, 2002, GENE DEV, V16, P421, DOI 10.1101/gad.219202; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Yang Y, 1997, DEVELOPMENT, V124, P4393; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008; Zuniga A, 1999, DEVELOPMENT, V126, P13	53	50	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5121	10.1371/journal.pone.0005121	http://dx.doi.org/10.1371/journal.pone.0005121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365553	Green Published, gold, Green Submitted			2022-12-27	WOS:000265509900001
J	di Tomaso, E; London, N; Fuja, D; Logie, J; Tyrrell, JA; Kamoun, W; Munn, LL; Jain, RK				di Tomaso, Emmanuelle; London, Nyall; Fuja, Daniel; Logie, James; Tyrrell, James A.; Kamoun, Walid; Munn, Lance L.; Jain, Rakesh K.			PDGF-C Induces Maturation of Blood Vessels in a Model of Glioblastoma and Attenuates the Response to Anti-VEGF Treatment	PLOS ONE			English	Article							PROTEASE-ACTIVATED LIGAND; GROWTH-FACTOR; KINASE INHIBITOR; RECEPTOR; EXPRESSION; BETA; CELL; CANCER; ANGIOGENESIS; VASCULATURE	Background: Recent clinical trials of VEGF inhibitors have shown promise in the treatment of recurrent glioblastomas (GBM). However, the survival benefit is usually short-lived as tumors escape anti-VEGF therapies. Here we tested the hypothesis that Platelet Derived Growth Factor-C (PDGF-C), an isoform of the PDGF family, affects GBM progression independent of VEGF pathway and hinders anti-VEGF therapy. Principal Findings: We first showed that PDGF-C is present in human GBMs. Then, we overexpressed or downregulated PDGF-C in a human GBM cell line, U87MG, and grew them in cranial windows in nude mice to assess vessel structure and function using intravital microscopy. PDGF-C overexpressing tumors had smaller vessel diameters and lower vascular permeability compared to the parental or siRNA-transfected tumors. Furthermore, vessels in PDGF-C overexpressing tumors had more extensive coverage with NG2 positive perivascular cells and a thicker collagen IV basement membrane than the controls. Treatment with DC101, an anti-VEGFR-2 antibody, induced decreases in vessel density in the parental tumors, but had no effect on the PDGF-C overexpressing tumors. Conclusion: These results suggest that PDGF-C plays an important role in glioma vessel maturation and stabilization, and that it can attenuate the response to anti-VEGF therapy, potentially contributing to escape from vascular normalization.			di Tomaso, E (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, EL Steele Lab Tumor Biol, Boston, MA 02114 USA.	munn@steele.mgh.harvard.edu; jain@steele.mgh.harvard.edu	Jain, Rakesh K/I-1384-2017; Tyrrell, James/A-6359-2010; Munn, Lance L/L-3950-2016	Jain, Rakesh K/0000-0001-7571-3548; Munn, Lance L/0000-0003-0698-7232; Fuja, Daniel/0000-0002-9351-7580	NCI NIH HHS [P01 CA080124, P01-CA80124] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA080124] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Bhardwaj B, 1996, CLIN CANCER RES, V2, P773; Black P, 1996, PEDIATR NEUROSURG, V24, P74, DOI 10.1159/000121020; Campbell JS, 2007, DIFFERENTIATION, V75, P843, DOI 10.1111/j.1432-0436.2007.00235.x; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Cloughesy TF, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.2010b; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; di Tomaso E, 2005, CANCER RES, V65, P5740, DOI 10.1158/0008-5472.CAN-04-4552; Eitner F, 2008, J AM SOC NEPHROL, V19, P281, DOI 10.1681/ASN.2007030290; FRAIZER GE, 1987, J CELL PHYSIOL, V133, P169, DOI 10.1002/jcp.1041330122; FUNA K, 1990, CANCER RES, V50, P748; George D, 2003, ADV EXP MED BIOL, V532, P141; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Gerstner ER, 2007, EXPERT OPIN INV DRUG, V16, P1895, DOI 10.1517/13543784.16.12.1895; Gordon GJ, 2005, AM J PATHOL, V166, P1827, DOI 10.1016/S0002-9440(10)62492-3; Hagendoorn J, 2006, CANCER RES, V66, P3360, DOI 10.1158/0008-5472.CAN-05-2655; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; HERMANSSON M, 1988, P NATL ACAD SCI USA, V85, P7748, DOI 10.1073/pnas.85.20.7748; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jain RK, 2008, PLOS MED, V5, P20, DOI 10.1371/journal.pmed.0050024; Jain RK, 2002, NAT REV CANCER, V2, P266, DOI 10.1038/nrc778; Jayson GC, 2005, J CLIN ONCOL, V23, P973, DOI 10.1200/JCO.2005.01.032; KAMOUN W, JCO IN PRESS; KAPLAN DR, 1979, BLOOD, V53, P1043; Kawai T, 1997, LAB INVEST, V77, P431; Kilic T, 2000, CANCER RES, V60, P5143; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Li J, 2001, NEUROLOGY, V56, P885, DOI 10.1212/WNL.56.7.885; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Li XR, 2003, CYTOKINE GROWTH F R, V14, P91, DOI 10.1016/S1359-6101(02)00090-4; Lokker NA, 2002, CANCER RES, V62, P3729; Shimizu F, 2008, J CELL PHYSIOL, V217, P388, DOI 10.1002/jcp.21508; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Sundberg C, 1997, AM J PATHOL, V151, P479; Tejada ML, 2006, CLIN CANCER RES, V12, P2676, DOI 10.1158/1078-0432.CCR-05-1770; Tyrrell JA, 2007, IEEE T MED IMAGING, V26, P223, DOI 10.1109/TMI.2006.889722; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; YUAN F, 1994, CANCER RES, V54, P4564	43	91	92	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5123	10.1371/journal.pone.0005123	http://dx.doi.org/10.1371/journal.pone.0005123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352490	gold, Green Published, Green Submitted			2022-12-27	WOS:000265505700019
J	Newhouse, S; Farrall, M; Wallace, C; Hoti, M; Burke, B; Howard, P; Onipinla, A; Lee, K; Shaw-Hawkins, S; Dobson, R; Brown, M; Samani, NJ; Dominiczak, AF; Connell, JM; Lathrop, GM; Kooner, J; Chambers, J; Elliott, P; Clarke, R; Collins, R; Laan, M; Org, E; Juhanson, P; Veldre, G; Viigimaa, M; Eyheramendy, S; Cappuccio, FP; Ji, C; Iacone, R; Strazzullo, P; Kumari, M; Marmot, M; Brunner, E; Caulfield, M; Munroe, PB				Newhouse, Stephen; Farrall, Martin; Wallace, Chris; Hoti, Mimoza; Burke, Beverley; Howard, Philip; Onipinla, Abiodun; Lee, Kate; Shaw-Hawkins, Sue; Dobson, Richard; Brown, Morris; Samani, Nilesh J.; Dominiczak, Anna F.; Connell, John M.; Lathrop, G. Mark; Kooner, Jaspal; Chambers, John; Elliott, Paul; Clarke, Robert; Collins, Rory; Laan, Maris; Org, Elin; Juhanson, Peeter; Veldre, Gudrun; Viigimaa, Margus; Eyheramendy, Susana; Cappuccio, Francesco P.; Ji, Chen; Iacone, Roberto; Strazzullo, Pasquale; Kumari, Meena; Marmot, Michael; Brunner, Eric; Caulfield, Mark; Munroe, Patricia B.			Polymorphisms in the WNK1 Gene Are Associated with Blood Pressure Variation and Urinary Potassium Excretion	PLOS ONE			English	Article								WNK1-a serine/threonine kinase involved in electrolyte homeostasis and blood pressure (BP) control-is an excellent candidate gene for essential hypertension (EH). We and others have previously reported association between WNK1 and BP variation. Using tag SNPs (tSNPs) that capture 100% of common WNK1 variation in HapMap, we aimed to replicate our findings with BP and to test for association with phenotypes relating to WNK1 function in the British Genetics of Hypertension (BRIGHT) study case-control resource (1700 hypertensive cases and 1700 normotensive controls). We found multiple variants to be associated with systolic blood pressure, SBP (7/28 tSNPs min-p = 0.0005), diastolic blood pressure, DBP (7/28 tSNPs min-p = 0.002) and 24 hour urinary potassium excretion (10/28 tSNPs min-p = 0.0004). Associations with SBP and urine potassium remained significant after correction for multiple testing (p = 0.02 and p = 0.01 respectively). The major allele (A) of rs765250, located in intron 1, demonstrated the strongest evidence for association with SBP, effect size 3.14 mmHg (95% CI: 1.23-4.9), DBP 1.9 mmHg (95% CI: 0.7-3.2) and hypertension, odds ratio (OR: 1.3 [95% CI: 1.0-1.7]). We genotyped this variant in six independent populations (n = 14,451) and replicated the association between rs765250 and SBP in a meta-analysis (p = 7 x 10(-3), combined with BRIGHT data-set p = 2 x 10(-4), n = 17,851). The associations of WNK1 with DBP and EH were not confirmed. Haplotype analysis revealed striking associations with hypertension and BP variation (global permutation p<10(-7)). We identified several common haplotypes to be associated with increased BP and multiple low frequency haplotypes significantly associated with lower BP (>10 mmHg reduction) and risk for hypertension (OR<0.60). Our data indicates that multiple rare and common WNK1 variants contribute to BP variation and hypertension, and provide compelling evidence to initiate further genetic and functional studies to explore the role of WNK1 in BP regulation and EH.	[Newhouse, Stephen; Wallace, Chris; Hoti, Mimoza; Burke, Beverley; Howard, Philip; Onipinla, Abiodun; Lee, Kate; Shaw-Hawkins, Sue; Dobson, Richard; Caulfield, Mark; Munroe, Patricia B.] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Clin Pharmacol & Barts & London Genome Ctr, London, England; [Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford OX1 2JD, England; [Brown, Morris] Univ Cambridge, Addenbrooke Hosp, Cambridge Inst Med Res, Cambridge CB2 1TN, England; [Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE1 7RH, Leics, England; [Dominiczak, Anna F.; Connell, John M.] Univ Glasgow, Western Infirmary, BHF Glasgow Cardiovasc Res Ctr, Div Cardiovas & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Lathrop, G. Mark] Ctr Natl Genotypage, Evry, France; [Kooner, Jaspal; Chambers, John; Elliott, Paul] Imperial Coll London, Natl Heart & Lung Inst, Fac Med, London, England; [Clarke, Robert; Collins, Rory] Univ Oxford, Clin Trial Serv Unit, Epidemiol Studies Unit, Oxford OX1 2JD, England; [Laan, Maris; Org, Elin; Juhanson, Peeter] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Veldre, Gudrun] Univ Tartu, Inst Mol & Cell Biol, Dept Cardiol, Tartu, Estonia; [Veldre, Gudrun; Viigimaa, Margus] N Estonia Med Ctr, Ctr Cardiol, Tallinn, Estonia; [Eyheramendy, Susana] Pontificia Univ Catolica Chile, Dept Stat, Santiago, Chile; [Cappuccio, Francesco P.; Ji, Chen] Clin Sci Res Inst, Warwick Med Sch, Coventry, W Midlands, England; [Iacone, Roberto; Strazzullo, Pasquale] Federico II Univ Naples, Sch Med, Dept Clin & Expt Med, Naples, Italy; [Kumari, Meena; Marmot, Michael; Brunner, Eric] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Glasgow; CEA; UDICE-French Research Universities; Universite Paris Saclay; Imperial College London; University of Oxford; University of Tartu; University of Tartu; Pontificia Universidad Catolica de Chile; University of Warwick; University of Naples Federico II; University of London; University College London	Newhouse, S (corresponding author), Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Clin Pharmacol & Barts & London Genome Ctr, London, England.	p.b.munroe@qmul.ac.uk	Viigimaa, Margus/AAX-3864-2020; Brunner, Eric/H-2114-2011; Org, Elin/AAJ-9631-2021; Marmot, M G/Y-3920-2019; Newhouse, Stephen J/C-9330-2011; Iacone, Roberto/M-2867-2016; Dominiczak, Anna F/D-2262-2009; Dominiczak, Anna F/P-9390-2017; Laan, Maris/A-4100-2011; Dobson, Richard j/C-9269-2011	Brunner, Eric/0000-0002-0595-4474; Marmot, M G/0000-0002-2431-6419; Newhouse, Stephen J/0000-0002-1843-9842; Iacone, Roberto/0000-0003-3360-3855; Dominiczak, Anna F/0000-0003-4913-3608; Laan, Maris/0000-0002-8519-243X; Dobson, Richard j/0000-0003-4224-9245; Eyheramendy, Susana/0000-0003-4723-9660; Munroe, Patricia/0000-0002-4176-2947; Kumari, Meena/0000-0001-9716-1035; Caulfield, Mark/0000-0001-9295-3594; Org, Elin/0000-0001-8688-9717; Org, Elin/0000-0003-1451-9375; Lee, Kathryn/0000-0001-6848-4767; Elliott, Paul/0000-0002-7511-5684; Burke, Beverley/0000-0002-4164-297X; Ji, Chen/0000-0003-4919-3299; Wallace, Chris/0000-0001-9755-1703; Viigimaa, Margus/0000-0001-5575-5978	Wellcome Trust International Senior Research Fellowship [070191/Z/03/Z]; Estonian Ministry of Education and Science [0182721s06]; Medical Research Council of Great Britain [G9521010D]; British Heart Foundation [PG02/128, FS/05/061/19501]; The William Harvey Research Foundation; Economic and Social Research Council; Health and Safety Executive; National Heart Lung and Blood Institute, US, NIH [HL36310]; National Institute on Aging, US, NIH [AG13196, AG1764406S1]; Agency for Health Care Policy Research [HS06516]; John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; Department of Health; MRC [G0400874, G9521010, MC_U137686857] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0100222, G9817803B, G8802774, G9521010, G0400874, MC_U137686857, G19/35] Funding Source: researchfish; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017644, R37AG013196, R01AG013196] Funding Source: NIH RePORTER	Wellcome Trust International Senior Research Fellowship(Wellcome Trust); Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); The William Harvey Research Foundation; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Health and Safety Executive; National Heart Lung and Blood Institute, US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging, US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The HYPEST sample collection was financed by Wellcome Trust International Senior Research Fellowship to Maris Laan (grant no. 070191/Z/03/Z) in Biomedical Science in Central Europe and by Estonian Ministry of Education and Science core grant no. 0182721s06. The BRIGHT study and current work are supported by the Medical Research Council of Great Britain (grant number; G9521010D) and the British Heart Foundation (grant number PG02/128). CW is funded by the British Heart Foundation (grant number: FS/05/061/19501). SJN is funded by the Medical Research Council and The William Harvey Research Foundation. Profs Dominiczak and Samani are British Heart Foundation Chairholders. The LOLIPOP Study was funded by the British Heart Foundation. The Whitehall II study has been supported by grants from the Medical Research Council; Economic and Social Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute (HL36310), US, NIH: National Institute on Aging (AG13196), US, NIH; Agency for Health Care Policy Research (HS06516); and the John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health. Samples from the English Longitudinal Study of Ageing (ELSA) DNA Repository (EDNAR), received support under a grant (AG1764406S1) awarded by the National Institute on Aging (NIA). ELSA was developed by a team of researchers based at the National Centre for Social Research, University College London and the Institute of Fiscal Studies. The data were collected by the National Centre for Social Research. The developers and funders of ELSA and the Archive do not bear any responsibility for the analyses or interpretations presented here. Michael Marmot is supported by a MRC Research Professorship. The Whitehall-1 study was supported by the British Heart Foundation and Medical Research Council. The funders of this work did not take part in study design, data collection, or analysis of these data. In addition, none of the funders took part in the decision to publish, or in preparation of this manuscript.	Achard JM, 2003, AM J MED, V114, P495, DOI 10.1016/S0002-9343(03)00054-8; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; Clarke R, 2007, ARCH INTERN MED, V167, P1373, DOI 10.1001/archinte.167.13.1373; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cope G, 2006, J AM SOC NEPHROL, V17, P1867, DOI 10.1681/ASN.2005111224; Cui JSS, 2003, HYPERTENSION, V41, P207, DOI 10.1161/01.HYP.0000044938.94050.E3; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Delaloy C, 2003, MOL CELL BIOL, V23, P9208, DOI 10.1128/MCB.23.24.9208-9221.2003; Delaloy C, 2006, AM J PATHOL, V169, P105, DOI 10.2353/ajpath.2006.051290; FU Y, 2006, AM J PHYSL RENAL PHY; Galletti F, 2007, J HYPERTENS, V25, P1671, DOI 10.1097/HJH.0b013e3281afa09e; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GOLBANG AP, 2006, AM J PHYSL RENAL PHY; GORDON RD, 1986, HYPERTENSION, V8, P93, DOI 10.1161/01.HYP.8.2.93; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P219; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; KANNEL WB, 1969, DIS CHEST, V56, P43, DOI 10.1378/chest.56.1.43; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Modiano G, 2005, EUR J HUM GENET, V13, P184, DOI 10.1038/sj.ejhg.5201306; Naray-Fejes-Toth A, 2004, P NATL ACAD SCI USA, V101, P17434, DOI 10.1073/pnas.0408146101; Newhouse SJ, 2005, HUM MOL GENET, V14, P1805, DOI 10.1093/hmg/ddi187; O'Reilly M, 2003, J AM SOC NEPHROL, V14, P2447, DOI 10.1097/01.ASN.0000089830.97681.3B; Petersen S, 2005, EUROPEAN CARDIOVASCU; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; Strazzullo P, 2006, J HYPERTENS, V24, P1633, DOI 10.1097/01.hjh.0000239300.48130.07; Subramanya AR, 2006, AM J PHYSIOL-RENAL, V290, pF619, DOI 10.1152/ajprenal.00280.2005; Tobin MD, 2008, HYPERTENSION, V51, P1658, DOI 10.1161/HYPERTENSIONAHA.108.112664; Tobin MD, 2005, CIRCULATION, V112, P3423, DOI 10.1161/CIRCULATIONAHA.105.555474; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; TOBIN MD, 2008, HYPERTENSION; Turner ST, 2005, HYPERTENSION, V46, P758, DOI 10.1161/01.HYP.0000186240.81996.57; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; WARD R, 1995, HYPERTENSION PATHOPH; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zhu XF, 2005, HUM MOL GENET, V14, P639, DOI 10.1093/hmg/ddi060	49	38	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2009	4	4							e5003	10.1371/journal.pone.0005003	http://dx.doi.org/10.1371/journal.pone.0005003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QB	19347040	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000265500900001
J	Cordeiro, MT; Braga-Neto, U; Nogueira, RMR; Marques, ETA				Cordeiro, Marli Tenorio; Braga-Neto, Ulisses; Ribeiro Nogueira, Rita Maria; Marques, Ernesto T. A., Jr.			Reliable Classifier to Differentiate Primary and Secondary Acute Dengue Infection Based on IgG ELISA	PLOS ONE			English	Article								Background: Dengue virus infection causes a wide spectrum of illness, ranging from sub-clinical to severe disease. Severe dengue is associated with sequential viral infections. A strict definition of primary versus secondary dengue infections requires a combination of several tests performed at different stages of the disease, which is not practical. Methods and Findings: We developed a simple method to classify dengue infections as primary or secondary based on the levels of dengue-specific IgG. A group of 109 dengue infection patients were classified as having primary or secondary dengue infection on the basis of a strict combination of results from assays of antigen-specific IgM and IgG, isolation of virus and detection of the viral genome by PCR tests performed on multiple samples, collected from each patient over a period of 30 days. The dengue-specific IgG levels of all samples from 59 of the patients were analyzed by linear discriminant analysis (LDA), and one-and two-dimensional classifiers were designed. The one-dimensional classifier was estimated by bolstered resubstitution error estimation to have 75.1% sensitivity and 92.5% specificity. The two-dimensional classifier was designed by taking also into consideration the number of days after the onset of symptoms, with an estimated sensitivity and specificity of 91.64% and 92.46%. The performance of the two-dimensional classifier was validated using an independent test set of standard samples from the remaining 50 patients. The classifications of the independent set of samples determined by the two-dimensional classifiers were further validated by comparing with two other dengue classification methods: hemagglutination inhibition (HI) assay and an in-house anti-dengue IgG-capture ELISA method. The decisions made with the two-dimensional classifier were in 100% accordance with the HI assay and 96% with the in-house ELISA. Conclusions: Once acute dengue infection has been determined, a 2-D classifier based on common dengue virus IgG kits can reliably distinguish primary and secondary dengue infections. Software for calculation and validation of the 2-D classifier is made available for download.	[Cordeiro, Marli Tenorio; Braga-Neto, Ulisses; Marques, Ernesto T. A., Jr.] Fiocruz MS, Aggeu Magalhaes Res Ctr, Virol & Expt Therapy Lab, Recife, PE, Brazil; [Cordeiro, Marli Tenorio] Cent Lab Publ Hlth, Secretar Saude Estado Pernambuco, Recife, PE, Brazil; [Ribeiro Nogueira, Rita Maria] Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil; [Braga-Neto, Ulisses] Texas A&M Univ, Dept Electr & Comp Engn, College Stn, TX USA; [Marques, Ernesto T. A., Jr.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD USA; [Marques, Ernesto T. A., Jr.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Texas A&M University System; Texas A&M University College Station; Johns Hopkins University; Johns Hopkins University	Cordeiro, MT (corresponding author), Fiocruz MS, Aggeu Magalhaes Res Ctr, Virol & Expt Therapy Lab, Recife, PE, Brazil.	emarques@jhmi.edu	Publica, Inct Saude/J-9544-2013; Marques, Ernesto/L-4514-2013; Marques, Ernesto T. A/L-4967-2013; Braga-Neto, Ulisses/ABI-2677-2020	Marques, Ernesto/0000-0003-3826-9358; Marques, Ernesto T. A/0000-0003-3826-9358; 	National Institute of Allergy and Infectious Diseases (NIAID/NIH) [U19 AI56541, N01 AI 40085]; Brazilian National Research Council (CNPq) [DCR 35.0382/2004.2]; Direct For Computer & Info Scie & Enginr [0845407] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI040085, U19AI056541, R01AI040085] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to acknowledge the support of the National Institute of Allergy and Infectious Diseases (NIAID/NIH), under Grants U19 AI56541 and N01 AI 40085. Dr. Braga-Neto would like to acknowledge the support of the Brazilian National Research Council (CNPq), under Grant DCR 35.0382/2004.2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAGA UM, 2005, GENOMIC SIGNAL PROCE; Braga-Neto U, 2004, PATTERN RECOGN, V37, P1267, DOI 10.1016/j.patcog.2003.08.017; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; CHUNGUE E, 1989, T ROY SOC TROP MED H, V83, P708, DOI 10.1016/0035-9203(89)90404-5; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128; GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead Scott B., 1997, P23; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Matheus S, 2005, J CLIN MICROBIOL, V43, P2793, DOI 10.1128/JCM.43.6.2793-2797.2005; Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1; MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985; RDevelopmentCoreTeam, 2005, R LANG ENV STAT COMP; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Schilling S, 2004, J CLIN VIROL, V31, P179, DOI 10.1016/j.jcv.2004.03.020; Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693; Vorndam AV, 1997, DENGUE DENGUE HEMORR; *WORLD ORG VOLC OB, 1997, DIR VOLC OBS 1996 19, P1	23	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e4945	10.1371/journal.pone.0004945	http://dx.doi.org/10.1371/journal.pone.0004945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340301	Green Published, gold, Green Submitted			2022-12-27	WOS:000265500700003
J	Dambacher, M; Rolfs, M; Gollner, K; Kliegl, R; Jacobs, AM				Dambacher, Michael; Rolfs, Martin; Goellner, Kristin; Kliegl, Reinhold; Jacobs, Arthur M.			Event-Related Potentials Reveal Rapid Verification of Predicted Visual Input	PLOS ONE			English	Article							INTERACTIVE ACTIVATION MODEL; TOP-DOWN INFLUENCES; WORD FORM AREA; SELECTIVE ATTENTION; SPATIAL ATTENTION; BRAIN POTENTIALS; VISUOSPATIAL ATTENTION; LETTER PERCEPTION; VENTRAL STREAM; CORTEX	Human information processing depends critically on continuous predictions about upcoming events, but the temporal convergence of expectancy-based top-down and input-driven bottom-up streams is poorly understood. We show that, during reading, event-related potentials differ between exposure to highly predictable and unpredictable words no later than 90 ms after visual input. This result suggests an extremely rapid comparison of expected and incoming visual information and gives an upper temporal bound for theories of top-down and bottom-up interactions in object recognition.	[Dambacher, Michael; Rolfs, Martin; Goellner, Kristin; Kliegl, Reinhold] Univ Potsdam, Dept Psychol, Potsdam, Germany; [Dambacher, Michael; Jacobs, Arthur M.] Free Univ Berlin, Dept Ed & Psychol, Berlin, Germany; [Rolfs, Martin] Univ Paris 05, CNRS, Lab Psychol Percept, Paris, France	University of Potsdam; Free University of Berlin; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Dambacher, M (corresponding author), Univ Potsdam, Dept Psychol, Potsdam, Germany.	michael.dambacher@uni-potsdam.de	Kliegl, Reinhold/AAD-3463-2019; Kliegl, Reinhold/A-1276-2009; Rolfs, Martin/A-7214-2008	Kliegl, Reinhold/0000-0002-0180-8488; Kliegl, Reinhold/0000-0002-0180-8488; Jacobs, Arthur/0000-0002-7910-3955; Rolfs, Martin/0000-0002-8214-8556; Dambacher, Michael/0000-0003-3712-0594	Deutsche Forschungsgemeinschaft [FOR868/1, KL655/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by Deutsche Forschungsgemeinschaft, grants FOR868/1 and KL655/6-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AnlloVento L, 1996, PERCEPT PSYCHOPHYS, V58, P191, DOI 10.3758/BF03211875; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Carlsson K, 2000, J COGNITIVE NEUROSCI, V12, P691, DOI 10.1162/089892900562318; Chaumon M, 2008, J VISION, V8, DOI 10.1167/8.3.10; Churchland P., 1994, LARGE SCALE NEURONAL, P23; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Dambacher M, 2006, BRAIN RES, V1084, P89, DOI 10.1016/j.brainres.2006.02.010; Davidson PR, 2003, CURR OPIN NEUROBIOL, V13, P232, DOI 10.1016/S0959-4388(03)00038-2; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037/0096-3445.129.4.481; Di Lollo V, 2001, J EXP PSYCHOL GEN, V130, P479, DOI 10.1037/0096-3445.130.3.479; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Geyken A., 2007, IDIOMS COLLOCATIONS, P23; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Grossberg S, 1999, CONSCIOUS COGN, V8, P1, DOI 10.1006/ccog.1998.0372; Guyonneau R, 2004, J PHYSIOL-PARIS, V98, P487, DOI 10.1016/j.jphysparis.2005.09.004; Hayhoe M, 2000, VIS COGN, V7, P43, DOI 10.1080/135062800394676; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hopf JM, 2004, J NEUROSCI, V24, P1822, DOI 10.1523/JNEUROSCI.3564-03.2004; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kelly SP, 2008, CEREB CORTEX, V18, P2629, DOI 10.1093/cercor/bhn022; Kliegl R, 2006, J EXP PSYCHOL GEN, V135, P12, DOI 10.1037/0096-3445.135.1.12; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Kutas M., 2006, HDB PSYCHOLINGUISTIC, P659, DOI [10.1016/B978-012369374-7/50018-3, DOI 10.1016/B978-012369374-7/50018-3]; Kveraga K, 2007, BRAIN COGNITION, V65, P145, DOI 10.1016/j.bandc.2007.06.007; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lleras A, 2005, PSYCHOL SCI, V16, P684, DOI 10.1111/j.1467-9280.2005.01596.x; Lleras A, 2007, PERCEPT PSYCHOPHYS, V69, P980, DOI 10.3758/BF03193936; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; MANGUN GR, 1993, ATTENTION PERFORM, V14, P219; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Martinez A, 2001, VISION RES, V41, P1437, DOI 10.1016/S0042-6989(00)00267-4; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; O'Regan JK, 2000, VIS COGN, V7, P191, DOI 10.1080/135062800394766; OREGAN JK, 1992, CAN J PSYCHOL, V46, P461, DOI 10.1037/h0084327; Penolazzi B, 2007, BIOL PSYCHOL, V74, P374, DOI 10.1016/j.biopsycho.2006.09.008; Pitts MA, 2008, BRAIN COGNITION, V67, P11, DOI 10.1016/j.bandc.2007.10.004; Poghosyan V, 2007, NEUROIMAGE, V35, P759, DOI 10.1016/j.neuroimage.2006.11.052; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RUMELHART DE, 1982, PSYCHOL REV, V89, P60, DOI 10.1037/0033-295X.89.1.60; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Schoenfeld MA, 2007, CEREB CORTEX, V17, P2468, DOI 10.1093/cercor/bhl154; Sereno SC, 2003, PSYCHOL SCI, V14, P328, DOI 10.1111/1467-9280.14471; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; ULLMAN S, 1995, CEREB CORTEX, V5, P1, DOI 10.1093/cercor/5.1.1; Valdes-Sosa M, 1998, J COGNITIVE NEUROSCI, V10, P137, DOI 10.1162/089892998563743; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; VanRullen R, 2002, VISION RES, V42, P2593, DOI 10.1016/S0042-6989(02)00298-5; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Williams MA, 2008, NAT NEUROSCI, V11, P1439, DOI 10.1038/nn.2218; Worden MS, 2000, J NEUROSCI, V20; Ziegler JC, 1998, MEM COGNITION, V26, P490, DOI 10.3758/BF03201158	61	60	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5047	10.1371/journal.pone.0005047	http://dx.doi.org/10.1371/journal.pone.0005047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PR	19333386	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499900012
J	Ogonuki, N; Inoue, K; Hirose, M; Miura, I; Mochida, K; Sato, T; Mise, N; Mekada, K; Yoshiki, A; Abe, K; Kurihara, H; Wakana, S; Ogura, A				Ogonuki, Narumi; Inoue, Kimiko; Hirose, Michiko; Miura, Ikuo; Mochida, Keiji; Sato, Takahiro; Mise, Nathan; Mekada, Kazuyuki; Yoshiki, Atsushi; Abe, Kuniya; Kurihara, Hiroki; Wakana, Shigeharu; Ogura, Atsuo			A High-Speed Congenic Strategy Using First-Wave Male Germ Cells	PLOS ONE			English	Article								Background: In laboratory mice and rats, congenic breeding is essential for analyzing the genes of interest on specific genetic backgrounds and for analyzing quantitative trait loci. However, in theory it takes about 3-4 years to achieve a strain carrying about 99% of the recipient genome at the tenth backcrossing (N10). Even with marker-assisted selection, the so-called 'speed congenic strategy', it takes more than a year at N4 or N5. Methodology/Principal Findings: Here we describe a new high-speed congenic system using round spermatids retrieved from immature males (22-25 days of age). We applied the technique to three genetically modified strains of mice: transgenic (TG), knockin (KI) and N-ethyl-N-nitrosourea (ENU)-induced mutants. The donor mice had mixed genetic backgrounds of C57BL/6 (B6):DBA/2 or B6:129 strains. At each generation, males used for backcrossing were selected based on polymorphic marker analysis and their round spermatids were injected into B6 strain oocytes. Backcrossing was repeated until N4 or N5. For the TG and ENU-mutant strains, the N5 generation was achieved on days 188 and 190 and the proportion of B6-homozygous loci was 100% (74 markers) and 97.7% (172/176 markers), respectively. For the KI strain, N4 was achieved on day 151, all the 86 markers being B6-homozygous as early as on day 106 at N3. The carrier males at the final generation were all fertile and propagated the modified genes. Thus, three congenic strains were established through rapid generation turnover between 41 and 44 days. Conclusions/Significance: This new high-speed breeding strategy enables us to produce congenic strains within about half a year. It should provide the fastest protocol for precise definition of the phenotypic effects of genes of interest on desired genetic backgrounds.	[Ogonuki, Narumi; Inoue, Kimiko; Hirose, Michiko; Miura, Ikuo; Mochida, Keiji; Mise, Nathan; Mekada, Kazuyuki; Yoshiki, Atsushi; Abe, Kuniya; Wakana, Shigeharu; Ogura, Atsuo] RIKEN, BioResource Ctr, Tsukuba, Ibaraki, Japan; [Inoue, Kimiko; Ogura, Atsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Sato, Takahiro; Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metabolism, Tokyo, Japan; Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrative Med, Tokyo, Japan; [Sato, Takahiro; Ogura, Atsuo] Banyu Pharm Co Ltd, Tsukuba Safety Assessment Lab, Tsukuba, Ibaraki, Japan	RIKEN; University of Tsukuba; University of Tokyo; University of Tokyo	Ogonuki, N (corresponding author), RIKEN, BioResource Ctr, Tsukuba, Ibaraki, Japan.	ogura@rtc.riken.go.jp	Ogura, Atsuo/J-3916-2014; Yoshiki, Atsushi/O-6162-2019; 名丹, 三瀬/AAD-1036-2021	Ogura, Atsuo/0000-0003-0447-1988; Yoshiki, Atsushi/0000-0002-9450-5151; Kurihara, Hiroki/0000-0002-6476-5593	KAKENHI [20062012, 19300151]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (20062012 [A.O.] and 19300151 [A.O.]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Armstrong NJ, 2006, MAMM GENOME, V17, P273, DOI 10.1007/s00335-005-0123-y; Behringer R, 1998, NAT GENET, V18, P108, DOI 10.1038/ng0298-108; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; DORMAN AFE, 2008, BRAIN BEHAV IN PRESS; Flaherty L, 1981, MOUSE BIOMEDICAL RES, P215; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; Hayashi S, 2003, BIOL REPROD, V69, P1170, DOI 10.1095/biolreprod.103.016832; Hirabayashi M, 2002, MOL REPROD DEV, V62, P295, DOI 10.1002/mrd.10127; Jahnukainen K, 2004, BIOL REPROD, V70, P290, DOI 10.1095/biolreprod.103.018390; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; Kishigami S, 2006, DEV BIOL, V289, P195, DOI 10.1016/j.ydbio.2005.10.026; LIVY DJ, 1991, J HERED, V82, P459, DOI 10.1093/oxfordjournals.jhered.a111128; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Masuya H, 2007, HUM MOL GENET, V16, P2366, DOI 10.1093/hmg/ddm195; MEKADA K, 2009, EXP ANIM IN PRESS; Miki H, 2006, J REPROD DEVELOP, V52, P239, DOI 10.1262/jrd.17078; Miki H, 2004, J REPROD DEVELOP, V50, P131, DOI 10.1262/jrd.50.131; MIKI H, GENESIS IN PRESS; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagy A., 2003, MANIPULATING MOUSE E; Ogonuki N, 2006, P NATL ACAD SCI USA, V103, P13098, DOI 10.1073/pnas.0605755103; Ogura A, 1998, P NATL ACAD SCI USA, V95, P5611, DOI 10.1073/pnas.95.10.5611; OGURA A, 1993, BIOL REPROD, V48, P219, DOI 10.1095/biolreprod48.2.219; Pacholczyk G, 2008, BIOTECHNIQUES, V44, P413, DOI 10.2144/000112706; Pravenec M, 2007, GENOME RES, V17, P1319, DOI 10.1101/gr.6548207; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Sato T, 2008, DEVELOPMENT, V135, P755, DOI 10.1242/dev.012708; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Shimozawa N, 2002, GENESIS, V34, P203, DOI 10.1002/gene.10143; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262; Yoshida N, 2007, NAT PROTOC, V2, P296, DOI 10.1038/nprot.2007.7; Yoshiki A, 2006, ILAR J, V47, P94, DOI 10.1093/ilar.47.2.94; Ziyyat A, 2001, HUM REPROD, V16, P1449, DOI 10.1093/humrep/16.7.1449	38	30	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4943	10.1371/journal.pone.0004943	http://dx.doi.org/10.1371/journal.pone.0004943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333383	Green Submitted, gold, Green Published			2022-12-27	WOS:000265499900005
J	Smith, MI; Huang, YY; Deshmukh, M				Smith, Michelle I.; Huang, Yolanda Y.; Deshmukh, Mohanish			Skeletal Muscle Differentiation Evokes Endogenous XIAP to Restrict the Apoptotic Pathway	PLOS ONE			English	Article								Myotube apoptosis occurs normally during muscle development and aging but it can lead to destruction of skeletal muscle in neuromuscular diseases. Therefore, understanding how myotube apoptosis is regulated is important for developing novel strategies for treatment of muscle loss. We investigated the regulation of apoptosis in skeletal muscle and report a striking increase in resistance to apoptosis following differentiation. We find mitotic C2C12 cells (myoblast-like cells) are sensitive to cytosolic cytochrome c microinjection. However, differentiated C2C12 cells (myotube-like cells) and primary myotubes are markedly resistant. This resistance is due to endogenous X-linked inhibitor of apoptotic protein (XIAP). Importantly, the selective difference in the ability of XIAP to block myotube but not myoblast apoptosis is not due to a change in XIAP but rather a decrease in Apaf-1 expression. This decrease in Apaf-1 links XIAP to caspase activation and death. Our findings suggest that in order for myotubes to die, they may degrade XIAP, functionally inactivate XIAP or upregulate Apaf-1. Importantly, we identify a role for endogenous Smac in overcoming XIAP to allow myotube death. However, in postmitotic cardiomyocytes, where XIAP also restricts apoptosis, endogenous Smac was not capable of overcoming XIAP to cause death. These results show that as skeletal muscle differentiate, they become resistant to apoptosis because of the ability of XIAP to regulate caspase activation. The increased restriction of apoptosis in myotubes is presumably important to ensure the long term survival of these postmitotic cells as they play a vital role in the physiology of organisms.	[Smith, Michelle I.; Huang, Yolanda Y.; Deshmukh, Mohanish] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA; [Smith, Michelle I.; Huang, Yolanda Y.; Deshmukh, Mohanish] Univ N Carolina, Neurosci Ctr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Smith, MI (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA.	mohanish@med.unc.edu			National Institutes of Health (NIH) [GM078366]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078366] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant GM078366 to MD. NIH had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Aure K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061; Beauparlant P, 2003, CURR OPIN DRUG DISC, V6, P179; Bruusgaard JC, 2008, J CLIN INVEST, V118, P1450, DOI 10.1172/JCI34022; Burgess DH, 1999, CELL DEATH DIFFER, V6, P256, DOI 10.1038/sj.cdd.4400489; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Ellerby HM, 1997, J NEUROSCI, V17, P6165; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Fu WN, 2003, ONCOGENE, V22, P451, DOI 10.1038/sj.onc.1206147; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Furukawa Y, 2005, MOL CANCER RES, V3, P325, DOI 10.1158/1541-7786.MCR-04-0105; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Ho AT, 2007, MOL CELL BIOL, V27, P5673, DOI 10.1128/MCB.00188-07; Ho AT, 2004, CELL CYCLE, V3, P446; Ho AT, 2004, EMBO J, V23, P460, DOI 10.1038/sj.emboj.7600039; Ikezoe K, 2002, ACTA NEUROPATHOL, V103, P531, DOI 10.1007/s00401-001-0502-8; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Migheli A, 1997, NEUROGENETICS, V1, P81, DOI 10.1007/s100480050012; Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93; Okada H, 2002, MOL CELL BIOL, V22, P3509, DOI 10.1128/MCB.22.10.3509-3517.2002; Potts MB, 2005, J CELL BIOL, V171, P925, DOI 10.1083/jcb.200504082; Potts PR, 2003, J CELL BIOL, V163, P789, DOI 10.1083/jcb.200307130; Sandri M, 1999, INT J BIOCHEM CELL B, V31, P1373, DOI 10.1016/S1357-2725(99)00063-1; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tews DS, 2008, APPL IMMUNOHISTO M M, V16, P66; Tews DS, 1997, J NEUROPATH EXP NEUR, V56, P150, DOI 10.1097/00005072-199702000-00005; Tews DS, 1996, NEUROMUSCULAR DISORD, V6, P265, DOI 10.1016/0960-8966(96)00018-1; Tews DS, 2002, NEUROMUSCULAR DISORD, V12, P613, DOI 10.1016/S0960-8966(02)00030-5; Van Loo G, 2002, CELL DEATH DIFFER, V9, P301, DOI 10.1038/sj.cdd.4400966; Vaughn AE, 2007, CELL DEATH DIFFER, V14, P973, DOI 10.1038/sj.cdd.4402084; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wang XD, 2001, GENE DEV, V15, P2922; Wright KM, 2004, J CELL BIOL, V167, P303, DOI 10.1083/jcb.200406073	41	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5097	10.1371/journal.pone.0005097	http://dx.doi.org/10.1371/journal.pone.0005097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333375	Green Submitted, Green Published, gold			2022-12-27	WOS:000265499900027
J	Jafa, K; McElroy, P; Fitzpatrick, L; Borkowf, CB; MacGowan, R; Margolis, A; Robbins, K; Youngpairoj, AS; Stratford, D; Greenberg, A; Taussig, J; Shouse, RL; LaMarre, M; McLellan-Lemal, E; Heneine, W; Sullivan, PS				Jafa, Krishna; McElroy, Peter; Fitzpatrick, Lisa; Borkowf, Craig B.; MacGowan, Robin; Margolis, Andrew; Robbins, Ken; Youngpairoj, Ae Saekhou; Stratford, Dale; Greenberg, Alan; Taussig, Jennifer; Shouse, R. Luke; LaMarre, Madeleine; McLellan-Lemal, Eleanor; Heneine, Walid; Sullivan, Patrick S.			HIV Transmission in a State Prison System, 1988-2005	PLOS ONE			English	Article							DRUG-RESISTANCE; HEALTH	Introduction: HIV prevalence among state prison inmates in the United States is more than five times higher than among nonincarcerated persons, but HIV transmission within U.S. prisons is sparsely documented. We investigated 88 HIV seroconversions reported from 1988-2005 among male Georgia prison inmates. Methods: We analyzed medical and administrative data to describe seroconverters' HIV testing histories and performed a case-crossover analysis of their risks before and after HIV diagnosis. We sequenced the gag, env, and pol genes of seroconverters' HIV strains to identify genetically-related HIV transmission clusters and antiretroviral resistance. We combined risk, genetic, and administrative data to describe prison HIV transmission networks. Results: Forty-one (47%) seroconverters were diagnosed with HIV from July 2003-June 2005 when voluntary annual testing was offered. Seroconverters were less likely to report sex (OR [odds ratio] = 0.02, 95% CI [confidence interval]: 0-0.10) and tattooing (OR = 0.03, 95% CI: <0.01-0.20) in prison after their HIV diagnosis than before. Of 67 seroconverters' specimens tested, 33 (49%) fell into one of 10 genetically-related clusters; of these, 25 (76%) reported sex in prison before their HIV diagnosis. The HIV strains of 8 (61%) of 13 antiretroviral-naive and 21 (40%) of 52 antiretroviral-treated seroconverters were antiretroviral-resistant. Discussion: Half of all HIV seroconversions were identified when routine voluntary testing was offered, and seroconverters reduced their risks following their diagnosis. Most genetically-related seroconverters reported sex in prison, suggesting HIV transmission through sexual networks. Resistance testing before initiating antiretroviral therapy is important for newly-diagnosed inmates.			Jafa, K (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	kjafa@psi.org	McLellan-Lemal, Eleanor/J-9720-2012	McLellan-Lemal, Eleanor/0000-0002-1884-9315; MacGowan, Robin/0000-0002-8712-2849; Sullivan, Patrick Sean/0000-0002-7728-0587				Alatrakchi N, 2005, AIDS, V19, P25, DOI 10.1097/00002030-200501030-00003; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P421; [Anonymous], 2006, CRIMINOL PUBLIC POL, DOI DOI 10.1111/J.1745-9133.2006.00101.X; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P512; Hammett TM, 2006, AM J PUBLIC HEALTH, V96, P974, DOI 10.2105/AJPH.2005.066993; Johnson JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000638; Macher A, 2006, EMERG INFECT DIS, V12, P669, DOI 10.3201/eid1204.050484; MARUSCHAK L, 2006, BUREAU JUSTICE STAT; May JP, 2002, AIDS EDUC PREV, V14, P85, DOI 10.1521/aeap.14.7.85.23863; McQuillan GM, 2006, JAIDS-J ACQ IMM DEF, V41, P651, DOI 10.1097/01.qai.0000194235.31078.f6; Stephenson BL, 2005, PUBLIC HEALTH REP, V120, P84, DOI 10.1177/003335490512000114; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789; Wolfe MI, 2001, AM J PUBLIC HEALTH, V91, P1220, DOI 10.2105/AJPH.91.8.1220	13	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5416	10.1371/journal.pone.0005416	http://dx.doi.org/10.1371/journal.pone.0005416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	440GG	19412547	gold, Green Submitted, Green Published			2022-12-27	WOS:000265688200005
J	Majava, V; Kursula, P				Majava, Viivi; Kursula, Petri			Domain Swapping and Different Oligomeric States for the Complex Between Calmodulin and the Calmodulin-Binding Domain of Calcineurin A	PLOS ONE			English	Article								Background: Calmodulin (CaM) is a ubiquitously expressed calcium sensor that engages in regulatory interactions with a large number of cellular proteins. Previously, a unique mode of CaM target recognition has been observed in the crystal structure of a complex between CaM and the CaM-binding domain of calcineurin A. Methodology/Principal Findings: We have solved a high-resolution crystal structure of a complex between CaM and the CaM-binding domain of calcineurin A in a novel crystal form, which shows a dimeric assembly of calmodulin, as observed before in the crystal state. We note that the conformation of CaM in this complex is very similar to that of unliganded CaM, and a detailed analysis revels that the CaM-binding motif in calcineurin A is of a novel '1-11' type. However, using small-angle X-ray scattering (SAXS), we show that the complex is fully monomeric in solution, and a structure of a canonically collapsed CaM-peptide complex can easily be fitted into the SAXS data. This result is also supported by size exclusion chromatography, where the addition of the ligand peptide decreases the apparent size of CaM. In addition, we studied the energetics of binding by isothermal titration calorimetry and found them to closely resemble those observed previously for ligand peptides from CaM-dependent kinases. Conclusions/Significance: Our results implicate that CaM can also form a complex with the CaM-binding domain of calcineurin in a 1: 1 stoichiometry, in addition to the previously observed 2: 2 arrangement in the crystal state. At the structural level, going from 2: 2 association to two 1: 1 complexes will require domain swapping in CaM, accompanied by the characteristic bending of the central linker helix between the two lobes of CaM.			Majava, V (corresponding author), Univ Oulu, Dept Biochem, Oulu, Finland.	petri.kursula@oulu.fi	Kursula, Petri/AAF-4563-2020; Kursula, Petri/K-1058-2012	Kursula, Petri/0000-0001-8529-3751; Kursula, Petri/0000-0001-8529-3751				Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; Brokx RD, 2001, J BIOL CHEM, V276, P14083, DOI 10.1074/jbc.M011026200; Carruthers NJ, 2008, BIOCHEMISTRY-US, V47, P3085, DOI 10.1021/bi702044x; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hayashi N, 2000, PROTEIN SCI, V9, P1905, DOI 10.1110/ps.9.10.1905; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; HEIDORN DB, 1989, BIOCHEMISTRY-US, V28, P6757, DOI 10.1021/bi00442a032; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Izumi Y, 2008, BIOCHEMISTRY-US, V47, P7158, DOI 10.1021/bi702416b; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kursula P., 2004, J APPL CRYSTALLOGR, V37, P347; Kursula P, 2007, ACTA CRYSTALLOGR F, V63, P653, DOI 10.1107/S1744309107034525; Majava V, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-10; Majava V, 2008, FEBS J, V275, P4583, DOI 10.1111/j.1742-4658.2008.06601.x; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noguchi M, 2004, FEBS LETT, V573, P121, DOI 10.1016/j.febslet.2004.07.079; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Ursby T, 2004, AIP CONF PROC, V705, P1241, DOI 10.1063/1.1758025; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Ye QL, 2008, PROTEINS, V73, P19, DOI 10.1002/prot.22032; Ye QL, 2006, BIOCHEMISTRY-US, V45, P738, DOI 10.1021/bi0521801; Zhang Y, 2008, J MOL RECOGNIT, V21, P267, DOI 10.1002/jmr.895	37	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5402	10.1371/journal.pone.0005402	http://dx.doi.org/10.1371/journal.pone.0005402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404396	Green Published, Green Submitted, gold			2022-12-27	WOS:000265614900013
J	Zakharian, E; Thyagarajan, B; French, RJ; Pavlov, E; Rohacs, T				Zakharian, Eleonora; Thyagarajan, Baskaran; French, Robert J.; Pavlov, Evgeny; Rohacs, Tibor			Inorganic Polyphosphate Modulates TRPM8 Channels	PLOS ONE			English	Article								Polyphosphate (polyP) is an inorganic polymer built of tens to hundreds of phosphates, linked by high-energy phosphoanhydride bonds. PolyP forms complexes and modulates activities of many proteins including ion channels. Here we investigated the role of polyP in the function of the transient receptor potential melastatin 8 (TRPM8) channel. Using whole-cell patch-clamp and fluorescent calcium measurements we demonstrate that enzymatic breakdown of polyP by exopolyphosphatase (scPPX1) inhibits channel activity in human embryonic kidney and F-11 neuronal cells expressing TRPM8. We demonstrate that the TRPM8 channel protein is associated with polyP. Furthermore, addition of scPPX1 altered the voltage-dependence and blocked the activity of the purified TRPM8 channels reconstituted into planar lipid bilayers, where the activity of the channel was initiated by cold and menthol in the presence of phosphatidylinositol 4,5-biphosphate (PtdIns(4,5) P-2). The biochemical analysis of the TRPM8 protein also uncovered the presence of poly-(R)-3-hydroxybutyrate (PHB), which is frequently associated with polyP. We conclude that the TRPM8 protein forms a stable complex with polyP and its presence is essential for normal channel activity.			Zakharian, E (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave, Newark, NJ 07103 USA.	zakharel@umdnj.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055159] Funding Source: NIH RePORTER; NINDS NIH HHS [NS055159, R01 NS055159] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abeele FV, 2006, J BIOL CHEM, V281, P40174, DOI 10.1074/jbc.M605779200; Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Andersson DA, 2007, J NEUROSCI, V27, P3347, DOI 10.1523/JNEUROSCI.4846-06.2007; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; BRAUCHI S, 2004, CLUES UNDERSTANDING, P15494; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Das S, 1997, P NATL ACAD SCI USA, V94, P9075, DOI 10.1073/pnas.94.17.9075; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; GRIFFIN JB, 1965, STUDIES PHOSPHORUS M, V7, P4427; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; HEGERMANN J, 2008, POLYPHOSPHATE STREPT, P174; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; HUANG R, 1996, POLY 3 HYDROXYBUTYRA, P22196; HUANG RP, 1995, J BACTERIOL, V177, P486, DOI 10.1128/jb.177.2.486-490.1995; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; KORNBERG A, 1995, INORGANIC POLYPHOSPH, P491; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Kumble KD, 1996, J BIOL CHEM, V271, P27146, DOI 10.1074/jbc.271.43.27146; Li Q, 2004, FEBS LETT, V576, P231, DOI 10.1016/j.febslet.2004.09.017; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P1, DOI 10.1007/s00424-007-0311-6; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Negoda A, 2007, P NATL ACAD SCI USA, V104, P4342, DOI 10.1073/pnas.0700495104; Negoda A, 2009, BBA-BIOMEMBRANES, V1788, P608, DOI 10.1016/j.bbamem.2008.12.017; Pavlov E, 2005, BIOPHYS J, V88, P2614, DOI 10.1529/biophysj.104.057281; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; REUSCH RN, 1995, BIOPHYS J, V69, P754, DOI 10.1016/S0006-3495(95)79958-1; REUSCH RN, 1988, P NATL ACAD SCI USA, V85, P4176, DOI 10.1073/pnas.85.12.4176; Reusch RN, 1997, FEBS LETT, V412, P592, DOI 10.1016/S0014-5793(97)00863-6; REUSCH RN, 1999, STREPTOMYCES LIVIDAN, P15666; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V455, P157, DOI 10.1007/s00424-007-0275-6; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; TAMMENKOSKI M, 2007, KINETIC MUTATIONAL A, P9302; Tammenkoski M, 2008, BIOCHEMISTRY-US, V47, P9707, DOI 10.1021/bi8010847; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, J PHYSIOL-LONDON, V582, P939, DOI 10.1113/jphysiol.2007.132522; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100; WURST H, 1994, J BIOL CHEM, V269, P10996; Xian M, 2007, BBA-BIOMEMBRANES, V1768, P2660, DOI 10.1016/j.bbamem.2007.06.019; Zakharian E, 2007, BIOPHYS J, V92, P588, DOI 10.1529/biophysj.106.095273; Zakharian E, 2004, BIOCHEM BIOPH RES CO, V322, P1059, DOI 10.1016/j.bbrc.2004.08.027; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	53	96	101	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5404	10.1371/journal.pone.0005404	http://dx.doi.org/10.1371/journal.pone.0005404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404398	Green Published, Green Submitted, gold			2022-12-27	WOS:000265614900015
J	Arch, VS; Grafe, TU; Gridi-Papp, M; Narins, PM				Arch, Victoria S.; Grafe, T. Ulmar; Gridi-Papp, Marcos; Narins, Peter M.			Pure Ultrasonic Communication in an Endemic Bornean Frog	PLOS ONE			English	Article							GRAY TREEFROG; CALL; ENERGETICS; RESPONSES; EVOLUTION; SIGNALS; HYLA; EAR	Huia cavitympanum, an endemic Bornean frog, is the first amphibian species known to emit exclusively ultrasonic (i.e., >20 kHz) vocal signals. To test the hypothesis that these frogs use purely ultrasonic vocalizations for intraspecific communication, we performed playback experiments with male frogs in their natural calling sites. We found that the frogs respond with increased calling to broadcasts of conspecific calls containing only ultrasound. The field study was complemented by electrophysiological recordings from the auditory midbrain and by laser Doppler vibrometer measurements of the tympanic membrane's response to acoustic stimulation. These measurements revealed that the frog's auditory system is broadly tuned over high frequencies, with peak sensitivity occurring within the ultrasonic frequency range. Our results demonstrate that H. cavitympanum is the first non-mammalian vertebrate described to communicate with purely ultrasonic acoustic signals. These data suggest that further examination of the similarities and differences in the high-frequency/ultrasonic communication systems of H. cavitympanum and Odorrana tormota, an unrelated frog species that produces and detects ultrasound but does not emit exclusively ultrasonic calls, will afford new insights into the mechanisms underlying vertebrate high-frequency communication.			Arch, VS (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA.	varch@ucla.edu			NIDCD NIH HHS [R01 DC000222-27, DC-00222, R01 DC000222] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000222] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Arch VS, 2008, ANIM BEHAV, V76, P1423, DOI 10.1016/j.anbehav.2008.05.012; Arch VS, 2008, BIOL LETTERS, V4, P19, DOI 10.1098/rsbl.2007.0494; Au W. W., 1993, SONAR DOLPHINS; Capranica R.R., 1965, EVOKED VOCAL RESPONS; Dooling RJ, 2000, SPR HDB AUD, V13, P308; EHRET G, 1981, NATURWISSENSCHAFTEN, V68, P208, DOI 10.1007/BF01047208; FELLERS GM, 1979, COPEIA, P286, DOI 10.2307/1443416; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; Feng AS, 2002, NATURWISSENSCHAFTEN, V89, P352, DOI 10.1007/s00114-002-0335-x; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; Gerhardt HC, 2000, BEHAV ECOL SOCIOBIOL, V48, P243, DOI 10.1007/s002650000226; GRIDI-PAPP M., 2003, SOUNDRULER ACOUSTIC; Gridi-Papp M, 2008, P NATL ACAD SCI USA, V105, P11014, DOI 10.1073/pnas.0802210105; Griffin D.R., 1958, LISTENING DARK ACOUS; Heffner H.E., 1998, COMP PSYCHOL HDB, V1st, P290; Heffner H.E., 2007, SENSES COMPREHENSIVE, P55; Kinsler L. E., 1962, FUNDAMENTALS ACOUSTI, V2nd; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; LOPEZ PT, 1988, ANIM BEHAV, V36, P1295, DOI 10.1016/S0003-3472(88)80198-2; Mann DA, 2001, J ACOUST SOC AM, V109, P3048, DOI 10.1121/1.1368406; MARQUEZ R, 2001, ACOUSTIC COMPETITION, P1142; Mason MJ, 2002, J EXP BIOL, V205, P3153; MASTERTO.B, 1969, J ACOUST SOC AM, V45, P966, DOI 10.1121/1.1911574; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Narins PM, 2004, J ACOUST SOC AM, V115, P910, DOI 10.1121/1.1636851; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; NARINS PM, 1978, J COMP PHYSIOL, V127, P1, DOI 10.1007/BF00611921; Penna M, 2005, ANIM BEHAV, V70, P639, DOI 10.1016/j.anbehav.2004.11.022; PRESTWICH KN, 1994, AM ZOOL, V34, P625, DOI 10.1093/icb/34.6.625; PRESTWICH KN, 1989, J EXP BIOL, V144, P53; Pytte CL, 2004, J COMP PHYSIOL A, V190, P665, DOI 10.1007/s00359-004-0525-4; RONKEN DA, 1990, HEARING RES, V47, P63, DOI 10.1016/0378-5955(90)90167-N; Ryan M.J., 1988, P637; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; Sales GD, 1974, ULTRASONIC COMMUNICA; Schwartz JJ, 1998, ANIM BEHAV, V56, P55, DOI 10.1006/anbe.1998.0737; SCHWARTZ JJ, 1989, J COMP PHYSIOL A, V166, P37; SCHWARTZ JJ, 1994, AM ZOOL, V34, P616; Shen JX, 2008, NATURE, V453, P914, DOI 10.1038/nature06719; Suthers RA, 2006, J EXP BIOL, V209, P4984, DOI 10.1242/jeb.02594; WELLS KD, 1986, BEHAV ECOL SOCIOBIOL, V19, P9, DOI 10.1007/BF00303837; Zakon H.H., 1988, P125	42	35	37	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5413	10.1371/journal.pone.0005413	http://dx.doi.org/10.1371/journal.pone.0005413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401782	Green Published, gold			2022-12-27	WOS:000265601100027
J	Vambutas, A; DeVoti, J; Goldofsky, E; Gordon, M; Lesser, M; Bonagura, V				Vambutas, Andrea; DeVoti, James; Goldofsky, Elliot; Gordon, Michael; Lesser, Martin; Bonagura, Vincent			Alternate Splicing of Interleukin-1 Receptor Type II (IL1R2) In Vitro Correlates with Clinical Glucocorticoid Responsiveness in Patients with AIED	PLOS ONE			English	Article							INNER-EAR DISEASE; MUCKLE-WELLS-SYNDROME; IL-1 DECOY RECEPTOR; HEARING-LOSS; T-CELLS; INNATE IMMUNITY; EXPRESSION; INDUCTION; HEAT-SHOCK-PROTEIN-70; DEXAMETHASONE	Autoimmune Inner Ear Disease (AIED) is poorly characterized clinically, with no definitive laboratory test. All patients suspected of having AIED are given glucocorticoids during periods of acute hearing loss, however, only half initially respond, and still fewer respond over time. We hypothesized that AIED is a systemic autoimmune disease characterized by dysfunctional peripheral blood mononuclear cells (PBMC) responses to a unique cochlear antigen(s). To test this hypothesis, we examined end-stage AIED patients undergoing cochlear implant surgery and compared autologous perilymph stimulated PBMC from AIED patients to controls. We determined that autologous perilymph from AIED patients was unable to induce expression of a long membrane-bound Interleukin-1 Receptor Type II (mIL1R2) transcript in PBMC as compared with controls, despite similar expression of the short soluble IL1R2 (sIL1R2) transcript ( p < 0.05). IL1R2 is a molecular decoy that traps interleukin-1 beta (IL-1 beta) and does not initiate subsequent signaling events, thereby suppressing an inflammatory response. IL1R2 transcript length is regulated by alternate splicing, and the major inhibitory function is attributed to the full-length mIL1R2. In addition, IL1R2 expression is induced by dexamethasone. Separately, we prospectively examined patients with newer onset glucocorticoid-responsive AIED. Immediately prior to clinical treatment for acute deterioration of hearing thresholds, their PBMC demonstrated a robust induction of mIL1R2 in PBMC in response to dexamethasone in vitro that correlated with a clinical response to prednisone in vivo (p < 0.0001) as measured by hearing restoration. In contrast, clinically steroid unresponsive patients demonstrated high basal levels of mIL1R2 in their PBMC and only minimally augmented expression in response to dexamethasone. Thus, induced expression of mIL1R2 appears to be a protective mechanism in hearing homeostasis and warrants further investigation in a large prospective clinical trial to determine if IL1R2 can be used as a specific biomarker for AIED.			Vambutas, A (corresponding author), N Shore LU Hlth Syst, Dept Otolaryngol, Apelian Cochlear Implant Ctr, Clinical Teaching Campus Albert Einstein Coll Med, New Hyde Pk, NY USA.	vambutas@lij.edu		Bonagura, Vincent/0000-0002-0681-2099				Agrup C, 2006, CURR OPIN NEUROL, V19, P26, DOI 10.1097/01.wco.0000194143.02171.46; Alsaeid K, 2006, JOINT BONE SPINE, V73, P62, DOI 10.1016/j.jbspin.2004.12.006; Amor-Dorado JC, 2005, ACTA OTO-LARYNGOL, V125, P1277, DOI 10.1080/00016480510012228; Attur MG, 2002, J IMMUNOL, V168, P2001, DOI 10.4049/jimmunol.168.4.2001; Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Berrocal JRG, 2002, ANN OTO RHINOL LARYN, V111, P989, DOI 10.1177/000348940211101107; Bessis N, 2000, EUR J IMMUNOL, V30, P867, DOI 10.1002/1521-4141(200003)30:3<867::AID-IMMU867>3.0.CO;2-M; Broughton SS, 2004, SEMIN ARTHRITIS RHEU, V34, P544, DOI 10.1016/j.semarthrit.2004.07.001; Brown EA, 1996, CYTOKINE, V8, P828; Cohen S, 2005, OTOL NEUROTOL, V26, P903, DOI 10.1097/01.mao.0000185082.28598.87; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Colotta F, 1996, J IMMUNOL, V156, P2534; Cui XL, 2003, J IMMUNOL, V171, P6814, DOI 10.4049/jimmunol.171.12.6814; Dickensheets HL, 1997, J IMMUNOL, V159, P6226; Docagne F, 2005, EUR J NEUROSCI, V21, P1205, DOI 10.1111/j.1460-9568.2005.03965.x; Fujioka M, 2006, J NEUROSCI RES, V83, P575, DOI 10.1002/jnr.20764; Gloddek B, 2002, ACTA OTO-LARYNGOL, V122, P10, DOI 10.1080/00016480260094901; Harris JP, 2003, JAMA-J AM MED ASSOC, V290, P1875, DOI 10.1001/jama.290.14.1875; Hashimoto S, 2005, AUDIOL NEURO-OTOL, V10, P35, DOI 10.1159/000082306; Hirose K, 2005, J COMP NEUROL, V489, P180, DOI 10.1002/cne.20619; Iwai H, 1999, ANN OTO RHINOL LARYN, V108, P1146, DOI 10.1177/000348949910801209; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Liu CL, 1996, J BIOL CHEM, V271, P20965, DOI 10.1074/jbc.271.34.20965; Lorenz RR, 2002, J NEUROIMMUNOL, V130, P173, DOI 10.1016/S0165-5728(02)00190-X; Mantovani A, 2003, INT ARCH ALLERGY IMM, V132, P109, DOI 10.1159/000073711; Mantovani A, 1998, ANN NY ACAD SCI, V840, P338, DOI 10.1111/j.1749-6632.1998.tb09573.x; Matsuki T, 2006, INT IMMUNOL, V18, P399, DOI 10.1093/intimm/dxh379; MCCABE BF, 1979, ANN OTO RHINOL LARYN, V88, P585, DOI 10.1177/000348947908800501; Mirault T, 2006, ARTHRITIS RHEUM-US, V54, P1697, DOI 10.1002/art.21807; MOSCICKI RA, 1994, JAMA-J AM MED ASSOC, V272, P611, DOI 10.1001/jama.272.8.611; Neumann D, 2000, J IMMUNOL, V165, P3350, DOI 10.4049/jimmunol.165.6.3350; Niparko JK, 2005, OTOL NEUROTOL, V26, P908, DOI 10.1097/01.mao.0000185081.28598.5c; Orlando S, 1997, J BIOL CHEM, V272, P31764, DOI 10.1074/jbc.272.50.31764; Park SN, 2006, LARYNGOSCOPE, V116, P121, DOI 10.1097/01.mlg.0000187401.75156.b2; Penton-Rol G, 1999, J IMMUNOL, V162, P2931; RE F, 1994, J EXP MED, V179, P739, DOI 10.1084/jem.179.2.739; Reefhuis J, 2003, NEW ENGL J MED, V349, P435, DOI 10.1056/NEJMoa031101; Ruckenstein Michael J, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P426, DOI 10.1097/01.moo.0000136101.95662.aa; Ryan AF, 2002, ACTA OTO-LARYNGOL, V122, P38, DOI 10.1080/00016480260094965; Solares CA, 2004, J CLIN INVEST, V113, P1210, DOI 10.1172/JCI200418195; Trune DR, 1998, HEARING RES, V116, P65, DOI 10.1016/S0378-5955(97)00198-6; Wuorimaa T, 2001, SCAND J IMMUNOL, V53, P422, DOI 10.1046/j.1365-3083.2001.00882.x; Yamazaki T, 2008, ARTHRITIS RHEUM, V58, P864, DOI 10.1002/art.23261; Yeom K, 2003, LARYNGOSCOPE, V113, P1770, DOI 10.1097/00005537-200310000-00020; Zantut-Wittmann DE, 2004, HORM METAB RES, V36, P492, DOI 10.1055/s-2004-825732; Zeitoun H, 2005, ARCH OTOLARYNGOL, V131, P665, DOI 10.1001/archotol.131.8.665	46	44	46	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5293	10.1371/journal.pone.0005293	http://dx.doi.org/10.1371/journal.pone.0005293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401759	gold, Green Submitted, Green Published			2022-12-27	WOS:000265601100003
J	Li, H; Kristensen, DM; Coleman, MK; Mushegian, A				Li, Hua; Kristensen, David M.; Coleman, Michael K.; Mushegian, Arcady			Detection of Biochemical Pathways by Probabilistic Matching of Phyletic Vectors	PLOS ONE			English	Article							CELLULAR PATHWAYS; REVERSE GYRASE; VI SECRETION; PROTEIN; GENE; EVOLUTION; ARCHAEAL; GENOMES; TRAITS	A phyletic vector, also known as a phyletic (or phylogenetic) pattern, is a binary representation of the presences and absences of orthologous genes in different genomes. Joint occurrence of two or more genes in many genomes results in closely similar binary vectors representing these genes, and this similarity between gene vectors may be used as a measure of functional association between genes. Better understanding of quantitative properties of gene co-occurrences is needed for systematic studies of gene function and evolution. We used the probabilistic iterative algorithm Psi-square to find groups of similar phyletic vectors. An extended Psi-square algorithm, in which pseudocounts are implemented, shows better sensitivity in identifying proteins with known functional links than our earlier hierarchical clustering approach. At the same time, the specificity of inferring functional associations between genes in prokaryotic genomes is strongly dependent on the pathway: phyletic vectors of the genes involved in energy metabolism and in de novo biosynthesis of the essential precursors tend to be lumped together, whereas cellular modules involved in secretion, motility, assembly of cell surfaces, biosynthesis of some coenzymes, and utilization of secondary carbon sources tend to be identified with much greater specificity. It appears that the network of gene coinheritance in prokaryotes contains a giant connected component that encompasses most biosynthetic subsystems, along with a series of more independent modules involved in cell interaction with the environment.			Li, H (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	hul@stowers.org	Mushegian, Arcady/ABF-5387-2021	Mushegian, Arcady/0000-0002-6809-9225				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bardy SL, 2003, MICROBIOL-SGM, V149, P295, DOI 10.1099/mic.0.25948-0; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brochier-Armanet Celine, 2007, Archaea, V2, P83; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1; Glazko G, 2005, BIOINFORMATICS, V21, P2, DOI 10.1093/bioinformatics/bti1201; Glazko G, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-13; Glazko GV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r32; Goh CS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-257; Jim K, 2004, GENOME RES, V14, P109; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Kensche PR, 2008, J R SOC INTERFACE, V5, P151, DOI 10.1098/rsif.2007.1047; Koonin EV, 1996, TRENDS GENET, V12, P334, DOI 10.1016/0168-9525(96)20010-1; Korbel JO, 2005, PLOS BIOL, V3, P815, DOI 10.1371/journal.pbio.0030134; Levesque M, 2003, CURR BIOL, V13, P129, DOI 10.1016/S0960-9822(03)00009-5; Liolios K, 2006, NUCLEIC ACIDS RES, V34, pD332, DOI 10.1093/nar/gkj145; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Romero H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r66; Sadreyev R, 2003, J MOL BIOL, V326, P317, DOI 10.1016/S0022-2836(02)01371-2; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; VONMERING C, 2007, NUCL ACIDS RES, V35; Wu J, 2003, BIOINFORMATICS, V19, P1524, DOI 10.1093/bioinformatics/btg187; Wu Jie, 2005, Genome Inform, V16, P142	29	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5326	10.1371/journal.pone.0005326	http://dx.doi.org/10.1371/journal.pone.0005326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390636	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514400012
J	Houmani, JL; Ruf, IK				Houmani, Jennifer L.; Ruf, Ingrid K.			Clusters of Basic Amino Acids Contribute to RNA Binding and Nucleolar Localization of Ribosomal Protein L22	PLOS ONE			English	Article								The ribosomal protein L22 is a component of the 60S eukaryotic ribosomal subunit. As an RNA-binding protein, it has been shown to interact with both cellular and viral RNAs including 28S rRNA and the Epstein-Barr virus encoded RNA, EBER-1. L22 is localized to the cell nucleus where it accumulates in nucleoli. Although previous studies demonstrated that a specific amino acid sequence is required for nucleolar localization, the RNA-binding domain has not been identified. Here, we investigated the hypothesis that the nucleolar accumulation of L22 is linked to its ability to bind RNA. To address this hypothesis, mutated L22 proteins were generated to assess the contribution of specific amino acids to RNA binding and protein localization. Using RNA-protein binding assays, we demonstrate that basic amino acids 80-93 are required for high affinity binding of 28S rRNA and EBER-1 by L22. Fluorescence localization studies using GFP-tagged mutated L22 proteins further reveal that basic amino acids 80-93 are critical for nucleolar accumulation and for incorporation into ribosomes. Our data support the growing consensus that the nucleolar accumulation of ribosomal proteins may not be mediated by a defined localization signal, but rather by specific interaction with established nucleolar components such as rRNA.			Houmani, JL (corresponding author), Shriners Hosp Children, Div Res, Portland, OR 97201 USA.	iruf@uci.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007319] Funding Source: NIH RePORTER; NIAID NIH HHS [T32-AI007319, T32 AI007319] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Annilo T, 1998, BIOCHEM BIOPH RES CO, V249, P759, DOI 10.1006/bbrc.1998.9187; Arava Yoav, 2003, Methods Mol Biol, V224, P79; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; Chang SN, 2000, FEBS LETT, V484, P22, DOI 10.1016/S0014-5793(00)02118-9; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; CLARKE PA, 1991, NUCLEIC ACIDS RES, V19, P243, DOI 10.1093/nar/19.2.243; Da Costa L, 2003, BLOOD, V101, P5039, DOI 10.1182/blood-2002-12-3878; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DOBBELSTEIN M, 1995, J VIROL, V69, P8027, DOI 10.1128/JVI.69.12.8027-8034.1995; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; Fok V, 2006, RNA, V12, P872, DOI 10.1261/rna.2339606; Fujiwara T, 2006, EXP CELL RES, V312, P1703, DOI 10.1016/j.yexcr.2006.02.002; Gustafson WC, 1998, BIOCHEM J, V331, P387, DOI 10.1042/bj3310387; HATANAKA M, 1990, BIOESSAYS, V12, P143, DOI 10.1002/bies.950120310; Kubota S, 1999, ONCOGENE, V18, P1503, DOI 10.1038/sj.onc.1202429; Kundu-Michalik S, 2008, MOL BIOL EVOL, V25, P580, DOI 10.1093/molbev/msn002; LAVERGNE JP, 1987, FEBS LETT, V216, P83, DOI 10.1016/0014-5793(87)80761-5; Le SY, 2000, MOL BIOL CELL, V11, P999, DOI 10.1091/mbc.11.3.999; Leopardi R, 1996, P NATL ACAD SCI USA, V93, P4572, DOI 10.1073/pnas.93.10.4572; Leopardi R, 1997, J VIROL, V71, P1133, DOI 10.1128/JVI.71.2.1133-1139.1997; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; Lipsius E, 2005, BIOCHEM BIOPH RES CO, V333, P1353, DOI 10.1016/j.bbrc.2005.06.043; Matsson H, 2004, MOL CELL BIOL, V24, P4032, DOI 10.1128/MCB.24.9.4032-4037.2004; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; Michael WM, 1996, J BIOL CHEM, V271, P11571, DOI 10.1074/jbc.271.19.11571; MICHOT B, 1984, NUCLEIC ACIDS RES, V12, P4259, DOI 10.1093/nar/12.10.4259; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Narayanan A, 1999, EMBO J, V18, P5120, DOI 10.1093/emboj/18.18.5120; Olson MOJ, 2005, HISTOCHEM CELL BIOL, V123, P203, DOI 10.1007/s00418-005-0754-9; Quaye IKE, 1996, EUR J CELL BIOL, V69, P151; Rosorius O, 2000, J BIOL CHEM, V275, P12061, DOI 10.1074/jbc.275.16.12061; Russo G, 2005, BIOCHEM J, V385, P289, DOI 10.1042/BJ20040371; SCHMIDT C, 1995, MOL BIOL CELL, V6, P1875, DOI 10.1091/mbc.6.12.1875; SCHMIDTZACHMANN MS, 1993, J CELL SCI, V105, P799; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Stuger R, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P205; Timmers ACJ, 1999, FEBS LETT, V452, P335, DOI 10.1016/S0014-5793(99)00669-9; TOCZYSKI DP, 1993, MOL CELL BIOL, V13, P703, DOI 10.1128/MCB.13.1.703; TOCZYSKI DP, 1994, P NATL ACAD SCI USA, V91, P3463, DOI 10.1073/pnas.91.8.3463; TOCZYSKI DPW, 1991, EMBO J, V10, P459, DOI 10.1002/j.1460-2075.1991.tb07968.x; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wood J, 2001, J VIROL, V75, P1348, DOI 10.1128/JVI.75.3.1348-1358.2001; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8	44	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5306	10.1371/journal.pone.0005306	http://dx.doi.org/10.1371/journal.pone.0005306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390581	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514200017
J	Wyman, SK; Parkin, RK; Mitchell, PS; Fritz, BR; O'Briant, K; Godwin, AK; Urban, N; Drescher, CW; Knudsen, BS; Tewari, M				Wyman, Stacia K.; Parkin, Rachael K.; Mitchell, Patrick S.; Fritz, Brian R.; O'Briant, Kathy; Godwin, Andrew K.; Urban, Nicole; Drescher, Charles W.; Knudsen, Beatrice S.; Tewari, Muneesh			Repertoire of microRNAs in Epithelial Ovarian Cancer as Determined by Next Generation Sequencing of Small RNA cDNA Libraries	PLOS ONE			English	Article							MIR-200 FAMILY; E-CADHERIN; MESENCHYMAL TRANSITION; TRANSCRIPTIONAL REPRESSOR; EXPRESSION PROFILES; SURFACE EPITHELIUM; ZEB1; IDENTIFICATION; SIGNATURES; CELLS	Background: MicroRNAs (miRNAs) are small regulatory RNAs that are implicated in cancer pathogenesis and have recently shown promise as blood-based biomarkers for cancer detection. Epithelial ovarian cancer is a deadly disease for which improved outcomes could be achieved by successful early detection and enhanced understanding of molecular pathogenesis that leads to improved therapies. A critical step toward these goals is to establish a comprehensive view of miRNAs expressed in epithelial ovarian cancer tissues as well as in normal ovarian surface epithelial cells. Methodology: We used massively parallel pyrosequencing (i.e., "454 sequencing'') to discover and characterize novel and known miRNAs expressed in primary cultures of normal human ovarian surface epithelium (HOSE) and in tissue from three of the most common histotypes of ovarian cancer. Deep sequencing of small RNA cDNA libraries derived from normal HOSE and ovarian cancer samples yielded a total of 738,710 high-quality sequence reads, generating comprehensive digital profiles of miRNA expression. Expression profiles for 498 previously annotated miRNAs were delineated and we discovered six novel miRNAs and 39 candidate miRNAs. A set of 124 miRNAs was differentially expressed in normal versus cancer samples and 38 miRNAs were differentially expressed across histologic subtypes of ovarian cancer. Taqman qRT-PCR performed on a subset of miRNAs confirmed results of the sequencing-based study. Conclusions: This report expands the body of miRNAs known to be expressed in epithelial ovarian cancer and provides a useful resource for future studies of the role of miRNAs in the pathogenesis and early detection of ovarian cancer.			Wyman, SK (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	mtewari@fhcrc.org		Mitchell, Patrick/0000-0001-8375-9060	NCI NIH HHS [T32 CA009657, P50 CA083638, 5 T32 CA09657-16, P50 CA083636, P50 CA83636] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA083638] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; BAR M, 2008, STEM CELLS; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Berkenblit A, 2005, J REPROD MED, V50, P426; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Cummins JM, 2006, ONCOGENE, V25, P6220, DOI 10.1038/sj.onc.1209914; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Dyck HG, 1996, INT J CANCER, V69, P429, DOI 10.1002/(SICI)1097-0215(19961220)69:6<429::AID-IJC1>3.0.CO;2-6; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Gregoire L, 1998, IN VITRO CELL DEV-AN, V34, P636; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li NFF, 2004, LAB INVEST, V84, P923, DOI 10.1038/labinvest.3700093; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zou XH, 2008, CELL RES, V18, DOI 10.1038/cr.2008.171	52	198	218	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5311	10.1371/journal.pone.0005311	http://dx.doi.org/10.1371/journal.pone.0005311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390579	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514200022
J	Buddenhagen, CE; Chimera, C; Clifford, P				Buddenhagen, Christopher Evan; Chimera, Charles; Clifford, Patti			Assessing Biofuel Crop Invasiveness: A Case Study	PLOS ONE			English	Article							RISK-ASSESSMENT SYSTEM; PROPAGULE PRESSURE; PLANTS; INVASIONS; PATTERN; MODEL	Background: There is widespread interest in biofuel crops as a solution to the world's energy needs, particularly in light of concerns over greenhouse-gas emissions. Despite reservations about their adverse environmental impacts, no attempt has been made to quantify actual, relative or potential invasiveness of terrestrial biofuel crops at an appropriate regional or international scale, and their planting continues to be largely unregulated. Methodology/Principal Findings: Using a widely accepted weed risk assessment system, we analyzed a comprehensive list of regionally suitable biofuel crops to show that seventy percent have a high risk of becoming invasive versus one-quarter of non-biofuel plant species and are two to four times more likely to establish wild populations locally or be invasive in Hawaii or in other locations with a similar climate. Conclusions/Significance: Because of climatic and ecological similarities, predictions of biofuel crop invasiveness in Hawaii are applicable to other vulnerable island and subtropical ecosystems worldwide. We demonstrate the utility of an accessible and scientifically proven risk assessment protocol that allows users to predict if introduced species will become invasive in their region of interest. Other evidence supports the contention that propagule pressure created by extensive plantings will exacerbate invasions, a scenario expected with large-scale biofuel crop cultivation. Proactive measures, such as risk assessments, should be employed to predict invasion risks, which could then be mitigated via implementation of appropriate planting policies and adoption of the "polluter-pays'' principle.			Buddenhagen, CE (corresponding author), Univ Hawaii Manoa, Pacific Cooperat Studies Unit, Honolulu, HI 96822 USA.	cbuddenhagen@gmail.com	Buddenhagen, Christopher/J-3942-2019	Buddenhagen, Christopher/0000-0002-3016-1054				Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; Caley P, 2006, BIOL INVASIONS, V8, P1595, DOI 10.1007/s10530-004-0010-6; Chow J, 2003, SCIENCE, V302, P1528, DOI 10.1126/science.1091939; Daehler CC, 2004, CONSERV BIOL, V18, P360, DOI 10.1111/j.1523-1739.2004.00066.x; Daehler CC, 1998, BIOL CONSERV, V84, P167, DOI 10.1016/S0006-3207(97)00096-7; Daehler CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004462; Denslow JS, 2003, ANN MO BOT GARD, V90, P119, DOI 10.2307/3298531; Diez JM, 2008, ECOL LETT, V11, P674, DOI 10.1111/j.1461-0248.2008.01178.x; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Gordon DR, 2008, DIVERS DISTRIB, V14, P234, DOI 10.1111/j.1472-4642.2007.00460.x; Keller RP, 2007, P NATL ACAD SCI USA, V104, P203, DOI 10.1073/pnas.0605787104; Kinoshita CM., 1999, SITING EVALUATION BI; Knowler D, 2005, ECOL ECON, V52, P341, DOI 10.1016/j.ecolecon.2004.06.019; Kumar JV, 1996, THERMOCHIM ACTA, V279, P111; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; LONSDALE WM, 1994, AUST J ECOL, V19, P345, DOI 10.1111/j.1442-9993.1994.tb00498.x; Low T., 2007, WEEDY TRUTH BIOFUELS; Parker C, 2007, WEED SCI, V55, P386, DOI 10.1614/WS-06-168; Paynter Q, 2003, AUST SYST BOT, V16, P81, DOI 10.1071/SB01025; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pimentel D., 2005, NAT RESOUR RES, V14, P65, DOI [DOI 10.1007/S11053-005-4679-8, 10.1007/s11053-005-4679-8]; Poteet MD., 2006, BIODIESEL CROP IMPLE; Pysek P, 1998, OIKOS, V82, P282, DOI 10.2307/3546968; R Core Team, 2018, R LANG ENV STAT COMP; Raghu S, 2006, SCIENCE, V313, P1742, DOI 10.1126/science.1129313; Raghu S, 2007, ILL NAT STEWARD, V16, P30; REJMANEK M, 2002, INVASIVE ALIEN SPECI; Rouget M, 2003, AM NAT, V162, P713, DOI 10.1086/379204; Scharlemann JPW, 2008, SCIENCE, V319, P43, DOI 10.1126/science.1153103; Staples GW., 2005, TROPICAL GARDEN FLOR; Turn S.Q., 2005, PHYSICOCHEMICAL ANAL; Turn SQ, 2002, ANAL HAWAII BIOMASS; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Weber J, 2009, J ENVIRON MANAGE, V90, P798, DOI 10.1016/j.jenvman.2008.01.012; [No title captured]	37	83	85	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5261	10.1371/journal.pone.0005261	http://dx.doi.org/10.1371/journal.pone.0005261			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384412	gold, Green Published			2022-12-27	WOS:000265513900011
J	Heuvelin, E; Lebreton, C; Grangette, C; Pot, B; Cerf-Bensussan, N; Heyman, M				Heuvelin, Elise; Lebreton, Corinne; Grangette, Corinne; Pot, Bruno; Cerf-Bensussan, Nadine; Heyman, Martine			Mechanisms Involved in Alleviation of Intestinal Inflammation by Bifidobacterium Breve Soluble Factors	PLOS ONE			English	Article								Objectives: Soluble factors released by Bifidobacterium breve C50 (Bb) alleviate the secretion of pro-inflammatory cytokines by immune cells, but their effect on intestinal epithelium remains elusive. To decipher the mechanisms accounting for the cross-talk between bacteria/soluble factors and intestinal epithelium, we measured the capacity of the bacteria, its conditioned medium (Bb-CM) and other Gram(+) commensal bacteria to dampen inflammatory chemokine secretion. Methods: TNF alpha-induced chemokine (CXCL8) secretion and alteration of NF-kappa B and AP-1 signalling pathways by Bb were studied by EMSA, confocal microscopy and western blotting. Anti-inflammatory capacity was also tested in vivo in a model of TNBS-induced colitis in mice. Results: Bb and Bb-CM, but not other commensal bacteria, induced a time and dose-dependent inhibition of CXCL8 secretion by epithelial cells driven by both AP-1 and NF-kappa B transcription pathways and implying decreased phosphorylation of p38-MAPK and IkB-alpha molecules. In TNBS-induced colitis in mice, Bb-CM decreased the colitis score and inflammatory cytokine expression, an effect reproduced by dendritic cell conditioning with Bb-CM. Conclusions: Bb and secreted soluble factors contribute positively to intestinal homeostasis by attenuating chemokine production. The results indicate that Bb down regulate inflammation at the epithelial level by inhibiting phosphorylations involved in inflammatory processes and by protective conditioning of dendritic cells.			Heuvelin, E (corresponding author), INSERM, U793, Paris, France.	martine.heyman@inserm.fr	Pot, Bruno DF/I-6645-2012; Cerf-Bensussan, nadine/H-9505-2017	Cerf-Bensussan, nadine/0000-0003-0665-1245				Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Borruel N, 2002, GUT, V51, P659, DOI 10.1136/gut.51.5.659; Foligne B, 2006, DIGEST DIS SCI, V51, P390, DOI 10.1007/s10620-006-3143-x; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Gribar SC, 2008, J LEUKOCYTE BIOL, V83, P493, DOI 10.1189/jlb.0607358; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; ISOLAURI E, 1995, VACCINE, V13, P310, DOI 10.1016/0264-410X(95)93319-5; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Ko JS, 2007, WORLD J GASTROENTERO, V13, P1962, DOI 10.3748/wjg.v13.i13.1962; Lee J, 2006, ANN NY ACAD SCI, V1072, P351, DOI 10.1196/annals.1326.022; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Ma DL, 2004, INFECT IMMUN, V72, P5308, DOI 10.1128/IAI.72.9.5308-5314.2004; McCole DF, 2007, CURR OPIN GASTROEN, V23, P647, DOI 10.1097/MOG.0b013e3282f0153b; Menard S, 2004, GUT, V53, P821, DOI 10.1136/gut.2003.026252; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Petrof EO, 2004, GASTROENTEROLOGY, V127, P1474, DOI 10.1053/j.gastro.2004.09.001; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; TEN RM, 1992, EMBO J, V11, P195, DOI 10.1002/j.1460-2075.1992.tb05042.x; Tien MT, 2006, J IMMUNOL, V176, P1228, DOI 10.4049/jimmunol.176.2.1228	23	82	110	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5184	10.1371/journal.pone.0005184	http://dx.doi.org/10.1371/journal.pone.0005184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381276	Green Published, gold			2022-12-27	WOS:000265510800003
J	Cohan, D; Gomez, E; Greenberg, M; Washington, S; Charlebois, ED				Cohan, Deborah; Gomez, Elvira; Greenberg, Mara; Washington, Sierra; Charlebois, Edwin D.			Patient Perspectives with Abbreviated versus Standard Pre-Test HIV Counseling in the Prenatal Setting: A Randomized-Controlled, Non-Inferiority Trial	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DECISION AID; POSTMENOPAUSAL WOMEN; PREGNANT-WOMEN; THERAPY	Background: In the US, an unacceptably high percentage of pregnant women do not undergo prenatal HIV testing. Previous studies have found increased uptake of prenatal HIV testing with abbreviated pre-test counseling, however little is known about patient decision making, testing satisfaction and knowledge in this setting. Methodology/Findings: A randomized-controlled, non-inferiority trial was conducted from October 2006 through February 2008 at San Francisco General Hospital (SFGH), the public teaching hospital of the City and County of San Francisco. A total of 278 English-and Spanish-speaking pregnant women were randomized to receive either abbreviated or standard nurse-performed HIV test counseling at the initial prenatal visit. Patient decision making experience was compared between abbreviated versus standard HIV counseling strategies among a sample of low-income, urban, ethnically diverse prenatal patients. The primary outcome was the decisional conflict score (DCS) using O'Connor low-literacy scale and secondary outcomes included satisfaction with test decision, basic HIV knowledge and HIV testing uptake. We conducted an intention-to-treat analysis of 278 women -134 (48.2%) in the abbreviated arm (AA) and 144 (51.8%) in the standard arm (SA). There was no significant difference in the proportion of women with low decisional conflict (71.6% in AA vs. 76.4% in SA, p = .37), and the observed mean difference between the groups of 3.88 (95% CI: -0.65, 8.41) did not exceed the non-inferiority margin. HIV testing uptake was very high (97.8%) and did not differ significantly between the 2 groups (99.3% in AA vs. 96.5% in SA, p = .12). Likewise, there was no difference in satisfaction with testing decision (97.8% in AA vs. 99.3% in SA, p = .36). However, women in AA had significantly lower mean HIV knowledge scores (78.4%) compared to women in SA (83.7%, p<0.01). Conclusions/Significance: This study suggests that streamlining the pre-test counseling process, while associated with slightly lower knowledge, does not compromise patient decision making or satisfaction regarding HIV testing. Trial Registration: Clinical Trials. gov NCT00503308			Cohan, D (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	cohand@obgyn.ucsf.edu	Gomez, Elvira/I-2663-2014	Gomez, Elvira/0000-0002-9223-6357	NATIONAL INSTITUTE ON DRUG ABUSE [K23DA016174] Funding Source: NIH RePORTER; NIDA NIH HHS [K23DA016174, K23 DA016174] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; [Anonymous], 2002, RED OBST BARR OFF HI; [Anonymous], 2006, MMWR RECOMM REP; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Carusi D, 1998, OBSTET GYNECOL, V91, P540, DOI 10.1016/S0029-7844(97)00714-X; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1013; Chou R, 2005, ANN INTERN MED, V143, P38, DOI 10.7326/0003-4819-143-1-200507050-00009; Cohan D, 2008, JAIDS-J ACQ IMM DEF, V49, P571, DOI 10.1097/QAI.0b013e31818d5e11; Cranney A, 2002, PATIENT EDUC COUNS, V47, P245, DOI 10.1016/S0738-3991(01)00218-X; Dixon WJ., 1983, INTRO STAT ANAL; Gattellari M, 2004, J MED SCREEN, V11, P165, DOI 10.1258/0969141042467386; Kuppermann M, 2006, OBSTET GYNECOL, V107, P1087, DOI 10.1097/01.AOG.0000214953.90248.db; Kuppermann M, 2009, OBSTET GYNECOL, V113, P53, DOI 10.1097/AOG.0b013e31818e7ec4; Lalonde L., 2006, INT J PHARM PRACT, V14, P51, DOI [10.1211/ijpp.14.1.0007, DOI 10.1211/ijpp.14.1.0007]; Laupacis A, 2006, PATIENT EDUC COUNS, V61, P458, DOI 10.1016/j.pec.2005.05.014; Man-Son-Hing M, 1999, JAMA-J AM MED ASSOC, V282, P737, DOI 10.1001/jama.282.8.737; Murray E, 2001, BMJ-BRIT MED J, V323, P490, DOI 10.1136/bmj.323.7311.490; *NAT HIV AIDS CLIN, 2008, COMP STAT HIV TEST L; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; O'Connor AM, 1998, MED DECIS MAKING, V18, P295, DOI 10.1177/0272989X9801800307; OBRIEN R, 1993, APPL ANAL VARIANCE B; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; *OTT HLTH RES I OT, US MAN DEC CONFL SCA; Phillips KA, 1997, J ACQ IMMUN DEF SYND, V14, P174, DOI 10.1097/00042560-199702010-00012; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Rahangdale L, 2008, J WOMENS HEALTH, V17, P465, DOI 10.1089/jwh.2007.0545; Siminoff Laura A., 2000, Health Expect, V3, P26, DOI 10.1046/j.1369-6513.2000.00074.x; Simpson W M, 1999, Health Technol Assess, V3, P1; Simpson WM, 1998, BRIT MED J, V316, P262, DOI 10.1136/bmj.316.7127.262; Stringer EM, 2001, OBSTET GYNECOL, V98, P1104, DOI 10.1016/S0029-7844(01)01631-3; 2002, MMWR MORB MORTAL WKL, V51, P93	31	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2009	4	4							e5166	10.1371/journal.pone.0005166	http://dx.doi.org/10.1371/journal.pone.0005166			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437TS	19367335	Green Submitted, gold, Green Published			2022-12-27	WOS:000265510400002
J	Bax, DA; Little, SE; Gaspar, N; Perryman, L; Marshall, L; Viana-Pereira, M; Jones, TA; Williams, RD; Grigoriadis, A; Vassal, G; Workman, P; Sheer, D; Reis, RM; Pearson, ADJ; Hargrave, D; Jones, C				Bax, Dorine A.; Little, Suzanne E.; Gaspar, Nathalie; Perryman, Lara; Marshall, Lynley; Viana-Pereira, Marta; Jones, Tania A.; Williams, Richard D.; Grigoriadis, Anita; Vassal, Gilles; Workman, Paul; Sheer, Denise; Reis, Rui M.; Pearson, Andrew D. J.; Hargrave, Darren; Jones, Chris			Molecular and Phenotypic Characterisation of Paediatric Glioma Cell Lines as Models for Preclinical Drug Development	PLOS ONE			English	Article								Background: Although paediatric high grade gliomas resemble their adult counterparts in many ways, there appear to be distinct clinical and biological differences. One important factor hampering the development of new targeted therapies is the relative lack of cell lines derived from childhood glioma patients, as it is unclear whether the well-established adult lines commonly used are representative of the underlying molecular genetics of childhood tumours. We have carried out a detailed molecular and phenotypic characterisation of a series of paediatric high grade glioma cell lines in comparison to routinely used adult lines. Principal Findings: All lines proliferate as adherent monolayers and express glial markers. Copy number profiling revealed complex genomes including amplification and deletions of genes known to be pivotal in core glioblastoma signalling pathways. Expression profiling identified 93 differentially expressed genes which were able to distinguish between the adult and paediatric high grade cell lines, including a number of kinases and co-ordinated sets of genes associated with DNA integrity and the immune response. Significance: These data demonstrate that glioma cell lines derived from paediatric patients show key molecular differences to those from adults, some of which are well known, whilst others may provide novel targets for evaluation in primary tumours. We thus provide the rationale and demonstrate the practicability of using paediatric glioma cell lines for preclinical and mechanistic studies.			Bax, DA (corresponding author), Inst Canc Res, Paediat Oncol, Sutton, Surrey, England.	chris.jones@icr.ac.uk	Reis, Rui M/C-2859-2009; Reis, Rui Manuel/B-1744-2018; Hargrave, Darren R/H-1066-2014; Corbett-Jones, Tania A/E-4891-2013; Jones, Chris/ABE-6059-2021; Sheer, Denise/C-6705-2011; Viana-Pereira, Marta/E-1317-2014; Jones, Tania/C-8912-2011; Reis, Rui Manuel/AAD-6470-2020	Reis, Rui M/0000-0002-9639-7940; Reis, Rui Manuel/0000-0002-9639-7940; Hargrave, Darren R/0000-0001-8219-9807; Corbett-Jones, Tania A/0000-0002-0067-3382; Jones, Chris/0000-0001-8118-2296; Sheer, Denise/0000-0001-9067-1796; Viana-Pereira, Marta/0000-0003-3087-0624; Jones, Tania/0000-0002-0067-3382; Reis, Rui Manuel/0000-0002-9639-7940; Grigoriadis, Anita/0000-0003-3434-201X	Cancer Research UK [A8318, C1178/A10294, C309/A8274, C309/A2187] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Bar EE, 2008, J NEUROPATH EXP NEUR, V67, P878, DOI 10.1097/NEN.0b013e3181845622; Bobola MS, 2005, CLIN CANCER RES, V11, P2747, DOI 10.1158/1078-0432.CCR-04-2045; Brantley EC, 2008, MOL CANCER RES, V6, P675, DOI 10.1158/1541-7786.MCR-07-2180; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Broniscer A, 2006, J NEURO-ONCOL, V76, P313, DOI 10.1007/s11060-005-7409-5; Broniscer A, 2007, J CLIN ONCOL, V25, P682, DOI 10.1200/JCO.2006.06.8213; Cheng Y, 1999, HUM PATHOL, V30, P1284, DOI 10.1016/S0046-8177(99)90057-6; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Eils R, 1998, CYTOGENET CELL GENET, V82, P160, DOI 10.1159/000015092; Faury D, 2007, J CLIN ONCOL, V25, P1196, DOI 10.1200/JCO.2006.07.8626; Fruehauf JP, 2006, CLIN CANCER RES, V12, P4523, DOI 10.1158/1078-0432.CCR-05-1830; GASPAR N, DIFFERENTIAL M UNPUB; Gaspar N, 2009, CANCER RES, V69, P1966, DOI 10.1158/0008-5472.CAN-08-3131; Gilles FH, 2000, CANCER-AM CANCER SOC, V88, P1477, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1477::AID-CNCR28>3.3.CO;2-#; Hargrave Darren R, 2007, Expert Rev Neurother, V7, P1029, DOI 10.1586/14737175.7.8.1029; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jeuken JW, 2007, LAB INVEST, V87, P1055, DOI 10.1038/labinvest.3700664; Johannessen TCA, 2008, CANCER TREAT REV, V34, P558, DOI 10.1016/j.ctrv.2008.03.125; Krupp W, 2004, CANCER GENET CYTOGEN, V153, P32, DOI 10.1016/j.cancergencyto.2003.12.017; Lambros MBK, 2006, LAB INVEST, V86, P398, DOI 10.1038/labinvest.3700390; Ma JG, 2002, BIOCHEM PHARMACOL, V63, P1219, DOI 10.1016/S0006-2952(02)00876-6; McLendon R, 2008, NATURE; Nakamura M, 2007, NEURO-ONCOLOGY, V9, P113, DOI 10.1215/15228517-2006-036; Nicholson HS, 2007, CANCER, V110, P1542, DOI 10.1002/cncr.22961; Nygren AOH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni127; Parkinson JF, 2008, J CLIN NEUROSCI, V15, P1, DOI 10.1016/j.jocn.2007.06.005; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pollack IF, 2006, J CLIN ONCOL, V24, P3431, DOI 10.1200/JCO.2006.05.7265; Potter N, 2008, NEOPLASIA, V10, P757, DOI 10.1593/neo.07914; Rebetz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001936; Reddy A T, 2001, Curr Neurol Neurosci Rep, V1, P137, DOI 10.1007/s11910-001-0009-7; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; Rickert CH, 2001, AM J PATHOL, V158, P1525, DOI 10.1016/S0002-9440(10)64103-X; Ruggiero A, 2006, J NEURO-ONCOL, V77, P89, DOI 10.1007/s11060-005-9011-2; Stone AR, 2004, AM J PATHOL, V165, P1151, DOI 10.1016/S0002-9440(10)63376-7; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tchirkov A, 2007, BRIT J CANCER, V96, P474, DOI 10.1038/sj.bjc.6603586; WASSON JC, 1990, CANCER RES, V50, P2987; Wen PY, 2006, CLIN CANCER RES, V12, P4899, DOI 10.1158/1078-0432.CCR-06-0773; Wick W, 2006, CURR PHARM DESIGN, V12, P341, DOI 10.2174/138161206775201901; Wong KK, 2006, CANCER RES, V66, P11172, DOI 10.1158/0008-5472.CAN-06-2438	42	89	92	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2009	4	4							e5209	10.1371/journal.pone.0005209	http://dx.doi.org/10.1371/journal.pone.0005209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TO	19365568	Green Published, Green Submitted, gold			2022-12-27	WOS:000265510000004
J	Woods, DL; Stecker, GC; Rinne, T; Herron, TJ; Cate, AD; Yund, EW; Liao, I; Kang, XJ				Woods, David L.; Stecker, G. Christopher; Rinne, Teemu; Herron, Timothy J.; Cate, Anthony D.; Yund, E. William; Liao, Isaac; Kang, Xiaojian			Functional Maps of Human Auditory Cortex: Effects of Acoustic Features and Attention	PLOS ONE			English	Article								Background: While human auditory cortex is known to contain tonotopically organized auditory cortical fields (ACFs), little is known about how processing in these fields is modulated by other acoustic features or by attention. Methodology/Principal Findings: We used functional magnetic resonance imaging (fMRI) and population-based cortical surface analysis to characterize the tonotopic organization of human auditory cortex and analyze the influence of tone intensity, ear of delivery, scanner background noise, and intermodal selective attention on auditory cortex activations. Medial auditory cortex surrounding Heschl's gyrus showed large sensory (unattended) activations with two mirror-symmetric tonotopic fields similar to those observed in non-human primates. Sensory responses in medial regions had symmetrical distributions with respect to the left and right hemispheres, were enlarged for tones of increased intensity, and were enhanced when sparse image acquisition reduced scanner acoustic noise. Spatial distribution analysis suggested that changes in tone intensity shifted activation within isofrequency bands. Activations to monaural tones were enhanced over the hemisphere contralateral to stimulation, where they produced activations similar to those produced by binaural sounds. Lateral regions of auditory cortex showed small sensory responses that were larger in the right than left hemisphere, lacked tonotopic organization, and were uninfluenced by acoustic parameters. Sensory responses in both medial and lateral auditory cortex decreased in magnitude throughout stimulus blocks. Attention-related modulations (ARMs) were larger in lateral than medial regions of auditory cortex and appeared to arise primarily in belt and parabelt auditory fields. ARMs lacked tonotopic organization, were unaffected by acoustic parameters, and had distributions that were distinct from those of sensory responses. Unlike the gradual adaptation seen for sensory responses, ARMs increased in amplitude throughout stimulus blocks. Conclusions/Significance: The results are consistent with the view that medial regions of human auditory cortex contain tonotopically organized core and belt fields that map the basic acoustic features of sounds while surrounding higher-order parabelt regions are tuned to more abstract stimulus attributes. Intermodal selective attention enhances processing in neuronal populations that are partially distinct from those activated by unattended stimuli.			Woods, DL (corresponding author), VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA USA.	dlwoods@ucdavis.edu	Rinne, Teemu/A-6090-2009; Cate, Anthony/R-5104-2019	Rinne, Teemu/0000-0002-3142-9438; Cate, Anthony/0000-0003-0135-1622; Herron, Timothy/0000-0002-4297-014X; Woods, David/0000-0002-8804-3587; Yund, E./0000-0002-6833-0052	NIDCD NIH HHS [R01 DC005814] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alho K, 1999, COGNITIVE BRAIN RES, V7, P335, DOI 10.1016/S0926-6410(98)00036-6; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Behne N, 2005, J NEUROPHYSIOL, V93, P414, DOI 10.1152/jn.00568.2004; BENDOR D, 2008, J NEUROPHYSIOL; Bilecen D, 2002, NEUROIMAGE, V17, P710, DOI 10.1006/nimg.2002.1133; Bilecen D, 1998, HEARING RES, V126, P19, DOI 10.1016/S0378-5955(98)00139-7; Brechmann A, 2002, J NEUROPHYSIOL, V87, P423, DOI 10.1152/jn.00187.2001; Bunzeck N, 2005, NEUROIMAGE, V26, P1119, DOI 10.1016/j.neuroimage.2005.03.013; CASCIARO S, 2008, MAGN RESON IMAGING; Chung MK, 2005, NEUROIMAGE, V25, P1256, DOI 10.1016/j.neuroimage.2004.12.052; Ciaramitaro VM, 2007, J NEUROPHYSIOL, V98, P2399, DOI 10.1152/jn.00580.2007; Clare S, 1999, MAGNET RESON MED, V42, P1117, DOI 10.1002/(SICI)1522-2594(199912)42:6<1117::AID-MRM16>3.0.CO;2-J; Degerman A, 2006, BRAIN RES, V1077, P123, DOI 10.1016/j.brainres.2006.01.025; Desai R, 2005, NEUROIMAGE, V26, P1019, DOI 10.1016/j.neuroimage.2005.03.024; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Devlin JT, 2003, J NEUROSCI, V23, P11516; Di Salle F, 2001, NEUROIMAGE, V13, P328, DOI 10.1006/nimg.2000.0683; Dorsaint-Pierre R, 2006, BRAIN, V129, P1164, DOI 10.1093/brain/awl055; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; Engelien A, 2002, NEUROIMAGE, V16, P944, DOI 10.1006/nimg.2002.1149; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Gaab N, 2007, HUM BRAIN MAPP, V28, P703, DOI 10.1002/hbm.20298; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Haist F, 2001, BRAIN LANG, V76, P340, DOI 10.1006/brln.2000.2433; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hall DA, 2002, MAGN RESON IMAGING, V20, P695, DOI 10.1016/S0730-725X(02)00607-0; Halpern AR, 2004, NEUROPSYCHOLOGIA, V42, P1281, DOI 10.1016/j.neuropsychologia.2003.12.017; Harms MP, 2002, J NEUROPHYSIOL, V88, P1433, DOI 10.1152/jn.2002.88.3.1433; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Hwang JH, 2005, ORL-J OTO-RHIN-LARYN, V67, P242, DOI 10.1159/000089501; Inan S, 2004, NEUROIMAGE, V21, P886, DOI 10.1016/j.neuroimage.2003.10.029; Jancke L, 1998, NEUROPSYCHOLOGIA, V36, P875, DOI 10.1016/S0028-3932(98)00019-0; Jancke L, 2003, COGNITIVE BRAIN RES, V16, P257, DOI 10.1016/S0926-6410(02)00281-1; Jancke L, 2001, BRAIN LANG, V78, P349, DOI 10.1006/brln.2000.2476; Jancke L, 2002, HEARING RES, V170, P166, DOI 10.1016/S0378-5955(02)00488-4; Johnson JA, 2006, NEUROIMAGE, V31, P1673, DOI 10.1016/j.neuroimage.2006.02.026; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Kang XJ, 2007, MAGN RESON IMAGING, V25, P1070, DOI 10.1016/j.mri.2006.12.005; Kang XJ, 2004, NEUROIMAGE, V22, P1657, DOI 10.1016/j.neuroimage.2004.04.013; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kayser C, 2007, J NEUROSCI, V27, P1824, DOI 10.1523/JNEUROSCI.4737-06.2007; Langers DRM, 2007, NEUROIMAGE, V35, P709, DOI 10.1016/j.neuroimage.2006.12.013; Langers DRM, 2007, NEUROIMAGE, V34, P264, DOI 10.1016/j.neuroimage.2006.09.002; Lasota KJ, 2003, J COMPUT ASSIST TOMO, V27, P213, DOI 10.1097/00004728-200303000-00018; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Le TH, 2001, MAGNET RESON MED, V45, P254, DOI 10.1002/1522-2594(200102)45:2<254::AID-MRM1034>3.0.CO;2-J; Lehmann C, 2007, NEUROIMAGE, V34, P1637, DOI 10.1016/j.neuroimage.2006.11.011; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; Lipschutz B, 2002, NEUROIMAGE, V17, P643, DOI 10.1006/nimg.2002.1184; MIDDLEBROOKS JC, 1981, J NEUROSCI, V1, P107, DOI 10.1523/JNEUROSCI.01-01-00107.1981; Mohr CM, 1999, J ACOUST SOC AM, V105, P2738, DOI 10.1121/1.426942; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Mozolic JL, 2008, EXP BRAIN RES, V184, P39, DOI 10.1007/s00221-007-1080-3; Mulert C, 2005, NEUROIMAGE, V28, P49, DOI 10.1016/j.neuroimage.2005.05.041; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; Petkov CI, 2006, PLOS BIOL, V4, P1213, DOI 10.1371/journal.pbio.0040215; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Recanzone GH, 2008, ANNU REV PSYCHOL, V59, P119, DOI 10.1146/annurev.psych.59.103006.093544; Rinne T, 2005, HUM BRAIN MAPP, V26, P94, DOI 10.1002/hbm.20123; Rinne T, 2007, NEUROREPORT, V18, P1311, DOI 10.1097/WNR.0b013e32826fb3bb; Rinne T, 2007, NEUROSCI LETT, V416, P247, DOI 10.1016/j.neulet.2007.01.077; Sadagopan S, 2008, J NEUROSCI, V28, P3415, DOI 10.1523/JNEUROSCI.2743-07.2008; Scarff CJ, 2004, HUM BRAIN MAPP, V22, P341, DOI 10.1002/hbm.20043; Schmidt CF, 2008, HUM BRAIN MAPP, V29, P46, DOI 10.1002/hbm.20372; Schonwiesner M, 2007, CEREB CORTEX, V17, P492, DOI 10.1093/cercor/bhj165; Schonwiesner M, 2002, NEUROIMAGE, V17, P1144, DOI 10.1006/nimg.2002.1250; SCHREINER CE, 1992, EXP BRAIN RES, V92, P105; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; Shah NJ, 2000, NEUROIMAGE, V12, P100, DOI 10.1006/nimg.2000.0588; Sigalovsky IS, 2006, NEUROIMAGE, V32, P1524, DOI 10.1016/j.neuroimage.2006.05.023; STUDEBAKER GA, 1987, J ACOUST SOC AM, V81, P1130, DOI 10.1121/1.394633; Sweet RA, 2005, J COMP NEUROL, V491, P270, DOI 10.1002/cne.20702; Talavage TM, 2004, J NEUROPHYSIOL, V91, P1282, DOI 10.1152/jn.01125.2002; Talavage TM, 2000, HEARING RES, V150, P225, DOI 10.1016/S0378-5955(00)00203-3; Tzourio N., 1993, Society for Neuroscience Abstracts, V19, P1285; Upadhyay J, 2007, CEREB CORTEX, V17, P2420, DOI 10.1093/cercor/bhl150; Wessinger CM, 1997, HUM BRAIN MAPP, V5, P18, DOI 10.1002/(SICI)1097-0193(1997)5:1<18::AID-HBM3>3.0.CO;2-Q; Woldorff MG, 1999, HUM BRAIN MAPP, V7, P49, DOI 10.1002/(SICI)1097-0193(1999)7:1<49::AID-HBM5>3.3.CO;2-A; Woodruff PWR, 1996, NEUROREPORT, V7, P1909, DOI 10.1097/00001756-199608120-00007; Yang YH, 2000, MAGNET RESON MED, V43, P185, DOI 10.1002/(SICI)1522-2594(200002)43:2<185::AID-MRM4>3.0.CO;2-3; Yetkin FZ, 2004, LARYNGOSCOPE, V114, P512, DOI 10.1097/00005537-200403000-00024; Yoo SS, 2005, NEUROSCI LETT, V383, P1, DOI 10.1016/j.neulet.2005.03.025; Zaehle T, 2007, RESTOR NEUROL NEUROS, V25, P251	93	112	113	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5183	10.1371/journal.pone.0005183	http://dx.doi.org/10.1371/journal.pone.0005183			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365552	gold, Green Published, Green Submitted			2022-12-27	WOS:000265509900012
J	Rothen, N; Meier, B				Rothen, Nicolas; Meier, Beat			Do Synesthetes Have a General Advantage in Visual Search and Episodic Memory? A Case for Group Studies	PLOS ONE			English	Article							SYNAESTHETIC COLORS; ASPERGER-SYNDROME; SINGLE-PATIENT; SAVANT MEMORY; ACTIVATION; MECHANISMS; WORDS; FORM	Background: Some studies, most of them case-reports, suggest that synesthetes have an advantage in visual search and episodic memory tasks. The goal of this study was to examine this hypothesis in a group study. Methodology/Principal Findings: In the present study, we tested thirteen grapheme-color synesthetes and we compared their performance on a visual search task and a memory test to an age-, handedness-, education-, and gender-matched control group. The results showed no significant group differences (all relevant ps>.50). For the visual search task effect sizes indicated a small advantage for synesthetes (Cohen's d between .19 and .32). No such advantage was found for episodic memory (Cohen's d,. 05). Conclusions/Significance: The results indicate that synesthesia per se does not seem to lead to a strong performance advantage. Rather, the superior performance of synesthetes observed in some case-report studies may be due to individual differences, to a selection bias or to a strategic use of synesthesia as a mnemonic. In order to establish universal effects of synesthesia on cognition single-case studies must be complemented by group studies.			Rothen, N (corresponding author), Univ Bern, Dept Psychol, Bern, Switzerland.	beat.meier@psy.unibe.ch; nicolas.rothen@psy.unibe.ch	Rothen, Nicolas/A-2620-2012; Meier, Beat/E-5306-2011	Rothen, Nicolas/0000-0002-8874-8341; Meier, Beat/0000-0003-3303-6854				Baron-Cohen S, 2007, J CONSCIOUSNESS STUD, V14, P237; BARONCOHEN S, 1987, PERCEPTION, V16, P761, DOI 10.1068/p160761; Bor D, 2007, NEUROCASE, V13, P311, DOI 10.1080/13554790701844945; CARAMAZZA A, 1986, BRAIN COGNITION, V5, P41, DOI 10.1016/0278-2626(86)90061-8; Cytowic Richard, 1997, SYNAESTHESIA CLASSIC, P17; Dixon MJ, 2004, COGN AFFECT BEHAV NE, V4, P335, DOI 10.3758/CABN.4.3.335; Edquist J, 2006, CORTEX, V42, P222, DOI 10.1016/S0010-9452(08)70347-2; Elias LJ, 2003, COGNITIVE BRAIN RES, V16, P232, DOI 10.1016/S0926-6410(02)00278-1; ERICSSON KA, 1982, AM SCI, V70, P607; Gheri C, 2008, P ROY SOC B-BIOL SCI, V275, P841, DOI 10.1098/rspb.2007.1457; Grossenbacher PG, 2001, TRENDS COGN SCI, V5, P36, DOI 10.1016/S1364-6613(00)01571-0; Hubbard EM, 2005, NEURON, V48, P509, DOI 10.1016/j.neuron.2005.10.012; Hubbard EM, 2005, NEURON, V45, P975, DOI 10.1016/j.neuron.2005.02.008; Laeng B, 2004, PSYCHOL SCI, V15, P277, DOI 10.1111/j.0956-7976.2004.00666.x; Luria A., 1968, MIND MNEMONIST; Meier B, 2007, NEUROSCIENCE, V147, P569, DOI 10.1016/j.neuroscience.2007.04.008; Meier B, 2009, NEUROPSYCHOLOGIA, V47, P1208, DOI 10.1016/j.neuropsychologia.2009.01.009; Mills CB, 2006, CORTEX, V42, P155, DOI 10.1016/S0010-9452(08)70340-X; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; Palmeri TJ, 2002, P NATL ACAD SCI USA, V99, P4127, DOI 10.1073/pnas.022049399; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Schneider W., 2002, E PRIME USERS GUIDE; Smilek D, 2002, PSYCHOL SCI, V13, P548, DOI 10.1111/1467-9280.00496; WARD J, 2005, SYNAESTHESIA RES PRO; Ward J, 2006, CORTEX, V42, P129, DOI 10.1016/S0010-9452(08)70336-8; Witthoft N, 2006, CORTEX, V42, P175, DOI 10.1016/S0010-9452(08)70342-3; Yaro C, 2007, Q J EXP PSYCHOL, V60, P681, DOI 10.1080/17470210600785208; ZURIF E, 1991, BRAIN COGNITION, V16, P198, DOI 10.1016/0278-2626(91)90006-T	29	56	56	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5037	10.1371/journal.pone.0005037	http://dx.doi.org/10.1371/journal.pone.0005037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437RX	19352425	Green Submitted, Green Published, gold			2022-12-27	WOS:000265505700003
J	Gruber, AJ; Hussain, RJ; O'Donnell, P				Gruber, Aaron J.; Hussain, Rifat J.; O'Donnell, Patricio			The Nucleus Accumbens: A Switchboard for Goal-Directed Behaviors	PLOS ONE			English	Article								Reward intake optimization requires a balance between exploiting known sources of rewards and exploring for new sources. The prefrontal cortex (PFC) and associated basal ganglia circuits are likely candidates as neural structures responsible for such balance, while the hippocampus may be responsible for spatial/contextual information. Although studies have assessed interactions between hippocampus and PFC, and between hippocampus and the nucleus accumbens (NA), it is not known whether 3-way interactions among these structures vary under different behavioral conditions. Here, we investigated these interactions with multichannel recordings while rats explored an operant chamber and while they performed a learned lever-pressing task for reward in the same chamber shortly afterward. Neural firing and local field potentials in the NA core synchronized with hippocampal activity during spatial exploration, but during lever pressing they instead synchronized more strongly with the PFC. The latter is likely due to transient drive of NA neurons by bursting prefrontal activation, as in vivo intracellular recordings in anesthetized rats revealed that NA up states can transiently synchronize with spontaneous PFC activity and PFC stimulation with a bursting pattern reliably evoked up states in NA neurons. Thus, the ability to switch synchronization in a task-dependent manner indicates that the NA core can dynamically select its inputs to suit environmental demands, thereby contributing to decision-making, a function that was thought to primarily depend on the PFC.			Gruber, AJ (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	podon002@umaryland.edu		O'Donnell, Patricio/0000-0001-7788-624X; Gruber, Aaron/0000-0003-2700-5429	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060131] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH060131, MH60131] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], [No title captured]; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Block AE, 2007, CEREB CORTEX, V17, P1625, DOI 10.1093/cercor/bhl073; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Carelli RM, 2002, PHYSIOL BEHAV, V76, P379, DOI 10.1016/S0031-9384(02)00760-6; Christakou A, 2004, J NEUROSCI, V24, P773, DOI 10.1523/JNEUROSCI.0949-03.2004; Collins P, 1998, J COGNITIVE NEUROSCI, V10, P332, DOI 10.1162/089892998562771; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; DeCoteau WE, 2007, P NATL ACAD SCI USA, V104, P5644, DOI 10.1073/pnas.0700818104; DeCoteau WE, 2007, J NEUROPHYSIOL, V97, P3800, DOI 10.1152/jn.00108.2007; Floresco SB, 2006, J NEUROSCI, V26, P2449, DOI 10.1523/JNEUROSCI.4431-05.2006; French SJ, 2002, J COMP NEUROL, V446, P151, DOI 10.1002/cne.10191; Fuster J., 2015, PREFRONTAL CORTEX, V5th; Gonzalez-Hernandez JA, 2002, HUM BRAIN MAPP, V17, P37, DOI 10.1002/hbm.10051; Goto Y, 2002, J NEUROSCI, V22, P9070; Goto Y, 2001, J NEUROSCI, V21, P4498, DOI 10.1523/JNEUROSCI.21-12-04498.2001; Goto Y, 2001, J NEUROSCI, V21; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Groenewegen HJ, 1996, PROG BRAIN RES, V107, P485; GRUBER A, 2008, SYNAPSE IN PRESS; Haddon JE, 2006, J NEUROSCI, V26, P2933, DOI 10.1523/JNEUROSCI.3243-05.2006; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; KELLEY AE, 1982, NEUROSCIENCE, V7, P2321, DOI 10.1016/0306-4522(82)90198-1; LEUNG LS, 1993, CAN J PHYSIOL PHARM, V71, P311, DOI 10.1139/y93-049; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Narayanan NS, 2008, J NEUROPHYSIOL, V100, P520, DOI 10.1152/jn.00035.2008; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; O'Donnell P, 2003, EUR J NEUROSCI, V17, P429, DOI 10.1046/j.1460-9568.2003.02463.x; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Ostlund SB, 2005, J NEUROSCI, V25, P7763, DOI 10.1523/JNEUROSCI.1921-05.2005; Perlstein WM, 2003, BIOL PSYCHIAT, V53, P25, DOI 10.1016/S0006-3223(02)01675-X; Peters YM, 2005, SYNAPSE, V56, P74, DOI 10.1002/syn.20129; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Steriade M, 1998, Sleep Res Online, V1, P1; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Tabuchi ET, 2000, HIPPOCAMPUS, V10, P717, DOI 10.1002/1098-1063(2000)10:6<717::AID-HIPO1009>3.0.CO;2-3; Vertes RP, 2005, HIPPOCAMPUS, V15, P923, DOI 10.1002/hipo.20118	41	81	81	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5062	10.1371/journal.pone.0005062	http://dx.doi.org/10.1371/journal.pone.0005062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352511	Green Submitted, Green Published, gold			2022-12-27	WOS:000265505300008
J	Hasan, Z; Jamil, B; Ashraf, M; Islam, M; Yusuf, MS; Khan, JA; Hussain, R				Hasan, Zahra; Jamil, Bushra; Ashraf, Mussarat; Islam, Muniba; Yusuf, Muhammad S.; Khan, Javaid A.; Hussain, Rabia			ESAT6-Induced IFN gamma and CXCL9 Can Differentiate Severity of Tuberculosis	PLOS ONE			English	Article								Background: Protective responses against Mycobacterium tuberculosis are dependent on appropriate T cell and macrophage activation. Mycobacterial antigen six kDa early secreted antigenic target (ESAT6) and culture filtrate protein 10 (CFP10) can detect M. tuberculosis specific IFN gamma responses. However, most studies have been performed in non-endemic regions and to study pulmonary tuberculosis (PTB). We have studied ESAT6 and CFP10 induced cytokine and chemokines responses in PTB and extrapulmonary (EPul) TB. Methodology: IFN gamma, IL10, CXCL9 and CCL2 responses were determined using an ex vivo whole blood assay system in PTB (n = 30) and EPulTB patients with limited (LNTB, n = 24) or severe (SevTB, n = 22) disease, and in healthy endemic controls (ECs). Responses to bacterial LPS were also determined. Principal Findings: ESAT6- and CFP10-induced IFN gamma was comparable between ECs and TB patients. Both ESAT6- and CFP10-induced IFN gamma secretion was greater in LNTB than PTB. ESAT6- induced CXCL9 was greater in EPulTB as compared with PTB, with an increase in SevTB as compared with LNTB. CFP10-induced CCL2 was higher in PTB than LNTB patients. LPS-stimulated CXCL9 was greatest in SevTB and LPS-induced CCL2 was increased in PTB as compared with LNTB patients. A positive correlation between ESAT6- induced IFN gamma and CXCL9 was present in all TB patients, but IFN gamma and CCL2 was only correlated in LNTB. ESAT-induced CCL2 and CXCL9 were significantly associated in LNTB while correlation in response to LPS was only present in SevTB. Conclusions: ESAT6 induced IFN gamma and CXCL9 can differentiate between limited and severe TB infections.	[Hasan, Zahra; Ashraf, Mussarat; Islam, Muniba; Yusuf, Muhammad S.; Hussain, Rabia] Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan; [Jamil, Bushra; Khan, Javaid A.] Aga Khan Univ, Dept Med, Karachi, Pakistan	Aga Khan University; Aga Khan University	Hasan, Z (corresponding author), Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan.	zahra.hasan@aku.edu	Hussain, Rabia/E-9982-2015; Hasan, Zahra/AAF-2191-2020; Hasan, Zahra/F-5111-2015	Hasan, Zahra/0000-0001-7580-372X; 	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases; Third World Academy of Sciences for the Developing World (TWAS)	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases; Third World Academy of Sciences for the Developing World (TWAS)	This investigation received financial support from the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). The project was partially supported by Research Grant from the Third World Academy of Sciences for the Developing World (TWAS). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abramo C, 2006, MICROBES INFECT, V8, P45, DOI 10.1016/j.micinf.2005.05.019; Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Black GF, 2003, CLIN DIAGN LAB IMMUN, V10, P602, DOI 10.1128/CDLI.10.4.602-611.2003; Bonecini-Almeida MG, 2004, INFECT IMMUN, V72, P2628, DOI 10.1128/IAI.72.5.2628-2634.2004; Brice GT, 2001, J IMMUNOL METHODS, V257, P55, DOI 10.1016/S0022-1759(01)00446-X; Britton WJ, 2005, TUBERCULOSIS, V85, P137, DOI 10.1016/j.tube.2004.06.003; Brock I, 2001, INT J TUBERC LUNG D, V5, P462; Cagatay AA, 2004, SCAND J INFECT DIS, V36, P799, DOI 10.1080/00365540410025339; CHEE CBE, 2008, J CLIN MICROBIOL; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; CROFTON J, 1990, CROFTON DOUGLAS RESP, P395; Demissie A, 2006, INFECT IMMUN, V74, P2817, DOI 10.1128/IAI.74.5.2817-2822.2006; Dlugovitzky D, 1997, FEMS IMMUNOL MED MIC, V18, P203, DOI 10.1016/S0928-8244(97)00040-0; Ebdrup L, 2003, SCAND J INFECT DIS, V35, P244, DOI 10.1080/00365540310000274; Flynn JL, 2000, CURR OPIN IMMUNOL, V12, P432, DOI 10.1016/S0952-7915(00)00116-3; GONZALEZJUARRER.M, 2008, AM J RESP CELL M SEP; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Hasan Z, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-14; Hasan Z, 2006, SCAND J IMMUNOL, V63, P241, DOI 10.1111/j.1365-3083.2006.01733.x; Hasan Z, 2009, SCAND J IMMUNOL, V69, P259, DOI 10.1111/j.1365-3083.2008.02217.x; Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3; HUSSAIN R, 1996, ASIAN J TROP MED PUB, V27, P1; Hussain R, 2007, CLIN VACCINE IMMUNOL, V14, P1578, DOI 10.1128/CVI.00289-07; Jamil B, 2007, TUBERCULOSIS, V87, P279, DOI 10.1016/j.tube.2007.03.004; Kobashi Y, 2008, CHEST, V7, P1995; Mastroianni CM, 1998, CLIN EXP IMMUNOL, V114, P210; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Mendez-Samperio P, 2002, CLIN DIAGN LAB IMMUN, V9, P802, DOI 10.1128/CDLI.9.4.802-807.2002; Murray PJ, 1999, INFECT IMMUN, V67, P3087, DOI 10.1128/IAI.67.6.3087-3095.1999; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Ravn P, 2005, CLIN DIAGN LAB IMMUN, V12, P491, DOI 10.1128/CDLI.12.4.491-496.2005; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Sahiratmadja E, 2007, INFECT IMMUN, V75, P820, DOI 10.1128/IAI.00602-06; Scott HM, 2002, INFECT IMMUN, V70, P5946, DOI 10.1128/IAI.70.11.5946-5954.2002; Sharma SK, 2002, J CLIN IMMUNOL, V22, P345, DOI 10.1023/A:1020604331886; Thwaites GE, 2003, J INFECT DIS, V188, P1105, DOI 10.1086/378642; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Ulrichs T, 2000, INFECT IMMUN, V68, P6073, DOI 10.1128/IAI.68.10.6073-6076.2000; Ulrichs T, 2000, INT J TUBERC LUNG D, V4, P1181; Walrath E, 2005, AM J RESP CELL MOL, V33, P48, DOI 10.1165/rcmb.2005-0060OC; Weir RE, 2004, INFECT IMMUN, V72, P1807, DOI 10.1128/IAI.72.3.1807-1811.2004; Weir RE, 2008, TUBERCULOSIS, V88, P31, DOI 10.1016/j.tube.2007.10.001; Whiting D, 2004, J IMMUNOL, V172, P7417, DOI 10.4049/jimmunol.172.12.7417; *WHO, 2008, COUNTR PROF PAK, P133	45	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5158	10.1371/journal.pone.0005158	http://dx.doi.org/10.1371/journal.pone.0005158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340290	Green Submitted, Green Published, gold			2022-12-27	WOS:000265500700028
J	Grzybek, M; Kubiak, J; Lach, A; Przybylo, M; Sikorski, AF				Grzybek, Michal; Kubiak, Jakub; Lach, Agnieszka; Przybylo, Magdalena; Sikorski, Aleksander F.			A Raft-Associated Species of Phosphatidylethanolamine Interacts with Cholesterol Comparably to Sphingomyelin. A Langmuir-Blodgett Monolayer Study	PLOS ONE			English	Article							LIPID RAFTS; DOMAIN FORMATION; QUANTITATIVE-ANALYSIS; MEMBRANE DOMAINS; MODEL MEMBRANES; RESONANCE; PROTEINS; VESICLES; DYNAMICS; LEAFLET	Background: Specific interactions between sphingomyelin (SM) and cholesterol (Ch) are commonly believed to play a key role in the formation of rafts in the biological membranes. A weakness of this model is the implication that these microdomains are confined to the outer bilayer leaflet. The cytoplasmic leaflet, which contains the bulk of phosphatidylethanolamine (PE), phosphatidylserine (PS) and phosphatidylinositol (PI), is thought also to harbour half of the membrane cholesterol. Moreover, SLPE (1-stearoyl-2-linoleoyl-sn-glycero-3-phosphatidyl-ethanolamine) has recently been shown to be enriched in isolated detergent-resistant membranes (DRM), and this enrichment was independent of the method of isolation of DRM. Methodology/Principal Findings: Here we present quantitative evidence coming from Langmuir-Blodgett monolayer experiments that SLPE forms complex with Ch similar to that between SM and Ch. The energies of these interactions as calculated form the monolayer studies are highly negative. FRAP analysis showed that NBD-Ch recovery was similar in liposomes composed of DOPC/Ch SM or SLPE but not DPPE, providing further evidence that SLPE may form an l(o) phase in the presence of high Ch concentration. Experiments on the solubility of DOPC liposomes containing DPPE/Ch (1:1), SM/Ch (1:1) or SLPE/Ch (1:1) showed the presence of Triton X-100 insoluble floating fraction (TIFF) in the case of SM/Ch or SLPE/Ch but not in DPPE/Ch containing liposomes. Quantitative determination of particular lipid species in the TIFF fraction confirms the conclusion that SLPE (or similar PE species) could be an important constituent of the inner leaflet raft. Conclusion: Such interactions suggest a possible existence of inner-leaflet nanoscale assemblies composed of cholesterol complexes with SLPE or similar unsaturated PE species.	[Grzybek, Michal; Kubiak, Jakub; Lach, Agnieszka; Sikorski, Aleksander F.] Univ Wroclaw, Biotechnol Fac, Lab Cytobiochem, PL-50138 Wroclaw, Poland; [Przybylo, Magdalena; Sikorski, Aleksander F.] Academ Ctr Biotechnol Lipid Aggregates, Wroclaw, Poland	University of Wroclaw	Grzybek, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	afsbc@ibmb.uni.wroc.pl	Sikorski, Aleksander F/C-3361-2009; Sikorski, Aleksander/HGD-5159-2022; Grzybek, Michal/D-3802-2017; Przybylo, Magda/Y-8014-2018	Grzybek, Michal/0000-0003-2083-0506; Sikorski, Aleksander F./0000-0003-3779-8266; Kubiak, Jakub/0000-0002-6734-9763; Przybylo, Magda/0000-0002-0216-6456; Biernatowska, Agnieszka/0000-0002-7028-8412	University of Wroclaw Research Fund	University of Wroclaw Research Fund	University of Wroclaw Research Fund. The funder had no role in study design, data collection and analysis, decision to publish or prepaartion of the manuscript.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Chachaty C, 2005, BIOPHYS J, V88, P4032, DOI 10.1529/biophysj.104.054155; Collado MI, 2005, BIOCHEMISTRY-US, V44, P4911, DOI 10.1021/bi0474970; Coste V, 2006, BBA-BIOMEMBRANES, V1758, P460, DOI 10.1016/j.bbamem.2006.03.003; Coste V, 2006, COLLOID SURFACE A, V282, P402, DOI 10.1016/j.colsurfa.2005.12.044; COURCHAINE AJ, 1959, CLIN CHEM, V5, P609; Crane JM, 2004, BIOPHYS J, V86, P2965, DOI 10.1016/S0006-3495(04)74347-7; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Dynarowicz-Latka P, 2004, COLLOID SURFACE B, V37, P21, DOI 10.1016/j.colsurfb.2004.06.007; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Eisenberg S, 2006, MOL CELL BIOL, V26, P7190, DOI 10.1128/MCB.01059-06; Frazier ML, 2007, BIOPHYS J, V92, P2422, DOI 10.1529/biophysj.106.100107; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; GOODRICH F, 1985, P 2 INT C SURF ACT 8; Grzybek M, 2005, GEN PHYSIOL BIOPHYS, V24, P449; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Holopainen JM, 2004, BIOPHYS J, V86, P1510, DOI 10.1016/S0006-3495(04)74219-8; Kiessling V, 2006, BIOPHYS J, V91, P3313, DOI 10.1529/biophysj.106.091421; Koumanov KS, 2005, ARCH BIOCHEM BIOPHYS, V434, P150, DOI 10.1016/j.abb.2004.10.025; Li XM, 2003, BIOPHYS J, V85, P3788, DOI 10.1016/S0006-3495(03)74794-8; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; MARSH D, 1976, BIOCHEMISTRY-US, V15, P3570, DOI 10.1021/bi00661a027; McConnell H, 2006, P NATL ACAD SCI USA, V103, P1184, DOI 10.1073/pnas.0510514103; McQuaw CM, 2005, LANGMUIR, V21, P807, DOI 10.1021/la0479455; Pare C, 1998, BIOPHYS J, V74, P899, DOI 10.1016/S0006-3495(98)74013-5; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Pucadyil TJ, 2007, J PHYS CHEM B, V111, P1975, DOI 10.1021/jp066092h; Quinn PJ, 2005, BBA-BIOMEMBRANES, V1713, P5, DOI 10.1016/j.bbamem.2005.04.013; Radhakrishnan A, 2005, P NATL ACAD SCI USA, V102, P12662, DOI 10.1073/pnas.0506043102; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Rinia HA, 2001, FEBS LETT, V501, P92, DOI 10.1016/S0014-5793(01)02636-9; Rog T, 2006, BIOPHYS J, V91, P3756, DOI 10.1529/biophysj.106.080887; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Shaikh SR, 2006, J AM CHEM SOC, V128, P5375, DOI 10.1021/ja057949b; Shaikh SR, 2002, BIOCHEMISTRY-US, V41, P10593, DOI 10.1021/bi025712b; Shaw JE, 2006, BIOPHYS J, V90, P2170, DOI 10.1529/biophysj.105.073510; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Slotte JP, 1999, CHEM PHYS LIPIDS, V102, P13, DOI 10.1016/S0009-3084(99)00071-7; Sostarecz AG, 2004, J AM CHEM SOC, V126, P13882, DOI 10.1021/ja0472127; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Wang TY, 2001, BIOPHYS J, V81, P2762, DOI 10.1016/S0006-3495(01)75919-X	49	31	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2009	4	3							e5053	10.1371/journal.pone.0005053	http://dx.doi.org/10.1371/journal.pone.0005053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PP	19330037	gold, Green Published, Green Submitted			2022-12-27	WOS:000265499700004
J	Paoloni, MC; Tandle, A; Mazcko, C; Hanna, E; Kachala, S; LeBlanc, A; Newman, S; Vail, D; Henry, C; Thamm, D; Sorenmo, K; Hajitou, A; Pasqualini, R; Arap, W; Khanna, C; Libutti, SK				Paoloni, Melissa C.; Tandle, Anita; Mazcko, Christina; Hanna, Engy; Kachala, Stefan; LeBlanc, Amy; Newman, Shelley; Vail, David; Henry, Carolyn; Thamm, Douglas; Sorenmo, Karin; Hajitou, Amin; Pasqualini, Renata; Arap, Wadih; Khanna, Chand; Libutti, Steven K.			Launching a Novel Preclinical Infrastructure: Comparative Oncology Trials Consortium Directed Therapeutic Targeting of TNF alpha to Cancer Vasculature	PLOS ONE			English	Article								Background: Under the direction and sponsorship of the National Cancer Institute, we report on the first pre-clinical trial of the Comparative Oncology Trials Consortium (COTC). The COTC is a novel infrastructure to integrate cancers that naturally develop in pet dogs into the development path of new human drugs. Trials are designed to address questions challenging in conventional preclinical models and early phase human trials. Large animal spontaneous cancer models can be a valuable addition to successful studies of cancer biology and novel therapeutic drug, imaging and device development. Methodology/Principal Findings: Through this established infrastructure, the first trial of the COTC (COTC001) evaluated a targeted AAV-phage vector delivering tumor necrosis factor (RGD-A-TNF) to alpha V integrins on tumor endothelium. Trial progress and data was reviewed contemporaneously using a web-enabled electronic reporting system developed for the consortium. Dose-escalation in cohorts of 3 dogs (n = 24) determined an optimal safe dose (5x10(12) transducing units intravenous) of RGD-A-TNF. This demonstrated selective targeting of tumor-associated vasculature and sparing of normal tissues assessed via serial biopsy of both tumor and normal tissue. Repetitive dosing in a cohort of 14 dogs, at the defined optimal dose, was well tolerated and led to objective tumor regression in two dogs (14%), stable disease in six (43%), and disease progression in six (43%) via Response Evaluation Criteria in Solid Tumors (RECIST). Conclusions/Significance: The first study of the COTC has demonstrated the utility and efficiency of the established infrastructure to inform the development of new cancer drugs within large animal naturally occurring cancer models. The preclinical evaluation of RGD-A-TNF within this network provided valuable and necessary data to complete the design of first-in-man studies.	[Paoloni, Melissa C.; Mazcko, Christina; Khanna, Chand] NCI, Comparat Oncol Program, Ctr Canc Res, Bethesda, MD 20892 USA; [Tandle, Anita; Hanna, Engy; Kachala, Stefan; Libutti, Steven K.] NCI, Surg Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [LeBlanc, Amy; Newman, Shelley] Univ Tennessee, Knoxville, TN 37996 USA; [Vail, David] Univ Wisconsin, Madison, WI 53706 USA; [Henry, Carolyn] Univ Missouri, Columbia, MO 65211 USA; [Thamm, Douglas] Colorado State Univ, Ft Collins, CO 80523 USA; [Sorenmo, Karin] Univ Penn, Philadelphia, PA 19104 USA; [Hajitou, Amin] Imperial Coll London, Wright Flemming Inst, Dept Gene Therapy, London, England; [Hajitou, Amin] Imperial Coll London, Wright Flemming Inst, Div Med, London, England; [Pasqualini, Renata; Arap, Wadih] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Houston, TX USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Tennessee System; University of Tennessee Knoxville; University of Wisconsin System; University of Wisconsin Madison; University of Missouri System; University of Missouri Columbia; Colorado State University; University of Pennsylvania; Imperial College London; Imperial College London; University of Texas System; UTMD Anderson Cancer Center	Paoloni, MC (corresponding author), NCI, Comparat Oncol Program, Ctr Canc Res, Bethesda, MD 20892 USA.	khannac@mail.nih.gov	Thamm, Douglas/AAG-3672-2020; Newman, Shelley/M-4954-2019; Thamm, Douglas H/I-5976-2013	Thamm, Douglas H/0000-0002-8914-7767; Newman, Shelley/0000-0002-3471-4816; Hajitou, Amin/0000-0003-1119-5686; , Carolyn/0000-0002-2761-5203	Center for Cancer Research, National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIGBC010569, Z01BC010569] Funding Source: NIH RePORTER; MRC [G0701159] Funding Source: UKRI; Medical Research Council [G0701159] Funding Source: researchfish	Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank the Center for Cancer Research, National Cancer Institute, NIH for their support of this work. This research was made possible in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arce C, 2001, PLATELETS, V12, P69, DOI 10.1080/09537100020032828; Bellomi Massimo, 2004, Radiol Med, V107, P450; Eisenhauer EA, 2007, ANN ONCOL, V18, P29, DOI 10.1093/annonc/mdm290; Fosmire SP, 2004, LAB INVEST, V84, P562, DOI 10.1038/labinvest.3700080; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Hajitou A, 2006, TRENDS CARDIOVAS MED, V16, P80, DOI 10.1016/j.tcm.2006.01.003; HAJITOU A, 2008, P NATL ACAD SCI US; Hajitou A, 2007, NAT PROTOC, V2, P523, DOI 10.1038/nprot.2007.51; Hansen K, 2004, EUR J CANCER, V40, P858, DOI 10.1016/j.ejca.2003.11.031; HWU P, 1993, J IMMUNOL, V150, P4104; JULKA PK, 2008, BR J RADIOL; Khanna C, 2003, CURR CANCER DRUG TAR, V3, P265, DOI 10.2174/1568009033481903; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Larue SM, 1999, INT J HYPERTHER, V15, P475; *NAT CANC I US, 2007, CANC CENTR CLIN DAT; *NCI, 2007, CANC CENTR CLIN DAT; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Park JO, 2003, JPN J CLIN ONCOL, V33, P533, DOI 10.1093/jjco/hyg093; Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Siddiqui F, 2007, MOL CANCER THER, V6, P380, DOI 10.1158/1535-7163.MCT-06-0342; TANDLE A, 2008, CANCER IN PRESS; Tandle A, 2009, CANCER-AM CANCER SOC, V115, P128, DOI 10.1002/cncr.24001; ten Hagen TLM, 2003, TECHNOL CANCER RES T, V2, P195; ten Hagen TLM, 2002, J LIPOSOME RES, V12, P149, DOI 10.1081/LPR-120004788; Thamm DH, 2006, RES VET SCI, V81, P76, DOI 10.1016/j.rvsc.2005.09.005; Thrall DE, 2006, INT J HYPERTHER, V22, P365, DOI 10.1080/02656730600836386; Thumshirn G, 2003, CHEM-EUR J, V9, P2717, DOI 10.1002/chem.200204304; Tsuchida Y, 2001, MED PEDIATR ONCOL, V37, P1, DOI 10.1002/mpo.1154; Vail David M, 2004, Vet Comp Oncol, V2, P194, DOI 10.1111/j.1476-5810.2004.0053a.x; van Horssen R, 2006, APOPTOSIS, V11, P2137, DOI 10.1007/s10495-006-0284-5; van Kempen LCL, 2006, EUR J CELL BIOL, V85, P61, DOI 10.1016/j.ejcb.2005.10.003; Vujaskovic Z, 2000, INT J RADIAT ONCOL, V46, P179, DOI 10.1016/S0360-3016(99)00362-4; WITHROW SJ, 1993, CANCER-AM CANCER SOC, V71, P2484, DOI 10.1002/1097-0142(19930415)71:8<2484::AID-CNCR2820710810>3.0.CO;2-D; WITHROW SJ, 1991, CLIN ORTHOP RELAT R, P159; Zakarija A, 2005, CURR OPIN ONCOL, V17, P578, DOI 10.1097/01.cco.0000183672.15133.ab	37	92	93	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2009	4	3							e4972	10.1371/journal.pone.0004972	http://dx.doi.org/10.1371/journal.pone.0004972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PP	19330034	gold, Green Submitted, Green Published			2022-12-27	WOS:000265499700001
J	Miyagawa, T; Honda, M; Kawashima, M; Shimada, M; Tanaka, S; Honda, Y; Tokunaga, K				Miyagawa, Taku; Honda, Makoto; Kawashima, Minae; Shimada, Mihoko; Tanaka, Susumu; Honda, Yutaka; Tokunaga, Katsushi			Polymorphism Located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1*0602 Haplotype Confer Susceptibility to CNS Hypersomnias (Essential Hypersomnia)	PLOS ONE			English	Article								Background: SNP rs5770917 located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1* 0602 haplotype were previously identified as susceptibility loci for narcolepsy with cataplexy. This study was conducted in order to investigate whether these genetic markers are associated with Japanese CNS hypersomnias (essential hypersomnia: EHS) other than narcolepsy with cataplexy. Principal Findings: EHS was significantly associated with SNP rs5770917 (P(allele) = 3.6x10(-3); OR = 1.56; 95% c. i.: 1.12 - 2.15) and HLA-DRB1*1501-DQB1* 0602 haplotype (P(positivity) = 9.2x10(-11); OR = 3.97; 95% c. i.: 2.55-6.19). No interaction between the two markers (SNP rs5770917 and HLA-DRB1*1501-DQB1* 0602 haplotype) was observed in EHS. Conclusion: CPT1B, CHKB and HLA are candidates for susceptibility to CNS hypersomnias (EHS), as well as narcolepsy with cataplexy.			Miyagawa, T (corresponding author), Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan.	miyagawa-taku@umin.ac.jp	Tanaka, Susumu/AAC-4739-2019	Tanaka, Susumu/0000-0003-4804-7839				Anderson KN, 2007, SLEEP, V30, P1274, DOI 10.1093/sleep/30.10.1274; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Fioravanti M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000269.pub3; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; HONDA Y, 1986, SLEEP, V9, P133, DOI 10.1093/sleep/9.1.133; HONDA Y, 1998, GENETIC ASPECTS NARC, P341; Hong SC, 2006, SLEEP, V29, P1429, DOI 10.1093/sleep/29.11.1429; JUJI T, 1984, TISSUE ANTIGENS, V24, P316, DOI 10.1111/j.1399-0039.1984.tb02144.x; Kent C, 1997, BBA-LIPID LIPID MET, V1348, P79, DOI 10.1016/S0005-2760(97)00112-4; Komada Y, 2005, PSYCHIAT CLIN NEUROS, V59, P194, DOI 10.1111/j.1440-1819.2005.01357.x; Kuwajima M, 2007, ENDOCR J; LANGDON N, 1984, LANCET, V2, P1178; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Nishino S, 1997, PROG NEUROBIOL, V52, P27, DOI 10.1016/S0301-0082(96)00070-6; Tafti M, 2003, NAT GENET, V34, P320, DOI 10.1038/ng1174; Yoshida G, 2006, NEUROSCI RES, V55, P78, DOI 10.1016/j.neures.2006.02.003; Zweigner J, 2004, J EXP MED, V200, P99, DOI 10.1084/jem.20032100	22	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5394	10.1371/journal.pone.0005394	http://dx.doi.org/10.1371/journal.pone.0005394			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404393	Green Published, Green Submitted, gold			2022-12-27	WOS:000265614900008
J	Guo, J; Jou, W; Gavrilova, O; Hall, KD				Guo, Juen; Jou, William; Gavrilova, Oksana; Hall, Kevin D.			Persistent Diet-Induced Obesity in Male C57BL/6 Mice Resulting from Temporary Obesigenic Diets	PLOS ONE			English	Article							ADIPOSE-TISSUE; LEPTIN RESISTANCE; RISK-FACTORS; INSULIN; RATS; REVERSAL; DEFENSE; FAT; INSIGHTS	Background: Does diet-induced obesity persist after an obesigenic diet is removed? We investigated this question by providing male C57BL/6 mice with free access to two different obesigenic diets followed by a switch to chow to determine if obesity was reversible. Methodology/Principal Findings: Male C57BL/6 mice were randomly assigned to five weight-matched groups: 1) C group that continuously received a chow diet; 2) HF group on a 60% high fat diet; 3) EN group on the high fat diet plus liquid Ensure (R); 4) HF-C group switched from high fat to chow after 7 weeks; 5) EN-C group switched from high fat plus Ensure (R) to chow after 7 weeks. All food intake was ad libitum. Body weight was increased after 7 weeks on both obesigenic diets (44.6 +/- 0.65, 39.8 +/- 0.63, and 28.6 +/- 0.63 g for EN, HF, and C groups, respectively) and resulted in elevated concentrations of serum insulin, glucose, and leptin and lower serum triglycerides. Development of obesity in HF and EN mice was caused by increased energy intake and a relative decrease of average energy output along with decreased ambulatory activity. After the switch to chow, the HF-C and EN-C groups lost weight but subsequently maintained a state of persistent obesity in comparison to the C group (34.8 +/- 1.2, 34.1 +/- 1.2 vs. 30.8 +/- 0.8 g respectively; P < 0.05) with a 40-50% increase of body fat. All serum hormones and metabolites returned to control levels with the exception of a trend for increased leptin. The HF-C and EN-C groups had an average energy output in line with the C group and the persistent obesity was maintained despite a non-significant increase of energy intake of less than 1 kcal/d at the end of the study. Conclusion: Our results illustrate the importance of considering the history of energy imbalance in determining body weight and that a persistent elevation of body weight after removal of obesigenic diets can result from very small increases of energy intake.			Guo, J (corresponding author), NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA.	kevinh@niddk.nih.gov	Hall, Kevin/F-2383-2010	Hall, Kevin/0000-0003-4062-3133; Guo, Juen/0000-0003-2876-5884	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK070002, ZICDK070002, Z01DK013038, ZIADK013038] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BARTNESS TJ, 1992, AM J PHYSIOL, V263, pR790, DOI 10.1152/ajpregu.1992.263.4.R790; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493; Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; Chen M, 2004, ENDOCRINOLOGY, V145, P4094, DOI 10.1210/en.2004-0038; Corp N, 1997, PHYSIOL ZOOL, V70, P610, DOI 10.1086/515876; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dina C, 2008, CURR OPIN CLIN NUTR, V11, P378, DOI 10.1097/MCO.0b013e328303e5e6; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Flatt JP, 1997, OBES RES, V5, P632, DOI 10.1002/j.1550-8528.1997.tb00585.x; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Ginsberg HN, 2005, ARCH MED RES, V36, P232, DOI 10.1016/j.arcmed.2005.01.005; Hall K, 2002, DIABETES, V51, pA607; Hall KD, 2008, INT J OBESITY, V32, P573, DOI 10.1038/sj.ijo.0803720; HARRINGTON ME, 1983, PHYSIOL BEHAV, V30, P763, DOI 10.1016/0031-9384(83)90175-0; HARRIS RBS, 1989, P SOC EXP BIOL MED, V191, P82; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; HILL JO, 1989, INT J OBESITY, V13, P711; HimmsHagen J, 1997, SCIENCE, V276, P1132, DOI 10.1126/science.276.5315.1132; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; James WPT, 2008, OBES REV, V9, P6, DOI 10.1111/j.1467-789X.2007.00432.x; KESSLER JI, 1963, J CLIN INVEST, V42, P362, DOI 10.1172/JCI104722; Levin BE, 1998, AM J PHYSIOL-REG I, V274, pR412, DOI 10.1152/ajpregu.1998.274.2.R412; Levin BE, 2002, AM J PHYSIOL-REG I, V282, pR46, DOI 10.1152/ajpregu.2002.282.1.R46; LEWIS GF, 1995, J CLIN INVEST, V95, P158, DOI 10.1172/JCI117633; LLADO I, 1991, INT J OBESITY, V15, P415; Meugnier E, 2007, OBESITY, V15, P2583, DOI 10.1038/oby.2007.310; Parekh PI, 1998, METABOLISM, V47, P1089, DOI 10.1016/S0026-0495(98)90283-9; PECKHAM SC, 1962, RES DEV TECH REP, V546; ROGERS PJ, 1985, PHYSIOL BEHAV, V35, P493, DOI 10.1016/0031-9384(85)90129-5; ROLLS BJ, 1980, J PHYSIOL-LONDON, V298, P415, DOI 10.1113/jphysiol.1980.sp013091; SCLAFANI A, 1976, PHYSIOL BEHAV, V17, P461, DOI 10.1016/0031-9384(76)90109-8; Speakman JR, 2004, J NUTR, V134, p2090S, DOI 10.1093/jn/134.8.2090S; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Tam J, 2009, CELL METAB, V9, P52, DOI 10.1016/j.cmet.2008.11.005; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697	37	82	83	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5370	10.1371/journal.pone.0005370	http://dx.doi.org/10.1371/journal.pone.0005370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401758	gold, Green Published, Green Submitted			2022-12-27	WOS:000265601100012
J	Pinese, M; Scarlett, CJ; Kench, JG; Colvin, EK; Segara, D; Henshall, SM; Sutherland, RL; Biankin, AV				Pinese, Mark; Scarlett, Christopher J.; Kench, James G.; Colvin, Emily K.; Segara, Davendra; Henshall, Susan M.; Sutherland, Robert L.; Biankin, Andrew V.			Messina: A Novel Analysis Tool to Identify Biologically Relevant Molecules in Disease	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; FALSE DISCOVERY RATE; BREAST-CANCER	Background: Morphologically similar cancers display heterogeneous patterns of molecular aberrations and follow substantially different clinical courses. This diversity has become the basis for the definition of molecular phenotypes, with significant implications for therapy. Microarray or proteomic expression profiling is conventionally employed to identify disease-associated genes, however, traditional approaches for the analysis of profiling experiments may miss molecular aberrations which define biologically relevant subtypes. Methodology/Principal Findings: Here we present Messina, a method that can identify those genes that only sometimes show aberrant expression in cancer. We demonstrate with simulated data that Messina is highly sensitive and specific when used to identify genes which are aberrantly expressed in only a proportion of cancers, and compare Messina to contemporary analysis techniques. We illustrate Messina by using it to detect the aberrant expression of a gene that may play an important role in pancreatic cancer. Conclusions/Significance: Messina allows the detection of genes with profiles typical of markers of molecular subtype, and complements existing methods to assist the identification of such markers. Messina is applicable to any global expression profiling data, and to allow its easy application has been packaged into a freely-available stand-alone software package.			Pinese, M (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia.	a.biankin@garvan.org.au	Sutherland, Robert L/A-8378-2008	Colvin, Emily/0000-0002-5435-5902; Scarlett, Christopher/0000-0002-4140-7785; Pinese, Mark/0000-0001-5078-6687; Biankin, Andrew/0000-0002-0362-5597; Kench, James Geoffrey/0000-0001-8687-4988				Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Li L, 2007, PHYSIOL GENOMICS, V32, P154, DOI 10.1152/physiolgenomics.00259.2006; Nadeau C, 2003, MACH LEARN, V52, P239, DOI 10.1023/A:1024068626366; Segara D, 2005, CLIN CANCER RES, V11, P3587, DOI 10.1158/1078-0432.CCR-04-1813; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tibshirani R, 2007, BIOSTATISTICS, V8, P2, DOI 10.1093/biostatistics/kxl005; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2008, CANCER CELL, V13, P519, DOI 10.1016/j.ccr.2008.04.016; Widakowich C, 2007, INT J BIOCHEM CELL B, V39, P1375, DOI 10.1016/j.biocel.2007.04.015	15	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5337	10.1371/journal.pone.0005337	http://dx.doi.org/10.1371/journal.pone.0005337			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399185	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514900004
J	Drews-Elger, K; Ortells, MC; Rao, A; Lopez-Rodriguez, C; Aramburu, J				Drews-Elger, Katherine; Carmen Ortells, M.; Rao, Anjana; Lopez-Rodriguez, Cristina; Aramburu, Jose			The Transcription Factor NFAT5 Is Required for Cyclin Expression and Cell Cycle Progression in Cells Exposed to Hypertonic Stress	PLOS ONE			English	Article							ENHANCER-BINDING PROTEIN; RESPONSE ELEMENT; OSMOTIC-STRESS; STIMULATES TRANSCRIPTION; TARGETED DISRUPTION; FACTOR TONEBP; GENE; ACTIVATION; HYPERNATREMIA; CONTRIBUTES	Background: Hypertonicity can perturb cellular functions, induce DNA damage-like responses and inhibit proliferation. The transcription factor NFAT5 induces osmoprotective gene products that allow cells to adapt to sustained hypertonic conditions. Although it is known that NFAT5-deficient lymphocytes and renal medullary cells have reduced proliferative capacity and viability under hypertonic stress, less is understood about the contribution of this factor to DNA damage responses and cell cycle regulation. Methodology/Principal Findings: We have generated conditional knockout mice to obtain NFAT5(-/-) T lymphocytes, which we used as a model of proliferating cells to study NFAT5-dependent responses. We show that hypertonicity triggered an early, NFAT5-independent, genotoxic stress-like response with induction of p53, p21 and GADD45, downregulation of cyclins, and cell cycle arrest. This was followed by an NFAT5-dependent adaptive phase in wild-type cells, which induced an osmoprotective gene expression program, downregulated stress markers, resumed cyclin expression and proliferation, and displayed enhanced NFAT5 transcriptional activity in S and G2/M. In contrast, NFAT5(-/-) cells failed to induce osmoprotective genes and exhibited poorer viability. Although surviving NFAT5(-/-) cells downregulated genotoxic stress markers, they underwent cell cycle arrest in G1/S and G2/M, which was associated with reduced expression of cyclins E1, A2 and B1. We also show that pathologic hypertonicity levels, as occurring in plasma of patients and animal models of osmoregulatory disorders, inhibited the induction of cyclins and aurora B kinase in response to T cell receptor stimulation in fresh NFAT5(-/-) lymphocytes. Conclusions/Significance: We conclude that NFAT5 facilitates cell proliferation under hypertonic conditions by inducing an osmoadaptive response that enables cells to express fundamental regulators needed for cell cycle progression.			Drews-Elger, K (corresponding author), Univ Pompeu Fabra & Barcelona Biomed Res Pk PRBB, Dept Ciencies Expt & Salut, Barcelona, Spain.	cristina.lopez-rodriguez@upf.edu; jose.aramburu@upf.edu	Lopez-Rodriguez, C/G-4482-2014; Aramburu, J/G-8991-2014	Lopez-Rodriguez, C/0000-0002-2311-2406; Aramburu, J/0000-0001-9279-9523; Drews-Elger, Katherine/0000-0001-9540-0610				Aramburu J, 2006, BIOCHEM PHARMACOL, V72, P1597, DOI 10.1016/j.bcp.2006.07.002; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Caetano MS, 2002, FASEB J, V16, P1940, DOI 10.1096/fj.02-0282fje; Carvalho LDS, 2007, CELL CYCLE, V6, P1789, DOI 10.4161/cc.6.14.4473; Chen Y, 2007, AM J PHYSIOL-RENAL, V292, pP981, DOI 10.1152/ajprenal.00493.2005; CHILTON LA, 1995, WESTERN J MED, V163, P74; COOKE CR, 1993, AM J KIDNEY DIS, V22, P44, DOI 10.1016/S0272-6386(12)70165-8; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; Dmitrieva N, 2000, J BIOL CHEM, V275, P18243, DOI 10.1074/jbc.M000522200; Dmitrieva NI, 2005, MUTAT RES-FUND MOL M, V569, P65, DOI 10.1016/j.mrfmmm.2004.06.053; Dogan E, 2005, ADV THER, V22, P429, DOI 10.1007/BF02849861; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Held T, 2006, MOL CELL BIOL, V26, P8099, DOI 10.1128/MCB.01332-06; Huang Xuan, 2006, Methods Mol Biol, V314, P73; Irarrazabal CE, 2004, P NATL ACAD SCI USA, V101, P8809, DOI 10.1073/pnas.0403062101; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Ito T, 2007, J BIOL CHEM, V282, P1152, DOI 10.1074/jbc.M609547200; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Ka T, 2003, DIABETES NUTR METAB, V16, P317; Kino T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000081; Ko BCB, 2002, J BIOL CHEM, V277, P46085, DOI 10.1074/jbc.M208138200; Kojima R, 2004, BIOCHEM J, V380, P783, DOI 10.1042/BJ20040313; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lam AKM, 2004, J BIOL CHEM, V279, P48048, DOI 10.1074/jbc.M407224200; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Loyher ML, 2004, NEUROSCIENCE, V124, P89, DOI 10.1016/j.neuroscience.2003.10.025; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Maallem S, 2006, NEUROSCIENCE, V137, P51, DOI 10.1016/j.neuroscience.2005.07.037; Mak SK, 2004, J BIOL CHEM, V279, P39075, DOI 10.1074/jbc.M406643200; McDill BW, 2006, P NATL ACAD SCI USA, V103, P6952, DOI 10.1073/pnas.0602087103; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Morancho B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-13; Nakata Y, 2007, MOL CELL BIOL, V27, P2048, DOI 10.1128/MCB.01100-06; Nakayama Y, 2000, J BIOL CHEM, V275, P38275, DOI 10.1074/jbc.M004678200; Navarro P, 2008, BIOCHEM BIOPH RES CO, V372, P326, DOI 10.1016/j.bbrc.2008.05.067; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; Papadimitriou A, 1997, J PEDIATR ENDOCR MET, V10, P547; Paut O, 1999, PAEDIATR ANAESTH, V9, P171, DOI 10.1046/j.1460-9592.1999.9220325.x; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; SCHORN T, 1991, KLIN WOCHENSCHR, V69, P436, DOI 10.1007/BF01666829; Sheen MR, 2006, AM J PHYSIOL-RENAL, V291, pF1014, DOI 10.1152/ajprenal.00153.2006; Shim EH, 2002, EMBO REP, V3, P857, DOI 10.1093/embo-reports/kvf175; Song JX, 2007, NAT IMMUNOL, V8, P64, DOI 10.1038/ni1413; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Trama J, 2002, J IMMUNOL, V169, P5477, DOI 10.4049/jimmunol.169.10.5477; Wang DZ, 1995, ANN NY ACAD SCI, V766, P182, DOI 10.1111/j.1749-6632.1995.tb26661.x; Wang Y, 2005, J BIOL CHEM, V280, P19986, DOI 10.1074/jbc.M501689200; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yuan JP, 2004, ONCOGENE, V23, P5843, DOI 10.1038/sj.onc.1207757; Yun J, 2000, J CLIN INVEST, V106, P1361, DOI 10.1172/JCI9154	58	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5245	10.1371/journal.pone.0005245	http://dx.doi.org/10.1371/journal.pone.0005245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381288	Green Published, gold, Green Submitted			2022-12-27	WOS:000265513800013
J	You, YN; Short, KR; Jourdan, M; Klaus, KA; Walrand, S; Nair, KS				You, Y. Nancy; Short, Kevin R.; Jourdan, Marion; Klaus, Katherine A.; Walrand, Stephane; Nair, K. Sreekumaran			The Effect of High Glucocorticoid Administration and Food Restriction on Rodent Skeletal Muscle Mitochondrial Function and Protein Metabolism	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; SYNTHESIS RATES; OLD RATS; LEUCINE OXIDATION; ATP PRODUCTION; AMINO-ACIDS; STARVATION; TURNOVER; EXERCISE; HUMANS	Background: Glucocorticoids levels are high in catabolic conditions but it is unclear how much of the catabolic effects are due to negative energy balance versus glucocorticoids and whether there are distinct effects on metabolism and functions of specific muscle proteins. Methodology/Principal Findings: We determined whether 14 days of high dose methylprednisolone (MPred, 4 mg/kg/d) Vs food restriction (FR, food intake matched to MPred) in rats had different effects on muscle mitochondrial function and protein fractional synthesis rates (FSR). Lower weight loss (15%) occurred in FR than in MPred (30%) rats, while a 15% increase occurred saline-treated Controls. The per cent muscle loss was significantly greater for MPred than FR. Mitochondrial protein FSR in MPred rats was lower in soleus (51 and 43%, respectively) and plantaris (25 and 55%) than in FR, while similar decline in protein FSR of the mixed, sarcoplasmic, and myosin heavy chain occurred. Mitochondrial enzymatic activity and ATP production were unchanged in soleus while in plantaris cytochrome c oxidase activity was lower in FR than Control, and ATP production rate with pyruvate + malate in MPred plantaris was 28% lower in MPred. Branched-chain amino acid catabolic enzyme activities were higher in both FR and MPred rats indicating enhanced amino acid oxidation capacity. Conclusion/Significance: MPred and FR had little impact on mitochondrial function but reduction in muscle protein synthesis occurred in MPred that could be explained on the basis of reduced food intake. A greater decline in proteolysis may explain lesser muscle loss in FR than in MPred rats.			You, YN (corresponding author), Mayo Clin, Coll Med, Endocrine Res Unit, Rochester, MN 55905 USA.	nair.sree@mayo.edu	Short, Kevin R/AAC-2553-2020	Short, Kevin R/0000-0001-6704-9587	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041973, T32DK007352] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK41973, R01 DK041973, T32 DK007352, T32-DK07352] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AFTRING RP, 1988, AM J PHYSIOL, V254, pE292, DOI 10.1152/ajpendo.1988.254.3.E292; Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790; BALAGOPAL P, 1994, ANAL BIOCHEM, V221, P72, DOI 10.1006/abio.1994.1381; Barazzoni R, 2005, ENDOCRINOLOGY, V146, P2098, DOI 10.1210/en.2004-1396; BEAUFRERE B, 1989, AM J PHYSIOL, V257, pE712, DOI 10.1152/ajpendo.1989.257.5.E712; Bezaire V, 2001, AM J PHYSIOL-ENDOC M, V281, pE975, DOI 10.1152/ajpendo.2001.281.5.E975; Boirie Y, 2001, DIABETES, V50, P2652, DOI 10.2337/diabetes.50.12.2652; Cooper AJL, 2002, ANAL BIOCHEM, V308, P100, DOI 10.1016/S0003-2697(02)00243-9; CZERWINSKI SM, 1989, J APPL PHYSIOL, V67, P2311, DOI 10.1152/jappl.1989.67.6.2311; CZERWINSKI SM, 1987, J APPL PHYSIOL, V63, P1504, DOI 10.1152/jappl.1987.63.4.1504; Dardevet D, 1998, J ENDOCRINOL, V156, P83, DOI 10.1677/joe.0.1560083; DARDEVET D, 1995, J CLIN INVEST, V96, P2113, DOI 10.1172/JCI118264; Duclos M, 2004, AM J PHYSIOL-ENDOC M, V286, pE159, DOI 10.1152/ajpendo.00281.2003; EMERY PW, 1995, CLIN SCI, V89, P383, DOI 10.1042/cs0890383; ESSEN P, 1992, CLIN PHYSIOL, V12, P287, DOI 10.1111/j.1475-097X.1992.tb00834.x; Fu AZ, 1998, AM J PHYSIOL-ENDOC M, V275, pE1023, DOI 10.1152/ajpendo.1998.275.6.E1023; HICKSON RC, 1995, AM J PHYSIOL-ENDOC M, V268, pE730, DOI 10.1152/ajpendo.1995.268.4.E730; KELLY FJ, 1986, MUSCLE NERVE, V9, P1, DOI 10.1002/mus.880090102; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; LIEU FK, 1993, J APPL PHYSIOL, V75, P763, DOI 10.1152/jappl.1993.75.2.763; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Liu ZQ, 2001, J CLIN ENDOCR METAB, V86, P2136, DOI 10.1210/jc.86.5.2136; Ljungqvist OH, 1997, AM J PHYSIOL-ENDOC M, V273, pE564, DOI 10.1152/ajpendo.1997.273.3.E564; Lofberg E, 2002, EUR J CLIN INVEST, V32, P345, DOI 10.1046/j.1365-2362.2002.00993.x; LOUARD RJ, 1994, J CLIN ENDOCR METAB, V79, P278, DOI 10.1210/jc.79.1.278; MAGNUSSON K, 1990, METABOLISM, V39, P1113, DOI 10.1016/0026-0495(90)90080-V; MARONE JR, 1994, J APPL PHYSIOL, V77, P1685; Minet-Quinard R, 2000, JPEN-PARENTER ENTER, V24, P30, DOI 10.1177/014860710002400130; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Mittendorfer B, 2005, J PHYSIOL-LONDON, V563, P203, DOI 10.1113/jphysiol.2004.077180; PAULSON JC, 1954, J AM CHEM SOC, V76, P6198, DOI 10.1021/ja01652a104; POLLA B, 1994, ACTA PHYSIOL SCAND, V151, P353, DOI 10.1111/j.1748-1716.1994.tb09754.x; QUAN ZY, 1991, METABOLISM, V40, P1263, DOI 10.1016/0026-0495(91)90026-S; Rieu I, 2004, EXP GERONTOL, V39, P1315, DOI 10.1016/j.exger.2004.06.005; Robinson JB., 1987, MITOCHONDRIA PRACTIC, P153, DOI DOI 10.1016/J.BBRC.2005.02.135; Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364; Rooyackers OE, 1997, MUSCLE NERVE, pS93; Savary I, 1998, BRIT J NUTR, V79, P297, DOI 10.1079/BJN19980047; SHERWIN RS, 1978, J CLIN INVEST, V61, P1471, DOI 10.1172/JCI109067; Shimomura Y, 2001, CURR OPIN CLIN NUTR, V4, P419, DOI 10.1097/00075197-200109000-00013; Short KR, 2007, AM J PHYSIOL-ENDOC M, V292, pE642, DOI 10.1152/ajpendo.00397.2006; Short KR, 2004, J CLIN ENDOCR METAB, V89, P6198, DOI 10.1210/jc.2004-0908; Short KR, 2001, AM J PHYSIOL-ENDOC M, V280, pE761, DOI 10.1152/ajpendo.2001.280.5.E761; Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001; Weber K, 2002, ENDOCRINOLOGY, V143, P177, DOI 10.1210/en.143.1.177; WIBOM R, 1990, SCAND J CLIN LAB INV, V50, P143, DOI 10.3109/00365519009089146; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; WING SS, 1993, AM J PHYSIOL, V264, pE668, DOI 10.1152/ajpendo.1993.264.4.E668	48	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2009	4	4							e5283	10.1371/journal.pone.0005283	http://dx.doi.org/10.1371/journal.pone.0005283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437UZ	19381333	Green Submitted, Green Published, gold			2022-12-27	WOS:000265513700003
J	Cundiff, P; Liu, LD; Wang, YP; Zou, JH; Pan, YW; Abel, G; Duan, X; Ming, GL; Englund, C; Hevner, R; Xia, ZG				Cundiff, Paige; Liu, Lidong; Wang, Yupeng; Zou, Junhui; Pan, Yung-Wei; Abel, Glen; Duan, Xin; Ming, Guo-Li; Englund, Chris; Hevner, Robert; Xia, Zhengui			ERK5 MAP Kinase Regulates Neurogenin1 during Cortical Neurogenesis	PLOS ONE			English	Article								The commitment of multi-potent cortical progenitors to a neuronal fate depends on the transient induction of the basic-helix-loop-helix (bHLH) family of transcription factors including Neurogenin 1 (Neurog1). Previous studies have focused on mechanisms that control the expression of these proteins while little is known about whether their pro-neural activities can be regulated by kinase signaling pathways. Using primary cultures and ex vivo slice cultures, here we report that both the transcriptional and pro-neural activities of Neurog1 are regulated by extracellular signal-regulated kinase (ERK) 5 signaling in cortical progenitors. Activation of ERK5 potentiated, while blocking ERK5 inhibited Neurog1-induced neurogenesis. Furthermore, endogenous ERK5 activity was required for Neurog1-initiated transcription. Interestingly, ERK5 activation was sufficient to induce Neurog1 phosphorylation and ERK5 directly phosphorylated Neurog1 in vitro. We identified S179/S208 as putative ERK5 phosphorylation sites in Neurog1. Mutations of S179/S208 to alanines inhibited the transcriptional and pro-neural activities of Neurog1. Our data identify ERK5 phosphorylation of Neurog1 as a novel mechanism regulating neuronal fate commitment of cortical progenitors.			Cundiff, P (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	zxia@u.washington.edu	Ming, Guo-li/J-7880-2013	Ming, Guo-li/0000-0002-2517-6075	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019193] Funding Source: NIH RePORTER; NIA NIH HHS [AG19193, R01 AG019193] Funding Source: Medline; NIDDK NIH HHS [P30 DK056465] Funding Source: Medline; NIGMS NIH HHS [T32GM07750, T32 GM007750] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Britan A, 2006, SHOCK WAVES, V16, P1, DOI 10.1007/s00193-006-0019-0; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Coyle-Rink J, 2002, CANCER BIOL THER, V1, P640, DOI 10.4161/cbt.313; Cude K, 2007, J CELL BIOL, V177, P253, DOI 10.1083/jcb.200609166; Dinev D, 2001, EMBO REP, V2, P829, DOI 10.1093/embo-reports/kve177; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 2000, GENE DEV, V14, P67; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Irvin DK, 2003, DEV NEUROSCI-BASEL, V25, P162, DOI 10.1159/000072265; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kim S, 2002, EXP MOL MED, V34, P469, DOI 10.1038/emm.2002.65; Kolk SM, 2005, MOL CELL NEUROSCI, V30, P538, DOI 10.1016/j.mcn.2005.08.017; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Liu LD, 2006, P NATL ACAD SCI USA, V103, P9697, DOI 10.1073/pnas.0603373103; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Moore KB, 2002, NEURON, V34, P183, DOI 10.1016/S0896-6273(02)00666-9; Morrow T, 2001, DEVELOPMENT, V128, P3585; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Nadarajah B, 2002, NAT NEUROSCI, V5, P218, DOI 10.1038/nn813; Nelson BR, 2007, DEV BIOL, V304, P479, DOI 10.1016/j.ydbio.2007.01.001; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Olson JM, 2001, DEV BIOL, V234, P174, DOI 10.1006/dbio.2001.0245; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; SCHUURMANS C, 2004, EMBO J; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Tang HB, 2004, CELL SIGNAL, V16, P551, DOI 10.1016/j.cellsig.2003.09.006; Tsai RYL, 2000, J NEUROSCI, V20, P3725, DOI 10.1523/JNEUROSCI.20-10-03725.2000; Vavvas D, 1997, J BIOL CHEM, V272, P13255, DOI 10.1074/jbc.272.20.13255; Vojtek AB, 2003, MOL CELL BIOL, V23, P4417, DOI 10.1128/MCB.23.13.4417-4427.2003; Vosper JMD, 2007, BIOCHEM J, V407, P277, DOI 10.1042/BJ20070064; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	58	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5204	10.1371/journal.pone.0005204	http://dx.doi.org/10.1371/journal.pone.0005204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365559	Green Published, gold			2022-12-27	WOS:000265509900017
J	Elleuche, S; Poggeler, S				Elleuche, Skander; Poeggeler, Stefanie			beta-Carbonic Anhydrases Play a Role in Fruiting Body Development and Ascospore Germination in the Filamentous Fungus Sordaria macrospora	PLOS ONE			English	Article								Carbon dioxide (CO2) is among the most important gases for all organisms. Its reversible interconversion to bicarbonate (HCO3-) reaches equilibrium spontaneously, but slowly, and can be accelerated by a ubiquitous group of enzymes called carbonic anhydrases (CAs). These enzymes are grouped by their distinct structural features into alpha-, beta-, gamma-, delta-and zeta-classes. While physiological functions of mammalian, prokaryotic, plant and algal CAs have been extensively studied over the past years, the role of beta-CAs in yeasts and the human pathogen Cryptococcus neoformans has been elucidated only recently, and the function of CAs in multicellular filamentous ascomycetes is mostly unknown. To assess the role of CAs in the development of filamentous ascomycetes, the function of three genes, cas1, cas2 and cas3 (carbonic anhydrase of Sordaria) encoding beta-class carbonic anhydrases was characterized in the filamentous ascomycetous fungus Sordaria macrospora. Fluorescence microscopy was used to determine the localization of GFP- and DsRED-tagged CAs. While CAS1 and CAS3 are cytoplasmic enzymes, CAS2 is localized to the mitochondria. To assess the function of the three isoenzymes, we generated knock-out strains for all three cas genes (Delta cas1, Delta cas2, and Delta cas3) as well as all combinations of double mutants. No effect on vegetative growth, fruiting-body and ascospore development was seen in the single mutant strains lacking cas1 or cas3, while single mutant Delta cas2 was affected in vegetative growth, fruiting-body development and ascospore germination, and the double mutant strain Delta cas1/2 was completely sterile. Defects caused by the lack of cas2 could be partially complemented by elevated CO2 levels or overexpression of cas1, cas3, or a non-mitochondrial cas2 variant. The results suggest that CAs are required for sexual reproduction in filamentous ascomycetes and that the multiplicity of isoforms results in redundancy of specific and non-specific functions.			Elleuche, S (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Genet Eukaryot Microorganisms, Gottingen, Germany.	spoegge@gwdg.de		Elleuche, Skander/0000-0002-7259-9935				Aguilera J, 2005, FEMS YEAST RES, V5, P579, DOI 10.1016/j.femsyr.2004.09.009; Aguilera J, 2005, BIOCHEM J, V391, P311, DOI 10.1042/BJ20050556; Amoroso G, 2005, MOL MICROBIOL, V56, P549, DOI 10.1111/j.1365-2958.2005.04560.x; Bahn YS, 2006, CURR OPIN MICROBIOL, V9, P572, DOI 10.1016/j.mib.2006.09.003; Bahn YS, 2005, CURR BIOL, V15, P2013, DOI 10.1016/j.cub.2005.09.047; Casey JR, 2006, BIOCHEM CELL BIOL, V84, P930, DOI 10.1139/O06-184; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Clark D, 2004, BIOCHEM J, V379, P609, DOI 10.1042/BJ20031711; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cronk JD, 2001, PROTEIN SCI, V10, P911, DOI 10.1110/ps.46301; ELLEUCHE S, 2009, CURR GENET IN PRESS; Elleuche S, 2008, BIOCHEM BIOPH RES CO, V366, P239, DOI 10.1016/j.bbrc.2007.11.126; Elleuche S, 2008, FUNGAL GENET BIOL, V45, P1458, DOI 10.1016/j.fgb.2008.08.005; Engh I, 2007, EUKARYOT CELL, V6, P831, DOI 10.1128/EC.00269-06; Eriksson M, 1996, P NATL ACAD SCI USA, V93, P12031, DOI 10.1073/pnas.93.21.12031; ESSER K, 1982, CRYPTOGAMS CYANAOBAC; Fabre N, 2007, PLANT CELL ENVIRON, V30, P617, DOI 10.1111/j.1365-3040.2007.01651.x; GIORDANO M, 2003, PLANT PHYSL, V132; Gotz R, 1999, YEAST, V15, P855, DOI 10.1002/(SICI)1097-0061(199907)15:10A<855::AID-YEA425>3.0.CO;2-C; GUILLOTON MB, 1993, J BACTERIOL, V175, P1443, DOI 10.1128/JB.175.5.1443-1451.1993; Henry RP, 1996, ANNU REV PHYSIOL, V58, P523, DOI 10.1146/annurev.ph.58.030196.002515; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; Innocenti A, 2008, BIOORG MED CHEM LETT, V18, P5066, DOI 10.1016/j.bmcl.2008.07.122; James P, 1996, GENETICS, V144, P1425; Janus D, 2007, APPL ENVIRON MICROB, V73, P962, DOI 10.1128/AEM.02127-06; Kamerewerd J, 2008, GENETICS, V180, P191, DOI 10.1534/genetics.108.091603; Kimber MS, 2000, EMBO J, V19, P1407, DOI 10.1093/emboj/19.7.1407; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Kuck U, 2005, MOL GENET GENOMICS, V274, P307, DOI 10.1007/s00438-005-0021-8; KUCK U, 2005, PRODUCTION RECOMBINA, P215; Kusian B, 2002, J BACTERIOL, V184, P5018, DOI 10.1128/JB.184.18.5018-5026.2002; Levina NN, 2006, FUNGAL GENET BIOL, V43, P65, DOI 10.1016/j.fgb.2005.06.008; McGinn PJ, 2008, PHYSIOL PLANTARUM, V133, P78, DOI 10.1111/j.1399-3054.2007.01039.x; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Mitsuhashi S, 2000, J BIOL CHEM, V275, P5521, DOI 10.1074/jbc.275.8.5521; Mitsuhashi S, 2004, APPL MICROBIOL BIOT, V63, P592, DOI 10.1007/s00253-003-1402-8; Mogensen EG, 2006, EUKARYOT CELL, V5, P103, DOI 10.1128/EC.5.1.103-111.2006; MOGENSEN EG, 2008, MYCOTA, V6, P83; NAGAO Y, 1994, P NATL ACAD SCI USA, V91, P10330, DOI 10.1073/pnas.91.22.10330; Nolting N, 2006, MOL MICROBIOL, V62, P853, DOI 10.1111/j.1365-2958.2006.05415.x; Nolting N, 2006, EUKARYOT CELL, V5, P1043, DOI 10.1128/EC.00086-06; Nowrousian M, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-64; Nowrousian M, 1999, MOL CELL BIOL, V19, P450; Nowrousian M, 2004, FUNGAL GENET BIOL, V41, P285, DOI 10.1016/j.fgb.2003.10.005; Nowrousian M, 2007, FUNGAL GENET BIOL, V44, P602, DOI 10.1016/j.fgb.2006.09.009; Parisi G, 2004, PLANT MOL BIOL, V55, P193, DOI 10.1007/s11103-004-0149-7; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Poggeler S, 2006, MOL GENET GENOMICS, V275, P492, DOI 10.1007/s00438-006-0107-y; Poggeler S, 2006, GENE, V378, P1, DOI 10.1016/j.gene.2006.03.020; Poggeler S, 1997, GENETICS, V147, P567; Poggeler S, 2003, CURR GENET, V43, P54, DOI 10.1007/s00294-003-0370-y; Poggeler S., 2008, FUNGAL GENET REP, V55, P8, DOI [10.4148/1941-4765.1083, DOI 10.4148/1941-4765.1083]; Poggeler S, 2006, MYCOTA, P325; Raven JA, 2001, PLANT CELL ENVIRON, V24, P261; Sambrook J., 2001, MOL CLONING LAB MANU; SCHLICKER C, 2008, J MOL BIOL; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Smith KS, 2002, J BACTERIOL, V184, P4240, DOI 10.1128/JB.184.15.4240-4245.2002; Smith KS, 1999, J BACTERIOL, V181, P6247, DOI 10.1128/JB.181.20.6247-6253.1999; Smith KS, 1999, P NATL ACAD SCI USA, V96, P15184, DOI 10.1073/pnas.96.26.15184; Strop P, 2001, J BIOL CHEM, V276, P10299, DOI 10.1074/jbc.M009182200; SUAREZ C, 2005, J BIOL CHEM, V0280; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; Sunderhaus S, 2006, J BIOL CHEM, V281, P6482, DOI 10.1074/jbc.M511542200; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; Tetu SG, 2007, PLANT PHYSIOL, V144, P1316, DOI 10.1104/pp.107.098152; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tripp BC, 2001, J BIOL CHEM, V276, P48615, DOI 10.1074/jbc.R100045200; Xu Y, 2008, NATURE, V452, P56, DOI 10.1038/nature06636	70	33	35	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5177	10.1371/journal.pone.0005177	http://dx.doi.org/10.1371/journal.pone.0005177			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365544	gold, Green Published, Green Submitted			2022-12-27	WOS:000265509900007
J	Nackley, AG; Shabalina, SA; Lambert, JE; Conrad, MS; Gibson, DG; Spiridonov, AN; Satterfield, SK; Diatchenko, L				Nackley, Andrea G.; Shabalina, Svetlana A.; Lambert, Jason E.; Conrad, Mathew S.; Gibson, Dustin G.; Spiridonov, Alexey N.; Satterfield, Sarah K.; Diatchenko, Luda			Low Enzymatic Activity Haplotypes of the Human Catechol-O-Methyltransferase Gene: Enrichment for Marker SNPs	PLOS ONE			English	Article								Catechol-O-methyltransferase (COMT) is an enzyme that plays a key role in the modulation of catechol-dependent functions such as cognition, cardiovascular function, and pain processing. Three common haplotypes of the human COMT gene, divergent in two synonymous and one nonsynonymous (val(158) met) position, designated as low (LPS), average (APS), and high pain sensitive (HPS), are associated with experimental pain sensitivity and risk of developing chronic musculoskeletal pain conditions. APS and HPS haplotypes produce significant functional effects, coding for 3- and 20-fold reductions in COMT enzymatic activity, respectively. In the present study, we investigated whether additional minor single nucleotide polymorphisms (SNPs), accruing in 1 to 5% of the population, situated in the COMT transcript region contribute to haplotype-dependent enzymatic activity. Computer analysis of COMT ESTs showed that one synonymous minor SNP (rs769224) is linked to the APS haplotype and three minor SNPs (two synonymous: rs6267, rs740602 and one nonsynonymous: rs8192488) are linked to the HPS haplotype. Results from in silico and in vitro experiments revealed that inclusion of allelic variants of these minor SNPs in APS or HPS haplotypes did not modify COMT function at the level of mRNA folding, RNA transcription, protein translation, or enzymatic activity. These data suggest that neutral variants are carried with APS and HPS haplotypes, while the high activity LPS haplotype displays less linked variation. Thus, both minor synonymous and nonsynonymous SNPs in the coding region are markers of functional APS and HPS haplotypes rather than independent contributors to COMT activity.			Nackley, AG (corresponding author), Univ N Carolina, Sch Dent, Ctr Neurosensory Disorders, Chapel Hill, NC 27515 USA.	lbdiatch@email.unc.edu	Shabalina, Svetlana/N-8939-2013	Shabalina, Svetlana/0000-0003-2272-7473; Gibson, Dustin/0000-0002-9073-3376	NCRR NIH HHS [KL2 RR025746, K12 KL2 RR025746] Funding Source: Medline; NIDCR NIH HHS [R01-DE016558, U01 DE017018, R01 DE016558, U01-DE017018] Funding Source: Medline; NIDDK NIH HHS [R24 DK067674] Funding Source: Medline; NINDS NIH HHS [P01-NS065685] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE017018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK067674] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alsobrook JP, 2002, AM J MED GENET, V114, P116, DOI 10.1002/ajmg.10040; Bray NJ, 2003, AM J HUM GENET, V73, P152, DOI 10.1086/376578; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Chen RD, 1996, PROTEIN SCI, V5, P287; Devlin AM, 2000, HUM MOL GENET, V9, P2837, DOI 10.1093/hmg/9.19.2837; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Diatchenko L, 2006, PAIN, V125, P216, DOI 10.1016/j.pain.2006.05.024; Diatchenko L, 2006, AM J MED GENET B, V141B, P449, DOI 10.1002/ajmg.b.30324; Domschke K, 2004, INT J NEUROPSYCHOPH, V7, P183, DOI 10.1017/s146114570400416X; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142; Frisch A, 2001, MOL PSYCHIATR, V6, P243, DOI 10.1038/sj.mp.4000830; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Goldstein David S, 2003, Endocr Regul, V37, P69; Gursoy S, 2003, RHEUMATOL INT, V23, P104, DOI 10.1007/s00296-002-0260-5; Harden RN, 2004, ANESTH ANALG, V99, P1478, DOI 10.1213/01.ANE.0000132549.25154.ED; Hayden EP, 2006, GENES BRAIN BEHAV, V5, P85, DOI 10.1111/j.1601-183X.2005.00138.x; Hintsanen M, 2008, J OCCUP ENVIRON MED, V50, P649, DOI 10.1097/JOM.0b013e318165c7ec; Hong JP, 2008, AM J MED GENET B, V147B, P658, DOI 10.1002/ajmg.b.30649; Izumi T, 1999, J MOL BIOL, V287, P47, DOI 10.1006/jmbi.1999.2573; Kamide K, 2007, J HYPERTENS, V25, P103, DOI 10.1097/HJH.0b013e3280103a40; Kaplan N, 2001, GENET EPIDEMIOL, V20, P432, DOI 10.1002/gepi.1012; Karayiorgou M, 1997, P NATL ACAD SCI USA, V94, P4572, DOI 10.1073/pnas.94.9.4572; Kern AD, 2004, NAT GENET, V36, P1207, DOI 10.1038/ng1451; Kimura M., 1985, J GENET, V64, P7, DOI [10.1007/BF02923549, DOI 10.1007/BF02923549]; KIRBY DA, 1995, P NATL ACAD SCI USA, V92, P9047, DOI 10.1073/pnas.92.20.9047; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; KREITMAN M, 1991, GENETICS, V127, P565; Kunugi H, 1997, NEUROSCI LETT, V221, P202, DOI 10.1016/S0304-3940(96)13289-4; Lavigne JA, 1997, CANCER RES, V57, P5493; Lee SG, 2005, HUM GENET, V116, P319, DOI 10.1007/s00439-004-1239-y; Lievers KJA, 2002, ATHEROSCLEROSIS, V164, P269, DOI 10.1016/S0021-9150(02)00065-5; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; LUNDSTROM K, 1991, DNA CELL BIOL, V10, P181, DOI 10.1089/dna.1991.10.181; MARBACH JJ, 1976, J DENT RES, V55, P711, DOI 10.1177/00220345760550043801; Masuda M, 2002, ANN CLIN BIOCHEM, V39, P589, DOI 10.1258/000456302760413379; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MATVEEVA OV, 1993, NUCLEIC ACIDS RES, V21, P1007, DOI 10.1093/nar/21.4.1007; McGrath M, 2004, AM J PSYCHIAT, V161, P1703, DOI 10.1176/appi.ajp.161.9.1703; Michaelovsky E, 2008, INT J NEUROPSYCHOPH, V11, P351, DOI 10.1017/S1461145707008085; Muntjewerff JW, 2008, EUR NEUROPSYCHOPHARM, V18, P99, DOI 10.1016/j.euroneuro.2007.06.005; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; NACKLEY AG, 2005, COMT MODULATES PAIN; Nackley AG, 2007, PAIN, V128, P199, DOI 10.1016/j.pain.2006.09.022; NAZIPOVA NN, 1995, COMPUT APPL BIOSCI, V11, P423; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Nygard O, 1998, AM J CLIN NUTR, V67, P263, DOI 10.1093/ajcn/67.2.263; OGURTSOV AY, 2006, BIOINFORMATICS; Oroszi G, 2004, PHARMACOGENOMICS, V5, P1037, DOI 10.1517/14622416.5.8.1037; Palmatier MA, 2004, MOL PSYCHIATR, V9, P859, DOI 10.1038/sj.mp.4001496; Qian QJ, 2003, AM J MED GENET B, V118B, P103, DOI 10.1002/ajmg.b.10064; RAJA SN, 1995, ANN MED, V27, P241, DOI 10.3109/07853899509031966; Rakvag TT, 2005, PAIN, V116, P73, DOI 10.1016/j.pain.2005.03.032; Schulein R, 2001, J BIOL CHEM, V276, P8384, DOI 10.1074/jbc.M007045200; SENGUPTA S, 2008, NEUROPSYCHOPHARMACOL; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; SHIBATA K, 2008, GENET EPIDEMIOL; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; SIMMONS GM, 1994, MOL BIOL EVOL, V11, P666; Slade Gary D, 2008, Semin Orthod, V14, P146, DOI 10.1053/j.sodo.2008.02.005; TENHUNEN J, 1993, DNA CELL BIOL, V12, P253, DOI 10.1089/dna.1993.12.253; Thompson PA, 1998, CANCER RES, V58, P2107; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Vargas-Alarcon G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2316; Williams HJ, 2007, SCHIZOPHRENIA BULL, V33, P635, DOI 10.1093/schbul/sbm019; Woo JM, 2004, J PSYCHIATR RES, V38, P365, DOI 10.1016/j.jpsychires.2004.01.001; Yoritaka A, 1997, J NEURAL TRANSM, V104, P1313, DOI 10.1007/BF01294732; Zhu BT, 2002, HISTOL HISTOPATHOL, V17, P1283, DOI 10.14670/HH-17.1283; Zhu GS, 2004, PSYCHOPHARMACOLOGY, V177, P178, DOI 10.1007/s00213-004-1938-z; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	74	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5237	10.1371/journal.pone.0005237	http://dx.doi.org/10.1371/journal.pone.0005237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365560	Green Published, Green Submitted, gold			2022-12-27	WOS:000265509900019
J	Varea, O; Garrido, JJ; Dopazo, A; Mendez, P; Garcia-Segura, LM; Wandosell, F				Varea, Olga; Garrido, Juan Jose; Dopazo, Ana; Mendez, Pablo; Garcia-Segura, Luis Miguel; Wandosell, Francisco			Estradiol Activates beta-Catenin Dependent Transcription in Neurons	PLOS ONE			English	Article								Estradiol may fulfill a plethora of functions in neurons, in which much of its activity is associated with its capacity to directly bind and dimerize estrogen receptors. This hormone-protein complex can either bind directly to estrogen response elements (ERE's) in gene promoters, or it may act as a cofactor at non-ERE sites interacting with other DNA-binding elements such as AP-1 or c-Jun. Many of the neuroprotective effects described for estrogen have been associated with this mode of action. However, recent evidence suggests that in addition to these "genomic effects", estrogen may also act as a more general "trophic factor" triggering cytoplasmic signals and extending the potential activity of this hormone. We demonstrated that estrogen receptor alpha associates with beta-catenin and glycogen synthase kinase 3 in the brain and in neurons, which has since been confirmed by others. Here, we show that the action of estradiol activates beta-catenin transcription in neuroblastoma cells and in primary cortical neurons. This activation is time and concentration-dependent, and it may be abolished by the estrogen receptor antagonist ICI 182780. The transcriptional activation of beta-catenin is dependent on lymphoid enhancer binding factor-1 (LEF-1) and a truncated-mutant of LEF-1 almost completely blocks estradiol TCF-mediated transcription. Transcription of a TCF-reporter in a transgenic mouse model is enhanced by estradiol in a similar fashion to that produced by Wnt3a. In addition, activation of a luciferase reporter driven by the engrailed promoter with three LEF-1 repeats was mediated by estradiol. We established a cell line that constitutively expresses a dominant-negative LEF-1 and it was used in a gene expression microarray analysis. In this way, genes that respond to estradiol or Wnt3a, sensitive to LEF-1, could be identified and validated. Together, these data demonstrate the existence of a new signaling pathway controlled by estradiol in neurons. This pathway shares some elements of the insulin-like growth factor-1/Insulin and Wnt signaling pathways, however, our data strongly suggest that it is different from that of both these ligands. These findings may reveal a set of new physiological roles for estrogens, at least in the Central Nervous System (CNS).	[Varea, Olga; Garrido, Juan Jose; Wandosell, Francisco] CSIC UAM, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Varea, Olga; Garrido, Juan Jose; Wandosell, Francisco] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Dopazo, Ana] Ctr Nacl Invest Cardiovasc, Genom Unit, Madrid, Spain; [Mendez, Pablo; Garcia-Segura, Luis Miguel] CSIC, Inst Cajal, Lab Neuroact Steroids, E-28002 Madrid, Spain; [Garrido, Juan Jose] CSIC, Inst Cajal, Lab Neuronal Polar, Madrid, Spain	CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Varea, O (corresponding author), CSIC UAM, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.	fwandosell@cbm.uam.es	Garrido, Juan Jose/E-6782-2012; Dopazo, Ana/N-1159-2014; Wandosell, Francisco/AAV-6391-2020; Garcia-Segura, Luis M/U-3711-2017; Wandosell, Francisco/G-6105-2015; Mendez, Pablo/J-7552-2017	Garrido, Juan Jose/0000-0002-4499-4487; Dopazo, Ana/0000-0002-4910-1684; Garcia-Segura, Luis M/0000-0002-2450-2916; Wandosell, Francisco/0000-0001-6537-2321; , Olga/0000-0002-1408-495X; Varea, Olga/0000-0001-7425-6250; Mendez, Pablo/0000-0001-9862-6818				Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Belcher SM, 2001, J PHARMACOL EXP THER, V299, P408; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Cardona-Gomez P, 2004, MOL CELL NEUROSCI, V25, P363, DOI 10.1016/j.mcn.2003.10.008; Cordey M, 2003, J NEUROCHEM, V84, P1340, DOI 10.1046/j.1471-4159.2003.01631.x; Culmsee C, 1999, J CEREBR BLOOD F MET, V19, P1263, DOI 10.1097/00004647-199911000-00011; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Demay F, 2001, ENDOCRINOLOGY, V142, P3340, DOI 10.1210/en.142.8.3340; Dubal DB, 1999, J NEUROSCI, V19, P6385; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; Galceran J, 2000, DEVELOPMENT, V127, P469; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Garcia C, 2007, J CELL BIOCHEM, V102, P665, DOI 10.1002/jcb.21324; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Honda K, 2000, J NEUROSCI RES, V60, P321, DOI 10.1002/(SICI)1097-4547(20000501)60:3<321::AID-JNR6>3.3.CO;2-K; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Kenchappa RS, 2004, FASEB J, V18, P1102, DOI 10.1096/fj.03-1075fje; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; McCullough LD, 2003, TRENDS ENDOCRIN MET, V14, P228, DOI 10.1016/S1043-2760(03)00076-6; McGrew LL, 1999, MECH DEVELOP, V87, P21, DOI 10.1016/S0925-4773(99)00136-7; McKenna NJ, 2001, ANN NY ACAD SCI, V949, P3; Mendez P, 2003, MOL BRAIN RES, V112, P170, DOI 10.1016/S0169-328X(03)00088-3; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Miller DB, 1998, ANN NY ACAD SCI, V844, P153, DOI 10.1111/j.1749-6632.1998.tb08230.x; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morissette M, 2007, NEUROPHARMACOLOGY, V52, P1509, DOI 10.1016/j.neuropharm.2007.02.004; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Quintanilla RA, 2005, J BIOL CHEM, V280, P11615, DOI 10.1074/jbc.M411936200; Ray S, 2008, MOL ENDOCRINOL, V22, P1125, DOI 10.1210/me.2007-0445; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Sansom OJ, 2005, J BIOL CHEM, V280, P28463, DOI 10.1074/jbc.M500191200; Sawada H, 2000, FASEB J, V14, P1202, DOI 10.1096/fasebj.14.9.1202; Sawada H, 2002, NEUROPHARMACOLOGY, V42, P1056, DOI 10.1016/S0028-3908(02)00049-7; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Simpkins JW, 2004, STROKE, V35, P2648, DOI 10.1161/01.STR.0000143734.59507.88; Singh M, 1999, J NEUROSCI, V19, P1179; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Toran-Allerand CD, 1999, FRONT NEUROENDOCRIN, V20, P97, DOI 10.1006/frne.1999.0177; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; Wang CN, 2001, J BIOL CHEM, V276, P5287, DOI 10.1074/jbc.M006406200; Wise PM, 2003, ENDOCRINE, V21, P11, DOI 10.1385/ENDO:21:1:11; Wise PM, 2001, ENDOCRINOLOGY, V142, P969, DOI 10.1210/en.142.3.969; Wise PM, 2000, BIOL REPROD, V63, P982, DOI 10.1095/biolreprod63.4.982; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Yu XR, 2004, J BIOL CHEM, V279, P13086, DOI 10.1074/jbc.M313283200; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008	59	57	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2009	4	4							e5153	10.1371/journal.pone.0005153	http://dx.doi.org/10.1371/journal.pone.0005153			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437SB	19360103	Green Published, gold, Green Submitted			2022-12-27	WOS:000265506100001
J	Krawchuk, MA; Moritz, MA; Parisien, MA; Van Dorn, J; Hayhoe, K				Krawchuk, Meg A.; Moritz, Max A.; Parisien, Marc-Andre; Van Dorn, Jeff; Hayhoe, Katharine			Global Pyrogeography: the Current and Future Distribution of Wildfire	PLOS ONE			English	Article							CLIMATE-CHANGE; SPATIAL-PATTERNS; PLANT MIGRATION; FIRE REGIMES; BURNED AREA; FOREST; MODELS; WORLD; VARIABILITY; ECOSYSTEMS	Climate change is expected to alter the geographic distribution of wildfire, a complex abiotic process that responds to a variety of spatial and environmental gradients. How future climate change may alter global wildfire activity, however, is still largely unknown. As a first step to quantifying potential change in global wildfire, we present a multivariate quantification of environmental drivers for the observed, current distribution of vegetation fires using statistical models of the relationship between fire activity and resources to burn, climate conditions, human influence, and lightning flash rates at a coarse spatiotemporal resolution (100 km, over one decade). We then demonstrate how these statistical models can be used to project future changes in global fire patterns, highlighting regional hotspots of change in fire probabilities under future climate conditions as simulated by a global climate model. Based on current conditions, our results illustrate how the availability of resources to burn and climate conditions conducive to combustion jointly determine why some parts of the world are fire-prone and others are fire-free. In contrast to any expectation that global warming should necessarily result in more fire, we find that regional increases in fire probabilities may be counter-balanced by decreases at other locations, due to the interplay of temperature and precipitation variables. Despite this net balance, our models predict substantial invasion and retreat of fire across large portions of the globe. These changes could have important effects on terrestrial ecosystems since alteration in fire activity may occur quite rapidly, generating ever more complex environmental challenges for species dispersing and adjusting to new climate conditions. Our findings highlight the potential for widespread impacts of climate change on wildfire, suggesting severely altered fire regimes and the need for more explicit inclusion of fire in research on global vegetation-climate change dynamics and conservation planning.			Krawchuk, MA (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	mmoritz@nature.berkeley.edu						[Anonymous], 1989, APPL LINEAR REGRESSI; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Arora VK, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000042; Bachelet D, 2005, CAN J FOREST RES, V35, P2244, DOI 10.1139/X05-086; BALSHI MS, 2008, GLOBAL CHANGE BIOL, V14, P1, DOI DOI 10.1111/J.1365-2486.2008.01679.X; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Boschetti L, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021229; Brooks ML, 2006, J ARID ENVIRON, V67, P148, DOI 10.1016/j.jaridenv.2006.09.027; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Calef MP, 2008, EARTH INTERACT, V12, DOI 10.1175/2007EI220.1; Carmona-Moreno C, 2005, GLOBAL CHANGE BIOL, V11, P1537, DOI 10.1111/j.1365-2486.2005.01003.x; Christian HJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002347; Chuvieco E, 2008, GLOBAL CHANGE BIOL, V14, P1488, DOI 10.1111/j.1365-2486.2008.01585.x; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Clement RM, 2001, HOLOCENE, V11, P419, DOI 10.1191/095968301678302850; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cochrane MA, 2002, J TROP ECOL, V18, P311, DOI 10.1017/S0266467402002237; Covey C, 2003, GLOBAL PLANET CHANGE, V37, P103, DOI 10.1016/S0921-8181(02)00193-5; Currie DJ, 2007, J BIOGEOGR, V34, P2009, DOI 10.1111/j.1365-2699.2007.01808.x; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Dissing D, 2003, CAN J FOREST RES, V33, P770, DOI [10.1139/x02-214, 10.1139/X02-214]; DWYER E, 2000, BIOMASS BURNING ITS, P358; Fischlin A., 2007, CONTRIBUTION WORKING, P211; Flannigan MD, 1998, J VEG SCI, V9, P469, DOI 10.2307/3237261; Giglio L, 2006, ATMOS CHEM PHYS, V6, P957, DOI 10.5194/acp-6-957-2006; Giglio L, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000142; Goldammer JG, 1998, CLIMATIC CHANGE, V39, P273, DOI 10.1023/A:1005371923658; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hicke JA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000101; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoeting JA, 2006, ECOL APPL, V16, P87, DOI 10.1890/04-0576; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; HOSMER DW, 2000, WILEY PS TX, P1; Imhoff ML, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007377; IPCC-TGICA, 2007, GEN GUID US SCEN DAT; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Kasischke ES, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017859; Kindermann GE, 2008, SILVA FENN, V42, P387, DOI 10.14214/sf.244; KRAWCHUK MA, 2008, CLIMATIC CH IN PRESS; Laris P, 2006, GEOGR J, V172, P271, DOI 10.1111/j.1475-4959.2006.00215.x; LAVOREL S, 2006, MITIGATION STRATEGIE, DOI DOI 10.1007/S11027-006-9046-5; Le Page Y., 2007, ATMOS CHEM PHYS DISC, V7, P17299, DOI DOI 10.5194/ACPD-7-17299-2007; League BL, 2000, J TROP ECOL, V16, P747, DOI 10.1017/S0266467400001693; Legendre P, 2002, ECOGRAPHY, V25, P601, DOI 10.1034/j.1600-0587.2002.250508.x; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Malilay J., 1999, REV FACTORS AFFECTIN; Manly B.F.J., 2002, RESOURCE SELECTION A; MARLON JR, 2008, NATURE GEOSCI; Meyn A, 2007, PROG PHYS GEOG, V31, P287, DOI 10.1177/0309133307079365; Moritz MA, 2008, CLIMATIC CHANGE, V87, pS265, DOI 10.1007/s10584-007-9361-1; Mota BW, 2006, ATMOS CHEM PHYS, V6, P1409, DOI 10.5194/acp-6-1409-2006; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Neilson RP, 2005, BIOSCIENCE, V55, P749, DOI 10.1641/0006-3568(2005)055[0749:FRTGPM]2.0.CO;2; Parisien MA, 2009, ECOL MONOGR, V79, P127, DOI 10.1890/07-1289.1; Pitman AJ, 2007, CLIMATIC CHANGE, V84, P383, DOI 10.1007/s10584-007-9243-6; Potter C, 2003, GLOBAL PLANET CHANGE, V39, P201, DOI 10.1016/j.gloplacha.2003.07.001; Purves D, 2008, SCIENCE, V320, P1452, DOI 10.1126/science.1155359; R Foundation for Statistical Computing V. Austria. . R Development Core Team, 2008, R LANG ENV STAT COMP; Riano D, 2007, GLOBAL CHANGE BIOL, V13, P40, DOI 10.1111/j.1365-2486.2006.01268.x; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; Shlisky A., 2007, FIRE ECOSYSTEMS PEOP; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; Stocks B. J., 2003, Journal of Geophysical Research, V108, pFFR5, DOI 10.1029/2001JD000484; Thonicke K, 2001, GLOBAL ECOL BIOGEOGR, V10, P661, DOI 10.1046/j.1466-822X.2001.00175.x; Thornthwaite CW, 1940, ECOLOGY, V21, P17, DOI 10.2307/1930614; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; VANDERWERF GR, 2008, GLOBAL BIOGEOCHEMICA, V22; Venevsky S, 2007, ENVIRON MODELL SOFTW, V22, P104, DOI 10.1016/j.envsoft.2006.02.002; Wagner C. E. van, 1987, Forestry Technical Report - Canadian Forestry Service; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; WHITTAKER R H, 1975, P385	77	591	603	9	211	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5102	10.1371/journal.pone.0005102	http://dx.doi.org/10.1371/journal.pone.0005102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352494	gold, Green Published			2022-12-27	WOS:000265505700011
J	Gawlik, K; Shiryaev, SA; Zhu, WH; Motamedchaboki, K; Desjardins, R; Day, R; Remacle, AG; Stec, B; Strongin, AY				Gawlik, Katarzyna; Shiryaev, Sergey A.; Zhu, Wenhong; Motamedchaboki, Khatereh; Desjardins, Roxane; Day, Robert; Remacle, Albert G.; Stec, Boguslaw; Strongin, Alex Y.			Autocatalytic Activation of the Furin Zymogen Requires Removal of the Emerging Enzyme's N-Terminus from the Active Site	PLOS ONE			English	Article								Background: Before furin can act on protein substrates, it must go through an ordered process of activation. Similar to many other proteinases, furin is synthesized as a zymogen (profurin) which becomes active only after the autocatalytic removal of its auto-inhibitory prodomain. We hypothesized that to activate profurin its prodomain had to be removed and, in addition, the emerging enzyme's N-terminus had to be ejected from the catalytic cleft. Methodology/Principal Findings: We constructed and analyzed the profurin mutants in which the egress of the emerging enzyme's N-terminus from the catalytic cleft was restricted. Mutants were autocatalytically processed at only the primary cleavage site Arg-Thr-Lys-Arg(107) down arrow Asp(108), but not at both the primary and the secondary (Arg-Gly-Val-Thr-Lys-Arg(75) down arrow Ser(76)) cleavage sites, yielding, as a result, the full-length prodomain and mature furins commencing from the N-terminal Asp108. These correctly processed furin mutants, however, remained self-inhibited by the constrained N-terminal sequence which continuously occupied the S' sub-sites of the catalytic cleft and interfered with the functional activity. Further, using the in vitro cleavage of the purified prodomain and the analyses of colon carcinoma LoVo cells with the reconstituted expression of the wild-type and mutant furins, we demonstrated that a three-step autocatalytic processing including the cleavage of the prodomain at the previously unidentified Arg-Leu-Gln-Arg(89) down arrow Glu(90) site, is required for the efficient activation of furin. Conclusions/Significance: Collectively, our results show the restrictive role of the enzyme's N-terminal region in the autocatalytic activation mechanisms. In a conceptual form, our data apply not only to profurin alone but also to a range of self-activated proteinases.	[Gawlik, Katarzyna; Shiryaev, Sergey A.; Zhu, Wenhong; Motamedchaboki, Khatereh; Remacle, Albert G.; Stec, Boguslaw; Strongin, Alex Y.] Burnham Inst Med Res, La Jolla, CA USA; [Desjardins, Roxane; Day, Robert] Univ Sherbrooke, Sherbrooke, PQ, Canada	Sanford Burnham Prebys Medical Discovery Institute; University of Sherbrooke	Gawlik, K (corresponding author), Burnham Inst Med Res, La Jolla, CA USA.	strongin@burnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016; Stec, Boguslaw/0000-0002-8696-0349	National Institutes of Health [RR020843, CA83017, CA77470]; Susan G. Komen Breast Cancer Foundation [BCTR123106]; CIHR; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health Grants RR020843, CA83017, and CA77470, and by the Susan G. Komen Breast Cancer Foundation Grant BCTR123106 (all to AYS), and CIHR grant to RD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bhattacharjya S, 2007, BIOPOLYMERS, V86, P329, DOI 10.1002/bip.20748; Bissonnette L, 2004, BIOCHEM J, V379, P757, DOI 10.1042/BJ20031902; CREEMERS JWM, 1995, J BIOL CHEM, V270, P2695, DOI 10.1074/jbc.270.6.2695; Feliciangeli SF, 2006, J BIOL CHEM, V281, P16108, DOI 10.1074/jbc.M600760200; Fugere M, 2005, TRENDS PHARMACOL SCI, V26, P294, DOI 10.1016/j.tips.2005.04.006; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; GALLAGHER T, 1995, STRUCTURE, V3, P907, DOI 10.1016/S0969-2126(01)00225-8; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Khatib AM, 2002, AM J PATHOL, V160, P1921, DOI 10.1016/S0002-9440(10)61140-6; Lazure C, 2002, CURR PHARM DESIGN, V8, P511, DOI 10.2174/1381612023395691; LEDUC R, 1992, J BIOL CHEM, V267, P14304; LEWIS JH, 1978, BLOOD, V51, P129; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lopez-Otin C, 2008, J BIOL CHEM; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; REHEMTULLA A, 1992, P NATL ACAD SCI USA, V89, P8235, DOI 10.1073/pnas.89.17.8235; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Rockwell NC, 2004, TRENDS BIOCHEM SCI, V29, P80, DOI 10.1016/j.tibs.2003.12.006; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SIEZEN RJ, 1995, INTRAMOLECULAR CHAPE, P233; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; Tangrea MA, 2002, J MOL BIOL, V320, P801, DOI 10.1016/S0022-2836(02)00543-0; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r	38	23	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5031	10.1371/journal.pone.0005031	http://dx.doi.org/10.1371/journal.pone.0005031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352504	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505300005
J	Rokka, A; Antonenkov, VD; Soininen, R; Immonen, HL; Pirila, PL; Bergmann, U; Sormunen, RT; Weckstrom, M; Benz, R; Hiltunen, JK				Rokka, Aare; Antonenkov, Vasily D.; Soininen, Raija; Immonen, Hanna L.; Pirila, Paivi L.; Bergmann, Ulrich; Sormunen, Raija T.; Weckstrom, Matti; Benz, Roland; Hiltunen, J. Kalervo			Pxmp2 Is a Channel-Forming Protein in Mammalian Peroxisomal Membrane	PLOS ONE			English	Article								Background: Peroxisomal metabolic machinery requires a continuous flow of organic and inorganic solutes across peroxisomal membrane. Concerning small solutes, the molecular nature of their traffic has remained an enigma. Methods/Principal Findings: In this study, we show that disruption in mice of the Pxmp2 gene encoding Pxmp2, which belongs to a family of integral membrane proteins with unknown function, leads to partial restriction of peroxisomal membrane permeability to solutes in vitro and in vivo. Multiple-channel recording of liver peroxisomal preparations reveals that the channel-forming components with a conductance of 1.3 nS in 1.0 M KCl were lost in Pxmp2(-/-) mice. The channel-forming properties of Pxmp2 were confirmed with recombinant protein expressed in insect cells and with native Pxmp2 purified from mouse liver. The Pxmp2 channel, with an estimated diameter of 1.4 nm, shows weak cation selectivity and no voltage dependence. The long-lasting open states of the channel indicate its functional role as a protein forming a general diffusion pore in the membrane. Conclusions/Significance: Pxmp2 is the first peroxisomal channel identified, and its existence leads to prediction that the mammalian peroxisomal membrane is permeable to small solutes while transfer of "bulky'' metabolites, e. g., cofactors (NAD/H, NADP/H, and CoA) and ATP, requires specific transporters.			Rokka, A (corresponding author), Univ Oulu, Dept Biochem, Bioctr Oulu, Oulu, Finland.	vasily.antonenkov@oulu.fi; kalervo.hiltunen@oulu.fi		Benz, Roland/0000-0002-9510-9265				Abdelraheim SR, 2003, BIOCHEM J, V374, P329, DOI 10.1042/BJ20030441; Antonenkov VD, 2006, BBA-MOL CELL RES, V1763, P1697, DOI 10.1016/j.bbamcr.2006.08.044; Antonenkov VD, 2005, CELL MOL LIFE SCI, V62, P2886, DOI 10.1007/s00018-005-5233-x; Antonenkov VD, 2004, J CELL SCI, V117, P5633, DOI 10.1242/jcs.01485; Antonenkov VD, 2004, AM J PHYSIOL-CELL PH, V287, pC1623, DOI 10.1152/ajpcell.00142.2004; Bakker BM, 2000, P NATL ACAD SCI USA, V97, P2087, DOI 10.1073/pnas.030539197; BAUDHUIN P, 1969, ANN NY ACAD SCI, V168, P214, DOI 10.1111/j.1749-6632.1969.tb43111.x; BENZ R, 1988, EUR J BIOCHEM, V176, P1, DOI 10.1111/j.1432-1033.1988.tb14245.x; Berthemy A, 1999, J PHARMACEUT BIOMED, V19, P429, DOI 10.1016/S0731-7085(98)00200-3; CHEN N, 1988, BIOCHIM BIOPHYS ACTA, V945, P135, DOI 10.1016/0005-2736(88)90476-2; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Dansen TB, 2000, NAT CELL BIOL, V2, P51, DOI 10.1038/71375; Drago I, 2008, J BIOL CHEM, V283, P14384, DOI 10.1074/jbc.M800600200; Gasmi L, 2001, BIOCHEM J, V357, P33, DOI 10.1042/0264-6021:3570033; Gouveia AMM, 1999, ANAL BIOCHEM, V274, P270, DOI 10.1006/abio.1999.4281; Iida R, 2003, J BIOL CHEM, V278, P6301, DOI 10.1074/jbc.M210886200; Jankowski A, 2001, J BIOL CHEM, V276, P48748, DOI 10.1074/jbc.M109003200; Kaulin YA, 1998, BIOPHYS J, V74, P2918, DOI 10.1016/S0006-3495(98)77999-8; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Lasorsa FM, 2004, BIOCHEM J, V381, P581, DOI 10.1042/BJ20040856; Lasorsa FM, 2008, J BIOL CHEM, V283, P15300, DOI 10.1074/jbc.M800648200; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; MORIYAMA Y, 1992, FEBS LETT, V302, P18, DOI 10.1016/0014-5793(92)80274-K; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Otte DM, 2003, GENE, V313, P119, DOI 10.1016/S0378-1119(03)00667-X; Palmieri L, 2001, EMBO J, V20, P5049, DOI 10.1093/emboj/20.18.5049; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Price N., 2001, PRINCIPLES PROBLEMS; Qi C, 1999, J BIOL CHEM, V274, P15775, DOI 10.1074/jbc.274.22.15775; Reumann S, 1998, EUR J BIOCHEM, V251, P359, DOI 10.1046/j.1432-1327.1998.2510359.x; REUMANN S, 1995, J BIOL CHEM, V270, P17559, DOI 10.1074/jbc.270.29.17559; Savolainen K, 2004, HUM MOL GENET, V13, P955, DOI 10.1093/hmg/ddh107; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Trott A, 2004, EUKARYOT CELL, V3, P620, DOI 10.1128/EC.3.3.620-631.2004; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; van Roermund CWT, 2004, J CELL SCI, V117, P4231, DOI 10.1242/jcs.01305; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; VANVELDHOVEN PP, 1987, J BIOL CHEM, V262, P4310; VERLEUR N, 1993, EUR J BIOCHEM, V218, P75, DOI 10.1111/j.1432-1033.1993.tb18353.x; Visser WF, 2007, BIOCHEM J, V401, P365, DOI 10.1042/BJ20061352; Wanders RJA, 2007, PFLUG ARCH EUR J PHY, V453, P719, DOI 10.1007/s00424-006-0142-x; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; ZWACKA RM, 1994, EMBO J, V13, P5129, DOI 10.1002/j.1460-2075.1994.tb06842.x	44	101	103	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5090	10.1371/journal.pone.0005090	http://dx.doi.org/10.1371/journal.pone.0005090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352492	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505300013
J	Tian, WZ; Liou, HC				Tian, Wenzhi; Liou, Hsiou-Chi			RNAi-Mediated c-Rel Silencing Leads to Apoptosis of B Cell Tumor Cells and Suppresses Antigenic Immune Response In Vivo	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR REL; CHICKEN SPLEEN-CELLS; T-CELLS; MULTIPLE-MYELOMA; CYCLE PROGRESSION; GENE-EXPRESSION; MICE LACKING; SPLENIC MICROARCHITECTURE; LYMPHOCYTE-PROLIFERATION	c-Rel is a member of the Rel/NF-kappa B transcription factor family and is predominantly expressed in lymphoid and myeloid cells, playing a critical role in lymphocyte proliferation and survival. Persistent activation of the c-Rel signal transduction pathway is associated with allergies, inflammation, autoimmune diseases, and a variety of human malignancies. To explore the potential of targeting c-Rel as a therapeutic agent for these disorders, we designed a small interfering RNA (siRNA) to silence c-Rel expression in vitro and in vivo. C-Rel-siRNA expression via a retroviral vector in a B cell tumor cell line leads to growth arrest and apoptosis of the tumor cells. Silencing c-Rel in primary B cells in vitro compromises their proliferative and survival response to CD40 activation signals, similar to the impaired response of c-Rel knockout B cells. Most important, in vivo silencing of c-Rel results in significant impairment in T cell-mediated immune responses to antigenic stimulation. Our study thus validates the efficacy of c-Rel-siRNA, and suggests the development of siRNA-based therapy, as well as small molecular inhibitors for the treatment of B cell tumors as well as autoimmune diseases.	[Tian, Wenzhi; Liou, Hsiou-Chi] Cornell Univ, Div Immunol, Dept Med, Weill Med Coll, New York, NY 10021 USA	Cornell University	Tian, WZ (corresponding author), Cornell Univ, Div Immunol, Dept Med, Weill Med Coll, New York, NY 10021 USA.	hcliou@med.cornell.edu			National Institutes of Health [CA68155, CA90405]; T32 postdoctoral fellowship; Leukemia & Lymphoma Society Scholar Award; NATIONAL CANCER INSTITUTE [R55CA068155, R01CA068155, R01CA090405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 postdoctoral fellowship; Leukemia & Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants (CA68155, CA90405), T32 postdoctoral fellowship (W. Tian), and the Leukemia & Lymphoma Society Scholar Award (H.-C. Liou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Andjelic S, 1998, EUR J IMMUNOL, V28, P570, DOI 10.1002/(SICI)1521-4141(199802)28:02<570::AID-IMMU570>3.0.CO;2-M; Andjelic S, 2000, J IMMUNOL, V165, P3860, DOI 10.4049/jimmunol.165.7.3860; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Banerjee D, 2005, IMMUNITY, V23, P445, DOI 10.1016/j.immuni.2005.09.012; Banerji L, 2001, ONCOGENE, V20, P7352, DOI 10.1038/sj.onc.1204951; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BEG AA, 1996, SCIENCE, V274, P784; Bernal A, 2001, BLOOD, V98, P3050, DOI 10.1182/blood.V98.10.3050; Birmingham A, 2007, NAT PROTOC, V2, P2068, DOI 10.1038/nprot.2007.278; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Campbell IK, 2000, J CLIN INVEST, V105, P1799, DOI 10.1172/JCI8298; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; CHANG CC, 1994, ONCOGENE, V9, P923; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen XF, 2003, CANCER RES, V63, P1059; Cheng SH, 2003, ONCOGENE, V22, P8472, DOI 10.1038/sj.onc.1206917; Chiorazzi N, 2007, BEST PRACT RES CL HA, V20, P399, DOI 10.1016/j.beha.2007.03.007; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Donjerkovic D, 2000, EUR J IMMUNOL, V30, P1154, DOI 10.1002/(SICI)1521-4141(200004)30:4<1154::AID-IMMU1154>3.0.CO;2-B; Donovan CE, 1999, J IMMUNOL, V163, P6827; Fan YJ, 2004, ONCOGENE, V23, P1030, DOI 10.1038/sj.onc.1207221; Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11; FANG W, 1995, J IMMUNOL, V155, P66; Feng B, 2004, CELL IMMUNOL, V232, P9, DOI 10.1016/j.cellimm.2005.01.006; Feng Biao, 2004, Med Immunol, V3, P1, DOI 10.1186/1476-9433-3-1; Finn PW, 2002, J LEUKOCYTE BIOL, V72, P1054; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Furman RR, 2000, J IMMUNOL, V164, P2200, DOI 10.4049/jimmunol.164.4.2200; Gerondakis S, 1998, CURR OPIN IMMUNOL, V10, P353, DOI 10.1016/S0952-7915(98)80175-1; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; GILMORE TD, 1992, CANCER SURV, V15, P69; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Gilmore TD, 2001, ONCOGENE, V20, P7098, DOI 10.1038/sj.onc.1204898; Gilmore TD, 2007, CANCER CELL, V12, P95, DOI 10.1016/j.ccr.2007.07.010; Grossmann M, 1999, INT J BIOCHEM CELL B, V31, P1209, DOI 10.1016/S1357-2725(99)00068-0; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663; Grumont RJ, 2002, MOL CELL, V10, P1283, DOI 10.1016/S1097-2765(02)00779-7; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Harling-McNabb L, 1999, INT IMMUNOL, V11, P1431, DOI 10.1093/intimm/11.9.1431; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Henke E, 2008, NAT BIOTECHNOL, V26, P91, DOI 10.1038/nbt1366; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Houldsworth J, 2004, BLOOD, V103, P1862, DOI 10.1182/blood-2003-04-1359; Hsia CY, 2002, INT IMMUNOL, V14, P905, DOI 10.1093/intimm/dxf055; Huang XG, 2004, P NATL ACAD SCI USA, V101, P17789, DOI 10.1073/pnas.0406111101; John M, 2007, NATURE, V449, P745, DOI 10.1038/nature06179; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Lam LT, 2005, CLIN CANCER RES, V11, P28; LAM LT, 2008, BLOOD; Lamhamedi-Cherradi SE, 2003, J IMMUNOL, V171, P4886, DOI 10.4049/jimmunol.171.9.4886; Lee H, 1995, Curr Top Microbiol Immunol, V194, P247; LEE HY, 1995, J EXP MED, V181, P1169, DOI 10.1084/jem.181.3.1169; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liou HC, 2003, BIOESSAYS, V25, P767, DOI 10.1002/bies.10306; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Mason N, 2002, J IMMUNOL, V168, P2590, DOI 10.4049/jimmunol.168.6.2590; Mason NJ, 2004, J IMMUNOL, V172, P3704, DOI 10.4049/jimmunol.172.6.3704; Mineva ND, 2007, J BIOL CHEM, V282, P17475, DOI 10.1074/jbc.M607313200; Mittal V, 2004, NAT REV GENET, V5, P355, DOI 10.1038/nrg1323; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P5056, DOI 10.1073/pnas.91.11.5056; Naito Y, 2004, NUCLEIC ACIDS RES, V32, pW124, DOI 10.1093/nar/gkh442; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; O'Connor S, 2004, MOL CELL BIOL, V24, P4895, DOI 10.1128/MCB.24.11.4895-4908.2004; Owyang AM, 2001, J IMMUNOL, V167, P4948, DOI 10.4049/jimmunol.167.9.4948; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Romano MF, 1998, BLOOD, V92, P990; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Schauer SL, 1996, J IMMUNOL, V157, P81; Siebelt F, 1997, CELL IMMUNOL, V181, P13, DOI 10.1006/cimm.1997.1198; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Starczynowski DT, 2005, ONCOGENE, V24, P7355, DOI 10.1038/sj.onc.1208902; Starczynowski DT, 2003, ONCOGENE, V22, P6928, DOI 10.1038/sj.onc.1206801; Strasser A, 1999, EUR J IMMUNOL, V29, P928, DOI 10.1002/(SICI)1521-4141(199903)29:03<928::AID-IMMU928>3.3.CO;2-G; Tian WZ, 2005, CELL IMMUNOL, V235, P72, DOI 10.1016/j.cellimm.2005.07.004; Tian WZ, 2005, CELL IMMUNOL, V234, P39, DOI 10.1016/j.cellimm.2005.04.021; Tumang JR, 1998, EUR J IMMUNOL, V28, P4299, DOI 10.1002/(SICI)1521-4141(199812)28:12<4299::AID-IMMU4299>3.0.CO;2-Y; Tumang JR, 2002, CELL IMMUNOL, V217, P47, DOI 10.1016/S0008-8749(02)00513-0; Venkataraman L, 1996, J IMMUNOL, V157, P1149; VENKATARAMAN L, 1995, J EXP MED, V181, P1091, DOI 10.1084/jem.181.3.1091; Wang WH, 1997, IMMUNITY, V6, P165, DOI 10.1016/S1074-7613(00)80423-9; WEIH F, 1994, ONCOGENE, V9, P3289; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Weinmann AS, 2001, NAT IMMUNOL, V2, P51, DOI 10.1038/83168; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Wu M, 1997, CURR TOP MICROBIOL, V224, P91; Wu M, 1996, MOL CELL BIOL, V16, P5015; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x; Yang H, 2002, TRANSPLANTATION, V74, P291, DOI 10.1097/00007890-200208150-00002	105	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2009	4	4							e5028	10.1371/journal.pone.0005028	http://dx.doi.org/10.1371/journal.pone.0005028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RS	19347041	Green Submitted, Green Published, gold			2022-12-27	WOS:000265505200003
J	Zimmermann, G; Wang, LP; Vaughan, AG; Manoli, DS; Zhang, F; Deisseroth, K; Baker, BS; Scott, MP				Zimmermann, Gregor; Wang, Li-ping; Vaughan, Alexander G.; Manoli, Devanand S.; Zhang, Feng; Deisseroth, Karl; Baker, Bruce S.; Scott, Matthew P.			Manipulation of an Innate Escape Response in Drosophila: Photoexcitation of acj6 Neurons Induces the Escape Response	PLOS ONE			English	Article								Background: The genetic analysis of behavior in Drosophila melanogaster has linked genes controlling neuronal connectivity and physiology to specific neuronal circuits underlying a variety of innate behaviors. We investigated the circuitry underlying the adult startle response, using photoexcitation of neurons that produce the abnormal chemosensory jump 6 (acj6) transcription factor. This transcription factor has previously been shown to play a role in neuronal pathfinding and neurotransmitter modality, but the role of acj6 neurons in the adult startle response was largely unknown. Principal Findings: We show that the activity of these neurons is necessary for a wild-type startle response and that excitation is sufficient to generate a synthetic escape response. Further, we show that this synthetic response is still sensitive to the dose of acj6 suggesting that that acj6 mutation alters neuronal activity as well as connectivity and neurotransmitter production. Results/Significance: These results extend the understanding of the role of acj6 and of the adult startle response in general. They also demonstrate the usefulness of activity-dependent characterization of neuronal circuits underlying innate behaviors in Drosophila, and the utility of integrating genetic analysis into modern circuit analysis techniques.	[Zimmermann, Gregor; Scott, Matthew P.] Stanford Univ, Dept Dev Biol, Dept Genet, Dept Bioengn, Stanford, CA 94305 USA; [Wang, Li-ping; Zhang, Feng; Deisseroth, Karl] Stanford Univ, Dept Bioengn & Psychiat, Stanford, CA 94305 USA; [Vaughan, Alexander G.; Manoli, Devanand S.; Baker, Bruce S.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Zimmermann, G (corresponding author), Stanford Univ, Dept Dev Biol, Dept Genet, Dept Bioengn, Stanford, CA 94305 USA.	mscott@stanford.edu	Wang, Liping/ABF-6317-2020; Wang, Liping/B-2827-2012; Macrae, Rhiannon/AAX-1536-2020	Wang, Liping/0000-0001-6893-3809; Manoli, Devanand/0000-0002-7238-2330	HHMI; NIH [RGM085818, Director's Pioneer Award Program]; California Institute of Regenerative Medicine; NARSAD; APIRE; Snyder Foundation; Culpeper Foundation; Coulter Foundation; Klingenstein Foundation; Whitehall Foundation; McKnight Foundation; Albert Yu and Mary Bechmann Foundation; NIDA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085818] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NARSAD(NARSAD); APIRE; Snyder Foundation; Culpeper Foundation; Coulter Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Whitehall Foundation; McKnight Foundation; Albert Yu and Mary Bechmann Foundation; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	GZ and MS were supported by HHMI. BB, DM and AV were supported by NIH RGM085818 and HHMI. LW was supported by the California Institute of Regenerative Medicine. FS was supported by the NIH. KD was supported by NARSAD, APIRE and the Snyder, Culpeper, Coulter, Klingenstein, Whitehall, McKnight, and Albert Yu and Mary Bechmann Foundations, as well as by NIMH, NIDA, and the NIH Director's Pioneer Award Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYER RK, 1991, P NATL ACAD SCI USA, V88, P5467, DOI 10.1073/pnas.88.12.5467; Bate Michael, 1993, P1013; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brazier M A, 1993, J Hist Neurosci, V2, P53; Certel SJ, 2000, DEVELOPMENT, V127, P2395; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Lee MH, 2002, J NEUROSCI, V22, P5291; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; MCGUIRE SE, 2004, SCI STKE, P16; MCKENNA M, 1989, P NATL ACAD SCI USA, V86, P8118, DOI 10.1073/pnas.86.20.8118; Naderi Sait, 2004, Neurosurg Focus, V16, pE15; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Piccolino M, 2006, CR BIOL, V329, P303, DOI 10.1016/j.crvi.2006.03.002; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; SHIBATA S, 1984, BRAIN RES, V302, P83, DOI 10.1016/0006-8993(84)91287-3; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; SUH G, 2007, CURR BIOL; Suster ML, 2003, J NEUROBIOL, V55, P233, DOI 10.1002/neu.10202; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036	31	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5100	10.1371/journal.pone.0005100	http://dx.doi.org/10.1371/journal.pone.0005100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340304	Green Published, gold, Green Submitted			2022-12-27	WOS:000265500700013
J	Parvanova, I; Epiphanio, S; Fauq, A; Golde, TE; Prudencio, M; Mota, MM				Parvanova, Iana; Epiphanio, Sabrina; Fauq, Abdul; Golde, Todd E.; Prudencio, Miguel; Mota, Maria M.			A Small Molecule Inhibitor of Signal Peptide Peptidase Inhibits Plasmodium Development in the Liver and Decreases Malaria Severity	PLOS ONE			English	Article							GAMMA-SECRETASE INHIBITOR; IN-VITRO; INTRAMEMBRANE PROTEOLYSIS; CORE PROTEIN; FALCIPARUM; TARGETS; INFECTION; CELLS; IDENTIFICATION; SPOROZOITES	The liver stage of Plasmodium's life cycle is the first, obligatory step in malaria infection. Decreasing the hepatic burden of Plasmodium infection decreases the severity of disease and constitutes a promising strategy for malaria prophylaxis. The efficacy of the gamma-secretase and signal peptide peptidase inhibitor LY411,575 in targeting Plasmodium liver stages was evaluated both in human hepatoma cell lines and in mouse primary hepatocytes. LY411,575 was found to prevent Plasmodium's normal development in the liver, with an IC50 of approximately 80 nM, without affecting hepatocyte invasion by the parasite. In vivo results with a rodent model of malaria showed that LY411,575 decreases the parasite load in the liver and increases by 55% the resistance of mice to cerebral malaria, one of the most severe malaria-associated syndromes. Our data show that LY411,575 does not exert its effect via the Notch signaling pathway suggesting that it may interfere with Plasmodium development through an inhibition of the parasite's signal peptide peptidase. We therefore propose that selective signal peptide peptidase inhibitors could be potentially used for preventive treatment of malaria in humans.	[Parvanova, Iana; Epiphanio, Sabrina; Prudencio, Miguel; Mota, Maria M.] Univ Lisbon, Fac Med, Inst Med Mol, Unidade Malaria, P-1699 Lisbon, Portugal; [Fauq, Abdul; Golde, Todd E.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL USA; [Prudencio, Miguel; Mota, Maria M.] Inst Gulbenkian Ciencias, Oeiras, Portugal	Universidade de Lisboa; Mayo Clinic; Instituto Gulbenkian de Ciencia	Parvanova, I (corresponding author), Vetsuisse Fac Bern, Dept Clin Res & VPH, Div Mol Pathobiol, Bern, Switzerland.	mmota@fm.ul.pt	Prudêncio, Miguel/D-2032-2012; Mota, Maria/AAF-2048-2019; Epiphanio, Sabrina/C-7572-2012; Prudêncio, Miguel/ABD-9282-2021	Prudêncio, Miguel/0000-0003-1746-6029; Epiphanio, Sabrina/0000-0001-6094-9750; Prudêncio, Miguel/0000-0003-1746-6029; Mota, Maria Manuel/0000-0002-2858-1041	Fundacao para a Ciencia e Tecnologia [SFRH/BPD/32284/2006, BPD/31598/2006, SFRH/BI/15849]; EMBO YIP; European Science Foundation [EURYI Award]; Howard Hughes Medical Institute [International Scholar]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); EMBO YIP(European Molecular Biology Organization (EMBO)); European Science Foundation(European Science Foundation (ESF)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by Fundacao para a Ciencia e Tecnologia. I.P., S.E and M.P. were recipients of FCT fellowships (SFRH/BPD/32284/2006, BPD/31598/2006 and SFRH/BI/15849, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was performed in the scope of the FP6 BioMalPar Network of Excellence. M.M.M. is an EMBO YIP, is a recipient of a EURYI Award from European Science Foundation and is a Howard Hughes Medical Institute International Scholar.	Andrews KT, 2006, ANTIMICROB AGENTS CH, V50, P639, DOI 10.1128/AAC.50.2.639-648.2006; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; BAILLY E, 1992, J PROTOZOOL, V39, P593, DOI 10.1111/j.1550-7408.1992.tb04856.x; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Casso DJ, 2005, GENETICS, V170, P139, DOI 10.1534/genetics.104.039933; Cunha-Rodrigues Margarido, 2006, Biotechnology Journal, V1, P321, DOI 10.1002/biot.200500038; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Ersmark K, 2006, MED RES REV, V26, P626, DOI 10.1002/med.20082; Fauq AH, 2007, BIOORG MED CHEM LETT, V17, P6392, DOI 10.1016/j.bmcl.2007.07.062; FRANCIS SE, 1994, EMBO J, V13, P306, DOI 10.1002/j.1460-2075.1994.tb06263.x; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Fuwa H, 2007, ACS CHEM BIOL, V2, P408, DOI 10.1021/cb700073y; Golde TE, 2003, J CLIN INVEST, V111, P11, DOI 10.1172/JCI200317527; Golde TE, 2006, J NEUROCHEM, V99, P689, DOI 10.1111/j.1471-4159.2006.04211.x; Goncalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169; Grigorenko AP, 2004, P NATL ACAD SCI USA, V101, P14955, DOI 10.1073/pnas.0406462101; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Heimann M, 2006, J VIROL, V80, P1915, DOI 10.1128/JVI.80.4.1915-1921.2006; Hobbs CV, 2009, J INFECT DIS, V199, P134, DOI 10.1086/594369; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Li XR, 2008, MOL BIOCHEM PARASIT, V158, P22, DOI 10.1016/j.molbiopara.2007.11.007; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Mota MM, 2002, BIOESSAYS, V24, P149, DOI 10.1002/bies.10050; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Nyborg AC, 2006, FASEB J, V20, P1671, DOI 10.1096/fj.06-5762com; Prudencio M, 2008, CELL MICROBIOL, V10, P218, DOI 10.1111/j.1462-5822.2007.01032.x; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Rosenthal PJ, 2002, CURR PHARM DESIGN, V8, P1659, DOI 10.2174/1381612023394197; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Siemers E, 2005, CLIN NEUROPHARMACOL, V28, P126, DOI 10.1097/01.wnf.0000167360.27670.29; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925	37	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5078	10.1371/journal.pone.0005078	http://dx.doi.org/10.1371/journal.pone.0005078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337374	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500600020
J	Papadopoulos, A				Papadopoulos, Anthony			Hydrodynamics-Based Functional Forms of Activity Metabolism: A Case for the Power-Law Polynomial Function in Animal Swimming Energetics	PLOS ONE			English	Article								The first-degree power-law polynomial function is frequently used to describe activity metabolism for steady swimming animals. This function has been used in hydrodynamics-based metabolic studies to evaluate important parameters of energetic costs, such as the standard metabolic rate and the drag power indices. In theory, however, the power-law polynomial function of any degree greater than one can be used to describe activity metabolism for steady swimming animals. In fact, activity metabolism has been described by the conventional exponential function and the cubic polynomial function, although only the power-law polynomial function models drag power since it conforms to hydrodynamic laws. Consequently, the first-degree power-law polynomial function yields incorrect parameter values of energetic costs if activity metabolism is governed by the power-law polynomial function of any degree greater than one. This issue is important in bioenergetics because correct comparisons of energetic costs among different steady swimming animals cannot be made unless the degree of the power-law polynomial function derives from activity metabolism. In other words, a hydrodynamics-based functional form of activity metabolism is a power-law polynomial function of any degree greater than or equal to one. Therefore, the degree of the power-law polynomial function should be treated as a parameter, not as a constant. This new treatment not only conforms to hydrodynamic laws, but also ensures correct comparisons of energetic costs among different steady swimming animals. Furthermore, the exponential power-law function, which is a new hydrodynamics-based functional form of activity metabolism, is a special case of the power-law polynomial function. Hence, the link between the hydrodynamics of steady swimming and the exponential-based metabolic model is defined.	[Papadopoulos, Anthony] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Papadopoulos, A (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	anthony.papadopoulos@ttu.edu			National Science Foundation [DEB-0616942]	National Science Foundation(National Science Foundation (NSF))	Support for this work was provided by National Science Foundation award DEB-0616942 to Sean H. Rice. NSF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DE, 1990, BIOL BULL, V179, P186, DOI 10.2307/1541768; Beamish F.W.H., 1978, FISH PHYSIOL, V7, P101; Behrens JW, 2006, J EXP MAR BIOL ECOL, V331, P208, DOI 10.1016/j.jembe.2005.10.012; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Briggs CT, 1997, CAN J FISH AQUAT SCI, V54, P859, DOI 10.1139/cjfas-54-4-859; CULIK BM, 1994, J EXP BIOL, V197, P65; FINNEY RL, 1994, CALCULUS; Fish FE, 1999, J EXP BIOL, V202, P353; Fry FEJ, 1971, FISH PHYSIOL, VVI, P1, DOI DOI 10.1016/S1546-5098(08)60146-6; Fung YC, 1990, BIOMECHANICS MOTION; Goldstein S, 1929, P R SOC LOND A-CONTA, V123, P225, DOI 10.1098/rspa.1929.0067; GORDON MS, 1989, FISH PHYSIOL BIOCHEM, V6, P341, DOI 10.1007/BF01875604; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; KAUFMANN R, 1990, J EXP BIOL, V150, P343; Kleinz M., 2000, COLL MATH J, V31, P82, DOI DOI 10.1080/07468342.2000.11974118; Korsmeyer KE, 2002, J EXP BIOL, V205, P1253; METCALFE NB, 1995, ANIM BEHAV, V49, P431, DOI 10.1006/anbe.1995.0056; Ohlberger J, 2006, J COMP PHYSIOL B, V176, P17, DOI 10.1007/s00360-005-0024-0; Papadopoulos A, 2008, T AM FISH SOC, V137, P997, DOI 10.1577/T07-116.1; Pettersson LB, 1999, OECOLOGIA, V121, P12, DOI 10.1007/s004420050901; Pettersson LB, 2000, P ROY SOC B-BIOL SCI, V267, P759, DOI 10.1098/rspb.2000.1068; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Schultz WW, 2002, INTEGR COMP BIOL, V42, P1018, DOI 10.1093/icb/42.5.1018; Speyer Edward, 1994, 6 ROADS NEWTON GREAT; TUCKER VA, 1970, COMP BIOCHEM PHYSIOL, V34, P841, DOI 10.1016/0010-406X(70)91006-6; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; Wardle CS, 1996, J FISH BIOL, V49, P854, DOI 10.1111/j.1095-8649.1996.tb00084.x; Webb P. W., 1978, FISH PHYSIOL, VVII, P189; Webb P.W., 1975, B FISH RES BD CAN, V199, P109; Webb Paul W., 1993, P47; WEIHS D, 1973, NATURE, V245, P48, DOI 10.1038/245048a0; WEISENBORN AJ, 1995, SIAM J APPL MATH, V55, P577, DOI 10.1137/S0036139993260526; WEISENBORN AJ, 1993, SIAM J APPL MATH, V53, P601, DOI 10.1137/0153031; WIESER W, 1990, FUNCT ECOL, V4, P233, DOI 10.2307/2389342; Wu T. Y., 1977, SCALE EFFECTS ANIMAL, P203; WU TYT, 1971, J FLUID MECH, V46, P545, DOI 10.1017/S0022112071000697	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4852	10.1371/journal.pone.0004852	http://dx.doi.org/10.1371/journal.pone.0004852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333397	gold, Green Submitted, Green Published			2022-12-27	WOS:000265499900002
J	Lei, Y; Moore, CB; Liesman, RM; O'Connor, BP; Bergstralh, DT; Chen, ZJJ; Pickles, RJ; Ting, JPY				Lei, Yu; Moore, Chris B.; Liesman, Rachael M.; O'Connor, Brian P.; Bergstralh, Daniel T.; Chen, Zhijian J.; Pickles, Raymond J.; Ting, Jenny P. -Y.			MAVS-Mediated Apoptosis and Its Inhibition by Viral Proteins	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; ANTIVIRAL SIGNALING PROTEIN; NF-KAPPA-B; ACTIVATION; IDENTIFICATION; MITOCHONDRIA; INFECTION; PATHWAYS; IPAF	Background: Host responses to viral infection include both immune activation and programmed cell death. The mitochondrial antiviral signaling adaptor, MAVS (IPS-1, VISA or Cardif) is critical for host defenses to viral infection by inducing type-1 interferons (IFN-I), however its role in virus-induced apoptotic responses has not been elucidated. Principal Findings: We show that MAVS causes apoptosis independent of its function in initiating IFN-I production. MAVS-induced cell death requires mitochondrial localization, is caspase dependent, and displays hallmarks of apoptosis. Furthermore, MAVS(-/-) fibroblasts are resistant to Sendai virus-induced apoptosis. A functional screen identifies the hepatitis C virus NS3/4A and the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) nonstructural protein (NSP15) as inhibitors of MAVS-induced apoptosis, possibly as a method of immune evasion. Significance:This study describes a novel role for MAVS in controlling viral infections through the induction of apoptosis, and identifies viral proteins which inhibit this host response.	[Lei, Yu; Moore, Chris B.; O'Connor, Brian P.; Bergstralh, Daniel T.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Lei, Yu] Univ N Carolina, Dept Oral Biol, Chapel Hill, NC 27599 USA; [Moore, Chris B.] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA; [Liesman, Rachael M.; O'Connor, Brian P.; Pickles, Raymond J.; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Mol Biol, Dallas, TX 75390 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lei, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	Jenny_Ting@med.unc.edu	Lei, Yu Leo/ABF-1293-2020; Ariel, Pablo/AGJ-4118-2022; Chen, Zhijian/C-6039-2012	Lei, Yu Leo/0000-0002-9868-9824; Chen, Zhijian/0000-0002-8475-8251; Bergstralh, Dan/0000-0003-1689-3715	NIAID	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from NIAID for SERCEB and Human Immunology to J.P.-Y.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2001, TRENDS BIOCHEM SCI, V26, P390, DOI 10.1016/S0968-0004(01)01844-8; Bouchier-Hayes L, 2002, EMBO REP, V3, P616, DOI 10.1093/embo-reports/kvf139; Chan-Yeung M, 2003, RESPIROLOGY, V8, P131, DOI 10.1046/j.1440-1843.2003.00453.x; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Chen CY, 2007, J INFECT DIS, V196, P405, DOI 10.1086/519166; Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; FREIMAN M, 2003, J VIROL, V133, P101; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Griffin DE, 1997, ANNU REV MICROBIOL, V51, P565, DOI 10.1146/annurev.micro.51.1.565; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Heylbroeck C, 2000, J VIROL, V74, P3781, DOI 10.1128/JVI.74.8.3781-3792.2000; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Iseni F, 2002, EMBO J, V21, P5141, DOI 10.1093/emboj/cdf513; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; LAN YL, 2005, CURR OPIN IMMUNOL, V17, P404; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miagkov AV, 1998, P NATL ACAD SCI USA, V95, P13859, DOI 10.1073/pnas.95.23.13859; MOORE CB, 2006, NATURE, V151, P573; Moore CB, 2008, IMMUNITY, V28, P735, DOI 10.1016/j.immuni.2008.05.005; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; PEIRIS JS, 2001, LANCET BIOL, V361, P1767; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sadasivam S, 2005, ONCOGENE, V24, P627, DOI 10.1038/sj.onc.1208201; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tan YX, 2007, J VIROL, V81, P6346, DOI 10.1128/JVI.00090-07; TING JP, 2000, IMMUNITY, V20, P285; van Deventer HW, 2008, AM J PATHOL, V173, P253, DOI 10.2353/ajpath.2008.070732; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; YE Z, 2008, ASARS CON PROTEIN OR; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; YONEYAMA M, 2005, J IMMUNOL, V173, P2581; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	50	151	156	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2009	4	5							e5466	10.1371/journal.pone.0005466	http://dx.doi.org/10.1371/journal.pone.0005466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NK	19404494	Green Published, Green Submitted, gold			2022-12-27	WOS:000278066700001
J	Kind, T; Scholz, M; Fiehn, O				Kind, Tobias; Scholz, Martin; Fiehn, Oliver			How Large Is the Metabolome? A Critical Analysis of Data Exchange Practices in Chemistry	PLOS ONE			English	Article							IDENTIFICATION; WEB; ANNOTATION; EXTRACTION; TOOLS	Background: Calculating the metabolome size of species by genome-guided reconstruction of metabolic pathways misses all products from orphan genes and from enzymes lacking annotated genes. Hence, metabolomes need to be determined experimentally. Annotations by mass spectrometry would greatly benefit if peer-reviewed public databases could be queried to compile target lists of structures that already have been reported for a given species. We detail current obstacles to compile such a knowledge base of metabolites. Results: As an example, results are presented for rice. Two rice (oryza sativa) subspecies have been fully sequenced, oryza japonica and oryza indica. Several major small molecule databases were compared for listing known rice metabolites comprising PubChem, Chemical Abstracts, Beilstein, Patent databases, Dictionary of Natural Products, SetupX/BinBase, KNApSAcK DB, and finally those databases which were obtained by computational approaches, i.e. RiceCyc, KEGG, and Reactome. More than 5,000 small molecules were retrieved when searching these databases. Unfortunately, most often, genuine rice metabolites were retrieved together with non-metabolite database entries such as pesticides. Overlaps from database compound lists were very difficult to compare because structures were either not encoded in machine-readable format or because compound identifiers were not cross-referenced between databases. Conclusions: We conclude that present databases are not capable of comprehensively retrieving all known metabolites. Metabolome lists are yet mostly restricted to genome-reconstructed pathways. We suggest that providers of (bio) chemical databases enrich their database identifiers to PubChem IDs and InChIKeys to enable cross-database queries. In addition, peer-reviewed journal repositories need to mandate submission of structures and spectra in machine readable format to allow automated semantic annotation of articles containing chemical structures. Such changes in publication standards and database architectures will enable researchers to compile current knowledge about the metabolome of species, which may extend to derived information such as spectral libraries, organ-specific metabolites, and cross-study comparisons.			Fiehn, O (corresponding author), Univ Calif Davis, Genome Ctr Metabol, Davis, CA 95616 USA.	ofiehn@ucdavis.edu	Kind, Tobias/A-7553-2010	Kind, Tobias/0000-0002-1908-4916	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013932] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES13932] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; [Anonymous], DICT NATURAL PRODUCT; APODACA R, IMAGE METADATA CHEMI; Arita M, 2003, GENOME RES, V13, P2455, DOI 10.1101/gr.1212003; AUSTIN R, 2001, PIUG N E WORKSH; BAKER DB, 1980, J CHEM INF COMP SCI, V20, P193, DOI 10.1021/ci60024a001; Casher O, 2006, J CHEM INF MODEL, V46, P2396, DOI 10.1021/ci060139c; CASPI R, 2008, GENOME DATABASES NUC, V36, pD623; ChEBI, CHEM ENT BIOL INT; *CHEM ABSTR DAT, CAS SCIFINDER AC PRO; *CHEM4WORLD, 2007, SEMRICH CHEM INF; *CHEMAXON, 2008, INSTANT J CHEM; *CROSSFIRE BEILST, CROSSFIRE BEILSTEIN; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; DESILVA LB, 1995, TETRAHEDRON LETT, V36, P1997, DOI 10.1016/0040-4039(95)00211-T; Downing J, 2008, J CHEM INF MODEL, V48, P1571, DOI 10.1021/ci7004737; *ED HUM DEV, ED HUM DEV AN ONT; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; FIEHN O, 2007, CELLULAR METABOLOMIC; FILIPPOV IV, 2009, J CHEM INFORM MODELI; FLAXBART D, CHEM ABSTRACTS CENTE; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; HELLER SR, 2005, INCHI OPEN ACCESS OP; HELLER SR, IUPAC INT CHEM IDENT; Hill DW, 2008, ANAL CHEM, V80, P5574, DOI 10.1021/ac800548g; IBISON P, 1993, J CHEM INF COMP SCI, V33, P338, DOI 10.1021/ci00013a010; *IBM, IBM CHEM SEARCH ENG; Jaiswal P, 2006, NUCLEIC ACIDS RES, V34, pD717, DOI 10.1093/nar/gkj154; *KEGG DAT, KYOT ENC GEN GEN; Kidd R, 2009, INTEGR BIOL, V1, P293, DOI 10.1039/b905032a; KIND T, 2008, LCGC, V26, P176; KIND T, RICEORYZA SATIVA MET; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kind T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-234; *KNAPSACK, COMPR SPEC MET REL; Kuhn S, 2007, J CHEM INF MODEL, V47, P2015, DOI 10.1021/ci600531a; *LIPID MAPS, LIPID MET PATHW; MCDANIEL JR, 1992, J CHEM INF COMP SCI, V32, P373, DOI 10.1021/ci00008a018; Mu FP, 2007, BIOINFORMATICS, V23, P3193, DOI 10.1093/bioinformatics/btm498; Murray-Rust P, 2008, NATURE, V451, P648, DOI 10.1038/451648a; *NCBI ENTR, NCBI ENTR LIF SCI SE; *NCHI RES SERV, INCHI RES SERV CHEMS; Oikawa A, 2006, PLANT PHYSIOL, V142, P398, DOI 10.1104/pp.106.080317; *ORYZ, INT RIC SCI DAT; Ott MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-517; Paley SM, 2006, NUCLEIC ACIDS RES, V34, P3771, DOI 10.1093/nar/gkl334; Park J, 2009, CHEM CENT J, V3, DOI 10.1186/1752-153X-3-4; *PUBMED CENTR, PUBMED CENTR DIG ARC; *REACT, REACT CURAT KNOWLEDG; RHODES J, 2007, PAC S BIOC, P15; *RICECYE, RIC MET PATHW; *RSC, RSC PROJ PROSP; Schymanski EL, 2008, ANAL CHIM ACTA, V615, P136, DOI 10.1016/j.aca.2008.03.060; *SETUPX, STUD DES DAT MET PRO; *SMILES, SIMPL MOL INNP LIN; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; STEIN SE, OPEN STANDARD CHEM S; Steinbeck C, 2004, PHYTOCHEMISTRY, V65, P2711, DOI 10.1016/j.phytochem.2004.08.027; Strasser BJ, 2008, SCIENCE, V322, P537, DOI 10.1126/science.1163399; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; *SURECHEM, SURECHEM CHEM PAT SE; Taylor CF, 2008, NAT BIOTECHNOL, V26, P889, DOI 10.1038/nbt.1411; Wheeler DL, 2007, NUCL ACIDS RES; Williams AJ, 2008, DRUG DISCOV TODAY, V13, P502, DOI 10.1016/j.drudis.2008.03.015; Willighagen EL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-487; WISHART DS, 2007, HUMAN METABOLOME DAT, V35, pD521; Zhou YY, 2007, J CHEM INF MODEL, V47, P1386, DOI 10.1021/ci700092v; DUKES PHYTOCHEMICAL	68	88	89	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5440	10.1371/journal.pone.0005440	http://dx.doi.org/10.1371/journal.pone.0005440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415114	Green Published, gold, Green Submitted			2022-12-27	WOS:000265836700012
J	Li, G; Peskind, ER; Millard, SP; Chi, P; Sokal, I; Yu, CE; Bekris, LM; Raskind, MA; Galasko, DR; Montine, TJ				Li, Ge; Peskind, Elaine R.; Millard, Steven P.; Chi, Peter; Sokal, Izabela; Yu, Chang-En; Bekris, Lynn M.; Raskind, Murray A.; Galasko, Douglas R.; Montine, Thomas J.			Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor and Cognitive Function in Non-Demented Subjects	PLOS ONE			English	Article								Background: Brain-derived neurotrophic factor (BDNF) is an activity-dependent secreted protein that is critical to organization of neuronal networks and synaptic plasticity, especially in the hippocampus. We tested hypothesis that reduced CSF BDNF is associated with age-related cognitive decline. Methodology/Principal Findings, and Conclusions/Significance: CSF concentration of BDNF, A beta(42) and total tau were measured in 128 cognitively normal adults (Normals), 21 patients with Alzheimer's disease (AD), and nine patients with Mild Cognitive Impairment. Apolipoprotein E and BDNF SNP rs6265 genotype were determined. Neuropsychological tests were performed at baseline for all subjects and at follow-up visits in 50 Normals. CSF BDNF level was lower in AD patients compared to age-matched Normals (p = 0.02). CSF BDNF concentration decreased with age among Normals and was higher in women than men (both p<0.001). After adjusting for age, gender, education, CSF A beta(42) and total tau, and APOE and BDNF genotypes, lower CSF BDNF concentration was associated poorer immediate and delayed recall at baseline (both p<0.05) and in follow up of approximately 3 years duration (both p<0.01). Conclusions/Significance: Reduced CSF BDNF was associated with age-related cognitive decline, suggesting a potential mechanism that may contribute in part to cognitive decline in older individuals.			Li, G (corresponding author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	gli@u.washington.edu			NIA NIH HHS [R01 AG023185, P50 AG005136-26, AG05136, U01 AG016976, P50-AG005136, P50 AG005136, AG023185] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG023185, P50AG005136, U01AG016976] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bekris LM, 2008, J ALZHEIMERS DIS, V13, P255; Blasko I, 2006, DEMENT GERIATR COGN, V21, P9, DOI 10.1159/000089137; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; CRAFT S, 1993, BEHAV NEUROSCI, V107, P926; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Gomez RG, 2006, ARCH CLIN NEUROPSYCH, V21, P771, DOI 10.1016/j.acn.2006.06.012; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; HIXSON JE, 1990, J LIPID RES, V31, P545; *INS CORP, 2008, CORP I S PLUS; Laske C, 2006, J NEURAL TRANSM, V113, P1217, DOI 10.1007/s00702-005-0397-y; Laske C, 2007, J PSYCHIATR RES, V41, P387, DOI 10.1016/j.jpsychires.2006.01.014; Li G, 2007, NEUROLOGY, V69, P631, DOI 10.1212/01.wnl.0000267428.62582.aa; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Milliken JK, 2000, STAT MED, V19, P1617, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1617::AID-SIM450>3.0.CO;2-C; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P411, DOI 10.1111/j.1601-183X.2007.00363.x; Nagatsu T, 2000, ADV RES NEURODEGENER, V8, P277; Newcomer JW, 1998, ARCH GEN PSYCHIAT, V55, P995, DOI 10.1001/archpsyc.55.11.995; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Reitan RM, 1985, HALSTEAD REITAN NEUR; Sohrabji F, 2006, FRONT NEUROENDOCRIN, V27, P404, DOI 10.1016/j.yfrne.2006.09.003; *TEAM R D C, 2008, LANG ENV STAT COMP; Wechsler D, 1983, MANUAL WECHSLER MEMO; Zhang J, 2005, J ALZHEIMERS DIS, V7, P125; Zhang J, 2008, AM J CLIN PATHOL, V129, P526, DOI 10.1309/W01Y0B808EMEH12L	25	104	106	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5424	10.1371/journal.pone.0005424	http://dx.doi.org/10.1371/journal.pone.0005424			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412541	Green Submitted, gold, Green Published			2022-12-27	WOS:000265688200011
J	Vallabhajosyula, RR; Chakravarti, D; Lutfeali, S; Ray, A; Raval, A				Vallabhajosyula, Ravishankar R.; Chakravarti, Deboki; Lutfeali, Samina; Ray, Animesh; Raval, Alpan			Identifying Hubs in Protein Interaction Networks	PLOS ONE			English	Article								Background: In spite of the scale-free degree distribution that characterizes most protein interaction networks (PINs), it is common to define an ad hoc degree scale that defines "hub'' proteins having special topological and functional significance. This raises the concern that some conclusions on the functional significance of proteins based on network properties may not be robust. Methodology: In this paper we present three objective methods to define hub proteins in PINs: one is a purely topological method and two others are based on gene expression and function. By applying these methods to four distinct PINs, we examine the extent of agreement among these methods and implications of these results on network construction. Conclusions: We find that the methods agree well for networks that contain a balance between error-free and unbiased interactions, indicating that the hub concept is meaningful for such networks.			Vallabhajosyula, RR (corresponding author), Keck Grad Inst Appl Life Sci, Claremont, CA USA.	alpan.raval@cgu.edu		Ray, Animesh/0000-0002-0120-5820; Raval, Alpan/0000-0002-2689-3594				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Aragues R, 2007, PLOS COMPUT BIOL, V3, P1761, DOI 10.1371/journal.pcbi.0030178; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batada NN, 2007, PLOS BIOL, V5, P1202, DOI 10.1371/journal.pbio.0050154; Batada NN, 2006, PLOS BIOL, V4, P1720, DOI 10.1371/journal.pbio.0040317; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Grosse I, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041905; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jin GX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001207; Kemmeren P, 2002, MOL CELL, V9, P1133, DOI 10.1016/S1097-2765(02)00531-2; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Maslov S, 2002, FEBS LETT, V530, P255, DOI 10.1016/S0014-5793(02)03428-2; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Reguly T, 2006, J BIOL, V5, P10; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; SERRANO MA, 2005, PHYS REV E, V72; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Soffer SN, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.057101; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056104; VOSS RF, 1992, PHYS REV LETT, V68, P3805, DOI 10.1103/PhysRevLett.68.3805; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WONG AKC, 1985, IEEE T PATTERN ANAL, V7, P599, DOI 10.1109/TPAMI.1985.4767707; Wuchty S, 2005, PROTEOMICS, V5, P444, DOI 10.1002/pmic.200400962; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636	44	130	133	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5344	10.1371/journal.pone.0005344	http://dx.doi.org/10.1371/journal.pone.0005344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399170	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000265514900009
J	Johansson, LE; Johansson, LM; Danielsson, P; Norgren, S; Johansson, S; Marcus, C; Ridderstrale, M				Johansson, Lovisa E.; Johansson, Lina M.; Danielsson, Pernilla; Norgren, Svante; Johansson, Stina; Marcus, Claude; Ridderstrale, Martin			Genetic Variance in the Adiponutrin Gene Family and Childhood Obesity	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; BODY-MASS INDEX; INSULIN SENSITIVITY; ADIPOSE-TISSUE; MINIMAL-MODEL; FTO GENE; ASSOCIATION; EXPRESSION; CHILDREN; GLUCOSE	Aim: The adiponutrin gene family consists of five genes (PNPLA1-5) coding for proteins with both lipolytic and lipogenic properties. PNPLA3 has previously been associated with adult obesity. Here we investigated the possible association between genetic variants in these genes and childhood and adolescent obesity. Methods/Results: Polymorphisms in the five genes of the adiponutrin gene family were selected and genotyped using the Sequenom platform in a childhood and adolescent obesity case-control study. Six variants in PNPLA1 showed association with obesity (rs9380559, rs12212459, rs1467912, rs4713951, rs10947600, and rs12199580, p<0.05 after adjustment for age and gender). Three variants in PNPLA3 showed association with obesity before, but not after, adjustment for age and gender (rs139051, rs12483959, and rs2072907, p>0.05). When analyzing these SNPs in relation to phenotypes, two SNPs in the PNPLA3 gene showed association with insulin sensitivity (rs12483959: beta = -0.053, p = 0.016, and rs2072907: beta = -0.049, p = 0.024). No associations were seen for PNPLA2, PNPLA4, and PNPLA5. Conclusions: Genetic variation in the adiponutrin gene family does not seem to contribute strongly to obesity in children and adolescents. PNPLA1 exhibited a modest effect on obesity and PNPLA3 on insulin sensitivity. These data, however, require confirmation in other cohorts and ethnic groups.			Johansson, LE (corresponding author), Lund Univ, Dept Clin Sci Malmo, Lund, Sweden.	lovisa.johansson@med.lu.se	Marcus, Claude/ABE-1177-2020; Ridderstråle, Martin/F-7678-2012; Danielsson, Pernilla/ABD-9660-2020; Reinius, Lovisa/C-4555-2014	Marcus, Claude/0000-0003-0890-2650; Danielsson, Pernilla/0000-0002-4674-2638; Reinius, Lovisa/0000-0001-5029-0120				Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baulande S, 2001, J BIOL CHEM, V276, P33336, DOI 10.1074/jbc.M105193200; Bergman RN, 2005, HORM RES, V64, P8, DOI 10.1159/000089312; BERGMAN RN, 1989, DIABETES, V38, P1512, DOI 10.2337/diabetes.38.12.1512; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Garenc C, 2002, INT J OBESITY, V26, P220, DOI 10.1038/sj.ijo.0801872; Hoffstedt J, 2001, DIABETES, V50, P2410, DOI 10.2337/diabetes.50.10.2410; *INT HAPMAP PROJ, NATURE, V426, P789; Jacobsson JA, 2008, BIOCHEM BIOPH RES CO, V368, P476, DOI 10.1016/j.bbrc.2008.01.087; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Johansson LE, 2006, DIABETES, V55, P826, DOI 10.2337/diabetes.55.03.06.db05-1075; Johansson LE, 2008, EUR J ENDOCRINOL, V159, P577, DOI 10.1530/EJE-08-0426; Klannemark M, 1998, DIABETOLOGIA, V41, P1516, DOI 10.1007/s001250051099; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lavebratt C, 2002, EUR J CLIN INVEST, V32, P938, DOI 10.1046/j.1365-2362.2002.01075.x; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Magre J, 1998, DIABETES, V47, P284, DOI 10.2337/diab.47.2.284; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Morinder G, 2009, ACTA PAEDIATR, V98, P132, DOI 10.1111/j.1651-2227.2008.01030.x; MOSSBERG HO, 1989, LANCET, V2, P491; Mulder H, 2003, J BIOL CHEM, V278, P36380, DOI 10.1074/jbc.M213032200; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2004, CLIN GENET, V65, P93, DOI 10.1111/j.0009-9163.2004.00196.x; ROLLANDCACHERA MF, 1982, AM J CLIN NUTR, V36, P178, DOI 10.1093/ajcn/36.1.178; Rossner SM, 2008, DIABETES CARE, V31, P802, DOI 10.2337/dc07-1655; Schoenborn V, 2006, DIABETES, V55, P1270, DOI 10.2337/db05-1498; Wang SP, 2001, OBES RES, V9, P119, DOI 10.1038/oby.2001.15; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Wolf G, 2005, NUTR REV, V63, P166, DOI 10.1301/nr.2005.may.166-170	37	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5327	10.1371/journal.pone.0005327	http://dx.doi.org/10.1371/journal.pone.0005327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390624	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514400013
J	Woyke, T; Xie, G; Copeland, A; Gonzalez, JM; Han, C; Kiss, H; Saw, JH; Senin, P; Yang, C; Chatterji, S; Cheng, JF; Eisen, JA; Sieracki, ME; Stepanauskas, R				Woyke, Tanja; Xie, Gary; Copeland, Alex; Gonzalez, Jose M.; Han, Cliff; Kiss, Hajnalka; Saw, Jimmy H.; Senin, Pavel; Yang, Chi; Chatterji, Sourav; Cheng, Jan-Fang; Eisen, Jonathan A.; Sieracki, Michael E.; Stepanauskas, Ramunas			Assembling the Marine Metagenome, One Cell at a Time	PLOS ONE			English	Article								The difficulty associated with the cultivation of most microorganisms and the complexity of natural microbial assemblages, such as marine plankton or human microbiome, hinder genome reconstruction of representative taxa using cultivation or metagenomic approaches. Here we used an alternative, single cell sequencing approach to obtain high-quality genome assemblies of two uncultured, numerically significant marine microorganisms. We employed fluorescence-activated cell sorting and multiple displacement amplification to obtain hundreds of micrograms of genomic DNA from individual, uncultured cells of two marine flavobacteria from the Gulf of Maine that were phylogenetically distant from existing cultured strains. Shotgun sequencing and genome finishing yielded 1.9 Mbp in 17 contigs and 1.5 Mbp in 21 contigs for the two flavobacteria, with estimated genome recoveries of about 91% and 78%, respectively. Only 0.24% of the assembling sequences were contaminants and were removed from further analysis using rigorous quality control. In contrast to all cultured strains of marine flavobacteria, the two single cell genomes were excellent Global Ocean Sampling (GOS) metagenome fragment recruiters, demonstrating their numerical significance in the ocean. The geographic distribution of GOS recruits along the Northwest Atlantic coast coincided with ocean surface currents. Metabolic reconstruction indicated diverse potential energy sources, including biopolymer degradation, proteorhodopsin photometabolism, and hydrogen oxidation. Compared to cultured relatives, the two uncultured flavobacteria have small genome sizes, few non-coding nucleotides, and few paralogous genes, suggesting adaptations to narrow ecological niches. These features may have contributed to the abundance of the two taxa in specific regions of the ocean, and may have hindered their cultivation. We demonstrate the power of single cell DNA sequencing to generate reference genomes of uncultured taxa from a complex microbial community of marine bacterioplankton. A combination of single cell genomics and metagenomics enabled us to analyze the genome content, metabolic adaptations, and biogeography of these taxa.			Woyke, T (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA USA.	rstepanauskas@bigelow.org	Gonzalez, Jose M./C-3333-2013; Saw, Jimmy HW/A-9972-2009; Eisen, Jonathan A./H-2706-2019; Saw, Jimmy/J-1360-2019	Gonzalez, Jose M./0000-0002-9926-3323; Saw, Jimmy HW/0000-0001-8353-3854; Eisen, Jonathan A./0000-0002-0159-2197; Saw, Jimmy/0000-0001-8353-3854; Senin, Pavel/0000-0001-5517-7768; Stepanauskas, Ramunas/0000-0003-4458-3108; Cheng, Jan-Fang/0000-0001-7315-7613; Yang, Chi/0000-0002-1676-5185; Sieracki, Michael/0000-0001-7959-1832; Han, Cliff/0000-0003-1972-0692				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atamna-Ismaeel N, 2008, ISME J, V2, P656, DOI 10.1038/ismej.2008.27; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Braun ST, 1999, FEMS MICROBIOL ECOL, V28, P273, DOI 10.1016/S0168-6496(98)00132-9; Caspi R, 2006, NUCLEIC ACIDS RES, V34, pD511, DOI 10.1093/nar/gkj128; Chatterji S, 2008, LECT N BIOINFORMAT, V4955, P17; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Eddy SR, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-18; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Gonzalez JM, 2008, P NATL ACAD SCI USA, V105, P8724, DOI 10.1073/pnas.0712027105; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Haefner B, 2003, DRUG DISCOV TODAY, V8, P536, DOI 10.1016/S1359-6446(03)02713-2; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; LASKEN RS, 2007, BMC BIOTECHNOLOGY, V7; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Moran MA, 2007, NAT REV MICROBIOL, V5, P792, DOI 10.1038/nrmicro1746; PACE NR, 1986, ADV MICROB ECOL, V9, P1; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Punshon S, 2008, MAR CHEM, V108, P215, DOI 10.1016/j.marchem.2007.11.010; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Rogers YC, 2005, BIOTECHNIQUES, V39, P31, DOI 10.2144/05391BM01; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Stingl U, 2007, ISME J, V1, P361, DOI 10.1038/ismej.2007.49; Stingl U, 2007, APPL ENVIRON MICROB, V73, P2290, DOI 10.1128/AEM.02559-06; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vila M, 2004, APPL ENVIRON MICROB, V70, P4648, DOI 10.1128/AEM.70.8.4648-4657.2004; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	55	246	256	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5299	10.1371/journal.pone.0005299	http://dx.doi.org/10.1371/journal.pone.0005299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390573	Green Submitted, gold, Green Published			2022-12-27	WOS:000265514200012
J	Chen, XF; Ding, BJ; LeJeune, D; Ruggiero, C; Li, SS				Chen, Xuefeng; Ding, Baojin; LeJeune, Danielle; Ruggiero, Christine; Li, Shisheng			Rpb1 Sumoylation in Response to UV Radiation or Transcriptional Impairment in Yeast	PLOS ONE			English	Article								Covalent modifications of proteins by ubiquitin and the Small Ubiquitin-like MOdifier (SUMO) have been revealed to be involved in a plethora of cellular processes, including transcription, DNA repair and DNA damage responses. It has been well known that in response to DNA damage that blocks transcription elongation, Rpb1, the largest subunit of RNA polymerase II (Pol II), is ubiquitylated and subsequently degraded in mammalian and yeast cells. However, it is still an enigma regarding how Pol II responds to damaged DNA and conveys signal(s) for DNA damage-related cellular processes. We found that Rpb1 is also sumoylated in yeast cells upon UV radiation or impairment of transcription elongation, and this modification is independent of DNA damage checkpoint activation. Ubc9, an E2 SUMO conjugase, and Siz1, an E3 SUMO ligase, play important roles in Rpb1 sumoylation. K1487, which is located in the acidic linker region between the C-terminal domain and the globular domain of Rpb1, is the major sumoylation site. Rpb1 sumoylation is not affected by its ubiquitylation, and vice versa, indicating that the two processes do not crosstalk. Abolishment of Rpb1 sumoylation at K1487 does not affect transcription elongation or transcription coupled repair (TCR) of UV-induced DNA damage. However, deficiency in TCR enhances UV-induced Rpb1 sumoylation, presumably due to the persistence of transcription-blocking DNA lesions in the transcribed strand of a gene. Remarkably, abolishment of Rpb1 sumoylation at K1487 causes enhanced and prolonged UV-induced phosphorylation of Rad53, especially in TCR-deficient cells, suggesting that the sumoylation plays a role in restraining the DNA damage checkpoint response caused by transcription-blocking lesions. Our results demonstrate a novel covalent modification of Rpb1 in response to UV induced DNA damage or transcriptional impairment, and unravel an important link between the modification and the DNA damage checkpoint response.			Chen, XF (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	shli@vetmed.lsu.edu	Li, Shisheng/H-9126-2012; Chen, Xuefeng/C-3410-2013; Ding, Baojin/J-5479-2015	Tatum, Danielle/0000-0002-3281-3853; Ding, Baojin/0000-0002-2149-2599	NIEHS NIH HHS [ES012718, R01 ES012718] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012718] Funding Source: NIH RePORTER; Direct For Biological Sciences [0745229] Funding Source: National Science Foundation	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; CHEN JZ, 1993, J THERM SPRAY TECHN, V2, P357; Chen XF, 2007, MOL CELL BIOL, V27, P4617, DOI 10.1128/MCB.00404-07; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Derheimer FA, 2007, P NATL ACAD SCI USA, V104, P12778, DOI 10.1073/pnas.0705317104; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Dohmen RJ, 2005, METHOD ENZYMOL, V399, P799, DOI 10.1016/S0076-6879(05)99052-6; Dotiwala F, 2007, P NATL ACAD SCI USA, V104, P11358, DOI 10.1073/pnas.0609636104; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Giannattasio M, 2004, EMBO J, V23, P429, DOI 10.1038/sj.emboj.7600051; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hyle JW, 2003, J BIOL CHEM, V278, P28470, DOI 10.1074/jbc.M303736200; Ii T, 2007, CELL CYCLE, V6, P2800, DOI 10.4161/cc.6.22.4882; Jansen LET, 2000, EMBO J, V19, P6498, DOI 10.1093/emboj/19.23.6498; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnston J.R., 1994, MOL GENETICS YEAST P; JONES EW, 1991, METHOD ENZYMOL, V194, P428; Laine JP, 2006, TRENDS GENET, V22, P430, DOI 10.1016/j.tig.2006.06.006; LEJEUNE D, 2008, DNA REPAIR AMST; Li SS, 2006, MOL CELL BIOL, V26, P9430, DOI 10.1128/MCB.01656-06; Li SS, 1996, CARCINOGENESIS, V17, P1549, DOI 10.1093/carcin/17.8.1549; Li SS, 2000, METHODS, V22, P170, DOI 10.1006/meth.2000.1058; Li SS, 2004, J BIOL CHEM, V279, P14418, DOI 10.1074/jbc.M312004200; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; Li T, 2007, DNA REPAIR, V6, P1679, DOI 10.1016/j.dnarep.2007.06.004; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; Lindstrom DL, 2001, GENETICS, V159, P487; Ljungman M, 1996, ONCOGENE, V13, P823; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Lloyd RS, 2005, MUTAT RES-FUND MOL M, V577, P77, DOI 10.1016/j.mrfmmm.2005.04.003; Lommel L, 2000, P NATL ACAD SCI USA, V97, P9088, DOI 10.1073/pnas.150130197; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; MULLEN JR, 2008, ACTIVATION SLX5 SLX8; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Ribar B, 2006, MOL CELL BIOL, V26, P3999, DOI 10.1128/MCB.00293-06; Sambrook J., 2001, MOL CLONING LAB MANU; SANCHEZDIAZ A, 2004, SCI STKE, pPL8, DOI DOI 10.1126/STKE.2232004PL8; SIKORSKI RS, 1989, GENETICS, V122, P19; Somesh BP, 2007, CELL, V129, P57, DOI 10.1016/j.cell.2007.01.046; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; TIPPER DJ, 1973, J BACTERIOL, V116, P245, DOI 10.1128/JB.116.1.245-256.1973; Tornaletti S, 1999, J BIOL CHEM, V274, P24124, DOI 10.1074/jbc.274.34.24124; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; VANHOFFEN A, 1993, NUCLEIC ACIDS RES, V21, P5890, DOI 10.1093/nar/21.25.5890; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VENEMA J, 1991, MOL CELL BIOL, V11, P4128, DOI 10.1128/MCB.11.8.4128; VERHAGE R, 1994, MOL CELL BIOL, V14, P6135, DOI 10.1128/MCB.14.9.6135; Verhage RA, 1996, MOL CELL BIOL, V16, P496; Wang Z, 2006, GENETICS, V172, P1499, DOI 10.1534/genetics.105.052811; WOOD JL, 2007, DNA REPAIR GENETIC I, P1; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Zhang H, 2003, J BIOL CHEM, V278, P9382, DOI 10.1074/jbc.M300061200; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299	75	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5267	10.1371/journal.pone.0005267	http://dx.doi.org/10.1371/journal.pone.0005267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384408	Green Published, gold			2022-12-27	WOS:000265513900012
J	Vega, VB; Cheung, E; Palanisamy, N; Sung, WK				Vega, Vinsensius B.; Cheung, Edwin; Palanisamy, Nallasivam; Sung, Wing-Kin			Inherent Signals in Sequencing-Based Chromatin-ImmunoPrecipitation Control Libraries	PLOS ONE			English	Article								Background: The growth of sequencing-based Chromatin Immuno-Precipitation studies call for a more in-depth understanding of the nature of the technology and of the resultant data to reduce false positives and false negatives. Control libraries are typically constructed to complement such studies in order to mitigate the effect of systematic biases that might be present in the data. In this study, we explored multiple control libraries to obtain better understanding of what they truly represent. Methodology: First, we analyzed the genome-wide profiles of various sequencing-based libraries at a low resolution of 1 Mbp, and compared them with each other as well as against aCGH data. We found that copy number plays a major influence in both ChIP-enriched as well as control libraries. Following that, we inspected the repeat regions to assess the extent of mapping bias. Next, significantly tag-rich 5 kbp regions were identified and they were associated with various genomic landmarks. For instance, we discovered that gene boundaries were surprisingly enriched with sequenced tags. Further, profiles between different cell types were noticeably distinct although the cell types were somewhat related and similar. Conclusions: We found that control libraries bear traces of systematic biases. The biases can be attributed to genomic copy number, inherent sequencing bias, plausible mapping ambiguity, and cell-type specific chromatin structure. Our results suggest careful analysis of control libraries can reveal promising biological insights.			Vega, VB (corresponding author), Genome Inst Singapore, Computat & Math Biol Grp, Singapore, Singapore.	sungk@gis.a-star.edu.sg	Palanisamy, Nallasivam/ABC-8844-2020	Palanisamy, Nallasivam/0000-0002-0633-9772; Sung, Wing-Kin/0000-0001-7806-7086				BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhinge AA, 2007, GENOME RES, V17, P910, DOI 10.1101/gr.5574907; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Vega VB, 2008, LECT NOTES COMPUT SC, V5103, P130, DOI 10.1007/978-3-540-69389-5_16; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	16	33	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2009	4	4							e5241	10.1371/journal.pone.0005241	http://dx.doi.org/10.1371/journal.pone.0005241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TS	19367334	Green Published, gold, Green Submitted			2022-12-27	WOS:000265510400008
J	Fritz, JA; Behm, CA				Fritz, Julie-Anne; Behm, Carolyn A.			CUTI-1: A Novel Tetraspan Protein Involved in C. elegans CUTicle Formation and Epithelial Integrity	PLOS ONE			English	Article								The nematode cuticle is a tough extracellular matrix composed primarily of cross-linked collagens and non-collagenous cuticulins. It is required for nematode motility and protection from the external environment. Little is known about how the complex process of cuticle formation has been adapted to the specialized requirements of the nematode cuticle, which is structurally and compositionally unique from other organisms. The C. elegans gene cuti-1 (CUTicle and epithelial Integrity) encodes a nematode-specific protein. We have shown that CUTI-1 is expressed in the epithelia and in seam cells. Within these tissues the expression of cuti-1 mRNA cycles throughout development in line with the molting cycle, a process that involves synthesis of a new cuticle. In addition, knockdown of cuti-1 by RNA interference (RNAi) results in worms that display post-embryonic phenotypes related to cuticle dysfunction and defects in epithelial integrity. This is one of the first reports of a nematode-specific protein involved in extracellular matrix formation. It provides further insight into how novel ways have evolved to regulate the formation of the cuticle, which is the primary protective barrier and skeletal component of nematodes.			Fritz, JA (corresponding author), Australian Natl Univ, Coll Med Biol & Environm, Sch Biol, Canberra, ACT, Australia.	Carolyn.Behm@anu.edu.au	Behm, Carolyn A/A-2102-2008	Behm, Carolyn A/0000-0002-0603-221X				Bercher M, 2001, J CELL BIOL, V154, P415, DOI 10.1083/jcb.200103035; Berezikov E, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh033; BIRD DM, 1989, MOL CELL BIOL, V9, P4119, DOI 10.1128/MCB.9.10.4119; BRENNER S, 1974, GENETICS, V77, P71; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Cheong KH, 1999, P NATL ACAD SCI USA, V96, P6241, DOI 10.1073/pnas.96.11.6241; Costa M, 1997, DEV BIOL, V184, P373, DOI 10.1006/dbio.1997.8530; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Gissendanner CR, 2004, DEV BIOL, V266, P399, DOI 10.1016/j.ydbio.2003.10.014; Hashmi S, 2004, J BIOL CHEM, V279, P6035, DOI 10.1074/jbc.M312346200; Hong L, 2001, J CELL BIOL, V154, P403, DOI 10.1083/jcb.200007075; Hresko MC, 1999, J CELL BIOL, V146, P659, DOI 10.1083/jcb.146.3.659; Johnstone IL, 2000, TRENDS GENET, V16, P21, DOI 10.1016/S0168-9525(99)01857-0; JOHNSTONE IL, 1994, BIOESSAYS, V16, P171, DOI 10.1002/bies.950160307; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; Johnstone IL, 1996, MOL BIOCHEM PARASIT, V80, P103, DOI 10.1016/0166-6851(96)02682-5; Koh K, 2001, DEVELOPMENT, V128, P2867; KRAMER JM, 1994, ANNU REV GENET, V28, P95; KRAMER JM, 1997, C ELEGANS, V2, P471; Lackner MR, 2005, CANCER CELL, V7, P325, DOI 10.1016/j.ccr.2005.03.024; McMahon L, 2001, J CELL SCI, V114, P2265; Michaux G, 2000, CURR BIOL, V10, P1098, DOI 10.1016/S0960-9822(00)00695-3; Moribe H, 2004, J CELL SCI, V117, P5209, DOI 10.1242/jcs.01403; Nakamura N, 1997, J BIOL CHEM, V272, P11344; PARK YS, 1994, DEV BIOL, V163, P112, DOI 10.1006/dbio.1994.1127; PODBILEWICZ B, 1994, DEV BIOL, V161, P408, DOI 10.1006/dbio.1994.1041; Praitis V, 2001, GENETICS, V157, P1217; Roberts B, 2003, MOL BIOL CELL, V14, P4414, DOI 10.1091/mbc.E03-03-0162; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; SINGH RN, 1978, NEMATOLOGICA, V24, P63, DOI 10.1163/187529278X00074; Thein MC, 2003, DEV DYNAM, V226, P523, DOI 10.1002/dvdy.10259; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190	36	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5117	10.1371/journal.pone.0005117	http://dx.doi.org/10.1371/journal.pone.0005117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357781	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505900003
J	Ou, HY; He, XY; Shao, YC; Tai, C; Rajakumar, K; Deng, ZX				Ou, Hong-Yu; He, Xinyi; Shao, Yucheng; Tai, Cui; Rajakumar, Kumar; Deng, Zixin			dndDB: A Database Focused on Phosphorothioation of the DNA Backbone	PLOS ONE			English	Article								Background: The Dnd DNA degradation phenotype was first observed during electrophoresis of genomic DNA from Streptomyces lividans more than 20 years ago. It was subsequently shown to be governed by the five-gene dnd cluster. Similar gene clusters have now been found to be widespread among many other distantly related bacteria. Recently the dnd cluster was shown to mediate the incorporation of sulphur into the DNA backbone via a sequence-selective, stereo-specific phosphorothioate modification in Escherichia coli B7A. Intriguingly, to date all identified dnd clusters lie within mobile genetic elements, the vast majority in laterally transferred genomic islands. Methodology: We organized available data from experimental and bioinformatics analyses about the DNA phosphorothioation phenomenon and associated documentation as a dndDB database. It contains the following detailed information: (i) Dnd phenotype; (ii) dnd gene clusters; (iii) genomic islands harbouring dnd genes; (iv) Dnd proteins and conserved domains. As of 25 December 2008, dndDB contained data corresponding to 24 bacterial species exhibiting the Dnd phenotype reported in the scientific literature. In addition, via in silico analysis, dndDB identified 26 syntenic dnd clusters from 25 species of Eubacteria and Archaea, 25 dnd-bearing genomic islands and one dnd plasmid containing 114 dnd genes. A further 397 other genes coding for proteins with varying levels of similarity to Dnd proteins were also included in dndDB. A broad range of similarity search, sequence alignment and phylogenetic tools are readily accessible to allow for to individualized directions of research focused on dnd genes. Conclusion: dndDB can facilitate efficient investigation of a wide range of aspects relating to dnd DNA modification and other island-encoded functions in host organisms. dndDB version 1.0 is freely available at http://mml.sjtu.edu.cn/dndDB/.			Ou, HY (corresponding author), Shanghai Jiao Tong Univ, Lab Microbial Metab, Shanghai 200030, Peoples R China.	zxdeng@sjtu.edu.cn	OU, Hong-Yu/O-5208-2019	OU, Hong-Yu/0000-0001-9439-1660				Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; He X, 2007, MOL MICROBIOL, V65, P1034, DOI 10.1111/j.1365-2958.2007.05846.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liang JD, 2007, NUCLEIC ACIDS RES, V35, P2944, DOI 10.1093/nar/gkm176; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Ou HY, 2007, NUCLEIC ACIDS RES, V35, pW97, DOI 10.1093/nar/gkm380; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Wang HM, 2006, BIOINFORMATICS, V22, P2308, DOI 10.1093/bioinformatics/btl389; Wang LR, 2007, NAT CHEM BIOL, V3, P709, DOI 10.1038/nchembio.2007.39; You DL, 2008, CHEMBIOCHEM, V9, P1879, DOI 10.1002/cbic.200800033; You DL, 2007, BIOCHEMISTRY-US, V46, P6126, DOI 10.1021/bi602615k; Zhang CT, 2003, BIOINFORMATICS, V19, P593, DOI 10.1093/bioinformatics/btg041; ZHOU XF, 1988, NUCLEIC ACIDS RES, V16, P4341, DOI 10.1093/nar/16.10.4341; Zhou XF, 2005, MOL MICROBIOL, V57, P1428, DOI 10.1111/j.1365-2958.2005.04764.x; Zhou XF, 2004, APPL ENVIRON MICROB, V70, P7110, DOI 10.1128/AEM.70.12.7110-7118.2004	22	43	53	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5132	10.1371/journal.pone.0005132	http://dx.doi.org/10.1371/journal.pone.0005132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357771	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505900008
J	Tintu, A; Rouwet, E; Verlohren, S; Brinkmann, J; Ahmad, S; Crispi, F; van Bilsen, M; Carmeliet, P; Staff, AC; Tjwa, M; Cetin, I; Gratacos, E; Hernandez-Andrade, E; Hofstra, L; Jacobs, M; Lamers, WH; Morano, I; Safak, E; Ahmed, A; le Noble, F				Tintu, Andrei; Rouwet, Ellen; Verlohren, Stefan; Brinkmann, Joep; Ahmad, Shakil; Crispi, Fatima; van Bilsen, Marc; Carmeliet, Peter; Staff, Anne Cathrine; Tjwa, Marc; Cetin, Irene; Gratacos, Eduard; Hernandez-Andrade, Edgar; Hofstra, Leo; Jacobs, Michael; Lamers, Wouter H.; Morano, Ingo; Safak, Erdal; Ahmed, Asif; le Noble, Ferdinand			Hypoxia Induces Dilated Cardiomyopathy in the Chick Embryo: Mechanism, Intervention, and Long-Term Consequences	PLOS ONE			English	Article								Background: Intrauterine growth restriction is associated with an increased future risk for developing cardiovascular diseases. Hypoxia in utero is a common clinical cause of fetal growth restriction. We have previously shown that chronic hypoxia alters cardiovascular development in chick embryos. The aim of this study was to further characterize cardiac disease in hypoxic chick embryos. Methods: Chick embryos were exposed to hypoxia and cardiac structure was examined by histological methods one day prior to hatching (E20) and at adulthood. Cardiac function was assessed in vivo by echocardiography and ex vivo by contractility measurements in isolated heart muscle bundles and isolated cardiomyocytes. Chick embryos were exposed to vascular endothelial growth factor (VEGF) and its scavenger soluble VEGF receptor-1 (sFlt-1) to investigate the potential role of this hypoxia-regulated cytokine. Principal Findings: Growth restricted hypoxic chick embryos showed cardiomyopathy as evidenced by left ventricular (LV) dilatation, reduced ventricular wall mass and increased apoptosis. Hypoxic hearts displayed pump dysfunction with decreased LV ejection fractions, accompanied by signs of diastolic dysfunction. Cardiomyopathy caused by hypoxia persisted into adulthood. Hypoxic embryonic hearts showed increases in VEGF expression. Systemic administration of rhVEGF(165) to normoxic chick embryos resulted in LV dilatation and a dose-dependent loss of LV wall mass. Lowering VEGF levels in hypoxic embryonic chick hearts by systemic administration of sFlt-1 yielded an almost complete normalization of the phenotype. Conclusions/Significance: Our data show that hypoxia causes a decreased cardiac performance and cardiomyopathy in chick embryos, involving a significant VEGF-mediated component. This cardiomyopathy persists into adulthood.			Tintu, A (corresponding author), Max Delbruck Ctr Mol Med, Lab Angiogenesis & Cardiovasc Pathol, Berlin, Germany.	lenoble@mdc-berlin.de	van Bilsen, Marc/E-8342-2016; Ahmed, Asif/ABE-9544-2020; Gratacos, Eduard/AAR-4939-2020; Ahmed, Asif/A-7268-2010; cetin, irene/K-6112-2016; Carmeliet, Peter/AAQ-5140-2020; Ahmad, Shakil/A-9421-2008; le Noble, Ferdinand/L-7867-2017; Lamers, Wouter H./D-2965-2012	Ahmed, Asif/0000-0002-8755-8546; Gratacos, Eduard/0000-0002-7405-7224; cetin, irene/0000-0002-9217-3034; Carmeliet, Peter/0000-0001-7961-1821; Ahmad, Shakil/0000-0002-9294-0475; Verlohren, Stefan/0000-0003-3507-8636; Crispi, Fatima/0000-0002-7422-5240; Goswami, Kaushal/0000-0002-7052-4358	MRC [G0601295] Funding Source: UKRI; British Heart Foundation [RG/09/001/25940] Funding Source: Medline; Medical Research Council [G0601295] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Dor Y, 2001, DEVELOPMENT, V128, P1531; Dumont EA, 2001, NAT MED, V7, P1352, DOI 10.1038/nm1201-1352; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Feucht M, 1997, AM J PATHOL, V151, P1407; Fong TAT, 1999, CANCER RES, V59, P99; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Gupta S, 2007, ANTIOXID REDOX SIGN, V9, P623, DOI 10.1089/ars.2007.1474; Haase H, 2006, FASEB J, V20, P865, DOI 10.1096/fj.05-5414com; Hein S, 2000, CARDIOVASC RES, V45, P273, DOI 10.1016/S0008-6363(99)00268-0; HEIN S, 1994, J MOL CELL CARDIOL, V26, P1291, DOI 10.1006/jmcc.1994.1148; Holubarsch C, 1996, CIRCULATION, V94, P683, DOI 10.1161/01.CIR.94.4.683; Ingelfinger JR, 2004, CURR OPIN NEPHROL HY, V13, P459, DOI 10.1097/01.mnh.0000133977.09688.2f; Katz AM, 2006, CIRCULATION, V113, P1922, DOI 10.1161/CIRCULATIONAHA.106.620765; Leeson CPM, 2001, CIRCULATION, V103, P1264; Louey S, 2005, EARLY HUM DEV, V81, P745, DOI 10.1016/j.earlhumdev.2005.07.001; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Morrison JL, 2007, AM J PHYSIOL-REG I, V293, pR306, DOI 10.1152/ajpregu.00798.2006; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; NICOLAIDES KH, 1989, AM J OBSTET GYNECOL, V161, P996, DOI 10.1016/0002-9378(89)90770-9; Nosek TM, 1997, AM J PHYSIOL-HEART C, V273, pH1464, DOI 10.1152/ajpheart.1997.273.3.H1464; PARDI G, 1993, NEW ENGL J MED, V328, P692, DOI 10.1056/NEJM199303113281004; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Rouwet EV, 2002, CIRCULATION, V105, P2791, DOI 10.1161/01.CIR.0000017497.47084.06; SCHAPER J, 1991, CIRCULATION, V83, P504, DOI 10.1161/01.CIR.83.2.504; Sharma SK, 2006, PEDIATR RES, V59, P116, DOI 10.1203/01.pdr.0000191579.63339.90; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; STEWART DE, 1985, J MOL CELL CARDIOL, V17, P389, DOI 10.1016/S0022-2828(85)80138-3; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Sugishita Y, 2004, DEV BIOL, V267, P294, DOI 10.1016/j.ydbio.2003.11.017; TATSUMI R, 1995, ANAL BIOCHEM, V224, P28, DOI 10.1006/abio.1995.1004; Tintu AN, 2007, ENDOTHELIUM-J ENDOTH, V14, P353, DOI 10.1080/10623320701746347; van Heerebeek L, 2006, CIRCULATION, V113, P1966, DOI 10.1161/CIRCULATIONAHA.105.587519; Verburg BO, 2008, CIRCULATION, V117, P649, DOI 10.1161/CIRCULATIONAHA.107.709717; Villamor E, 2004, AM J PHYSIOL-REG I, V287, pR642, DOI 10.1152/ajpregu.00611.2003; Wu YM, 2002, CIRCULATION, V106, P1384, DOI 10.1161/01.CIR.0000029804.61510.02; Yue XP, 2001, AM J PHYSIOL-HEART C, V280, pH2240, DOI 10.1152/ajpheart.2001.280.5.H2240; Zile MR, 2002, CIRCULATION, V105, P1503, DOI 10.1161/hc1202.105290; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	42	95	97	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5155	10.1371/journal.pone.0005155	http://dx.doi.org/10.1371/journal.pone.0005155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357774	Green Published, Green Accepted, gold			2022-12-27	WOS:000265505900015
J	Hashimoto, Y; Loftis, DW; Adams, JC				Hashimoto, Yosuke; Loftis, David W.; Adams, Josephine C.			Fascin-1 Promoter Activity Is Regulated by CREB and the Aryl Hydrocarbon Receptor in Human Carcinoma Cells	PLOS ONE			English	Article							ACTIN-BUNDLING PROTEIN; INDEPENDENT PROGNOSTIC VALUE; ELEMENT-BINDING PROTEIN; MATURE DENDRITIC CELLS; BREAST-CANCER; TRANSCRIPTIONAL ACTIVATION; GENOME SEQUENCE; COLON-CANCER; EXPRESSION; GENE	Background: Fascin is an actin-bundling protein that is absent from most normal epithelia yet is upregulated in multiple forms of human carcinoma, where its expression correlates clinically with a poor prognosis. How fascin-1 transcription is activated in carcinoma cells is largely unknown, although the hypothesis of regulation by beta-catenin signaling has received attention. The question is important because of the clinical significance of fascin expression in human carcinomas. Methodology/Principal Findings: Through comparative genomics we made an unbiased analysis of the DNA sequence of the fascin-1 promoter region from six mammalian species. We identified two regions in which highly conserved motifs are concentrated. Luciferase promoter reporter assays for the human fascin-1 promoter were carried out in fascin-positive and negative human breast and colon carcinoma cells, and in human dermal fibroblasts that are constitutively fascin-positive. In all fascin-positive cells, the region 2219/+114 that contains multiple highly conserved motifs had strong transcriptional activity. The region 22953/21582 appeared to contain repressor activity. By examining the effects of single or multiple point mutations of conserved motifs within the 2219/+114 region on transcriptional reporter activity, we identified for the first time that the conserved CREB and AhR binding motifs are major determinants of transcriptional activity in human colon carcinoma cells. Chromatin immunoprecipitations for CREB, AhR or beta-catenin from extracts from fascin-positive or -negative human colon carcinoma cells identified that CREB and AhR specifically associate with the 2219/+114 region of the FSCN1 promoter in fascin-positive colon carcinoma cells. An association of beta-catenin was not specific to fascin-positive cells. Conclusion: Upregulation of fascin-1 in aggressive human carcinomas appears to have a multi-factorial basis. The data identify novel roles for CREB and AhR as major, specific regulators of FSCN-1 transcription in human carcinoma cells but do not support the hypothesis that beta-catenin signaling has a central role.	[Hashimoto, Yosuke; Loftis, David W.; Adams, Josephine C.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH USA; [Adams, Josephine C.] Cleveland Clin, Cleveland Clin Lerner Coll Med, Dept Mol Med, Cleveland, OH USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Hashimoto, Y (corresponding author), Shizuoka Canc Ctr, Shizuoka, Japan.	adamsj@ccf.org	Adams, Josephine C/B-1121-2009	Adams, Josephine C/0000-0002-2225-4947	Association for International Cancer Research [04-033]	Association for International Cancer Research	Supported by Association for International Cancer Research grant 04-033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk John J. Jr., 2001, Journal of Insect Science (Tucson), V1, P1; Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Al-Alwan MM, 2001, J IMMUNOL, V166, P338, DOI 10.4049/jimmunol.166.1.338; Anilkumar N, 2003, EMBO J, V22, P5390, DOI 10.1093/emboj/cdg521; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Blanchette M, 2003, NUCLEIC ACIDS RES, V31, P3840, DOI 10.1093/nar/gkg606; Bros M, 2003, J IMMUNOL, V171, P1825, DOI 10.4049/jimmunol.171.4.1825; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; De Arcangelis A, 2004, GENE EXPR PATTERNS, V4, P637, DOI 10.1016/j.modgep.2004.04.012; EDWARDS RA, 1995, CELL MOTIL CYTOSKEL, V32, P1, DOI 10.1002/cm.970320102; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Geyeregger R, 2007, BLOOD, V109, P4288, DOI 10.1182/blood-2006-08-043422; Ghosh R, 2007, NEOPLASIA, V9, P893, DOI 10.1593/neo.07502; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Grothey A, 2000, ONCOGENE, V19, P4864, DOI 10.1038/sj.onc.1203838; Hashimoto Y, 2005, CLIN CANCER RES, V11, P2597, DOI 10.1158/1078-0432.CCR-04-1378; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Hashimoto Y, 2004, ONCOLOGY-BASEL, V67, P262, DOI 10.1159/000081327; Hashimoto Y, 2007, MOL BIOL CELL, V18, P4591, DOI 10.1091/mbc.E07-02-0157; Hashimoto Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-241; HORWITZ KB, 1978, CANCER RES, V38, P2434; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Ionov Y, 2004, P NATL ACAD SCI USA, V101, P1273, DOI 10.1073/pnas.0307276101; Jawhari AU, 2003, AM J PATHOL, V162, P69, DOI 10.1016/S0002-9440(10)63799-6; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Knuppel R, 1994, J Comput Biol, V1, P191, DOI 10.1089/cmb.1994.1.191; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lambrechts A, 2004, INT J BIOCHEM CELL B, V36, P1890, DOI 10.1016/j.biocel.2004.01.024; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li J, 2007, EMBO J, V26, P2284, DOI 10.1038/sj.emboj.7601667; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Megiorni F, 2005, NEUROSCI LETT, V381, P169, DOI 10.1016/j.neulet.2005.02.027; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Min J, 2006, HYPERTENSION, V47, P1189, DOI 10.1161/01.HYP.0000222892.37375.4d; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mosialos G, 1996, AM J PATHOL, V148, P593; Pelosi G, 2003, BRIT J CANCER, V88, P537, DOI 10.1038/sj.bjc.6600731; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Puppa G, 2007, BRIT J CANCER, V96, P1118, DOI 10.1038/sj.bjc.6603690; Ross R, 2003, GENE THER, V10, P1035, DOI 10.1038/sj.gt.3301968; Ross R, 1998, J IMMUNOL, V160, P3776; Ross R, 2000, J INVEST DERMATOL, V115, P658, DOI 10.1046/j.1523-1747.2000.00112.x; Schlezinger JJ, 2006, BIOL CHEM, V387, P1175, DOI 10.1515/BC.2006.145; Shan ZT, 2008, ANAT REC, V291, P519, DOI 10.1002/ar.20686; Soshilov A, 2008, J BIOL CHEM, V283, P32995, DOI 10.1074/jbc.M802414200; Sosinsky A, 2003, NUCLEIC ACIDS RES, V31, P3589, DOI 10.1093/nar/gkg544; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Xie JJ, 2005, BIOCHEM BIOPH RES CO, V337, P355, DOI 10.1016/j.bbrc.2005.09.055; Yang F, 2004, J BIOL CHEM, V279, P35403, DOI 10.1074/jbc.M404055200; Yang XH, 2005, ONCOGENE, V24, P7869, DOI 10.1038/sj.onc.1208938; Yoder BJ, 2005, CLIN CANCER RES, V11, P186; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zigeuner R, 2006, UROLOGY, V68, P518, DOI 10.1016/j.urology.2006.03.032	61	39	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5130	10.1371/journal.pone.0005130	http://dx.doi.org/10.1371/journal.pone.0005130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340314	gold, Green Submitted, Green Published			2022-12-27	WOS:000265500700021
J	Hu, YM; Coates, ARM				Hu, Yanmin; Coates, Anthony R. M.			Acute and Persistent Mycobacterium tuberculosis Infections Depend on the Thiol Peroxidase TPX	PLOS ONE			English	Article								The macrophage is the natural niche of Mycobacterium tuberculosis infection. In order to combat oxidative and nitrosative stresses and persist in macrophages successfully, M. tuberculosis is endowed with a very efficient antioxidant complex. Amongst these antioxidant enzymes, TpX is the only one in M. tuberculosis with sequence homology to thiol peroxidase. Previous reports have demonstrated that the M. tuberculosis TpX protein functions as a peroxidase in vitro. It is the dominant antioxidant which protects M. tuberculosis against oxidative and nitrosative stresses. The level of the protein increases in oxidative stress. To determine the roles of tpx gene in M. tuberculosis survival and virulence in vivo, we constructed an M. tuberculosis strain lacking the gene. The characteristics of the mutant were examined in an in vitro stationary phase model, in response to stresses; in murine bone marrow derived macrophages and in an acute and an immune resistant model of murine tuberculosis. The tpx mutant became sensitive to H(2)O(2) and NO compared to the wild type strain. Enzymatic analysis using bacterial extracts from the WT and the tpx mutant demonstrated that the mutant contains reduced peroxidase activity. As a result of this, the mutant failed to grow and survive in macrophages. The growth deficiency in macrophages became more pronounced after interferon-gamma activation. In contrast, its growth was significantly restored in the macrophages of inducible nitric oxide synthase (iNOS or NOS2) knockout mice. Moreover, the tpx mutant was impaired in its ability to initiate an acute infection and to maintain a persistent infection. Its virulence was attenuated. Our results demonstrated that tpx is required for M. tuberculosis to deal with oxidative and nitrosative stresses, to survive in macrophages and to establish acute and persistent infections in animal tuberculosis models.	[Hu, Yanmin; Coates, Anthony R. M.] St Georges Univ London, Div Cellular & Mol Med, Ctr Infect, London, England	St Georges University London	Hu, YM (corresponding author), St Georges Univ London, Div Cellular & Mol Med, Ctr Infect, London, England.	acoates@sgul.ac.uk		Hu, Yanmin/0000-0003-0630-5342; Coates, Anthony/0000-0001-8052-3175	European Community's Sixth Framework Programme; Burton Medical Trust	European Community's Sixth Framework Programme; Burton Medical Trust	This research was supported by the European Community's Sixth Framework Programme to the project NEWTBDRUGS. The publication reflects only the author's views. The European Community is not liable for any use that may be made of the information herein. The financial support of the Burton Medical Trust is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Cha MK, 1996, J BACTERIOL, V178, P5610, DOI 10.1128/jb.178.19.5610-5614.1996; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Chiavolini D, 2008, INFECT IMMUN, V76, P486, DOI 10.1128/IAI.00862-07; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crawford RM, 1996, INFECT IMMUN, V64, P2188, DOI 10.1128/IAI.64.6.2188-2192.1996; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Dhandayuthapani S, 1996, J BACTERIOL, V178, P3641, DOI 10.1128/jb.178.12.3641-3649.1996; Dosanjh NS, 2005, FEMS MICROBIOL LETT, V249, P87, DOI 10.1016/j.femsle.2005.06.004; Dussurget O, 2001, INFECT IMMUN, V69, P529, DOI 10.1128/IAI.69.1.529-533.2001; Edwards KM, 2001, AM J RESP CRIT CARE, V164, P2213, DOI 10.1164/ajrccm.164.12.2106093; Ehlers S, 1999, IMMUNOLOGY, V98, P313; Hillas PJ, 2000, J BIOL CHEM, V275, P18801, DOI 10.1074/jbc.M001001200; Hu YM, 2008, INFECT IMMUN, V76, P1535, DOI 10.1128/IAI.01078-07; Hu YM, 2000, J BACTERIOL, V182, P6358, DOI 10.1128/JB.182.22.6358-6365.2000; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Hu YM, 2004, FEMS MICROBIOL LETT, V237, P415, DOI 10.1016/j.femsle.2004.07.005; Jaeger T, 2004, ARCH BIOCHEM BIOPHYS, V423, P182, DOI 10.1016/j.abb.2003.11.021; Jaeger Timo, 2007, V44, P207; Kawahara M, 1996, MICROBIOL IMMUNOL, V40, P575, DOI 10.1111/j.1348-0421.1996.tb01111.x; Kim SY, 2002, REDOX REP, V7, P79, DOI 10.1179/135100002125000307; KUSUNOSE E, 1976, J BIOCHEM, V80, P1343, DOI 10.1093/oxfordjournals.jbchem.a131407; La Carbona S, 2007, MOL MICROBIOL, V66, P1148, DOI 10.1111/j.1365-2958.2007.05987.x; LEFFORD MJ, 1980, INFECT IMMUN, V28, P508; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Master SS, 2002, MICROBIOL-SGM, V148, P3139, DOI 10.1099/00221287-148-10-3139; Milano A, 1996, MOL MICROBIOL, V19, P113, DOI 10.1046/j.1365-2958.1996.352876.x; MORLEY D, 1993, J CARDIOVASC PHARM, V22, pS3, DOI 10.1097/00005344-199306227-00003; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; ORME IM, 1988, AM REV RESPIR DIS, V137, P716, DOI 10.1164/ajrccm/137.3.716; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; PARISH TSN, 1998, ELECTROPORATION MYCO; Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001; Rho BS, 2006, J MOL BIOL, V361, P850, DOI 10.1016/j.jmb.2006.05.076; Rouse DA, 1996, MOL MICROBIOL, V22, P583, DOI 10.1046/j.1365-2958.1996.00133.x; Sambrook J., 2002, MOL CLONING LAB MANU; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; Springer B, 2001, INFECT IMMUN, V69, P5967, DOI 10.1128/IAI.69.10.5967-5973.2001; Stehr M, 2006, ACTA CRYSTALLOGR D, V62, P563, DOI 10.1107/S0907444906008249; Trujillo M, 2006, J BIOL CHEM, V281, P20555, DOI 10.1074/jbc.M601008200; WAYNE LG, 1988, INFECT IMMUN, V56, P936, DOI 10.1128/IAI.56.4.936-941.1988; Wengenack NL, 1999, BIOCHEM BIOPH RES CO, V256, P485, DOI 10.1006/bbrc.1999.0358; Zahrt TC, 2002, ANTIOXID REDOX SIGN, V4, P141, DOI 10.1089/152308602753625924	45	40	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5150	10.1371/journal.pone.0005150	http://dx.doi.org/10.1371/journal.pone.0005150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340292	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000265500700027
J	Thatte, HS; He, XD; Goyal, RK				Thatte, Hemant S.; He, Xue D.; Goyal, Raj K.			Imaging of Nitric Oxide in Nitrergic Neuromuscular Neurotransmission in the Gut	PLOS ONE			English	Article							PEPTIDE-VIP; 4,5-DIAMINOFLUORESCEIN; SYNTHASE	Background: Numerous functional studies have shown that nitrergic neurotransmission plays a central role in peristalsis and sphincter relaxation throughout the gut and impaired nitrergic neurotransmission has been implicated in clinical disorders of all parts of the gut. However, the role of nitric oxide (NO) as a neurotransmitter continues to be controversial because: 1) the cellular site of production during neurotransmission is not well established; 2) NO may interacts with other inhibitory neurotransmitter candidates, making it difficult to understand its precise role. Methodology/Principal Findings: Imaging NO can help resolve many of the controversies regarding the role of NO in nitrergic neurotransmission. Imaging of NO and its cellular site of production is now possible. NO forms quantifiable fluorescent compound with diaminofluorescein (DAF) and allows imaging of NO with good specificity and sensitivity in living cells. In this report we describe visualization and regulation of NO and calcium (Ca2+) in the myenteric nerve varicosities during neurotransmission using multiphoton microscopy. Our results in mice gastric muscle strips provide visual proof that NO is produced de novo in the nitrergic nerve varicosities upon nonadrenergic noncholinergic (NANC) nerve stimulation. These studies show that NO is a neurotransmitter rather than a mediator. Changes in NO production in response to various pharmacological treatments correlated well with changes in slow inhibitory junction potential of smooth muscles. Conclusions/Significance: Dual imaging and electrophysiologic studies provide visual proof that during nitrergic neurotransmission NO is produced in the nerve terminals. Such studies may help define whether NO production or its signaling pathway is responsible for impaired nitrergic neurotransmission in pathological states.	[Thatte, Hemant S.] VA Boston Hlth Care Syst, Cardiothorac Div, Dept Surg, Boston, MA USA; [Thatte, Hemant S.; He, Xue D.; Goyal, Raj K.] Harvard Univ, Sch Med, Boston, MA USA; [He, Xue D.; Goyal, Raj K.] VA Boston Hlth Care Syst, Ctr Swallow & Motil Disorders, Dept Med, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Thatte, HS (corresponding author), VA Boston Hlth Care Syst, Cardiothorac Div, Dept Surg, Boston, MA USA.	Raj_Goyal@hms.harvard.edu			NIDDK [DK 062867]; Office of Research and Development, Medical Research Service, Department of Veterans Affairs [VA Merit Review Award]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062867] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in parts by a research grant DK 062867 from the NIDDK and a VA Merit Review Award from the Office of Research and Development, Medical Research Service, Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BULT H, 1990, NATURE, V345, P346, DOI 10.1038/345346a0; Chaudhury A, 2008, AM J PHYSIOL-GASTR L, V295, pG442, DOI 10.1152/ajpgi.90280.2008; CRIST JR, 1992, J PHYSIOL-LONDON, V447, P119, DOI 10.1113/jphysiol.1992.sp018994; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; HE XD, 1993, J PHYSIOL-LONDON, V461, P485, DOI 10.1113/jphysiol.1993.sp019524; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; IGNARRO LJ, 1990, NATURE, V347, P131, DOI 10.1038/347131b0; Jourd'Heuil D, 2002, FREE RADICAL BIO MED, V33, P676, DOI 10.1016/S0891-5849(02)00955-3; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Mashimo H, 1996, J CLIN INVEST, V98, P8, DOI 10.1172/JCI118781; Murthy KS, 1998, AM J PHYSIOL-CELL PH, V275, pC1409, DOI 10.1152/ajpcell.1998.275.6.C1409; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Rao YM, 2008, AM J PHYSIOL-GASTR L, V294, pG627, DOI 10.1152/ajpgi.00519.2007; Sanders KM, 2007, J PHYSIOL-LONDON, V578, P33, DOI 10.1113/jphysiol.2006.122473; Suedof Thomas C., 2008, V184, P1; Sumiyoshi H, 2004, J CELL BIOL, V166, P591, DOI 10.1083/jcb.200402054; Suzuki N, 2002, J BIOL CHEM, V277, P47, DOI 10.1074/jbc.M108195200; Thatte HS, 2003, ANN THORAC SURG, V75, P1145, DOI 10.1016/S0003-4975(02)04705-7; Toda N, 2005, PHARMACOL REV, V57, P315, DOI 10.1124/pr.57.3.4; Toda N, 2003, PHARMACOL REV, V55, P271, DOI 10.1124/pr.55.2.3; Van Geldre LA, 2004, CURR PHARM DESIGN, V10, P2483; Vittal H, 2007, NAT CLIN PRACT GASTR, V4, P336, DOI 10.1038/ncpgasthep0838; Ye XY, 2004, ANALYST, V129, P1200, DOI 10.1039/b409394a	24	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e4990	10.1371/journal.pone.0004990	http://dx.doi.org/10.1371/journal.pone.0004990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340298	Green Published, gold, Green Submitted			2022-12-27	WOS:000265500700005
J	Crill, WD; Hughes, HR; Delorey, MJ; Chang, GJJ				Crill, Wayne D.; Hughes, Holly R.; Delorey, Mark J.; Chang, Gwong-Jen J.			Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens	PLOS ONE			English	Article							WEST-NILE-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; PROTEIN-DOMAIN-III; JAPANESE ENCEPHALITIS-VIRUS; LINKED-IMMUNOSORBENT-ASSAY; ENVELOPE-PROTEIN; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; FUSION LOOP; AMINO-ACID	Dengue virus (DENV) is a serious mosquito-borne pathogen causing significant global disease burden, either as classic dengue fever (DF) or in its most severe manifestation dengue hemorrhagic fever (DHF). Nearly half of the world's population is at risk of dengue disease and there are estimated to be millions of infections annually; a situation which will continue to worsen with increasing expansion of the mosquito vectors and epidemic DF/DHF. Currently there are no available licensed vaccines or antivirals for dengue, although significant effort has been directed toward the development of safe and efficacious dengue vaccines for over 30 years. Promising vaccine candidates are in development and testing phases, but a better understanding of immune responses to DENV infection and vaccination is needed. Humoral immune responses to DENV infection are complex and may exacerbate pathogenicity, yet are essential for immune protection. In this report, we develop DENV-2 envelope (E) protein epitope-specific antigens and measure immunoglobulin responses to three distinct epitopes in DENV-2 infected human serum samples. Immunoglobulin responses to DENV-2 infection exhibited significant levels of individual variation. Antibody populations targeting broadly cross-reactive epitopes centered on the fusion peptide in structural domain II were large, highly variable, and greater in primary than in secondary DENV-2 infected sera. E protein domain III cross-reactive immunoglobulin populations were similarly variable and much larger in IgM than in IgG. DENV-2 specific domain III IgG formed a very small proportion of the antibody response yet was significantly correlated with DENV-2 neutralization, suggesting that the highly protective IgG recognizing this epitope in murine studies plays a role in humans as well. This report begins to tease apart complex humoral immune responses to DENV infection and is thus important for improving our understanding of dengue disease and immunological correlates of protection, relevant to DENV vaccine development and testing.	[Crill, Wayne D.; Hughes, Holly R.; Delorey, Mark J.; Chang, Gwong-Jen J.] Ctr Dis Control & Prevent, Arbovirus Dis Branch, Div Vector Borne Infect Dis, Publ Hlth Serv,US Dept Hlth & Human Serv, Ft Collins, CO USA	Centers for Disease Control & Prevention - USA; United States Public Health Service	Crill, WD (corresponding author), Ctr Dis Control & Prevent, Arbovirus Dis Branch, Div Vector Borne Infect Dis, Publ Hlth Serv,US Dept Hlth & Human Serv, Ft Collins, CO USA.	wcrill@cdc.gov			CDC, DVBID	CDC, DVBID(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	CDC, DVBID is a federally funded national public health Lab (USCDC) and all funding for this work was supported by such federal funding. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.	Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001; Barrera R, 2008, AM J TROP MED HYG, V78, P666, DOI 10.4269/ajtmh.2008.78.666; BLOK J, 1989, ARCH VIROL, V105, P39, DOI 10.1007/BF01311115; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Casella G., 2021, STAT INFERENCE; Chang GJJ, 2000, J VIROL, V74, P4244, DOI 10.1128/JVI.74.9.4244-4252.2000; Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4; Chang Gwong-Jen J, 2004, Expert Rev Vaccines, V3, P199, DOI 10.1586/14760584.3.2.199; Chiou SS, 2008, CLIN VACCINE IMMUNOL, V15, P825, DOI 10.1128/CVI.00004-08; Crill WD, 2007, J GEN VIROL, V88, P1169, DOI 10.1099/vir.0.82640-0; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; Farrar J, 2007, TROP MED INT HEALTH, V12, P695, DOI [10.1111/j.1365-3156.2007.01838, 10.1111/j.1365-3156.2007.01838.x]; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Goncalvez AP, 2004, J VIROL, V78, P12919, DOI 10.1128/JVI.78.23.12919-12928.2004; Gonzalez D, 2005, INT J INFECT DIS, V9, P280, DOI 10.1016/j.ijid.2004.07.012; Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08; Gromowski GD, 2007, VIROLOGY, V366, P349, DOI 10.1016/j.virol.2007.05.042; Gubler D.J., 2006, NOVART FDN SYMP, V277, P16, DOI DOI 10.1002/0470058005.CH2; Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzman MG, 2007, EMERG INFECT DIS, V13, P282, DOI 10.3201/eid1302.060539; HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162; Hiramatsu K, 1996, VIROLOGY, V224, P437, DOI 10.1006/viro.1996.0550; HOMBACH J, 2007, SCI CONSULTATION IMM; Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Kuno G, 2001, AM J TROP MED HYG, V65, P671, DOI 10.4269/ajtmh.2001.65.671; Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Lai CJ, 2007, J VIROL, V81, P12766, DOI 10.1128/JVI.01420-07; Lehmann E. L., 1998, THEORY POINT ESTIMAT; LIN B, 1994, VIROLOGY, V202, P885, DOI 10.1006/viro.1994.1410; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Lisova O, 2007, J GEN VIROL, V88, P2387, DOI 10.1099/vir.0.83028-0; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; Lok SM, 2001, J MED VIROL, V65, P315, DOI 10.1002/jmv.2036; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Maillard RA, 2008, J BIOL CHEM, V283, P613, DOI 10.1074/jbc.M706031200; Martin DA, 2004, CLIN DIAGN LAB IMMUN, V11, P1130, DOI 10.1128/CDLI.11.6.1130-1133.2004; Martin DA, 2002, CLIN DIAGN LAB IMMUN, V9, P544, DOI 10.1128/CDLI.9.3.544-549.2002; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Monath TP, 2007, NEW ENGL J MED, V357, P2222, DOI 10.1056/NEJMp0707161; NITAYAPHAN S, 1990, VIROLOGY, V177, P541, DOI 10.1016/0042-6822(90)90519-W; Normile D, 2007, SCIENCE, V317, P1494, DOI 10.1126/science.317.5844.1494; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Rigau-Perez JG, 2006, LANCET INFECT DIS, V6, P297, DOI 10.1016/S1473-3099(06)70465-0; Roberson JA, 2007, J CLIN MICROBIOL, V45, P3167, DOI 10.1128/JCM.01143-07; Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Senior K, 2007, LANCET INFECT DIS, V7, P636, DOI 10.1016/S1473-3099(07)70221-9; Shu PY, 2003, CLIN DIAGN LAB IMMUN, V10, P622, DOI 10.1128/CDLI.10.4.622-630.2003; Solomon T, 2001, J INFECTION, V42, P104, DOI 10.1053/jinf.2001.0802; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07; Takada A, 2003, REV MED VIROL, V13, P387, DOI 10.1002/rmv.405; Tesh RB, 2002, EMERG INFECT DIS, V8, P245, DOI 10.3201/eid0803.010238; Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06; Trainor NB, 2007, VIROLOGY, V360, P398, DOI 10.1016/j.virol.2006.10.033; TRIRAWATANAPONG T, 1992, GENE, V116, P139, DOI 10.1016/0378-1119(92)90509-N; Wallace MJ, 2003, J GEN VIROL, V84, P1723, DOI 10.1099/vir.0.18980-0; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; 2007, MMWR MORB MORTAL WKL, V57, P577	70	123	132	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e4991	10.1371/journal.pone.0004991	http://dx.doi.org/10.1371/journal.pone.0004991			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337372	Green Published, gold, Green Submitted			2022-12-27	WOS:000265500600005
J	Fels, D				Fels, Daniel			Cellular Communication through Light	PLOS ONE			English	Article							BIOPHOTON EMISSION; LUMINESCENCE; GROWTH	Information transfer is a fundamental of life. A few studies have reported that cells use photons (from an endogenous source) as information carriers. This study finds that cells can have an influence on other cells even when separated with a glass barrier, thereby disabling molecule diffusion through the cell-containing medium. As there is still very little known about the potential of photons for intercellular communication this study is designed to test for non-molecule-based triggering of two fundamental properties of life: cell division and energy uptake. The study was performed with a cellular organism, the ciliate Paramecium caudatum. Mutual exposure of cell populations occurred under conditions of darkness and separation with cuvettes (vials) allowing photon but not molecule transfer. The cell populations were separated either with glass allowing photon transmission from 340 nm to longer waves, or quartz being transmittable from 150 nm, i.e. from UV-light to longer waves. Even through glass, the cells affected cell division and energy uptake in neighboring cell populations. Depending on the cuvette material and the number of cells involved, these effects were positive or negative. Also, while paired populations with lower growth rates grew uncorrelated, growth of the better growing populations was correlated. As there were significant differences when separating the populations with glass or quartz, it is suggested that the cell populations use two (or more) frequencies for cellular information transfer, which influences at least energy uptake, cell division rate and growth correlation. Altogether the study strongly supports a cellular communication system, which is different from a molecule-receptor-based system and hints that photon-triggering is a fine tuning principle in cell chemistry.	[Fels, Daniel] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Fels, Daniel] Univ Paris 06, Med Ctr, Lab Parasitol Evolut, UMR 7103, Paris, France	University of Basel; Swiss Tropical & Public Health Institute; UDICE-French Research Universities; Sorbonne Universite	Fels, D (corresponding author), Swiss Trop Inst, CH-4002 Basel, Switzerland.	daniel.fels@unibas.ch						ALBRECHTBUEHLER G, 1992, P NATURAL ACAD SCI, V89, P8299; Beloussov LV, 2007, BIOPHOTONICS AND COHERENT SYSTEMS IN BIOLOGY, P139; Chwirot W B, 1992, RECENT ADV BIOPHOTON, P259; Cohen S, 1997, Skin Res Technol, V3, P177, DOI 10.1111/j.1600-0846.1997.tb00184.x; COLLI L, 1955, EXPERIENTIA, V11, P479, DOI 10.1007/BF02166829; Fels D, 2006, P ROY SOC B-BIOL SCI, V273, P1031, DOI 10.1098/rspb.2005.3404; FENCHEL T, 1980, MICROBIAL ECOL, V6, P1, DOI 10.1007/BF02020370; GALANTSEV VP, 1993, EXPERIENTIA, V49, P870, DOI 10.1007/BF01952600; GALLE M, 1991, EXPERIENTIA, V47, P457, DOI 10.1007/BF01959943; GURWITSCH A, 1926, PROBLEM ZELLTEILUNG, P1; GURWITSCH A, 1923, ARCH ENTWICKLUNGSMEC, V52, P11; Ho M.W., 1992, RECENT ADV BIOPHOTON, P287; Ho M.-W., 1994, BIOELECTRODYNAMICS B; Ho M-W., 1999, RAINBOW WORM PHYS OR; Jaffe LF, 2005, LUMINESCENCE, V20, P414, DOI 10.1002/bio.866; Lambing K., 1992, RECENT ADV BIOPHOTON, P393; Levin M, 2003, BIOELECTROMAGNETICS, V24, P295, DOI 10.1002/bem.10104; Mei W. P., 1992, RECENT ADV BIOPHOTON, P243; MEI WP, 1994, BIOELECTRODYNAMICS B, P269; Musumeci F, 1999, EUROPHYS LETT, V47, P736, DOI 10.1209/epl/i1999-00452-6; NIGGLI HJ, 1992, J PHOTOCH PHOTOBIO B, V14, P144, DOI 10.1016/1011-1344(92)85090-H; POPOV G A, 1963, Biofizika, V8, P317; Popp FA, 2000, SCI CHINA SER C, V43, P507; POPP FA, 1988, EXPERIENTIA, V44, P543, DOI 10.1007/BF01953300; POPP FA, 2006, H FROHLICH FRS PHYS, P139; POPP FA, 1989, ELECTROMAGNETIC BIOI; Popp FA, 2007, BIOPHOTONICS AND COHERENT SYSTEMS IN BIOLOGY, P17; QUICKENDEN TI, 1976, PHOTOCHEM PHOTOBIOL, V23, P201, DOI 10.1111/j.1751-1097.1976.tb07242.x; SAS, 2003, JMP STAT GRAPH GUID; SHEN X, 1994, EXPERIENTIA, V50, P963, DOI 10.1007/BF01923488; STREHLER BL, 1951, J GEN PHYSIOL, V34, P809, DOI 10.1085/jgp.34.6.809; Takeda M, 2004, CANCER SCI, V95, P656, DOI 10.1111/j.1349-7006.2004.tb03325.x; Van Wijk R, 2007, BIOPHOTONICS AND COHERENT SYSTEMS IN BIOLOGY, P177; VANWIJK R, 1988, EXPERIENTIA, V44, P586	34	71	75	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5086	10.1371/journal.pone.0005086	http://dx.doi.org/10.1371/journal.pone.0005086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19340303	Green Published, gold, Green Submitted			2022-12-27	WOS:000265500600022
J	Ozawa, A; Speaker, RB; Lindberg, I				Ozawa, Akihiko; Speaker, Richard B., III; Lindberg, Iris			Enzymatic Characterization of a Human Acyltransferase Activity	PLOS ONE			English	Article								Background: Non-histone protein acylation is increasingly recognized as an important posttranslational modification, but little is known as to the biochemical properties of protein serine acylating enzymes. Methodology/Principal Findings: We here report that we have identified a metal-stimulated serine octanoyltransferase activity in microsomes from human erythroleukemic (HEL) cells. The HEL acylating enzyme was linear with respect to time and protein, exhibited a neutral pH optimum (stimulated by cobalt and zinc), and inhibited by chelating reagents. Hydroxylamine treatment removed most, but not all, of the attached radioactivity. A salt extract of microsomal membranes contained the major portion of enzyme activity, indicating that this acyltransferase is not an integral membrane protein. Sucrose density fractionation showed that the acyltransferase activity is concentrated in the endoplasmic reticulum. In competition experiments, the acyltransferase was well inhibited by activated forms of fatty acids containing at least eight to fourteen carbons, but not by acetyl CoA. The zinc-stimulated HEL acyltransferase did not octanoylate proenkephalin, proopiomelanocortin, His-tagged proghrelin, or proghrelin lacking the amino-terminal His-tag stub of Gly-Ala-Met. The peptides des-acyl ghrelin and ACTH were also not acylated; however, des-acyl ghrelin containing the N-terminal tripeptide Gly-Ala-Met was acylated. Mutagenesis studies indicated a requirement for serine five residues from the amino terminus, reminiscent of myristoyl transferase, but not of ghrelin acylation. However, recombinant myristoyl transferase could not recapitulate the hydroxylamine sensitivity, zinc-stimulation, nor EDTA inhibition obtained with HEL acyltransferase, properties preserved in the HEL cell enzyme purified through four sequential chromatographic steps. Conclusions/Significance: In conclusion, our data demonstrate the presence of a zinc-stimulated acyltransferase activity concentrated in the endoplasmic reticulum in HEL cells which is likely to contribute to medium-chain protein lipidation.			Ozawa, A (corresponding author), Univ Maryland, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	ilind001@umaryland.edu	Ozawa, Akihiko/U-4426-2019; Lindberg, Iris/Q-3825-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005084] Funding Source: NIH RePORTER; NIDA NIH HHS [DA05084, R56 DA005084, R01 DA005084] Funding Source: Medline; NIDDK NIH HHS [R01 DK049703] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; De Vriese C, 2005, ENDOCRINOLOGY, V146, P1514, DOI 10.1210/en.2004-0964; EBERWINE JH, 1987, P NATL ACAD SCI USA, V84, P1449, DOI 10.1073/pnas.84.5.1449; GLEMBOTSKI CC, 1982, J BIOL CHEM, V257, P501; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; HIGGINS JA, 1966, BIOCHEM J, V99, P631, DOI 10.1042/bj0990631; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; KO MH, 2008, J BIOL CHEM; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; LINDBERG I, 1991, ENDOCRINOLOGY, V128, P1849, DOI 10.1210/endo-128-4-1849; Liu L, 1996, J BIOL CHEM, V271, P23269, DOI 10.1074/jbc.271.38.23269; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Ozawa A, 2007, ANAL BIOCHEM, V366, P182, DOI 10.1016/j.ab.2007.04.020; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Wilkinson CW, 2006, PEPTIDES, V27, P453, DOI 10.1016/j.peptides.2005.05.029; WOODFORD TA, 1979, J BIOL CHEM, V254, P4993; Yang J, 2008, P NATL ACAD SCI USA, V105, P10750, DOI 10.1073/pnas.0805353105; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	22	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2009	4	5							e5426	10.1371/journal.pone.0005426	http://dx.doi.org/10.1371/journal.pone.0005426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440RC	19412546	Green Published, gold, Green Submitted			2022-12-27	WOS:000265716400002
J	van der Elst, EM; Okuku, HS; Nakamya, P; Muhaari, A; Davies, A; McClelland, RS; Price, MA; Smith, AD; Graham, SM; Sanders, EJ				van der Elst, Elisabeth M.; Okuku, Haile Selassie; Nakamya, Phellister; Muhaari, Allan; Davies, Alun; McClelland, R. Scott; Price, Matthew A.; Smith, Adrian D.; Graham, Susan M.; Sanders, Eduard J.			Is Audio Computer-Assisted Self-Interview (ACASI) Useful in Risk Behaviour Assessment of Female and Male Sex Workers, Mombasa, Kenya?	PLOS ONE			English	Article							ANAL INTERCOURSE; DRUG-USE; RELIABILITY; INFECTION; TRIALS; AIDS; MEN	Background: Audio computer-assisted self-interview (ACASI) may elicit more frequent reporting of socially sensitive behaviours than face-to-face (FtF)-interview. However, no study compared responses to both methods in female and male sex workers (FSW; MSW) in Africa. Methodology/Principal Findings: We sequentially enrolled adults recruited for an HIV-1 intervention trial into a comparative study of ACASI and FtF-interview, in a clinic near Mombasa, Kenya. Feasibility and acceptability of ACASI, and a comparative analysis of enrolment responses between ACASI and FtF on an identical risk assessment questionnaire were evaluated. In total, 139 women and 259 men, 81% of eligible cohort participants, completed both interviews. ACASI captured a higher median number of regular (2 vs. 1, p<0.001, both genders) and casual partners in the last week ( 3 vs. 2, p = 0.04 in women; 2 vs. 1, p<0.001 in men). Group sex (21.6 vs. 13.5%, p<0.001, in men), intravenous drug use (IDU; 10.8 vs. 2.3%, p<0.001 in men; 4.4 vs. 0%, p = 0.03 in women), and rape (8.9 vs. 3.9%, p = 0.002, in men) were reported more frequently in ACASI. A surprisingly high number of women reported in ACASI that they had paid for sex (49.3 vs. 5.8%, p<0.001). Behaviours for recruitment (i.e. anal sex, sex work, sex between males) were reported less frequently in ACASI. The majority of women (79.2%) and men (69.7%) felt that answers given in ACASI were more honest. Volunteers who were not able to take ACASI (84 men, and 37 women) mostly lacked reading skills. Conclusions/Significance: About 1 in 5 cohort participants was not able to complete ACASI, mostly for lack of reading skills. Participants who completed ACASI were more likely to report IDU, rape, group sex, and payment for sex by women than when asked in FtF interview. ACASI appears to be a useful tool for high risk behaviour assessments in the African context.			van der Elst, EM (corresponding author), KEMRI, Ctr Geog Med Res Coast, Kilifi, Kenya.	ESanders@kilifi.kemri-wellcome.org	Graham, Susan/W-6133-2019; Smith, Adrian D/A-6336-2009	Graham, Susan/0000-0001-7847-8686; Smith, Adrian/0000-0003-0036-1490	NIAID NIH HHS [P30 AI027757] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Armitage P., 2002, STAT METHODS MED RES; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bloom DE, 1998, SCIENCE, V280, P847, DOI 10.1126/science.280.5365.847; Brody S, 2003, INT J STD AIDS, V14, P431, DOI 10.1258/095646203322025704; Caceres CF, 2007, AIDS, V21, pS49; Des Jarlais DC, 1999, LANCET, V353, P1657, DOI 10.1016/S0140-6736(98)07026-3; Geibel S, 2007, AIDS, V21, P1349, DOI 10.1097/QAD.0b013e328017f843; GRIENSVEN VF, 2006, AM J EPIDEMIOL, V163, P271; Grijsen ML, 2008, SEX TRANSM INFECT, V84, P364, DOI 10.1136/sti.2007.028852; Hewett PC, 2004, SEX TRANSM INFECT, V80, P43, DOI 10.1136/sti.2004.013250; Johnson AM, 2001, AIDS, V15, P111, DOI 10.1097/00002030-200101050-00016; Kissinger P, 1999, AM J EPIDEMIOL, V149, P950, DOI 10.1093/oxfordjournals.aje.a009739; Kurth AE, 2004, SEX TRANSM DIS, V31, P719, DOI 10.1097/01.olq.0000145855.36181.13; Lane T, 2006, AIDS, V20, P123, DOI 10.1097/01.aids.0000198083.55078.02; LOGGERENBERG VF, 2008, PLOS ONE, V3, pE1954; MCKIRNAN DJ, 1994, AIDS RES HUM RETROV, V10, pS285; Mensch BS, 2003, DEMOGRAPHY, V40, P247, DOI 10.1353/dem.2003.0017; MENSCH BS, 2008, SEXUAL BEHAV STI III, V1554, P8538; Minnis AM, 2007, CONTRACEPTION, V75, P59, DOI 10.1016/j.contraception.2006.07.002; Ramjee G, 1999, SEX TRANSM DIS, V26, P374, DOI 10.1097/00007435-199908000-00002; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; SMITH AD, 2009, 16 C RETR OPP INF MO; *STATACORP, 2007, STAT SOFTW REL 9 2; TURNER AN, 2008, J CLIN EPIDEM; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; van de Wijgert J, 2000, INT J EPIDEMIOL, V29, P885, DOI 10.1093/ije/29.5.885; Waruru Anthony K, 2005, BMC Med Inform Decis Mak, V5, P24, DOI 10.1186/1472-6947-5-24; Williams ML, 2000, AIDS EDUC PREV, V12, P199	28	72	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5340	10.1371/journal.pone.0005340	http://dx.doi.org/10.1371/journal.pone.0005340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412535	gold, Green Published, Green Submitted			2022-12-27	WOS:000265688200002
J	Bastonero, S; Le Priol, Y; Armand, M; Bernard, CS; Reynaud-Gaubert, M; Olive, D; Parzy, D; de Bentzmann, S; Capo, C; Mege, JL				Bastonero, Sonia; Le Priol, Yannick; Armand, Martine; Bernard, Christophe S.; Reynaud-Gaubert, Martine; Olive, Daniel; Parzy, Daniel; de Bentzmann, Sophie; Capo, Christian; Mege, Jean-Louis			New Microbicidal Functions of Tracheal Glands: Defective Anti-Infectious Response to Pseudomonas aeruginosa in Cystic Fibrosis	PLOS ONE			English	Article								Tracheal glands (TG) may play a specific role in the pathogenesis of cystic fibrosis (CF), a disease due to mutations in the cftr gene and characterized by airway inflammation and Pseudomonas aeruginosa infection. We compared the gene expression of wild-type TG cells and TG cells with the cftr Delta F508 mutation (CF-TG cells) using microarrays covering the whole human genome. In the absence of infection, CF-TG cells constitutively exhibited an inflammatory signature, including genes that encode molecules such as IL-1 alpha, IL-beta, IL-32, TNFSF14, LIF, CXCL1 and PLAU. In response to P. aeruginosa, genes associated with IFN-gamma response to infection (CXCL10, IL-24, IFN gamma R2) and other mediators of anti-infectious responses (CSF2, MMP1, MMP3, TLR2, S100 calcium-binding proteins A) were markedly up-regulated in wild-type TG cells. This microbicidal signature was silent in CF-TG cells. The deficiency of genes associated with IFN-gamma response was accompanied by the defective membrane expression of IFN gamma R2 and altered response of CF-TG cells to exogenous IFN-gamma. In addition, CF-TG cells were unable to secrete CXCL10, IL-24 and S100A8/S100A9 in response to P. aeruginosa. The differences between wild-type TG and CF-TG cells were due to the cftr mutation since gene expression was similar in wild-type TG cells and CF-TG cells transfected with a plasmid containing a functional cftr gene. Finally, we reported an altered sphingolipid metabolism in CF-TG cells, which may account for their inflammatory signature. This first comprehensive analysis of gene expression in TG cells proposes a protective role of wild- type TG against airborne pathogens and reveals an original program in which antiinfectious response was deficient in TG cells with a cftr mutation. This defective response may explain why host response does not contribute to protection against P. aeruginosa in CF.			Bastonero, S (corresponding author), Fac Med Marseille, CNRS, UMR 6236, Unite Rech Malad Infectieuses Trop & Emergentes, F-13385 Marseille, France.	Jean-Louis.Mege@univmed.fr	Reynaud-Gaubert, Martine LM/P-6958-2016; ARMAND, Martine/O-5780-2016; MEGE, JEAN-LOUIS/O-6063-2016	ARMAND, Martine/0000-0002-8712-6620; Bernard, Christophe/0000-0003-0582-3471; Le Priol, Yannick/0000-0002-5176-0857				Abul-Milh M, 2001, GLYCOCONJUGATE J, V18, P253, DOI 10.1023/A:1012460824913; Al-Aloul M, 2004, THORAX, V59, P334, DOI 10.1136/thx.2003.014258; Armand M, 1996, AM J PHYSIOL-GASTR L, V271, pG172, DOI 10.1152/ajpgi.1996.271.1.G172; Auge N, 1996, J BIOL CHEM, V271, P19251, DOI 10.1074/jbc.271.32.19251; Backhed F, 2002, J BIOL CHEM, V277, P18198, DOI 10.1074/jbc.M111640200; Ballard ST, 2007, RESP PHYSIOL NEUROBI, V159, P271, DOI 10.1016/j.resp.2007.06.017; BASBAUM CB, 1990, ANNU REV PHYSIOL, V52, P97; Bastonero S, 2005, J GENE MED, V7, P1439, DOI 10.1002/jgm.789; Beck DC, 2000, J BIOL CHEM, V275, P3365, DOI 10.1074/jbc.275.5.3365; Bonfield TL, 1999, J ALLERGY CLIN IMMUN, V104, P72, DOI 10.1016/S0091-6749(99)70116-8; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brown GR, 2005, J IMMUNOL, V174, P4688, DOI 10.4049/jimmunol.174.8.4688; Caudell EG, 2002, J IMMUNOL, V168, P6041, DOI 10.4049/jimmunol.168.12.6041; CHOW CW, 1982, EUR J PEDIATR, V139, P240, DOI 10.1007/BF00442171; Chun J, 2006, J IMMUNOL, V177, P1330, DOI 10.4049/jimmunol.177.2.1330; Coraux C, 2004, AM J RESP CELL MOL, V30, P605, DOI 10.1165/rcmb.2003-0056OC; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dinarello CA, 2004, CURR OPIN PHARMACOL, V4, P378, DOI 10.1016/j.coph.2004.03.010; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Escotte S, 2006, AM J RESP CELL MOL, V34, P348, DOI 10.1165/rcmb.2005-0191OC; Filali M, 2002, NOVART FDN SYMP, V248, P38; Ghigo E, 2002, INFECT IMMUN, V70, P1501, DOI 10.1128/IAI.70.3.1501-1506.2002; Hart CA, 2002, BRIT MED BULL, V61, P81, DOI 10.1093/bmb/61.1.81; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Inglis SK, 2005, PEDIATR PULM, V40, P279, DOI 10.1002/ppul.20183; Inoue D, 2006, RESP PHYSIOL NEUROBI, V154, P484, DOI 10.1016/j.resp.2005.11.006; Jayaraman S, 2001, P NATL ACAD SCI USA, V98, P8119, DOI 10.1073/pnas.131087598; Kammouni W, 1999, AM J RESP CELL MOL, V20, P684, DOI 10.1165/ajrcmb.20.4.3341; Kammouni W, 1997, INFECT IMMUN, V65, P5176, DOI 10.1128/IAI.65.12.5176-5183.1997; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Knight D, 2001, PULM PHARMACOL THER, V14, P169, DOI 10.1006/pupt.2001.0282; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Leduc D, 2007, INFECT IMMUN, V75, P3848, DOI 10.1128/IAI.00015-07; LUSTER AD, 1987, MOL CELL BIOL, V7, P3723, DOI 10.1128/MCB.7.10.3723; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MERTEN M, 1996, HUMAN CELL CULTURE P, P201; Merten MD, 1996, AM J RESP CELL MOL, V15, P520, DOI 10.1165/ajrcmb.15.4.8879186; MERTEN MD, 1993, AM J PHYSIOL, V264, pL93, DOI 10.1152/ajplung.1993.264.2.L93; Moreilhon C, 2005, PHYSIOL GENOMICS, V20, P244, DOI 10.1152/physiolgenomics.00135.2004; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; MUSSO T, 1995, BLOOD, V86, P1961, DOI 10.1182/blood.V86.5.1961.bloodjournal8651961; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Pollara G, 2005, J CELL PHYSIOL, V205, P161, DOI 10.1002/jcp.20473; Schneider K, 2004, IMMUNOL REV, V202, P49, DOI 10.1111/j.0105-2896.2004.00206.x; SEO J, 2008, J BACTERIOL IN PRESS; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; Ulrich M, 1998, AM J RESP CELL MOL, V19, P83, DOI 10.1165/ajrcmb.19.1.3137; Venkatakrishnan A, 2000, AM J RESP CELL MOL, V23, P396, DOI 10.1165/ajrcmb.23.3.3949; Verhaeghe C, 2007, J CYST FIBROS, V6, P304, DOI 10.1016/j.jcf.2006.12.001; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Vos JB, 2005, PHYSIOL GENOMICS, V21, P324, DOI 10.1152/physiolgenomics.00289.2004; Wagener JS, 1997, PEDIATR PULM, P267; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Xu GL, 2007, J IMMUNOL, V179, P6901, DOI 10.4049/jimmunol.179.10.6901; Zabner J, 2005, AM J PHYSIOL-LUNG C, V289, pL545, DOI 10.1152/ajplung.00065.2005; Zaborina O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040043	66	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5357	10.1371/journal.pone.0005357	http://dx.doi.org/10.1371/journal.pone.0005357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399182	Green Published, gold, Green Submitted			2022-12-27	WOS:000265514900016
J	Wang, SS; Purdue, MP; Cerhan, JR; Zheng, TZ; Menashe, I; Armstrong, BK; Lan, Q; Hartge, P; Kricker, A; Zhang, YW; Morton, LM; Vajdic, CM; Holford, TR; Severson, RK; Grulich, A; Leaderer, BP; Davis, S; Cozen, W; Yeager, M; Chanock, SJ; Chatterjee, N; Rothman, N				Wang, Sophia S.; Purdue, Mark P.; Cerhan, James R.; Zheng, Tongzhang; Menashe, Idan; Armstrong, Bruce K.; Lan, Qing; Hartge, Patricia; Kricker, Anne; Zhang, Yawei; Morton, Lindsay M.; Vajdic, Claire M.; Holford, Theodore R.; Severson, Richard K.; Grulich, Andrew; Leaderer, Brian P.; Davis, Scott; Cozen, Wendy; Yeager, Meredith; Chanock, Stephen J.; Chatterjee, Nilanjan; Rothman, Nathaniel			Common Gene Variants in the Tumor Necrosis Factor (TNF) and TNF Receptor Superfamilies and NF-kappa B Transcription Factors and Non-Hodgkin Lymphoma Risk	PLOS ONE			English	Article								Background: A promoter polymorphism in the pro-inflammatory cytokine tumor necrosis factor (TNF) (TNF G-308A) is associated with increased non-Hodgkin lymphoma (NHL) risk. The protein product, TNF-alpha, activates the nuclear factor kappa beta (NF-kappa B) transcription factor, and is critical for inflammatory and apoptotic responses in cancer progression. We hypothesized that the TNF and NF-kappa B pathways are important for NHL and that gene variations across the pathways may alter NHL risk. Methodology/Principal Findings: We genotyped 500 tag single nucleotide polymorphisms (SNPs) from 48 candidate gene regions (defined as 20 kb 5', 10 kb 3') in the TNF and TNF receptor superfamilies and the NF-kappa B and related transcription factors, in 1946 NHL cases and 1808 controls pooled from three independent population-based case-control studies. We obtaineded a gene region-level summary of association by computing the minimum p-value ("minP test''). We used logistic regression to compute odds ratios and 95% confidence intervals for NHL and four major NHL subtypes in relation to SNP genotypes and haplotypes. For NHL, the tail strength statistic supported an overall relationship between the TNF/NF-kappa B pathway and NHL (p = 0.02). We confirmed the association between TNF/LTA on chromosome 6p21.3 with NHL and found the LTA rs2844484 SNP most significantly and specifically associated with the major subtype, diffuse large B-cell lymphoma (DLBCL) (p-trend = 0.001). We also implicated for the first time, variants in NFKBIL1 on chromosome 6p21.3, associated with NHL. Other gene regions identified as statistically significantly associated with NHL included FAS, IRF4, TNFSF13B, TANK, TNFSF7 and TNFRSF13C. Accordingly, the single most significant SNPs associated with NHL were FAS rs4934436 (p-trend = 0.0024), IRF4 rs12211228 (p-trend = 0.0026), TNFSF13B rs2582869 (p-trend = 0.0055), TANK rs1921310 (p-trend = 0.0025), TNFSF7 rs16994592 (p-trend = 0.0024), and TNFRSF13C rs6002551 (p-trend = 0.0074). All associations were consistent in each study with no apparent specificity for NHL subtype. Conclusions/Significance: Our results provide consistent evidence that variation in the TNF superfamily of genes and specifically within chromosome 6p21.3 impacts lymphomagenesis. Further characterization of these susceptibility loci and identification of functional variants are warranted.			Wang, SS (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Rockville, MD USA.	wangso@mail.nih.gov	Morton, Lindsay/AAE-7495-2022; Morton, Lindsay M/B-5234-2015; Menashe, Idan/W-6214-2019; Yeager, Meredith/AAA-5322-2020; Vajdic, Claire/AAP-5940-2020; Purdue, Mark P/C-9228-2016; Menashe, Idan/AAC-8670-2020	Morton, Lindsay/0000-0001-9767-2310; Morton, Lindsay M/0000-0001-9767-2310; Purdue, Mark P/0000-0003-1177-3108; Menashe, Idan/0000-0003-1961-1461; WANG, SOPHIA/0000-0003-2597-9393; Cerhan, James/0000-0002-7482-178X; Vajdic, Claire/0000-0002-3612-8298	DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC067008, N01PC067010, N01PC065064, N01PC067009] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIACP010124, ZIACP010206, R01CA062006] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N02-PC-71105, N01 PC065064, R01 CA062006, N01-PC-67009, N01 PC067008, N01 PC067010, N01 PC067009] Funding Source: Medline	DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Altemeier WA, 2007, J LEUKOCYTE BIOL, V82, P721, DOI 10.1189/jlb.1006652; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; AUPHAN N, 1997, ARCH TOXICOL S, P87; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatti P, 2005, CANCER EPIDEM BIOMAR, V14, P2449, DOI 10.1158/1055-9965.EPI-05-0463; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cerhan JR, 2008, CANCER EPIDEM BIOMAR, V17, P3161, DOI 10.1158/1055-9965.EPI-08-0536; Cerhan JR, 2007, BLOOD, V110, P4455, DOI 10.1182/blood-2007-05-088682; Chatterjee N, 2004, CANCER EPIDEM BIOMAR, V13, P1415; Chen BSE, 2006, GENET EPIDEMIOL, V30, P495, DOI 10.1002/gepi.20162; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; Fillatreau S, 2006, NAT IMMUNOL, V7, P704, DOI 10.1038/ni0706-704; Garcia-Closas M, 2001, CANCER EPIDEM BIOMAR, V10, P687; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; Ho L, 2005, BLOOD, V105, P2891, DOI 10.1182/blood-2004-06-2297; Hughes AM, 2004, INT J CANCER, V110, P429, DOI 10.1002/ijc.20128; Jardin F, 2007, PATHOL BIOL, V55, P73, DOI 10.1016/j.patbio.2006.04.001; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Keller SA, 2000, BLOOD, V96, P2537; KLEIHUES P, 2001, PATHOLOGY GENETICS T; Lan Q, 2006, BLOOD, V107, P4101, DOI 10.1182/blood-2005-10-4160; Lossos IS, 2007, CANCER CELL, V12, P189, DOI 10.1016/j.ccr.2007.08.012; Lyu MA, 2007, MOL CANCER THER, V6, P460, DOI 10.1158/1535-7163.MCT-06-0254; Mackay F, 2004, CURR OPIN PHARMACOL, V4, P347, DOI 10.1016/j.coph.2004.02.009; Mackay F, 2006, SEMIN IMMUNOL, V18, P261, DOI 10.1016/j.smim.2006.07.003; Morton LM, 2007, BLOOD, V110, P695, DOI 10.1182/blood-2006-11-051672; Novak AJ, 2006, J CLIN ONCOL, V24, P983, DOI 10.1200/JCO.2005.02.7938; Okamoto K, 2003, AM J HUM GENET, V72, P303, DOI 10.1086/346067; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Ponzoni M, 2007, ADV ANAT PATHOL, V14, P25, DOI 10.1097/PAP.0b013e31802f0495; Purdue MP, 2007, CARCINOGENESIS, V28, P704, DOI 10.1093/carcin/bgl200; Rao VK, 2006, HEMATOLOGY, V11, P15, DOI 10.1080/10245330500329094; Rosenwald A, 2003, LEUKEMIA LYMPHOMA, V44, pS41, DOI 10.1080/10428190310001623775; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Roth W.-M., 2006, ED RES REV, V1, P27, DOI DOI 10.1016/J.EDUREV.2006.01.002; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Schmidt M, 2000, J CLIN ONCOL, V18, P3331, DOI 10.1200/JCO.2000.18.19.3331; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Skibola CF, 2008, BLOOD, V111, P4348, DOI 10.1182/blood-2007-09-112144; Taylor J, 2006, BIOSTATISTICS, V7, P167, DOI 10.1093/biostatistics/kxj009; Wang SS, 2006, CANCER RES, V66, P9771, DOI 10.1158/0008-5472.CAN-06-0324; Westfall Peter H, 2002, Methods Mol Biol, V184, P143; Whiteside TL, 2007, IMMUNOL INVEST, V36, P25, DOI 10.1080/08820130600991893; Yaccoby S, 2008, LEUKEMIA, V22, P406, DOI 10.1038/sj.leu.2405048; Zhang YW, 2004, AM J EPIDEMIOL, V159, P148, DOI 10.1093/aje/kwh033	51	81	82	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5360	10.1371/journal.pone.0005360	http://dx.doi.org/10.1371/journal.pone.0005360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390683	Green Published, gold, Green Submitted			2022-12-27	WOS:000265514400022
J	Wray, J; Williamson, EA; Royce, M; Shaheen, M; Beck, BD; Lee, SH; Nickoloff, JA; Hromas, R				Wray, Justin; Williamson, Elizabeth A.; Royce, Melanie; Shaheen, Montaser; Beck, Brian D.; Lee, Suk-Hee; Nickoloff, Jac A.; Hromas, Robert			Metnase Mediates Resistance to Topoisomerase II Inhibitors in Breast Cancer Cells	PLOS ONE			English	Article								DNA replication produces tangled, or catenated, chromatids, that must be decatenated prior to mitosis or catastrophic genomic damage will occur. Topoisomerase II alpha (Topo II alpha) is the primary decatenating enzyme. Cells monitor catenation status and activate decatenation checkpoints when decatenation is incomplete, which occurs when Topo II alpha is inhibited by chemotherapy agents such as the anthracyclines and epididophyllotoxins. We recently demonstrated that the DNA repair component Metnase (also called SETMAR) enhances Topo II alpha-mediated decatenation, and hypothesized that Metnase could mediate resistance to Topo II alpha inhibitors. Here we show that Metnase interacts with Topo II alpha in breast cancer cells, and that reducing Metnase expression significantly increases metaphase decatenation checkpoint arrest. Repression of Metnase sensitizes breast cancer cells to Topo II alpha inhibitors, and directly blocks the inhibitory effect of the anthracycline adriamycin on Topo II alpha-mediated decatenation in vitro. Thus, Metnase may mediate resistance to Topo II alpha inhibitors, and could be a biomarker for clinical sensitivity to anthracyclines. Metnase could also become an important target for combination chemotherapy with current Topo II alpha inhibitors, specifically in anthracycline-resistant breast cancer.			Wray, J (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Med, Canc Res & Treatment Ctr,Div Hematol Oncol, Albuquerque, NM 87131 USA.	rhromas@salud.unm.edu			NCI NIH HHS [R01 CA100862, R01 CA092111, P30 CA118100, CA100862, CA92111] Funding Source: Medline; NCRR NIH HHS [S10 RR019287, P20 RR11830, S10 RR19287, 1 S10 RR14668, S10 RR016918] Funding Source: Medline; NHLBI NIH HHS [R01 HL093606, HL093606] Funding Source: Medline; NIDDK NIH HHS [T32 DK0075-20] Funding Source: Medline; NIGMS NIH HHS [R01 GM084020] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092111, P30CA118100, R01CA100862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014668, P20RR011830, S10RR016918, S10RR019287] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084020] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; Binaschi M., 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P113, DOI 10.2174/1568011013354723; Clarke DJ, 2000, BIOESSAYS, V22, P351, DOI 10.1002/(SICI)1521-1878(200004)22:4<351::AID-BIES5>3.0.CO;2-W; Clarke DJ, 2006, CELL CYCLE, V5, P1925, DOI 10.4161/cc.5.17.3200; Damelin M, 2007, BRIT J CANCER, V96, P201, DOI 10.1038/sj.bjc.6603537; Deming PB, 2002, J BIOL CHEM, V277, P36832, DOI 10.1074/jbc.M206109200; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Doherty SC, 2003, J NATL CANCER I, V95, P1859, DOI 10.1093/jnci/djg120; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Felix CA, 2001, MED PEDIATR ONCOL, V36, P525, DOI 10.1002/mpo.1125; Garces CA, 2004, AM SURGEON, V70, P565; Hromas R, 2008, DNA REPAIR, V7, P1927, DOI 10.1016/j.dnarep.2008.08.002; ISHIDA R, 1991, CANCER RES, V51, P4909; Lee SH, 2005, P NATL ACAD SCI USA, V102, P18075, DOI 10.1073/pnas.0503676102; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; Nakagawa T, 2004, CANCER RES, V64, P4826, DOI 10.1158/0008-5472.CAN-04-0871; Richardson DS, 1997, BLOOD REV, V11, P201, DOI 10.1016/S0268-960X(97)90020-5; Roman Y, 2007, BIOCHEMISTRY-US, V46, P11369, DOI 10.1021/bi7005477; Skoufias DA, 2004, MOL CELL, V15, P977, DOI 10.1016/j.molcel.2004.08.018; Toyoda Y, 2006, MOL BIOL CELL, V17, P2287, DOI 10.1091/mbc.E05-11-1089; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Williamson EA, 2008, NUCLEIC ACIDS RES, V36, P5822, DOI 10.1093/nar/gkn560; Williamson EA, 2008, BIOCHIMIE, V90, P1422, DOI 10.1016/j.biochi.2008.05.010	24	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5323	10.1371/journal.pone.0005323	http://dx.doi.org/10.1371/journal.pone.0005323			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390626	Green Submitted, Green Published, gold			2022-12-27	WOS:000265514400011
J	Brea-Calvo, G; Siendones, E; Sanchez-Alcazar, JA; de Cabo, R; Navas, P				Brea-Calvo, Gloria; Siendones, Emilio; Sanchez-Alcazar, Jose A.; de Cabo, Rafael; Navas, Placido			Cell Survival from Chemotherapy Depends on NF-kappa B Transcriptional Up-Regulation of Coenzyme Q Biosynthesis	PLOS ONE			English	Article							ANTIOXIDANT SYSTEM; INDUCED APOPTOSIS; OXIDATIVE STRESS; RECEPTOR-ALPHA; CANCER-CELLS; GENE; EXPRESSION; CAMPTOTHECIN; DETOXIFICATION; ACTIVATION	Background: Coenzyme Q (CoQ) is a lipophilic antioxidant that is synthesized by a mitochondrial complex integrated by at least ten nuclear encoded COQ gene products. CoQ increases cell survival under different stress conditions, including mitochondrial DNA (mtDNA) depletion and treatment with cancer drugs such as camptothecin (CPT). We have previously demonstrated that CPT induces CoQ biosynthesis in mammal cells. Methodology/Principal Findings: CPT activates NF-kappa B that binds specifically to two kappa B binding sites present in the 5'-flanking region of the COQ7 gene. This binding is functional and induces both the COQ7 expression and CoQ biosynthesis. The inhibition of NF-kappa B activation increases cell death and decreases both, CoQ levels and COQ7 expression induced by CPT. In addition, using a cell line expressing very low of NF-kappa B, we demonstrate that CPT was incapable of enhancing enhance both CoQ biosynthesis and COQ7 expression in these cells. Conclusions/Significance: We demonstrate here, for the first time, that a transcriptional mechanism mediated by NF-kappa B regulates CoQ biosynthesis. This finding contributes new data for the understanding of the regulation of the CoQ biosynthesis pathway.			Brea-Calvo, G (corresponding author), Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain.	pnavas@upo.es	de Cabo, Rafael/E-7996-2010; Brea-Calvo, Gloria/N-4728-2014; Sanchéz-Alcázar, José A. A/L-4925-2014; NAVAS, PLACIDO/R-5943-2019; de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael/0000-0003-2830-5693; Brea-Calvo, Gloria/0000-0001-5536-6868; Sanchéz-Alcázar, José A. A/0000-0001-9705-1469; NAVAS, PLACIDO/0000-0002-4115-7966; de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442; Siendones Castillo, Emilio/0000-0001-6006-563X	NATIONAL INSTITUTE ON AGING [ZIAAG000362, ZIAAG000368] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arroyo A, 2004, METHOD ENZYMOL, V378, P207; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Barroso MP, 1997, J BIOENERG BIOMEMBR, V29, P259, DOI 10.1023/A:1022462111175; Bentinger M, 2003, J MOL BIOL, V326, P795, DOI 10.1016/S0022-2836(02)01447-X; Brea-Calvo G, 2006, FREE RADICAL BIO MED, V40, P1293, DOI 10.1016/j.freeradbiomed.2005.11.014; De Cabo R, 2004, EXP GERONTOL, V39, P297, DOI 10.1016/j.exger.2003.12.003; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; GomezDiaz C, 1997, BIOCHEM BIOPH RES CO, V234, P79, DOI 10.1006/bbrc.1997.6582; Gorman A, 1997, FEBS LETT, V404, P27, DOI 10.1016/S0014-5793(97)00069-0; Haddad JJ, 2004, BIOCHEM BIOPH RES CO, V316, P969, DOI 10.1016/j.bbrc.2004.02.162; Hiraoka W, 1998, J CLIN INVEST, V102, P1961, DOI 10.1172/JCI3437; HSIANG YH, 1988, CANCER RES, V48, P1722; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawamukai M, 2002, J BIOSCI BIOENG, V94, P511, DOI 10.1016/S1389-1723(02)80188-8; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; Mates JM, 2000, INT J BIOCHEM CELL B, V32, P157, DOI 10.1016/S1357-2725(99)00088-6; Nakai D, 2001, BIOCHEM BIOPH RES CO, V289, P463, DOI 10.1006/bbrc.2001.5977; Navarro F, 1998, FASEB J, V12, P1665, DOI 10.1096/fasebj.12.15.1665; Navas P, 2007, MITOCHONDRION, V7, pS34, DOI 10.1016/j.mito.2007.02.010; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Piret B, 1996, NUCLEIC ACIDS RES, V24, P4242, DOI 10.1093/nar/24.21.4242; POMMIER Y, 2006, NATURE REV, V6, P802; Quinzii CM, 2007, NEUROCHEM RES, V32, P723, DOI 10.1007/s11064-006-9190-z; Reinhold WC, 2003, CANCER RES, V63, P1000; Sancho P, 2003, MOL PHARMACOL, V63, P581, DOI 10.1124/mol.63.3.581; Schoonbroodt S, 2000, J IMMUNOL, V164, P4292, DOI 10.4049/jimmunol.164.8.4292; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHUG J, 1997, COMPUTATIONAL BIOL I; Simizu S, 1998, J BIOL CHEM, V273, P26900, DOI 10.1074/jbc.273.41.26900; Somasundaram S, 2002, CANCER RES, V62, P3868; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Storz P, 2007, TRENDS CELL BIOL, V17, P13, DOI 10.1016/j.tcb.2006.11.003; Storz P, 2003, CELL CYCLE, V2, pA8, DOI 10.4161/cc.2.1.234; Teferedegne B, 2006, MOL CELL BIOL, V26, P5759, DOI 10.1128/MCB.00271-06; Timur M, 2005, ACTA BIOCHIM POL, V52, P897; Tomasetti M, 2001, FASEB J, V15, P1425, DOI 10.1096/fj.00-0694fje; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Turunen M, 2000, J MOL BIOL, V297, P607, DOI 10.1006/jmbi.2000.3596; TURUNEN M, 2004, BIOCHIM BIOPHYS ACTA, V1660, P177; Villalba JM, 2000, ANTIOXID REDOX SIGN, V2, P213, DOI 10.1089/ars.2000.2.2-213; Wenzel U, 2004, CARCINOGENESIS, V25, P703, DOI 10.1093/carcin/bgh079; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Xu Y, 2007, J BIOL CHEM, V282, P15981, DOI 10.1074/jbc.M608979200	50	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5301	10.1371/journal.pone.0005301	http://dx.doi.org/10.1371/journal.pone.0005301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390650	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514200014
J	Lee, JB; Jang, JE; Song, MK; Chang, J				Lee, Jee-Boong; Jang, Ji-Eun; Song, Man Ki; Chang, Jun			Intranasal Delivery of Cholera Toxin Induces Th17-Dominated T-Cell Response to Bystander Antigens	PLOS ONE			English	Article								Cholera toxin (CT) is a potent vaccine adjuvant, which promotes mucosal immunity to protein antigen given by nasal route. It has been suggested that CT promotes T helper type 2 (Th2) response and suppresses Th1 response. We here report the induction of Th17-dominated responses in mice by intranasal delivery of CT. This dramatic Th17-driving effect of CT, which was dependent on the B subunit, was observed even in Th1 or Th2-favored conditions of respiratory virus infection. These dominating Th17 responses resulted in the significant neutrophil accumulation in the lungs of mice given CT. Both in vitro and in vivo treatment of CT induced strongly augmented IL-6 production, and Th17-driving ability of CT was completely abolished in IL-6 knockout mice, indicating a role of this cytokine in the Th17-dominated T-cell responses by CT. These data demonstrate a novel Th17-driving activity of CT, and help understand the mechanisms of CT adjuvanticity to demarcate T helper responses.			Lee, JB (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea.	tcell@ewha.ac.kr		CHANG, JUN/0000-0002-8423-5987				Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BOGAERT D, 2009, INFECT IMMUN; Braun MC, 1999, J EXP MED, V189, P541, DOI 10.1084/jem.189.3.541; BROMANDER AK, 1993, SCAND J IMMUNOL, V37, P452, DOI 10.1111/j.1365-3083.1993.tb03318.x; Chang J, 2004, J IMMUNOL, V172, P2818, DOI 10.4049/jimmunol.172.5.2818; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Cong YZ, 1996, EUR J IMMUNOL, V26, P2587, DOI 10.1002/eji.1830261108; Eriksson K, 2003, INFECT IMMUN, V71, P1740, DOI 10.1128/IAI.71.4.1740-1747.2003; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; Guinazu N, 2004, MICROBES INFECT, V6, P1250, DOI 10.1016/j.micinf.2004.07.010; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Imaoka K, 1998, J IMMUNOL, V161, P5952; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kawamura YI, 2003, EUR J IMMUNOL, V33, P3205, DOI 10.1002/eji.200324135; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kurono Y, 1999, J INFECT DIS, V180, P122, DOI 10.1086/314827; Lavelle EC, 2003, J IMMUNOL, V171, P2384, DOI 10.4049/jimmunol.171.5.2384; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu SJ, 2007, J LEUKOCYTE BIOL, V82, P354, DOI 10.1189/jlb.0207111; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lukens MV, 2006, VIROLOGY, V352, P157, DOI 10.1016/j.virol.2006.04.023; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; MARINARO M, 1995, J IMMUNOL, V155, P4621; MCGEE DW, 1993, INFECT IMMUN, V61, P4637, DOI 10.1128/IAI.61.11.4637-4644.1993; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Priebe GP, 2008, J IMMUNOL, V181, P4965, DOI 10.4049/jimmunol.181.7.4965; Ryan EJ, 2000, J IMMUNOL, V165, P5750, DOI 10.4049/jimmunol.165.10.5750; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Schaffeler MP, 1997, INT IMMUNOL, V9, P1555, DOI 10.1093/intimm/9.10.1555; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Simecka JW, 2000, INFECT IMMUN, V68, P672, DOI 10.1128/IAI.68.2.672-679.2000; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Williams NA, 1999, IMMUNOL TODAY, V20, P95, DOI 10.1016/S0167-5699(98)01397-8; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; XUAMANO JC, 1993, J EXP MED, V178, P1309, DOI 10.1084/jem.178.4.1309; Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267; Yanagita M, 1999, J IMMUNOL, V162, P3559	44	82	84	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2009	4	4							e5190	10.1371/journal.pone.0005190	http://dx.doi.org/10.1371/journal.pone.0005190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437SB	19360100	Green Submitted, Green Published, gold			2022-12-27	WOS:000265506100005
J	Elvang, T; Christensen, JP; Billeskov, R; Hoang, TTKT; Holst, P; Thomsen, AR; Andersen, P; Dietrich, J				Elvang, Tara; Christensen, Jan P.; Billeskov, Rolf; Hoang, Truc Thi Kim Thanh; Holst, Peter; Thomsen, Allan Randrup; Andersen, Peter; Dietrich, Jes			CD4 and CD8 T Cell Responses to the M. tuberculosis Ag85B-TB10.4 Promoted by Adjuvanted Subunit, Adenovector or Heterologous Prime Boost Vaccination	PLOS ONE			English	Article								Background: Although CD4 T cells are crucial for defense against M. tb, it is still not clear whether the optimal response against M. tb in fact involves both CD4 and CD8 T cells. To test this, we used a new vaccine strategy that generated a strong balanced T cell response consisting of both CD4 and CD8 T cells. Methods and Findings: To compare CD4 and CD8 responses against Ag85B-TB10.4 (H4), H4 was delivered as a subunit vaccine in cationic liposomes (CAF01), expressed in Ad5 (Ad-H4) or as a heterologous prime boost vaccination. H4/CAF01 induced primarily CD4 T cells and Ad-H4 gave predominantly a CD8 T cell response. In contrast, the heterologous prime boost combination resulted in augmentation of both the CD4 and CD8 response. The majority (>40%) of the CD4 T cells induced by the heterologous prime boost protocol were polyfunctional, and expressed IFN-gamma(+), IL-2(+), and TNF-alpha(+), whereas most of the CD8 T cells expressed IFN-gamma(+) and TNF-alpha(+) and possessed strong cytotoxic potential. The heterologous prime boost protocol also gave an increase in protective efficacy against M. tb challenge compared to H4/CAF01 and Ad-H4. Both the H4 specific CD4 and CD8 T cells were recruited to the site of infection, at the onset of infection. However, compared to CD8 T cells, CD4 T cells showed more extensive recruitment and were the main T cell subset proliferating at the site of infection. Conclusions/Significance: Heterologous prime boost based on H4, produced an additive effect on the priming of CD4 and CD8 cells and in terms of the protective capacity of the vaccine, and therefore represent an interesting new vaccine strategy against M. tb. However, CD4 and CD8 T cells respond very differently to live M. tb challenge, in a manner which supports the consensus that CD4 T cells do play the major role during the early stages of an M. tb infection.			Elvang, T (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	JDI@ssi.dk	Christensen, Jan Pravsgaard/I-4782-2017	Christensen, Jan Pravsgaard/0000-0002-4299-9479; Andersen, Peter/0000-0002-5869-2551; Billeskov, Rolf/0000-0003-4533-7304; Holst, Peter Johannes/0000-0002-1279-304X; Thomsen, Allan Randrup/0000-0002-2392-9803				Andersen P, 2005, MICROBES INFECT, V7, P911, DOI 10.1016/j.micinf.2005.03.013; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Behar SM, 1999, J EXP MED, V189, P1973, DOI 10.1084/jem.189.12.1973; Bennekov T, 2006, EUR J IMMUNOL, V36, P3346, DOI 10.1002/eji.200636128; Billeskov R, 2007, J IMMUNOL, V179, P3973, DOI 10.4049/jimmunol.179.6.3973; Brodin P, 2004, J INFECT DIS, V190, P115, DOI 10.1086/421468; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Derrick SC, 2004, INFECT IMMUN, V72, P1685, DOI 10.1128/IAI.72.3.1685-1692.2004; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Feng CG, 2001, INT IMMUNOL, V13, P451, DOI 10.1093/intimm/13.4.451; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; Hervas-Stubbs S, 2006, INFECT IMMUN, V74, P3396, DOI 10.1128/IAI.02086-05; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Johansen P, 2004, EUR J IMMUNOL, V34, P91, DOI 10.1002/eji.200324231; Kristensen NN, 2002, J GEN VIROL, V83, P2123, DOI 10.1099/0022-1317-83-9-2123; Majlessi L, 2003, INFECT IMMUN, V71, P7173, DOI 10.1128/IAI.71.12.7173-7177.2003; McShane H, 2005, TUBERCULOSIS, V85, P47, DOI 10.1016/j.tube.2004.09.015; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; McShane H, 2001, INFECT IMMUN, V69, P681, DOI 10.1128/IAI.69.2.681-686.2001; MULLER I, 1987, INFECT IMMUN, V55, P2037; Novy P, 2007, J IMMUNOL, V179, P8243, DOI 10.4049/jimmunol.179.12.8243; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Santosuosso M, 2007, J IMMUNOL, V178, P2387, DOI 10.4049/jimmunol.178.4.2387; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; Sauzet JP, 1996, INT IMMUNOL, V8, P457, DOI 10.1093/intimm/8.4.457; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Skjot RLV, 2002, INFECT IMMUN, V70, P5446, DOI 10.1128/IAI.70.10.5446-5453.2002; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; Tascon RE, 1998, INFECT IMMUN, V66, P830, DOI 10.1128/IAI.66.2.830-834.1998; Thomsen AR, 1996, J IMMUNOL, V157, P3074; Turner J, 2001, AM J RESP CELL MOL, V24, P203, DOI 10.1165/ajrcmb.24.2.4370; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Wu Y, 2008, INFECT IMMUN, V76, P2249, DOI 10.1128/IAI.00024-08	41	56	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5139	10.1371/journal.pone.0005139	http://dx.doi.org/10.1371/journal.pone.0005139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357780	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505900009
J	de Mello, WA; de Paiva, TM; Ishida, MA; Benega, MA; dos Santos, MC; Viboud, C; Miller, MA; Alonso, WJ				de Mello, Wyller Alencar; de Paiva, Terezinha Maria; Ishida, Maria Akiko; Benega, Margarete Aparecida; dos Santos, Mirleide Cordeiro; Viboud, Cecile; Miller, Mark A.; Alonso, Wladimir J.			The Dilemma of Influenza Vaccine Recommendations when Applied to the Tropics: The Brazilian Case Examined Under Alternative Scenarios	PLOS ONE			English	Article								Since 1999 the World Health Organization issues annually an additional influenza vaccine composition recommendation. This initiative aimed to extend to the Southern Hemisphere (SH) the benefits-previously enjoyed only by the Northern Hemisphere (NH)-of a vaccine recommendation issued as close as possible to the moment just before the onset of the influenza epidemic season. A short time between the issue of the recommendation and vaccine delivery is needed to maximize the chances of correct matching between putative circulating strains and one of the three strains present in the vaccine composition. Here we compare the effectiveness of the SH influenza vaccination adopted in Brazil with hypothetical alternative scenarios defined by different timings of vaccine delivery and/or composition. Scores were based on the temporal overlap between vaccine-induced protection and circulating strains. Viral data were obtained between 1999 and 2007 from constant surveillance and strain characterization in two Brazilian cities: Belem, located at the Equatorial region, and Sao Paulo, at the limit between the tropical and subtropical regions. Our results show that, among currently feasible options, the best strategy for Brazil would be to adopt the NH composition and timing, as in such case protection would increase from 30% to 65% (p<.01) if past data can be used as a prediction of the future. The influenza season starts in Brazil (and in the equator virtually ends) well before the SH winter, making the current delivery of the SH vaccination in April too late to be effective. Since Brazil encompasses a large area of the Southern Hemisphere, our results point to the possibility of these conclusions being similarly valid for other tropical regions.			de Mello, WA (corresponding author), Brazilian Minist Hlth, Secretary Surveillance Hlth, WHO Global Influenza Surveillance Network, IEC, Ananindeua, Para, Brazil.	alonsow@mail.nih.gov	Alonso, Wladimir J./N-9223-2017	Alonso, Wladimir J./0000-0001-7038-0801				Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Antunes JLF, 2007, INT J EPIDEMIOL, V36, P1319, DOI 10.1093/ije/dym208; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; CHAKRAVERTY P, 1986, J HYG-CAMBRIDGE, V97, P347, DOI 10.1017/S0022172400065438; CUNHA SS, 2005, REV SAUDE PUBL, V39, P129; Fedson DS, 2008, BIOLOGICALS, V36, P346, DOI 10.1016/j.biologicals.2008.07.001; Fisher NI, 1996, STAT ANAL CIRCULAR D; Forleo-Neto Eduardo, 2003, Rev. Soc. Bras. Med. Trop., V36, P267, DOI 10.1590/S0037-86822003000200011; Francisco PMSB, 2005, REV SAUDE PUBL, V39, P75, DOI 10.1590/S0034-89102005000100010; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Gross PA, 1997, CLIN DIAGN LAB IMMUN, V4, P491, DOI 10.1128/CDLI.4.4.491-492.1997; Hampson AW, 2008, ANN ACAD MED SINGAP, V37, P510; *INMET, 2008, CLIM GRAPH; Jones TA, 2006, COMPUT GEOSCI-UK, V32, P166, DOI 10.1016/j.cageo.2005.06.009; Kitler ME, 2002, VACCINE, V20, pS5, DOI 10.1016/S0264-410X(02)00121-4; MELLO WA, 2007, VIROLOGIC SURVEILLAN; MOURA FE, 2007, INFLUENZA INFECT NE; RAMBAUT A, 2008, NATURE; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Straliotto Selir M., 2002, Rev. Soc. Bras. Med. Trop., V35, P283, DOI 10.1590/S0037-86822002000400002; *SVS MS, 2005, BRAZ PREP PLAN CONFR; Tsuchiya LRRV, 2005, J INFECTION, V51, P401, DOI 10.1016/j.jinf.2004.12.002; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; *WHO, 2008, REC INFL VACC COMP; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121	26	54	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5095	10.1371/journal.pone.0005095	http://dx.doi.org/10.1371/journal.pone.0005095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352506	gold, Green Published			2022-12-27	WOS:000265505700009
J	Marrone, A; Ballantyne, J				Marrone, April; Ballantyne, Jack			Changes in Dry State Hemoglobin over Time Do Not Increase the Potential for Oxidative DNA Damage in Dried Blood	PLOS ONE			English	Article								Background: Hemoglobin (Hb) is the iron-containing oxygen transport protein present in the red blood cells of vertebrates. Ancient DNA and forensic scientists are particularly interested in Hb reactions in the dry state because both regularly encounter aged, dried bloodstains. The DNA in such stains may be oxidatively damaged and, in theory, may be deteriorated by the presence of Hb. To understand the nature of the oxidative systems potentially available to degrade DNA in the presence of dried Hb, we need to determine what molecular species Hb forms over time. These species will determine what type of iron (i.e. Fe2+/Fe3+/Fe4+) is available to participate in further chemical reactions. The availability of "free'' iron will affect the ability of the system to undergo Fenton-type reactions which generate the highly reactive hydroxyl radical (OH center dot). The OH center dot can directly damage DNA. Methodology/Principal Findings: Oxygenated Hb (oxyHb) converts over time to oxidized Hb (metHb), but this happens more quickly in the dry state than in the hydrated state, as shown by monitoring stabilized oxyHb. In addition, dry state oxyHb converts into at least one other unknown species other than metHb. Although "free'' iron was detectable as both Fe2+ and Fe3+ in dry and hydrated oxyHb and metHb, the amount of ions detected did not increase over time. There was no evidence that Hb becomes more prone to generating OH center dot as it ages in either the hydrated or dry states. Conclusions: The Hb molecule in the dried state undergoes oxidative changes and releases reactive Fe(II) cations. These changes, however, do not appear to increase the ability of Hb to act as a more aggressive Fenton reagent over time. Nevertheless, the presence of Hb in the vicinity of DNA in dried bloodstains creates the opportunity for OH center dot-induced oxidative damage to the deoxyribose sugar and the DNA nucleobases.			Marrone, A (corresponding author), Univ Cent Florida, Dept Chem, Grad Program Chem, Orlando, FL 32816 USA.	jballant@mail.ucf.edu						BUCKNALL T, 1978, CARBOHYD RES, V62, P49, DOI 10.1016/S0008-6215(00)83377-7; CARTER P, 1971, ANAL BIOCHEM, V40, P450, DOI 10.1016/0003-2697(71)90405-2; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; FATTORINI P, 2004, INT C SERIES PROGR F, P559; FLITTER W, 1983, FEBS LETT, V158, P310, DOI 10.1016/0014-5793(83)80602-4; FRENCH JK, 1978, BIOCHEM J, V173, P19, DOI 10.1042/bj1730019; Fujita N, 2007, FREE RADICAL BIO MED, V42, P353, DOI 10.1016/j.freeradbiomed.2006.11.001; GOLDSTEIN S, 1993, FREE RADICAL BIO MED, V15, P435, DOI 10.1016/0891-5849(93)90043-T; Goswami T, 2002, BIOCHEM CELL BIOL, V80, P679, DOI 10.1139/O02-159; Grootveld M, 1986, Free Radic Res Commun, V1, P243, DOI 10.3109/10715768609051634; Guclu K, 2005, TALANTA, V65, P1226, DOI 10.1016/j.talanta.2004.08.048; Gutteridge J M, 1986, Free Radic Res Commun, V1, P173, DOI 10.3109/10715768609083149; GUTTERIDGE JMC, 1978, ANAL BIOCHEM, V91, P250, DOI 10.1016/0003-2697(78)90838-2; GUTTERIDGE JMC, 1984, FEBS LETT, V172, P245, DOI 10.1016/0014-5793(84)81134-5; GUTTERIDGE JMC, 1984, BIOCHEM J, V224, P761, DOI 10.1042/bj2240761; GUTTERIDGE JMC, 1982, INT J BIOCHEM, V14, P891, DOI 10.1016/0020-711X(82)90071-4; GUTTERIDGE JMC, 1988, BIOCHEM J, V253, P932, DOI 10.1042/bj2530932; GUTTERIDGE JMC, 1984, BIOCHEM J, V224, P697, DOI 10.1042/bj2240697; GUTTERIDGE JMC, 1986, FEBS LETT, V201, P291, DOI 10.1016/0014-5793(86)80626-3; GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P263, DOI 10.1042/bj1990263; GUTTERIDGE JMC, 1981, FEBS LETT, V128, P343, DOI 10.1016/0014-5793(81)80113-5; GUTTERIDGE JMC, 1987, BIOCHEM J, V243, P709, DOI 10.1042/bj2430709; GUTTERIDGE JMC, 1986, BIOCHEM J, V234, P225, DOI 10.1042/bj2340225; GUTTERIDGE JMC, 1990, BIOCHEM J, V269, P169, DOI 10.1042/bj2690169; GUTTERIDGE JMC, 1985, FEBS LETT, V185, P19, DOI 10.1016/0014-5793(85)80732-8; HALLIWELL B, 1978, FEBS LETT, V92, P321, DOI 10.1016/0014-5793(78)80779-0; HALLIWELL B, 1981, FEBS LETT, V128, P347, DOI 10.1016/0014-5793(81)80114-7; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; MOORHOUSE CP, 1985, BIOCHIM BIOPHYS ACTA, V843, P261, DOI 10.1016/0304-4165(85)90147-3; NAIR V, 1984, LIPIDS, V19, P804, DOI 10.1007/BF02534475; OCONNELL M, 1986, BIOCHEM J, V234, P727, DOI 10.1042/bj2340727; ONORI N, 2006, INTERNALTION C SERIE, P510; PUPPO A, 1988, BIOCHEM J, V249, P185, DOI 10.1042/bj2490185; RACHMILEWITZ EA, 1971, J BIOL CHEM, V246, P3356; Riggs A., 1981, Methods in Enzymology, V76, P5; Sozgen K, 2006, TALANTA, V68, P1601, DOI 10.1016/j.talanta.2005.08.043; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; WHITBURN KD, 1982, J BIOL CHEM, V257, P1860; WINTERBOURN CC, 1976, BIOCHEM J, V155, P493, DOI 10.1042/bj1550493; WINTERBOURN CC, 1990, METHOD ENZYMOL, V186, P265	41	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5110	10.1371/journal.pone.0005110	http://dx.doi.org/10.1371/journal.pone.0005110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352435	Green Submitted, Green Published, gold			2022-12-27	WOS:000265505700014
J	Kajiwara, Y; Akram, A; Katsel, P; Haroutunian, V; Schmeidler, J; Beecham, G; Haines, JL; Pericak-Vance, MA; Buxbaum, JD				Kajiwara, Yuji; Akram, Afia; Katsel, Pavel; Haroutunian, Vahram; Schmeidler, James; Beecham, Gary; Haines, Jonathan L.; Pericak-Vance, Margaret A.; Buxbaum, Joseph D.			FE65 Binds Teashirt, Inhibiting Expression of the Primate-Specific Caspase-4	PLOS ONE			English	Article								The Alzheimer disease (AD) amyloid protein precursor (APP) can bind the FE65 adaptor protein and this complex can regulate gene expression. We carried out yeast two-hybrid studies with a PTB domain of FE65, focusing on those genes that might be involved in nuclear signaling, and identified and validated Teashirt proteins as FE65 interacting proteins in neurons. Using reporter systems, we observed that FE65 could simultaneously recruit SET, a component of the inhibitor of acetyl transferase, and Teashirt, which in turn recruited histone deacetylases, to produce a powerful gene-silencing complex. We screened stable cell lines with a macroarray focusing on AD-related genes and identified CASP4, encoding caspase-4, as a target of this silencing complex. Chromatin immunoprecipitation showed a direct interaction of FE65 and Teashirt3 with the promoter region of CASP4. Expression studies in postmortem samples demonstrated decreasing expression of Teashirt and increasing expression of caspase-4 with progressive cognitive decline. Importantly, there were significant increases in caspase-4 expression associated with even the earliest neuritic plaque changes in AD. We evaluated a case-control cohort and observed evidence for a genetic association between the Teashirt genes TSHZ1 and TSHZ3 and AD, with the TSHZ3 SNP genotype correlating with expression of Teashirt3. The results were consistent with a model in which reduced expression of Teashirt3, mediated by genetic or other causes, increases caspase-4 expression, leading to progression of AD. Thus the cell biological, gene expression and genetic data support a role for Teashirt/caspase-4 in AD biology. As caspase-4 shows evidence of being a primate-specific gene, current models of AD and other neurodegenerative conditions may be incomplete because of the absence of this gene in the murine genome.	[Kajiwara, Yuji; Akram, Afia; Buxbaum, Joseph D.] Mt Sinai Sch Med, Lab Mol Neuropsychiat, New York, NY USA; [Kajiwara, Yuji; Akram, Afia; Katsel, Pavel; Haroutunian, Vahram; Schmeidler, James; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Kajiwara, Yuji; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Beecham, Gary; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, Miami Inst Human Genom, Miami, FL USA; [Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Miami; Vanderbilt University	Kajiwara, Y (corresponding author), Mt Sinai Sch Med, Lab Mol Neuropsychiat, New York, NY USA.	joseph.buxbaum@mssm.edu	Haines, Jonathan/C-3374-2012; Buxbaum, Joseph D/G-6001-2010	Haines, Jonathan/0000-0002-4351-4728; Buxbaum, Joseph/0000-0001-8898-8313; kajiwara, yuji/0000-0002-9307-8215	National Institute of Health [AG021792, AG005138, AG010491, AG002219]; G. Harold and Leila Y. Mathers Research Professor of Geriatrics and Adult Development; NIH-NCI [CA095823]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002219, P01AG010491, R01AG021792, P50AG005138] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Research Professor of Geriatrics and Adult Development; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Health Grants AG021792 (JDB, PI), AG005138 (Dr. M. Sano, PI; JDB, PL), AG010491 (Dr. S. E. Gandy, PI; JDB, PL), and AG002219 (VH, PI; JDB, PL). Dr. Buxbaum is the G. Harold and Leila Y. Mathers Research Professor of Geriatrics and Adult Development. The MS-MSRF was supported by an NIH-NCI shared resources grant (CA095823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre E, 1996, MECH DEVELOP, V59, P191, DOI 10.1016/0925-4773(96)00594-1; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Bruni P, 2002, J BIOL CHEM, V277, P35481, DOI 10.1074/jbc.M205227200; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Caubit X, 2005, J COMP NEUROL, V486, P76, DOI 10.1002/cne.20500; Caubit X, 2000, MECH DEVELOP, V91, P445, DOI 10.1016/S0925-4773(99)00318-4; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; Dokmanovic M, 2005, J CELL BIOCHEM, V96, P293, DOI 10.1002/jcb.20532; Dracheva S, 2005, J NEUROSCI RES, V79, P868, DOI 10.1002/jnr.20423; Dracheva S, 2004, J NEUROSCI RES, V76, P581, DOI 10.1002/jnr.20122; Dracheva S, 2003, J NEUROCHEM, V87, P1402, DOI 10.1046/j.1471-4159.2003.02115.x; Dracheva S, 2001, AM J PSYCHIAT, V158, P1400, DOI 10.1176/appi.ajp.158.9.1400; DUILIO A, 1991, NUCLEIC ACIDS RES, V19, P5269, DOI 10.1093/nar/19.19.5269; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; Friedlander RM, 1997, NATURE, V388, P31, DOI 10.1038/40299; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Furuya T, 2004, J NEUROSCI, V24, P1865, DOI 10.1523/JNEUROSCI.3309-03.2004; Gallet A, 1998, CURR BIOL, V8, P893, DOI 10.1016/S0960-9822(07)00369-7; Gallet A, 2000, DEVELOPMENT, V127, P5509; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Haroutunian V, 1998, ARCH NEUROL-CHICAGO, V55, P1185, DOI 10.1001/archneur.55.9.1185; HAROUTUNIAN V, 2007, NEUROBIOL AGING; Hass MR, 2005, J BIOL CHEM, V280, P36895, DOI 10.1074/jbc.M502861200; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kang SJ, 2003, J NEUROSCI, V23, P5455; Kordower JH, 2001, ANN NEUROL, V49, P202, DOI 10.1002/1531-8249(20010201)49:2<202::AID-ANA40>3.3.CO;2-V; Lee HJ, 2001, J BIOL CHEM, V276, P16597, DOI 10.1074/jbc.C000909200; LIN JZ, 2000, INT J NONLINEAR SCI, V1, P275; Manfroid I, 2004, DEVELOPMENT, V131, P1065, DOI 10.1242/dev.00977; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; PALMERT MR, 1988, SCIENCE, V241, P1080, DOI 10.1126/science.2457949; Pompl PN, 2003, ARCH NEUROL-CHICAGO, V60, P369, DOI 10.1001/archneur.60.3.369; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; REINHARD C, 2005, EMBO J; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Taghli-Lamallem O, 2007, DEV BIOL, V307, P142, DOI 10.1016/j.ydbio.2007.04.028; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Waltzer L, 2001, EMBO J, V20, P137, DOI 10.1093/emboj/20.1.137; WANG LY, 1996, J POLYM RES, V3, P1; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Yang Z, 2006, J BIOL CHEM, V281, P4207, DOI 10.1074/jbc.M508445200; Zambrano N, 1998, J BIOL CHEM, V273, P20128, DOI 10.1074/jbc.273.32.20128; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399	55	30	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5071	10.1371/journal.pone.0005071	http://dx.doi.org/10.1371/journal.pone.0005071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343227	Green Published, gold			2022-12-27	WOS:000265500800008
J	Singh, U; Bongcam-Rudloff, E; Westermark, B				Singh, Umashankar; Bongcam-Rudloff, Erik; Westermark, Bengt			A DNA Sequence Directed Mutual Transcription Regulation of HSF1 and NFIX Involves Novel Heat Sensitive Protein Interactions	PLOS ONE			English	Article							NUCLEAR-FACTOR-I; BINDING DOMAIN; SACCHAROMYCES-CEREVISIAE; BRAIN-DEVELOPMENT; GENE-EXPRESSION; MICROARRAY DATA; MESSENGER-RNA; SHOCK FACTOR; REPLICATION; IDENTIFICATION	Background: Though the Nuclear factor 1 family member NFIX has been strongly implicated in PDGFB-induced glioblastoma, its molecular mechanisms of action remain unknown. HSF1, a heat shock-related transcription factor is also a powerful modifier of carcinogenesis by several factors, including PDGFB. How HSF1 transcription is controlled has remained largely elusive. Methodology/Principal Findings: By combining microarray expression profiling and a yeast-two-hybrid screen, we identified that NFIX and its interactions with CGGBP1 and HMGN1 regulate expression of HSF1. We found that CGGBP1 organizes a bifunctional transcriptional complex at small CGG repeats in the HSF1 promoter. Under chronic heat shock, NFIX uses CGGBP1 and HMGN1 to get recruited to this promoter and in turn affects their binding to DNA. Results show that the interactions of NFIX with CGGBP1 and HMGN1 in the soluble fraction are heat shock sensitive due to preferential localization of CGGBP1 to heterochromatin after heat shock. HSF1 in turn was found to bind to the NFIX promoter and repress its expression in a heat shock sensitive manner. Conclusions/Significance: NFIX and HSF1 exert a mutual transcriptional repressive effect on each other which requires CGG repeat in HSF1 promoter and HSF1 binding site in NFIX promoter. We unravel a unique mechanism of heat shock sensitive DNA sequence-directed reciprocal transcriptional regulation between NFIX and HSF1. Our findings provide new insights into mechanisms of transcription regulation under stress.	[Singh, Umashankar; Westermark, Bengt] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; [Bongcam-Rudloff, Erik] Uppsala Univ, Linnaeus Ctr Bioinformat, Uppsala, Sweden	Uppsala University; Uppsala University	Singh, U (corresponding author), Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden.	umashankar.singh@genpat.uu.se; bengt.westermark@genpat.uu.se	Singh, Umashankar/ABE-3830-2020	Singh, Umashankar/0000-0001-8578-8201	Emil Ragna-Borjessons Minnesfond [postdoctoral fellowships]; Cancerfonden [UFV-PA 2008/2876, 070129]; Barncancerfonden [05/028]; Vetenskapradet [K2008-66X-20759-01-3, 521-2007-2033]	Emil Ragna-Borjessons Minnesfond; Cancerfonden(Swedish Cancer Society); Barncancerfonden; Vetenskapradet	Umashankar Singh was supported by postdoctoral fellowships from Emil Ragna-Borjessons Minnesfond and Cancerfonden (UFV-PA 2008/2876). This work was funded by grants to Bengt Westermark from Barncancerfonden (05/028), Cancerfonden (070129) and Vetenskapradet (K2008-66X-20759-01-3 and 521-2007-2033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevizopoulos A, 1995, GENE DEV, V9, P3051, DOI 10.1101/gad.9.24.3051; Belova GI, 2008, J BIOL CHEM, V283, P8080, DOI 10.1074/jbc.M709782200; Blomquist P, 1996, J BIOL CHEM, V271, P153, DOI 10.1074/jbc.271.1.153; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; Chaudhry AZ, 1999, J BIOL CHEM, V274, P7072, DOI 10.1074/jbc.274.11.7072; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; Clouaire T, 2008, CELL MOL LIFE SCI, V65, P1509, DOI 10.1007/s00018-008-7324-y; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Deissler H, 1997, J BIOL CHEM, V272, P16761, DOI 10.1074/jbc.272.27.16761; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Fletcher CF, 1999, MAMM GENOME, V10, P390, DOI 10.1007/s003359901008; Fujimura K, 2008, EXP CELL RES, V314, P543, DOI 10.1016/j.yexcr.2007.10.024; Gopalan SM, 2006, J BIOL CHEM, V281, P13126, DOI 10.1074/jbc.M601194200; Gottardo R, 2003, BIOSTATISTICS, V4, P597, DOI 10.1093/biostatistics/4.4.597; GOUNARI F, 1990, EMBO J, V9, P559, DOI 10.1002/j.1460-2075.1990.tb08143.x; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; HENNIGHAUSEN L, 1985, NATURE, V314, P289, DOI 10.1038/314289a0; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; LEEGWATER PAJ, 1985, EMBO J, V4, P1515, DOI 10.1002/j.1460-2075.1985.tb03811.x; Lonnstedt I, 2002, STAT SINICA, V12, P31; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Naumann F, 2004, GENOMICS, V83, P106, DOI 10.1016/S0888-7543(03)00212-X; NOWOCK J, 1985, NUCLEIC ACIDS RES, V13, P2045, DOI 10.1093/nar/13.6.2045; Ouellet S, 2006, NUCLEIC ACIDS RES, V34, P6472, DOI 10.1093/nar/gkl861; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SCHUUR ER, 1995, CELL GROWTH DIFFER, V6, P219; Shi Y, 2007, MOL CELL, V28, P79, DOI 10.1016/j.molcel.2007.08.028; Shu TZ, 2003, J NEUROSCI, V23, P203; SLATER MR, 1987, MOL CELL BIOL, V7, P1906, DOI 10.1128/MCB.7.5.1906; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; TAMAI KT, 1994, MOL CELL BIOL, V14, P8155, DOI 10.1128/MCB.14.12.8155; Wendler WMF, 1997, J BIOL CHEM, V272, P8482, DOI 10.1074/jbc.272.13.8482; West KL, 2004, BIOCHEM SOC T, V32, P918, DOI 10.1042/BST0320918; WESTERMARK B, 1995, GLIA, V15, P257, DOI 10.1002/glia.440150307; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Yamamoto A, 2006, BIOCHEM BIOPH RES CO, V346, P1324, DOI 10.1016/j.bbrc.2006.06.057	46	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5050	10.1371/journal.pone.0005050	http://dx.doi.org/10.1371/journal.pone.0005050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337383	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500600014
J	Sandhya, S; Rani, SS; Pankaj, B; Govind, MK; Offmann, B; Srinivasan, N; Sowdhamini, R				Sandhya, Sankaran; Rani, Saane Sudha; Pankaj, Barah; Govind, Madabosse Kande; Offmann, Bernard; Srinivasan, Narayanaswamy; Sowdhamini, Ramanathan			Length Variations amongst Protein Domain Superfamilies and Consequences on Structure and Function	PLOS ONE			English	Article								Background: Related protein domains of a superfamily can be specified by proteins of diverse lengths. The structural and functional implications of indels in a domain scaffold have been examined. Methodology: In this study, domain superfamilies with large length variations (more than 30% difference from average domain size, referred as 'length-deviant' superfamilies and 'length-rigid' domain superfamilies (<10% length difference from average domain size) were analyzed for the functional impact of such structural differences. Our delineated dataset, derived from an objective algorithm, enables us to address indel roles in the presence of peculiar structural repeats, functional variation, protein-protein interactions and to examine 'domain contexts' of proteins tolerant to large length variations. Amongst the top-10 length-deviant superfamilies analyzed, we found that 80% of length-deviant superfamilies possess distant internal structural repeats and nearly half of them acquired diverse biological functions. In general, length-deviant superfamilies have higher chance, than length-rigid superfamilies, to be engaged in internal structural repeats. We also found that similar to 40% of length-deviant domains exist as multi-domain proteins involving interactions with domains from the same or other superfamilies. Indels, in diverse domain superfamilies, were found to participate in the accretion of structural and functional features amongst related domains. With specific examples, we discuss how indels are involved directly or indirectly in the generation of oligomerization interfaces, introduction of substrate specificity, regulation of protein function and stability. Conclusions: Our data suggests a multitude of roles for indels that are specialized for domain members of different domain superfamilies. These specialist roles that we observe and trends in the extent of length variation could influence decision making in modeling of new superfamily members. Likewise, the observed limits of length variation, specific for each domain superfamily would be particularly relevant in the choice of alignment length search filters commonly applied in protein sequence analysis.	[Sandhya, Sankaran; Rani, Saane Sudha; Pankaj, Barah; Govind, Madabosse Kande; Sowdhamini, Ramanathan] Natl Ctr Biol Sci TIFR, Bangalore, Karnataka, India; [Offmann, Bernard] Univ La Reunion, Lab Biochim Genet Mol, BP 7151, La Reunion, France; [Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of La Reunion; Indian Institute of Science (IISC) - Bangalore	Sandhya, S (corresponding author), Natl Ctr Biol Sci TIFR, GKVK Campus, Bangalore, Karnataka, India.	mini@ncbs.res.in	OFFMANN, Bernard/B-5901-2011	OFFMANN, Bernard/0000-0002-6845-5883; Sandhya, Sankaran/0000-0003-0055-302X; Barah, Pankaj/0000-0001-7039-7996	Department of Biotechnology, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	R.S. was an International Senior Research Fellow of the Wellcome Trust, U.K.. S.S. thanks the Council of Scientific and Industrial Research, India for Ph.D research fellowship. We gratefully acknowledge NCBS-TIFR for infrastructural support. N.S. would like to thank Department of Biotechnology, India for financial support. We thank Profs. Saraswathi Vishweshwara and M.K. Mathew for useful discussions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apic G, 2001, Bioinformatics, V17 Suppl 1, pS83; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2247, DOI 10.1093/nar/19.suppl.2247; Benini S, 2000, BIOCHEMISTRY-US, V39, P13115, DOI 10.1021/bi000402j; Benson SD, 2002, ACTA CRYSTALLOGR D, V58, P39, DOI 10.1107/S0907444901017279; Benson SD, 1999, CELL, V98, P825, DOI 10.1016/S0092-8674(00)81516-0; Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734; Bhaduri A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-35; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Cunane LM, 2000, J MOL BIOL, V295, P357, DOI 10.1006/jmbi.1999.3290; Ekman D, 2007, J MOL BIOL, V372, P1337, DOI 10.1016/j.jmb.2007.06.022; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041; Gough J, 2002, ACTA CRYSTALLOGR D, V58, P1897, DOI 10.1107/S0907444902015160; Heringa J, 1998, CURR OPIN STRUC BIOL, V8, P338, DOI 10.1016/S0959-440X(98)80068-7; Heringa J, 1997, CURR OPIN STRUC BIOL, V7, P416, DOI 10.1016/S0959-440X(97)80060-7; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HUTCHINSON EG, 1990, PROTEINS, V8, P203, DOI 10.1002/prot.340080303; Jiang H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-444; KLEYWEGT GJ, 1994, CCP4 ESF EACBM NEWSL, V31, P9; Leiros I, 2000, STRUCTURE, V8, P655, DOI 10.1016/S0969-2126(00)00150-7; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; PASCARELLA S, 1992, J MOL BIOL, V224, P461, DOI 10.1016/0022-2836(92)91008-D; Pearl F, 2005, NUCLEIC ACIDS RES, V33, pD247, DOI 10.1093/nar/gki024; Quiocho FA, 2000, CURR OPIN STRUC BIOL, V10, P78, DOI 10.1016/S0959-440X(99)00053-6; Redfern OC, 2008, CURR OPIN STRUC BIOL, V18, P394, DOI 10.1016/j.sbi.2008.05.007; Reeves GA, 2006, J MOL BIOL, V360, P725, DOI 10.1016/j.jmb.2006.05.035; RUSSELL RB, 1994, J MOL BIOL, V244, P332, DOI 10.1006/jmbi.1994.1733; Rux JJ, 2003, J VIROL, V77, P9553, DOI 10.1128/JVI.77.17.9553-9566.2003; SALI A, 1990, J MOL BIOL, V212, P403, DOI 10.1016/0022-2836(90)90134-8; Sandhya S, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-28; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911; Than ME, 1997, J MOL BIOL, V271, P629, DOI 10.1006/jmbi.1997.1181; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; van Asselt EJ, 1999, STRUCT FOLD DES, V7, P1167, DOI 10.1016/S0969-2126(00)80051-9; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wolf Y, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-19; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	44	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4981	10.1371/journal.pone.0004981	http://dx.doi.org/10.1371/journal.pone.0004981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333395	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499900008
J	Liu, S; Ji, K; Chen, JM; Tai, D; Jiang, WM; Hou, GY; Chen, J; Li, JP; Huang, BX				Liu, Shuo; Ji, Kang; Chen, Jiming; Tai, Di; Jiang, Wenming; Hou, Guangyu; Chen, Jie; Li, Jinping; Huang, Baoxu			Panorama Phylogenetic Diversity and Distribution of Type A Influenza Virus	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; HEMAGGLUTININ GENE; SOUTHERN CHINA; H1N2 VIRUS; SWINE; PIGS; EVOLUTION; EMERGENCE; TRANSMISSION; H2	Background: Type A influenza virus is one of important pathogens of various animals, including humans, pigs, horses, marine mammals and birds. Currently, the viral type has been classified into 16 hemagglutinin and 9 neuraminidase subtypes, but the phylogenetic diversity and distribution within the viral type largely remain unclear from the whole view. Methodology/Principal Findings: The panorama phylogenetic trees of influenza A viruses were calculated with representative sequences selected from approximately 23000 candidates available in GenBank using web servers in NCBI and the software MEGA 4.0. Lineages and sublineages were classified according to genetic distances, topology of the phylogenetic trees and distributions of the viruses in hosts, regions and time. Conclusions/Significance: Here, two panorama phylogenetic trees of type A influenza virus covering all the 16 hemagglutinin subtypes and 9 neuraminidase subtypes, respectively, were generated. The trees provided us whole views and some novel information to recognize influenza A viruses including that some subtypes of avian influenza viruses are more complicated than Eurasian and North American lineages as we thought in the past. They also provide us a framework to generalize the history and explore the future of the viral circulation and evolution in different kinds of hosts. In addition, a simple and comprehensive nomenclature system for the dozens of lineages and sublineages identified within the viral type was proposed, which if universally accepted, will facilitate communications on the viral evolution, ecology and epidemiology.	[Liu, Shuo; Ji, Kang; Chen, Jiming; Tai, Di; Jiang, Wenming; Hou, Guangyu; Chen, Jie; Li, Jinping; Huang, Baoxu] China Anim Hlth & Epidemiol Ctr, Lab Anim Epidemiol Surveillance, Qingdao, Peoples R China; [Ji, Kang; Tai, Di] Univ NE China, Coll Vet Sci, Harbin, Peoples R China	China Animal Health & Epidemiology Center	Liu, S (corresponding author), China Anim Hlth & Epidemiol Ctr, Lab Anim Epidemiol Surveillance, Qingdao, Peoples R China.	jmchen66@yahoo.cn	Chen, Jiming/AAA-3575-2020; Chen, Ji-Ming/AHD-7398-2022	Chen, Jiming/0000-0003-3155-3145; Chen, Jiming/0000-0002-0404-0830	Avian Influenza Surveillance Program of the Ministry of Agriculture of P. R. China	Avian Influenza Surveillance Program of the Ministry of Agriculture of P. R. China	This work was partially supported by the Avian Influenza Surveillance Program of the Ministry of Agriculture of P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks J, 1998, ARCH VIROL, V143, P781, DOI 10.1007/s007050050329; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Brown IH, 1997, J GEN VIROL, V78, P553, DOI 10.1099/0022-1317-78-3-553; Brown IH, 1998, J GEN VIROL, V79, P2947, DOI 10.1099/0022-1317-79-12-2947; Brown IH, 1997, ARCH VIROL, V142, P1045, DOI 10.1007/s007050050140; CALLAN RJ, 1995, J GEN VIROL, V76, P199, DOI 10.1099/0022-1317-76-1-199; Campitelli L, 1997, VIROLOGY, V232, P310, DOI 10.1006/viro.1997.8514; CHAMBERS TM, 1991, ARCH VIROL, V116, P261, DOI 10.1007/BF01319247; Chen JM, 2007, ARCH VIROL, V152, P415, DOI 10.1007/s00705-006-0852-6; CHENG J, 2007, J UBIQUITOUS COMPUTI, V1, P35, DOI DOI 10.1166/JUCI.2007.004; Choi YK, 2004, EMERG INFECT DIS, V10, P2156, DOI 10.3201/eid1012.040581; Chutinimitkul S, 2008, ARCH VIROL, V153, P1049, DOI 10.1007/s00705-008-0097-7; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Guan Y, 1996, J VIROL, V70, P8041, DOI 10.1128/JVI.70.11.8041-8046.1996; GUO YJ, 1992, VIROLOGY, V188, P245, DOI 10.1016/0042-6822(92)90754-D; Karasin AI, 2004, J CLIN MICROBIOL, V42, P4349, DOI 10.1128/JCM.42.9.4349-4354.2004; KIDA H, 1988, VIROLOGY, V162, P160, DOI 10.1016/0042-6822(88)90405-9; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Macken CA, 2006, J GEN VIROL, V87, P2803, DOI 10.1099/vir.0.81454-0; Makarova NA, 1999, J GEN VIROL, V80, P3167, DOI 10.1099/0022-1317-80-12-3167; Marozin S, 2002, J GEN VIROL, V83, P735, DOI 10.1099/0022-1317-83-4-735; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Muller I, 2005, BIOL RES, V38, P55, DOI 10.4067/S0716-97602005000100008; NAEVE CW, 1983, VIROLOGY, V129, P298, DOI 10.1016/0042-6822(83)90169-1; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Payungporn S, 2008, EMERG INFECT DIS, V14, P902, DOI 10.3201/eid1406.071270; SCHAFER JR, 1993, VIROLOGY, V194, P781, DOI 10.1006/viro.1993.1319; Shin JY, 2006, J CLIN MICROBIOL, V44, P3923, DOI 10.1128/JCM.00904-06; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang Y, 2005, AVIAN DIS, V49, P207, DOI 10.1637/7288-101304R; WAHLGREN J, 2008, VECTOR BORNE ZOONOTI; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO OIE FAO H5N1, 2008, UN NOM SYST HIGHL PA; Widjaja L, 2004, J VIROL, V78, P8771, DOI 10.1128/JVI.78.16.8771-8779.2004; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06; Yu H, 2008, J CLIN MICROBIOL, V46, P1067, DOI 10.1128/JCM.01257-07; Zell R, 2008, J GEN VIROL, V89, P271, DOI 10.1099/vir.0.83338-0	43	84	98	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e5022	10.1371/journal.pone.0005022	http://dx.doi.org/10.1371/journal.pone.0005022			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PO	19325912	Green Published, gold			2022-12-27	WOS:000265499600007
J	Zhang, B; Chang, JF; Fu, M; Huang, J; Kashyap, R; Salavaggione, E; Jain, S; Shashikant, K; Deardorff, MA; Uzielli, MLG; Dorsett, D; Beebe, DC; Jay, PY; Heuckeroth, RO; Krantz, I; Milbrandt, J				Zhang, Bin; Chang, Jufang; Fu, Ming; Huang, Jie; Kashyap, Rakesh; Salavaggione, Ezequiel; Jain, Sanjay; Shashikant, Kulkarni; Deardorff, Matthew A.; Uzielli, Maria L. Giovannucci; Dorsett, Dale; Beebe, David C.; Jay, Patrick Y.; Heuckeroth, Robert O.; Krantz, Ian; Milbrandt, Jeffrey			Dosage Effects of Cohesin Regulatory Factor PDS5 on Mammalian Development: Implications for Cohesinopathies	PLOS ONE			English	Article								Cornelia de Lange syndrome (CdLS), a disorder caused by mutations in cohesion proteins, is characterized by multisystem developmental abnormalities. PDS5, a cohesion protein, is important for proper chromosome segregation in lower organisms and has two homologues in vertebrates (PDS5A and PDS5B). Pds5B mutant mice have developmental abnormalities resembling CdLS; however the role of Pds5A in mammals and the association of PDS5 proteins with CdLS are unknown. To delineate genetic interactions between Pds5A and Pds5B and explore mechanisms underlying phenotypic variability, we generated Pds5A-deficient mice. Curiously, these mice exhibit multiple abnormalities that were previously observed in Pds5B-deficient mice, including cleft palate, skeletal patterning defects, growth retardation, congenital heart defects and delayed migration of enteric neuron precursors. They also frequently display renal agenesis, an abnormality not observed in Pds5B(-/-) mice. While Pds5A(-/-) and Pds5B(-/-) mice die at birth, embryos harboring 3 mutant Pds5 alleles die between E11.5 and E12.5 most likely of heart failure, indicating that total Pds5 gene dosage is critical for normal development. In addition, characterization of these compound homozygous-heterozygous mice revealed a severe abnormality in lens formation that does not occur in either Pds5A(-/-) or Pds5B(-/-) mice. We further identified a functional missense mutation (R1292Q) in the PDS5B DNA-binding domain in a familial case of CdLS, in which affected individuals also develop megacolon. This study shows that PDS5A and PDS5B functions other than those involving chromosomal dynamics are important for normal development, highlights the sensitivity of key developmental processes on PDS5 signaling, and provides mechanistic insights into how PDS5 mutations may lead to CdLS.			Zhang, B (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	jmilbrandt@wustl.edu	Huang, Jie/D-7728-2014	Milbrandt, Jeffrey/0000-0002-5477-7689; Heuckeroth, Robert/0000-0002-3282-1765; Dorsett, Dale/0000-0002-0507-2762; jain, sanjay/0000-0003-2804-127X	NCI NIH HHS [CA111966, R01 CA111966] Funding Source: Medline; NEI NIH HHS [EY04853, R01 EY004853] Funding Source: Medline; NIA NIH HHS [RF1 AG013730, R01 AG013730, AG13730] Funding Source: Medline; NICHD NIH HHS [HD001487, HD047396, K08 HD047396-03, P01 HD052860-040003, P01 HD052860, K08 HD047396-05, K08 HD047396, L40 HD045452, P01 HD052860-030003, L40 HD045452-04, K12 HD001487, K08 HD047396-04] Funding Source: Medline; NIDDK NIH HHS [DK57038, R01 DK057038, DK6459201] Funding Source: Medline; NIGMS NIH HHS [R01 GM055683-08, R01 GM055683, R01 GM055683-09] Funding Source: Medline; NINDS NIH HHS [P30 NS057105] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD052860] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD047396, K12HD001487] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA111966] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY004853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057038, R01DK064592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG013730, R01AG013730] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANGRIST M, 1995, HUM MOL GENET, V4, P821, DOI 10.1093/hmg/4.5.821; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Auricchio A, 1999, AM J HUM GENET, V64, P1216, DOI 10.1086/302329; Benard CY, 2004, DEVELOPMENT, V131, P5947, DOI 10.1242/dev.01433; Broeker PL, 1996, CURR TOP MICROBIOL, V211, P259; Chen F, 2002, J BIOL CHEM, V277, P16775, DOI 10.1074/jbc.M201322200; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Dorsett D, 2005, DEVELOPMENT, V132, P4743, DOI 10.1242/dev.02064; Dorsett D, 1999, CURR OPIN GENET DEV, V9, P505, DOI 10.1016/S0959-437X(99)00002-7; DORSETT D, 2006, CHROMOSOMA; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Gause M, 2008, BIOESSAYS, V30, P715, DOI 10.1002/bies.20787; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Honaramooz A, 2002, NATURE, V418, P778, DOI 10.1038/nature00918; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Horsfield JA, 2007, DEVELOPMENT, V134, P2639, DOI 10.1242/dev.002485; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Hutson MR, 2007, SEMIN CELL DEV BIOL, V18, P101, DOI 10.1016/j.semcdb.2006.12.004; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; JACKSON L, 1993, AM J MED GENET, V47, P940, DOI 10.1002/ajmg.1320470703; Jain S, 2004, DEVELOPMENT, V131, P5503, DOI 10.1242/dev.01421; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Khadake JR, 1997, FEBS LETT, V400, P193, DOI 10.1016/S0014-5793(96)01393-2; Kline AD, 2007, AM J MED GENET C, V145C, P248, DOI 10.1002/ajmg.c.30137; Kozma C, 1996, AM J MED GENET, V66, P445, DOI 10.1002/(SICI)1096-8628(19961230)66:4<445::AID-AJMG12>3.3.CO;2-S; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Kumar D, 2004, GENE, V328, P187, DOI 10.1016/j.gene.2003.12.013; Lalatta F, 2007, GENET MED, V9, P188, DOI 10.1097/GIM.0b013e31803183dd; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; Maher JF, 1996, P NATL ACAD SCI USA, V93, P6716, DOI 10.1073/pnas.93.13.6716; Mehta AV, 1997, AM J MED GENET, V71, P434, DOI 10.1002/(SICI)1096-8628(19970905)71:4<434::AID-AJMG12>3.0.CO;2-H; Metcalf CE, 2006, J BIOL CHEM, V281, P30015, DOI 10.1074/jbc.M606289200; MISULOVIN Z, 2007, CHROMOSOMA; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; PTACEK LJ, 1963, J PEDIATR-US, V63, P1000, DOI 10.1016/S0022-3476(63)80234-6; Ritchie K, 2008, J CELL BIOL, V180, P315, DOI 10.1083/jcb.200706083; ROBINSON LK, 1985, AM J MED GENET, V22, P109, DOI 10.1002/ajmg.1320220112; Russell KL, 2001, AM J MED GENET, V104, P267, DOI 10.1002/ajmg.10066; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Schule B, 2005, AM J HUM GENET, V77, P1117, DOI 10.1086/498695; Seitan VC, 2006, PLOS BIOL, V4, P1411, DOI 10.1371/journal.pbio.0040242; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; Wang F, 2003, MOL CELL BIOL, V23, P7698, DOI 10.1128/MCB.23.21.7698-7707.2003; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884	59	65	66	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5232	10.1371/journal.pone.0005232	http://dx.doi.org/10.1371/journal.pone.0005232			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412548	Green Published, Green Submitted, gold			2022-12-27	WOS:000265688200001
J	Zhu, WZ; Santana, LF; Laflamme, MA				Zhu, Wei-Zhong; Santana, Luis F.; Laflamme, Michael A.			Local Control of Excitation-Contraction Coupling in Human Embryonic Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							INTRACELLULAR CA2+ OSCILLATIONS; RABBIT VENTRICULAR MYOCYTES; RAT-HEART CELLS; SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE; CARDIAC-CELLS; DEVELOPMENTAL-CHANGES; FUNCTIONAL-PROPERTIES; MUSCLE; CHANNEL	We investigated the mechanisms of excitation-contraction (EC) coupling in human embryonic stem cell-derived cardiomyocytes (hESC-CMs) and fetal ventricular myocytes (hFVMs) using patch-clamp electrophysiology and confocal microscopy. We tested the hypothesis that Ca2+ influx via voltage-gated L-type Ca2+ channels activates Ca2+ release from the sarcoplasmic reticulum (SR) via a local control mechanism in hESC-CMs and hFVMs. Field-stimulated, whole-cell [Ca2+] i transients in hESC-CMs required Ca2+ entry through L-type Ca2+ channels, as evidenced by the elimination of such transients by either removal of extracellular Ca2+ or treatment with diltiazem, an L-type channel inhibitor. Ca2+ release from the SR also contributes to the [Ca2+] i transient in these cells, as evidenced by studies with drugs interfering with either SR Ca2+ release (i. e. ryanodine and caffeine) or reuptake (i. e. thapsigargin and cyclopiazonic acid). As in adult ventricular myocytes, membrane depolarization evoked large L-type Ca2+ currents (ICa) and corresponding whole-cell [Ca2+] i transients in hESCCMs and hFVMs, and the amplitude of both ICa and the [Ca2+] i transients were finely graded by the magnitude of the depolarization. hESC-CMs exhibit a decreasing EC coupling gain with depolarization to more positive test potentials, "tail'' [Ca2+] i transients upon repolarization from extremely positive test potentials, and co-localized ryanodine and sarcolemmal Ltype Ca2+ channels, all findings that are consistent with the local control hypothesis. Finally, we recorded Ca2+ sparks in hESC-CMs and hFVMs. Collectively, these data support a model in which tight, local control of SR Ca2+ release by the ICa during EC coupling develops early in human cardiomyocytes.			Zhu, WZ (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	santana@u.washington.edu; laflamme@u.washington.edu	Laflamme, Michael/AAV-6791-2021; Santana, Luis/AAF-9298-2019; Zhu, Wei-Zhong/G-4919-2011	Laflamme, Michael/0000-0001-5908-880X; Santana, Luis/0000-0002-4297-8029; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085686, R01HL064387, R24HL064387, K08HL080431] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL080431, HL064387, HL085686, R01 HL064387, R24 HL064387, HL080431, R01 HL085686] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALKE CW, 1994, J PHYSIOL-LONDON, V474, P447, DOI 10.1113/jphysiol.1994.sp020036; Bers DM, 2001, EXCITATION CONTRACTI; BEUCKELMANN DJ, 1988, J PHYSIOL-LONDON, V405, P233, DOI 10.1113/jphysiol.1988.sp017331; CANNELL MB, 1987, SCIENCE, V238, P1419, DOI 10.1126/science.2446391; Cannell MB, 1997, BIOPHYS J, V73, P112, DOI 10.1016/S0006-3495(97)78052-4; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; CLEEMANN L, 1991, J PHYSIOL-LONDON, V432, P283, DOI 10.1113/jphysiol.1991.sp018385; Collier ML, 2000, J GEN PHYSIOL, V115, P653, DOI 10.1085/jgp.115.5.653; Dilly KW, 2006, J PHYSIOL-LONDON, V572, P227, DOI 10.1113/jphysiol.2005.102020; Dolnikov K, 2006, STEM CELLS, V24, P236, DOI 10.1634/stemcells.2005-0036; Escobar AL, 2004, AM J PHYSIOL-HEART C, V286, pH971, DOI 10.1152/ajpheart.00308.2003; FABIATO A, 1979, NATURE, V281, P146, DOI 10.1038/281146a0; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; Fu JD, 2005, FASEB J, V19, P181, DOI 10.1096/fj.05-4501fje; Galli GLJ, 2006, AM J PHYSIOL-REG I, V291, pR1781, DOI 10.1152/ajpregu.00421.2006; Haddock PS, 1999, CIRC RES, V85, P415, DOI 10.1161/01.RES.85.5.415; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Huang J, 2008, AM J PHYSIOL-CELL PH, V294, pC516, DOI 10.1152/ajpcell.00417.2007; Itzhaki I, 2006, ANN NY ACAD SCI, V1080, P207, DOI 10.1196/annals.1380.017; Janowski E, 2006, ANN NY ACAD SCI, V1080, P154, DOI 10.1196/annals.1380.014; Johnson BD, 1997, J GEN PHYSIOL, V110, P135, DOI 10.1085/jgp.110.2.135; Katsube Y, 1996, EUR J PHARMACOL, V317, P391, DOI 10.1016/S0014-2999(96)00745-5; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Laflamme MA, 1999, AM J PHYSIOL-HEART C, V277, pH1841, DOI 10.1152/ajpheart.1999.277.5.H1841; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li GR, 1998, AM J PHYSIOL-HEART C, V275, pH369, DOI 10.1152/ajpheart.1998.275.2.H369; LIU J, 2007, STEM CELLS; Liu WR, 2002, LIFE SCI, V71, P1279, DOI 10.1016/S0024-3205(02)01826-X; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; Lukyanenko V, 2001, BIOPHYS J, V81, P785, DOI 10.1016/S0006-3495(01)75741-4; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; MILEDI R, 1983, J PHYSIOL-LONDON, V340, P649, DOI 10.1113/jphysiol.1983.sp014785; MORAD M, 1983, NATURE, V304, P635, DOI 10.1038/304635a0; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; NABAUER M, 1992, J PHYSIOL-LONDON, V457, P627; NABAUER M, 1989, SCIENCE, V244, P800, DOI 10.1126/science.2543067; NIGGLI E, 1990, SCIENCE, V250, P565, DOI 10.1126/science.2173135; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Pieske B, 1999, CIRC RES, V85, P38; Reinecke H, 2008, CIRC RES, V103, P1058, DOI 10.1161/CIRCRESAHA.108.180588; ROSE WC, 1992, J PHYSIOL-LONDON, V456, P267, DOI 10.1113/jphysiol.1992.sp019336; Santana LF, 2002, J PHYSIOL-LONDON, V544, P57, DOI 10.1113/jphysiol.2002.020552; Santana LF, 1997, J PHYSIOL-LONDON, V503, P21, DOI 10.1111/j.1469-7793.1997.021bi.x; Santana LF, 1996, CIRC RES, V78, P166, DOI 10.1161/01.RES.78.1.166; Santana LF, 1997, HEART VESSELS, P44; Sartiani L, 2007, STEM CELLS, V25, P1136, DOI 10.1634/stemcells.2006-0466; Sasse P, 2007, J GEN PHYSIOL, V130, P133, DOI 10.1085/jgp.200609575; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Soeller C, 1997, BIOPHYS J, V73, P97, DOI 10.1016/S0006-3495(97)78051-2; STERN MD, 1992, BIOPHYS J, V63, P497, DOI 10.1016/S0006-3495(92)81615-6; TANAKA H, 1989, J MOL CELL CARDIOL, V21, P1305, DOI 10.1016/0022-2828(89)90676-7; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ufret-Vincenty CA, 2001, J BIOL CHEM, V276, P28197, DOI 10.1074/jbc.M102548200; Viatchenko-Karpinski S, 1999, P NATL ACAD SCI USA, V96, P8259, DOI 10.1073/pnas.96.14.8259; WIER WG, 1994, J PHYSIOL-LONDON, V474, P463, DOI 10.1113/jphysiol.1994.sp020037; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Zhu Wei-Zhong, 2009, Transplant Rev (Orlando), V23, P53, DOI 10.1016/j.trre.2008.05.005	61	60	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5407	10.1371/journal.pone.0005407	http://dx.doi.org/10.1371/journal.pone.0005407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404384	Green Submitted, gold, Green Published			2022-12-27	WOS:000265614900018
J	Arnsdorf, EJ; Tummala, P; Jacobs, CR				Arnsdorf, Emily J.; Tummala, Padmaja; Jacobs, Christopher R.			Non-Canonical Wnt Signaling and N-Cadherin Related beta-Catenin Signaling Play a Role in Mechanically Induced Osteogenic Cell Fate	PLOS ONE			English	Article								Background: Understanding how the mechanical microenvironment influences cell fate, and more importantly, by what molecular mechanisms, will enhance not only the knowledge of mesenchymal stem cell biology but also the field of regenerative medicine. Mechanical stimuli, specifically loading induced oscillatory fluid flow, plays a vital role in promoting healthy bone development, homeostasis and morphology. Recent studies suggest that such loading induced fluid flow has the potential to regulate osteogenic differentiation via the upregulation of multiple osteogenic genes; however, the molecular mechanisms involved in the transduction of a physical signal into altered cell fate have yet to be determined. Methods and Principal Findings: Using immuno-staining, western blot analysis and luciferase assays, we demonstrate the oscillatory fluid flow regulates beta-catenin nuclear translocation and gene transcription. Additionally, real time RT-PCR analysis suggests that flow induces Wnt5a and Ror2 upregulation, both of which are essential for activating the small GTPase, RhoA, upon flow exposure. Furthermore, although beta-catenin phosphorylation is not altered by flow, its association with N-cadherin is, indicating that flow-induced beta-catenin signaling is initiated by adherens junction signaling. Conclusion: We propose that the mechanical microenvironment of bone has the potential to regulate osteogenic differentiation by initiating multiple key molecular pathways that are essential for such lineage commitment. Specifically, non-canonical Wnt5a signaling involving Ror2 and RhoA as well as N-cadherin mediated beta-catenin signaling are necessary for mechanically induced osteogenic differentiation.			Arnsdorf, EJ (corresponding author), VA Palo Alto Hlth Care Syst, Bone & Joint R&D Ctr, Palo Alto, CA USA.	emily.arnsdorf@gmail.com			NIAMS NIH HHS [AR45989, R01 AR045989] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045989] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21097; Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Batra NN, 2005, J BIOMECH, V38, P1909, DOI 10.1016/j.jbiomech.2004.08.009; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; BROWN TD, 1990, J BIOMECH, V23, P893, DOI 10.1016/0021-9290(90)90354-6; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CARTER DR, 1989, J BIOMECH, V22, P231, DOI 10.1016/0021-9290(89)90091-2; Carter DR, 1998, CLIN ORTHOP RELAT R, pS41; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200; Dehority W, 1999, AM J PHYSIOL-ENDOC M, V276, pE62; Dong YF, 2006, J CELL PHYSIOL, V208, P77, DOI 10.1002/jcp.20656; DU SJ, 1995, MOL CELL BIOL, V15, P2625; El-Tanani M, 2001, CANCER RES, V61, P5619; FROST HM, 1988, CALCIFIED TISSUE INT, V42, P145, DOI 10.1007/BF02556327; FROST HM, 1987, BONE MINER, V2, P73; Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hanai J, 2002, J CELL BIOL, V158, P529, DOI 10.1083/jcb.200203064; Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Katoh M, 2005, ONCOL REP, V14, P1583; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; Katoh Y, 2005, INT J ONCOL, V27, P275; Kim CH, 2006, BONE, V39, P1043, DOI 10.1016/j.bone.2006.05.017; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; KRAHL H, 1994, AM J SPORT MED, V22, P751, DOI 10.1177/036354659402200605; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Lamb KJ, 2003, INT J EXP PATHOL, V84, P191, DOI 10.1046/j.1365-2613.2003.00353.x; Li YJ, 2004, J ORTHOP RES, V22, P1283, DOI 10.1016/j.orthres.2004.04.002; Liu Y., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P323; Liu Y, 2007, MOL ENDOCRINOL, V21, P376, DOI 10.1210/me.2006-0342; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Muller T, 2002, EXP CELL RES, V280, P119, DOI 10.1006/excr.2002.5630; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; OBERLENDER SA, 1994, CELL ADHES COMMUN, V2, P521, DOI 10.3109/15419069409014216; OBERLENDER SA, 1994, DEVELOPMENT, V120, P177; Orsulic S, 1999, J CELL SCI, V112, P1237; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Reinhold MI, 2007, J BIOL CHEM, V282, P3653, DOI 10.1074/jbc.M608995200; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Riddle RC, 2006, AM J PHYSIOL-CELL PH, V290, pC776, DOI 10.1152/ajpcell.00082.2005; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Saunders MM, 2003, BONE, V32, P350, DOI 10.1016/S8756-3282(03)00025-5; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Shimokawa T, 2003, CANCER RES, V63, P6116; Smith JC, 2000, PHILOS T ROY SOC B, V355, P923, DOI 10.1098/rstb.2000.0627; Spater D, 2006, EUR CELLS MATER, V12, P71; Srinivasan S, 2000, MED ENG PHYS, V22, P127, DOI 10.1016/S1350-4533(00)00021-7; Steck R, 2000, MED ENG PHYS, V22, P117, DOI 10.1016/S1350-4533(00)00017-5; Tate MLK, 2000, J EXP BIOL, V203, P2737; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Toyofuku T, 2000, J CELL BIOL, V150, P225, DOI 10.1083/jcb.150.1.225; Triplett Jason W., 2007, Molecular & Cellular Biomechanics, V4, P13; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; Turner CH, 2006, ANN NY ACAD SCI, V1068, P429, DOI 10.1196/annals.1346.039; Wang FS, 2007, BONE, V40, P485, DOI 10.1016/j.bone.2006.09.004; Wang Y, 2007, J TISSUE ENG REGEN M, V1, P39, DOI 10.1002/term.6; Wolff J., 1986, LAW BONE REMODELING; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200; Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhong N, 2006, BONE, V39, P5, DOI 10.1016/j.bone.2005.12.008; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019; Zou LJ, 2006, ADV EXP MED BIOL, V585, P431	84	129	136	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5388	10.1371/journal.pone.0005388	http://dx.doi.org/10.1371/journal.pone.0005388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401766	Green Published, Green Submitted, gold			2022-12-27	WOS:000265601100022
J	Eswarappa, SM				Eswarappa, Sandeepa M.			Location of Pathogenic Bacteria during Persistent Infections: Insights from an Analysis Using Game Theory	PLOS ONE			English	Article							LYSOSOME FUSION; MACROPHAGES; TUBERCULOSIS; EVOLUTION	Bacterial persistent infections are responsible for a significant amount of the human morbidity and mortality. Unlike acute bacterial infections, it is very difficult to treat persistent bacterial infections (e.g. tuberculosis). Knowledge about the location of pathogenic bacteria during persistent infection will help to treat such conditions by designing novel drugs which can reach such locations. In this study, events of bacterial persistent infections were analyzed using game theory. A game was defined where the pathogen and the host are the two players with a conflict of interest. Criteria for the establishment of Nash equilibrium were calculated for this game. This theoretical model, which is very simple and heuristic, predicts that during persistent infections pathogenic bacteria stay in both intracellular and extracellular compartments of the host. The result of this study implies that a bacterium should be able to survive in both intracellular and extracellular compartments of the host in order to cause persistent infections. This explains why persistent infections are more often caused by intracellular pathogens like Mycobacterium and Salmonella. Moreover, this prediction is in consistence with the results of previous experimental studies.			Eswarappa, SM (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis, Res Lab, Bangalore 560012, Karnataka, India.	sandeep@mcbl.iisc.ernet.in	Eswarappa, Sandeep/AFG-1997-2022	Muthanegere Eswarappa, Sandeepa/0000-0003-4479-5354; Eswarappa, Sandeep/0000-0002-7903-5198				Alizon S, 2005, AM NAT, V165, pE155, DOI 10.1086/430053; Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; Anderson RM, 1998, INT J PARASITOL, V28, P551, DOI 10.1016/S0020-7519(97)00207-5; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; BUCHMEIER NA, 1991, INFECT IMMUN, V59, P2232, DOI 10.1128/IAI.59.7.2232-2238.1991; Fenton A, 2006, P ROY SOC B-BIOL SCI, V273, P2083, DOI 10.1098/rspb.2006.3552; HELLRIEGEL B, 1992, P ROY SOC B-BIOL SCI, V250, P249, DOI 10.1098/rspb.1992.0156; HOF H, 2002, OPPORTUNITIES INTRAC; KAZI JL, 1990, J PATHOL, V161, P65, DOI 10.1002/path.1711610111; Kreikemeyer B, 2004, INT J MED MICROBIOL, V294, P177, DOI 10.1016/j.ijmm.2004.06.017; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Read JM, 2006, THEOR POPUL BIOL, V70, P201, DOI 10.1016/j.tpb.2006.04.006; TIMOTHY L, 2001, PRINCIPLES BACTERIAL, P509; Young D, 2008, NAT REV MICROBIOL, V6, P520, DOI 10.1038/nrmicro1919; Zheng PY, 2003, CELL MICROBIOL, V5, P25, DOI 10.1046/j.1462-5822.2003.00250.x	21	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5383	10.1371/journal.pone.0005383	http://dx.doi.org/10.1371/journal.pone.0005383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401783	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000265601100020
J	Osman, F; Gaskell, L; Whitby, MC				Osman, Fekret; Gaskell, Louise; Whitby, Matthew C.			Efficient Second Strand Cleavage during Holliday Junction Resolution by RuvC Requires Both Increased Junction Flexibility and an Exposed 5 ' Phosphate	PLOS ONE			English	Article								Background: Holliday junction (HJ) resolution is a critical step during homologous recombination. In Escherichia coli this job is performed by a member of the RNase H/Integrase superfamily called RuvC, whereas in Schizosaccharomyces pombe it has been attributed to the XPF family member Mus81-Eme1. HJ resolution is achieved through the sequential cleavage of two strands of like polarity at or close to the junction crossover point. RuvC functions as a dimer, whereas Mus81-Eme1 is thought to function as a dimer of heterodimers. However, in both cases the multimer contains two catalytic sites, which act independently and sequentially during the resolution reaction. To ensure that both strands are cleaved before the nuclease dissociates from the junction, the rate of second strand cleavage is greatly enhanced compared to that of the first. The enhancement of second strand cleavage has been attributed to the increased flexibility of the nicked HJ, which would facilitate rapid engagement of the second active site and scissile bond. Here we have investigated whether other properties of the nicked HJ are important for enhancing second strand cleavage. Principal Findings: A comparison of the efficiency of cleavage of nicked HJs with and without a 59 phosphate at the nick site shows that a 59 phosphate is required for most of the enhancement of second strand cleavage by RuvC. In contrast Mus81-Eme1 cleaves nicked HJs with and without a 59 phosphate with equal efficiency, albeit there are differences in cleavage site selection. Conclusions: Our data show that efficient HJ resolution by RuvC depends on the 59 phosphate revealed by incision of the first strand. This is a hitherto unappreciated factor in promoting accelerated second strand cleavage. However, a 59 phosphate is not a universal requirement since efficient cleavage by Mus81-Eme1 appears to depend solely on the increased junction flexibility that is developed by the first incision.			Osman, F (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	matthew.whitby@bioch.ox.ac.uk		Whitby, Matthew/0000-0003-0951-3374	Wellcome Trust [057586/Z/99/A] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bastin-Shanower SA, 2003, MOL CELL BIOL, V23, P3487, DOI 10.1128/MCB.23.10.3487-3496.2003; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Ceschini S, 2001, EMBO J, V20, P6601, DOI 10.1093/emboj/20.23.6601; Chang JH, 2008, GENE DEV, V22, P1093, DOI 10.1101/gad.1618708; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Declais AC, 2008, CURR OPIN STRUC BIOL, V18, P86, DOI 10.1016/j.sbi.2007.11.001; DUNDERDALE HJ, 1994, J BIOL CHEM, V269, P5187; Fogg JM, 2000, BIOCHEMISTRY-US, V39, P16125, DOI 10.1021/bi001886m; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Gaskell LJ, 2007, EMBO J, V26, P1891, DOI 10.1038/sj.emboj.7601645; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Klenchin VA, 2008, NUCLEIC ACIDS RES, V36, P5855, DOI 10.1093/nar/gkn577; Lilley DMJ, 2001, NAT REV MOL CELL BIO, V2, P433, DOI 10.1038/35073057x; Liu J, 2004, J MOL BIOL, V343, P851, DOI 10.1016/j.jmb.2004.08.079; Mullen JR, 2001, GENETICS, V157, P103; Ogrunc M, 2003, J BIOL CHEM, V278, P21715, DOI 10.1074/jbc.M302484200; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Osman F, 2007, DNA REPAIR, V6, P1004, DOI 10.1016/j.dnarep.2007.02.019; PARSONS PA, 1990, FUNCT ECOL, V4, P265; Sha RJ, 2000, BIOCHEMISTRY-US, V39, P11982, DOI 10.1021/bi001037z; Shah R, 1997, EMBO J, V16, P1464, DOI 10.1093/emboj/16.6.1464; SHAH R, 1994, CELL, V79, P853, DOI 10.1016/0092-8674(94)90074-4; Sharples GJ, 2001, MOL MICROBIOL, V39, P823, DOI 10.1046/j.1365-2958.2001.02284.x; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; Whitby MC, 1998, J BIOL CHEM, V273, P35063, DOI 10.1074/jbc.273.52.35063	26	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5347	10.1371/journal.pone.0005347	http://dx.doi.org/10.1371/journal.pone.0005347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399178	Green Submitted, Green Published, gold			2022-12-27	WOS:000265514900011
J	Cornelissen, PL; Kringelbach, ML; Ellis, AW; Whitney, C; Holliday, IE; Hansen, PC				Cornelissen, Piers L.; Kringelbach, Morten L.; Ellis, Andrew W.; Whitney, Carol; Holliday, Ian E.; Hansen, Peter C.			Activation of the Left Inferior Frontal Gyrus in the First 200 ms of Reading: Evidence from Magnetoencephalography (MEG)	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; TIME-COURSE; SPATIAL-DISTRIBUTION; LETTER STRINGS; FORM AREA; BRAIN; ORGANIZATION; PERCEPTION; DYNAMICS; CORTEX	Background: It is well established that the left inferior frontal gyrus plays a key role in the cerebral cortical network that supports reading and visual word recognition. Less clear is when in time this contribution begins. We used magnetoencephalography (MEG), which has both good spatial and excellent temporal resolution, to address this question. Methodology/Principal Findings: MEG data were recorded during a passive viewing paradigm, chosen to emphasize the stimulus-driven component of the cortical response, in which right-handed participants were presented words, consonant strings, and unfamiliar faces to central vision. Time-frequency analyses showed a left-lateralized inferior frontal gyrus (pars opercularis) response to words between 100-250 ms in the beta frequency band that was significantly stronger than the response to consonant strings or faces. The left inferior frontal gyrus response to words peaked at,130 ms. This response was significantly later in time than the left middle occipital gyrus, which peaked at,115 ms, but not significantly different from the peak response in the left mid fusiform gyrus, which peaked at,140 ms, at a location coincident with the fMRI defined visual word form area (VWFA). Significant responses were also detected to words in other parts of the reading network, including the anterior middle temporal gyrus, the left posterior middle temporal gyrus, the angular and supramarginal gyri, and the left superior temporal gyrus. Conclusions/Significance: These findings suggest very early interactions between the vision and language domains during visual word recognition, with speech motor areas being activated at the same time as the orthographic word-form is being resolved within the fusiform gyrus. This challenges the conventional view of a temporally serial processing sequence for visual word recognition in which letter forms are initially decoded, interact with their phonological and semantic representations, and only then gain access to a speech code.			Cornelissen, PL (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	p.cornelissen@psych.york.ac.uk	Kringelbach, Morten L/AAF-5508-2020; Cornelissen, Piers/F-5391-2010; Kringelbach, Morten/AAW-5847-2021; Cornelissen, Piers L/K-4914-2012; Hansen, Peter C/F-3163-2010	Kringelbach, Morten/0000-0002-3908-6898; Cornelissen, Piers L/0000-0002-2695-9581; Hansen, Peter C/0000-0002-4948-1007	Wellcome Trust [GR068580] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ashby J, 2009, BIOL PSYCHOL, V80, P84, DOI 10.1016/j.biopsycho.2008.03.009; Assadollahi R, 2003, NEUROREPORT, V14, P1183, DOI 10.1097/00001756-200306110-00016; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Ben-Shachar M, 2007, NEUROIMAGE, V37, P1396, DOI 10.1016/j.neuroimage.2007.05.060; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Brookes MJ, 2005, NEUROIMAGE, V26, P302, DOI 10.1016/j.neuroimage.2005.01.050; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; Carreiras M, 2005, PSYCHOL SCI, V16, P585, DOI 10.1111/j.1467-9280.2005.01579.x; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; CORNELISSEN P, 1995, VISION RES, V35, P1483, DOI 10.1016/0042-6989(95)98728-R; Cornelissen P, 2003, J COGNITIVE NEUROSCI, V15, P731, DOI 10.1162/jocn.2003.15.5.731; Cornelissen PL, 1998, VISION RES, V38, P471, DOI 10.1016/S0042-6989(97)00199-5; David Milner A, 1995, MAG VISUAL BRAIN ACT; DEHAENE S, 1995, NEUROREPORT, V6, P2153, DOI 10.1097/00001756-199511000-00014; Dejerine J., 1895, ANATOMIE CTR NERVEUX, VVol. 1; Dhond RP, 2001, J NEUROSCI, V21, P3564, DOI 10.1523/JNEUROSCI.21-10-03564.2001; Dhond RP, 2007, HUM BRAIN MAPP, V28, P355, DOI 10.1002/hbm.20282; Ellis AW, 2006, NEUROIMAGE, V33, P958, DOI 10.1016/j.neuroimage.2006.07.040; FERRERA VP, 1992, NATURE, V358, P756, DOI 10.1038/358756a0; Fiebach CJ, 2002, J COGNITIVE NEUROSCI, V14, P11, DOI 10.1162/089892902317205285; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Fink G. R., 2006, BROCAS REGION; Gold BT, 2007, J COGNITIVE NEUROSCI, V19, P1983, DOI 10.1162/jocn.2007.19.12.1983; Hadjipapas A, 2005, CLIN NEUROPHYSIOL, V116, P1300, DOI 10.1016/j.clinph.2005.01.014; Halgren E, 2006, NEUROIMAGE, V30, P1401, DOI 10.1016/j.neuroimage.2005.10.053; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P51, DOI 10.1016/0928-4257(94)90093-0; Hansen PC, 2001, NEUROREPORT, V12, P1527, DOI 10.1097/00001756-200105250-00045; Harm MW, 2004, PSYCHOL REV, V111, P662, DOI 10.1037/0033-295X.111.3.662; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Heim S, 2005, COGNITIVE BRAIN RES, V25, P982, DOI 10.1016/j.cogbrainres.2005.09.022; Hillebrand A, 2005, INT REV NEUROBIOL, V68, P149, DOI 10.1016/S0074-7742(05)68006-3; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hirata M, 2002, NEUROSCI LETT, V318, P73, DOI 10.1016/S0304-3940(01)02483-1; Ioannides AA, 2006, NEUROSCIENTIST, V12, P524, DOI 10.1177/1073858406293696; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Joubert S, 2004, BRAIN LANG, V89, P9, DOI 10.1016/S0093-934X(03)00403-6; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kober H, 2001, HUM BRAIN MAPP, V14, P236, DOI 10.1002/hbm.1056; Kujala J, 2007, CEREB CORTEX, V17, P1476, DOI 10.1093/cercor/bhl059; Lachaux JP, 2008, CEREB CORTEX, V18, P443, DOI 10.1093/cercor/bhm085; Lee HW, 1999, PSYCHON B REV, V6, P624, DOI 10.3758/BF03212971; Liu LC, 1996, BRAIN TOPOGR, V8, P385, DOI 10.1007/BF01186914; LUKATELA G, 1994, J EXP PSYCHOL GEN, V123, P331, DOI 10.1037/0096-3445.123.4.331; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Maratos FA, 2007, NEUROIMAGE, V34, P371, DOI 10.1016/j.neuroimage.2006.09.017; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; Martin-Loeches M, 1999, BRAIN LANG, V70, P364, DOI 10.1006/brln.1999.2178; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; Pammer K, 2004, NEUROIMAGE, V22, P1819, DOI 10.1016/j.neuroimage.2004.05.004; PATTON HD, 1982, PHYSL BIOPHYSICS, V4, P101; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Press W. H., 1992, ART SCI COMPUTING; Pugh KR, 1996, BRAIN, V119, P1221, DOI 10.1093/brain/119.4.1221; Pugh KR, 1997, J EXP PSYCHOL HUMAN, V23, P299, DOI 10.1037/0096-1523.23.2.299; PULVERMULLER F, 1995, ELECTROEN CLIN NEURO, V94, P357, DOI 10.1016/0013-4694(94)00291-R; Pulvermuller F, 2001, EUR J NEUROSCI, V13, P201, DOI 10.1046/j.0953-816X.2000.01380.x; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Robinson S.E., 1999, RECENT ADV BIOMAGNET, P302; Rossell SL, 2003, NEUROPSYCHOLOGIA, V41, P550, DOI 10.1016/S0028-3932(02)00181-1; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Salmelin R, 2000, BRAIN, V123, P1184, DOI 10.1093/brain/123.6.1184; Salmelin R, 2007, CLIN NEUROPHYSIOL, V118, P237, DOI 10.1016/j.clinph.2006.07.316; Sekihara K, 2002, IEEE T BIO-MED ENG, V49, P1534, DOI 10.1109/TBME.2002.805485; Seteno S. C., 1998, NEUROREPORT, V9, P2195; Singh KD, 2002, NEUROIMAGE, V16, P103, DOI 10.1006/nimg.2001.1050; Singh KD, 2006, METHODS MIND, P291; Snyder HR, 2007, J COGNITIVE NEUROSCI, V19, P761, DOI 10.1162/jocn.2007.19.5.761; Sperling AJ, 2003, NEUROPSYCHOLOGIA, V41, P1422, DOI 10.1016/S0028-3932(03)00044-7; Talcott JB, 2000, P NATL ACAD SCI USA, V97, P2952, DOI 10.1073/pnas.040546597; Taniguchi M, 2000, NEUROIMAGE, V12, P298, DOI 10.1006/nimg.2000.0611; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Tarkiainen A, 2003, NEUROIMAGE, V19, P1194, DOI 10.1016/S1053-8119(03)00161-7; Ukai S, 2002, NEUROSCI LETT, V334, P9, DOI 10.1016/S0304-3940(02)01002-9; Van Veen B. D., 1988, IEEE ASSP Magazine, V5, P4, DOI 10.1109/53.665; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wilson T, 2005, EXP BRAIN RES, V162, P1, DOI 10.1007/s00221-004-2099-3; YOUNG MP, 1995, PHILOS T ROY SOC B, V348, P281, DOI 10.1098/rstb.1995.0069	89	105	105	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2009	4	4							e5359	10.1371/journal.pone.0005359	http://dx.doi.org/10.1371/journal.pone.0005359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VI	19396362	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000265514600006
J	Gliozzi, AS; Guiot, C; Delsanto, PP				Gliozzi, Antonio S.; Guiot, Caterina; Delsanto, Pier Paolo			A New Computational Tool for the Phenomenological Analysis of Multipassage Tumor Growth Curves	PLOS ONE			English	Article							CANCER; SPHEROIDS; MODEL; BIOLOGY	Multipassage experiments are performed by subcutaneous implantation in lab animals (usually mice) of a small number of cells from selected human lines. Tumor cells are then passaged from one mouse to another by harvesting them from a growing tumor and implanting them into other healthy animals. This procedure may be extremely useful to investigate the various mechanisms involved in the long term evolution of tumoral growth. It has been observed by several researchers that, contrary to what happens in in vitro experiments, there is a significant growth acceleration at each new passage. This result is explained by a new method of analysis, based on the Phenomenological Universalities approach. It is found that, by means of a simple rescaling of time, it is possible to collapse all the growth curves, corresponding to the successive passages, into a single curve, belonging to the Universality Class U2. Possible applications are proposed and the need of further experimental evidence is discussed.			Gliozzi, AS (corresponding author), Politecn Torino, Dept Phys, Turin, Italy.	antonio.gliozzi@polito.it	Gliozzi, Antonio/G-7769-2012; guiot, caterina/C-6708-2009	guiot, caterina/0000-0001-8529-1625; GLIOZZI, ANTONIO/0000-0003-1084-0444				BENIERS AJMC, 1992, AM J PATHOL, V140, P483; BOGDEN AE, 1978, CANCER RES, V38, P59; Castorina P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.188701; Chignola R, 2000, CELL PROLIFERAT, V33, P219, DOI 10.1046/j.1365-2184.2000.00174.x; Delsanto PP, 2008, J THEOR BIOL, V250, P16, DOI 10.1016/j.jtbi.2007.09.023; Delsanto PP, 2009, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-5; Delsanto PP, 2000, PHYS REV E, V62, P2547, DOI 10.1103/PhysRevE.62.2547; Delsanto PP, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148105; Delsanto PP, 2005, PHYS SCRIPTA, VT118, P157, DOI 10.1238/Physica.Topical.118a00157; Delsanto PP, 2004, APPL PHYS LETT, V85, P4225, DOI 10.1063/1.1812842; Delsanto PP, 2007, UNIVERSALITY NONCLAS; DELSANTO PP, 2008, APPL PHYS LETT UNPUB; FIDLER IJ, 1978, CANCER RES, V38, P2651; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FREYER JP, 1986, CANCER RES, V46, P3504; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Guiot C, 2003, J THEOR BIOL, V225, P147, DOI 10.1016/S0022-5193(03)00221-2; Guiot C, 2007, PHYS BIOL, V4, pP1, DOI 10.1088/1478-3975/4/4/P01; Kerbel RS, 2003, CANCER BIOL THER, V2, pS134; MCCREDIE JA, 1971, CANCER, V27, P635, DOI 10.1002/1097-0142(197103)27:3<635::AID-CNCR2820270319>3.0.CO;2-F; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pugno N, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046103; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Sansone BC, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.021903; Savage VM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000171; Scalerandi M, 1999, PHYS REV E, V59, P2206, DOI 10.1103/PhysRevE.59.2206; Shen XH, 2006, CANCER BIOL THER, V5, P1313, DOI 10.4161/cbt.5.10.3157; Steel GG, 1977, GROWTH KINETICS TUMO; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 2004, PHYS TODAY, V57, P36, DOI 10.1063/1.1809090	33	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2009	4	4							e5358	10.1371/journal.pone.0005358	http://dx.doi.org/10.1371/journal.pone.0005358			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VI	19396358	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514600005
J	Koenig, JE; Sharp, C; Dlutek, M; Curtis, B; Joss, M; Boucher, Y; Doolittle, WF				Koenig, Jeremy E.; Sharp, Christine; Dlutek, Marlena; Curtis, Bruce; Joss, Michael; Boucher, Yan; Doolittle, W. Ford			Integron Gene Cassettes and Degradation of Compounds Associated with Industrial Waste: The Case of the Sydney Tar Ponds	PLOS ONE			English	Article								Integrons are genetic platforms that accelerate lateral gene transfer (LGT) among bacteria. They were first detected on plasmids bearing single and multiple drug resistance determinants in human pathogens, and it is abundantly clear that integrons have played a major role in the evolution of this public health menace. Similar genetic elements can be found in nonpathogenic environmental bacteria and in metagenomic environmental DNA samples, and it is reasonable to suppose that integrons have facilitated microbial adaptation through LGT in niches outside infectious disease wards. Here we show that a heavily impacted estuary, exposed for almost a century to products of coal and steel industries, has developed a rich and unique cassette metagenome, containing genes likely to aid in the catabolism of compounds associated with industrial waste found there. In addition, we report that the most abundant cassette recovered in this study is one that encodes a putative LysR protein. This autoregulatory transcriptional regulator is known to activate transcription of linked target genes or unlinked regulons encoding diverse functions including chlorocatechol and dichlorophenol catabolism. Finally, only class 1 integrase genes were amplified in this study despite using different primer sets, and it may be that the cassettes present in the Tar Ponds will prove to be associated with class 1 integrase genes. Nevertheless, our cassette library provides a snapshot of a complex evolutionary process involving integron-meditated LGT likely to be important in natural bioremediation.			Koenig, JE (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	j.edmund.koenig@gmail.com	Boucher, Yan/A-5505-2010; Boucher, Yann Felix/H-4576-2019; Sharp, Christine/L-1439-2014; Boucher, Yan/A-2618-2014	Boucher, Yann Felix/0000-0002-0036-6083; Doolittle, W. Ford/0000-0002-4675-8832				Atlas RM, 2005, HDB MEDIA ENV MICROB; ATWELL PHP, 1982, AMBIENT AIR PAH STUD; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; BAND PCM, 2003, MORTALITY RATES SYDN, P1961; Boucher Y, 2007, TRENDS MICROBIOL, V15, P301, DOI 10.1016/j.tim.2007.05.004; CHAO A, 1984, SCAND J STAT, V11, P265; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; COCO WM, 1993, J BACTERIOL, V175, P417, DOI 10.1128/JB.175.2.417-427.1993; Collis CM, 2002, MOL MICROBIOL, V46, P1415, DOI 10.1046/j.1365-2958.2002.03260.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dodds L, 2001, CAN J PUBLIC HEALTH, V92, P331, DOI 10.1007/BF03404991; Elsaied H, 2007, ENVIRON MICROBIOL, V9, P2298, DOI 10.1111/j.1462-2920.2007.01344.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ferraroni M, 2006, J MOL BIOL, V360, P788, DOI 10.1016/j.jmb.2006.05.046; FERRY JG, 1992, J BACTERIOL, V174, P5489, DOI 10.1128/JB.174.17.5489-5495.1992; Furimsky E, 2002, ENVIRON MANAGE, V30, P872, DOI 10.1007/s00267-002-2649-z; Gillings M, 2008, J BACTERIOL, V190, P5095, DOI 10.1128/JB.00152-08; GORDON D, 2004, CURRENT PROTOCOLS BI; Guernsey JR, 2000, CAN J PUBLIC HEALTH, V91, P285, DOI 10.1007/BF03404291; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Holmes AJ, 2003, ENVIRON MICROBIOL, V5, P383, DOI 10.1046/j.1462-2920.2003.00429.x; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jackson BE, 1999, ARCH MICROBIOL, V171, P107, DOI 10.1007/s002030050685; *JDAC LE, 2000, PHAS 2 3 ENV SIT ASS; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Katz LA, 2000, MOL PHYLOGENET EVOL, V14, P318, DOI 10.1006/mpev.1999.0695; KOENIG JE, 2008, ENV MICROBIOL; Lambert TW, 2004, ENVIRON HEALTH PERSP, V112, P35, DOI 10.1289/ehp.6423; Lawrence JG, 1996, GENETICS, V143, P1843; LEVESQUE C, 1994, GENE, V142, P49, DOI 10.1016/0378-1119(94)90353-0; Lovley DR, 2001, SCIENCE, V293, P1444, DOI 10.1126/science.1063294; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Mongodin EF, 2006, PLOS GENET, V2, P2094, DOI 10.1371/journal.pgen.0020214; Nemergut DR, 2004, APPL ENVIRON MICROB, V70, P1160, DOI 10.1128/AEM.70.2.1160-1168.2004; ORNSTON LN, 1966, J BIOL CHEM, V241, P3795; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; PLATT A, 1995, MICROBIOL-UK, V141, P2223, DOI 10.1099/13500872-141-9-2223; QIU R, 2008, J HAZARD MAT; ROTHMEL RK, 1990, J BACTERIOL, V172, P922, DOI 10.1128/jb.172.2.922-931.1990; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shen XH, 2005, SCI CHINA SER C, V48, P241, DOI 10.1360/062004-32; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STOKES HW, 1989, MOL MICROBIOL, V3, P1669, DOI 10.1111/j.1365-2958.1989.tb00153.x; Stokes HW, 2001, APPL ENVIRON MICROB, V67, P5240, DOI 10.1128/AEM.67.11.5240-5246.2001; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmis KN, 1999, TRENDS BIOTECHNOL, V17, P201, DOI 10.1016/S0167-7799(98)01295-5; Wright MS, 2008, ISME J, V2, P417, DOI 10.1038/ismej.2008.8; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708	54	35	37	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5276	10.1371/journal.pone.0005276	http://dx.doi.org/10.1371/journal.pone.0005276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390587	Green Published, gold, Green Submitted			2022-12-27	WOS:000265514200007
J	Altieri, AH; Trussell, GC; Ewanchuk, PJ; Bernatchez, G; Bracken, MES				Altieri, Andrew H.; Trussell, Geoffrey C.; Ewanchuk, Patrick J.; Bernatchez, Genevieve; Bracken, Matthew E. S.			Consumers Control Diversity and Functioning of a Natural Marine Ecosystem	PLOS ONE			English	Article								Background: Our understanding of the functional consequences of changes in biodiversity has been hampered by several limitations of previous work, including limited attention to trophic interactions, a focus on species richness rather than evenness, and the use of artificially assembled communities. Methodology and Principal Findings: In this study, we manipulated the density of an herbivorous snail in natural tide pools and allowed seaweed communities to assemble in an ecologically relevant and non-random manner. Seaweed species evenness and biomass-specific primary productivity (mg O-2 h(-1) g(-1)) were higher in tide pools with snails because snails preferentially consumed an otherwise dominant seaweed species that can reduce biomass-specific productivity rates of algal assemblages. Although snails reduced overall seaweed biomass in tide pools, they did not affect gross primary productivity at the scale of tide pools (mg O-2 h(-1) pool(-1) or mg O-2 h(-1) m(-2)) because of the enhanced biomass-specific productivity associated with grazer-mediated increases in algal evenness. Significance: Our results suggest that increased attention to trophic interactions, diversity measures other than richness, and particularly the effects of consumers on evenness and primary productivity, will improve our understanding of the relationship between diversity and ecosystem functioning and allow more effective links between experimental results and real-world changes in biodiversity.			Altieri, AH (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	g.trussell@neu.edu	Bracken, Matthew E S/B-1259-2008; Altieri, Andrew H/P-1738-2017; Bracken, Matthew E.S./I-9359-2019; Trussell, Geoffrey/AAQ-9165-2020	Bracken, Matthew E S/0000-0002-0068-7485; Bracken, Matthew E.S./0000-0002-0068-7485; Altieri, Andrew/0000-0001-7439-8742				Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Binzer T, 2005, MAR ECOL PROG SER, V287, P65, DOI 10.3354/meps287065; Bjork M, 2004, MAR ECOL PROG SER, V284, P109, DOI 10.3354/meps284109; Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Bracken MES, 2007, ECOLOGY, V88, P2211, DOI 10.1890/06-0881.1; Bruno JF, 2005, ECOL LETT, V8, P1048, DOI 10.1111/j.1461-0248.2005.00808.x; Bruno JF, 2006, OIKOS, V115, P170, DOI 10.1111/j.2006.0030-1299.14927.x; Brush MJ, 2003, ESTUARIES, V26, P916, DOI 10.1007/BF02803350; CARPENTER RC, 1986, ECOL MONOGR, V56, P345, DOI 10.2307/1942551; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Duffy JE, 2002, OIKOS, V99, P201, DOI 10.1034/j.1600-0706.2002.990201.x; Duffy JE, 2005, ECOL LETT, V8, P301, DOI 10.1111/j.1461-0248.2005.00725.x; Flombaum P, 2008, P NATL ACAD SCI USA, V105, P6087, DOI 10.1073/pnas.0704801105; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; JOHNSON WS, 1974, ECOLOGY, V55, P450, DOI 10.2307/1935235; Kirwan L, 2007, J ECOL, V95, P530, DOI 10.1111/j.1365-2745.2007.01225.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LUBCHENCO J, 1978, AM NAT, V112, P23, DOI 10.1086/283250; Mulder CPH, 1999, ECOL LETT, V2, P237; Mulder CPH, 2004, OIKOS, V107, P50, DOI 10.1111/j.0030-1299.2004.13110.x; Nielsen KJ, 2003, P NATL ACAD SCI USA, V100, P7660, DOI 10.1073/pnas.0932534100; Nielsen KJ, 2001, ECOL MONOGR, V71, P187, DOI 10.1890/0012-9615(2001)071[0187:BUATDF]2.0.CO;2; Nijs I, 2000, OIKOS, V88, P57, DOI 10.1034/j.1600-0706.2000.880107.x; Paine RT, 2002, SCIENCE, V296, P736, DOI 10.1126/science.1069811; Pfister CA, 2007, ECOLOGY, V88, P1647, DOI 10.1890/06-1913.1; Quinn GP, 2003, EXPT DESIGN DATA ANA; SANDEEN MI, 1954, PHYSIOL ZOOL, V27, P350, DOI 10.1086/physzool.27.4.30152371; Schmitz OJ, 2003, ECOL LETT, V6, P156, DOI 10.1046/j.1461-0248.2003.00412.x; Schmitz OJ, 2006, ECOLOGY, V87, P1432, DOI 10.1890/0012-9658(2006)87[1432:PHLEOE]2.0.CO;2; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Stachowicz JJ, 2008, P NATL ACAD SCI USA, V105, P18842, DOI 10.1073/pnas.0806425105; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; STEINAUER EM, 1995, ECOLOGY, V76, P1195, DOI 10.2307/1940926; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Wilsey BJ, 2005, ECOLOGY, V86, P1178, DOI 10.1890/04-0394; Wilsey BJ, 2000, ECOLOGY, V81, P887, DOI 10.1890/0012-9658(2000)081[0887:BAEFIO]2.0.CO;2; Witman JD, 2004, P NATL ACAD SCI USA, V101, P15664, DOI 10.1073/pnas.0404300101; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	45	24	24	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5291	10.1371/journal.pone.0005291	http://dx.doi.org/10.1371/journal.pone.0005291			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384410	Green Published, gold, Green Submitted			2022-12-27	WOS:000265513900018
J	Angulo, E; Courchamp, F				Angulo, Elena; Courchamp, Franck			Rare Species Are Valued Big Time	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; RARITY; TRADE	Background: It has recently been postulated that the value humans place on rarity could cause the extinction of rare species. This is because people are willing to pay the high costs of exploiting the last individuals. Many hobbies, such as ecotourism or the keeping of exotic pets may cause this effect-known as the anthropogenic Allee effect. However, the entire theory relies on the insofar undemonstrated assumption that people do value rarity. Methodology/Principal Findings: In order to quantify how much people valued rare species relative to common ones, we created online slideshows of photographs of either rare or common species on an Internet web site. The slideshow with photographs of rare species attracted more visitors, and visitors spent, in general, more time waiting to view it. Conclusions/Significance: We provide evidence that people value rare more than common species. As we did not target consumers of a specific market, this finding suggests that the anthropogenic Allee effect is likely be driven by a large part of the population. Given the substantial participation in our online experiment, we highlight the potential of the world wide web resource as a tool for conservation action. However, the evidence presented here that the general public value rare species, combined with the assumption that anthropogenic Allee effect is operating, implies that conservationists should be prudent when using rarity to promote conservation.			Angulo, E (corresponding author), Univ Paris 11, CNRS, UMR 8079, F-91405 Orsay, France.	franck.courchamp@u-psud.fr	Angulo, Elena/A-8107-2013; Courchamp, Franck/ABE-7204-2020	Angulo, Elena/0000-0001-5545-4032; Courchamp, Franck/0000-0001-7605-4548				BAIN DE, 2002, MODEL LINKING ENERGE; Barnes JI, 1996, ECOL ECON, V18, P215, DOI 10.1016/0921-8009(96)00035-3; Brook BW, 2006, NATURE, V444, P555, DOI 10.1038/444555a; Clark C.W., 1990, MATH BIOECONOMICS OP; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Duarte-Quiroga A, 2003, AM J PRIMATOL, V61, P53, DOI 10.1002/ajp.10108; GAULT A, CONSERVATION LETT, V1, P199; Hall RJ, 2008, CONSERV LETT, V1, P75, DOI 10.1111/j.1755-263X.2008.00013.x; Jepson P, 2005, ORYX, V39, P442, DOI 10.1017/S0030605305001110; Li YM, 2000, BIODIVERS CONSERV, V9, P901; Martin-Lopez B, 2007, BIOL CONSERV, V139, P67, DOI 10.1016/j.biocon.2007.06.005; Ojea E, 2007, ECOL ECON, V63, P807, DOI 10.1016/j.ecolecon.2007.02.003; Rivalan P, 2007, NATURE, V447, P529, DOI 10.1038/447529a; SAS Institute Inc, 2004, SAS 9 1 3 HELP DOC; Slone TH, 1997, ECOL ECON, V21, P77, DOI 10.1016/S0921-8009(96)00096-1; StatSoft Inc. Statistica, 2001, DAT AN SOFTW SYST VE; Torgler B, 2007, ECOL ECON, V63, P536, DOI 10.1016/j.ecolecon.2006.12.013	17	35	35	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5215	10.1371/journal.pone.0005215	http://dx.doi.org/10.1371/journal.pone.0005215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437VB	19384416	Green Published, Green Submitted, gold			2022-12-27	WOS:000265513900003
J	Liu, LN; Aartsma, TJ; Thomas, JC; Zhou, BC; Zhang, YZ				Liu, Lu-Ning; Aartsma, Thijs J.; Thomas, Jean-Claude; Zhou, Bai-Cheng; Zhang, Yu-Zhong			FRAP Analysis on Red Alga Reveals the Fluorescence Recovery Is Ascribed to Intrinsic Photoprocesses of Phycobilisomes than Large-Scale Diffusion	PLOS ONE			English	Article							EXCITATION-ENERGY TRANSFER; LIGHT STATE TRANSITION; PORPHYRIDIUM-CRUENTUM; SUPRAMOLECULAR ARCHITECTURE; PHOTOSYNTHETIC MEMBRANE; THYLAKOID MEMBRANES; PROTEIN DIFFUSION; MOBILITY; PHYCOERYTHRIN; SPECTROSCOPY	Background: Phycobilisomes (PBsomes) are the extrinsic antenna complexes upon the photosynthetic membranes in red algae and most cyanobacteria. The PBsomes in the cyanobacteria has been proposed to present high lateral mobility on the thylakoid membrane surface. In contrast, direct measurement of PBsome motility in red algae has been lacking so far. Methodology/Principal Findings: In this work, we investigated the dynamics of PBsomes in the unicellular red alga Porphyridium cruentum in vivo and in vitro, using fluorescence recovery after photobleaching (FRAP). We found that part of the fluorescence recovery could be detected in both partially- and wholly-bleached wild-type and mutant F11 (UTEX 637) cells. Such partial fluorescence recovery was also observed in glutaraldehyde-treated and betaine-treated cells in which PBsome diffusion should be restricted by cross-linking effect, as well as in isolated PBsomes immobilized on the glass slide. Conclusions/Significance: On the basis of our previous structural results showing the PBsome crowding on the native photosynthetic membrane as well as the present FRAP data, we concluded that the fluorescence recovery observed during FRAP experiment in red algae is mainly ascribed to the intrinsic photoprocesses of the bleached PBsomes in situ, rather than the rapid diffusion of PBsomes on thylakoid membranes in vivo. Furthermore, direct observations of the fluorescence dynamics of phycoerythrins using FRAP demonstrated the energetic decoupling of phycoerythrins in PBsomes against strong excitation light in vivo, which is proposed as a photoprotective mechanism in red algae attributed by the PBsomes in response to excess light energy.			Liu, LN (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn	Liu, Lu-Ning/B-1460-2009	Liu, Lu-Ning/0000-0002-8884-4819				Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Arteni AA, 2008, PHOTOSYNTH RES, V95, P169, DOI 10.1007/s11120-007-9264-z; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bald D, 1996, PHOTOSYNTH RES, V49, P103, DOI 10.1007/BF00117661; BIGGINS J, 1989, PHOTOSYNTH RES, V20, P1, DOI 10.1007/BF00028620; BIGGINS J, 1983, BIOCHIM BIOPHYS ACTA, V724, P111, DOI 10.1016/0005-2728(83)90031-2; BRIMBLE S, 1989, BIOCHIM BIOPHYS ACTA, V973, P315, DOI 10.1016/S0005-2728(89)80438-4; BRUCE D, 1985, BIOCHIM BIOPHYS ACTA, V806, P237, DOI 10.1016/0005-2728(85)90101-X; BRUCE D, 1989, BIOCHIM BIOPHYS ACTA, V974, P66, DOI 10.1016/S0005-2728(89)80166-5; Colyer C, 2005, ANAL BIOANAL CHEM, V382, P559, DOI 10.1007/s00216-004-3020-4; DILWORTH MF, 1981, PLANT PHYSIOL, V67, P608, DOI 10.1104/pp.67.4.608; FICNER R, 1993, EUR J BIOCHEM, V218, P103, DOI 10.1111/j.1432-1033.1993.tb18356.x; GANTT E, 1974, BIOCHEMISTRY-US, V13, P2960, DOI 10.1021/bi00711a027; GANTT E, 1966, J CELL BIOL, V29, P423, DOI 10.1083/jcb.29.3.423; GANTT E, 1976, BIOCHIM BIOPHYS ACTA, V430, P375, DOI 10.1016/0005-2728(76)90093-1; GANTT E, 1965, J CELL BIOL, V26, P365, DOI 10.1083/jcb.26.2.365; Gantt E., 2003, LIGHT HARVESTING ANT, P307, DOI DOI 10.1007/978-94-017-2087-8_10; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; JONES RF, 1963, PHYSIOL PLANTARUM, V16, P636, DOI 10.1111/j.1399-3054.1963.tb08342.x; Joshua S, 2004, PLANT PHYSIOL, V135, P2112, DOI 10.1104/pp.104.046110; Kana R, 2009, FEBS LETT, V583, P670, DOI 10.1016/j.febslet.2009.01.016; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; Kirchhoff H, 2008, PLANT PHYSIOL, V146, P1571, DOI 10.1104/pp.107.115170; Kondo K, 2009, PHOTOSYNTH RES, V99, P217, DOI 10.1007/s11120-008-9399-6; Li DH, 2004, BBA-BIOENERGETICS, V1608, P114, DOI 10.1016/j.bbabio.2003.11.002; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001; Liu LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003134; Liu LN, 2008, J BIOL CHEM, V283, P34946, DOI 10.1074/jbc.M805114200; Loos D, 2004, BIOPHYS J, V87, P2598, DOI 10.1529/biophysj.104.046219; LUNDELL DJ, 1981, J BIOL CHEM, V256, P3580; LUNDELL DJ, 1984, J BIOL CHEM, V259, P5472; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; McConnell MD, 2002, PLANT PHYSIOL, V130, P1201, DOI 10.1104/pp.009845; Mullineaux CW, 2008, PHOTOSYNTH RES, V95, P175, DOI 10.1007/s11120-007-9249-y; Mullineaux CW, 2005, TRENDS PLANT SCI, V10, P521, DOI 10.1016/j.tplants.2005.09.001; Mullineaux CW, 2005, J EXP BOT, V56, P389, DOI 10.1093/jxb/eri064; Mullineaux CW, 2004, J EXP BOT, V55, P1207, DOI 10.1093/jxb/erh106; Mullineaux CW, 1997, NATURE, V390, P421, DOI 10.1038/37157; Mullineaux CW, 2002, TRENDS PLANT SCI, V7, P237, DOI 10.1016/S1360-1385(02)02283-5; MUSTARDY L, 1992, P NATL ACAD SCI USA, V89, P10021, DOI 10.1073/pnas.89.21.10021; Ray K, 2008, ANAL CHEM, V80, P6942, DOI 10.1021/ac800760z; REDLINGER T, 1981, PLANT PHYSIOL, V68, P1375, DOI 10.1104/pp.68.6.1375; Sarcina M, 2001, J BIOL CHEM, V276, P46830, DOI 10.1074/jbc.M107111200; Schluchter WM, 1996, PHOTOCHEM PHOTOBIOL, V64, P53, DOI 10.1111/j.1751-1097.1996.tb02421.x; SIVAN A, 1993, PHYCOLOGIA, V32, P68, DOI 10.2216/i0031-8884-32-1-68.1; SIVAN A, 1995, J PHYCOL, V31, P167, DOI 10.1111/j.0022-3646.1995.00167.x; Verkman AS, 2002, TRENDS BIOCHEM SCI, V27, P27, DOI 10.1016/S0968-0004(01)02003-5; Yang SZ, 2007, BBA-BIOENERGETICS, V1767, P15, DOI 10.1016/j.bbabio.2006.11.012; Zehetmayer P, 2004, BBA-BIOENERGETICS, V1608, P35, DOI 10.1016/j.bbabio.2003.10.003; Zehetmayer P, 2002, BIOPHYS J, V83, P407, DOI 10.1016/S0006-3495(02)75178-3; ZHANG F, 1993, BIOESSAYS, V15, P579, DOI 10.1002/bies.950150903; ZILINSKAS BA, 1986, PHOTOSYNTH RES, V10, P7, DOI 10.1007/BF00024183	54	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2009	4	4							e5295	10.1371/journal.pone.0005295	http://dx.doi.org/10.1371/journal.pone.0005295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437UZ	19381335	Green Published, Green Submitted, gold			2022-12-27	WOS:000265513700004
J	Jain, D; Roy, N; Chattopadhyay, D				Jain, Deepti; Roy, Nilanjan; Chattopadhyay, Debasis			CaZF, a Plant Transcription Factor Functions through and Parallel to HOG and Calcineurin Pathways in Saccharomyces cerevisiae to Provide Osmotolerance	PLOS ONE			English	Article								Salt-sensitive yeast mutants were deployed to characterize a gene encoding a C2H2 zinc finger protein (CaZF) that is differentially expressed in a drought-tolerant variety of chickpea (Cicer arietinum) and provides salinity-tolerance in transgenic tobacco. In Saccharomyces cerevisiae most of the cellular responses to hyper-osmotic stress is regulated by two interconnected pathways involving high osmolarity glycerol mitogen-activated protein kinase (Hog1p) and Calcineurin (CAN), a Ca(2+)/calmodulin-regulated protein phosphatase 2B. In this study, we report that heterologous expression of CaZF provides osmotolerance in S. cerevisiae through Hog1p and Calcineurin dependent as well as independent pathways. CaZF partially suppresses salt-hypersensitive phenotypes of hog1, can and hog1can mutants and in conjunction, stimulates HOG and CAN pathway genes with subsequent accumulation of glycerol in absence of Hog1p and CAN. CaZF directly binds to stress response element (STRE) to activate STRE-containing promoter in yeast. Transactivation and salt tolerance assays of CaZF deletion mutants showed that other than the transactivation domain a C-terminal domain composed of acidic and basic amino acids is also required for its function. Altogether, results from this study suggests that CaZF is a potential plant salt-tolerance determinant and also provide evidence that in budding yeast expression of HOG and CAN pathway genes can be stimulated in absence of their regulatory enzymes to provide osmotolerance.			Jain, D (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	debasis_chattopadhyay@nipgr.res.in	Roy, Nilanjan/I-5113-2014	Roy, Nilanjan/0000-0002-4888-2079; Chattopadhyay, Debasis/0000-0002-5754-4987; Roy, Nilanjan/0000-0001-8788-7350				ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Bressan RA, 1998, TRENDS PLANT SCI, V3, P411, DOI 10.1016/S1360-1385(98)01331-4; BREUDER T, 1994, P NATL ACAD SCI USA, V91, P5372, DOI 10.1073/pnas.91.12.5372; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Cagney G, 2000, METHOD ENZYMOL, V328, P3, DOI 10.1016/S0076-6879(00)28386-9; Covic L, 1999, BBA-MOL CELL RES, V1451, P242, DOI 10.1016/S0167-4889(99)00096-8; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Dreyer I, 1999, J EXP BOT, V50, P1073, DOI 10.1093/jexbot/50.suppl_1.1073; Eriksson P, 2000, J BIOL CHEM, V275, P29368, DOI 10.1074/jbc.M001663200; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; Fan L, 1997, PLANT CELL, V9, P2183, DOI 10.1105/tpc.9.12.2183; FROMMER WB, 1995, ANNU REV PLANT PHYS, V46, P419, DOI 10.1146/annurev.pp.46.060195.002223; Ganster RW, 1998, GENETICS, V150, P31; Garcia-Gimeno MA, 2000, MOL CELL BIOL, V20, P4340, DOI 10.1128/MCB.20.12.4340-4349.2000; GARCIADEBLAS B, 1993, MOL GEN GENET, V236, P363, DOI 10.1007/BF00277134; GARRETTENGELE P, 1995, MOL CELL BIOL, V15, P4103; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; HARO R, 1993, PHYSIOL PLANTARUM, V89, P868, DOI 10.1111/j.1399-3054.1993.tb05298.x; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Kafadar KA, 2004, EUKARYOT CELL, V3, P1147, DOI 10.1128/EC.3.5.1147-1153.2004; Kim JC, 2001, PLANT J, V25, P247, DOI 10.1046/j.1365-313x.2001.00947.x; Lippuner V, 1996, J BIOL CHEM, V271, P12859, DOI 10.1074/jbc.271.22.12859; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; LUAN S, 1993, P NATL ACAD SCI USA, V90, P2202, DOI 10.1073/pnas.90.6.2202; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Mager WH, 2002, FEMS YEAST RES, V2, P251, DOI 10.1016/S1567-1356(02)00116-2; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Maskin L, 2007, BIOCHEM BIOPH RES CO, V352, P831, DOI 10.1016/j.bbrc.2006.11.115; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Matsumoto TK, 2001, PLANT MOL BIOL, V45, P489, DOI 10.1023/A:1010659207604; Mendizabal I, 1998, FEBS LETT, V425, P323, DOI 10.1016/S0014-5793(98)00249-X; MENDOZA I, 1994, J BIOL CHEM, V269, P8792; Michael AJ, 1996, PLANT MOL BIOL, V30, P1051, DOI 10.1007/BF00020815; Moretti MB, 2006, PHYSIOL PLANTARUM, V127, P111, DOI 10.1111/j.1399-3054.2006.00664.x; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; NAKAMURA T, 1993, EMBO J, V12, P4063, DOI 10.1002/j.1460-2075.1993.tb06090.x; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; Obata T, 2007, PLANT PHYSIOL, V144, P1978, DOI 10.1104/pp.107.101154; Ohkawa T, 2005, J VIROL, V79, P15258, DOI 10.1128/JVI.79.24.15258-15264.2005; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Pardo JM, 1998, P NATL ACAD SCI USA, V95, P9681, DOI 10.1073/pnas.95.16.9681; Platara M, 2006, J BIOL CHEM, V281, P36632, DOI 10.1074/jbc.M606483200; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Proft M, 1999, MOL CELL BIOL, V19, P537; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rep M, 1999, MOL CELL BIOL, V19, P5474; Ruiz A, 2007, EUKARYOT CELL, V6, P2175, DOI 10.1128/EC.00337-07; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SCHULLER C, 1994, EMBO J, V13, P4382, DOI 10.1002/j.1460-2075.1994.tb06758.x; SERRANO R, 1994, CRIT REV PLANT SCI, V13, P121, DOI 10.1080/713608057; Shukla RK, 2006, PLANT PHYSIOL, V142, P113, DOI 10.1104/pp.106.081752; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Soyano T, 2003, GENE DEV, V17, P1055, DOI 10.1101/gad.1071103; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; TAKATSUJI H, 1992, EMBO J, V11, P241, DOI 10.1002/j.1460-2075.1992.tb05047.x; TAKATSUJI H, 1994, PLANT CELL, V6, P947, DOI 10.1105/tpc.6.7.947; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; WACH A, 1994, YEAST, V10, P1808; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Zakrzewska A, 2007, EUKARYOT CELL, V6, P600, DOI 10.1128/EC.00355-06; ZHAO S, 1994, GENE, V146, P215, DOI 10.1016/0378-1119(94)90295-X	76	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5154	10.1371/journal.pone.0005154	http://dx.doi.org/10.1371/journal.pone.0005154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365545	Green Published, gold			2022-12-27	WOS:000265509900003
J	Wilson, CW; Chen, MH; Chuang, PT				Wilson, Christopher W.; Chen, Miao-Hsueh; Chuang, Pao-Tien			Smoothened Adopts Multiple Active and Inactive Conformations Capable of Trafficking to the Primary Cilium	PLOS ONE			English	Article								Activation of Hedgehog (Hh) signaling requires the transmembrane protein Smoothened (Smo), a member of the G-protein coupled receptor superfamily. In mammals, Smo translocates to the primary cilium upon binding of Hh ligands to their receptor, Patched (Ptch1), but it is unclear if ciliary trafficking of Smo is sufficient for pathway activation. Here, we demonstrate that cyclopamine and jervine, two structurally related inhibitors of Smo, force ciliary translocation of Smo. Treatment with SANT-1, an unrelated Smo antagonist, abrogates cyclopamine-and jervine-mediated Smo translocation. Further, activation of protein kinase A, either directly or through activation of Gas, causes Smo to translocate to a proximal region of the primary cilium. We propose that Smo adopts multiple inactive and active conformations, which influence its localization and trafficking on the primary cilium.			Wilson, CW (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	pao-tien.chuang@ucsf.edu		Chen, Miao-Hsueh/0000-0002-9715-3067				Bijlsma MF, 2006, PLOS BIOL, V4, P1397, DOI 10.1371/journal.pbio.0040232; BROWN M, 1986, J VIROL, V60, P290, DOI 10.1128/JVI.60.1.290-293.1986; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; CODINA J, 1983, P NATL ACAD SCI-BIOL, V80, P4276, DOI 10.1073/pnas.80.14.4276; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Gerber AN, 2007, ONCOGENE, V26, P1122, DOI 10.1038/sj.onc.1209891; GILL DM, 1978, P NATL ACAD SCI USA, V75, P3050, DOI 10.1073/pnas.75.7.3050; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Koide T, 2006, DEVELOPMENT, V133, P2395, DOI 10.1242/dev.02393; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sasaki H, 1997, DEVELOPMENT, V124, P1313; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Shiba D, 2009, J CELL SCI, V122, P44, DOI 10.1242/jcs.037408; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	40	88	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5182	10.1371/journal.pone.0005182	http://dx.doi.org/10.1371/journal.pone.0005182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365551	Green Published, gold, Green Submitted			2022-12-27	WOS:000265509900011
J	Tristan, A; Benito, Y; Montserret, R; Boisset, S; Dusserre, E; Penin, F; Ruggiero, F; Etienne, J; Lortat-Jacob, H; Lina, G; Bowden, MG; Vandenesch, F				Tristan, Anne; Benito, Yvonne; Montserret, Roland; Boisset, Sandrine; Dusserre, Eric; Penin, Francois; Ruggiero, Florence; Etienne, Jerome; Lortat-Jacob, Hugues; Lina, Gerard; Bowden, M. Gabriela; Vandenesch, Francois			The Signal Peptide of Staphylococcus aureus Panton Valentine Leukocidin LukS Component Mediates Increased Adhesion to Heparan Sulfates	PLOS ONE			English	Article								Staphylococcus aureus necrotizing pneumonia is a severe disease caused by S. aureus strains carrying the Panton Valentine leukocidin (PVL) genes (lukS-PV & lukF-PV) encoded on various bacteriophages (such as phiSLT). Clinical PVL+ strains isolated from necrotizing pneumonia display an increased attachment to matrix molecules (type I and IV collagens and laminin), a phenotype that could play a role in bacterial adhesion to damaged airway epithelium during the early stages of necrotizing pneumonia (J Infect Dis 2004; 190: 1506-15). To investigate the basis of the observed adhesion of S. aureus PVL+ strains, we compared the ability of PVL+ and their isogenic PVL - strains to attach to various immobilized matrix molecules. The expression of recombinant fragments of the PVL subunits and the addition of synthetic peptides indicated that the processed LukS-PV signal peptide (LukS-PV SP) was sufficient to significantly enhance the ability of S. aureus to attach to extracellular matrix (ECM) components. Furthermore, we showed that adhesion to ECM components was inhibited by heparin and heparan sulfates (HS) suggesting that in vivo, HS could function as a molecular bridge between the matrix and S. aureus expressing the LukS-PV signal peptide. Site directed mutagenesis, biochemical and structural analyses of the LukS-PV signal peptide indicate that this peptide is present at the S. aureus surface, binds to HS in solid phase assay, and mediates the enhanced S. aureus matrix component adhesion. Our data suggests that after its cleavage by signal peptidase, the signal peptide is released from the membrane and associates to the cell wall through its unique C-terminus sequence, while its highly positively charged N-terminus is exposed on the bacterial surface, allowing its interaction with extracellular matrix-associated HS. This mechanism may provide a molecular bridge that enhances the attachment of the S. aureus PVL+ strains to ECM components exposed at damaged epithelial sites.	[Tristan, Anne; Boisset, Sandrine; Dusserre, Eric; Etienne, Jerome; Lina, Gerard; Vandenesch, Francois] Univ Lyon 1, Fac Laennec, F-69365 Lyon, France; [Tristan, Anne; Benito, Yvonne; Boisset, Sandrine; Dusserre, Eric; Etienne, Jerome; Lina, Gerard; Vandenesch, Francois] INSERM, Ctr Natl Reference Staphylocoques, U851, Lyon, France; [Tristan, Anne; Benito, Yvonne; Boisset, Sandrine; Etienne, Jerome; Lina, Gerard; Vandenesch, Francois] Hosp Civils Lyon, Ctr Biol Est, Lyon, France; [Montserret, Roland; Penin, Francois; Ruggiero, Florence] Univ Lyon, Inst Biol Chim Proteines, IFR128 BioSci Gerland Lyon Sud, UMR 5086, Lyon, France; [Lortat-Jacob, Hugues] CNRS, Inst Biol Struct, CEA, UJF, UMR 5075, Lyon, France; [Bowden, M. Gabriela] Texas A&M Univ Syst, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Extracellular Matrix Biol, Houston, TX USA	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Tristan, A (corresponding author), Univ Lyon 1, Fac Laennec, F-69365 Lyon, France.	anne.tristan@chu-lyon.fr	TRISTAN, Anne/GSN-8306-2022; Boisset, Sandrine SB/D-8144-2014; ETIENNE, Jerome/C-5471-2014; Vandenesch, Francois/C-7209-2014; Lina, Gerard J/L-9352-2014; Tristan, Anne/L-9464-2014	TRISTAN, Anne/0000-0001-9471-2655; Boisset, Sandrine SB/0000-0001-8717-8749; ETIENNE, Jerome/0000-0002-3348-3315; Vandenesch, Francois/0000-0001-9412-7106; RUGGIERO, Florence/0000-0003-2915-5359; Lina, Gerard/0000-0002-9236-7998	French Ministry of Research; Texas A&M University System HSC [Research Exigency Grant]; National Institutes of Health [AI020624]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020624] Funding Source: NIH RePORTER	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Texas A&M University System HSC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a research grant from the French Ministry of Research to F.V., a Research Exigency Grant from The Texas A&M University System HSC to M.G.B, National Institutes of Health grant AI020624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alken M, 2005, BIOCHEM J, V390, P455, DOI 10.1042/BJ20050113; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Badiou C, 2008, CLIN MICROBIOL INFEC, V14, P1180, DOI 10.1111/j.1469-0691.2008.02105.x; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Chanut-Delalande H, 2001, J BIOL CHEM, V276, P24352, DOI 10.1074/jbc.M101182200; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; de Bentzmann S, 2004, J INFECT DIS, V190, P1506, DOI 10.1086/424521; Delacoux F, 2000, J BIOL CHEM, V275, P29377, DOI 10.1074/jbc.M004724200; Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083; FIRTH N, 1994, J BACTERIOL, V176, P5871, DOI 10.1128/JB.176.18.5871-5873.1994; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gillet Y, 2007, CLIN INFECT DIS, V45, P315, DOI 10.1086/519263; Harraghy N, 2003, MICROBIOL-SGM, V149, P2701, DOI 10.1099/mic.0.26465-0; Hayashida A, 2009, AM J PATHOL, V174, P509, DOI 10.2353/ajpath.2009.080394; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019; JONES CL, 1986, J BACTERIOL, V166, P29, DOI 10.1128/jb.166.1.29-33.1986; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Laguri C, 2008, CARBOHYD RES, V343, P2018, DOI 10.1016/j.carres.2008.01.047; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lyon GJ, 2004, PEPTIDES, V25, P1389, DOI 10.1016/j.peptides.2003.11.026; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Martoglio B, 2003, BIOCHEM SOC T, V31, P1243; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; Montserret R, 1999, BIOCHEMISTRY-US, V38, P6479, DOI 10.1021/bi9900222; Montserret R, 2000, BIOCHEMISTRY-US, V39, P8362, DOI 10.1021/bi000208x; NOVICK RP, 1963, J GEN MICROBIOL, V33, P121, DOI 10.1099/00221287-33-1-121; O'Brien LM, 2002, CELL MICROBIOL, V4, P759, DOI 10.1046/j.1462-5822.2002.00231.x; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Que YA, 2000, INFECT IMMUN, V68, P3516, DOI 10.1128/IAI.68.6.3516-3522.2000; REDDY GL, 1989, J BIOL CHEM, V264, P16591; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANANTONIO JD, 1994, J CELL BIOL, V125, P1179, DOI 10.1083/jcb.125.5.1179; Sarrazin S, 2005, J BIOL CHEM, V280, P37558, DOI 10.1074/jbc.M507729200; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; van Wely KHM, 2001, FEMS MICROBIOL REV, V25, P437, DOI 10.1016/S0168-6445(01)00062-6; Vives RR, 2004, J BIOL CHEM, V279, P54327, DOI 10.1074/jbc.M409760200; von Heijne G, 1998, NATURE, V396, P111, DOI 10.1038/24036; WATSON DC, 1988, BIOCHEM J, V252, P87, DOI 10.1042/bj2520087; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371	46	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2009	4	4							e5042	10.1371/journal.pone.0005042	http://dx.doi.org/10.1371/journal.pone.0005042			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RS	19347045	Green Submitted, Green Published, gold			2022-12-27	WOS:000265505200004
J	Kotnik, K; Popova, E; Todiras, M; Mori, MA; Alenina, N; Seibler, J; Bader, M				Kotnik, Katarina; Popova, Elena; Todiras, Mihail; Mori, Marcelo A.; Alenina, Natalia; Seibler, Jost; Bader, Michael			Inducible Transgenic Rat Model for Diabetes Mellitus Based on shRNA-Mediated Gene Knockdown	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; RNA INTERFERENCE; EXPRESSION; MICE; INDUCTION; PHENOTYPES; VECTORS	The rat is an important animal model in biomedical research, but gene targeting technology is not established for this species. Therefore, we aimed to produce transgenic knockdown rats using shRNA technology and pronuclear microinjection. To this purpose, we employed a tetracycline-inducible shRNA expression system targeting the insulin receptor (IR). Doxycycline (DOX) treatment of the resulting transgenic rats led to a dose-dependent and reversible increase in blood glucose caused by ubiquitous inhibition of IR expression and signalling. We could neither detect an interferon response nor disturbances in microRNA processing after DOX treatment excluding toxic effects of shRNA expression. Low dose DOX treatment induced a chronic state of diabetes mellitus. In conclusion, we have developed a technology which allows the specific, inducible, and reversible suppression of any gene of interest in the rat. Our first transgenic rat line generated with this method represents an inducible model for diabetes mellitus.	[Kotnik, Katarina; Popova, Elena; Todiras, Mihail; Mori, Marcelo A.; Alenina, Natalia; Seibler, Jost; Bader, Michael] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Kotnik, Katarina] Free Univ Berlin, Dept Biol Chem & Pharm, D-1000 Berlin, Germany; [Seibler, Jost] TaconicArtemis Pharmaceut GmbH, Cologne, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin	Kotnik, K (corresponding author), Max Delbruck Ctr Mol Med MDC, Berlin, Germany.	mbader@mdc-berlin.de	Mori, Marcelo A/R-2881-2018; Bader, Michael/K-2124-2013; Todiras, Mihail/AAT-4426-2020	Mori, Marcelo A/0000-0001-7112-5263; Todiras, Mihail/0000-0002-9373-4753; Bader, Michael/0000-0003-4780-4164; Popova, Elena/0000-0002-3043-9650	German Ministry for Education and Research (RiNA-Network RNA Technologies, Berlin)	German Ministry for Education and Research (RiNA-Network RNA Technologies, Berlin)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant of the German Ministry for Education and Research (RiNA-Network RNA Technologies, Berlin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Barbosa ME, 2005, METH MOLEC MED, V112, P339; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cao Wen, 2005, Journal of Applied Genetics, V46, P217; Carmell MA, 2003, NAT STRUCT BIOL, V10, P91, DOI 10.1038/nsb896; Chen LG, 2005, INT J GREEN ENERGY, V2, P307, DOI 10.1080/01971520500198916; Coumoul X, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni100; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng127; Dann CT, 2006, P NATL ACAD SCI USA, V103, P11246, DOI 10.1073/pnas.0604657103; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; GATZ C, 1988, P NATL ACAD SCI USA, V85, P1394, DOI 10.1073/pnas.85.5.1394; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansuy IM, 2000, CURR OPIN NEUROBIOL, V10, P593, DOI 10.1016/S0959-4388(00)00127-6; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Peng SH, 2006, P NATL ACAD SCI USA, V103, P2252, DOI 10.1073/pnas.0511034103; Popova E, 2005, TRANSGENIC RES, V14, P729, DOI 10.1007/s11248-005-7218-9; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Saito Y, 2005, J BIOL CHEM, V280, P42826, DOI 10.1074/jbc.M507685200; Seibler J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni065; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Tofovic SP, 2003, METH MOLEC MED, V86, P29; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Xia XG, 2006, PLOS GENET, V2, P73, DOI 10.1371/journal.pgen.0020010; Xu P, 2008, HYPERTENSION, V51, P574, DOI 10.1161/HYPERTENSIONAHA.107.102764; Yu J, 2006, GENESIS, V44, P252, DOI 10.1002/dvg.20213	35	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5124	10.1371/journal.pone.0005124	http://dx.doi.org/10.1371/journal.pone.0005124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340286	Green Accepted, Green Published, gold			2022-12-27	WOS:000265500700019
J	Wingo, SN; Gallardo, TD; Akbay, EA; Liang, MC; Contreras, CM; Boren, T; Shimamura, T; Miller, DS; Sharpless, NE; Bardeesy, N; Kwiatkowski, DJ; Schorge, JO; Wong, KK; Castrillon, DH				Wingo, Shana N.; Gallardo, Teresa D.; Akbay, Esra A.; Liang, Mei-Chi; Contreras, Cristina M.; Boren, Todd; Shimamura, Takeshi; Miller, David S.; Sharpless, Norman E.; Bardeesy, Nabeel; Kwiatkowski, David J.; Schorge, John O.; Wong, Kwok-Kin; Castrillon, Diego H.			Somatic LKB1 Mutations Promote Cervical Cancer Progression	PLOS ONE			English	Article								Human Papilloma Virus (HPV) is the etiologic agent for cervical cancer. Yet, infection with HPV is not sufficient to cause cervical cancer, because most infected women develop transient epithelial dysplasias that spontaneously regress. Progression to invasive cancer has been attributed to diverse host factors such as immune or hormonal status, as no recurrent genetic alterations have been identified in cervical cancers. Thus, the pressing question as to the biological basis of cervical cancer progression has remained unresolved, hampering the development of novel therapies and prognostic tests. Here we show that at least 20% of cervical cancers harbor somatically-acquired mutations in the LKB1 tumor suppressor. Approximately one-half of tumors with mutations harbored single nucleotide substitutions or microdeletions identifiable by exon sequencing, while the other half harbored larger monoallelic or biallelic deletions detectable by multiplex ligation probe amplification (MLPA). Biallelic mutations were identified in most cervical cancer cell lines; HeLa, the first human cell line, harbors a homozygous 25 kb deletion that occurred in vivo. LKB1 inactivation in primary tumors was associated with accelerated disease progression. Median survival was only 13 months for patients with LKB1-deficient tumors, but.100 months for patients with LKB1-wild type tumors (P = 0.015, log rank test; hazard ratio = 0.25, 95% CI = 0.083 to 0.77). LKB1 is thus a major cervical tumor suppressor, demonstrating that acquired genetic alterations drive progression of HPV-induced dysplasias to invasive, lethal cancers. Furthermore, LKB1 status can be exploited clinically to predict disease recurrence.	[Wingo, Shana N.; Boren, Todd] Univ Texas SW Med Ctr Dallas, Div Gynecol Oncol, Dallas, TX 75390 USA; [Gallardo, Teresa D.; Akbay, Esra A.; Contreras, Cristina M.; Miller, David S.; Castrillon, Diego H.] Univ Texas SW, Simmons Comprehensive Canc Ctr, Dept Pathol, Dallas, TX 75390 USA; [Liang, Mei-Chi; Shimamura, Takeshi; Wong, Kwok-Kin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; [Sharpless, Norman E.] Univ N Carolina, Sch Med, Lineberger Comprehensive Canc Ctr, Dept Med & Genet, Chapel Hill, NC USA; [Bardeesy, Nabeel] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA; [Kwiatkowski, David J.] Brigham and Womens Hosp, Dept Med, Boston, MA USA; [Schorge, John O.] Massachusetts Gen Hosp, Div Gynecol Oncol, Boston, MA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Wingo, SN (corresponding author), Univ Texas SW Med Ctr Dallas, Div Gynecol Oncol, Dallas, TX 75390 USA.	diego.castrillon@utsouthwestern.edu	Miller, David Scott/H-4604-2011	Miller, David Scott/0000-0002-8215-5887; Akbay, Esra/0000-0002-4149-2529; Sharpless, Norman/0000-0001-7078-9455; wong, kwok kin/0000-0001-6323-235X; Liang, Mei-Chih/0000-0002-7389-2455	Sidney Kimmel Translational Science Awards; NIH NRSA [fellowship]; American Cancer Society/UT Southwestern Simmons Comprehensive Cancer Center [Young Investigator Award]; National Center for Research Resources [K26RR024196]; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024196] Funding Source: NIH RePORTER	Sidney Kimmel Translational Science Awards; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society/UT Southwestern Simmons Comprehensive Cancer Center(American Cancer Society); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded through Sidney Kimmel Translational Science Awards to D.H.C., K.K.W., N.B., and N.E.S., an NIH NRSA F31 fellowship to C.M.C., a Young Investigator Award from the American Cancer Society/UT Southwestern Simmons Comprehensive Cancer Center to D.H.C, and the National Center for Research Resources (K26RR024196) (D.H.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Avizienyte E, 1999, AM J PATHOL, V154, P677, DOI 10.1016/S0002-9440(10)65314-X; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bonin S, 2005, J CLIN PATHOL, V58, P313, DOI 10.1136/jcp.2004.016477; BOSHART M, 1984, EMBO J, V3, P1151, DOI 10.1002/j.1460-2075.1984.tb01944.x; Boudeau J, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9112; Connolly DC, 2000, AM J PATHOL, V156, P339, DOI 10.1016/S0002-9440(10)64735-9; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Crum CP, 2006, DIAGNOSTIC GYNECOLOG; Dall KL, 2008, CANCER RES, V68, P8249, DOI 10.1158/0008-5472.CAN-08-1741; Ellenson LH, 2004, CANCER CELL, V5, P533, DOI 10.1016/j.ccr.2004.05.029; Esteller M, 2000, ONCOGENE, V19, P164, DOI 10.1038/sj.onc.1203227; GEY GO, 1952, CANCER RES, V12, P264; Gurumurthy S, 2008, CANCER RES, V68, P55, DOI 10.1158/0008-5472.CAN-07-3225; Hearle N, 2006, CLIN CANCER RES, V12, P3209, DOI 10.1158/1078-0432.CCR-06-0083; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; HSU SH, 1976, SCIENCE, V191, P392, DOI 10.1126/science.1246620; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; JONES HW, 1971, OBSTET GYNECOL, V38, P945; Jones HW, 1997, AM J OBSTET GYNECOL, V176, pS227, DOI 10.1016/S0002-9378(97)70379-X; Launonen V, 2000, CANCER RES, V60, P546; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Nezu J, 1999, BIOCHEM BIOPH RES CO, V261, P750, DOI 10.1006/bbrc.1999.1047; Pearson HB, 2008, CANCER RES, V68, P2223, DOI 10.1158/0008-5472.CAN-07-5169; PUCK TT, 1955, P NATL ACAD SCI USA, V41, P432, DOI 10.1073/pnas.41.7.432; Schoell WMJ, 1999, SEMIN SURG ONCOL, V16, P203, DOI 10.1002/(SICI)1098-2388(199904/05)16:3<203::AID-SSU2>3.0.CO;2-C; Steben M, 2007, GYNECOL ONCOL, V107, pS2, DOI 10.1016/j.ygyno.2007.07.067; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Young RH, 2002, HISTOPATHOLOGY, V41, P185, DOI 10.1046/j.1365-2559.2002.01462.x; ZURHAUSEN H, 1976, CANCER RES, V36, P794	32	202	224	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5137	10.1371/journal.pone.0005137	http://dx.doi.org/10.1371/journal.pone.0005137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340305	Green Submitted, gold, Green Published			2022-12-27	WOS:000265500700022
J	Rohozinski, J; Anderson, ML; Broaddus, RE; Edwards, CL; Bishop, CE				Rohozinski, Jan; Anderson, Matthew L.; Broaddus, Russell E.; Edwards, Creighton L.; Bishop, Colin E.			Spermatogenesis Associated Retrogenes Are Expressed in the Human Ovary and Ovarian Cancers	PLOS ONE			English	Article								Background: Ovarian cancer is the second most prevalent gynecologic cancer in women. However, it is by far the most lethal. This is generally attributed to the absence of easily detectable markers specific to ovarian cancers that can be used for early diagnosis and specific therapeutic targets. Methodology/Principal Findings: Using end point PCR we have found that a family of retrogenes, previously thought to be expressed only in the male testis during spermatogenesis in man, are also expressed in normal ovarian tissue and a large percentage of ovarian cancers. In man there are at least eleven such autosomal retrogenes, which are intronless copies of genes on the X chromosome, essential for normal spermatogenesis and expressed specifically in the human testis. We tested for the expression of five of the known retrogenes, UTP14C, PGK2, RPL10L, RPL39L and UBL4B in normal human ovary and ovarian cancers. Conclusions/Significance: We propose that the activation of the testis specific retrogenes in the ovary and ovarian cancers is of biological significance in humans. Because these retrogenes are specifically expressed in the ovary and ovarian cancers in the female they may prove useful in developing new diagnostic and/or therapeutic targets for ovarian cancer.	[Rohozinski, Jan; Anderson, Matthew L.; Edwards, Creighton L.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Rohozinski, Jan; Bishop, Colin E.] Wake Forest Univ, Inst Regenerat Med, Winston Salem, NC 27109 USA; [Broaddus, Russell E.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX USA	Baylor College of Medicine; Wake Forest University; University of Texas System; UTMD Anderson Cancer Center	Rohozinski, J (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	janr@bcm.edu	Anderson, Matthew/C-4755-2019	Anderson, Matthew/0000-0002-2081-4672; Rohozinski, Jan/0000-0001-7872-2984	Saks Fifth Avenue Key to a Cure Foundations; Joann Rosenberg Fund for Ovarian Cancer Research; Ovarian Cancer Research Program of the Department of Obstetrics and Gynecology, Baylor College of Medicine; CLE	Saks Fifth Avenue Key to a Cure Foundations; Joann Rosenberg Fund for Ovarian Cancer Research; Ovarian Cancer Research Program of the Department of Obstetrics and Gynecology, Baylor College of Medicine; CLE	Funding for this work provided by Saks Fifth Avenue Key to a Cure Foundations, the Joann Rosenberg Fund for Ovarian Cancer Research and the Ovarian Cancer Research Program of the Department of Obstetrics and Gynecology, Baylor College of Medicine and an anonymous donation channeled through CLE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altinok G, 2006, PROSTATE CANCER P D, V9, P77, DOI 10.1038/sj.pcan.4500848; Betran E, 2004, CELL CYCLE, V3, P873; BLAKE CCF, 1981, PHILOS T ROY SOC B, V293, P93, DOI 10.1098/rstb.1981.0063; BOEL P, 1995, IMMUNITY, V2, P167, DOI 10.1016/S1074-7613(95)80053-0; Bradley J, 2004, NAT GENET, V36, P872, DOI 10.1038/ng1390; Brenner H, 2002, LANCET, V360, P1131, DOI 10.1016/S0140-6736(02)11199-8; Chan JK, 2006, OBSTET GYNECOL, V108, P521, DOI 10.1097/01.AOG.0000231680.58221.a7; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; Duan Z, 2002, ANTICANCER RES, V22, P1933; Edelson MI, 1998, ONCOGENE, V16, P197, DOI 10.1038/sj.onc.1201479; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Ganesan S, 2002, CELL, V111, P393, DOI 10.1016/S0092-8674(02)01052-8; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; Grizzi F, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-3; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; HENDRIKSEN PJM, 1995, DEV BIOL, V170, P730, DOI 10.1006/dbio.1995.1252; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Hogdall EVS, 2004, CANCER, V100, P2387, DOI 10.1002/cncr.20213; Hwang TL, 2006, PROTEOMICS, V6, P2259, DOI 10.1002/pmic.200500345; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kleene KC, 2001, MECH DEVELOP, V106, P3, DOI 10.1016/S0925-4773(01)00413-0; Lay AJ, 2000, NATURE, V408, P869, DOI 10.1038/35048596; Leary DJ, 2004, MOL BIOL CELL, V15, P281, DOI 10.1091/mbc.e03-06-0363; Liao DZJ, 2003, CANCER INVEST, V21, P641, DOI 10.1081/CNV-120022385; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Palma M, 2006, CRIT REV ONCOL HEMAT, V57, P1, DOI 10.1016/j.critrevonc.2005.05.003; Rohozinski J, 2006, BIOL REPROD, V74, P644, DOI 10.1095/biolreprod.105.046698; Rohozinski J, 2004, P NATL ACAD SCI USA, V101, P11695, DOI 10.1073/pnas.0401130101; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shiao MS, 2007, MOL BIOL EVOL, V24, P2242, DOI 10.1093/molbev/msm153; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Spatz A, 2004, NAT REV CANCER, V4, P617, DOI 10.1038/nrc1413; Stalberg P, 2004, J CLIN ENDOCR METAB, V89, P2326, DOI 10.1210/jc.2003-031228; Suri A, 2006, EXPERT OPIN BIOL TH, V6, P379, DOI 10.1517/14712598.6.4.379; Thakur A, 2005, BREAST CANCER RES TR, V93, P135, DOI 10.1007/s10549-005-4516-0; Uechi T, 2002, NUCLEIC ACIDS RES, V30, P5369, DOI 10.1093/nar/gkf696; Uechi T, 2001, GENOMICS, V72, P223, DOI 10.1006/geno.2000.6470; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vigodner M, 2006, AM J PHYSIOL-ENDOC M, V290, pE1022, DOI 10.1152/ajpendo.00527.2005; Wang PJ, 2004, TRENDS ENDOCRIN MET, V15, P79, DOI 10.1016/j.tem.2004.01.007; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wong YF, 2006, INT J CANCER, V118, P2461, DOI 10.1002/ijc.21660; Yang F, 2007, GENE EXPR PATTERNS, V7, P131, DOI 10.1016/j.modgep.2006.06.002; Zendman AJW, 2003, J CELL PHYSIOL, V194, P272, DOI 10.1002/jcp.10215	48	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5064	10.1371/journal.pone.0005064	http://dx.doi.org/10.1371/journal.pone.0005064			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333399	gold, Green Submitted, Green Published			2022-12-27	WOS:000265499900016
J	Granville, CA; Memmott, RM; Balogh, A; Mariotti, J; Kawabata, S; Han, W; LoPiccolo, J; Foley, J; Liewehr, DJ; Steinberg, SM; Fowler, DH; Hollander, MC; Dennis, PA				Granville, Courtney A.; Memmott, Regan M.; Balogh, Andria; Mariotti, Jacopo; Kawabata, Shigeru; Han, Wei; LoPiccolo, Jaclyn; Foley, Jason; Liewehr, David J.; Steinberg, Seth M.; Fowler, Daniel H.; Hollander, M. Christine; Dennis, Phillip A.			A Central Role for Foxp3+Regulatory T Cells in K-Ras-Driven Lung Tumorigenesis	PLOS ONE			English	Article								Background: K-Ras mutations are characteristic of human lung adenocarcinomas and occur almost exclusively in smokers. In preclinical models, K-Ras mutations are necessary for tobacco carcinogen-driven lung tumorigenesis and are sufficient to cause lung adenocarcinomas in transgenic mice. Because these mutations confer resistance to commonly used cytotoxic chemotherapies and targeted agents, effective therapies that target K-Ras are needed. Inhibitors of mTOR such as rapamycin can prevent K-Ras-driven lung tumorigenesis and alter the proportion of cytotoxic and Foxp3+ regulatory T cells, suggesting that lung-associated T cells might be important for tumorigenesis. Methods: Lung tumorigenesis was studied in three murine models that depend on mutant K-Ras; a tobacco carcinogen-driven model, a syngeneic inoculation model, and a transgenic model. Splenic and lung-associated T cells were studied using flow cytometry and immunohistochemistry. Foxp3+ cells were depleted using rapamycin, an antibody, or genetic ablation. Results: Exposure of A/J mice to a tobacco carcinogen tripled lung-associated Foxp3+ cells prior to tumor development. At clinically relevant concentrations, rapamycin prevented this induction and reduced lung tumors by 90%. In A/J mice inoculated with lung adenocarcinoma cells resistant to rapamycin, antibody-mediated depletion of Foxp3+ cells reduced lung tumorigenesis by 80%. Likewise, mutant K-Ras transgenic mice lacking Foxp3+ cells developed 75% fewer lung tumors than littermates with Foxp3+ cells. Conclusions: Foxp3+ regulatory T cells are required for K-Ras-mediated lung tumorigenesis in mice. These studies support clinical testing of rapamycin or other agents that target Treg in K-Ras driven human lung cancer.	[Granville, Courtney A.; Memmott, Regan M.; Balogh, Andria; Kawabata, Shigeru; Han, Wei; LoPiccolo, Jaclyn; Hollander, M. Christine; Dennis, Phillip A.] NCI, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Mariotti, Jacopo; Foley, Jason; Fowler, Daniel H.] NCI, Ctr Canc Res, Expt Transplant & Immunol Branch, Bethesda, MD USA; [Liewehr, David J.; Steinberg, Seth M.] NCI, Ctr Canc Res, Biostat & Data Management Sect, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Granville, CA (corresponding author), NCI, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	pdennis@nih.gov	Kawabata, Shigeru/C-1506-2014; Liewehr, David J/GWV-3570-2022; mariotti, jacopo/AAQ-8057-2021	Kawabata, Shigeru/0000-0003-3948-4500; mariotti, jacopo/0000-0001-6528-9296; Memmott, Regan/0000-0001-5881-9252	Intramural Research Program of the NIH, Center for Cancer Research, National Cancer Institute; NATIONAL CANCER INSTITUTE [Z01SC010288, Z01SC010292, ZIASC010288, ZIASC010292, ZIABC011220] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, Center for Cancer Research, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELINSKY SA, 1992, CANCER RES, V52, P3164; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen GY, 2008, J IMMUNOL, V180, P5163, DOI 10.4049/jimmunol.180.8.5163; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Ebert LM, 2008, CANCER RES, V68, P3001, DOI 10.1158/0008-5472.CAN-07-5664; Granville CA, 2007, CLIN CANCER RES, V13, P2281, DOI 10.1158/1078-0432.CCR-06-2570; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V88; Ishibashi Y, 2006, ONCOL REP, V15, P1315; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Liu M, 2005, CANCER RES, V65, P5325, DOI 10.1158/0008-5472.CAN-04-4589; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; MILLS NE, 1995, CANCER RES, V55, P1444; Mita MM, 2008, J CLIN ONCOL, V26, P361, DOI 10.1200/JCO.2007.12.0345; Murin S, 2004, CHEST, V125, P1467, DOI 10.1378/chest.125.4.1467; O'Donnell A, 2008, J CLIN ONCOL, V26, P1588, DOI 10.1200/JCO.2007.14.0988; Petersen RP, 2006, CANCER-AM CANCER SOC, V107, P2866, DOI 10.1002/cncr.22282; Razani-Boroujerdi S, 2007, AM J RESP CELL MOL, V36, P13, DOI 10.1165/rcmb.2005-0330OC; Rioux N, 1998, CANCER RES, V58, P5354; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Schwarz S, 2008, J ORAL PATHOL MED, V37, P485, DOI 10.1111/j.1600-0714.2008.00641.x; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; Smyth LJC, 2007, CHEST, V132, P156, DOI 10.1378/chest.07-0083; Vuillemenot BR, 2004, CARCINOGENESIS, V25, P623, DOI 10.1093/carcin/bgh038; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Westra WH, 1996, CANCER RES, V56, P2224; WESTRA WH, 1993, CANCER-AM CANCER SOC, V72, P432, DOI 10.1002/1097-0142(19930715)72:2<432::AID-CNCR2820720219>3.0.CO;2-#; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wislez M, 2005, CANCER RES, V65, P3226, DOI 10.1158/0008-5472.CAN-04-4420; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	34	54	60	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2009	4	3							e5061	10.1371/journal.pone.0005061	http://dx.doi.org/10.1371/journal.pone.0005061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PP	19330036	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499700006
J	Kanie, Y; Yamamoto-Hino, M; Karino, Y; Yokozawa, H; Nishihara, S; Ueda, R; Goto, S; Kanie, O				Kanie, Yoshimi; Yamamoto-Hino, Miki; Karino, Yayoi; Yokozawa, Hiroki; Nishihara, Shoko; Ueda, Ryu; Goto, Satoshi; Kanie, Osamu			Insight into the Regulation of Glycan Synthesis in Drosophila Chaoptin Based on Mass Spectrometry	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-I; LINKED OLIGOSACCHARIDES; MONOCLONAL-ANTIBODIES; MANNOSIDASE-II; GLYCOPROTEIN; GLYCOSYLATION; MELANOGASTER; SPECIFICITY; MUTATIONS; PROTEINS	Background: A variety of N-glycans attached to protein are known to involve in many important biological functions. Endoplasmic reticulum (ER) and Golgi localized enzymes are responsible to this template-independent glycan synthesis resulting glycoforms at each asparagine residues. The regulation mechanism such glycan synthesis remains largely unknown. Methodology/Principal Findings: In order to investigate the relationship between glycan structure and protein conformation, we analyzed a glycoprotein of Drosophila melanogaster, chaoptin (Chp), which is localized in photoreceptor cells and is bound to the cell membrane via a glycosylphosphatidylinositol anchor. Detailed analysis based on mass spectrometry revealed the presence of 13 N-glycosylation sites and the composition of the glycoform at each site. The synthetic pathway of glycans was speculated from the observed glycan structures and the composition at each N-glycosylation site, where the presence of novel routes were suggested. The distribution of glycoforms on a Chp polypeptide suggested that various processing enzymes act on the exterior of Chp in the Golgi apparatus, although virtually no enzyme can gain access to the interior of the horseshoe-shaped scaffold, hence explaining the presence of longer glycans within the interior. Furthermore, analysis of Chp from a mutant (RNAi against dolichyl-phosphate a-D-mannosyltransferase), which affects N-glycan synthesis in the ER, revealed that truncated glycan structures were processed. As a result, the distribution of glycoforms was affected for the high-mannose-type glycans only, whereas other types of glycans remained similar to those observed in the control and wild-type. Conclusions/Significance: These results indicate that glycan processing depends largely on the backbone structure of the parent polypeptide. The information we obtained can be applied to other members of the LRR family of proteins.			Kanie, O (corresponding author), Mitsubishi Kagaku Inst Life Sci MITILS, Tokyo, Japan.	kokanee@mitils.jp	Kanie, Osamu/D-1741-2010	Kanie, Osamu/0000-0003-4147-6868; Nishihara, Shoko/0000-0002-1668-2603; Kanie, Yoshimi/0000-0002-8476-2234				ALTMANN F, 1993, GLYCOBIOLOGY, V3, P619, DOI 10.1093/glycob/3.6.619; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Brancia FL, 2000, RAPID COMMUN MASS SP, V14, P2070, DOI 10.1002/1097-0231(20001115)14:21<2070::AID-RCM133>3.0.CO;2-G; Branza-Nichita N, 2000, J BIOL CHEM, V275, P8169, DOI 10.1074/jbc.275.11.8169; Bykova NV, 2006, ANAL CHEM, V78, P1093, DOI 10.1021/ac0512711; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; Cointe D, 2000, GLYCOBIOLOGY, V10, P511, DOI 10.1093/glycob/10.5.511; CUMMING D A, 1991, Glycobiology, V1, P115, DOI 10.1093/glycob/1.2.115; Dell A, 2001, SCIENCE, V291, P2351, DOI 10.1126/science.1058890; Fabini G, 2001, J BIOL CHEM, V276, P28058, DOI 10.1074/jbc.M100573200; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; GAY NJ, 1991, FEBS LETT, V291, P87, DOI 10.1016/0014-5793(91)81110-T; Hale JE, 2000, ANAL BIOCHEM, V287, P110, DOI 10.1006/abio.2000.4834; Harazono A, 2005, GLYCOBIOLOGY, V15, P447, DOI 10.1093/glycob/cwi033; HASE S, 1978, BIOCHEM BIOPH RES CO, V85, P257, DOI 10.1016/S0006-291X(78)80037-0; HASE S, 1990, ANAL BIOCHEM, V184, P135, DOI 10.1016/0003-2697(90)90025-5; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hirai-Fujita Y, 2008, FEBS LETT, V582, P2572, DOI 10.1016/j.febslet.2008.06.028; Ito Y, 2005, CURR OPIN STRUC BIOL, V15, P481, DOI 10.1016/j.sbi.2005.08.012; KAJAVA AV, 1995, STRUCTURE, V3, P867, DOI 10.1016/S0969-2126(01)00222-2; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kolarich D, 2006, BBA-GEN SUBJECTS, V1760, P715, DOI 10.1016/j.bbagen.2005.11.012; KRANTZ DD, 1991, J BIOL CHEM, V266, P16801; KRANTZ DE, 1990, EMBO J, V9, P1969, DOI 10.1002/j.1460-2075.1990.tb08325.x; LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x; LOWE JB, 1999, ESSENTIALS GLYCOBIOL, P486; Nishihara S, 2004, GLYCOCONJUGATE J, V21, P63, DOI 10.1023/B:GLYC.0000043750.80389.14; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; POLLOCK JA, 1990, GENE DEV, V4, P806, DOI 10.1101/gad.4.5.806; REINKE R, 1988, CELL, V52, P291, DOI 10.1016/0092-8674(88)90518-1; Rendic D, 2006, J BIOL CHEM, V281, P3343, DOI 10.1074/jbc.M508334200; Rosenbaum EE, 2006, NEURON, V49, P229, DOI 10.1016/j.neuron.2005.12.011; Sarkar M, 2006, J BIOL CHEM, V281, P12776, DOI 10.1074/jbc.M512769200; Staudacher E, 1998, GLYCOCONJUGATE J, V15, P355, DOI 10.1023/A:1006969701231; Tanner S, 2008, J PROTEOME RES, V7, P170, DOI 10.1021/pr070444v; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; TULSIANI DRP, 1982, J BIOL CHEM, V257, P3660; VANVACTOR D, 1988, CELL, V52, P281, DOI 10.1016/0092-8674(88)90517-X; Wada Y, 2004, ANAL CHEM, V76, P6560, DOI 10.1021/ac049062o; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wilson IBH, 1998, GLYCOBIOLOGY, V8, P651, DOI 10.1093/glycob/8.7.651; WUHER M, 2004, RAPID COMMUN MASS SP, V18, P1741; Wuhrer M, 2007, J CHROMATOGR B, V849, P115, DOI 10.1016/j.jchromb.2006.09.041; YAMAWAKIKATAOKA Y, 1989, P NATL ACAD SCI USA, V86, P5693, DOI 10.1073/pnas.86.15.5693; Yano H, 2009, CELL TISSUE RES, V336, P137, DOI 10.1007/s00441-009-0753-6; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2; ZIPURSKY SL, 1985, P NATL ACAD SCI USA, V82, P1855, DOI 10.1073/pnas.82.6.1855	50	18	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5434	10.1371/journal.pone.0005434	http://dx.doi.org/10.1371/journal.pone.0005434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415110	Green Submitted, Green Published, gold			2022-12-27	WOS:000265836700007
J	Leclerc, PM; Matthews, AP; Garenne, ML				Leclerc, Pauline M.; Matthews, Alan P.; Garenne, Michel L.			Fitting the HIV Epidemic in Zambia: A Two-Sex Micro-Simulation Model	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; FEMALE SEX WORKERS; HETEROSEXUAL TRANSMISSION; COMMERCIAL SEX; COTE-DIVOIRE; COITAL ACT; CONDOM USE; INFECTION; COUPLES; IMPACT	Background: In describing and understanding how the HIV epidemic spreads in African countries, previous studies have not taken into account the detailed periods at risk. This study is based on a micro-simulation model (individual-based) of the spread of the HIV epidemic in the population of Zambia, where women tend to marry early and where divorces are not frequent. The main target of the model was to fit the HIV seroprevalence profiles by age and sex observed at the Demographic and Health Survey conducted in 2001. Methods and Findings: A two-sex micro-simulation model of HIV transmission was developed. Particular attention was paid to precise age-specific estimates of exposure to risk through the modelling of the formation and dissolution of relationships: marriage (stable union), casual partnership, and commercial sex. HIV transmission was exclusively heterosexual for adults or vertical (mother-to-child) for children. Three stages of HIV infection were taken into account. All parameters were derived from empirical population-based data. Results show that basic parameters could not explain the dynamics of the HIV epidemic in Zambia. In order to fit the age and sex patterns, several assumptions were made: differential susceptibility of young women to HIV infection, differential susceptibility or larger number of encounters for male clients of commercial sex workers, and higher transmission rate. The model allowed to quantify the role of each type of relationship in HIV transmission, the proportion of infections occurring at each stage of disease progression, and the net reproduction rate of the epidemic (R-0 = 1.95). Conclusions: The simulation model reproduced the dynamics of the HIV epidemic in Zambia, and fitted the age and sex pattern of HIV seroprevalence in 2001. The same model could be used to measure the effect of changing behaviour in the future.			Garenne, ML (corresponding author), Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France.	mgarenne@pasteur.fr	GARENNE, Michel/A-7712-2013	GARENNE, Michel/0000-0001-6073-7803				ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0; [Anonymous], 2008, OPEN DEMOGRAPHY J, DOI [DOI 10.2174/1874918600801010001, 10.2174/1874918600801010001]; Artzrouni M, 2002, AIDS, V16, pW1; Auvert B, 2000, COMPUT BIOMED RES, V33, P84, DOI 10.1006/cbmr.1999.1533; Boily MC, 1996, SEX TRANSM DIS, V23, P312, DOI 10.1097/00007435-199607000-00012; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Bongaarts J, 2007, POP STUD-J DEMOG, V61, P73, DOI 10.1080/00324720601048343; Brewis A, 2005, J BIOSOC SCI, V37, P499, DOI 10.1017/S002193200400690X; BROUARD N, 1991, BROUARD APPROACH FOR; CARPENTER G, 1899, LANCET, V1, P13; *CENTR STAT OFF ZA, 2003, ZAMB DHS 2001 02; *CENTR STAT OFF ZA, 1997, ZAMB DHS 1996; *CENTR STAT OFF ZA, 1993, ZAMB DHS 1992; Cowan FM, 2005, JAIDS-J ACQ IMM DEF, V40, P371, DOI 10.1097/01.qai.0000162420.93243.ff; Dabis F, 2002, LANCET, V359, P2097, DOI 10.1016/S0140-6736(02)08909-2; Desgrees-du-Lou A, 2008, REPROD HEALTH MATTER, V16, P151, DOI 10.1016/S0968-8080(08)32407-0; DJOMAND G, 1995, J ACQ IMMUN DEF SYND, V10, P358; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Garenne M, 2004, INT J STD AIDS, V15, P65, DOI 10.1258/095646204322637326; GARENNE M, 2003, PREMARITAL FERTILITY; GARENNE M, 2005, 35 INFECT YOUNG WOME; Ghys PD, 2002, AIDS, V16, P251, DOI 10.1097/00002030-200201250-00015; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; Gisselquist D, 2003, INT J STD AIDS, V14, P148, DOI 10.1258/095646203762869151; Glynn JR, 2003, JAIDS-J ACQ IMM DEF, V33, P526, DOI 10.1097/00126334-200308010-00015; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Hallett TB, 2007, SEX TRANSM INFECT, V83, pI50, DOI 10.1136/sti.2006.023606; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; Hunter SC, 2003, J BIOSOC SCI, V35, P189, DOI 10.1017/S0021932003001895; Isingo R, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000299405.06658.a8; KAMLA VC, 2008, 10 INT C ZAR PAU APP, V17; KAMLA VC, 2008, INDIVIDUAL BASE MODE; Korenromp EL, 2000, AIDS, V14, P573, DOI 10.1097/00002030-200003310-00013; Korenromp EL, 2005, J INFECT DIS, V191, pS168, DOI 10.1086/425274; Korenromp EL, 2000, MATH POPUL STUD, V8, P135, DOI DOI 10.1080/08898480009525479; Leclerc PM, 2008, INT J STD AIDS, V19, P660, DOI 10.1258/ijsa.2008.008099; Leclerc PM, 2007, DEMOGR RES, V16, P121, DOI 10.4054/DemRes.2007.16.5; LECLERC PM, 2008, AJUSTEMENT PROFILS S; Leonard L, 2000, AIDS EDUC PREV, V12, P21; LERIDON H, 1993, POPULATION, V48, P1381, DOI 10.2307/1534182; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; MATTHEWS A, 2008, PICRATE MODEL FITTIN; Mindel A, 2001, BRIT MED J, V322, P1290, DOI 10.1136/bmj.322.7297.1290; Mishra V, 2006, B WORLD HEALTH ORGAN, V84, P537, DOI 10.2471/BLT.05.029520; Morison L, 2001, AIDS, V15, pS61, DOI 10.1097/00002030-200108004-00007; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; NGBICHI JM, 1995, AIDS, V9, P951, DOI 10.1097/00002030-199508000-00018; Orroth KK, 2007, SEX TRANSM INFECT, V83, pI5, DOI 10.1136/sti.2006.023531; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Pinkerton SD, 2008, AIDS BEHAV, V12, P677, DOI 10.1007/s10461-007-9329-1; PIOT P, 1988, SOZ PRAVENTIV MED, V33, P336, DOI 10.1007/BF02084300; PIOT P, 1987, J INFECT DIS, V155, P1108, DOI 10.1093/infdis/155.6.1108; Poonia B, 2006, J ENDOCRINOL, V190, P829, DOI 10.1677/joe.1.06873; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; SERWADDA D, 1995, AIDS, V9, P745, DOI 10.1097/00002030-199507000-00012; SEWANKAMBO NK, 1987, AIDS, V1, P113; Stover J, 1998, AIDS, V12, pS29; Talbott JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000543; *UNAIDS WHO UNICEF, 2008, EP FACT SHEET HIV AI; Van der Ploeg CPB, 1998, INTERFACES, V28, P84, DOI 10.1287/inte.28.3.84; van Vliet C, 2001, B WORLD HEALTH ORGAN, V79, P442; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262	67	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5439	10.1371/journal.pone.0005439	http://dx.doi.org/10.1371/journal.pone.0005439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	442JE	19415113	Green Published, gold, Green Submitted			2022-12-27	WOS:000265836700011
J	Dobson, J; Bowtell, R; Garcia-Prieto, A; Pankhurst, Q				Dobson, Jon; Bowtell, Richard; Garcia-Prieto, Ana; Pankhurst, Quentin			Safety Implications of High-Field MRI: Actuation of Endogenous Magnetic Iron Oxides in the Human Body	PLOS ONE			English	Article							BIOGENIC MAGNETITE; ELECTROMAGNETIC-FIELDS; EXPOSURE; TISSUE; 9.4T	Background: Magnetic Resonance Imaging scanners have become ubiquitous in hospitals and high-field systems (greater than 3 Tesla) are becoming increasingly common. In light of recent European Union moves to limit high-field exposure for those working with MRI scanners, we have evaluated the potential for detrimental cellular effects via nanomagnetic actuation of endogenous iron oxides in the body. Methodology: Theoretical models and experimental data on the composition and magnetic properties of endogenous iron oxides in human tissue were used to analyze the forces on iron oxide particles. Principal Finding and Conclusions: Results show that, even at 9.4 Tesla, forces on these particles are unlikely to disrupt normal cellular function via nanomagnetic actuation.			Dobson, J (corresponding author), Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England.	bea22@keele.ac.uk	Dobson, Jon P/C-8323-2009; Garcia-Prieto, Ana/F-2079-2012	Dobson, Jon P/0000-0002-8108-5362; Garcia-Prieto, Ana/0000-0001-7080-3974; Bowtell, Richard/0000-0001-8656-412X	MRC [G9900259] Funding Source: UKRI; Medical Research Council [G9900259] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDRIOLASILVA AK, 2006, RADIAT ENVIRON BIOPH, V45, P245; Atkinson IC, 2007, J MAGN RESON IMAGING, V26, P1222, DOI 10.1002/jmri.21150; Bassen H, 2005, HEALTH PHYS, V89, P684, DOI 10.1097/01.HP.0000172545.71238.15; Cartmell Sarah H, 2002, IEEE Trans Nanobioscience, V1, P92, DOI 10.1109/TNB.2002.806945; Collingwood JF, 2005, J ALZHEIMERS DIS, V7, P267; de Vocht F, 2006, J MAGN RESON IMAGING, V23, P291, DOI 10.1002/jmri.20510; Dobson J, 1996, BIOCHEM BIOPH RES CO, V227, P718, DOI 10.1006/bbrc.1996.1575; Dobson J, 2002, EXP BRAIN RES, V144, P122, DOI 10.1007/s00221-002-1066-0; Dobson J, 2008, NAT NANOTECHNOL, V3, P139, DOI 10.1038/nnano.2008.39; Dobson J, 2006, IEEE T NANOBIOSCI, V5, P173, DOI 10.1109/TNB.2006.880823; Glover PM, 2007, BIOELECTROMAGNETICS, V28, P349, DOI 10.1002/bem.20316; Hautot D, 2003, P ROY SOC B-BIOL SCI, V270, pS62, DOI 10.1098/rsbl.2003.0012; Hayden ME, 2006, J PHYS-CONDENS MAT, V18, pS2877, DOI 10.1088/0953-8984/18/38/S23; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; KIRSCHVINK JL, 1992, PHYS REV A, V46, P2178, DOI 10.1103/PhysRevA.46.2178; KIRSCHVINK JL, 1992, P NATL ACAD SCI USA, V89, P7683, DOI 10.1073/pnas.89.16.7683; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Pankhurst Q, 2008, J ALZHEIMERS DIS, V13, P49; Pannalal SJ, 2005, EARTH PLANET SC LETT, V236, P856, DOI 10.1016/j.epsl.2005.05.019; Schultheiss-Grassi PP, 1999, BBA-GEN SUBJECTS, V1426, P212, DOI 10.1016/S0304-4165(98)00160-3; Schulz TK, 1997, J TRAUMA STRESS, V10, P351, DOI 10.1002/jts.2490100217; Vaughan T, 2006, MAGN RESON MED, V56, P1274, DOI 10.1002/mrm.21073; Walker LM, 1999, FEBS LETT, V459, P39, DOI 10.1016/S0014-5793(99)01169-2; [No title captured]	24	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2009	4	5							e5431	10.1371/journal.pone.0005431	http://dx.doi.org/10.1371/journal.pone.0005431			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440RC	19412550	Green Published, gold, Green Submitted			2022-12-27	WOS:000265716400004
J	Gibbons, DL; Lin, W; Creighton, CJ; Zheng, SL; Berel, D; Yang, YA; Raso, MG; Liu, DD; Wistuba, II; Lozano, G; Kurie, JM				Gibbons, Don L.; Lin, Wei; Creighton, Chad J.; Zheng, Shuling; Berel, Dror; Yang, Yanan; Raso, Maria Gabriela; Liu, Diane D.; Wistuba, Ignacio I.; Lozano, Guillermina; Kurie, Jonathan M.			Expression Signatures of Metastatic Capacity in a Genetic Mouse Model of Lung Adenocarcinoma	PLOS ONE			English	Article								Background: Non-small cell lung cancer (NSCLC) is the foremost cause of cancer-related death in Western countries, which is due partly to the propensity of NSCLC cells to metastasize. The biologic basis for NSCLC metastasis is not well understood. Methodology/Principal Findings: Here we addressed this deficiency by transcriptionally profiling tumors from a genetic mouse model of human lung adenocarcinoma that develops metastatic disease owing to the expression of K-ras(G12D) and p53(R172H). We identified 2,209 genes that were differentially expressed in distant metastases relative to matched lung tumors. Mining of publicly available data bases revealed this expression signature in a subset of NSCLC patients who had a poorer prognosis than those without the signature. Conclusions/Significance: These findings provide evidence that K-ras(G12D); p53(R172H) mice recapitulate features of human NSCLC metastasis and will provide a useful platform on which to study the biologic basis for lung adenocarcinoma metastasis and its prevention by novel agents.			Gibbons, DL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA.	creighto@bcm.edu; jkurie@mdanderson.org	Yang, Yanan/F-1592-2010; Raso, Maria Gabriela/J-9898-2019; raso, maria/AAS-2118-2020	raso, maria/0000-0003-2105-5556	NCI NIH HHS [R01 CA122608, R01 CA132608, P50 CA070907, T32 CA009666, R01 CA1322608, 5 T32 CA009666, P30 CA125123, P50 CA70907] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009666, P50CA070907, P30CA125123] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Creighton CJ, 2008, RNA, V14, P2290, DOI 10.1261/rna.1188208; Creighton CJ, 2008, J CLIN ONCOL, V26, P4078, DOI 10.1200/JCO.2007.13.4429; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Zheng S, 2007, ONCOGENE, V26, P6896, DOI 10.1038/sj.onc.1210493	19	57	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5401	10.1371/journal.pone.0005401	http://dx.doi.org/10.1371/journal.pone.0005401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404390	gold, Green Published, Green Submitted			2022-12-27	WOS:000265614900012
J	Hansen, CA; Barnett, AG; Jalaludin, BB; Morgan, GG				Hansen, Craig A.; Barnett, Adrian G.; Jalaludin, Bin B.; Morgan, Geoffrey G.			Ambient Air Pollution and Birth Defects in Brisbane, Australia	PLOS ONE			English	Article							ADVERSE PREGNANCY OUTCOMES; HAZARDOUS-WASTE SITES; RESIDENTIAL-MOBILITY; CONGENITAL-ANOMALIES; LANDFILL SITES; RISK; HEALTH; EXPOSURE; PROXIMITY; CHILDREN	Background: Birth defects are a major public health concern as they are the leading cause of neonatal and infant mortality. Observational studies have linked environmental pollution to adverse birth outcomes, including congenital anomalies. This study examined potential associations between ambient air pollution and congenital heart defects and cleft lip or palate among births in Brisbane, Australia (1998-2004). Methods: Ambient air pollution levels were averaged over weeks 3-8 of pregnancy among 150,308 births. Using a case control design, we used conditional logistic regression and matched cases to 5 controls. Analyses were conducted using all births, and then births where the mother resided within 6 and 12 kilometers of an ambient air quality monitor. Findings: When analyzing all births there was no indication that ambient air pollution in Brisbane was associated with a higher risk of cardiac defects. Among births where the mother resided within 6 kilometers of an ambient air quality monitor, a 5 ppb increase in O-3 was associated with an increased risk of pulmonary artery and valve defects (OR 2.96, 95% CI: 1.34, 7.52) while a 0.6 ppb increase in SO2 was associated with an increased risk of aortic artery and valve defects (OR 10.76, 95% CI: 1.50, 179.8). For oral cleft defects among all births, the only adverse association was between SO2 and cleft lip with or without cleft palate (OR 1.27, 95% CI: 1.01, 1.62). However, various significant inverse associations were also found between air pollutants and birth defects. Conclusions: This study found mixed results and it is difficult to conclude whether ambient air pollution in Brisbane has an adverse association with the birth defects examined. Studies using more detailed estimates of air pollution exposure are needed.			Hansen, CA (corresponding author), US EPA, Natl Ctr Environm Assessment, Durham, NC USA.	a.barnett@qut.edu.au	Jalaludin, Bin/ABC-1066-2020; Hansen, Craig/C-7543-2014	Jalaludin, Bin/0000-0001-7664-9621; Hansen, Craig/0000-0002-5227-0155; Morgan, Geoffrey/0000-0003-4046-2405; Barnett, Adrian/0000-0001-6339-0374				[Anonymous], NATL VITAL STAT REPO; Australian Bureau of Statistics, 2001, ASGC; Australian Bureau of Statistics, 2001, 2039055001 AUSTR BUR; Barnett AG, 2006, ENVIRON HEALTH PERSP, V114, P1018, DOI 10.1289/ehp.8674; Barnett AG, 2005, AM J RESP CRIT CARE, V171, P1272, DOI 10.1164/rccm.200411-1586OC; Boothe VL, 2008, J ENVIRON HEALTH, V70, P33; BOOTHE VL, 2008, J ENV HLTH, V70, P55; Canfield MA, 2006, J EXPO SCI ENV EPID, V16, P538, DOI 10.1038/sj.jes.7500501; Cordier S, 2004, OCCUP ENVIRON MED, V61, P8; De la Vega Alberto, 2006, P R Health Sci J, V25, P343; Dolk H, 2003, BRIT MED BULL, V68, P25, DOI 10.1093/bmb/ldg024; Dolk H, 1998, LANCET, V352, P423, DOI 10.1016/S0140-6736(98)01352-X; Dummer TJB, 2003, ARCH ENVIRON HEALTH, V58, P692, DOI 10.3200/AEOH.58.11.692-698; Dummer TJB, 2003, J EPIDEMIOL COMMUN H, V57, P456, DOI 10.1136/jech.57.6.456; Elliott P, 2001, BRIT MED J, V323, P363, DOI 10.1136/bmj.323.7309.363; Fell DB, 2004, PAEDIATR PERINAT EP, V18, P408, DOI 10.1111/j.1365-3016.2004.00580.x; Finnell RH, 2002, ANNU REV PHARMACOL, V42, P181, DOI 10.1146/annurev.pharmtox.42.083001.110955; Garry VF, 2002, ENVIRON HEALTH PERSP, V110, P441, DOI 10.1289/ehp.02110s3441; Gilboa SM, 2005, AM J EPIDEMIOL, V162, P238, DOI 10.1093/aje/kwi189; Glinianaia SV, 2004, EPIDEMIOLOGY, V15, P36, DOI 10.1097/01.ede.0000101023.41844.ac; Hanke Wojciech, 2004, Int J Occup Med Environ Health, V17, P223; Hansen C, 2006, BJOG-INT J OBSTET GY, V113, P935, DOI 10.1111/j.1471-0528.2006.01010.x; Hansen CA, 2008, ENVIRON HEALTH PERSP, V116, P362, DOI 10.1289/ehp.10720; Hwang BF, 2008, ENVIRON HEALTH PERSP, V116, P1411, DOI 10.1289/ehp.11311; KHOURY MJ, 1988, J CLIN EPIDEMIOL, V41, P15, DOI 10.1016/0895-4356(88)90004-2; Krost B, 2006, INT J ORAL MAX SURG, V35, P215, DOI 10.1016/j.ijom.2005.08.007; Kuehn CM, 2007, ENVIRON RES, V103, P405, DOI 10.1016/j.envres.2006.08.008; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Lacasana M, 2005, EUR J EPIDEMIOL, V20, P183, DOI 10.1007/s10654-004-3005-9; LUBIN JH, 1988, STAT MED, V7, P363, DOI 10.1002/sim.4780070302; Maisonet M, 2004, ENVIRON RES, V95, P106, DOI 10.1016/j.envres.2004.01.001; NEALE D, 2001, 38 QUEENSL GOV ENV P; Orr M, 2002, INT J HYG ENVIR HEAL, V205, P19, DOI 10.1078/1438-4639-00126; Palmer SR, 2005, ENVIRON HEALTH PERSP, V113, P1362, DOI 10.1289/ehp.7487; PLUMMER M, 2008, JAGS VERSION 1 0 3 M; Ritz B, 2002, AM J EPIDEMIOL, V155, P17, DOI 10.1093/aje/155.1.17; Ritz B, 2008, BASIC CLIN PHARMACOL, V102, P182, DOI 10.1111/j.1742-7843.2007.00161.x; RUSHTON L, 1999, AIR POLLUTION HLTH; SELLER M, 2004, GENETIC CAUSES CONGE; SHAW GM, 1992, ARCH ENVIRON HEALTH, V47, P236, DOI 10.1080/00039896.1992.9938355; Siffel C, 2005, BIRTH DEFECTS RES A, V73, P655, DOI 10.1002/bdra.20207; Slama R, 2008, ENVIRON HEALTH PERSP, V116, P791, DOI 10.1289/ehp.11074; Sram RJ, 2005, ENVIRON HEALTH PERSP, V113, P375, DOI 10.1289/ehp.6362; Stillerman KP, 2008, REPROD SCI, V15, P631, DOI 10.1177/1933719108322436; STRICKLAND MJ, 2009, AM J EPIDEM IN PRESS; Suarez L, 2007, ANN EPIDEMIOL, V17, P772, DOI 10.1016/j.annepidem.2007.05.005	46	98	104	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5408	10.1371/journal.pone.0005408	http://dx.doi.org/10.1371/journal.pone.0005408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404385	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000265614900019
J	Marcos, S; Moreau, J; Backer, S; Job, D; Andrieux, A; Bloch-Gallego, E				Marcos, Severine; Moreau, Julie; Backer, Stephanie; Job, Didier; Andrieux, Annie; Bloch-Gallego, Evelyne			Tubulin Tyrosination Is Required for the Proper Organization and Pathfinding of the Growth Cone	PLOS ONE			English	Article								Background: During development, neuronal growth cones integrate diffusible and contact guidance cues that are conveyed to both actin and microtubule (MT) cytoskeletons and ensure axon outgrowth and pathfinding. Although several post-translational modifications of tubulin have been identified and despite their strong conservation among species, their physiological roles during development, especially in the nervous sytem, are still poorly understood. Methodology/Findings: Here, we have dissected the role of a post-translational modification of the last amino acid of the alpha-tubulin on axonal growth by analyzing the phenotype of precerebellar neurons in Tubulin tyrosin ligase knock-out mice (TTL(-/-)) through in vivo, ex vivo and in vitro analyses. TTL(-/-) neurons are devoid of tyrosinated tubulin. Their pathway shows defects in vivo, ex vivo, in hindbrains open-book preparations or in vitro, in a collagen matrix. Their axons still orient toward tropic cues, but they emit supernumerary branches and their growth cones are enlarged and exhibit an emission of mis-oriented filopodia. Further analysis of the TTL(-/-) growth cone intracellular organization also reveals that the respective localization of actin and MT filaments is disturbed, with a decrease in the distal accumulation of Myosin IIB, as well as a concomitant Rac1 over-activation in the hindbrain. Pharmacological inhibition of Rac1 over-activation in TTL(-/-) neurons can rescue Myosin IIB localization. Conclusions/Significance: In the growth cone, we propose that tubulin tyrosination takes part in the relative arrangement of actin and MT cytoskeletons, in the regulation of small GTPases activity, and consequently, in the proper morphogenesis, organization and pathfinding of the growth cone during development.			Marcos, S (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France.	evelyne.bloch-gallego@inserm.fr	Bloch-Gallego, Evelyne/P-5072-2017; ANDRIEUX, ANNIE/B-2134-2017	ANDRIEUX, ANNIE/0000-0002-4022-6405; Bloch-Gallego, Evelyne/0000-0003-2779-6187; Moreau, Julie Liliane Marguerite/0000-0003-1559-7703				Alcantara S, 2000, DEVELOPMENT, V127, P1359; Backer S, 2002, NEUROSCIENCE, V113, P743, DOI 10.1016/S0306-4522(02)00221-X; Backer S, 2007, J NEUROSCI, V27, P10323, DOI 10.1523/JNEUROSCI.1102-07.2007; Bloch-Gallego E, 2005, BRAIN RES REV, V49, P253, DOI 10.1016/j.brainresrev.2005.01.003; Bloch-Gallego E, 1999, J NEUROSCI, V19, P4407; Bouquet C, 2004, J NEUROSCI, V24, P7204, DOI 10.1523/JNEUROSCI.2254-04.2004; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Brown J, 2003, J HISTOCHEM CYTOCHEM, V51, P421, DOI 10.1177/002215540305100403; Burnette DT, 2008, DEV CELL, V15, P163, DOI 10.1016/j.devcel.2008.05.016; Causeret F, 2004, DEVELOPMENT, V131, P2841, DOI 10.1242/dev.01162; Causeret F, 2002, DEV BIOL, V246, P429, DOI 10.1006/dbio.2002.0681; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; Gallo G, 2006, J CELL SCI, V119, P3413, DOI 10.1242/jcs.03084; Gonzalez-Billault C, 2002, J NEUROSCI RES, V67, P713, DOI 10.1002/jnr.10161; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Grabham PW, 2003, J CELL SCI, V116, P3739, DOI 10.1242/jcs.00686; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Kaverina I, 2000, CURR BIOL, V10, P739, DOI 10.1016/S0960-9822(00)00544-3; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; KENNEDY TE, 1994, CELL, V78, P435; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; LAMOUREUX P, 1989, Nature (London), V340, P159, DOI 10.1038/340159a0; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; MANSFIELD SG, 1991, J NEUROCYTOL, V20, P654, DOI 10.1007/BF01187067; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; PATURLE L, 1989, BIOCHEMISTRY-US, V28, P2698, DOI 10.1021/bi00432a050; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Sibarita JB, 2005, ADV BIOCHEM ENG BIOT, V95, P201, DOI 10.1007/b102215; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Utreras E, 2008, DEV NEUROSCI-BASEL, V30, P200, DOI 10.1159/000109863; van Leeuwen FN, 1999, NAT CELL BIOL, V1, P242, DOI 10.1038/12068; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Watanabe Takashi, 2005, Novartis Found Symp, V269, P92; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; WEBSTER DR, 1990, J CELL BIOL, V111, P113, DOI 10.1083/jcb.111.1.113; WEHLAND J, 1987, J CELL SCI, V88, P185; Wittmann T, 2001, J CELL SCI, V114, P3795; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Zhou FQ, 2004, J NEUROBIOL, V58, P84, DOI 10.1002/neu.10278; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	58	45	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5405	10.1371/journal.pone.0005405	http://dx.doi.org/10.1371/journal.pone.0005405			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404406	Green Published, Green Submitted, gold			2022-12-27	WOS:000265614900016
J	Widder, S; Macia, J; Sole, R				Widder, Stefanie; Macia, Javier; Sole, Ricard			Monomeric Bistability and the Role of Autoloops in Gene Regulation	PLOS ONE			English	Article							POSITIVE FEEDBACK; NETWORKS; DIFFERENTIATION; BIOLOGY; LAMBDA; MODELS; SWITCH	Genetic toggle switches are widespread in gene regulatory networks (GRN). Bistability, namely the ability to choose among two different stable states, is an essential feature of switching and memory devices. Cells have many regulatory circuits able to provide bistability that endow a cell with efficient and reliable switching between different physiological modes of operation. It is often assumed that negative feedbacks with cooperative binding (i.e. the formation of dimers or multimers) are a prerequisite for bistability. Here we analyze the relation between bistability in GRN under monomeric regulation and the role of autoloops under a deterministic setting. Using a simple geometric argument, we show analytically that bistability can also emerge without multimeric regulation, provided that at least one regulatory autoloop is present.			Widder, S (corresponding author), Complex Syst Lab ICREA UPF, Barcelona Biomed Res Pk PRBB GRIB, Barcelona, Spain.	javier.macia@upf.edu	Widder, Stefanie/B-9584-2014; Solé, Ricard/I-3379-2015	Widder, Stefanie/0000-0003-0733-5666; Sole, Ricard/0000-0001-6974-1008	ICREA Funding Source: Custom	ICREA(ICREA)		Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bundschuh R, 2003, J THEOR BIOL, V220, P261, DOI 10.1006/jtbi.2003.3164; Cherry JL, 2000, J THEOR BIOL, V203, P117, DOI 10.1006/jtbi.2000.1068; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hasty J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148101; Hasty J, 2001, CHAOS, V11, P207, DOI 10.1063/1.1345702; Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; Lipshtat A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.188101; LOINGER A, 2007, PHYS REV E; LOINGER A, 2007, ANNU REV GENET, P409; Lopes FJP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000184; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; McDaniel R, 2005, CURR OPIN BIOTECH, V16, P476, DOI 10.1016/j.copbio.2005.07.002; Noireaux V, 2003, P NATL ACAD SCI USA, V100, P12672, DOI 10.1073/pnas.2135496100; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Santillan M, 2004, BIOPHYS J, V86, P75, DOI 10.1016/S0006-3495(04)74085-0; Sole RV, 2007, PHILOS T R SOC B, V362, P1727, DOI 10.1098/rstb.2007.2065; Tian TH, 2004, J THEOR BIOL, V227, P229, DOI 10.1016/j.jtbi.2003.11.003; Tian TH, 2006, P NATL ACAD SCI USA, V103, P8372, DOI 10.1073/pnas.0507818103; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; TYSON JJ, 1978, PROGR THEORETICAL BI, V11, P1; Walczak AM, 2005, BIOPHYS J, V88, P828, DOI 10.1529/biophysj.104.050666; Warren PB, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.128101; Warren PB, 2005, J PHYS CHEM B, V109, P6812, DOI 10.1021/jp045523y; Widder S, 2007, J THEOR BIOL, V246, P395, DOI 10.1016/j.jtbi.2007.01.004; Wolf DM, 1998, J THEOR BIOL, V195, P167, DOI 10.1006/jtbi.1998.0790	35	12	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5399	10.1371/journal.pone.0005399	http://dx.doi.org/10.1371/journal.pone.0005399			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404388	Green Published, Green Submitted, gold			2022-12-27	WOS:000265614900011
J	Pezzotti, A; Kraft, P; Hankinson, SE; Hunter, DJ; Buring, J; Cox, DG				Pezzotti, Annamaria; Kraft, Peter; Hankinson, Susan E.; Hunter, David J.; Buring, Julie; Cox, David G.			The Mitochondrial A10398G Polymorphism, Interaction with Alcohol Consumption, and Breast Cancer Risk	PLOS ONE			English	Article								Polymorphisms in the mitochondrial genome are hypothesized to be associated with risk of various diseases, including cancer. However, there has been conflicting evidence for associations between a common polymorphism in the mitochondrial genome (A10398G, G10398A in some prior reports) and breast cancer risk. Reactive oxygen species, a by-product of mitochondrial energy production, can lead to oxidative stress and DNA damage in both the mitochondria and their cells. Alcohol consumption, which may also lead to oxidative stress, is associated with breast cancer risk. Therefore, we hypothesized that polymorphisms in the mitochondrial genome interact with alcohol consumption to alter breast cancer risk. We genotyped the A10398G polymorphism in a case-control study nested within the Nurses' Health Study (NHS, 1,561 cases, 2,209 controls). We observed an interaction between alcohol consumption (yes/no) and A10398G on breast cancer risk (p-int = 0.03). The risk associated with alcohol consumption was limited to carriers of the 10398G allele (Odds Ratio 1.52, 95% Confidence Interval 1.10-2.08 comparing drinkers to non-drinkers). However, we were unable to replicate these findings in the Women's Health Study (WHS, 678 cases, 669 controls), although the power to detect this interaction in the WHS was low (power = 0.57). Further examination of this interaction, such as sufficiently powered epidemiological studies of cancer risk or associations with biomarkers of oxidative stress, may provide further evidence for GxE interactions between the A10398G mitochondrial polymorphism and alcohol consumption on breast cancer risk.			Pezzotti, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA.	COX@lyon.fnclcc.fr	Cox, David/ABA-7454-2020; Cox, David G/A-2023-2009	Cox, David G/0000-0002-2152-9259; Cox, David/0000-0003-2047-4687	NATIONAL CANCER INSTITUTE [P01CA087969, U01CA049449, R01CA065725, R01CA049449, R03CA130050] Funding Source: NIH RePORTER; NCI NIH HHS [CA65725, U01 CA049449, R03 CA130050, R01 CA065725, CA87969, P01 CA087969, CA49449, CA130050, R01 CA049449] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554; BONDY SC, 1992, TOXICOL LETT, V63, P231, DOI 10.1016/0378-4274(92)90086-Y; Canter JA, 2005, CANCER RES, V65, P8028, DOI 10.1158/0008-5472.CAN-05-1428; DARVISHI K, 2006, CANC LETT; Edland SD, 2002, ALZ DIS ASSOC DIS, V16, P1, DOI 10.1097/00002093-200201000-00001; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Giacchetti M, 2004, J MED GENET, V41, P293, DOI 10.1136/jmg.2003.015289; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ishii H, 1997, J GASTROEN HEPATOL, V12, pS272, DOI 10.1111/j.1440-1746.1997.tb00510.x; Latsoudis H, 2008, J HUM GENET, V53, P349, DOI 10.1007/s10038-008-0259-1; Mancuso M, 2004, NEUROSCI LETT, V371, P158, DOI 10.1016/j.neulet.2004.08.060; Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4; NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K; REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Setiawan VW, 2008, CANCER GENET CYTOGEN, V181, P16, DOI 10.1016/j.cancergencyto.2007.10.019; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; Suzuki R, 2005, JNCI-J NATL CANCER I, V97, P1601, DOI 10.1093/jnci/dji341; t Hart LM, 2005, DIABETES, V54, P1892, DOI 10.2337/diabetes.54.6.1892; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Zsurka G, 1998, BIOL PSYCHIAT, V44, P371, DOI 10.1016/S0006-3223(97)00461-7	24	40	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5356	10.1371/journal.pone.0005356	http://dx.doi.org/10.1371/journal.pone.0005356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390621	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514400021
J	Liu, JF; Gu, X; Robbins, D; Li, G; Shi, RH; McCord, JM; Zhao, YF				Liu, Jianfeng; Gu, Xin; Robbins, Delira; Li, Guohong; Shi, Runhua; McCord, Joe M.; Zhao, Yunfeng			Protandim, a Fundamentally New Antioxidant Approach in Chemoprevention Using Mouse Two-Stage Skin Carcinogenesis as a Model	PLOS ONE			English	Article							NF-KAPPA-B; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; GENE-EXPRESSION; PROTEIN-KINASE; CANCER; 12-O-TETRADECANOYLPHORBOL-13-ACETATE; INFLAMMATION; APOPTOSIS; CYTOKINES	Oxidative stress is an important contributor to cancer development. Consistent with that, antioxidant enzymes have been demonstrated to suppress tumorigenesis when being elevated both in vitro and in vivo, making induction of these enzymes a more potent approach for cancer prevention. Protandim, a well-defined combination of widely studied medicinal plants, has been shown to induce superoxide dismutase (SOD) and catalase activities and reduce superoxide generation and lipid peroxidation in healthy human subjects. To investigate whether Protandim can suppress tumor formation by a dietary approach, a two-stage mouse skin carcinogenesis study was performed. At the end of the study, the mice on a Protandim-containing basal diet had similar body weight compared with those on the basal diet, which indicated no overt toxicity by Protandim. After three weeks on the diets, there was a significant increase in the expression levels of SOD and catalase, in addition to the increases in SOD activities. Importantly, at the end of the carcinogenesis study, both skin tumor incidence and multiplicity were reduced in the mice on the Protandim diet by 33% and 57% respectively, compared with those on basal diet. Biochemical and histological studies revealed that the Protandim diet suppressed tumor promoter-induced oxidative stress (evidenced by reduction of protein carbonyl levels), cell proliferation (evidenced by reduction of skin hyperplasia and suppression of PKC/JNK/Jun pathway), and inflammation (evidenced by reduction of ICAM-1/VCAM-1 expression, NF-kappa B binding activity, and nuclear p65/p50 levels). Overall, induction of antioxidant enzymes by Protandim may serve as a practical and potent approach for cancer prevention.			Liu, JF (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA.	yzhao1@lsuhsc.edu	McCord, Joe/GWU-8607-2022		NHLBI NIH HHS [R01 HL087990] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087990] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Avila GE, 2005, J PHARMACOL EXP THER, V315, P170, DOI 10.1124/jpet.105.087585; Ballaz Santiago, 2003, Clin Lung Cancer, V5, P46, DOI 10.3816/CLC.2003.n.021; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bauer JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001313; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Cataisson C, 2005, J IMMUNOL, V174, P1686, DOI 10.4049/jimmunol.174.3.1686; Chaurasia SS, 2000, PHARMACOL RES, V41, P663, DOI 10.1006/phrs.1999.0634; Chowdhuri DK, 2002, PHYTOTHER RES, V16, P639, DOI 10.1002/ptr.1023; Clark J, 2006, MOL NUTR FOOD RES, V50, P144, DOI 10.1002/mnfr.200500135; Das KC, 1997, AM J RESP CELL MOL, V17, P713, DOI 10.1165/ajrcmb.17.6.2809; Das M, 2002, PHYTOTHER RES, V16, pS40, DOI 10.1002/ptr.797; DiDonato JA, 2000, METHOD ENZYMOL, V322, P393; DIKSHIT M, 1995, INDIAN J MED RES, V101, P31; Dressler J, 2000, FORENSIC SCI INT, V113, P173, DOI 10.1016/S0379-0738(00)00258-9; Farrow B, 2002, SURG ONCOL, V10, P153, DOI 10.1016/S0960-7404(02)00015-4; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Fujiki H, 2005, CHEM REC, V5, P119, DOI 10.1002/tcr.20039; FUJISAWA H, 1992, Journal of Dermatology (Tokyo), V19, P78; Gazak R, 2007, CURR MED CHEM, V14, P315, DOI 10.2174/092986707779941159; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Hoshiyama Y, 2005, J EPIDEMIOL, V15, pS109, DOI 10.2188/jea.15.S109; Israel A, 2003, NATURE, V423, P596, DOI 10.1038/423596a; Jakubikova J, 2006, J AGR FOOD CHEM, V54, P1656, DOI 10.1021/jf052717h; Jayaprakasam B, 2003, LIFE SCI, V74, P125, DOI 10.1016/j.lfs.2003.07.007; Lu YP, 1997, CANCER RES, V57, P1468; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Marks Friedrich, 2007, V174, P37; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Na HK, 2008, ARCH BIOCHEM BIOPHYS, V476, P171, DOI 10.1016/j.abb.2008.04.003; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Narayanan BA, 2006, CURR CANCER DRUG TAR, V6, P711, DOI 10.2174/156800906779010218; Nelson SK, 2006, FREE RADICAL BIO MED, V40, P341, DOI 10.1016/j.freeradbiomed.2005.08.043; Oberley LW, 2005, BIOMED PHARMACOTHER, V59, P143, DOI 10.1016/j.biopha.2005.03.006; OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457; OBERLEY LW, 1979, CANCER RES, V39, P1141; Pries R, 2006, EXPERT REV ANTICANC, V6, P1195, DOI 10.1586/14737140.6.9.1195; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rose-John Stefan, 2007, V174, P57; Ruckert R, 2000, BRIT J DERMATOL, V143, P1036, DOI 10.1046/j.1365-2133.2000.03784.x; Russo A, 2005, PHYTOMEDICINE, V12, P305, DOI 10.1016/j.phymed.2003.12.008; Schaar D, 2006, CANCER CHEMOTH PHARM, V57, P789, DOI 10.1007/s00280-005-0125-1; Seril DN, 2003, CARCINOGENESIS, V24, P353, DOI 10.1093/carcin/24.3.353; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Singh RP, 2006, ENDOCR-RELAT CANCER, V13, P751, DOI 10.1677/erc.1.01126; Singh Sarvjeet, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P259, DOI 10.2174/187152006776930918; Soto C, 2003, COMP BIOCHEM PHYS C, V136, P205, DOI 10.1016/S1532-0456(03)00214-X; Stuart EC, 2006, LIFE SCI, V79, P2329, DOI 10.1016/j.lfs.2006.07.036; Velmurugan K, 2009, FREE RADICAL BIO MED, V46, P430, DOI 10.1016/j.freeradbiomed.2008.10.050; Wright TI, 2006, J AM ACAD DERMATOL, V54, P933, DOI 10.1016/j.jaad.2005.08.062; Zhang XP, 2007, CLIN CANCER RES, V13, P7181, DOI 10.1158/1078-0432.CCR-07-1133; Zhao YF, 2001, CANCER RES, V61, P6082; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835; Zhao YF, 2001, ANTIOXID REDOX SIGN, V3, P375, DOI 10.1089/15230860152409022; Zhao Yunfeng, 2003, Methods Mol Biol, V218, P177; Zheng X, 2006, CLIN CANCER RES, V12, P3444, DOI 10.1158/1078-0432.CCR-05-2823	56	37	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5284	10.1371/journal.pone.0005284	http://dx.doi.org/10.1371/journal.pone.0005284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384424	Green Published, gold, Green Submitted			2022-12-27	WOS:000265513900017
J	Segal, E; Pan, HZ; Ofek, P; Udagawa, T; Kopeckova, P; Kopecek, J; Satchi-Fainaro, R				Segal, Ehud; Pan, Huaizhong; Ofek, Paula; Udagawa, Taturo; Kopeckova, Pavla; Kopecek, Jindrich; Satchi-Fainaro, Ronit			Targeting Angiogenesis-Dependent Calcified Neoplasms Using Combined Polymer Therapeutics	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; DRUG-DELIVERY; COMBINATION CHEMOTHERAPY; ANTITUMOR-ACTIVITY; HPMA COPOLYMER; CATHEPSIN-K; PHASE-II; BONE; ALENDRONATE	Background: There is an immense clinical need for novel therapeutics for the treatment of angiogenesis-dependent calcified neoplasms such as osteosarcomas and bone metastases. We developed a new therapeutic strategy to target bone metastases and calcified neoplasms using combined polymer-bound angiogenesis inhibitors. Using an advanced "living polymerization'' technique, the reversible addition-fragmentation chain transfer (RAFT), we conjugated the aminobisphosphonate alendronate (ALN), and the potent anti-angiogenic agent TNP-470 with N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer through a Glycine-Glycine-Proline-Norleucine linker, cleaved by cathepsin K, a cysteine protease overexpressed at resorption sites in bone tissues. In this approach, dual targeting is achieved. Passive accumulation is possible due to the increase in molecular weight following polymer conjugation of the drugs, thus extravasating from the tumor leaky vessels and not from normal healthy vessels. Active targeting to the calcified tissues is achieved by ALN's affinity to bone mineral. Methods and Finding: The anti-angiogenic and antitumor potency of HPMA copolymer-ALN-TNP-470 conjugate was evaluated both in vitro and in vivo. We show that free and conjugated ALN-TNP-470 have synergistic anti-angiogenic and antitumor activity by inhibiting proliferation, migration and capillary-like tube formation of endothelial and human osteosarcoma cells in vitro. Evaluation of anti-angiogenic, antitumor activity and body distribution of HPMA copolymer-ALN-TNP470 conjugate was performed on severe combined immunodeficiency ( SCID) male mice inoculated with mCherry-labeled MG-63-Ras human osteosarcoma and by modified Miles permeability assay. Our targeted bi-specific conjugate reduced VEGF-induced vascular hyperpermeability by 92% and remarkably inhibited osteosarcoma growth in mice by 96%. Conclusions: This is the first report to describe a new concept of a narrowly-dispersed combined polymer therapeutic designed to target both tumor and endothelial compartments of bone metastases and calcified neoplasms at a single administration. This new approach of co-delivery of two synergistic drugs may have clinical utility as a potential therapy for angiogenesis-dependent cancers such as osteosarcoma and bone metastases.			Segal, E (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	ronitsf@post.tau.ac.il	Satchi-Fainaro, Ronit/F-9137-2011	Satchi-Fainaro, Ronit/0000-0002-7360-7837; Ofek, Paula/0000-0002-8516-1107	NIGMS NIH HHS [R01 GM069847] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069847] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bagi CM, 2005, ADV DRUG DELIVER REV, V57, P995, DOI 10.1016/j.addr.2004.12.014; Becker CM, 2006, AM J PATHOL, V168, P2074, DOI 10.2353/ajpath.2006.051133; Benny O, 2008, NAT BIOTECHNOL, V26, P799, DOI 10.1038/nbt1415; Berenson JR, 1999, ANNU REV MED, V50, P237; Bhargava P, 1999, CLIN CANCER RES, V5, P1989; Cheng YY, 2004, PEDIATR BLOOD CANCER, V42, P410, DOI 10.1002/pbc.20019; Chesler L, 2007, CANCER RES, V67, P9435, DOI 10.1158/0008-5472.CAN-07-1316; Chuman Hirokazu, 2004, Gan To Kagaku Ryoho, V31, P1331; Claffey KP, 1996, CANCER RES, V56, P172; DuBois S, 2007, CANCER-AM CANCER SOC, V109, P813, DOI 10.1002/cncr.22455; Duncan R, 2001, J CONTROL RELEASE, V74, P135, DOI 10.1016/S0168-3659(01)00328-5; Duncan R, 2006, J DRUG TARGET, V14, P337, DOI 10.1080/10611860600833856; DUNN D, 1977, CANCER-AM CANCER SOC, V40, P3054, DOI 10.1002/1097-0142(197712)40:6<3054::AID-CNCR2820400644>3.0.CO;2-A; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; El-Mabhouh AA, 2006, NUCL MED BIOL, V33, P715, DOI 10.1016/j.nucmedbio.2006.06.004; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gittens SA, 2005, ADV DRUG DELIVER REV, V57, P1011, DOI 10.1016/j.addr.2004.12.015; Font RG, 2008, MED ORAL PATOL ORAL, V13, pE318; Greco F, 2007, J CONTROL RELEASE, V117, P28, DOI 10.1016/j.jconrel.2006.10.012; Haag R, 2006, ANGEW CHEM INT EDIT, V45, P1198, DOI 10.1002/anie.200502113; Hashimoto K, 2005, CANCER RES, V65, P540; Hashimoto K, 2007, BIOCHEM BIOPH RES CO, V354, P478, DOI 10.1016/j.bbrc.2007.01.014; Hering Flavio, 2003, Int. braz j urol., V29, P228, DOI 10.1590/S1677-55382003000300006; Hillner BE, 2000, SEMIN RADIAT ONCOL, V10, P250, DOI 10.1053/S1053-4296(00)80042-9; Hruby M, 2006, J APPL POLYM SCI, V101, P3192, DOI 10.1002/app.23446; Husmann K, 2008, MOL CARCINOGEN, V47, P66, DOI 10.1002/mc.20362; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Inoue R, 2005, BRIT J PHARMACOL, V146, P633, DOI 10.1038/sj.bjp.0706373; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; KRINICK NL, 1994, J BIOMAT SCI-POLYM E, V5, P303, DOI 10.1163/156856294X00040; Kuljanin J, 2002, J PHARMACEUT BIOMED, V28, P1215, DOI 10.1016/S0731-7085(02)00021-3; Lipton A, 2002, CANCER INVEST, V20, P45, DOI 10.1081/CNV-120014886; Lipton A, 2008, CANCER TREAT REV, V34, pS25, DOI 10.1016/j.ctrv.2008.03.008; Marino JP, 2007, J MED CHEM, V50, P3777, DOI 10.1021/jm061182w; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mercadante S, 1997, PAIN, V69, P1, DOI 10.1016/S0304-3959(96)03267-8; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; MILLER K, 2008, WILEY ENCY CHEM BIOL; Molinuevo MS, 2007, EUR J PHARMACOL, V562, P28, DOI 10.1016/j.ejphar.2007.01.054; MORISHITA T, 1995, JPN J CLIN ONCOL, V25, P25; Motl S, 2005, AM J HEALTH-SYST PH, V62, P1021, DOI 10.1093/ajhp/62.10.1021; MOURAD JJ, 2007, ANN ONCOL; Pan HZ, 2008, MOL PHARMACEUT, V5, P548, DOI 10.1021/mp800003u; Pan HZ, 2006, J DRUG TARGET, V14, P425, DOI 10.1080/10611860600834219; Peterson CM, 1996, CANCER RES, V56, P3980; Quan GMY, 2006, CANCER METAST REV, V25, P707, DOI 10.1007/s10555-006-9031-1; Quattrocchi CC, 2007, RADIOL MED, V112, P1049, DOI 10.1007/s11547-007-0205-x; Russell RGG, 2007, PEDIATRICS, V119, pS150, DOI 10.1542/peds.2006-2023H; Russell RGG, 1999, BONE, V25, P97, DOI 10.1016/S8756-3282(99)00116-7; RUSSELL RGG, 1970, LANCET, V2, P899, DOI 10.1016/S0140-6736(70)92070-2; Sanfilippo NJ, 2008, J CLIN ONCOL, V26, P2973, DOI 10.1200/JCO.2007.14.4105; Santini D, 2007, CLIN CANCER RES, V13, P6850, DOI 10.1158/1078-0432.CCR-07-4408; Satchi-Fainaro R, 2006, ADV POLYM SCI, V193, P1, DOI 10.1007/12_024; Satchi-Fainaro R, 2005, CANCER CELL, V7, P251, DOI 10.1016/j.ccr.2005.02.007; Satchi-Fainaro R, 2004, NAT MED, V10, P255, DOI 10.1038/nm1002; Satchi-Fainaro R, 2002, J DRUG TARGET, V10, P529, DOI 10.1080/1061186021000051062; SATCHIFAINARO R, 2008, ANGIOGENESIS INTEGRA, P387; SEGAL E, 2009, PLOS ONE IN PRESS; Sevcik MA, 2004, PAIN, V111, P169, DOI 10.1016/j.pain.2004.06.015; Seymour LW, 2002, J CLIN ONCOL, V20, P1668, DOI 10.1200/JCO.2002.20.6.1668; Shiah JG, 2000, CLIN CANCER RES, V6, P1008; TOL J, 2008, ANN ONCOL; Traina TA, 2007, HEMATOL ONCOL CLIN N, V21, P303, DOI 10.1016/j.hoc.2007.03.006; Tucker LA, 2008, ONCOGENE, V27, P3967, DOI 10.1038/onc.2008.14; Tuomela JM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-81; Uludag H, 2002, CURR PHARM DESIGN, V8, P1929, DOI 10.2174/1381612023393585; Vicent MJ, 2005, ANGEW CHEM INT EDIT, V44, P4061, DOI 10.1002/anie.200462960; Wang D, 2003, BIOCONJUGATE CHEM, V14, P853, DOI 10.1021/bc034090j; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wunder JS, 2007, LANCET ONCOL, V8, P513, DOI 10.1016/S1470-2045(07)70169-9; Zangari M, 2004, CLIN CANCER RES, V10, P88, DOI 10.1158/1078-0432.CCR-0221-3; Zhang Y, 2006, CHEM BIOL, V13, P1001, DOI 10.1016/j.chembiol.2006.07.010; Zhao YX, 2008, BIOORGAN MED CHEM, V16, P6333, DOI 10.1016/j.bmc.2008.05.012	75	98	107	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5233	10.1371/journal.pone.0005233	http://dx.doi.org/10.1371/journal.pone.0005233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381291	gold, Green Published			2022-12-27	WOS:000265513800009
J	Carson, RG; Oytam, Y; Riek, S				Carson, Richard G.; Oytam, Yalchin; Riek, Stephan			Artificial Gravity Reveals that Economy of Action Determines the Stability of Sensorimotor Coordination	PLOS ONE			English	Article							MOTOR CORTEX; BIMANUAL COORDINATION; CEREBRAL ACTIVATION; MOVEMENT; PERCEPTION; DYNAMICS; REPRESENTATION; PET	Background: When we move along in time with a piece of music, we synchronise the downward phase of our gesture with the beat. While it is easy to demonstrate this tendency, there is considerable debate as to its neural origins. It may have a structural basis, whereby the gravitational field acts as an orientation reference that biases the formulation of motor commands. Alternatively, it may be functional, and related to the economy with which motion assisted by gravity can be generated by the motor system. Methodology/Principal Findings: We used a robotic system to generate a mathematical model of the gravitational forces acting upon the hand, and then to reverse the effect of gravity, and invert the weight of the limb. In these circumstances, patterns of coordination in which the upward phase of rhythmic hand movements coincided with the beat of a metronome were more stable than those in which downward movements were made on the beat. When a normal gravitational force was present, movements made down-on-the-beat were more stable than those made up-on-the-beat. Conclusions/Significance: The ubiquitous tendency to make a downward movement on a musical beat arises not from the perception of gravity, but as a result of the economy of action that derives from its exploitation.			Carson, RG (corresponding author), Queens Univ Belfast, Sch Psychol, Belfast BT7 1NN, Antrim, North Ireland.	r.g.carson@qub.ac.uk	Riek, Stephan/A-1506-2010	Riek, Stephan/0000-0002-8355-8426; Lauwereyns, Jan/0000-0003-0551-2550; Carson, Richard/0000-0002-1190-2814				ARNHEIM R, 1984, MUSIC QUART, V70, P295; BEEK PJ, 1979, JUGGLING DYNAMICS; BINDER JR, 1994, COGNITIVE BRAIN RES, V2, P31, DOI 10.1016/0926-6410(94)90018-3; Blinkenberg M, 1996, J CEREBR BLOOD F MET, V16, P794, DOI 10.1097/00004647-199609000-00004; BYBLOW WD, 1994, HUM MOVEMENT SCI, V13, P3, DOI 10.1016/0167-9457(94)90027-2; Carroll TJ, 2001, P ROY SOC B-BIOL SCI, V268, P221, DOI 10.1098/rspb.2000.1356; Carson RG, 1998, EXP BRAIN RES, V121, P103, DOI 10.1007/s002210050442; Carson RG, 1996, EXP BRAIN RES, V110, P99; Carson RG, 1999, P ROY SOC B-BIOL SCI, V266, P853, DOI 10.1098/rspb.1999.0715; Carson RG, 2006, J APPL PHYSIOL, V101, P1506, DOI 10.1152/japplphysiol.00544.2006; Gentili R, 2007, NEUROSCIENCE, V145, P20, DOI 10.1016/j.neuroscience.2006.11.035; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HUFNAGEL A, 1990, J NEUROL, V237, P416, DOI 10.1007/BF00314732; HUMPHREY DR, 1986, FED PROC, V45, P2687; JANTZEN KJ, 2008, J COGN NEUROSCI; KELSO JAS, 1984, AM J PHYSIOL, V246, P1000; Lee DN, 1998, ECOL PSYCHOL, V10, P221, DOI 10.1207/s15326969eco103&4_4; LEMON R, 1988, TRENDS NEUROSCI, V11, P501, DOI 10.1016/0166-2236(88)90012-4; Luppino G, 2000, NEWS PHYSIOL SCI, V15, P219; Mayville JM, 2001, HUM BRAIN MAPP, V14, P65, DOI 10.1002/hbm.1042; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Mechsner F, 2001, NATURE, V414, P69, DOI 10.1038/35102060; Pozzo T, 1998, BRAIN RES REV, V28, P92, DOI 10.1016/S0165-0173(98)00030-7; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Riek S, 2004, HUM MOVEMENT SCI, V23, P431, DOI 10.1016/j.humov.2004.08.016; Schlaug G, 1996, NEUROREPORT, V7, P879, DOI 10.1097/00001756-199603220-00009; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Schneider C, 2002, EXP BRAIN RES, V146, P86, DOI 10.1007/s00221-002-1137-2; Turner RS, 1998, J NEUROPHYSIOL, V80, P2162, DOI 10.1152/jn.1998.80.4.2162	31	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5248	10.1371/journal.pone.0005248	http://dx.doi.org/10.1371/journal.pone.0005248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437TN	19365561	Green Published, gold, Green Submitted			2022-12-27	WOS:000265509900020
J	Bunck, M; Czibere, L; Horvath, C; Graf, C; Frank, E; Kessler, MS; Murgatroyd, C; Muller-Myhsok, B; Gonik, M; Weber, P; Putz, B; Muigg, P; Panhuysen, M; Singewald, N; Bettecken, T; Deussing, JM; Holsboer, F; Spengler, D; Landgraf, R				Bunck, Mirjam; Czibere, Ludwig; Horvath, Charlotte; Graf, Cornelia; Frank, Elisabeth; Kessler, Melanie S.; Murgatroyd, Chris; Mueller-Myhsok, Bertram; Gonik, Mariya; Weber, Peter; Puetz, Benno; Muigg, Patrik; Panhuysen, Markus; Singewald, Nicolas; Bettecken, Thomas; Deussing, Jan M.; Holsboer, Florian; Spengler, Dietmar; Landgraf, Rainer			A Hypomorphic Vasopressin Allele Prevents Anxiety-Related Behavior	PLOS ONE			English	Article								Background: To investigate neurobiological correlates of trait anxiety, CD1 mice were selectively bred for extremes in anxiety-related behavior, with high (HAB) and low (LAB) anxiety-related behavior mice additionally differing in behavioral tests reflecting depression-like behavior. Methodology/Principal Findings: In this study, microarray analysis, in situ hybridization, quantitative real-time PCR and immunohistochemistry revealed decreased expression of the vasopressin gene (Avp) in the hypothalamic paraventricular (PVN) and supraoptic (SON) nuclei of adult LAB mice compared to HAB, NAB (normal anxiety-related behavior) and HABxLAB F1 intercross controls, without detecting differences in receptor expression or density. By sequencing the regions 2.5 kbp up-and downstream of the Avp gene locus, we could identify several polymorphic loci, differing between the HAB and LAB lines. In the gene promoter, a deletion of twelve bp D(22180-2191) is particularly likely to contribute to the reduced Avp expression detected in LAB animals under basal conditions. Indeed, allele-specific transcription analysis of F1 animals revealed a hypomorphic LAB-specific Avp allele with a reduced transcription rate by 75% compared to the HAB-specific allele, thus explaining line-specific Avp expression profiles and phenotypic features. Accordingly, intra-PVN Avp mRNA levels were found to correlate with anxiety-related and depression-like behaviors. In addition to this correlative evidence, a significant, though moderate, genotype/phenotype association was demonstrated in 258 male mice of a freely-segregating F2 panel, suggesting a causal contribution of the Avp promoter deletion to anxiety-related behavior. Discussion: Thus, the identification of polymorphisms in the Avp gene promoter explains gene expression differences in association with the observed phenotype, thus further strengthening the concept of the critical involvement of centrally released AVP in trait anxiety.			Bunck, M (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	czibere@mpipsykl.mpg.de	Pütz, Benno/P-2630-2016; Deussing, Jan M/ABB-5993-2021; Müller-Myhsok, Bertram/A-3289-2013	Pütz, Benno/0000-0002-2208-209X; Deussing, Jan/0000-0002-9329-5252; Murgatroyd, Chris/0000-0002-6885-7794; Czibere, Ludwig/0000-0002-7508-5841; Singewald, Nicolas/0000-0002-0166-3370				Alikhani-Koupaei R, 2007, FASEB J, V21, P3618, DOI 10.1096/fj.07-8140com; Bielsky IF, 2005, NEURON, V47, P503, DOI 10.1016/j.neuron.2005.06.031; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; BIRKETT SD, 1993, ANN NY ACAD SCI, V689, P83, DOI 10.1111/j.1749-6632.1993.tb55539.x; Bohus B, 1998, PROG BRAIN RES, V119, P555; Bruins J, 2006, PSYCHONEUROENDOCRINO, V31, P80, DOI 10.1016/j.psyneuen.2005.06.001; Cervino AC, 2005, GENOMICS, V86, P505, DOI 10.1016/j.ygeno.2005.07.010; Chakrabarty A, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-14; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; Delaval K, 2004, CURR OPIN GENET DEV, V14, P188, DOI 10.1016/j.gde.2004.01.005; Deussing JM, 2007, J CEREBR BLOOD F MET, V27, P1476, DOI 10.1038/sj.jcbfm.9600451; Egashira N, 2007, BEHAV BRAIN RES, V178, P123, DOI 10.1016/j.bbr.2006.12.009; Engin E, 2008, NEUROPEPTIDES, V42, P411, DOI 10.1016/j.npep.2008.04.004; Fava M, 2000, NEURON, V28, P335, DOI 10.1016/S0896-6273(00)00112-4; Fields RL, 2003, J NEUROSCI, V23, P7801; Frank E, 2008, EUR J PHARMACOL, V583, P226, DOI 10.1016/j.ejphar.2007.11.063; Gillespie NA, 2004, TWIN RES, V7, P39, DOI 10.1375/13690520460741435; Griebel G, 2002, P NATL ACAD SCI USA, V99, P6370, DOI 10.1073/pnas.092012099; Hetzenauer A, 2006, NEUROSCIENCE, V139, P1005, DOI 10.1016/j.neuroscience.2006.01.059; IVELL R, 1984, P NATL ACAD SCI-BIOL, V81, P2006, DOI 10.1073/pnas.81.7.2006; Jacobi F, 2004, PSYCHOL MED, V34, P597, DOI 10.1017/S0033291703001399; Ji CH, 1999, ENDOCRINOLOGY, V140, P4564, DOI 10.1210/en.140.10.4564; Kas MJH, 2007, MOL PSYCHIATR, V12, P324, DOI 10.1038/sj.mp.4001979; Keck ME, 2003, NEUROPSYCHOPHARMACOL, V28, P235, DOI 10.1038/sj.npp.1300040; Kessler MS, 2007, EUR J NEUROSCI, V26, P2857, DOI 10.1111/j.1460-9568.2007.05917.x; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kraus RJ, 2001, VIROLOGY, V287, P89, DOI 10.1006/viro.2001.1024; Kromer SA, 2005, J NEUROSCI, V25, P4375, DOI 10.1523/JNEUROSCI.0115-05.2005; Landgraf R, 2001, ENDOCR J, V48, P517, DOI 10.1507/endocrj.48.517; LANDGRAF R, 1995, J NEUROSCI, V15, P4250; Landgraf R, 2007, NEUROSCI BIOBEHAV R, V31, P89, DOI 10.1016/j.neubiorev.2006.07.003; Landgraf Rainer, 2006, CNS & Neurological Disorders-Drug Targets, V5, P167, DOI 10.2174/187152706776359664; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mlynarik M, 2007, HORM BEHAV, V51, P395, DOI 10.1016/j.yhbeh.2006.12.007; Muller MB, 2003, NEUROPSYCHOPHARMACOL, V28, P1991, DOI 10.1038/sj.npp.1300257; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; NEUMANN ID, 2008, PROG BRAIN RES, V170; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PORSOLT RD, 1978, EUR J PHARMACOL, V51, P291, DOI 10.1016/0014-2999(78)90414-4; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Ring RH, 2005, CURR PHARM DESIGN, V11, P205, DOI 10.2174/1381612053382241; Sanders A. R., 1999, NEUROBIOLOGY MENTAL, P299; Scott LV, 2002, J AFFECT DISORDERS, V72, P113, DOI 10.1016/S0165-0327(02)00026-5; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Tsolakidou A, 2008, MOL CELL NEUROSCI, V38, P444, DOI 10.1016/j.mcn.2008.04.005; Turri MG, 2004, MAMM GENOME, V15, P69, DOI [10.1007/S00335-003-3032-y, 10.1007/s00335-003-3032-y]; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Veenema AH, 2008, PROG BRAIN RES, V170, P261, DOI 10.1016/S0079-6123(08)00422-6; Verbalis JG, 2003, REV ENDOCR METAB DIS, V4, P177, DOI 10.1023/A:1022946220908; VILLAR MJ, 1994, BRAIN RES, V644, P273, DOI 10.1016/0006-8993(94)91690-X; Waldherr M, 2007, P NATL ACAD SCI USA, V104, P16681, DOI 10.1073/pnas.0705860104; Wigger A, 2004, NEUROPSYCHOPHARMACOL, V29, P1, DOI 10.1038/sj.npp.1300290; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Willis-Owen SAG, 2006, EUR J HUM GENET, V14, P721, DOI 10.1038/sj.ejhg.5201569; Young LJ, 2001, AM J MED GENET, V105, P53, DOI 10.1002/1096-8628(20010108)105:1<53::AID-AJMG1059>3.3.CO;2-L	60	47	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5129	10.1371/journal.pone.0005129	http://dx.doi.org/10.1371/journal.pone.0005129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357765	Green Submitted, Green Published, gold			2022-12-27	WOS:000265505900007
J	Fitze, PS; Cote, J; San-Jose, LM; Meylan, S; Isaksson, C; Andersson, S; Rossi, JM; Clobert, J				Fitze, Patrick S.; Cote, Julien; San-Jose, Luis Martin; Meylan, Sandrine; Isaksson, Caroline; Andersson, Staffan; Rossi, Jean-Marc; Clobert, Jean			Carotenoid-Based Colours Reflect the Stress Response in the Common Lizard	PLOS ONE			English	Article							CORTICOSTERONE LEVELS; PLUMAGE COLORATION; IMMUNE FUNCTION; SEXUAL ATTRACTIVENESS; SOCIAL-DOMINANCE; OXIDATIVE STRESS; HORMONES; SURVIVAL; PIGMENTATION; REPRODUCTION	Under chronic stress, carotenoid-based colouration has often been shown to fade. However, the ecological and physiological mechanisms that govern colouration still remain largely unknown. Colour changes may be directly induced by the stressor (for example through reduced carotenoid intake) or due to the activation of the physiological stress response (PSR, e. g. due to increased blood corticosterone concentrations). Here, we tested whether blood corticosterone concentration affected carotenoid-based colouration, and whether a trade-off between colouration and PSR existed. Using the common lizard (Lacerta vivipara), we correlatively and experimentally showed that elevated blood corticosterone levels are associated with increased redness of the lizard's belly. In this study, the effects of corticosterone did not depend on carotenoid ingestion, indicating the absence of a trade-off between colouration and PSR for carotenoids. While carotenoid ingestion increased blood carotenoid concentration, colouration was not modified. This suggests that carotenoid-based colouration of common lizards is not severely limited by dietary carotenoid intake. Together with earlier studies, these findings suggest that the common lizard's carotenoid-based colouration may be a composite trait, consisting of fixed (e. g. genetic) and environmentally elements, the latter reflecting the lizard's PSR.	[Fitze, Patrick S.; San-Jose, Luis Martin] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; [Fitze, Patrick S.; San-Jose, Luis Martin] IPE CSIC, Inst Pirenaico Ecol, Jaca, Huesca, Spain; [Cote, Julien; Meylan, Sandrine; Rossi, Jean-Marc; Clobert, Jean] Univ Paris 06, Lab Ecol, Paris, France; [Cote, Julien] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Isaksson, Caroline; Andersson, Staffan] Gothenburg Univ, Dept Zool, Gothenburg, Sweden; [Clobert, Jean] CNRS Moulis, Stn Ecol Expt, USR2936, Moulis, Saint Girons, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Davis; University of Gothenburg; Centre National de la Recherche Scientifique (CNRS)	Fitze, PS (corresponding author), CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain.	patrick.fitze@mncn.csic.es	Cote, Julien/B-7809-2011; Fitze, Patrick S./C-1377-2011; Fitze, Patrick S/A-4719-2011; Garcia, Luis San-José/AAC-5620-2019; Andersson, Staffan/B-1534-2010; sandrine, MEYLAN/AAD-3073-2020; San-Jose, Luis/I-9433-2012	Cote, Julien/0000-0002-4453-5969; Fitze, Patrick S./0000-0002-6298-2471; Fitze, Patrick S/0000-0002-6298-2471; Garcia, Luis San-José/0000-0003-1351-4679; Andersson, Staffan/0000-0003-1474-3596; Sandrine, MEYLAN/0000-0002-0865-3335				Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; AXELROD J, 1984, SCIENCE, V224, P452, DOI 10.1126/science.6143403; Bartolomucci A, 2005, NEUROSCI BIOBEHAV R, V29, P67, DOI 10.1016/j.neubiorev.2004.06.009; BAUWENS D, 1987, Amphibia-Reptilia, V8, P49, DOI 10.1163/156853887X00045; BELTHOFF JR, 1994, CONDOR, V96, P614, DOI 10.2307/1369464; BENDICH A, 1989, J NUTR, V119, P112, DOI 10.1093/jn/119.1.112; Bentley P., 1998, COMP VERTEBRATE ENDO; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Blount JD, 2001, ECOL LETT, V4, P393, DOI 10.1046/j.1461-0248.2001.00255.x; Brawner WR, 2000, AUK, V117, P952, DOI 10.1642/0004-8038(2000)117[0952:EOCAMI]2.0.CO;2; Bremner JD, 1999, BIOL PSYCHIAT, V45, P797, DOI 10.1016/S0006-3223(99)00009-8; Breuner CW, 2003, HORM BEHAV, V43, P115, DOI 10.1016/S0018-506X(02)00020-X; Cabezas S, 2007, HORM BEHAV, V51, P313, DOI 10.1016/j.yhbeh.2006.11.004; Caesar S, 2007, BIOL J LINN SOC, V90, P491, DOI 10.1111/j.1095-8312.2007.00739.x; Calisi RM, 2007, J COMP PHYSIOL B, V177, P641, DOI 10.1007/s00360-007-0162-7; Cash WB, 1999, J EXP ZOOL, V284, P637, DOI 10.1002/(SICI)1097-010X(19991101)284:6<637::AID-JEZ5>3.0.CO;2-N; Chapple DG, 2002, AUSTRAL ECOL, V27, P565, DOI 10.1046/j.1442-9993.2002.01217.x; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Comendant T, 2003, J EVOLUTION BIOL, V16, P948, DOI 10.1046/j.1420-9101.2003.00598.x; Cooper WE, 1992, BIOL REPTILIA HORMON, V18, P298; Cote J, 2008, J EVOLUTION BIOL, V21, P1165, DOI 10.1111/j.1420-9101.2008.01534.x; Cote J, 2006, HORM BEHAV, V49, P320, DOI 10.1016/j.yhbeh.2005.08.004; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; CZECZUGA B, 1980, COMP BIOCHEM PHYS B, V65, P755, DOI 10.1016/0305-0491(80)90194-7; Dufty AM, 2002, TRENDS ECOL EVOL, V17, P190, DOI 10.1016/S0169-5347(02)02498-9; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Fitze PS, 2008, J EVOLUTION BIOL, V21, P246, DOI 10.1111/j.1420-9101.2007.01447.x; Fitze PS, 2008, ECOL LETT, V11, P432, DOI 10.1111/j.1461-0248.2008.01158.x; Fitze PS, 2007, AM NAT, V169, pS137, DOI 10.1086/510094; Fitze PS, 2005, EVOLUTION, V59, P2451, DOI 10.1554/05-208.1; Fitze PS, 2003, OECOLOGIA, V137, P148, DOI 10.1007/s00442-003-1323-3; Fitze PS, 2003, EVOLUTION, V57, P144; GAVAUD J, 1986, GEN COMP ENDOCR, V63, P11, DOI 10.1016/0016-6480(86)90176-0; Goodwin T. W., 1984, BIOCH CAROTENOIDS; HILL GE, 1992, AUK, V109, P1; HILL GE, 1991, NATURE, V350, P337, DOI 10.1038/350337a0; Hill GE, 2006, DIGIT SIGNAL PROCESS; Hu Y, 2000, ENDOCRINE, V13, P123, DOI 10.1385/ENDO:13:1:123; Isaksson C, 2008, P ROY SOC B-BIOL SCI, V275, P309, DOI 10.1098/rspb.2007.1474; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P745, DOI 10.1016/j.cbpc.2004.09.014; Hai L, 2006, COMP BIOCHEM PHYS A, V144, P11, DOI 10.1016/j.cbpa.2006.01.032; Littell R. C, 1996, SAS SYSTEM MIXED MOD; McEwen BS, 1997, BRAIN RES REV, V23, P79, DOI 10.1016/S0165-0173(96)00012-4; McGraw KJ, 2006, BEHAV ECOL SOCIOBIOL, V60, P117, DOI 10.1007/s00265-005-0135-3; McGraw KJ, 2000, P ROY SOC B-BIOL SCI, V267, P1525, DOI 10.1098/rspb.2000.1174; McGraw KJ, 2004, CONDOR, V106, P390, DOI 10.1650/7384; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; Meylan S, 2005, HORM BEHAV, V48, P44, DOI 10.1016/j.yhbeh.2004.11.022; Meylan S, 2003, COMP BIOCHEM PHYS A, V134, P497, DOI 10.1016/S1095-6433(02)00343-4; Meylan S, 2007, OIKOS, V116, P650, DOI 10.1111/j.2007.0030-1299.15432.x; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; Moore IT, 2003, HORM BEHAV, V43, P39, DOI 10.1016/S0018-506X(02)00038-7; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; PARTALLI V, 1987, COMP BIOCH PHYSL B, V82, P767; SAPOLSKY R M, 1992, P287; SERVATIUS RJ, 1994, LIFE SCI, V55, P1611, DOI 10.1016/0024-3205(94)00327-0; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sinervo B, 2003, SCIENCE, V300, P1949, DOI 10.1126/science.1083109; Sinervo B, 2001, EVOLUTION, V55, P2040; Sinervo B, 2007, AM NAT, V170, P663, DOI 10.1086/522092; Tschirren B, 2003, J EVOLUTION BIOL, V16, P91, DOI 10.1046/j.1420-9101.2003.00483.x; Vercken E, 2007, J EVOLUTION BIOL, V20, P221, DOI 10.1111/j.1420-9101.2006.01208.x; Vercken E, 2008, ECOSCIENCE, V15, P320, DOI 10.2980/15-3-3135; Vercken E, 2007, HORM BEHAV, V51, P379, DOI 10.1016/j.yhbeh.2006.12.006; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; Wingfield JC, 2002, INTEGR COMP BIOL, V42, P600, DOI 10.1093/icb/42.3.600; WINGFIELD JC, 1999, HORMONES BEHAV ECOLO, P1	70	79	80	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5111	10.1371/journal.pone.0005111	http://dx.doi.org/10.1371/journal.pone.0005111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352507	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505700015
J	Lopez, MV; Viale, DL; Cafferata, EGA; Bravo, AI; Carbone, C; Gould, D; Chernajovsky, Y; Podhajcer, OL				Lopez, M. Veronica; Viale, Diego L.; Cafferata, Eduardo G. A.; Bravo, Alicia I.; Carbone, Cecilia; Gould, David; Chernajovsky, Yuti; Podhajcer, Osvaldo L.			Tumor Associated Stromal Cells Play a Critical Role on the Outcome of the Oncolytic Efficacy of Conditionally Replicative Adenoviruses	PLOS ONE			English	Article							SPARC EXPRESSION; GENE-EXPRESSION; CYSTEINE SPARC; NEOPLASTIC PROGRESSION; COLORECTAL-CANCER; VIRAL REPLICATION; UP-REGULATION; PROTEIN; PROMOTER; MELANOMA	The clinical efficacy of conditionally replicative oncolytic adenoviruses (CRAd) is still limited by the inefficient infection of the tumor mass. Since tumor growth is essentially the result of a continuous cross-talk between malignant and tumor-associated stromal cells, targeting both cell compartments may profoundly influence viral efficacy. Therefore, we developed SPARC promoter-based CRAds since the SPARC gene is expressed both in malignant cells and in tumor-associated stromal cells. These CRAds, expressing or not the Herpes Simplex thymidine kinase gene (Ad-F512 and Ad(I)-F512-TK, respectively) exerted a lytic effect on a panel of human melanoma cells expressing SPARC; but they were completely attenuated in normal cells of different origins, including fresh melanocytes, regardless of whether cells expressed or not SPARC. Interestingly, both CRAds displayed cytotoxic activity on SPARC positive-transformed human microendothelial HMEC-1 cells and WI-38 fetal fibroblasts. Both CRAds were therapeutically effective on SPARC positive-human melanoma tumors growing in nude mice but exhibited restricted efficacy in the presence of co-administered HMEC-1 or WI-38 cells. Conversely, co-administration of HMEC-1 cells enhanced the oncolytic efficacy of Ad(I)-F512-TK on SPARC-negative MIA PaCa-2 pancreatic cancer cells in vivo. Moreover, conditioned media produced by stromal cells pre-infected with the CRAds enhanced the in vitro viral oncolytic activity on pancreatic cancer cells, but not on melanoma cells. The whole data indicate that stromal cells might play an important role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses.			Lopez, MV (corresponding author), IIBBA CONICET, Inst Leloir, Lab Mol & Cellular Therapy, Buenos Aires, DF, Argentina.	opodhajcer@leloir.org.ar	Cafferata, Eduardo/AAY-1076-2021	podhajcer, osvaldo/0000-0002-6512-8553; Cafferata, Eduardo G/0000-0001-5089-3757	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Alemany R, 2007, MOL ASPECTS MED, V28, P42, DOI 10.1016/j.mam.2006.12.002; BELLAHCENE A, 1995, AM J PATHOL, V146, P95; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Bilbao R, 2000, GENE THER, V7, P1824, DOI 10.1038/sj.gt.3301312; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Briggs J, 2002, ONCOGENE, V21, P7077, DOI 10.1038/sj.onc.1205857; Chlenski A, 2007, ONCOGENE, V26, P4513, DOI 10.1038/sj.onc.1210247; CLARK CJ, 2008, J CELL BIOCH; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; DOMINGUEZ P, 1991, J BONE MINER RES, V6, P1127; Fisher K, 2006, CURR OPIN MOL THER, V8, P301; Gonzalez R, 2006, J VIROL, V80, P964, DOI 10.1128/JVI.80.2.964-974.2006; Goodrum FD, 1997, J VIROL, V71, P548, DOI 10.1128/JVI.71.1.548-561.1997; Gros A, 2008, CANCER RES, V68, P8928, DOI 10.1158/0008-5472.CAN-08-1145; Hafner M, 1995, MATRIX BIOL, V14, P733, DOI 10.1016/S0945-053X(05)80016-2; HEDLEY SJ, 2006, CANC IMMUNOL IMMUNOT; HODGE LD, 1969, VIROLOGY, V37, P554, DOI 10.1016/0042-6822(69)90273-6; Infante JR, 2007, J CLIN ONCOL, V25, P319, DOI 10.1200/JCO.2006.07.8824; Jakubczak JL, 2003, CANCER RES, V63, P1490; Kadonaga JT, 2002, EXP MOL MED, V34, P259, DOI 10.1038/emm.2002.36; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kato Y, 2001, BIOCHEM BIOPH RES CO, V287, P422, DOI 10.1006/bbrc.2001.5622; Kim JH, 2006, JNCI-J NATL CANCER I, V98, P1482, DOI 10.1093/jnci/djj397; Koukourakis MI, 2003, CANCER RES, V63, P5376; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; Ledda F, 1997, J INVEST DERMATOL, V108, P210, DOI 10.1111/1523-1747.ep12334263; Ledda MF, 1997, NAT MED, V3, P171, DOI 10.1038/nm0297-171; Lieber A, 1996, J VIROL, V70, P8944, DOI 10.1128/JVI.70.12.8944-8960.1996; Lopez MV, 2006, MOL CANCER THER, V5, P2503, DOI 10.1158/1535-7163.MCT-06-0286; Martin-Duque P, 2004, HUM GENE THER, V15, P995, DOI 10.1089/hum.2004.15.995; Marx J, 2008, SCIENCE, V320, P38, DOI 10.1126/science.320.5872.38; Mathis JM, 2005, ONCOGENE, V24, P7775, DOI 10.1038/sj.onc.1209044; Mok W, 2007, CANCER RES, V67, P10664, DOI 10.1158/0008-5472.CAN-07-3107; Nettelbeck DM, 2004, INT J CANCER, V108, P136, DOI 10.1002/ijc.11563; Petersen S, 2001, DIS COLON RECTUM, V44, P322, DOI 10.1007/BF02234727; PODHAJCER OL, 2008, CANC METASTASIS REV; Porte H, 1998, CLIN CANCER RES, V4, P1375; PORTE H, 1995, INT J CANCER, V64, P70, DOI 10.1002/ijc.2910640114; Rempel SA, 2001, J NEURO-ONCOL, V53, P149, DOI 10.1023/A:1012201300188; Rempel SA, 1999, CLIN CANCER RES, V5, P237; Rivera AA, 2004, GENE THER, V11, P1694, DOI 10.1038/sj.gt.3302346; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; SAGE H, 1989, J HISTOCHEM CYTOCHEM, V37, P819, DOI 10.1177/37.6.2723400; Sakai N, 2001, HUM PATHOL, V32, P1064, DOI 10.1053/hupa.2001.28244; Sato N, 2003, ONCOGENE, V22, P5021, DOI 10.1038/sj.onc.1206807; Savontaus MJ, 2002, GENE THER, V9, P972, DOI 10.1038/sj.gt.3301747; Selden C, 2007, J GENE MED, V9, P67, DOI 10.1002/jgm.1000; Shi Q, 2004, J BIOL CHEM, V279, P52200, DOI 10.1074/jbc.M409630200; Sova P, 2004, MOL THER, V9, P496, DOI 10.1016/j.ymthe.2003.12.008; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Thomas R, 2000, CLIN CANCER RES, V6, P1140; Vaha-Koskela MJV, 2007, CANCER LETT, V254, P178, DOI 10.1016/j.canlet.2007.02.002; VERNON RB, 1991, BIOL REPROD, V44, P157, DOI 10.1095/biolreprod44.1.157; Volk AL, 2003, CANCER BIOL THER, V2, P511, DOI 10.4161/cbt.2.5.440; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Yamamoto M, 2003, GASTROENTEROLOGY, V125, P1203, DOI 10.1016/S0016-5085(03)01196-X; Yamanaka M, 2001, J UROLOGY, V166, P2495, DOI 10.1016/S0022-5347(05)65623-6; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201	59	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5119	10.1371/journal.pone.0005119	http://dx.doi.org/10.1371/journal.pone.0005119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19337591	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505700018
J	Moraes, JC; Coope, A; Morari, J; Cintra, DE; Roman, EA; Pauli, JR; Romanatto, T; Carvalheira, JB; Oliveira, ALR; Saad, MJ; Velloso, LA				Moraes, Juliana C.; Coope, Andressa; Morari, Joseane; Cintra, Dennys E.; Roman, Erika A.; Pauli, Jose R.; Romanatto, Talita; Carvalheira, Jose B.; Oliveira, Alexandre L. R.; Saad, Mario J.; Velloso, Licio A.			High-Fat Diet Induces Apoptosis of Hypothalamic Neurons	PLOS ONE			English	Article								Consumption of dietary fats is amongst the most important environmental factors leading to obesity. In rodents, the consumption of fat-rich diets blunts leptin and insulin anorexigenic signaling in the hypothalamus by a mechanism dependent on the in situ activation of inflammation. Since inflammatory signal transduction can lead to the activation of apoptotic signaling pathways, we evaluated the effect of high-fat feeding on the induction of apoptosis of hypothalamic cells. Here, we show that consumption of dietary fats induce apoptosis of neurons and a reduction of synaptic inputs in the arcuate nucleus and lateral hypothalamus. This effect is dependent upon diet composition, and not on caloric intake, since pair-feeding is not sufficient to reduce the expression of apoptotic markers. The presence of an intact TLR4 receptor, protects cells from further apoptotic signals. In diet-induced inflammation of the hypothalamus, TLR4 exerts a dual function, on one side activating pro-inflammatory pathways that play a central role in the development of resistance to leptin and insulin, and on the other side restraining further damage by controlling the apoptotic activity.	[Moraes, Juliana C.; Coope, Andressa; Morari, Joseane; Cintra, Dennys E.; Roman, Erika A.; Pauli, Jose R.; Romanatto, Talita; Carvalheira, Jose B.; Saad, Mario J.; Velloso, Licio A.] Univ Estadual Campinas, Dept Internal Med, Campinas, SP, Brazil; [Oliveira, Alexandre L. R.] Univ Estadual Campinas, Dept Anat, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Moraes, JC (corresponding author), Univ Estadual Campinas, Dept Internal Med, Campinas, SP, Brazil.	lavelloso@fcm.unicamp.br	Saad, Mario/ABD-8262-2020; Romanatto, Talita/D-7359-2012; Carvalheira, Jose B/H-8405-2012; Velloso, Licio/AAJ-3778-2020; Morari, Joseane/G-2568-2016; Cintra, Dennys E/N-7758-2017; Oliveira, Alexandre/AAI-6815-2020; Oliveira, Alexandre L. R./C-4436-2012; Pauli, José Rdrigo/AAD-2763-2021; Carvalheira, Jose Barreto Campello/E-8562-2013	Cintra, Dennys E/0000-0002-7954-5630; Oliveira, Alexandre/0000-0003-4224-4575; Oliveira, Alexandre L. R./0000-0003-4224-4575; Pauli, José Rdrigo/0000-0002-6129-1521; Carvalheira, Jose Barreto Campello/0000-0002-0136-0943; Coope, Andressa/0000-0002-7356-9690; Morari, Joseane/0000-0002-0728-4283; Contin Moraes Garotti, Juliana/0000-0002-7143-0644	Fundacao de 395 Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de 396 Desenvolvimento Cientifico e Tecnologico	Fundacao de 395 Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de 396 Desenvolvimento Cientifico e Tecnologico	This work was supported by grants from Fundacao de 395 Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de 396 Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Araujo EP, 2004, J ENDOCRINOL, V181, P25, DOI 10.1677/joe.0.1810025; Astrup A, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00428.x; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bertelli DF, 2006, ENDOCRINOLOGY, V147, P5385, DOI 10.1210/en.2006-0280; Carvalheira JBC, 2001, FEBS LETT, V500, P119, DOI 10.1016/S0014-5793(01)02591-1; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; De Souza CT, 2007, FASEB J, V21, P1153, DOI 10.1096/fj.06-7148com; De Souza CT, 2005, DIABETOLOGIA, V48, P1860, DOI 10.1007/s00125-005-1866-4; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Degasperi GR, 2008, FEBS LETT, V582, P3103, DOI 10.1016/j.febslet.2008.08.006; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Hanisch UK, 2008, TRENDS NEUROSCI, V31, P176, DOI 10.1016/j.tins.2008.01.005; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Lu Y, 2006, J BIOL CHEM, V281, P36683, DOI 10.1074/jbc.M607374200; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Pasinetti GM, 2008, J NEUROCHEM, V106, P1503, DOI 10.1111/j.1471-4159.2008.05454.x; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Picardi PK, 2008, ENDOCRINOLOGY, V149, P3870, DOI 10.1210/en.2007-1506; Rintamaki R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001482; Ryu KY, 2008, P NATL ACAD SCI USA, V105, P4016, DOI 10.1073/pnas.0800096105; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Siegel RM, 2003, IMMUNOL RES, V27, P499, DOI 10.1385/IR:27:2-3:499; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; WADE GN, 1982, PHYSIOL BEHAV, V29, P701, DOI 10.1016/0031-9384(82)90242-6; WEST DB, 1994, J CLIN INVEST, V94, P1410, DOI 10.1172/JCI117477; Xue B, 2007, J BIOL CHEM, V282, P23829, DOI 10.1074/jbc.M609680200	32	282	288	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5045	10.1371/journal.pone.0005045	http://dx.doi.org/10.1371/journal.pone.0005045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340313	Green Submitted, Green Published, gold			2022-12-27	WOS:000265500700010
J	Kelly, H; Carville, K; Grant, K; Jacoby, P; Tran, T; Barr, I				Kelly, Heath; Carville, Kylie; Grant, Kristina; Jacoby, Peter; Tran, Thomas; Barr, Ian			Estimation of Influenza Vaccine Effectiveness from Routine Surveillance Data	PLOS ONE			English	Article								Background: Influenza vaccines are reviewed each year, and often changed, in an effort to maintain their effectiveness against drifted influenza viruses. There is however no regular review of influenza vaccine effectiveness during, or at the end of, Australian influenza seasons. It is possible to use a case control method to estimate vaccine effectiveness from surveillance data when all patients in a surveillance system are tested for influenza and their vaccination status is known. Methodology/Principal Findings: Influenza-like illness (ILI) surveillance is conducted during the influenza season in sentinel general practices scattered throughout Victoria, Australia. Over five seasons 2003-7, data on age, sex and vaccination status were collected and nose and throat swabs were offered to patients presenting within three days of the onset of their symptoms. Swabs were tested using a reverse transcriptase polymerase chain reaction (RT-PCR) test. Those positive for influenza were sent to the World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza where influenza virus culture and strain identification was attempted. We used a retrospective case control design in five consecutive influenza seasons, and estimated influenza vaccine effectiveness (VE) for patients of all ages to be 53% (95% CI 38-64), but 41% (95% CI 19-57) adjusted for age group and year. The adjusted VE for all adults aged at least 20 years, the age groups for whom a benefit of vaccination could be shown, was 51% (95% CI 34-63). Comparison of VE estimates with vaccine and circulating strain matches across the years did not reveal any significant differences. Conclusions/Significance: These estimates support other field studies of influenza vaccine effectiveness, given that theoretical considerations suggest that these values may underestimate true effectiveness, depending on test specificity and the ratio of the influenza ILI attack rate to the non-influenza ILI attack rate. Incomplete recording of vaccination status and under-representation of children in patients from whom a swab was collected limit the data. Improvements have been implemented for prospective studies.	[Kelly, Heath; Carville, Kylie; Grant, Kristina; Tran, Thomas] Victorian Infect Dis Reference Lab, Epidemiol Unit, Melbourne, Vic, Australia; [Kelly, Heath; Carville, Kylie; Grant, Kristina; Tran, Thomas] Victorian Infect Dis Reference Lab, Virus Identificat Lab, Melbourne, Vic, Australia; [Jacoby, Peter] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA, Australia; [Barr, Ian] World Hlth Org, Collaborating Ctr Reference & Res Influenza, Melbourne, FL USA	Victorian Infectious Diseases Reference Laboratory; Victorian Infectious Diseases Reference Laboratory; Telethon Kids Institute; University of Western Australia; World Health Organization	Kelly, H (corresponding author), Victorian Infect Dis Reference Lab, Epidemiol Unit, Melbourne, Vic, Australia.	Heath.kelly@mh.org.au		Barr, Ian/0000-0002-7351-418X; Carville, Kylie/0000-0002-3663-8802	Victorian Government Department of Human Services	Victorian Government Department of Human Services	This study was conducted as part of routine work funded in part by the Victorian Government Department of Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing. The sentinel influenza surveillance program receives support from the Victorian Department of Human Services.	Clothier H, 2006, AUST NZ J PUBL HEAL, V30, P337, DOI 10.1111/j.1467-842X.2006.tb00846.x; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Jefferson TO, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub3; Kelly H, 2000, Commun Dis Intell, V24, P379; Legrand J, 2006, VACCINE, V24, P6605, DOI 10.1016/j.vaccine.2006.05.063; Monto AS, 2004, PEDIATR INFECT DIS J, V23, pS58, DOI 10.1097/01.inf.0000108193.91607.34; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Newall AT, 2008, VACCINE, V26, P2142, DOI 10.1016/j.vaccine.2008.01.050; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; *PAN AM HLTH ORG C, 1982, CONC PROC LAB BAS IN; Prosser LA, 2008, PHARMACOECONOMICS, V26, P163, DOI 10.2165/00019053-200826020-00006; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; StataCorp, 2008, STAT SOFTW REL 10 0; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; Watts CG, 2003, AUST NZ J PUBL HEAL, V27, P409, DOI 10.1111/j.1467-842X.2003.tb00418.x; WRIGHT PF, 1980, AM J EPIDEMIOL, V112, P814, DOI 10.1093/oxfordjournals.aje.a113053; Zangwill KM, 2004, PEDIATR INFECT DIS J, V23, P189, DOI 10.1097/01.inf.0000116292.46143.d6	20	75	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5079	10.1371/journal.pone.0005079	http://dx.doi.org/10.1371/journal.pone.0005079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333374	Green Published, gold			2022-12-27	WOS:000265499900022
J	Wang, ZL; Shufesky, WJ; Montecalvo, A; Divito, SJ; Larregina, AT; Morelli, AE				Wang, Zhiliang; Shufesky, William J.; Montecalvo, Angela; Divito, Sherrie J.; Larregina, Adriana T.; Morelli, Adrian E.			In Situ-Targeting of Dendritic Cells with Donor-Derived Apoptotic Cells Restrains Indirect Allorecognition and Ameliorates Allograft Vasculopathy	PLOS ONE			English	Article								Chronic allograft vasculopathy (CAV) is an atheromatous-like lesion that affects vessels of transplanted organs. It is a component of chronic rejection that conventional immuno-suppression fails to prevent, and is a major cause of graft loss. Indirect allo-recognition through T cells and allo-Abs are critical during CAV pathogenesis. We tested whether the indirect allo-response and its impact on CAV is down-regulated by in situ-delivery of donor Ags to recipient's dendritic cells (DCs) in lymphoid organs in a pro-tolerogenic fashion, through administration of donor splenocytes undergoing early apoptosis. Following systemic injection, donor apoptotic cells were internalized by splenic CD11c(hi) CD8 alpha(+) and CD8(-) DCs, but not by CD11c(int) plasmacytoid DCs. Those DCs that phagocytosed apoptotic cells in vivo remained quiescent, resisted ex vivo-maturation, and presented allo-Ag for up to 3 days. Administration of donor apoptotic splenocytes, unlike cells alive, (i) promoted deletion, FoxP3 expression and IL-10 secretion, and decreased IFN-gamma-release in indirect pathway CD4 T cells; and (ii) reduced cross-priming of anti-donor CD8 T cells in vivo. Targeting recipient's DCs with donor apoptotic cells reduced significantly CAV in a fully-mismatched aortic allograft model. The effect was donor specific, dependent on the physical characteristics of the apoptotic cells, and was associated to down-regulation of the indirect type-1 T cell allo-response and secretion of allo-Abs, when compared to recipients treated with donor cells alive or necrotic. Down-regulation of indirect allo-recognition through in situ-delivery of donor-Ag to recipient's quiescent DCs constitutes a promising strategy to prevent/ameliorate indirect allorecognition and CAV.	[Wang, Zhiliang; Shufesky, William J.; Montecalvo, Angela; Divito, Sherrie J.; Morelli, Adrian E.] Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15260 USA; [Wang, Zhiliang; Shufesky, William J.; Montecalvo, Angela; Divito, Sherrie J.; Morelli, Adrian E.] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA 15260 USA; [Larregina, Adriana T.; Morelli, Adrian E.] Univ Pittsburgh, Med Ctr, Dept Dermatol, Pittsburgh, PA 15260 USA; [Larregina, Adriana T.] Univ Pittsburgh, Med Ctr, Dept Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, ZL (corresponding author), Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15260 USA.	morelli@imap.pitt.edu			National Institutes of Health [R01 HL075512, HL077545, R01 CA100893]; Therakos; NATIONAL CANCER INSTITUTE [R01CA100893] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075512, R01HL077545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Therakos; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Institutes of Health R01 HL075512 and HL077545 (A.E.M), R01 CA100893 (A.T.L.), and a grant from Therakos (to A.E.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, AM J TRANSPLANT, V5, P1808, DOI 10.1111/j.1600-6143.2005.00954.x; Barr ML, 1998, NEW ENGL J MED, V339, P1744, DOI 10.1056/NEJM199812103392404; Benichou G, 1999, J IMMUNOL, V162, P352; Benitez-Ribas D, 2006, J EXP MED, V203, P1629, DOI 10.1084/jem.20052364; Bittencourt MD, 2001, BLOOD, V98, P224, DOI 10.1182/blood.V98.1.224; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Dalgaard J, 2005, J LEUKOCYTE BIOL, V77, P689, DOI 10.1189/jlb.1204711; Diao J, 2007, J IMMUNOL, V179, P2713, DOI 10.4049/jimmunol.179.5.2713; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dzik S, 2002, TRANSFUSION, V42, P1221, DOI 10.1046/j.1537-2995.2002.00175.x; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fadok VA, 1998, BIOCHEM SOC T, V26, P653, DOI 10.1042/bst0260653; Ferguson TA, 2002, J IMMUNOL, V168, P5589, DOI 10.4049/jimmunol.168.11.5589; Fugier-Vivier IJ, 2005, J EXP MED, V201, P373, DOI 10.1084/jem.20041399; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gatza E, 2008, BLOOD, V112, P1515, DOI 10.1182/blood-2007-11-125542; George JF, 2008, J HEART LUNG TRANSPL, V27, P616, DOI 10.1016/j.healun.2008.02.015; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hoeffel G, 2007, IMMUNITY, V27, P481, DOI 10.1016/j.immuni.2007.07.021; Hornick PI, 2000, CIRCULATION, V101, P2405, DOI 10.1161/01.CIR.101.20.2405; Illigens BM, 2002, HUM IMMUNOL, V63, P912, DOI 10.1016/S0198-8859(02)00449-4; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kishimoto K, 2004, J AM SOC NEPHROL, V15, P2423, DOI 10.1097/01.ASN.0000137883.20961.2D; Kitchens WH, 2007, AM J TRANSPLANT, V7, P2675, DOI 10.1111/j.1600-6143.2007.01997.x; Kleinclauss F, 2006, CELL DEATH DIFFER, V13, P41, DOI 10.1038/sj.cdd.4401699; LECHLER RI, 1990, IMMUNOL TODAY, V11, P83, DOI 10.1016/0167-5699(90)90033-6; LEE RS, 1994, J EXP MED, V179, P865, DOI 10.1084/jem.179.3.865; Lee RS, 2001, P NATL ACAD SCI USA, V98, P3276, DOI 10.1073/pnas.051584498; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Lorber MI, 1999, TRANSPLANTATION, V67, P897, DOI 10.1097/00007890-199903270-00018; Maeda A, 2005, J IMMUNOL, V174, P5968, DOI 10.4049/jimmunol.174.10.5968; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Morelli AE, 2006, AM J TRANSPLANT, V6, P254, DOI 10.1111/j.1600-6143.2005.01197.x; Morelli AE, 2003, BLOOD, V101, P611, DOI 10.1182/blood-2002-06-1769; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Morelli AE, 2000, TRANSPLANTATION, V69, P2647, DOI 10.1097/00007890-200006270-00027; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Perruche S, 2004, AM J TRANSPLANT, V4, P1361, DOI 10.1111/j.1600-6143.2004.00509.x; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Pietra BA, 2000, J CLIN INVEST, V106, P1003, DOI 10.1172/JCI10467; Quezada SA, 2003, BLOOD, V102, P1920, DOI 10.1182/blood-2003-02-0586; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ren GW, 2008, J IMMUNOL, V181, P3277, DOI 10.4049/jimmunol.181.5.3277; Russell PS, 1997, TRANSPLANTATION, V64, P1531, DOI 10.1097/00007890-199712150-00005; Russell PS, 2001, J IMMUNOL, V167, P5731, DOI 10.4049/jimmunol.167.10.5731; RUSSELL PS, 1994, J IMMUNOL, V152, P5135; RUSSELL PS, 1994, AM J PATHOL, V144, P260; Sapoznikov A, 2007, J EXP MED, V204, P1923, DOI 10.1084/jem.20062373; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; SivaSai KSR, 1999, TRANSPLANTATION, V67, P1094, DOI 10.1097/00007890-199904270-00002; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stuart LM, 2002, J IMMUNOL, V168, P1627, DOI 10.4049/jimmunol.168.4.1627; Sun E, 2004, CELL DEATH DIFFER, V11, P1258, DOI 10.1038/sj.cdd.4401500; Sun H, 1998, MICROSURG, V18, P368, DOI 10.1002/(SICI)1098-2752(1998)18:6<368::AID-MICR5>3.0.CO;2-F; Uehara S, 2005, J IMMUNOL, V175, P3424, DOI 10.4049/jimmunol.175.5.3424; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; Vella JP, 1999, TRANSPLANTATION, V67, P1523, DOI 10.1097/00007890-199906270-00005; Verbovetski I, 2002, J EXP MED, V196, P1553, DOI 10.1084/jem.20020263; Viret C, 2000, J IMMUNOL, V164, P4627, DOI 10.4049/jimmunol.164.9.4627; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wang Z, 2006, AM J TRANSPLANT, V6, P1297, DOI 10.1111/j.1600-6143.2006.01308.x; Wang ZL, 2005, TRANSPLANTATION, V79, P869, DOI 10.1097/01.TP.0000157120.43052.3A; Weiss MJ, 2008, FRONT BIOSCI-LANDMRK, V13, P2980, DOI 10.2741/2903; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Yamada A, 2003, AM J TRANSPLANT, V3, P23, DOI 10.1034/j.1600-6143.2003.30105.x; Yu G, 2006, J EXP MED, V203, P1851, DOI 10.1084/jem.20060603	77	39	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4940	10.1371/journal.pone.0004940	http://dx.doi.org/10.1371/journal.pone.0004940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333400	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000265499900004
J	Guerin, A; d'Aubenton-Carafa, Y; Marrakchi, E; Da Silva, C; Wincker, P; Mazan, S; Retaux, S				Guerin, Adele; d'Aubenton-Carafa, Yves; Marrakchi, Emna; Da Silva, Corinne; Wincker, Patrick; Mazan, Sylvie; Retaux, Sylvie			Neurodevelopment Genes in Lampreys Reveal Trends for Forebrain Evolution in Craniates	PLOS ONE			English	Article							LIM-HOMEODOMAIN; EVO-DEVO; EXPRESSION; CELL; BRAIN; PROLIFERATION; TELENCEPHALON; TRANSCRIPTION; VERTEBRATE; MIGRATION	The forebrain is the brain region which has undergone the most dramatic changes through vertebrate evolution. Analyses conducted in lampreys are essential to gain insight into the broad ancestral characteristics of the forebrain at the dawn of vertebrates, and to understand the molecular basis for the diversifications that have taken place in cyclostomes and gnathostomes following their splitting. Here, we report the embryonic expression patterns of 43 lamprey genes, coding for transcription factors or signaling molecules known to be involved in cell proliferation, stemcellness, neurogenesis, patterning and regionalization in the developing forebrain. Systematic expression patterns comparisons with model organisms highlight conservations likely to reflect shared features present in the vertebrate ancestors. They also point to changes in signaling systems-pathways which control the growth and patterning of the neuroepithelium-, which may have been crucial in the evolution of forebrain anatomy at the origin of vertebrates.			Guerin, A (corresponding author), Inst Alfred Fessard, CNRS, UPR2197, Equipe Dev Evolut Cerveau Anterieur, Gif Sur Yvette, France.	retaux@inaf.cnrs-gif.fr		DA SILVA, Corinne/0000-0002-7618-7831				Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Baston E, 2007, RECENT PAT ANTI-CANC, V2, P31, DOI 10.2174/157489207779561453; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BULLOCK TH, 1984, NEUROSCI LETT, V48, P145, DOI 10.1016/0304-3940(84)90010-7; BUTLER AB, 1996, COMP VERTEBRATE NEUR, P349; Carrera I, 2008, BRAIN RES BULL, V75, P405, DOI 10.1016/j.brainresbull.2007.10.013; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Cobos I, 2001, DEV BIOL, V239, P30, DOI 10.1006/dbio.2001.0422; Derobert Y, 2002, DEV BIOL, V247, P390, DOI 10.1006/dbio.2002.0700; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Fischer T, 2007, NEUROSCIENCE, V147, P693, DOI 10.1016/j.neuroscience.2007.04.060; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Hammond KL, 2006, DEVELOPMENT, V133, P1347, DOI 10.1242/dev.02306; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Joly JS, 2007, SEMIN CELL DEV BIOL, V18, P512, DOI 10.1016/j.semcdb.2007.06.001; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; Kawauchi H, 2006, GEN COMP ENDOCR, V148, P3, DOI 10.1016/j.ygcen.2005.10.011; Kim AS, 2001, MECH DEVELOP, V103, P167, DOI 10.1016/S0925-4773(01)00342-2; Kim SH, 1998, MECH DEVELOP, V78, P193, DOI 10.1016/S0925-4773(98)00137-3; Kuratani S, 2002, GENESIS, V34, P175, DOI 10.1002/gene.10142; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; McCauley DW, 2008, ZOOL SCI, V25, P982, DOI 10.2108/zsj.25.982; McCauley DW, 2002, GENE, V287, P129, DOI 10.1016/S0378-1119(01)00894-0; Metin C, 2007, DEVELOPMENT, V134, P2815, DOI 10.1242/dev.02869; Meulemans D, 2003, DEV BIOL, V264, P430, DOI 10.1016/j.ydbio.2003.09.006; Miyake A, 2005, DEV BIOL, V288, P259, DOI 10.1016/j.ydbio.2005.09.042; Moreno N, 2008, DEV NEUROBIOL, V68, P504, DOI 10.1002/dneu.20603; Murakami Y, 2001, DEVELOPMENT, V128, P3521; Muruganandan S, 2008, CLIN PHARMACOL THER, V83, P818, DOI 10.1038/clpt.2008.50; Myojin M, 2001, J EXP ZOOL, V291, P68, DOI 10.1002/jez.6; Nakayama Y, 2008, DEV BIOL, V313, P752, DOI 10.1016/j.ydbio.2007.11.013; Ogasawara M, 2001, GENESIS, V30, P51, DOI 10.1002/gene.1032; Ohtanii K, 2008, J EXP ZOOL PART B, V310B, P596, DOI 10.1002/jez.b.21231; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Osorio J, 2005, DEV BIOL, V288, P100, DOI 10.1016/j.ydbio.2005.08.042; Osorio J, 2008, DEV GENES EVOL, V218, P221, DOI 10.1007/s00427-008-0208-1; Osorio J, 2006, GENE EXPR PATTERNS, V6, P873, DOI 10.1016/j.modgep.2006.02.007; Ota KG, 2006, ZOOL SCI, V23, P403, DOI 10.2108/zsj.23.403; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Peng G, 2006, DEVELOPMENT, V133, P3191, DOI 10.1242/dev.02485; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Sauka-Spengler T, 2007, DEV CELL, V13, P405, DOI 10.1016/j.devcel.2007.08.005; Stoilov I, 2001, DRUG METAB DRUG INTE, V18, P33, DOI DOI 10.1515/DMDI.2001.18.1.33); Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Suda Y, 2009, DEV BIOL, V325, P282, DOI 10.1016/j.ydbio.2008.09.018; TAHARA Y, 1988, ZOOL SCI, V5, P109; Tendeng C, 2006, GENE EXPR PATTERNS, V6, P761, DOI 10.1016/j.modgep.2006.01.006; Tessmar-Raible K, 2007, SEMIN CELL DEV BIOL, V18, P492, DOI 10.1016/j.semcdb.2007.04.007; Ueki T, 1998, DEV GENES EVOL, V208, P223, DOI 10.1007/s004270050176; vanderWees J, 1996, MECH DEVELOP, V54, P173, DOI 10.1016/0925-4773(95)00471-8; Villar-Cheda B, 2006, J COMP NEUROL, V494, P986, DOI 10.1002/cne.20851; Walshe J, 2003, DEVELOPMENT, V130, P4337, DOI 10.1242/dev.00660; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Weigle C, 1999, EUR J MORPHOL, V37, P122, DOI 10.1076/ejom.37.2.122.4751; Winkler C, 2003, GENOME RES, V13, P1067, DOI 10.1101/gr.1097503; Wullimann MF, 2000, ANAT EMBRYOL, V202, P385, DOI 10.1007/s004290000115; Wullimann MF, 1999, ANAT EMBRYOL, V199, P329, DOI 10.1007/s004290050232	62	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5374	10.1371/journal.pone.0005374	http://dx.doi.org/10.1371/journal.pone.0005374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399187	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514900023
J	Muigg, P; Scheiber, S; Salchner, P; Bunck, M; Landgraf, R; Singewald, N				Muigg, Patrik; Scheiber, Sandra; Salchner, Peter; Bunck, Mirjam; Landgraf, Rainer; Singewald, Nicolas			Differential Stress-Induced Neuronal Activation Patterns in Mouse Lines Selectively Bred for High, Normal or Low Anxiety	PLOS ONE			English	Article							DEPRESSION-LIKE BEHAVIOR; EARLY GENE-EXPRESSION; ELEVATED-PLUS-MAZE; C-FOS EXPRESSION; NOVELTY-SEEKING; INDIVIDUAL-DIFFERENCES; PREFRONTAL CORTEX; NEURAL CIRCUITS; BRAIN ACTIVITY; ANIMAL-MODELS	There is evidence for a disturbed perception and processing of emotional information in pathological anxiety. Using a rat model of trait anxiety generated by selective breeding, we previously revealed differences in challenge-induced neuronal activation in fear/anxiety-related brain areas between high (HAB) and low (LAB) anxiety rats. To confirm whether findings generalize to other species, we used the corresponding HAB/LAB mouse model and investigated c-Fos responses to elevated open arm exposure. Moreover, for the first time we included normal anxiety mice (NAB) for comparison. The results confirm that HAB mice show hyperanxious behavior compared to their LAB counterparts, with NAB mice displaying an intermediate anxiety phenotype. Open arm challenge revealed altered c-Fos response in prefrontal-cortical, limbic and hypothalamic areas in HAB mice as compared to LAB mice, and this was similar to the differences observed previously in the HAB/LAB rat lines. In mice, however, additional differential c-Fos response was observed in subregions of the amygdala, hypothalamus, nucleus accumbens, midbrain and pons. Most of these differences were also seen between HAB and NAB mice, indicating that it is predominately the HAB line showing altered neuronal processing. Hypothalamic hypoactivation detected in LAB versus NAB mice may be associated with their low-anxiety/high-novelty- seeking phenotype. The detection of similarly disturbed activation patterns in a key set of anxiety-related brain areas in two independent models reflecting psychopathological states of trait anxiety confirms the notion that the altered brain activation in HAB animals is indeed characteristic of enhanced (pathological) anxiety, providing information for potential targets of therapeutic intervention.			Muigg, P (corresponding author), Univ Innsbruck, Dept Pharmacol & Toxicol, Inst Pharm, CMBI, A-6020 Innsbruck, Austria.	nicolas.singewald@uibk.ac.at		Singewald, Nicolas/0000-0002-0166-3370				Anand A, 2003, ANN NY ACAD SCI, V985, P370; Bernard JF, 1998, J COMP NEUROL, V401, P429; Blizard DA, 2002, BEHAV GENET, V32, P277, DOI 10.1023/A:1020206120248; Bremner J Douglas, 2004, Expert Rev Neurother, V4, P275, DOI 10.1586/14737175.4.2.275; Bremner JD, 1996, SYNAPSE, V23, P39, DOI 10.1002/(SICI)1098-2396(199605)23:1<39::AID-SYN5>3.3.CO;2-Y; Cannistraro Paul A, 2003, Psychopharmacol Bull, V37, P8; Clement Y, 2002, BRAIN RES BULL, V57, P57, DOI 10.1016/S0361-9230(01)00637-2; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Davidson RJ, 2002, BIOL PSYCHIAT, V52, P478, DOI 10.1016/S0006-3223(02)01458-0; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Do-Rego JC, 2002, PHARMACOL BIOCHEM BE, V72, P411, DOI 10.1016/S0091-3057(01)00761-4; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; DUNCAN GE, 1993, J NEUROSCI, V13, P3932; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; Ferguson GD, 2004, NEUROPHARMACOLOGY, V47, P604, DOI 10.1016/j.neuropharm.2004.05.008; FRANCATI V, 2006, DEPRESS ANXIETY; Frank E, 2006, BEHAV NEUROSCI, V120, P60, DOI 10.1037/0735-7044.120.1.60; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; GRAEFF FG, 1994, BRAZ J MED BIOL RES, V27, P811; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Harro J, 2001, BRAIN RES REV, V38, P79, DOI 10.1016/S0165-0173(01)00082-0; Henderson ND, 2004, BEHAV GENET, V34, P267, DOI 10.1023/B:BEGE.0000017872.25069.44; Holsboer F, 1996, ENDOCR REV, V17, P187, DOI 10.1210/er.17.2.187; Kabbaj M, 2001, NEUROSCIENCE, V106, P535, DOI 10.1016/S0306-4522(01)00291-3; Kent Justine M, 2003, Curr Psychiatry Rep, V5, P266, DOI 10.1007/s11920-003-0055-8; Kessler MS, 2007, EUR J NEUROSCI, V26, P2857, DOI 10.1111/j.1460-9568.2007.05917.x; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Kovacs KJ, 1996, J NEUROSCI, V16, P262; Kromer SA, 2005, J NEUROSCI, V25, P4375, DOI 10.1523/JNEUROSCI.0115-05.2005; Landgraf R, 2007, NEUROSCI BIOBEHAV R, V31, P89, DOI 10.1016/j.neubiorev.2006.07.003; Laxmi TR, 2003, BEHAV BRAIN RES, V145, P89, DOI 10.1016/S0166-4328(03)00101-3; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Lovick TA, 1996, PROG BRAIN RES, V107, P301; Mairesse J, 2007, PSYCHONEUROENDOCRINO, V32, P765, DOI 10.1016/j.psyneuen.2007.03.013; Mallo T, 2007, BEHAV BRAIN RES, V177, P269, DOI 10.1016/j.bbr.2006.11.022; Martinez M, 2002, STRESS, V5, P3, DOI 10.1080/102538902900012369; Matrov D, 2007, NEUROSCI LETT, V413, P154, DOI 10.1016/j.neulet.2006.11.076; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Morilak DA, 2005, PROG NEURO-PSYCHOPH, V29, P1214, DOI 10.1016/j.pnpbp.2005.08.007; Muigg P, 2007, BIOL PSYCHIAT, V61, P782, DOI 10.1016/j.biopsych.2006.08.035; Muigg P, 2008, EUR J NEUROSCI, V28, P2299, DOI 10.1111/j.1460-9568.2008.06511.x; Nguyen NK, 2009, SYNAPSE, V63, P236, DOI 10.1002/syn.20597; Ohl F, 2005, HANDB EXP PHARM, V169, P35; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Pawlak CR, 2008, NEUROSCI BIOBEHAV R, V32, P1544, DOI 10.1016/j.neubiorev.2008.06.007; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Ponder CA, 2007, GENES BRAIN BEHAV, V6, P736, DOI 10.1111/j.1601-183X.2007.00306.x; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rosen JB, 1998, BRAIN RES, V796, P132, DOI 10.1016/S0006-8993(98)00294-7; Salchner P, 2006, NEUROPHARMACOLOGY, V50, P1048, DOI 10.1016/j.neuropharm.2006.02.008; Salome N, 2004, BIOL PSYCHIAT, V55, P715, DOI 10.1016/j.biopsych.2003.10.021; Salome N, 2006, BEHAV NEUROSCI, V120, P719, DOI 10.1037/0735-7044.120.3.719; Shekhar A, 2005, STRESS, V8, P209, DOI 10.1080/10253890500504557; Shepard JD, 2008, BEHAV BRAIN RES, V186, P239, DOI 10.1016/j.bbr.2007.08.013; Singewald N, 2003, BIOL PSYCHIAT, V53, P275, DOI 10.1016/S0006-3223(02)01574-3; Singewald N, 2007, NEUROSCI BIOBEHAV R, V31, P18, DOI 10.1016/j.neubiorev.2006.02.003; Stead JDH, 2006, BEHAV GENET, V36, P697, DOI 10.1007/s10519-006-9058-7; Steimer T, 2003, STRESS, V6, P87, DOI 10.1080/1025389031000111320; Strohle A, 2003, PHARMACOPSYCHIATRY, V36, pS207; Suaudeau C, 2000, PHYSIOL BEHAV, V71, P517, DOI 10.1016/S0031-9384(00)00383-8; Sved AF, 2002, PHYSIOL BEHAV, V77, P737, DOI 10.1016/S0031-9384(02)00927-7; Talbot CJ, 2003, MAMM GENOME, V14, P223, DOI 10.1007/s00335-002-3059-5; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; van Eden CG, 2000, PROG BRAIN RES, V126, P49; WATANABE Y, 1994, NEUROREPORT, V5, P1321, DOI 10.1097/00001756-199406270-00006; Zangenehpour S, 2002, MOL BRAIN RES, V109, P221, DOI 10.1016/S0169-328X(02)00556-9	69	56	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5346	10.1371/journal.pone.0005346	http://dx.doi.org/10.1371/journal.pone.0005346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399175	gold, Green Submitted, Green Published			2022-12-27	WOS:000265514900010
J	Dubois, V; Debreyer, C; Quentin, C; Parissi, V				Dubois, Veronique; Debreyer, Carole; Quentin, Claudine; Parissi, Vincent			In Vitro Recombination Catalyzed by Bacterial Class 1 Integron Integrase IntI1 Involves Cooperative Binding and Specific Oligomeric Intermediates	PLOS ONE			English	Article								Gene transfer via bacterial integrons is a major pathway for facilitating the spread of antibiotic resistance genes across bacteria. Recently the mechanism underlying the recombination catalyzed by class 1 integron recombinase (IntI1) between attC and attI1 was highlighted demonstrating the involvement of a single-stranded intermediary on the attC site. However, the process allowing the generation of this single-stranded substrate has not been determined, nor have the active IntI1.DNA complexes been identified. Using the in vitro strand transfer assay and a crosslink strategy we previously described we demonstrated that the single-stranded attC sequences could be generated in the absence of other bacterial proteins in addition to IntI. This suggests a possible role for this protein in stabilizing and/or generating this structure. The mechanism of folding of the active IntI.DNA complexes was further analyzed and we show here that it involves a cooperative binding of the protein to each recombination site and the emergence of different oligomeric species specific for each DNA substrate. These findings provide further insight into the recombination reaction catalyzed by IntI1.			Dubois, V (corresponding author), Univ Victor Segalen Bordeaux 2, CNRS, UMR 5097, Lab Cellular & Mol Microbiol & Pathogen MCMP, Bordeaux, France.	vincent.parissi@reger.u-bordeaux2.fr	QUENTIN, Claudine/A-9701-2012; Dubois, Veronique/F-9378-2011					Bouvier M, 2005, EMBO J, V24, P4356, DOI 10.1038/sj.emboj.7600898; Collis CM, 1998, MOL MICROBIOL, V29, P477, DOI 10.1046/j.1365-2958.1998.00936.x; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; Collis CM, 2001, J BACTERIOL, V183, P2535, DOI 10.1128/JB.183.8.2535-2542.2001; Demarre G, 2007, NUCLEIC ACIDS RES, V35, P6475, DOI 10.1093/nar/gkm709; Dubois V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001315; Dubois W, 2002, ANTIMICROB AGENTS CH, V46, P638, DOI 10.1128/AAC.46.3.638-645.2002; Dufour E, 1999, J MOL BIOL, V285, P1339, DOI 10.1006/jmbi.1998.2430; Falbo V, 1999, ANTIMICROB AGENTS CH, V43, P693, DOI 10.1128/AAC.43.3.693; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Francia MV, 1999, J BACTERIOL, V181, P6844, DOI 10.1128/JB.181.21.6844-6849.1999; HALL RM, 1991, MOL MICROBIOL, V5, P1941, DOI 10.1111/j.1365-2958.1991.tb00817.x; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; HALL RM, 1999, ANN N Y ACAD SCI, V870; Holmes AJ, 2003, ENVIRON MICROBIOL, V5, P383, DOI 10.1046/j.1462-2920.2003.00429.x; MacDonald D, 2006, NATURE, V440, P1157, DOI 10.1038/nature04643; PETSKO GA, 1985, METHOD ENZYMOL, V114, P147; RECCHIA GD, 1994, NUCLEIC ACIDS RES, V22, P2071, DOI 10.1093/nar/22.11.2071; Stokes HW, 1997, MOL MICROBIOL, V26, P731, DOI 10.1046/j.1365-2958.1997.6091980.x	19	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5228	10.1371/journal.pone.0005228	http://dx.doi.org/10.1371/journal.pone.0005228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381299	Green Published, gold, Green Submitted			2022-12-27	WOS:000265513800008
J	Mohammad, KS; Chen, CG; Balooch, G; Stebbins, E; McKenna, CR; Davis, H; Niewolna, M; Peng, XH; Nguyen, DHN; Ionova-Martin, SS; Bracey, JW; Hogue, WR; Wong, DH; Ritchie, RO; Suva, LJ; Derynck, R; Guise, TA; Alliston, T				Mohammad, Khalid S.; Chen, Carol G.; Balooch, Guive; Stebbins, Elizabeth; McKenna, C. Ryan; Davis, Holly; Niewolna, Maria; Peng, Xiang Hong; Nguyen, Daniel H. N.; Ionova-Martin, Sophi S.; Bracey, John W.; Hogue, William R.; Wong, Darren H.; Ritchie, Robert O.; Suva, Larry J.; Derynck, Rik; Guise, Theresa A.; Alliston, Tamara			Pharmacologic Inhibition of the TGF-beta Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone	PLOS ONE			English	Article								During development, growth factors and hormones cooperate to establish the unique sizes, shapes and material properties of individual bones. Among these, TGF-beta has been shown to developmentally regulate bone mass and bone matrix properties. However, the mechanisms that control postnatal skeletal integrity in a dynamic biological and mechanical environment are distinct from those that regulate bone development. In addition, despite advances in understanding the roles of TGF-beta signaling in osteoblasts and osteoclasts, the net effects of altered postnatal TGF-beta signaling on bone remain unclear. To examine the role of TGF-beta in the maintenance of the postnatal skeleton, we evaluated the effects of pharmacological inhibition of the TGF-beta type I receptor (T beta RI) kinase on bone mass, architecture and material properties. Inhibition of T beta RI function increased bone mass and multiple aspects of bone quality, including trabecular bone architecture and macro-mechanical behavior of vertebral bone. T beta RI inhibitors achieved these effects by increasing osteoblast differentiation and bone formation, while reducing osteoclast differentiation and bone resorption. Furthermore, they induced the expression of Runx2 and EphB4, which promote osteoblast differentiation, and ephrinB2, which antagonizes osteoclast differentiation. Through these anabolic and anti-catabolic effects, T beta RI inhibitors coordinate changes in multiple bone parameters, including bone mass, architecture, matrix mineral concentration and material properties, that collectively increase bone fracture resistance. Therefore, T beta RI inhibitors may be effective in treating conditions of skeletal fragility.			Mohammad, KS (corresponding author), Univ Virginia, Div Endocrinol, Dept Internal Med, Charlottesville, VA 22903 USA.	tamara.alliston@ucsf.edu	Ritchie, Robert O/A-8066-2008; Mohammad, Khalid/AFE-4205-2022; Mohammad, Khalid/AAE-9569-2022	Ritchie, Robert O/0000-0002-0501-6998; Alliston, Tamara/0000-0001-9992-2897; Suva, Larry/0000-0002-2892-9757	NIDCR NIH HHS [R03 DE016868, R03 DE016868-02] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE016868] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Alliston Tamara, 2008, P667; [Anonymous], 1990, E399 ASTM; Arany PR, 2006, P NATL ACAD SCI USA, V103, P9250, DOI 10.1073/pnas.0602473103; *ASTM, 2006, E1820 ASTM; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Bonniaud P, 2005, AM J RESP CRIT CARE, V171, P889, DOI 10.1164/rccm.200405-612OC; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; CURREY JD, 1969, J BIOMECH, V2, P477, DOI 10.1016/0021-9290(69)90023-2; Currey JD, 1999, J EXP BIOL, V202, P3285; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Derynck Rik, 2008, P613; Erlebacher A, 1998, MOL BIOL CELL, V9, P1903, DOI 10.1091/mbc.9.7.1903; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; Fox SW, 2005, MOL CELL ENDOCRINOL, V243, P19, DOI 10.1016/j.mce.2005.09.008; Gaddy-Kurten D, 2002, ENDOCRINOLOGY, V143, P74, DOI 10.1210/en.143.1.74; Gaspar NJ, 2007, MOL PHARMACOL, V72, P152, DOI 10.1124/mol.106.029025; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; Giuliani N, 1998, BONE, V22, P455, DOI 10.1016/S8756-3282(98)00033-7; Hernandez CJ, 2006, BONE, V39, P1173, DOI 10.1016/j.bone.2006.06.001; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Iida-Klein A, 2006, J BONE MINER RES, V21, P274, DOI 10.1359/JBMR.051017; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kaneda T, 2000, J IMMUNOL, V165, P4254, DOI 10.4049/jimmunol.165.8.4254; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kapoun AM, 2006, MOL PHARMACOL, V70, P518, DOI 10.1124/mol.105.021600; Karsdal MA, 2003, J BIOL CHEM, V278, P44975, DOI 10.1074/jbc.M303905200; Karst M, 2004, J CELL PHYSIOL, V200, P99, DOI 10.1002/jcp.20036; KINNEY JH, 1994, SCANNING MICROSCOPY, V8, P197; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lin AH, 2005, J IMMUNOL, V175, P547, DOI 10.4049/jimmunol.175.1.547; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Murakami T, 1998, BIOCHEM BIOPH RES CO, V252, P747, DOI 10.1006/bbrc.1998.9723; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3; OREFFO ROC, 1989, BIOCHEM BIOPH RES CO, V158, P817, DOI 10.1016/0006-291X(89)92795-2; OURSLER MJ, 1994, J BONE MINER RES, V9, P443; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Perrien DS, 2007, ENDOCRINOLOGY, V148, P1654, DOI 10.1210/en.2006-0848; Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2; RITCHIE RO, 2008, BONE; Stabnov L, 2002, BONE, V30, P909, DOI 10.1016/S8756-3282(02)00738-X; Suva LJ, 2008, AM J PATHOL, V172, P430, DOI 10.2353/ajpath.2008.070417; TAKAHASHI N, 2002, PRINCIPLES BONE BIOL, P109; THIRUNAVUKKARAS.K, 2001, J BIOL CHEM, V12, P12; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; ZAHOOR A, 1989, ELECT POWER RES I; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6	54	125	136	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5275	10.1371/journal.pone.0005275	http://dx.doi.org/10.1371/journal.pone.0005275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19357790	Green Published, Green Submitted, gold			2022-12-27	WOS:000265510600013
J	Webb, BT; McClay, JL; Vargas-Irwin, C; York, TP; van den Oord, EJCG				Webb, Bradley Todd; McClay, Joseph L.; Vargas-Irwin, Cristina; York, Timothy P.; van den Oord, Edwin J. C. G.			In Silico Whole Genome Association Scan for Murine Prepulse Inhibition	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; FALSE DISCOVERY RATE; ACOUSTIC STARTLE RESPONSE; EXPERIMENTAL UNIT LEADS; CHROMOGRANIN-B; DRAMATIC OVERESTIMATION; INAPPROPRIATE CHOICE; GENETIC-VARIATION; BIPOLAR DISORDER; SECRETOGRANIN-II	Background: The complex trait of prepulse inhibition (PPI) is a sensory gating measure related to schizophrenia and can be measured in mice. Large-scale public repositories of inbred mouse strain genotypes and phenotypes such as PPI can be used to detect Quantitative Trait Loci (QTLs) in silico. However, the method has been criticized for issues including insufficient number of strains, not controlling for false discoveries, the complex haplotype structure of inbred mice, and failing to account for genotypic and phenotypic subgroups. Methodology/Principal Findings: We have implemented a method that addresses these issues by incorporating phylogenetic analyses, multilevel regression with mixed effects, and false discovery rate (FDR) control. A genome-wide scan for PPI was conducted using over 17,000 single nucleotide polymorphisms (SNPs) in 37 strains phenotyped. Eighty-nine SNPs were significant at a false discovery rate (FDR) of 5%. After accounting for long-range linkage disequilibrium, we found 3 independent QTLs located on murine chromosomes 1 and 13. One of the PPI positives corresponds to a region of human chromosome 6p which includes DTNBP1, a gene implicated in schizophrenia. Another region includes the gene Tsn which alters PPI when knocked out. These genes also appear to have correlated expression with PPI. Conclusions/Significance: These results support the usefulness of using an improved in silico mapping method to identify QTLs for complex traits such as PPI which can be then be used for to help identify loci influencing schizophrenia in humans.			Webb, BT (corresponding author), Virginia Commonwealth Univ, Ctr Biomarker Res & Personalized Med, Richmond, VA 23284 USA.	btwebb@vcu.edu	McClay, Joseph/C-9931-2009; Webb, Bradley T/B-1459-2009	McClay, Joseph/0000-0002-3628-2447; Webb, Bradley T/0000-0002-0576-5366				Anokhin AP, 2003, NEUROSCI LETT, V353, P45, DOI 10.1016/j.neulet.2003.09.014; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brown BW, 1997, STAT MED, V16, P2511, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2511::AID-SIM693>3.0.CO;2-4; Cadenhead KS, 2000, AM J PSYCHIAT, V157, P1660, DOI 10.1176/appi.ajp.157.10.1660; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1205, DOI 10.1001/archpsyc.62.11.1205; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chesler EJ, 2001, SCIENCE, V294; Cho YS, 2004, J BIOL CHEM, V279, P31514, DOI 10.1074/jbc.M401442200; Darvasi A, 2001, SCIENCE, V294; Fernando RL, 2004, GENETICS, V166, P611, DOI 10.1534/genetics.166.1.611; Funke B, 2004, AM J HUM GENET, V75, P891, DOI 10.1086/425279; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Grubb SC, 2004, BIOINFORMATICS, V20, P2857, DOI 10.1093/bioinformatics/bth299; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; Guo AY, 2009, NUCLEIC ACIDS RES, V37, pD840, DOI 10.1093/nar/gkn816; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Hinterhoelzl JK, 2003, J NEUROCHEM, V87, P13, DOI 10.1046/j.1471-4159.2003.01989.x; Hitzemann R, 2008, PHARMACOL BIOCHEM BE, V90, P525, DOI 10.1016/j.pbb.2008.04.004; Hsueh Huey-miin, 2003, J Biopharm Stat, V13, P675, DOI 10.1081/BIP-120024202; Iijima Y, 2004, BIOL PSYCHIAT, V56, P10, DOI 10.1016/j.biopsych.2004.03.012; Itokawa M, 2003, PHARMACOGENETICS, V13, P271, DOI 10.1097/00008571-200305000-00006; Iwayama-Shigeno Y, 2005, NEUROSCI LETT, V378, P102, DOI 10.1016/j.neulet.2004.12.013; Joober R, 2003, NEUROPSYCHOPHARMACOL, V28, P819, DOI 10.1038/sj.npp.1300065; Joober R, 2002, NEUROPSYCHOPHARMACOL, V27, P765, DOI 10.1016/S0893-133X(02)00333-0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kirov G, 2004, BIOL PSYCHIAT, V55, P971, DOI 10.1016/j.biopsych.2004.01.025; Kline L, 1998, PSYCHOPHARMACOLOGY, V139, P322, DOI 10.1007/s002130050723; Korn EL, 2004, J STAT PLAN INFER, V124, P379, DOI 10.1016/S0378-3758(03)00211-8; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li T, 2005, MOL PSYCHIATR, V10, P1037, DOI 10.1038/sj.mp.4001718; Liao GC, 2004, SCIENCE, V306, P690, DOI 10.1126/science.1100636; Marksteiner J, 2001, NEUROSCIENCE, V104, P325, DOI 10.1016/S0306-4522(01)00081-1; McCaughran J, 1999, BEHAV GENET, V29, P21, DOI 10.1023/A:1021433705004; McCaughran J, 1997, PSYCHOPHARMACOLOGY, V134, P131, DOI 10.1007/s002130050434; Mhyre TR, 2005, GENES BRAIN BEHAV, V4, P209, DOI 10.1111/j.1601-183X.2004.00102.x; Millar JK, 2000, GENOMICS, V67, P69, DOI 10.1006/geno.2000.6239; Myers KM, 2005, BIOL PSYCHIAT, V58, P67, DOI 10.1016/j.biopsych.2005.03.023; Palmer AA, 2003, NEUROPSYCHOPHARMACOL, V28, P818, DOI 10.1038/sj.npp.1300064; Palmer AA, 2003, PSYCHOPHARMACOLOGY, V165, P270, DOI 10.1007/s00213-002-1258-0; Park YG, 2003, GENOME RES, V13, P118, DOI 10.1101/gr.786403; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Petryshen TL, 2005, GENETICS, V171, P1895, DOI 10.1534/genetics.105.045658; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; Sabatti C, 2003, GENETICS, V164, P829; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Searle SR., 1992, VARIANCE COMPONENTS; Smith JD, 2003, ARTERIOSCL THROM VAS, V23, P117, DOI 10.1161/01.ATV.0000047461.18902.80; Stein JM, 2006, J NEUROSCI, V26, P2184, DOI 10.1523/JNEUROSCI.4437-05.2006; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; TANG J, 2006, NEUROSCI LETT; Tang JX, 2003, MOL PSYCHIATR, V8, P717, DOI 10.1038/sj.mp.4001287; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; Thomson PA, 2005, MOL PSYCHIATR, V10, P657, DOI 10.1038/sj.mp.4001669; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Torkamanzehi A, 2008, J GENET GENOMICS, V35, P139, DOI 10.1016/S1673-8527(08)60020-X; Tsai CA, 2003, BIOMETRICS, V59, P1071, DOI 10.1111/j.0006-341X.2003.00123.x; Van Den Bogaert A, 2003, AM J HUM GENET, V73, P1438, DOI 10.1086/379928; van den Oord EJCG, 2005, MOL PSYCHIATR, V10, P230, DOI 10.1038/sj.mp.4001581; van den Oord EJCG, 2003, MOL PSYCHIATR, V8, P499, DOI 10.1038/sj.mp.4001263; van den Oord EJCG, 2003, TRENDS GENET, V19, P537, DOI 10.1016/j.tig.2003.08.003; van den Oord EJCG, 2001, STAT METHODS MED RES, V10, P393, DOI 10.1177/096228020101000603; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; Vendruscolo Leandro Franco, 2006, Behav Brain Funct, V2, P21, DOI 10.1186/1744-9081-2-21; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Webb BT, 2008, PHARMACOGENET GENOM, V18, P751, DOI 10.1097/FPC.0b013e32830162bc; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Williams NM, 2004, ARCH GEN PSYCHIAT, V61, P336, DOI 10.1001/archpsyc.61.4.336; Williams RW, 2004, MAMM GENOME, V15, P637, DOI 10.1007/s00335-004-2380-6; Williams RW, 2001, GENOME BIOL, V2; Willott JF, 2003, BEHAV NEUROSCI, V117, P716, DOI 10.1037/0735-7044.117.4.716; Zhang BF, 2002, NEUROSCI LETT, V323, P229, DOI 10.1016/S0304-3940(02)00145-3	81	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5246	10.1371/journal.pone.0005246	http://dx.doi.org/10.1371/journal.pone.0005246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370154	gold, Green Published, Green Submitted			2022-12-27	WOS:000265510600008
J	Verreck, FAW; Vervenne, RAW; Kondova, I; van Kralingen, KW; Remarque, EJ; Braskamp, G; van der Werff, NM; Kersbergen, A; Ottenhoff, THM; Heidt, PJ; Gilbert, SC; Gicquel, B; Hill, AVS; Martin, C; McShane, H; Thomas, AW				Verreck, Frank A. W.; Vervenne, Richard A. W.; Kondova, Ivanela; van Kralingen, Klaas W.; Remarque, Edmond J.; Braskamp, Gerco; van der Werff, Nicole M.; Kersbergen, Ariena; Ottenhoff, Tom H. M.; Heidt, Peter J.; Gilbert, Sarah C.; Gicquel, Brigitte; Hill, Adrian V. S.; Martin, Carlos; McShane, Helen; Thomas, Alan W.			MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques	PLOS ONE			English	Article							NONHUMAN PRIMATE MODEL; MYCOBACTERIUM-TUBERCULOSIS; ENHANCED IMMUNOGENICITY; SUBUNIT VACCINE; RECOMBINANT BCG; INFECTION; IMMUNITY; MVA85A; RESEMBLES; RESPONSES	Background: Continuous high global tuberculosis (TB) mortality rates and variable vaccine efficacy of Mycobacterium bovis Bacille Calmette-Guerin (BCG) motivate the search for better vaccine regimes. Relevant models are required to downselect the most promising vaccines entering clinical efficacy testing and to identify correlates of protection. Methods and Findings: Here, we evaluated immunogenicity and protection against Mycobacterium tuberculosis in rhesus monkeys with two novel strategies: BCG boosted by modified vaccinia virus Ankara expressing antigen 85A (MVA.85A), and attenuated M. tuberculosis with a disrupted phoP gene (SO2) as a single-dose vaccine. Both strategies were well tolerated, and immunogenic as evidenced by induction of specific IFN gamma responses. Antigen 85A-specific IFN gamma secretion was specifically increased by MVA.85A boosting. Importantly, both MVA. 85A and SO2 treatment significantly reduced pathology and chest X-ray scores upon infectious challenge with M. tuberculosis Erdman strain. MVA. 85A and SO2 treatment also showed reduced average lung bacterial counts (1.0 and 1.2 log respectively, compared with 0.4 log for BCG) and significant protective effect by reduction in C-reactive protein levels, body weight loss, and decrease of erythrocyte-associated hematologic parameters (MCV, MCH, Hb, Ht) as markers of inflammatory infection, all relative to non-vaccinated controls. Lymphocyte stimulation revealed Ag85A-induced IFN gamma levels post-infection as the strongest immunocorrelate for protection (spearman's rho: -0.60). Conclusions: Both the BCG/MVA.85A prime-boost regime and the novel live attenuated, phoP deficient TB vaccine candidate SO2 showed significant protective efficacy by various parameters in rhesus macaques. Considering the phylogenetic relationship between macaque and man and the similarity in manifestations of TB disease, these data support further development of these primary and combination TB vaccine candidates.			Verreck, FAW (corresponding author), Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands.	verreck@bprc.nl	Martin, Carlos/A-7283-2008; Heidt, Peter/GQQ-8459-2022; Remarque, Ed/AAE-8643-2020; Remarque, Edmond J/B-2217-2010; Gilbert, Sarah C./H-2857-2019	Martin, Carlos/0000-0003-2993-5478; Gilbert, Sarah C./0000-0002-6823-9750; McShane, Helen/0000-0002-2126-5142	Wellcome Trust [076943] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aguilar D, 2007, CLIN EXP IMMUNOL, V147, P330, DOI 10.1111/j.1365-2249.2006.03284.x; Asensio JAG, 2008, EXPERT OPIN BIOL TH, V8, P201, DOI 10.1517/14712598.8.2.201 ; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Baumann S, 2006, CURR OPIN IMMUNOL, V18, P438, DOI 10.1016/j.coi.2006.05.016; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Flynn JL, 2003, TUBERCULOSIS, V83, P116, DOI 10.1016/S1472-9792(02)00059-8; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Hussey G, 2007, PAEDIATR RESPIR REV, V8, P148, DOI 10.1016/j.prrv.2007.04.009; Ibango HB, 2006, LANCET INFECT DIS, V6, P522, DOI 10.1016/S1473-3099(06)70552-7; Kamath AT, 2005, VACCINE, V23, P3753, DOI 10.1016/j.vaccine.2005.03.001; Kita Y, 2005, VACCINE, V23, P2132, DOI 10.1016/j.vaccine.2005.01.057; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Langermans JAM, 2001, P NATL ACAD SCI USA, V98, P11497, DOI 10.1073/pnas.201404898; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; McMurray DN, 2000, CLIN INFECT DIS, V30, pS210, DOI 10.1086/313885; McShane H, 2005, TUBERCULOSIS, V85, P47, DOI 10.1016/j.tube.2004.09.015; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; McShane H, 2001, INFECT IMMUN, V69, P681, DOI 10.1128/IAI.69.2.681-686.2001; MLIKACABANNE N, 1995, AM J RESP CRIT CARE, V152, P786, DOI 10.1164/ajrccm.152.2.7633743; Pathan AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001052; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Sugawara I, 2007, TUBERCULOSIS, V87, P518, DOI 10.1016/j.tube.2007.06.002; Walsh GP, 1996, NAT MED, V2, P430, DOI 10.1038/nm0496-430; Williams A, 2005, TUBERCULOSIS, V85, P29, DOI 10.1016/j.tube.2004.09.009; World Health Organization, 2008, GLOB TUB CONTR SURV	33	163	174	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2009	4	4							e5264	10.1371/journal.pone.0005264	http://dx.doi.org/10.1371/journal.pone.0005264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TS	19367339	Green Published, gold, Green Submitted			2022-12-27	WOS:000265510400009
J	Benachenhou, F; Jern, P; Oja, M; Sperber, G; Blikstad, V; Somervuo, P; Kaski, S; Blomberg, J				Benachenhou, Farid; Jern, Patric; Oja, Merja; Sperber, Goran; Blikstad, Vidar; Somervuo, Panu; Kaski, Samuel; Blomberg, Jonas			Evolutionary Conservation of Orthoretroviral Long Terminal Repeats (LTRs) and ab initio Detection of Single LTRs in Genomic Data	PLOS ONE			English	Article							ENDOGENOUS RETROVIRAL SEQUENCES; DE-NOVO IDENTIFICATION; MURINE LEUKEMIA-VIRUS; HIDDEN MARKOV-MODELS; R-REGION; TRANSCRIPTION INITIATION; ANTISENSE TRANSCRIPTS; TRANSPOSABLE ELEMENTS; PROVIRAL STRUCTURE; PROMOTER ACTIVITY	Background: Retroviral LTRs, paired or single, influence the transcription of both retroviral and non-retroviral genomic sequences. Vertebrate genomes contain many thousand endogenous retroviruses (ERVs) and their LTRs. Single LTRs are difficult to detect from genomic sequences without recourse to repetitiveness or presence in a proviral structure. Understanding of LTR structure increases understanding of LTR function, and of functional genomics. Here we develop models of orthoretroviral LTRs useful for detection in genomes and for structural analysis. Principal Findings: Although mutated, ERV LTRs are more numerous and diverse than exogenous retroviral (XRV) LTRs. Hidden Markov models (HMMs), and alignments based on them, were created for HML- (human MMTV-like), general-beta-, gamma-and lentiretroviruslike LTRs, plus a general-vertebrate LTR model. Training sets were XRV LTRs and RepBase LTR consensuses. The HML HMM was most sensitive and detected 87% of the HML LTRs in human chromosome 19 at 96% specificity. By combining all HMMs with a low cutoff, for screening, 71% of all LTRs found by RepeatMasker in chromosome 19 were found. HMM consensus sequences had a conserved modular LTR structure. Target site duplications (TG-CA), TATA (occasionally absent), an AATAAA box and a T-rich region were prominent features. Most of the conservation was located in, or adjacent to, R and U5, with evidence for stem loops. Several of the long HML LTRs contained long ORFs inserted after the second A rich module. HMM consensus alignment allowed comparison of functional features like transcriptional start sites (sense and antisense) between XRVs and ERVs. Conclusion: The modular conserved and redundant orthoretroviral LTR structure with three A-rich regions is reminiscent of structurally relaxed Giardia promoters. The five HMMs provided a novel broad range, repeat-independent, ab initio LTR detection, with prospects for greater generalisation, and insight into LTR structure, which may aid development of LTR-targeted pharmaceuticals.			Benachenhou, F (corresponding author), Uppsala Univ, Dept Med Sci, Virol Sect, Uppsala, Sweden.	Jonas.Blomberg@medsci.uu.se	Kaski, Samuel/B-6684-2008; Jern, Patric/AAR-2133-2021	Kaski, Samuel/0000-0003-1925-9154; Jern, Patric/0000-0003-3393-5825; Blomberg, Jonas/0000-0001-6492-2491				AHMED YF, 1991, CELL, V64, P727, DOI 10.1016/0092-8674(91)90502-P; Anderssen S, 1997, VIROLOGY, V234, P14, DOI 10.1006/viro.1997.8590; Andersson AC, 2005, J VIROL, V79, P9270, DOI 10.1128/JVI.79.14.9270-9284.2005; Andersson ML, 1999, J GEN VIROL, V80, P255, DOI 10.1099/0022-1317-80-1-255; ARMOUR JAL, 1989, NUCLEIC ACIDS RES, V17, P4925, DOI 10.1093/nar/17.13.4925; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Barton N. H., 2007, EVOLUTION; Baust C, 2000, GENOMICS, V66, P98, DOI 10.1006/geno.2000.6175; Blikstad V, 2008, CELL MOL LIFE SCI, V65, P3348, DOI 10.1007/s00018-008-8495-2; Blusch JH, 1997, GENOMICS, V43, P52, DOI 10.1006/geno.1997.4790; Brand M, 1999, NEURAL COMPUT, V11, P1155, DOI 10.1162/089976699300016395; Briquet S, 2002, VIROLOGY, V292, P177, DOI 10.1006/viro.2001.1224; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Caspi A, 2006, GENOME RES, V16, P260, DOI 10.1101/gr.4361206; Cavanagh MH, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-15; CHANG NT, 2006, J BIOMED SCI; CHEN HR, 1984, NUCLEIC ACIDS RES, V12, P1767, DOI 10.1093/nar/12.4.1767; CHRISTY RJ, 1988, MOL CELL BIOL, V8, P1093, DOI 10.1128/MCB.8.3.1093; Coffin J, 1997, RETROVIRUSES; COFFIN J, 1997, RETROVIRUSES, P776; COFFIN JM, 1997, RETROVIRUSES, P225; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Cupelli L, 1998, J VIROL, V72, P7807, DOI 10.1128/JVI.72.10.7807-7814.1998; CUPELLI LA, 1991, J VIROL, V65, P6961, DOI 10.1128/JVI.65.12.6961-6968.1991; Domansky AN, 2000, FEBS LETT, V472, P191, DOI 10.1016/S0014-5793(00)01460-5; Dunn CA, 2006, GENE, V366, P335, DOI 10.1016/j.gene.2005.09.003; Durbin R., 1998, BIOL SEQUENCE ANAL P; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Elisaphenko EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002521; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; FEUCHTER A, 1990, NUCLEIC ACIDS RES, V18, P1261, DOI 10.1093/nar/18.5.1261; Frech K, 1997, J MOL BIOL, V270, P674, DOI 10.1006/jmbi.1997.1140; Frech K, 1996, VIROLOGY, V224, P256, DOI 10.1006/viro.1996.0527; Futuyma D. J., 2005, EVOLUTION; GUNTAKA RV, 1993, MICROBIOL REV, V57, P511, DOI 10.1128/MMBR.57.3.511-521.1993; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heinemeyer T, 1999, NUCLEIC ACIDS RES, V27, P318, DOI 10.1093/nar/27.1.318; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; Jern P, 2005, J VIROL, V79, P6325, DOI 10.1128/JVI.79.10.6325-6337.2005; Jern P, 2004, VIROLOGY, V327, P93, DOI 10.1016/j.virol.2004.06.023; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kalyanaraman Anantharaman, 2006, Journal of Bioinformatics and Computational Biology, V4, P197, DOI 10.1142/S021972000600203X; Karlin S, 2005, P NATL ACAD SCI USA, V102, P13355, DOI 10.1073/pnas.0501804102; Katzourakis A, 2007, P NATL ACAD SCI USA, V104, P6261, DOI 10.1073/pnas.0700471104; KELLY RG, 1994, GENOMICS, V24, P509, DOI 10.1006/geno.1994.1660; Kovalskaya E, 2006, VIROLOGY, V346, P373, DOI 10.1016/j.virol.2005.11.007; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; KROGH A, 1995, ISMB, V3, P215; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAMANTIA G, 1992, NUCLEIC ACIDS RES, V20, P4129, DOI 10.1093/nar/20.16.4129; Lavrentieva I, 1998, HUM GENET, V102, P107, DOI 10.1007/s004390050662; Leib-Mosch CSW, 2005, INFLUENCE HUMAN ENDO; Leupin O, 2005, EMBO REP, V6, P956, DOI 10.1038/sj.embor.7400502; Ludwig LB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-80; MAGER DL, 1989, VIROLOGY, V173, P591, DOI 10.1016/0042-6822(89)90570-9; MAGER DL, 2003, RETROVIRAL REPEAT SE; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nesterova TB, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-2; Oja M, 2005, INT J NEURAL SYST, V15, P163, DOI 10.1142/S0129065705000177; PIERCE J, 1993, J VIROL, V67, P415, DOI 10.1128/JVI.67.1.415-424.1993; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rho M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-90; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Seifarth W, 1998, J VIROL, V72, P8384, DOI 10.1128/JVI.72.10.8384-8391.1998; Sjottem E, 1996, J VIROL, V70, P188; SPERBER GO, 2007, NUCL ACIDS RES; Tek AL, 2005, GENETICS, V170, P1231, DOI 10.1534/genetics.105.041087; Teodorovic S, 2007, NUCLEIC ACIDS RES, V35, P2544, DOI 10.1093/nar/gkm105; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trubetskoy AM, 1999, J VIROL, V73, P3477, DOI 10.1128/JVI.73.4.3477-3483.1999; Wolgamot G, 1999, J VIROL, V73, P9803, DOI 10.1128/JVI.73.12.9803-9809.1999; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Zhang Z, 1999, J GEN VIROL, V80, P3065, DOI 10.1099/0022-1317-80-12-3065; ZUKER M, 1999, ALGORITHMS THERMODYN	79	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5179	10.1371/journal.pone.0005179	http://dx.doi.org/10.1371/journal.pone.0005179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365549	Green Published, gold, Green Submitted			2022-12-27	WOS:000265509900009
J	Gile, GH; Faktorova, D; Castlejohn, CA; Burger, G; Lang, BF; Farmer, MA; Lukes, J; Keeling, PJ				Gile, Gillian H.; Faktorova, Drahomira; Castlejohn, Christina A.; Burger, Gertraud; Lang, B. Franz; Farmer, Mark A.; Lukes, Julius; Keeling, Patrick J.			Distribution and Phylogeny of EFL and EF-1 alpha in Euglenozoa Suggest Ancestral Co-Occurrence Followed by Differential Loss	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; EARLY EVOLUTION; N.-SP.; GENOME; RNA; KINETOPLASTIDS; DIVERSITY; SEQUENCE; GENE; TREE	Background: The eukaryotic elongation factor EF-1 alpha (also known as EF1A) catalyzes aminoacyl-tRNA binding by the ribosome during translation. Homologs of this essential protein occur in all domains of life, and it was previously thought to be ubiquitous in eukaryotes. Recently, however, a number of eukaryotes were found to lack EF-1 alpha and instead encode a related protein called EFL (for EF-Like). EFL-encoding organisms are scattered widely across the tree of eukaryotes, and all have close relatives that encode EF-1 alpha. This intriguingly complex distribution has been attributed to multiple lateral transfers because EFL's near mutual exclusivity with EF-1 alpha makes an extended period of co-occurrence seem unlikely. However, differential loss may play a role in EFL evolution, and this possibility has been less widely discussed. Methodology/Principal Findings: We have undertaken an EST-and PCR-based survey to determine the distribution of these two proteins in a previously under-sampled group, the Euglenozoa. EF-1 alpha was found to be widespread and monophyletic, suggesting it is ancestral in this group. EFL was found in some species belonging to each of the three euglenozoan lineages, diplonemids, kinetoplastids, and euglenids. Conclusions/Significance: Interestingly, the kinetoplastid EFL sequences are specifically related despite the fact that the lineages in which they are found are not sisters to one another, suggesting that EFL and EF-1 alpha co-occurred in an early ancestor of kinetoplastids. This represents the strongest phylogenetic evidence to date that differential loss has contributed to the complex distribution of EFL and EF-1 alpha.			Gile, GH (corresponding author), Univ British Columbia, Canadian Inst Adv Res, Vancouver, BC, Canada.	ggile@interchange.ubc.ca	Faktorová, Drahomíra/G-7292-2014; Lukes, Julius/H-6760-2012	Faktorová, Drahomíra/0000-0001-9623-2233; Lukes, Julius/0000-0002-0578-6618; Keeling, Patrick/0000-0002-7644-0745				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Atkins MS, 2000, J EUKARYOT MICROBIOL, V47, P400, DOI 10.1111/j.1550-7408.2000.tb00067.x; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Breglia SA, 2007, J EUKARYOT MICROBIOL, V54, P86, DOI 10.1111/j.1550-7408.2006.00233.x; Dimmic MW, 2002, J MOL EVOL, V55, P65, DOI 10.1007/s00239-001-2304-y; Dykova I, 2003, EUR J PROTISTOL, V39, P37, DOI 10.1078/0932-4739-00901; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Gile GH, 2006, PROTIST, V157, P435, DOI 10.1016/j.protis.2006.06.002; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kamikawa R, 2008, P NATL ACAD SCI USA, V105, P6965, DOI 10.1073/pnas.0711084105; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keeling PJ, 2004, P NATL ACAD SCI USA, V101, P15380, DOI 10.1073/pnas.0404505101; Lai DH, 2008, P NATL ACAD SCI USA, V105, P1999, DOI 10.1073/pnas.0711799105; Lara E, 2009, ENVIRON MICROBIOL, V11, P47, DOI 10.1111/j.1462-2920.2008.01737.x; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Leander BS, 2007, BIOESSAYS, V29, P987, DOI 10.1002/bies.20645; LUKES J, 1994, EMBO J, V13, P5086, DOI 10.1002/j.1460-2075.1994.tb06838.x; Lukes J, 2006, MOL BIOCHEM PARASIT, V148, P125, DOI 10.1016/j.molbiopara.2006.03.008; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; Makiuchi T, 2008, PROTIST, V159, P459, DOI 10.1016/j.protis.2008.02.002; Marande W, 2005, EUKARYOT CELL, V4, P1137, DOI 10.1128/EC.4.6.1137-1146.2005; Marshall WL, 2008, PROTIST, V159, P415, DOI 10.1016/j.protis.2008.03.003; Maslov DA, 1999, PROTIST, V150, P33, DOI 10.1016/S1434-4610(99)70007-6; Moreira D, 1999, MOL BIOL EVOL, V16, P234, DOI 10.1093/oxfordjournals.molbev.a026105; Moreira D, 2004, INT J SYST EVOL MICR, V54, P1861, DOI 10.1099/ijs.0.63081-0; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; Noble GP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-82; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Podlipaev SA, 2004, J EUKARYOT MICROBIOL, V51, P283, DOI 10.1111/j.1550-7408.2004.tb00568.x; RIOU G, 1969, P NATL ACAD SCI USA, V62, P210, DOI 10.1073/pnas.62.1.210; Rodriguez-Ezpeleta N, 2007, CURR BIOL, V17, P1420, DOI 10.1016/j.cub.2007.07.036; RODRIGUEZEZPELE.N, 2009, GENERATION ANAL; Roy J, 2007, PROTIST, V158, P385, DOI 10.1016/j.protis.2007.03.002; Roy J, 2007, J EUKARYOT MICROBIOL, V54, P137, DOI 10.1111/j.1550-7408.2007.00244.x; Ruiz-Trillo I, 2006, J EUKARYOT MICROBIOL, V53, P379, DOI 10.1111/j.1550-7408.2006.00118.x; SAKAGUCHI M, 2008, GENE IN PRESS; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Simpson AGB, 2004, PROTIST, V155, P407, DOI 10.1078/1434461042650389; Simpson AGB, 2004, MOL PHYLOGENET EVOL, V30, P201, DOI 10.1016/S1055-7903(03)00177-5; Simpson AGB, 2002, MOL BIOL EVOL, V19, P2071, DOI 10.1093/oxfordjournals.molbev.a004032; Simpson AGB, 2003, INT J SYST EVOL MICR, V53, P1759, DOI 10.1099/ijs.0.02578-0; Simpson AGB, 2006, MOL BIOL EVOL, V23, P615, DOI 10.1093/molbev/msj068; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; von der Heyden S, 2005, INT J SYST EVOL MICR, V55, P2605, DOI 10.1099/ijs.0.63606-0; von der Heyden S, 2004, J EUKARYOT MICROBIOL, V51, P402; Votypka J, 2002, PARASITOLOGY, V125, P253, DOI 10.1017/S0031182002002093; Yoon HS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-14; Yurchenko V, 2006, J EUKARYOT MICROBIOL, V53, P103, DOI 10.1111/j.1550-7408.2005.00078.x; Yurchenko VY, 2006, PARASITOLOGY, V133, P537, DOI 10.1017/S0031182006000746; Yurchenko VY, 2008, PROTIST, V159, P99, DOI 10.1016/j.protis.2007.07.003	61	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5162	10.1371/journal.pone.0005162	http://dx.doi.org/10.1371/journal.pone.0005162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357788	Green Published, gold, Green Submitted			2022-12-27	WOS:000265505900018
J	Gingras, MC; Zhang, YL; Kharitidi, D; Barr, AJ; Knapp, S; Tremblay, ML; Pause, A				Gingras, Marie-Claude; Zhang, Yu Ling; Kharitidi, Dmitri; Barr, Alastair J.; Knapp, Stefan; Tremblay, Michel L.; Pause, Arnim			HD-PTP Is a Catalytically Inactive Tyrosine Phosphatase Due to a Conserved Divergence in Its Phosphatase Domain	PLOS ONE			English	Article								Background: The HD-PTP protein has been described as a tumor suppressor candidate and based on its amino acid sequence, categorized as a classical non-transmembrane protein tyrosine phosphatase (PTP). To date, no HD-PTP phosphorylated substrate has been identified and controversial results concerning its catalytic activity have been recently reported. Methodology and Results: Here we report a rigorous enzymatic analysis demonstrating that the HD-PTP protein does not harbor tyrosine phosphatase or lipid phosphatase activity using the highly sensitive DiFMUP substrate and a panel of different phosphatidylinositol phosphates. We found that HD-PTP tyrosine phosphatase inactivity is caused by an evolutionary conserved amino acid divergence of a key residue located in the HD-PTP phosphatase domain since its back mutation is sufficient to restore the HD-PTP tyrosine phosphatase activity. Moreover, in agreement with a tumor suppressor activity, HD-PTP expression leads to colony growth reduction in human cancer cell lines, independently of its catalytic PTP activity status. Conclusion: In summary, we demonstrate that HD-PTP is a catalytically inactive protein tyrosine phosphatase. As such, we identify one residue involved in its inactivation and show that its colony growth reduction activity is independent of its PTP activity status in human cancer cell lines.	[Gingras, Marie-Claude; Zhang, Yu Ling; Kharitidi, Dmitri; Tremblay, Michel L.; Pause, Arnim] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada; [Gingras, Marie-Claude; Zhang, Yu Ling; Kharitidi, Dmitri; Tremblay, Michel L.; Pause, Arnim] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Barr, Alastair J.; Knapp, Stefan] Univ Oxford, Nuffield Dept Med, Structur Genom Consortium, Oxford OX1 2JD, England	McGill University; McGill University; University of Oxford	Gingras, MC (corresponding author), McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada.	arnim.pause@mcgill.ca	Knapp, Stefan/AAG-2347-2019	Knapp, Stefan/0000-0001-5995-6494; Barr, Alastair/0000-0001-7738-8419	CIHR McGill University [fellowship, studentship]; Fond de la recherche en sante du Quebec (FRSQ) [fellowship]; Kidney Foundation of Canada [fellowship]; Maysie MacSporran graduate studentship award; Jeanne and Jean-Louis Levesque Chair in Cancer Research; NCIC/CCS; Canada Research Chair in Molecular Oncology	CIHR McGill University(Canadian Institutes of Health Research (CIHR)); Fond de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Kidney Foundation of Canada; Maysie MacSporran graduate studentship award; Jeanne and Jean-Louis Levesque Chair in Cancer Research; NCIC/CCS; Canada Research Chair in Molecular Oncology(Canada Research Chairs)	MCG was supported by a CIHR McGill University Cancer Consortium fellowship and a fellowship from Fond de la recherche en sante du Quebec (FRSQ) and holds a Kidney Foundation of Canada fellowship. YLZ holds a McGill Canderel studentship stipend award and DK holds a CIHR McGill University Cancer Consortium studentships and a Maysie MacSporran graduate studentship award. MLT holds a Jeanne and Jean-Louis Levesque Chair in Cancer Research and a NCIC/CCS operating grant and AP a Canada Research Chair in Molecular Oncology. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institute, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Cao LG, 1998, J BIOL CHEM, V273, P21077, DOI 10.1074/jbc.273.33.21077; Castiglioni S, 2007, BIOCHEM BIOPH RES CO, V364, P534, DOI 10.1016/j.bbrc.2007.10.022; Chiarugi P, 2005, CELL MOL LIFE SCI, V62, P931, DOI 10.1007/s00018-004-4448-1; Doyotte A, 2008, P NATL ACAD SCI USA, V105, P6308, DOI 10.1073/pnas.0707601105; Drake PG, 2003, BIOCHEM J, V373, P393, DOI 10.1042/BJ20021851; Fitzgerald LR, 1997, J NEUROCHEM, V68, P1820; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; HESSON LB, 2007, EVALUATION 3P21 3 TU; Imreh S, 2003, GENE CHROMOSOME CANC, V38, P307, DOI 10.1002/gcc.10271; Ji Lin, 2005, Future Oncol, V1, P79, DOI 10.1517/14796694.1.1.79; Jiang SX, 1998, GENE, V215, P345, DOI 10.1016/S0378-1119(98)00282-0; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Magistrelli G, 1996, BIOCHEM BIOPH RES CO, V227, P581, DOI 10.1006/bbrc.1996.1549; MARIOTTI M, 2008, INT BIOCH CELL BIOL; Miura GI, 2008, DEVELOPMENT, V135, P1913, DOI 10.1242/dev.017202; Montalibet J, 2005, METHODS, V35, P2, DOI 10.1016/j.ymeth.2004.07.002; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Peters GH, 2003, BIOCHIMIE, V85, P527, DOI 10.1016/S0300-9084(03)00036-1; Peters KG, 2003, J INORG BIOCHEM, V96, P321, DOI 10.1016/S0162-0134(03)00236-8; Stuible M, 2007, CHEMBIOCHEM, V8, P179, DOI 10.1002/cbic.200600287; Tabernero L, 2008, FEBS J, V275, P867, DOI 10.1111/j.1742-4658.2008.06251.x; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Toyooka S, 2000, BIOCHEM BIOPH RES CO, V278, P671, DOI 10.1006/bbrc.2000.3870; Welbourn S, 2005, J BIOL CHEM, V280, P29604, DOI 10.1074/jbc.M505019200; Welte S, 2005, ANAL BIOCHEM, V338, P32, DOI 10.1016/j.ab.2004.11.047; Wishart MJ, 1998, TRENDS BIOCHEM SCI, V23, P301, DOI 10.1016/S0968-0004(98)01241-9; Wu Gen Sheng, 2003, Methods Mol Biol, V223, P207	33	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5105	10.1371/journal.pone.0005105	http://dx.doi.org/10.1371/journal.pone.0005105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340315	Green Published, gold, Green Submitted			2022-12-27	WOS:000265500700015
J	Thomsen, PF; Elias, S; Gilbert, MTP; Haile, J; Munch, K; Kuzmina, S; Froese, DG; Sher, A; Holdaway, RN; Willerslev, E				Thomsen, Philip Francis; Elias, Scott; Gilbert, M. Thomas P.; Haile, James; Munch, Kasper; Kuzmina, Svetlana; Froese, Duane G.; Sher, Andrei; Holdaway, Richard N.; Willerslev, Eske			Non-Destructive Sampling of Ancient Insect DNA	PLOS ONE			English	Article							MUSEUM SPECIMENS; BONE GELATIN; NEW-ZEALAND; SEQUENCES; ICE; AGE; EXTRACTION; EVOLUTION; SEDIMENTS; DEPOSITS	Background: A major challenge for ancient DNA (aDNA) studies on insect remains is that sampling procedures involve at least partial destruction of the specimens. A recent extraction protocol reveals the possibility of obtaining DNA from past insect remains without causing visual morphological damage. We test the applicability of this protocol on historic museum beetle specimens dating back to AD 1820 and on ancient beetle chitin remains from permafrost (permanently frozen soil) dating back more than 47,000 years. Finally, we test the possibility of obtaining ancient insect DNA directly from non-frozen sediments deposited 3280-1800 years ago - an alternative approach that also does not involve destruction of valuable material. Methodology/Principal Findings: The success of the methodological approaches are tested by PCR and sequencing of COI and 16S mitochondrial DNA (mtDNA) fragments of 77-204 base pairs (-bp) in size using species-specific and general insect primers. Conclusion/Significance: The applied non-destructive DNA extraction method shows promising potential on insect museum specimens of historical age as far back as AD 1820, but less so on the ancient permafrost-preserved insect fossil remains tested, where DNA was obtained from samples up to ca. 26,000 years old. The non-frozen sediment DNA approach appears to have great potential for recording the former presence of insect taxa not normally preserved as macrofossils and opens new frontiers in research on ancient biodiversity.	[Thomsen, Philip Francis; Gilbert, M. Thomas P.; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum, Ctr Ancient Genet & Environm, Copenhagen, Denmark; [Thomsen, Philip Francis; Gilbert, M. Thomas P.; Willerslev, Eske] Univ Copenhagen, Inst Biol, Copenhagen, Denmark; [Elias, Scott] Univ London, Geogr Dept, London WC1E 7HU, England; [Haile, James] Univ Oxford, Henry Wellcome Ancient Biomol Ctr, Dept Zool, Oxford OX1 2JD, England; [Munch, Kasper] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Kuzmina, Svetlana; Froese, Duane G.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2M7, Canada; [Sher, Andrei] Russian Acad Sci, Severtsov Inst Ecol & Evolut, Moscow 117901, Russia; [Holdaway, Richard N.] Palaecol Res Ltd, Christchurch, New Zealand; [Holdaway, Richard N.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand	University of Copenhagen; University of Copenhagen; University of London; University of Oxford; University of California System; University of California Berkeley; University of Alberta; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; University of Canterbury	Thomsen, PF (corresponding author), Univ Copenhagen, Nat Hist Museum, Ctr Ancient Genet & Environm, Copenhagen, Denmark.	ewillerslev@snm.ku.dk	Thomsen, Philip Francis/AAE-9354-2019; Willerslev, Eske/AAA-5686-2019; Kuzmina, Svetlana/AAN-7520-2021; Willerslev, Eske/A-9619-2011; Gilbert, Marcus TP/A-8936-2013; Munch, Kasper/A-1434-2010	Thomsen, Philip Francis/0000-0002-9867-4366; Willerslev, Eske/0000-0002-7081-6748; Gilbert, Marcus TP/0000-0002-5805-7195; Munch, Kasper/0000-0003-2880-6252; Elias, Scott/0000-0002-1498-1060	Danish National Research Foundation; The Leverhulme Foundation [F/07 537/T]; Natural Science and Engineering Research Council of Canada; Alberta Ingenuity New Faculty Award; New Zealand Foundation for Research, Science and Technology; Marsden Fund of the Royal Society of New Zealand; The Lundbeck Foundation; Arts and Humanities Research Council	Danish National Research Foundation(Danmarks Grundforskningsfond); The Leverhulme Foundation; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ingenuity New Faculty Award; New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); Marsden Fund of the Royal Society of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); The Lundbeck Foundation(Lundbeckfonden); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	EW and PFT were supported by the Danish National Research Foundation. SE was supported by The Leverhulme Foundation, F/07 537/T. DGF and SK were supported by grants from the Natural Science and Engineering Research Council of Canada and Alberta Ingenuity New Faculty Award. RNH was supported by New Zealand Foundation for Research, Science and Technology and the Marsden Fund of the Royal Society of New Zealand. KM was supported by The Lundbeck Foundation. JH was supported by the Arts and Humanities Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN JJ, 1997, P BIOL SCI, V22, P467; Binladen J, 2006, GENETICS, V172, P733, DOI 10.1534/genetics.105.049718; CANO R J, 1992, Medical Science Research, V20, P619; CANO R J, 1992, Medical Science Research, V20, P249; Chapco W, 2004, MOL PHYLOGENET EVOL, V30, P810, DOI 10.1016/S1055-7903(03)00209-4; DESALLE R, 1992, SCIENCE, V257, P1933, DOI 10.1126/science.1411508; FROGGATT PC, 1990, NEW ZEAL J GEOL GEOP, V33, P89, DOI 10.1080/00288306.1990.10427576; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Goldstein PZ, 2003, MOL ECOL, V12, P1993, DOI 10.1046/j.1365-294X.2003.01860.x; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Hansen AJ, 2006, GENETICS, V173, P1175, DOI 10.1534/genetics.106.057349; Harper GL, 2006, BIOL J LINN SOC, V88, P447, DOI 10.1111/j.1095-8312.2006.00632.x; Hartley CJ, 2006, P NATL ACAD SCI USA, V103, P8757, DOI 10.1073/pnas.0509590103; Hebsgaard MB, 2005, TRENDS MICROBIOL, V13, P212, DOI 10.1016/j.tim.2005.03.010; Holdaway RN, 1999, J ROY SOC NEW ZEAL, V29, P185, DOI 10.1080/03014223.1999.9517592; Holdaway RN, 2002, J ROY SOC NEW ZEAL, V32, P463, DOI 10.1080/03014223.2002.9517705; Mandrioli M, 2008, MUS MANAGE CURATOR, V23, P193, DOI 10.1080/09647770802012375; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Reiss RA, 2006, QUATERNARY SCI REV, V25, P1877, DOI 10.1016/j.quascirev.2006.01.009; Rohland N, 2004, BIOTECHNIQUES, V36, P814, DOI 10.2144/04365ST05; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Watts PC, 2007, J INSECT CONSERV, V11, P195, DOI 10.1007/s10841-006-9024-y; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Willerslev E, 2004, TRENDS ECOL EVOL, V19, P141, DOI 10.1016/j.tree.2003.11.010; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758	27	85	90	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5048	10.1371/journal.pone.0005048	http://dx.doi.org/10.1371/journal.pone.0005048			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337382	gold, Green Published, Green Submitted			2022-12-27	WOS:000265500600013
J	Bouguermouh, S; Fortin, G; Baba, N; Rubio, M; Sarfati, M				Bouguermouh, Salim; Fortin, Genevieve; Baba, Nobuyasu; Rubio, Manuel; Sarfati, Marika			CD28 Co-Stimulation Down Regulates Th17 Development	PLOS ONE			English	Article								Th17 cells are implicated in host defence and autoimmune diseases. CD28/B7 co-stimulation is involved in the induction and progression of autoimmune diseases, but its role in controlling murine Th17 cell fate remains to be clarified. We here report that soluble anti-CD28 mAb suppressed the differentiation of anti-CD3-stimulated naive CD4(+) T cells into IL-17-producing cells. CD28 co-stimulation reduced the frequency of proliferating cells that produce IL-17. We provide evidence for an IL-2 and IFN-gamma-dependent mechanism of CD28-mediated IL-17 suppression. CD28 blockade of Th17 development was correlated with a decrease rather than an increase in the percentage of Foxp3(+) T cells. In APC/T cell co-cultures, mature dendritic cells (DC) were less efficient than immature DC in their ability to support Th17 cell differentiation, while CTLA4-Ig, an agent blocking CD28/B7 and CTLA4/B7 interactions, facilitated both murine and human Th17 differentiation. This study identifies the importance of B7 co-stimulatory molecules in the negative regulation of Th17 development. These unexpected results caution targeting the CD28/B7 pathways in the treatment of human autoimmune diseases.	[Bouguermouh, Salim; Fortin, Genevieve; Baba, Nobuyasu; Rubio, Manuel; Sarfati, Marika] Univ Montreal, Notre Dame Hosp, CHUM Res Ctr, Immunoregulat Lab, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Bouguermouh, S (corresponding author), Univ Montreal, Notre Dame Hosp, CHUM Res Ctr, Immunoregulat Lab, Montreal, PQ H3C 3J7, Canada.	m.sarfati@umontreal.ca	Baba, Nobuyasu/AAF-8593-2019	Baba, Nobuyasu/0000-0001-9945-080X	Canadian Institute for Health and Research (CIHR) [MOP-53152, Canada Graduate Scholarships Doctoral Award]	Canadian Institute for Health and Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by grant from the Canadian Institute for Health and Research (CIHR Grant, MOP-53152). S.B. is a recipient of the Canadian Institutes for health Research/Canada Graduate Scholarships Doctoral Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JR, 1999, J CLIN INVEST, V103, P1243, DOI 10.1172/JCI5857; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Amezcua-Guerra LM, 2006, GUT, V55, P1059, DOI 10.1136/gut.2006.095539; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Betti M, 2006, ANN ONCOL, V17, P235; Burchill MA, 2003, INFECT IMMUN, V71, P3437, DOI 10.1128/IAI.71.6.3437-3442.2003; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Iliopoulou BP, 2007, J IMMUNOL, V179, P8076, DOI 10.4049/jimmunol.179.12.8076; Jabs C, 2002, EUR J IMMUNOL, V32, P2687, DOI 10.1002/1521-4141(200209)32:9<2687::AID-IMMU2687>3.0.CO;2-1; JENKINS MK, 1991, J IMMUNOL, V147, P2461; Kim G, 2007, J IMMUNOL, V178, P5563, DOI 10.4049/jimmunol.178.9.5563; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; KOLLOCH RE, 2004, PERFUSION-GERMANY, V17, P467; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kotloski NJ, 2008, CLIN VACCINE IMMUNOL, V15, P1199, DOI 10.1128/CVI.00129-08; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Lohr J, 2003, NAT IMMUNOL, V4, P664, DOI 10.1038/ni939; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Perrin PJ, 1999, CLIN IMMUNOL, V91, P41, DOI 10.1006/clim.1998.4684; Perrin PJ, 1996, J NEUROIMMUNOL, V65, P31, DOI 10.1016/0165-5728(95)00172-7; RACKE MK, 1995, J CLIN INVEST, V96, P2195, DOI 10.1172/JCI118274; Radhakrishnan S, 2008, J IMMUNOL, V181, P3137, DOI 10.4049/jimmunol.181.5.3137; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schraven B, 2008, IMMUNITY, V28, P591, DOI 10.1016/j.immuni.2008.04.003; Sharpe AH, 2006, NEW ENGL J MED, V355, P973, DOI 10.1056/NEJMp068087; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; St Clair EW, 2008, J CLIN INVEST, V118, P1344, DOI 10.1172/JCI35382; Steinhaus M, 2008, OSTEOLOGIE, V17, P205; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Van VQ, 2006, EMBO J, V25, P5560, DOI 10.1038/sj.emboj.7601415; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	52	82	86	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5087	10.1371/journal.pone.0005087	http://dx.doi.org/10.1371/journal.pone.0005087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333372	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499900023
J	Kuiper, JWP; van Horssen, R; Oerlemans, F; Peters, W; van Dommelen, MMT; Lindert, MMT; ten Hagen, TLM; Janssen, E; Fransen, JAM; Wieringa, B				Kuiper, Jan W. P.; van Horssen, Remco; Oerlemans, Frank; Peters, Wilma; van Dommelen, Michiel M. T.; Lindert, Mariska M. te; ten Hagen, Timo L. M.; Janssen, Edwin; Fransen, Jack A. M.; Wieringa, Be			Local ATP Generation by Brain-Type Creatine Kinase (CK-B) Facilitates Cell Motility	PLOS ONE			English	Article								Background: Creatine Kinases (CK) catalyze the reversible transfer of high-energy phosphate groups between ATP and phosphocreatine, thereby playing a storage and distribution role in cellular energetics. Brain-type CK (CK-B) deficiency is coupled to loss of function in neural cell circuits, altered bone-remodeling by osteoclasts and complement-mediated phagocytotic activity of macrophages, processes sharing dependency on actomyosin dynamics. Methodology/Principal Findings: Here, we provide evidence for direct coupling between CK-B and actomyosin activities in cortical microdomains of astrocytes and fibroblasts during spreading and migration. CK-B transiently accumulates in membrane ruffles and ablation of CK-B activity affects spreading and migration performance. Complementation experiments in CK-B-deficient fibroblasts, using new strategies to force protein relocalization from cytosol to cortical sites at membranes, confirmed the contribution of compartmentalized CK-B to cell morphogenetic dynamics. Conclusion/Significance: Our results provide evidence that local cytoskeletal dynamics during cell motility is coupled to on-site availability of ATP generated by CK-B.	[Kuiper, Jan W. P.; van Horssen, Remco; Oerlemans, Frank; Peters, Wilma; van Dommelen, Michiel M. T.; Lindert, Mariska M. te; Janssen, Edwin; Fransen, Jack A. M.; Wieringa, Be] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands; [ten Hagen, Timo L. M.] Erasmus MC, Dept Surg Oncol, Rotterdam, Netherlands	Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC	Kuiper, JWP (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands.	b.wieringa@ncmls.ru.nl	Fransen, Jack/E-8924-2010; Wieringa, Berend/A-5346-2011	Fransen, Jack/0000-0002-0571-7639; Wieringa, Berend/0000-0001-9192-8020	Dutch Cancer Society [KUN-2002-1763]; Dutch Organization of Scientific Research (NWO-ZON-MW) [901-01-191]	Dutch Cancer Society(KWF Kankerbestrijding); Dutch Organization of Scientific Research (NWO-ZON-MW)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Dutch Cancer Society, Grant KUN-2002-1763 and the Dutch Organization of Scientific Research (NWO-ZON-MW), Grant 901-01-191 (to BW). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Beckner ME, 2005, LAB INVEST, V85, P316, DOI 10.1038/labinvest.3700239; Bernstein BW, 2003, J NEUROSCI, V23, P1; Braissant O, 2001, MOL BRAIN RES, V86, P193, DOI 10.1016/S0169-328X(00)00269-2; Castellano F, 1999, CURR BIOL, V9, P351, DOI 10.1016/S0960-9822(99)80161-4; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Collavin L, 1999, ONCOGENE, V18, P5879, DOI 10.1038/sj.onc.1202970; Cougoule C, 2004, SEMIN CELL DEV BIOL, V15, P679, DOI 10.1016/j.semcdb.2004.09.001; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; Cuppen E, 1999, J CELL SCI, V112, P3299; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; de Groof AJC, 2002, J BIOL CHEM, V277, P5275, DOI 10.1074/jbc.M108157200; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; de Hoop MJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 1, P154; DEKOK YJM, 1995, MOL CELL BIOCHEM, V143, P59, DOI 10.1007/BF00925927; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Dringen R, 1998, J NEUROCHEM, V70, P835; Dzeja PP, 2004, MOL CELL BIOCHEM, V256, P13, DOI 10.1023/B:MCBI.0000009856.23646.38; Fournier HN, 2002, J BIOL CHEM, V277, P20895, DOI 10.1074/jbc.M200200200; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Hirrlinger J, 2004, EUR J NEUROSCI, V20, P2235, DOI 10.1111/j.1460-9568.2004.03689.x; Hornemann T, 2003, J MOL BIOL, V332, P877, DOI 10.1016/S0022-2836(03)00921-5; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Janssen E, 2000, EMBO J, V19, P6371, DOI 10.1093/emboj/19.23.6371; Janssen E, 2003, J BIOL CHEM, V278, P30441, DOI 10.1074/jbc.M303150200; Jost CR, 2002, EUR J NEUROSCI, V15, P1692, DOI 10.1046/j.1460-9568.2002.02001.x; Kraft T, 2000, J MUSCLE RES CELL M, V21, P691, DOI 10.1023/A:1005623002979; Kuiper JWP, 2008, PLOS BIOL, V6, P568, DOI 10.1371/journal.pbio.0060051; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Mahajan VB, 2000, P NATL ACAD SCI USA, V97, P12062, DOI 10.1073/pnas.97.22.12062; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Michiels F, 2000, METHOD ENZYMOL, V325, P295; MOONEY DJ, 1995, J CELL SCI, V108, P2311; Mulvaney PT, 1998, INT J CANCER, V78, P46, DOI 10.1002/(SICI)1097-0215(19980925)78:1<46::AID-IJC9>3.0.CO;2-X; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rittling SR, 1996, EXP CELL RES, V229, P7, DOI 10.1006/excr.1996.0337; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Schmitz HD, 2002, CELL BIOL INT, V26, P155, DOI 10.1006/cbir.2001.0819; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; SISTERMANS EA, 1995, CELL TISSUE RES, V280, P435, DOI 10.1007/s004410050372; Steeghs K, 1997, CELL, V89, P93, DOI 10.1016/S0092-8674(00)80186-5; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Tachikawa M, 2004, EUR J NEUROSCI, V20, P144, DOI 10.1111/j.1460-9568.2004.03478.x; van Horssen R, 2006, J CELL BIOCHEM, V99, P1536, DOI 10.1002/jcb.20994; van Horssen R, 2009, J BIOL CHEM, V284, P1620, DOI 10.1074/jbc.M806974200; Ventura-Clapier R, 2004, MOL CELL BIOCHEM, V256, P29, DOI 10.1023/B:MCBI.0000009857.69730.97; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wallimann T, 1985, Cell Muscle Motil, V6, P239; Wang YME, 1998, J NEUROSCI, V18, P987; Wojtas K, 1997, MOL BIOL CELL, V8, P1665, DOI 10.1091/mbc.8.9.1665; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136	58	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5030	10.1371/journal.pone.0005030	http://dx.doi.org/10.1371/journal.pone.0005030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333390	gold, Green Published, Green Submitted			2022-12-27	WOS:000265499900011
J	Champion, CI; Kickhoefer, VA; Liu, GC; Moniz, RJ; Freed, AS; Bergmann, LL; Vaccari, D; Raval-Fernandes, S; Chan, AM; Rome, LH; Kelly, KA				Champion, Cheryl I.; Kickhoefer, Valerie A.; Liu, Guangchao; Moniz, Raymond J.; Freed, Amanda S.; Bergmann, Liisa L.; Vaccari, Dana; Raval-Fernandes, Sujna; Chan, Ann M.; Rome, Leonard H.; Kelly, Kathleen A.			A Vault Nanoparticle Vaccine Induces Protective Mucosal Immunity	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; NALP3 INFLAMMASOME; CHLAMYDIA INFECTION; ANTIBODY-RESPONSES; OVIDUCT PATHOLOGY; GENITAL-INFECTION; DENDRITIC CELLS; MOUSE MODEL; IMMUNIZATION; RESISTANCE	Background: Generation of robust cell-mediated immune responses at mucosal surfaces while reducing overall inflammation is a primary goal for vaccination. Here we report the use of a recombinant nanoparticle as a vaccine delivery platform against mucosal infections requiring T cell-mediated immunity for eradication. Methodology/Principal Findings: We encapsulated an immunogenic protein, the major outer membrane protein (MOMP) of Chlamydia muridarum, within hollow, vault nanocapsules (MOMP-vaults) that were engineered to bind IgG for enhanced immunity. Intranasal immunization (i.n) with MOMP-vaults induced anti-chlamydial immunity plus significantly attenuated bacterial burden following challenge infection. Vault immunization induced anti-chlamydial immune responses and inflammasome formation but did not activate toll-like receptors. Moreover, MOMP-vault immunization enhanced microbial eradication without the inflammation usually associated with adjuvants. Conclusions/Significance: Vault nanoparticles containing immunogenic proteins delivered to the respiratory tract by the i.n. route can act as "smart adjuvants'' for inducing protective immunity at distant mucosal surfaces while avoiding destructive inflammation.			Champion, CI (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA.	kkelly@mednet.ucla.edu	LIU, GUANGCHAO/F-2810-2011; Rome, Leonard H/E-8786-2016	Rome, Leonard H/0000-0002-1236-2063; Kickhoefer, Valerie/0000-0002-0048-0580	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI026328, R01AI026328, R01AI079004] Funding Source: NIH RePORTER; NIAID NIH HHS [AI026328, R01 AI026328, R21 AI026328] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hansen J, 2008, J INFECT DIS, V198, P758, DOI 10.1086/590670; He Q, 2007, IMMUNOLOGY, V122, P28, DOI 10.1111/j.1365-2567.2007.02608.x; Heijnen IAFM, 1996, J CLIN INVEST, V97, P331, DOI 10.1172/JCI118420; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Ifere Godwin O., 2007, Journal of Microbiology Immunology and Infection, V40, P188; Izquierdo MA, 1996, AM J PATHOL, V148, P877; KEDERSHA NL, 1991, J CELL BIOL, V112, P225, DOI 10.1083/jcb.112.2.225; Kelly KA, 1996, INFECT IMMUN, V64, P4976, DOI 10.1128/IAI.64.12.4976-4983.1996; Kickhoefer VA, 2005, P NATL ACAD SCI USA, V102, P4348, DOI 10.1073/pnas.0500929102; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Kickhoefer VA, 2001, J CELL BIOL, V152, P157, DOI 10.1083/jcb.152.1.157; Kickhoefer VA, 2009, ACS NANO, V3, P27, DOI 10.1021/nn800638x; Kong LB, 1999, STRUCT FOLD DES, V7, P371, DOI 10.1016/S0969-2126(99)80050-1; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Kozlowski PA, 2002, J IMMUNOL, V169, P566, DOI 10.4049/jimmunol.169.1.566; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Liu W, 2008, IMMUNOLOGY, V123, P290, DOI 10.1111/j.1365-2567.2007.02642.x; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maxion HK, 2004, INFECT IMMUN, V72, P6330, DOI 10.1128/IAI.72.11.6330-6340.2004; Maxion HK, 2002, INFECT IMMUN, V70, P1538, DOI 10.1128/IAI.70.3.1538-1546.2002; MESTECKY J, 1987, J CLIN IMMUNOL, V7, P265, DOI 10.1007/BF00915547; Mikyas Y, 2004, J MOL BIOL, V344, P91, DOI 10.1016/j.jmb.2004.09.021; Moore T, 2003, J INFECT DIS, V188, P617, DOI 10.1086/377134; Murthy AK, 2007, INFECT IMMUN, V75, P666, DOI 10.1128/IAI.01280-06; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; Oliveira MLS, 2007, EXPERT REV VACCINES, V6, P419, DOI 10.1586/14760584.6.3.419; Pal S, 2006, VACCINE, V24, P766, DOI 10.1016/j.vaccine.2005.08.074; Pal S, 2005, INFECT IMMUN, V73, P8153, DOI 10.1128/IAI.73.12.8153-8160.2005; Poderycki MJ, 2006, BIOCHEMISTRY-US, V45, P12184, DOI 10.1021/bi0610552; RANK RG, 1999, MODELS IMMUNITY, P239; Stephen AG, 2001, J BIOL CHEM, V276, P23217, DOI 10.1074/jbc.C100226200; Tanaka H, 2009, SCIENCE, V323, P384, DOI 10.1126/science.1164975; *US DEP HHS, 2000, SEX TRANSM DIS SURV; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; *WHO DOHA, 2001, GLOB PREV INC SEL CU; Zuercher AW, 2002, J IMMUNOL, V168, P1796, DOI 10.4049/jimmunol.168.4.1796	43	89	99	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5409	10.1371/journal.pone.0005409	http://dx.doi.org/10.1371/journal.pone.0005409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404403	gold, Green Published			2022-12-27	WOS:000265614900020
J	Chaouche-Drider, N; Kaparakis, M; Karrar, A; Fernandez, MI; Carneiro, LAM; Viala, J; Boneca, IG; Moran, AP; Philpott, DJ; Ferrero, RL				Chaouche-Drider, Nadia; Kaparakis, Maria; Karrar, Abdulgader; Fernandez, Maria-Isabel; Carneiro, Letitia A. M.; Viala, Jerome; Boneca, Ivo Gomperts; Moran, Anthony P.; Philpott, Dana J.; Ferrero, Richard L.			A Commensal Helicobacter sp of the Rodent Intestinal Flora Activates TLR2 and NOD1 Responses in Epithelial Cells	PLOS ONE			English	Article								Helicobacter spp. represent a proportionately small but significant component of the normal intestinal microflora of animal hosts. Several of these intestinal Helicobacter spp. are known to induce colitis in mouse models, yet the mechanisms by which these bacteria induce intestinal inflammation are poorly understood. To address this question, we performed in vitro co-culture experiments with mouse and human epithelial cell lines stimulated with a selection of Helicobacter spp., including known pathogenic species as well as ones for which the pathogenic potential is less clear. Strikingly, a member of the normal microflora of rodents, Helicobacter muridarum, was found to be a particularly strong inducer of CXC chemokine (Cxcl1/KC, Cxcl2/MIP-2) responses in a murine intestinal epithelial cell line. Time-course studies revealed a biphasic pattern of chemokine responses in these cells, with H. muridarum lipopolysaccharide (LPS) mediating early (24-48 h) responses and live bacteria seeming to provoke later (48-72 h) responses. H. muridarum LPS per se was shown to induce CXC chemokine production in HEK293 cells stably expressing Toll-like receptor 2 (TLR2), but not in those expressing TLR4. In contrast, live H. muridarum bacteria were able to induce NF-kappa B reporter activity and CXC chemokine responses in TLR2-deficient HEK293 and in AGS epithelial cells. These responses were attenuated by transient transfection with a dominant negative construct to NOD1, and by stable expression of NOD1 siRNA, respectively. Thus, the data suggest that both TLR2 and NOD1 may be involved in innate immune sensing of H. muridarum by epithelial cells. This work identifies H. muridarum as a commensal bacterium with pathogenic potential and underscores the potential roles of ill-defined members of the normal flora in the initiation of inflammation in animal hosts. We suggest that H. muridarum may act as a confounding factor in colitis model studies in rodents.			Chaouche-Drider, N (corresponding author), Inst Pasteur, Unite Pathogenie Bacterienne Muqueuses, Paris, France.	Richard.Ferrero@med.monash.edu.au	Boneca, Ivo G/H-1677-2014; Carneiro, Leticia/T-8978-2019; Kaparakis-Liaskos, Maria/R-9321-2019; Kaparakis-Liaskos, Maria/I-6511-2013; Ferrero, Richard/U-1332-2017	Boneca, Ivo G/0000-0001-8122-509X; Carneiro, Leticia/0000-0001-5870-8288; Kaparakis-Liaskos, Maria/0000-0002-8964-4456; Kaparakis-Liaskos, Maria/0000-0002-8964-4456; Ferrero, Richard/0000-0001-6817-6211	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; Boutin SR, 2005, INFECT IMMUN, V73, P8449, DOI 10.1128/IAI.73.12.8449-8452.2005; Cahill RJ, 1997, INFECT IMMUN, V65, P3126, DOI 10.1128/IAI.65.8.3126-3131.1997; Cario E, 2002, AM J PATHOL, V160, P165, DOI 10.1016/S0002-9440(10)64360-X; Dieleman LA, 2000, INFECT IMMUN, V68, P5107, DOI 10.1128/IAI.68.9.5107-5113.2000; Fernandez MI, 2003, IMMUNITY, V18, P739, DOI 10.1016/S1074-7613(03)00122-5; FERRERO RL, 2001, HELICOBACTER PYLORI, P565; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Garhart CA, 2003, INFECT IMMUN, V71, P910, DOI 10.1128/IAI.71.2.910-921.2003; Ge ZM, 2008, MICROBES INFECT, V10, P726, DOI 10.1016/j.micinf.2008.03.011; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Girardin SE, 2002, TRENDS MICROBIOL, V10, P193, DOI 10.1016/S0966-842X(02)02334-X; Hisamatsu T, 2003, J BIOL CHEM, V278, P32962, DOI 10.1074/jbc.M304355200; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Jiang HQ, 2002, GASTROENTEROLOGY, V122, P1346, DOI 10.1053/gast.2002.32959; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Kurt-Jones EA, 2004, J ENDOTOXIN RES, V10, P419, DOI 10.1179/096805104225006516; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; LEE A, 1993, ZBL BAKT-INT J MED M, V280, P38; Lee SK, 2003, MICROBES INFECT, V5, P1345, DOI 10.1016/j.micinf.2003.09.018; MacDonald TT, 2000, INFLAMM BOWEL DIS, V6, P116, DOI 10.1097/00054725-200005000-00008; Maggio-Price L, 2002, AM J PATHOL, V160, P739, DOI 10.1016/S0002-9440(10)64894-8; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; MAZZUCCHELLI L, 1994, AM J PATHOL, V144, P997; MORAN AP, 1992, J BACTERIOL, V174, P1370, DOI 10.1128/jb.174.4.1370-1377.1992; Odenbreit S, 2001, CELL MICROBIOL, V3, P21, DOI 10.1046/j.1462-5822.2001.00088.x; Ohtsuka Y, 2001, GUT, V49, P526, DOI 10.1136/gut.49.4.526; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; PHILLIPS MW, 1983, APPL ENVIRON MICROB, V45, P675, DOI 10.1128/AEM.45.2.675-683.1983; Philpott DJ, 2002, CELL MICROBIOL, V4, P285, DOI 10.1046/j.1462-5822.2002.00189.x; QUEIROZ DMM, 1992, LAB ANIM, V26, P288, DOI 10.1258/002367792780745760; Remick DG, 2001, AM J PATHOL, V159, P1149, DOI 10.1016/S0002-9440(10)61791-9; Savard Christopher E, 2002, BMC Gastroenterol, V2, P23, DOI 10.1186/1471-230X-2-23; Shomer NH, 1997, INFECT IMMUN, V65, P4858, DOI 10.1128/IAI.65.11.4858-4864.1997; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Sterzenbach T, 2007, INFECT IMMUN, V75, P2717, DOI 10.1128/IAI.01935-06; Triantafilou M, 2007, CELL MICROBIOL, V9, P2030, DOI 10.1111/j.1462-5822.2007.00935.x; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131	46	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5396	10.1371/journal.pone.0005396	http://dx.doi.org/10.1371/journal.pone.0005396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401779	Green Published, Green Submitted, gold			2022-12-27	WOS:000265601100024
J	Dey, D; Saxena, M; Paranjape, AN; Krishnan, V; Giraddi, R; Kumar, MV; Mukherjee, G; Rangarajan, A				Dey, Devaveena; Saxena, Meera; Paranjape, Anurag N.; Krishnan, Visalakshi; Giraddi, Rajashekhar; Kumar, M. Vijaya; Mukherjee, Geetashree; Rangarajan, Annapoorni			Phenotypic and Functional Characterization of Human Mammary Stem/Progenitor Cells in Long Term Culture	PLOS ONE			English	Article								Background: Cancer stem cells exhibit close resemblance to normal stem cells in phenotype as well as function. Hence, studying normal stem cell behavior is important in understanding cancer pathogenesis. It has recently been shown that human breast stem cells can be enriched in suspension cultures as mammospheres. However, little is known about the behavior of these cells in long-term cultures. Since extensive self-renewal potential is the hallmark of stem cells, we undertook a detailed phenotypic and functional characterization of human mammospheres over long-term passages. Methodology: Single cell suspensions derived from human breast 'organoids' were seeded in ultra low attachment plates in serum free media. Resulting primary mammospheres after a week (termed T1 mammospheres) were subjected to passaging every 7th day leading to the generation of T2, T3, and T4 mammospheres. Principal Findings: We show that primary mammospheres contain a distinct side-population (SP) that displays a CD24(low)/CD44(low) phenotype, but fails to generate mammospheres. Instead, the mammosphere-initiating potential rests within the CD44(high)/CD24(low) cells, in keeping with the phenotype of breast cancer-initiating cells. In serial sphere formation assays we find that even though primary (T1) mammospheres show telomerase activity and fourth passage T4 spheres contain label-retaining cells, they fail to initiate new mammospheres beyond T5. With increasing passages, mammospheres showed an increase in smaller sized spheres, reduction in proliferation potential and sphere forming efficiency, and increased differentiation towards the myoepithelial lineage. Significantly, staining for senescence-associated beta-galactosidase activity revealed a dramatic increase in the number of senescent cells with passage, which might in part explain the inability to continuously generate mammospheres in culture. Conclusions: Thus, the self-renewal potential of human breast stem cells is exhausted within five in vitro passages of mammospheres, suggesting the need for further improvisation in culture conditions for their long-term maintenance.			Dey, D (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	anu@mrdg.iisc.ernet.in	Paranjape, Anurag N./P-1255-2018	Paranjape, Anurag N./0000-0001-6119-0766; Saxena, Meera/0000-0002-4060-4218; Giraddi, Rajshekhar/0000-0001-9728-7674; Mukherjee, Geetashree/0000-0003-4954-0035				Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alvi AJ, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr563; Betts DH, 2008, BIOGERONTOLOGY, V9, P19, DOI 10.1007/s10522-007-9113-7; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Braun KM, 2004, J INVEST DERM SYMP P, V9, P196, DOI 10.1111/j.1087-0024.2004.09313.x; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Clarke RB, 2003, CELL PROLIFERAT, V36, P45, DOI 10.1046/j.1365-2184.36.s.1.5.x; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Deng GR, 1996, SCIENCE, V274, P2057, DOI 10.1126/science.274.5295.2057; DEOME KB, 1959, CANCER RES, V19, P515; Diallo R, 2001, J PATHOL, V193, P27, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH747>3.0.CO;2-H; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ebbesen P, 2004, ACTA ONCOL, V43, P598, DOI 10.1080/02841860410020220; FLORES I, 2006, CURRENT OPINION CELL, V18, P1; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hiyama E, 1996, J NATL CANCER I, V88, P116, DOI 10.1093/jnci/88.2.116; KALIRAI H, 2006, J PATHOLOGY; Kim M, 2002, CLIN CANCER RES, V8, P22; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lakhani SR, 1999, J PATHOL, V189, P496, DOI 10.1002/(SICI)1096-9896(199912)189:4&lt;496::AID-PATH485&gt;3.0.CO;2-D; Lan L, 2007, J CLIN ENDOCR METAB, V92, P3681, DOI 10.1210/jc.2007-0281; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Lin TT, 2006, CELL RES, V16, P857, DOI 10.1038/sj.cr.7310107; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; LYNCH MD, 2006, BREAST CANC RES, V8; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Mouthon MA, 2006, J NEUROCHEM, V99, P807, DOI 10.1111/j.1471-4159.2006.04118.x; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shi XD, 2007, DEV BIOL, V312, P396, DOI 10.1016/j.ydbio.2007.09.042; Singh SK, 2003, CANCER RES, V63, P5821; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Smith GH, 2001, MICROSC RES TECHNIQ, V52, P190, DOI 10.1002/1097-0029(20010115)52:2<190::AID-JEMT1005>3.0.CO;2-O; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2006, NATURE, P1; Storms RW, 2000, BLOOD, V96, P2125; Triel C, 2004, EXP CELL RES, V295, P79, DOI 10.1016/j.yexcr.2003.11.032; Tsai YC, 1996, CANCER RES, V56, P402; Uchida N, 1996, BLOOD, V88, P1297, DOI 10.1182/blood.V88.4.1297.bloodjournal8841297; Villadsen R, 2005, APMIS, V113, P903, DOI 10.1111/j.1600-0463.2005.apm_344.x; Wagner M, 2000, EXP GERONTOL, V35, P729, DOI 10.1016/S0531-5565(00)00141-8; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; Wright WE, 2001, CURR OPIN GENET DEV, V11, P98, DOI 10.1016/S0959-437X(00)00163-5; Zipori D, 2004, NAT REV GENET, V5, P873, DOI 10.1038/nrg1475	54	86	99	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5329	10.1371/journal.pone.0005329	http://dx.doi.org/10.1371/journal.pone.0005329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390630	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000265514400015
J	Gupta, S; Salam, N; Srivastava, V; Singla, R; Behera, D; Khayyam, KU; Korde, R; Malhotra, P; Saxena, R; Natarajan, K				Gupta, Shashank; Salam, Nasir; Srivastava, Varsha; Singla, Rupak; Behera, Digamber; Khayyam, Khalid U.; Korde, Reshma; Malhotra, Pawan; Saxena, Rajiv; Natarajan, Krishnamurthy			Voltage Gated Calcium Channels Negatively Regulate Protective Immunity to Mycobacterium tuberculosis	PLOS ONE			English	Article							DENDRITIC CELLS; PHAGOSOME MATURATION; GENE-EXPRESSION; ACTIVATION; RESPONSES; ANTIGEN; DIFFERENTIATION; MACROPHAGES; INHIBITION; IMMUNOLOGY	Mycobacterium tuberculosis modulates levels and activity of key intracellular second messengers to evade protective immune responses. Calcium release from voltage gated calcium channels (VGCC) regulates immune responses to pathogens. In this study, we investigated the roles of VGCC in regulating protective immunity to mycobacteria in vitro and in vivo. Inhibiting L-type or R-type VGCC in dendritic cells (DCs) either using antibodies or by siRNA increased calcium influx in an inositol 1,4,5-phosphate and calcium release calcium activated channel dependent mechanism that resulted in increased expression of genes favoring pro-inflammatory responses. Further, VGCC-blocked DCs activated T cells that in turn mediated killing of M. tuberculosis inside macrophages. Likewise, inhibiting VGCC in infected macrophages and PBMCs induced calcium influx, upregulated the expression of pro-inflammatory genes and resulted in enhanced killing of intracellular M. tuberculosis. Importantly, compared to healthy controls, PBMCs of tuberculosis patients expressed higher levels of both VGCC, which were significantly reduced following chemotherapy. Finally, blocking VGCC in vivo in M. tuberculosis infected mice using specific antibodies increased intracellular calcium and significantly reduced bacterial loads. These results indicate that L-type and R-type VGCC play a negative role in M. tuberculosis infection by regulating calcium mobilization in cells that determine protective immunity.			Gupta, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India.	natrajan@icgeb.res.in	Salam, Nasir/C-8049-2015; Tuluc, Petronel/C-2527-2011; Gupta, Shashank/E-7382-2016	Salam, Nasir/0000-0001-9133-1304; Gupta, Shashank/0000-0003-0445-5195				Balkhi MY, 2004, J INFECT DIS, V189, P1598, DOI 10.1086/383328; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Berggren PO, 2004, CELL, V119, P273, DOI 10.1016/j.cell.2004.09.033; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; CANTRELL D, 1993, ANNU REV IMMUNOL, V14, P259; Cattaruzza M, 2000, BRIT J PHARMACOL, V129, P1155, DOI 10.1038/sj.bjp.0703192; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Foote S, 1999, NAT GENET, V21, P345, DOI 10.1038/7663; Henderson RA, 1997, J IMMUNOL, V159, P635; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; Hsu SF, 2001, J IMMUNOL, V166, P6126, DOI 10.4049/jimmunol.166.10.6126; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Kaufmann SHE, 2000, NAT MED, V6, P955, DOI 10.1038/79631; Kincaid EZ, 2003, J IMMUNOL, V171, P2042, DOI 10.4049/jimmunol.171.4.2042; Latchumanan VK, 2005, TUBERCULOSIS, V85, P377, DOI 10.1016/j.tube.2005.08.007; Latchumanan VK, 2002, J IMMUNOL, V169, P6856, DOI 10.4049/jimmunol.169.12.6856; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Ma XJ, 1997, J BIOL CHEM, V272, P10389; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; Matza D, 2008, IMMUNITY, V28, P64, DOI 10.1016/j.immuni.2007.11.020; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Noble A, 2000, J IMMUNOL, V164, P1807, DOI 10.4049/jimmunol.164.4.1807; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; Poggi A, 1998, J BIOL CHEM, V273, P7205, DOI 10.1074/jbc.273.13.7205; Premkumar DRD, 2000, J APPL PHYSIOL, V88, P1898, DOI 10.1152/jappl.2000.88.5.1898; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Salam N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002869; Singhal A, 2007, INFECT IMMUN, V75, P2500, DOI 10.1128/IAI.01743-06; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; SNUTCH TP, 2004, VOLTAGE GATED CALCIU, P1; Sousa CRE, 2001, IMMUNITY, V14, P495; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Tantral L, 2004, CELL BIOCHEM FUNCT, V22, P35, DOI 10.1002/cbf.1050; Tian T, 2005, J IMMUNOL, V175, P3268, DOI 10.4049/jimmunol.175.5.3268; Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527; Verhasselt V, 1999, J IMMUNOL, V162, P2569; *WHO, 2002, WHO FACT SHEET; Wieland H, 2006, FEMS IMMUNOL MED MIC, V47, P296, DOI 10.1111/j.1574-695X.2006.00092.x	42	42	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5305	10.1371/journal.pone.0005305	http://dx.doi.org/10.1371/journal.pone.0005305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390594	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514200016
J	Ordonez, L; Bernard, I; L'Faqihi-Olive, FE; Tervaert, JWC; Damoiseaux, J; Saoudi, A				Ordonez, Laurence; Bernard, Isabelle; L'Faqihi-Olive, Fatima-Ezzahra; Tervaert, Jan Willem Cohen; Damoiseaux, Jan; Saoudi, Abdelhadi			CD45RC Isoform Expression Identifies Functionally Distinct T Cell Subsets Differentially Distributed between Healthy Individuals and AAV Patients	PLOS ONE			English	Article								In animal models of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), the proportion of CD45RC T cell subsets is important for disease susceptibility. Their human counterparts are, however, functionally ill defined. In this report, we studied their distribution in healthy controls (HC), AAV patients and in Systemic lupus erythematous (SLE) patients as disease controls. We showed that CD45RC expression level on human CD4 and CD8 T cells identifies subsets that are highly variable among individuals. Interestingly, AAV patients exhibit an increased proportion of CD45RC low CD4 T cells as compared to HC and SLE patients. This increase is stable over time and independent of AAV subtype, ANCA specificity, disease duration, or number of relapses. We also analyzed the cytokine profile of purified CD4 and CD8 CD45RC T cell subsets from HC, after stimulation with anti-CD3 and anti-CD28 mAbs. The CD45RC subsets exhibit different cytokine profiles. Type-1 cytokines (IL-2, IFN-gamma and TNF-alpha) were produced by all CD45RC T cell subsets, while the production of IL-17, type-2 (IL-4, IL-5) and regulatory (IL-10) cytokines was restricted to the CD45RC low subset. In conclusion, we have shown that CD45RC expression divides human T cells in functionally distinct subsets that are imbalanced in AAV. Since this imbalance is stable over time and independent of several disease parameters, we hypothesize that this is a pre-existing immune abnormality involved in the etiology of AAV.			Ordonez, L (corresponding author), Hop Purpan, IFR 30, U563, INSERM, Toulouse, France.	abdelhadi.saoudi@inserm.fr	SAOUDI, Abdelhadi/K-6719-2014; Damoiseaux, Jan/B-8993-2009; tervaert, jan willem cohen/AAB-1111-2019	SAOUDI, Abdelhadi/0000-0001-7015-8178; Damoiseaux, Jan/0000-0003-4007-6985; Bernard, Isabelle/0000-0002-5847-1281				Abdulahad WH, 2006, KIDNEY INT, V70, P938, DOI 10.1038/sj.ki.5001670; Abdulahad WH, 2008, ARTHRITIS RHEUM-US, V58, P2196, DOI 10.1002/art.23557; Abdulahad WH, 2007, ANN NY ACAD SCI, V1107, P22, DOI 10.1196/annals.1381.003; Abdulahad WH, 2007, ARTHRITIS RHEUM, V56, P2080, DOI 10.1002/art.22692; Bernard I, 1998, EUR CYTOKINE NETW, V9, P613; BROUWER E, 1993, J EXP MED, V177, P905, DOI 10.1084/jem.177.4.905; Bunce C, 1997, J EXP MED, V185, P767, DOI 10.1084/jem.185.4.767; Csernok E, 1999, ARTHRITIS RHEUM, V42, P742, DOI 10.1002/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I; ESNAULT VLM, 1992, LAB INVEST, V67, P114; Field AC, 2003, J IMMUNOL, V170, P2508, DOI 10.4049/jimmunol.170.5.2508; Fournie GJ, 2001, IMMUNOL REV, V184, P145, DOI 10.1034/j.1600-065x.2001.1840114.x; HAGEN EC, 1995, CLIN NEPHROL, V43, P351; Hargreaves M, 1997, IMMUNOLOGY, V91, P323, DOI 10.1046/j.1365-2567.1997.00267.x; Haubitz M, 1998, NEPHROL DIAL TRANSPL, V13, P2074, DOI 10.1093/ndt/13.8.2074; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Jagiello P, 2005, ARTHRITIS RHEUM-US, V52, P4039, DOI 10.1002/art.21487; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Kiely PDW, 1997, J IMMUNOL, V159, P5100; Lamprecht P, 2007, ARTHRITIS RHEUM-US, V56, P1725, DOI 10.1002/art.22693; LOCKWOOD CM, 1993, LANCET, V341, P1620, DOI 10.1016/0140-6736(93)90759-A; Ludviksson BR, 1998, J IMMUNOL, V160, P3602; LUQMANI RA, 1994, Q J MED, V87, P671; Marinaki S, 2005, CLIN EXP IMMUNOL, V140, P181, DOI 10.1111/j.1365-2249.2005.02731.x; Mas M, 2004, J IMMUNOL, V172, P6354, DOI 10.4049/jimmunol.172.10.6354; MATHIESON PW, 1993, J EXP MED, V177, P1309, DOI 10.1084/jem.177.5.1309; MATHIESON PW, 1992, LAB INVEST, V67, P121; Mayet WJ, 1999, SCAND J IMMUNOL, V49, P585; MCKNIGHT AJ, 1991, EUR J IMMUNOL, V21, P1187, DOI 10.1002/eji.1830210514; Muller A, 2008, Z RHEUMATOL, V67, P72, DOI 10.1007/s00393-007-0236-7; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; Popa ER, 1999, J ALLERGY CLIN IMMUN, V103, P885, DOI 10.1016/S0091-6749(99)70434-3; Popa ER, 2002, ARTHRITIS RHEUM, V46, P1894, DOI 10.1002/art.10384; Ruth AJ, 2006, J AM SOC NEPHROL, V17, P1940, DOI 10.1681/ASN.2006020108; SCHLESIER M, 1995, RHEUMATOL INT, V14, P213, DOI 10.1007/BF00262300; SCHMITT WH, 1992, ARTHRITIS RHEUM, V35, P1088, DOI 10.1002/art.1780350914; Schweickert R, 2003, HUM FACTORS, V45, P77, DOI 10.1518/hfes.45.1.77.27230; Slot MC, 2008, CLIN IMMUNOL, V128, P39, DOI 10.1016/j.clim.2008.03.506; STEGEMAN CA, 1993, CLIN EXP IMMUNOL, V91, P415; STREULI M, 1987, J EXP MED, V166, P1548, DOI 10.1084/jem.166.5.1548; Subra JF, 2001, J IMMUNOL, V166, P2944, DOI 10.4049/jimmunol.166.5.2944; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tchilian EZ, 2006, TRENDS IMMUNOL, V27, P146, DOI 10.1016/j.it.2006.01.001; van Wijngaarden RAFDL, 2008, CLIN J AM SOC NEPHRO, V3, P237, DOI 10.2215/CJN.03550807; Vorechovsky I, 2001, NAT GENET, V29, P22, DOI 10.1038/ng723; WILDE B, 2008, NEPHROL DIAL TRANSPL; Xystrakis E, 2004, BLOOD, V104, P3294, DOI 10.1182/blood-2004-03-1214; Xystrakis E, 2004, J IMMUNOL, V173, P3140, DOI 10.4049/jimmunol.173.5.3140	50	28	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5287	10.1371/journal.pone.0005287	http://dx.doi.org/10.1371/journal.pone.0005287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381293	Green Published, gold, Green Submitted			2022-12-27	WOS:000265513800018
J	Randis, TM; Kulkarni, R; Aguilar, JL; Ratner, AJ				Randis, Tara M.; Kulkarni, Ritwij; Aguilar, Jorge L.; Ratner, Adam J.			Antibody-Based Detection and Inhibition of Vaginolysin, the Gardnerella vaginalis Cytolysin	PLOS ONE			English	Article								Bacterial vaginosis (BV) is the most common vaginal infection worldwide and is associated with significant adverse sequelae. We have recently characterized vaginolysin (VLY), the human-specific cytotoxin produced by Gardnerella vaginalis and believed to play a critical role in the pathogenesis of BV and its associated morbidities. We hypothesize that novel antibody-based strategies may be useful for detection of VLY and for inhibition of its toxic effects on human cells. Using purified toxin as an immunogen, we generated polyclonal rabbit immune serum (IS) against VLY. A western blot of G. vaginalis lysate was probed with IS and a single band (57 kD) identified. Immunofluorescence techniques using IS detected VLY production by G. vaginalis. In addition, we have developed a sandwich ELISA assay capable of VLY quantification at ng/ml concentrations in the supernatant of growing G. vaginalis. To investigate the potential inhibitory role of IS on VLY-mediated cell lysis, we exposed human erythrocytes to VLY or VLY pretreated with IS and determined the percent hemolysis. Pretreatment with IS resulted in a significant reduction in VLY-mediated lysis. Similarly, both human cervical carcinoma cells and vaginal epithelial cells exhibited reduced cytolysis following exposure to VLY with IS compared to VLY alone. These results confirm that antibody-based techniques are an effective means of VLY detection. Furthermore, VLY antiserum functions as an inhibitor of VLY-CD59 interaction, mitigating cell lysis. These strategies may have a potential role in the diagnosis and treatment of BV.			Randis, TM (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.	ar127@columbia.edu		Ratner, Adam/0000-0003-1761-794X; Randis, Tara/0000-0003-0348-6766	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI065450] Funding Source: NIH RePORTER; NIAID NIH HHS [AI065450, K08 AI065450] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; BRISELDEN AM, 1994, J CLIN MICROBIOL, V32, P148, DOI 10.1128/JCM.32.1.148-152.1994; Calderon E, 1997, Infect Dis Obstet Gynecol, V5, P226, DOI 10.1155/S1064744997000380; COHEN CR, 1995, AIDS, V9, P1093, DOI 10.1097/00002030-199509000-00017; Donders GGG, 2002, BJOG-INT J OBSTET GY, V109, P34, DOI 10.1016/S1470-0328(02)00432-9; Eschenbach D A, 1984, Scand J Urol Nephrol Suppl, V86, P213; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; FREDRICKS DN, 2009, J CLIN MICROBIOL; GARDNER HL, 1955, AM J OBSTET GYNECOL, V69, P962, DOI 10.1016/0002-9378(55)90095-8; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Hedges SR, 2006, J INFECT DIS, V193, P556, DOI 10.1086/499824; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hogan VK, 2007, MATERN CHILD HLTH J, V11, P532, DOI 10.1007/s10995-007-0205-4; Josey WE, 2008, INT J STD AIDS, V19, P152, DOI 10.1258/ijsa.2007.007260; Keane FEA, 2005, SEX TRANSM INFECT, V81, P155, DOI 10.1136/sti.2004.009902; Klein LL, 2004, AM J OBSTET GYNECOL, V190, P1493, DOI 10.1016/j.ajog.2004.03.014; Koumans EH, 2001, SEX TRANSM DIS, V28, P292, DOI 10.1097/00007435-200105000-00011; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; McDonald HM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub3; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; Myziuk L, 2003, J CLIN MICROBIOL, V41, P1925, DOI 10.1128/JCM.41.5.1925-1928.2003; NELSON DB, 2008, J PERINAT MED; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; SCHWEBKE JR, 2008, SEX TRANSM DIS; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Tam M T, 1998, Infect Dis Obstet Gynecol, V6, P204, DOI 10.1155/S1064744998000416; WATTS DH, 1989, OBSTET GYNECOL, V73, P52; West B, 2003, SEX TRANSM DIS, V30, P483, DOI 10.1097/00007435-200306000-00003	28	25	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5207	10.1371/journal.pone.0005207	http://dx.doi.org/10.1371/journal.pone.0005207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370149	Green Published, gold, Green Submitted			2022-12-27	WOS:000265510600003
J	Worter, V; Schweigreiter, R; Kinzel, B; Mueller, M; Barske, C; Bock, G; Frentzel, S; Bandtlow, CE				Woerter, Verena; Schweigreiter, Ruediger; Kinzel, Bernd; Mueller, Matthias; Barske, Carmen; Boeck, Guenther; Frentzel, Stefan; Bandtlow, Christine E.			Inhibitory Activity of Myelin-Associated Glycoprotein on Sensory Neurons Is Largely Independent of NgR1 and NgR2 and Resides within Ig-Like Domains 4 and 5	PLOS ONE			English	Article								Myelin-associated glycoprotein (MAG) is a sialic acid binding Ig-like lectin (Siglec) which has been characterized as potent myelin-derived inhibitor of neurite outgrowth. Two members of the Nogo-receptor (NgR) family, NgR1 and NgR2, have been identified as neuronal binding proteins of MAG. In addition, gangliosides have been proposed to bind to and confer the inhibitory activity of MAG on neurons. In this study, we investigated the individual contribution of NgRs and gangliosides to MAG-mediated inhibition of sensory neurons derived from dorsal root ganglia (DRG) of ngr1, ngr2 or ngr1/ngr2 deletion mutants. We found no disinhibition of neurite growth in the absence of either NgR1 or NgR2. Sensory neurons deficient for both NgR proteins displayed only a moderate reduction of MAG-mediated inhibition of neurite growth. If treated with Vibrio cholerae neuraminidase (VCN), inhibition by MAG is further attenuated but still not annulled. Thus, disrupting all known protein and ganglioside receptors for MAG in sensory neurons does not fully abolish its inhibitory activity pointing to the existence of as yet unidentified receptors for MAG. Moreover, by employing a variety of protein mutants, we identified the Ig-like domains 4 or 5 of MAG as necessary and sufficient for growth arrest, whereas abolishing MAG's ability to bind to sialic acid did not interfere with its inhibitory activity. These findings provide new insights into the inhibitory function of MAG and suggest similarities but also major differences in MAG inhibition between sensory and central nervous system (CNS) neurons.			Worter, V (corresponding author), Innsbruck Med Univ, Div Neurobiochem, Bioctr, Innsbruck, Austria.	christine.bandtlow@i-med.ac.at						Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Barrette B, 2007, MOL CELL NEUROSCI, V34, P519, DOI 10.1016/j.mcn.2006.12.004; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cao ZX, 2007, J NEUROSCI, V27, P9146, DOI 10.1523/JNEUROSCI.2404-07.2007; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; Lauren J, 2003, MOL CELL NEUROSCI, V24, P581, DOI 10.1016/S1044-7431(03)00199-4; Lauren J, 2007, J BIOL CHEM, V282, P5715, DOI 10.1074/jbc.M609797200; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Mehta NR, 2007, J BIOL CHEM, V282, P27875, DOI 10.1074/jbc.M704055200; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Niederost B, 2002, J NEUROSCI, V22, P10368; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Quarles RH, 2007, J NEUROCHEM, V100, P1431, DOI 10.1111/j.1471-4159.2006.04319.x; Schafer M, 1996, NEURON, V16, P1107, DOI 10.1016/S0896-6273(00)80137-3; Schweigreiter R, 2004, MOL CELL NEUROSCI, V27, P163, DOI 10.1016/j.mcn.2004.06.004; Schweigreiter R, 2007, PROTEOMICS, V7, P4457, DOI 10.1002/pmic.200700499; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Sicotte M, 2003, MOL CELL NEUROSCI, V23, P251, DOI 10.1016/S1044-7431(03)00053-8; Tang S, 1997, J CELL BIOL, V138, P1355, DOI 10.1083/jcb.138.6.1355; Turnley AM, 1998, NEUROREPORT, V9, P1987, DOI 10.1097/00001756-199806220-00013; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Venkatesh K, 2007, J CELL BIOL, V177, P393, DOI 10.1083/jcb.200702102; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Vyas AA, 2005, J BIOL CHEM, V280, P16305, DOI 10.1074/jbc.M500250200; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Williams G, 2008, J BIOL CHEM, V283, P16641, DOI 10.1074/jbc.M802067200; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yang HB, 1999, J NEUROSCI RES, V55, P687, DOI 10.1002/(SICI)1097-4547(19990315)55:6<687::AID-JNR4>3.0.CO;2-6; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102	41	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2009	4	4							e5218	10.1371/journal.pone.0005218	http://dx.doi.org/10.1371/journal.pone.0005218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TS	19367338	Green Published, Green Submitted, gold			2022-12-27	WOS:000265510400007
J	Aranko, AS; Zuger, S; Buchinger, E; Iwai, H				Aranko, A. Sesilja; Zuger, Sara; Buchinger, Edith; Iwai, Hideo			In Vivo and In Vitro Protein Ligation by Naturally Occurring and Engineered Split DnaE Inteins	PLOS ONE			English	Article								Background: Protein trans-splicing by naturally occurring split DnaE inteins is used for protein ligation of foreign peptide fragments. In order to widen biotechnological applications of protein trans-splicing, it is highly desirable to have split inteins with shorter C-terminal fragments, which can be chemically synthesized. Principal Findings: We report the identification of new functional split sites in DnaE inteins from Synechocystis sp. PCC6803 and from Nostoc punctiforme. One of the newly engineered split intein bearing C-terminal 15 residues showed more robust protein trans-splicing activity than naturally occurring split DnaE inteins in a foreign context. During the course of our experiments, we found that protein ligation by protein trans-splicing depended not only on the splicing junction sequences, but also on the foreign extein sequences. Furthermore, we could classify the protein trans-splicing reactions in foreign contexts with a simple kinetic model into three groups according to their kinetic parameters in the presence of various reducing agents. Conclusion: The shorter C-intein of the newly engineered split intein could be a useful tool for biotechnological applications including protein modification, incorporation of chemical probes, and segmental isotopic labelling. Based on kinetic analysis of the protein splicing reactions, we propose a general strategy to improve ligation yields by protein trans-splicing, which could significantly enhance the applications of protein ligation by protein trans-splicing.	[Buchinger, Edith] Aalborg Univ, Chem & Environm Engn, Dept Biotechnol, Aalborg, Denmark	Aalborg University	Aranko, AS (corresponding author), Univ Helsinki, Inst Biotechnol, Res Program Struct Biol & Biophys, Helsinki, Finland.	hideo.iwai@helsinki.fi	Aranko, Aino Sesilja/N-1224-2016; Iwaï, Hideo/A-6416-2009	Aranko, Aino Sesilja/0000-0001-9425-3524; Iwaï, Hideo/0000-0001-7376-5264				Buskirk AR, 2004, P NATL ACAD SCI USA, V101, P10505, DOI 10.1073/pnas.0402762101; Dassa B, 2007, BIOCHEMISTRY-US, V46, P322, DOI 10.1021/bi0611762; Derbyshire V, 1997, P NATL ACAD SCI USA, V94, P11466, DOI 10.1073/pnas.94.21.11466; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Forrer P, 1998, GENE, V224, P45, DOI 10.1016/S0378-1119(98)00538-1; Heinamaki K, 2009, BIOMOL NMR ASSIGN, V3, P41, DOI 10.1007/s12104-008-9137-1; Hiraga K, 2005, J MOL BIOL, V354, P916, DOI 10.1016/j.jmb.2005.09.088; HIRATA R, 1990, J BIOL CHEM, V265, P6726; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Iwai H, 2001, J BIOL CHEM, V276, P16548, DOI 10.1074/jbc.M011639200; Iwai H, 2008, J PEPT SCI, V14, P183; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; Kurpiers T, 2007, ANGEW CHEM INT EDIT, V46, P5234, DOI 10.1002/anie.200700719; Ludwig C, 2006, ANGEW CHEM INT EDIT, V45, P5218, DOI 10.1002/anie.200600570; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; Mills KV, 1998, P NATL ACAD SCI USA, V95, P3543, DOI 10.1073/pnas.95.7.3543; Mootz HD, 2003, J AM CHEM SOC, V125, P10561, DOI 10.1021/ja0362813; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Muona M, 2008, CHEMBIOCHEM, V9, P2958, DOI 10.1002/cbic.200800604; OEEMIG JS, 2009, SOLUTION STRUCTURE D, DOI DOI 10.1016/J.FEBSLET.2009.03.058; Otomo T, 1999, J BIOMOL NMR, V14, P105, DOI 10.1023/A:1008308128050; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Perler FB, 1997, CURR OPIN CHEM BIOL, V1, P292, DOI 10.1016/S1367-5931(97)80065-8; REICHMAN CT, 1992, CELL GROWTH DIFFER, V3, P451; Schwartz EC, 2007, NAT CHEM BIOL, V3, P50, DOI 10.1038/nchembio832; Southworth MW, 1998, EMBO J, V17, P918, DOI 10.1093/emboj/17.4.918; Sun P, 2005, J MOL BIOL, V353, P1093, DOI 10.1016/j.jmb.2005.09.039; Sun WC, 2004, J BIOL CHEM, V279, P35281, DOI 10.1074/jbc.M405491200; Williams NK, 2002, J BIOL CHEM, V277, P7790, DOI 10.1074/jbc.M110303200; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Xu MQ, 2005, CURR OPIN BIOTECH, V16, P440, DOI 10.1016/j.copbio.2005.06.012; Yamazaki T, 1998, J AM CHEM SOC, V120, P5591, DOI 10.1021/ja980776o; Zuger S, 2005, NAT BIOTECHNOL, V23, P736, DOI 10.1038/nbt1097	36	58	62	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5185	10.1371/journal.pone.0005185	http://dx.doi.org/10.1371/journal.pone.0005185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365564	Green Published, gold			2022-12-27	WOS:000265509900013
J	Raz, S; Retzkin, S; Pavlicek, T; Hoffman, A; Kimchi, H; Zehavi, D; Beiles, A; Nevo, E				Raz, Shmuel; Retzkin, Sion; Pavlicek, Tomas; Hoffman, Adam; Kimchi, Hagay; Zehavi, Dan; Beiles, Avigdor; Nevo, Eviatar			Scorpion Biodiversity and Interslope Divergence at "Evolution Canyon'', Lower Nahal Oren Microsite, Mt. Carmel, Israel	PLOS ONE			English	Article							MOUNT-CARMEL; DIVERSITY; PLANTS	Background: Local natural laboratories, designated by us as the "Evolution Canyon'' model, are excellent tools to study regional and global ecological dynamics across life. They present abiotic and biotic contrasts locally, permitting the pursuit of observations and experiments across diverse taxa sharing sharp microecological subdivisions. Higher solar radiation received by the "African savannah-like'' south-facing slopes (AS) in canyons north of the equator than by the opposite "European maquis-like'' north-facing slopes (ES) is associated with higher abiotic stress. Scorpions are a suitable taxon to study interslope biodiversity differences, associated with the differences in abiotic factors (climate, drought), due to their ability to adapt to dry environments. Methodology/Principal Findings: Scorpions were studied by the turning stone method and by UV light methods. The pattern observed in scorpions was contrasted with similar patterns in several other taxa at the same place. As expected, the AS proved to be significantly more speciose regarding scorpions, paralleling the interslope patterns in taxa such as lizards and snakes, butterflies (Rhopalocera), beetles (families Tenebrionidae, Dermestidae, Chrysomelidae), and grasshoppers (Orthoptera). Conclusions/Significance: Our results support an earlier conclusion stating that the homogenizing effects of migration and stochasticity are not able to eliminate the interslope intra-and interspecific differences in biodiversity despite an interslope distance of only 100 m at the "EC'' valley bottom. In our opinion, the interslope microclimate selection, driven mainly by differences in insolance, could be the primary factor responsible for the observed interslope pattern.			Raz, S (corresponding author), Univ Haifa, Dept Environm & Evolutionary Biol, IL-31999 Haifa, Israel.	razshmu@gmail.com	Pavlicek, Tomas/C-4768-2008; רז, שמואל/ABD-3478-2021					Chikatunov V, 2000, BIOL J LINN SOC, V69, P139, DOI 10.1006/bijl.1999.0322; CLOUDSLEY-THOMPSON J. L., 1962, ENTOMOL EXPTL ET APPL, V5, P270; Fet V., 2000, Catalog of the scorpions of the world (1758-1998); Grishkan I, 2000, ISRAEL J PLANT SCI, V48, P297, DOI 10.1560/LAJV-KKNY-F0HD-59KG; HADLEY N F, 1974, Journal of Arachnology, V2, P11; HADLEY NF, 1972, AM SCI, V60, P338; HADLEY NF, 1970, J EXP BIOL, V53, P547; Harry M, 1999, BIOLOGIA, V54, P685; KARCZ Y., 1959, BULL RES COUNC ISRAEL SECT G GEO SCI, V8G, P119; Kravchenko Vasiliy, 2002, Ecologia Mediterranea, V28, P99; LEVY G, 1985, PLANTS ANIMALS LAND, V2, P17; Levy G., 1980, FAUNA PALAESTINA ARA; Melamud V, 2007, ACTA ZOOL ACAD SCI H, V53, P381; *MIN LAB EL PUBL C, 1970, ATL ISR; Nevo E, 1999, ISR J PLANT SCI, V47, P49, DOI 10.1080/07929978.1999.10676751; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 1997, THEOR POPUL BIOL, V52, P231, DOI 10.1006/tpbi.1997.1330; Nevo E, 1996, ISR J ZOOL, V42, P395; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nevo E, 2006, ISR J ECOL EVOL, V52, P485; Palmer A. Richard, 2003, P279; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Pavlicek T, 1996, ISR J ZOOL, V42, P449; PAVLICEK T, 2009, ECOL MED IN PRESS, V34; Pavlicek T, 2008, BIOL J LINN SOC, V93, P147; Pavlicek Tomas, 2002, Journal of the Entomological Research Society, V4, P25; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; Polis G.A., 1990, P247; Sissom W.D., 1990, P445; VANVALEN L, 1962, EVOLUTION, V16, P125; Vilenkin B, 2009, ECOL MODEL, V220, P657, DOI 10.1016/j.ecolmodel.2008.12.012; WARBURG MR, 1981, COMP BIOCHEM PHYS A, V68, P277, DOI 10.1016/0300-9629(81)90354-6; WARBURG MR, 1979, J ARID ENVIRON, V2, P339, DOI 10.1016/S0140-1963(18)31688-4; Warburg MR, 1997, BIODIVERS CONSERV, V6, P1377, DOI 10.1023/A:1018389730440; WARBURG MR, 1980, COMP BIOCHEM PHYS A, V67, P47, DOI 10.1016/0300-9629(80)90407-7; WARBURG MR, 1978, S ZOOL SOC LOND, V42, P161; Wasser SP, 1995, ISR J PLANT SCI, V43, P367, DOI 10.1080/07929978.1995.10676623	37	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5214	10.1371/journal.pone.0005214	http://dx.doi.org/10.1371/journal.pone.0005214			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357787	Green Published, gold, Green Submitted			2022-12-27	WOS:000265505900026
J	Maekawa, M; Takashima, N; Matsumata, M; Ikegami, S; Kontani, M; Hara, Y; Kawashima, H; Owada, Y; Kiso, Y; Yoshikawa, T; Inokuchi, K; Osumi, N				Maekawa, Motoko; Takashima, Noriko; Matsumata, Miho; Ikegami, Shiro; Kontani, Masanori; Hara, Yoshinobu; Kawashima, Hiroshi; Owada, Yuji; Kiso, Yoshinobu; Yoshikawa, Takeo; Inokuchi, Kaoru; Osumi, Noriko			Arachidonic Acid Drives Postnatal Neurogenesis and Elicits a Beneficial Effect on Prepulse Inhibition, a Biological Trait of Psychiatric Illnesses	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; BINDING PROTEINS; PRENATAL EXPOSURE; HIPPOCAMPAL NEUROGENESIS; EICOSAPENTAENOIC ACID; DENTATE GYRUS; SCHIZOPHRENIA; ADULT; RAT; STARTLE	Prepulse inhibition (PPI) is a compelling endophenotype (biological markers) for mental disorders including schizophrenia. In a previous study, we identified Fabp7, a fatty acid binding protein 7 as one of the genes controlling PPI in mice and showed that this gene was associated with schizophrenia. We also demonstrated that disrupting Fabp7 dampened hippocampal neurogenesis. In this study, we examined a link between neurogenesis and PPI using different animal models and exploring the possibility of postnatal manipulation of neurogenesis affecting PPI, since gene-deficient mice show biological disturbances from prenatal stages. In parallel, we tested the potential for dietary polyunsaturated fatty acids (PUFAs), arachidonic acid (ARA) and/or docosahexaenoic acid (DHA), to promote neurogenesis and improve PPI. PUFAs are ligands for Fabp members and are abundantly expressed in neural stem/progenitor cells in the hippocampus. Our results are: (1) an independent model animal, Pax6(+/-) rats, exhibited PPI deficits along with impaired postnatal neurogenesis; (2) methylazoxymethanol acetate (an anti-proliferative drug) elicited decreased neurogenesis even in postnatal period, and PPI defects in young adult rats (10 weeks) when the drug was given at the juvenile stage (4-5 weeks); (3) administering ARA for 4 weeks after birth promoted neurogenesis in wild type rats; (4) raising Pax6 (+/-) pups on an ARA-containing diet enhanced neurogenesis and partially improved PPI in adult animals. These results suggest the potential benefit of ARA in ameliorating PPI deficits relevant to psychiatric disorders and suggest that the effect may be correlated with augmented postnatal neurogenesis.			Maekawa, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Dev Neurobiol, Sendai, Miyagi 980, Japan.	osumi@mail.tains.tohoku.ac.jp	Inokuchi, Kaoru/AAI-9693-2020; Yoshikawa, Takeo/F-9599-2019; Kiso, Yoshinobu/D-5424-2012; Osumi, Noriko/T-2823-2019	Inokuchi, Kaoru/0000-0002-5393-3133; Osumi, Noriko/0000-0003-0548-6452; Kawashima, Hiroshi/0000-0003-4249-0426; hara, Yoshinobu/0000-0001-6339-5116; Owada, Yuji/0000-0002-5109-0531				Arai Y, 2005, J NEUROSCI, V25, P9752, DOI 10.1523/JNEUROSCI.2512-05.2005; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brunskill EW, 2005, EUR J NEUROSCI, V22, P1265, DOI 10.1111/j.1460-9568.2005.04291.x; Chen YJJ, 2008, J NEUROSCI, V28, P6872, DOI 10.1523/JNEUROSCI.1815-08.2008; DAS GD, 1970, BRAIN RES, V21, P122, DOI 10.1016/0006-8993(70)90026-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fukaya T, 2007, NEUROBIOL AGING, V28, P1179, DOI 10.1016/j.neurobiolaging.2006.05.023; Fukuda S, 2003, J NEUROSCI, V23, P9357; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Ghashghaei HT, 2006, P NATL ACAD SCI USA, V103, P1930, DOI 10.1073/pnas.0510410103; HACHEY DL, 1987, J LIPID RES, V28, P1185; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Heird WC, 2001, PEDIATR CLIN N AM, V48, P173, DOI 10.1016/S0031-3955(05)70292-3; Horrobin DF, 2002, PROSTAG LEUKOTR ESS, V66, P83, DOI 10.1054/plef.2001.0338; Hyman SE, 2008, NATURE, V455, P890, DOI 10.1038/nature07454; Kamnasaran D, 2003, J MED GENET, V40, P325, DOI 10.1136/jmg.40.5.325; Kawakita E, 2006, NEUROSCIENCE, V139, P991, DOI 10.1016/j.neuroscience.2006.01.021; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Le Pen G, 2006, NEUROSCIENCE, V143, P395, DOI 10.1016/j.neuroscience.2006.08.004; Lin SH, 2007, SCHIZOPHRENIA BULL, V33, P174, DOI 10.1093/schbul/sbl038; Lipska BK, 1995, PSYCHOPHARMACOLOGY, V122, P35, DOI 10.1007/BF02246439; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Maekawa M, 2005, GENES CELLS, V10, P1001, DOI 10.1111/j.1365-2443.2005.00893.x; Molina-Holgado F, 2007, EUR J NEUROSCI, V25, P629, DOI 10.1111/j.1460-9568.2007.05322.x; Muskiet FAJ, 2006, J NUTR BIOCHEM, V17, P717, DOI 10.1016/j.jnutbio.2006.02.001; Osumi N, 1997, DEVELOPMENT, V124, P2961; Owada Y, 1996, J CHEM NEUROANAT, V12, P113, DOI 10.1016/S0891-0618(96)00192-5; Peet M, 2001, SCHIZOPHR RES, V49, P243, DOI 10.1016/S0920-9964(00)00083-9; Pieper AA, 2005, P NATL ACAD SCI USA, V102, P14052, DOI 10.1073/pnas.0506713102; Sakuradani E, 1999, EUR J BIOCHEM, V260, P208, DOI 10.1046/j.1432-1327.1999.00131.x; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Smesny S, 2004, J PSYCHIAT RES, V38, P537, DOI 10.1016/j.jpsychires.2004.01.007; Smesny S, 2007, NEUROPSYCHOPHARMACOL, V32, P2067, DOI 10.1038/sj.npp.1301343; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Su KP, 2001, EUR NEUROPSYCHOPHARM, V11, P295, DOI 10.1016/S0924-977X(01)00098-0; SUSSER ES, 1992, ARCH GEN PSYCHIAT, V49, P983; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Uchida K, 2002, ZOOL SCI, V19, P1211, DOI 10.2108/zsj.19.1211; Veerkamp JH, 2001, J MOL NEUROSCI, V16, P133, DOI 10.1385/JMN:16:2-3:133; Venna VR, 2009, PSYCHONEUROENDOCRINO, V34, P199, DOI 10.1016/j.psyneuen.2008.08.025; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297	48	87	91	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5085	10.1371/journal.pone.0005085	http://dx.doi.org/10.1371/journal.pone.0005085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437RX	19352438	Green Published, gold, Green Submitted			2022-12-27	WOS:000265505700008
J	Mutabingwa, TK; Muze, K; Ord, R; Briceno, M; Greenwood, BM; Drakeley, C; Whitty, CJM				Mutabingwa, Theonest K.; Muze, Kandi; Ord, Rosalynn; Briceno, Marnie; Greenwood, Brian M.; Drakeley, Chris; Whitty, Christopher J. M.			Randomized Trial of Artesunate plus Amodiaquine, Sulfadoxine-Pyrimethamine plus Amodiaquine, Chlorproguanal-Dapsone and SP for Malaria in Pregnancy in Tanzania	PLOS ONE			English	Article							UNCOMPLICATED FALCIPARUM-MALARIA; ARTEMETHER-LUMEFANTRINE; SAFETY; EFFICACY; PHARMACOKINETICS; COMBINATION; CHILDREN; RISK; CHLOROQUINE; PREVENTION	Background: Malaria in pregnancy is serious, and drug resistance in Africa is spreading. Drugs have greater risks in pregnancy and determining the safety and efficacy of drugs in pregnancy is therefore a priority. This study set out to determine the efficacy and safety of several antimalarial drugs and combinations in pregnant women with uncomplicated malaria. Methods: Pregnant women with non-severe, slide proven, falciparum malaria were randomised to one of 4 regimes: sulfadoxine-pyrimethamine [SP]; chlorproguanil-dapsone [CD]; SP+amodiaquine [SP+AQ] or amodiaquine+artesunate [AQ+AS]. Randomisation was on a 1: 2: 2: 2 ratio. Women were admitted for treatment, and followed at days 7, 14, 21, 28 after the start of treatment, at delivery and 6 weeks after delivery to determine adverse events, clinical and parasitological outcomes. Primary outcome was parasitological failure by day 28. Results: 1433 pregnant women were screened, of whom 272 met entry criteria and were randomised; 28 to SP, 81 to CD, 80 to SP+AQ and 83 to AQ+AS. Follow-up to day 28 post treatment was 251/272 (92%), and to 6 weeks following delivery 91%. By day 28 parasitological failure rates were 4/26 (15%, 95% CI 4-35) in the SP, 18/77 (23%, 95% CI 14-34) in the CD, 1/73 (1% 95% CI 7-0.001) in the SP+AQ and 7/75 (9% 95% CI 4-18) in the AQ+AS arms respectively. After correction by molecular markers for reinfection the parasitological failure rates at day 28 were 18% for CD, 1% for SP+AQ and 4.5% for AQ+AS. There were two maternal deaths during the trial. There was no apparent excess of stillbirths or adverse birth outcomes in any arm. Parasitological responses were strikingly better in pregnant women than in children treated with the same drugs at this site. Conclusions: Failure rates with monotherapy were unacceptably high. The two combinations tested were efficacious and appeared safe. It should not be assumed that efficacy in pregnancy is the same as in children.			Mutabingwa, TK (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	tk.bingwa@yahoo.com	Whitty, Christopher/C-7740-2012	Whitty, Christopher/0000-0002-6076-5027				Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4; [Anonymous], 2007, ASS SAF ART COMP PRE; Brentlinger PE, 2006, LANCET INFECT DIS, V6, P100, DOI 10.1016/S1473-3099(06)70383-8; Bukirwa H, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004531.pub2; D'Alessandro U, 2006, LANCET, V368, P1306, DOI 10.1016/S0140-6736(06)69532-9; Deen JL, 2001, T ROY SOC TROP MED H, V95, P424, DOI 10.1016/S0035-9203(01)90204-4; Dellicour S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-15; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Diagne N, 1997, T ROY SOC TROP MED H, V91, P166, DOI 10.1016/S0035-9203(97)90209-1; Garner P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub2; Greenwood B, 2007, LANCET INFECT DIS, V7, P169, DOI 10.1016/S1473-3099(07)70028-2; KAHN G, 1985, J AM ACAD DERMATOL, V13, P838, DOI 10.1016/S0190-9622(85)80416-3; KEUTER M, 1990, BMJ-BRIT MED J, V301, P466, DOI 10.1136/bmj.301.6750.466; Martensson A, 2005, CLIN INFECT DIS, V41, P1079, DOI 10.1086/444460; McGready R, 2001, CLIN INFECT DIS, V33, P2009, DOI 10.1086/324349; McGready R, 2006, EUR J CLIN PHARMACOL, V62, P1021, DOI 10.1007/s00228-006-0199-7; Mendez F, 2006, AM J TROP MED HYG, V75, P640, DOI 10.4269/ajtmh.2006.75.640; Mockenhaupt FP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-119; Mutabingwa T, 2001, LANCET, V358, P1218, DOI 10.1016/S0140-6736(01)06344-9; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Nosten F, 2007, LANCET INFECT DIS, V7, P118, DOI 10.1016/S1473-3099(07)70023-3; Obonyo CO, 2007, T ROY SOC TROP MED H, V101, P117, DOI 10.1016/j.trstmh.2006.07.001; Shulman CE, 1996, T ROY SOC TROP MED H, V90, P535, DOI 10.1016/S0035-9203(96)90312-0; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Slutsker L, 2007, CURR OPIN INFECT DIS, V20, P3, DOI 10.1097/QCO.0b013e328012c5cd; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Staedke SG, 2004, LANCET, V364, P1950, DOI 10.1016/S0140-6736(04)17478-3; Steketee RW, 1996, AM J TROP MED HYG, V55, P17, DOI 10.4269/ajtmh.1996.55.17; Tagbor H, 2007, TROP MED INT HEALTH, V12, P1288, DOI 10.1111/j.1365-3156.2007.01927.x; Tagbor H, 2006, LANCET, V368, P1349, DOI 10.1016/S0140-6736(06)69559-7; Tagbor HK, 2007, EXPERT OPIN DRUG SAF, V6, P631, DOI 10.1517/14740338.6.6.631; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Vallely A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-16; Verhoeff FH, 1998, ANN TROP MED PARASIT, V92, P141, DOI 10.1080/00034989859979; WANGBOONSKUL J, 1993, EUR J CLIN PHARMACOL, V44, P247, DOI 10.1007/BF00271366; Ward SA, 2007, LANCET INFECT DIS, V7, P136, DOI 10.1016/S1473-3099(07)70025-7; Watson-Jones D, 2007, B WORLD HEALTH ORGAN, V85, P9, DOI 10.2471/BLT.06.033258; White NJ, 2007, LANCET INFECT DIS, V7, P549, DOI 10.1016/S1473-3099(07)70187-1; Whitty CJM, 2005, BJOG-INT J OBSTET GY, V112, P1189, DOI 10.1111/j.1471-0528.2005.00714.x; WHO, 2006, GUID TREATM MAL; WHO, 2012, MAN SEV MAL PRACT HD, V3; World Health Organization, 2003, WHOCDSMAL20031094	42	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5138	10.1371/journal.pone.0005138	http://dx.doi.org/10.1371/journal.pone.0005138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352498	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000265505700024
J	Eme, L; Moreira, D; Talla, E; Brochier-Armanet, C				Eme, Laura; Moreira, David; Talla, Emmanuel; Brochier-Armanet, Celine			A Complex Cell Division Machinery Was Present in the Last Common Ancestor of Eukaryotes	PLOS ONE			English	Article								Background: The midbody is a transient complex structure containing proteins involved in cytokinesis. Up to now, it has been described only in Metazoa. Other eukaryotes present a variety of structures implied in the last steps of cell division, such as the septum in fungi or the phragmoplast in plants. However, it is unclear whether these structures are homologous (derive from a common ancestral structure) or analogous (have distinct evolutionary origins). Recently, the proteome of the hamster midbody has been characterized and 160 proteins identified. Methodology/Principal Findings: Using phylogenomic approaches, we show here that nearly all of these 160 proteins (95%) are conserved across metazoan lineages. More surprisingly, we show that a large part of the mammalian midbody components (91 proteins) were already present in the last common ancestor of all eukaryotes (LECA) and were most likely involved in the construction of a complex multi-protein assemblage acting in cell division. Conclusions/Significance: Our results indicate that the midbodies of non-mammalian metazoa are likely very similar to the mammalian one and that the ancestor of Metazoa possessed a nearly modern midbody. Moreover, our analyses support the hypothesis that the midbody and the structures involved in cytokinesis in other eukaryotes derive from a large and complex structure present in LECA, likely involved in cytokinesis. This is an additional argument in favour of the idea of a complex ancestor for all contemporary eukaryotes.	[Eme, Laura; Talla, Emmanuel; Brochier-Armanet, Celine] CNRS, Chim Bacterienne Lab, UPR 9043, F-13277 Marseille, France; [Moreira, David] Univ Paris 11, CNRS, UMR 8079, Unite Ecol Syst Evolut, Orsay, France; [Talla, Emmanuel] Univ Aix Marseille 2, Marseille, France; [Brochier-Armanet, Celine] Univ Aix Marseille 1, Marseille, France	Centre National de la Recherche Scientifique (CNRS); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Eme, L (corresponding author), CNRS, Chim Bacterienne Lab, UPR 9043, F-13277 Marseille, France.	celine.brochier@ifr88.cnrs-mrs.fr	Moreira, David/F-7445-2012; Eme, Laura/G-8468-2015; Brochier-Armanet, Celine/B-7898-2011	Moreira, David/0000-0002-2064-5354; Eme, Laura/0000-0002-0510-8868; Brochier-Armanet, Celine/0000-0003-4669-3589; TALLA, Emmanuel/0000-0002-7775-8296	Ministre de l'Enseignement Superieur et de la Recherche; Action Thematique et Incitative sur Programme (ATIP) of the French Centre National de la Recherche Scientifique, CNRS; French Agence Nationale de la Recherche [JC05_44674]	Ministre de l'Enseignement Superieur et de la Recherche; Action Thematique et Incitative sur Programme (ATIP) of the French Centre National de la Recherche Scientifique, CNRS(Centre National de la Recherche Scientifique (CNRS)); French Agence Nationale de la Recherche(French National Research Agency (ANR))	LE is the recipient of a grant from the Ministre de l'Enseignement Superieur et de la Recherche. CBA is supported by an Action Thematique et Incitative sur Programme (ATIP) of the French Centre National de la Recherche Scientifique, CNRS. This work was supported by a grant from the French Agence Nationale de la Recherche (ANR JC05_44674). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bapteste E, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r85; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Broadwater S.J., 1992, CYTOSKELETON ALGAE, P93; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; Demidov D, 2005, PLANT CELL, V17, P836, DOI 10.1105/tpc.104.029710; DURBIN R, 1999, BIOL SEQUENCE ANAL; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Eisen JA, 2003, SCIENCE, V300, P1706, DOI 10.1126/science.1086292; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Field C, 1999, CURR OPIN CELL BIOL, V11, P68, DOI 10.1016/S0955-0674(99)80009-X; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Flemming W., 1891, ARCH MIKROSK ANAT, V37, P685, DOI [DOI 10.1007/BF02954311, 10.1007/BF02954311]; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; FRANKE WW, 1970, Z ZELLFORSCH MIK ANA, V105, P405, DOI 10.1007/BF00335464; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Jurgens G, 2005, ANNU REV PLANT BIOL, V56, P281, DOI 10.1146/annurev.arplant.55.031903.141636; Jurgens G, 2005, TRENDS CELL BIOL, V15, P277, DOI 10.1016/j.tcb.2005.03.005; Kanoh J, 2003, CELL MOL LIFE SCI, V60, P2295, DOI 10.1007/s00018-003-3245-y; Ke YW, 2003, CELL RES, V13, P69, DOI 10.1038/sj.cr.7290152; Keith W Nicol, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004507; Koumandou VL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-29; LAMOND AI, 1993, BIOESSAYS, V15, P595, DOI 10.1002/bies.950150905; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lopez-Bautista JM, 2003, INT J SYST EVOL MICR, V53, P1715, DOI 10.1099/ijs.0.02561-0; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; Mans BJ, 2004, CELL CYCLE, V3, P1612; MULLINS JM, 1982, J CELL BIOL, V94, P654, DOI 10.1083/jcb.94.3.654; Neujahr R, 1998, J CELL SCI, V111, P1227; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Ohno S., 1970, EVOLUTION GENE DUPLI; Otegui MS, 2005, TRENDS CELL BIOL, V15, P404, DOI 10.1016/j.tcb.2005.06.003; Pazour GJ, 2004, CURR BIOL, V14, pR575, DOI 10.1016/j.cub.2004.07.017; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Pickett-Heaps JD, 1999, AM J BOT, V86, P153, DOI 10.2307/2656933; Robinson DN, 2000, TRENDS CELL BIOL, V10, P228, DOI 10.1016/S0962-8924(00)01747-5; SAWITZKY H, 1995, J CELL BIOL, V130, P1359, DOI 10.1083/jcb.130.6.1359; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Staub E, 2004, BIOESSAYS, V26, P567, DOI 10.1002/bies.20032; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Terada Y, 2001, CELL STRUCT FUNCT, V26, P653, DOI 10.1247/csf.26.653; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verma DPS, 2001, ANNU REV PLANT PHYS, V52, P751, DOI 10.1146/annurev.arplant.52.1.751; Walther A, 2003, FUNGAL GENET BIOL, V40, P187, DOI 10.1016/j.fgb.2003.08.005	50	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5021	10.1371/journal.pone.0005021	http://dx.doi.org/10.1371/journal.pone.0005021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352429	Green Published, gold, Green Submitted			2022-12-27	WOS:000265505300004
J	Reffay, M; Gambin, Y; Benabdelhak, H; Phan, G; Taulier, N; Ducruix, A; Hodges, RS; Urbach, W				Reffay, Myriam; Gambin, Yann; Benabdelhak, Houssain; Phan, Gilles; Taulier, Nicolas; Ducruix, Arnaud; Hodges, Robert S.; Urbach, Wladimir			Tracking Membrane Protein Association in Model Membranes	PLOS ONE			English	Article							DILUTE SURFACTANT SOLUTIONS; BICONTINUOUS CUBIC PHASES; MULTIDRUG EFFLUX SYSTEM; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; FUSION PROTEIN; SPONGE PHASES; X-RAY; ANALYTICAL ULTRACENTRIFUGATION	Membrane proteins are essential in the exchange processes of cells. In spite of great breakthrough in soluble proteins studies, membrane proteins structures, functions and interactions are still a challenge because of the difficulties related to their hydrophobic properties. Most of the experiments are performed with detergent-solubilized membrane proteins. However widely used micellar systems are far from the biological two-dimensions membrane. The development of new biomimetic membrane systems is fundamental to tackle this issue. We present an original approach that combines the Fluorescence Recovery After fringe Pattern Photobleaching technique and the use of a versatile sponge phase that makes it possible to extract crucial informations about interactions between membrane proteins embedded in the bilayers of a sponge phase. The clear advantage lies in the ability to adjust at will the spacing between two adjacent bilayers. When the membranes are far apart, the only possible interactions occur laterally between proteins embedded within the same bilayer, whereas when membranes get closer to each other, interactions between proteins embedded in facing membranes may occur as well. After validating our approach on the streptavidin-biotinylated peptide complex, we study the interactions between two membrane proteins, MexA and OprM, from a Pseudomonas aeruginosa efflux pump. The mode of interaction, the size of the protein complex and its potential stoichiometry are determined. In particular, we demonstrate that: MexA is effectively embedded in the bilayer; MexA and OprM do not interact laterally but can form a complex if they are embedded in opposite bilayers; the population of bound proteins is at its maximum for bilayers separated by a distance of about 200 angstrom, which is the periplasmic thickness of Pseudomonas aeruginosa. We also show that the MexA-OprM association is enhanced when the position and orientation of the protein is restricted by the bilayers. We extract a stoichiometry for the complex that exhibits a strong pH dependance: from 2 to 6 MexA per OprM trimer when the pH decreases from 7.5 to 5.5. Our technique allows to study membrane protein associations in a membrane environment. It provides some challenging information about complexes such as geometry and stoichiometry.	[Reffay, Myriam; Gambin, Yann; Urbach, Wladimir] Univ Paris 06, CNRS, Phys Stat Lab, Ecole Normale Super,UMR 8550, Paris, France; [Benabdelhak, Houssain; Taulier, Nicolas; Urbach, Wladimir] Univ Paris 06, UPMC, Lab Imager Parametrique, UMR 7623, Paris, France; [Benabdelhak, Houssain; Taulier, Nicolas] CNRS, LIP, UMR 7623, Paris, France; [Phan, Gilles; Ducruix, Arnaud] Univ Paris 05, Lab Cristallograph RMN Biol, CNRS, UMR8015, Paris, France; [Hodges, Robert S.] Univ Colorado, Dept Biochem & Mol Genet, Denver, CO USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of Colorado System; University of Colorado Denver	Reffay, M (corresponding author), Univ Paris 06, CNRS, Phys Stat Lab, Ecole Normale Super,UMR 8550, Paris, France.	urbach@lps.ens.fr	GAMBIN, Yann/M-8799-2014; Taulier, Nicolas/C-3965-2011; URBACH, Wladimir/AAA-5969-2022; REFFAY, Myriam/D-3736-2018; GAMBIN, Yann/AAI-8501-2021; Urbach, Wladimir/AAG-9004-2019	Taulier, Nicolas/0000-0003-1017-1068; URBACH, Wladimir/0000-0002-1673-6923; Urbach, Wladimir/0000-0002-1673-6923; Reffay, Myriam/0000-0002-3695-2789; GAMBIN, Yann/0000-0001-7378-8976	Ministere de l'Education, de la Recherche et de la Technologie (MERT); ANR-BLANC eFFLUX [0263-01]	Ministere de l'Education, de la Recherche et de la Technologie (MERT); ANR-BLANC eFFLUX(French National Research Agency (ANR))	MR and GP were supported by a fellowship from the Ministere de l'Education, de la Recherche et de la Technologie (MERT). Financial support from ANR-BLANC eFFLUX 0263-01 is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Andersen C, 2000, EMBO REP, V1, P313, DOI 10.1093/embo-reports/kvd075; ANDERSON DM, 1990, J PHYS CHEM-US, V94, P8683, DOI 10.1021/j100387a012; BALINOV B, 1991, J PHYS CHEM-US, V95, P5931, DOI 10.1021/j100168a041; Bokma E, 2006, FEBS LETT, V580, P5339, DOI 10.1016/j.febslet.2006.09.005; Broutin I, 2005, ACTA CRYSTALLOGR F, V61, P315, DOI 10.1107/S1744309105005014; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Camacho-Carvajal MM, 2004, MOL CELL PROTEOMICS, V3, P176, DOI 10.1074/mcp.T300010-MCP200; CATES ME, 1988, EUROPHYS LETT, V5, P733, DOI 10.1209/0295-5075/5/8/012; CATES ME, 1990, J PHYS-CONDENS MAT, V2, pSA339, DOI 10.1088/0953-8984/2/S/053; Cooper MA, 2007, J MOL RECOGNIT, V20, P154, DOI 10.1002/jmr.826; COULON C, 1991, PHYS REV LETT, V66, P1709, DOI 10.1103/PhysRevLett.66.1709; DAVOUST J, 1982, EMBO J, V1, P1233, DOI 10.1002/j.1460-2075.1982.tb00018.x; Ebel C, 2000, BIOPHYS J, V78, P385, DOI 10.1016/S0006-3495(00)76601-X; Fernandez-Recio J, 2004, FEBS LETT, V578, P5, DOI 10.1016/j.febslet.2004.10.097; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Freyssingeas E, 1996, LANGMUIR, V12, P6028, DOI 10.1021/la9605246; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; GAMBIN Y, 2006, THESIS UPMC PARIS; GRAHAM LL, 1991, TRENDS BIOCHEM SCI, V16, P328, DOI 10.1016/0968-0004(91)90135-I; HELM CA, 1991, P NATL ACAD SCI USA, V88, P8169, DOI 10.1073/pnas.88.18.8169; HENDRICKSON WA, 1989, P NATL ACAD SCI USA, V86, P2190, DOI 10.1073/pnas.86.7.2190; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Ip H, 2003, J BIOL CHEM, V278, P50474, DOI 10.1074/jbc.M305152200; KALB E, 1992, THIN SOLID FILMS, V210, P763, DOI 10.1016/0040-6090(92)90397-T; Katsamba PS, 2002, METHODS, V26, P95, DOI 10.1016/S1046-2023(02)00012-9; Kleman M, 1999, PRAMANA-J PHYS, V53, P107, DOI 10.1007/s12043-999-0143-3; Kurtisovski E, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.258103; Lambert O, 2005, J STRUCT BIOL, V150, P50, DOI 10.1016/j.jsb.2005.01.001; Laurer JH, 1997, LANGMUIR, V13, P2177, DOI 10.1021/la9608876; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Lu JR, 1998, J PHYS CHEM B, V102, P5785, DOI 10.1021/jp973315i; Mahjoub HF, 1998, PHYS REV LETT, V81, P2076, DOI 10.1103/PhysRevLett.81.2076; Maldonado A, 2004, J PHYS CHEM B, V108, P2893, DOI 10.1021/jp0266751; Maldonado A, 1996, PHYS REV E, V54, P1774, DOI 10.1103/PhysRevE.54.1774; McKeegan KS, 2003, TRENDS MICROBIOL, V11, P21, DOI 10.1016/S0966-842X(02)00010-0; Mokhonov V, 2005, PROTEIN EXPRES PURIF, V40, P91, DOI 10.1016/j.pep.2004.10.002; Naji A, 2007, BIOPHYS J, V93, pL49, DOI 10.1529/biophysj.l07.119222; Narita S, 2003, BIOCHEM BIOPH RES CO, V308, P922, DOI 10.1016/S0006-291X(03)01512-2; Poole K, 2001, CURR OPIN MICROBIOL, V4, P500, DOI 10.1016/S1369-5274(00)00242-3; PORTE G, 1992, J PHYS-CONDENS MAT, V4, P8649, DOI 10.1088/0953-8984/4/45/002; PORTE G, 1989, J PHYS-PARIS, V50, P1335, DOI 10.1051/jphys:0198900500110133500; REFFAY M, 2007, THESIS UPMC PARIS; Rivas G, 1999, METHODS, V19, P194, DOI 10.1006/meth.1999.0851; ROUX D, 1992, J PHYS CHEM-US, V96, P4174, DOI 10.1021/j100190a017; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SKOURI M, 1991, J PHYS II, V1, P1121, DOI 10.1051/jp2:1991208; Stone HA, 1998, J FLUID MECH, V369, P151, DOI 10.1017/S0022112098001980; STREY R, 1990, LANGMUIR, V6, P1635, DOI 10.1021/la00101a003; SWORDS NA, 1993, BIOCHEM J, V289, P215, DOI 10.1042/bj2890215; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Trepout S, 2007, LANGMUIR, V23, P2647, DOI 10.1021/la062227z; VANEDE J, 1989, J CHROMATOGR, V476, P319, DOI 10.1016/S0021-9673(01)93879-8; Wadsten P, 2006, J MOL BIOL, V364, P44, DOI 10.1016/j.jmb.2006.06.043; Yoneyama H, 2000, J BIOL CHEM, V275, P4628, DOI 10.1074/jbc.275.7.4628; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190	59	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5035	10.1371/journal.pone.0005035	http://dx.doi.org/10.1371/journal.pone.0005035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337368	Green Published, gold			2022-12-27	WOS:000265500600011
J	Pan, D; Zhang, LQ				Pan, Deng; Zhang, Liqing			Burst of Young Retrogenes and Independent Retrogene Formation in Mammals	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GENE DUPLICATION; DROSOPHILA-MELANOGASTER; PROCESSED PSEUDOGENES; DNA LOSS; EVOLUTION; GENOME; RATES; RETROTRANSPOSONS; IDENTIFICATION	Retroposition and retrogenes gain increasing attention as recent studies show that they play an important role in human new gene formation. Here we examined the patterns of retrogene distribution in 8 mammalian genomes using 4 non-mammalian genomes as a contrast. There has been a burst of young retrogenes not only in primate lineages as suggested in a recent study, but also in other mammalian lineages. In mammals, most of the retrofamilies (the gene families that have retrogenes) are shared between species. In these shared retrofamilies, 14%-18% of functional retrogenes may have originated independently in multiple mammalian species. Notably, in the independently originated retrogenes, there is an enrichment of ribosome related gene function. In sharp contrast, none of these patterns hold in non-mammals. Our results suggest that the recruitment of the specific L1 retrotransposons in mammals might have been an important evolutionary event for the split of mammals and non-mammals and retroposition continues to be an important active process in shaping the dynamics of mammalian genomes, as compared to being rather inert in non-mammals.	[Pan, Deng; Zhang, Liqing] Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA; [Zhang, Liqing] Virginia Tech, Program Genet Bioinformat & Computat Biol, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Pan, D (corresponding author), Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA.	lqzhang@vt.edu	Pan, Deng/F-1794-2011		NSF [IIS-0710945]; AdvanceVT	NSF(National Science Foundation (NSF)); AdvanceVT	NSF Grant IIS-0710945 and AdvanceVT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There is no financial interest.	Bai YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r11; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Boissinot SP, 2004, J MOL EVOL, V58, P122, DOI 10.1007/s00239-003-2539-x; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; Brosius J, 1999, TRENDS GENET, V15, P304, DOI 10.1016/S0168-9525(99)01783-7; BURCH JBE, 1993, P NATL ACAD SCI USA, V90, P8199, DOI 10.1073/pnas.90.17.8199; Casavant NC, 2000, GENETICS, V154, P1809; Crainey JL, 2005, MOL BIOL EVOL, V22, P2190, DOI 10.1093/molbev/msi217; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eickbush TH, 2002, CURR OPIN GENET DEV, V12, P669, DOI 10.1016/S0959-437X(02)00359-3; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Ezawa K, 2006, MOL BIOL EVOL, V23, P927, DOI 10.1093/molbev/msj093; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Furano AV, 2000, PROG NUCLEIC ACID RE, V64, P255, DOI 10.1016/S0079-6603(00)64007-2; Furano AV, 2004, TRENDS GENET, V20, P9, DOI 10.1016/j.tig.2003.11.006; Gentles AJ, 1999, TRENDS GENET, V15, P47, DOI 10.1016/S0168-9525(98)01648-5; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Graves JAM, 2002, TRENDS GENET, V18, P517, DOI 10.1016/S0168-9525(02)02772-5; Haas NB, 2001, GENE, V265, P175, DOI 10.1016/S0378-1119(01)00344-4; Harrison PM, 2003, NUCLEIC ACIDS RES, V31, P1033, DOI 10.1093/nar/gkg169; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Killian JK, 2001, MAMM GENOME, V12, P513, DOI 10.1007/s003350020026; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Li W. H, 1997, MOL EVOLUTION; Marques AC, 2005, PLOS BIOL, V3, P1970, DOI 10.1371/journal.pbio.0030357; Muller J, 2004, MOL ECOL NOTES, V4, P786, DOI 10.1111/j.1471-8286.2004.00813.x; Nikolaev SI, 2007, P NATL ACAD SCI USA, V104, P20443, DOI 10.1073/pnas.0705658104; Pan D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r158; Pavlicek A, 2006, TRENDS GENET, V22, P69, DOI 10.1016/j.tig.2005.11.005; Petrov DA, 1998, MOL BIOL EVOL, V15, P293, DOI 10.1093/oxfordjournals.molbev.a025926; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; R Development Core Team, 2006, R LANG ENV STAT COMP; Robinson R, 2005, PLOS BIOL, V3, P1860, DOI 10.1371/journal.pbio.0030396; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Volff JN, 2003, TRENDS GENET, V19, P674, DOI 10.1016/j.tig.2003.10.006; Wakefield MJ, 2003, EMBO REP, V4, P143, DOI 10.1038/sj.embor.embor739; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zhang ZL, 2002, GENOME RES, V12, P1466, DOI 10.1101/gr.331902	51	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e5040	10.1371/journal.pone.0005040	http://dx.doi.org/10.1371/journal.pone.0005040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PO	19325906	Green Submitted, Green Published, gold			2022-12-27	WOS:000265499600009
J	Pradhan, AAA; Becker, JAJ; Scherrer, G; Tryoen-Toth, P; Filliol, D; Matifas, A; Massotte, D; Gaveriaux-Ruff, C; Kieffer, BL				Pradhan, Amynah A. A.; Becker, Jerome A. J.; Scherrer, Gregory; Tryoen-Toth, Petra; Filliol, Dominique; Matifas, Audrey; Massotte, Dominique; Gaveriaux-Ruff, Claire; Kieffer, Brigitte L.			In Vivo Delta Opioid Receptor Internalization Controls Behavioral Effects of Agonists	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; NEUROPATHIC PAIN; MEMBRANE TRAFFICKING; CHRONIC INFLAMMATION; MORPHINE-TOLERANCE; KNOCKOUT MICE; SPINAL-CORD; MU; ENDOCYTOSIS; DESENSITIZATION	Background: GPCRs regulate a remarkable diversity of biological functions, and are thus often targeted for drug therapies. Stimulation of a GPCR by an extracellular ligand triggers receptor signaling via G proteins, and this process is highly regulated. Receptor activation is typically accompanied by desensitization of receptor signaling, a complex feedback regulatory process of which receptor internalization is postulated as a key event. The in vivo significance of GPCR internalization is poorly understood. In fact, the majority of studies have been performed in transfected cell systems, which do not adequately model physiological environments and the complexity of integrated responses observed in the whole animal. Methods and Findings: In this study, we used knock-in mice expressing functional fluorescent delta opioid receptors (DOR-eGFP) in place of the native receptor to correlate receptor localization in neurons with behavioral responses. We analyzed the pain-relieving effects of two delta receptor agonists with similar signaling potencies and efficacies, but distinct internalizing properties. An initial treatment with the high (SNC80) or low (AR-M100390) internalizing agonist equally reduced CFA-induced inflammatory pain. However, subsequent drug treatment produced highly distinct responses. Animals initially treated with SNC80 showed no analgesic response to a second dose of either delta receptor agonist. Concomitant receptor internalization and G-protein uncoupling were observed throughout the nervous system. This loss of function was temporary, since full DOR-eGFP receptor responses were restored 24 hours after SNC80 administration. In contrast, treatment with AR-M100390 resulted in retained analgesic response to a subsequent agonist injection, and ex vivo analysis showed that DOR-eGFP receptor remained G protein-coupled on the cell surface. Finally SNC80 but not AR-M100390 produced DOR-eGFP phosphorylation, suggesting that the two agonists produce distinct active receptor conformations in vivo which likely lead to differential receptor trafficking. Conclusions: Together our data show that delta agonists retain full analgesic efficacy when receptors remain on the cell surface. In contrast, delta agonist-induced analgesia is abolished following receptor internalization, and complete behavioral desensitization is observed. Overall these results establish that, in the context of pain control, receptor localization fully controls receptor function in vivo. This finding has both fundamental and therapeutic implications for slow-recycling GPCRs.			Pradhan, AAA (corresponding author), Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, Illkirch Graffenstaden, France.	briki@igbmc.u-strasbg.fr	GAVERIAUX-RUFF, Claire/A-9671-2017; Pradhan, Amynah/AAX-7719-2020; Becker, Jerome/I-7879-2016	GAVERIAUX-RUFF, Claire/0000-0002-3523-8102; Becker, Jerome/0000-0002-0039-0067; massotte, dominique/0000-0002-8758-1009; Toth, Petra/0000-0003-4573-4705; Scherrer, Gregory/0000-0002-1983-5126	NIDA NIH HHS [P50 DA005010, DA05010] Funding Source: Medline	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; Befort K, 2001, J BIOL CHEM, V276, P3130, DOI 10.1074/jbc.M006352200; Bernard W, 2006, TRENDS NEUROSCI, V29, P140, DOI 10.1016/j.tins.2006.01.006; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Brandt MR, 2001, J PHARMACOL EXP THER, V299, P629; Cahill CM, 2003, PAIN, V101, P199, DOI 10.1016/S0304-3959(02)00333-0; CALDERON SN, 1994, J MED CHEM, V37, P2125, DOI 10.1021/jm00040a002; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Fraser GL, 2000, BRIT J PHARMACOL, V129, P1668, DOI 10.1038/sj.bjp.0703248; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gastard M, 2000, BMC NEUROSCI, V1, DOI 10.1186/1471-2202-1-1; Gaveriaux-Ruff C, 2008, EUR J NEUROSCI, V27, P2558, DOI 10.1111/j.1460-9568.2008.06223.x; Gendron L, 2006, J NEUROSCI, V26, P953, DOI 10.1523/JNEUROSCI.3598-05.2006; Hasbi A, 2000, J PHARMACOL EXP THER, V293, P237; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; Hurley RW, 2000, J NEUROSCI, V20, P1249, DOI 10.1523/JNEUROSCI.20-03-01249.2000; Jutkiewicz EM, 2005, J PHARMACOL EXP THER, V315, P414, DOI 10.1124/jpet.105.088831; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Kieffer BL, 2002, CELL, V108, P587, DOI 10.1016/S0092-8674(02)00666-9; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Ko JL, 1999, MOL BRAIN RES, V69, P171, DOI 10.1016/S0169-328X(99)00094-7; Law PY, 2000, J BIOL CHEM, V275, P32057, DOI 10.1074/jbc.M002395200; Law PY, 2004, DELTA RECEPTOR, P61; Maestri-El Kouhen O, 2000, J BIOL CHEM, V275, P36659, DOI 10.1074/jbc.M006788200; Malatynska E, 1996, J PHARMACOL EXP THER, V278, P1083; Marie N, 2003, LIFE SCI, V73, P1691, DOI 10.1016/S0024-3205(03)00489-2; Mika J, 2001, EUR J PHARMACOL, V415, P31, DOI 10.1016/S0014-2999(01)00814-7; Morinville A, 2004, J NEUROSCI, V24, P5549, DOI 10.1523/JNEUROSCI.2719-03.2004; Nadal X, 2006, EUR J NEUROSCI, V23, P830, DOI 10.1111/j.1460-9568.2006.04569.x; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Tappe-Theodor A, 2007, J NEUROSCI, V27, P4165, DOI 10.1523/JNEUROSCI.5648-06.2007; Trapaidze N, 1996, J BIOL CHEM, V271, P29279, DOI 10.1074/jbc.271.46.29279; Trapaidze N, 2000, MOL BRAIN RES, V76, P220, DOI 10.1016/S0169-328X(00)00002-4; Van Bockstaele EJ, 2001, NEUROSCIENCE, V108, P467, DOI 10.1016/S0306-4522(01)00426-2; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Wei ZY, 2000, J MED CHEM, V43, P3895, DOI 10.1021/jm000229p; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5	46	148	148	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5425	10.1371/journal.pone.0005425	http://dx.doi.org/10.1371/journal.pone.0005425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412545	Green Published, gold			2022-12-27	WOS:000265688200012
J	Huang, YL; Walstrom, A; Zhang, LW; Zhao, Y; Cui, M; Ye, L; Zheng, JLC				Huang, Yunlong; Walstrom, Angelique; Zhang, Luwen; Zhao, Yong; Cui, Min; Ye, Ling; Zheng, Jialin C.			Type I Interferons and Interferon Regulatory Factors Regulate TNF-Related Apoptosis-Inducing Ligand (TRAIL) in HIV-1-Infected Macrophages	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RIG-I; TRANSCRIPTION FACTOR; T-CELLS; TARGETED DISRUPTION; MEDIATED APOPTOSIS; ANTIVIRAL RESPONSE; POSITIVE FEEDBACK; ALPHA-INTERFERON; INNATE IMMUNITY	TNF-related apoptosis-inducing ligand (TRAIL) is a member of the TNF family that participates in HIV-1 pathogenesis through the depletion of CD4(+) T cells. TRAIL is expressed on the cell membrane of peripheral immune cells and can be cleaved into a soluble, secreted form. The regulation of TRAIL in macrophages during HIV-1 infection is not completely understood. In this study, we investigated the mechanism(s) of TRAIL expression in HIV-1-infected macrophages, an important cell type in HIV-1 pathogenesis. A human monocyte-derived macrophage (MDM) culture system was infected with macrophage-tropic HIV-1ADA, HIV-1JR-FL, or HIV-1BAL strains. TRAIL, predominantly the membrane-bound form, increased following HIV-1 infection. We found that HIV-1 infection also induced interferon regulatory factor (IRF)-1, IRF-7 gene expression and signal transducers and activators of transcription 1 (STAT1) activation. Small interfering RNA knockdown of IRF-1 or IRF-7, but not IRF-3, reduced STAT1 activation and TRAIL expression. Furthermore, the upregulation of IRF-1, IRF-7, TRAIL, and the activation of STAT1 by HIV-1 infection was reduced by the treatment of type I interferon (IFN)-neutralizing antibodies. In addition, inhibition of STAT1 by fludarabine abolished IRF-1, IRF-7, and TRAIL upregulation. We conclude that IRF-1, IRF-7, type I IFNs, and STAT1 form a signaling feedback loop that is critical in regulating TRAIL expression in HIV-1-infected macrophages.			Huang, YL (corresponding author), Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Lab Neurotoxicol, Omaha, NE 68182 USA.	jzheng@unmc.edu	cui, min/HGD-8340-2022; Huang, Yunlong/J-6554-2015	Huang, Yunlong/0000-0002-3328-1924	NCRR NIH HHS [P20RR15635, P20 RR015635] Funding Source: Medline; NIMH NIH HHS [R21 MH083525, R21MH83525] Funding Source: Medline; NINDS NIH HHS [R01 NS061642, R01 NS41858, P01NS43985, R01 NS041858, P01 NS043985, R01NS61642] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041858, P01NS043985, R01NS061642] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbate I, 2000, CLIN EXP IMMUNOL, V122, P374, DOI 10.1046/j.1365-2249.2000.01378.x; Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; Battistini A, 2002, J INTERF CYTOK RES, V22, P27, DOI 10.1089/107999002753452638; Bovolenta C, 1999, BLOOD, V94, P4202, DOI 10.1182/blood.V94.12.4202.424k22_4202_4209; Brown JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003664; Clarke N, 2004, EMBO J, V23, P3051, DOI 10.1038/sj.emboj.7600302; Cotter RL, 2001, J VIROL, V75, P4308, DOI 10.1128/JVI.75.9.4308-4320.2001; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Ehrlich S, 2003, CYTOKINE, V24, P244, DOI 10.1016/S1043-4666(03)00094-2; Esser R, 1996, BLOOD, V88, P3474, DOI 10.1182/blood.V88.9.3474.bloodjournal8893474; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Fischl MA, 1997, J ACQ IMMUN DEF SYND, V16, P247, DOI 10.1097/00042560-199712010-00005; Frank DA, 1999, NAT MED, V5, P444, DOI 10.1038/7445; GABUZDA DH, 1986, ANN NEUROL, V20, P289, DOI 10.1002/ana.410200304; GARTNER S, 1990, AIDS RES HUM RETROV, V6, P1017, DOI 10.1089/aid.1990.6.1017; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GENDELMAN HE, 1989, AIDS, V3, P475, DOI 10.1097/00002030-198908000-00001; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; GESSANI S, 1994, J VIROL, V68, P1983, DOI 10.1128/JVI.68.3.1983-1986.1994; Gong B, 2000, BIOCHEM BIOPH RES CO, V278, P747, DOI 10.1006/bbrc.2000.3872; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Halaas O, 2000, SCAND J IMMUNOL, V51, P244; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Herbeuval JP, 2005, BLOOD, V105, P2458, DOI 10.1182/blood-2004-08-3058; Herbeuval JP, 2005, P NATL ACAD SCI USA, V102, P13974, DOI 10.1073/pnas.0505251102; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang YL, 2006, J IMMUNOL, V177, P2304, DOI 10.4049/jimmunol.177.4.2304; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kayagaki N, 1999, J IMMUNOL, V162, P2639; Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Leaman DW, 1996, FASEB J, V10, P1578, DOI 10.1096/fasebj.10.14.9002549; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li XX, 1996, J BIOL CHEM, V271, P5790, DOI 10.1074/jbc.271.10.5790; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Okumura A, 2008, VIROLOGY, V373, P85, DOI 10.1016/j.virol.2007.10.042; Oritani K, 2001, CYTOKINE GROWTH F R, V12, P337, DOI 10.1016/S1359-6101(01)00009-0; Park SY, 2004, EUR J BIOCHEM, V271, P4222, DOI 10.1111/j.1432-1033.2004.04362.x; Peng H, 2005, J NEUROSCI RES, V82, P295, DOI 10.1002/jnr.20629; Romieu-Mourez R, 2006, CANCER RES, V66, P10576, DOI 10.1158/0008-5472.CAN-06-1279; Ryan LA, 2004, J NEUROIMMUNOL, V148, P127, DOI 10.1016/j.jneuroim.2003.11.019; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sgarbanti M, 2002, J EXP MED, V195, P1359, DOI 10.1084/jem.20010753; SGARBANTI M, 2008, J VIROL; Shieh JTC, 1998, J VIROL, V72, P4243, DOI 10.1128/JVI.72.5.4243-4249.1998; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; SZEBENI J, 1991, J VIROL, V65, P6362, DOI 10.1128/JVI.65.11.6362-6364.1991; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; TECCHIO C, 2004, BLOOD; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Yang YD, 2003, J VIROL, V77, P6700, DOI 10.1128/JVI.77.12.6700-6708.2003; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang MJ, 2001, J BIOMED SCI, V8, P290, DOI 10.1159/000054045; Zhao ML, 2001, J NEUROIMMUNOL, V115, P182, DOI 10.1016/S0165-5728(00)00463-X	73	33	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5397	10.1371/journal.pone.0005397	http://dx.doi.org/10.1371/journal.pone.0005397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404407	Green Published, gold			2022-12-27	WOS:000265614900010
J	Cox, KH; Ruiz-Bustos, E; Courtney, HS; Dale, JB; Pence, MA; Nizet, V; Aziz, RK; Gerling, I; Price, SM; Hasty, DL				Cox, Kathleen H.; Ruiz-Bustos, Eduardo; Courtney, Harry S.; Dale, James B.; Pence, Morgan A.; Nizet, Victor; Aziz, Ramy K.; Gerling, Ivan; Price, Susan M.; Hasty, David L.			Inactivation of DltA Modulates Virulence Factor Expression in Streptococcus pyogenes	PLOS ONE			English	Article							GROUP-A STREPTOCOCCI; ALANYL-LIPOTEICHOIC ACID; TEICHOIC-ACIDS; D-ALANINE; STAPHYLOCOCCUS-AUREUS; M-PROTEIN; LACTOCOCCUS-LACTIS; PHOSPHOLIPASE A(2); BACILLUS-SUBTILIS; RESISTANCE	Background: D-alanylated lipoteichoic acid is a virtually ubiquitous component of Gram-positive cell walls. Mutations in the dltABCD operon of numerous species exhibit pleiotropic effects, including reduced virulence, which has been attributed to increased binding of cationic antimicrobial peptides to the more negatively charged cell surface. In this study, we have further investigated the effects that mutating dltA has on virulence factor expression in Streptococcus pyogenes. Methodology/Principal Findings: Isogenic Delta dltA mutants had previously been created in two distinct M1T1 isolates of S. pyogenes. Immunoblots, flow cytometry, and immunofluorescence were used to quantitate M protein levels in these strains, as well as to assess their ability to bind complement. Bacteria were tested for their ability to interact with human PMN and to grow in whole human blood. Message levels for emm, sic, and various regulatory elements were assessed by quantitative RT-PCR. Cell walls of Delta dltA mutants contained much less M protein than cell walls of parent strains and this correlated with reduced levels of emm transcripts, increased deposition of complement, increased association of bacteria with polymorphonuclear leukocytes, and reduced bacterial growth in whole human blood. Transcription of at least one other gene of the mga regulon, sic, which encodes a protein that inactivates antimicrobial peptides, was also dramatically reduced in Delta dltA mutants. Concomitantly, ccpA and rofA were unaffected, while rgg and arcA were up-regulated. Conclusions/Significance: This study has identified a novel mechanism for the reduced virulence of dltA mutants of Streptococcus pyogenes in which gene regulatory networks somehow sense and respond to the loss of DltA and lack of D-alanine esterification of lipoteichoic acid. The mechanism remains to be determined, but the data indicate that the status of D-alanine-lipoteichoic acid can significantly influence the expression of at least some streptococcal virulence factors and provide further impetus to targeting the dlt operon of Gram-positive pathogens in the search for novel antimicrobial compounds.			Cox, KH (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA.	dhasty@utmem.edu	Nizet, Victor/AAF-3190-2019; Pence, Morgan A./N-1620-2019; Aziz, Ramy/B-2918-2009	Pence, Morgan A./0000-0003-0239-0228; Nizet, Victor/0000-0003-3847-0422; Ruiz-Bustos, Eduardo/0000-0002-9539-3569; Dale, James/0000-0001-9860-9233; Aziz, Ramy/0000-0002-4448-7100	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI010085, R55AI010085, R01AI077780, R01AI010085] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; Almengor AC, 2007, J BACTERIOL, V189, P8405, DOI 10.1128/JB.01038-07; ARCHIBALD AR, 1973, BIOCHIM BIOPHYS ACTA, V291, P629; Biswas I, 2001, INFECT IMMUN, V69, P7029, DOI 10.1128/IAI.69.11.7029-7038.2001; Boyd DA, 2000, J BACTERIOL, V182, P6055, DOI 10.1128/JB.182.21.6055-6065.2000; CAPARON MG, 1992, J BACTERIOL, V174, P5693, DOI 10.1128/JB.174.17.5693-5701.1992; CAPARON MG, 1987, P NATL ACAD SCI USA, V84, P8677, DOI 10.1073/pnas.84.23.8677; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Chaussee MS, 1999, INFECT IMMUN, V67, P1715; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; Chaussee MS, 2002, INFECT IMMUN, V70, P762, DOI 10.1128/IAI.70.2.762-770.2002; Clemans DL, 1999, INFECT IMMUN, V67, P2464, DOI 10.1128/IAI.67.5.2464-2474.1999; Courtney HS, 1997, INFECT IMMUN, V65, P2472, DOI 10.1128/IAI.65.6.2472-2474.1997; Craynest M, 2003, LETT APPL MICROBIOL, V37, P75, DOI 10.1046/j.1472-765X.2003.01357.x; Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Fernie-King BA, 2004, IMMUNOLOGY, V111, P444, DOI 10.1111/j.0019-2805.2004.01837.x; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; Frick IM, 2003, J BIOL CHEM, V278, P16561, DOI 10.1074/jbc.M301995200; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Gryllos I, 2007, MOL MICROBIOL, V65, P671, DOI 10.1111/j.1365-2958.2007.05818.x; Hartas J, 1999, MICROB PATHOGENESIS, V26, P25, DOI 10.1006/mpat.1998.0244; Hasty DL, 2006, J IMMUNOL, V176, P5567, DOI 10.4049/jimmunol.176.9.5567; Hoe NP, 2002, P NATL ACAD SCI USA, V99, P7646, DOI 10.1073/pnas.112039899; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; HORSTMANN RD, 1992, INFECT IMMUN, V60, P5036, DOI 10.1128/IAI.60.12.5036-5041.1992; Hunt CL, 2006, J IMMUNOL, V176, P4987, DOI 10.4049/jimmunol.176.8.4987; Hyyrylainen HL, 2000, J BIOL CHEM, V275, P26696; JACKSWEIS J, 1982, J IMMUNOL, V128, P1897; Jeng A, 2003, J BACTERIOL, V185, P1208, DOI 10.1128/JB.185.4.1208-1217.2003; Kazmi SU, 2001, INFECT IMMUN, V69, P4988, DOI 10.1128/IAI.69.8.4988-4995.2001; Koprivnjak T, 2002, J BIOL CHEM, V277, P47636, DOI 10.1074/jbc.M205104200; Koprivnjak T, 2006, J BACTERIOL, V188, P3622, DOI 10.1128/JB.188.10.3622-3630.2006; Kovacs M, 2006, J BACTERIOL, V188, P5797, DOI 10.1128/JB.00336-06; KRAUS W, 1987, J IMMUNOL, V139, P3084; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kristian SA, 2005, J BACTERIOL, V187, P6719, DOI 10.1128/JB.187.19.6719-6725.2005; LAMBERT PA, 1975, BIOCHEM J, V151, P671, DOI 10.1042/bj1510671; Lancefield RC, 1928, J EXP MED, V47, P91, DOI 10.1084/jem.47.1.91; LANCEFIELD RC, 1957, J EXP MED, V106, P525, DOI 10.1084/jem.106.4.525; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; May JJ, 2005, FEBS J, V272, P2993, DOI 10.1111/j.1742-4658.2005.04700.x; MCIVER KS, 1995, INFECT IMMUN, V63, P4540, DOI 10.1128/IAI.63.11.4540-4542.1995; McIver KS, 1997, J BACTERIOL, V179, P5178, DOI 10.1128/jb.179.16.5178-5187.1997; McLellan DGJ, 2001, INFECT IMMUN, V69, P2943, DOI 10.1128/IAI.69.5.2943-2949.2001; Morfeldt E, 2001, J IMMUNOL, V167, P3870, DOI 10.4049/jimmunol.167.7.3870; Neely MN, 2003, J BACTERIOL, V185, P5166, DOI 10.1128/JB.185.17.5166-5174.2003; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Nouaille S, 2004, APPL ENVIRON MICROB, V70, P1600, DOI 10.1128/AEM.70.3.1600-1607.2004; Palumbo E, 2006, J BACTERIOL, V188, P3709, DOI 10.1128/JB.188.10.3709-3715.2006; Pandiripally V, 2002, INFECT IMMUN, V70, P6206, DOI 10.1128/IAI.70.11.6206-6214.2002; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Perez-Caballero D, 2000, EUR J IMMUNOL, V30, P1243, DOI 10.1002/(SICI)1521-4141(200004)30:4<1243::AID-IMMU1243>3.0.CO;2-D; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Steen A, 2005, J BACTERIOL, V187, P114, DOI 10.1128/JB.187.1.114-124.2005; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Thwaite JE, 2002, APPL ENVIRON MICROB, V68, P227, DOI 10.1128/AEM.68.1.227-234.2002; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; WHITNACK E, 1985, J EXP MED, V162, P1983, DOI 10.1084/jem.162.6.1983; WHITNACK E, 1982, J CLIN INVEST, V69, P1042, DOI 10.1172/JCI110508	65	33	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5366	10.1371/journal.pone.0005366	http://dx.doi.org/10.1371/journal.pone.0005366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401780	Green Published, Green Submitted			2022-12-27	WOS:000265601100010
J	Weinreb, GE; Kapustina, MT; Jacobson, K; Elston, TC				Weinreb, Gabriel E.; Kapustina, Maryna T.; Jacobson, Ken; Elston, Timothy C.			In Silico Generation of Alternative Hypotheses Using Causal Mapping (CMAP)	PLOS ONE			English	Article								Previously, we introduced causal mapping (CMAP) as an easy to use systems biology tool for studying the behavior of biological processes that occur at the cellular and molecular level. CMAP is a coarse-grained graphical modeling approach in which the system of interest is modeled as an interaction map between functional elements of the system, in a manner similar to portrayals of signaling pathways commonly used by molecular cell biologists. CMAP describes details of the interactions while maintaining the simplicity of other qualitative methods (e. g., Boolean networks). In this paper, we use the CMAP methodology as a tool for generating hypotheses about the mechanisms that regulate molecular and cellular systems. Furthermore, our approach allows competing hypotheses to be ranked according to a fitness index and suggests experimental tests to distinguish competing high fitness hypotheses. To motivate the CMAP as a hypotheses generating tool and demonstrate the methodology, we first apply this protocol to a simple test-case of a three-element signaling module. Our methods are next applied to the more complex phenomenon of cortical oscillations observed in spreading cells. This analysis produces two high fitness hypotheses for the mechanism that underlies this dynamic behavior and suggests experiments to distinguish the hypotheses. The method can be widely applied to other cellular systems to generate and compare alternative hypotheses based on experimentally observed data and using computer simulations.			Weinreb, GE (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA.	weinreb@med.unc.edu	Kapustina, Maryna/B-8929-2014		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, R01GM078994] Funding Source: NIH RePORTER; NIGMS NIH HHS [U54 GM064346, R01 GM078994, GM64346, GM078994] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu-Asab M, 2008, PROTEOM CLIN APPL, V2, P122, DOI 10.1002/prca.200780047; Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; Alon U., 2006, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Alon U, 2007, NATURE, V446, P497, DOI 10.1038/446497a; An S, 2007, ECONOMET REV, V26, P113, DOI 10.1080/07474930701220071; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Bilmes JA, 2006, IEICE T INF SYST, VE89D, P869, DOI 10.1093/ietisy/e89-d.3.869; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cedersund G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000096; Cho KH, 2007, IET SYST BIOL, V1, P149, DOI 10.1049/iet-syb:20060075; Ding Y, 2006, RNA, V12, P323, DOI 10.1261/rna.2274106; Ghahramani Z, 1998, LECT NOTES ARTIF INT, V1387, P168, DOI 10.1007/BFb0053999; Goutsias J, 2007, CURR PHARM DESIGN, V13, P1415, DOI 10.2174/138161207780765945; Kapustina M, 2008, BIOPHYS J, V94, P4605, DOI 10.1529/biophysj.107.121335; KAUFFMAN K, 1993, ORIGINS ORDER SELF O; KIGHTLEY D, 2004, P PAC S BIOC, V9, P510; KNOX BE, 1986, P NATL ACAD SCI USA, V83, P2345, DOI 10.1073/pnas.83.8.2345; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; LIEU CA, 2007, SYSTEMS BIOL APPL PE; Nefian AV, 2002, EURASIP J APPL SIG P, V2002, P1274, DOI 10.1155/S1110865702206083; Pletjushkina OJ, 2001, CELL MOTIL CYTOSKEL, V48, P235, DOI 10.1002/cm.1012.abs; Salbreux G, 2007, PHYS BIOL, V4, P268, DOI 10.1088/1478-3975/4/4/004; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Thakar J, 2007, PLOS COMPUT BIOL, V3, P1022, DOI 10.1371/journal.pcbi.0030109; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; Weinreb GE, 2006, CELL MOTIL CYTOSKEL, V63, P523, DOI 10.1002/cm.20143	29	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5378	10.1371/journal.pone.0005378	http://dx.doi.org/10.1371/journal.pone.0005378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401774	Green Published, gold, Green Submitted			2022-12-27	WOS:000265601100016
J	Ganguli-Indra, G; Wasylyk, C; Liang, XB; Millon, R; Leid, M; Wasylyk, B; Abecassis, J; Indra, A				Ganguli-Indra, Gitali; Wasylyk, Christine; Liang, Xiaobo; Millon, Regine; Leid, Mark; Wasylyk, Bohdan; Abecassis, Joseph; Indra, Arup			CTIP2 Expression in Human Head and Neck Squamous Cell Carcinoma Is Linked to Poorly Differentiated Tumor Status	PLOS ONE			English	Article							STEM-CELLS; NURD COMPLEX; ORAL-CANCER; BCL11B; GENE; PROMOTER; BMI-1; MARKERS; PROLIFERATION; EPIDEMIOLOGY	Background: We have demonstrated earlier that CTIP2 is highly expressed in mouse skin during embryogenesis and in adulthood. CTIP2 mutant mice die at birth with epidermal differentiation defects and a compromised epidermal permeability barrier suggesting its role in skin development and/or homeostasis. CTIP2 has also been suggested to function as tumor suppressor in cells, and several reports have described a link between chromosomal rearrangements of CTIP2 and human T cell acute lymphoblast leukemia (T-ALL). The aim of the present study was to look into the pattern of CTIP2 expression in Head and Neck Squamous Cell Carcinoma (HNSCC). Methodology/Principal Findings: In the present study, we analyzed CTIP2 expression in human HNSCC cell lines by western blotting, in paraffin embedded archival specimens by immunohistochemistry (IHC), and in cDNA samples of human HNSCC by qRT-PCR. Elevated levels of CTIP2 protein was detected in several HNSCC cell lines. CTIP2 staining was mainly detected in the basal layer of the head and neck normal epithelium. CTIP2 expression was found to be significantly elevated in HNSCC (p, 0.01), and increase in CTIP2 expression was associated with poorly differentiated tumor status. Nuclear co-localization of CTIP2 protein and cancer stem cell (CSC) marker BMI1 was observed in most, if not all of the cells expressing BMI1 in moderately and poorly differentiated tumors. Conclusions/Significance: We report for the first time expression of transcriptional regulator CTIP2 in normal human head and neck epithelia. A statistically significant increase in the expression of CTIP2 was detected in the poorly differentiated samples of the human head and neck tumors. Actual CTIP2, rather than the long form of CTIP2 (CTIP2L) was found to be more relevant to the differentiation state of the tumors. Results demonstrated existence of distinct subsets of cancer cells, which express CTIP2 and underscores the use of CTIP2 and BMI1 co-labeling to distinguish tumor initiating cells or cancer stem cells (CSCs) from surrounding cancer cells.			Ganguli-Indra, G (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	indrag@onid.orst.edu; arup.indra@oregonstate.edu	Indra, Gitali/G-2963-2016; Wasylyk, Bohdan/ABG-6778-2020; Indra, Arup/AAG-2376-2019	Wasylyk, Bohdan/0000-0002-1718-1237; Indra, Arup/0000-0001-6137-7555	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR056008] Funding Source: Medline; NIEHS NIH HHS [P30 ES000210, ES00210] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Chang SS, 2008, J SURG ONCOL, V97, P640, DOI 10.1002/jso.21023; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Friedlander PL, 2003, ARCH OTOLARYNGOL, V129, P363, DOI 10.1001/archotol.129.3.363; GANGULIINDRA G, 2009, EXP DERMATO IN PRESS; Glinsky GV, 2008, J CLIN ONCOL, V26, P2846, DOI 10.1200/JCO.2008.17.0266; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; GOLONZHKA O, 2008, J INVEST DERMATOL; Golonzhka O, 2007, GENE EXPR PATTERNS, V7, P754, DOI 10.1016/j.modgep.2007.06.002; Indra AK, 2005, DEV BIOL, V285, P28, DOI 10.1016/j.ydbio.2005.05.043; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kamimura K, 2007, ONCOGENE, V26, P5840, DOI 10.1038/sj.onc.1210388; Korkaya H, 2007, BIODRUGS, V21, P299, DOI 10.2165/00063030-200721050-00002; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Lu SL, 2006, HEAD NECK-J SCI SPEC, V28, P945, DOI 10.1002/hed.20397; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; MacLeod RAF, 2004, CANCER GENET CYTOGEN, V153, P88, DOI 10.1016/j.cancergencyto.2004.02.020; Marur S, 2008, MAYO CLIN PROC, V83, P489, DOI 10.4065/83.4.489; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Patel V, 2001, CRIT REV ORAL BIOL M, V12, P55, DOI 10.1177/10454411010120010401; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Prince MEP, 2008, J CLIN ONCOL, V26, P2871, DOI 10.1200/JCO.2007.15.1613; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Rodrigo JP, 2003, ACTA OTO-LARYNGOL, V123, P100, DOI 10.1080/0036554021000028073; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Schliephake H, 2003, INT J ORAL MAX SURG, V32, P233, DOI 10.1054/ijom.2002.0383; Seghatoleslam A, 2006, BIOCHEM BIOPH RES CO, V339, P422, DOI 10.1016/j.bbrc.2005.11.026; Senawong T, 2005, ARCH BIOCHEM BIOPHYS, V434, P316, DOI 10.1016/j.abb.2004.10.028; SPITZ MR, 1994, SEMIN ONCOL, V21, P281; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927	42	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5367	10.1371/journal.pone.0005367	http://dx.doi.org/10.1371/journal.pone.0005367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399189	Green Published, gold			2022-12-27	WOS:000265514900020
J	Mongiat, LA; Esposito, MS; Lombardi, G; Schinder, AF				Mongiat, Lucas A.; Esposito, M. Soledad; Lombardi, Gabriela; Schinder, Alejandro F.			Reliable Activation of Immature Neurons in the Adult Hippocampus	PLOS ONE			English	Article								Neurons born in the adult dentate gyrus develop, mature, and connect over a long interval that can last from six to eight weeks. It has been proposed that, during this period, developing neurons play a relevant role in hippocampal signal processing owing to their distinctive electrical properties. However, it has remained unknown whether immature neurons can be recruited into a network before synaptic and functional maturity have been achieved. To address this question, we used retroviral expression of green fluorescent protein to identify developing granule cells of the adult mouse hippocampus and investigate the balance of afferent excitation, intrinsic excitability, and firing behavior by patch clamp recordings in acute slices. We found that glutamatergic inputs onto young neurons are significantly weaker than those of mature cells, yet stimulation of cortical excitatory axons elicits a similar spiking probability in neurons at either developmental stage. Young neurons are highly efficient in transducing ionic currents into membrane depolarization due to their high input resistance, which decreases substantially in mature neurons as the inward rectifier potassium (Kir) conductance increases. Pharmacological blockade of Kir channels in mature neurons mimics the high excitability characteristic of young neurons. Conversely, Kir overexpression induces mature-like firing properties in young neurons. Therefore, the differences in excitatory drive of young and mature neurons are compensated by changes in membrane excitability that render an equalized firing activity. These observations demonstrate that the adult hippocampus continuously generates a population of highly excitable young neurons capable of information processing.			Mongiat, LA (corresponding author), Consejo Nacl Invest Cient & Tecn, Leloir Inst, Lab Neuronal Plast, RA-1033 Buenos Aires, DF, Argentina.	aschinder@leloir.org.ar	Mongiat, Lucas/GXG-5680-2022	Mongiat, Lucas/0000-0003-2643-8062; Esposito, Maria Soledad/0000-0003-0673-4219; Schinder, Alejandro/0000-0003-4863-8348	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Ambrogini P, 2004, BRAIN RES, V1017, P21, DOI 10.1016/j.brainres.2004.05.039; Atherton JF, 2005, J NEUROSCI, V25, P8272, DOI 10.1523/JNEUROSCI.1475-05.2005; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Cathala L, 2003, J NEUROSCI, V23, P6074, DOI 10.1523/JNEUROSCI.23-14-06074.2003; Couillard-Despres S, 2006, EUR J NEUROSCI, V24, P1535, DOI 10.1111/j.1460-9568.2006.05039.x; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Enikolopov Grigori, 2008, V52, P81; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Faulkner RL, 2008, P NATL ACAD SCI USA, V105, P14157, DOI 10.1073/pnas.0806658105; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Hille B., 2001, ION CHANNELS EXCITAB, P131; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Karschin C, 1996, J NEUROSCI, V16, P3559; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Laplagne DA, 2007, EUR J NEUROSCI, V25, P2973, DOI 10.1111/j.1460-9568.2007.05549.x; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Owen JM, 1999, EXP PHYSIOL, V84, P471, DOI 10.1017/S0958067099018060; Pratt KG, 2007, J NEUROSCI, V27, P8268, DOI 10.1523/JNEUROSCI.1738-07.2007; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schmidt-Hieber C, 2008, J PHYSIOL-LONDON, V586, P1849, DOI 10.1113/jphysiol.2007.150151; Schulz DJ, 2006, J EXP BIOL, V209, P4821, DOI 10.1242/jeb.02567; Takigawa T, 2002, J PHYSIOL-LONDON, V539, P67, DOI 10.1113/jphysiol.2001.012883; Tanaka S, 2003, J NEUROPHYSIOL, V89, P1288, DOI 10.1152/jn.00850.2002; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	46	177	180	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5320	10.1371/journal.pone.0005320	http://dx.doi.org/10.1371/journal.pone.0005320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399173	Green Submitted, Green Published, gold			2022-12-27	WOS:000265514900002
J	Adam, R; Gunturkun, O				Adam, Ruth; Guentuerkuen, Onur			When One Hemisphere Takes Control: Metacontrol in Pigeons (Columba livia)	PLOS ONE			English	Article							INTERHEMISPHERIC INTERACTION; INFORMATION; DOMINANCE; CUES	Background: Vertebrate brains are composed of two hemispheres that receive input, compute, and interact to form a unified response. How the partially different processes of both hemispheres are integrated to create a single output is largely unknown. In some cases one hemisphere takes charge of the response selection-a process known as metacontrol. Thus far, this phenomenon has only been shown in a handful of studies with primates, mostly conducted in humans. Metacontrol, however, is even more relevant for animals like birds with laterally placed eyes and complete chiasmatic decussation since visual input to the hemispheres is largely different. Methodology/Principal Findings: Homing pigeons (Columba livia) were trained with a color discrimination task. Each hemisphere was trained with a different color pair and therefore had a different experience. Subsequently, the pigeons were binocularly examined with two additional stimuli that combined the positive color of one hemisphere with a negative color that had been shown to the other, omitting the availability of a coherent solution and confronting the pigeons with a conflicting situation. Some of the pigeons responded to both stimuli, indicating that none of the hemispheres dominated the overall preference. Some birds, however, responded primarily to one of the conflicting stimuli, showing that they based their choice on the left-or right-monocularly learned color pair, indicating hemispheric metacontrol. Conclusions/Significance: We could demonstrate for the first time that metacontrol is a widespread phenomenon that also exists in birds, and thus in principle requires no corpus callosum. Our results are closely similar to those in humans: monocular performance was higher than binocular one and animals displayed different modes of hemispheric dominance. Thus, metacontrol is a dynamic and widely distributed process that possibly constitutes a requirement for all animals with a bipartite brain to confront the problem of choosing between two hemisphere-bound behavioral options.			Adam, R (corresponding author), Max Planck Inst Biol Cybernet, Tubingen, Germany.	ruth.adam@tuebingen.mpg.de		Gunturkun, Onur/0000-0003-4173-5233				BELGER A, 1992, NEUROPSYCHOLOGIA, V30, P923, DOI 10.1016/0028-3932(92)90036-L; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Gunturkun Onur, 2000, P1, DOI 10.1016/B978-012747605-6/50002-X; HARDY O, 1984, BRAIN RES, V311, P65, DOI 10.1016/0006-8993(84)91399-4; HELLIGE JB, 1990, ANNU REV PSYCHOL, V41, P55, DOI 10.1146/annurev.ps.41.020190.000415; HELLIGE JB, 1989, J EXP PSYCHOL HUMAN, V15, P711, DOI 10.1037/0096-1523.15.4.711; HELLIGE JB, 1988, BRAIN COGNITION, V7, P39, DOI 10.1016/0278-2626(88)90020-6; HELLIGE JB, 1989, MEM COGNITION, V17, P770, DOI 10.3758/BF03202638; HERRNSTEIN RJ, 1976, J EXP PSYCHOL ANIM B, V2, P285, DOI 10.1037/0097-7403.2.4.285; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jimenez Ortega L, 2008, BEHAV BRAIN RES, V193, P69, DOI 10.1016/j.bbr.2008.04.022; Kavcic V, 2000, BEHAV BRAIN RES, V111, P71, DOI 10.1016/S0166-4328(00)00141-8; LAZARUSMAINKA G, 1978, PSYCHOL RES-PSYCH FO, V40, P15, DOI 10.1007/BF00308460; LEVY J, 1976, J EXP PSYCHOL HUMAN, V2, P299, DOI 10.1037/0096-1523.2.3.299; Prior H, 2001, LEARN MEMORY, V8, P44, DOI 10.1101/lm.36201; ROBERT F, 1969, EXP BRAIN RES, V9, P123; Rose J, 2008, J NEUROSCI METH, V175, P104, DOI 10.1016/j.jneumeth.2008.08.006; Skiba M, 2000, BRAIN LANG, V73, P254, DOI 10.1006/brln.2000.2306; Theiss MPH, 2003, NEUROREPORT, V14, P879, DOI 10.1097/00001756-200305060-00021; Urgesi C, 2005, COGNITIVE BRAIN RES, V24, P513, DOI 10.1016/j.cogbrainres.2005.03.005; Weekes NY, 1997, NEUROPSYCHOLOGIA, V35, P37, DOI 10.1016/S0028-3932(96)00042-5; WEIDNER C, 1985, BRAIN RES, V340, P99, DOI 10.1016/0006-8993(85)90778-4; Yamazaki Y, 2007, COGNITION, V104, P315, DOI 10.1016/j.cognition.2006.07.004	23	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5307	10.1371/journal.pone.0005307	http://dx.doi.org/10.1371/journal.pone.0005307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437VE	19390578	Green Submitted, Green Published, gold			2022-12-27	WOS:000265514200018
J	Jain, R; Kumar, S; Gourinath, S; Bhattacharya, S; Bhattacharya, A				Jain, Ruchi; Kumar, Shivesh; Gourinath, Samudrala; Bhattacharya, Sudha; Bhattacharya, Alok			N- and C-Terminal Domains of the Calcium Binding Protein EhCaBP1 of the Parasite Entamoeba histolytica Display Distinct Functions	PLOS ONE			English	Article								Entamoeba histolytica, a protozoan parasite, is the causative agent of amoebiasis, and calcium signaling is thought to be involved in amoebic pathogenesis. EhCaBP1, a Ca(2+) binding protein of E. histolytica, is essential for parasite growth. High resolution crystal structure of EhCaBP1 suggested an unusual arrangement of the EF-hand domains in the N-terminal part of the structure, while C-terminal part of the protein was not traced. The structure revealed a trimer with amino terminal domains of the three molecules interacting in a head-to-tail manner forming an assembled domain at the interface with EF1 and EF2 motifs of different molecules coming close to each other. In order to understand the specific roles of the two domains of EhCaBP1, the molecule was divided into two halves, and each half was separately expressed. The domains were characterized with respect to their structure, as well as specific functional features, such as ability to activate kinase and bind actin. The domains were also expressed in E. histolytica cells along with green fluorescent protein. The results suggest that the N-terminal domain retains some of the properties, such as localization in phagocytic cups and activation of kinase. Crystal structure of EhCaBP1 with Phenylalanine revealed that the assembled domains, which are similar to Calmodulin N-terminal domain, bind to Phenylalanine revealing the binding mode to the target proteins. The C-terminal domain did not show any of the activities tested. However, over-expression in amebic cells led to a dominant negative phenotype. The results suggest that the two domains of EhCaBP1 are functionally and structurally different from each other. Both the domains are required for structural stability and full range of functional diversity.			Jain, R (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	alok.bhattacharya@gmail.com						BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bhattacharya A, 2006, ARCH MED RES, V37, P221, DOI 10.1016/j.arcmed.2005.10.002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakrabarty P, 2004, J BIOL CHEM, V279, P12898, DOI 10.1074/jbc.M304716200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Gopal B, 1997, BIOCHEMISTRY-US, V36, P10910, DOI 10.1021/bi9702546; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; Hirata KK, 2007, EXP PARASITOL, V115, P192, DOI 10.1016/j.exppara.2006.08.004; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Jain R, 2008, CELL MICROBIOL, V10, P1373, DOI 10.1111/j.1462-5822.2008.01134.x; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Kumar S, 2007, PROTEINS, V68, P990, DOI 10.1002/prot.21455; KUNG C, 1992, CELL CALCIUM, V13, P413, DOI 10.1016/0143-4160(92)90054-V; Mohan PMK, 2008, PROTEINS, V70, P1147, DOI 10.1002/prot.21751; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Mukherjee S, 2007, BIOCHEMISTRY-US, V46, P9911, DOI 10.1021/bi700477h; OROZCO E, 1983, J EXP MED, V158, P1511, DOI 10.1084/jem.158.5.1511; PRASAD J, 1992, MOL BIOCHEM PARASIT, V52, P137, DOI 10.1016/0166-6851(92)90044-K; Sahoo N, 2004, J CELL SCI, V117, P3625, DOI 10.1242/jcs.01198; Sahoo N, 2003, MOL BIOCHEM PARASIT, V126, P281, DOI 10.1016/S0166-6851(02)00284-0; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SUNDARALINGAM M, 1985, SCIENCE, V227, P945, DOI 10.1126/science.3969570; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Yadava N, 1997, MOL BIOCHEM PARASIT, V84, P69, DOI 10.1016/S0166-6851(96)02782-X; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33	29	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5269	10.1371/journal.pone.0005269	http://dx.doi.org/10.1371/journal.pone.0005269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384409	Green Published, gold, Green Submitted			2022-12-27	WOS:000265513900013
J	Bronsvoort, BMD; Koterwas, B; Land, F; Handel, IG; Tucker, J; Morgan, KL; Tanya, VN; Abdoel, TH; Smits, HL				Bronsvoort, Barend M. deC.; Koterwas, Bronwyn; Land, Fiona; Handel, Ian G.; Tucker, James; Morgan, Kenton L.; Tanya, Vincent N.; Abdoel, Theresia H.; Smits, Henk L.			Comparison of a Flow Assay for Brucellosis Antibodies with the Reference cELISA Test in West African Bos indicus	PLOS ONE			English	Article								Brucellosis is considered by the Food and Agricultural Organisation and the World Health Organisation as one of the most widespread zoonoses in the world. It is a major veterinary public health challenge as animals are almost exclusively the source of infection for people. It is often undiagnosed in both human patients and the animal sources and it is widely acknowledged that the epidemiology of brucellosis in humans and animals is poorly understood, particularly in sub-Saharan Africa. It is therefore important to develop better diagnostic tools in order to improve our understanding of the epidemiology and also for use in the field for disease control and eradication. As with any new diagnostic test, it is essential that it is validated in as many populations as possible in order to characterise its performance and improve the interpretation of its results. This paper describes a comparison between a new lateral flow assasy (LFA) for bovine brucellosis and the widely used cELISA in a no gold standard analysis to estimate test performance in this West African cattle population. A Bayesian formulation of the Hui-Walter latent class model incorporated previous studies' data on sensitivity and specificity of the cELISA. The results indicate that the new LFA is very sensitive (similar to 87%) and highly specific (similar to 97%). The analysis also suggests that the current cut-off of the cELSIA may not be optimal for this cattle population but alternative cutoffs did not significantly change the estimates of the LFA. This study demonstrates the potential usefulness of this simple to use test in field based surveillance and control which could be easily adopted for use in developing countries with only basic laboratory facilities.			Bronsvoort, BMD (corresponding author), Univ Edinburgh, Ctr Trop Vet Med, Roslin Inst, Easter Bush Vet Ctr, Roslin, Midlothian, Scotland.	mark.bronsvoort@ed.ac.uk		Bronsvoort, Mark/0000-0002-3271-8485	Wellcome Trust [053840] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abdoel T, 2008, VET MICROBIOL, V130, P312, DOI 10.1016/j.vetmic.2008.01.009; Abdoel TH, 2007, DIAGN MICR INFEC DIS, V57, P123, DOI 10.1016/j.diagmicrobio.2006.08.017; Bernard F, 2005, PREV VET MED, V67, P267, DOI 10.1016/j.prevetmed.2004.11.002; Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005; Bronsvoort BMD, 2003, TROP ANIM HEALTH PRO, V35, P491, DOI 10.1023/A:1027302525301; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; CAROFF M, 1984, INFECT IMMUN, V46, P384, DOI 10.1128/IAI.46.2.384-388.1984; CECCHINI G, 1992, VET RES COMMUN, V16, P425, DOI 10.1007/BF01839019; CORBEL MJ, 1996, BOVINE BRUCELLOSIS; CORBEL MJ, 2006, BRUCELLOSIS HUMANS A; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; DIAZAPARICIO E, 1993, J CLIN MICROBIOL, V31, P3136; DOMENECH J, 1982, REV ELEV MED VET PAY, V35, P15; DOMENECH J, 1982, REV ELEV MED VET PAY, V35, P113; Fosgate GT, 2003, AM J VET RES, V64, P57, DOI 10.2460/ajvr.2003.64.57; Gall D, 2004, REV SCI TECH OIE, V23, P989; Gall D, 1998, CLIN DIAGN LAB IMMUN, V5, P654, DOI 10.1128/CDLI.5.5.654-661.1998; Gardner IA, 2000, PREV VET MED, V45, P107, DOI 10.1016/S0167-5877(00)00119-7; HILBINK F, 1995, NEW ZEAL VET J, V43, P175, DOI 10.1080/00480169.1995.35884; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Irmak H, 2004, AM J TROP MED HYG, V70, P688, DOI 10.4269/ajtmh.2004.70.688; Mantur B G, 2007, Indian J Med Microbiol, V25, P188; McDermott JJ, 2002, VET MICROBIOL, V90, P111, DOI 10.1016/S0378-1135(02)00249-3; McGiven JA, 2006, REV SCI TECH OIE, V25, P1039, DOI 10.20506/rst.25.3.1714; McGiven JA, 2003, J IMMUNOL METHODS, V278, P171, DOI 10.1016/S0022-1759(03)00201-1; Muma JB, 2007, VET MICROBIOL, V125, P187, DOI 10.1016/j.vetmic.2007.05.012; Nielsen K, 2002, VET MICROBIOL, V90, P447, DOI 10.1016/S0378-1135(02)00229-8; NIELSEN KH, 1995, VET IMMUNOL IMMUNOP, V46, P285, DOI 10.1016/0165-2427(94)05361-U; Nielsen KH, 1996, PREV VET MED, V26, P17, DOI 10.1016/0167-5877(95)00513-7; Pinsky NA, 2003, CLIN DIAGN LAB IMMUN, V10, P19, DOI 10.1128/CDLI.10.1.19-21.2003; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; Shey-Njila O., 2005, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V58, P139; Smits HL, 2003, CLIN DIAGN LAB IMMUN, V10, P1141, DOI 10.1128/CDLI.10.6.1141-1146.2003; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; Stack JA, 1999, VET REC, V145, P735, DOI 10.1136/vr.145.25.735; Teshale S, 2006, REV MED VET-TOULOUSE, V157, P557; Toft N, 2005, PREV VET MED, V68, P19, DOI 10.1016/j.prevetmed.2005.01.006; Weynants V, 1996, VET MICROBIOL, V48, P101, DOI 10.1016/0378-1135(95)00153-0	39	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2009	4	4							e5221	10.1371/journal.pone.0005221	http://dx.doi.org/10.1371/journal.pone.0005221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437UZ	19381332	Green Published, Green Submitted, gold			2022-12-27	WOS:000265513700002
J	Jia, LL; Zhang, L; Shao, C; Song, EL; Sun, W; Li, MX; Gao, YH				Jia, Lulu; Zhang, Ling; Shao, Chen; Song, Eli; Sun, Wei; Li, Mingxi; Gao, Youhe			An Attempt to Understand Kidney's Protein Handling Function by Comparing Plasma and Urine Proteomes	PLOS ONE			English	Article								Background: With the help of proteomics technology, the human plasma and urine proteomes, which closely represent the protein compositions of the input and output of the kidney, respectively, have been profiled in much greater detail by different research teams. Many datasets have been accumulated to form "reference profiles'' of the plasma and urine proteomes. Comparing these two proteomes may help us understand the protein handling aspect of kidney function in a way, however, which has been unavailable until the recent advances in proteomics technology. Methodology/Principal Findings: After removing secreted proteins downstream of the kidney, 2611 proteins in plasma and 1522 in urine were identified with high confidence and compared based on available proteomic data to generate three subproteomes, the plasma-only subproteome, the plasma-and-urine subproteome, and the urine-only subproteome, and they correspond to three groups of proteins that are handled in three different ways by the kidney. The available experimental molecular weights of the proteins in the three subproteomes were collected and analyzed. Since the functions of the overrepresented proteins in the plasma-and-urine subproteome are probably the major functions that can be routinely regulated by excretion from the kidney in physiological conditions, Gene Ontology term enrichment in the plasma-and-urine subproteome versus the whole plasma proteome was analyzed. Protease activity, calcium and growth factor binding proteins, and coagulation and immune response-related proteins were found to be enriched. Conclusion/Significance: The comparison method described in this paper provides an illustration of a new approach for studying organ functions with a proteomics methodology. Because of its distinctive input (plasma) and output (urine), it is reasonable to predict that the kidney will be the first organ whose functions are further elucidated by proteomic methods in the near future. It can also be anticipated that there will be more applications for proteomics in organ function research.			Jia, LL (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Dept Physiol & Pathophysiol, Beijing 100730, Peoples R China.	gaoyouhe@pumc.edu.cn	Li, Mingxi/I-4588-2013	Li, Mingxi/0000-0002-1876-4186				Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Adamski M, 2005, PROTEOMICS, V5, P3246, DOI 10.1002/pmic.200500186; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Castagna A, 2005, J PROTEOME RES, V4, P1917, DOI 10.1021/pr050153r; COJOCEL C, 1983, RENAL PHYSIOL BIOCH, V6, P258; Cui SY, 1996, AM J PHYSIOL-RENAL, V271, pF900, DOI 10.1152/ajprenal.1996.271.4.F900; DOHI SR, 1959, AM J PHYSIOL, V196, P924, DOI 10.1152/ajplegacy.1959.196.4.924; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; HANSEN NE, 1971, J CLIN INVEST, V50, P1473, DOI 10.1172/JCI106632; KEELER R, 1970, CAN J PHYSIOL PHARM, V48, P131, DOI 10.1139/y70-021; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kim JY, 2005, PROTEOMICS, V5, P3376, DOI 10.1002/pmic.200401220; LI YGR, 2008, PROTEOM CLIN APPL, V2, P543; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Martens L, 2006, PROTEOMICS, V6, P5076, DOI 10.1002/pmic.200600291; MOGIELNICKI RP, 1971, J CLIN INVEST, V50, P901, DOI 10.1172/JCI106562; O'Riordan E, 2005, CURR OPIN NEPHROL HY, V14, P579, DOI 10.1097/01.mnh.0000168425.60729.36; Oh J, 2004, PROTEOMICS, V4, P3485, DOI 10.1002/pmic.200401018; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Pieper R, 2004, PROTEOMICS, V4, P1159, DOI 10.1002/pmic.200300661; Ping PP, 2005, PROTEOMICS, V5, P3506, DOI 10.1002/pmic.200500140; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; RABINOVITCH M, 1956, AM J PHYSIOL, V187, P525, DOI 10.1152/ajplegacy.1956.187.3.525; Russo LM, 2002, AM J KIDNEY DIS, V39, P899, DOI 10.1053/ajkd.2002.32764; Schenk S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-41; States DJ, 2006, NAT BIOTECHNOL, V24, P333, DOI 10.1038/nbt1183; Sun W, 2005, PROTEOMICS, V5, P4994, DOI 10.1002/pmic.200401334; Thongboonkerd V, 2005, PROTEOMICS, V5, P1033, DOI 10.1002/pmic.200401012; WALDMANN TA, 1972, J CLIN INVEST, V51, P2162, DOI 10.1172/JCI107023; Wang LJ, 2006, MOL CELL PROTEOMICS, V5, P560, DOI 10.1074/mcp.D500013-MCP200; WEBER MH, 1988, J CHROMATOGR-BIOMED, V429, P315, DOI 10.1016/S0378-4347(00)83876-1; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273	34	51	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2009	4	4							e5146	10.1371/journal.pone.0005146	http://dx.doi.org/10.1371/journal.pone.0005146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437UZ	19381340	Green Published, gold, Green Submitted			2022-12-27	WOS:000265513700001
J	Jordan, PW; Saunders, NJ				Jordan, Philip W.; Saunders, Nigel J.			Host Iron Binding Proteins Acting as Niche Indicators for Neisseria meningitidis	PLOS ONE			English	Article								Neisseria meningitidis requires iron, and in the absence of iron alters its gene expression to increase iron acquisition and to make the best use of the iron it has. During different stages of colonization and infection available iron sources differ, particularly the host iron-binding proteins haemoglobin, transferrin, and lactoferrin. This study compared the transcriptional responses of N. meningitidis, when grown in the presence of these iron donors and ferric iron, using microarrays. Specific transcriptional responses to the different iron sources were observed, including genes that are not part of the response to iron restriction. Comparisons between growth on haemoglobin and either transferrin or lactoferrin identified changes in 124 and 114 genes, respectively, and 33 genes differed between growth on transferrin or lactoferrin. Comparison of gene expression from growth on haemoglobin or ferric iron showed that transcription is also affected by the entry of either haem or ferric iron into the cytoplasm. This is consistent with a model in which N. meningitidis uses the relative availability of host iron donor proteins as niche indicators. Growth in the presence of haemoglobin is associated with a response likely to be adaptive to survival within the bloodstream, which is supported by serum killing assays that indicate growth on haemoglobin significantly increases survival, and the response to lactoferrin is associated with increased expression of epithelial cell adhesins and oxidative stress response molecules. The transferrin receptor is the most highly transcribed receptor and has the fewest genes specifically induced in its presence, suggesting this is the favoured iron source for the bacterium. Most strikingly, the responses to haemoglobin, which is associated with unrestricted growth, indicates a low iron transcriptional profile, associated with an aggressive phenotype that may be adaptive to access host iron sources but which may also underlie the lethal features of meningococcal septicaemia, when haemoglobin may become a major source of iron.			Jordan, PW (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Bacterial Pathogenesis & Funct Genom Grp, S Parks Rd, Oxford OX1 3RE, England.	nigel.saunders@path.ox.ac.uk	Saunders, Nigel J/W-6745-2019	Saunders, Nigel/0000-0002-0160-4573				Adhikari P, 1996, J BACTERIOL, V178, P2145, DOI 10.1128/jb.178.7.2145-2149.1996; AHMED S, 2005, LPS MEDIATED SERUM R; ALAALDEEN DAA, 1993, INFECT IMMUN, V61, P751, DOI 10.1128/IAI.61.2.751-759.1993; ALAALDEEN DAA, 1993, J MED MICROBIOL, V38, P442, DOI 10.1099/00222615-38-6-442; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; APPELMELK BJ, 1994, INFECT IMMUN, V62, P2628, DOI 10.1128/IAI.62.6.2628-2632.1994; ARCHIBALD FS, 1979, FEMS MICROBIOL LETT, V6, P159; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Banerjee A, 1998, P NATL ACAD SCI USA, V95, P10872, DOI 10.1073/pnas.95.18.10872; BELLAMY W, 1992, J APPL BACTERIOL, V73, P472, DOI 10.1111/j.1365-2672.1992.tb05007.x; BIRCH HE, 1986, J BIOL CHEM, V261, P8077; Biswas GD, 1997, MOL MICROBIOL, V24, P169, DOI 10.1046/j.1365-2958.1997.3421692.x; Biville F, 2004, MOL MICROBIOL, V53, P1267, DOI 10.1111/j.1365-2958.2004.04207.x; BJERKNES R, 1995, INFECT IMMUN, V63, P160, DOI 10.1128/IAI.63.1.160-167.1995; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Carson SDB, 1999, J BACTERIOL, V181, P2895, DOI 10.1128/JB.181.9.2895-2901.1999; CHEN CY, 1993, MOL MICROBIOL, V10, P311, DOI 10.1111/j.1365-2958.1993.tb01957.x; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; Chipperfield JR, 2000, BIOMETALS, V13, P165, DOI 10.1023/A:1009227206890; Cornelissen CN, 1997, MOL MICROBIOL, V26, P25, DOI 10.1046/j.1365-2958.1997.5381914.x; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; Delany I, 2006, J BACTERIOL, V188, P2483, DOI 10.1128/JB.188.7.2483-2492.2006; Delany I, 2003, J BACTERIOL, V185, P6032, DOI 10.1128/JB.185.20.6032-6041.2003; Drake SL, 1997, MOL MICROBIOL, V23, P657, DOI 10.1046/j.1365-2958.1997.2511618.x; Ducey TF, 2005, J BACTERIOL, V187, P4865, DOI 10.1128/JB.187.14.4865-4874.2005; DYER DW, 1988, INFECT IMMUN, V56, P977, DOI 10.1128/IAI.56.4.977-983.1988; ELLISON RT, 1988, INFECT IMMUN, V56, P2774, DOI 10.1128/IAI.56.11.2774-2781.1988; Enz S, 2000, J BACTERIOL, V182, P637, DOI 10.1128/JB.182.3.637-646.2000; Estabrook MM, 2004, J IMMUNOL, V172, P3784, DOI 10.4049/jimmunol.172.6.3784; Ferreiros CM, 1998, REV MED MICROBIOL, V9, P29; Grifantini R, 2003, P NATL ACAD SCI USA, V100, P9542, DOI 10.1073/pnas.1033001100; Griffiths E, 1999, IRON INFECT MOL PHYS, P1; Griffiths NJ, 2007, CELL MICROBIOL, V9, P2968, DOI 10.1111/j.1462-5822.2007.01038.x; Gunesekere IC, 2006, J BACTERIOL, V188, P4769, DOI 10.1128/JB.01807-05; Hagen TA, 2006, MOL MICROBIOL, V62, P1144, DOI 10.1111/j.1365-2958.2006.05429.x; Hauck CR, 1997, FEBS LETT, V405, P86, DOI 10.1016/S0014-5793(97)00163-4; Hendrixson DR, 2003, MOL MICROBIOL, V47, P607, DOI 10.1046/j.1365-2958.2003.03327.x; HOLBEIN BE, 1980, INFECT IMMUN, V29, P886; Holmes K, 2005, MICROBIOL-SGM, V151, P243, DOI 10.1099/mic.0.27412-0; HUSSEIN S, 1981, EUR J BIOCHEM, V117, P431, DOI 10.1111/j.1432-1033.1981.tb06357.x; Kahler CM, 2006, J BIOL CHEM, V281, P19939, DOI 10.1074/jbc.M601308200; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Khun HH, 1998, INFECT IMMUN, V66, P2330, DOI 10.1128/IAI.66.5.2330-2336.1998; KING GJ, 1978, INFECT IMMUN, V21, P575, DOI 10.1128/IAI.21.2.575-584.1978; KLAUSNER RD, 1983, P NATL ACAD SCI-BIOL, V80, P2263, DOI 10.1073/pnas.80.8.2263; LAMBDEN PR, 1979, J GEN MICROBIOL, V114, P305, DOI 10.1099/00221287-114-2-305; Larson JA, 2004, MOL MICROBIOL, V53, P807, DOI 10.1111/j.1365-2958.2004.04169.x; Larson JA, 2002, INFECT IMMUN, V70, P1461, DOI 10.1128/IAI.70.3.1461-1467.2002; LETENDRE ED, 1983, INFECT IMMUN, V39, P50, DOI 10.1128/IAI.39.1.50-59.1983; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; LEWIS LA, 1995, J BACTERIOL, V177, P1299, DOI 10.1128/jb.177.5.1299-1306.1995; Lewis LA, 1997, MOL MICROBIOL, V23, P737, DOI 10.1046/j.1365-2958.1997.2501619.x; Lin L, 1997, MOL MICROBIOL, V24, P1083, DOI 10.1046/j.1365-2958.1997.4191776.x; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahren S, 2003, J BACTERIOL, V185, P1796, DOI 10.1128/JB.185.6.1796-1802.2003; MASSON P, 1965, EXPERIENTIA, V21, P604, DOI 10.1007/BF02151559; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; MICKELSEN PA, 1981, INFECT IMMUN, V33, P555, DOI 10.1128/IAI.33.2.555-564.1981; MICKELSEN PA, 1982, INFECT IMMUN, V35, P915, DOI 10.1128/IAI.35.3.915-920.1982; Morelle S, 2005, MOL MICROBIOL, V55, P853, DOI 10.1111/j.1365-2958.2004.04426.x; OCHS M, 1995, MOL MICROBIOL, V15, P119, DOI 10.1111/j.1365-2958.1995.tb02226.x; Overton TW, 2006, J BIOL CHEM, V281, P33115, DOI 10.1074/jbc.M607056200; Padron J, 1999, FEMS IMMUNOL MED MIC, V25, P385, DOI 10.1016/S0928-8244(99)00113-3; PARUCHURI DK, 1990, P NATL ACAD SCI USA, V87, P333, DOI 10.1073/pnas.87.1.333; Paustian ML, 2002, J BACTERIOL, V184, P6714, DOI 10.1128/JB.184.23.6714-6720.2002; Peak IRA, 2000, FEMS IMMUNOL MED MIC, V28, P329, DOI 10.1111/j.1574-695X.2000.tb01494.x; PETTERSSON A, 1994, MICROB PATHOGENESIS, V17, P395, DOI 10.1006/mpat.1994.1085; PLAUT AG, 1975, SCIENCE, V190, P1103, DOI 10.1126/science.810892; Ram S, 2003, J BIOL CHEM, V278, P50853, DOI 10.1074/jbc.M308364200; Richardson AR, 1999, J BACTERIOL, V181, P2067, DOI 10.1128/JB.181.7.2067-2074.1999; Rohde KH, 2002, MOL MICROBIOL, V43, P335, DOI 10.1046/j.1365-2958.2002.02745.x; Rohde KH, 2004, INFECT IMMUN, V72, P2494, DOI 10.1128/IAI.72.5.2494-2506.2004; Rouse RJD, 2004, BIOTECHNIQUES, V36, P464, DOI 10.2144/04363RR02; Rowe HA, 2007, CELL MICROBIOL, V9, P154, DOI 10.1111/j.1462-5822.2006.00775.x; SAAL LH, 2002, GENOME BIOL, V3; Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x; Scarselli M, 2006, MOL MICROBIOL, V61, P631, DOI 10.1111/j.1365-2958.2006.05261.x; SCHREIBER G, 1986, INFLAMMATION, V10, P59, DOI 10.1007/BF00916041; Schryvers AB, 1999, MOL MICROBIOL, V32, P1117, DOI 10.1046/j.1365-2958.1999.01411.x; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Snyder LAS, 2005, MICROBIOL-SGM, V151, P4005, DOI 10.1099/mic.0.27925-0; Stears RL, 2000, PHYSIOL GENOMICS, V3, P93, DOI 10.1152/physiolgenomics.2000.3.2.93; STEPHENS DS, 1981, J INFECT DIS, V143, P525, DOI 10.1093/infdis/143.4.525; Stohl EA, 2005, MOL MICROBIOL, V58, P520, DOI 10.1111/j.1365-2958.2005.04839.x; Stojiljkovic I, 1996, J BACTERIOL, V178, P4670, DOI 10.1128/jb.178.15.4670-4678.1996; Stojiljkovic I, 1997, J BACTERIOL, V179, P805, DOI 10.1128/jb.179.3.805-812.1997; Stojiljkovic I, 1997, FEMS MICROBIOL LETT, V151, P41, DOI 10.1016/S0378-1097(97)00135-3; THOMPSON SA, 1993, MOL MICROBIOL, V9, P85, DOI 10.1111/j.1365-2958.1993.tb01671.x; THOMPSON SA, 1993, INFECT IMMUN, V61, P2906, DOI 10.1128/IAI.61.7.2906-2911.1993; TSAI J, 1988, INFECT IMMUN, V56, P3132, DOI 10.1128/IAI.56.12.3132-3138.1988; UMEYAMA M, 2006, BIOCHIM BIOPHYS ACTA; van Putten JPM, 1998, J EXP MED, V188, P941, DOI 10.1084/jem.188.5.941; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; WALL RA, 1986, LANCET, V2, P624; Welch RA, 1995, INFECT AGENT DIS, V4, P254; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	99	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5198	10.1371/journal.pone.0005198	http://dx.doi.org/10.1371/journal.pone.0005198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352437	Green Submitted, gold, Green Published			2022-12-27	WOS:000265505700026
J	Placanica, L; Zhu, L; Li, YM				Placanica, Lisa; Zhu, Lei; Li, Yue-Ming			Gender- and Age-Dependent gamma-Secretase Activity in Mouse Brain and Its Implication in Sporadic Alzheimer Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ESTROGEN REPLACEMENT THERAPY; BETA-DEGRADING ENZYMES; POSTMENOPAUSAL WOMEN; CELL FATE; PRESENILIN-1; DEMENTIA; NOTCH; RISK; AD	Alzheimer disease (AD) is an age-related disorder. Aging and female gender are two important risk factors associated with sporadic AD. However, the mechanism by which aging and gender contribute to the pathogenesis of sporadic AD is unclear. It is well known that genetic mutations in gamma-secretase result in rare forms of early onset AD due to the aberrant production of A beta 42 peptides, which are the major constituents of senile plaques. However, the effect of age and gender on gamma-secretase has not been fully investigated. Here, using normal wild-type mice, we show mouse brain gamma-secretase exhibits gender-and age-dependent activity. Both male and female mice exhibit increased A beta 42:A beta 40 ratios in aged brain, which mimics the effect of familial mutations of Presenilin-1, Presenlin-2, and the amyloid precursor protein on A beta production. Additionally, female mice exhibit much higher gamma-secretase activity in aged brain compared to male mice. Furthermore, both male and female mice exhibit a steady decline in Notch1 gamma-secretase activity with aging. Using a small molecule affinity probe we demonstrate that male mice have less active gamma-secretase complexes than female mice, which may account for the gender-associated differences in activity in aged brain. These findings demonstrate that aging can affect gamma-secretase activity and specificity, suggesting a role for gamma-secretase in sporadic AD. Furthermore, the increased APP gamma-secretase activity seen in aged females may contribute to the increased incidence of sporadic AD in women and the aggressive A beta plaque pathology seen in female mouse models of AD. In addition, deceased Notch gamma-secretase activity may also contribute to neurodegeneration. Therefore, this study implicates altered gamma-secretase activity and specificity as a possible mechanism of sporadic AD during aging.			Placanica, L (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA.	liy2@mskcc.org	LI, Yue/GRS-8071-2022		NCI NIH HHS [T32 CA062948-11A, T32 CA062948] Funding Source: Medline; NIA NIH HHS [R01 AG026660, R01-AG026660] Funding Source: Medline; NIGMS NIH HHS [T32GM073546-01A1, T32 GM073546] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026660] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asthana S, 2001, NEUROLOGY, V57, P605, DOI 10.1212/WNL.57.4.605; Beher D, 2003, BIOCHEMISTRY-US, V42, P8133, DOI 10.1021/bi034045z; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Deng Y, 2006, J NEUROSCI, V26, P3845, DOI 10.1523/JNEUROSCI.5384-05.2006; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Espeland MA, 2004, JAMA-J AM MED ASSOC, V291, P2959, DOI 10.1001/jama.291.24.2959; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Funalot B, 2004, MOL PSYCHIATR, V9, P1122, DOI 10.1038/sj.mp.4001584; Greenfield JP, 2000, FRONT BIOSCI, V5, pD72, DOI 10.2741/Greenfield; Handler M, 2000, DEVELOPMENT, V127, P2593; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; Hock B J Jr, 2001, Trends Genet, V17, pS7, DOI 10.1016/S0168-9525(01)02449-0; Howlett DR, 2004, BRAIN RES, V1017, P130, DOI 10.1016/j.brainres.2004.05.029; Hy LX, 2000, NEUROLOGY, V55, P198, DOI 10.1212/WNL.55.2.198; Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390; JAFFE AB, 1994, J BIOL CHEM, V269, P13065; Jalbert JJ, 2008, EPIDEMIOL REV, V30, P15, DOI 10.1093/epirev/mxn008; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; Kern A, 2006, J BIOL CHEM, V281, P2405, DOI 10.1074/jbc.M505625200; Kim HJ, 2007, LIVER INT, V27, P633, DOI 10.1111/j.1478-3231.2007.01481.x; Kim WY, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-2; Kolovou GD, 2008, ANGIOLOGY, V59, p54S, DOI 10.1177/0003319708319645; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; LaRosa J C, 1992, Womens Health Issues, V2, P102, DOI 10.1016/S1049-3867(05)80278-6; LAROSA JC, 1990, CAN J CARDIOL, V6, pB23; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lukiw WL, 2005, CELL MOL NEUROBIOL, V25, P475, DOI 10.1007/s10571-005-4010-6; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; MOLSA PK, 1982, ACTA NEUROL SCAND, V65, P541; Mulnard RI, 2000, JAMA-J AM MED ASSOC, V283, P1007, DOI 10.1001/jama.283.8.1007; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; PaganiniHill A, 1996, ARCH INTERN MED, V156, P2213, DOI 10.1001/archinte.156.19.2213; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schafer S, 2007, J NEURAL TRANSM, V114, P387, DOI 10.1007/s00702-006-0580-9; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; Verhoeven MO, 2009, MENOPAUSE, V16, P37, DOI 10.1097/gme.0b013e31817c42d6; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Walker ES, 2005, J NEUROCHEM, V92, P294, DOI 10.1111/j.1471-4159.2004.02858.x; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Wang PN, 2000, NEUROLOGY, V54, P2061, DOI 10.1212/WNL.54.11.2061; Xu HX, 2006, ANN NY ACAD SCI, V1089, P324, DOI 10.1196/annals.1386.036; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Yin YI, 2007, J BIOL CHEM, V282, P23639, DOI 10.1074/jbc.M704601200; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Yue X, 2005, P NATL ACAD SCI USA, V102, P19198, DOI 10.1073/pnas.0505203102	64	69	71	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5088	10.1371/journal.pone.0005088	http://dx.doi.org/10.1371/journal.pone.0005088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352431	Green Submitted, gold, Green Published			2022-12-27	WOS:000265505300011
J	Pingitore, NE; Clague, JW; Amaya, MA; Maciejewska, B; Reynoso, JJ				Pingitore, Nicholas E., Jr.; Clague, Juan W.; Amaya, Maria A.; Maciejewska, Beata; Reynoso, Jesus J.			Urban Airborne Lead: X-Ray Absorption Spectroscopy Establishes Soil as Dominant Source	PLOS ONE			English	Article								Background: Despite the dramatic decrease in airborne lead over the past three decades, there are calls for regulatory limits on this potent pediatric neurotoxin lower even than the new (2008) US Environmental Protection Agency standard. To achieve further decreases in airborne lead, what sources would need to be decreased and what costs would ensue? Our aim was to identify and, if possible, quantify the major species (compounds) of lead in recent ambient airborne particulate matter collected in El Paso, TX, USA. Methodology/Principal Findings: We used synchrotron-based XAFS (x-ray absorption fine structure) to identify and quantify the major Pb species. XAFS provides molecular-level structural information about a specific element in a bulk sample. Pb-humate is the dominant form of lead in contemporary El Paso air. Pb-humate is a stable, sorbed complex produced exclusively in the humus fraction of Pb-contaminated soils; it also is the major lead species in El Paso soils. Thus such soil must be the dominant source, and its resuspension into the air, the transfer process, providing lead particles to the local air. Conclusions/Significance: Current industrial and commercial activity apparently is not a major source of airborne lead in El Paso, and presumably other locales that have eliminated such traditional sources as leaded gasoline. Instead, local contaminated soil, legacy of earlier anthropogenic Pb releases, serves as a long-term reservoir that gradually leaks particulate lead to the atmosphere. Given the difficulty and expense of large-scale soil remediation or removal, fugitive soil likely constrains a lower limit for airborne lead levels in many urban settings.	[Pingitore, Nicholas E., Jr.; Clague, Juan W.; Maciejewska, Beata] Univ Texas El Paso, Dept Geol Sci, El Paso, TX 79968 USA; [Pingitore, Nicholas E., Jr.; Amaya, Maria A.] Univ Texas El Paso, Sch Nurs, El Paso, TX 79968 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso	Pingitore, NE (corresponding author), Univ Texas El Paso, Dept Geol Sci, El Paso, TX 79968 USA.	nick@geo.utep.edu			National Institute of Environmental Health Sciences (NIEHS), NIH [1RO1-ES11367, 1 S11 ES013339-01A1]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program; SSRL-DOE-UTEP Gateway Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [S11ES013339, R01ES011367] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); SSRL-DOE-UTEP Gateway Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This publication was made possible by grant numbers 1RO1-ES11367 and 1 S11 ES013339-01A1 from the National Institute of Environmental Health Sciences (NIEHS), NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIEHS, NIH. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. Partial travel and on-site support was provided by SSRL-DOE-UTEP Gateway Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNEST JL, 1983, NEW ENGL J MED, V308, P1373, DOI 10.1056/NEJM198306093082301; [Anonymous], 1988, NAT EXT LEAD POIS CH; Bargar JR, 1997, GEOCHIM COSMOCHIM AC, V61, P2639, DOI 10.1016/S0016-7037(97)00125-7; Bargar JR, 1997, GEOCHIM COSMOCHIM AC, V61, P2617, DOI 10.1016/S0016-7037(97)00124-5; Bargar JR, 1996, GEOCHIM COSMOCHIM AC, V60, P3541, DOI 10.1016/0016-7037(96)00222-0; BARGAR JR, 2007, MOL ENV INTERFACE SC; Casteel SW, 2006, ENVIRON HEALTH PERSP, V114, P1162, DOI 10.1289/ehp.8852; Charles D, 2007, SCIENCE, V316, P973; Choel M, 2006, ATMOS ENVIRON, V40, P4439, DOI 10.1016/j.atmosenv.2006.04.027; DAVIDSON CI, 1992, HUMAN LEAD EXPOSURE, P65; Elzinga EJ, 2002, ENVIRON SCI TECHNOL, V36, P4352, DOI 10.1021/es0158509; Gulson B, 2007, SCI TOTAL ENVIRON, V381, P169, DOI 10.1016/j.scitotenv.2007.03.018; Guo XY, 2006, ENVIRON TOXICOL CHEM, V25, P2366, DOI 10.1897/05-636R.1; Harris AR, 2005, ENVIRON SCI TECHNOL, V39, P7410, DOI 10.1021/es050642s; Huggins FE, 2000, J HAZARD MATER, V74, P1, DOI 10.1016/S0304-3894(99)00195-8; JAKLEVIC JM, 1980, ENVIRON SCI TECHNOL, V14, P437, DOI 10.1021/es60164a009; Kabata-Pendias A., 1992, TRACE ELEMENTS SOILS; Lankey RL, 1998, ENVIRON RES, V78, P86, DOI 10.1006/enrs.1998.3853; Manceau A, 1996, ENVIRON SCI TECHNOL, V30, P1540, DOI 10.1021/es9505154; McBride M. B., 1994, ENV CHEM SOILS; Mielke HW, 2008, ENVIRON GEOCHEM HLTH, V30, P231, DOI 10.1007/s10653-007-9111-3; Morin G, 1999, AM MINERAL, V84, P420; O'Day PA, 2004, AM MINERAL, V89, P572, DOI 10.2138/am-2004-0412; Ostergren JD, 1999, ENVIRON SCI TECHNOL, V33, P1627, DOI 10.1021/es980660s; Pingitore N. E., 2005, US MEXICAN BORDER EN, P131; RAO KJ, 1984, J CHEM PHYS, V81, P4832, DOI 10.1063/1.447509; ROE AL, 1991, LANGMUIR, V7, P367, DOI 10.1021/la00050a029; Sposito G, 1989, CHEM SOILS; Stokstad E, 2008, SCIENCE, V319, P146, DOI 10.1126/science.319.5860.146a; Trivedi P, 2003, ENVIRON SCI TECHNOL, V37, P908, DOI 10.1021/es0257927; U.S. Environmental Protection Agency, 2008, FIN NAT AMB AIR QUAL; *US EPA, 2008, FACT SHEET FIN REV N; Werner ML, 2007, ENVIRON SCI TECHNOL, V41, P4919, DOI 10.1021/es070430q; Xia K, 1997, GEOCHIM COSMOCHIM AC, V61, P2211, DOI 10.1016/S0016-7037(97)00079-3; Young TM, 2002, ENVIRON SCI TECHNOL, V36, P2484, DOI 10.1021/es015609u; 2007, CHEM ENG NEWS, V85, P39	36	24	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5019	10.1371/journal.pone.0005019	http://dx.doi.org/10.1371/journal.pone.0005019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340295	Green Published, gold, Green Submitted			2022-12-27	WOS:000265500700007
J	Wagner, RN; Proell, M; Kufer, TA; Schwarzenbacher, R				Wagner, Roland N.; Proell, Martina; Kufer, Thomas A.; Schwarzenbacher, Robert			Evaluation of Nod-Like Receptor (NLR) Effector Domain Interactions	PLOS ONE			English	Article							NF-KAPPA-B; CONTAINING APAF1-LIKE PROTEIN; CASPASE-RECRUITMENT DOMAIN; FAMILY-MEMBER; NALP3 INFLAMMASOME; REGULATES ACTIVATION; CROHNS-DISEASE; CYTOCHROME-C; CARD PROTEIN; PYRIN DOMAIN	Members of the Nod-like receptor (NLR) family recognize intracellular pathogens and recruit a variety of effector molecules, including pro-caspases and kinases, which in turn are implicated in cytokine processing and NF-kappa B activation. In order to elucidate the intricate network of NLR signaling, which is still fragmentary in molecular terms, we applied comprehensive yeast two-hybrid analysis for unbiased evaluation of physical interactions between NLRs and their adaptors (ASC, CARD8) as well as kinase RIPK2 and inflammatory caspases (C1, C2, C4, C5) under identical conditions. Our results confirmed the interaction of NOD1 and NOD2 with RIPK2, and between NLRP3 and ASC, but most importantly, our studies revealed hitherto unrecognized interactions of NOD2 with members of the NLRP subfamily. We found that NOD2 specifically and directly interacts with NLRP1, NLRP3 and NLRP12. Furthermore, we observed homodimerization of the RIPK2 CARD domains and identified residues in NOD2 critical for interaction with RIPK2. In conclusion, our work provides further evidence for the complex network of protein-protein interactions underlying NLR function.	[Wagner, Roland N.; Proell, Martina; Schwarzenbacher, Robert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Kufer, Thomas A.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-5000 Cologne, Germany	Salzburg University; University of Cologne	Wagner, RN (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	robert.schwarzenbacher@sbg.ac.at	Kufer, Thomas A/I-5146-2015	Kufer, Thomas A/0000-0003-4563-0412	MCEXT [033534]; Deutsche Forschungsgemeinschaft [SFB 670]; Federation of European Biochemical Societies (FEBS); Austrian Academy of Sciences [DOC-FFORTE-fellowship]	MCEXT; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federation of European Biochemical Societies (FEBS); Austrian Academy of Sciences	This work was supported by MCEXT-033534 to RS and by funds from the Deutsche Forschungsgemeinschaft (SFB 670) and the Federation of European Biochemical Societies (FEBS) to TAK. MP was supported by a DOC-FFORTE-fellowship of the Austrian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Carneiro LAM, 2008, J PATHOL, V214, P136, DOI 10.1002/path.2271; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Damiano JS, 2001, GENOMICS, V75, P77, DOI 10.1006/geno.2001.6579; Dostert C, 2008, ADV DRUG DELIVER REV, V60, P830, DOI 10.1016/j.addr.2007.12.003; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Faustin B, 2008, TRENDS CELL BIOL, V18, P4, DOI 10.1016/j.tcb.2007.10.004; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Geddes BJ, 2001, BIOCHEM BIOPH RES CO, V284, P77, DOI 10.1006/bbrc.2001.4928; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hlaing T, 2001, J BIOL CHEM, V276, P9230, DOI 10.1074/jbc.M009853200; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Jayapandian M, 2007, NUCLEIC ACIDS RES, V35, pD566, DOI 10.1093/nar/gkl859; Kinoshita T, 2006, INT IMMUNOL, V18, P1701, DOI 10.1093/intimm/dxl104; Kufer TA, 2008, MOL BIOSYST, V4, P380, DOI 10.1039/b718948f; Li HL, 1997, J BIOL CHEM, V272, P21010, DOI 10.1074/jbc.272.34.21010; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2001, CURR BIOL, V11, pR118, DOI 10.1016/S0960-9822(01)00056-2; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; Masumoto J, 2001, BIOCHEM BIOPH RES CO, V280, P652, DOI 10.1006/bbrc.2000.4190; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Pan QL, 2007, J LEUKOCYTE BIOL, V82, P177, DOI 10.1189/jlb.1006627; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pathan N, 2001, J BIOL CHEM, V276, P32220, DOI 10.1074/jbc.M100433200; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rosenstiel P, 2006, P NATL ACAD SCI USA, V103, P3280, DOI 10.1073/pnas.0505423103; Srimathi T, 2008, J BIOL CHEM, V283, P15390, DOI 10.1074/jbc.M801589200; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552; Stilo R, 2002, FEBS LETT, V521, P165, DOI 10.1016/S0014-5793(02)02869-7; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; YERETSSIAN G, 2008, CYTOKINE; Yoo NJ, 2002, BIOCHEM BIOPH RES CO, V299, P652, DOI 10.1016/S0006-291X(02)02714-6	66	47	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e4931	10.1371/journal.pone.0004931	http://dx.doi.org/10.1371/journal.pone.0004931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337385	Green Submitted, gold, Green Published			2022-12-27	WOS:000265500600004
J	Iyer, SS; Accardi, CJ; Ziegler, TR; Blanco, RA; Ritzenthaler, JD; Rojas, M; Roman, J; Jones, DP				Iyer, Smita S.; Accardi, Carolyn J.; Ziegler, Thomas R.; Blanco, Roberto A.; Ritzenthaler, Jeffrey D.; Rojas, Mauricio; Roman, Jesse; Jones, Dean P.			Cysteine Redox Potential Determines Pro-Inflammatory IL-1 beta Levels	PLOS ONE			English	Article							ACUTE LUNG INJURY; OXIDATIVE STRESS; THIOL/DISULFIDE REDOX; PROTEIN-SYNTHESIS; PLASMA; GLUTATHIONE; STATE; INTERLEUKIN-1; EXPRESSION; CYTOKINES	Background: Cysteine (Cys) and its disulfide, cystine (CySS) represent the major extracellular thiol/disulfide redox control system. The redox potential (E-h) of Cys/CySS is centered at approximately -80 mV in the plasma of healthy adults, and oxidation of Eh Cys/CySS is implicated in inflammation associated with various diseases. Methodology/Principal Findings: The purpose of the present study was to determine whether oxidized E-h Cys/CySS is a determinant of interleukin (IL)-1 beta levels. Results showed a 1.7-fold increase in secreted pro-IL-1 beta levels in U937 monocytes exposed to oxidized E-h Cys/CySS (246 mV), compared to controls exposed to a physiological E-h of 280 mV (P,<0.01). In LPS-challenged mice, preservation of plasma E-h Cys/CySS from oxidation by dietary sulfur amino acid (SAA) supplementation, was associated with a 1.6-fold decrease in plasma IL-1 beta compared to control mice fed an isonitrogenous SAA-adequate diet (P<0.01). Analysis of Eh Cys/CySS and IL-1 beta in human plasma revealed a significant positive association between oxidized Eh Cys/CySS and IL-1 beta after controlling for age, gender, and BMI (P<0.001). Conclusions/Significance: These data show that oxidized extracellular E-h Cys/CySS is a determinant of IL-1 beta levels, and suggest that strategies to preserve E-h Cys/CySS may represent a means to control IL-1 beta in inflammatory disease states.	[Iyer, Smita S.; Jones, Dean P.] Emory Univ, Nutr & Hlth Sci Program, Atlanta, GA 30322 USA; [Accardi, Carolyn J.; Ziegler, Thomas R.; Blanco, Roberto A.] Emory Univ, Div Endocrinol Metabolism & Lipids, Atlanta, GA 30322 USA; [Ritzenthaler, Jeffrey D.; Rojas, Mauricio; Roman, Jesse; Jones, Dean P.] Emory Univ, Div Pulmonary Allergy & Critical Care Med, Atlanta, GA 30322 USA; [Iyer, Smita S.; Rojas, Mauricio] Emory Univ, Ctr Translat Res Lung, Atlanta, GA 30322 USA; [Rojas, Mauricio] Emory Univ, McKelvey Ctr Lung Transplant Pulmonary Vasc Dis, Atlanta, GA 30322 USA; [Iyer, Smita S.; Jones, Dean P.] Emory Univ, Clin Biomarkers Lab, Atlanta, GA 30322 USA; [Roman, Jesse] Emory Univ, Atlanta VA Med Ctr, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center	Iyer, SS (corresponding author), Emory Univ, Nutr & Hlth Sci Program, Atlanta, GA 30322 USA.	dpjones@emory.edu	Iyer, Smita/S-5398-2017; Iyer, Swaminathan/GRS-9668-2022		NIH [ES009047, ES01195]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR023356, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009047] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	NIH Grants ES009047, ES01195. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 2007, AM J PHYSIOL-REG I, V293, pR1069, DOI 10.1152/ajpregu.00195.2007; Blanco RA, 2007, AM J CLIN NUTR, V86, P1016, DOI 10.1093/ajcn/86.4.1016; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Compher C, 2008, JPEN-PARENTER ENTER, V32, P645, DOI 10.1177/0148607108326070; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Fan Z, 2007, AM J PATHOL, V171, P938, DOI 10.2353/ajpath.2007.061083; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Go YM, 2005, CIRCULATION, V111, P2973, DOI 10.1161/CIRCULATIONAHA.104.515155; Go YM, 2007, FREE RADICAL BIO MED, V42, P363, DOI 10.1016/j.freeradbiomed.2006.11.005; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; HUNTER EAL, 1994, J NUTR, V124, P2319, DOI 10.1093/jn/124.12.2319; INOUE Y, 1995, J SURG RES, V58, P693, DOI 10.1006/jsre.1995.1109; Iyer SS, 2009, AM J RESP CELL MOL, V40, P90, DOI 10.1165/rcmb.2007-0447OC; Jensen GL, 2008, JPEN-PARENTER ENTER, V32, P656, DOI 10.1177/0148607108324585; Jiang SN, 2005, INVEST OPHTH VIS SCI, V46, P1054, DOI 10.1167/iovs.04-0949; Johnson JM, 2008, CLIN CHIM ACTA, V396, P43, DOI 10.1016/j.cca.2008.06.020; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0; Jones DP, 1998, CLIN CHIM ACTA, V275, P175, DOI 10.1016/S0009-8981(98)00089-8; Jones DP, 2002, FREE RADICAL BIO MED, V33, P1290, DOI 10.1016/S0891-5849(02)01040-7; Kao SJ, 2006, CLIN EXP PHARMACOL P, V33, P33, DOI 10.1111/j.1440-1681.2006.04320.x; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Kolls JK, 2006, J CLIN INVEST, V116, P860, DOI 10.1172/JCI28111; Malmezat T, 2000, AM J PHYSIOL-ENDOC M, V279, pE1391; MINAMIYA Y, 1995, AM J RESP CRIT CARE, V152, P348, DOI 10.1164/ajrccm.152.1.7599844; Moriarty SE, 2003, FREE RADICAL BIO MED, V35, P1582, DOI 10.1016/j.freeradbiomed.2003.09.006; Moriarty-Craige SE, 2005, AM J OPHTHALMOL, V140, P1020, DOI 10.1016/j.ajo.2005.06.043; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Moriarty-Craige SE, 2007, AM J OPHTHALMOL, V143, P206, DOI 10.1016/j.ajo.2006.09.056; Neuman RB, 2007, CLIN CHEM, V53, P1652, DOI 10.1373/clinchem.2006.083923; Nkabyo YS, 2006, J NUTR, V136, P1242, DOI 10.1093/jn/136.5.1242; Petrovsky N, 1998, CYTOKINE, V10, P307, DOI 10.1006/cyto.1997.0289; Ramirez A, 2007, AM J PHYSIOL-LUNG C, V293, pL972, DOI 10.1152/ajplung.00010.2007; Ritzenthaler J, 1998, IMMUNOLOGY, V95, P264; Rojas M, 2005, AM J PHYSIOL-LUNG C, V288, pL333, DOI 10.1152/ajplung.00334.2004; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Waehre T, 2004, CIRCULATION, V109, P1966, DOI 10.1161/01.CIR.0000125700.33637.B1; YEH M, 2007, DETERMINING MONITORI	44	77	79	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e5017	10.1371/journal.pone.0005017	http://dx.doi.org/10.1371/journal.pone.0005017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PO	19325908	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499600005
J	Amine, A; Rivera, S; Opolon, P; Dekkal, M; Biard, DSF; Bouamar, H; Louache, F; McKay, MJ; Bourhis, J; Deutsch, E; Vozenin-Brotons, MC				Amine, Abdessamad; Rivera, Sofia; Opolon, Paule; Dekkal, Mehdi; Biard, Denis S. F.; Bouamar, Hakim; Louache, Fawzia; McKay, Michael J.; Bourhis, Jean; Deutsch, Eric; Vozenin-Brotons, Marie-Catherine			Novel Anti-Metastatic Action of Cidofovir Mediated by Inhibition of E6/E7, CXCR4 and Rho/ROCK Signaling in HPV+ Tumor Cells	PLOS ONE			English	Article								Cervical cancer is frequently associated with HPV infection. The expression of E6 and E7 HPV oncoproteins is a key factor in its carcinogenicity and might also influence its virulence, including metastatic conversion. The cellular mechanisms involved in metastatic spread remain elusive, but pro-adhesive receptors and their ligands, such as SDF-1 alpha and CXCR4 are implicated. In the present study, we assessed the possible relationship between SDF-1 alpha/CXCR4 signaling, E6/E7 status and the metastatic process. We found that SDF-1 alpha stimulated the invasion of E6/E7-positive cancer cell lines (HeLa and TC-1) in Matrigel though CXCR4 and subsequent Rho/ROCK activation. In pulmonary metastatic foci generated by TC-1 cells IV injection a high proportion of cells expressed membrane-associated CXCR4. In both cases models (in vitro and in vivo) cell adhesion and invasion was abrogated by CXCR4 immunological blockade supporting a contribution of SDF-1 alpha/CXCR4 to the metastatic process. E6 and E7 silencing using stable knock-down and the approved anti-viral agent, Cidofovir decreased CXCR4 gene expression as well as both, constitutive and SDF-1 alpha-induced cell invasion. In addition, Cidofovir inhibited lung metastasis (both adhesion and invasion) supporting contribution of E6 and E7 oncoproteins to the metastatic process. Finally, potential signals activated downstream SDF-1 alpha/CXCR4 and involved in lung homing of E6/E7-expressing tumor cells were investigated. The contribution of the Rho/ROCK pathway was suggested by the inhibitory effect triggered by Cidofovir and further confirmed using Y-27632 (a small molecule ROCK inhibitor). These data suggest a novel and highly translatable therapeutic approach to cervix cancer, by inhibition of adhesion and invasion of circulating HPV-positive tumor cells, using Cidofovir and/or ROCK inhibition.	[Amine, Abdessamad; Rivera, Sofia; Dekkal, Mehdi; Bourhis, Jean; Deutsch, Eric; Vozenin-Brotons, Marie-Catherine] Inst Radioprotect & Surete Nucl, Inst Gustave Roussy, Lab UPRES, EA Radiosensibilite Tumeurs & Tissue Sains 27 10, Villejuif, France; [Opolon, Paule] Inst Gustave Roussy, Lab Vectorol Transfert Genes, UMR 8121, Villejuif, France; [Biard, Denis S. F.] Inst A Lwoff, CNRS, INSERM, CEA DSV iRCM, BP 8, Villejuif, France; [Bouamar, Hakim; Louache, Fawzia] Inst Gustave Roussy, INSERM, U 790, Villejuif, France; [McKay, Michael J.] Australian Natl Univ, Canberra, ACT, Australia; [McKay, Michael J.] Canberra Hosp, Canberra, ACT, Australia	UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; CEA; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Australian National University; Australian National University; Canberra Hospital	Amine, A (corresponding author), Inst Radioprotect & Surete Nucl, Inst Gustave Roussy, Lab UPRES, EA Radiosensibilite Tumeurs & Tissue Sains 27 10, Villejuif, France.	vozenin@igr.fr	McKay, Michael/ABA-9029-2021; Louache, Fawzia/M-4901-2017; Vozenin, Marie-Catherine/AAR-2268-2021	Louache, Fawzia/0000-0002-4247-5421; Vozenin, Marie-Catherine/0000-0002-2109-8073; Bourhis, Jean/0000-0001-5162-1171; BIARD, Denis Serge Francois/0000-0001-9697-4392; deutsch, eric/0000-0002-8223-3697; Sofia, Rivera/0000-0002-3096-5642	Association pour la Recherche sur le Cancer [fellows, 3881, 4970]; Electricite de France	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Electricite de France	A. A. and S. R. are fellows of the Association pour la Recherche sur le Cancer. D. B. acknowledges a grant from Electricite de France. This study was partly supported by the Association pour la Recherche sur le Cancer, contract n 3881 and 4970. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkarim B, 2002, ONCOGENE, V21, P2334, DOI 10.1038/sj.onc.1205006; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amine A, 2006, RADIAT RES, V166, P600, DOI 10.1667/RR0423.1; Andrei G, 1998, ONCOL RES, V10, P533; Andrei G, 2001, ONCOL RES, V12, P397, DOI 10.3727/096504001108747855; Bai L, 2006, INT J GYNECOL CANCER, V16, P718, DOI 10.1111/j.1525-1438.2006.00380.x; Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Bartolome RA, 2004, CANCER RES, V64, P2534, DOI 10.1158/0008-5472.CAN-03-3398; Biard DSF, 2007, NUCLEIC ACIDS RES, V35, P3535, DOI 10.1093/nar/gkm195; Charette ST, 2007, ONCOGENE, V26, P7386, DOI 10.1038/sj.onc.1210541; CHEN LP, 1993, P NATL ACAD SCI USA, V90, P6523, DOI 10.1073/pnas.90.14.6523; CLAAS ECJ, 1989, AM J PATHOL, V135, P703; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Donne AJ, 2007, HEAD NECK-J SCI SPEC, V29, P741, DOI 10.1002/hed.20572; FUCHS PG, 1989, INT J CANCER, V43, P41, DOI 10.1002/ijc.2910430110; Hostetler KY, 2006, MOL CANCER THER, V5, P156, DOI 10.1158/1535-7163.MCT-05-0200; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Lai CH, 2007, J CLIN ONCOL, V25, P3628, DOI 10.1200/JCO.2007.11.2995; Leung T, 1996, MOL CELL BIOL, V16, P5313; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liang ZX, 2004, CANCER RES, V64, P4302, DOI 10.1158/0008-5472.CAN-03-3958; Liang ZX, 2005, CANCER RES, V65, P967; Licitra L, 2006, J CLIN ONCOL, V24, P5630, DOI 10.1200/JCO.2005.04.6136; Lin KY, 1996, CANCER RES, V56, P21; Liotta LA, 2001, NATURE, V410, P24, DOI 10.1038/35065180; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murakami T, 2002, CANCER RES, V62, P7328; Murdoch C, 2000, IMMUNOL REV, V177, P175, DOI 10.1034/j.1600-065X.2000.17715.x; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; Narisawa-Saito M, 2008, CANCER RES, V68, P5699, DOI 10.1158/0008-5472.CAN-07-6862; Peng SB, 2005, MOL CANCER RES, V3, P227; Rein DT, 2004, J GENE MED, V6, P1281, DOI 10.1002/jgm.606; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; Sima N, 2007, GYNECOL ONCOL, V106, P299, DOI 10.1016/j.ygyno.2007.04.039; Sirianni N, 2005, ORAL ONCOL, V41, P423, DOI 10.1016/j.oraloncology.2004.11.003; Smith-McCune K, 1999, P NATL ACAD SCI USA, V96, P6999, DOI 10.1073/pnas.96.12.6999; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Titus B, 2005, CRIT REV EUKAR GENE, V15, P103, DOI 10.1615/CritRevEukaryotGeneExpr.v15.i2.20; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wu SF, 2006, CLIN CANCER RES, V12, P2032, DOI 10.1158/1078-0432.CCR-05-2567; Yasmeen A, 2007, CELL CYCLE, V6, P2038, DOI 10.4161/cc.6.16.4555; Yoshida S, 2008, J VIROL, V82, P8820, DOI 10.1128/JVI.02363-07; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zhang JP, 2007, INT J GYNECOL CANCER, V17, P478, DOI 10.1111/j.1525-1438.2007.00786.x; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024; ZURHAUSEN H, 2009, VIROLOGY	53	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2009	4	3							e5018	10.1371/journal.pone.0005018	http://dx.doi.org/10.1371/journal.pone.0005018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PM	19325708	Green Submitted, Green Published, gold			2022-12-27	WOS:000265499400007
J	Dupuis, L; de Aguilar, JLG; Echaniz-Laguna, A; Eschbach, J; Rene, F; Oudart, H; Halter, B; Huze, C; Schaeffer, L; Bouillaud, F; Loeffler, JP				Dupuis, Luc; de Aguilar, Jose-Luis Gonzalez; Echaniz-Laguna, Andoni; Eschbach, Judith; Rene, Frederique; Oudart, Hugues; Halter, Benoit; Huze, Caroline; Schaeffer, Laurent; Bouillaud, Frederic; Loeffler, Jean-Philippe			Muscle Mitochondrial Uncoupling Dismantles Neuromuscular Junction and Triggers Distal Degeneration of Motor Neurons	PLOS ONE			English	Article								Background: Amyotrophic lateral sclerosis (ALS), the most frequent adult onset motor neuron disease, is associated with hypermetabolism linked to defects in muscle mitochondrial energy metabolism such as ATP depletion and increased oxygen consumption. It remains unknown whether muscle abnormalities in energy metabolism are causally involved in the destruction of neuromuscular junction (NMJ) and subsequent motor neuron degeneration during ALS. Methodology/Principal Findings: We studied transgenic mice with muscular overexpression of uncoupling protein 1 (UCP1), a potent mitochondrial uncoupler, as a model of muscle restricted hypermetabolism. These animals displayed age-dependent deterioration of the NMJ that correlated with progressive signs of denervation and a mild late-onset motor neuron pathology. NMJ regeneration and functional recovery were profoundly delayed following injury of the sciatic nerve and muscle mitochondrial uncoupling exacerbated the pathology of an ALS animal model. Conclusions/Significance: These findings provide the proof of principle that a muscle restricted mitochondrial defect is sufficient to generate motor neuron degeneration and suggest that therapeutic strategies targeted at muscle metabolism might prove useful for motor neuron diseases.			Dupuis, L (corresponding author), INSERM, Lab Signalisat Mol & Neurodegenerescence, U692, Strasbourg, France.	ldupuis@unistra.fr; loeffler@unistra.fr	Bouillaud, Frédéric R/L-3238-2017; Dupuis, Luc/A-6981-2012; LOEFFLER, Jean-Philippe/AAS-4401-2020	Bouillaud, Frédéric R/0000-0002-7518-9237; schaeffer, laurent/0000-0001-6600-503X; Dupuis, Luc/0000-0002-0902-5824				Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Couplan E, 2002, J BIOL CHEM, V277, P43079, DOI 10.1074/jbc.M206726200; De Souza AS, 2004, J NEUROTRAUM, V21, P627, DOI 10.1089/089771504774129955; DEAGUILAR JLG, 2007, J NEUROCHEM; Desport JC, 2001, AM J CLIN NUTR, V74, P328; Desport JC, 2005, NEURODEGENER DIS, V2, P202, DOI 10.1159/000089626; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2003, FASEB J, V17, P2091, DOI 10.1096/fj.02-1182fje; Dupuis L, 2002, NEUROBIOL DIS, V10, P358, DOI 10.1006/nbdi.2002.0522; Dupuis L, 2000, NEUROBIOL DIS, V7, P274, DOI 10.1006/nbdi.2000.0292; DUPUIS L, 2008, NEUROLOGY; Dupuis L, 2004, NEURODEGENER DIS, V1, P245, DOI 10.1159/000085063; Fergani A, 2007, J LIPID RES, V48, P1571, DOI 10.1194/jlr.M700017-JLR200; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; FUNALOT B, 2008, AMYOTROPH LATERAL SC, P1; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hamer PW, 2002, J ANAT, V200, P69, DOI 10.1046/j.0021-8782.2001.00008.x; Han DH, 2004, AM J PHYSIOL-ENDOC M, V286, pE347, DOI 10.1152/ajpendo.00434.2003; Hoerter J, 2004, CIRCULATION, V110, P528, DOI 10.1161/01.CIR.0000137824.30476.0E; Jimenez-Mallebrera C, 2005, CELL MOL LIFE SCI, V62, P809, DOI 10.1007/s00018-004-4510-4; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Mattson MP, 2007, NEUROMOL MED, V9, P17, DOI 10.1385/NMM:9:1:17; Meier T, 1998, EUR J NEUROSCI, V10, P3141, DOI 10.1046/j.1460-9568.1998.00320.x; Miller TM, 2006, P NATL ACAD SCI USA, V103, P19546, DOI 10.1073/pnas.0609411103; Pedersen WA, 1999, BRAIN RES, V833, P117, DOI 10.1016/S0006-8993(99)01471-7; Ricquier D, 2005, P NUTR SOC, V64, P47, DOI 10.1079/PNS2004408; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007; Towne C, 2008, MOL THER, V16, P1018, DOI 10.1038/mt.2008.73; You SJ, 1997, GLIA, V20, P87, DOI 10.1002/(SICI)1098-1136(199706)20:2<87::AID-GLIA1>3.0.CO;2-1	34	153	157	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5390	10.1371/journal.pone.0005390	http://dx.doi.org/10.1371/journal.pone.0005390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404401	gold, Green Published, Green Submitted			2022-12-27	WOS:000265614900007
J	Ferrara, G; Argenyi, Z; Argenziano, G; Cerio, R; Cerroni, L; Di Blasi, A; Feudale, EAA; Giorgio, CM; Massone, C; Nappi, O; Tomasini, C; Urso, C; Zalaudek, I; Kittler, H; Soyer, HP				Ferrara, Gerardo; Argenyi, Zsolt; Argenziano, Giuseppe; Cerio, Rino; Cerroni, Lorenzo; Di Blasi, Arturo; Feudale, Elisa A. A.; Giorgio, Caterina M.; Massone, Cesare; Nappi, Oscar; Tomasini, Carlo; Urso, Carmelo; Zalaudek, Iris; Kittler, Harald; Soyer, H. Peter			The Influence of Clinical Information in the Histopathologic Diagnosis of Melanocytic Skin Neoplasms	PLOS ONE			English	Article							MELANOMA; LESIONS; ACCURACY; HISTORY; READ; NEVI	Background: We tested the relevance of clinical information in the histopathologic evaluation of melanocytic skin neoplasm (MSN). Methods: Histopathologic specimens from 99 clinically atypical MSN were circulated among ten histopathologists; each case had clinical information available in a database with a five-step procedure (no information; age/sex/location; clinical diagnosis; clinical image; dermoscopic image); each step had a histopathologic diagnosis (D1 through D5); each diagnostic step had a level of diagnostic confidence (LDC) ranging from 1 (no diagnostic certainty) to 5 (absolute diagnostic certainty). The comparison of the LDC was employed with an analysis of variance (ANOVA) for repeated measures. Findings: In D1 (no information), 36/99 cases (36.3%) had unanimous diagnosis; in D5 (full information available), 51/99 cases (51.5%) had unanimous diagnosis (p for difference between proportions <0.001). The observer agreement expressed as kappa increased significantly from D1 to D5. The mean LDC linearly increased for each observer from D1 through D5 (p for linear trend <0.001). On average, each histopathologist changed his initial diagnosis in 7 cases (range: 2-23). Most diagnostic changes were in D2 (age/sex/location). Interpretation: The histopathologic criteria for the diagnosis of MSN can work as such, but the final histopathologic diagnosis is a clinically-aided interpretation. Clinical data sometimes reverse the initial histopathologic evaluation.			Ferrara, G (corresponding author), Gaetano Rummo Gen Hosp, Dept Pathol, Benevento, Italy.	p.soyer@uq.edu.au	Zalaudek, Iris/AAL-5436-2020; Zalaudek, Iris/E-5910-2010; Soyer, H. Peter/W-3791-2017; Kittler, Harald/K-7574-2013; Argenziano, Giuseppe/E-5926-2010; Soyer, H. Peter/E-6000-2010; Kittler, Harald/AAK-1502-2020	Zalaudek, Iris/0000-0002-7878-4955; Zalaudek, Iris/0000-0002-7878-4955; Soyer, H. Peter/0000-0002-4770-561X; Argenziano, Giuseppe/0000-0003-1413-8214; Soyer, H. Peter/0000-0002-4770-561X; KITTLER, HARALD/0000-0002-0051-8016; URSO, CARMELO/0000-0002-3746-2917; massone, cesare/0000-0002-0996-643X				Abbey LM, 1998, ORAL SURG ORAL MED O, V85, P74, DOI 10.1016/S1079-2104(98)90401-2; Argenziano G, 2006, J CLIN ONCOL, V24, P1877, DOI 10.1200/JCO.2005.05.0864; Argenziano G, 2000, INTERACTIVE ATLAS DE; Barnhill RL, 2006, AM J DERMATOPATH, V28, P75, DOI 10.1097/01.dad.0000188868.19869.3b; Bauer J, 2001, ARCH DERMATOL, V137, P1338; Cerroni L, 2001, AM J DERMATOPATH, V23, P370, DOI 10.1097/00000372-200108000-00015; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Corona R, 1996, J CLIN ONCOL, V14, P1218, DOI 10.1200/JCO.1996.14.4.1218; Drut R, 1999, PEDIATR DEVEL PATHOL, V2, P473, DOI 10.1007/s100249900151; Elder DE, 2004, PATHOLOGY, V36, P428, DOI 10.1080/00313020412331283905; Farmer ER, 1996, HUM PATHOL, V27, P528, DOI 10.1016/S0046-8177(96)90157-4; Ferrara G, 2008, HISTOPATHOLOGY, V52, P523, DOI 10.1111/j.1365-2559.2008.02943.x; Ferrara G, 2005, ARCH DERMATOL, V141, P1381, DOI 10.1001/archderm.141.11.1381; Ferrara G, 2004, J TELEMED TELECARE, V10, P34, DOI 10.1258/135763304322764176; Ferrara G, 2002, CANCER, V95, P1094, DOI 10.1002/cncr.10768; Ferrara G, 2002, CLIN DERMATOL, V20, P228, DOI 10.1016/S0738-081X(02)00230-4; FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106; Fleiss JL, 1981, STAT METHODS RATES P, P2; Griscom NT, 2002, RADIOLOGY, V223, P9, DOI 10.1148/radiol.2231011274; Lowes M A, 2000, Australas J Dermatol, V41, P109, DOI 10.1046/j.1440-0960.2000.00406.x; Loy CT, 2004, JAMA-J AM MED ASSOC, V292, P1602, DOI 10.1001/jama.292.13.1602; Meghini C., 1993, SIGIR Forum, P298; Raab SS, 2000, AM J CLIN PATHOL, V114, P78, DOI 10.1309/4099-QALD-NVGF-TM4G; SCHREIBER MH, 1963, JAMA-J AM MED ASSOC, V185, P399, DOI 10.1001/jama.1963.03060050077027; SHITABATA PK, DO CLIN HIST SUBMITT; Soyer HP, 2005, ARCH DERMATOL, V141, P209, DOI 10.1001/archderm.141.2.209; SOYER HP, 1989, AM J DERMATOPATH, V11, P1, DOI 10.1097/00000372-198902000-00001; Soyer HP, 2000, EUR J DERMATOL, V10, P22; Weedon D, 2002, SKIN PATHOLOGY, P803; Zalaudek I, 2004, BRIT J DERMATOL, V150, P64, DOI 10.1111/j.1365-2133.2004.05657.x	31	53	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5375	10.1371/journal.pone.0005375	http://dx.doi.org/10.1371/journal.pone.0005375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404399	Green Submitted, gold, Green Published			2022-12-27	WOS:000265614900003
J	Friedman, S; Lu, M; Schultz, A; Thomas, D; Lin, RY				Friedman, Susan; Lu, Min; Schultz, Atara; Thomas, Dolly; Lin, Reigh-Yi			CD133(+) Anaplastic Thyroid Cancer Cells Initiate Tumors in Immunodeficient Mice and Are Regulated by Thyrotropin	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; STEM-LIKE CELLS; HEMATOPOIETIC STEM; IDENTIFICATION; EXPRESSION; MARKER; GENE; LINE	Background: Anaplastic thyroid cancer (ATC) is one of the most lethal human malignancies. Its rapid onset and resistance to conventional therapeutics contribute to a mean survival of six months after diagnosis and make the identification of thyroid-cancer-initiating cells increasingly important. Methodology/Principal Findings: In prior studies of ATC cell lines, CD133(+) cells exhibited stem-cell-like features such as high proliferation, self-renewal and colony-forming ability in vitro. Here we show that transplantation of CD133(+) cells, but not CD133(-) cells, into immunodeficient NOD/SCID mice is sufficient to induce growth of tumors in vivo. We also describe how the proportion of ATC cells that are CD133(+) increases dramatically over three months of culture, from 7% to more than 80% of the total. This CD133(+) cell pool can be further separated by flow cytometry into two distinct populations: CD133(+/high) and CD133(+/low). Although both subsets are capable of long-term tumorigenesis, the rapidly proliferating CD133(+/high) cells are by far the most efficient. They also express high levels of the stem cell antigen Oct4 and the receptor for thyroid stimulating hormone, TSHR. Treating ATC cells with TSH causes a three-fold increase in the numbers of CD133(+) cells and elicits a dose-dependent up-regulation of the expression of TSHR and Oct4 in these cells. More importantly, immunohistochemical analysis of tissue specimens from ATC patients indicates that CD133 is highly expressed on tumor cells but not on neighboring normal thyroid cells. Conclusions/Significance: To our knowledge, this is the first report indicating that CD133(+) ATC cells are solely responsible for tumor growth in immunodeficient mice. Our data also give a unique insight into the regulation of CD133 by TSH. These highly tumorigenic CD133(+) cells and the activated TSH signaling pathway may be useful targets for future ATC therapies.			Friedman, S (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY USA.	reigh-yi.lin@mssm.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068057] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK068057] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*ACS, 2008, CANC FACTS FIG; Ahn SH, 2008, ARCH OTOLARYNGOL, V134, P190, DOI 10.1001/archoto.2007.36; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Chen ST, 2002, J ENDOCRINOL, V175, P459, DOI 10.1677/joe.0.1750459; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; De Falco V, 2007, CANCER RES, V67, P11821, DOI 10.1158/0008-5472.CAN-07-0899; De Vita G, 2005, MOL ENDOCRINOL, V19, P76, DOI 10.1210/me.2004-0172; Dou J, 2007, CELL MOL IMMUNOL, V4, P467; Fagin JA, 1996, CANCER RES, V56, P765; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; FERRANDINA G, 2007, INT J GYNECOL CANC; Fiore L, 1997, J CLIN ENDOCR METAB, V82, P4094, DOI 10.1210/jc.82.12.4094; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hwang JH, 2003, J CLIN ENDOCR METAB, V88, P408, DOI 10.1210/jc.2002-021381; Katoh Y, 2007, INT J MOL MED, V19, P967; Klein WM, 2007, MODERN PATHOL, V20, P102, DOI 10.1038/modpathol.3800720; Lin RY, 2007, THYROID, V17, P1019, DOI 10.1089/thy.2007.0183; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ma YH, 2008, J NEURO-ONCOL, V86, P31, DOI 10.1007/s11060-007-9439-7; METAYE T, 2008, J ENDOCRINOL; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Piccirillo SGM, 2007, ERNST SCHERING FOUND, V5, P59, DOI 10.1007/2789_2007_044; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Pierie JPEN, 2002, ANN SURG ONCOL, V9, P57, DOI 10.1245/aso.2002.9.1.57; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rountree CB, 2008, HEPATOLOGY, V47, P1288, DOI 10.1002/hep.22141; Schuppert F, 1996, THYROID, V6, P575, DOI 10.1089/thy.1996.6.575; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh SK, 2003, CANCER RES, V63, P5821; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Thomas D, 2008, ENDOCR-RELAT CANCER, V15, P51, DOI 10.1677/ERC-07-0210; van Staveren WCG, 2007, CANCER RES, V67, P8113, DOI 10.1158/0008-5472.CAN-06-4026; Yano Y, 2007, ONCOL REP, V18, P441; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zito G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003544	41	61	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5395	10.1371/journal.pone.0005395	http://dx.doi.org/10.1371/journal.pone.0005395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404394	Green Published, gold, Green Submitted			2022-12-27	WOS:000265614900009
J	Cai, X; Nash, Z; Conley, SM; Fliesler, SJ; Cooper, MJ; Naash, MI				Cai, Xue; Nash, Zack; Conley, Shannon M.; Fliesler, Steven J.; Cooper, Mark J.; Naash, Muna I.			A Partial Structural and Functional Rescue of a Retinitis Pigmentosa Model with Compacted DNA Nanoparticles	PLOS ONE			English	Article								Previously we have shown that compacted DNA nanoparticles can drive high levels of transgene expression after subretinal injection in the mouse eye. Here we delivered compacted DNA nanoparticles containing a therapeutic gene to the retinas of a mouse model of retinitis pigmentosa. Nanoparticles containing the wild-type retinal degeneration slow (Rds) gene were injected into the subretinal space of rds(+/-) mice on postnatal day 5. Gene expression was sustained for up to four months at levels up to four times higher than in controls injected with saline or naked DNA. The nanoparticles were taken up into virtually all photoreceptors and mediated significant structural and biochemical rescue of the disease without histological or functional evidence of toxicity. Electroretinogram recordings showed that nanoparticle-mediated gene transfer restored cone function to a near-normal level in contrast to transfer of naked plasmid DNA. Rod function was also improved. These findings demonstrate that compacted DNA nanoparticles represent a viable option for development of gene-based interventions for ocular diseases and obviate major barriers commonly encountered with non-viral based therapies.			Cai, X (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA.	muna-naash@ouhsc.edu	Fliesler, Steven J./AAE-9243-2020	Fliesler, Steven/0000-0002-2557-142X	NATIONAL EYE INSTITUTE [R01EY007361, R55EY010609, R01EY018656, R56EY010609, R01EY010609] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY018656, R01 EY010609, EY018656, R01 EY007361, EY007361, R01 EY018656-02, R01 EY010609-09, EY10609, R56 EY010609] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Cai X, 2008, VISION RES, V48, P319, DOI 10.1016/j.visres.2007.07.012; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen X, 2008, MOL THER, V16, P333, DOI 10.1038/sj.mt.6300365; Cheng T, 1997, J NEUROSCI, V17, P8118, DOI 10.1523/jneurosci.17-21-08118.1997; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; CONNELL GJ, 1990, BIOCHEMISTRY-US, V29, P4691, DOI 10.1021/bi00471a025; COOPER MJ, 2007, MOL THERAPY S, V15, P315; Davis PB, 2007, AAPS J, V9, pE11, DOI 10.1208/aapsj0901002; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Farjo R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000038; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; Fink TL, 2006, GENE THER, V13, P1048, DOI 10.1038/sj.gt.3302761; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Kedzierski W, 1999, J NEUROCHEM, V72, P430, DOI 10.1046/j.1471-4159.1999.0720430.x; Khoubian FJ, 2005, RETINA-J RET VIT DIS, V25, P999, DOI 10.1097/00006982-200512000-00008; Konstan MW, 2004, HUM GENE THER, V15, P1255, DOI 10.1089/hum.2004.15.1255; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; LAM BL, 1995, AM J OPHTHALMOL, V119, P65, DOI 10.1016/S0002-9394(14)73815-2; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Li C, 2003, INVEST OPHTH VIS SCI, V44, P2433, DOI 10.1167/iovs.02-1152; Li CB, 2001, OPTOMETRY VISION SCI, V78, P425, DOI 10.1097/00006324-200106000-00015; LIOU GI, 1990, J BIOL CHEM, V265, P8373; Liu G, 2003, J BIOL CHEM, V278, P32578, DOI 10.1074/jbc.M305776200; Luo D, 2000, NAT BIOTECHNOL, V18, P893, DOI 10.1038/78523; MA JS, 1995, GENOMICS, V28, P212, DOI 10.1006/geno.1995.1133; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Nour M, 2004, INVEST OPHTH VIS SCI, V45, P2514, DOI 10.1167/iovs.04-0065; Nour M, 2003, INVEST OPHTH VIS SCI, V44, P4505, DOI 10.1167/iovs.03-0453; Pang JJ, 2006, MOL VIS, V12, P756; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Sarra GM, 2001, HUM MOL GENET, V10, P2353, DOI 10.1093/hmg/10.21.2353; Schlichtenbrede FC, 2003, J GENE MED, V5, P757, DOI 10.1002/jgm.401; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; YUREK DM, 2005, MOL THERAPUETICS, V11, pS253; Ziady AG, 2003, MOL THER, V8, P936, DOI 10.1016/j.ymthe.2003.07.007; Ziady AG, 2003, MOL THER, V8, P948, DOI 10.1016/j.ymthe.2003.09.002	50	82	85	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5290	10.1371/journal.pone.0005290	http://dx.doi.org/10.1371/journal.pone.0005290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390689	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514400001
J	Page, N; Schall, N; Strub, JM; Quinternet, M; Chaloin, O; Decossas, M; Cung, MT; Van Dorsselaer, A; Briand, JP; Muller, S				Page, Nicolas; Schall, Nicolas; Strub, Jean-Marc; Quinternet, Marc; Chaloin, Olivier; Decossas, Marion; Cung, Manh Thong; Van Dorsselaer, Alain; Briand, Jean-Paul; Muller, Sylviane			The Spliceosomal Phosphopeptide P140 Controls the Lupus Disease by Interacting with the HSC70 Protein and via a Mechanism Mediated by gamma delta T Cells	PLOS ONE			English	Article								The phosphopeptide P140 issued from the spliceosomal U1-70K snRNP protein is recognized by lupus CD4(+) T cells, transiently abolishes T cell reactivity to other spliceosomal peptides in P140-treated MRL/lpr mice, and ameliorates their clinical features. P140 modulates lupus patients' T cell response ex vivo and is currently included in phase IIb clinical trials. Its underlying mechanism of action remains elusive. Here we show that P140 peptide binds a unique cell-surface receptor, the constitutively-expressed chaperone HSC70 protein, known as a presenting-protein. P140 induces apoptosis of activated MRL/lpr CD4(+) T cells. In P140-treated mice, it increases peripheral blood lymphocyte apoptosis and decreases B cell, activated T cell, and CD4(-)CD8(-)B220(+) T cell counts via a specific mechanism strictly depending on gamma delta T cells. Expression of inflammation-linked genes is rapidly regulated in CD4(+) T cells. This work led us to identify a powerful pathway taken by a newly-designed therapeutic peptide to immunomodulate lupus autoimmunity.			Page, N (corresponding author), Inst Biol Mol & Cellulaire, CNRS, UPR9021, F-67084 Strasbourg, France.	s.muller@ibmc.u-strasbg.fr	Muller, Sylviane/J-5319-2014	Strub, Jean-Marc/0000-0001-6224-3428; decossas, marion/0000-0003-0810-4309; QUINTERNET, Marc/0000-0002-8299-7136				Auger I, 1996, NAT MED, V2, P306, DOI 10.1038/nm0396-306; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Callebaut C, 1997, J BIOL CHEM, V272, P7159, DOI 10.1074/jbc.272.11.7159; Catusse J, 2008, P NATL ACAD SCI USA, V105, P10262, DOI 10.1073/pnas.0800585105; CLORE GM, 1986, J MOL BIOL, V191, P523, DOI 10.1016/0022-2836(86)90146-4; Craft J, 1999, IMMUNOL RES, V19, P245, DOI 10.1007/BF02786492; Diegel ML, 2002, INT IMMUNOPHARMACOL, V2, P1451, DOI 10.1016/S1567-5769(02)00090-5; Ellis S, 2000, J HISTOCHEM CYTOCHEM, V48, P321, DOI 10.1177/002215540004800302; Fournel S, 2005, NAT CHEM BIOL, V1, P377, DOI 10.1038/nchembio746; GOODMAN T, 1989, J EXP MED, V170, P1569, DOI 10.1084/jem.170.5.1569; Goulvestre C, 2005, J IMMUNOL, V175, P6959, DOI 10.4049/jimmunol.175.10.6959; GRONENBORN AM, 1995, CRIT REV BIOCHEM MOL, V30, P351, DOI 10.3109/10409239509083489; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; ITO S, 1990, CLIN EXP IMMUNOL, V81, P446; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUMAR A, 1981, J AM CHEM SOC, V103, P3654, DOI 10.1021/ja00403a008; Lorenz HM, 2005, ANN RHEUM DIS, V64, P1517, DOI 10.1136/ard.2005.035329; LUNARDI C, 1991, CLIN EXP IMMUNOL, V86, P203; MANDELL RB, 1992, EXP CELL RES, V198, P164, DOI 10.1016/0014-4827(92)90163-3; Monneaux F, 2000, EUR J IMMUNOL, V30, P2191; Monneaux F, 2005, J IMMUNOL, V175, P5839, DOI 10.4049/jimmunol.175.9.5839; Monneaux F, 2004, ARTHRITIS RHEUM-US, V50, P3232, DOI 10.1002/art.20510; Monneaux F, 2003, EUR J IMMUNOL, V33, P287, DOI 10.1002/immu.200310002; Monneaux F, 2001, INT IMMUNOL, V13, P1155, DOI 10.1093/intimm/13.9.1155; Monneaux F, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2317; Muller S, 2008, ARTHRITIS RHEUM-US, V58, P3873, DOI 10.1002/art.24027; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; Nisole S, 1999, J BIOL CHEM, V274, P27875, DOI 10.1074/jbc.274.39.27875; O'Brien RL, 2007, IMMUNOL REV, V215, P77, DOI 10.1111/j.1600-065X.2006.00477.x; Panjwani N, 1999, J IMMUNOL, V163, P1936; PARK K, 1993, PROTEIN SCI, V2, P325; Peng SL, 1996, J IMMUNOL, V157, P5689; PETERMAN GM, 1993, J IMMUNOL, V151, P6546; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Renno T, 1998, EUR J IMMUNOL, V28, P540, DOI 10.1002/(SICI)1521-4141(199802)28:02<540::AID-IMMU540>3.3.CO;2-P; Riccieri V, 2000, LUPUS, V9, P333, DOI 10.1191/096120300678828460; Robak E, 2001, MEDIAT INFLAMM, V10, P179, DOI 10.1080/09629350120080300; Rus V, 2007, J IMMUNOL, V178, P3962, DOI 10.4049/jimmunol.178.6.3962; SCHEEK RM, 1989, METHOD ENZYMOL, V177, P204; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; SKOURI M, 1991, FEBS LETT, V295, P84, DOI 10.1016/0014-5793(91)81391-K; TAMURA Y, 1993, J IMMUNOL, V151, P5516; Thedrez A, 2007, IMMUNOL REV, V215, P123, DOI 10.1111/j.1600-065X.2006.00468.x; Watanabe H, 1998, CLIN IMMUNOL IMMUNOP, V88, P91, DOI 10.1006/clin.1998.4553; Wei YQ, 1996, CANCER RES, V56, P1104; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Yi YJ, 2000, J IMMUNOL, V165, P6627, DOI 10.4049/jimmunol.165.11.6627	54	51	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5273	10.1371/journal.pone.0005273	http://dx.doi.org/10.1371/journal.pone.0005273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390596	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514200006
J	Pasupuleti, M; Schmidtchen, A; Chalupka, A; Ringstad, L; Malmsten, M				Pasupuleti, Mukesh; Schmidtchen, Artur; Chalupka, Anna; Ringstad, Lovisa; Malmsten, Martin			End-Tagging of Ultra-Short Antimicrobial Peptides by W/F Stretches to Facilitate Bacterial Killing	PLOS ONE			English	Article								Background: Due to increasing resistance development among bacteria, antimicrobial peptides (AMPs), are receiving increased attention. Ideally, AMP should display high bactericidal potency, but low toxicity against (human) eukaryotic cells. Additionally, short and proteolytically stable AMPs are desired to maximize bioavailability and therapeutic versatility. Methodology and Principal Findings: A facile approach is demonstrated for reaching high potency of ultra-short antimicrobal peptides through end-tagging with W and F stretches. Focusing on a peptide derived from kininogen, KNKGKKNGKH (KNK10) and truncations thereof, end-tagging resulted in enhanced bactericidal effect against Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus. Through end-tagging, potency and salt resistance could be maintained down to 4-7 amino acids in the hydrophilic template peptide. Although tagging resulted in increased eukaryotic cell permeabilization at low ionic strength, the latter was insignificant at physiological ionic strength and in the presence of serum. Quantitatively, the most potent peptides investigated displayed bactericidal effects comparable to, or in excess of, that of the benchmark antimicrobial peptide LL-37. The higher bactericidal potency of the tagged peptides correlated to a higher degree of binding to bacteria, and resulting bacterial wall rupture. Analogously, tagging enhanced peptide-induced rupture of liposomes, particularly anionic ones. Additionally, end-tagging facilitated binding to bacterial lipopolysaccharide, both effects probably contributing to the selectivity displayed by these peptides between bacteria and eukaryotic cells. Importantly, W-tagging resulted in peptides with maintained stability against proteolytic degradation by human leukocyte elastase, as well as staphylococcal aureolysin and V8 proteinase. The biological relevance of these findings was demonstrated ex vivo for pig skin infected by S. aureus and E. coli. Conclusions/Significance: End-tagging by hydrophobic amino acid stretches may be employed to enhance bactericidal potency also of ultra-short AMPs at maintained limited toxicity. The approach is of general applicability, and facilitates straightforward synthesis of hydrophobically modified AMPs without the need for post-peptide synthesis modifications.			Pasupuleti, M (corresponding author), Lund Univ, Dept Clin Sci, Sect Dermatol & Venereol, Lund, Sweden.	martin.malmsten@farmaci.uu.se	Pasupuleti, Mukesh/AAF-4066-2020; Pasupuleti, Mukesh/H-7605-2013; Schmidtchen, Artur/F-9507-2015; Pasupuleti, Mukesh/AAD-9977-2020	Pasupuleti, Mukesh/0000-0001-6337-6257; 				Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Avrahami D, 2004, J BIOL CHEM, V279, P12277, DOI 10.1074/jbc.M312260200; Avrahami D, 2003, BIOCHEMISTRY-US, V42, P14946, DOI 10.1021/bi035142v; Avrahami D, 2002, BIOCHEMISTRY-US, V41, P2254, DOI 10.1021/bi011549t; Bernard P, 2008, CURR OPIN INFECT DIS, V21, P122, DOI 10.1097/QCO.0b013e3282f44c63; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; CHENG F, 1992, GLYCOBIOLOGY, V2, P553, DOI 10.1093/glycob/2.6.553; Costa MC, 2007, J CHEM ENG DATA, V52, P30, DOI 10.1021/je060146z; del Rio G, 2001, FEBS LETT, V494, P213, DOI 10.1016/S0014-5793(01)02348-1; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005; EMBER JA, 1991, BIOCHEMISTRY-US, V30, P3603, DOI 10.1021/bi00229a003; Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haney EF, 2007, BBA-BIOMEMBRANES, V1768, P2355, DOI 10.1016/j.bbamem.2007.04.018; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Javadpour MM, 1996, J MED CHEM, V39, P3107, DOI 10.1021/jm9509410; Jenssen H, 2007, CHEM BIOL DRUG DES, V70, P134, DOI 10.1111/j.1747-0285.2007.00543.x; Jerala R, 2007, EXPERT OPIN INV DRUG, V16, P1159, DOI 10.1517/13543784.16.8.1159; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Li X, 2006, BBA-BIOMEMBRANES, V1758, P1203, DOI 10.1016/j.bbamem.2006.03.032; Lorenz D, 1998, J GEN PHYSIOL, V112, P577, DOI 10.1085/jgp.112.5.577; Makovitzki A, 2005, BIOCHEMISTRY-US, V44, P9775, DOI 10.1021/bi0502386; Makovitzki A, 2008, BIOCHEMISTRY-US, V47, P10630, DOI 10.1021/bi8011675; Malmsten M, 1996, J COLLOID INTERF SCI, V178, P160, DOI 10.1006/jcis.1996.0104; Malmsten M, 1998, J COLLOID INTERF SCI, V204, P104, DOI 10.1006/jcis.1998.5568; Malmsten M, 2007, GROWTH FACTORS, V25, P60, DOI 10.1080/08977190701344120; Malmsten M, 2006, MATRIX BIOL, V25, P294, DOI 10.1016/j.matbio.2006.04.003; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; McDonnell G, 1999, J MICROBIOL METH, V35, P31, DOI 10.1016/S0167-7012(98)00094-3; McInturff JE, 2005, J INVEST DERMATOL, V125, P256, DOI 10.1111/j.0022-202X.2005.23805.x; Nell MJ, 2006, PEPTIDES, V27, P649, DOI 10.1016/j.peptides.2005.09.016; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; Pasupuleti M, 2008, BIOCHEMISTRY-US, V47, P9057, DOI 10.1021/bi800991e; Pasupuleti M, 2007, J BIOL CHEM, V282, P2520, DOI 10.1074/jbc.M607848200; Petersen FNR, 2005, BIOPHYS J, V89, P3985, DOI 10.1529/biophysj.105.061804; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Ringstad L, 2008, LANGMUIR, V24, P208, DOI 10.1021/la702538k; Ringstad L, 2007, BBA-BIOMEMBRANES, V1768, P715, DOI 10.1016/j.bbamem.2006.11.016; Ringstad L, 2006, LANGMUIR, V22, P5042, DOI 10.1021/la060317y; Ringstad L, 2007, BIOPHYS J, V92, P87, DOI 10.1529/biophysj.106.088161; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; SCHMIDTCHEN A, 2008, J BIOL CHEM; Sonesson A, 2007, BBA-BIOMEMBRANES, V1768, P346, DOI 10.1016/j.bbamem.2006.10.017; Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009; Taboureau O, 2006, CHEM BIOL DRUG DES, V68, P48, DOI 10.1111/j.1747-0285.2006.00405.x; Toke O, 2005, BIOPOLYMERS, V80, P717, DOI 10.1002/bip.20286; Tossi A, 2000, BIOPOLYMERS, V55, P4; Tourmousoglou CE, 2008, J CHEMOTHERAPY, V20, P312, DOI 10.1179/joc.2008.20.3.312; ULEVITCH RJ, 1978, IMMUNOCHEMISTRY, V15, P157, DOI 10.1016/0161-5890(78)90144-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021; [No title captured]	57	83	86	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5285	10.1371/journal.pone.0005285	http://dx.doi.org/10.1371/journal.pone.0005285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381271	Green Published, Green Submitted, gold			2022-12-27	WOS:000265510800014
J	Laufer, S; Rubinsky, B				Laufer, Shlomi; Rubinsky, Boris			Cellular Phone Enabled Non-Invasive Tissue Classifier	PLOS ONE			English	Article							ELECTRICAL-IMPEDANCE MEASUREMENTS; DIELECTRIC-PROPERTIES; TRANSMISSION; PARAMETERS	Cellular phone technology is emerging as an important tool in the effort to provide advanced medical care to the majority of the world population currently without access to such care. In this study, we show that non-invasive electrical measurements and the use of classifier software can be combined with cellular phone technology to produce inexpensive tissue characterization. This concept was demonstrated by the use of a Support Vector Machine (SVM) classifier to distinguish through the cellular phone between heart and kidney tissue via the non-invasive multi-frequency electrical measurements acquired around the tissues. After the measurements were performed at a remote site, the raw data were transmitted through the cellular phone to a central computational site and the classifier was applied to the raw data. The results of the tissue analysis were returned to the remote data measurement site. The classifiers correctly determined the tissue type with a specificity of over 90%. When used for the detection of malignant tumors, classifiers can be designed to produce false positives in order to ensure that no tumors will be missed. This mode of operation has applications in remote non-invasive tissue diagnostics in situ in the body, in combination with medical imaging, as well as in remote diagnostics of biopsy samples in vitro.			Laufer, S (corresponding author), Hebrew Univ Jerusalem, Sch Comp Sci & Engn, Ctr Bioengn, Serv Humanity & Soc, Jerusalem, Israel.	Shlomi.laufer@mail.huji.ac.il	Rubinsky, Boris/B-4439-2010	Rubinsky, Boris/0000-0002-2794-1543; Laufer, Shlomi/0000-0003-1469-5985				Bazzani A, 2001, PHYS MED BIOL, V46, P1651, DOI 10.1088/0031-9155/46/6/305; BLANZ V, 1996, COMP VIEW BASED OBJE, P251; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chiracharit W, 2004, P ANN INT IEEE EMBS, V26, P1581; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Gabriel S, 1996, PHYS MED BIOL, V41, P2271, DOI 10.1088/0031-9155/41/11/003; Gallego JR, 2005, IEEE T INF TECHNOL B, V9, P13, DOI 10.1109/TITB.2004.838362; Glickman YA, 2002, IEEE T MED IMAGING, V21, P710, DOI 10.1109/TMI.2002.800605; Granot Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002075; Gunn S. R., 1998, ISIS TECH REP, V14, P5; Halter RJ, 2008, PHYSIOL MEAS, V29, pS111, DOI 10.1088/0967-3334/29/6/S10; HWAN CM, 2007, BIOMEDICAL ENG IEEE, V54, P700; Ivorra A, 2007, BIOELECTROCHEMISTRY, V70, P287, DOI 10.1016/j.bioelechem.2006.10.005; Joachims T., 1999, ADV KERNEL METHODS S; Joachims T., 1998, EUROPEAN C MACHINE L, V1398, P137, DOI [DOI 10.1007/BFB0026683, 10.1007/BFb0026683]; Jossinet J, 1999, ANN NY ACAD SCI, V873, P30, DOI 10.1111/j.1749-6632.1999.tb09446.x; Jossinet J, 1996, MED BIOL ENG COMPUT, V34, P346, DOI 10.1007/BF02520002; KIMURA S, 1994, CHEST, V105, P1679, DOI 10.1378/chest.105.6.1679; Kumar S, 2008, INT J TELEMED APPL, V2008, DOI 10.1155/2008/459185; LAUFER S, 2008, BIOMEDICAL IN PRESS; Osuna E, 1997, NEURAL NETWORKS FOR SIGNAL PROCESSING VII, P276, DOI 10.1109/NNSP.1997.622408; Otten DM, 2004, TECHNOL CANCER RES T, V3, P125, DOI 10.1177/153303460400300205; Rashvand HF, 2008, IET COMMUN, V2, P237, DOI 10.1049/iet-com:20070361; Rasid MFA, 2005, IEEE T INF TECHNOL B, V9, P35, DOI 10.1109/TITB.2004.840070; RIGAUD B, 1995, PHYSIOL MEAS, V16, pA15, DOI 10.1088/0967-3334/16/3A/002; RUBINSKY BA, 2004, METHOD APPARATUS REM; SCHMIDT MS, IDENTIFYING SPEAKERS; Scholkopf B., 2002, LEARNING KERNELS SUP, P626; SUROWIEC AJ, 1988, IEEE T BIO-MED ENG, V35, P257, DOI 10.1109/10.1374; Vapnik V, 2000, NEURAL COMPUT, V12, P2013, DOI 10.1162/089976600300015042; Vapnik V., 1995, NATURE STAT LEARNING, P188	31	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5178	10.1371/journal.pone.0005178	http://dx.doi.org/10.1371/journal.pone.0005178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365554	Green Submitted, Green Published, gold			2022-12-27	WOS:000265509900008
J	Kibuuka, H; Guwatudde, D; Kimutai, R; Maganga, L; Maboko, L; Watyema, C; Sawe, F; Shaffer, D; Matsiko, D; Millard, M; Michael, N; Wabwire-Mangen, F; Robb, M				Kibuuka, Hannah; Guwatudde, David; Kimutai, Robert; Maganga, Lucas; Maboko, Leonard; Watyema, Cecilia; Sawe, Fredrick; Shaffer, Douglas; Matsiko, Dickson; Millard, Monica; Michael, Nelson; Wabwire-Mangen, Fred; Robb, Merlin			Contraceptive Use in Women Enrolled into Preventive HIV Vaccine Trials: Experience from a Phase I/II Trial in East Africa	PLOS ONE			English	Article								Background: HIV vaccine trials generally require that pregnant women are excluded from participation, and contraceptive methods must be used to prevent pregnancy during the trial. However, access to quality services and misconceptions associated with contraceptive methods may impact on their effective use in developing countries. We describe the pattern of contraceptive use in a multi-site phase I/IIa HIV Vaccine trial in East Africa (Uganda, Kenya and Tanzania) and factors that may have influenced their use during the trial. Methods: Pregnancy prevention counseling was provided to female participants during informed consent process and at each study visit. Participants' methods of contraception used were documented. Methods of contraceptives were provided on site. Pregnancy testing was done at designated visits during the trial. Obstacles to contraceptive use were identified and addressed at each visit. Results: Overall, 103 (31.8%) of a total of 324 enrolled volunteers were females. Female participants were generally young with a mean age of 29(+/- 7.2), married (49.5%) and had less than high school education (62.1%). Hormonal contraceptives were the most common method of contraception (58.3%) followed by condom use (22.3%). The distribution of methods of contraception among the three sites was similar except for more condom use and less abstinence in Uganda. The majority of women (85.4%) reported to contraceptive use prior to screening. The reasons for not using contraception included access to quality services, insufficient knowledge of certain methods, and misconceptions. Conclusion: Although hormonal contraceptives were frequently used by females participating in the vaccine trial, misconceptions and their incorrect use might have led to inconsistent use resulting in undesired pregnancies. The study underscores the need for an integrated approach to pregnancy prevention counseling during HIV vaccine trials.			Kibuuka, H (corresponding author), Makerere Univ, Walter Reed Project, Kampala, Uganda.	hkibuuka@muwrp.org						AGYEI WKA, 1995, J BIOSOC SCI, V27, P47, DOI 10.1017/S0021932000006994; Biddlecom AE, 1998, STUD FAMILY PLANN, V29, P360, DOI 10.2307/172249; CAO H, JID, V15, P887; Guinan M E, 1995, J Am Med Womens Assoc (1972), V50, P74; *INT AIDS VACC IN, 2008, IAVI DAT PREV AIDS V; KAMAU RK, E AFRICAN MED J, V73, P651; Lande R, 2006, POPULATION REPORTS K; Lane T., 2004, INT FAMILY PLANNING, V30; MILLS E, PLOS MED, V3, pE94; NAKKAZI E, 2003, E AFRICAN       0804; RAYMOND EG, SEXUALLY TRANSMITTED, V34, P1035; SEIBER E, 2007, INT FAMILY PLANNING, V33, P177; Trussell J, 2004, CONTRACEPTIVE TECHNO; *UNAIDS WHO, 2006, AIDS EP UPD; WAKASIAKA S, 2005, AIDS VACCINE HDB GLO, P179; Wassenaar DR, 2005, HARVARD HLTH POLICY, V6, P124; Weidle PJ, 2002, LANCET, V359, P2261, DOI 10.1016/S0140-6736(02)09297-8; 2002, WOMEN HIDE CONTRACEP; 2006, FERTILITY RATES UGAN	19	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2009	4	4							e5164	10.1371/journal.pone.0005164	http://dx.doi.org/10.1371/journal.pone.0005164			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437SB	19360102	Green Published, gold, Green Submitted			2022-12-27	WOS:000265506100003
J	Winrow, CJ; Williams, DL; Kasarskis, A; Millstein, J; Laposky, AD; Yang, HS; Mrazek, K; Zhou, L; Owens, JR; Radzicki, D; Preuss, F; Schadt, EE; Shimomura, K; Vitaterna, MH; Zhang, C; Koblan, KS; Renger, JJ; Turek, FW				Winrow, Christopher J.; Williams, Deanna L.; Kasarskis, Andrew; Millstein, Joshua; Laposky, Aaron D.; Yang, He S.; Mrazek, Karrie; Zhou, Lili; Owens, Joseph R.; Radzicki, Daniel; Preuss, Fabian; Schadt, Eric E.; Shimomura, Kazuhiro; Vitaterna, Martha H.; Zhang, Chunsheng; Koblan, Kenneth S.; Renger, John J.; Turek, Fred W.			Uncovering the Genetic Landscape for Multiple Sleep-Wake Traits	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; MEMORY; REM	Despite decades of research in defining sleep-wake properties in mammals, little is known about the nature or identity of genes that regulate sleep, a fundamental behaviour that in humans occupies about one-third of the entire lifespan. While genome-wide association studies in humans and quantitative trait loci (QTL) analyses in mice have identified candidate genes for an increasing number of complex traits and genetic diseases, the resources and time-consuming process necessary for obtaining detailed quantitative data have made sleep seemingly intractable to similar large-scale genomic approaches. Here we describe analysis of 20 sleep-wake traits from 269 mice from a genetically segregating population that reveals 52 significant QTL representing a minimum of 20 genomic loci. While many (28) QTL affected a particular sleep-wake trait (e.g., amount of wake) across the full 24-hr day, other loci only affected a trait in the light or dark period while some loci had opposite effects on the trait during the light vs. dark. Analysis of a dataset for multiple sleep-wake traits led to previously undetected interactions (including the differential genetic control of number and duration of REM bouts), as well as possible shared genetic regulatory mechanisms for seemingly different unrelated sleep-wake traits (e.g., number of arousals and REM latency). Construction of a Bayesian network for sleep-wake traits and loci led to the identification of sub-networks of linkage not detectable in smaller data sets or limited single-trait analyses. For example, the network analyses revealed a novel chain of causal relationships between the chromosome 17@29cM QTL, total amount of wake, and duration of wake bouts in both light and dark periods that implies a mechanism whereby overall sleep need, mediated by this locus, in turn determines the length of each wake bout. Taken together, the present results reveal a complex genetic landscape underlying multiple sleep-wake traits and emphasize the need for a systems biology approach for elucidating the full extent of the genetic regulatory mechanisms of this complex and universal behavior.			Winrow, CJ (corresponding author), Merck Res Labs, Dept Depress & Circadian Rhythms, West Point, PA USA.	fturek@northwestern.edu	Koblan, Kenneth/GPX-3213-2022; Winrow, Christopher/K-1864-2014	Winrow, Christopher/0000-0001-8248-4157; Radzicki, Daniel/0000-0003-0675-2652				Benca RM, 2005, PRINCIPLES PRACTICE, P1311, DOI DOI 10.1016/B0.72.160797.7/50119.1; BOTTCHER SG, 2003, J STAT SOFTW, V8, P1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Carskadon MA, 2005, PRINCIPLES PRACTICE, P13; Cureton E.E., 1983, FACTOR ANAL APPL APP; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; Graves L, 2001, TRENDS NEUROSCI, V24, P237, DOI 10.1016/S0166-2236(00)01744-6; Huber R, 1999, J SLEEP RES, V8, P30; Kwong LN, 2007, GENETICS, V176, P1237, DOI 10.1534/genetics.107.071217; Laposky AD, 2006, AM J PHYSIOL-REG I, V290, pR894, DOI 10.1152/ajpregu.00304.2005; Lee J, 2004, P NATL ACAD SCI USA, V101, P18195, DOI 10.1073/pnas.0408089101; Li Y, 2006, J CHEM INF MODEL, V46, P1742, DOI 10.1021/ci050463u; Maret S, 2005, SCIENCE, V310, P111, DOI 10.1126/science.1117623; McCarley RW, 2007, SLEEP MED, V8, P302, DOI 10.1016/j.sleep.2007.03.005; O'Hara Bruce F., 2007, CNS & Neurological Disorders-Drug Targets, V6, P71, DOI 10.2174/187152707779940745; Peterson MJ, 2006, PSYCHIAT CLIN N AM, V29, P1009, DOI 10.1016/j.psc.2006.09.003; Smith CT, 2004, LEARN MEMORY, V11, P714, DOI 10.1101/lm.74904; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tafti M, 2003, NAT GENET, V34, P320, DOI 10.1038/ng1174; Tafti M, 2002, J APPL PHYSIOL, V92, P1339, DOI 10.1152/japplphysiol.00834.2001; Toth LA, 1999, BEHAV GENET, V29, P329, DOI 10.1023/A:1021609917126; Tucker AM, 2007, J SLEEP RES, V16, P170, DOI 10.1111/j.1365-2869.2007.00594.x; Zhu HQ, 2007, COMPUT BIOL MED, V37, P793, DOI 10.1016/j.compbiomed.2006.08.015	25	28	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2009	4	4							e5161	10.1371/journal.pone.0005161	http://dx.doi.org/10.1371/journal.pone.0005161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437SB	19360106	Green Published, Green Submitted, gold			2022-12-27	WOS:000265506100002
J	Iorns, E; Lord, CJ; Grigoriadis, A; McDonald, S; Fenwick, K; MacKay, A; Mein, CA; Natrajan, R; Savage, K; Tamber, N; Reis, JS; Turner, NC; Ashworth, A				Iorns, Elizabeth; Lord, Christopher J.; Grigoriadis, Anita; McDonald, Sarah; Fenwick, Kerry; MacKay, Alan; Mein, Charles A.; Natrajan, Rachael; Savage, Kay; Tamber, Narinder; Reis-Filho, Jorge S.; Turner, Nicholas C.; Ashworth, Alan			Integrated Functional, Gene Expression and Genomic Analysis for the Identification of Cancer Targets	PLOS ONE			English	Article							BREAST-CANCER; ENDOCRINE THERAPY; BASAL-LIKE; ONCOGENE; PIK3CA; KINASE; AMPLIFICATION; ADDICTION; APOPTOSIS; ILLUMINA	The majority of new drug approvals for cancer are based on existing therapeutic targets. One approach to the identification of novel targets is to perform high-throughput RNA interference (RNAi) cellular viability screens. We describe a novel approach combining RNAi screening in multiple cell lines with gene expression and genomic profiling to identify novel cancer targets. We performed parallel RNAi screens in multiple cancer cell lines to identify genes that are essential for viability in some cell lines but not others, suggesting that these genes constitute key drivers of cellular survival in specific cancer cells. This approach was verified by the identification of PIK3CA, silencing of which was selectively lethal to the MCF7 cell line, which harbours an activating oncogenic PIK3CA mutation. We combined our functional RNAi approach with gene expression and genomic analysis, allowing the identification of several novel kinases, including WEE1, that are essential for viability only in cell lines that have an elevated level of expression of this kinase. Furthermore, we identified a subset of breast tumours that highly express WEE1 suggesting that WEE1 could be a novel therapeutic target in breast cancer. In conclusion, this strategy represents a novel and effective strategy for the identification of functionally important therapeutic targets in cancer.			Iorns, E (corresponding author), Inst Canc Res, Break Breast Canc Res Ctr, London SW3 6JB, England.	alan.ashworth@icr.ac.uk	Lord, Christopher J/B-3295-2012; Lord, Christopher/AAX-7130-2021	Lord, Christopher J/0000-0002-3226-0515; Mein, Charles/0000-0003-0811-9658; Natrajan, Rachael/0000-0002-9987-2946; Grigoriadis, Anita/0000-0003-3434-201X; Turner, Nicholas/0000-0001-8937-0873	Cancer Research UK [A8363] Funding Source: Medline; Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Breast Cancer Now		Abdi Herve, 2007, ENCYCL MEASUR STATIS, V2, P651; ARRIOLA E, 2008, LAB INVEST; ARRIOLA E, 2007, BREAST CANC RES TREA; Arriola E, 2007, LAB INVEST, V87, P75, DOI 10.1038/labinvest.3700495; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Collins I, 2006, NAT CHEM BIOL, V2, P689, DOI 10.1038/nchembio840; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Jonkers J, 2004, CANCER CELL, V6, P535, DOI 10.1016/j.ccr.2004.12.002; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Kawabe T, 2004, MOL CANCER THER, V3, P513; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Ma YY, 2000, ONCOGENE, V19, P2739, DOI 10.1038/sj.onc.1203597; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Palmer BD, 2006, J MED CHEM, V49, P4896, DOI 10.1021/jm0512591; Reis JS, 2005, J PATHOL, V207, P1, DOI 10.1002/path.1806; Rodriguez-Pinilla SM, 2007, J CLIN PATHOL, V60, P1017, DOI 10.1136/jcp.2006.043869; Savage K, 2007, CLIN CANCER RES, V13, P90, DOI 10.1158/1078-0432.CCR-06-1371; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Wu GJ, 2005, BREAST CANCER RES, V7, pR609, DOI 10.1186/bcr1262	37	98	103	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5120	10.1371/journal.pone.0005120	http://dx.doi.org/10.1371/journal.pone.0005120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357772	Green Submitted, gold, Green Published			2022-12-27	WOS:000265505900004
J	Kitamura, N; Araya, R; Kudoh, M; Kishida, H; Kimura, T; Murayama, M; Takashima, A; Sakamaki, Y; Hashikawa, T; Ito, S; Ohtsuki, S; Terasaki, T; Wess, J; Yamada, M				Kitamura, Naohito; Araya, Runa; Kudoh, Moeko; Kishida, Haruo; Kimura, Tetsuya; Murayama, Miyuki; Takashima, Akihiko; Sakamaki, Yuriko; Hashikawa, Tsutomu; Ito, Shingo; Ohtsuki, Sumio; Terasaki, Tetsuya; Wess, Juergen; Yamada, Masahisa			Beneficial Effects of Estrogen in a Mouse Model of Cerebrovascular Insufficiency	PLOS ONE			English	Article								Background: The M-5 muscarinic acetylcholine receptor is known to play a crucial role in mediating acetylcholine dependent dilation of cerebral blood vessels. Previously, we reported that male M-5 muscarinic acetylcholine knockout mice (M5R(-/-) mice) suffer from a constitutive constriction of cerebral arteries, reduced cerebral blood flow, dendritic atrophy, and short-term memory loss, without necrosis and/or inflammation in the brain. Methodology/Principal Findings: We employed the Magnetic Resonance Angiography to study the area of the basilar artery in male and female M5R(-/-) mice. Here we show that female M5R(-/-) mice did not show the reduction in vascular area observed in male M5R(-/-) mice. However, ovariectomized female M5R(-/-) mice displayed phenotypic changes similar to male M5R(-/-) mice, strongly suggesting that estrogen plays a key role in the observed gender differences. We found that 17 beta-estradiol (E2) induced nitric oxide release and ERK activation in a conditional immortalized mouse brain cerebrovascular endothelial cell line. Agonists of ER alpha, ER beta, and GPR30 promoted ERK activation in this cell line. Moreover, in vivo magnetic resonance imaging studies showed that the cross section of the basilar artery was restored to normal in male M5R(-/-) mice treated with E2. Treatment with E2 also improved the performance of male M5R(-/-) mice in a cognitive test and reduced the atrophy of neural dendrites in the cerebral cortex and hippocampus. M5R(-/-) mice also showed astrocyte swelling in cortex and hippocampus using the three-dimensional reconstruction of electron microscope images. This phenotype was reversed by E2 treatment, similar to the observed deficits in dendrite morphology and the number of synapses. Conclusions/Significance: Our findings indicate that M5R(-/-) mice represent an excellent novel model system to study the beneficial effects of estrogen on cerebrovascular function and cognition. E2 may offer new therapeutic perspectives for the treatment of cerebrovascular insufficiency related memory dysfunction.			Kitamura, N (corresponding author), RIKEN Brain Sci Inst, Yamada Res Unit, Saitama, Japan.	masahisa@brain.riken.jp	Terasaki, Tetsuya/K-6730-2012; Ohtsuki, Sumio/S-4360-2016	Terasaki, Tetsuya/0000-0002-6332-7575; Ohtsuki, Sumio/0000-0003-4634-7133	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075020] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Araya R, 2006, NEUROBIOL DIS, V24, P334, DOI 10.1016/j.nbd.2006.07.010; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; Chambliss KL, 2002, ENDOCR REV, V23, P665, DOI 10.1210/er.2001-0045; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Dodel RC, 1999, J NEUROCHEM, V73, P1453, DOI 10.1046/j.1471-4159.1999.0731453.x; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Eglen RM, 2000, BRIT J PHARMACOL, V130, P13, DOI 10.1038/sj.bjp.0703276; Faraci FM, 1999, CIRC RES, V85, P1214; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gao X, 2001, NEUROSCIENCE, V103, P385, DOI 10.1016/S0306-4522(01)00014-8; Green PS, 1997, J NEUROSCI, V17, P511; Grossini E, 2008, ENDOCRINOLOGY, V149, P2678, DOI 10.1210/en.2007-1361; Guo XM, 2005, J BIOL CHEM, V280, P19704, DOI 10.1074/jbc.M501244200; Haas E, 2007, HYPERTENSION, V49, P1358, DOI 10.1161/HYPERTENSIONAHA.107.089995; Hamel E, 2004, PROG BRAIN RES, V145, P171, DOI 10.1016/S0079-6123(02)45012-7; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; Hosoya K, 2000, AAPS PHARMSCI, V2; Hotta H, 2002, JPN J PHYSIOL, V52, P383, DOI 10.2170/jjphysiol.52.383; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Jia J, 2009, EXP NEUROL, V215, P48, DOI 10.1016/j.expneurol.2008.09.015; Jung YW, 2007, NEUROSCI RES, V59, P152, DOI 10.1016/j.neures.2007.06.1470; KARAS RH, 1994, CIRCULATION, V89, P1943, DOI 10.1161/01.CIR.89.5.1943; Khurana S, 2005, EUR J PHARMACOL, V517, P103, DOI 10.1016/j.ejphar.2005.05.037; Kim Jin Kyung, 2006, Nucl Recept Signal, V4, pe013; KimSchulze S, 1996, CIRCULATION, V94, P1402, DOI 10.1161/01.CIR.94.6.1402; Lamping KG, 2004, ARTERIOSCL THROM VAS, V24, P1253, DOI 10.1161/01.ATV.0000130661.82773.ca; LIAO CF, 1989, J BIOL CHEM, V264, P7328; Ma E, 1997, NEUROSCIENCE, V79, P591, DOI 10.1016/S0306-4522(96)00674-4; McCullough LD, 2001, STROKE, V32, P796, DOI 10.1161/01.STR.32.3.796; MELLERGARD P, 1993, EXP BRAIN RES, V95, P371; Meng W, 1996, AM J PHYSIOL-HEART C, V271, pH1145, DOI 10.1152/ajpheart.1996.271.3.H1145; Mor G, 1999, J NEUROBIOL, V40, P484, DOI 10.1002/(SICI)1097-4695(19990915)40:4<484::AID-NEU6>3.0.CO;2-C; Ohtsuki S, 2002, J CEREBR BLOOD F MET, V22, P1327, DOI 10.1097/01.WCB.0000033966.83623.7D; Oishi A, 2004, BIOCHEM BIOPH RES CO, V324, P193, DOI 10.1016/j.bbrc.2004.09.032; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Reever CM, 1997, LIFE SCI, V60, P1105, DOI 10.1016/S0024-3205(97)00054-4; REHNCRONA S, 1985, ANN EMERG MED, V14, P770, DOI 10.1016/S0196-0644(85)80055-X; ROSENBLUM WI, 1986, STROKE, V17, P494, DOI 10.1161/01.STR.17.3.494; Santizo RA, 2000, STROKE, V31, P2231, DOI 10.1161/01.STR.31.9.2231; SARIA A, 1983, J NEUROSCI METH, V8, P41, DOI 10.1016/0165-0270(83)90050-X; Sato A, 2004, NEUROSCI LETT, V361, P90, DOI 10.1016/j.neulet.2004.01.004; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; Slezak M, 2003, TRENDS NEUROSCI, V26, P531, DOI 10.1016/j.tins.2003.08.005; Sobey CG, 1997, STROKE, V28, P837, DOI 10.1161/01.STR.28.4.837; Sykova E, 2002, HIPPOCAMPUS, V12, P269, DOI 10.1002/hipo.1101; Tayebati SK, 2003, NEUROSCIENCE, V122, P205, DOI 10.1016/S0306-4522(03)00513-X; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; WANG SZ, 1994, J PHARMACOL EXP THER, V268, P552; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; WOOLLEY CS, 1994, J NEUROSCI, V14, P7680; Xia Y, 2004, ENDOCRINOLOGY, V145, P4550, DOI 10.1210/en.2004-0327; Yamada M, 2001, P NATL ACAD SCI USA, V98, P14096, DOI 10.1073/pnas.251542998; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745; YAO H, 1995, J CEREBR BLOOD F MET, V15, P398, DOI 10.1038/jcbfm.1995.50; Yong Y, 2005, BRAIN RES, V1054, P192, DOI 10.1016/j.brainres.2005.05.069; Zivadinovic D, 2005, BREAST CANCER RES, V7, pR130, DOI 10.1186/bcr959	62	25	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5159	10.1371/journal.pone.0005159	http://dx.doi.org/10.1371/journal.pone.0005159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357782	Green Published, gold, Green Submitted			2022-12-27	WOS:000265505900017
J	Li, T; Wang, EK; Dong, SJ				Li, Tao; Wang, Erkang; Dong, Shaojun			A Grafting Strategy for the Design of Improved G-Quadruplex Aptamers and High-Activity DNAzymes	PLOS ONE			English	Article								Nucleic acid aptamers are generally obtained by in vitro selection. Some have G-rich consensus sequences with ability to fold into the four-stranded structures known as G-quadruplexes. A few G-quadruplex aptamers have proven to bind hemin to form a new class of DNAzyme with the peroxidase-like activity, which can be significantly promoted by appending an appropriate base-pairing duplex onto the G-quadruplex structures of aptamers. Knowing the structural role of base pairing, here we introduce a novel grafting strategy for the design of improved G-quadruplex aptamers and high-activity DNAzymes. To demonstrate this strategy, three existing G-quadruplex aptamers are chosen as the first generation. A base-pairing DNA duplex is grafted onto the G-quadruplex motif of the first generation aptamers. Consequently, three new aptamers with the quadruplex/duplex DNA structures are produced as the second generation. The hemin-binding affinities and DNAzyme functions of the second generation aptamers are characterized and compared with the first generation. The results indicate three G-quadruplex aptamers obtained by the grafting strategy have more excellent properties than the corresponding original aptamers. Our findings suggest that, if the structures and functions of existing aptamers are thoroughly known, the grafting strategy can be facilely utilized to improve the aptamer properties and thereby producing better next-generation aptamers. This provides a simple but effective approach to the design of nucleic acid aptamers and DNAzymes.			Li, T (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China.	dongsj@ciac.jl.cn	Li, Tao/B-4586-2012; , 汪尔康/P-1748-2019; , 董绍俊/P-5166-2019	Li, Tao/0000-0002-9724-3812; , 董绍俊/0000-0002-0263-6577				Andreola ML, 2001, BIOCHEMISTRY-US, V40, P10087, DOI 10.1021/bi0108599; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Breaker RR, 1997, NAT BIOTECHNOL, V15, P427, DOI 10.1038/nbt0597-427; Breaker RR, 2004, NATURE, V432, P838, DOI 10.1038/nature03195; Chinnapen DJF, 2002, BIOCHEMISTRY-US, V41, P5202, DOI 10.1021/bi015785f; CIESIOLKA J, 1995, RNA, V1, P538; Cox JC, 2001, BIOORGAN MED CHEM, V9, P2525, DOI 10.1016/S0968-0896(01)00028-1; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Gopinath SCB, 2006, J BIOCHEM, V139, P837, DOI 10.1093/jb/mvj095; Green LS, 1996, BIOCHEMISTRY-US, V35, P14413, DOI 10.1021/bi961544+; Hamula CLA, 2006, TRAC-TREND ANAL CHEM, V25, P681, DOI 10.1016/j.trac.2006.05.007; HARADA K, 1995, EMBO J, V14, P5798, DOI 10.1002/j.1460-2075.1995.tb00268.x; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Hofmann HP, 1997, RNA, V3, P1289; HUIZENGA DE, 1995, BIOCHEMISTRY-US, V34, P656, DOI 10.1021/bi00002a033; Kikuchi K, 2005, NUCLEIC ACIDS RES, V33, P683, DOI 10.1093/nar/gki215; Li T, 2008, CHEM COMMUN, P5520, DOI 10.1039/b809296f; Li T, 2008, CHEM COMMUN, P3654, DOI 10.1039/b805565c; Li T, 2007, CHEM COMMUN, P4209, DOI 10.1039/b712165b; Li T, 2009, CHEM-EUR J, V15, P2059, DOI 10.1002/chem.200801825; Li T, 2009, CHEM COMMUN, P580, DOI 10.1039/b815814b; Li T, 2009, CHEM-EUR J, V15, P3347, DOI 10.1002/chem.200900056; Li T, 2009, ANAL CHEM, V81, P2144, DOI 10.1021/ac900188y; Li T, 2009, CHEM-EUR J, V15, P1036, DOI 10.1002/chem.200801282; Li YF, 1996, BIOCHEMISTRY-US, V35, P6911, DOI 10.1021/bi960038h; Li YF, 1996, NAT STRUCT BIOL, V3, P743, DOI 10.1038/nsb0996-743; Liu JW, 2004, ANAL CHEM, V76, P1627, DOI 10.1021/ac0351769; Liu JW, 2006, ANGEW CHEM INT EDIT, V45, P90, DOI 10.1002/anie.200502589; Lu Y, 2002, CHEM-EUR J, V8, P4589; MACAYA RF, 1995, BIOCHEMISTRY-US, V34, P4478, DOI 10.1021/bi00013a041; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; Mikuma T, 2003, CHEM COMMUN, P1708, DOI 10.1039/b303643j; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Pavlov V, 2004, ANAL CHEM, V76, P2152, DOI 10.1021/ac035219l; Sen D, 1998, CURR OPIN CHEM BIOL, V2, P680, DOI 10.1016/S1367-5931(98)80103-8; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Stojanovic MN, 2001, J AM CHEM SOC, V123, P4928, DOI 10.1021/ja0038171; Tang ZW, 2007, ANAL CHEM, V79, P4900, DOI 10.1021/ac070189y; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; Tombelli S, 2005, BIOSENS BIOELECTRON, V20, P2424, DOI 10.1016/j.bios.2004.11.006; Travascio P, 2001, J AM CHEM SOC, V123, P1337, DOI 10.1021/ja0023534; Travascio P, 1998, CHEM BIOL, V5, P505, DOI 10.1016/S1074-5521(98)90006-0; Travascio P, 1999, CHEM BIOL, V6, P779, DOI 10.1016/S1074-5521(99)80125-2; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; WU QY, 1992, J BIOL CHEM, V267, P24408; Yi X, 2004, CHEMBIOCHEM, V5, P374, DOI 10.1002/cbic.200300794	47	25	27	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5126	10.1371/journal.pone.0005126	http://dx.doi.org/10.1371/journal.pone.0005126			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357767	Green Published, gold, Green Submitted			2022-12-27	WOS:000265505900006
J	Meiller, TF; Hube, B; Schild, L; Shirtliff, ME; Scheper, MA; Winkler, R; Ton, A; Jabra-Rizk, MA				Meiller, Timothy F.; Hube, Bernhard; Schild, Lydia; Shirtliff, Mark E.; Scheper, Mark A.; Winkler, Robert; Ton, Amy; Jabra-Rizk, Mary Ann			A Novel Immune Evasion Strategy of Candida albicans: Proteolytic Cleavage of a Salivary Antimicrobial Peptide	PLOS ONE			English	Article							SECRETED ASPARTYL PROTEINASES; ANTIFUNGAL ACTIVITY; GENE-EXPRESSION; HISTATIN 5; DEGRADATION; FAMILY; COLONIZATION; EPIDEMIOLOGY; ACTIVATION; VIRULENCE	Oropharyngeal candidiasis is an opportunistic infection considered to be a harbinger of AIDS. The etiologic agent Candida albicans is a fungal species commonly colonizing human mucosal surfaces. However, under conditions of immune dysfunction, colonizing C. albicans can become an opportunistic pathogen causing superficial or even life-threatening infections. The reasons behind this transition, however, are not clear. In the oral cavity, salivary antimicrobial peptides are considered to be an important part of the host innate defense system in the prevention of microbial colonization. Histatin-5 specifically has exhibited potent activity against C. albicans. Our previous studies have shown histatin-5 levels to be significantly reduced in the saliva of HIV+ individuals, indicating an important role for histatin-5 in keeping C. albicans in its commensal stage. The versatility in the pathogenic potential of C. albicans is the result of its ability to adapt through the regulation of virulence determinants, most notably of which are proteolytic enzymes (Saps), involved in tissue degradation. In this study, we show that C. albicans cells efficiently and rapidly degrade histatin-5, resulting in loss of its anti-candidal potency. In addition, we demonstrate that this cellular activity is due to proteolysis by a member of the secreted aspartic proteases (Sap) family involved in C. albicans pathogenesis. Specifically, the proteolysis was attributed to Sap9, in turn identifying histatin-5 as the first host-specific substrate for that isoenzyme. These findings demonstrate for the first time the ability of a specific C. albicans enzyme to degrade and deactivate a host antimicrobial peptide involved in the protection of the oral mucosa against C. albicans, thereby providing new insights into the factors directing the transition of C. albicans from commensal to pathogen, with important clinical implications for alternative therapy. This report characterizes the first defined mechanism behind the enhanced susceptibility of HIV+ individuals to oral candidiasis since the emergence of HIV.	[Meiller, Timothy F.; Scheper, Mark A.; Ton, Amy; Jabra-Rizk, Mary Ann] Univ Maryland, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Meiller, Timothy F.; Scheper, Mark A.] Univ Maryland Med Syst, Marlene & Stewart Greenbaum Canc Ctr, Baltimore, MD USA; [Hube, Bernhard; Schild, Lydia] Hans Knoell Inst HKI, Leibniz Inst Nat Product Res & Infect Biol, Dept Microb Pathogen Mechanisms, Jena, Germany; [Hube, Bernhard] Univ Jena, Jena, Germany; [Shirtliff, Mark E.] Univ Maryland, Dental Sch, Dept Microb Pathogenesis, Baltimore, MD USA; [Shirtliff, Mark E.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD USA; [Winkler, Robert] Hans Knoell Inst HKI, Leibniz Inst Nat Product Res & Infect Biol, Dept Biomol Chem, Jena, Germany; [Jabra-Rizk, Mary Ann] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Hans Knoll Institute (HKI); University System of Maryland; University of Maryland Baltimore	Meiller, TF (corresponding author), Univ Maryland, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA.	mrizk@umaryland.edu	Winkler, Robert/A-1500-2009; Shirtliff, Mark E/H-2563-2017	Winkler, Robert/0000-0001-6732-1958; Shirtliff, Mark E/0000-0002-8913-3445; Hube, Bernhard/0000-0002-6028-0425	NIH [DE14424, DE016257]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K22DE014424, R03DE016257] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH grants DE14424 and DE016257. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2006, J BIOL CHEM, V281, P688, DOI 10.1074/jbc.M509297200; Borg-von Zepelin M, 1998, MOL MICROBIOL, V28, P543, DOI 10.1046/j.1365-2958.1998.00815.x; Brown AJP, 2007, CURR OPIN MICROBIOL, V10, P307, DOI 10.1016/j.mib.2007.04.001; Calderone RA., 2002, CANDIDA CANDIDIASIS; Cannon RD, 1999, CRIT REV ORAL BIOL M, V10, P359, DOI 10.1177/10454411990100030701; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; De Bernardis F, 1999, J INFECT DIS, V179, P201, DOI 10.1086/314546; de Repentigny L, 2004, CLIN MICROBIOL REV, V17, P729, DOI 10.1128/CMR.17.4.729-759.2004; DeBernardis F, 1996, INFECT IMMUN, V64, P466, DOI 10.1128/IAI.64.2.466-471.1996; EDGAR WM, 1992, BRIT DENT J, V172, P305, DOI 10.1038/sj.bdj.4807861; Edgerton M, 1998, J BIOL CHEM, V273, P20438, DOI 10.1074/jbc.273.32.20438; Fidel P L Jr, 2006, Adv Dent Res, V19, P80; Gagnon-Arsenault I, 2008, MOL MICROBIOL, V69, P982, DOI 10.1111/j.1365-2958.2008.06339.x; Gyurko C, 2001, ANTON LEEUW INT J G, V79, P297, DOI 10.1023/A:1012070600340; Helmerhorst EJ, 2006, ARCH ORAL BIOL, V51, P1061, DOI 10.1016/j.archoralbio.2006.06.005; Helmerhorst EJ, 1999, J BIOL CHEM, V274, P7286, DOI 10.1074/jbc.274.11.7286; Helmerhorst EJ, 2001, P NATL ACAD SCI USA, V98, P14637, DOI 10.1073/pnas.141366998; Hube B, 1996, Curr Top Med Mycol, V7, P55; Hube B, 1997, INFECT IMMUN, V65, P3529, DOI 10.1128/IAI.65.9.3529-3538.1997; Hube B, 2006, FUTURE MICROBIOL, V1, P209, DOI 10.2217/17460913.1.2.209; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Jainkittivong A, 1998, ORAL MICROBIOL IMMUN, V13, P181, DOI 10.1111/j.1399-302X.1998.tb00730.x; Jang WS, 2008, ANTIMICROB AGENTS CH, V52, P497, DOI 10.1128/AAC.01199-07; KLEIN RS, 1984, NEW ENGL J MED, V311, P354, DOI 10.1056/NEJM198408093110602; Koshlukova SE, 1999, J BIOL CHEM, V274, P18872, DOI 10.1074/jbc.274.27.18872; Koshlukova SE, 2000, INFECT IMMUN, V68, P6848, DOI 10.1128/IAI.68.12.6848-6856.2000; Kretschmar M, 2002, MICROB PATHOGENESIS, V32, P61, DOI 10.1006/mpat.2001.0478; Kumamoto CA, 2008, CURR OPIN MICROBIOL, V11, P325, DOI 10.1016/j.mib.2008.05.008; LAL K, 1992, J ACQ IMMUN DEF SYND, V5, P904; Li XWS, 2003, J BIOL CHEM, V278, P28553, DOI 10.1074/jbc.M300680200; MANDEL ID, 1992, J ORAL PATHOL MED, V21, P209, DOI 10.1111/j.1600-0714.1992.tb00103.x; Mochon AB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000190; Munro CA, 2002, TRENDS MICROBIOL, V10, P173, DOI 10.1016/S0966-842X(02)02330-2; Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Naglik JR, 2008, MICROBIOL-SGM, V154, P3266, DOI 10.1099/mic.0.2008/022293-0; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Ruissen ALA, 2003, BIOL CHEM, V384, P183, DOI 10.1515/BC.2003.020; Sanglard D, 1997, INFECT IMMUN, V65, P3539, DOI 10.1128/IAI.65.9.3539-3546.1997; Staib P, 2000, P NATL ACAD SCI USA, V97, P6102, DOI 10.1073/pnas.110031497; Torres SR, 2009, MYCOSES, V52, P11, DOI 10.1111/j.1439-0507.2008.01602.x; Villar CC, 2007, INFECT IMMUN, V75, P2126, DOI 10.1128/IAI.00054-07; XU L, 1993, ARCH ORAL BIOL, V38, P277, DOI 10.1016/0003-9969(93)90133-7	45	93	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5039	10.1371/journal.pone.0005039	http://dx.doi.org/10.1371/journal.pone.0005039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352427	Green Published, gold, Green Submitted			2022-12-27	WOS:000265505300006
J	Gajendran, N; Vanhecke, D; Brinkmann, V; Kaufmann, SHE				Gajendran, Nadesan; Vanhecke, Dominique; Brinkmann, Volker; Kaufmann, Stefan H. E.			Identifying Activated T Cells in Reconstituted RAG Deficient Mice Using Retrovirally Transduced Pax5 Deficient Pro-B Cells	PLOS ONE			English	Article								Various methods have been used to identify activated T cells such as binding of MHC tetramers and expression of cell surface markers in addition to cytokine-based assays. In contrast to these published methods, we here describe a strategy to identify T cells that respond to any antigen and track the fate of these activated T cells. We constructed a retroviral double-reporter construct with enhanced green fluorescence protein (EGFP) and a far-red fluorescent protein from Heteractis crispa (HcRed). LTR-driven EGFP expression was used to enrich and identify transduced cells, while HcRed expression is driven by the CD40Ligand (CD40L) promoter, which is inducible and enables the identification and cell fate tracing of T cells that have responded to infection/inflammation. Pax5 deficient pro-B cells that can give rise to different hematopoietic cells like T cells, were retrovirally transduced with this double-reporter cassette and were used to reconstitute the T cell pool in RAG1 deifcient mice that lack T and B cells. By using flow cytometry and histology, we identified activated T cells that had developed from Pax5 deficient pro-B cells and responded to infection with the bacterial pathogen Listeria monocytogenes. Microscopic examination of organ sections allowed visual identification of HcRed-expressing cells. To further characterize the immune response to a given stimuli, this strategy can be easily adapted to identify other cells of the hematopoietic system that respond to infection/inflammation. This can be achieved by using an inducible reporter, choosing the appropriate promoter, and reconstituting mice lacking cells of interest by injecting gene-modified Pax5 deficient pro-B cells.	[Gajendran, Nadesan; Vanhecke, Dominique; Brinkmann, Volker; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Vanhecke, Dominique] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Berlin, Germany	Max Planck Society; Max Planck Society	Gajendran, N (corresponding author), Univ Basel, Inst Physiol, Basel, Switzerland.	N.Gajendran@unibas.ch; kaufmann@mpiib-berlin.mpg.de	Brinkmann, Volker/A-6015-2009; Kaufmann, Stefan HE/I-5454-2014	Kaufmann, Stefan HE/0000-0001-9866-8268; , Nadesan/0000-0002-7463-4220	Max Planck Society	Max Planck Society(Max Planck Society)	Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Goulder PJR, 2000, J EXP MED, V192, P1819, DOI 10.1084/jem.192.12.1819; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Marchant JS, 2001, NAT BIOTECHNOL, V19, P645, DOI 10.1038/90249; Maris CH, 2003, J IMMUNOL, V171, P2393, DOI 10.4049/jimmunol.171.5.2393; Ng LG, 2008, IMMUNOL REV, V221, P147, DOI 10.1111/j.1600-065X.2008.00596.x; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; ROLINK A, 1993, BLOOD, V81, P2290; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Rolink AG, 2002, IMMUNOL LETT, V82, P35, DOI 10.1016/S0165-2478(02)00016-0; Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5	14	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5115	10.1371/journal.pone.0005115	http://dx.doi.org/10.1371/journal.pone.0005115			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340306	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500700018
J	Khan, A; Shover, W; Goodliffe, JM				Khan, Abid; Shover, Wesley; Goodliffe, Julie M.			Su(z)2 Antagonizes Auto-Repression of Myc in Drosophila, Increasing Myc Levels and Subsequent Trans-Activation	PLOS ONE			English	Article								All tumor cell lines that have been tested are defective for Myc auto-repression, and have high levels of Myc produced from wild type loci and re-arranged loci. Like mammalian Myc auto-repression, Myc protein represses the expression of its gene, dmyc, in Drosophila. This activity requires Polycomb (Pc), since RNAi for Pc in the embryo eliminates Myc auto-repression. We have observed that upon depletion of Polycomb in the embryo, levels of one of 18 different chromatin-binding genetic regulators, Su(z)2, rise dramatically. We pursued the possibility that increased levels of this protein, Su(z)2, interfere with Myc auto-repression, potentially explaining the loss of auto-repression upon Pc RNAi. We report that embryos expressing both ectopic Myc and ectopic Su(z)2 fail in Myc auto-repression. Surprisingly, histone H3K27 tri-methylation at the dmyc locus is inversely correlated with the presence of auto-repression. We show phenotypic consequences of potent dmyc auto-repression, and their complete reversal by ectopic Su(z)2: dmyc auto-repression induced a diminutive (dm) phenotype, and upon elimination of auto-repression by Su(z)2, overall levels of Myc increased and completely rescued the phenotype. We show that this increase in Myc levels caused dramatic activation of Myc activation targets. These data suggest that Su(z)2 is capable of increasing the potency of Myc activity by eliminating Myc's feedback regulation by auto-repression. Although Su(z) 2 eliminated Myc auto-repression, we found that Myc repression of other genes is not affected by Su(z)2. These data suggest a unique antagonistic role for Su(z)2 in Myc auto-repression, and a potential mechanism for cancer-cell specific loss of Myc auto-repression.	[Khan, Abid; Shover, Wesley; Goodliffe, Julie M.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte	Khan, A (corresponding author), Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA.	jmgoodli@uncc.edu	Khan, Abid/Y-8454-2019	Khan, Abid/0000-0003-0968-8705	NIH [CA135481]; NATIONAL CANCER INSTITUTE [R15CA135481] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by a grant from the NIH to JMG: CA135481. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JY, 2004, MOL CELL BIOL, V24, P7737, DOI 10.1128/MCB.24.17.7737-7747.2004; Barsyte-Lovejoy D, 2004, ONCOGENE, V23, P3481, DOI 10.1038/sj.onc.1207487; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brown SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-442; BRUNK BP, 1991, GENETICS, V128, P119; BRUNK BP, 1991, NATURE, V353, P351, DOI 10.1038/353351a0; BUNKER CA, 1994, MOL CELL BIOL, V14, P1721, DOI 10.1128/MCB.14.3.1721; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cowling VH, 2008, ONCOGENE, V27, P1327, DOI 10.1038/sj.onc.1210734; Cowling VH, 2007, MOL CELL BIOL, V27, P2059, DOI 10.1128/MCB.01828-06; David Allis C., 2007, EPIGENETICS-US; de la Cova C, 2006, SEMIN CANCER BIOL, V16, P303, DOI 10.1016/j.semcancer.2006.07.010; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gallant P, 2006, CURR TOP MICROBIOL, V302, P235; Goodliffe JM, 2005, GENE DEV, V19, P2941, DOI 10.1101/gad.1352305; Goodliffe JM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-40; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; GRIGNANI F, 1990, EMBO J, V9, P3913, DOI 10.1002/j.1460-2075.1990.tb07612.x; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lo SM, 2009, MOL CELL BIOL, V29, P515, DOI 10.1128/MCB.01044-08; Maines JZ, 2004, DEVELOPMENT, V131, P775, DOI 10.1242/dev.00932; Mao DYL, 2004, NUCLEIC ACIDS RES, V32, P3462, DOI 10.1093/nar/gkh669; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Mohd-Sarip A, 2005, GENE DEV, V19, P1755, DOI 10.1101/gad.347005; Mohd-Sarip A, 2002, MOL CELL BIOL, V22, P7473, DOI 10.1128/MCB.22.21.7473-7483.2002; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Sauvageau M, 2008, PLOS BIOL, V6, P678, DOI 10.1371/journal.pbio.0060113; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; SHARP EJ, 1994, DEV BIOL, V161, P379, DOI 10.1006/dbio.1994.1039; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; VANLOHUIZEN M, 1991, NATURE, V353, P353, DOI 10.1038/353353a0; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Zaffran S, 1998, DEVELOPMENT, V125, P3571	53	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5076	10.1371/journal.pone.0005076	http://dx.doi.org/10.1371/journal.pone.0005076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333393	Green Published, gold, Green Submitted			2022-12-27	WOS:000265499900021
J	Tam, J; Duda, DG; Perentes, JY; Quadri, RS; Fukumura, D; Jain, RK				Tam, Joshua; Duda, Dan G.; Perentes, Jean Y.; Quadri, Rehan S.; Fukumura, Dai; Jain, Rakesh K.			Blockade of VEGFR2 and Not VEGFR1 Can Limit Diet-Induced Fat Tissue Expansion: Role of Local versus Bone Marrow-Derived Endothelial Cells	PLOS ONE			English	Article								Background: We investigated if new vessel formation in fat involves the contribution of local tissue-derived endothelial cells (i.e., angiogenesis) or bone marrow-derived cells (BMDCs, i.e. vasculogenesis) and if antiangiogenic treatment by blockade of vascular endothelial growth factor (VEGF) receptors can prevent diet-induced obesity (DIO). Methodology/Principal Findings: We performed restorative bone marrow transplantation into wild-type mice using transgenic mice expressing green fluorescent protein (GFP) constitutively (driven by beta-actin promoter) or selectively in endothelial cells (under Tie2 promoter activation) as donors. The presence of donor BMDCs in recipient mice was investigated in fat tissue vessels after DIO using in vivo and ex vivo fluorescence microscopy. We investigated the roles of VEGF receptors 1 and 2 (VEGFR1/VEGFR2) by inducing DIO in mice and treating them with blocking monoclonal antibodies. We found only marginal (less than 1%) incorporation of BMDCs in fat vessels during DIO. When angiogenesis was inhibited by blocking VEGFR2 in mice with DIO, treated mice had significantly lower body weights than control animals. In contrast, blocking VEGFR1 had no discernable effect on the weight gain during DIO. Conclusions/Significance: Formation of new vessels in fat tissues during DIO is largely due to angiogenesis rather than de novo vasculogenesis. Antiangiogenic treatment by blockade of VEGFR2 but not VEGFR1 may limit adipose tissue expansion.	[Tam, Joshua; Duda, Dan G.; Perentes, Jean Y.; Quadri, Rehan S.; Fukumura, Dai; Jain, Rakesh K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA; [Tam, Joshua; Duda, Dan G.; Perentes, Jean Y.; Quadri, Rehan S.; Fukumura, Dai; Jain, Rakesh K.] Harvard Univ, Sch Med, Boston, MA USA; [Tam, Joshua] Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Perentes, Jean Y.] Ctr Hosp Univ Vaudois CHUV, Div Thorac & Vasc Surg, Lausanne, Switzerland	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Tam, J (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA.	dai@steele.mgh.harvard.edu; jain@steele.mgh.harvard.edu	Jain, Rakesh K/I-1384-2017; Duda, Dan G/H-8523-2014	Jain, Rakesh K/0000-0001-7571-3548; Duda, Dan G/0000-0001-7065-8797; Perentes, Jean/0000-0001-7918-0793	National Institutes of Health [P01CA80124, R01CA96915, R01CA115767, R01CA85140, R01CA126642]; NATIONAL CANCER INSTITUTE [P01CA080124, R01CA096915, R01CA126642, R24CA085140, R01CA115767, T32CA073479, R01CA085140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was partially supported by National Institutes of Health grants P01CA80124, R01CA96915, R01CA115767, R01CA85140, and R01CA126642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brakenhielm E, 2004, CIRC RES, V94, P1579, DOI 10.1161/01.RES.0000132745.76882.70; Brown EB, 2001, NAT MED, V7, P864, DOI 10.1038/89997; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; CLAFFEY KP, 1992, J BIOL CHEM, V267, P16317; Duda DG, 2006, BLOOD, V107, P2774, DOI 10.1182/blood-2005-08-3210; Duda DG, 2004, CANCER RES, V64, P5920, DOI 10.1158/0008-5472.CAN-04-1268; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA; Gealekman O, 2008, AM J PHYSIOL-ENDOC M, V295, pE1056, DOI 10.1152/ajpendo.90345.2008; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hausman GJ, 2004, J ANIM SCI, V82, P925; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Izumi Y, 2003, CANCER RES, V63, P747; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lai N, 2009, TISSUE ENG PT A, V15, P1053, DOI 10.1089/ten.tea.2008.0101; Le Lay S, 2001, BIOCHEM BIOPH RES CO, V289, P564, DOI 10.1006/bbrc.2001.6015; Ledoux S, 2008, DIABETES, V57, P3247, DOI 10.2337/db07-1812; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Lijnen HR, 2008, CARDIOVASC RES, V78, P286, DOI 10.1093/cvr/cvm007; Lijnen HR, 2006, DIABETES, V55, P2698, DOI 10.2337/db06-0526; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Miyazawa-Hoshimoto S, 2005, AM J PHYSIOL-ENDOC M, V288, pE1128, DOI 10.1152/ajpendo.00003.2004; Miyazawa-Hoshimoto S, 2003, DIABETOLOGIA, V46, P1483, DOI 10.1007/s00125-003-1221-6; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Silha JV, 2005, INT J OBESITY, V29, P1308, DOI 10.1038/sj.ijo.0802987; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Voros G, 2005, ENDOCRINOLOGY, V146, P4545, DOI 10.1210/en.2005-0532; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983	36	71	76	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4974	10.1371/journal.pone.0004974	http://dx.doi.org/10.1371/journal.pone.0004974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333381	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499900007
J	Bryhn, AC				Bryhn, Andreas C.			Sustainable Phosphorus Loadings from Effective and Cost-Effective Phosphorus Management Around the Baltic Sea	PLOS ONE			English	Article								Nutrient over-enrichment of the Baltic Sea, accompanied by intensified algal blooms and decreasing water clarity, has aroused widespread concern in the surrounding countries during the last four decades. This work has used a well-tested dynamic mass-balance model to investigate which decrease in total phosphorus loading would be required to meet the environmental goal to restore the trophic state in the Baltic Sea to pre-1960s levels. Furthermore, the extent to which various abatement options may decrease the phosphorus loading in a cost-effective manner has been studied. Upgrading urban sewage treatment in the catchment could, alone or in combination with banning phosphates in detergents, be sufficient to meet the set environmental goal, at an estimated annual basin-wide cost of 0.21-0.43 billion euro. Such a plan would potentially decrease the total phosphorus loading to the Baltic Sea with 6,650-10,200 tonnes per year.			Bryhn, AC (corresponding author), Uppsala Univ, Dept Earth Sci, Uppsala, Sweden.	andreas.bryhn@geo.uu.se						Aarup T, 2002, OCEANOLOGIA, V44, P323; Bergstrom L., 2007, REPORT FOOD, V21, P4; BOESCH D, 2006, 5529 SWED EPA; Bowes MJ, 2008, SCI TOTAL ENVIRON, V395, P125, DOI 10.1016/j.scitotenv.2008.01.054; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Conley DJ, 2002, ENVIRON SCI TECHNOL, V36, P5315, DOI 10.1021/es025763w; Finni T, 2001, AMBIO, V30, P172, DOI 10.1639/0044-7447(2001)030[0172:THOCBI]2.0.CO;2; Fleming-Lehtinen V., 2009, WATER TRANSPARENCY B; Gren IM, 2001, ENVIRON RESOUR ECON, V20, P41, DOI 10.1023/A:1017512113454; GREN IM, 2008, 5877 SWED EPA; Hakanson L., 2008, EUTROPHICATION BALTI; HAKANSON L, 2009, OPEN MAR BIOL J, V3, P36; *HELCOM, 2007, BALT SEA UN EUTR; *HELCOM NEFCO, 2007, EC AN BSAP FOC EUTR; KIIRIKKI M, 1999, COST EFFECTIVE WATER; Kohler J, 2006, J BUS CHEM, V2, P15; LARSSON U, 1985, AMBIO, V14, P9; PITKANEN H, 2007, 15 FINN ENV; Savchuk OP, 2008, J MARINE SYST, V74, P485, DOI 10.1016/j.jmarsys.2008.03.008; Schernewski G, 2005, J MARINE SYST, V53, P109, DOI 10.1016/j.jmarsys.2004.03.007; Schindler D.W., 2008, PNAS, V105, P11039; Schou J.S., 2006, 592 NERI; Stalnacke P, 1999, ENVIRON MONIT ASSESS, V58, P173, DOI 10.1023/A:1006073015871; *SWED EPA, 2008, 5840 SWED EPA; Tonderski KS, 2005, AMBIO, V34, P544, DOI 10.1639/0044-7447(2005)034[0544:MTIOPW]2.0.CO;2; Turner RK, 1999, ECOL ECON, V30, P333, DOI 10.1016/S0921-8009(99)00046-4; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2	27	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2009	4	5							e5417	10.1371/journal.pone.0005417	http://dx.doi.org/10.1371/journal.pone.0005417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440RC	19412551	gold, Green Published			2022-12-27	WOS:000265716400001
J	Young, JD; Martel, J; Young, D; Young, A; Hung, CM; Young, L; Chao, YJ; Young, J; Wu, CY				Young, John D.; Martel, Jan; Young, David; Young, Andrew; Hung, Chin-Ming; Young, Lena; Chao, Ying-Jie; Young, James; Wu, Cheng-Yeu			Characterization of Granulations of Calcium and Apatite in Serum as Pleomorphic Mineralo-Protein Complexes and as Precursors of Putative Nanobacteria	PLOS ONE			English	Article							HUMAN ALPHA-2-HS GLYCOPROTEIN; FETUIN-A; RANDALLS PLAQUE; MATRIX VESICLES; CALCIFYING NANOPARTICLES; VASCULAR CALCIFICATION; HYDROXYAPATITE CRYSTALS; MEDIATED CALCIFICATION; TUMORAL CALCINOSIS; AORTIC-STENOSIS	Calcium and apatite granulations are demonstrated here to form in both human and fetal bovine serum in response to the simple addition of either calcium or phosphate, or a combination of both. These granulations are shown to represent precipitating complexes of protein and hydroxyapatite (HAP) that display marked pleomorphism, appearing as round, laminated particles, spindles, and films. These same complexes can be found in normal untreated serum, albeit at much lower amounts, and appear to result from the progressive binding of serum proteins with apatite until reaching saturation, upon which the mineralo-protein complexes precipitate. Chemically and morphologically, these complexes are virtually identical to the so-called nanobacteria (NB) implicated in numerous diseases and considered unusual for their small size, pleomorphism, and the presence of HAP. Like NB, serum granulations can seed particles upon transfer to serum-free medium, and their main protein constituents include albumin, complement components 3 and 4A, fetuin-A, and apolipoproteins A1 and B100, as well as other calcium and apatite binding proteins found in the serum. However, these serum mineralo-protein complexes are formed from the direct chemical binding of inorganic and organic phases, bypassing the need for any biological processes, including the long cultivation in cell culture conditions deemed necessary for the demonstration of NB. Thus, these serum granulations may result from physiologically inherent processes that become amplified with calcium phosphate loading or when subjected to culturing in medium. They may be viewed as simple mineralo-protein complexes formed from the deployment of calcification-inhibitory pathways used by the body to cope with excess calcium phosphate so as to prevent unwarranted calcification. Rather than representing novel pathophysiological mechanisms or exotic lifeforms, these results indicate that the entities described earlier as NB most likely originate from calcium and apatite binding factors in the serum, presumably calcification inhibitors, that upon saturation, form seeds for HAP deposition and growth. These calcium granulations are similar to those found in organisms throughout nature and may represent the products of more general calcium regulation pathways involved in the control of calcium storage, retrieval, tissue deposition, and disposal.			Young, JD (corresponding author), Chang Gung Univ, Lab Nanomat, Gueishan, Taiwan.	dingeyoung@hotmail.com		Young, David/0000-0002-8290-5561; Martel, Jan/0000-0003-0879-109X				Abbott A, 2000, NATURE, V408, P394, DOI 10.1038/35044241; Abbott A, 1999, NATURE, V401, P105, DOI 10.1038/43525; Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Aizenberg J, 1996, ADV MATER, V8, P222, DOI 10.1002/adma.19960080307; ALI SY, 1970, P NATL ACAD SCI USA, V67, P1513, DOI 10.1073/pnas.67.3.1513; Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576; ANDERSON L, 1946, SURG GYNECOL OBSTET, V82, P275; AOKI H, 1996, T ANN M SOC BIOM CON; ASHTON BA, 1974, EUR J BIOCHEM, V45, P525, DOI 10.1111/j.1432-1033.1974.tb03577.x; Ayman A, 2008, EUR PHYS J-SPEC TOP, V153, P497, DOI 10.1140/epjst/e2008-00493-5; Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C; Barrere F, 2006, INT J NANOMED, V1, P317; Benesch J, 2008, TISSUE ENG PART B-RE, V14, P433, DOI 10.1089/ten.teb.2008.0121; Benzerara K, 2003, P NATL ACAD SCI USA, V100, P7438, DOI 10.1073/pnas.0832464100; Benzerara K, 2006, J INVEST MED, V54, P367, DOI 10.2310/6650.2006.06016; BLUMENTHAL NC, 1989, CLIN ORTHOP RELAT R, P279; Bonucci E, 2002, J BONE MINER METAB, V20, P249, DOI 10.1007/s007740200037; BOSKEY AL, 1983, CLIN ORTHOP RELAT R, P258; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Bradbury J, 1998, LANCET, V352, P121, DOI 10.1016/S0140-6736(98)85032-0; Bratos-Perez MA, 2008, EUR HEART J, V29, P371, DOI 10.1093/eurheartj/ehm592; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; Cantet S, 2001, VIRCHOWS ARCH, V439, P683, DOI 10.1007/s004280100425; Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994; CARR R J, 1954, Br J Urol, V26, P105, DOI 10.1111/j.1464-410X.1954.tb06073.x; Carson DA, 1998, P NATL ACAD SCI USA, V95, P7846, DOI 10.1073/pnas.95.14.7846; Chen CW, 2004, J MATER CHEM, V14, P2425, DOI 10.1039/b315095j; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; Ciftcioglu N, 1999, KIDNEY INT, V56, P1893, DOI 10.1046/j.1523-1755.1999.00755.x; Ciftcioglu N, 2002, ANTIMICROB AGENTS CH, V46, P2077, DOI 10.1128/AAC.46.7.2077-2086.2002; Ciftcioglu N, 1998, PATHOPHYSIOLOGY, V4, P259, DOI DOI 10.1016/S0928-4680(97)10001-3; Ciftcioglu N, 2006, J INVEST MED, V54, P385, DOI 10.2310/6650.2006.06018; Ciftcioglu N, 2007, LANCET, V369, P2078, DOI 10.1016/S0140-6736(07)60977-5; Ciftcioglu N, 2008, INT J NANOMED, V3, P105; Cisar JO, 2000, P NATL ACAD SCI USA, V97, P11511, DOI 10.1073/pnas.97.21.11511; Coe FL, 2005, J CLIN INVEST, V115, P2598, DOI 10.1172/JCI26662; Colfen H, 2005, ANGEW CHEM INT EDIT, V44, P5576, DOI 10.1002/anie.200500496; DAVEAU M, 1988, FEBS LETT, V241, P191, DOI 10.1016/0014-5793(88)81059-7; Day M, 1998, NEW SCI, V159, P11; de Puala AR, 2005, MED ENG PHYS, V27, P237, DOI 10.1016/j.medengphy.2004.10.007; DEMUL FFM, 1986, J DENT RES, V65, P437, DOI 10.1177/00220345860650031301; DERESINSKI S, 2008, CLIN INFECT DIS, V46, pR5; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Doherty TM, 2003, P NATL ACAD SCI USA, V100, P11201, DOI 10.1073/pnas.1932554100; Domingue GJ, 1997, CLIN MICROBIOL REV, V10, P320, DOI 10.1128/CMR.10.2.320; Dorrell S, 1999, MOL MED TODAY, V5, P373, DOI 10.1016/S1357-4310(99)01553-1; Evan A, 2006, KIDNEY INT, V69, P1313, DOI 10.1038/sj.ki.5000238; Evan AP, 2007, ANAT REC, V290, P1315, DOI 10.1002/ar.20580; Evan AP, 2003, J CLIN INVEST, V111, P607, DOI 10.1172/JCI200317038; FLEISCH H, 1972, J DENT RES, V51, P324; FOLK RL, 1993, J SEDIMENT PETROL, V63, P990, DOI 10.1306/D4267C67-2B26-11D7-8648000102C1865D; Frost RL, 2007, SPECTROCHIM ACTA A, V66, P979, DOI 10.1016/j.saa.2006.04.036; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Garcia-Ruiz JM, 2009, SCIENCE, V323, P362, DOI 10.1126/science.1165349; GARNETT J, 1990, BIOCHEM J, V266, P863; GENGE BR, 1990, J BIOL CHEM, V265, P4703; Genge BR, 2007, J BIOL CHEM, V282, P26035, DOI 10.1074/jbc.M701057200; Ghadially FN, 2001, ULTRASTRUCT PATHOL, V25, P243; Goodman WG, 2002, J NEPHROL, V15, pS82; Gupta HS, 2006, P NATL ACAD SCI USA, V103, P17741, DOI 10.1073/pnas.0604237103; HAGGITT RC, 1971, J UROLOGY, V106, P342, DOI 10.1016/S0022-5347(17)61284-9; Hamilton A, 2000, MICROBIOL TODAY, V27, P182; Harasawa R, 2006, IN VITRO CELL DEV-AN, V42, P13; Hatori M, 1996, TOHOKU J EXP MED, V180, P359, DOI 10.1620/tjem.180.359; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Hendig D, 2006, CLIN CHEM, V52, P227, DOI 10.1373/clinchem.2005.059253; HIRSCHMAN A, 1983, CALCIFIED TISSUE INT, V35, P791, DOI 10.1007/BF02405125; Hjelle JT, 2000, KIDNEY INT, V57, P2360, DOI 10.1046/j.1523-1755.2000.00096.x; HOGAN J, 2003, NEW SCI, V2422, P14; HOPKINS M, 2008, NANOBACTERIA THEORY; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ix JH, 2007, CIRCULATION, V115, P2533, DOI 10.1161/CIRCULATIONAHA.106.682450; Jahnen-Dechent W, 2001, Z Kardiol, V90 Suppl 3, P47; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; JAHNENDECHENT W, 2004, PROGR BIOL MOL BIOL, P243; Jersmann HPA, 2003, CLIN SCI, V105, P273, DOI 10.1042/CS20030126; Johansson L, 2003, CYTOTECHNOLOGY, V42, P67, DOI 10.1023/B:CYTO.0000009820.72920.cf; Kajander EO, 2006, LETT APPL MICROBIOL, V42, P549, DOI 10.1111/j.1472-765X.2006.01945.x; Kajander EO, 1997, P SOC PHOTO-OPT INS, V3111, P420, DOI 10.1117/12.278796; Kajander EO, 2003, UROL RES, V31, P47, DOI 10.1007/s002440-003-0304-7; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; Kale S, 2000, NAT BIOTECHNOL, V18, P954, DOI 10.1038/79439; Ketteler M, 2005, PEDIATR NEPHROL, V20, P383, DOI 10.1007/s00467-004-1614-x; Ketteler M, 2005, NEPHROL DIAL TRANSPL, V20, P673, DOI 10.1093/ndt/gfh734; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; KHAN SR, 1984, UROLOGY, V23, P194, DOI 10.1016/0090-4295(84)90021-9; Kirkland BL, 1999, GEOLOGY, V27, P347, DOI 10.1130/0091-7613(1999)027<0347:AOFNLO>2.3.CO;2; Kokubun S, 1996, SPINE, V21, P249, DOI 10.1097/00007632-199601150-00017; Kumar V, 2006, J INVEST MED, V54, P412, DOI 10.2310/6650.2006.06021; LEBRETON JP, 1979, J CLIN INVEST, V64, P1118, DOI 10.1172/JCI109551; LEE YS, 1993, J ELECTRON MICROSC, V42, P156; LEWIS JG, 1980, IMMUNOLOGY, V39, P317; Lieske JC, 2008, NAT CLIN PRACT NEPHR, V4, P308, DOI 10.1038/ncpneph0794; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; MATSUZAWA T, 1971, J HISTOCHEM CYTOCHEM, V19, P801, DOI 10.1177/19.12.801; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4; Miller VM, 2004, AM J PHYSIOL-HEART C, V287, pH1115, DOI 10.1152/ajpheart.00075.2004; Narasimhulu KV, 2005, BIOPHYS CHEM, V114, P137, DOI 10.1016/j.bpc.2004.11.013; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; OHNISHI T, 1991, J BIOL CHEM, V266, P14636; Olson RE, 1998, J NUTR, V128, p439S, DOI 10.1093/jn/128.2.439S; Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001; Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561; Pigino G, 2005, TISSUE CELL, V37, P223, DOI 10.1016/j.tice.2005.02.001; PLATE U, 1994, CELL TISSUE RES, V278, P543; Potter K, 2002, J BONE MINER RES, V17, P652, DOI 10.1359/jbmr.2002.17.4.652; Price PA, 2006, ARTERIOSCL THROM VAS, V26, P1079, DOI 10.1161/01.ATV.0000216406.44762.7c; Price PA, 2004, J BIOL CHEM, V279, P19169, DOI 10.1074/jbc.M307880200; Price PA, 2004, J BIOL CHEM, V279, P1594, DOI 10.1074/jbc.M305199200; Price PA, 2003, J BIOL CHEM, V278, P22153, DOI 10.1074/jbc.M300739200; Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200; Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200; Price PA, 2009, J BIOL CHEM, V284, P4594, DOI 10.1074/jbc.M803205200; QUELCH KJ, 1984, CALCIFIED TISSUE INT, V36, P545, DOI 10.1007/BF02405363; Raoult D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040041; Raz S, 2002, BIOL BULL-US, V203, P269, DOI 10.2307/1543569; Reynolds JL, 2005, J AM SOC NEPHROL, V16, P2920, DOI 10.1681/ASN.2004100895; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Robinson C, 2007, J DENT RES, V86, P677, DOI 10.1177/154405910708600801; ROBINSON C, 1981, J CRYST GROWTH, V53, P160, DOI 10.1016/0022-0248(81)90062-2; Rochette CN, 2009, CHEMBIOCHEM, V10, P735, DOI 10.1002/cbic.200800719; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Russell RGG, 1999, J BONE MINER RES, V14, P53, DOI 10.1002/jbmr.5650140212; Ryall RL, 2008, UROL RES, V36, P77, DOI 10.1007/s00240-007-0131-3; Saey TH, 2008, SCI NEWS, V173, P6; Samoylov AM, 2005, CELLS TISSUES ORGANS, V179, P115, DOI 10.1159/000085003; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Schoppet M, 2008, KIDNEY INT, V73, P384, DOI 10.1038/sj.ki.5002696; Schwartz MAK, 2008, INT J NANOMED, V3, P243; Shiekh FA, 2009, CLIN NEPHROL, V71, P1; Sillitoe RH, 1996, SCIENCE, V272, P1153, DOI 10.1126/science.272.5265.1153; Singh S, 2008, J COLLOID INTERF SCI, V319, P322, DOI 10.1016/j.jcis.2007.09.059; Stenvinkel P, 2005, KIDNEY INT, V67, P2383, DOI 10.1111/j.1523-1755.2005.00345.x; TERKELTAUB RA, 1988, ARTHRITIS RHEUM, V31, P1081, DOI 10.1002/art.1780310901; Thiele L, 2003, BIOMATERIALS, V24, P1409, DOI 10.1016/S0142-9612(02)00525-2; Travis J, 1998, SCI NEWS, V154, P75; Travis J, 2000, SCI NEWS, V158, P328; Urbano P, 2007, PLOS PATHOG, V3, P567, DOI 10.1371/journal.ppat.0030055; Vali H, 2001, GEOCHIM COSMOCHIM AC, V65, P63, DOI 10.1016/S0016-7037(00)00525-1; Vallet-Regi M, 2000, CHEM MATER, V12, P961, DOI 10.1021/cm991110b; Vandenbulcke F, 1998, ECOTOX ENVIRON SAFE, V41, P258, DOI 10.1006/eesa.1998.1706; Wainwright M, 1999, MICROBIOL-SGM, V145, P2623, DOI 10.1099/00221287-145-10-2623; WALTON AG, 1970, CALC TISS RES, V6, P162, DOI 10.1007/BF02196195; Wang AYM, 2005, NEPHROL DIAL TRANSPL, V20, P1676, DOI 10.1093/ndt/gfh891; Westenfeld R, 2007, TRENDS CARDIOVAS MED, V17, P124, DOI 10.1016/j.tcm.2007.02.005; Wiesmann HP, 2003, J ORAL MAXIL SURG, V61, P1455, DOI 10.1016/j.joms.2003.05.001; Wong F, 2007, NAT CLIN PRACT GASTR, V4, P43, DOI 10.1038/ncpgasthep0680; WUTHIER RE, 1978, BIOCHEMISTRY-US, V17, P1431, DOI 10.1021/bi00601a011; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004417; Zhou HY, 2007, ANN NY ACAD SCI, V1116, P323, DOI 10.1196/annals.1402.023; Zhou L, 2008, SMALL, V4, P1566, DOI 10.1002/smll.200800520; Ziegler A, 2005, MICRON, V36, P137, DOI 10.1016/j.micron.2004.09.006	157	49	57	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5421	10.1371/journal.pone.0005421	http://dx.doi.org/10.1371/journal.pone.0005421			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412552	Green Published, Green Submitted, gold			2022-12-27	WOS:000265688200008
J	Sato, K; Sakamoto, KQ; Watanuki, Y; Takahashi, A; Katsumata, N; Bost, CA; Weimerskirch, H				Sato, Katsufumi; Sakamoto, Kentaro Q.; Watanuki, Yutaka; Takahashi, Akinori; Katsumata, Nobuhiro; Bost, Charles-Andre; Weimerskirch, Henri			Scaling of Soaring Seabirds and Implications for Flight Abilities of Giant Pterosaurs	PLOS ONE			English	Article							WANDERING ALBATROSSES	The flight ability of animals is restricted by the scaling effects imposed by physical and physiological factors. In comparisons of the power available from muscle and the mechanical power required to fly, it is predicted that the margin between the powers should decrease with body size and that flying animals have a maximum body size. However, predicting the absolute value of this upper limit has proven difficult because wing morphology and flight styles varies among species. Albatrosses and petrels have long, narrow, aerodynamically efficient wings and are considered soaring birds. Here, using animal-borne accelerometers, we show that soaring seabirds have two modes of flapping frequencies under natural conditions: vigorous flapping during takeoff and sporadic flapping during cruising flight. In these species, high and low flapping frequencies were found to scale with body mass (mass(-0.30) and mass(-0.18)) in a manner similar to the predictions from biomechanical flight models (mass(-1/3) and mass(-1/6)). These scaling relationships predicted that the maximum limits on the body size of soaring animals are a body mass of 41 kg and a wingspan of 5.1 m. Albatross-like animals larger than the limit will not be able to flap fast enough to stay aloft under unfavourable wind conditions. Our result therefore casts doubt on the flying ability of large, extinct pterosaurs. The largest extant soarer, the wandering albatross, weighs about 12 kg, which might be a pragmatic limit to maintain a safety margin for sustainable flight and to survive in a variable environment.	[Sato, Katsufumi; Katsumata, Nobuhiro] Univ Tokyo, Ocean Res Inst, Int Coastal Res Ctr, Otsuchi, Iwate, Japan; [Sakamoto, Kentaro Q.] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Watanuki, Yutaka] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan; [Takahashi, Akinori] Natl Inst Polar Res, Itabashi Ku, Tachikawa, Tokyo 1908518, Japan; [Bost, Charles-Andre; Weimerskirch, Henri] CNRS, Ctr Etud Biol Chize, Beauvoir Sur Niort, France	University of Tokyo; Hokkaido University; Hokkaido University; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Centre National de la Recherche Scientifique (CNRS)	Sato, K (corresponding author), Univ Tokyo, Ocean Res Inst, Int Coastal Res Ctr, Otsuchi, Iwate, Japan.	katsu@ori.u-tokyo.ac.jp	Sakamoto, Kentaro/A-4843-2012; Weimerskirch, Henri/K-7306-2019; Weimerskirch, Henri/F-5562-2013; Sakamoto, Kentaro/N-7424-2019	Sakamoto, Kentaro/0000-0002-8499-799X; Weimerskirch, Henri/0000-0002-0457-586X; Sakamoto, Kentaro/0000-0002-8499-799X				Alexander RM., 2003, PRINCIPLES ANIMAL LO; Attenborough D., 1998, LIFE BIRDS; BRAMWELL CD, 1974, PHILOS T R SOC B, V267, P503, DOI 10.1098/rstb.1974.0007; Brooke M, 2004, ALBATROSSES PETRELS; Calder WA., 1984, SIZE FUNCTION LIFE H; Chatterjee S., 2004, GEOLOGICAL SOC AM SP, V376, P1, DOI DOI 10.1130/0-8137-2376-0.1; GREENEWALT CH, 1975, SCIENCE, V188, P676, DOI 10.1126/science.188.4189.676; Hill A. V., 1950, Science Progress London, V38, P209; JOUVENTIN P, 1990, NATURE, V343, P746, DOI 10.1038/343746a0; LAWSON DA, 1975, SCIENCE, V187, P947, DOI 10.1126/science.187.4180.947; MARDEN JH, 1994, AM J PHYSIOL, V266, pR1077, DOI 10.1152/ajpregu.1994.266.4.R1077; NORBERG RA, 1996, AVIAN ENERGETICS NUT, P199; PENNYCUICK CJ, 1982, PHILOS T ROY SOC B, V300, P75, DOI 10.1098/rstb.1982.0158; PENNYCUICK CJ, 1968, J EXP BIOL, V49, P527; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Pennycuick CJ., 1975, AVIAN BIOL, P1971; RAYNER JMV, 1987, CURRENT ORNITHOLOGY, V5, P1; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sato K, 2008, J EXP BIOL, V211, P58, DOI 10.1242/jeb.009811; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Shaffer SA, 2001, J ANIM ECOL, V70, P864, DOI 10.1046/j.0021-8790.2001.00548.x; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Unwin DM., 2006, PTEROSAURS DEEP TIME; VIDELER JJ, 2005, AVIAN FLIGH; VONHELMHOLTZ H, 1874, MBER K AKAD WISS BER, P501; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Witton MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002271	29	35	36	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5400	10.1371/journal.pone.0005400	http://dx.doi.org/10.1371/journal.pone.0005400			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401767	gold, Green Published			2022-12-27	WOS:000265601100026
J	Abdelalim, EM; Tooyama, I				Abdelalim, Essam Mohamed; Tooyama, Ikuo			BNP Signaling Is Crucial For Embryonic Stem Cell Proliferation	PLOS ONE			English	Article							NATRIURETIC PEPTIDE RECEPTOR; ENDOCHONDRAL OSSIFICATION; TRANSGENIC MICE; ACTIVATION; EXPRESSION; LACKING; PLURIPOTENCY; ROLES; GENE; H2AX	Background: Embryonic stem (ES) cells have unlimited proliferation potential, and can differentiate into several cell types, which represent ideal sources for cell-based therapy. This high-level proliferative ability is attributed to an unusual type of cell cycle. The Signaling pathways that regulate the proliferation of ES cells are of great interest. Methodology/Principal Findings: In this study, we show that murine ES cells specifically express brain natriuretic peptide (BNP), and its signaling is essential for ES cell proliferation. We found that BNP and its receptor (NPR-A, natriuretic peptide receptor-A) were highly expressed in self-renewing murine ES cells, whereas the levels were markedly reduced after ES cell differentiation by the withdrawal of LIF. Targeting of BNP with short interfering RNA ( siRNA) resulted in the inhibition of ES cell proliferation, as indicated by a marked reduction in the cell number and colony size, a significant reduction in DNA synthesis, and decreased numbers of cells in S phase. BNP knockdown in ES cells led to the up-regulation of gamma-aminobutyric acid receptor A (GABAAR) genes, and activation of phosphorylated histone (gamma-H2AX), which negatively affects ES cell proliferation. In addition, knockdown of BNP increased the rate of apoptosis and reduced the expression of the transcription factor Ets-1. Conclusions/Significance: Appropriate BNP expression is essential for the maintenance of ES cell propagation. These findings establish BNP as a novel endogenous regulator of ES cell proliferation.			Abdelalim, EM (corresponding author), Shiga Univ Med Sci, Mol Neurosci Res Ctr, Setatsukinowa Cho, Otsu, Shiga 52021, Japan.	essam@belle.shiga-med.ac.jp	Abdelalim, Essam M./Q-8275-2019	Abdelalim, Essam M./0000-0001-7764-6772; Tooyama, Ikuo/0000-0001-8054-9666				Abdelalim EM, 2006, BIOCHEM BIOPH RES CO, V340, P689, DOI 10.1016/j.bbrc.2005.12.057; Abdelalim EM, 2006, PEPTIDES, V27, P1886, DOI 10.1016/j.peptides.2006.01.001; ABELL TJ, 1989, BIOCHEM BIOPH RES CO, V160, P1392, DOI 10.1016/S0006-291X(89)80158-5; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; GARBERS DL, 1992, CELL, V71, P1; Heo JS, 2006, AM J PHYSIOL-CELL PH, V290, pC123, DOI 10.1152/ajpcell.00142.2005; HOHN SWM, 1995, SCIENCE, V267, P679; Ichijima Y, 2005, BIOCHEM BIOPH RES CO, V336, P807, DOI 10.1016/j.bbrc.2005.08.164; KOLLER KJ, 1991, SCIENCE, V252, P120, DOI 10.1126/science.1672777; Kong X, 2008, CANCER RES, V68, P249, DOI 10.1158/0008-5472.CAN-07-3086; Kumar P, 2009, BIOSCIENCE REP, V29, P57, DOI 10.1042/BSR20080094; Levin ER, 1998, NEW ENGL J MED, V339, P321; Lianguzova MS, 2007, CELL BIOL INT, V31, P330, DOI 10.1016/j.cellbi.2007.01.019; MINAMINO N, 1988, BIOCHEM BIOPH RES CO, V155, P470; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ogawa K, 2004, GENES CELLS, V9, P471, DOI 10.1111/j.1356-9597.2004.00736.x; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Pikkarainen S, 2003, J BIOL CHEM, V278, P3969, DOI 10.1074/jbc.M205616200; SAVATIER P, 1994, ONCOGENE, V9, P809; Schulz S, 2005, PEPTIDES, V26, P1024, DOI 10.1016/j.peptides.2004.08.027; Silberbach M, 2001, CELL SIGNAL, V13, P221, DOI 10.1016/S0898-6568(01)00139-5; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; STEINHELPER ME, 1990, HYPERTENSION, V16, P301, DOI 10.1161/01.HYP.16.3.301; Suda M, 1998, P NATL ACAD SCI USA, V95, P2337, DOI 10.1073/pnas.95.5.2337; SUDA Y, 1987, J CELL PHYSIOL, V133, P197, DOI 10.1002/jcp.1041330127; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; Tamura N, 2004, P NATL ACAD SCI USA, V101, P17300, DOI 10.1073/pnas.0407894101; Tamura N, 2000, P NATL ACAD SCI USA, V97, P4239, DOI 10.1073/pnas.070371497; Yasoda A, 1998, J BIOL CHEM, V273, P11695, DOI 10.1074/jbc.273.19.11695; Yu YC, 2006, J NEUROSCI, V26, P696, DOI 10.1523/JNEUROSCI.3653-05.2006	34	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5341	10.1371/journal.pone.0005341	http://dx.doi.org/10.1371/journal.pone.0005341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399180	Green Submitted, gold, Green Published			2022-12-27	WOS:000265514900006
J	Jacobson, MA; Ditmer, DP; Sinclair, E; Martin, JN; Deeks, SG; Hunt, P; Mocarski, ES; Shiboski, C				Jacobson, Mark A.; Ditmer, Dirk P.; Sinclair, Elizabeth; Martin, Jeffrey N.; Deeks, Steven G.; Hunt, Peter; Mocarski, Edward S.; Shiboski, Caroline			Human Herpesvirus Replication and Abnormal CD8+T Cell Activation and Low CD4+T Cell Counts in Antiretroviral-Suppressed HIV-Infected Patients	PLOS ONE			English	Article								Background: Most HIV-infected patients receiving virologically suppressive antiretroviral therapy continue to have abnormal, generalized T cell activation. We explored whether the degree of ongoing cytomegalovirus (CMV), Epstein-Barr virus (EBV) and Kaposi's sarcoma herpesvirus (KSHV) replication was associated with higher virus-specific T cell activation and the failure to achieve normal absolute CD4+ T cell counts in the face of long-term suppressive antiretroviral therapy. Methodology: Longitudinally collected PBMC and saliva specimens obtained from HIV-infected patients on effective antiretroviral therapy for at least one year (plasma HIV RNA <75 copies/mL) were examined using a multiplex CMV, EBV and KSHV DNA PCR assay. Eleven cases were chosen who had CD8+ T cell CD38+ HLA-DR+ expression >10% and plateau absolute CD4+ T cell counts <500 cells/mu L. Five controls from the same study had CD8+ T cell CD38 expression <10% and plateau absolute CD4+ T cell counts >500 cells/mu L. Results and Conclusions: Among all subjects combined, 18% of PMBC samples were positive for CMV DNA, and 27%, 73% and 24% of saliva samples were positive for CMV, EBV and KSHV DNA, respectively. No significant differences or trends were observed between cases and controls in proportions of all CMV, EBV or KSHV DNA positive specimens, proportions of subjects in each group that intermittently or continuously shed CMV, EBV or KSHV DNA in saliva, or the median number of genome copies of CMV, EBV and KSHV DNA in saliva. Overall, number of genome copies in saliva were lower for KSHV than for CMV and lower for CMV than for EBV. Although replication of CMV, EBV and KSHV persists in many antiretroviralsuppressed, HIV-infected patients, we observed no evidence in this pilot case-control study that the magnitude of such human herpesvirus replication is associated with abnormally increased CD8+ T cell activation and sub-normal plateau absolute CD4+ T cell counts following virologically suppressive antiretroviral therapy.			Jacobson, MA (corresponding author), Univ Calif San Francisco, Dept Med, Posit Hlth Program, San Francisco, CA 94143 USA.	mjacobson@php.ucsf.edu	Hunt, Peter W./P-2976-2017; Mocarski, Edward/ABC-2893-2020	Hunt, Peter W./0000-0002-4571-4870; dittmer, dirk/0000-0003-4968-5656	NCRR NIH HHS [UL1 RR024131] Funding Source: Medline; NIAID NIH HHS [U01 AI68636, U01 AI068636, P30 AI027763] Funding Source: Medline; NIDCR NIH HHS [R01 DE018304-01, R01 DE018304-02, DE018304, R01 DE018304-03, R01 DE018304] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, U01AI068636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018304] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Boeckh M, 1997, TRANSPLANTATION, V64, P108, DOI 10.1097/00007890-199707150-00020; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Casper C, 2008, J INFECT DIS, V198, P23, DOI 10.1086/588820; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; HATANO H, 2009, 16 C RETR OPP INF MO; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hilscher C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni181; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Jacobson MA, 2002, JAIDS, V31, P472, DOI 10.1097/00126334-200212150-00003; Jebbink J, 2003, J MOL DIAGN, V5, P15, DOI 10.1016/S1525-1578(10)60446-1; JIANG W, 2009, J INFECT DIS    0305; JIAO Y, 2008, IMMUNOLOGY; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Mathotra U, 2006, CLIN IMMUNOL, V119, P95, DOI 10.1016/j.clim.2005.11.010; Miller CS, 2006, J CLIN MICROBIOL, V44, P2409, DOI 10.1128/JCM.00256-06; Ndhlovu LC, 2008, J LEUKOCYTE BIOL, V83, P254, DOI 10.1189/jlb.0507281; Nicastri E, 2008, CURR HIV RES, V6, P261, DOI 10.2174/157016208784325010; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Potena L, 2007, J CLIN MICROBIOL, V45, P1804, DOI 10.1128/JCM.01362-06; Razonable RR, 2002, TRANSPLANTATION, V73, P968, DOI 10.1097/00007890-200203270-00025; van Baarle D, 2002, AIDS, V16, P2001, DOI 10.1097/00002030-200210180-00004	29	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5277	10.1371/journal.pone.0005277	http://dx.doi.org/10.1371/journal.pone.0005277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381272	Green Published, Green Submitted, gold			2022-12-27	WOS:000265510800013
J	Logozzi, M; De Milito, A; Lugini, L; Borghi, M; Calabro, L; Spada, M; Perdicchio, M; Marino, ML; Federici, C; Iessi, E; Brambilla, D; Venturi, G; Lozupone, F; Santinami, M; Huber, V; Maio, M; Rivoltini, L; Fais, S				Logozzi, Mariantonia; De Milito, Angelo; Lugini, Luana; Borghi, Martina; Calabro, Luana; Spada, Massimo; Perdicchio, Maurizio; Marino, Maria Lucia; Federici, Cristina; Iessi, Elisabetta; Brambilla, Daria; Venturi, Giulietta; Lozupone, Francesco; Santinami, Mario; Huber, Veronica; Maio, Michele; Rivoltini, Licia; Fais, Stefano			High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients	PLOS ONE			English	Article								Background: Metastatic melanoma is an untreatable cancer lacking reliable and non-invasive markers of disease progression. Exosomes are small vesicles secreted by normal as well as tumor cells. Human tumor-derived exosomes are involved in malignant progression and we evaluated the presence of exosomes in plasma of melanoma patients as a potential tool for cancer screening and follow-up. Methodology/Principal Findings: We designed an in-house sandwich ELISA (Exotest) to capture and quantify exosomes in plasma based on expression of housekeeping proteins (CD63 and Rab-5b) and a tumor-associated marker (caveolin-1). Western blot and flow cytometry analysis of exosomes were used to confirm the Exotest-based findings. The Exotest allowed sensitive detection and quantification of exosomes purified from human tumor cell culture supernatants and plasma from SCID mice engrafted with human melanoma. Plasma levels of exosomes in melanoma-engrafted SCID mice correlated to tumor size. We evaluated the levels of plasma exosomes expressing CD63 and caveolin-1 in melanoma patients (n = 90) and healthy donors (n = 58). Consistently, plasma exosomes expressing CD63 (504 +/- 315) or caveolin-1 (619 +/- 310) were significantly increased in melanoma patients as compared to healthy donors (223 +/- 125 and 228 +/- 102, respectively). While the Exotest for CD63+ plasma exosomes had limited sensitivity (43%) the Exotest for detection of caveolin-1+ plasma exosomes showed a higher sensitivity (68%). Moreover, caveolin-1+ plasma exosomes were significantly increased with respect to CD63+ exosomes in the patients group. Conclusions/Significance: We describe a new non-invasive assay allowing detection and quantification of human exosomes in plasma of melanoma patients. Our results suggest that the Exotest for detection of plasma exosomes carrying tumor-associated antigens may represent a novel tool for clinical management of cancer patients.			Logozzi, M (corresponding author), Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Unit Antitumor Drugs, Viale Regina Elena 299, I-00161 Rome, Italy.	stefano.fais@iss.it	Iessi, Elisabetta/O-2460-2017; Fais, Stefano/J-8638-2016; Spada, Massimo/Z-1345-2019; BORGHI, MARTINA/M-4355-2015; VENTURI, GIULIETTA/O-8123-2015; Huber, Veronica/D-1618-2017; Santinami, Mario/I-3795-2017; Lugini, Luana/J-8672-2016; rivoltini, licia/I-2450-2012; Spada, Massimo/R-9563-2017; Federici, Cristina/O-4676-2016; Lozupone, Francesco/H-2998-2016; Calabrò, Luana/AAC-9920-2019; Perdicchio, Maurizio/HGB-2966-2022	Iessi, Elisabetta/0000-0001-7221-9173; Fais, Stefano/0000-0001-9060-2766; Spada, Massimo/0000-0003-0751-1893; BORGHI, MARTINA/0000-0001-6313-0273; VENTURI, GIULIETTA/0000-0002-9078-8350; Huber, Veronica/0000-0001-6304-3575; Santinami, Mario/0000-0001-8436-4757; Lugini, Luana/0000-0002-8778-2601; rivoltini, licia/0000-0002-2409-6225; Spada, Massimo/0000-0003-0751-1893; Federici, Cristina/0000-0001-6366-0231; Lozupone, Francesco/0000-0002-4959-9400; Maio, Michele/0000-0002-0323-6321; coral, sandra/0000-0002-1308-3082; De Milito, Angelo/0000-0003-2591-2914; calabro', luana/0000-0002-3044-0889	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; Bard MP, 2004, AM J RESP CELL MOL, V31, P114, DOI 10.1165/rcmb.2003-0238OC; Bartalev SA, 2008, CONTEMP PROBL ECOL, V1, P1, DOI 10.1134/S1995425508010013; BERGMANN C, 2008, HEAD NECK       1215; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Brochez L, 2000, BRIT J DERMATOL, V143, P256, DOI 10.1046/j.1365-2133.2000.03649.x; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cantiani L, 2007, CANCER RES, V67, P7675, DOI 10.1158/0008-5472.CAN-06-4697; Chaput N, 2003, ADV EXP MED BIOL, V532, P215; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; FERRONE S, 1995, IMMUNOL TODAY, V16, P487, DOI 10.1016/0167-5699(95)80033-6; Fine SW, 2001, AM J CLIN PATHOL, V115, P719; GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1; Hauschild A, 2001, RECENT RESULTS CANC, V158, P169; Huber V, 2005, GASTROENTEROLOGY, V128, P1796, DOI 10.1053/j.gastro.2005.03.045; Huber V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-63; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Llorente A, 2004, J CELL SCI, V117, P5343, DOI 10.1242/jcs.01420; Lugini L, 2006, CANCER RES, V66, P3629, DOI 10.1158/0008-5472.CAN-05-3204; Maeurer MJ, 1996, J CLIN INVEST, V98, P1633, DOI 10.1172/JCI118958; Olver Christine, 2007, V43, P99, DOI 10.1007/978-1-4020-5943-8_7; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Soderberg A, 2007, FREE RADICAL BIO MED, V43, P90, DOI 10.1016/j.freeradbiomed.2007.03.026; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Tahir SA, 2003, CLIN CANCER RES, V9, P3653; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thompson JA, 2002, SEMIN ONCOL, V29, P361, DOI 10.1053/sonc.2002.34115; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Whiteside TL, 2005, BRIT J CANCER, V92, P209, DOI 10.1038/sj.bjc.6602360	38	641	691	7	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5219	10.1371/journal.pone.0005219	http://dx.doi.org/10.1371/journal.pone.0005219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381331	Green Published, Green Submitted, gold			2022-12-27	WOS:000265510800008
J	Kern, AD				Kern, Andrew D.			Correcting the Site Frequency Spectrum for Divergence-Based Ascertainment	PLOS ONE			English	Article							ULTRACONSERVED ELEMENTS; POPULATION-GENETICS; SELECTION; POLYMORPHISM	Comparative genomics based on sequenced referenced genomes is essential to hypothesis generation and testing within population genetics. However, selection of candidate regions for further study on the basis of elevated or depressed divergence between species leads to a divergence-based ascertainment bias in the site frequency spectrum within selected candidate loci. Here, a method to correct this problem is developed that obtains maximum-likelihood estimates of the unascertained allele frequency distribution using numerical optimization. I show how divergence-based ascertainment may mimic the effects of natural selection and offer correction formulae for performing proper estimation into the strength of selection in candidate regions in a maximum-likelihood setting.			Kern, AD (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	andrew.d.kern@dartmouth.edu						Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Bustamante CD, 2001, GENETICS, V159, P1779; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; Gillespie JH, 1997, GENE, V205, P291, DOI 10.1016/S0378-1119(97)00470-8; HEY J, 1991, GENETICS, V128, P831; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Kern AD, 2004, GENETICS, V167, P725, DOI 10.1534/genetics.103.020883; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Press W. H., 1992, ART SCI COMPUTING; SAWYER SA, 1992, GENETICS, V132, P1161; TAJIMA F, 1989, GENETICS, V123, P585; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102	16	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5152	10.1371/journal.pone.0005152	http://dx.doi.org/10.1371/journal.pone.0005152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370150	Green Published, gold, Green Submitted			2022-12-27	WOS:000265510600001
J	Mandolesi, G; Autuori, E; Cesa, R; Premoselli, F; Cesare, P; Strata, P				Mandolesi, Georgia; Autuori, Eleonora; Cesa, Roberta; Premoselli, Federica; Cesare, Paolo; Strata, Piergiorgio			GluR delta 2 Expression in the Mature Cerebellum of Hotfoot Mice Promotes Parallel Fiber Synaptogenesis and Axonal Competition	PLOS ONE			English	Article								Glutamate receptor delta 2 (GluR delta 2) is selectively expressed in the cerebellum, exclusively in the spines of the Purkinje cells (PCs) that are in contact with parallel fibers (PFs). Although its structure is similar to ionotropic glutamate receptors, it has no channel function and its ligand is unknown. The GluR delta 2-null mice, such as knockout and hotfoot have profoundly altered cerebellar circuitry, which causes ataxia and impaired motor learning. Notably, GluR delta 2 in PC-PF synapses regulates their maturation and strengthening and induces long term depression (LTD). In addition, GluR delta 2 participates in the highly territorial competition between the two excitatory inputs to the PC; the climbing fiber (CF), which innervates the proximal dendritic compartment, and the PF, which is connected to spiny distal branchlets. Recently, studies have suggested that GluR delta 2 acts as an adhesion molecule in PF synaptogenesis. Here, we provide in vivo and in vitro evidence that supports this hypothesis. Through lentiviral rescue in hotfoot mice, we noted a recovery of PC-PF contacts in the distal dendritic domain. In the proximal domain, we observed the formation of new spines that were innervated by PFs and a reduction in contact with the CF; ie, the pattern of innervation in the PC shifted to favor the PF input. Moreover, ectopic expression of GluR delta 2 in HEK293 cells that were cocultured with granule cells or in cerebellar Golgi cells in the mature brain induced the formation of new PF contacts. Collectively, our observations show that GluR delta 2 is an adhesion molecule that induces the formation of PF contacts independently of its cellular localization and promotes heterosynaptic competition in the PC proximal dendritic domain.			Mandolesi, G (corresponding author), IRCCS, EBRI Santa Lucia Fdn, Rome, Italy.	g.mandolesi@hsantalucia.it	Mandolesi, Georgia/G-6595-2011; Autuori, Eleonora/J-5868-2014	Mandolesi, Georgia/0000-0003-3612-6820; Cesare, Paolo/0000-0003-1324-5974				Andrasfalvy BK, 2001, J NEUROSCI, V21, P9151, DOI 10.1523/JNEUROSCI.21-23-09151.2001; Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Castejon OJ, 2000, BIOCELL, V24, P13; Cesa R, 2003, J NEUROSCI, V23, P2363; Cesa R, 2007, J NEUROSCI, V27, P4603, DOI 10.1523/JNEUROSCI.5617-06.2007; Cesa R, 2008, P NATL ACAD SCI USA, V105, P18988, DOI 10.1073/pnas.0806979105; Deglon N, 2005, J GENE MED, V7, P530, DOI 10.1002/jgm.707; Dieudonne S, 1998, J PHYSIOL-LONDON, V510, P845, DOI 10.1111/j.1469-7793.1998.845bj.x; ECCLES JC, 1967, EXP BRAIN RES, V3, P81; Eccles JC, 1967, CEREBELLUM NEURONAL; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; GUASTAVINO JM, 1990, BRAIN RES, V523, P199, DOI 10.1016/0006-8993(90)91488-3; HAMORI J, 1966, EXP BRAIN RES, V2, P35; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Ichikawa R, 2002, J NEUROSCI, V22, P8487; Jiang CG, 2002, TRENDS BIOCHEM SCI, V27, P506, DOI 10.1016/S0968-0004(02)02190-4; Kakegawa W, 2007, J PHYSIOL-LONDON, V584, P89, DOI 10.1113/jphysiol.2007.141291; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kirsch J, 1996, MOL CELL NEUROSCI, V8, P93, DOI 10.1006/mcne.1996.0048; Kohda K, 2003, MOL BRAIN RES, V110, P27, DOI 10.1016/S0169-328X(02)00561-2; Kohda K, 2007, EUR J NEUROSCI, V25, P1357, DOI 10.1111/j.1460-9568.2007.05412.x; Kurihara H, 1997, J NEUROSCI, V17, P9613; Lalouette A, 2001, NEUROSCIENCE, V105, P443, DOI 10.1016/S0306-4522(01)00193-2; Lalouette A, 1998, GENOMICS, V50, P9, DOI 10.1006/geno.1998.5314; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; MANDOLESI G, NEUROSCIENCE; MASON CA, 1986, NEUROSCIENCE, V19, P1319, DOI 10.1016/0306-4522(86)90146-6; Matsuda S, 2002, EUR J NEUROSCI, V16, P1507, DOI 10.1046/j.1460-9568.2002.02219.x; Morando L, 2001, P NATL ACAD SCI USA, V98, P9954, DOI 10.1073/pnas.171098398; Nakagami Ryoichi, 2008, Keio Journal of Medicine, V57, P105, DOI 10.2302/kjm.57.105; NORDQUIST DT, 1988, J NEUROSCI, V8, P4780; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; Palay S. L., 1974, CEREBELLAR CORTEX CY; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; ROSSI F, 1991, J COMP NEUROL, V308, P513, DOI 10.1002/cne.903080403; ROSSI F, 1991, J COMP NEUROL, V308, P536, DOI 10.1002/cne.903080404; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SMEYNE RJ, 1995, MOL CELL NEUROSCI, V6, P230, DOI 10.1006/mcne.1995.1019; SOTELO C, 1975, BRAIN RES, V98, P574, DOI 10.1016/0006-8993(75)90374-1; Studler B, 2002, NEUROSCIENCE, V114, P123, DOI 10.1016/S0306-4522(02)00206-3; Takeuchi T, 2005, J NEUROSCI, V25, P2146, DOI 10.1523/JNEUROSCI.4740-04.2005; Uemura T, 2008, BIOCHEM BIOPH RES CO, V377, P1315, DOI 10.1016/j.bbrc.2008.10.170; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Watanabe M, 2008, TOHOKU J EXP MED, V214, P175, DOI 10.1620/tjem.214.175; Yuzaki M, 2004, CEREBELLUM, V3, P89, DOI 10.1080/14734220410028921; Yuzaki M, 2003, NEUROSCI RES, V46, P11, DOI 10.1016/S0168-0102(03)00036-1; Zhao HM, 1997, J NEUROCHEM, V68, P1041	53	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5243	10.1371/journal.pone.0005243	http://dx.doi.org/10.1371/journal.pone.0005243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370152	Green Submitted, Green Published, gold			2022-12-27	WOS:000265510600007
J	Ahluwalia, TS; Khullar, M; Ahuja, M; Kohli, HS; Bhansali, A; Mohan, V; Venkatesan, R; Rai, TS; Sud, K; Singal, PK				Ahluwalia, Tarunveer Singh; Khullar, Madhu; Ahuja, Monica; Kohli, Harbir Singh; Bhansali, Anil; Mohan, Viswanathan; Venkatesan, Radha; Rai, Taranjit Singh; Sud, Kamal; Singal, Pawan K.			Common Variants of Inflammatory Cytokine Genes Are Associated with Risk of Nephropathy in Type 2 Diabetes among Asian Indians	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; PROMOTER POLYMORPHISM; RENAL-INSUFFICIENCY; CANDIDATE GENE; CCR5; DISEASE; EPIDEMIOLOGY; PROGRESSION; TGF-BETA-1; JAPANESE	Background: Inflammatory cytokine genes have been proposed as good candidate genes for conferring susceptibility to diabetic nephropathy. In the present study, we examined the combined effect of multiple alleles of pro inflammatory cytokine genes for determining the risk of nephropathy in type 2 diabetic patients. Methodology/Principal Findings: Eight single nucleotide polymorphisms (SNPs) of pro-inflammatory cytokine genes (CCL2, TGFB1, IL8, CCR5, and MMP9) were genotyped in two independently ascertained type 2 diabetic cohorts with (DN) and without nephropathy (DM); consisting of patients from North India (n = 495) and South India (n = 188). Genotyping was carried out using PCR, allele specific oligonucleotide-PCR (ASO-PCR), PCR-RFLP and TaqMan allelic discrimination assays and the gene-gene interaction among genetic variants were determined by multi dimensional reduction (MDR) software. Serum high sensitive CRP (hs-CRP) levels were measured by ELISA. The hs-CRP levels were significantly higher in DN as compared to the DM group (p < 0.05). The CCL2, IL8, CCR5 and MMP9 polymorphisms were found to be associated with the risk of diabetic nephropathy. Frequency of CCL2 II, IL8 -251AA, CCR5 59029AA and MMP9 279Gln/Gln genotypes were significantly higher in DN than in DM group (p < 0.05) and associated with an increased risk of nephropathy in both North and South Indian cohorts. CCR5 DD and IL8 -251AA genotypes were more prevalent in North Indian DN group only. The co-occurrence of risk associated genotypes (II, -2518GG (CCL2), DD (CCR5) and 279Gln/Gln (MMP9) conferred a tenfold increased risk of nephropathy among type 2 diabetics (p < 0.0002). Conclusion: The present study highlights that common variants of inflammatory cytokine genes exert a modest effect on risk of DN and a combination of risk alleles confer a substantial increased risk of nephropathy in type 2 diabetes among Asian Indians.			Ahluwalia, TS (corresponding author), Postgrad Inst Med Educ & Res, Dept Nephrol, Chandigarh 160012, India.	madhu.khullar@gmail.com	Ahluwalia, Tarunveer Singh/C-5549-2009; Rai, Taranjit Singh/A-3659-2012; KOHLI, HARBIR SINGH/AHA-5966-2022; Singh, Taranjit/ABE-8233-2020	Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Rai, Taranjit Singh/0000-0002-7276-7492; Singh, Taranjit/0000-0002-7276-7492; Kohli, Harbir/0000-0003-4806-2297; Khullar, Madhu/0000-0003-4461-2466				Ahluwalia TS, 2008, MOL CELL BIOCHEM, V314, P9, DOI 10.1007/s11010-008-9759-8; Ahluwalia TS, 2009, DNA CELL BIOL, V28, P141, DOI 10.1089/dna.2008.0810; Akai Y, 2001, AM J KIDNEY DIS, V38, pS182, DOI 10.1053/ajkd.2001.27439; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Chinoy H, 2007, RHEUMATOLOGY, V46, P604, DOI 10.1093/rheumatology/kel359; FALK RJ, 1983, DIABETES, V32, P34, DOI 10.2337/diab.32.2.S34; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Gordon D, 2002, HUM HERED, V54, P22, DOI 10.1159/000066696; Gordon D, 2003, Pac Symp Biocomput, P490; Greene CN, 2008, HUM GENET, V124, P255, DOI 10.1007/s00439-008-0548-y; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hanson RL, 2007, DIABETES, V56, P975, DOI 10.2337/db06-1072; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; Hirakawa S, 2003, AM J KIDNEY DIS, V42, P133, DOI 10.1016/S0272-6386(03)00416-5; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Ibrahim S, 2008, SAUDI J KIDNEY DIS T, V19, P911; Jacobsen P, 2003, J AM SOC NEPHROL, V14, P2843, DOI 10.1097/01.ASN.0000092139.19587.51; Lee SH, 2005, NEPHROLOGY, V10, pS32, DOI 10.1111/j.1440-1797.2005.00454.x; Maeda S, 2007, KIDNEY INT, V72, pS43, DOI 10.1038/sj.ki.5002385; Maeda S, 2001, KIDNEY INT, V60, P1428, DOI 10.1046/j.1523-1755.2001.00945.x; Maeda S, 2008, KIDNEY INT, V74, P413, DOI 10.1038/ki.2008.291; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Mlynarski WM, 2005, DIABETES, V54, P3331, DOI 10.2337/diabetes.54.11.3331; Mokubo A, 2006, DIABETES RES CLIN PR, V73, P89, DOI 10.1016/j.diabres.2005.12.006; Moon JY, 2007, J KOREAN MED SCI, V22, P810, DOI 10.3346/jkms.2007.22.5.810; Nakajima K, 2002, DIABETES, V51, P238, DOI 10.2337/diabetes.51.1.238; Navarro JF, 2006, NEPHROL DIAL TRANSPL, V21, P3428, DOI 10.1093/ndt/gfl469; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Pociot F, 1998, J AM SOC NEPHROL, V9, P2302; Prasad P, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-20; Prasad P, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-42; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Rivero A, 2009, CLIN SCI, V116, P479, DOI 10.1042/CS20080394; Rovin BH, 2002, KIDNEY INT, V62, P261, DOI 10.1046/j.1523-1755.2002.00438.x; Ruster C, 2008, FRONT BIOSCI-LANDMRK, V13, P944, DOI 10.2741/2734; Shipley JM, 1996, J BIOL CHEM, V271, P4335; SINGH S, 2002, PEOPLE INDIA INTRO N; Tashiro K, 2002, J CLIN LAB ANAL, V16, P1, DOI 10.1002/jcla.2057; Vielhauer V, 2001, J AM SOC NEPHROL, V12, P1173, DOI 10.1681/ASN.V1261173; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wong TYH, 2003, KIDNEY INT, V63, P1831, DOI 10.1046/j.1523-1755.2003.00919.x	43	59	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5168	10.1371/journal.pone.0005168	http://dx.doi.org/10.1371/journal.pone.0005168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357773	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505900021
J	Kita-Matsuo, H; Barcova, M; Prigozhina, N; Salomonis, N; Wei, K; Jacot, JG; Nelson, B; Spiering, S; Haverslag, R; Kim, C; Talantova, M; Bajpai, R; Calzolari, D; Terskikh, A; McCulloch, AD; Price, JH; Conklin, BR; Chen, HSV; Mercola, M				Kita-Matsuo, Hiroko; Barcova, Maria; Prigozhina, Natalie; Salomonis, Nathan; Wei, Karen; Jacot, Jeffrey G.; Nelson, Brandon; Spiering, Sean; Haverslag, Rene; Kim, Changsung; Talantova, Maria; Bajpai, Ruchi; Calzolari, Diego; Terskikh, Alexey; McCulloch, Andrew D.; Price, Jeffrey H.; Conklin, Bruce R.; Chen, H. S. Vincent; Mercola, Mark			Lentiviral Vectors and Protocols for Creation of Stable hESC Lines for Fluorescent Tracking and Drug Resistance Selection of Cardiomyocytes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SARCOPLASMIC-RETICULUM; IN-VITRO; GENE; ENRICHMENT; BRACHYURY; SURVIVAL; DIFFERENTIATION; FIBROBLASTS; EXPRESSION	Background: Developmental, physiological and tissue engineering studies critical to the development of successful myocardial regeneration therapies require new ways to effectively visualize and isolate large numbers of fluorescently labeled, functional cardiomyocytes. Methodology/Principal Findings: Here we describe methods for the clonal expansion of engineered hESCs and make available a suite of lentiviral vectors for that combine Blasticidin, Neomycin and Puromycin resistance based drug selection of pure populations of stem cells and cardiomyocytes with ubiquitous or lineage-specific promoters that direct expression of fluorescent proteins to visualize and track cardiomyocytes and their progenitors. The phospho-glycerate kinase (PGK) promoter was used to ubiquitously direct expression of histone-2B fused eGFP and mCherry proteins to the nucleus to monitor DNA content and enable tracking of cell migration and lineage. Vectors with T/Brachyury and alpha-myosin heavy chain (alpha MHC) promoters targeted fluorescent or drug-resistance proteins to early mesoderm and cardiomyocytes. The drug selection protocol yielded 96% pure cardiomyocytes that could be cultured for over 4 months. Puromycin-selected cardiomyocytes exhibited a gene expression profile similar to that of adult human cardiomyocytes and generated force and action potentials consistent with normal fetal cardiomyocytes, documenting these parameters in hESC-derived cardiomyocytes and validating that the selected cells retained normal differentiation and function. Conclusion/Significance: The protocols, vectors and gene expression data comprise tools to enhance cardiomyocyte production for large-scale applications.			Kita-Matsuo, H (corresponding author), Burnham Inst Med Res, La Jolla, CA USA.	mmercola@burnham.org	Conklin, Bruce/E-4738-2019; Terskikh, Alexey/U-8407-2019	Jacot, Jeffrey/0000-0002-1272-5055; Conklin, Bruce/0000-0003-1463-6061; Bajpai, Ruchi/0000-0001-7737-3567	NHGRI NIH HHS [R01 HG003053, HG003053] Funding Source: Medline; NHLBI NIH HHS [5P01HL46345-12, U01 HL066621, R37 HL059502, P01 HL046345, HL66621, R33HL088266, R33 HL088266, R37HL059502] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046345, U01HL066621, R33HL088266, R37HL059502] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003053] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Anderson D, 2007, MOL THER, V15, P2027, DOI 10.1038/sj.mt.6300303; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; Barcova M, 2007, HUMAN STEM CELL MANUAL: A LABORATORY GUIDE, P227, DOI 10.1016/B978-012370465-8/50022-3; Binah O, 2007, J ELECTROCARDIOL, V40, pS192, DOI 10.1016/j.jelectrocard.2007.05.035; BLUHM WF, 1995, J BIOMECH, V28, P1119, DOI 10.1016/0021-9290(94)00018-Y; Clements D, 1996, MECH DEVELOP, V56, P139, DOI 10.1016/0925-4773(96)00520-5; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Dolnikov K, 2006, STEM CELLS, V24, P236, DOI 10.1634/stemcells.2005-0036; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; HOSLER BA, 1993, MOL CELL BIOL, V13, P2919, DOI 10.1128/MCB.13.5.2919; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JACOT JG, 2008, BIOPHYSICAL IN PRESS; Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B; KIM C, 2008, EXTRA CARDIAC UNPUB; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Liu J, 2007, STEM CELLS, V25, P3038, DOI 10.1634/stemcells.2007-0549; Marganski WA, 2003, METHOD ENZYMOL, V361, P197; Muller M, 2000, FASEB J, V14, P2540, DOI 10.1096/fj.00-0002com; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Mummery Christine L, 2007, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01f02s2; Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Pertz O, 2004, J CELL SCI, V117, P1313, DOI 10.1242/jcs.01117; Salomonis N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r12; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Shen FM, 2006, CYTOM PART A, V69A, P563, DOI 10.1002/cyto.a.20283; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Synnergren J, 2008, STEM CELLS, V26, P1831, DOI 10.1634/stemcells.2007-1033; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu CH, 2006, STEM CELLS DEV, V15, P631, DOI 10.1089/scd.2006.15.631; Yamada S, 1999, LIVER, V19, P253, DOI 10.1111/j.1478-3231.1999.tb00043.x; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	43	176	189	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5046	10.1371/journal.pone.0005046	http://dx.doi.org/10.1371/journal.pone.0005046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352491	gold, Green Published, Green Submitted			2022-12-27	WOS:000265505700004
J	Gajate, C; Gonzalez-Camacho, F; Mollinedo, F				Gajate, Consuelo; Gonzalez-Camacho, Fernando; Mollinedo, Faustino			Involvement of Raft Aggregates Enriched in Fas/CD95 Death-Inducing Signaling Complex in the Antileukemic Action of Edelfosine in Jurkat Cells	PLOS ONE			English	Article							LIPID RAFTS; SELECTIVE APOPTOSIS; MEMBRANE RAFTS; FAS; RECEPTOR; ET-18-OCH3; INDUCTION; LIGAND; REDISTRIBUTION; RECRUITMENT	Background: Recent evidence suggests that co-clustering of Fas/CD95 death receptor and lipid rafts plays a major role in death receptor-mediated apoptosis. Methodology/Principal Findings: By a combination of genetic, biochemical, and ultrastructural approaches, we provide here compelling evidence for the involvement of lipid raft aggregates containing recruited Fas/CD95 death receptor, Fas-associated death domain-containing protein (FADD), and procaspase-8 in the induction of apoptosis in human T-cell leukemia Jurkat cells by the antitumor drug edelfosine, the prototype compound of a promising family of synthetic antitumor lipids named as synthetic alkyl-lysophospholipid analogues. Co-immunoprecipitation assays revealed that edelfosine induced the generation of the so-called death-inducing signaling complex (DISC), made up of Fas/CD95, FADD, and procaspase-8, in lipid rafts. Electron microscopy analyses allowed to visualize the formation of raft clusters and their colocalization with DISC components Fas/CD95, FADD, and procaspase-8 following edelfosine treatment of Jurkat cells. Silencing of Fas/CD95 by RNA interference, transfection with a FADD dominant-negative mutant that blocks Fas/CD95 signaling, and specific inhibition of caspase-8 prevented the apoptotic response triggered by edelfosine, hence demonstrating the functional role of DISC in drug-induced apoptosis. By using radioactive labeled edelfosine and a fluorescent analogue, we found that edelfosine accumulated in lipid rafts, forming edelfosine-rich membrane raft clusters in Jurkat leukemic T-cells. Disruption of these membrane raft domains abrogated drug uptake and drug-induced DISC assembly and apoptosis. Thus, edelfosine uptake into lipid rafts was critical for the onset of both co-aggregation of DISC in membrane rafts and subsequent apoptotic cell death. Conclusions/Significance: This work shows the involvement of DISC clusters in lipid raft aggregates as a supramolecular and physical entity responsible for the induction of apoptosis in leukemic cells by the antitumor drug edelfosine. Our data set a novel framework and paradigm in leukemia therapy, as well as in death receptor-mediated apoptosis.	[Gajate, Consuelo; Gonzalez-Camacho, Fernando; Mollinedo, Faustino] Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain; [Gajate, Consuelo] Hosp Univ Salamanca, Unidad Investigac, Campus Miguel Unamuno, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca	Gajate, C (corresponding author), Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, Campus Miguel Unamuno, E-37008 Salamanca, Spain.	cgajate@usal.es; fmollin@usal.es	González-Camacho, Fernando/P-1610-2014; 2009, Secribsal/A-1266-2012	Gajate, Consuelo/0000-0003-0604-6459; Gonzalez-Camacho, Fernando/0000-0003-3175-9004	Fondo de Investigacion Sanitaria and European Commission [06/0813]; Ministerio de Ciencia e Innovacion of Spain [SAF2008-02251, RD06/0020/1037]; Junta de Castilla y Leon [CSI01A08, SAN673/SA32/08]; Fundacion la Caixa [BM05-30-0]; Fundacion de Investigacion Medica Mutua Madrilena; Ramon y Cajal Program from the Ministerio de Ciencia e Innovacion of Spain	Fondo de Investigacion Sanitaria and European Commission(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Fundacion la Caixa(La Caixa Foundation); Fundacion de Investigacion Medica Mutua Madrilena; Ramon y Cajal Program from the Ministerio de Ciencia e Innovacion of Spain	This work was supported by grants from Fondo de Investigacion Sanitaria and European Commission (FIS-FEDER 06/0813), Ministerio de Ciencia e Innovacion of Spain (SAF2008-02251 and RD06/0020/1037 - Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III), Junta de Castilla y Leon (CSI01A08, SAN673/SA32/08, and GR15 - Experimental Therapeutics and Translational Oncology Program), Fundacion la Caixa (BM05-30-0), and Fundacion de Investigacion Medica Mutua Madrilena (FMM). CG is supported by the Ramon y Cajal Program from the Ministerio de Ciencia e Innovacion of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabaner C, 1999, BRIT J PHARMACOL, V127, P813, DOI 10.1038/sj.bjp.0702606; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Christian AE, 1997, J LIPID RES, V38, P2264; Delmas D, 2003, J BIOL CHEM, V278, P41482, DOI 10.1074/jbc.M304896200; Gajate C, 2000, INT J CANCER, V85, P674, DOI 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z; Gajate C, 2005, J BIOL CHEM, V280, P11641, DOI 10.1074/jbc.M411781200; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Gajate C, 2000, INT J CANCER, V86, P208, DOI 10.1002/(SICI)1097-0215(20000415)86:2<208::AID-IJC10>3.0.CO;2-E; Gajate C, 2003, CLIN CANCER RES, V9, P1535; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Gajate C, 1998, MOL PHARMACOL, V53, P602, DOI 10.1124/mol.53.4.602; Gajate C, 2007, BLOOD, V109, P711, DOI 10.1182/blood-2006-04-016824; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hofmann TG, 2001, INT J CANCER, V93, P185, DOI 10.1002/ijc.1316; Hueber AO, 2002, EMBO REP, V3, P190, DOI 10.1093/embo-reports/kvf022; KELLEY EE, 1993, BIOCHEM PHARMACOL, V45, P2435, DOI 10.1016/0006-2952(93)90224-K; Lacour S, 2004, CANCER RES, V64, P3593, DOI 10.1158/0008-5472.CAN-03-2787; Mollinedo F, 2003, J IMMUNOL, V170, P1034, DOI 10.4049/jimmunol.170.2.1034; Mollinedo F, 1997, CANCER RES, V57, P1320; MOLLINEDO F, 1994, BIOCHEM J, V302, P325, DOI 10.1042/bj3020325; Mollinedo F, 2007, EXPERT OPIN THER PAT, V17, P385, DOI 10.1517/13543776.17.4.385; Mollinedo F, 2006, DRUG RESIST UPDATE, V9, P51, DOI 10.1016/j.drup.2006.04.002; Mollinedo Faustino, 2006, P13; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Nieto-Miguel T, 2007, CANCER RES, V67, P10368, DOI 10.1158/0008-5472.CAN-07-0278; Nieto-Miguel T, 2006, J BIOL CHEM, V281, P14833, DOI 10.1074/jbc.M511251200; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Ruiter GA, 1999, CANCER RES, V59, P2457; Scheel-Toellner D, 2002, BIOCHEM BIOPH RES CO, V297, P876, DOI 10.1016/S0006-291X(02)02311-2; SCHON A, 1989, BIOCHEMISTRY-US, V28, P5019, DOI 10.1021/bi00438a017; Tanaka M, 1997, J IMMUNOL, V158, P2303; Tsutsumi T, 1998, BBA-LIPID LIPID MET, V1390, P73, DOI 10.1016/S0005-2760(97)00171-9; van der Luit AH, 2007, MOL CANCER THER, V6, P2337, DOI 10.1158/1535-7163.MCT-07-0202; Zaremberg V, 2005, J BIOL CHEM, V280, P38047, DOI 10.1074/jbc.M502849200	36	90	91	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5044	10.1371/journal.pone.0005044	http://dx.doi.org/10.1371/journal.pone.0005044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352436	Green Submitted, gold, Green Published			2022-12-27	WOS:000265505300007
J	Jobe, O; Donofrio, G; Sun, GP; Liepinsh, D; Schwenk, R; Krzych, U				Jobe, Ousman; Donofrio, Gina; Sun, Guangping; Liepinsh, Dmitry; Schwenk, Robert; Krzych, Urszula			Immunization with Radiation-Attenuated Plasmodium berghei Sporozoites Induces Liver cCD8 alpha+DC that Activate CD8(+)T Cells against Liver-Stage Malaria	PLOS ONE			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; ANTIGEN-PRESENTING FUNCTIONS; CD8 T-CELLS; PROTECTIVE IMMUNITY; PROTRACTED PROTECTION; BACTERIAL-ANTIGENS; CROSS-PRESENTATION; CUTTING EDGE; IN-VITRO; SPLEEN	Immunization with radiation (gamma)-attenuated Plasmodia sporozoites (gamma-spz) confers sterile and long-lasting immunity against malaria liver-stage infection. In the P. berghei gamma-spz model, protection is linked to liver CD8(+) T cells that express an effector/memory (T-EM) phenotype, (CD(44hi)CD45RB(lo)CD62L(lo)), and produce IFN-gamma. However, neither the antigen presenting cells (APC) that activate these CD8(+) T-EM cells nor the site of their induction have been fully investigated. Because conventional (c) CD8 alpha(+) DC (a subset of CD11c(+) DC) are considered the major inducers of CD8(+) T cells, in this study we focused primarily on cCD8 alpha(+) DC from livers of mice immunized with Pb gamma-spz and asked whether the cCD8 alpha(+) DC might be involved in the activation of CD8(+) T-EM cells. We demonstrate that multiple exposures of mice to Pb gamma-spz lead to a progressive and nearly concurrent accumulation in the liver but not the spleen of both the CD11c(+)NK1.1(-) DC and CD8(+) T-EM cells. Upon adoptive transfer, liver CD11c(+)NK1.1(-) DC from Pb gamma-spz-immunized mice induced protective immunity against sporozoite challenge. Moreover, in an in vitro system, liver cCD8 alpha(+) DC induced naive CD8(+) T cells to express the CD8(+) T-EM phenotype and to secrete IFN-gamma. The in vitro induction of functional CD8(+) T-EM cells by cCD8 alpha(+) DC was inhibited by anti-MHC class I and anti-IL-12 mAbs. These data suggest that liver cCD8 alpha(+) DC present liver-stage antigens to activate CD8(+) T-EM cells, the pre-eminent effectors against pre-erythrocytic malaria. These results provide important implications towards a design of anti-malaria vaccines.	[Jobe, Ousman; Donofrio, Gina; Sun, Guangping; Liepinsh, Dmitry; Schwenk, Robert; Krzych, Urszula] Walter Reed Army Inst Res, Dept Cellular Immunol, Div Malaria Vaccine Dev, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Jobe, O (corresponding author), Walter Reed Army Inst Res, Dept Cellular Immunol, Div Malaria Vaccine Dev, Silver Spring, MD USA.	urszula.krzych@.amedd.army.mil			NIH (UK) [AI43411]; US Medical Research and Materiel Command; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI043411, R01AI046438] Funding Source: NIH RePORTER	NIH (UK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by NIH grant AI43411 (UK) and US Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjuere F, 1999, BLOOD, V93, P590, DOI 10.1182/blood.V93.2.590.402k11_590_598; BACKER R, 2008, EUR J IMMUNOL; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Berenzon D, 2003, J IMMUNOL, V171, P2024, DOI 10.4049/jimmunol.171.4.2024; Bertolino P, 2001, J IMMUNOL, V166, P5430, DOI 10.4049/jimmunol.166.9.5430; Bruna-Romero O, 2001, INFECT IMMUN, V69, P5173, DOI 10.1128/IAI.69.8.5173-5176.2001; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Chen L, 2007, J LEUKOCYTE BIOL, V81, P1422, DOI 10.1189/jlb.1106674; Chung Y, 2007, EUR J IMMUNOL, V37, P1453, DOI 10.1002/eji.200636544; De Smedt T, 2001, J LEUKOCYTE BIOL, V69, P951; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Doolan DL, 1999, J IMMUNOL, V163, P884; Garrigan K, 1996, BLOOD, V88, P3508, DOI 10.1182/blood.V88.9.3508.bloodjournal8893508; Grauer O, 2002, HISTOCHEM CELL BIOL, V117, P351, DOI 10.1007/s00418-002-0384-4; Hammad H, 2004, CLIN EXP ALLERGY, V34, P1834, DOI 10.1111/j.1365-2222.2004.02133.x; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 1997, NAT MED, V3, P80, DOI 10.1038/nm0197-80; Jewell NA, 2007, J VIROL, V81, P9790, DOI 10.1128/JVI.00530-07; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Johansson C, 2004, J IMMUNOL, V172, P2496, DOI 10.4049/jimmunol.172.4.2496; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kawamura K, 2006, BLOOD, V107, P1031, DOI 10.1182/blood-2005-04-1737; Klein I, 2006, J EXP MED, V203, P437, DOI 10.1084/jem.20051775; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Leiriao P, 2005, J INFECT DIS, V191, P1576, DOI 10.1086/429635; Lian ZX, 2003, J IMMUNOL, V170, P2323, DOI 10.4049/jimmunol.170.5.2323; Matsuno K, 2000, INT REV CYTOL, V197, P83, DOI 10.1016/S0074-7696(00)97003-7; Matsuno Kenjiro, 2002, Dev Immunol, V9, P143, DOI 10.1080/1044667031000137610; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Mehal WZ, 1999, J IMMUNOL, V163, P3202; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Nardin E, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P397; O'Connell PJ, 2000, J IMMUNOL, V165, P795, DOI 10.4049/jimmunol.165.2.795; Pillarisetty VG, 2004, J IMMUNOL, V172, P1009, DOI 10.4049/jimmunol.172.2.1009; Plebanski M, 2005, IMMUNOL CELL BIOL, V83, P307, DOI 10.1111/j.1440-1711.2005.01325.x; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Pradel Gabriele, 2004, Comp Hepatol, V3 Suppl 1, pS47, DOI 10.1186/1476-5926-2-S1-S47; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; SCHELLER LF, 1995, P NATL ACAD SCI USA, V92, P4066, DOI 10.1073/pnas.92.9.4066; Schulz O, 2002, IMMUNOLOGY, V107, P183, DOI 10.1046/j.1365-2567.2002.01513.x; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P10700, DOI 10.1073/pnas.91.22.10700; SHIN SCJ, 1982, J PROTOZOOL, V29, P448, DOI 10.1111/j.1550-7408.1982.tb05431.x; Shu SA, 2007, CLIN EXP IMMUNOL, V149, P335, DOI 10.1111/j.1365-2249.2007.03419.x; Steers N, 2005, EUR J IMMUNOL, V35, P2335, DOI 10.1002/eji.200425680; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Valenzuela J, 2002, J IMMUNOL, V169, P6842, DOI 10.4049/jimmunol.169.12.6842; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; White KL, 1996, J IMMUNOL, V156, P3374; Wilson DC, 2008, J IMMUNOL, V180, P5935, DOI 10.4049/jimmunol.180.9.5935; Wilson NS, 2004, IMMUNOL CELL BIOL, V82, P91, DOI 10.1111/j.1440-1711.2004.01216.x; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Wuensch SA, 2006, J IMMUNOL, V177, P1689, DOI 10.4049/jimmunol.177.3.1689; Wykes MN, 2007, PLOS PATHOG, V3, P904, DOI 10.1371/journal.ppat.0030096	59	52	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2009	4	4							e5075	10.1371/journal.pone.0005075	http://dx.doi.org/10.1371/journal.pone.0005075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QB	19347042	Green Published, gold, Green Submitted			2022-12-27	WOS:000265500900003
J	Moroz, E; Carlin, S; Dyomina, K; Burke, S; Thaler, HT; Blasberg, R; Serganova, I				Moroz, Ekaterina; Carlin, Sean; Dyomina, Katerina; Burke, Sean; Thaler, Howard T.; Blasberg, Ronald; Serganova, Inna			Real-Time Imaging of HIF-1 alpha Stabilization and Degradation	PLOS ONE			English	Article								HIF-1 alpha is overexpressed in many human cancers compared to normal tissues due to the interaction of a multiplicity of factors and pathways that reflect specific genetic alterations and extracellular stimuli. We developed two HIF-1a chimeric reporter systems, HIF-1 alpha/FLuc and HIF-1 alpha(Delta ODDD)/FLuc, to investigate the tightly controlled level of HIF-1 alpha protein in normal (NIH3T3 and HEK293) and glioma (U87) cells. These reporter systems provided an opportunity to investigate the degradation of HIF-1 alpha in different cell lines, both in culture and in xenografts. Using immunofluorescence microscopy, we observed different patterns of subcellular localization of HIF-1 alpha/FLuc fusion protein between normal cells and cancer cells; similar differences were observed for HIF-1 alpha in non-transduced, wild-type cells. A dynamic cytoplasmic-nuclear exchange of the fusion protein and HIF-1 alpha was observed in NIH3T3 and HEK293 cells under different conditions (normoxia, CoCl(2) treatment and hypoxia). In contrast, U87 cells showed a more persistent nuclear localization pattern that was less affected by different growing conditions. Employing a kinetic model for protein degradation, we were able to distinguish two components of HIF-1 alpha/FLuc protein degradation and quantify the half-life of HIF-1 alpha fusion proteins. The rapid clearance component (t(1/2) similar to 4-6 min) was abolished by the hypoxia-mimetic CoCl(2), MG132 treatment and deletion of ODD domain, and reflects the oxygen/VHL-dependent degradation pathway. The slow clearance component (t(1/2) similar to 200 min) is consistent with other unidentified non-oxygen/VHL-dependent degradation pathways. Overall, the continuous bioluminescence readout of HIF-1 alpha/FLuc stabilization in vitro and in vivo will facilitate the development and validation of therapeutics that affect the stability and accumulation of HIF-1 alpha.	[Moroz, Ekaterina; Dyomina, Katerina; Blasberg, Ronald; Serganova, Inna] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Carlin, Sean; Burke, Sean] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Blasberg, Ronald] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Thaler, Howard T.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Moroz, E (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA.	blasberg@neuro1.mskcc.org		Serganova, Inna/0000-0003-3561-8663; Carlin, Sean/0000-0002-5401-0648	NIH [P50 CA86438-01, PO1 CA115675, P30 CA08748]; Byrne Foundation; NIH Small-Animal Imaging Research Program (SAIRP) [R24 CA83084]; Flow Cytometry Facility; NATIONAL CANCER INSTITUTE [R24CA083084, P50CA086438, P01CA115675, P30CA008748] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Byrne Foundation; NIH Small-Animal Imaging Research Program (SAIRP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flow Cytometry Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants P50 CA86438-01 and PO1 CA115675. The work of SC and SB is supported in part by the Byrne Foundation. Technical services were provided by the MSKCC Small-Animal Imaging Core Facility, supported in part by NIH Small-Animal Imaging Research Program (SAIRP) grant R24 CA83084 and NIH Center grant P30 CA08748 and Flow Cytometry Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Belozerov VE, 2005, ANTI-CANCER DRUG, V16, P901, DOI 10.1097/01.cad.0000180116.85912.69; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Brader P, 2007, MOL CANCER THER, V6, P2900, DOI 10.1158/1535-7163.MCT-07-0432; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Che Jiantu, 2005, Mol Imaging, V4, P128; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Creighton-Gutteridge M, 2007, CLIN CANCER RES, V13, P1010, DOI 10.1158/1078-0432.CCR-06-2301; Dekanty A, 2005, J CELL SCI, V118, P5431, DOI 10.1242/jcs.02648; Demidenko ZN, 2005, ONCOGENE, V24, P4829, DOI 10.1038/sj.onc.1208636; Di Cristofano C, 2007, AM J SURG PATHOL, V31, P1875, DOI 10.1097/PAS.0b013e318094fed8; Escuin D, 2005, CANCER RES, V65, P9021, DOI 10.1158/0008-5472.CAN-04-4095; Feldser D, 1999, CANCER RES, V59, P3915; Frede S, 2005, CANCER RES, V65, P4690, DOI 10.1158/0008-5472.CAN-04-3877; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Generali D, 2006, ENDOCR-RELAT CANCER, V13, P921, DOI 10.1677/erc.1.01216; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; HARADA H, 2008, J BIOL CHEM; Harada H, 2007, BIOCHEM BIOPH RES CO, V360, P791, DOI 10.1016/j.bbrc.2007.06.149; Harada H, 2005, MOL IMAGING, V4, P182; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Huang M, 2008, CIRCULATION, V118, pS226, DOI 10.1161/CIRCULATIONAHA.107.760785; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kaelin WG, 2002, GENE DEV, V16, P1441, DOI 10.1101/gad.1003602; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kaper F, 2006, CANCER RES, V66, P1561, DOI 10.1158/0008-5472.CAN-05-3375; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Kong XG, 2007, J BIOL CHEM, V282, P15498, DOI 10.1074/jbc.M700704200; Krishnamachary B, 2003, CANCER RES, V63, P1138; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lee S, 1999, MOL CELL BIOL, V19, P1486; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Liu Q, 2004, P NATL ACAD SCI USA, V101, P4302, DOI 10.1073/pnas.0400265101; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mylonis I, 2006, J BIOL CHEM, V281, P33095, DOI 10.1074/jbc.M605058200; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Ponomarev V, 2003, NEOPLASIA, V5, P245, DOI 10.1016/S1476-5586(03)80056-8; Pore N, 2006, MOL CANCER RES, V4, P471, DOI 10.1158/1541-7786.MCR-05-0234; Powis G, 2004, MOL CANCER THER, V3, P647; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rapisarda A, 2002, CANCER RES, V62, P4316; Robey IF, 2005, NEOPLASIA, V7, P324, DOI 10.1593/neo.04430; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2006, EXPERT OPIN THER TAR, V10, P267, DOI 10.1517/14728222.10.2.267; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SEMENZA GL, 2006, NOVART FDN SYMP, V272, P33, DOI DOI 10.1002/9780470035009.CH2; SEMENZA GL, 2006, NOVART FDN SYMP, V272, P8, DOI DOI 10.1002/9780470035009.CH2; Semenza Gregg L, 2006, Novartis Found Symp, V272, P2; Serganova I, 2004, CANCER RES, V64, P6101, DOI 10.1158/0008-5472.CAN-04-0842; Stolze I, 2002, BLOOD, V100, P2623, DOI 10.1182/blood-2001-12-0169; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tan C, 2005, CANCER RES, V65, P605; Viola RJ, 2008, AM J ROENTGENOL, V191, P1779, DOI 10.2214/AJR.07.4060; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wiedmann MW, 2005, CURR CANCER DRUG TAR, V5, P171, DOI 10.2174/1568009053765771; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Yeom CJ, 2008, J NUCL MED, V49, P1489, DOI 10.2967/jnumed.107.044461; Zheng XW, 2006, MOL CELL BIOL, V26, P4628, DOI 10.1128/MCB.02236-05; Zhong H, 1999, CANCER RES, V59, P5830; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391	75	82	88	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2009	4	4							e5077	10.1371/journal.pone.0005077	http://dx.doi.org/10.1371/journal.pone.0005077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QB	19347037	gold, Green Submitted, Green Published			2022-12-27	WOS:000265500900004
J	Qutob, D; Tedman-Jones, J; Dong, SM; Kuflu, K; Pham, H; Wang, YC; Dou, DL; Kale, SD; Arredondo, FD; Tyler, BM; Gijzen, M				Qutob, Dinah; Tedman-Jones, Jennifer; Dong, Suomeng; Kuflu, Kuflom; Pham, Hai; Wang, Yuanchao; Dou, Daolong; Kale, Shiv D.; Arredondo, Felipe D.; Tyler, Brett M.; Gijzen, Mark			Copy Number Variation and Transcriptional Polymorphisms of Phytophthora sojae RXLR Effector Genes Avr1a and Avr3a	PLOS ONE			English	Article								The importance of segmental duplications and copy number variants as a source of genetic and phenotypic variation is gaining greater appreciation, in a variety of organisms. Now, we have identified the Phytophthora sojae avirulence genes Avr1a and Avr3a and demonstrate how each of these Avr genes display copy number variation in different strains of P. sojae. The Avr1a locus is a tandem array of four near-identical copies of a 5.2 kb DNA segment. Two copies encoding Avr1a are deleted in some P. sojae strains, causing changes in virulence. In other P. sojae strains, differences in transcription of Avr1a result in gain of virulence. For Avr3a, there are four copies or one copy of this gene, depending on the P. sojae strain. In P. sojae strains with multiple copies of Avr3a, this gene occurs within a 10.8 kb segmental duplication that includes four other genes. Transcriptional differences of the Avr3a gene among P. sojae strains cause changes in virulence. To determine the extent of duplication within the superfamily of secreted proteins that includes Avr1a and Avr3a, predicted RXLR effector genes from the P. sojae and the P. ramorum genomes were compared by counting trace file matches from whole genome shotgun sequences. The results indicate that multiple, near-identical copies of RXLR effector genes are prevalent in oomycete genomes. We propose that multiple copies of particular RXLR effectors may contribute to pathogen fitness. However, recognition of these effectors by plant immune systems results in selection for pathogen strains with deleted or transcriptionally silenced gene copies.	[Qutob, Dinah; Tedman-Jones, Jennifer; Dong, Suomeng; Kuflu, Kuflom; Pham, Hai; Gijzen, Mark] Agr & Agri Food Canada, London, ON, Canada; [Dong, Suomeng; Wang, Yuanchao; Dou, Daolong] Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Peoples R China; [Dou, Daolong; Kale, Shiv D.; Arredondo, Felipe D.; Tyler, Brett M.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA USA	Agriculture & Agri Food Canada; Nanjing Agricultural University; Virginia Polytechnic Institute & State University	Qutob, D (corresponding author), Agr & Agri Food Canada, London, ON, Canada.	ark.gijzen@agr.gc.ca	Van Pham, Hai/AAA-5116-2022; Gijzen, Mark/C-6284-2011; Dou, Daolong/AAW-1678-2021; wang, yuanchao/G-9667-2011	Gijzen, Mark/0000-0002-3715-6389; Dou, Daolong/0000-0001-5226-6642; wang, yuanchao/0000-0001-5803-5343	Agriculture and Agri-Food Canada; Canadian Crop Genomics Initiative; National Research Initiative of the United States Department of Agriculture [2001-35319-14251, 2002-35600-12747, 2007-35319-18100, 2007-35600-18530]; United States National Science Foundation [MCB-0242131, MCB-0731969]	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Canadian Crop Genomics Initiative; National Research Initiative of the United States Department of Agriculture; United States National Science Foundation(National Science Foundation (NSF))	This research was supported by grants to MG from Agriculture and Agri-Food Canada, Canadian Crop Genomics Initiative, and to BMT from the National Research Initiative of the United States Department of Agriculture (2001-35319-14251, 2002-35600-12747, 2007-35319-18100 and 2007-35600-18530) and from the United States National Science Foundation (MCB-0242131 and MCB-0731969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BHAT RG, 1993, EXP MYCOL, V17, P122, DOI 10.1006/emyc.1993.1011; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Burnham KD, 2003, CROP SCI, V43, P1610, DOI 10.2135/cropsci2003.1610; Catanzariti AM, 2007, FEMS MICROBIOL LETT, V269, P181, DOI 10.1111/j.1574-6968.2007.00684.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; CHURCHILL GA, 1993, P NATL ACAD SCI USA, V90, P16, DOI 10.1073/pnas.90.1.16; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; FORSTER H, 1994, MOL PLANT MICROBE IN, V7, P780, DOI 10.1094/MPMI-7-0780; Gijzen M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-6; Grouffaud S, 2008, MICROBIOL-SGM, V154, P3743, DOI 10.1099/mic.0.2008/021964-0; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jiang RHY, 2006, GENOME RES, V16, P827, DOI 10.1101/gr.5193806; Jiang RHY, 2006, MOL PLANT MICROBE IN, V19, P1311, DOI 10.1094/MPMI-19-1311; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kasuga T, 1997, MOL PLANT MICROBE IN, V10, P1035, DOI 10.1094/MPMI.1997.10.9.1035; Korbel JO, 2008, CURR OPIN STRUC BIOL, V18, P366, DOI 10.1016/j.sbi.2008.02.005; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; MacGregor T, 2002, GENETICS, V160, P949; Mao YX, 1996, FUNGAL GENET BIOL, V20, P43, DOI 10.1006/fgbi.1996.0008; May KJ, 2002, FUNGAL GENET BIOL, V37, P1, DOI 10.1016/S1087-1845(02)00027-0; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Mideros S, 2007, PHYTOPATHOLOGY, V97, P655, DOI 10.1094/PHYTO-97-5-0655; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Qutob D, 2000, PLANT PHYSIOL, V123, P243, DOI 10.1104/pp.123.1.243; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Qutob D, 2006, PLANT CELL, V18, P3721, DOI 10.1105/tpc.106.044180; Qutob D, 2006, TRENDS MICROBIOL, V14, P470, DOI 10.1016/j.tim.2006.09.004; Ranathunge K, 2008, PHYTOPATHOLOGY, V98, P1179, DOI 10.1094/PHYTO-98-11-1179; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Rentel MC, 2008, P NATL ACAD SCI USA, V105, P1091, DOI 10.1073/pnas.0711215105; Sambrook J., 2002, MOL CLONING LAB MANU; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Sokal R.R., 2012, BIOMETRY; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tyler BM, 2002, ANNU REV PHYTOPATHOL, V40, P137, DOI 10.1146/annurev.phyto.40.120601.125310; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; WARD EWB, 1979, PHYTOPATHOLOGY, V69, P951, DOI 10.1094/Phyto-69-951; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Wrather JA, 2006, J NEMATOL, V38, P173; Zhang X, 2006, MOL PLANT MICROBE IN, V19, P1302, DOI 10.1094/MPMI-19-1302	52	107	114	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5066	10.1371/journal.pone.0005066	http://dx.doi.org/10.1371/journal.pone.0005066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343173	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500800007
J	Yan, YT; Dalmasso, G; Nguyen, HTT; Obertone, TS; Sitaraman, SV; Merlin, D				Yan, Yutao; Dalmasso, Guillaume; Nguyen, Hang Thi Thu; Obertone, Tracy S.; Sitaraman, Shanthi V.; Merlin, Didier			Ste20-Related Proline/Alanine-Rich Kinase (SPAK) Regulated Transcriptionally by Hyperosmolarity Is Involved in Intestinal Barrier Function	PLOS ONE			English	Article								The Ste20-related protein proline/alanine-rich kinase (SPAK) plays important roles in cellular functions such as cell differentiation and regulation of chloride transport, but its roles in pathogenesis of intestinal inflammation remain largely unknown. Here we report significantly increased SPAK expression levels in hyperosmotic environments, such as mucosal biopsy samples from patients with Crohn's disease, as well as colon tissues of C57BL/6 mice and Caco2-BBE cells treated with hyperosmotic medium. NF-kappa B and Sp1-binding sites in the SPAK TATA-less promoter are essential for SPAK mRNA transcription. Hyperosmolarity increases the ability of NF-kappa B and Sp1 to bind to their binding sites. Knock-down of either NF-kappa B or Sp1 by siRNA reduces the hyperosmolarity-induced SPAK expression levels. Furthermore, expression of NF-kappa B, but not Sp1, was upregulated by hyperosmolarity in vivo and in vitro. Nuclear run-on assays showed that hyperosmolarity increases SPAK expression levels at the transcriptional level, without affecting SPAK mRNA stability. Knockdown of SPAK expression by siRNA or overexpression of SPAK in cells and transgenic mice shows that SPAK is involved in intestinal permeability in vitro and in vivo. Together, our data suggest that SPAK, the transcription of which is regulated by hyperosmolarity, plays an important role in epithelial barrier function.	[Yan, Yutao; Dalmasso, Guillaume; Nguyen, Hang Thi Thu; Obertone, Tracy S.; Sitaraman, Shanthi V.; Merlin, Didier] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA	Emory University	Yan, YT (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	yyan2@emory.edu	Dalmasso, Guillaume/N-2443-2018; Nguyen, Hang/N-2441-2018	Dalmasso, Guillaume/0000-0002-3433-870X; Nguyen, Hang/0000-0001-7431-5126	National Institutes of Health of Diabetes and Digestive and Kidney Diseases [R24-DK-064399, RO1-DK-061941, RO1-DK55850]; Crohn's and Colitis Foundation of America [research fellowship]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, R01DK055850, R01DK061941] Funding Source: NIH RePORTER	National Institutes of Health of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health of Diabetes and Digestive and Kidney Diseases by grants R24-DK-064399 (center grant), RO1-DK-061941 (to D. Merlin), RO1-DK55850 (S. Sitaraman). Y. Yan is a recipient of a research fellowship award from the Crohn's and Colitis Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOLHASSANI M, 2008, INFLAMM RES; Asakawa H, 1997, J DIABETES COMPLICAT, V11, P176, DOI 10.1016/S1056-8727(97)00004-4; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; BAGNASCO SM, 1988, AM J PHYSIOL, V254, pC788, DOI 10.1152/ajpcell.1988.254.6.C788; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Baudouin-Legros M, 2000, AM J PHYSIOL-CELL PH, V278, pC49, DOI 10.1152/ajpcell.2000.278.1.C49; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; CHEROMCHA DP, 1988, DIGEST DIS SCI, V33, pS78, DOI 10.1007/BF01538135; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Craxton A, 1998, J IMMUNOL, V161, P3225; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Dignass AU, 2004, ALIMENT PHARM THER, V20, P9, DOI 10.1111/j.1365-2036.2004.02047.x; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Duzgun SA, 2000, J CELL BIOCHEM, V76, P567, DOI 10.1002/(SICI)1097-4644(20000315)76:4<567::AID-JCB5>3.0.CO;2-W; El-Sherbeny A, 2004, INVEST OPHTH VIS SCI, V45, P694, DOI 10.1167/iovs.03-0503; Endo J, 2000, FEBS LETT, V468, P234, DOI 10.1016/S0014-5793(00)01219-9; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Galvez AS, 2003, J BIOL CHEM, V278, P38484, DOI 10.1074/jbc.M211824200; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Garg P, 2006, J IMMUNOL, V177, P4103, DOI 10.4049/jimmunol.177.6.4103; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GNONI GV, 1985, BIOCHEM BIOPH RES CO, V128, P525, DOI 10.1016/0006-291X(85)90078-6; Gomez-Gonzalo M, 2001, J BIOL CHEM, V276, P35435, DOI 10.1074/jbc.M103020200; Goyette P, 2007, ANN MED, V39, P177, DOI 10.1080/07853890701197615; Hallows KR, 1996, J CELL PHYSIOL, V167, P60, DOI 10.1002/(SICI)1097-4652(199604)167:1<60::AID-JCP7>3.0.CO;2-A; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; Hashimoto S, 1999, AM J RESP CRIT CARE, V159, P634, DOI 10.1164/ajrccm.159.2.9712090; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hirano F, 1998, MOL CELL BIOL, V18, P1266, DOI 10.1128/MCB.18.3.1266; HIRAYAMA T, 1995, MOL GEN GENET, V249, P127, DOI 10.1007/BF00290358; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hollenbach E, 2004, FASEB J, V18, P1550, DOI 10.1096/fj.04-1642fje; Howe KL, 2005, AM J PATHOL, V167, P1587, DOI 10.1016/S0002-9440(10)61243-6; Hubert A, 2004, BIOCHIMIE, V86, P533, DOI 10.1016/j.biochi.2004.07.009; Ilic D, 2007, AM J PATHOL, V170, P2055, DOI 10.2353/ajpath.2007.061277; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; Katsuyama I, 2003, J OCUL PHARMACOL TH, V19, P281, DOI 10.1089/108076803321908400; KATZ KD, 1989, GASTROENTEROLOGY, V97, P927, DOI 10.1016/0016-5085(89)91499-6; KERR LD, 1993, NATURE, V365, P412, DOI 10.1038/365412a0; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Kyriakis JM, 1999, J BIOL CHEM, V274, P5259, DOI 10.1074/jbc.274.9.5259; Lang KS, 2003, AM J PHYSIOL-CELL PH, V284, pC200, DOI 10.1152/ajpcell.00259.2002; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li DQ, 2004, INVEST OPHTH VIS SCI, V45, P4302, DOI 10.1167/iovs.04-0299; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Li YQ, 2004, EMBO J, V23, P1112, DOI 10.1038/sj.emboj.7600125; Loitsch SM, 2000, BIOCHEM BIOPH RES CO, V276, P571, DOI 10.1006/bbrc.2000.3504; Luo LH, 2007, CORNEA, V26, P452, DOI 10.1097/ICO.0b013e318030d259; Luo Lihui, 2005, Eye Contact Lens, V31, P186, DOI 10.1097/01.ICL.0000162759.79740.46; MORIYAMA T, 1989, J BIOL CHEM, V264, P16810; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; Nemeth ZH, 2002, AM J PATHOL, V161, P987, DOI 10.1016/S0002-9440(10)64259-9; Nguyen M, 2007, J EXP MED, V204, P1383, DOI 10.1084/jem.20061205; NWAGWU M, 1980, J EMBRYOL EXP MORPH, V56, P253; Ochi H, 2002, EUR J IMMUNOL, V32, P1821, DOI 10.1002/1521-4141(200207)32:7<1821::AID-IMMU1821>3.0.CO;2-A; Omori K, 2007, AM J PHYSIOL-CELL PH, V293, pC1523, DOI 10.1152/ajpcell.00524.2006; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Poli A, 2002, MICROCIRCULATION, V9, P419, DOI 10.1038/sj.mn.7800149; Rizoli SB, 2000, AM J PHYSIOL-CELL PH, V279, pC619, DOI 10.1152/ajpcell.2000.279.3.C619; Safdar Z, 2003, J CLIN INVEST, V112, P1541, DOI 10.1172/JCI200318370; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; SANCEAU J, 1995, J BIOL CHEM, V270, P27920, DOI 10.1074/jbc.270.46.27920; SANDLE GI, 1990, GASTROENTEROLOGY, V99, P97, DOI 10.1016/0016-5085(90)91235-X; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; SCHILLI R, 1982, GUT, V23, P326, DOI 10.1136/gut.23.4.326; Schweigel M, 2005, J COMP PHYSIOL B, V175, P575, DOI 10.1007/s00360-005-0021-3; Shapiro L, 1997, EXP CELL RES, V231, P354, DOI 10.1006/excr.1997.3476; SHASBY DM, 1982, CIRC RES, V51, P657, DOI 10.1161/01.RES.51.5.657; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; SHU HB, 1993, MOL CELL BIOL, V13, P6283, DOI 10.1128/MCB.13.10.6283; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Stockton RA, 2004, J BIOL CHEM, V279, P46621, DOI 10.1074/jbc.M408877200; Stockton R, 2007, MOL BIOL CELL, V18, P2346, DOI 10.1091/mbc.E06-07-0584; Topper JN, 1997, J CLIN INVEST, V99, P2941, DOI 10.1172/JCI119489; VERNIA P, 1988, DIGEST DIS SCI, V33, P1353, DOI 10.1007/BF01536987; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; Wagner S, 2002, J BIOL CHEM, V277, P37685, DOI 10.1074/jbc.M205899200; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yan Y, 2007, BBA-GENE STRUCT EXPR, V1769, P106, DOI 10.1016/j.bbaexp.2007.01.003; Yan Y, 2008, AM J PATHOL, V173, P1013, DOI 10.2353/ajpath.2008.080339; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; ZENZIEGREGORY B, 1993, MOL CELL BIOL, V13, P3841, DOI 10.1128/MCB.13.7.3841; ZHANG DE, 1994, J BIOL CHEM, V269, P11425; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	97	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5049	10.1371/journal.pone.0005049	http://dx.doi.org/10.1371/journal.pone.0005049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343169	gold, Green Submitted, Green Published			2022-12-27	WOS:000265500800006
J	Wang, Y; Amdam, GV; Rueppell, O; Wallrichs, MA; Fondrk, MK; Kaftanoglu, O; Page, RE				Wang, Ying; Amdam, Gro V.; Rueppell, Olav; Wallrichs, Megan A.; Fondrk, M. Kim; Kaftanoglu, Osman; Page, Robert E., Jr.			PDK1 and HR46 Gene Homologs Tie Social Behavior to Ovary Signals	PLOS ONE			English	Article							REPRODUCTIVE GROUND-PLAN; COLONY-LEVEL SELECTION; PROGRAMMED CELL-DEATH; APIS-MELLIFERA; HONEY-BEE; JUVENILE-HORMONE; EXPRESSION; RECEPTOR; DIFFERENTIATION; ARCHITECTURE	The genetic basis of division of labor in social insects is a central question in evolutionary and behavioral biology. The honey bee is a model for studying evolutionary behavioral genetics because of its well characterized age-correlated division of labor. After an initial period of within-nest tasks, 2-3 week-old worker bees begin foraging outside the nest. Individuals often specialize by biasing their foraging efforts toward collecting pollen or nectar. Efforts to explain the origins of foraging specialization suggest that division of labor between nectar and pollen foraging specialists is influenced by genes with effects on reproductive physiology. Quantitative trait loci (QTL) mapping of foraging behavior also reveals candidate genes for reproductive traits. Here, we address the linkage of reproductive anatomy to behavior, using backcross QTL analysis, behavioral and anatomical phenotyping, candidate gene expression studies, and backcross confirmation of gene-to-anatomical trait associations. Our data show for the first time that the activity of two positional candidate genes for behavior, PDK1 and HR46, have direct genetic relationships to ovary size, a central reproductive trait that correlates with the nectar and pollen foraging bias of workers. These findings implicate two genes that were not known previously to influence complex social behavior. Also, they outline how selection may have acted on gene networks that affect reproductive resource allocation and behavior to facilitate the evolution of social foraging in honey bees.	[Wang, Ying; Amdam, Gro V.; Fondrk, M. Kim; Kaftanoglu, Osman; Page, Robert E., Jr.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Amdam, Gro V.] Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Rueppell, Olav; Wallrichs, Megan A.] Univ N Carolina Greensboro, Dept Biol, Greensboro, NC USA	Arizona State University; Arizona State University-Tempe; Norwegian University of Life Sciences; University of North Carolina; University of North Carolina Greensboro	Wang, Y (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	ying.wang.6@asu.edu	Wang, Ying/H-1172-2012; Rueppell, Olav/G-2679-2010	Rueppell, Olav/0000-0001-5370-4229	NIA [PO1 AG22500]; NSF [0615502]; Norwegian Research Council [175413, 180504, 185306]; PEW Foundation; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NSF(National Science Foundation (NSF)); Norwegian Research Council(Research Council of NorwayEuropean Commission); PEW Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the NIA grant PO1 AG22500 to R. E. Page Jr., NSF grant #0615502 to O. Rueppell and G.V. Amdam, and Norwegian Research Council 175413, 180504 and 185306, and the PEW Foundation to G.V. Amdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1003; Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Barchuk Angel Roberto, 2002, Journal of Insect Science (Tucson), V2, P1; Brotherton PNM, 2001, BEHAV ECOL, V12, P590, DOI 10.1093/beheco/12.5.590; CALDERONE NW, 1992, BEHAV ECOL SOCIOBIOL, V30, P219, DOI 10.1007/BF00166706; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Capella ICS, 2002, CELL TISSUE RES, V307, P265, DOI 10.1007/s00441-001-0490-y; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; DEBORAHSMITHA, 1997, BEHAV ECOL, V8, P384; Drummond-Barbosa D, 2004, DEV BIOL, V266, P310, DOI 10.1016/j.ydbio.2003.10.028; FAULKES CG, 1991, J REPROD FERTIL, V93, P427; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; Humphries MA, 2003, J COMP PHYSIOL A, V189, P555, DOI 10.1007/s00359-003-0433-z; HUNT GJ, 1995, GENETICS, V141, P1537; Hunt GJ, 2007, NATURWISSENSCHAFTEN, V94, P247, DOI 10.1007/s00114-006-0183-1; Jiang CA, 2000, MOL CELL, V5, P445, DOI 10.1016/S1097-2765(00)80439-6; Kapitskaya MZ, 2000, MOL CELL ENDOCRINOL, V160, P25, DOI 10.1016/S0303-7207(99)00253-1; Kethidi DR, 2005, J INSECT PHYSIOL, V51, P393, DOI 10.1016/j.jinsphys.2004.12.007; Labuhn M, 1997, GERONTOLOGY, V43, P261; Lam G, 1999, DEV BIOL, V212, P204, DOI 10.1006/dbio.1999.9343; Lam GT, 1997, DEVELOPMENT, V124, P1757; Lee CY, 2002, DEV BIOL, V252, P138, DOI 10.1006/dbio.2002.0838; Lindauer M., 1953, BEE WORLD, V34, P63, DOI [10.1080/0005772X.1953.11094788, DOI 10.1080/0005772X.1953.11094788]; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; NICOLE B, 2008, PHYSIOL BEHAV, V94, P349; Oldroyd BP, 2008, PLOS BIOL, V6, P463, DOI 10.1371/journal.pbio.0060056; Orgogozo V, 2006, GENETICS, V173, P197, DOI 10.1534/genetics.105.054098; PAGE RE, 1995, BEHAV ECOL SOCIOBIOL, V36, P135, DOI 10.1007/BF00170718; Page RE, 2000, J HERED, V91, P474, DOI 10.1093/jhered/91.6.474; Page RE, 2007, BIOESSAYS, V29, P334, DOI 10.1002/bies.20549; Page RE, 2006, CURR TOP DEV BIOL, V74, P253, DOI 10.1016/S0070-2153(06)74008-X; Page Robert E. Jr, 2009, P357; Pankiw T, 2003, J COMP PHYSIOL A, V189, P675, DOI 10.1007/s00359-003-0442-y; Pankiw T, 2001, BEHAV ECOL SOCIOBIOL, V51, P87, DOI 10.1007/s002650100408; Ragoussis J, 2006, PLOS GENET, V2, P920, DOI 10.1371/journal.pgen.0020100; Richard DS, 2005, J INSECT PHYSIOL, V51, P455, DOI 10.1016/j.jinsphys.2004.12.013; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; ROBINSON GE, 1991, J INSECT PHYSIOL, V37, P929, DOI 10.1016/0022-1910(91)90008-N; Rueppell O, 2008, J INSECT BEHAV, V21, P317, DOI 10.1007/s10905-008-9135-2; Rueppell O, 2006, GENETICS, V172, P243, DOI 10.1534/genetics.105.046490; Rueppell O, 2004, GENETICS, V167, P1767, DOI 10.1534/genetics.103.021949; Ruppell O, 2004, J HERED, V95, P481, DOI 10.1093/jhered/esh072; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schug MD, 2004, GENET RES, V83, P19, DOI 10.1017/S0016672303006542; Solignac M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r66; Sullivan AA, 2003, MOL ENDOCRINOL, V17, P2125, DOI 10.1210/me.2002-0430; Szathmary E, 1995, MAJOR TRANSITIONS EV; Takemoto K, 2007, P NATL ACAD SCI USA, V104, P13367, DOI 10.1073/pnas.0702733104; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Tsuruda JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003397; West-Eberhard M.J., 1987, P35; West-Eberhard Mary Jane, 1996, P290; Whitfield CW, 2006, SCIENCE, V314, P642, DOI 10.1126/science.1132772; WINSTON ML, 1987, BIOL HONEY BEE, P235; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011	61	45	45	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e4899	10.1371/journal.pone.0004899	http://dx.doi.org/10.1371/journal.pone.0004899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340296	Green Published, gold, Green Submitted			2022-12-27	WOS:000265500700002
J	Zvuloni, A; Artzy-Randrup, Y; Stone, L; Kramarsky-Winter, E; Barkan, R; Loya, Y				Zvuloni, Assaf; Artzy-Randrup, Yael; Stone, Lewi; Kramarsky-Winter, Esti; Barkan, Roy; Loya, Yossi			Spatio-Temporal Transmission Patterns of Black-Band Disease in a Coral Community	PLOS ONE			English	Article							REEF; SPREAD	Background: Transmission mechanisms of black-band disease (BBD) in coral reefs are poorly understood, although this disease is considered to be one of the most widespread and destructive coral infectious diseases. The major objective of this study was to assess transmission mechanisms of BBD in the field based on the spatio-temporal patterns of the disease. Methodology/Principal Findings: 3,175 susceptible and infected corals were mapped over an area of 10x10 m in Eilat (northern Gulf of Aqaba, Red Sea) and the distribution of the disease was examined monthly throughout almost two full disease cycles (June 2006-December 2007). Spatial and spatio-temporal analyses were applied to infer the transmission pattern of the disease and to calculate key epidemiological parameters such as R-0 (basic reproduction number). We show that the prevalence of the disease is strongly associated with high water temperature. When water temperatures rise and disease prevalence increases, infected corals exhibit aggregated distributions on small spatial scales of up to 1.9 m. Additionally, newly-infected corals clearly appear in proximity to existing infected corals and in a few cases in direct contact with them. We also present and test a model of water-borne infection, indicating that the likelihood of a susceptible coral becoming infected is defined by its spatial location and by the relative spatial distribution of nearby infected corals found in the site. Conclusions/Significance: Our results provide evidence that local transmission, but not necessarily by direct contact, is likely to be an important factor in the spread of the disease over the tested spatial scale. In the absence of potential disease vectors with limited mobility (e. g., snails, fireworms) in the studied site, water-borne infection is likely to be a significant transmission mechanism of BBD. Our suggested model of water-borne transmission supports this hypothesis. The spatio-temporal analysis also points out that infected corals surviving a disease season appear to play a major role in the reintroduction of the disease to the coral community in the following season.	[Zvuloni, Assaf; Kramarsky-Winter, Esti; Loya, Yossi] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Zvuloni, Assaf] Interuniv Inst Marine Sci Eilat, H Steinitz Marine Biol Lab, Elat, Israel; [Artzy-Randrup, Yael; Stone, Lewi] Tel Aviv Univ, Dept Zool, Biomathemat Unit, IL-69978 Tel Aviv, Israel; [Barkan, Roy] Tel Aviv Univ, Dept Geophys & Planet Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University	Zvuloni, A (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	zvolonia@post.tau.ac.il	Loya, Joseph/AAJ-9014-2020; Barkan, Roy/GZK-9665-2022; Loya, Yossi/J-3039-2012; Kramarsky-Winter, Esti/H-2205-2012	Loya, Yossi/0000-0001-6870-9444; Stone, Lewi/0000-0002-6465-579X	Israel Science Foundation (ISF); Tel Aviv University [Raynor Chair for Environmental Conservation Research]; World Bank and the Global Environmental Facility (GEF); Yeshaya Horowitz Center for Complexity Science; EU-ITC [EPIWORK]	Israel Science Foundation (ISF)(Israel Science Foundation); Tel Aviv University; World Bank and the Global Environmental Facility (GEF); Yeshaya Horowitz Center for Complexity Science; EU-ITC	This work was supported by: (1) the Israel Science Foundation (ISF) to YL and the Raynor Chair for Environmental Conservation Research Tel Aviv University to YL, and (2) the World Bank and the Global Environmental Facility (GEF) through the Coral Reef Targeted Research and Capacity Building for Management program, Coral Bleaching and Local Environmental Responses working group. YA-R was supported by the Yeshaya Horowitz Center for Complexity Science. LS acknowledges support from the EU-ITC grant EPIWORK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2006, MAR ECOL PROG SER, V318, P103, DOI 10.3354/meps318103; ANDERSON R M, 1991; Antonious A, 1973, ASS ISL MAR LAB CARI, V10, P3; Antonius A., 1988, P293; ANTONIUS A, 1985, PSZNI MAR ECOL, V6, P197; ANTONIUS A, 1981, 4TH P INT COR REEF S, V2, P3; BESAG J, 1977, J ROYAL STAT SOC B, V39, P193, DOI DOI 10.1016/J.FORECO.2009.04.009; Bruckner AW, 1997, B MAR SCI, V61, P919; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Diggle PJ, 1983, STAT ANAL SPATIAL PO; DINSDALE EA, 2002, P 9 INT COR REEF S B, V2, P1239; EDMUNDS PJ, 1991, CORAL REEFS, V10, P161, DOI 10.1007/BF00572175; Edmunds PJ, 2000, CORAL REEFS, V19, P69, DOI 10.1007/s003380050229; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Garzon-Ferreira J, 2001, HYDROBIOLOGIA, V460, P65, DOI 10.1023/A:1013133818360; Gil-Agudelo DL, 2001, B MAR SCI, V69, P619; Goreau TJ, 1998, REV BIOL TROP, V46, P157; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hayes RL, 1998, REV BIOL TROP, V46, P173; Jolles AE, 2002, ECOLOGY, V83, P2373, DOI 10.1890/0012-9658(2002)083[2373:DTOAIS]2.0.CO;2; Kuta KG, 1996, CORAL REEFS, V15, P219, DOI 10.1007/BF01787455; Kuta KG, 2002, CORAL REEFS, V21, P393, DOI 10.1007/s00338-002-0261-6; KUTA KG, 1997, P 8 INT COR REEF S, V1, P575; Mitchell R, 1975, MICROB ECOL, V2, P227, DOI 10.1007/BF02010442; Page C, 2006, DIS AQUAT ORGAN, V69, P41, DOI 10.3354/dao069041; Richardson LL, 1996, MICROBIAL ECOL, V32, P323; Richardson LL, 2004, CORAL HEALTH AND DISEASE, P325; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Ritchie KB, 2001, HYDROBIOLOGIA, V460, P131, DOI 10.1023/A:1013181718805; Roberts MG, 2007, J MATH BIOL, V55, P803, DOI 10.1007/s00285-007-0112-8; Rodriguez S, 2008, CORAL REEFS, V27, P381, DOI 10.1007/s00338-007-0341-8; ROSENBLATT M, 1956, ANN MATH STAT, V27, P832, DOI 10.1214/aoms/1177728190; Rutzler K, 1983, PSZNI MAR ECOL, V4, P329, DOI DOI 10.1111/J.1439-0485.1983.TB00118.X; Santavy D.L., 1997, P607; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Sussman M, 2003, ENVIRON MICROBIOL, V5, P250, DOI 10.1046/j.1462-2920.2003.00424.x; Sutherland KP, 2004, CORAL HEALTH AND DISEASE, P289; TAYLOR D, 1983, PSZNI MAR ECOL, V4, P320; Wand MP., 1994, KERNEL SMOOTHING; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; WEIL E, 2003, P 9 INT COR REEF S, V1, P1231; WEINBERG S, 1981, BIJDR DIERKD, V51, P199; Williams EH, 1990, ATOLL RES B, P330, DOI DOI 10.5479/SI.00775630.335.1; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Zvuloni A, 2008, LIMNOL OCEANOGR-METH, V6, P144, DOI 10.4319/lom.2008.6.144	50	56	56	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e4993	10.1371/journal.pone.0004993	http://dx.doi.org/10.1371/journal.pone.0004993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337384	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500600006
J	Fishburn, IS; Kareiva, P; Gaston, KJ; Armsworth, PR				Fishburn, Isla S.; Kareiva, Peter; Gaston, Kevin J.; Armsworth, Paul R.			The Growth of Easements as a Conservation Tool	PLOS ONE			English	Article								Background: The numerous studies examining where efforts to conserve biodiversity should be targeted are not matched by comparable research efforts addressing how conservation investments should be structured and what balance of conservation approaches works best in what contexts. An obvious starting point is to examine the past allocation of effort among conservation approaches and how this has evolved. Methodology/Principal Findings: We examine the past allocation of conservation investment between conservation easements and fee simple acquisitions using the largest land trust in operation, The Nature Conservancy (TNC), as a case study. We analyse the balance of investments across the whole of the US and in individual states when measured in terms of the area protected and upfront cost of protecting land. Conclusions/Significance: Across the US as a whole, the proportion of conservation investment allocated to easements is growing exponentially. Already 70% of the area of land protected in a given year, and half of all the financial investment in land conservation, is allocated to easements. The growth rate of conservation easements varies by a factor of two across states when measured in terms of the area protected and by a factor of three in terms of financial expenditure. Yet, we were unable to find consistent predictors that explained this variation. Our results underscore the urgency of implementing best practice guidelines for designing easements and of initiating a wider discussion of what balance of conservation approaches is desirable.	[Fishburn, Isla S.; Gaston, Kevin J.; Armsworth, Paul R.] Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England; [Kareiva, Peter] Santa Clara Univ Project Office, Nature Conservancy, Santa Clara, CA USA	University of Sheffield; Santa Clara University	Fishburn, IS (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England.	isla.fishburn@sheffield.ac.uk		Armsworth, Paul/0000-0003-0918-0573	Natural Environment Reserach Council, British Ecological Society	Natural Environment Reserach Council, British Ecological Society	Natural Environment Reserach Council, British Ecological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armsworth PR, 2008, CONSERV LETT, V1, P182, DOI 10.1111/j.1755-263X.2008.00028.x; Balmford A, 2005, GLOBAL CHANGE BIOL, V11, P1594, DOI 10.1111/j.1365-2486.2005.001035.x; BYERS E, 2005, CONSERVATION EASEMEN; *CPI, 2006, INFL CALC; Daily GC, 2001, NATURE, V411, P245, DOI 10.1038/35077178; Dana A., 1989, STAN ENV LJ, V8, P2; Di Leva C. E., 2002, REV EUR COMP INT ENV, V11, P84, DOI [10.1111/1467-9388.00305, DOI 10.1111/1467-9388.00305]; Environmental Law Institute, 2003, LEG TOOLS INC PRIV L; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; FISHBURN IS, 2009, CONSERVATIO IN PRESS, DOI DOI 10.1111/J.1755-263X.2008.00045; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Kiesecker JM, 2007, FRONT ECOL ENVIRON, V5, P125, DOI 10.1890/1540-9295(2007)5[125:CEICAQ]2.0.CO;2; Krebs C.J., 1999, ECOLOGICAL METHODOLO, P551; Land Trust Alliance (LTA), 2006, 2005 NAT LAND TRUST; *LTA, 2003, LAND TRUST ALL LAND; Matson PA, 2006, CONSERV BIOL, V20, P709, DOI 10.1111/j.1523-1739.2006.00442.x; Merenlender AM, 2004, CONSERV BIOL, V18, P65, DOI 10.1111/j.1523-1739.2004.00401.x; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; NATURESERVE, 2021, NATURESERVE EXPL; Newburn D, 2005, CONSERV BIOL, V19, P1411, DOI 10.1111/j.1523-1739.2005.00199.x; Parker, 2002, COST EFFECTIVE STRAT; Parker DP, 2004, NAT RESOUR J, V44, P483; Pimm S, 2006, P NATL ACAD SCI USA, V103, P10941, DOI 10.1073/pnas.0604181103; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rissman AR, 2007, CONSERV BIOL, V21, P709, DOI 10.1111/j.1523-1739.2007.00660.x; ROSENZWEIG ML, 2003, WIN WIN ECOLOGY EART, P172; Scherr SJ, 2008, PHILOS T R SOC B, V363, P477, DOI 10.1098/rstb.2007.2165; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Stephens S., 2001, Ecological Management & Restoration, V2, P189, DOI 10.1046/j.1442-8903.2001.00083.x; Stewart RR, 2007, CONSERV BIOL, V21, P346, DOI 10.1111/j.1523-1739.2006.00618.x; *US CENS BUR, 2004, CENS POP HOUS POP HO; Wilcove David S., 2000, P239; Wright JB, 1998, ENVIRON CONSERV, V25, P95, DOI 10.1017/S0376892998000149; *WWF, 2004, LIV PLAN REP 2004; Yuan-Farrell C, 2005, NAT AREA J, V25, P282	37	51	51	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2009	4	3							e4996	10.1371/journal.pone.0004996	http://dx.doi.org/10.1371/journal.pone.0004996			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PM	19325711	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000265499400004
J	Alsharifi, M; Furuya, Y; Bowden, TR; Lobigs, M; Koskinen, A; Regner, M; Trinidad, L; Boyle, DB; Mullbacher, A				Alsharifi, Mohammed; Furuya, Yoichi; Bowden, Timothy R.; Lobigs, Mario; Koskinen, Aulikki; Regner, Matthias; Trinidad, Lee; Boyle, David B.; Muellbacher, Arno			Intranasal Flu Vaccine Protective against Seasonal and H5N1 Avian Influenza Infections	PLOS ONE			English	Article								Background: Influenza A (flu) virus causes significant morbidity and mortality worldwide, and current vaccines require annual updating to protect against the rapidly arising antigenic variations due to antigenic shift and drift. In fact, current subunit or split flu vaccines rely exclusively on antibody responses for protection and do not induce cytotoxic T (Tc) cell responses, which are broadly cross-reactive between virus strains. We have previously reported that gamma-ray inactivated flu virus can induce cross-reactive Tc cell responses. Methodology/Principal Finding: Here, we report that intranasal administration of purified gamma-ray inactivated human influenza A virus preparations (gamma-Flu) effectively induces heterotypic and cross-protective immunity. A single intranasal administration of gamma-A/PR8[H1N1] protects mice against lethal H5N1 and other heterotypic infections. Conclusions/Significance: Intranasal gamma-Flu represents a unique approach for a cross-protective vaccine against both seasonal as well as possible future pandemic influenza A virus infections.			Alsharifi, M (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Canberra, ACT 2601, Australia.	mohammed.alsharifi@imvs.sa.gov.au; arno.mullbacher@anu.edu.au	Bowden, Timothy R/H-6362-2013; lobigs, mario/ABC-5711-2020					ADA GL, 1986, CURR TOP MICROBIOL, V128, P1; Alsharifi M, 2005, J IMMUNOL, V175, P4635, DOI 10.4049/jimmunol.175.7.4635; BENNINK J, 1978, IMMUNOLOGY, V35, P503; BRACIALE TJ, 1978, J EXP MED, V147, P1236, DOI 10.1084/jem.147.4.1236; *CDCP, 2008, FLUVIEW WEEKL INFL S; ELLIOTT LH, 1982, J CLIN MICROBIOL, V16, P704, DOI 10.1128/JCM.16.4.704-708.1982; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Heine HG, 2007, AVIAN DIS, V51, P370, DOI 10.1637/7587-040206R.1; *INT AT EN AG, 1973, TECHN REP SER INT AT, P62; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; LAVER WG, 1969, PURIFICATION INFLUEN, P82; Lowy RJ, 2001, ANTIVIR RES, V52, P261, DOI 10.1016/S0166-3542(01)00169-3; LUPTON HW, 1981, J INFECT DIS, V143, P291, DOI 10.1093/infdis/143.2.291; Moskophidis D, 1998, J EXP MED, V188, P223, DOI 10.1084/jem.188.2.223; Mullbacher A, 2006, LANCET INFECT DIS, V6, P255, DOI 10.1016/S1473-3099(06)70443-1; MULLBACHER A, 1988, IMMUNOL CELL BIOL, V66, P153, DOI 10.1038/icb.1988.19; Mullbacher A, 1999, EUR J IMMUNOL, V29, P1228; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roy S, 2007, VACCINE, V25, P6845, DOI 10.1016/j.vaccine.2007.07.035; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; WEISS AA, 2007, MICROBE, V2, P489	22	50	53	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5336	10.1371/journal.pone.0005336	http://dx.doi.org/10.1371/journal.pone.0005336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401775	Green Published, gold, Green Submitted			2022-12-27	WOS:000265601100005
J	Azad, P; Zhou, D; Russo, E; Haddad, GG				Azad, Priti; Zhou, Dan; Russo, Erilynn; Haddad, Gabriel G.			Distinct Mechanisms Underlying Tolerance to Intermittent and Constant Hypoxia in Drosophila melanogaster	PLOS ONE			English	Article								Background: Constant hypoxia (CH) and intermittent hypoxia (IH) occur during several pathological conditions such as asthma and obstructive sleep apnea. Our research is focused on understanding the molecular mechanisms that lead to injury or adaptation to hypoxic stress using Drosophila as a model system. Our current genome-wide study is designed to investigate gene expression changes and identify protective mechanism(s) in D. melanogaster after exposure to severe (1% O-2) intermittent or constant hypoxia. Methodology/Principal Findings: Our microarray analysis has identified multiple gene families that are up- or down-regulated in response to acute CH or IH. We observed distinct responses to IH and CH in gene expression that varied in the number of genes and type of gene families. We then studied the role of candidate genes (up- or down-regulated) in hypoxia tolerance (adult survival) for longer periods (CH-7 days, IH-10 days) under severe CH or IH. Heat shock proteins up-regulation (specifically Hsp23 and Hsp70) led to a significant increase in adult survival (as compared to controls) of P-element lines during CH. In contrast, during IH treatment the up- regulation of Mdr49 and l(2) 08717 genes (P-element lines) provided survival advantage over controls. This suggests that the increased transcript levels following treatment with either paradigm play an important role in tolerance to severe hypoxia. Furthermore, by over-expressing Hsp70 in specific tissues, we found that up- regulation of Hsp70 in heart and brain play critical role in tolerance to CH in flies. Conclusions/Significance: We observed that the gene expression response to IH or CH is specific and paradigm-dependent. We have identified several genes Hsp23, Hsp70, CG1600, l(2) 08717 and Mdr49 that play an important role in hypoxia tolerance whether it is in CH or IH. These data provide further clues about the mechanisms by which IH or CH lead to cell injury and morbidity or adaptation and survival.			Azad, P (corresponding author), Univ Calif San Diego, Dept Pediat, Sect Resp Med, La Jolla, CA 92093 USA.	ghaddad@ucsd.edu	Zhou, Dan/T-7203-2017	Zhou, Dan/0000-0001-6401-9040; Azad, Priti/0000-0002-7615-9507	NINDS NIH HHS [R01 NS037756] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037756] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beere HM, 2001, TRENDS CELL BIOL, V11, P6, DOI 10.1016/S0962-8924(00)01874-2; Bianchi-Frias D, 2004, PLOS BIOL, V2, P975, DOI 10.1371/journal.pbio.0020178; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; Chen L, 2004, MOL BRAIN RES, V131, P93, DOI 10.1016/j.molbrainres.2004.08.013; DAHLQUIST KD, 2004, CURR PROTOC BIOINFOR, pCH7; Dermaut B, 2005, J CELL BIOL, V170, P127, DOI 10.1083/jcb.200412001; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Douglas RM, 2007, AM J PHYSIOL-REG I, V292, pR1254, DOI 10.1152/ajpregu.00404.2006; Fan CH, 2005, PHYSIOL GENOMICS, V22, P292, DOI 10.1152/physiolgenomics.00217.2004; Farahani R, 2008, PEDIATR PULM, V43, P20, DOI 10.1002/ppul.20729; Fortini ME, 2000, J CELL BIOL, V150, pF23, DOI 10.1083/jcb.150.2.F23; Fortini ME, 2000, TRENDS GENET, V16, P161, DOI 10.1016/S0168-9525(99)01939-3; Gabai VL, 2002, MOL CELL BIOL, V22, P3415, DOI 10.1128/MCB.22.10.3415-3424.2002; Giffard RG, 2004, J EXP BIOL, V207, P3213, DOI 10.1242/jeb.01034; HADDAD GG, 1993, PROG NEUROBIOL, V40, P277, DOI 10.1016/0301-0082(93)90014-J; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; Han Z, 2006, DEVELOPMENT, V133, P1175, DOI 10.1242/dev.02285; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Huang H, 2007, PHYSIOL GENOMICS, V29, P260, DOI 10.1152/physiolgenomics.00166.2006; Iacobas DA, 2008, FUNCT INTEGR GENOMIC, V8, P265, DOI 10.1007/s10142-008-0082-y; Iacobas DA, 2006, BIOCHEM BIOPH RES CO, V349, P329, DOI 10.1016/j.bbrc.2006.08.056; Kanaan A, 2006, AM J PHYSIOL-REG I, V290, pR1105, DOI 10.1152/ajpregu.00535.2005; Krishnan SN, 1997, J INSECT PHYSIOL, V43, P203, DOI 10.1016/S0022-1910(96)00084-4; Laridon B, 2008, GENE EXPR PATTERNS, V8, P275, DOI 10.1016/j.gep.2007.12.003; Latchman DS, 2001, CARDIOVASC RES, V51, P637, DOI 10.1016/S0008-6363(01)00354-6; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lipton SA, 2001, NATURE, V413, P118, DOI 10.1038/35093186; Liu JC, 2007, CHINESE MED J-PEKING, V120, P578, DOI 10.1097/00029330-200704010-00010; Ma E, 2001, J CLIN INVEST, V107, P685, DOI 10.1172/JCI11625; Ma E, 1997, MOL BRAIN RES, V46, P325, DOI 10.1016/S0169-328X(97)00074-0; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Nanduri J, 2007, ESSAYS BIOCHEM, V43, P91, DOI 10.1042/bse0430091; Ratcliffe PJ, 2006, CLIN MED, V6, P573, DOI 10.7861/clinmedicine.6-6-573; SCHMAUSS C, 2002, SCI STKE, pPE26; Simonsen A, 2007, GENETICS, V176, P1283, DOI 10.1534/genetics.106.065011; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Trivedi Seema, 2007, Recent Pat DNA Gene Seq, V1, P134; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wreden CC, 2005, J BIOL CHEM, V280, P1408, DOI 10.1074/jbc.M411295200; WU CT, 1991, MOL CELL BIOL, V11, P3940, DOI 10.1128/MCB.11.8.3940; Wu W, 2008, PHYSIOL GENOMICS, V36, P24, DOI 10.1152/physiolgenomics.00258.2007; Xia SL, 2005, PHYSIOL GENOMICS, V20, P195, DOI 10.1152/physiolgenomics.00093.2003; YANG MY, 1995, NEURON, V15, P45; YAO KM, 1994, J NEUROCHEM, V63, P41; Yenari MA, 2002, ADV EXP MED BIOL, V513, P281; Yi P, 2006, SCIENCE, V313, P1301, DOI 10.1126/science.1127704; Yin J, 2006, CANCER RES, V66, P2937, DOI 10.1158/0008-5472.CAN-05-2615; Zhou D, 2008, PHYSIOL GENOMICS, V32, P370, DOI 10.1152/physiolgenomics.00147.2007; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490	50	68	70	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5371	10.1371/journal.pone.0005371	http://dx.doi.org/10.1371/journal.pone.0005371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401761	Green Published, gold, Green Submitted			2022-12-27	WOS:000265601100013
J	Yamauchi, K; Hasegawa, K; Chuma, S; Nakatsuji, N; Suemori, H				Yamauchi, Kaori; Hasegawa, Kouichi; Chuma, Shinichiro; Nakatsuji, Norio; Suemori, Hirofumi			In Vitro Germ Cell Differentiation from Cynomolgus Monkey Embryonic Stem Cells	PLOS ONE			English	Article								Background: Mouse embryonic stem (ES) cells can differentiate into female and male germ cells in vitro. Primate ES cells can also differentiate into immature germ cells in vitro. However, little is known about the differentiation markers and culture conditions for in vitro germ cell differentiation from ES cells in primates. Monkey ES cells are thus considered to be a useful model to study primate gametogenesis in vitro. Therefore, in order to obtain further information on germ cell differentiation from primate ES cells, this study examined the ability of cynomolgus monkey ES cells to differentiate into germ cells in vitro. Methods and Findings: To explore the differentiation markers for detecting germ cells differentiated from ES cells, the expression of various germ cell marker genes was examined in tissues and ES cells of the cynomolgus monkey (Macaca fascicularis). VASA is a valuable gene for the detection of germ cells differentiated from ES cells. An increase of VASA expression was observed when differentiation was induced in ES cells via embryoid body (EB) formation. In addition, the expression of other germ cell markers, such as NANOS and PIWIL1 genes, was also up-regulated as the EB differentiation progressed. Immunocytochemistry identified the cells expressing stage-specific embryonic antigen (SSEA) 1, OCT-4, and VASA proteins in the EBs. These cells were detected in the peripheral region of the EBs as specific cell populations, such as SSEA1-positive, OCT-4-positive cells, OCT-4-positive, VASA-positive cells, and OCT-4-negative, VASA-positive cells. Thereafter, the effect of mouse gonadal cell-conditioned medium and growth factors on germ cell differentiation from monkey ES cells was examined, and this revealed that the addition of BMP4 to differentiating ES cells increased the expression of SCP1, a meiotic marker gene. Conclusion: VASA is a valuable gene for the detection of germ cells differentiated from ES cells in monkeys, and the identification and characterization of germ cells derived from ES cells are possible by using reported germ cell markers in vivo, including SSEA1, OCT-4, and VASA, in vitro as well as in vivo. These findings are thus considered to help elucidate the germ cell developmental process in primates.			Yamauchi, K (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Stem Cell Res Ctr,Lab Embryon Stem Cell Res, Sakyo Ku, Kyoto, Japan.	hsuemori@frontier.kyoto-u.ac.jp	Hasegawa, Kouichi/Y-9349-2019	Hasegawa, Kouichi/0000-0001-5947-5471; Suemori, Hirofumi/0000-0002-3565-3111				Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2003, CYTOGENET GENOME RES, V101, P261, DOI 10.1159/000074346; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; Cairns LA, 2003, BLOOD, V102, P3954, DOI 10.1182/blood-2003-04-1296; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Caricasole AAD, 1998, ONCOGENE, V16, P95, DOI 10.1038/sj.onc.1201515; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chuma S, 2001, DEV BIOL, V229, P468, DOI 10.1006/dbio.2000.9989; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Costa Y, 2005, J CELL SCI, V118, P2755, DOI 10.1242/jcs.02402; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; DOBSON MJ, 1994, J CELL SCI, V107, P2749; Dong LW, 1996, J MOL RECOGNIT, V9, P383, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<383::AID-JMR269>3.0.CO;2-Z; FOX N, 1981, DEV BIOL, V83, P391, DOI 10.1016/0012-1606(81)90487-5; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; HEYTING C, 1988, CHROMOSOMA, V96, P325, DOI 10.1007/BF00286921; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Jaruzelska J, 2003, DEV GENES EVOL, V213, P120, DOI 10.1007/s00427-003-0303-2; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Kerr CL, 2008, HUM REPROD, V23, P589, DOI 10.1093/humrep/dem411; Kerr CL, 2008, STEM CELLS, V26, P412, DOI 10.1634/stemcells.2007-0605; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Lacham-Kaplan O, 2004, REPRODUCTION, V128, P147, DOI 10.1530/rep.1.00220; Lacham-Kaplan O, 2006, STEM CELLS, V24, P266, DOI 10.1634/stemcells.2005-0204; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; Larsson M, 2000, EUR J CELL BIOL, V79, P718, DOI 10.1078/0171-9335-00097; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; MCPHERRON AC, 1993, J BIOL CHEM, V268, P3444; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091, DOI 10.1002/j.1460-2075.1992.tb05616.x; Meuwissen RLJ, 1997, GENOMICS, V39, P377, DOI 10.1006/geno.1996.4373; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Mossman AK, 2005, STEM CELLS DEV, V14, P656, DOI 10.1089/scd.2005.14.656; Noce T, 2001, CELL STRUCT FUNCT, V26, P131, DOI 10.1247/csf.26.131; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohta H, 2000, DEVELOPMENT, V127, P2125; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Polisetty N, 2008, MOL VIS, V14, P431; Ponchel F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-18; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; SAGE J, 1995, BBA-GENE STRUCT EXPR, V1263, P258, DOI 10.1016/0167-4781(95)00126-2; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Stoop H, 2001, LAB INVEST, V81, P919, DOI 10.1038/labinvest.3780302; Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191; Suzuki A, 2007, DEVELOPMENT, V134, P77, DOI 10.1242/dev.02697; Teramura T, 2007, CLONING STEM CELLS, V9, P144, DOI 10.1089/clo.2006.0070; Tilgner K, 2008, STEM CELLS, V26, P3075, DOI 10.1634/stemcells.2008-0289; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Xu M, 2001, INT J BIOCHEM CELL B, V33, P1172, DOI 10.1016/S1357-2725(01)00089-9; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Ying Y, 2001, P NATL ACAD SCI USA, V98, P7858, DOI 10.1073/pnas.151242798; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594	71	47	53	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5338	10.1371/journal.pone.0005338	http://dx.doi.org/10.1371/journal.pone.0005338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399191	Green Submitted, Green Published, gold			2022-12-27	WOS:000265514900005
J	Hunt, WG; Watson, RT; Oaks, JL; Parish, CN; Burnham, KK; Tucker, RL; Belthoff, JR; Hart, G				Hunt, W. Grainger; Watson, Richard T.; Oaks, J. Lindsay; Parish, Chris N.; Burnham, Kurt K.; Tucker, Russell L.; Belthoff, James R.; Hart, Garret			Lead Bullet Fragments in Venison from Rifle-Killed Deer: Potential for Human Dietary Exposure	PLOS ONE			English	Article							BLOOD-LEAD; COGNITIVE FUNCTION; NORTHERN ONTARIO; 1ST NATIONS; BONE LEAD; MU-G/DL; SHOT; CHILDREN; PEOPLE; ADULTS	Human consumers of wildlife killed with lead ammunition may be exposed to health risks associated with lead ingestion. This hypothesis is based on published studies showing elevated blood lead concentrations in subsistence hunter populations, retention of ammunition residues in the tissues of hunter-killed animals, and systemic, cognitive, and behavioral disorders associated with human lead body burdens once considered safe. Our objective was to determine the incidence and bioavailability of lead bullet fragments in hunter-killed venison, a widely-eaten food among hunters and their families. We radiographed 30 eviscerated carcasses of White-tailed Deer (Odocoileus virginianus) shot by hunters with standard lead-core, copper-jacketed bullets under normal hunting conditions. All carcasses showed metal fragments (geometric mean = 136 fragments, range = 15-409) and widespread fragment dispersion. We took each carcass to a separate meat processor and fluoroscopically scanned the resulting meat packages; fluoroscopy revealed metal fragments in the ground meat packages of 24 (80%) of the 30 deer; 32% of 234 ground meat packages contained at least one fragment. Fragments were identified as lead by ICP in 93% of 27 samples. Isotope ratios of lead in meat matched the ratios of bullets, and differed from background lead in bone. We fed fragment-containing venison to four pigs to test bioavailability; four controls received venison without fragments from the same deer. Mean blood lead concentrations in pigs peaked at 2.29 mg/dL (maximum 3.8 mg/dL) 2 days following ingestion of fragment-containing venison, significantly higher than the 0.63 mg/dL averaged by controls. We conclude that people risk exposure to bioavailable lead from bullet fragments when they eat venison from deer killed with standard lead-based rifle bullets and processed under normal procedures. At risk in the U. S. are some ten million hunters, their families, and low-income beneficiaries of venison donations.			Hunt, WG (corresponding author), Peregrine Fund, Boise, ID USA.	grainger@peregrinefund.org	Fazli, Ghazal/AAE-8320-2022					AVERY D, 2009, INGESTION LEAD SPENT, DOI DOI 10.4080/ILSA.2009.0114; Bjerregaard P, 2004, ENVIRON HEALTH PERSP, V112, P1496, DOI 10.1289/ehp.7083; Borja-Aburto VH, 1999, AM J EPIDEMIOL, V150, P590, DOI 10.1093/oxfordjournals.aje.a010057; Braun JM, 2006, ENVIRON HEALTH PERSP, V114, P1904, DOI 10.1289/ehp.9478; Burger J, 1998, RISK ANAL, V18, P563, DOI 10.1023/B:RIAN.0000005931.39844.35; CARTER A, 2007, SHOOTING ILLUSTA JUL; *CDCP US, 1991, PREV LEAD POIS YOUNG; Cecil KM, 2008, PLOS MED, V5, P741, DOI 10.1371/journal.pmed.0050112; CORNATZER WE, 2009, INGESTION LEAD SPENT, DOI DOI 10.4080/ILSA.2009.0111; Dobrowolska A, 2008, EUR J WILDLIFE RES, V54, P231, DOI 10.1007/s10344-007-0134-y; Ekong EB, 2006, KIDNEY INT, V70, P2074, DOI 10.1038/sj.ki.5001809; Gilbert SG, 2006, NEUROTOXICOLOGY, V27, P693, DOI 10.1016/j.neuro.2006.06.008; Hanning RM, 2003, J ENVIRON MONITOR, V5, P241, DOI 10.1039/b208220a; Hauser R, 2008, ENVIRON HEALTH PERSP, V116, P976, DOI 10.1289/ehp.10516; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; Iqbal S., 2008, EPI AID TRIP REPORT; Johansen P, 2004, ENVIRON POLLUT, V127, P125, DOI 10.1016/S0269-7491(03)00255-0; Johansen P, 2006, ENVIRON POLLUT, V142, P93, DOI 10.1016/j.envpol.2005.09.015; Jusko TA, 2008, ENVIRON HEALTH PERSP, V116, P243, DOI 10.1289/ehp.10424; Krone O., 2009, INGESTION LEAD SPENT; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Levesque B, 2003, OCCUP ENVIRON MED, V60, P693, DOI 10.1136/oem.60.9.693; Levin R, 2008, ENVIRON HEALTH PERSP, V116, P1285, DOI 10.1289/ehp.11241; Lustberg M, 2002, ARCH INTERN MED, V162, P2443, DOI 10.1001/archinte.162.21.2443; Mateo R, 2007, SCI TOTAL ENVIRON, V372, P480, DOI 10.1016/j.scitotenv.2006.10.022; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; Needleman HL, 2002, NEUROTOXICOL TERATOL, V24, P711, DOI 10.1016/S0892-0362(02)00269-6; Schnaas L, 2006, ENVIRON HEALTH PERSP, V114, P791, DOI 10.1289/ehp.8552; Schwartz BS, 2007, INT REV PSYCHIATR, V19, P671, DOI 10.1080/09540260701797936; Shih RA, 2007, ENVIRON HEALTH PERSP, V115, P483, DOI 10.1289/ehp.9786; STROUD RK, 2009, INGESTION LEAD SPENT, DOI DOI 10.4080/ILSA.2009.0109; Tellez-Rojo MM, 2004, AM J EPIDEMIOL, V160, P668, DOI 10.1093/aje/kwh271; Titus K., 2009, INGESTION LEAD SPENT, P137; Tsuji LJS, 2008, B ENVIRON CONTAM TOX, V80, P14, DOI 10.1007/s00128-007-9281-9; Tsuji LJS, 2008, SCI TOTAL ENVIRON, V405, P180, DOI 10.1016/j.scitotenv.2008.06.048; Tsuji LJS, 2008, SCI TOTAL ENVIRON, V393, P291, DOI 10.1016/j.scitotenv.2008.01.022; *US EPA, 2007, EST REL BIOAV LEAD S; US Fish and Wildlife Service, 2006, 2006 NAT SURV FISH H; Warren C, 2000, BRUSH DEATH SOCIAL H; WATSON RT, 2009, INGESTION LEAD SPENT, DOI DOI 10.4080/ILSA.2009.0117; Wright JP, 2008, PLOS MED, V5, P732, DOI 10.1371/journal.pmed.0050101	42	115	118	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5330	10.1371/journal.pone.0005330	http://dx.doi.org/10.1371/journal.pone.0005330			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390698	Green Published, gold			2022-12-27	WOS:000265514400016
J	Cooper, KG; Zarnowski, R; Woods, JP				Cooper, Kendal G.; Zarnowski, Robert; Woods, Jon P.			Histoplasma capsulatum Encodes a Dipeptidyl Peptidase Active against the Mammalian Immunoregulatory Peptide, Substance P	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; ASPERGILLUS-FUMIGATUS; AMINOPEPTIDASE-M; GENE-EXPRESSION; IV; INFLAMMATION; DIPEPTIDYL(AMINO)PEPTIDASE-IV; PROTEINASES; SPECIFICITY; VIRULENCE	The pathogenic fungus Histoplasma capsulatum secretes dipeptidyl peptidase (Dpp) IV enzyme activity and has two putative DPPIV homologs (HcDPPIVA and HcDPPIVB). We previously showed that HcDPPIVB is the gene responsible for the majority of secreted DppIV activity in H. capsulatum culture supernatant, while we could not detect any functional contribution from HcDPPIVA. In order to determine whether HcDPPIVA encodes a functional DppIV enzyme, we expressed HcDPPIVA in Pichia pastoris and purified the recombinant protein. The recombinant enzyme cleaved synthetic DppIV substrates and had similar biochemical properties to other described DppIV enzymes, with temperature and pH optima of 42 degrees C and 8, respectively. Recombinant HcDppIVA cleaved the host immunoregulatory peptide substance P, indicating the enzyme has the potential to affect the immune response during infection. Expression of HcDPPIVA under heterologous regulatory sequences in H. capsulatum resulted in increased secreted DppIV activity, indicating that the encoded protein can be expressed and secreted by its native organism. However, HcDPPIVA was not required for virulence in a murine model of histoplasmosis. This work reports a fungal enzyme that can function to cleave the immunomodulatory host peptide substance P.			Woods, JP (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	jpwoods@wisc.edu	Zarnowski, Robert/A-2786-2009	Zarnowski, Robert/0000-0001-6343-1500	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052303] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL55949, R01 HL055949] Funding Source: Medline; NIAID NIH HHS [R01 AI52303, R01 AI052303] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aertgeerts K, 2004, PROTEIN SCI, V13, P145, DOI 10.1110/ps.03352504; AHMAD S, 1992, J PHARMACOL EXP THER, V260, P1257; Beauvais A, 1997, INFECT IMMUN, V65, P3042, DOI 10.1128/IAI.65.8.3042-3047.1997; Bhatia M, 2006, AM J PHYSIOL-LUNG C, V291, pL896, DOI 10.1152/ajplung.00053.2006; BLUM AM, 1993, J IMMUNOL, V151, P225; Bohse ML, 2007, INFECT IMMUN, V75, P2811, DOI 10.1128/IAI.00304-07; Cano M V, 2001, Semin Respir Infect, V16, P109; CASCIERI MA, 1992, MOL PHARMACOL, V41, P1096; Chien CH, 2006, BIOCHEMISTRY-US, V45, P7006, DOI 10.1021/bi060401c; Christensen JE, 2003, J BACTERIOL, V185, P3297, DOI 10.1128/JB.185.11.3297-3306.2003; Dickerson C, 1998, J LEUKOCYTE BIOL, V63, P602, DOI 10.1002/jlb.63.5.602; Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x; Grouzmann E, 2002, FASEB J, V16, P1132, DOI 10.1096/fj.01-0939fje; HUBE B, 1994, MOL MICROBIOL, V14, P87, DOI 10.1111/j.1365-2958.1994.tb01269.x; Kaufman G, 2005, INFECT IMMUN, V73, P6584, DOI 10.1128/IAI.73.10.6584-6590.2005; Kumagai Y, 2005, INFECT IMMUN, V73, P2655, DOI 10.1128/IAI.73.5.2655-2664.2005; Kumagai Y, 2000, INFECT IMMUN, V68, P716, DOI 10.1128/IAI.68.2.716-724.2000; Lambeir AM, 2001, FEBS LETT, V507, P327, DOI 10.1016/S0014-5793(01)02982-9; Landis BN, 2008, RESPIRATION, V75, P89, DOI 10.1159/000106267; Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x; Oravecz T, 1997, J EXP MED, V186, P1865, DOI 10.1084/jem.186.11.1865; Reinke E, 2006, IMMUNOL LETT, V104, P102, DOI 10.1016/j.imlet.2005.11.009; Rementeria Aitor, 2005, Revista Iberoamericana de Micologia, V22, P1, DOI 10.1016/S1130-1406(05)70001-2; Retallack DM, 1999, GENE, V230, P181, DOI 10.1016/S0378-1119(99)00071-2; Sandor M, 2003, TRENDS IMMUNOL, V24, P44, DOI 10.1016/S1471-4906(02)00006-6; Struyf S, 1999, J IMMUNOL, V162, P4903; Tartar A, 2004, MYCOPATHOLOGIA, V158, P201, DOI 10.1023/B:MYCO.0000041905.17948.42; WANG LH, 1991, PEPTIDES, V12, P1357, DOI 10.1016/0196-9781(91)90220-J; Weinstock JV, 2004, FRONT BIOSCI, V9, P1936, DOI 10.2741/1375; Weinstock JV, 1998, ANN NY ACAD SCI, V840, P532, DOI 10.1111/j.1749-6632.1998.tb09592.x; Woods JP, 1998, INFECT IMMUN, V66, P1697, DOI 10.1128/IAI.66.4.1697-1707.1998; Yagishita H, 2001, INFECT IMMUN, V69, P7159, DOI 10.1128/IAI.69.11.7159-7161.2001; Zarnowski R, 2008, MOL MICROBIOL, V70, P352, DOI 10.1111/j.1365-2958.2008.06410.x; Zarnowski R, 2007, DIAGN MICR INFEC DIS, V59, P39, DOI 10.1016/j.diagmicrobio.2007.03.020	34	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5281	10.1371/journal.pone.0005281	http://dx.doi.org/10.1371/journal.pone.0005281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384411	Green Published, Green Submitted, gold			2022-12-27	WOS:000265513900016
J	Frey, S; Balu, S; Greusing, S; Rothen, N; Cajochen, C				Frey, Sylvia; Balu, Silvia; Greusing, Sarah; Rothen, Nicolas; Cajochen, Christian			Consequences of the Timing of Menarche on Female Adolescent Sleep Phase Preference	PLOS ONE			English	Article							MORNINGNESS-EVENINGNESS; RECALLED AGE; MELATONIN; ACCURACY; PUBERTY; PATTERNS; ASSOCIATION; TEMPERATURE; EXCRETION; BEHAVIOR	Most parents experience their children's puberty as a dramatic change in family life. This is not surprising considering the dynamics of physical and psychosocial maturation which occur during adolescence. A reasonable question, particularly from the parents' perspective, is: when does this vibrant episode end and adulthood finally start? The aim of the present study was to assess the relationship between puberty and the changes in sleep phase preferences during female maturation and adulthood by a cross-sectional survey. The results from 1'187 females aged 5 to 51 years based on self-report measures of sleep preferences on weekdays and on free days as well as the occurrence of menarche, show that in contrast to prepubertal children, adolescent females exhibit a striking progression in delaying their sleep phase preference until 5 years after menarche. Thereafter, the sleep phase preference switches to advancing. The current study provides evidence that a clear shift in sleep-wake cycles temporally linked to menarche heralds the beginning of "adult-like'' sleep-wake behaviour in women and can be used as a (chrono) biological marker for the onset of adulthood.			Frey, S (corresponding author), Univ Basel, Ctr Chronobiol, Psychiat Univ Hosp, Basel, Switzerland.	silvia.frey@upkbs.ch	Rothen, Nicolas/A-2620-2012; Cajochen, Christian/N-6748-2014	Rothen, Nicolas/0000-0002-8874-8341; 				Acebo C, 2003, SLEEP, V26, pA113; AKERSTEDT T, 1976, BIOL PSYCHOL, V4, P277, DOI 10.1016/0301-0511(76)90019-3; BERGSTENBRUCEFORS A, 1976, ANN HUM BIOL, V3, P71, DOI 10.1080/03014467600001151; Biro FM, 2006, J PEDIATR-US, V148, P234, DOI 10.1016/j.jpeds.2005.10.020; Bogaert AF, 2005, J ADOLESCENCE, V28, P541, DOI 10.1016/j.adolescence.2004.10.008; Carrier J, 1997, J SLEEP RES, V6, P230, DOI 10.1111/j.1365-2869.1997.00230.x; CARSKADON M A, 1990, Pediatrician, V17, P5; CARSKADON MA, 1993, SLEEP, V16, P258, DOI 10.1093/sleep/16.3.258; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; CARSKADON MA, 1980, SLEEP, V2, P453; CAVALLO A, 1992, NEUROENDOCRINOLOGY, V55, P372, DOI 10.1159/000126147; CROWLEY SJ, 2008, PRACTICAL WEEKEND CA; Czeisler CA, 2000, PRINCIPLES PRACTICE, P353; DAMON A, 1974, HUM BIOL, V46, P381; DAMON A, 1969, HUM BIOL, V41, P161; Duffy JF, 2002, NEUROSCI LETT, V318, P117, DOI 10.1016/S0304-3940(01)02427-2; Duffy JF, 1999, J INVEST MED, V47, P141; Giannotti F, 2002, J SLEEP RES, V11, P191, DOI 10.1046/j.1365-2869.2002.00302.x; Griefahn B, 2003, J PINEAL RES, V34, P26, DOI 10.1034/j.1600-079X.2003.02931.x; Gupta NK, 2002, AM J HUM BIOL, V14, P762, DOI 10.1002/ajhb.10093; HAGG U, 1980, ACTA ODONTOL SCAND, V38, P179, DOI 10.3109/00016358009004718; Hansen M, 2005, PEDIATRICS, V115, P1555, DOI 10.1542/peds.2004-1649; Kerkhof GA, 1996, NEUROSCI LETT, V218, P153, DOI 10.1016/S0304-3940(96)13140-2; Knutson KL, 2005, AM J HUM BIOL, V17, P418, DOI 10.1002/ajhb.20405; KOLATA G, 1984, SCIENCE, V223, P272, DOI 10.1126/science.6701512; Koo MM, 1997, ANN HUM BIOL, V24, P61, DOI 10.1080/03014469700004782; Laberge L, 2001, J SLEEP RES, V10, P59, DOI 10.1046/j.1365-2869.2001.00242.x; LARGO RH, 1983, HELV PAEDIATR ACTA, V38, P229; LIVSON N, 1962, HUM BIOL, V34, P218; Mongrain V, 2004, J BIOL RHYTHM, V19, P248, DOI 10.1177/0748730404264365; PETTA D, 1984, SLEEP RES, V13, P86, DOI DOI 10.1080/15402000903425462; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; von Schantz M, 2003, J ROY SOC MED, V96, P486, DOI 10.1258/jrsm.96.10.486; Waldhauser F, 1998, EXP GERONTOL, V33, P759, DOI 10.1016/S0531-5565(98)00054-0; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351	38	42	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5217	10.1371/journal.pone.0005217	http://dx.doi.org/10.1371/journal.pone.0005217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437VB	19384418	Green Published, gold, Green Submitted			2022-12-27	WOS:000265513900004
J	Pecinka, A; Rosa, M; Schikora, A; Berlinger, M; Hirt, H; Luschnig, C; Scheid, OM				Pecinka, Ales; Rosa, Marisa; Schikora, Adam; Berlinger, Marc; Hirt, Heribert; Luschnig, Christian; Scheid, Ortrun Mittelsten			Transgenerational Stress Memory Is Not a General Response in Arabidopsis	PLOS ONE			English	Article								Adverse conditions can trigger DNA damage as well as DNA repair responses in plants. A variety of stress factors are known to stimulate homologous recombination, the most accurate repair pathway, by increasing the concentration of necessary enzymatic components and the frequency of events. This effect has been reported to last into subsequent generations not exposed to the stress. To establish a basis for a genetic analysis of this transgenerational stress memory, a broad range of treatments was tested for quantitative effects on homologous recombination in the progeny. Several Arabidopsis lines, transgenic for well-established recombination traps, were exposed to 10 different physical and chemical stress treatments, and scored for the number of somatic homologous recombination (SHR) events in the treated generation as well as in the two subsequent generations that were not treated. These numbers were related to the expression level of genes involved in homologous recombination and repair. SHR was enhanced after the majority of treatments, confirming previous data and adding new effective stress types, especially interference with chromatin. Compounds that directly modify DNA stimulated SHR to values exceeding previously described induction rates, concomitant with an induction of genes involved in SHR. In spite of the significant stimulation in the stressed generations, the two subsequent non-treated generations only showed a low and stochastic increase in SHR that did not correlate with the degree of stimulation in the parental plants. Transcripts coding for SHR enzymes generally returned to pre-treatment levels in the progeny. Thus, transgenerational effects on SHR frequency are not a general response to abiotic stress in Arabidopsis and may require special conditions.	[Pecinka, Ales; Rosa, Marisa; Scheid, Ortrun Mittelsten] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol GMI, A-1010 Vienna, Austria; [Schikora, Adam; Hirt, Heribert] INRA URGV, Plant Genom Res Unit, Evry, France; [Berlinger, Marc; Luschnig, Christian] Univ Nat Resources & Appl Life Sci BOKU, Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Natural Resources & Life Sciences, Vienna	Pecinka, A (corresponding author), Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol GMI, A-1010 Vienna, Austria.	ortrun.mittelsten_scheid@gmi.oeaw.ac.at	Hirt, Heribert/A-2061-2013; Rosa, Marisa/R-4902-2019; Pecinka, Ales/T-9125-2017; Schikora, Adam/B-4842-2014	Rosa, Marisa/0000-0003-2793-8560; Pecinka, Ales/0000-0001-9277-1766; Schikora, Adam/0000-0002-0869-6423; Luschnig, Christian/0000-0003-2099-9280; Mittelsten Scheid, Ortrun/0000-0002-7757-4809				Ataian Y, 2006, BIOCHEM CELL BIOL, V84, P490, DOI 10.1139/O06-075; BABBS CF, 1989, PLANT PHYSIOL, V90, P1267, DOI 10.1104/pp.90.4.1267; BAUBEC T, 2008, PLANT J; BAUR M, 1990, MOL CELL BIOL, V10, P492, DOI 10.1128/MCB.10.2.492; Beemster GTS, 2002, PLANT PHYSIOL, V129, P854, DOI 10.1104/pp.002923; Bleuyard JY, 2005, PLANT J, V41, P533, DOI 10.1111/j.1365-313X.2004.02318.x; Boyko A, 2005, MUTAT RES-FUND MOL M, V572, P73, DOI 10.1016/j.mrfmmm.2004.12.011; Boyko A, 2006, MUTAT RES-FUND MOL M, V602, P100, DOI 10.1016/j.mrfmmm.2006.08.008; Boyko A, 2006, PLANT CELL PHYSIOL, V47, P736, DOI 10.1093/pcp/pcj045; Bray CM, 2005, NEW PHYTOL, V168, P511, DOI 10.1111/j.1469-8137.2005.01548.x; Britt AB, 1999, TRENDS PLANT SCI, V4, P20, DOI 10.1016/S1360-1385(98)01355-7; Chang S, 2005, J BIOL CHEM, V280, P796, DOI 10.1074/jbc.M409053200; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Claussen CA, 1999, CHEM REV, V99, P2797, DOI 10.1021/cr980449z; Culligan KM, 2006, PLANT J, V48, P947, DOI 10.1111/j.1365-313X.2006.02931.x; Day CD, 2000, GENE DEV, V14, P2869, DOI 10.1101/gad.849600; Endo M, 2006, EMBO J, V25, P5579, DOI 10.1038/sj.emboj.7601434; Filkowski J, 2004, PLANT J, V38, P1, DOI 10.1111/j.1365-313X.2004.02025.x; Friesner JD, 2005, MOL BIOL CELL, V16, P2566, DOI 10.1091/mbc.E04-10-0890; Fritsch O, 2004, MOL CELL, V16, P479, DOI 10.1016/j.molcel.2004.09.034; Gherbi H, 2001, EMBO REP, V2, P287, DOI 10.1093/embo-reports/kve069; Hanin M, 2000, PLANT J, V24, P183, DOI 10.1046/j.1365-313x.2000.00867.x; Hanin M, 2003, CURR OPIN PLANT BIOL, V6, P157, DOI 10.1016/S1369-5266(03)00016-5; Hasdai M, 2006, ANN APPL BIOL, V148, P113, DOI 10.1111/j.1744-7348.2006.00044.x; Kimura S, 2006, CHEM REV, V106, P753, DOI 10.1021/cr040482n; Kirik A, 2006, PLANT CELL, V18, P2431, DOI 10.1105/tpc.106.045088; Kovalchuk I, 2003, NATURE, V423, P760, DOI 10.1038/nature01683; Kunz BA, 2006, INT REV CYTOL, V255, P1, DOI 10.1016/S0074-7696(06)55001-6; Kurepa J, 1998, PLANT J, V14, P759, DOI 10.1046/j.1365-313x.1998.00168.x; Lafarge S, 2003, NUCLEIC ACIDS RES, V31, P1148, DOI 10.1093/nar/gkg202; LEBEL EG, 1993, P NATL ACAD SCI USA, V90, P422, DOI 10.1073/pnas.90.2.422; Li LL, 2004, PLANT J, V40, P1007, DOI 10.1111/j.1365-313X.2004.02270.x; Lucht JM, 2002, NAT GENET, V30, P311, DOI 10.1038/ng846; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; Mengiste T, 1999, EMBO J, V18, P4505, DOI 10.1093/emboj/18.16.4505; Molinier J, 2005, MUTAT RES-FUND MOL M, V571, P235, DOI 10.1016/j.mrfmmm.2004.09.016; Molinier J, 2004, PLANT CELL, V16, P342, DOI 10.1105/tpc.019042; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Nabatiyan A, 2006, MOL CELL BIOL, V26, P1839, DOI 10.1128/MCB.26.5.1839-1849.2006; Preuss SB, 2003, GENETICS, V164, P323; PUCHTA H, 1991, NUCLEIC ACIDS RES, V19, P2693, DOI 10.1093/nar/19.10.2693; PUCHTA H, 1995, PLANT J, V7, P203, DOI 10.1046/j.1365-313X.1995.7020203.x; PUCHTA H, 1995, PLANT MOL BIOL, V28, P281, DOI 10.1007/BF00020247; Ricaud L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000430; Ridgway P, 2000, J CELL SCI, V113, P2647; Ries G, 2000, P NATL ACAD SCI USA, V97, P13425, DOI 10.1073/pnas.230251897; Ries G, 2000, NATURE, V406, P98, DOI 10.1038/35017595; Schuermann D, 2005, TRENDS GENET, V21, P172, DOI 10.1016/j.tig.2005.01.002; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Shaked H, 2006, GENETICS, V173, P985, DOI 10.1534/genetics.105.051664; SLOOTEN L, 1995, PLANT PHYSIOL, V107, P737, DOI 10.1104/pp.107.3.737; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Sreenivasulu N, 2007, GENE, V388, P1, DOI 10.1016/j.gene.2006.10.009; Sun XQ, 2008, MOL BIOL EVOL, V25, P2079, DOI 10.1093/molbev/msn158; SWOBODA P, 1994, EMBO J, V13, P484, DOI 10.1002/j.1460-2075.1994.tb06283.x; Takeda S, 2004, GENE DEV, V18, P782, DOI 10.1101/gad.295404; TINLAND B, 1994, P NATL ACAD SCI USA, V91, P8000, DOI 10.1073/pnas.91.17.8000; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Young LW, 2005, GENOME, V48, P547, DOI 10.1139/G05-003; Zhou L, 2002, J MOL BIOL, V321, P591, DOI 10.1016/S0022-2836(02)00676-9	60	113	113	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5202	10.1371/journal.pone.0005202	http://dx.doi.org/10.1371/journal.pone.0005202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381297	gold, Green Published			2022-12-27	WOS:000265513800002
J	Silva, RM; Duarte, ICN; Paredes, JA; Lima-Costa, T; Perrot, M; Boucherie, H; Goodfellow, BJ; Gomes, AC; Mateus, DD; Moura, GR; Santos, MAS				Silva, Raquel M.; Duarte, Iven C. N.; Paredes, Joao A.; Lima-Costa, Tatiana; Perrot, Michel; Boucherie, Helian; Goodfellow, Brian J.; Gomes, Ana C.; Mateus, Denisa D.; Moura, Gabriela R.; Santos, Manuel A. S.			The Yeast PNC1 Longevity Gene Is Up-Regulated by mRNA Mistranslation	PLOS ONE			English	Article								Translation fidelity is critical for protein synthesis and to ensure correct cell functioning. Mutations in the protein synthesis machinery or environmental factors that increase synthesis of mistranslated proteins result in cell death and degeneration and are associated with neurodegenerative diseases, cancer and with an increasing number of mitochondrial disorders. Remarkably, mRNA mistranslation plays critical roles in the evolution of the genetic code, can be beneficial under stress conditions in yeast and in Escherichia coli and is an important source of peptides for MHC class I complex in dendritic cells. Despite this, its biology has been overlooked over the years due to technical difficulties in its detection and quantification. In order to shed new light on the biological relevance of mistranslation we have generated codon misreading in Saccharomyces cerevisiae using drugs and tRNA engineering methodologies. Surprisingly, such mistranslation up-regulated the longevity gene PNC1. Similar results were also obtained in cells grown in the presence of amino acid analogues that promote protein misfolding. The overall data showed that PNC1 is a biomarker of mRNA mistranslation and protein misfolding and that PNC1-GFP fusions can be used to monitor these two important biological phenomena in vivo in an easy manner, thus opening new avenues to understand their biological relevance.			Silva, RM (corresponding author), Univ Porto, Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	msantos@ua.pt	Gomes, Ana Catarina/A-2628-2015; Silva, Raquel M/B-8337-2008; Moura, Gabriela R/E-6717-2010; Mateus, Denisa D/J-8827-2014; Moura, Gabriela/GPF-9079-2022; Goodfellow, Brian J/F-4638-2016; Santos, Manuel/E-6704-2010	Gomes, Ana Catarina/0000-0002-4989-6026; Silva, Raquel M/0000-0001-5926-8042; Moura, Gabriela R/0000-0003-2243-6123; Mateus, Denisa D/0000-0002-8665-5176; Moura, Gabriela/0000-0003-2243-6123; Goodfellow, Brian J/0000-0003-3191-7121; Santos, Manuel/0000-0002-0437-1146; Lima Costa, Tatiana/0000-0002-0675-8096; Paredes, Joao/0000-0002-7788-8939				Anderson RM, 2003, SCIENCE, V302, P2124, DOI 10.1126/science.1088697; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; BOUCHERIE H, 1995, YEAST, V11, P601, DOI 10.1002/yea.320110702; Boucherie H, 1996, ELECTROPHORESIS, V17, P1683, DOI 10.1002/elps.1150171106; BOUCHERIE H, 2005, YEAST PROTOCOLS, P47; EDELMANN P, 1977, CELL, V10, P131, DOI 10.1016/0092-8674(77)90147-7; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Farabaugh PJ, 1999, EMBO J, V18, P1427, DOI 10.1093/emboj/18.6.1427; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Gietz R.D., 1994, MOL GENETICS YEAST P, P121; Gomes AC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r206; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kimata Y, 2004, J CELL SCI, V117, P2283, DOI 10.1242/jcs.01078; Knight RD, 2001, J MOL EVOL, V53, P299, DOI 10.1007/s002390010220; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Lahue E, 2005, YEAST, V22, P537, DOI 10.1002/yea.1231; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104; Miranda I, 2006, YEAST, V23, P203, DOI 10.1002/yea.1350; Miranda I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000996; MURGOLA EJ, 1984, J MOL BIOL, V175, P19, DOI 10.1016/0022-2836(84)90442-X; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Ortego BC, 2007, BIOCHEMISTRY-US, V46, P13864, DOI 10.1021/bi602660s; PARKER J, 1986, MOL GEN GENET, V204, P70, DOI 10.1007/BF00330189; Rabilloud T, 2002, BIOCHEMISTRY-US, V41, P144, DOI 10.1021/bi0114776; Reverter-Branchat G, 2004, J BIOL CHEM, V279, P31983, DOI 10.1074/jbc.M404849200; Santos MAS, 2004, TRENDS GENET, V20, P95, DOI 10.1016/j.tig.2003.12.009; Santos MAS, 1996, EMBO J, V15, P5060, DOI 10.1002/j.1460-2075.1996.tb00886.x; SCHULTZ DW, 1994, J MOL BIOL, V235, P1377, DOI 10.1006/jmbi.1994.1094; Silva RM, 2007, EMBO J, V26, P4555, DOI 10.1038/sj.emboj.7601876; Silva Raquel M., 2004, Briefings in Functional Genomics & Proteomics, V3, P35, DOI 10.1093/bfgp/3.1.35; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 2003, SCIENCE, V301, P1859, DOI 10.1126/science.1090465; Singer MS, 1998, GENETICS, V150, P613; Smith JS, 1998, GENETICS, V149, P1205; Stansfield I, 1998, J MOL BIOL, V282, P13, DOI 10.1006/jmbi.1998.1976; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang HY, 2006, EXP GERONTOL, V41, P718, DOI 10.1016/j.exger.2006.06.003; Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Yewdell JW, 2001, J CELL SCI, V114, P845	50	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5212	10.1371/journal.pone.0005212	http://dx.doi.org/10.1371/journal.pone.0005212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381334	gold, Green Published, Green Submitted			2022-12-27	WOS:000265510800007
J	Subramanian, S; Hardt, M; Choe, Y; Niles, RK; Johansen, EB; Legac, J; Gut, J; Kerr, ID; Craik, CS; Rosenthal, PJ				Subramanian, Shoba; Hardt, Markus; Choe, Youngchool; Niles, Richard K.; Johansen, Eric B.; Legac, Jennifer; Gut, Jiri; Kerr, Iain D.; Craik, Charles S.; Rosenthal, Philip J.			Hemoglobin Cleavage Site-Specificity of the Plasmodium falciparum Cysteine Proteases Falcipain-2 and Falcipain-3	PLOS ONE			English	Article								The Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3 degrade host hemoglobin to provide free amino acids for parasite protein synthesis. Hemoglobin hydrolysis has been described as an ordered process initiated by aspartic proteases, but cysteine protease inhibitors completely block the process, suggesting that cysteine proteases can also initiate hemoglobin hydrolysis. To characterize the specific roles of falcipains, we used three approaches. First, using random P-1-P-4 amino acid substrate libraries, falcipain-2 and falcipain-3 demonstrated strong preference for cleavage sites with Leu at the P-2 position. Second, with overlapping peptides spanning alpha and beta globin and proteolysis-dependent O-18 labeling, hydrolysis was seen at many cleavage sites. Third, with intact hemoglobin, numerous cleavage products were identified. Our results suggest that hemoglobin hydrolysis by malaria parasites is not a highly ordered process, but rather proceeds with rapid cleavage by falcipains at multiple sites. However, falcipain-2 and falcipain-3 show strong specificity for P-2 Leu in small peptide substrates, in agreement with the specificity in optimized small molecule inhibitors that was identified previously. These results are consistent with a principal role of falcipain-2 and falcipain-3 in the hydrolysis of hemoglobin by P. falciparum and with the possibility of developing small molecule inhibitors with optimized specificity as antimalarial agents.			Subramanian, S (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	prosenthal@medsfgh.ucsf.edu	Hardt, Markus/M-8569-2019	Hardt, Markus/0000-0002-2300-216X; Subramanian, Shoba/0000-0002-4206-3400	NIAID NIH HHS [AI35707, R29 AI035800, R01 AI035800, P01 AI035707, R56 AI035800, AI AI035800] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035800, R56AI035800, R29AI035800, P01AI035707] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Alker AP, 2007, AM J TROP MED HYG, V76, P641, DOI 10.4269/ajtmh.2007.76.641; Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Bennett TN, 2004, MOL BIOCHEM PARASIT, V133, P99, DOI 10.1016/j.molbiopara.2003.09.008; Bonilla JA, 2007, INT J PARASITOL, V37, P317, DOI 10.1016/j.ijpara.2006.11.008; Bonilla JA, 2007, MOL MICROBIOL, V65, P64, DOI 10.1111/j.1365-2958.2007.05768.x; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Brindley PJ, 2001, MOL BIOCHEM PARASIT, V112, P103, DOI 10.1016/S0166-6851(00)00351-0; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Dahl EL, 2005, MOL BIOCHEM PARASIT, V139, P205, DOI 10.1016/j.molbiopara.2004.11.009; Dalal S, 2007, J BIOL CHEM, V282, P35978, DOI 10.1074/jbc.M703643200; Dasaradhi PVN, 2007, MOL BIOCHEM PARASIT, V156, P12, DOI 10.1016/j.molbiopara.2007.06.008; Dasaradhi PVN, 2005, BIOCHEM BIOPH RES CO, V336, P1062, DOI 10.1016/j.bbrc.2005.08.213; Debela M, 2006, J BIOL CHEM, V281, P25678, DOI 10.1074/jbc.M602372200; Dhawan S, 2003, J BIOL CHEM, V278, P30180, DOI 10.1074/jbc.M305132200; Drew ME, 2008, J BIOL CHEM, V283, P12870, DOI 10.1074/jbc.M708949200; Eggleson KK, 1999, J BIOL CHEM, V274, P32411, DOI 10.1074/jbc.274.45.32411; Fairhurst RM, 2003, BLOOD, V101, P3309, DOI 10.1182/blood-2002-10-3105; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; GAMBOADE DN, 1996, BLOOD, V87, P4448; Goetz DH, 2007, BIOCHEMISTRY-US, V46, P8744, DOI 10.1021/bi0621415; Hanspal M, 2002, BLOOD, V100, P1048, DOI 10.1182/blood-2002-01-0101; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; Hogg T, 2006, J BIOL CHEM, V281, P25425, DOI 10.1074/jbc.M603776200; Kerr LD, 2009, J MED CHEM, V52, P852, DOI 10.1021/jm8013663; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Kolakovich KA, 1997, MOL BIOCHEM PARASIT, V87, P123, DOI 10.1016/S0166-6851(97)00062-5; KROGSTAD DJ, 1985, J CELL BIOL, V101, P2302, DOI 10.1083/jcb.101.6.2302; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Lee BJ, 2003, ANTIMICROB AGENTS CH, V47, P3810, DOI 10.1128/AAC.47.12.3810-3814.2003; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; Miyagi M, 2007, MASS SPECTROM REV, V26, P121, DOI 10.1002/mas.20116; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Murata CE, 2003, J BIOL CHEM, V278, P38022, DOI 10.1074/jbc.M306842200; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; Pandey KC, 2005, P NATL ACAD SCI USA, V102, P9138, DOI 10.1073/pnas.0502368102; Pandey KC, 2004, J BIOL CHEM, V279, P3484, DOI 10.1074/jbc.M310536200; Robinson S, 2008, PROTEOMICS, V8, P435, DOI 10.1002/pmic.200700680; Rosenthal PJ, 1996, ANTIMICROB AGENTS CH, V40, P1600, DOI 10.1128/AAC.40.7.1600; ROSENTHAL PJ, 1991, J CLIN INVEST, V88, P1467, DOI 10.1172/JCI115456; Rosenthal PJ, 2005, MOLECULAR APPROACHES TO MALARIA, P311; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; Rugles SW, 2004, J BIOL CHEM, V279, P30751, DOI 10.1074/jbc.M400949200; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Shenai BR, 2002, MOL BIOCHEM PARASIT, V122, P99, DOI 10.1016/S0166-6851(02)00075-0; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Sijwali PS, 2002, J BIOL CHEM, V277, P14910, DOI 10.1074/jbc.M109680200; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481; Sijwali PS, 2001, PROTEIN EXPRES PURIF, V22, P128, DOI 10.1006/prep.2001.1416; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sojka D, 2007, INT J PARASITOL, V37, P713, DOI 10.1016/j.ijpara.2006.12.020; Subramanian S, 2007, J BIOL CHEM, V282, P24961, DOI 10.1074/jbc.M703316200; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Wang SX, 2006, P NATL ACAD SCI USA, V103, P11503, DOI 10.1073/pnas.0600489103; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; YAYON A, 1984, EMBO J, V3, P2695, DOI 10.1002/j.1460-2075.1984.tb02195.x	61	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5156	10.1371/journal.pone.0005156	http://dx.doi.org/10.1371/journal.pone.0005156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357776	gold, Green Submitted, Green Published			2022-12-27	WOS:000265505900016
J	Charles, C; Pantalacci, S; Tafforeau, P; Headon, D; Laudet, V; Viriot, L				Charles, Cyril; Pantalacci, Sophie; Tafforeau, Paul; Headon, Denis; Laudet, Vincent; Viriot, Laurent			Distinct Impacts of Eda and Edar Loss of Function on the Mouse Dentition	PLOS ONE			English	Article								Background: The Eda-A1-Edar signaling pathway is involved in the development of organs with an ectodermal origin, including teeth. In mouse, mutants are known for both the ligand, Eda-A1 (Tabby), and the receptor, Edar (Downless). The adult dentitions of these two mutants have classically been considered to be similar. However, previous studies mentioned differences in embryonic dental development between Eda Ta and Edar dl-J mutants. A detailed study of tooth morphology in mutants bearing losses of functions of these two genes thus appears necessary to test the pattern variability induced by the developmental modifications. Methodology/Principal Findings: 3D-reconstructions of the cheek teeth have been performed at the ESRF (Grenoble, France) by X-ray synchrotron microtomography to assess dental morphology. The morphological variability observed in Eda Ta and Edar dl-J mutants have then been compared in detail. Despite patchy similarities, our detailed work on cheek teeth in Eda Ta and Edar dl-J mice show that all dental morphotypes defined in Edar dl-J mice resolutely differ from those of Eda Ta mice. This study reveals that losses of function of Eda and Edar have distinct impacts on the tooth size and morphology, contrary to what has previously been thought. Conclusion/Signifiance: The results indicate that unknown mechanisms of the Eda pathway are implicated in tooth morphogenesis. Three hypotheses could explain our results; an unexpected role of the Xedar pathway (which is influenced by the Eda gene product but not that of Edar), a more complex connection than has been appreciated between Edar and another protein, or a ligand-independent activity for Edar. Further work is necessary to test these hypotheses and improve our understanding of the mechanisms of development.	[Charles, Cyril] Univ Poitiers, Inst Int Paleoprimatol Paleontol Humaine Evolut, CNRS, UMR 6046, Poitiers, France; [Pantalacci, Sophie; Laudet, Vincent; Viriot, Laurent] Univ Lyon, Inst Genom Fonct Lyon, CNRS, Ecole Normale Superieure Lyon, UMR 5242, Lyon, France; [Tafforeau, Paul] European Synchrotron Radiat Facil, Grenoble, France; [Headon, Denis] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Headon, Denis] Univ Edinburgh, Royal Dick Sch Vet Stud, Edinburgh EH8 9YL, Midlothian, Scotland	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); European Synchrotron Radiation Facility (ESRF); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Charles, C (corresponding author), Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA.	Laurent.Viriot@ens-lyon.fr	Charles, Cyril/E-7606-2011	Charles, Cyril/0000-0002-6930-039X; Viriot, Laurent/0000-0003-2092-588X; Tafforeau, Paul/0000-0002-5962-1683	ANR (Quenottes program).; Poitou-Charentes; Rhone-Alpes; Fondation pour la Recherche Medicale; Fondation Singer-Polignac; CNRS [fellowship]	ANR (Quenottes program).(French National Research Agency (ANR)); Poitou-Charentes(Region Nouvelle-Aquitaine); Rhone-Alpes(Region Auvergne-Rhone-Alpes); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Singer-Polignac; CNRS(Centre National de la Recherche Scientifique (CNRS))	This study has been supported by the ANR (Quenottes program). Other supports have been provided by the regions Poitou-Charentes and Rhone-Alpes, the Fondation pour la Recherche Medicale, and the Fondation Singer-Polignac. SP holds a fellowship from CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHARLES C, 2007, EUR J ORAL SCI, V114, P1; Charles C, 2009, ANAT REC, V292, P299, DOI 10.1002/ar.20804; Courtney JM, 2005, ARCH ORAL BIOL, V50, P159, DOI 10.1016/j.archoralbio.2004.11.019; Drew CF, 2007, DEV BIOL, V305, P232, DOI 10.1016/j.ydbio.2007.02.011; GRUNEBERG H, 1971, PROC R SOC SER B-BIO, V179, P139, DOI 10.1098/rspb.1971.0086; GRUNEBERG H, 1966, J EMBRYOL EXP MORPH, V15, P223; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Jaskoll T, 2003, ANAT REC PART A, V271A, P322, DOI 10.1002/ar.a.10045; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kristenova P, 2002, Orthod Craniofac Res, V5, P205, DOI 10.1034/j.1600-0544.2002.02225.x; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Newton K, 2004, MOL CELL BIOL, V24, P1608, DOI 10.1128/MCB.24.4.1608-1613.2004; Pantalacci S, 2008, MOL BIOL EVOL, V25, P912, DOI 10.1093/molbev/msn038; Peterkova R, 2005, ARCH ORAL BIOL, V50, P219, DOI 10.1016/j.archoralbio.2004.10.020; Peterson C., 2006, J POSIT PSYCHOL, V1, P17, DOI [10.1080/17439760500372739, DOI 10.1080/17439760500372739]; Pispa J, 1999, DEV BIOL, V216, P521, DOI 10.1006/dbio.1999.9514; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; SOFAER JA, 1977, ARCH ORAL BIOL, V22, P299, DOI 10.1016/0003-9969(77)90117-0; SOFAER JA, 1969, J EMBRYOL EXP MORPH, V22, P207; SOFAER JA, 1969, J EMBRYOL EXP MORPH, V22, P181; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Tucker AS, 2000, DEVELOPMENT, V127, P4691; Vaahtokari A, 1996, MECH DEVELOP, V54, P39, DOI 10.1016/0925-4773(95)00459-9; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523	30	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e4985	10.1371/journal.pone.0004985	http://dx.doi.org/10.1371/journal.pone.0004985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340299	Green Published, gold			2022-12-27	WOS:000265500700004
J	Mattei, V; Barenco, MG; Tasciotti, V; Garofalo, T; Longo, A; Boller, K; Lower, J; Misasi, R; Montrasio, F; Sorice, M				Mattei, Vincenzo; Barenco, Maria Grazia; Tasciotti, Vincenzo; Garofalo, Tina; Longo, Agostina; Boller, Klaus; Loewer, Johannes; Misasi, Roberta; Montrasio, Fabio; Sorice, Maurizio			Paracrine Diffusion of PrPC and Propagation of Prion Infectivity by Plasma Membrane-Derived Microvesicles	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PERIPHERAL NERVOUS-SYSTEM; SCRAPIE AGENT; ENDOTHELIAL MICROPARTICLES; SIGNALING COMPLEX; DENDRITIC CELLS; INCUBATION-TIME; CRUCIAL ROLE; PROTEIN PRP; B-CELLS	Cellular prion protein (PrPc) is a physiological constituent of eukaryotic cells. The cellular pathways underlying prions spread from the sites of prions infection/peripheral replication to the central nervous system are still not elucidated. Membrane-derived microvesicles (MVs) are submicron (0.1-1 mu m) particles, that are released by cells during plasma membrane shedding processes. They are usually liberated from different cell types, mainly upon activation as well as apoptosis, in this case, one of their hallmarks is the exposure of phosphatidylserine in the outer leaflet of the membrane. MVs are also characterized by the presence of adhesion molecules, MHC I molecules, as well as of membrane antigens typical of their cell of origin. Evidence exists that MVs shedding provide vehicles to transfer molecules among cells, and that MVs are important modulators of cell-to-cell communication. In this study we therefore analyzed the potential role of membrane-derived MVs in the mechanism(s) of PrPC diffusion and prion infectivity transmission. We first identified PrPC in association with the lipid raft components Fyn, flotillin-2, GM1 and GM3 in MVs from plasma of healthy human donors. Similar findings were found in MVs from cell culture supernatants of murine neuronal cells. Furthermore we demonstrated that PrPSc is released from infected murine neuronal cells in association with plasma membrane-derived MVs and that PrPSc-bearing MVs are infectious both in vitro and in vivo. The data suggest that MVs may contribute both to the intercellular mechanism(s) of PrPC diffusion and signaling as well as to the process of prion spread and neuroinvasion.	[Mattei, Vincenzo; Tasciotti, Vincenzo; Garofalo, Tina; Longo, Agostina; Misasi, Roberta; Sorice, Maurizio] Sapienza Univ, Dipartimento Med Sperimentale, Rome, Italy; [Mattei, Vincenzo; Tasciotti, Vincenzo; Sorice, Maurizio] Polo Univ Rieti Sabina Univ, Lab Med Sperimentale Patol Ambientale, Rieti, Italy; [Barenco, Maria Grazia; Boller, Klaus; Loewer, Johannes; Montrasio, Fabio] Paul Ehrlich Strasse, Paul Ehrlich Inst, Prion Res Grp, Langen, Germany	Sapienza University Rome; Paul Ehrlich Institute	Mattei, V (corresponding author), Sapienza Univ, Dipartimento Med Sperimentale, Rome, Italy.	maurizio.sorice@uniroma1.it	Sorice, Maurizio/Q-5079-2019; Sousa, Maria/HCI-9642-2022; Mattei, Vincenzo/AAQ-3667-2020	Mattei, Vincenzo/0000-0003-4677-088X; Garofalo, Tina/0000-0003-0645-2510; Sorice, Maurizio/0000-0003-3534-1502; Montrasio, Fabio/0000-0002-6069-1937	Sapienza University, Rome, Italy	Sapienza University, Rome, Italy	This work was supported by grants to Maurizio Sorice from Sapienza University, Rome, Italy. The funders had a role in data collection and analysis and in the preparation and publication of the manuscript.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Baj-Krzyworzeka M, 2002, EXP HEMATOL, V30, P450, DOI 10.1016/S0301-472X(02)00791-9; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Beringue V, 2000, J PATHOL, V190, P495, DOI 10.1002/(SICI)1096-9896(200003)190:4&lt;495::AID-PATH535&gt;3.0.CO;2-T; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Bons N, 2002, TRANSFUSION, V42, P513, DOI 10.1046/j.1537-2995.2002.00098.x; Brandner S, 1999, TRANSFUS CLIN BIOL, V6, P17, DOI 10.1016/S1246-7820(99)80007-X; BROWN KL, 2000, ARCH VIROL, V16, P13; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Dignat-George F, 2004, THROMB HAEMOSTASIS, V91, P667, DOI 10.1160/TH03-07-0487; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Fagge T, 2005, TRANSFUSION, V45, P504, DOI 10.1111/j.0041-1132.2005.04342.x; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Favereaux A, 2004, ARCH NEUROL-CHICAGO, V61, P747, DOI 10.1001/archneur.61.5.747; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Garofalo T, 2003, J BIOL CHEM, V278, P8309, DOI 10.1074/jbc.M207618200; Geminard C, 2004, TRAFFIC, V5, P181, DOI 10.1111/j.1600-0854.2004.0167.x; Glatzel M, 2000, J GEN VIROL, V81, P2813, DOI 10.1099/0022-1317-81-11-2813; Glaysher BR, 2007, J IMMUNOL, V178, P3757, DOI 10.4049/jimmunol.178.6.3757; HEYNINGEN SV, 1974, SCIENCE, V183, P656, DOI DOI 10.1126/SCIENCE.183.4125.656; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Joop K, 2001, THROMB HAEMOSTASIS, V85, P810; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; KOTANI M, 1992, BIOCHIM BIOPHYS ACTA, V1117, P97, DOI 10.1016/0304-4165(92)90168-T; Lee CCM, 2005, J NEUROPATH EXP NEUR, V64, P716, DOI 10.1097/01.jnen.0000175330.66715.08; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Ludlam CA, 2006, BRIT J HAEMATOL, V132, P13, DOI 10.1111/j.1365-2141.2005.05796.x; Mabbott NA, 2003, J VIROL, V77, P6845, DOI 10.1128/JVI.77.12.6845-6854.2003; Mabbott N, 2005, HAEMATOLOGICA, V90, P542; MacGregor I, 1999, VOX SANG, V77, P88; Maignien T, 2005, INT J PHARMACEUT, V298, P293, DOI 10.1016/j.ijpharm.2005.02.042; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Mattei V, 2004, FEBS LETT, V560, P14, DOI 10.1016/S0014-5793(04)00029-8; Mattei V, 2002, NEUROCHEM RES, V27, P743, DOI 10.1023/A:1020244621373; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Montrasio F, 2001, P NATL ACAD SCI USA, V98, P4034, DOI 10.1073/pnas.051609398; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Naslavsky N, 1999, J BIOL CHEM, V274, P20763, DOI 10.1074/jbc.274.30.20763; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Prinz M, 2004, J NEUROSCI, V24, P5974, DOI 10.1523/JNEUROSCI.0122-04.2004; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Raymond CR, 2007, J NEUROIMMUNOL, V187, P114, DOI 10.1016/j.jneuroim.2007.05.006; Robertson C, 2006, BLOOD, V107, P3907, DOI 10.1182/blood-2005-02-0802; Rozmyslowicz T, 2003, AIDS, V17, P33, DOI 10.1097/00002030-200301030-00006; Sabatier F, 2002, BLOOD, V99, P3962, DOI 10.1182/blood.V99.11.3962; Sethi S, 2007, J VIROL, V81, P4877, DOI 10.1128/JVI.02345-06; Simak J, 2006, TRANSFUS MED REV, V20, P1, DOI 10.1016/j.tmrv.2005.08.001; Slaughter N, 2003, CLIN IMMUNOL, V108, P138, DOI 10.1016/S1521-6616(03)00097-4; SOMERVILLE RA, 1990, J GEN VIROL, V71, P833, DOI 10.1099/0022-1317-71-4-833; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; SVENNERHOLM L, 1980, BIOCHIM BIOPHYS ACTA, V617, P97, DOI 10.1016/0005-2760(80)90227-1; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Towbin H, 1992, Biotechnology, V24, P145; Valaperta R, 2007, J NEUROCHEM, V100, P708, DOI 10.1111/j.1471-4159.2006.04279.x; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145	70	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5057	10.1371/journal.pone.0005057	http://dx.doi.org/10.1371/journal.pone.0005057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337375	gold, Green Published, Green Submitted			2022-12-27	WOS:000265500600016
J	Oulhen, N; Boulben, S; Bidinosti, M; Morales, J; Cormier, P; Cosson, B				Oulhen, Nathalie; Boulben, Sandrine; Bidinosti, Michael; Morales, Julia; Cormier, Patrick; Cosson, Bertrand			A Variant Mimicking Hyperphosphorylated 4E-BP Inhibits Protein Synthesis in a Sea Urchin Cell-Free, Cap-Dependent Translation System	PLOS ONE			English	Article							FACTOR 4E-BINDING PROTEIN-1; MESSENGER-RNA TRANSLATION; INITIATION-FACTOR 4E; EIF4E-BINDING PROTEINS; BINDING-PROTEIN; FERTILIZATION; PHOSPHORYLATION; EGGS; INSULIN; EIF4E	Background: 4E-BP is a translational inhibitor that binds to eIF4E to repress cap-dependent translation initiation. This critical protein: protein interaction is regulated by the phosphorylation of 4E-BP. Hypophosphorylated 4E-BP binds to eIF4E and inhibits cap-dependent translation, whereas hyperphosphorylated forms do not. While three 4E-BP proteins exist in mammals, only one gene encoding for 4E-BP is present in the sea urchin genome. The protein product has a highly conserved core domain containing the eIF4E-binding domain motif (YxxxxL Phi) and four of the regulatory phosphorylation sites. Methodology/Principal Findings: Using a sea urchin cell-free cap-dependent translation system prepared from fertilized eggs, we provide the first direct evidence that the sea urchin 4E-BP inhibits cap-dependent translation. We show here that a sea urchin 4E-BP variant, mimicking phosphorylation on four core residues required to abrogate binding to eIF4E, surprisingly maintains physical association to eIF4E and inhibits protein synthesis. Conclusions/Significance: Here, we examine the involvement of the evolutionarily conserved core domain and phosphorylation sites of sea urchin 4E-BP in the regulation of eIF4E-binding. These studies primarily demonstrate the conserved activity of the 4E-BP translational repressor and the importance of the eIF4E-binding domain in sea urchin. We also show that a variant mimicking hyperphosphorylation of the four regulatory phosphorylation sites common to sea urchin and human 4E-BP is not sufficient for release from eIF4E and translation promotion. Therefore, our results suggest that there are additional mechanisms to that of phosphorylation at the four critical sites of 4E-BP that are required to disrupt binding to eIF4E.	[Oulhen, Nathalie; Boulben, Sandrine; Morales, Julia; Cormier, Patrick; Cosson, Bertrand] Univ Paris 06, Equipe Traduct Cycle Cellulaire & Dev, Biol Stn, UMR 7150, Roscoff, France; [Oulhen, Nathalie; Boulben, Sandrine; Morales, Julia; Cormier, Patrick; Cosson, Bertrand] CNRS, Biol Stn, UMR 7150, Roscoff, France; [Oulhen, Nathalie; Boulben, Sandrine; Morales, Julia; Cormier, Patrick; Cosson, Bertrand] Univ Europeenne Bretagne, Bretagne, France; [Bidinosti, Michael] McGill Univ, Dept Biochem, Montreal, PQ H3A 2T5, Canada; [Bidinosti, Michael] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3A 2T5, Canada	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Bretagne Occidentale; McGill University; McGill University	Oulhen, N (corresponding author), Univ Paris 06, Equipe Traduct Cycle Cellulaire & Dev, Biol Stn, UMR 7150, Roscoff, France.	cosson@sb-roscoff.fr		Oulhen, NATHALIE/0000-0003-1046-360X; Cosson, Bertrand/0000-0003-3401-7137; Morales, Julia/0000-0003-1632-5419	Association pour la Recherche contre le Cancer (ARC, France) [4247, 3507]; Ligue Nationale contre le Cancer; Conseil Regional de Bretagne; Conseil General du Finistere	Association pour la Recherche contre le Cancer (ARC, France)(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Conseil Regional de Bretagne(Region Bretagne); Conseil General du Finistere(Region Bretagne)	This work was supported by Association pour la Recherche contre le Cancer (ARC, France; grants 4247 and 3507) to P.C., Ligue Nationale contre le Cancer (Delegations Departementales Finistere, Morbihan, Vendee et Cotes d'Armor) to P.C., Conseil Regional de Bretagne and Conseil General du Finistere. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRANDHORST BP, 1976, DEV BIOL, V52, P310, DOI 10.1016/0012-1606(76)90248-7; Carroll M, 2006, MOL CELL BIOL, V26, P8586, DOI 10.1128/MCB.00955-06; CLEMENS M, 1987, NATURE, V330, P699, DOI 10.1038/330699a0; COLIN AM, 1987, DEV BIOL, V123, P354, DOI 10.1016/0012-1606(87)90394-0; Cormier P, 2001, DEV BIOL, V232, P275, DOI 10.1006/dbio.2001.0206; Cormier Patrick, 2003, Prog Cell Cycle Res, V5, P469; DAVIDSON EH, 1982, SCIENCE, V217, P17, DOI 10.1126/science.6178156; Elia A, 2008, ONCOGENE, V27, P811, DOI 10.1038/sj.onc.1210678; EPEL D, 1990, CELL DIFFER DEV, V29, P1, DOI 10.1016/0922-3371(90)90019-S; EPEL D, 1967, P NATL ACAD SCI USA, V57, P899, DOI 10.1073/pnas.57.4.899; Fadden P, 1997, J BIOL CHEM, V272, P10240; FOERDER CA, 1977, P NATL ACAD SCI USA, V74, P4214, DOI 10.1073/pnas.74.10.4214; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; GRAINGER JL, 1987, MOL CELL BIOL, V7, P3947, DOI 10.1128/MCB.7.11.3947; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Heesom KJ, 1998, BIOCHEM J, V336, P39, DOI 10.1042/bj3360039; HUANG WI, 1987, P NATL ACAD SCI USA, V84, P6359, DOI 10.1073/pnas.84.18.6359; HUMPHREYS T, 1971, DEV BIOL, V26, P201, DOI 10.1016/0012-1606(71)90122-9; JAGUS R, 1993, DEV GENET, V14, P412, DOI 10.1002/dvg.1020140603; JAGUS R, 1992, J BIOL CHEM, V267, P15530; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; LAPASSET L, 2008, MOL REPROD DEV; Legagneux V, 1995, RNA, V1, P1001; LOPO AC, 1989, BIOCHEM J, V258, P553, DOI 10.1042/bj2580553; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; MATHEWS MB, 2007, TRANSLATIONAL CONTRO; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Morales J, 2006, DEV BIOL, V300, P293, DOI 10.1016/j.ydbio.2006.07.036; Oulhen N, 2007, J CELL SCI, V120, P425, DOI 10.1242/jcs.03339; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002; Raught B., 2007, TRANSLATIONAL CONTRO; Rousseau D, 1996, ONCOGENE, V13, P2415; Salardi Silvana, 2003, Pediatr Diabetes, V4, P4, DOI 10.1034/j.1399-5448.2003.00028.x; Salaun P, 2005, J CELL SCI, V118, P1385, DOI 10.1242/jcs.01716; Salaun P, 2004, EXP CELL RES, V296, P347, DOI 10.1016/j.yexcr.2004.02.013; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Sivan G, 2008, CELL CYCLE, V7, P741, DOI 10.4161/cc.7.6.5596; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; SONENBERG N, 1979, P NATL ACAD SCI USA, V76, P4345, DOI 10.1073/pnas.76.9.4345; Tee AR, 2002, MOL CELL BIOL, V22, P1674, DOI 10.1128/MCB.22.6.1674-1683.2002; Thompson B., 2007, TRANSLATIONAL CONTRO; Tomoo K, 2005, BBA-PROTEINS PROTEOM, V1753, P191, DOI 10.1016/j.bbapap.2005.07.023; Tomoo K, 2006, J BIOCHEM, V140, P237, DOI 10.1093/jb/mvj143; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TV Pestova, 2007, TRANSLATIONAL CONTRO; Wang XM, 2003, MOL CELL BIOL, V23, P1546, DOI 10.1128/MCB.23.5.1546-1557.2003; WINKLER MM, 1981, DEV BIOL, V84, P432, DOI 10.1016/0012-1606(81)90412-7	52	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5070	10.1371/journal.pone.0005070	http://dx.doi.org/10.1371/journal.pone.0005070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333389	Green Submitted, Green Published, gold			2022-12-27	WOS:000265499900019
J	Groger, M; Pasteiner, W; Ignatyev, G; Matt, U; Knapp, S; Atrasheuskaya, A; Bukin, E; Friedl, P; Zinkl, D; Hofer-Warbinek, R; Zacharowski, K; Petzelbauer, P; Reingruber, S				Groeger, Marion; Pasteiner, Waltraud; Ignatyev, George; Matt, Ulrich; Knapp, Sylvia; Atrasheuskaya, Alena; Bukin, Eugenij; Friedl, Peter; Zinkl, Daniela; Hofer-Warbinek, Renate; Zacharowski, Kai; Petzelbauer, Peter; Reingruber, Sonja			Peptide B beta(15-42) Preserves Endothelial Barrier Function in Shock	PLOS ONE			English	Article								Loss of vascular barrier function causes leak of fluid and proteins into tissues, extensive leak leads to shock and death. Barriers are largely formed by endothelial cell-cell contacts built up by VE-cadherin and are under the control of RhoGTPases. Here we show that a natural plasmin digest product of fibrin, peptide B beta 15-42 (also called FX06), significantly reduces vascular leak and mortality in animal models for Dengue shock syndrome. The ability of B beta 15-42 to preserve endothelial barriers is confirmed in rats i.v.-injected with LPS. In endothelial cells, B beta 15-42 prevents thrombin-induced stress fiber formation, myosin light chain phosphorylation and RhoA activation. The molecular key for the protective effect of B beta 15-42 is the src kinase Fyn, which associates with VE-cadherin-containing junctions. Following exposure to B beta 15-42 Fyn dissociates from VE-cadherin and associates with p190RhoGAP, a known antagonists of RhoA activation. The role of Fyn in transducing effects of B beta 15-42 is confirmed in Fyn(-/-) mice, where the peptide is unable to reduce LPS-induced lung edema, whereas in wild type littermates the peptide significantly reduces leak. Our results demonstrate a novel function for B beta 15-42. Formerly mainly considered as a degradation product occurring after fibrin inactivation, it has now to be considered as a signaling molecule. It stabilizes endothelial barriers and thus could be an attractive adjuvant in the treatment of shock.			Groger, M (corresponding author), Med Univ Vienna, Dept Dermatol, Vienna, Austria.	peter.petzelbauer@meduniwien.ac.at; sonja.reingruber@fibrexmedical.com	petzelbauer, peter/GLU-3941-2022; Knapp, Sylvia/J-3973-2013	Knapp, Sylvia/0000-0001-9016-5244; Ignatyev, George/0000-0002-9731-3681; Petzelbauer, Peter/0000-0001-7080-5259; Atrasheuskaya, Alena/0000-0002-9603-9895; Matt, Ulrich/0000-0002-1786-365X				Amerongen GPV, 2004, CIRC RES, V94, P1041, DOI 10.1161/01.RES.0000125627.77235.0C; Atar D, 2009, J AM COLL CARDIOL, V53, P720, DOI 10.1016/j.jacc.2008.12.017; Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x; Bach TL, 1998, J BIOL CHEM, V273, P30719, DOI 10.1074/jbc.273.46.30719; Bannerman DD, 1999, LAB INVEST, V79, P1181; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; Broman MT, 2007, TRENDS CARDIOVAS MED, V17, P151, DOI 10.1016/j.tcm.2007.03.004; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Bukin Ye. K., 2007, Voprosy Virusologii, V52, P32; Cary LA, 1996, J CELL SCI, V109, P1787; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Dejana E, 2001, THROMB HAEMOSTASIS, V86, P308; Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000; Fareed J, 1998, CLIN CHEM, V44, P1845; Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Gorlatov S, 2002, BIOCHEMISTRY-US, V41, P4107, DOI 10.1021/bi0160314; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; GRANT SGN, 1995, GENE DEV, V9, P1909, DOI 10.1101/gad.9.15.1909; GREEN TP, 1988, J LAB CLIN MED, V111, P173; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Konstantoulaki M, 2003, AM J PHYSIOL-LUNG C, V285, pL434, DOI 10.1152/ajplung.00075.2003; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Matsuda Naoyuki, 2007, Journal of Smooth Muscle Research, V43, P117, DOI 10.1540/jsmr.43.117; Minshall R. D., 2006, V176, P107; Nelson CM, 2004, MOL BIOL CELL, V15, P2943, DOI 10.1091/mbc.E03-10-0745; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Ohkawara H, 2005, J BIOL CHEM, V280, P10182, DOI 10.1074/jbc.M409547200; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Petzelbauer P, 2005, NAT MED, V11, P298, DOI 10.1038/nm1198; Roesner JP, 2007, CRIT CARE MED, V35, P1730, DOI 10.1097/01.CCM.0000269035.30231.76; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; Schaphorst KL, 1997, AM J RESP CELL MOL, V17, P443, DOI 10.1165/ajrcmb.17.4.2502; Sohn RH, 2005, BLOOD, V105, P3910, DOI 10.1182/blood-2004-03-0928; Srikiatkhachorn A, 2007, PEDIATR INFECT DIS J, V26, P283, DOI 10.1097/01.inf.0000258612.26743.10; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; van Hinsbergh VWM, 2002, J ANAT, V200, P549, DOI 10.1046/j.1469-7580.2002.00060.x; Amerongen GPV, 2007, ARTERIOSCL THROM VAS, V27, P2332, DOI 10.1161/ATVBAHA.107.152322; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Vouret-Craviari V, 1998, MOL BIOL CELL, V9, P2639, DOI 10.1091/mbc.9.9.2639; Wills BA, 2002, CLIN INFECT DIS, V35, P277, DOI 10.1086/341410; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Wu MH, 2005, J PHYSIOL-LONDON, V569, P359, DOI 10.1113/jphysiol.2005.096537; Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156	51	70	73	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5391	10.1371/journal.pone.0005391	http://dx.doi.org/10.1371/journal.pone.0005391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401765	Green Published, Green Submitted, gold			2022-12-27	WOS:000265601100023
J	Haag, KL; Gottstein, B; Ayala, FJ				Haag, Karen Luisa; Gottstein, Bruno; Ayala, Francisco Jose			The EG95 Antigen of Echinococcus spp. Contains Positively Selected Amino Acids, which May Influence Host Specificity and Vaccine Efficacy	PLOS ONE			English	Article							TAENIA-SOLIUM; GRANULOSUS; PREDICTION; CYSTICERCOSIS; DIVERSITY; RESPONSES; MODELS; DOMAIN; STAGE	Echinococcosis is a worldwide zoonotic parasitic disease of humans and various herbivorous domestic animals (intermediate hosts) transmitted by the contact with wild and domestic carnivores (definitive hosts), mainly foxes and dogs. Recently, a vaccine was developed showing high levels of protection against one parasite haplotype (G1) of Echinococcus granulosus, and its potential efficacy against distinct parasite variants or species is still unclear. Interestingly, the EG95 vaccine antigen is a secreted glycosylphosphatydilinositol (GPI)-anchored protein containing a fibronectin type III domain, which is ubiquitous in modular proteins involved in cell adhesion. EG95 is highly expressed in oncospheres, the parasite life cycle stage which actively invades the intermediate hosts. After amplifying and sequencing the complete CDS of 57 Echinococcus isolates belonging to 7 distinct species, we uncovered a large amount of genetic variability, which may influence protein folding. Two positively selected sites are outside the vaccine epitopes, but are predicted to alter protein conformation. Moreover, phylogenetic analyses indicate that EG95 isoform evolution is convergent with regard to the number of beta-sheets and alpha-helices. We conclude that having a variety of EG95 isoforms is adaptive for Echinococcus parasites, in terms of their ability to invade different hosts, and we propose that a mixture of isoforms could possibly maximize vaccine efficacy.			Haag, KL (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil.	karen.haag@ufrgs.br	Haag, Karen/R-1382-2016	Haag, Karen/0000-0003-1162-0152				Bonay P, 2002, MOL BIOCHEM PARASIT, V121, P269, DOI 10.1016/S0166-6851(02)00037-3; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chow C, 2004, EXP PARASITOL, V106, P183, DOI 10.1016/j.exppara.2004.03.009; Chow C, 2001, MOL BIOCHEM PARASIT, V118, P83, DOI 10.1016/S0166-6851(01)00373-5; Chow C, 2008, EXP PARASITOL, V119, P499, DOI 10.1016/j.exppara.2008.01.004; Filip LC, 2004, MOL BIOL EVOL, V21, P1504, DOI 10.1093/molbev/msh111; Gauci C, 2002, INFECT IMMUN, V70, P3969, DOI 10.1128/IAI.70.7.3969-3972.2002; Gauci CG, 2001, MOL BIOCHEM PARASIT, V112, P173, DOI 10.1016/S0166-6851(00)00364-9; Haag KL, 2008, TRENDS PARASITOL, V24, P96, DOI 10.1016/j.pt.2007.11.004; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Kyngdon CT, 2006, PARASITE IMMUNOL, V28, P191, DOI 10.1111/j.1365-3024.2006.00820.x; Lightowlers MW, 2006, PARASITOL INT, V55, pS39, DOI 10.1016/j.parint.2005.11.005; Lightowlers MW, 2003, INT J PARASITOL, V33, P1207, DOI 10.1016/S0020-7519(03)00174-7; Nakao M, 2007, PARASITOLOGY, V134, P713, DOI 10.1017/S0031182006001934; Nielsen R, 1998, GENETICS, V148, P929; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Suzuki Y, 2004, GENE, V328, P127, DOI 10.1016/j.gene.2003.11.020; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Waterkeyn J, 1997, MOL BIOCHEM PARASIT, V86, P75, DOI 10.1016/S0166-6851(97)90007-4; Woollard DJ, 2000, VACCINE, V19, P498, DOI 10.1016/S0264-410X(00)00192-4; Woollard DJ, 1999, VACCINE, V18, P785, DOI 10.1016/S0264-410X(99)00350-3; Woollard DJ, 2000, PARASITOLOGY, V121, P145, DOI 10.1017/S0031182099006186; Yang ZH, 2000, GENETICS, V155, P431; Zhang WB, 2003, AM J TROP MED HYG, V68, P40, DOI 10.4269/ajtmh.2003.68.40	29	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5362	10.1371/journal.pone.0005362	http://dx.doi.org/10.1371/journal.pone.0005362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401778	Green Published, gold			2022-12-27	WOS:000265601100009
J	Carpenter, BM; Gancz, H; Gonzalez-Nieves, RP; West, AL; Whitmire, JM; Michel, SLJ; Merrell, DS				Carpenter, Beth M.; Gancz, Hanan; Gonzalez-Nieves, Reyda P.; West, Abby L.; Whitmire, Jeannette M.; Michel, Sarah L. J.; Merrell, D. Scott			A Single Nucleotide Change Affects Fur-Dependent Regulation of sodB in H-pylori	PLOS ONE			English	Article								Helicobacter pylori is a significant human pathogen that has adapted to survive the many stresses found within the gastric environment. Superoxide Dismutase (SodB) is an important factor that helps H. pylori combat oxidative stress. sodB was previously shown to be repressed by the Ferric Uptake Regulator (Fur) in the absence of iron (apo-Fur regulation) [1]. Herein, we show that apo regulation is not fully conserved among all strains of H. pylori. apo-Fur dependent changes in sodB expression are not observed under iron deplete conditions in H. pylori strains G27, HPAG1, or J99. However, Fur regulation of pfr and amiE occurs as expected. Comparative analysis of the Fur coding sequence between G27 and 26695 revealed a single amino acid difference, which was not responsible for the altered sodB regulation. Comparison of the sodB promoters from G27 and 26695 also revealed a single nucleotide difference within the predicted Fur binding site. Alteration of this nucleotide in G27 to that of 26695 restored apo-Fur dependent sodB regulation, indicating that a single base difference is at least partially responsible for the difference in sodB regulation observed among these H. pylori strains. Fur binding studies revealed that alteration of this single nucleotide in G27 increased the affinity of Fur for the sodB promoter. Additionally, the single base change in G27 enabled the sodB promoter to bind to apo-Fur with affinities similar to the 26695 sodB promoter. Taken together these data indicate that this nucleotide residue is important for direct apo-Fur binding to the sodB promoter.			Carpenter, BM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA.	dmerrell@usuhs.mil	Gancz, Hanan/C-4330-2011	Gancz, Hanan/0000-0003-1107-3718	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI065529, R01AI065529] Funding Source: NIH RePORTER; NIAID NIH HHS [AI065529, R01 AI065529-02, R01 AI065529, R56 AI065529] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Ayala G, 2004, MICROB PATHOGENESIS, V37, P163, DOI 10.1016/j.micpath.2004.06.003; Bereswill S, 1998, FEMS MICROBIOL LETT, V159, P193, DOI 10.1016/S0378-1097(97)00566-1; BLASER MJ, 1990, J INFECT DIS, V161, P626, DOI 10.1093/infdis/161.4.626; Bury-Mone S, 2004, MOL MICROBIOL, V53, P623, DOI 10.1111/j.1365-2958.2004.04137.x; Carpenter BM, 2007, APPL ENVIRON MICROB, V73, P7506, DOI 10.1128/AEM.01084-07; Copass M, 1997, INFECT IMMUN, V65, P1949, DOI 10.1128/IAI.65.5.1949-1952.1997; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delany I, 2005, J BACTERIOL, V187, P7703, DOI 10.1128/JB.187.22.7703-7715.2005; Delany I, 2003, MOL MICROBIOL, V50, P1329, DOI 10.1046/j.1365-2958.2003.03757.x; Delany I, 2002, MOL MICROBIOL, V46, P1107, DOI 10.1046/j.1365-2958.2002.03227.x; Delany I, 2001, MOL MICROBIOL, V42, P1297, DOI 10.1046/j.1365-2958.2001.02696.x; Delany I, 2001, J BACTERIOL, V183, P4932, DOI 10.1128/JB.183.16.4932-4937.2001; DELORENZO V, 1987, J BACTERIOL, V169, P2624, DOI 10.1128/jb.169.6.2624-2630.1987; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; EATON KA, 1989, INFECT IMMUN, V57, P1119, DOI 10.1128/IAI.57.4.1119-1125.1989; Ernst FD, 2005, J BACTERIOL, V187, P3687, DOI 10.1128/JB.187.11.3687-3692.2005; Escolar L, 1998, J MOL BIOL, V283, P537, DOI 10.1006/jmbi.1998.2119; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Gancz H, 2006, INFECT IMMUN, V74, P602, DOI 10.1128/IAI.74.1.602-614.2006; Gancz H, 2008, J BACTERIOL, V190, P4100, DOI 10.1128/JB.01728-07; Gieseler S, 2005, MICROBES INFECT, V7, P437, DOI 10.1016/j.micinf.2004.11.018; GUTTERIDGE JMC, 1990, BIOCHEM J, V269, P169, DOI 10.1042/bj2690169; Mehta N, 2003, J BACTERIOL, V185, P726, DOI 10.1128/JB.185.3.726-734.2003; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Pflock M, 2007, CURR MICROBIOL, V54, P320, DOI 10.1007/s00284-006-0520-9; Rashid RA, 2006, MICROB PATHOGENESIS, V41, P207, DOI 10.1016/j.micpath.2006.07.006; Seyler RW, 2001, INFECT IMMUN, V69, P4034, DOI 10.1128/IAI.69.6.4034-4040.2001; SPIEGELHALDER C, 1993, INFECT IMMUN, V61, P5315, DOI 10.1128/IAI.61.12.5315-5325.1993; Thompson LJ, 2003, INFECT IMMUN, V71, P2643, DOI 10.1128/IAI.71.5.2643-2655.2003; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; van Amsterdam K, 2006, FEMS MICROBIOL REV, V30, P131, DOI 10.1111/j.1574-6976.2005.00006.x; van Vliet AHM, 2003, J BIOL CHEM, V278, P9052, DOI 10.1074/jbc.M207542200; Wang G, 2005, FREE RADICAL RES, V39, P1183, DOI 10.1080/10715760500194018	37	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5369	10.1371/journal.pone.0005369	http://dx.doi.org/10.1371/journal.pone.0005369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399190	Green Submitted, Green Published, gold			2022-12-27	WOS:000265514900021
J	Mellet, P; Massot, P; Madelin, G; Marque, SRA; Harte, E; Franconi, JM; Thiaudiere, E				Mellet, Philippe; Massot, Philippe; Madelin, Guillaume; Marque, Sylvain R. A.; Harte, Etienne; Franconi, Jean-Michel; Thiaudiere, Eric			New Concepts in Molecular Imaging: Non-Invasive MRI Spotting of Proteolysis Using an Overhauser Effect Switch	PLOS ONE			English	Article								Background: Proteolysis, involved in many processes in living organisms, is tightly regulated in space and time under physiological conditions. However deregulation can occur with local persistent proteolytic activities, e. g. in inflammation, cystic fibrosis, tumors, or pancreatitis. Furthermore, little is known about the role of many proteases, hence there is a need of new imaging methods to visualize specifically normal or disease-related proteolysis in intact bodies. Methodology/Principal Findings: In this paper, a new concept for non invasive proteolysis imaging is proposed. Overhauser-enhanced Magnetic Resonance Imaging (OMRI) at 0.2 Tesla was used to monitor the enzymatic hydrolysis of a nitroxide-labeled protein. In vitro, image intensity switched from 1 to 25 upon proteolysis due to the associated decrease in the motional correlation time of the substrate. The OMRI experimental device used in this study is consistent with protease imaging in mice at 0.2 T without significant heating. Simulations show that this enzymatic-driven OMRI signal switch can be obtained at lower frequencies suitable for larger animals or humans. Conclusions/Significance: The method is highly sensitive and makes possible proteolysis imaging in three dimensions with a good spatial resolution. Any protease could be targeted specifically through the use of taylor-made cleavable macromolecules. At short term OMRI of proteolysis may be applied to basic research as well as to evaluate therapeutic treatments in small animal models of experimental diseases.			Mellet, P (corresponding author), Univ Victor Segalen Bordeaux, INSERM, IFR 004, Bordeaux, France.	philippe.mellet@rmsb.u-bordeaux2.fr	Marque, Sylvain R.A./L-7096-2017	Marque, Sylvain R.A./0000-0002-3050-8468; Thiaudiere, Eric/0000-0002-9993-4035; Mellet, Philippe/0000-0001-5499-9735; Madelin, Guillaume/0000-0002-5556-5792				ABRAGAM A, 1957, COMPT REND ACAD SCI; Berliner L J, 2003, VIVO EPR ESR THEORY; Cui WN, 2004, MAGN RESON MED, V51, P616, DOI 10.1002/mrm.10719; Deng YM, 2006, COMPUT METH PROG BIO, V82, P67, DOI 10.1016/j.cmpb.2006.02.002; Freed JH, 1976, SPIN LABELING THEORY; Grant GPG, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm240; Grimm J, 2005, P NATL ACAD SCI USA, V102, P14404, DOI 10.1073/pnas.0503920102; GRUCKER D, 1990, MAGNET RESON MED, V14, P140, DOI 10.1002/mrm.1910140113; Krishna MC, 2002, P NATL ACAD SCI USA, V99, P2216, DOI 10.1073/pnas.042671399; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lancelot E, 2008, ARTERIOSCL THROM VAS, V28, P425, DOI 10.1161/ATVBAHA.107.149666; Li HH, 2006, MAGN RESON MED, V55, P669, DOI 10.1002/mrm.20804; Li HH, 2002, MAGNET RESON MED, V48, P530, DOI 10.1002/mrm.10222; Liebgott T, 2003, MAGNET RESON MED, V50, P391, DOI 10.1002/mrm.10534; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; LURIE DJ, 1988, J MAGN RESON, V76, P366, DOI 10.1016/0022-2364(88)90123-0; McIntyre JO, 2003, J CELL BIOCHEM, V90, P1087, DOI 10.1002/jcb.10713; Mizukami S, 2008, J AM CHEM SOC, V130, P794, DOI 10.1021/ja077058z; OVERHAUSER AW, 1953, PHYS REV, V92, P411, DOI 10.1103/PhysRev.92.411; Scherer RL, 2008, CANCER METAST REV, V27, P679, DOI 10.1007/s10555-008-9152-9; Southan C, 2001, DRUG DISCOV TODAY, V6, P681, DOI 10.1016/S1359-6446(01)01793-7; Spinney L, 2006, NATURE, V442, P736, DOI 10.1038/442736a; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Yigit MV, 2008, BIOCONJUGATE CHEM, V19, P412, DOI 10.1021/bc7003928; Yoo B, 2007, CONTRAST MEDIA MOL I, V2, P189, DOI 10.1002/cmmi.145; Zhao M, 2003, ANGEW CHEM INT EDIT, V42, P1375, DOI 10.1002/anie.200390352	27	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2009	4	4							e5244	10.1371/journal.pone.0005244	http://dx.doi.org/10.1371/journal.pone.0005244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VI	19396361	Green Submitted, Green Published, gold			2022-12-27	WOS:000265514600001
J	Pujol, J; Lopez-Sola, M; Ortiz, H; Vilanova, JC; Harrison, BJ; Yucel, M; Soriano-Mas, C; Cardoner, N; Deus, J				Pujol, Jesus; Lopez-Sola, Marina; Ortiz, Hector; Carles Vilanova, Joan; Harrison, Ben J.; Yucel, Murat; Soriano-Mas, Carles; Cardoner, Narcis; Deus, Joan			Mapping Brain Response to Pain in Fibromyalgia Patients Using Temporal Analysis of fMRI	PLOS ONE			English	Article								Background: Nociceptive stimuli may evoke brain responses longer than the stimulus duration often partially detected by conventional neuroimaging. Fibromyalgia patients typically complain of severe pain from gentle stimuli. We aimed to characterize brain response to painful pressure in fibromyalgia patients by generating activation maps adjusted for the duration of brain responses. Methodology/Principal Findings: Twenty-seven women (mean age: 47.8 years) were assessed with fMRI. The sample included nine fibromyalgia patients and nine healthy subjects who received 4 kg/cm(2) of pressure on the thumb. Nine additional control subjects received 6.8 kg/cm(2) to match the patients for the severity of perceived pain. Independent Component Analysis characterized the temporal dynamics of the actual brain response to pressure. Statistical parametric maps were estimated using the obtained time courses. Brain response to pressure (18 seconds) consistently exceeded the stimulus application (9 seconds) in somatosensory regions in all groups. fMRI maps following such temporal dynamics showed a complete pain network response (sensory-motor cortices, operculo-insula, cingulate cortex, and basal ganglia) to 4 kg/cm(2) of pressure in fibromyalgia patients. In healthy subjects, response to this low intensity pressure involved mainly somatosensory cortices. When matched for perceived pain (6.8 kg/cm(2)), control subjects showed also comprehensive activation of pain-related regions, but fibromyalgia patients showed significantly larger activation in the anterior insulabasal ganglia complex and the cingulate cortex. Conclusions/Significance: The results suggest that data-driven fMRI assessments may complement conventional neuroimaging for characterizing pain responses and that enhancement of brain activation in fibromyalgia patients may be particularly relevant in emotion-related regions.			Pujol, J (corresponding author), CRC Corp Sanitaria, Inst Alta Tecnol PRBB, Barcelona, Spain.	jpujol@crccorp.es	Cardoner, Narcis/H-8436-2015; Harrison, Ben J/I-2940-2014; Vilanova, Joan C/H-6104-2015; Menchón, José Manuel/A-4656-2010; Yücel, Murat/AAY-8124-2020; Cardoner, Narcis/AAD-5449-2022; Yucel, Murat/I-3004-2014; Yela, Joan Deus/F-3652-2011; Soriano-Mas, Carles/E-4028-2019	Vilanova, Joan C/0000-0003-2148-6751; Yücel, Murat/0000-0002-4705-452X; Cardoner, Narcis/0000-0001-9633-0888; Yucel, Murat/0000-0002-4705-452X; Soriano-Mas, Carles/0000-0003-4574-6597; LOPEZ SOLA, MARINA/0000-0002-5517-2665				Anand A, 2007, J NEUROPSYCH CLIN N, V19, P274, DOI 10.1176/appi.neuropsych.19.3.274; Apkarian AV, 1999, J NEUROPHYSIOL, V81, P2956, DOI 10.1152/jn.1999.81.6.2956; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; BRETT M, 2007, MNI BRAIN TALAIRACH; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Burgmer M, 2009, NEUROIMAGE, V44, P502, DOI 10.1016/j.neuroimage.2008.09.008; Calhoun VD, 2004, MAGN RESON IMAGING, V22, P1181, DOI 10.1016/j.mri.2004.09.004; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chen JI, 2002, J NEUROPHYSIOL, V88, P464, DOI 10.1152/jn.2002.88.1.464; Cook DB, 2004, J RHEUMATOL, V31, P364; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio A.R., 2005, DESCARTES ERROR EMOT; Farrell MJ, 2001, ARTHRITIS RHEUM, V44, pS394; Giesecke T, 2005, ARTHRITIS RHEUM-US, V52, P1577, DOI 10.1002/art.21008; Giesecke T, 2004, ARTHRITIS RHEUM-US, V50, P613, DOI 10.1002/art.20063; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Hu DW, 2005, NEUROIMAGE, V25, P746, DOI 10.1016/j.neuroimage.2004.12.031; JAMES W, 1994, PSYCHOL REV, V101, P205, DOI 10.1037/0033-295X.101.2.205; Lorenz IH, 2008, BRIT J ANAESTH, V100, P827, DOI 10.1093/bja/aen082; McKeown MJ, 2000, NEUROIMAGE, V11, P24, DOI 10.1006/nimg.1999.0518; Niddam DM, 2002, NEUROIMAGE, V17, P1437, DOI 10.1006/nimg.2002.1270; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Phillips ML, 2008, AM J PSYCHIAT, V165, P313, DOI 10.1176/appi.ajp.2007.07071066; Pollatos O, 2007, BRAIN RES, V1141, P178, DOI 10.1016/j.brainres.2007.01.026; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Price DD, 2005, J RHEUMATOL, V32, P22; Quigley MA, 2002, AM J NEURORADIOL, V23, P49; Quintana JM, 2003, ACTA PSYCHIAT SCAND, V107, P216, DOI 10.1034/j.1600-0447.2003.00062.x; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Ringler R, 2003, PAIN, V105, P445, DOI 10.1016/S0304-3959(03)00258-6; Smythe H, 2000, J RHEUMATOL, V27, P2536; Staud R, 2008, EUR J PAIN, V12, P1078, DOI 10.1016/j.ejpain.2008.02.002; Staud R, 2007, PAIN, V129, P130, DOI 10.1016/j.pain.2006.10.010; Talairach J., 1988, COPLANAR STEREOTAXIC; Tolle TR, 1999, ANN NEUROL, V45, P40, DOI 10.1002/1531-8249(199901)45:1<40::AID-ART8>3.0.CO;2-L; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Williams DA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2094; Wise RG, 2007, MAGN RESON IMAGING, V25, P801, DOI 10.1016/j.mri.2007.03.016; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	104	109	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5224	10.1371/journal.pone.0005224	http://dx.doi.org/10.1371/journal.pone.0005224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381292	Green Published, gold			2022-12-27	WOS:000265513800005
J	Reynolds, MG; Holman, RC; Christensen, KLY; Cheek, JE; Damon, IK				Reynolds, Mary G.; Holman, Robert C.; Christensen, Krista L. Yorita; Cheek, James E.; Damon, Inger K.			The Incidence of Molluscum contagiosum among American Indians and Alaska Natives	PLOS ONE			English	Article								Background: The epidemiology of Molluscum contagiosum (MC) in the United States is largely unknown, despite the fact that the virus is directly communicable and large outbreaks occur. This study provides population-based estimates to describe the epidemiology of MC in the United States among American Indian and Alaska Native (AI/AN) persons. This population was selected because of the comprehensiveness and quality of available data describing utilization of outpatient services. Principal Findings: Outpatient visits listing MC as a diagnosis in the Indian Health Service National Patient Information Reporting System during 2001-2005 were analyzed to assess patient characteristics, visit frequency and concurrent skin conditions. Outpatient visit rates and incidence rates were calculated based on known population denominators (retrospective cohort). Overall outpatient visit rates were also calculated for the general US population using national data. The average annual rate of MC-associated outpatient visits was 20.15/10,000 AI/AN persons for 2001-2005 (13,711 total visits), which was similar to the rate for the general US population (22.0/10,000 [95% CI: 16.9-27.1]). The incidence of MC-associated visits was 15.34/10,000. AI/AN children 1-4 years old had the highest incidence (77.12), more than twice that for children 5-14 years old (30.79); the incidence for infants (< 1 year) was higher than that for adults. AI/AN persons living in the West region had the highest incidence, followed by those in the East and Alaska regions (26.96, 22.88 and 21.38, respectively). There were age-specific associations between MC and concurrent skin conditions (e.g., atopic dermatitis, eczema). Conclusions: This study highlights the need for periodic population-based measurements to assess trends in incidence and healthcare utilization for MC in the United States. High rates of MC were found among AI/AN persons, especially among children,15 years old. The AI/AN population would benefit from greater availability of effective strategies for prevention and treatment of MCV infection.			Reynolds, MG (corresponding author), Ctr Dis Control & Prevent CDC, Poxvirus & Rabies Branch, Atlanta, GA 30333 USA.	nzr6@cdc.gov		Reynolds, Mary/0000-0001-7882-4614; Christensen, Krista/0000-0003-4431-336X				[Anonymous], 2005, INT CLASS DIS 9 REV; Bikowski JB, 2004, CUTIS, V73, P202; Braue A, 2005, PEDIATR DERMATOL, V22, P287, DOI 10.1111/j.1525-1470.2005.22401.x; Choong K Y, 1999, Australas J Dermatol, V40, P89, DOI 10.1046/j.1440-0960.1999.00327.x; Czelusta A, 2000, J AM ACAD DERMATOL, V43, P409, DOI 10.1067/mjd.2000.105158; Dohil MA, 2006, J AM ACAD DERMATOL, V54, P47, DOI 10.1016/j.jaad.2005.08.035; Hanna D, 2006, PEDIATR DERMATOL, V23, P574, DOI 10.1111/j.1525-1470.2006.00313.x; *IND HLTH SERV, 2006, OUTP VIS DAT MOLL CO; Indian Health Service, 2004, TRENDS IND HLTH 2000; Kakourou T, 2005, INT J DERMATOL, V44, P221, DOI 10.1111/j.1365-4632.2004.02074.x; Kleinbaum DG, 1998, APPL REGRESSION ANAL; KONING S, 1994, BRIT J GEN PRACT, V44, P417; MAHE A, 1995, T ROY SOC TROP MED H, V89, P467, DOI 10.1016/0035-9203(95)90068-3; Molino AC, 2004, PEDIATR DERMATOL, V21, P628, DOI 10.1111/j.0736-8046.2004.21602.x; Montgomery LE, 1996, AM J PUBLIC HEALTH, V86, P1401, DOI 10.2105/AJPH.86.10.1401; *NAT CTR HLTH STAT, 2007, NAT HOSP AMB MED CAR; *NATL CTR HLTH SAT, 2007, NAT AMB MED CAR SURV; OREN B, 1991, INFECTION, V19, P159, DOI 10.1007/BF01643239; PAULY CR, 1978, ARCH DERMATOL, V114, P391, DOI 10.1001/archderm.114.3.391; Research Triangle Institute, 2001, SUDAAN US MAN REL 8; RHOADES DA, 2000, AM INDIAN HLTH INNOV, P93; SCHAUB N, 1996, SCHWEIZ RUNDSCH MED, V85, P1162; SOLOMON LM, 1966, CAN MED ASSOC J, V95, P978; Theos AU, 2004, CUTIS, V74, P134; *US BUR CENS, 2006, INT EST POP AG SEX R; *US CDCP, 1996, MMWR-MORBID MORTAL W, V45, P1; Wollenberg A, 2004, CURR OPIN ALLERGY CL, V4, P271, DOI 10.1097/01.all.0000136758.66442.28	27	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5255	10.1371/journal.pone.0005255	http://dx.doi.org/10.1371/journal.pone.0005255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381289	gold, Green Published			2022-12-27	WOS:000265513800016
J	van den Berg, JM; van Koppen, E; Ahlin, A; Belohradsky, BH; Bernatowska, E; Corbeel, L; Espanol, T; Fischer, A; Kurenko-Deptuch, M; Mouy, R; Petropoulou, T; Roesler, J; Seger, R; Stasia, MJ; Valerius, NH; Weening, RS; Wolach, B; Roos, D; Kuijpers, TW				van den Berg, J. Merlijn; van Koppen, Elsbeth; Ahlin, Anders; Belohradsky, Bernd H.; Bernatowska, Ewa; Corbeel, Lucien; Espanol, Teresa; Fischer, Alain; Kurenko-Deptuch, Magdalena; Mouy, Richard; Petropoulou, Theoni; Roesler, Joachim; Seger, Reinhard; Stasia, Marie-Jose; Valerius, Niels H.; Weening, Ron S.; Wolach, Baruch; Roos, Dirk; Kuijpers, Taco W.			Chronic Granulomatous Disease: The European Experience	PLOS ONE			English	Article								CGD is an immunodeficiency caused by deletions or mutations in genes that encode subunits of the leukocyte NADPH oxidase complex. Normally, assembly of the NADPH oxidase complex in phagosomes of certain phagocytic cells leads to a "respiratory burst'', essential for the clearance of phagocytosed micro-organisms. CGD patients lack this mechanism, which leads to life-threatening infections and granuloma formation. However, a clear picture of the clinical course of CGD is hampered by its low prevalence (similar to 1:250,000). Therefore, extensive clinical data from 429 European patients were collected and analyzed. Of these patients 351 were males and 78 were females. X-linked (XL) CGD (gp91(phox) deficient) accounted for 67% of the cases, autosomal recessive (AR) inheritance for 33%. AR-CGD was diagnosed later in life, and the mean survival time was significantly better in AR patients (49.6 years) than in XL CGD (37.8 years), suggesting a milder disease course in AR patients. The disease manifested itself most frequently in the lungs (66% of patients), skin (53%), lymph nodes (50%), gastrointestinal tract (48%) and liver (32%). The most frequently cultured micro-organisms per episode were Staphylococcus aureus (30%), Aspergillus spp. (26%), and Salmonella spp. (16%). Surprisingly, Pseudomonas spp. (2%) and Burkholderia cepacia (< 1%) were found only sporadically. Lesions induced by inoculation with BCG occurred in 8% of the patients. Only 71% of the patients received antibiotic maintenance therapy, and 53% antifungal prophylaxis. 33% were treated with gamma-interferon. 24 patients (6%) had received a stem cell transplantation. The most prominent reason of death was pneumonia and pulmonary abscess (18/84 cases), septicemia (16/84) and brain abscess (4/84). These data provide further insight in the clinical course of CGD in Europe and hopefully can help to increase awareness and optimize the treatment of these patients.			van den Berg, JM (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.m.vandenberg@amc.nl	STASIA, Marie José/M-7165-2014	STASIA, Marie jose/0000-0003-4466-4880; Bernatowska, Ewa/0000-0002-0125-266X; van den Berg, J.Merlijn/0000-0001-9431-5457				ALIABADI H, 1989, NEW ENGL J MED, V321, P706, DOI 10.1056/NEJM198909143211102; Bielorai B, 2000, BONE MARROW TRANSPL, V26, P1025, DOI 10.1038/sj.bmt.1702651; Bustamante J, 2007, J ALLERGY CLIN IMMUN, V120, P32, DOI 10.1016/j.jaci.2007.04.034; Cale CM, 2007, CLIN EXP IMMUNOL, V148, P79, DOI 10.1111/j.1365-2249.2007.03321.x; De Ravin SS, 2006, PEDIATRICS, V117, pE590, DOI 10.1542/peds.2005-1349; EMMENDORFFER A, 1994, CYTOMETRY, V18, P147, DOI 10.1002/cyto.990180306; Goldblatt D, 1999, J PEDIATR-US, V134, P780, DOI 10.1016/S0022-3476(99)70299-4; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Jabado N, 1998, CLIN INFECT DIS, V27, P1437, DOI 10.1086/515015; Jones LBKR, 2008, CLIN EXP IMMUNOL, V152, P211, DOI 10.1111/j.1365-2249.2008.03644.x; Kobayashi SD, 2004, J IMMUNOL, V172, P636, DOI 10.4049/jimmunol.172.1.636; LACY DE, 1993, J INFECTION, V27, P301, DOI 10.1016/0163-4453(93)92271-W; LEE BW, 1994, ARTHRITIS RHEUM, V37, P773, DOI 10.1002/art.1780370524; Lee PPW, 2008, PEDIATR INFECT DIS J, V27, P224, DOI 10.1097/INF.0b013e31815b494c; Liese J, 2000, J PEDIATR-US, V137, P687, DOI 10.1067/mpd.2000.109112; MANZI S, 1991, ARTHRITIS RHEUM, V34, P101, DOI 10.1002/art.1780340116; Marciano BE, 2004, PEDIATRICS, V114, P462, DOI 10.1542/peds.114.2.462; Martire B, 2008, CLIN IMMUNOL, V126, P155, DOI 10.1016/j.clim.2007.09.008; Mauch L, 2007, CLIN CHEM, V53, P890, DOI 10.1373/clinchem.2006.083444; Meischl C, 1998, SPRINGER SEMIN IMMUN, V19, P417, DOI 10.1007/BF00792600; Ott MG, 2007, CURR GENE THER, V7, P155, DOI 10.2174/156652307780859044; Richardson MP, 1998, J IMMUNOL METHODS, V219, P187, DOI 10.1016/S0022-1759(98)00136-7; Roesler J, 2000, BLOOD, V95, P2150, DOI 10.1182/blood.V95.6.2150; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Roos D, 1996, BLOOD, V87, P1663; Segal BH, 2005, CLIN INFECT DIS, V40, P1684, DOI 10.1086/430068; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Seger RA, 2002, BLOOD, V100, P4344, DOI 10.1182/blood-2002-02-0583; Seger RA, 2008, BRIT J HAEMATOL, V140, P255, DOI 10.1111/j.1365-2141.2007.06880.x; Soler-Palacin P, 2007, ALLERGOL IMMUNOPATH, V35, P83, DOI 10.1157/13106774; Stein S, 2006, CURR OPIN MOL THER, V8, P415; THEK LG, 1998, AM J RESP CRIT CARE, V157, P1694; VOWELLS SJ, 1995, J IMMUNOL METHODS, V178, P89, DOI 10.1016/0022-1759(94)00247-T; Wang SM, 2005, DIAGN MICR INFEC DIS, V53, P149, DOI 10.1016/j.diagmicrobio.2005.04.015; WEENING RS, 1995, EUR J PEDIATR, V154, P295, DOI 10.1007/s004310050292; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Wolach B, 2005, BLOOD, V105, P61, DOI 10.1182/blood-2004-02-0675	37	467	472	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5234	10.1371/journal.pone.0005234	http://dx.doi.org/10.1371/journal.pone.0005234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381301	Green Published, gold, Green Submitted			2022-12-27	WOS:000265513800010
J	Tanaka, MM; Kendal, JR; Laland, KN				Tanaka, Mark M.; Kendal, Jeremy R.; Laland, Kevin N.			From Traditional Medicine to Witchcraft: Why Medical Treatments Are Not Always Efficacious	PLOS ONE			English	Article							CHINESE MEDICINE; SEXUAL SELECTION; TRANSMISSION; EVOLUTION; HOMEOPATHY; BEHAVIOR; SAFETY; FADS	Complementary medicines, traditional remedies and home cures for medical ailments are used extensively world-wide, representing more than US$60 billion sales in the global market. With serious doubts about the efficacy and safety of many treatments, the industry remains steeped in controversy. Little is known about factors affecting the prevalence of efficacious and non-efficacious self-medicative treatments. Here we develop mathematical models which reveal that the most efficacious treatments are not necessarily those most likely to spread. Indeed, purely superstitious remedies, or even maladaptive practices, spread more readily than efficacious treatments under specified circumstances. Low-efficacy practices sometimes spread because their very ineffectiveness results in longer, more salient demonstration and a larger number of converts, which more than compensates for greater rates of abandonment. These models also illuminate a broader range of phenomena, including the spread of innovations, medical treatment of animals, foraging behaviour, and self-medication in non-human primates.			Tanaka, MM (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	m.tanaka@unsw.edu.au	Laland, Kevin N/C-9482-2011	Laland, Kevin/0000-0002-2457-0900; Kendal, Jeremy/0000-0001-8644-3117	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abbot NC, 1996, NATURE, V381, P361, DOI 10.1038/381361a0; Abbott A, 2005, NATURE, V436, P898, DOI 10.1038/436898b; Ang HH, 2006, FOOD CHEM TOXICOL, V44, P1245, DOI 10.1016/j.fct.2006.01.014; BECK M, 1989, J COMP PSYCHOL, V103, P132, DOI 10.1037/0735-7036.103.2.132; Bentley RA, 2007, EVOL HUM BEHAV, V28, P151, DOI 10.1016/j.evolhumbehav.2006.10.002; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Bikhchandani S, 1998, J ECON PERSPECT, V12, P151, DOI 10.1257/jep.12.3.151; Boyd R., 1985, CULTURE EVOLUTIONARY; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Coultas JC, 2004, GROUP PROCESS INTERG, V7, P317, DOI 10.1177/1368430204046141; Dawkins Richard, 1976, SELFISH GENE; De Allegri M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-22; Ewens W.J., 1979, MATH POPULATION GENE, V9; Fiot J, 2006, J ETHNOPHARMACOL, V106, P173, DOI 10.1016/j.jep.2005.12.030; Garnier R, 2006, PRESSE MED, V35, P1177, DOI 10.1016/S0755-4982(06)74776-5; Giles J, 2007, NATURE, V446, P352, DOI 10.1038/446352a; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Hahn MW, 2003, P ROY SOC B-BIOL SCI, V270, pS120, DOI 10.1098/rsbl.2003.0045; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hsieh SC, 2006, PHARMACOEPIDEM DR S, V15, P889, DOI 10.1002/pds.1340; Huffman MA, 2004, PRIMATES, V45, P113, DOI 10.1007/s10329-003-0065-5; HUFFMAN MA, 2003, P NUT SOC, V62, P113; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; Laland KN, 1997, ANIM BEHAV, V53, P1161, DOI 10.1006/anbe.1996.0318; LALAND KN, 1994, THEOR POPUL BIOL, V45, P1, DOI 10.1006/tpbi.1994.1001; LEFEBVRE L, 1994, ANIM BEHAV, V47, P331, DOI 10.1006/anbe.1994.1046; LOSADA M, 2006, ECON BOT, V60, P374; Mace R, 2000, ANIM BEHAV, V59, P1, DOI 10.1006/anbe.1999.1287; Nesse R.M., 1994, WHY WE GET SICK NEW; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; Okeke TA, 2006, J BIOSOC SCI, V38, P491, DOI 10.1017/S002193200502660X; Pagel M, 2004, NATURE, V428, P275, DOI 10.1038/428275a; Palombo EA, 2006, PHYTOTHER RES, V20, P717, DOI 10.1002/ptr.1907; Patwardhan B, 2005, EVID-BASED COMPL ALT, V2, P465, DOI 10.1093/ecam/neh140; Reader S.M., 2003, ANIMAL INNOVATION; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; SILVER IA, 1983, EQUINE VET J S, V1, P1; Tanaka MM, 2002, THEOR POPUL BIOL, V62, P111, DOI 10.1006/tpbi.2002.1585; WERNER D, 1983, WHERE THERE IS DOCTO; WHITEN A, 1992, ADV STUD BEHAV, V21, P239, DOI 10.1016/S0065-3454(08)60146-1; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; *WHO, 2002, WHO TRAD MED SURG 20	46	58	61	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2009	4	4							e5192	10.1371/journal.pone.0005192	http://dx.doi.org/10.1371/journal.pone.0005192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437TS	19367333	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000265510400005
J	Bett, JS; Cook, C; Petrucelli, L; Bates, GP				Bett, John S.; Cook, Casey; Petrucelli, Leonard; Bates, Gillian P.			The Ubiquitin-Proteasome Reporter GFPu Does Not Accumulate in Neurons of the R6/2 Transgenic Mouse Model of Huntington's Disease	PLOS ONE			English	Article								Impairment of the ubiquitin-proteasome system (UPS) has long been considered an attractive hypothesis to explain the selective dysfunction and death of neurons in polyglutamine disorders such as Huntington's disease (HD). The fact that inclusion bodies in HD mouse models and patient brains are rich in ubiquitin and proteasome components suggests that the UPS may be hindered directly or indirectly by inclusion bodies or their misfolded monomeric or oligomeric precursors. However, studies into UPS function in various polyglutamine disease models have yielded conflicting results, suggesting mutant polyglutamine tracts may exert different effects on the UPS depending on protein context, expression level, subcellular localisation and cell-type. To investigate UPS function in a well-characterised mouse model of HD, we have crossed R6/2 HD mice with transgenic UPS reporter mice expressing the GFPu construct. The GFPu construct comprises GFP fused to a constitutive degradation signal (CL-1) that promotes its rapid degradation under conditions of a healthy UPS. Using a combination of immunoblot analysis, fluorescence and immunofluorescence microscopy studies, we found that steady-state GFPu levels were not detectably different between R6/2 and non-R6/2 brain. We observed no correlation between inclusion body formation and GFPu accumulation, suggesting no direct relationship between protein aggregation and global UPS inhibition in R6/2 mice. These findings suggest that while certain branches of the UPS can be impaired by mutant polyglutamine proteins, such proteins do not necessarily cause total blockade of UPS-dependent degradation. It is therefore likely that the relationship between mutant polyglutamine proteins and the UPS is more complex than originally anticipated.			Bett, JS (corresponding author), Kings Coll London, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England.	gillian.bates@kcl.ac.uk	Longo, Kenneth A/A-5631-2010; Bates, Gillian P/E-1146-2012	Bates, Gillian P/0000-0002-4041-6305	Wellcome Trust [66270] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bett JS, 2006, HUM MOL GENET, V15, P33, DOI 10.1093/hmg/ddi423; BETT JS, 2009, J CELL MOL IN PRESS; Bove J, 2006, ANN NEUROL, V60, P260, DOI 10.1002/ana.20937; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Diaz-Hernandez M, 2006, J NEUROCHEM, V98, P1585, DOI 10.1111/j.1471-4159.2006.03968.x; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goellner GM, 2003, INT J BIOCHEM CELL B, V35, P562, DOI 10.1016/S1357-2725(02)00388-6; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Kaytor MD, 2004, J NEUROCHEM, V89, P962, DOI 10.1111/j.1471-4159.2004.02376.x; Khan LA, 2006, J NEUROCHEM, V98, P576, DOI 10.1111/j.1471-4159.2006.03895.x; Kim MO, 2008, J NEUROSCI, V28, P3947, DOI 10.1523/JNEUROSCI.5667-07.2008; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; LI X, 2008, BRAIN RES REV; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menendez-Benito V, 2005, METHOD ENZYMOL, V399, P490, DOI 10.1016/S0076-6879(05)99034-4; Michalik A, 2004, NEUROBIOL DIS, V16, P202, DOI 10.1016/j.nbd.2003.12.020; Park Y, 2005, MOL CELLS, V19, P23; Pratt G, 2008, J BIOL CHEM, V283, P12919, DOI 10.1074/jbc.M709347200; Rusmini P, 2007, NEUROBIOL AGING, V28, P1099, DOI 10.1016/j.neurobiolaging.2006.05.015; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Seo H, 2004, ANN NEUROL, V56, P319, DOI 10.1002/ana.20207; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038	39	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5128	10.1371/journal.pone.0005128	http://dx.doi.org/10.1371/journal.pone.0005128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352500	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000265505700021
J	Walshe, TE; Saint-Geniez, M; Maharaj, ASR; Sekiyama, E; Maldonado, AE; D'Amore, PA				Walshe, Tony E.; Saint-Geniez, Magali; Maharaj, Arindel S. R.; Sekiyama, Eiichi; Maldonado, Angel E.; D'Amore, Patricia A.			TGF-beta Is Required for Vascular Barrier Function, Endothelial Survival and Homeostasis of the Adult Microvasculature	PLOS ONE			English	Article								Pericyte-endothelial cell (EC) interactions are critical to both vascular development and vessel stability. We have previously shown that TGF-beta signaling between EC and mural cells participates in vessel stabilization in vitro. We therefore investigated the role of TGF-beta signaling in maintaining microvessel structure and function in the adult mouse retinal microvasculature. TGF-beta signaling was inhibited by systemic expression of soluble endoglin (sEng) and inhibition was demonstrated by reduced phospho-smad2 in the adult retina. Blockade of TGF-beta signaling led to increased vascular and neural cell apoptosis in the retina, which was associated with decreased retinal function, as measured by electroretinogram (ERG). Perfusion of the inner retinal vasculature was impaired and was accompanied by defective autoregulation and loss of capillary integrity. Fundus angiography and Evans blue permeability assay revealed a breakdown of the blood-retinal-barrier that was characterized by decreased association between the tight junction proteins zo-1 and occludin. Inhibition of TGF-beta signaling in cocultures of EC and 10T1/2 cells corroborated the in vivo findings, with impaired EC barrier function, dissociation of EC from 10T1/2 cells, and endothelial cell death, supporting the role of EC-mesenchymal interactions in TGF-beta signaling. These results implicate constitutive TGF-beta signaling in maintaining the integrity and function of the adult microvasculature and shed light on the potential role of TGF-beta signaling in vasoproliferative and vascular degenerative retinal diseases.	[Walshe, Tony E.; Saint-Geniez, Magali; Maharaj, Arindel S. R.; Sekiyama, Eiichi; Maldonado, Angel E.; D'Amore, Patricia A.] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02115 USA; [Walshe, Tony E.; Saint-Geniez, Magali; Maharaj, Arindel S. R.; Sekiyama, Eiichi; Maldonado, Angel E.; D'Amore, Patricia A.] Harvard Univ, Sch Med, Dept Pathol, Schepens Eye Res Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Schepens Eye Research Institute	Walshe, TE (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02115 USA.	patricia.damore@schepens.harvard.edu	D'Amore, Patricia A/G-5660-2017; SAINT-GENIEZ, MAGALI/P-3509-2019; Walshe, Tony/AAJ-8833-2020	D'Amore, Patricia A/0000-0001-9652-8974; SAINT-GENIEZ, MAGALI/0000-0001-9897-138X; 	 [EY05318];  [P30EY14104];  [Research to Prevent Blindness Senior Scientific Investigator]; NATIONAL EYE INSTITUTE [P30EY014104, R01EY005318] Funding Source: NIH RePORTER	; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by EY05318 and by the Core grant for Vision Research P30EY14104. P.A.D. is a Research to Prevent Blindness Senior Scientific Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DH, 1995, J NEUROSCI RES, V42, P63, DOI 10.1002/jnr.490420108; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; BROWN MA, 1989, CLIN SCI, V77, P599, DOI 10.1042/cs0770599; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Collins NT, 2006, ARTERIOSCL THROM VAS, V26, P62, DOI 10.1161/01.ATV.0000194097.92824.b3; Darland D. C., 2001, Angiogenesis, V4, P11, DOI 10.1023/A:1016611824696; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; ENGERMAN RL, 1967, LAB INVEST, V17, P738; Ferguson G, 2000, MOL PHARMACOL, V57, P546, DOI 10.1124/mol.57.3.546; Fernandez-Lopez A, 2007, HUM MOL GENET, V16, P1515, DOI 10.1093/hmg/ddm069; Frank R, 1996, J INVEST DERMATOL, V106, P36, DOI 10.1111/1523-1747.ep12327182; FURUKAWA H, 1987, INVEST OPHTH VIS SCI, V28, P1752; Gao W, 2007, J MOL CELL CARDIOL, V42, P609, DOI 10.1016/j.yjmcc.2006.12.006; Garcia CM, 2004, DEV BRAIN RES, V152, P25, DOI 10.1016/j.devbrainres.2004.05.008; Gordon-Thomson C, 1998, INVEST OPHTH VIS SCI, V39, P1399; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Guerin CJ, 2001, EXP EYE RES, V73, P753, DOI 10.1006/exer.2001.1095; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Henry E, 1999, INVEST OPHTH VIS SCI, V40, P1710; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Lan Y, 2007, MOL CELL BIOL, V27, P7683, DOI 10.1128/MCB.00577-07; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P132, DOI 10.1016/S1089-8603(02)00127-1; LU Q, 2008, AM J PHYSL LUNG CELL; LUTTY GA, 1993, INVEST OPHTH VIS SCI, V34, P477; Ma L, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-11; MERWIN JR, 1990, J CELL PHYSIOL, V142, P117, DOI 10.1002/jcp.1041420115; Mitic LL, 1999, J CELL BIOL, V146, P683, DOI 10.1083/jcb.146.3.683; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Nagaoka T, 2002, INVEST OPHTH VIS SCI, V43, P3037; Neubauer K, 1999, J HEPATOL, V31, P692, DOI 10.1016/S0168-8278(99)80350-X; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Pfeiffer A, 1997, DIABETES, V46, pS26, DOI 10.2337/diab.46.2.S26; Ramsauer M, 2007, J CELL SCI, V120, P1810, DOI 10.1242/jcs.003533; SATO Y, 1989, J CELL BIOL, V109, P309, DOI 10.1083/jcb.109.1.309; Schonfelder U, 1998, MICROVASC RES, V56, P22, DOI 10.1006/mvre.1998.2086; Seki T, 2003, CIRC RES, V93, P682, DOI 10.1161/01.RES.0000095246.40391.3B; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; STEWART PA, 1994, J COMP NEUROL, V340, P566, DOI 10.1002/cne.903400409; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Thorpe PE, 2004, CLIN CANCER RES, V10, P415, DOI 10.1158/1078-0432.CCR-0642-03; Urase K, 1999, DEV BRAIN RES, V116, P69, DOI 10.1016/S0165-3806(99)00076-0; van Royen N, 2002, FASEB J, V16, P432, DOI 10.1096/fj.01-0563fje; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; WACHTMEISTER L, 1978, INVEST OPHTH VIS SCI, V17, P1176; Watabe T, 2003, J CELL BIOL, V163, P1303, DOI 10.1083/jcb.200305147; Yamanaka R, 2002, JPN J OPHTHALMOL, V46, P525, DOI 10.1016/S0021-5155(02)00536-1	54	152	156	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5149	10.1371/journal.pone.0005149	http://dx.doi.org/10.1371/journal.pone.0005149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340291	Green Published, gold, Green Submitted			2022-12-27	WOS:000265500700026
J	Dahlem, MA; Hadjikhani, N				Dahlem, Markus A.; Hadjikhani, Nouchine			Migraine Aura: Retracting Particle-Like Waves in Weakly Susceptible Cortex	PLOS ONE			English	Article							CORTICAL SPREADING DEPRESSION; PRIMARY VISUAL-CORTEX; HUMAN STRIATE CORTEX; EXCITATION WAVES; MODEL; PROPAGATION; SCOTOMAS; PATTERNS; FMRI; REPRESENTATION	Cortical spreading depression (SD) has been suggested to underlie migraine aura. Despite a precise match in speed, the spatio-temporal patterns of SD observed in animal cortex and aura symptoms mapped to the cortical surface ordinarily differ in aspects of size and shape. We show that this mismatch is reconciled by utilizing that both pattern types bifurcate from an instability point of generic reaction-diffusion models. To classify these spatio-temporal pattern we suggest a susceptibility scale having the value sigma = 1 at the instability point. We predict that human cortex is only weakly susceptible to SD (sigma < 1), and support this prediction by directly matching visual aura symptoms with anatomical landmarks using fMRI retinotopic mapping. Moreover, we use retinal SD to give a proof of concept of the existence of this instability point and describe how cortical susceptibility to SD must be adjusted for migraine drug testing. Close to the instability point at sigma = 1 the dynamical repertoire of cortical tissue is increased. As a consequence, the picture of an engulfing SD that became paradigmatic for migraine with aura needs to be modified in most cases towards a more spatially confined pattern that remains within the originating major gyrus or sulcus. Furthermore, we discuss the resulting implications on migraine pharmacology that is hitherto tested in the regime (sigma > 1), and potentially silent aura occurring below a second bifurcation point at sigma = 0 on the susceptible scale.	[Dahlem, Markus A.] Tech Univ Berlin, Inst Theoret Phys, Berlin, Germany; [Dahlem, Markus A.] Otto Von Guericke Univ, Klin Neurol II, Magdeburg, Germany; [Dahlem, Markus A.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Hadjikhani, Nouchine] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Martinos Ctr Biomed Imag, Charlestown, MA USA; [Hadjikhani, Nouchine] Brain Mind Inst, EPFL, Lausanne, Switzerland	Technical University of Berlin; Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); Harvard University; Massachusetts General Hospital; Ecole Polytechnique Federale de Lausanne	Dahlem, MA (corresponding author), Tech Univ Berlin, Inst Theoret Phys, Berlin, Germany.	dahlem@physik.tu-berlin.de	Dahlem, Markus/A-8805-2008; Hadjikhani, Nouchine/C-2018-2008	Dahlem, Markus/0000-0002-7532-0127; Hadjikhani, Nouchine/0000-0003-4075-3106	Deutsche Forschungsgemeinschaft [DA 602/1-1, SFB 555]; NIH [5PO1NS 35611]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Deutsche Forschungsgemeinschaft DA 602/1-1 and SFB 555, and by an NIH grant 5PO1NS 35611. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TJ, 1997, J NEUROSCI, V17, P2859; [Anonymous], 1988, EYE BRAIN VISION; Brand S, 1998, N-S ARCH PHARMACOL, V357, P419, DOI 10.1007/PL00005188; Dahlem MA, 2008, J THEOR BIOL, V251, P202, DOI 10.1016/j.jtbi.2007.11.019; Dahlem MA, 1997, EXP BRAIN RES, V115, P319, DOI 10.1007/PL00005700; Dahlem MA, 2000, EUR J NEUROSCI, V12, P767, DOI 10.1046/j.1460-9568.2000.00995.x; Dahlem MA, 2004, ANN PHYS-BERLIN, V13, P442, DOI 10.1002/andp.200410087; Dahlem MA, 2003, BIOL CYBERN, V88, P419, DOI 10.1007/s00422-003-0405-y; Davydov V. A., 1991, Soviet Physics - Uspekhi, V34, P665, DOI 10.1070/PU1991v034n08ABEH002462; Davydov VA, 2003, PHYS LETT A, V307, P265, DOI 10.1016/S0375-9601(02)01726-7; Davydov VA, 2002, EUROPHYS LETT, V59, P344, DOI 10.1209/epl/i2002-00200-6; Davydov VA, 2000, PHYS REV LETT, V85, P868, DOI 10.1103/PhysRevLett.85.868; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Farkas E, 2008, J CEREBR BLOOD F MET, V28, P251, DOI 10.1038/sj.jcbfm.9600569; ffytche DH, 1999, BRAIN, V122, P1247, DOI 10.1093/brain/122.7.1247; GaschlerMarkefski B, 1997, MAGN RESON MED, V38, P811, DOI 10.1002/mrm.1910380518; GORELOVA NA, 1983, J NEUROBIOL, V14, P353, DOI 10.1002/neu.480140503; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P308, DOI 10.1152/jn.1956.19.4.308; GRUSSER OJ, 1995, VISION RES, V35, P1125, DOI 10.1016/0042-6989(94)00187-Q; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Haken H., 1983, SYNERGETICS INTRO, DOI 10.1007/978-3-642-88338-5; Hakim V, 1999, PHYS REV E, V60, P5073, DOI 10.1103/PhysRevE.60.5073; Hanke W, 1999, RETINAL SPREADING DE; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; James MF, 1999, J PHYSIOL-LONDON, V519, P415, DOI 10.1111/j.1469-7793.1999.0415m.x; JUNG R, 1979, NEUROPSYCHOLOGIA, V17, P173, DOI 10.1016/0028-3932(79)90008-3; Kager H, 2000, J NEUROPHYSIOL, V84, P495, DOI 10.1152/jn.2000.84.1.495; KARMA A, 1991, PHYS REV LETT, V66, P2274, DOI 10.1103/PhysRevLett.66.2274; Lashley KS, 1941, ARCH NEURO PSYCHIATR, V46, P331, DOI 10.1001/archneurpsyc.1941.02280200137007; LAURITZEN M, 1987, TRENDS NEUROSCI, V10, P8, DOI 10.1016/0166-2236(87)90115-9; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Lehmenkuhler A, 1993, MIGRAINE BASIC MECH; Lotze M, 2000, NEUROIMAGE, V11, P473, DOI 10.1006/nimg.2000.0556; Makarova J, 2007, BIOPHYS J, V92, P4216, DOI 10.1529/biophysj.106.090332; MARTINSFERREIRA H, 1974, J NEUROPHYSIOL, V37, P773, DOI 10.1152/jn.1974.37.4.773; MASELKO J, 1989, NATURE, V339, P609, DOI 10.1038/339609a0; Mihaliuk E, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.065602; Mikhailov AS, 2006, PHYS REP, V425, P79, DOI 10.1016/j.physrep.2005.11.003; MILNER PM, 1958, ELECTROEN CLIN NEURO, V10, P705, DOI 10.1016/0013-4694(58)90073-7; Moskowitz MA, 2008, HEADACHE, V48, P688, DOI 10.1111/j.1526-4610.2008.01110.x; Muller M, 2000, J NEUROPHYSIOL, V84, P1869, DOI 10.1152/jn.2000.84.4.1869; Polimeni JR, 2006, VISION RES, V46, P3336, DOI 10.1016/j.visres.2006.03.006; POPPEL E, 1973, NATURWISSENSCHAFTEN, V60, P554; Qiu AQ, 2006, NEUROIMAGE, V31, P125, DOI 10.1016/j.neuroimage.2005.11.049; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; RICHARDS W, 1971, SCI AM, V224, P88, DOI 10.1038/scientificamerican0571-88; RODRIGUES PS, 1988, EXP BRAIN RES, V73, P659, DOI 10.1007/BF00406625; Roland PE, 1998, BRAIN RES REV, V26, P87, DOI 10.1016/S0165-0173(97)00058-1; Russell MB, 1996, BRAIN, V119, P355, DOI 10.1093/brain/119.2.355; Sakurai T, 2002, SCIENCE, V296, P2009, DOI 10.1126/science.1071265; Sanchez-del-Rio M, 2006, CURR OPIN NEUROL, V19, P294, DOI 10.1097/01.wco.0000227041.23694.5c; Scheller D, 1998, J NEUROSCI RES, V51, P85, DOI 10.1002/(SICI)1097-4547(19980101)51:1<85::AID-JNR9>3.0.CO;2-H; Schneider FM, 2009, CHAOS, V19, DOI 10.1063/1.3096411; SCHWARTZ EL, 1980, BIOL CYBERN, V37, P63, DOI 10.1007/BF00364246; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shepherd AJ, 2001, BRAIN, V124, P2310, DOI 10.1093/brain/124.11.2310; SHIBATA M, 1972, J NEUROPHYSIOL, V35, P381, DOI 10.1152/jn.1972.35.3.381; SILBERSTEIN SD, 2005, ATLAS MIGRAINE OTHER; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; STENSAAS SS, 1974, J NEUROSURG, V40, P747, DOI 10.3171/jns.1974.40.6.0747; Tootell RBH, 1998, TRENDS COGN SCI, V2, P174, DOI 10.1016/S1364-6613(98)01171-1; VANVALKENBURGH P, 2005, J VISION, V5, P90; Vincent MB, 2007, CEPHALALGIA, V27, P1368, DOI 10.1111/j.1468-2982.2007.01388.x; Watzlawick P., 1993, SITUATION IS HOPELES; Wiedemann M, 1996, N-S ARCH PHARMACOL, V353, P552, DOI 10.1007/BF00169175; Wilkinson F, 2003, PROG BRAIN RES, V144, P305, DOI 10.1016/S0079-6123(03)14402-1; Winfree AT, 1991, CHAOS, V1	68	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5007	10.1371/journal.pone.0005007	http://dx.doi.org/10.1371/journal.pone.0005007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337363	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500600008
J	Herfarth, HH; Grunert, M; Klebl, F; Strauch, U; Feuerbach, S; Scholmerich, J; Rogler, G; Schreyer, AG				Herfarth, Hans H.; Grunert, Michael; Klebl, Frank; Strauch, Ulrike; Feuerbach, Stefan; Schoelmerich, Juergen; Rogler, Gerhard; Schreyer, Andreas G.			Frequency and Nature of Incidental Extra-Enteric Lesions Found on Magnetic Resonance Enterography (MR-E) in Patients with Inflammatory Bowel Diseases (IBD)	PLOS ONE			English	Article							CROHNS-DISEASE; CT COLONOGRAPHY; CONVENTIONAL ENTEROCLYSIS; EXTRACOLONIC FINDINGS; VIRTUAL COLONOSCOPY; TREATMENT RESPONSE; ABDOMEN; PREVALENCE; ULTRASOUND; DISORDERS	Background: The aim of this study was to determine the occurrence of extra-enteric findings in a large cohort of patients undergoing magnetic resonance enterography (MR-E) and to classify the clinical significance of these findings. Materials and Methods: We retrospectively analyzed 1154 MR-E performed in 1006 patients referred to our radiological department between 1999-2005. The reasons for referral were suspected or proven inflammatory bowel diseases (IBD) (n = 710), further diagnostic work-up for small bowel disease because of non-specific abdominal symptoms (SBD; n = 182) or suspected small bowel malignancies (SBM; n = 114). All extra-enteric findings were reviewed by a radiologist and a gastroenterologist and were classified as having high, moderate, or low significance for further diagnostic or therapeutic procedures. Results: The average age of all patients was 40 +/- 16 (Mean +/- SD) years (y) (IBD 35 +/- 13 y; SBD 49 +/- 16 y; SBM 57 +/- 15 y). A total of 1113 extra-enteric findings were detected in 600 of 1006 patients (59.6%). Of these findings 180 (16.2%) were judged as having a high, 212 (19.0%) a moderate and 721 (64.8%) a low significance. On a per group basis in patients with IBD 12.0% of the findings were of major clinical significance compared to 13.7% and 33.3% in patients with SBD and SBM, respectively. The most common major findings were abscesses (69.9%) in the IBD group and extraintestinal tumors, metastases or masses in the SBD and SBM groups (41.9% and 74.2%, respectively). Conclusions: MR-E reveals a substantial number of extra-enteric findings, supporting the role of a cross-sectional imaging method for the evaluation of the small bowel.	[Herfarth, Hans H.; Grunert, Michael; Klebl, Frank; Strauch, Ulrike; Schoelmerich, Juergen; Rogler, Gerhard] Univ Regensburg, Dept Internal Med, D-8400 Regensburg, Germany; [Feuerbach, Stefan; Schreyer, Andreas G.] Univ Regensburg, Dept Radiol, D-8400 Regensburg, Germany	University of Regensburg; University of Regensburg	Herfarth, HH (corresponding author), Univ N Carolina, Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27515 USA.	hherf@med.unc.edu	Herfarth, Hans/K-7547-2019; Schreyer, Andreas G/A-1797-2012; Rogler, Gerhard/O-5308-2015; Grunert, Michael/AAC-8233-2021	Schreyer, Andreas G/0000-0002-2449-4397; Rogler, Gerhard/0000-0002-1733-9188; Schreyer, Andreas/0000-0002-2539-059X	NIH [R21 DK080408-01]; CCFA [senior research award]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK080408] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCFA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Hans Herfarth is supported in part by NIH R21 DK080408-01 and a senior research award of the CCFA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschoff AJ, 1997, ROFO-FORTSCHR RONTG, V167, P387, DOI 10.1055/s-2007-1015549; Bernstein CN, 2005, AM J GASTROENTEROL, V100, P2493, DOI 10.1111/j.1572-0241.2005.00239.x; BOOYA F, 2008, ABDOM IMAGING; Bruining DH, 2008, INFLAMM BOWEL DIS, V14, P1701, DOI 10.1002/ibd.20529; Debatin JF, 2003, GUT, V52, P17; FISHMAN EK, 1987, AM J ROENTGENOL, V148, P537, DOI 10.2214/ajr.148.3.537; Frokjaer JB, 2005, SCAND J GASTROENTERO, V40, P832, DOI 10.1080/00365520510015683; Gasche C, 1999, GUT, V44, P112, DOI 10.1136/gut.44.1.112; Gourtsoyiannis NC, 2006, EUR RADIOL, V16, P1915, DOI 10.1007/s00330-006-0248-8; Hara AK, 2000, RADIOLOGY, V215, P353, DOI 10.1148/radiology.215.2.r00ap33353; Hellstrom M, 2004, AM J ROENTGENOL, V182, P631, DOI 10.2214/ajr.182.3.1820631; Holzknecht N, 1998, RADIOLOGE, V38, P29, DOI 10.1007/s001170050320; Jamieson DH, 2003, AM J ROENTGENOL, V180, P1211, DOI 10.2214/ajr.180.5.1801211; KETTRITZ U, 1995, J CLIN GASTROENTEROL, V21, P249, DOI 10.1097/00004836-199510000-00018; Koh DM, 2001, AM J ROENTGENOL, V177, P1325, DOI 10.2214/ajr.177.6.1771325; Low RN, 2002, RADIOLOGY, V222, P652, DOI 10.1148/radiol.2223010811; Low RN, 2000, JMRI-J MAGN RESON IM, V11, P127, DOI 10.1002/(SICI)1522-2586(200002)11:2<127::AID-JMRI8>3.0.CO;2-G; Maccioni F, 2000, ABDOM IMAGING, V25, P219, DOI 10.1007/s002610000004; Maccioni F, 2002, ABDOM IMAGING, V27, P384, DOI 10.1007/s00261-001-0119-3; Madsen SM, 1997, ABDOM IMAGING, V22, P164, DOI 10.1007/s002619900163; Madsen SM, 1999, ABDOM IMAGING, V24, P232, DOI 10.1007/s002619900487; Maglinte DDT, 2006, EUR RADIOL, V16, P967, DOI 10.1007/s00330-005-0054-8; Mako EK, 2000, EUR J RADIOL, V35, P168, DOI 10.1016/S0720-048X(00)00239-4; Marcos HB, 2000, MAGN RESON IMAGING, V18, P263, DOI 10.1016/S0730-725X(99)00141-1; Ochsenkuhn T, 2004, SCAND J GASTROENTERO, V39, P953, DOI 10.1080/00365520410003218; Parente F, 2003, ALIMENT PHARM THER, V18, P1009, DOI 10.1046/j.1365-2036.2003.01796.x; Paulsen SR, 2006, RADIOGRAPHICS, V26, P641, DOI 10.1148/rg.263055162; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Potthast S, 2002, EUR RADIOL, V12, P1416, DOI 10.1007/s00330-001-1191-3; Rieber A, 2000, INT J COLORECTAL DIS, V15, P176, DOI 10.1007/s003840000219; Rieber A, 1998, RADIOLOGE, V38, P23, DOI 10.1007/s001170050319; Sailer J, 2005, AM J ROENTGENOL, V185, P1575, DOI 10.2214/AJR.04.1534; Schreyer AG, 2004, INFLAMM BOWEL DIS, V10, P45, DOI 10.1097/00054725-200401000-00008; Schreyer AG, 2002, INVEST RADIOL, V37, P528, DOI 10.1097/00004424-200209000-00008; Schreyer AG, 2004, CLIN GASTROENTEROL H, V2, P491, DOI 10.1016/S1542-3565(04)00168-5; Schunk K, 2000, INVEST RADIOL, V35, P431, DOI 10.1097/00004424-200007000-00006; SHOENUT JP, 1994, J CLIN GASTROENTEROL, V19, P31, DOI 10.1097/00004836-199407000-00009; Small WC, 1999, J MAGN RESON IMAGING, V10, P15, DOI 10.1002/(SICI)1522-2586(199907)10:1<15::AID-JMRI3>3.3.CO;2-O; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; Wiarda BM, 2006, AM J ROENTGENOL, V187, P522, DOI 10.2214/AJR.05.0511; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Xiong T, 2005, BRIT J RADIOL, V78, P22, DOI 10.1259/bjr/67998962	42	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e4863	10.1371/journal.pone.0004863	http://dx.doi.org/10.1371/journal.pone.0004863			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337373	Green Submitted, Green Published, gold			2022-12-27	WOS:000265500600003
J	Lopez-Leon, S; Choy, WC; Aulchenko, YS; Claes, SJ; Oostra, BA; Mackenbach, JP; van Duijn, CM; Janssens, ACJW				Lopez-Leon, Sandra; Choy, Wing Chi; Aulchenko, Yurii S.; Claes, Stephan J.; Oostra, Ben A.; Mackenbach, Johan P.; van Duijn, Cornelia M.; Janssens, A. Cecile J. W.			Genetic Factors Influence the Clustering of Depression among Individuals with Lower Socioeconomic Status	PLOS ONE			English	Article							MULTIVARIATE NORMAL-MODELS; TRAIT LINKAGE ANALYSIS; EDUCATIONAL-ATTAINMENT; MAJOR DEPRESSION; HERITABILITY; PREDISPOSITION; INEQUALITIES; POLYMORPHISM; PERSONALITY; ENVIRONMENT	Objective: To investigate the extent to which shared genetic factors can explain the clustering of depression among individuals with lower socioeconomic status, and to examine if neuroticism or intelligence are involved in these pathways. Methods: In total 2,383 participants (1,028 men and 1,355 women) of the Erasmus Rucphen Family Study were assessed with the Center for Epidemiologic Studies Depression Scale (CES-D) and the Hospital Anxiety and Depression Scale (HAD-SD). Socioeconomic status was assessed as the highest level of education obtained. The role of shared genetic factors was quantified by estimating genetic correlations (rho G) between symptoms of depression and education level, with and without adjustment for premorbid intelligence and neuroticism scores. Results: Higher level of education was associated with lower depression scores (partial correlation coefficient -0.09 for CES-D and -0.17 for HADS-D). Significant genetic correlations were found between education and both CES-D (rho G = -0.65) and HADS-D (rho G = -0.50). The genetic correlations remained statistically significant after adjusting for premorbid intelligence and neuroticism scores. Conclusions: Our study suggests that shared genetic factors play a role in the co-occurrence of lower socioeconomic status and symptoms of depression, which suggest that genetic factors play a role in health inequalities. Further research is needed to investigate the validity, causality and generalizability of our results.	[Lopez-Leon, Sandra; Choy, Wing Chi; Aulchenko, Yurii S.; Oostra, Ben A.; van Duijn, Cornelia M.] Erasmus Univ, Dept Epidemiol & Biostat, Med Ctr, Genet Epidemiol Unit, NL-3000 DR Rotterdam, Netherlands; [Lopez-Leon, Sandra; Choy, Wing Chi; Aulchenko, Yurii S.; Oostra, Ben A.; van Duijn, Cornelia M.] Erasmus Univ, Dept Clin Genet, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Claes, Stephan J.] Univ Leuven, Dept Psychiat, Louvain, Belgium; [Mackenbach, Johan P.; Janssens, A. Cecile J. W.] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; KU Leuven; Erasmus University Rotterdam; Erasmus MC	Lopez-Leon, S (corresponding author), Erasmus Univ, Dept Epidemiol & Biostat, Med Ctr, Genet Epidemiol Unit, NL-3000 DR Rotterdam, Netherlands.	a.janssens@erasmusmc.nl	janssens, cecile c/L-1075-2015; Aulchenko, Yurii/M-8270-2013	Aulchenko, Yurii/0000-0002-7899-1575; Van Duijn, Cornelia/0000-0002-2374-9204; Janssens, A Cecile/0000-0002-6153-4976; Claes, Stephan/0000-0002-1175-492X	Center for Medical Systems Biology (CMSB); Dutch Brain Foundation (Hersenstichting Nederland)	Center for Medical Systems Biology (CMSB); Dutch Brain Foundation (Hersenstichting Nederland)	The study was financially supported by the Center for Medical Systems Biology (CMSB) and the Dutch Brain Foundation (Hersenstichting Nederland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Baker LA, 1996, BEHAV GENET, V26, P89, DOI 10.1007/BF02359887; Boichard D., 2002, PEDIG FORTRAN PACKAG; Chamorro-Premuzic T, 2003, J RES PERS, V37, P319, DOI 10.1016/S0092-6566(02)00578-0; Falconer D. S., 1996, INTRO QUANTITATIVE G; Falconer D. S., 1981, INTRO QUANTITATIVE G; Fanous AH, 2004, NEUROTOX RES, V6, P43, DOI 10.1007/BF03033295; HOEKSTRA HAO, 1996, NEO PERSONALITY INDE; HOPPER JL, 1983, AM J EPIDEMIOL, V117, P344, DOI 10.1093/oxfordjournals.aje.a113547; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Hubacek JA, 2001, NEUROPSYCHOBIOLOGY, V43, P200, DOI 10.1159/000054890; Keltikangas-Jarvinen L, 2002, LEARN INDIVID DIFFER, V14, P23, DOI 10.1016/j.lindif.2003.04.001; LEON SL, 2007, MOL PSYCHIAT; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Lopez LS, 2005, BIOL PSYCHIAT, V57, P999, DOI 10.1016/j.biopsych.2005.01.030; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; LUYNCH M, 1998, GENETICS DATA ANAL Q; Mackenbach JP, 2005, J EPIDEMIOL COMMUN H, V59, P268, DOI 10.1136/jech.2004.026807; Manuck SB, 2005, PSYCHOL MED, V35, P519, DOI 10.1017/S0033291704003757; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ravnkilde B, 2002, SCAND J PSYCHOL, V43, P239, DOI 10.1111/1467-9450.00292; Santos RLP, 2006, DIABETOLOGIA, V49, P667, DOI 10.1007/s00125-006-0142-6; Schmand B, 1991, Tijdschr Gerontol Geriatr, V22, P15; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; TAMBS K, 1989, BEHAV GENET, V19, P209, DOI 10.1007/BF01065905; TEASDALE TW, 1984, NATURE, V309, P620, DOI 10.1038/309620a0; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; Turner RJ, 1999, J HEALTH SOC BEHAV, V40, P374, DOI 10.2307/2676332; van Koolwijk LME, 2007, INVEST OPHTH VIS SCI, V48, P3669, DOI 10.1167/iovs.06-1519; van Rijn MJE, 2007, J HYPERTENS, V25, P565, DOI 10.1097/HJH.0b013e32801449fb; VOGLER GP, 1983, BEHAV GENET, V13, P341, DOI 10.1007/BF01065772; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; *WHO, 1996, GLOB BURD DIS; Williams JT, 1999, AM J HUM GENET, V65, P1134, DOI 10.1086/302570; Zhu J, 2008, ADV GENET, V60, P603, DOI 10.1016/S0065-2660(07)00421-X; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5069	10.1371/journal.pone.0005069	http://dx.doi.org/10.1371/journal.pone.0005069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PR	19333388	gold, Green Published, Green Submitted			2022-12-27	WOS:000265499900018
J	Lingappa, JR; Kahle, E; Mugo, N; Mujugira, A; Magaret, A; Baeten, J; Bukusi, EA; Cohen, CR; Katabira, E; Ronald, A; Kiarie, J; Farquhar, C; Stewart, GJ; Makhema, J; Essex, M; Were, E; Fife, K; deBruyn, G; Gray, G; McIntyre, J; Manongi, R; Kapiga, S; Coetzee, D; Allen, S; Inambao, M; Kayitenkore, K; Karita, E; Kanweka, W; Delany, S; Rees, H; Vwalika, B; Coombs, RW; Morrow, R; Whittington, W; Corey, L; Wald, A; Celum, C				Lingappa, Jairam R.; Kahle, Erin; Mugo, Nelly; Mujugira, Andrew; Magaret, Amalia; Baeten, Jared; Bukusi, Elizabeth A.; Cohen, Craig R.; Katabira, Elly; Ronald, Allan; Kiarie, James; Farquhar, Carey; Stewart, Grace John; Makhema, Joseph; Essex, M.; Were, Edwin; Fife, Kenneth; deBruyn, Guy; Gray, Glenda; McIntyre, James; Manongi, Rachel; Kapiga, Saidi; Coetzee, David; Allen, Susan; Inambao, Mubiana; Kayitenkore, Kayitesi; Karita, Etienne; Kanweka, William; Delany, Sinead; Rees, Helen; Vwalika, Bellington; Coombs, Robert W.; Morrow, Rhoda; Whittington, William; Corey, Lawrence; Wald, Anna; Celum, Connie		Partners HSV 2 HIV 1 Transmission	Characteristics of HIV-1 Discordant Couples Enrolled in a Trial of HSV-2 Suppression to Reduce HIV-1 Transmission: The Partners Study	PLOS ONE			English	Article								Background: The Partners HSV-2/HIV-1 Transmission Study (Partners Study) is a phase III, placebo-controlled trial of daily acyclovir for genital herpes (HSV-2) suppression among HIV-1/HSV-2 co-infected persons to reduce HIV-1 transmission to their HIV-1 susceptible partners, which requires recruitment of HIV-1 serodiscordant heterosexual couples. We describe the baseline characteristics of this cohort. Methods: HIV-1 serodiscordant heterosexual couples, in which the HIV-1 infected partner was HSV-2 seropositive, had a CD4 count >= 250 cells/mcL and was not on antiretroviral therapy, were enrolled at 14 sites in East and Southern Africa. Demographic, behavioral, clinical and laboratory characteristics were assessed. Results: Of the 3408 HIV-1 serodiscordant couples enrolled, 67% of the HIV-1 infected partners were women. Couples had cohabitated for a median of 5 years (range 2-9) with 28% reporting unprotected sex in the month prior to enrollment. Among HIV-1 susceptible participants, 86% of women and 59% of men were HSV-2 seropositive. Other laboratory-diagnosed sexually transmitted infections were uncommon (< 5%), except for Trichomonas vaginalis in 14% of HIV-1 infected women. Median baseline CD4 count for HIV-1 infected participants was 462cells/mcL and median HIV-1 plasma RNA was 4.2 log(10) copies/mL. After adjusting for age and African region, correlates of HIV-1 RNA level included male gender (+ 0.24 log(10) copies/mL; p, 0.001) and CD4 count (-0.25 and-0.55 log(10) copies/mL for CD4 350-499 and >500 relative to <350, respectively, p, 0.001). Conclusions: The Partners Study successfully enrolled a cohort of 3408 heterosexual HIV-1 serodiscordant couples in Africa at high risk for HIV-1 transmission. Follow-up of this cohort will evaluate the efficacy of acyclovir for HSV-2 suppression in preventing HIV-1 transmission and provide insights into biological and behavioral factors determining heterosexual HIV-1 transmission.			Lingappa, JR (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	lingappa@u.washington.edu	Corey, Lawrence/AAE-1796-2020; John-Stewart, Grace/L-3650-2019; Wald, Anna/B-6272-2012; John-Stewart, Grace/U-3351-2019; Lingappa, Jairam/N-7760-2017	Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438; Mujugira, Andrew/0000-0001-6646-6733; Were, Edwin/0000-0002-4783-0795; Kapiga, Saidi/0000-0003-1753-4060; kiarie, james/0000-0003-4180-7858; Rees, Helen/0000-0003-1442-6734; , Erin/0000-0001-6060-9852; Ronald, Allan/0000-0002-5746-3490	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI038858, P30AI027757] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI027757, U01 AI038858, AI-38858] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; ALBRECHT MA, 1989, J VIROL, V63, P1861, DOI 10.1128/JVI.63.5.1861-1868.1989; Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1991, JAMA-J AM MED ASSOC, V266, P1657, DOI 10.1001/jama.266.12.1657; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; Ashley-Morrow R, 2004, CLIN MICROBIOL INFEC, V10, P530, DOI 10.1111/j.1469-0691.2004.00836.x; Auvert B, 2004, JAIDS-J ACQ IMM DEF, V36, P613, DOI 10.1097/00126334-200405010-00010; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Baeten JM, 2004, J INFECT DIS, V189, P1466, DOI 10.1086/383049; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bunnell RE, 2005, AIDS CARE, V17, P999, DOI 10.1080/09540120500100718; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Centers for Disease Control and Prevention, 2007, COUPL HIV COUNS TEST; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; DELANY SC, 2008, AIDS IN PRESS; DEWALQUE D, 2006, DISCORDANT COUPLES H; Dunne EF, 2008, JAIDS-J ACQ IMM DEF, V49, P77, DOI 10.1097/QAI.0b013e3181831832; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Freeman EE, 2004, AIDS, V18, P1715, DOI 10.1097/01.aids.0000139075.13906.2f; Freeman EE, 2007, SEX TRANSM INFECT, V83, pI17, DOI 10.1136/sti.2006.023549; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS69, DOI 10.1002/cyto.b.20397; GOLDEN MP, 1992, J INFECT DIS, V166, P494, DOI 10.1093/infdis/166.3.494; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Huppert JS, 2007, CLIN INFECT DIS, V45, P194, DOI 10.1086/518851; Ioannidis JPA, 1998, J INFECT DIS, V178, P349, DOI 10.1086/515621; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Lew J, 1998, J CLIN MICROBIOL, V36, P1471, DOI 10.1128/JCM.36.6.1471-1479.1998; Lingappa JR, 2007, DRUGS, V67, P155, DOI 10.2165/00003495-200767020-00001; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; Mbopi-Keou FX, 2003, JAIDS-J ACQ IMM DEF, V33, P121, DOI 10.1097/00126334-200306010-00001; Mole L, 1997, J INFECT DIS, V176, P766, DOI 10.1086/517297; Morrill AC, 2006, J HEALTH COMMUN, V11, P183, DOI 10.1080/10810730500526745; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Palo G, 2001, Herpes, V8, P50; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Schacker T, 2002, J INFECT DIS, V186, P1718, DOI 10.1086/345771; Schacker T, 1998, JAMA-J AM MED ASSOC, V280, P61, DOI 10.1001/jama.280.1.61; Stephenson R, 2008, AIDS CARE, V20, P395, DOI 10.1080/09540120701593497; TREMBLAY M, 1989, J MED VIROL, V29, P109, DOI 10.1002/jmv.1890290207; TUMWESIGYE E, 2008, 15 C RETR OPP INF CR; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wald Anna, 2004, Herpes, V11, P70; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; ZHU J, 2009, KEYST S PREV HIV AID; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; ZUCKERMAN RA, 2009, AIDS IN PRESS; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	56	66	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5272	10.1371/journal.pone.0005272	http://dx.doi.org/10.1371/journal.pone.0005272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404392	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000265614900001
J	Prabhakaran, S; Liang, XW; Skare, JT; Potts, JR; Hook, M				Prabhakaran, Sabitha; Liang, Xiaowen; Skare, Jonathan T.; Potts, Jennifer R.; Hook, Magnus			A Novel Fibronectin Binding Motif in MSCRAMMs Targets F3 Modules	PLOS ONE			English	Article								Background: BBK32 is a surface expressed lipoprotein and fibronectin (Fn)-binding microbial surface component recognizing adhesive matrix molecule (MSCRAMM) of Borrelia burgdorferi, the causative agent of Lyme disease. Previous studies from our group showed that BBK32 is a virulence factor in experimental Lyme disease and located the Fn-binding region to residues 21-205 of the lipoprotein. Methodology/Principal Findings: Studies aimed at identifying interacting sites between BBK32 and Fn revealed an interaction between the MSCRAMM and the Fn F3 modules. Further analysis of this interaction showed that BBK32 can cause the aggregation of human plasma Fn in a similar concentration-dependent manner to that of anastellin, the superfibronectin (sFn) inducing agent. The resulting Fn aggregates are conformationally distinct from plasma Fn as indicated by a change in available thermolysin cleavage sites. Recombinant BBK32 and anastellin affect the structure of Fn matrices formed by cultured fibroblasts and inhibit endothelial cell proliferation similarly. Within BBK32, we have located the sFn-forming activity to a region between residues 160 and 175 which contains two sequence motifs that are also found in anastellin. Synthetic peptides mimicking these motifs induce Fn aggregation, whereas a peptide with a scrambled sequence motif was inactive, suggesting that these motifs represent the sFn-inducing sequence. Conclusions/Significance: We conclude that BBK32 induces the formation of Fn aggregates that are indistinguishable from those formed by anastellin. The results of this study provide evidence for how bacteria can target host proteins to manipulate host cell activities.			Prabhakaran, S (corresponding author), Texas A & M Hlth Sci Ctr, Inst Biosci & Technol, College Stn, TX USA.			Liang, Xiaowen/0000-0002-6174-2951	British Heart Foundation Funding Source: Medline; NIAID NIH HHS [AI058086, AI20624, AI020624, R01 AI058086, R56 AI020624, R01 AI020624] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020624, R56AI020624, R01AI058086] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akerman ME, 2005, P NATL ACAD SCI USA, V102, P2040, DOI 10.1073/pnas.0409844102; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambesi A, 2005, CANCER RES, V65, P148; Briknarova K, 2003, J MOL BIOL, V332, P205, DOI 10.1016/S0022-2836(03)00890-8; CARNEMOLLA B, 1987, FEBS LETT, V215, P269, DOI 10.1016/0014-5793(87)80160-6; COMSTOCK LE, 1991, MICROB PATHOGENESIS, V10, P137, DOI 10.1016/0882-4010(91)90074-K; COMSTOCK LE, 1989, INFECT IMMUN, V57, P1626, DOI 10.1128/IAI.57.5.1626-1628.1989; DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165; Fikrig E, 2000, J IMMUNOL, V164, P5344, DOI 10.4049/jimmunol.164.10.5344; Heikkila T, 2002, J CLIN MICROBIOL, V40, P1174, DOI 10.1128/JCM.40.4.1174-1180.2002; Hussain M, 2001, J BACTERIOL, V183, P6778, DOI 10.1128/JB.183.23.6778-6786.2001; Ingham KC, 1997, J BIOL CHEM, V272, P1718, DOI 10.1074/jbc.272.3.1718; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Kingsley RA, 2004, MOL MICROBIOL, V52, P345, DOI 10.1111/j.1365-2958.2004.03995.x; Klein RM, 2003, J CELL SCI, V116, P4663, DOI 10.1242/jcs.00778; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; Liao YF, 1999, J BIOL CHEM, V274, P17876, DOI 10.1074/jbc.274.25.17876; MA Y, 1991, INFECT IMMUN, V59, P671, DOI 10.1128/IAI.59.2.671-678.1991; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; MCGAVIN MJ, 1993, J BIOL CHEM, V268, P23946; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Mosher DF, 1989, FIBRONECTIN; Norman MU, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000169; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; Ozeri V, 1996, EMBO J, V15, P989, DOI 10.1002/j.1460-2075.1996.tb00435.x; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Pasqualini R, 1996, NAT MED, V2, P1197, DOI 10.1038/nm1196-1197; Plaxco KW, 1997, J MOL BIOL, V270, P763, DOI 10.1006/jmbi.1997.1148; Plaxco KW, 1996, P NATL ACAD SCI USA, V93, P10703, DOI 10.1073/pnas.93.20.10703; Probert WS, 1998, MOL MICROBIOL, V30, P1003, DOI 10.1046/j.1365-2958.1998.01127.x; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Sechler JL, 2000, J CELL SCI, V113, P1491; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; SZCZEPANSKI A, 1990, J CLIN INVEST, V85, P1637, DOI 10.1172/JCI114615; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; TALAY SR, 1992, INFECT IMMUN, V60, P3837, DOI 10.1128/IAI.60.9.3837-3844.1992; THOMAS DD, 1989, INFECT IMMUN, V57, P1324, DOI 10.1128/IAI.57.4.1324-1326.1989; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331; Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620	42	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5412	10.1371/journal.pone.0005412	http://dx.doi.org/10.1371/journal.pone.0005412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404402	Green Published, gold, Green Submitted			2022-12-27	WOS:000265614900022
J	Jugessur, A; Shi, M; Gjessing, HK; Lie, RT; Wilcox, AJ; Weinberg, CR; Christensen, K; Boyles, AL; Daack-Hirsch, S; Trung, TN; Bille, C; Lidral, AC; Murray, JC				Jugessur, Astanand; Shi, Min; Gjessing, Hakon Kristian; Lie, Rolv Terje; Wilcox, Allen James; Weinberg, Clarice Ring; Christensen, Kaare; Boyles, Abee Lowman; Daack-Hirsch, Sandra; Trung, Truc Nguyen; Bille, Camilla; Lidral, Andrew Carl; Murray, Jeffrey Clark			Genetic Determinants of Facial Clefting: Analysis of 357 Candidate Genes Using Two National Cleft Studies from Scandinavia	PLOS ONE			English	Article								Background: Facial clefts are common birth defects with a strong genetic component. To identify fetal genetic risk factors for clefting, 1536 SNPs in 357 candidate genes were genotyped in two population-based samples from Scandinavia (Norway: 562 case-parent and 592 control-parent triads; Denmark: 235 case-parent triads). Methodology/Principal Findings: We used two complementary statistical methods, TRIMM and HAPLIN, to look for associations across these two national samples. TRIMM tests for association in each gene by using multi-SNP genotypes from case-parent triads directly without the need to infer haplotypes. HAPLIN on the other hand estimates the full haplotype distribution over a set of SNPs and estimates relative risks associated with each haplotype. For isolated cleft lip with or without cleft palate (I-CL/P), TRIMM and HAPLIN both identified significant associations with IRF6 and ADH1C in both populations, but only HAPLIN found an association with FGF12. For isolated cleft palate (I-CP), TRIMM found associations with ALX3, MKX, and PDGFC in both populations, but only the association with PDGFC was identified by HAPLIN. In addition, HAPLIN identified an association with ETV5 that was not detected by TRIMM. Conclusion/Significance: Strong associations with seven genes were replicated in the Scandinavian samples and our approach effectively replicated the strongest previously known association in clefting-with IRF6. Based on two national cleft cohorts of similar ancestry, two robust statistical methods and a large panel of SNPs in the most promising cleft candidate genes to date, this study identified a previously unknown association with clefting for ADH1C and provides additional candidates and analytic approaches to advance the field.			Jugessur, A (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	jeff-murray@uiowa.edu	Gjessing, Hakon K/A-5871-2012; Christensen, Kaare/C-2360-2009; Shi, Min/GXM-3977-2022; Wilcox, Allen J/C-7723-2019	Christensen, Kaare/0000-0002-5429-5292; Wilcox, Allen J/0000-0002-3376-1311; Daack-Hirsch, Sandra/0000-0003-1192-7154; Weinberg, Clarice/0000-0002-7713-8556; Boyles, Abee/0000-0002-8711-2077	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008559, K02DE015291, R01DE011948, P60DE013076, R01DE014667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605, ZIAES045005, ZIAES049027] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NIDCR NIH HHS [R01 DE011948, K02 DE015291, R01 DE014667-07, K02 DE015291-03, DE08559, R01 DE014667-04, R01 DE014667, R01 DE-11948-04, P60 DE013076, R01 DE014667-01, K02 DE015291-05, K02 DE015291-01, R01 DE014667-02, P60 DE13076, R01 DE014667-08, R01 DE014667-03, K02 DE015291-02, R01 DE008559, R37 DE008559, R01 DE014667-06, R01 DE014667-05, K02 DE015291-04] Funding Source: Medline; NIEHS NIH HHS [P30 ES05605, P30 ES005605] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Anderson DM, 2006, DEV DYNAM, V235, P792, DOI 10.1002/dvdy.20671; ARDINGER HH, 1989, AM J HUM GENET, V45, P348; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beier DR, 2004, GENETICA, V122, P65, DOI 10.1007/s10709-004-1437-5; BEIRAGHI S, 1994, CLIN GENET, V46, P255; Ben J, 2005, GENE EXPR PATTERNS, V5, P629, DOI 10.1016/j.modgep.2005.03.002; Beverdam A, 2001, MECH DEVELOP, V107, P163, DOI 10.1016/S0925-4773(01)00450-6; Beverdam A, 2001, DEVELOPMENT, V128, P3975; Bille C, 2005, CLEFT PALATE-CRAN J, V42, P255, DOI 10.1597/03-139.1; Blanton SH, 2004, AM J MED GENET A, V125A, P23, DOI 10.1002/ajmg.a.20426; BOYLES AL, 2008, GENET EPIDE IN PRESS; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; Brown NL, 2003, DEV GROWTH DIFFER, V45, P153; Cai JL, 2005, HUM MOL GENET, V14, P903, DOI 10.1093/hmg/ddi083; Cardon LR, 2003, TRENDS GENET, V19, P135, DOI 10.1016/S0168-9525(03)00022-2; Chevrier C, 2005, BIRTH DEFECTS RES A, V73, P114, DOI 10.1002/bdra.20103; Chiquet BT, 2007, HUM MOL GENET, V16, P2241, DOI 10.1093/hmg/ddm176; Choi SJ, 2008, EUR J HUM GENET; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DEROO LA, 2008, AM J EPIDEMIOL; DIEWERT VM, 1985, AM J ORTHOD DENTOFAC, V88, P64, DOI 10.1016/0002-9416(85)90107-1; Ding H, 2004, NAT GENET, V36, P1111, DOI 10.1038/ng1415; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Fisher R.A., 1958, STAT METHODS RES WOR; Garavelli L, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-42; GJESSING HK, 2006, ANN HUM GENET, P1; Gong SG, 2005, J DENT RES, V84, P69, DOI 10.1177/154405910508400112; Han J, 2006, BIRTH DEFECTS RES B, V77, P438, DOI 10.1002/bdrb.20094; Higgins AW, 2008, AM J HUM GENET, V82, P712, DOI 10.1016/j.ajhg.2008.01.011; HOOG JO, 1986, EUR J BIOCHEM, V159, P215, DOI 10.1111/j.1432-1033.1986.tb09855.x; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jezewski PA, 2003, J MED GENET, V40, P399, DOI 10.1136/jmg.40.6.399; Jin JZ, 2008, CELL TISSUE RES, V333, P29, DOI 10.1007/s00441-008-0612-x; Jugessur A, 2005, CURR OPIN GENET DEV, V15, P270, DOI 10.1016/j.gde.2005.03.003; Jugessur A, 2008, GENET EPIDEMIOL, V32, P413, DOI 10.1002/gepi.20314; Knight AS, 2006, DEV DYNAM, V235, P1441, DOI 10.1002/dvdy.20598; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Lee WC, 2003, INT J EPIDEMIOL, V32, P1120, DOI 10.1093/ije/dyg301; Lidral AC, 2005, CURR OPIN PEDIATR, V17, P731, DOI 10.1097/01.mop.0000185138.65820.7f; Lidral AC, 2004, BIRTH DEFECTS RES A, V70, P893, DOI 10.1002/bdra.20096; LIE RT, 1994, NEW ENGL J MED, V331, P1, DOI 10.1056/NEJM199407073310101; Liu H, 2006, GENE EXPR PATTERNS, V6, P632, DOI 10.1016/j.modgep.2005.11.012; Marazita M, 2002, CLEFT LIP PALATE ORI; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Marazita ML, 2002, AM J HUM GENET, V71, P349, DOI 10.1086/341944; MARAZITA ML, 2009, HUMAN HERED IN PRESS; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meijlink F, 1999, INT J DEV BIOL, V43, P651; MITCHELL LE, 1995, AM J HUM GENET, V57, P1130; Miyoshi T, 2006, DEV DYNAM, V235, P1941, DOI 10.1002/dvdy.20799; Mossey PA, 2002, CLEFT LIP PALATE ORI; Mowat DR, 2003, J MED GENET, V40, P305, DOI 10.1136/jmg.40.5.305; Mukherjee K, 2007, J MOL EVOL, V65, P137, DOI 10.1007/s00239-006-0023-0; Mukhopadhyay P, 2004, BIRTH DEFECTS RES A, V70, P912, DOI 10.1002/bdra.20095; Nie XG, 2006, ORAL DIS, V12, P102, DOI 10.1111/j.1601-0825.2005.01176.x; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Park JW, 2006, J MED GENET, V43, P598, DOI 10.1136/jmg.2005.040162; Pauws E, 2007, TRENDS GENET, V23, P631, DOI 10.1016/j.tig.2007.09.002; R Development Core Team, 2006, R LANG ENV STAT COMP; RAHIMOV F, 2008, NAT GENET IN PRESS; Rice TK, 2008, ADV GENET, V60, P293, DOI 10.1016/S0065-2660(07)00412-9; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Riley BM, 2007, AM J MED GENET A, V143A, P3228, DOI 10.1002/ajmg.a.31965; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SCHWEDER T, 1982, BIOMETRIKA, V69, P493; Sebastiani P, 2003, P NATL ACAD SCI USA, V100, P9900, DOI 10.1073/pnas.1633613100; Shi M, 2007, AM J HUM GENET, V81, P53, DOI 10.1086/518670; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; *STATACORP, 2003, STAT STAT SOFTW REL; Takagi T, 1998, DEVELOPMENT, V125, P21; ten Berge D, 1998, DEV BIOL, V199, P11, DOI 10.1006/dbio.1998.8921; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; Washbourne BJ, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-18; Welsh IC, 2007, MECH DEVELOP, V124, P746, DOI 10.1016/j.mod.2007.06.007; Wilcox AJ, 2007, BMJ-BRIT MED J, V334, P464, DOI 10.1136/bmj.39079.618287.0B; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507	81	75	76	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5385	10.1371/journal.pone.0005385	http://dx.doi.org/10.1371/journal.pone.0005385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401770	Green Published, gold			2022-12-27	WOS:000265601100021
J	Sanbe, A; Daicho, T; Mizutani, R; Endo, T; Miyauchi, N; Yamauchi, J; Tanonaka, K; Glabe, C; Tanoue, A				Sanbe, Atsushi; Daicho, Takuya; Mizutani, Reiko; Endo, Toshiya; Miyauchi, Noriko; Yamauchi, Junji; Tanonaka, Kouichi; Glabe, Charles; Tanoue, Akito			Protective Effect of Geranylgeranylacetone via Enhancement of HSPB8 Induction in Desmin-Related Cardiomyopathy	PLOS ONE			English	Article								Background: An arg120gly (R120G) missense mutation in HSPB5 (alpha-beta-crystallin), which belongs to the small heat shock protein (HSP) family, causes desmin-related cardiomyopathy (DRM), a muscle disease that is characterized by the formation of inclusion bodies, which can contain pre-amyloid oligomer intermediates (amyloid oligomer). While we have shown that small HSPs can directly interrupt amyloid oligomer formation, the in vivo protective effects of the small HSPs on the development of DRM is still uncertain. Methodology/Principal Findings: In order to extend the previous in vitro findings to in vivo, we used geranylgeranylacetone (GGA), a potent HSP inducer. Oral administration of GGA resulted not only in up-regulation of the expression level of HSPB8 and HSPB1 in the heart of HSPB5 R120G transgenic (R120G TG) mice, but also reduced amyloid oligomer levels and aggregates. Furthermore, R120G TG mice treated with GGA exhibited decreased heart size and less interstitial fibrosis, as well as improved cardiac function and survival compared to untreated R120G TG mice. To address possible mechanism(s) for these beneficial effects, cardiac-specific transgenic mice expressing HSPB8 were generated. Overexpression of HSPB8 led to a reduction in amyloid oligomer and aggregate formation, resulting in improved cardiac function and survival. Treatment with GGA as well as the overexpression of HSPB8 also inhibited cytochrome c release from mitochondria, activation of caspase-3 and TUNEL-positive cardiomyocyte death in the R120G TG mice. Conclusions/Significance: Expression of small HSPs such as HSPB8 and HSPB1 by GGA may be a new therapeutic strategy for patients with DRM.			Sanbe, A (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan.	asanbe@nch.go.jp	Longo, Kenneth A/A-5631-2010					Aron Y, 2001, CELL MOL LIFE SCI, V58, P1522, DOI 10.1007/PL00000792; Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Glembotski CC, 2008, J MOL CELL CARDIOL, V44, P453, DOI 10.1016/j.yjmcc.2007.10.017; Hansson O, 2003, BRAIN RES, V970, P47, DOI 10.1016/S0006-8993(02)04275-0; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; Kawahara Y, 2005, J PHARMACOL SCI, V99, P95, DOI 10.1254/jphs.FP0050343; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lee JS, 1998, BIOCHEM BIOPH RES CO, V244, P379, DOI 10.1006/bbrc.1998.8272; Lubitz SA, 2008, PROG CARDIOVASC DIS, V51, P58, DOI 10.1016/j.pcad.2007.10.003; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Matt P, 2007, J MOL CELL CARDIOL, V43, P792, DOI 10.1016/j.yjmcc.2007.08.011; Mochida S, 2007, J CLIN BIOCHEM NUTR, V41, P115, DOI 10.3164/jcbn.2007016; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; NAGINENI CN, 1989, FEBS LETT, V249, P89, DOI 10.1016/0014-5793(89)80022-5; Nishida K, 1998, JPN J PHARMACOL, V78, P519, DOI 10.1254/jjp.78.519; Ooie T, 2001, CIRCULATION, V104, P1837, DOI 10.1161/hc3901.095771; Otaka M, 2007, BIOCHEM BIOPH RES CO, V353, P399, DOI 10.1016/j.bbrc.2006.12.031; Sakabe M, 2008, CARDIOVASC RES, V78, P63, DOI 10.1093/cvr/cvn019; Sanbe A, 2005, P NATL ACAD SCI USA, V102, P13592, DOI 10.1073/pnas.0503324102; Sanbe A, 2005, CIRCULATION, V111, P2330, DOI 10.1161/01.CIR.0000164234.24957.75; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Sanbe A, 2007, J BIOL CHEM, V282, P555, DOI 10.1074/jbc.M605481200; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Simar D, 2007, J GERONTOL A-BIOL, V62, P1413, DOI 10.1093/gerona/62.12.1413; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Yamanaka K, 2003, J MOL CELL CARDIOL, V35, P785, DOI 10.1016/S0022-2828(03)00133-0; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	34	87	96	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5351	10.1371/journal.pone.0005351	http://dx.doi.org/10.1371/journal.pone.0005351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399179	gold, Green Published, Green Submitted			2022-12-27	WOS:000265514900013
J	Himmelreich, U; Malik, R; Kuhn, T; Daniel, HM; Somorjai, RL; Dolenko, B; Sorrell, TC				Himmelreich, Uwe; Malik, Richard; Kuhn, Till; Daniel, Heide-Marie; Somorjai, Ray L.; Dolenko, Brion; Sorrell, Tania C.			Rapid Etiological Classification of Meningitis by NMR Spectroscopy Based on Metabolite Profiles and Host Response	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; ACQUIRED BACTERIAL-MENINGITIS; CEREBROSPINAL-FLUID; IDENTIFICATION; MR; MICROORGANISMS; ADULTS; CSF; STRATEGY; H-1-NMR	Bacterial meningitis is an acute disease with high mortality that is reduced by early treatment. Identification of the causative microorganism by culture is sensitive but slow. Large volumes of cerebrospinal fluid (CSF) are required to maximise sensitivity and establish a provisional diagnosis. We have utilised nuclear magnetic resonance (NMR) spectroscopy to rapidly characterise the biochemical profile of CSF from normal rats and animals with pneumococcal or cryptococcal meningitis. Use of a miniaturised capillary NMR system overcame limitations caused by small CSF volumes and low metabolite concentrations. The analysis of the complex NMR spectroscopic data by a supervised statistical classification strategy included major, minor and unidentified metabolites. Reproducible spectral profiles were generated within less than three minutes, and revealed differences in the relative amounts of glucose, lactate, citrate, amino acid residues, acetate and polyols in the three groups. Contributions from microbial metabolism and inflammatory cells were evident. The computerised statistical classification strategy is based on both major metabolites and minor, partially unidentified metabolites. This data analysis proved highly specific for diagnosis (100% specificity in the final validation set), provided those with visible blood contamination were excluded from analysis; 6-8% of samples were classified as indeterminate. This proof of principle study suggests that a rapid etiologic diagnosis of meningitis is possible without prior culture. The method can be fully automated and avoids delays due to processing and selective identification of specific pathogens that are inherent in DNA-based techniques.			Himmelreich, U (corresponding author), Katholieke Univ Leuven, Fac Med, Biomed NMR Unit, Leuven, Belgium.	uwe.himmelreich@med.kuleuven.be	Sorrell, Tania/AAZ-5286-2020; Malik, Richard/I-2009-2019; Daniel, Heide-Marie/B-3161-2010	Himmelreich, Uwe/0000-0002-2060-8895; Sorrell, Tania/0000-0001-9460-0960				Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Aronin SI, 1998, ANN INTERN MED, V129, P862, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00004; BELL JD, 1987, CLIN SCI, V72, P563, DOI 10.1042/cs0720563; Coen M, 2005, CLIN INFECT DIS, V41, P1582, DOI 10.1086/497836; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Dekker LJ, 2005, MOL CELL PROTEOMICS, V4, P1341, DOI 10.1074/mcp.M500081-MCP200; Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j; Dunne VG, 2005, NMR BIOMED, V18, P24, DOI 10.1002/nbm.918; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004; Fishman RA., 1992, CEREBROSPINAL FLUID; Griffin JL, 2002, ANALYST, V127, P582, DOI 10.1039/b201207c; Himmelreich U., 2004, Trends in Applied Spectroscopy, V5, P269; Himmelreich U, 2005, RADIOLOGY, V236, P261, DOI 10.1148/radiol.2361040869; Himmelreich U, 2003, APPL ENVIRON MICROB, V69, P4566, DOI 10.1128/AEM.69.8.4566-4574.2003; Himmelreich U, 2003, MICROBES INFECT, V5, P285, DOI 10.1016/S1286-4579(03)00028-5; Himmelreich U, 2001, RADIOLOGY, V220, P122, DOI 10.1148/radiology.220.1.r01jl25122; HIRAOKA A, 1994, BIOL PHARM BULL, V17, P1; Hu Y, 2005, MOL CELL PROTEOMICS, V4, P2000, DOI 10.1074/mcp.M500207-MCP200; Levine J, 2000, J NEURAL TRANSM, V107, P843, DOI 10.1007/s007020070064; Lewczuk P, 2003, RAPID COMMUN MASS SP, V17, P1291, DOI 10.1002/rcm.1048; Lu CH, 2002, CLIN NEUROL NEUROSUR, V104, P352, DOI 10.1016/S0303-8467(02)00052-5; Maillet S, 1998, BRAIN RES PROTOC, V3, P123, DOI 10.1016/S1385-299X(98)00033-6; Maquelin K, 2002, J MICROBIOL METH, V51, P255, DOI 10.1016/S0167-7012(02)00127-6; Mariey L, 2001, VIB SPECTROSC, V26, P151, DOI 10.1016/S0924-2031(01)00113-8; NICHOLSON JK, 1989, PROG NUCL MAG RES SP, V21, P449, DOI 10.1016/0079-6565(89)80008-1; NICOLI F, 1993, NEUROSCI LETT, V154, P47, DOI 10.1016/0304-3940(93)90168-K; Nikulin AE, 1998, NMR BIOMED, V11, P209, DOI 10.1002/(SICI)1099-1492(199806/08)11:4/5<209::AID-NBM510>3.0.CO;2-5; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pfyffer GE, 1996, J CLIN MICROBIOL, V34, P834, DOI 10.1128/JCM.34.4.834-841.1996; Pope GA, 2007, YEAST, V24, P667, DOI 10.1002/yea.1499; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Schlegel H. G., 1992, ALLGEMEINE MIKROBIOL; Schlotterbeck G, 2002, ANAL CHEM, V74, P4464, DOI 10.1021/ac025556e; Selle H, 2005, COMB CHEM HIGH T SCR, V8, P801, DOI 10.2174/138620705774962391; Somorjai RL, 2004, COMPU BIOL, V5, P67; Somorjai RL, 2002, VIB SPECTROSC, V28, P97, DOI 10.1016/S0924-2031(01)00148-5; Subramanian A, 2005, NMR BIOMED, V18, P213, DOI 10.1002/nbm.944; TUNKEL AR, 2000, MANDELL DOUGLAS BENN, P959; Urbanczyk-Wochniak E, 2003, EMBO REP, V4, P989, DOI 10.1038/sj.embor.embor944; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; WEVERS RA, 1995, CLIN CHEM, V41, P744; WOOD M, 1998, MAJOR PROBLEMS NEURO; Yuan XL, 2005, J MASS SPECTROM, V40, P176, DOI 10.1002/jms.737	44	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5328	10.1371/journal.pone.0005328	http://dx.doi.org/10.1371/journal.pone.0005328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390697	Green Published, gold, Green Submitted			2022-12-27	WOS:000265514400014
J	van Leuken, R; Clijsters, L; van Zon, W; Lim, D; Yao, XB; Wolthuis, RMF; Yaffe, MB; Medema, RH; van Vugt, MATM				van Leuken, Renske; Clijsters, Linda; van Zon, Wouter; Lim, Dan; Yao, XueBiao; Wolthuis, Rob M. F.; Yaffe, Michael B.; Medema, Rene H.; van Vugt, Marcel A. T. M.			Polo-Like Kinase-1 Controls Aurora A Destruction by Activating APC/C-Cdh1	PLOS ONE			English	Article								Polo-like kinase-1 (Plk1) is activated before mitosis by Aurora A and its cofactor Bora. In mitosis, Bora is degraded in a manner dependent on Plk1 kinase activity and the E3 ubiquitin ligase SCF-beta TrCP. Here, we show that Plk1 is also required for the timely destruction of its activator Aurora A in late anaphase. It has been shown that Aurora A destruction is controlled by the auxiliary subunit Cdh1 of the Anaphase-Promoting Complex/Cyclosome (APC/C). Remarkably, we found that Plk1-depletion prevented the efficient dephosphorylation of Cdh1 during mitotic exit. Plk1 mediated its effect on Cdh1, at least in part, through direct phosphorylation of the human phosphatase Cdc14A, controlling the phosphorylation state of Cdh1. We conclude that Plk1 facilitates efficient Aurora A degradation through APC/C-Cdh1 activation after mitosis, with a potential role for hCdc14A.			van Leuken, R (corresponding author), Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands.	r.h.medema@umcutrecht.nl; m.vugt@onco.umcg.nl	Medema, Rene H/G-5415-2011; Medema, Rene H/E-2981-2013; Yao, Xuebiao/P-5771-2014	Medema, Rene/0000-0002-6754-0381; Wolthuis, Rob/0000-0002-3109-1588; Clijsters, Linda/0000-0002-3118-9702				Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bembenek J, 2001, J BIOL CHEM, V276, P48237, DOI 10.1074/jbc.M108126200; Bothos J, 2005, CANCER RES, V65, P6568, DOI 10.1158/0008-5472.CAN-05-0862; Chan EHY, 2008, CHROMOSOMA, V117, P457, DOI 10.1007/s00412-008-0165-5; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; Cuif MH, 1999, EMBO J, V18, P1772, DOI 10.1093/emboj/18.7.1772; DeBonis S, 2004, MOL CANCER THER, V3, P1079; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Descombes P, 1998, EMBO J, V17, P1328, DOI 10.1093/emboj/17.5.1328; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Geymonat M, 2002, CURR BIOL, V12, pR482, DOI 10.1016/S0960-9822(02)00963-6; Golan A, 2002, J BIOL CHEM, V277, P15552, DOI 10.1074/jbc.M111476200; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lee SE, 2001, CURR BIOL, V11, P784, DOI 10.1016/S0960-9822(01)00228-7; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li LW, 1997, J BIOL CHEM, V272, P29403, DOI 10.1074/jbc.272.47.29403; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Morisaki T, 2002, FEBS LETT, V529, P319, DOI 10.1016/S0014-5793(02)03360-4; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Pereira G, 2002, J CELL BIOL, V157, P367, DOI 10.1083/jcb.200112085; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Pfleger CM, 2000, GENE DEV, V14, P655; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Yoshida S, 2002, BIOCHEM BIOPH RES CO, V294, P687, DOI 10.1016/S0006-291X(02)00544-2; Yuan K, 2007, J BIOL CHEM, V282, P27414, DOI 10.1074/jbc.M703555200; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	74	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5282	10.1371/journal.pone.0005282	http://dx.doi.org/10.1371/journal.pone.0005282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390576	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514200010
J	Morgans, CW; Kensel-Hammes, P; Hurley, JB; Burton, K; Idzerda, R; McKnight, GS; Bajjalieh, SM				Morgans, Catherine W.; Kensel-Hammes, Patricia; Hurley, James B.; Burton, Kimberly; Idzerda, Rejean; McKnight, G. Stanley; Bajjalieh, Sandra M.			Loss of the Synaptic Vesicle Protein SV2B Results in Reduced Neurotransmission and Altered Synaptic Vesicle Protein Expression in the Retina	PLOS ONE			English	Article								The Synaptic Vesicle Protein 2 (SV2) family of transporter-like proteins is expressed exclusively in vesicles that undergo calcium-regulated exocytosis. Of the three isoforms expressed in mammals, SV2B is the most divergent. Here we report studies of SV2B location and function in the retina. Immunolabeling studies revealed that SV2B is detected in rod photoreceptor synaptic terminals where it is the primary isoform. In mice lacking SV2B, synaptic transmission at the synapse between photoreceptors and bipolar neurons was decreased, as evidenced by a significant reduction in the amplitude of the b-wave in electroretinogram recordings. Quantitative immunoblot analyses of whole eyes revealed that loss of SV2B was associated with reduced levels of synaptic vesicle proteins including synaptotagmin, VAMP, synaptophysin and the vesicular glutamate transporter V-GLUT1. Immunolabeling studies revealed that SV2B is detected in rod photoreceptor synaptic terminals where it is the primary isoform. Thus, SV2B contributes to the modulation of synaptic vesicle exocytosis and plays a significant role in regulating synaptic protein content.			Morgans, CW (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	bajjalie@u.washington.edu		Morgans, Catherine/0000-0002-7287-3447	NATIONAL EYE INSTITUTE [R01EY018625, P30EY001730, R01EY014700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059842] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY001730, 5 P30 EY001730, R01 EY018625, R01 EY014700] Funding Source: Medline; NIMH NIH HHS [R01 MH059842, R01 MH59842] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; BAJJALIEH SM, 1993, P NATL ACAD SCI USA, V90, P2150, DOI 10.1073/pnas.90.6.2150; BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; Berntson AK, 2003, J VISION, V3, P274, DOI 10.1167/3.4.3; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Galli T, 1996, J BIOL CHEM, V271, P2193, DOI 10.1074/jbc.271.4.2193; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; Hayashi T, 1998, J NEUROCHEM, V71, P356; Janz R, 1998, J NEUROSCI, V18, P9269; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; Morgans CW, 2005, VISUAL NEUROSCI, V22, P561, DOI 10.1017/S0952523805225038; Rao A, 2007, J NEUROSCI, V27, P14199, DOI 10.1523/JNEUROSCI.4934-07.2007; Rosenmund C, 2003, CURR OPIN NEUROBIOL, V13, P509, DOI 10.1016/j.conb.2003.09.011; Schivell AE, 2005, MOL CELL NEUROSCI, V29, P56, DOI 10.1016/j.mcn.2004.12.011; Schivell AE, 1996, J BIOL CHEM, V271, P27770, DOI 10.1074/jbc.271.44.27770; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Spiwoks-Becker I, 2001, NEUROSCIENCE, V107, P127, DOI 10.1016/S0306-4522(01)00345-1; Wang MM, 2003, J COMP NEUROL, V460, P106, DOI 10.1002/cne.10636; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000	33	37	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5230	10.1371/journal.pone.0005230	http://dx.doi.org/10.1371/journal.pone.0005230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381277	Green Published, gold, Green Submitted			2022-12-27	WOS:000265510800009
J	Cherbuin, N; Anstey, KJ; Reglade-Meslin, C; Sachdev, PS				Cherbuin, Nicolas; Anstey, Kaarin J.; Reglade-Meslin, Chantal; Sachdev, Perminder S.			In Vivo Hippocampal Measurement and Memory: A Comparison of Manual Tracing and Automated Segmentation in a Large Community-Based Sample	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; VOLUMETRICS; SUBREGION; RETRIEVAL; CORRELATE; AMNESIA; ONSET	While manual tracing is the method of choice in measuring hippocampal volume, its time intensive nature and proneness to human error make automated methods attractive, especially when applied to large samples. Few studies have systematically compared the performance of the two techniques. In this study, we measured hippocampal volumes in a large (N = 403) population-based sample of individuals aged 44-48 years using manual tracing by a trained researcher and automated procedure using Freesurfer (http://surfer.nmr.mgh.harvard.edu) imaging suite. Results showed that absolute hippocampal volumes assessed with these methods were significantly different, with automated measures using the Freesurfer software suite being significantly larger, by 23% for the left and 29% for the right hippocampus. The correlation between the two methods varied from 0.61 to 0.80, with lower correlations for hippocampi with visible abnormalities. Inspection of 2D and 3D models suggested that this difference was largely due to greater inclusion of boundary voxels by the automated method and variations in subiculum/entorhinal segmentation. The correlation between left and right hippocampal volumes was very similar by the two methods. The relationship of hippocampal volumes to selected sociodemographic and cognitive variables was not affected by the measurement method, with each measure showing an association with memory performance and suggesting that both were equally valid for this purpose. This study supports the use of automated measures, based on Freesurfer in this instance, as being sufficiently reliable and valid particularly in the context of larger sample sizes when the research question does not rely on 'true' hippocampal volumes.			Cherbuin, N (corresponding author), Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia.	nicolas.cherbuin@anu.edu.au	Sachdev, Perminder/ABC-1137-2020; Anstey, Kaarin/A-3852-2008; Cherbuin, Nicolas/A-8515-2008	Sachdev, Perminder/0000-0002-9595-3220; Anstey, Kaarin/0000-0002-9706-9316; Cherbuin, Nicolas/0000-0001-6481-0748				BADDELEY A, 1993, BRIT J CLIN PSYCHOL, V32, P55, DOI 10.1111/j.2044-8260.1993.tb01027.x; Batchelor S, 2008, CORTEX, V44, P170, DOI 10.1016/j.cortex.2006.05.003; Beauchamp MH, 2008, BRAIN, V131, P2986, DOI 10.1093/brain/awn227; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Carmichael OT, 2005, NEUROIMAGE, V27, P979, DOI 10.1016/j.neuroimage.2005.05.005; Cipolotti L, 2006, CURR OPIN NEUROL, V19, P593, DOI 10.1097/01.wco.0000247608.42320.f9; Csernansky JG, 2005, NEUROIMAGE, V25, P783, DOI 10.1016/j.neuroimage.2004.12.036; Delis DC., 2000, CALIFORNIA VERBAL LE; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Geuze E, 2005, MOL PSYCHIATR, V10, P147, DOI 10.1038/sj.mp.4001580; Hsu YY, 2002, J MAGN RESON IMAGING, V16, P305, DOI 10.1002/jmri.10163; KALPOUZOS G, 2008, J COGN NEUROSCI; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Kircher T, 2008, EUR ARCH PSY CLIN N, V258, P363, DOI 10.1007/s00406-008-0805-z; Kryukov V. I., 2008, Journal of Integrative Neuroscience, V7, P117, DOI 10.1142/S021963520800171X; Kumar R, 2005, DEMENT GERIATR COGN, V19, P67, DOI 10.1159/000082351; Lee HY, 2007, NEURORADIOLOGY, V49, P481, DOI 10.1007/s00234-007-0213-5; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maller JJ, 2006, HIPPOCAMPUS, V16, P80, DOI 10.1002/hipo.20133; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; OTERO C, 2008, ACTAS ESP PSIQUIATR; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Protopopescu X, 2008, HIPPOCAMPUS, V18, P985, DOI 10.1002/hipo.20468; Reminger SL, 2004, EPILEPSY BEHAV, V5, P687, DOI 10.1016/j.yebeh.2004.06.006; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Smith A., 1982, SYMBOL DIGIT MODALIT; Starkman MN, 2003, BIOL PSYCHIAT, V53, P233, DOI 10.1016/S0006-3223(02)01750-X; TAE WS, 2008, NEURORADIOLOGY; Thompson PM, 2007, ANN NY ACAD SCI, V1097, P183, DOI 10.1196/annals.1379.017; Vago DR, 2007, HIPPOCAMPUS, V17, P977, DOI 10.1002/hipo.20329; van de Pol LA, 2007, NEUROIMAGE, V34, P1036, DOI 10.1016/j.neuroimage.2006.10.033; Viskontas IV, 2009, HIPPOCAMPUS, V19, P265, DOI 10.1002/hipo.20503; WANG L, 2008, FULLY AUTOMATED MULT, P35; Watson C., 1997, ARCH NEUROL-CHICAGO, V9, P97; Xu F, 2007, NEUROSCIENCE, V146, P98, DOI 10.1016/j.neuroscience.2007.01.043	39	92	92	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5265	10.1371/journal.pone.0005265	http://dx.doi.org/10.1371/journal.pone.0005265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370155	Green Submitted, gold, Green Published			2022-12-27	WOS:000265510600012
J	Gorski, L; Duhe, JM; Flaherty, D				Gorski, Lisa; Duhe, Jessica M.; Flaherty, Denise			The Use of Flagella and Motility for Plant Colonization and Fitness by Different Strains of the Foodborne Pathogen Listeria monocytogenes	PLOS ONE			English	Article							HOST-CELL INVASION; PSEUDOMONAS-FLUORESCENS; MOLECULAR DETERMINANTS; SALMONELLA-ENTERICA; ROOT COLONIZATION; BIOFILM FORMATION; ALFALFA SPROUTS; ATTACHMENT; VIRULENCE; FOOD	The role of flagella and motility in the attachment of the foodborne pathogen Listeria monocytogenes to various surfaces is mixed with some systems requiring flagella for an interaction and others needing only motility for cells to get to the surface. In nature this bacterium is a saprophyte and contaminated produce is an avenue for infection. Previous studies have documented the ability of this organism to attach to and colonize plant tissue. Motility mutants were generated in three wild type strains of L. monocytogenes by deleting either flaA, the gene encoding flagellin, or motAB, genes encoding part of the flagellar motor, and tested for both the ability to colonize sprouts and for the fitness of that colonization. The motAB mutants were not affected in the colonization of alfalfa, radish, and broccoli sprouts; however, some of the flaA mutants showed reduced colonization ability. The best colonizing wild type strain was reduced in colonization on all three sprout types as a result of a flaA deletion. A mutant in another background was only affected on alfalfa. The third, a poor alfalfa colonizer was not affected in colonization ability by any of the deletions. Fitness of colonization was measured in experiments of competition between mixtures of mutant and parent strains on sprouts. Here the flaA and motAB mutants of the three strain backgrounds were impaired in fitness of colonization of alfalfa and radish sprouts, and one strain background showed reduced fitness of both mutant types on broccoli sprouts. Together these data indicate a role for flagella for some strains to physically colonize some plants, while the fitness of that colonization is positively affected by motility in almost all cases.			Gorski, L (corresponding author), USDA ARS, Produce Safety & Microbiol Res Unit, Albany, CA USA.	lisa.gorski@ars.usda.gov		Gorski, Lisa/0000-0003-2387-1012				Berger CN, 2009, ISME J, V3, P261, DOI 10.1038/ismej.2008.95; Chin-A-Woeng TFC, 2000, MOL PLANT MICROBE IN, V13, P1340, DOI 10.1094/MPMI.2000.13.12.1340; CROES CL, 1993, J GEN MICROBIOL, V139, P2261, DOI 10.1099/00221287-139-9-2261; Dekkers LC, 1998, MOL PLANT MICROBE IN, V11, P763, DOI 10.1094/MPMI.1998.11.8.763; DEWEGER LA, 1987, J BACTERIOL, V169, P2769, DOI 10.1128/jb.169.6.2769-2773.1987; DONS L, 1992, MOL MICROBIOL, V6, P2919, DOI 10.1111/j.1365-2958.1992.tb01751.x; Dons L, 2004, INFECT IMMUN, V72, P3237, DOI 10.1128/IAI.72.6.3237-3244.2004; Dussurget O, 2004, ANNU REV MICROBIOL, V58, P587, DOI 10.1146/annurev.micro.57.030502.090934; FACINELLI B, 1994, J CLIN MICROBIOL, V32, P2929, DOI 10.1128/JCM.32.12.2929-2935.1994; Facinelli B, 1998, MICROBIOL-SGM, V144, P109, DOI 10.1099/00221287-144-1-109; FARBER JM, 1990, NEW ENGL J MED, V322, P338; Fernandez LA, 2000, FEMS MICROBIOL REV, V24, P21, DOI 10.1111/j.1574-6976.2000.tb00531.x; Glaser P, 2001, SCIENCE, V294, P849; Gorski L, 2004, J FOOD PROTECT, V67, P2488, DOI 10.4315/0362-028X-67.11.2488; Gorski L, 2003, APPL ENVIRON MICROB, V69, P258, DOI 10.1128/AEM.69.1.258-266.2003; Gorski L, 2008, J FOOD PROTECT, V71, P1556, DOI 10.4315/0362-028X-71.8.1556; HEISICK JE, 1989, APPL ENVIRON MICROB, V55, P1925, DOI 10.1128/AEM.55.8.1925-1927.1989; Hirsch AM, 1999, CURR OPIN PLANT BIOL, V2, P320, DOI 10.1016/S1369-5266(99)80056-9; HOWIE WJ, 1987, PHYTOPATHOLOGY, V77, P286, DOI 10.1094/Phyto-77-286; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; Lemon KP, 2007, J BACTERIOL, V189, P4418, DOI 10.1128/JB.01967-06; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Lugtenberg BJJ, 2001, ANNU REV PHYTOPATHOL, V39, P461, DOI 10.1146/annurev.phyto.39.1.461; Martinez-Granero F, 2006, APPL ENVIRON MICROB, V72, P3429, DOI 10.1128/AEM.72.5.3429-3434.2006; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Merritt PM, 2007, J BACTERIOL, V189, P8005, DOI 10.1128/JB.00566-07; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; O'Neil HS, 2006, INFECT IMMUN, V74, P6675, DOI 10.1128/IAI.00886-06; SCHAFERKORDT S, 1995, BIOTECHNIQUES, V19, P720; SCHER FM, 1988, PHYTOPATHOLOGY, V78, P1055, DOI 10.1094/Phyto-78-1055; Schirm M, 2004, J BACTERIOL, V186, P6721, DOI 10.1128/JB.186.20.6721-6727.2004; SCHLECH WF, 1983, NEW ENGL J MED, V308, P203, DOI 10.1056/NEJM198301273080407; Strapp CM, 2003, J FOOD PROTECT, V66, P182, DOI 10.4315/0362-028X-66.2.182; Todhanakasem T, 2008, J BACTERIOL, V190, P6030, DOI 10.1128/JB.00155-08; TRIUECUOT P, 1991, GENE, V102, P99; Vatanyoopaisarn S, 2000, APPL ENVIRON MICROB, V66, P860, DOI 10.1128/AEM.66.2.860-863.2000; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001	37	35	38	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5142	10.1371/journal.pone.0005142	http://dx.doi.org/10.1371/journal.pone.0005142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357783	Green Submitted, Green Published, gold			2022-12-27	WOS:000265505900011
J	Grandgeorge, M; Hausberger, M; Tordjman, S; Deleau, M; Lazartigues, A; Lemonnier, E				Grandgeorge, Marine; Hausberger, Martine; Tordjman, Sylvie; Deleau, Michel; Lazartigues, Alain; Lemonnier, Eric			Environmental Factors Influence Language Development in Children with Autism Spectrum Disorders	PLOS ONE			English	Article							CENTRAL AUDITORY AREA; YOUNG-CHILDREN; FOLLOW-UP; SCHIZOPHRENIA; INPUT; BIRDSONG; MOTHER; HORSES	Background: While it is clearly admitted that normal behavioural development is determined by the interplay of genetic and environmental influences, this is much less the case for psychiatric disorders for which more emphasis has been given in the past decades on biological determinism. Thus, previous studies have shown that Autistic Spectrum Disorders (ASD) were not affected by parental style. However, animal research suggests that different behavioural traits can be differentially affected by genetic/environmental factors. Methodology/Principal Findings: In the present study we hypothesized that amongst the ASD, language disorders may be more sensitive to social factors as language is a social act that develops under social influences. Using the Autism Diagnostic Interview-Revised, we compared the early characteristics of sensori-motor and language development in a large sample of children with ASD (n = 162) with parents belonging to different levels of education. The results showed that children raised by parents with a high level of education displayed earlier language development. Moreover, they showed earlier first words and phrases if their mother was at a high level of education, which reveals an additional gender effect. Conclusions/Significance: To our knowledge this study may trigger important new lines of thought and research, help equilibrate social and purely biological perspectives regarding ASD and bring new hopes for environmentally based therapies.			Grandgeorge, M (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	marine.grandgeorge@univ-rennes1.fr	lemonnier, eric/K-1084-2016					*AM PSYCH ASS, DIAGN STAT MAN ME TR, V4; Bailey A, 1996, J CHILD PSYCHOL PSYC, V37, P89, DOI 10.1111/j.1469-7610.1996.tb01381.x; CHESS S, 1977, J AUTISM CHILD SCHIZ, V7, P69, DOI 10.1007/BF01531116; Cousillas H, 2004, EUR J NEUROSCI, V19, P3343, DOI 10.1111/j.0953-816X.2004.03376.x; Cousillas H, 2006, NATURWISSENSCHAFTEN, V93, P588, DOI 10.1007/s00114-006-0148-4; Cousillas H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002194; De Giacomo A, 1998, EUR CHILD ADOLES PSY, V7, P131, DOI 10.1007/s007870050058; DeMyer M. K., 1979, PARENTS CHILDREN AUT; Ensminger ME, 2003, MON PARENT, P13; Fletcher KL, 2005, DEV REV, V25, P64, DOI 10.1016/j.dr.2004.08.009; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; Franzek E, 1995, EUR PSYCHIAT, V10, P326, DOI 10.1016/0924-9338(96)80332-4; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; GINSBERG EH, 2000, SPRACHENTWICKLUNG, P463; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Hart B., 1995, MEANINGFUL DIFFERENC; Hausberger M, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P33; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; Hoff E, 2006, DEV REV, V26, P55, DOI 10.1016/j.dr.2005.11.002; Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; Hoff E, 2002, CHILD DEV, V73, P418, DOI 10.1111/1467-8624.00415; Hoff E., 2002, HDB PARENTING BIOL E, VVolume 2, P231, DOI DOI 10.4324/9780429401459-13; HOFFGINSBERG E, 1991, CHILD DEV, V62, P782, DOI 10.1111/j.1467-8624.1991.tb01569.x; Houpt KA, 2000, GENETICS OF THE HORSE, P281, DOI 10.1079/9780851994291.0281; Huttenlocher J, 2002, COGNITIVE PSYCHOL, V45, P337, DOI 10.1016/S0010-0285(02)00500-5; KANNER L, 1949, AM J ORTHOPSYCHIAT, V19, P416, DOI 10.1111/j.1939-0025.1949.tb05441.x; Kohn M. L., 1963, AM J SOCIOL, V68, P471, DOI [10.1086/223403, DOI 10.1086/223403]; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9645, DOI 10.1073/pnas.1733998100; Locke John L., 1997, P274, DOI 10.1017/CBO9780511758843.014; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; LUESCHER VA, 1998, EQUINE VET J, V27, P14; MCGREEVY PD, 1995, VET REC, V137, P36, DOI 10.1136/vr.137.2.36; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Pancsofar N, 2006, J APPL DEV PSYCHOL, V27, P571, DOI 10.1016/j.appdev.2006.08.003; Pinker S, 2002, BLANK SLATE MODERN D; Plomin R, 2001, NAT REV NEUROSCI, V2, P136, DOI 10.1038/35053584; Rimland B, 1964, INFANTILE AUTISM SYN; Robert JS, 2000, THEOR MED BIOETH, V21, P191, DOI 10.1023/A:1009913618140; Sanders LD, 2006, NEUROPSYCHOLOGIA, V44, P2126, DOI 10.1016/j.neuropsychologia.2005.10.007; SNOWDON CT, 1997, SOCIAL INFLUENCES VO, P380; Stevens C, 2008, BRAIN RES, V1205, P55, DOI 10.1016/j.brainres.2007.10.108; Swensen LD, 2007, CHILD DEV, V78, P542, DOI 10.1111/j.1467-8624.2007.01022.x; Tager-Flusberg H, 2000, DEVELOPMENTAL SCI, V3, P33; Tamis-LeMonda CS, 2004, CHILD DEV, V75, P1806, DOI 10.1111/j.1467-8624.2004.00818.x; Tienari P, 2004, BRIT J PSYCHIAT, V184, P216, DOI 10.1192/bjp.184.3.216; TIENARI P, 1994, BRIT J PSYCHIAT, V164, P20, DOI 10.1192/S0007125000292696; World Health Organization, 1994, COMP INT DIAGN INT V	48	13	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e4683	10.1371/journal.pone.0004683	http://dx.doi.org/10.1371/journal.pone.0004683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437RZ	19357766	Green Submitted, Green Published, gold			2022-12-27	WOS:000265505900001
J	Serrano, A; Rodriguez-Corsino, M; Losada, A				Serrano, Angel; Rodriguez-Corsino, Miriam; Losada, Ana			Heterochromatin Protein 1 (HP1) Proteins Do Not Drive Pericentromeric Cohesin Enrichment in Human Cells	PLOS ONE			English	Article								Sister chromatid cohesion mediated by cohesin is essential for accurate chromosome segregation. Classical studies suggest that heterochromatin promotes cohesion, but whether this happens through regulation of cohesin remains to be determined. Heterochromatin protein 1 (HP1) is a major component of heterochromatin. In fission yeast, the HP1 homologue Swi6 interacts with cohesin and is required for proper targeting and/or stabilization of cohesin at the centromeric region. To test whether this pathway is conserved in human cells, we have examined the behavior of cohesin in cells in which the levels of HP1 alpha, beta or gamma (the three HP1 proteins present in mammalian organisms) have been reduced by siRNA. We have also studied the consequences of treating human cells with drugs that change the histone modification profile of heterochromatin and thereby affect HP1 localization. Our results show no evidence for a requirement of HP1 proteins for either loading of bulk cohesin onto chromatin in interphase or retention of cohesin at pericentric heterochromatin in mitosis. However, depletion of HP1gamma leads to defects in mitotic progression.			Serrano, A (corresponding author), Spanish Natl Canc Res Ctr CNIO, Mol Oncol Programme, Chromosome Dynam Grp, Madrid, Spain.	alosada@cnio.es	Rodriguez-Corsino, Miriam/AAD-7625-2022; Losada, Ana/H-5917-2015	Losada, Ana/0000-0001-5251-3383; Rodriguez-Corsino, Miriam/0000-0002-4028-5237				Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; CLARKE DJ, 1993, J CELL SCI, V105, P563; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; De Lucia F, 2005, NUCLEIC ACIDS RES, V33, P2852, DOI 10.1093/nar/gki584; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Fanti L, 2003, GENETICA, V117, P135, DOI 10.1023/A:1022971407290; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; GATTI M, 1992, ANNU REV GENET, V26, P239, DOI 10.1146/annurev.ge.26.120192.001323; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; GONZALEZ C, 1991, EXP CELL RES, V192, P10, DOI 10.1016/0014-4827(91)90150-S; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hoque MT, 2001, J BIOL CHEM, V276, P5059, DOI 10.1074/jbc.M007809200; Inoue Y, 2008, PROC MONOGR ENG WATE, V1-2, P55; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kellum R, 2003, CURR TOP MICROBIOL, V274, P53; KELLUM R, 1995, J CELL SCI, V108, P1419; Koch B, 2008, CHROMOSOMA, V117, P199, DOI 10.1007/s00412-007-0139-z; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lee J, 2008, NAT CELL BIOL, V10, P42, DOI 10.1038/ncb1667; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Liu LP, 2005, NAT GENET, V37, P1361, DOI 10.1038/ng1662; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; Losada A, 2008, BBA-REV CANCER, V1786, P41, DOI 10.1016/j.bbcan.2008.04.003; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; MIYAZAKI WY, 1994, ANNU REV GENET, V28, P167, DOI 10.1146/annurev.ge.28.120194.001123; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; SHAMU CE, 1992, J CELL BIOL, V117, P921, DOI 10.1083/jcb.117.5.921; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Takata H, 2007, CURR BIOL, V17, P1356, DOI 10.1016/j.cub.2007.07.009; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; VIG BK, 1981, CYTOGENET CELL GENET, V31, P129, DOI 10.1159/000131638; Warren WD, 2000, CURR BIOL, V10, P1463, DOI 10.1016/S0960-9822(00)00806-X; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Weber SA, 2004, PLOS BIOL, V2, P1340, DOI 10.1371/journal.pbio.0020260; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; White SA, 2004, NAT CELL BIOL, V6, P696, DOI 10.1038/ncb0804-696; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016	66	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5118	10.1371/journal.pone.0005118	http://dx.doi.org/10.1371/journal.pone.0005118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352502	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505700017
J	Dey, R; Ji, KM; Liu, ZG; Chen, L				Dey, Raja; Ji, Kunmei; Liu, Zhigang; Chen, Lin			A Cytokine-Cytokine Interaction in the Assembly of Higher-Order Structure and Activation of the Interleukine-3:Receptor Complex	PLOS ONE			English	Article								Interleukine-3 (IL-3) binds its receptor and initiates a cascade of signaling processes that regulate the proliferation and differentiation of hematopoietic cells. To understand the detailed mechanisms of IL-3 induced receptor activation, we generated a homology model of the IL-3: receptor complex based on the closely related crystal structure of the GMCSF: receptor complex. Model-predicted interactions between IL-3 and its receptor are in excellent agreement with mutagenesis data, which validate the model and establish a detailed view of IL-3: receptor interaction. The homology structure reveals an IL-3: IL-3 interaction interface in a higher-order complex modeled after the dodecamer of the GMCSF:receptor complex wherein an analogous GM-CSF:GM-CSF interface is also identified. This interface is mediated by a proline-rich hydrophobic motif (PPLPLL) of the AA(loop that is highly exposed in the structure of isolated IL-3. Various experimental data suggest that this motif is required for IL-3 function through receptor-binding independent mechanisms. These observations are consistent with structure-function studies of the GM-CSF:receptor complex showing that formation of the higher-order cytokine: receptor complex is required for signaling. However, a key question not answered from previous studies is how cytokine binding facilitates the assembly of the higher-order complex. Our studies here reveal a potential cytokine-cytokine interaction that participates in the assembly of the dodecamer complex, thus linking cytokine binding to receptor activation.			Dey, R (corresponding author), Univ So Calif, Dept Biol Sci Mol & Computat Biol, Los Angeles, CA 90089 USA.	linchen@usc.edu	chen, Lin/A-3392-2008	chen, Lin/0000-0003-4798-6199; , Raja/0000-0002-1064-0824	NHLBI NIH HHS [R01 HL076334, HL076334] Funding Source: Medline; NIGMS NIH HHS [R01 GM064642, R01 GM077320] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077320, R01GM064642] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bagley CJ, 1996, J BIOL CHEM, V271, P31922, DOI 10.1074/jbc.271.50.31922; Barouch DH, 2002, J IMMUNOL, V168, P562, DOI 10.4049/jimmunol.168.2.562; BARRY SC, 1994, J BIOL CHEM, V269, P8488; BIESMA B, 1992, BLOOD, V80, P1141; Birnbaum RA, 2000, MOL CELL, V5, P189, DOI 10.1016/S1097-2765(00)80415-3; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; BRIZZI MF, 1994, J BIOL CHEM, V269, P31680; Carr PD, 2001, CELL, V104, P291, DOI 10.1016/S0092-8674(01)00213-6; Cook AD, 2001, ARTHRITIS RES, V3, P293, DOI 10.1186/ar318; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dellisanti CD, 2007, CHANNELS, V1, P234, DOI 10.4161/chan.4909; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Dirksen U, 1998, BLOOD, V92, P1097; DORSSERS LCJ, 1994, GROWTH FACTORS, V11, P93, DOI 10.3109/08977199409001051; DORSSERS LCJ, 1991, J BIOL CHEM, V266, P21310; Fleetwood AJ, 2005, CRIT REV IMMUNOL, V25, P405, DOI 10.1615/CritRevImmunol.v25.i5.50; GIANNI AM, 1993, ANN ONCOL, V4, P759, DOI 10.1093/oxfordjournals.annonc.a058661; Guthridge MA, 1998, STEM CELLS, V16, P301, DOI 10.1002/stem.160301; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAUSHANSKY K, 1992, J CLIN INVEST, V90, P1879, DOI 10.1172/JCI116065; Klein BK, 1997, J BIOL CHEM, V272, P22630, DOI 10.1074/jbc.272.36.22630; Korzenik JR, 2005, NEW ENGL J MED, V352, P2193, DOI 10.1056/NEJMoa041109; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Lilly MB, 2001, BLOOD, V97, P1662, DOI 10.1182/blood.V97.6.1662; LOKKER NA, 1991, EMBO J, V10, P2125, DOI 10.1002/j.1460-2075.1991.tb07746.x; LOKKER NA, 1991, J BIOL CHEM, V266, P10624; LOKKER NA, 1991, J IMMUNOL, V146, P893; LOPEZ AF, 1992, P NATL ACAD SCI USA, V89, P11842, DOI 10.1073/pnas.89.24.11842; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MILBURN MV, 1993, NATURE, V363, P172, DOI 10.1038/363172a0; Murphy JM, 2004, J BIOL CHEM, V279, P26500, DOI 10.1074/jbc.M402705200; Murphy JM, 2003, J BIOL CHEM, V278, P10572, DOI 10.1074/jbc.M211664200; Muto A, 1995, J ALLERGY CLIN IMMUN, V96, P1100, DOI 10.1016/S0091-6749(95)70195-8; OLINS PO, 1995, J BIOL CHEM, V270, P23754, DOI 10.1074/jbc.270.40.23754; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Ramshaw HS, 2002, EXP HEMATOL, V30, P1124, DOI 10.1016/S0301-472X(02)00903-7; Rozwarski DA, 1996, PROTEINS, V26, P304, DOI 10.1002/(SICI)1097-0134(199611)26:3<304::AID-PROT6>3.0.CO;2-D; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Sun XL, 2002, VACCINE, V20, P1466, DOI 10.1016/S0264-410X(01)00476-5; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; WOODCOCK JM, 1994, EMBO J, V13, P5176, DOI 10.1002/j.1460-2075.1994.tb06848.x; Woodcock JM, 1996, J BIOL CHEM, V271, P25999, DOI 10.1074/jbc.271.42.25999	46	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5188	10.1371/journal.pone.0005188	http://dx.doi.org/10.1371/journal.pone.0005188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352505	gold, Green Published, Green Submitted			2022-12-27	WOS:000265505300016
J	Ramduth, D; Day, CL; Thobakgale, CF; Mkhwanazi, NP; de Pierres, C; Reddy, S; van der Stok, M; Mncube, Z; Nair, K; Moodley, ES; Kaufmann, DE; Streeck, H; Coovadia, HM; Kiepiela, P; Goulder, PJR; Walker, BD				Ramduth, Danni; Day, Cheryl L.; Thobakgale, Christina F.; Mkhwanazi, Nompumelelo P.; de Pierres, Chantal; Reddy, Sharon; van der Stok, Mary; Mncube, Zenele; Nair, Kriebashne; Moodley, Eshia S.; Kaufmann, Daniel E.; Streeck, Hendrik; Coovadia, Hoosen M.; Kiepiela, Photini; Goulder, Philip J. R.; Walker, Bruce D.			Immunodominant HIV-1 Cd4+T Cell Epitopes in Chronic Untreated Clade C HIV-1 Infection	PLOS ONE			English	Article							CD4(+) T-CELLS; HIV-1-INFECTED SUBJECTS; COMPREHENSIVE ANALYSIS; DISEASE PROGRESSION; RESPONSES REVEALS; IMMUNE EVASION; GAG; PERSISTENCE; FREQUENCY; PROTEINS	Background: A dominance of Gag-specific CD8+ T cell responses is significantly associated with a lower viral load in individuals with chronic, untreated clade C human immunodeficiency virus type 1 (HIV-1) infection. This association has not been investigated in terms of Gag-specific CD4+ T cell responses, nor have clade C HIV-1-specific CD4+ T cell epitopes, likely a vital component of an effective global HIV-1 vaccine, been identified. Methodology/Principal Findings: Intracellular cytokine staining was conducted on 373 subjects with chronic, untreated clade C infection to assess interferon-gamma (IFN-gamma) responses by CD4+ T cells to pooled Gag peptides and to determine their association with viral load and CD4 count. Gag-specific IFN-gamma-producing CD4+ T cell responses were detected in 261/373 (70%) subjects, with the Gag responders having a significantly lower viral load and higher CD4 count than those with no detectable Gag response (p<0.0001 for both parameters). To identify individual peptides targeted by HIV-1-specific CD4+ T cells, separate ELISPOT screening was conducted on CD8-depleted PBMCs from 32 chronically infected untreated subjects, using pools of overlapping peptides that spanned the entire HIV-1 clade C consensus sequence, and reconfirmed by flow cytometry to be CD4+ mediated. The ELISPOT screening identified 33 CD4+ peptides targeted by 18/32 patients (56%), with 27 of the 33 peptides located in the Gag region. Although the breadth of the CD4+ responses correlated inversely with viral load (p = 0.015), the magnitude of the response was not significantly associated with viral load. Conclusions/Significance: These data indicate that in chronic untreated clade C HIV-1 infection, IFN-gamma-secreting Gag-specific CD4+ T cell responses are immunodominant, directed at multiple distinct epitopes, and associated with viral control.	[Ramduth, Danni; Day, Cheryl L.; Thobakgale, Christina F.; Mkhwanazi, Nompumelelo P.; de Pierres, Chantal; Reddy, Sharon; van der Stok, Mary; Mncube, Zenele; Nair, Kriebashne; Moodley, Eshia S.; Coovadia, Hoosen M.; Kiepiela, Photini; Goulder, Philip J. R.; Walker, Bruce D.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Day, Cheryl L.; Kaufmann, Daniel E.; Streeck, Hendrik; Goulder, Philip J. R.; Walker, Bruce D.] Harvard Univ, MIT, Massachusetts Gen Hosp E, Ragon Inst MGH, Charlestown, MA USA; [Goulder, Philip J. R.] Univ Oxford, Peter Medawar Bldg Pathogen Res, Nuffield Dept Med, Dept Pediat, Oxford OX1 2JD, England; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Kwazulu Natal; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Oxford; Howard Hughes Medical Institute	Ramduth, D (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa.	dramduth@gmail.com	Day, Cheryl/GQQ-9720-2022; Day, Cheryl L/J-9844-2012	Day, Cheryl L/0000-0002-6497-4846; Thobakgale-Tshabalala, Christina/0000-0001-5619-8894	US National Institute of Health [N01-A1-15422, 2 RO1AI46995-06, RO1AI067073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046995, R01AI067073] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the US National Institute of Health (Contract N01-A1-15422, 2 RO1AI46995-06, and RO1AI067073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Altfeld M, 2003, J VIROL, V77, P7330, DOI 10.1128/JVI.77.13.7330-7340.2003; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Day CL, 2003, J EXP MED, V198, P1773, DOI 10.1084/jem.20031947; Douek DC, 2002, J IMMUNOL, V168, P3099, DOI 10.4049/jimmunol.168.6.3099; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Duvall MG, 2006, J IMMUNOL, V176, P6973, DOI 10.4049/jimmunol.176.11.6973; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Geldmacher C, 2007, AIDS, V21, P135, DOI 10.1097/01.aids.0000247589.77061.f7; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Harari A, 2002, BLOOD, V100, P1381, DOI 10.1182/blood-2001-11-0080; Iyasere C, 2003, J VIROL, V77, P10900, DOI 10.1128/JVI.77.20.10900-10909.2003; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kaufmann DE, 2004, J VIROL, V78, P4463, DOI 10.1128/JVI.78.9.4463-4477.2004; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kurle S, 2004, AIDS RES HUM RETROV, V20, P1113, DOI 10.1089/aid.2004.20.1113; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Malhotra U, 2001, J CLIN INVEST, V107, P505, DOI 10.1172/JCI11275; Mattapallil JJ, 2006, J MED PRIMATOL, V35, P217, DOI 10.1111/j.1600-0684.2006.00170.x; McNeil AC, 2001, P NATL ACAD SCI USA, V98, P13878, DOI 10.1073/pnas.251539598; Ngumbela KC, 2008, AIDS RES HUM RETROV, V24, P72, DOI 10.1089/aid.2007.0124; Ondondo BO, 2008, EUR J IMMUNOL, V38, P3549, DOI 10.1002/eji.200838759; Palmer BE, 2002, J VIROL, V76, P5925, DOI 10.1128/JVI.76.12.5925-5936.2002; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Ramduth D, 2005, J INFECT DIS, V192, P1588, DOI 10.1086/496894; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; *UNAIDS, 2007, AIDS EP UP 07; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Yue FY, 2004, J IMMUNOL, V172, P2476, DOI 10.4049/jimmunol.172.4.2476; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	37	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5013	10.1371/journal.pone.0005013	http://dx.doi.org/10.1371/journal.pone.0005013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352428	Green Published, Green Submitted, gold			2022-12-27	WOS:000265505300003
J	Lewis, MJ; Pelham, HRB				Lewis, Michael J.; Pelham, Hugh R. B.			Inefficient Quality Control of Thermosensitive Proteins on the Plasma Membrane	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM DEGRADATION; ER-ASSOCIATED DEGRADATION; UBIQUITIN LIGASE; SACCHAROMYCES-CEREVISIAE; MULTIVESICULAR BODIES; YEAST; SYSTEM; ENDOCYTOSIS; STABILITY; REQUIRES	Background: Misfolded proteins are generally recognised by cellular quality control machinery, which typically results in their ubiquitination and degradation. For soluble cytoplasmic proteins, degradation is mediated by the proteasome. Membrane proteins that fail to fold correctly are subject to ER associated degradation (ERAD), which involves their extraction from the membrane and subsequent proteasome-dependent destruction. Proteins with abnormal transmembrane domains can also be recognised in the Golgi or endosomal system and targeted for destruction in the vacuole/lysosome. It is much less clear what happens to membrane proteins that reach their destination, such as the cell surface, and then suffer damage. Methodology/Principal Findings: We have tested the ability of yeast cells to degrade membrane proteins to which temperature-sensitive cytoplasmic alleles of the Ura3 protein or of phage lambda repressor have been fused. In soluble form, these proteins are rapidly degraded upon temperature shift, in part due to the action of the Doa10 and San1 ubiquitin ligases and the proteasome. When tethered to the ER protein Use1, they are also degraded. However, when tethered to a plasma membrane protein such as Sso1 they escape degradation, either in the vacuole or by the proteasome. Conclusions/Significance: Membrane proteins with a misfolded cytoplasmic domain appear not to be efficiently recognised and degraded once they have escaped the ER, even though their defective domains are exposed to the cytoplasm and potentially to cytoplasmic quality controls. Membrane tethering may provide a way to reduce degradation of unstable proteins.	[Lewis, Michael J.; Pelham, Hugh R. B.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Lewis, MJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	hp@mrc-lmb.cam.ac.uk			UK Medical Research Council; Medical Research Council [MC_U105178788] Funding Source: researchfish; MRC [MC_U105178788] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the UK Medical Research Council (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Gong XH, 2001, P NATL ACAD SCI USA, V98, P9104, DOI 10.1073/pnas.161282998; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; Pizzirusso M, 2004, MOL BIOL CELL, V15, P2401, DOI 10.1091/mbc.E03-10-0727; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Reggiori F, 2000, MOL BIOL CELL, V11, P3737, DOI 10.1091/mbc.11.11.3737; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; SUSSMAN R, 1962, CR HEBD ACAD SCI, V254, P1517; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; VOLLAND C, 1994, J BIOL CHEM, V269, P9833	31	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5038	10.1371/journal.pone.0005038	http://dx.doi.org/10.1371/journal.pone.0005038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337370	Green Published, Green Submitted, gold			2022-12-27	WOS:000265500600012
J	Quaia, C; Ying, HS; Nichols, AM; Optican, LM				Quaia, Christian; Ying, Howard S.; Nichols, Altah M.; Optican, Lance M.			The Viscoelastic Properties of Passive Eye Muscle in Primates. I: Static Forces and Step Responses	PLOS ONE			English	Article							GENERATING LINE SPECTRA; SUPERIOR OBLIQUE PALSY; SKELETAL-MUSCLE; EXTRAOCULAR-MUSCLES; RESTING TENSION; RAT MUSCLE; FIBERS; MECHANICS; MODEL; FROG	The viscoelastic properties of passive eye muscles are prime determinants of the deficits observed following eye muscle paralysis, the root cause of several types of strabismus. Our limited knowledge about such properties is hindering the ability of eye plant models to assist in formulating a patient's diagnosis and prognosis. To investigate these properties we conducted an extensive in vivo study of the mechanics of passive eye muscles in deeply anesthetized and paralyzed monkeys. We describe here the static length-tension relationship and the transient forces elicited by small step-like elongations. We found that the static force increases nonlinearly with length, as previously shown. As expected, an elongation step induces a fast rise in force, followed by a prolonged decay. The time course of the decay is however considerably more complex than previously thought, indicating the presence of several relaxation processes, with time constants ranging from 1 ms to at least 40 s. The mechanical properties of passive eye muscles are thus similar to those of many other biological passive tissues. Eye plant models, which for lack of data had to rely on (erroneous) assumptions, will have to be updated to incorporate these properties.	[Quaia, Christian; Nichols, Altah M.; Optican, Lance M.] NEI, Sensorimotor Res Lab, Bethesda, MD 20892 USA; [Ying, Howard S.] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Johns Hopkins University; Johns Hopkins Medicine	Quaia, C (corresponding author), NEI, Sensorimotor Res Lab, Bldg 10, Bethesda, MD 20892 USA.	quaiac@nei.nih.gov			National Eye Institute; NIH [EY19347, EY15025]; Knights' Templar Eye Foundation [Young Investigator Award]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [ZIAEY000302, Z01EY000302, K12EY015025, R01EY019347] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knights' Templar Eye Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the intramural research program of the National Eye Institute (CQ, AMN, LMO), by NIH grants NIH EY19347 and NIH EY15025 (HSY), the Knights' Templar Eye Foundation Young Investigator Award (HSY), and Research to Prevent Blindness Core Grant (HSY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, HDB STOCHASTIC METHO; BACHYRITA P, 1966, J GEN PHYSIOL, V49, P1177, DOI 10.1085/jgp.0491177; BAGNI MA, 1992, BIOPHYS J, V63, P1412, DOI 10.1016/S0006-3495(92)81718-6; BAGNI MA, 1995, J PHYSIOL-LONDON, V482, P391, DOI 10.1113/jphysiol.1995.sp020526; BARMACK NH, 1976, J NEUROPHYSIOL, V39, P1009, DOI 10.1152/jn.1976.39.5.1009; BARMACK NH, 1971, J NEUROPHYSIOL, V34, P1072, DOI 10.1152/jn.1971.34.6.1072; Breinin GM, 1962, ELECTROPHYSIOLOGY EX; Brown IE, 1996, J MUSCLE RES CELL M, V17, P221, DOI 10.1007/BF00124244; Buchthal F., 1951, DAN VIDENS SELS BIOL, V21, P1; Collins C.C., 1971, CONTROL EYE MOVEMENT, P283; COLLINS CC, 1975, J PHYSIOL-LONDON, V245, P351, DOI 10.1113/jphysiol.1975.sp010850; Collins CC., 1975, BASIC MECH OCULAR MO, P145; Croes SA, 2007, J NEUROSCI METH, V166, P53, DOI 10.1016/j.jneumeth.2007.06.024; EMRI I, 1994, RHEOL ACTA, V33, P60, DOI 10.1007/BF00453464; EMRI I, 1993, RHEOL ACTA, V32, P311, DOI 10.1007/BF00434195; EMRI I, 1995, INT J SOLIDS STRUCT, V32, P817, DOI 10.1016/0020-7683(94)00162-P; FORD LE, 1977, J PHYSIOL-LONDON, V269, P441, DOI 10.1113/jphysiol.1977.sp011911; FUCHS AF, 1971, J PHYSIOL-LONDON, V219, P155, DOI 10.1113/jphysiol.1971.sp009655; Goulding D, 1997, J MUSCLE RES CELL M, V18, P465, DOI 10.1023/A:1018650915751; Hakim OM, 2008, J AAPOS, V12, P62, DOI 10.1016/j.jaapos.2007.09.001; HILL AV, 1950, NATURE, V166, P415, DOI 10.1038/166415a0; HOROWITS R, 1987, J CELL BIOL, V105, P2217, DOI 10.1083/jcb.105.5.2217; HOROWITS R, 1986, NATURE, V323, P160, DOI 10.1038/323160a0; LINKE WA, 1994, BIOPHYS J, V67, P782, DOI 10.1016/S0006-3495(94)80538-7; MAGID A, 1985, SCIENCE, V230, P1280, DOI 10.1126/science.4071053; MILLER JM, 1984, COMPUT BIOMED RES, V17, P436, DOI 10.1016/0010-4809(84)90012-0; Mutungi G, 1996, J PHYSIOL-LONDON, V496, P827, DOI 10.1113/jphysiol.1996.sp021730; Mutungi G, 1996, J MUSCLE RES CELL M, V17, P357; Nekouzadeh A, 2005, P ROY SOC A-MATH PHY, V461, P1599, DOI 10.1098/rspa.2004.1437; NOLL W, 1961, REV MOD PHYS, V33, P239; Pinniger GJ, 2006, J PHYSIOL-LONDON, V573, P627, DOI 10.1113/jphysiol.2005.095448; Porter JD, 1996, NEUROLOGY, V46, P30, DOI 10.1212/WNL.46.1.30; Pryse KM, 2003, ANN BIOMED ENG, V31, P1287, DOI 10.1114/1.1615571; Puso MA, 1998, J BIOMECH ENG-T ASME, V120, P62, DOI 10.1115/1.2834308; Quaia C, 2008, PROG BRAIN RES, V171, P47, DOI 10.1016/S0079-6123(08)00607-9; Ramsey RW, 1940, J CELL COMPAR PHYSL, V15, P11, DOI 10.1002/jcp.1030150103; Robinson D.A., 1981, MODELS OCULOMOTOR BE, P21; ROBINSON DA, 1975, INVEST OPHTH VISUAL, V14, P801; ROBINSON DA, 1964, J PHYSIOL-LONDON, V174, P245, DOI 10.1113/jphysiol.1964.sp007485; ROBINSON DA, 1969, J APPL PHYSIOL, V26, P548, DOI 10.1152/jappl.1969.26.5.548; Scott AB, 1971, CONTROL EYE MOVEMENT, P327; Shan XY, 2007, INVEST OPHTH VIS SCI, V48, P2602, DOI 10.1167/iovs.06-1316; Shan XY, 2007, INVEST OPHTH VIS SCI, V48, P2612, DOI 10.1167/iovs.06-1318; Sklavos S, 2005, VISION RES, V45, P1525, DOI 10.1016/j.visres.2005.01.005; STONE SL, 1965, J PHYSIOL-LONDON, V181, P337, DOI 10.1113/jphysiol.1965.sp007765; Telley IA, 2007, J MUSCLE RES CELL M, V28, P89, DOI 10.1007/s10974-007-9107-8; Tschoegl N.W., 1989, PHENOMENOLOGICAL THE; TSCHOEGL NW, 1993, RHEOL ACTA, V32, P322, DOI 10.1007/BF00434196; Viidik A., 1980, BIOL COLLAGEN, P237; WANG K, 1991, P NATL ACAD SCI USA, V88, P7101, DOI 10.1073/pnas.88.16.7101; Wang K, 1996, ADV BIOPHYS, V33, P123; WILLETT JB, 1988, AM STAT, V42, P236, DOI 10.2307/2685031	52	27	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e4850	10.1371/journal.pone.0004850	http://dx.doi.org/10.1371/journal.pone.0004850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337381	Green Published, gold			2022-12-27	WOS:000265500600002
J	He, MA; Guo, H; Yang, XB; Zhang, XM; Zhou, L; Cheng, LX; Zeng, HS; Hu, FB; Tanguay, RM; Wu, TC				He, Meian; Guo, Huan; Yang, Xiaobo; Zhang, Xiaomin; Zhou, Li; Cheng, Longxian; Zeng, Hesong; Hu, Frank B.; Tanguay, Robert M.; Wu, Tangchun			Functional SNPs in HSPA1A Gene Predict Risk of Coronary Heart Disease	PLOS ONE			English	Article								Background: HSP70 plays crucial roles in endothelial cell apoptosis, which is involved in the early phase and progress of coronary heart disease (CHD). However, the association between polymorphisms of HSP70 genes and the risk of CHD still remains unclear. Our aim was to determine whether genetic variants in the HSPA1A gene are associated with the risk of CHD. Methodology/Principal Findings: By resequencing and genotyping, the associations of 2 single nucleotide polymorphisms (SNPs) + 190G/C (rs1043618) and -110A/C (rs1008438) in the HSPA1A gene with risk of CHD were determined in a 1,003 pairs case-control study. The SNP function was further analyzed using a luciferase reporter assay in two cell lines. The results indicated that +190CC genotype was associated with significantly higher risk of CHD when compared with +190GG genotype (OR = 1.56, 95% CI: 1.10-2.20, P = 0.012), while association between -110A/C polymorphism and CHD was not statistically significant (P>0.05). However, the -110C/+190C haplotype had a significantly higher risk of CHD when compared with the -110A/+190G haplotype (OR = 1.17, 95% CI: 1.01-1.34, P = 0.031). Luciferase reporter assays showed that the +190C allele resulted in 14%similar to 45% reduction in luciferase expression in endothelial and non-endothelial cells when compared with the +190G allele. Conclusions/Significance: The identified genetic variants in the HSPA1A gene combinatorially contribute towards the susceptibility to CHD likely by affecting the level of synthesis of HSP70. This study may provide useful markers for identification of subjects at risk for CHD.	[He, Meian; Guo, Huan; Yang, Xiaobo; Zhang, Xiaomin; Zhou, Li; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Inst Occupat Med, Wuhan, Hubei, Peoples R China; [He, Meian; Guo, Huan; Yang, Xiaobo; Zhang, Xiaomin; Zhou, Li; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Ministry of Ed Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China; [He, Meian; Cheng, Longxian] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiol, Wuhan, Peoples R China; [Zeng, Hesong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Cardiol, Wuhan, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA 02138 USA; [Tanguay, Robert M.] Univ Laval, Fac Med, Dept Med, Lab Cellular & Dev Genet, Quebec City, PQ G1K 7P4, Canada; [Tanguay, Robert M.] Univ Laval, CREFSIP, Quebec City, PQ G1K 7P4, Canada	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health; Laval University; Laval University	He, MA (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Inst Occupat Med, Wuhan, Hubei, Peoples R China.	wut@mails.tjmu.edu.cn	Zhang, Xiaomin/GVT-8927-2022; Zhang, Xiaomin/F-3206-2018		National Natural Science Foundation of China [30525031, 30430590]; NSFC-CIHR [30711120579, CCI-85673]; American Heart Association [Established Investigator Award]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-CIHR(Canadian Institutes of Health Research (CIHR)); American Heart Association(American Heart Association)	This study was supported by the National Natural Science Foundation of China (NSFC 30525031 and 30430590), NSFC-CIHR Collaborative Research Grant and NSFC (30711120579). Dr. Frank B. Hu's work was supported in part by the American Heart Association Established Investigator Award. TW and RMT also acknowledge support from a NNSFC-CIHR (Canadian Institutes of Health Research) collaborative research grant (CIHR CCI-85673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolla MK, 1998, DIS MARKERS, V13, P227, DOI 10.1155/1998/235151; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Cines DB, 1998, BLOOD, V91, P3527; Clemons NJ, 2005, J BIOL CHEM, V280, P9005, DOI 10.1074/jbc.M414165200; CURRIE RW, 1993, CIRCULATION, V87, P963, DOI 10.1161/01.CIR.87.3.963; Das DK, 2006, CARDIOVASC RES, V70, P254, DOI 10.1016/j.cardiores.2006.02.023; Ding KY, 2003, BIOINFORMATICS, V19, P2147, DOI 10.1093/bioinformatics/btg276; Durand E, 2004, CIRCULATION, V109, P2503, DOI 10.1161/01.CIR.0000130172.62481.90; Favatier F, 1997, CELL STRESS CHAPERON, V2, P141, DOI 10.1379/1466-1268(1997)002<0141:VIHGEA>2.3.CO;2; Fraile A, 1998, TISSUE ANTIGENS, V51, P382; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; He MA, 2008, CELL STRESS CHAPERON, V13, P231, DOI 10.1007/s12192-008-0025-5; HUTTER MM, 1994, CIRCULATION, V89, P355, DOI 10.1161/01.CIR.89.1.355; Jarjour W, 1996, HUM IMMUNOL, V45, P59, DOI 10.1016/0198-8859(95)00153-0; JOHNSON AD, 1995, ARTERIOSCL THROM VAS, V15, P27, DOI 10.1161/01.ATV.15.1.27; Kabakov AE, 2003, CELL STRESS CHAPERON, V8, P335, DOI 10.1379/1466-1268(2003)008<0335:HSPOHS>2.0.CO;2; Li CY, 2000, J BIOL CHEM, V275, P25665, DOI 10.1074/jbc.M906383199; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; MILNER CM, 1992, IMMUNOGENETICS, V36, P357; MILNER CM, 1990, IMMUNOGENETICS, V32, P242; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Organization W. H., 1992, WORLD HLTH STAT ANN; PUGLIESE A, 1992, DIABETES, V41, P788, DOI 10.2337/diabetes.41.7.788; Radford NB, 1996, P NATL ACAD SCI USA, V93, P2339, DOI 10.1073/pnas.93.6.2339; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Steel R, 2004, J BIOL CHEM, V279, P51490, DOI 10.1074/jbc.M401314200; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Suzuki K, 2000, BASIC RES CARDIOL, V95, P397, DOI 10.1007/s003950070039; Vargas-Alarcon G, 2002, ANN RHEUM DIS, V61, P48, DOI 10.1136/ard.61.1.48; Vivinus S, 2001, EUR J BIOCHEM, V268, P1908, DOI 10.1046/j.1432-1327.2001.02064.x; Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499; Wu YR, 2004, HUM GENET, V114, P236, DOI 10.1007/s00439-003-1050-1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	47	51	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4851	10.1371/journal.pone.0004851	http://dx.doi.org/10.1371/journal.pone.0004851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333379	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499900001
J	Weaver, EA; Nehete, PN; Buchl, SS; Senac, JS; Palmer, D; Ng, P; Sastry, KJ; Barry, MA				Weaver, Eric A.; Nehete, Pramod N.; Buchl, Stephanie S.; Senac, Julien S.; Palmer, Donna; Ng, Philip; Sastry, K. Jagannadha; Barry, Michael A.			Comparison of Replication-Competent, First Generation, and Helper-Dependent Adenoviral Vaccines	PLOS ONE			English	Article								All studies using human serotype 5 Adenovirus (Ad) vectors must address two major obstacles: safety and the presence of pre-existing neutralizing antibodies. Helper-Dependent (HD) Ads have been proposed as alternative vectors for gene therapy and vaccine development because they have an improved safety profile. To evaluate the potential of HD-Ad vaccines, we compared replication-competent (RC), first-generation (FG) and HD vectors for their ability to induce immune responses in mice. We show that RC-Ad5 and HD-Ad5 vectors generate stronger immune responses than FG-Ad5 vectors. HD-Ad5 vectors gave lower side effects than RC or FG-Ad, producing lower levels of tissue damage and anti-Ad T cell responses. Also, HD vectors have the benefit of being packaged by all subgroup C serotype helper viruses. We found that HD serotypes 1, 2, 5, and 6 induce anti-HIV responses equivalently. By using these HD serotypes in heterologous succession we showed that HD vectors can be used to significantly boost anti-HIV immune responses in mice and in FG-Ad5-immune macaques. Since HD vectors have been show to have an increased safety profile, do not possess any Ad genes, can be packaged by multiple serotype helper viruses, and elicit strong anti-HIV immune responses, they warrant further investigation as alternatives to FG vectors as gene-based vaccines.	[Weaver, Eric A.; Barry, Michael A.] Mayo Clin, Translat Immunovirol Program, Dept Internal Med, Div Infect Dis, Rochester, MN 55905 USA; [Barry, Michael A.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Barry, Michael A.] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Nehete, Pramod N.; Buchl, Stephanie S.; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Houston, TX USA; [Senac, Julien S.; Palmer, Donna; Ng, Philip] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Weaver, EA (corresponding author), Mayo Clin, Translat Immunovirol Program, Dept Internal Med, Div Infect Dis, Rochester, MN 55905 USA.	mab@mayo.edu		Sastry, Jagannadha/0000-0002-6987-4422; Nehete, Pramod/0000-0002-2815-2677	NIH [AI06795, AI065304, AI42694, AI46969, HL083047, DK067324]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046969, R21AI042694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067324] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH AI06795, AI065304, AI42694, AI46969, HL083047 and DK067324. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Brunetti-Pierri N, 2004, HUM GENE THER, V15, P35, DOI 10.1089/10430340460732445; Brunetti-Pierri N, 2007, MOL THER, V15, P732, DOI 10.1038/sj.mt.6300102; Casimiro DR, 2003, J VIROL, V77, P7663, DOI 10.1128/JVI.77.13.7663-7668.2003; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; Caulfield MJ, 2002, J VIROL, V76, P10038, DOI 10.1128/JVI.76.19.10038-10043.2002; Chen HH, 1997, P NATL ACAD SCI USA, V94, P1645, DOI 10.1073/pnas.94.5.1645; Clemens PR, 1996, GENE THER, V3, P965; Croyle MA, 2005, GENE THER, V12, P579, DOI 10.1038/sj.gt.3302441; Fields PA, 2000, MOL THER, V1, P225, DOI 10.1006/mthe.2000.0032; Fisher KJ, 1996, VIROLOGY, V217, P11, DOI 10.1006/viro.1996.0088; Harui A, 2004, GENE THER, V11, P1617, DOI 10.1038/sj.gt.3302332; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Lemckert AAC, 2005, J VIROL, V79, P9694, DOI 10.1128/JVI.79.15.9694-9701.2005; Lieber A, 1997, J VIROL, V71, P8798, DOI 10.1128/JVI.71.11.8798-8807.1997; Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036; Marshall E, 1999, SCIENCE, V286, P2244, DOI 10.1126/science.286.5448.2244; McCoy K, 2007, J VIROL, V81, P6594, DOI 10.1128/JVI.02497-06; Mercier GT, 2007, VACCINE, V25, P8687, DOI 10.1016/j.vaccine.2007.10.030; MITANI K, 1995, P NATL ACAD SCI USA, V92, P3854, DOI 10.1073/pnas.92.9.3854; Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015; Morral N, 1998, HUM GENE THER, V9, P2709, DOI 10.1089/hum.1998.9.18-2709; Morral N, 1999, P NATL ACAD SCI USA, V96, P12816, DOI 10.1073/pnas.96.22.12816; Muruve DA, 2004, J VIROL, V78, P5966, DOI 10.1128/JVI.78.11.5966-5972.2004; Nehete PN, 1998, VIRAL IMMUNOL, V11, P147, DOI 10.1089/vim.1998.11.147; Nehete PN, 1996, J CLIN IMMUNOL, V16, P115, DOI 10.1007/BF01540958; Nehete PN, 2001, VACCINE, V20, P813, DOI 10.1016/S0264-410X(01)00408-X; NEHETE PN, 1995, AIDS, V9, P567, DOI 10.1097/00002030-199506000-00006; Palmer D, 2003, MOL THER, V8, P846, DOI 10.1016/j.ymthe.2003.08.014; Parks RJ, 1999, GENE THER, V6, P1565, DOI 10.1038/sj.gt.3300995; Piedra PA, 1998, PEDIATRICS, V101, P1013, DOI 10.1542/peds.101.6.1013; Pinto AR, 2003, J IMMUNOL, V171, P6774, DOI 10.4049/jimmunol.171.12.6774; SASTRY KJ, 1991, AIDS, V5, P699, DOI 10.1097/00002030-199106000-00009; Shashkova EV, 2008, CANCER RES, V68, P5896, DOI 10.1158/0008-5472.CAN-08-0488; Shiver John, 2003, Res Initiat Treat Action, V8, P14; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Toietta G, 2002, MOL THER, V5, P204, DOI 10.1006/mthe.2002.0532; Tripathy SK, 1996, NAT MED, V2, P545, DOI 10.1038/nm0596-545; Weaver EA, 2006, J VIROL, V80, P6745, DOI 10.1128/JVI.02484-05; Yang YP, 1996, J VIROL, V70, P7209, DOI 10.1128/JVI.70.10.7209-7212.1996	40	55	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5059	10.1371/journal.pone.0005059	http://dx.doi.org/10.1371/journal.pone.0005059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333387	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499900015
J	Creagh, EM; Brumatti, G; Sheridan, C; Duriez, PJ; Taylor, RC; Cullen, SP; Adrain, C; Martin, SJ				Creagh, Emma M.; Brumatti, Gabriela; Sheridan, Clare; Duriez, Patrick J.; Taylor, Rebecca C.; Cullen, Sean P.; Adrain, Colin; Martin, Seamus J.			Bicaudal Is a Conserved Substrate for Drosophila and Mammalian Caspases and Is Essential for Cell Survival	PLOS ONE			English	Article							INDUCED APOPTOSIS; C-ELEGANS; ACTIVATION; DEATH; INHIBITOR; DRONC; IDENTIFICATION; COMPLEX; PATHWAYS; PROTEINS	Members of the caspase family of cysteine proteases coordinate cell death through restricted proteolysis of diverse protein substrates and play a conserved role in apoptosis from nematodes to man. However, while numerous substrates for the mammalian cell death-associated caspases have now been described, few caspase substrates have been identified in other organisms. Here, we have utilized a proteomics-based approach to identify proteins that are cleaved by caspases during apoptosis in Drosophila D-Mel2 cells, a subline of the Schneider S2 cell line. This approach identified multiple novel substrates for the fly caspases and revealed that bicaudal/beta NAC is a conserved substrate for Drosophila and mammalian caspases. RNAi-mediated silencing of bicaudal expression in Drosophila D-Mel2 cells resulted in a block to proliferation, followed by spontaneous apoptosis. Similarly, silencing of expression of the mammalian bicaudal homologue, beta NAC, in HeLa, HEK293T, MCF-7 and MRC5 cells also resulted in spontaneous apoptosis. These data suggest that bicaudal/beta NAC is essential for cell survival and is a conserved target of caspases from flies to man.	[Creagh, Emma M.; Brumatti, Gabriela; Sheridan, Clare; Duriez, Patrick J.; Taylor, Rebecca C.; Cullen, Sean P.; Adrain, Colin; Martin, Seamus J.] Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin, Ireland	Trinity College Dublin	Creagh, EM (corresponding author), Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin, Ireland.	martinsj@tcd.ie	Adrain, Colin/I-6259-2013; Creagh, Emma/AAX-1064-2021	Adrain, Colin/0000-0001-7597-4393; Creagh, Emma/0000-0001-7631-4370; Taylor, Rebecca/0000-0003-3429-3123; Martin, Seamus/0000-0002-8539-3143	Science Foundation Ireland [PI.1/B038]; Health Research Board of Ireland [post-doctoral fellowship]; Irish Research Council for Science and Engineering Technologies (IRCSET) [post-doctoral fellowship]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board of Ireland; Irish Research Council for Science and Engineering Technologies (IRCSET)(Irish Research Council for Science, Engineering and Technology)	This work was supported by a grant from Science Foundation Ireland (PI.1/B038) to S.J.M.. E.M.C. was supported, in part, by a post-doctoral fellowship award from the Health Research Board of Ireland. G.B. was supported, in part, by a post-doctoral fellowship award from the Irish Research Council for Science and Engineering Technologies (IRCSET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Adrain C, 2005, J BIOL CHEM, V280, P4663, DOI 10.1074/jbc.M410915200; Adrain C, 2006, TRENDS BIOCHEM SCI, V31, P243, DOI 10.1016/j.tibs.2006.03.004; Akdemir F, 2006, DEVELOPMENT, V133, P1457, DOI 10.1242/dev.02332; Beatrix B, 2000, J BIOL CHEM, V275, P37838, DOI 10.1074/jbc.M006368200; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; Chew SK, 2004, DEV CELL, V7, P897, DOI 10.1016/j.devcel.2004.09.016; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Croft DR, 2005, J CELL BIOL, V168, P245, DOI 10.1083/jcb.200409049; Daish TJ, 2004, DEV CELL, V7, P909, DOI 10.1016/j.devcel.2004.09.018; DENG JM, 1995, TRANSGENIC RES, V4, P264, DOI 10.1007/BF01969120; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Dorstyn L, 1999, P NATL ACAD SCI USA, V96, P4307, DOI 10.1073/pnas.96.8.4307; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Fraser AG, 1997, EMBO J, V16, P6192, DOI 10.1093/emboj/16.20.6192; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Igaki T, 2002, J BIOL CHEM, V277, P23103, DOI 10.1074/jbc.C200222200; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Kumar S, 2000, CELL DEATH DIFFER, V7, P1039, DOI 10.1038/sj.cdd.4400756; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Markesich DC, 2000, DEVELOPMENT, V127, P559; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Quinn LM, 2000, J BIOL CHEM, V275, P40416, DOI 10.1074/jbc.M002935200; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Song ZW, 1997, SCIENCE, V275, P536, DOI 10.1126/science.275.5299.536; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Taylor RC, 2007, J BIOL CHEM, V282, P15011, DOI 10.1074/jbc.M611051200; Thiede B, 2001, J BIOL CHEM, V276, P26044, DOI 10.1074/jbc.M101062200; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zimmermann KC, 2002, J CELL BIOL, V156, P1077, DOI 10.1083/jcb.20112068	42	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2009	4	3							e5055	10.1371/journal.pone.0005055	http://dx.doi.org/10.1371/journal.pone.0005055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PP	19330035	Green Published, gold, Green Accepted			2022-12-27	WOS:000265499700005
J	Tian, HG; Peng, H; Yao, Q; Chen, HX; Xie, Q; Tang, B; Zhang, WQ				Tian, Honggang; Peng, Han; Yao, Qiong; Chen, Hongxin; Xie, Qi; Tang, Bin; Zhang, Wenqing			Developmental Control of a Lepidopteran Pest Spodoptera exigua by Ingestion of Bacteria Expressing dsRNA of a Non-Midgut Gene	PLOS ONE			English	Article							CHITIN SYNTHASE GENE; RNA INTERFERENCE; AMINOPEPTIDASE-N; SYSTEMIC RNAI	Background: RNA interference (RNAi) induced through double stranded RNA (dsRNA) has been used widely to study gene function in insects. Recently, it has been reported that gene knockdown in several insects can be induced successfully through feeding with dsRNA. However, it is still unknown whether phenotypic silencing of genes not expressed in the midgut occurs after ingestion of insect dsRNA. Principal Findings: Using chitin synthase gene A (SeCHSA) as the target gene, which is expressed in the cuticle and tracheae of the lepidopteran pest Spodoptera exigua, we showed that the growth and development of S. exigua larvae fed Escherichia coli expressing dsRNA of SeCHSA was disturbed, resulting in lethality. In the 4th and 5th larval instars, prepupae, and pupae, the mean survival rates of insects fed the dsRNA-containing diet were 88.64%, 74.24%, 68.43% and 62.63% respectively. The survival rates in the 5(th) instar larvae, prepupae and pupae stages were significantly lower than those of all controls, and significant lethality differences were also found between dsSeCHSA treatment and dsControl or ddH(2)O control in the 4(th) instar larvae. The effects of ingesting bacterially expressed dsRNA on transcription of the target gene, tissue structure, and survival rates of insects were dose-dependent. Conclusions: Our results suggest that SeCHSA dsRNA may be useful as a means of insect pest control.			Tian, HG (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lsszwq@mail.sysu.edu.cn	Galdzicki, Michal/F-5682-2010; Kohane, Isaac Kohane/K-3716-2012; Tian, Honggang/AAW-4772-2020; zhang, wenqing/GYA-0786-2022; tian, ze/HDM-4308-2022; Yao, Huiqin/AAX-3787-2020	Galdzicki, Michal/0000-0002-8392-8183; Kohane, Isaac Kohane/0000-0003-2192-5160; Tian, Honggang/0000-0002-2205-0784; Yao, Huiqin/0000-0003-4742-8971; Chen, Hongxin/0000-0002-2955-4619; Wu, Erxi/0000-0002-1680-3639	NIGMS NIH HHS [R01 GM081871] Funding Source: Medline; NLM NIH HHS [2 T15 LM007092-16, T15 LM007092] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Chen X, 2008, B ENTOMOL RES, V98, P613, DOI 10.1017/S0007485308005932; Chen XF, 2007, INSECT BIOCHEM MOLEC, V37, P409, DOI 10.1016/j.ibmb.2007.01.006; Cruz J, 2007, MECH DEVELOP, V124, P180, DOI 10.1016/j.mod.2006.12.003; Cruz J, 2006, DEV BIOL, V297, P158, DOI 10.1016/j.ydbio.2006.06.048; Eleftherianos I, 2006, DEV COMP IMMUNOL, V30, P1099, DOI 10.1016/j.dci.2006.02.008; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Gura T, 2000, NATURE, V404, P804, DOI 10.1038/35009245; Huang JH, 2007, FEBS LETT, V581, P697, DOI 10.1016/j.febslet.2007.01.034; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kato N, 2006, INSECT BIOCHEM MOLEC, V36, P1, DOI 10.1016/j.ibmb.2005.09.003; Kooter JM, 1999, TRENDS PLANT SCI, V4, P340, DOI 10.1016/S1360-1385(99)01467-3; Lennefors BL, 2006, MOL BREEDING, V18, P313, DOI 10.1007/s11032-006-9030-5; Li Guanghong, 2002, Chinese Journal of Biological Control, V18, P132; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Meyering-Vos M, 2007, J INSECT PHYSIOL, V53, P840, DOI 10.1016/j.jinsphys.2007.04.003; Mito T, 2007, DEV BIOL, V303, P202, DOI 10.1016/j.ydbio.2006.11.003; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Orii H, 2003, DEV GENES EVOL, V213, P138, DOI 10.1007/s00427-003-0310-3; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Retnakaran A., 1987, Chitin and benzoylphenyl ureas., P205; Ronco M, 2008, DEV BIOL, V313, P80, DOI 10.1016/j.ydbio.2007.09.059; Sivakumar S, 2007, J BIOL CHEM, V282, P7312, DOI 10.1074/jbc.M607442200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tenllado F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-3; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005; Zimoch L, 2005, INSECT BIOCHEM MOLEC, V35, P515, DOI 10.1016/j.ibmb.2005.01.008	38	261	309	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6225	10.1371/journal.pone.0006225	http://dx.doi.org/10.1371/journal.pone.0006225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19381341	Green Submitted, gold, Green Published			2022-12-27	WOS:000268035400009
J	Wang, YF; Chen, ZL; Qiao, F; Ying, TY; Yuan, J; Zhong, ZJ; Zhou, L; Du, XY; Wang, ZJ; Zhao, J; Dong, SC; Jia, LL; Yuan, XT; Yang, RF; Sun, YS; Huang, LY				Wang, Yufei; Chen, Zeliang; Qiao, Feng; Ying, Tianyi; Yuan, Jing; Zhong, Zhijun; Zhou, Lei; Du, Xinying; Wang, Zhoujia; Zhao, Jin; Dong, Shicun; Jia, Leili; Yuan, Xitong; Yang, Ruifu; Sun, Yansong; Huang, Liuyu			Comparative Proteomics Analyses Reveal the virB of B-melitensis Affects Expression of Intracellular Survival Related Proteins	PLOS ONE			English	Article							HIGH-TEMPERATURE-REQUIREMENT; OUTER-MEMBRANE PROTEIN; BRUCELLA-ABORTUS; ESCHERICHIA-COLI; TRIGGER FACTOR; HEAT-SHOCK; IN-VIVO; HTRA; SUIS; IDENTIFICATION	Backgound: Brucella melitensis is a facultative, intracellular, pathogenic bacterium that replicates within macrophages. The type IV secretion system encoded by the virB operon (virB) is involved in Brucella intracellular survival. However, the underlying molecular mechanisms, especially the target proteins affected by the virB, remain largely unclear. Methodology/Principal Findings: In order to define the proteins affected by virB, the proteomes of wild-type and the virB mutant were compared under in vitro conditions where virB was highly activated. The differentially expressed proteins were identified by MALDI-TOF-MS. Forty-four down-regulated and eighteen up-regulated proteins which exhibited a 2-fold or greater change were identified. These proteins included those involved in amino acid transport and metabolism, lipid metabolism, energy production, cell membrane biogenesis, translation, post-translational modifications and protein turnover, as well as unknown proteins. Interestingly, several important virulence related proteins involved in intracellular survival, including VjbR, DnaK, HtrA, Omp25, and GntR, were down-regulated in the virB mutant. Transcription analysis of virB and vjbR at different growth phase showed that virB positively affect transcription of vjbR in a growth phase dependent manner. Quantitative RT-PCR showed that transcription of these genes was also affected by virB during macrophage cell infection, consistent with the observed decreased survival of the virB mutant in macrophage. Conclusions/Significance: These data indicated that the virB operon may control the intracellular survival of Brucella by affecting the expression of relevant proteins.			Wang, YF (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China.	Zeliangchen@yahoo.com; Huangly@nic.bmi.ac.cn		Qian, Pei-Yuan/0000-0003-4074-9078; wang, yong/0000-0003-3595-3867				Billard E, 2005, INFECT IMMUN, V73, P8418, DOI 10.1128/IAI.73.12.8418-8424.2005; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; CLOECKAERT A, 1992, J GEN MICROBIOL, V138, P1543, DOI 10.1099/00221287-138-7-1543; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Delrue RM, 2005, CELL MICROBIOL, V7, P1151, DOI 10.1111/j.1462-5822.2005.00543.x; Edmonds MD, 2002, RES VET SCI, V72, P235, DOI 10.1053/rvsc.2002.0555; Edmonds MD, 2002, VET MICROBIOL, V88, P205, DOI 10.1016/S0378-1135(02)00110-4; Edmonds MD, 2001, AM J VET RES, V62, P1461, DOI 10.2460/ajvr.2001.62.1461; ELZER PH, 1994, INFECT IMMUN, V62, P4135, DOI 10.1128/IAI.62.10.4135-4139.1994; ELZER PH, 1995, PLASMID, V33, P51, DOI 10.1006/plas.1995.1006; Elzer PH, 1996, INFECT IMMUN, V64, P4838, DOI 10.1128/IAI.64.11.4838-4841.1996; GEISOW MJ, 1981, J CELL BIOL, V89, P645, DOI 10.1083/jcb.89.3.645; Haine V, 2005, INFECT IMMUN, V73, P5578, DOI 10.1128/IAI.73.9.5578-5586.2005; Jubier-Maurin V, 2001, INFECT IMMUN, V69, P4823, DOI 10.1128/IAI.69.8.4823-4830.2001; Ko JY, 2003, CLIN MICROBIOL REV, V16, P65, DOI 10.1128/CMR.16.1.65-78.2003; Kohler S, 1996, MOL MICROBIOL, V20, P701, DOI 10.1111/j.1365-2958.1996.tb02510.x; Kohler S, 2002, INFECT IMMUN, V70, P1631, DOI 10.1128/IAI.70.3.1631-1634.2002; Kulakov YK, 1997, RES MICROBIOL, V148, P145, DOI 10.1016/S0923-2508(97)87645-0; Laskowska E, 1996, MOL MICROBIOL, V22, P555, DOI 10.1046/j.1365-2958.1996.1231493.x; Li SR, 1996, INFECT IMMUN, V64, P2088, DOI 10.1128/IAI.64.6.2088-2094.1996; LIN JS, 1995, INFECT IMMUN, V63, P1409, DOI 10.1128/IAI.63.4.1409-1414.1995; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda H, 1996, BIOL CHEM H-S, V377, P217; Nijskens C, 2008, MICROB PATHOGENESIS, V45, P134, DOI 10.1016/j.micpath.2008.04.005; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Phillips RW, 1997, RES VET SCI, V63, P165, DOI 10.1016/S0034-5288(97)90012-6; PITT A, 1992, J CLIN INVEST, V90, P1978, DOI 10.1172/JCI116077; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Taminiau B, 2002, INFECT IMMUN, V70, P3004, DOI 10.1128/IAI.70.6.3004-3011.2002; Teixeira-Gomes AP, 2000, INFECT IMMUN, V68, P2954, DOI 10.1128/IAI.68.5.2954-2961.2000; Uzureau S, 2007, J BACTERIOL, V189, P6035, DOI 10.1128/JB.00265-07; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Yamamoto T, 1996, INFECT IMMUN, V64, P2980, DOI 10.1128/IAI.64.8.2980-2987.1996; Yang XH, 2007, VACCINE, V25, P2261, DOI 10.1016/j.vaccine.2006.12.004	40	243	259	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5368	10.1371/journal.pone.0005368	http://dx.doi.org/10.1371/journal.pone.0005368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401764	gold, Green Published, Green Submitted			2022-12-27	WOS:000265601100011
J	Tian, Z; Palmer, N; Schmid, P; Yao, H; Galdzicki, M; Berger, B; Wu, EX; Kohane, IS				Tian, Ze; Palmer, Nathan; Schmid, Patrick; Yao, Hui; Galdzicki, Michal; Berger, Bonnie; Wu, Erxi; Kohane, Isaac S.			A Practical Platform for Blood Biomarker Study by Using Global Gene Expression Profiling of Peripheral Whole Blood	PLOS ONE			English	Article							OLIGONUCLEOTIDE ARRAY DATA; MESSENGER-RNA REDUCTION; SAMPLES; CELLS; PCR	Background: Although microarray technology has become the most common method for studying global gene expression, a plethora of technical factors across the experiment contribute to the variable of genome gene expression profiling using peripheral whole blood. A practical platform needs to be established in order to obtain reliable and reproducible data to meet clinical requirements for biomarker study. Methods and Findings: We applied peripheral whole blood samples with globin reduction and performed genome-wide transcriptome analysis using Illumina BeadChips. Real-time PCR was subsequently used to evaluate the quality of array data and elucidate the mode in which hemoglobin interferes in gene expression profiling. We demonstrated that, when applied in the context of standard microarray processing procedures, globin reduction results in a consistent and significant increase in the quality of beadarray data. When compared to their pre-globin reduction counterparts, post-globin reduction samples show improved detection statistics, lowered variance and increased sensitivity. More importantly, gender gene separation is remarkably clearer in post-globin reduction samples than in pre-globin reduction samples. Our study suggests that the poor data obtained from pre-globin reduction samples is the result of the high concentration of hemoglobin derived from red blood cells either interfering with target mRNA binding or giving the pseudo binding background signal. Conclusion: We therefore recommend the combination of performing globin mRNA reduction in peripheral whole blood samples and hybridizing on Illumina BeadChips as the practical approach for biomarker study.			Tian, Z (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Informat Program, Boston, MA 02115 USA.	bab@mit.edu; erxi.wu@ndsu.edu	Galdzicki, Michal/F-5682-2010; Kohane, Isaac Kohane/K-3716-2012; Tian, Honggang/AAW-4772-2020; zhang, wenqing/GYA-0786-2022; tian, ze/HDM-4308-2022; Yao, Huiqin/AAX-3787-2020	Galdzicki, Michal/0000-0002-8392-8183; Kohane, Isaac Kohane/0000-0003-2192-5160; Tian, Honggang/0000-0002-2205-0784; Yao, Huiqin/0000-0003-4742-8971; Chen, Hongxin/0000-0002-2955-4619; Wu, Erxi/0000-0002-1680-3639	NIGMS NIH HHS [R01 GM081871] Funding Source: Medline; NLM NIH HHS [2 T15 LM007092-16, T15 LM007092] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Chal V, 2005, J CLIN LAB ANAL, V19, P182, DOI 10.1002/jcla.20075; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; Debey S, 2006, GENOMICS, V87, P653, DOI 10.1016/j.ygeno.2005.11.010; Feezor RJ, 2004, PHYSIOL GENOMICS, V19, P247, DOI 10.1152/physiolgenomics.00020.2004; Field LA, 2007, CLIN BIOCHEM, V40, P499, DOI 10.1016/j.clinbiochem.2007.01.004; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Liu J, 2006, J MOL DIAGN, V8, P551, DOI 10.2353/jmoldx.2006.060021; Martin KJ, 2001, P NATL ACAD SCI USA, V98, P2646, DOI 10.1073/pnas.041622398; Osman I, 2006, CLIN CANCER RES, V12, P3374, DOI 10.1158/1078-0432.CCR-05-2081; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin LX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-23; Rainen L, 2002, CLIN CHEM, V48, P1883; Team. RDC, 2007, R LANG ENV STAT COMP; Thach DC, 2003, J IMMUNOL METHODS, V283, P269, DOI 10.1016/j.jim.2003.10.004; TIAN Z, 2008, CANC CHEMOTHER PHARM; Witten I. H., 2005, DATA MINING PRACTICA; Wright C, 2008, CLIN CHEM, V54, P396, DOI 10.1373/clinchem.2007.093419; Wu EX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003794	22	261	309	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5157	10.1371/journal.pone.0005157	http://dx.doi.org/10.1371/journal.pone.0005157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381341	Green Published, gold, Green Submitted			2022-12-27	WOS:000265510800002
J	Willemssen, R; Muller, T; Schwarz, M; Falkenstein, M; Beste, C				Willemssen, Rita; Mueller, Thomas; Schwarz, Michael; Falkenstein, Michael; Beste, Christian			Response Monitoring in De Novo Patients with Parkinson's Disease	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; COGNITIVE IMPAIRMENT; HUNTINGTONS-DISEASE; PREFRONTAL CORTEX; ERROR NEGATIVITY; DOPAMINE; TASK; SCHIZOPHRENIA; COMPENSATION; ATROPHY	Background: Parkinson's disease (PD) is accompanied by dysfunctions in a variety of cognitive processes. One of these is error processing, which depends upon phasic decreases of medial prefrontal dopaminergic activity. Until now, there is no study evaluating these processes in newly diagnosed, untreated patients with PD ("de novo PD''). Methodology/Principal Findings: Here we report large changes in performance monitoring processes using event-related potentials (ERPs) in de novo PD-patients. The results suggest that increases in medial frontal dopaminergic activity after an error (Ne) are decreased, relative to age-matched controls. In contrast, neurophysiological processes reflecting general motor response monitoring (Nc) are enhanced in de novo patients. Conclusions/Significance: It may be hypothesized that the Nc-increase is at costs of dopaminergic activity after an error; on a functional level errors may not always be detected and correct responses sometimes be misinterpreted as errors. This pattern differs from studies examining patients with a longer history of PD and may reflect compensatory processes, frequently occurring in pre-manifest stages of PD. From a clinical point of view the clearly attenuated Ne in the de novo PD patients may prove a useful additional tool for the early diagnosis of basal ganglia dysfunction in PD.	[Willemssen, Rita; Falkenstein, Michael; Beste, Christian] WHO Collaborating Res Ctr Dortmund, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Mueller, Thomas] St Joseph Hosp, Klin Weissensee, Dept Neurol, Berlin, Germany; [Schwarz, Michael] Klin Dortmund, Dept Neurol, Dortmund, Germany; [Beste, Christian] Ruhr Univ Bochum, Inst Cognitive Neurosci Biopsychol, Bochum, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Klinikum Dortmund; Ruhr University Bochum	Willemssen, R (corresponding author), WHO Collaborating Res Ctr Dortmund, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	willemssen@ifado.de	Falkenstein, Michael/ABA-7497-2020; Müller, Thomas/C-9317-2011; Ferrari, Davide/F-5644-2015; Di Virgilio, Francesco/J-3754-2018	Muller, Tobias/0000-0002-9801-3496; Ferrari, Davide/0000-0002-5727-9204; Di Virgilio, Francesco/0000-0003-3566-1362	Deutsche Forschungsgemeinschaft (DFG) [FA 211/16-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grant FA 211/16-1 to 3 from the Deutsche Forschungsgemeinschaft (DFG). No other financial and material support for this research and work was obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2002, CEREB CORTEX, V12, P840, DOI 10.1093/cercor/12.8.840; Allain S, 2004, NEUROSCI LETT, V372, P161, DOI 10.1016/j.neulet.2004.09.036; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Bartholow BD, 2005, PSYCHOPHYSIOLOGY, V42, P33, DOI 10.1111/j.1469-8986.2005.00258.x; BEST C, 2004, PLOS ONE, V1, pE86; Beste C, 2008, HUM BRAIN MAPP, V29, P121, DOI 10.1002/hbm.20374; Beste C, 2007, NEUROPSYCHOLOGIA, V45, P2922, DOI 10.1016/j.neuropsychologia.2007.06.004; Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; Brenneis C, 2003, MOVEMENT DISORD, V18, P1132, DOI 10.1002/mds.10502; Bruck A, 2004, J NEUROL NEUROSUR PS, V75, P1467, DOI 10.1136/jnnp.2003.031237; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Eppinger B, 2007, BIOL PSYCHOL, V75, P52, DOI 10.1016/j.biopsycho.2006.12.001; Fahn S., 1987, RECENT DEV PARKINSON, P153; Falkenstein M, 2001, NEUROREPORT, V12, P157, DOI 10.1097/00001756-200101220-00039; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, P192; Ford JM, 1999, PSYCHOPHYSIOLOGY, V36, P667, DOI 10.1111/1469-8986.3660667; Gehring W. J., 1990, PSYCHOPHYSIOLOGY, V27, pS34, DOI DOI 10.1111/J.1469-8986.1990.TB02175.X; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Hautzinger M., 1995, BECK DEPRESSIONS INV; Heaton R., 2003, WCST CV4 WISCONSIN C; Holroyd CB, 2002, NEUROPSYCHOLOGIA, V40, P2116, DOI 10.1016/S0028-3932(02)00052-0; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Kopp B, 1996, ELECTROEN CLIN NEURO, V99, P19, DOI 10.1016/0921-884X(96)95617-9; Lehrl S., 1977, MEHRFACHWAHL WORTSCH; Mathalon DH, 2002, J ABNORM PSYCHOL, V111, P22, DOI 10.1037//0021-843X.111.1.22; Mathewson KJ, 2005, BIOL PSYCHOL, V70, P88, DOI 10.1016/j.biopsycho.2004.12.005; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Muller T, 2000, J NEUROL SCI, V181, P98, DOI 10.1016/S0022-510X(00)00436-6; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; Nieuwenhuis S, 2002, COGN AFFECT BEHAV NE, V2, P19, DOI 10.3758/CABN.2.1.19; Perez XA, 2008, J NEUROCHEM, V105, P1861, DOI 10.1111/j.1471-4159.2008.05268.x; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Stemmer B, 2007, CLIN NEUROPHYSIOL, V118, P1223, DOI 10.1016/j.clinph.2007.02.019; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; Willemssen R, 2008, J NEURAL TRANSM, V115, P461, DOI 10.1007/s00702-007-0842-1; Willemssen R, 2004, PSYCHOPHYSIOLOGY, V41, P762, DOI 10.1111/j.1469-8986.2004.00201.x; Yordanova J, 2004, NEUROIMAGE, V22, P590, DOI 10.1016/j.neuroimage.2004.01.040	38	163	173	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e4898	10.1371/journal.pone.0004898	http://dx.doi.org/10.1371/journal.pone.0004898			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PO	19325909	Green Published, gold			2022-12-27	WOS:000265499600002
